<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26349842</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>11</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of the association between preoperative anaemia and mortality after surgery.</ArticleTitle><Pagination><StartPage>1314</StartPage><EndPage>1324</EndPage><MedlinePgn>1314-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.9861</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Numerous published studies have explored associations between anaemia and adverse outcomes after surgery. However, there are no evidence syntheses describing the impact of preoperative anaemia on postoperative outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis of observational studies exploring associations between preoperative anaemia and postoperative outcomes was performed. Studies investigating trauma, burns, transplant, paediatric and obstetric populations were excluded. The primary outcome was 30-day or in-hospital mortality. Secondary outcomes were acute kidney injury, stroke and myocardial infarction. Predefined analyses were performed for the cardiac and non-cardiac surgery subgroups. A post hoc analysis was undertaken to evaluate the relationship between anaemia and infection. Data are presented as odds ratios (ORs) with 95 per cent c.i.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From 8973 records, 24 eligible studies including 949&#x2009;445 patients were identified. Some 371&#x2009;594 patients (39&#xb7;1 per cent) were anaemic. Anaemia was associated with increased mortality (OR 2&#xb7;90, 2&#xb7;30 to 3&#xb7;68; I(2) &#x2009;=&#x2009;97 per cent; P&#x2009;&lt;&#x2009;0&#xb7;001), acute kidney injury (OR 3&#xb7;75, 2&#xb7;95 to 4&#xb7;76; I(2) &#x2009;=&#x2009;60 per cent; P&#x2009;&lt;&#x2009;0&#xb7;001) and infection (OR 1&#xb7;93, 1&#xb7;17 to 3&#xb7;18; I(2) &#x2009;=&#x2009;99 per cent; P&#x2009;=&#x2009;0&#xb7;01). Among cardiac surgical patients, anaemia was associated with stroke (OR 1&#xb7;28, 1&#xb7;06 to 1&#xb7;55; I(2) &#x2009;=&#x2009;0 per cent; P&#x2009;=&#x2009;0&#xb7;009) but not myocardial infarction (OR 1&#xb7;11, 0&#xb7;68 to 1&#xb7;82; I(2) &#x2009;=&#x2009;13 per cent; P&#x2009;=&#x2009;0&#xb7;67). Anaemia was associated with an increased incidence of red cell transfusion (OR 5&#xb7;04, 4&#xb7;12 to 6&#xb7;17; I(2) &#x2009;=&#x2009;96 per cent; P&#x2009;&lt;&#x2009;0&#xb7;001). Similar findings were observed in the cardiac and non-cardiac subgroups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Preoperative anaemia is associated with poor outcomes after surgery, although heterogeneity between studies was significant. It remains unclear whether anaemia is an independent risk factor for poor outcome or simply a marker of underlying chronic disease. However, red cell transfusion is much more frequent amongst anaemic patients.</AbstractText><CopyrightInformation>&#xa9; 2015 BJS Society Ltd Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fowler</LastName><ForeName>A J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phull</LastName><ForeName>M K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Departments of Anaesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allard</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillies</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care and Pain Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearse</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP_2014-04-022</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26349842</ArticleId><ArticleId IdType="doi">10.1002/bjs.9861</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37280579</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Mechanical ventilation in patients with acute brain injury: a systematic review with meta-analysis.</ArticleTitle><Pagination><StartPage>221</StartPage><MedlinePgn>221</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">221</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04509-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To describe the potential effects of ventilatory strategies on the outcome of acute brain-injured patients undergoing invasive mechanical ventilation.</AbstractText><AbstractText Label="DESIGN">Systematic review with an individual data meta-analysis.</AbstractText><AbstractText Label="SETTING">Observational and interventional (before/after) studies published up to August 22nd, 2022, were considered for inclusion. We investigated the effects of low tidal volume Vt&#x2009;&lt;&#x2009;8&#xa0;ml/Kg of IBW versus Vt&#x2009;&gt;&#x2009;&#x2009;=&#x2009;8&#xa0;ml/Kg of IBW, positive end-expiratory pressure (PEEP)&#x2009;&lt;&#x2009;or&#x2009;&gt;&#x2009;&#x2009;=&#x2009;5 cmH<sub>2</sub>O and protective ventilation (association of both) on relevant clinical outcomes.</AbstractText><AbstractText Label="POPULATION">Patients with acute brain injury (trauma or haemorrhagic stroke) with invasive mechanical ventilation for&#x2009;&#x2265;&#x2009;24&#xa0;h.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcome was mortality at 28&#xa0;days or in-hospital mortality. Secondary outcomes were the incidence of acute respiratory distress syndrome (ARDS), the duration of mechanical ventilation and the partial pressure of oxygen (PaO<sub>2</sub>)/fraction of inspired oxygen (FiO<sub>2</sub>) ratio.</AbstractText><AbstractText Label="RESULTS">The meta-analysis included eight studies with a total of 5639 patients. There was no difference in mortality between low and high tidal volume [Odds Ratio, OR 0.88 (95%Confidence Interval, CI 0.74 to 1.05), p&#x2009;=&#x2009;0.16, I<sup>2</sup>&#x2009;=&#x2009;20%], low and moderate to high PEEP [OR 0.8 (95% CI 0.59 to 1.07), p&#x2009;=&#x2009;0.13, I<sup>2</sup>&#x2009;=&#x2009;80%] or protective and non-protective ventilation [OR 1.03 (95% CI 0.93 to 1.15), p&#x2009;=&#x2009;0.6, I<sup>2</sup>&#x2009;=&#x2009;11]. Low tidal volume [OR 0.74 (95% CI 0.45 to 1.21, p&#x2009;=&#x2009;0.23, I<sup>2</sup>&#x2009;=&#x2009;88%], moderate PEEP [OR 0.98 (95% CI 0.76 to 1.26), p&#x2009;=&#x2009;0.9, I<sup>2</sup>&#x2009;=&#x2009;21%] or protective ventilation [OR 1.22 (95% CI 0.94 to 1.58), p&#x2009;=&#x2009;0.13, I<sup>2</sup>&#x2009;=&#x2009;22%] did not affect the incidence of acute respiratory distress syndrome. Protective ventilation improved the PaO<sub>2</sub>/FiO<sub>2</sub> ratio in the first five days of mechanical ventilation (p&#x2009;&lt;&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSIONS">Low tidal volume, moderate to high PEEP, or protective ventilation were not associated with mortality and lower incidence of ARDS in patients with acute brain injury undergoing invasive mechanical ventilation. However, protective ventilation improved oxygenation and could be safely considered in this setting. The exact role of ventilatory management on the outcome of patients with a severe brain injury needs to be more accurately delineated.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asehnoune</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France. karim.asehnoune@chu-nantes.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, H&#xf4;tel-Dieu, University Hospital of Nantes, 1 Place Alexis Ricordeau, 44093, Nantes, France. karim.asehnoune@chu-nantes.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rooze</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Robba</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care, San Martino Policlinico Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouras</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascia</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinotti</LastName><ForeName>Rapha&#xeb;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, 44000, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care, San Martino Policlinico Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roquilly</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, 44000, Nantes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="Y">Brain Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Dr Cinotti has received consulting fees for PAION outside the scope of the study. Dr Roquilly reported receiving grants and consulting fees from Merck and bioM&#xe9;rieux outside the scope of the study. Dr Asehnoune reported receiving lecture fees from Baxter, Fisher &amp; Paykel, and LFB and consulting fees from Edwards Lifesciences and LFB, outside the scope of this study. The other authors do not have any conflict of interest to declare. No competing interest is to be declared regarding the present work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>6</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37280579</ArticleId><ArticleId IdType="pmc">PMC10242967</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04509-3</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04509-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collaborators G. TBI and SCI (2019) Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2016;18:56&#x2013;87. doi: 10.1016/s1474-4422(18)30415-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30415-0</ArticleId><ArticleId IdType="pmc">PMC6291456</ArticleId><ArticleId IdType="pubmed">30497965</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877&#x2013;897. 10.1016/s1474-4422(17)30299-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641502</ArticleId><ArticleId IdType="pubmed">28931491</ArticleId></ArticleIdList></Reference><Reference><Citation>Roquilly A, Cinotti R, Jaber S, et al. Implementation of an evidence-based extubation readiness bundle in 499 brain-injured patients. a before-after evaluation of a quality improvement project. Am J Respir Crit Care Med. 2013;188:958&#x2013;966. doi: 10.1164/rccm.201301-0116oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201301-0116oc</ArticleId><ArticleId IdType="pubmed">23927561</ArticleId></ArticleIdList></Reference><Reference><Citation>Beduneau G, Pham T, Schortgen F, et al. Epidemiology of weaning outcome according to a new definition. The WIND Study. Am J Respir Crit Care Med. 2016 doi: 10.1164/rccm.201602-0320oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201602-0320oc</ArticleId><ArticleId IdType="pubmed">27626706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascia L, Andrews PJ. Acute lung injury in head trauma patients. Intensive Care Med. 1998;24:1115&#x2013;1116. doi: 10.1007/s001340050727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050727</ArticleId><ArticleId IdType="pubmed">9840251</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARDS Definition Task Force*. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526&#x2013;2533 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Cardoso SO, Manetta JA, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA J Am Med Assoc. 2012;308:1651&#x2013;1659. doi: 10.1001/jama.2012.13730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13730</ArticleId><ArticleId IdType="pubmed">23093163</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban A, Ferguson ND, Meade MO, et al. Evolution of mechanical ventilation in response to clinical research. Am J Respir Crit Care Med. 2008;177:170&#x2013;177. doi: 10.1164/rccm.200706-893oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200706-893oc</ArticleId><ArticleId IdType="pubmed">17962636</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Ferguson ND, Frutos-Vivar F, et al. Management and outcome of mechanically ventilated neurologic patients*. Crit Care Med. 2011;39:1482&#x2013;1492. doi: 10.1097/ccm.0b013e31821209a8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0b013e31821209a8</ArticleId><ArticleId IdType="pubmed">21378554</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Mrozek S, Perrigault PF, et al. A multi-faceted strategy to reduce ventilation-associated mortality in brain-injured patients. The BI-VILI project: a nationwide quality improvement project. Intensive Care Med. 2017;287:345&#x2013;414. doi: 10.1007/s00134-017-4764-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4764-6</ArticleId><ArticleId IdType="pubmed">28315940</ArticleId></ArticleIdList></Reference><Reference><Citation>Picetti E, Pelosi P, Taccone FS, et al. VENTILatOry strategies in patients with severe traumatic brain injury: the VENTILO survey of the European society of intensive care medicine (ESICM) Crit Care. 2020;24:158. doi: 10.1186/s13054-020-02875-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02875-w</ArticleId><ArticleId IdType="pmc">PMC7165367</ArticleId><ArticleId IdType="pubmed">32303255</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Higgins JPT, Hedges LV, Rothstein HR. Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res Synth Methods. 2017;8:5&#x2013;18. doi: 10.1002/jrsm.1230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1230</ArticleId><ArticleId IdType="pubmed">28058794</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Lasocki S, Seguin P, et al. Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury&#x2014;a multicentre prospective cohort study and systematic review. Crit Care. 2017;21:2383&#x2013;2411. doi: 10.1186/s13054-017-1918-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1918-4</ArticleId><ArticleId IdType="pmc">PMC5745762</ArticleId><ArticleId IdType="pubmed">29282104</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Seguin P, Lasocki S, et al. Extubation success prediction in a multicentric cohort of patients with severe brain injury. Anesthesiology. 2017;127:338&#x2013;346. doi: 10.1097/aln.0000000000001725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000001725</ArticleId><ArticleId IdType="pubmed">28640020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasocki S, Chudeau N, Papet T, et al. Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study. Crit Care. 2014;18:542. doi: 10.1186/s13054-014-0542-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0542-9</ArticleId><ArticleId IdType="pmc">PMC4219000</ArticleId><ArticleId IdType="pubmed">25529060</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Poole D, McNett M, et al. Mechanical ventilation in patients with acute brain injury: recommendations of the European society of intensive care medicine consensus. Intens Care Med. 2020;14:S261&#x2013;S314. doi: 10.1007/s00134-020-06283-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06283-0</ArticleId><ArticleId IdType="pmc">PMC7655906</ArticleId><ArticleId IdType="pubmed">33175276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesnut RM, Temkin N, Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367:2471&#x2013;2481. doi: 10.1056/nejmoa1207363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1207363</ArticleId><ArticleId IdType="pmc">PMC3565432</ArticleId><ArticleId IdType="pubmed">23234472</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth M, Thom&#xe9; C, Schmiedek,, et al. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants: clinical article. J Neurosurg. 2009;110:955&#x2013;960. doi: 10.3171/2008.2.17670.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2008.2.17670</ArticleId><ArticleId IdType="pubmed">19216650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Dionne S, Simard S, et al. High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology. 2012;116:1072&#x2013;1082. doi: 10.1097/aln.0b013e3182522df5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0b013e3182522df5</ArticleId><ArticleId IdType="pubmed">22450472</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301&#x2013;8. 10.1056/nejm200005043421801</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Dianti J, Tisminetzky M, Ferreyro BL, et al. Association of positive end-expiratory pressure and lung recruitment selection strategies with mortality in acute respiratory distress syndrome: a systematic review and network meta-analysis. Am J Resp Crit Care. 2022;205:1300&#x2013;1310. doi: 10.1164/rccm.202108-1972oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1972oc</ArticleId><ArticleId IdType="pubmed">35180042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball, L., Serpa Neto, A., Trifiletti, V. et al. Effects of higher PEEP and recruitment manoeuvres on mortality in patients with ARDS: a systematic review, meta-analysis, meta-regression and trial sequential analysis of randomized controlled trials. Intens Care Med Exp 8:39 10.1186/s40635-020-00322-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746429</ArticleId><ArticleId IdType="pubmed">33336325</ArticleId></ArticleIdList></Reference><Reference><Citation>Albaiceta GM, Brochard L, Santos CCD, et al. The central nervous system during lung injury and mechanical ventilation: a narrative review. Brit J Anaesth. 2021;127:648&#x2013;659. doi: 10.1016/j.bja.2021.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.05.038</ArticleId><ArticleId IdType="pubmed">34340836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina E, Pelosi P, Muriel A, et al. Association between ventilatory settings and development of acute respiratory distress syndrome in mechanically ventilated patients due to brain injury. J Crit Care. 2017;38:341&#x2013;345. doi: 10.1016/j.jcrc.2016.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.11.010</ArticleId><ArticleId IdType="pubmed">27914908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006 doi: 10.1097/01.ccm.0000201903.46435.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000201903.46435.35</ArticleId><ArticleId IdType="pubmed">16521258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn JM, Caldwell EC, Deem S, et al. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med. 2006;34:196&#x2013;202. doi: 10.1097/01.ccm.0000194540.44020.8e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000194540.44020.8e</ArticleId><ArticleId IdType="pubmed">16374174</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators WG for the Pr, Simonis FD, Neto AS et al. Effect of a low vs. intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: a randomized clinical trial. JAMA 2018;320:1872. 10.1001/jama.2018.14280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248136</ArticleId><ArticleId IdType="pubmed">30357256</ArticleId></ArticleIdList></Reference><Reference><Citation>Group WC and SC for the RelaC. Algera AG, Pisani L, et al. Effect of a lower vs. higher positive end-expiratory pressure strategy on ventilator-free days in ICU patients without ARDS. JAMA. 2020;324:2509&#x2013;2520. doi: 10.1001/jama.2020.23517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.23517</ArticleId><ArticleId IdType="pmc">PMC7726701</ArticleId><ArticleId IdType="pubmed">33295981</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ldner A, Kiss T, Neto AS, et al. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications. Anesthesiology. 2015;123:692&#x2013;713. doi: 10.1097/aln.0000000000000754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000000754</ArticleId><ArticleId IdType="pubmed">26120769</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, et al. Effect of intraoperative low tidal volume vs. conventional tidal volume on postoperative pulmonary complications in patients undergoing major surgery. JAMA. 2020;324:848&#x2013;911. doi: 10.1001/jama.2020.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="pubmed">32870298</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos NS, Bluth T, Hemmes SNT, et al. Intraoperative positive end-expiratory pressure and postoperative pulmonary complications: a patient-level meta-analysis of three randomized clinical trials. Brit J Anaesth. 2022;128:1040&#x2013;1051. doi: 10.1016/j.bja.2022.02.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.02.039</ArticleId><ArticleId IdType="pubmed">35431038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascia L, Zavala E, Bosma K, et al. High tidal volume is associated with the development of acute lung injury after severe brain injury: an international observational study. Crit Care Med. 2007;35:1815&#x2013;1820. doi: 10.1097/01.ccm.0000275269.77467.df.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000275269.77467.df</ArticleId><ArticleId IdType="pubmed">17568331</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmer J, Hou P, Wilcox SR, et al. Acute respiratory distress syndrome after spontaneous intracerebral hemorrhage*. Crit Care Med. 2013;41:1992&#x2013;2001. doi: 10.1097/ccm.0b013e31828a3f4d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0b013e31828a3f4d</ArticleId><ArticleId IdType="pmc">PMC3752686</ArticleId><ArticleId IdType="pubmed">23760151</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemer SN, Caldeira JB, Santos RG, et al. Effects of positive end-expiratory pressure on brain tissue oxygen pressure of severe traumatic brain injury patients with acute respiratory distress syndrome: a pilot study. J Crit Care. 2015;30:1263&#x2013;1266. doi: 10.1016/j.jcrc.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.07.019</ArticleId><ArticleId IdType="pubmed">26307004</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin J-M, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428&#x2013;437. doi: 10.1056/nejmoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Seguin P, Allary J, et al. Corti-TC Study Group. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomized placebo-controlled trial. Lancet Respir Med. 2014;2(9):706&#x2013;16. 10.1016/S2213-2600(14)70144-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25066331</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadka AB, Gopinath SP, Contant CF, et al. Relationship of brain tissue PO2 to outcome after severe head injury. Crit Care Med. 1998;26(9):1576&#x2013;1581. doi: 10.1097/00003246-199809000-00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199809000-00029</ArticleId><ArticleId IdType="pubmed">9751596</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Asgari S, Gupta A, et al. Lung injury is a predictor of cerebral hypoxia and mortality in traumatic brain injury. Front Neurol. 2020;11:771. doi: 10.3389/fneur.2020.00771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00771</ArticleId><ArticleId IdType="pmc">PMC7426476</ArticleId><ArticleId IdType="pubmed">32849225</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32870298</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effect of Intraoperative Low Tidal Volume vs Conventional Tidal Volume on Postoperative Pulmonary Complications in Patients Undergoing Major Surgery: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>848</StartPage><EndPage>858</EndPage><MedlinePgn>848-858</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2020.12866</ELocationID><Abstract><AbstractText Label="IMPORTANCE">In patients who undergo mechanical ventilation during surgery, the ideal tidal volume is unclear.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether low-tidal-volume ventilation compared with conventional ventilation during major surgery decreases postoperative pulmonary complications.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Single-center, assessor-blinded, randomized clinical trial of 1236 patients older than 40 years undergoing major noncardiothoracic, nonintracranial surgery under general anesthesia lasting more than 2 hours in a tertiary hospital in Melbourne, Australia, from February 2015 to February 2019. The last date of follow-up was February 17, 2019.</AbstractText><AbstractText Label="INTERVENTIONS">Patients were randomized to receive a tidal volume of 6 mL/kg predicted body weight (n&#x2009;=&#x2009;614; low tidal volume group) or a tidal volume of 10 mL/kg predicted body weight (n&#x2009;=&#x2009;592; conventional tidal volume group). All patients received positive end-expiratory pressure (PEEP) at 5 cm H2O.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was a composite of postoperative pulmonary complications within the first 7 postoperative days, including pneumonia, bronchospasm, atelectasis, pulmonary congestion, respiratory failure, pleural effusion, pneumothorax, or unplanned requirement for postoperative invasive or noninvasive ventilation. Secondary outcomes were postoperative pulmonary complications including development of pulmonary embolism, acute respiratory distress syndrome, systemic inflammatory response syndrome, sepsis, acute kidney injury, wound infection (superficial and deep), rate of intraoperative need for vasopressor, incidence of unplanned intensive care unit admission, rate of need for rapid response team call, intensive care unit length of stay, hospital length of stay, and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">Among 1236 patients who were randomized, 1206 (98.9%) completed the trial (mean age, 63.5 years; 494 [40.9%] women; 681 [56.4%] undergoing abdominal surgery). The primary outcome occurred in 231 of 608 patients (38%) in the low tidal volume group compared with 232 of 590 patients (39%) in the conventional tidal volume group (difference, -1.3% [95% CI, -6.8% to 4.2%]; risk ratio, 0.97 [95% CI, 0.84-1.11]; P&#x2009;=&#x2009;.64). There were no significant differences in any of the secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adult patients undergoing major surgery, intraoperative ventilation with low tidal volume compared with conventional tidal volume, with PEEP applied equally between groups, did not significantly reduce pulmonary complications within the first 7 postoperative days.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ANZCTR Identifier: ACTRN12614000790640.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karalapillai</LastName><ForeName>Dharshi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellard</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearce</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chong O</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oughton</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galtieri</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Amsterdam University Medical Centres, Location AMC, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastwood</LastName><ForeName>Glenn</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):306. doi: 10.1001/jama.2020.22627.</RefSource><PMID Version="1">33464328</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):307. doi: 10.1001/jama.2020.22630.</RefSource><PMID Version="1">33464329</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):306-307. doi: 10.1001/jama.2020.22633.</RefSource><PMID Version="1">33464330</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Peyton reported receipt of personal fees from Maquet Critical Care. Dr Wilson reported receipt of personal fees from Fisher Paykel. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32870298</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pii">2770010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meara JG, Leather AJM, Hagander L, et al. . Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386(9993):569-624. doi:10.1016/S0140-6736(15)60160-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60160-X</ArticleId><ArticleId IdType="pubmed">25924834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Bustamante A, Frendl G, Sprung J, et al. . Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the Perioperative Research Network Investigators. JAMA Surg. 2017;152(2):157-166. doi:10.1001/jamasurg.2016.4065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4065</ArticleId><ArticleId IdType="pmc">PMC5334462</ArticleId><ArticleId IdType="pubmed">27829093</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118(3):317-334. doi:10.1093/bja/aex002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex002</ArticleId><ArticleId IdType="pubmed">28186222</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CC, Harris EM, Vacchiano C, et al. . Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations. Br J Anaesth. 2019;123(6):898-913. doi:10.1016/j.bja.2019.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.08.017</ArticleId><ArticleId IdType="pubmed">31587835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendixen HH, Hedley-Whyte J, Laver MB. Impaired oxygenation in surgical patients during general anesthesia with controlled ventilation: a concept of atelectasis. N Engl J Med. 1963;269:991-996. doi:10.1056/NEJM196311072691901</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196311072691901</ArticleId><ArticleId IdType="pubmed">14059732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308. doi:10.1056/NEJM200005043421801</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005043421801</ArticleId><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Cardoso SO, Manetta JA, et al. . Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012;308(16):1651-1659. doi:10.1001/jama.2012.13730</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13730</ArticleId><ArticleId IdType="pubmed">23093163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zupancich E, Paparella D, Turani F, et al. . Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2005;130(2):378-383. doi:10.1016/j.jtcvs.2004.11.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2004.11.061</ArticleId><ArticleId IdType="pubmed">16077402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrigge H, Uhlig U, Baumgarten G, et al. . Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med. 2005;31(10):1379-1387. doi:10.1007/s00134-005-2767-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2767-1</ArticleId><ArticleId IdType="pubmed">16132888</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Miranda D, Gommers D, Struijs A, et al. . Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg. 2005;28(6):889-895. doi:10.1016/j.ejcts.2005.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.10.007</ArticleId><ArticleId IdType="pubmed">16271479</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, et al. ; IMPROVE Study Group . A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428-437. doi:10.1056/NEJMoa1301082</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanderer JP, Blum JM, Ehrenfeld JM. Intraoperative low-tidal-volume ventilation. N Engl J Med. 2013;369(19):1861. doi:10.1056/NEJMc1311316</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1311316</ArticleId><ArticleId IdType="pubmed">24195560</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW. Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth. 2014;113(1):97-108. doi:10.1093/bja/aeu054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu054</ArticleId><ArticleId IdType="pmc">PMC9585620</ArticleId><ArticleId IdType="pubmed">24623057</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Galtieri J, et al. . Current ventilation practice during general anaesthesia: a prospective audit in Melbourne, Australia. BMC Anesthesiol. 2014;14:85. doi:10.1186/1471-2253-14-85</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-14-85</ArticleId><ArticleId IdType="pmc">PMC4190393</ArticleId><ArticleId IdType="pubmed">25302048</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, et al. . Low tidal volume ventilation during anaesthesia for major surgery: protocol and statistical analysis plan. Crit Care Resusc. 2019;21(4):243-250.</Citation><ArticleIdList><ArticleId IdType="pubmed">31778630</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg L, Li M, Churilov L, et al. . Associations of fluid amount, type, and balance and acute kidney injury in patients undergoing major surgery. Anaesth Intensive Care. 2018;46(1):79-87. doi:10.1177/0310057X1804600112</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1804600112</ArticleId><ArticleId IdType="pubmed">29361260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ; PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology . High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;384(9942):495-503. doi:10.1016/S0140-6736(14)60416-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60416-5</ArticleId><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluth T, Serpa Neto A, Schultz MJ, et al. ; Writing Committee for the PROBESE Collaborative Group of the Protective Ventilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology; PROBESE Collaborative Group . Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients: a randomized clinical trial. JAMA. 2019;321(23):2292-2305. doi:10.1001/jama.2019.7505</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.7505</ArticleId><ArticleId IdType="pmc">PMC6582260</ArticleId><ArticleId IdType="pubmed">31157366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti AB, Suzumura &#xc9;A, Laranjeira LN, et al. ; Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial Investigators . Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318(14):1335-1345. doi:10.1001/jama.2017.14171</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14171</ArticleId><ArticleId IdType="pmc">PMC5710484</ArticleId><ArticleId IdType="pubmed">28973363</ArticleId></ArticleIdList></Reference><Reference><Citation>LAS VEGAS Investigators Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS&#x2014;an observational study in 29 countries. Eur J Anaesthesiol. 2017;34(8):492-507. doi:10.1097/EJA.0000000000000646</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC5502122</ArticleId><ArticleId IdType="pubmed">28633157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29370058</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>May</Month></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Permissive hypotension versus conventional resuscitation strategies in adult trauma patients with hemorrhagic shock: A systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>802</StartPage><EndPage>808</EndPage><MedlinePgn>802-808</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000001816</ELocationID><Abstract><AbstractText Label="BACKGROUND">Aggressive fluid resuscitation in trauma promotes deleterious effects such as clot disruption, dilutional coagulopathy and hypothermia. Animal studies suggest that permissive hypotension maintains appropriate organ perfusion, reduces bleeding and improves mortality. This review assesses the efficacy and safety of permissive hypotension in adult trauma patients with hemorrhagic shock.</AbstractText><AbstractText Label="METHODS">We searched the MEDLINE and EMBASE databases from inception to May 2017 for randomized controlled trials comparing permissive hypotension vs. conventional resuscitation following traumatic injury. We included preoperative and intraoperative resuscitation strategies. The primary outcome was 30-day or in-hospital mortality. Secondary outcomes included blood product utilization, estimated blood loss and in-hospital complications. Pooling was performed with a random-effects model.</AbstractText><AbstractText Label="RESULTS">We screened 722 abstracts, from which five randomized trials evaluating 1,158 patients were included. Blood pressure targets in the intervention arms varied from systolic BP 50 mm Hg to 70 mm Hg or mean arterial pressure of 50 mm Hg or higher as compared to systolic BP 65 mm Hg to 100 mm Hg or mean arterial pressure of 65 or higher in the control arms. Two studies evaluated only patients with penetrating injury while the remaining three additionally included blunt injuries. Four trials suggested a survival benefit for 30-day or in-hospital mortality with hypotensive resuscitation, although three studies were insufficiently powered to find statistical significance. Studies were of poor to moderate quality due to poor protocol reporting and lack of blinding. The pooled odds ratio was 0.70 (95% confidence interval, 0.53-0.92), suggesting a survival benefit for permissive hypotension. Those patients received fewer blood products and had lesser estimated blood loss.</AbstractText><AbstractText Label="CONCLUSION">Permissive hypotension may offer a survival benefit over conventional resuscitation for patients with hemorrhagic injury. It may additionally reduce blood loss and blood product utilization. However, the majority of studies were underpowered, thus reflecting a need for high quality, adequately powered trials.</AbstractText><AbstractText Label="PROSPERO REGISTRATION">Systematic Review, level II.CRD42017070526.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Ottawa Hospital Research Institute, Clinical Epidemiology Program (A.T.), University of Ottawa; Division of General Surgery (A.T., J.Y., J.L., M.M.), The Ottawa Hospital, Ottawa, ON; and Department of Anesthesiology (A.L.), University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yates</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lampron</LastName><ForeName>Jacinthe</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Matar</LastName><ForeName>Maher</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012771" MajorTopicYN="N">Shock, Hemorrhagic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014950" MajorTopicYN="N">Wounds, Penetrating</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29370058</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000001816</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38774674</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>102636</StartPage><MedlinePgn>102636</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102636</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2024.102636</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">General anaesthesia is provided to more than 300 million surgical patients worldwide, every year. It is administered either through total intravenous anaesthesia, using only intravenous agents, or through inhalational anaesthesia, using volatile anaesthetic agents. The debate on how this affects postoperative patient outcome is ongoing, despite an abundance of published trials. The relevance of this topic has grown by the increasing concern about the contribution of anaesthetic gases to the environmental impact of surgery. We aimed to summarise all available evidence on relevant patient outcomes with total intravenous anaesthesia versus inhalational anaesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this systematic review and meta-analysis, we searched PubMed/Medline, Embase and Cochrane Central Register of Controlled trials for works published from January 1, 1985 to August 1, 2023 for randomised controlled trials comparing total intravenous anaesthesia using propofol versus inhalational anaesthesia using the volatile anaesthetics sevoflurane, desflurane or isoflurane. Two reviewers independently screened titles, abstracts and full text articles, and assessed risk of bias using the Cochrane Collaboration tool. Outcomes were derived from a recent series of publications on consensus definitions for Standardised Endpoints for Perioperative trials (StEP). Primary outcomes covered mortality and organ-related morbidity. Secondary outcomes were related to anaesthetic and surgical morbidity. This study is registered with PROSPERO (CRD42023430492).</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">We included 317 randomised controlled trials, comprising 51,107 patients. No difference between total intravenous and inhalational anaesthesia was seen in the primary outcomes of in-hospital mortality (RR 1.05, 95% CI 0.67-1.66, 27 trials, 3846 patients), 30-day mortality (RR 0.97, 95% CI 0.70-1.36, 23 trials, 9667 patients) and one-year mortality (RR 1.14, 95% CI 0.88-1.48, 13 trials, 9317 patients). Organ-related morbidity was similar between groups except for the subgroup of elderly patients, in which total intravenous anaesthesia was associated with a lower incidence of postoperative cognitive dysfunction (RR 0.62, 95% CI 0.40-0.97, 11 trials, 3834 patients) and a better score on postoperative cognitive dysfunction tests (standardised mean difference 1.68, 95% CI 0.47-2.88, 9 trials, 4917 patients). In the secondary outcomes, total intravenous anaesthesia resulted in a lower incidence of postoperative nausea and vomiting (RR 0.61, 95% CI 0.56-0.67, 145 trials, 23,172 patients), less emergence delirium (RR 0.40, 95% CI 0.29-0.56, 32 trials, 4203 patients) and a higher quality of recovery score (QoR-40 mean difference 6.45, 95% CI 3.64-9.25, 17 trials, 1835 patients).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">The results indicate that postoperative mortality and organ-related morbidity was similar for intravenous and inhalational anaesthesia. Total intravenous anaesthesia offered advantages in postoperative recovery.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">Dutch Society for Anaesthesiology (NVA).</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kampman</LastName><ForeName>Jasper M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC Centre for Sustainable Healthcare, Amsterdam UMC, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermanides</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Markus W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilhuis</LastName><ForeName>Coenraad N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Equalis Strategy and Modeling, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloem</LastName><ForeName>Wouter Ah</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Equalis Strategy and Modeling, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schraag</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Becton-Dickinson, Winnersh, Wokingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradelli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>AdRes-Health Economics and Outcome Research, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Repping</LastName><ForeName>Sjoerd</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthcare Evaluation and Appropriate Use, National Healthcare Institute, Diemen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sperna Weiland</LastName><ForeName>Nicolaas H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC Centre for Sustainable Healthcare, Amsterdam UMC, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Environmental sustainability</Keyword><Keyword MajorTopicYN="N">Inhalational anaesthesia</Keyword><Keyword MajorTopicYN="N">Postoperative outcome</Keyword><Keyword MajorTopicYN="N">Total intravenous anaesthesia</Keyword><Keyword MajorTopicYN="N">Volatile anaesthetics</Keyword></KeywordList><CoiStatement>NSW and SR are both frequent speakers at public and private events on sustainability in healthcare, for which they have received travel reimbursements, but never any other financial payment. NSW chairs the Sustainability Taskforce of the Dutch Society for Anaesthesiology and is a member of the Sustainability Committee of the European Society for Anaesthesiology and Intensive Care (ESAIC). He is a section editor (anaesthesiology and intensive care) for the Amsterdam Medical Student Journal (AMSj). SR is a member of the advisory committee about sustainability at the University of Amsterdam. MH is section editor for Anaesthesia &amp; Analgesia, Journal of Clinical Medicine and Frontiers of Physiology, and has received research support and honorariums from BBraun, Fresenius, IDD Pharma and PAION. The other authors declare no relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>3</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38774674</ArticleId><ArticleId IdType="pmc">PMC11106536</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102636</ArticleId><ArticleId IdType="pii">S2589-5370(24)00215-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser T.G., Haynes A.B., Molina G., et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015;385(Suppl 2)</Citation><ArticleIdList><ArticleId IdType="pubmed">26313057</ArticleId></ArticleIdList></Reference><Reference><Citation>Noordzij P.G., Poldermans D., Schouten O., Bax J.J., Schreiner F.A., Boersma E. Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults. Anesthesiology. 2010;112(5):1105&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">20418691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels K., Karhausen J., Clambey E.T., Grenz A., Eltzschig H.K. Perioperative organ injury. Anesthesiology. 2013;119(6):1474&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929362</ArticleId><ArticleId IdType="pubmed">24126264</ArticleId></ArticleIdList></Reference><Reference><Citation>Semel M.E., Lipsitz S.R., Funk L.M., Bader A.M., Weiser T.G., Gawande A.A. Rates and patterns of death after surgery in the United States, 1996 and 2006. Surgery. 2012;151(2):171&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">21975292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunst G., Klein A.A. Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia. Anaesthesia. 2015;70(4):467&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402000</ArticleId><ArticleId IdType="pubmed">25764404</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagel P.S. Myocardial protection by volatile anesthetics in patients undergoing cardiac surgery: a critical review of the laboratory and clinical evidence. J&#xa0;Cardiothorac Vasc Anesth. 2013;27(5):972&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">23623887</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagel P.S., Crystal G.J. The discovery of myocardial preconditioning using volatile anesthetics: a history and contemporary clinical perspective. J&#xa0;Cardiothorac Vasc Anesth. 2018;32(3):1112&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">29398379</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Pizarro P., Koch S., Muret J., et al. Environmental sustainability in the operating room: a worldwide survey among anaesthesiologists. Eur J Anaesthesiol Intensive Care. 2023;2(4)</Citation></Reference><Reference><Citation>Pandit J.J., Andrade J., Bogod D.G., et al. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Br J Anaesth. 2014;113(4):549&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">25204697</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim A., Braat S., Hiller J., Riedel B. Inhalational versus propofol-based total intravenous anaesthesia: practice patterns and perspectives among Australasian anaesthetists. Anaesth Intensive Care. 2018;46(5):480&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">30189822</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin M.G., Chung C.K.E., Ip K.Y., Wiles M.D. Influence of propofol-based total intravenous anaesthesia on peri-operative outcome measures: a narrative review. Anaesthesia. 2020;75(Suppl 1):e90&#x2013;e100.</Citation><ArticleIdList><ArticleId IdType="pubmed">31903578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiller J.G., Perry N.J., Poulogiannis G., Riedel B., Sloan E.K. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">29283170</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G., Lomivorotov V.V., Nigro Neto C., et al. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. N&#xa0;Engl J Med. 2019;380(13):1214&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pubmed">30888743</ArticleId></ArticleIdList></Reference><Reference><Citation>Enlund M., Berglund A., Enlund A., et al. Impact of general anaesthesia on breast cancer survival: a 5-year follow up of a pragmatic, randomised, controlled trial, the CAN-study, comparing propofol and sevoflurane. eClinicalMedicine. 2023;60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10276257</ArticleId><ArticleId IdType="pubmed">37333664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler D.I., Pei L., Huang Y., et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet. 2019;394(10211):1807&#x2013;1815.</Citation><ArticleIdList><ArticleId IdType="pubmed">31645288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampman J.M., Sperna Weiland N.H. Anaesthesia and environment: impact of a green anaesthesia on economics. Curr Opin Anesthesiol. 2023;36(2):188&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9973446</ArticleId><ArticleId IdType="pubmed">36700462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman J.D., Chesebro B.B. Inhaled anaesthesia and analgesia contribute to climate change. BMJ. 2022;377</Citation><ArticleIdList><ArticleId IdType="pubmed">35675944</ArticleId></ArticleIdList></Reference><Reference><Citation>McGain F., Muret J., Lawson C., Sherman J.D. Environmental sustainability in anaesthesia and critical care. Br J Anaesth. 2020;125(5):680&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7421303</ArticleId><ArticleId IdType="pubmed">32798068</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichler P.-P., Jaccard I.S., Weisz U., Weisz H. International comparison of health care carbon footprints. Environ Res Lett. 2019;14(6)</Citation></Reference><Reference><Citation>Romanello M., Di Napoli C., Drummond P., et al. The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels. Lancet. 2022;400(10363):1619&#x2013;1654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7616806</ArticleId><ArticleId IdType="pubmed">36306815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulbaek Andersen M.P., Nielsen O.J., Sherman J.D. Assessing the potential climate impact of anaesthetic gases. Lancet Planet Health. 2023;7(7):e622&#x2013;e629.</Citation><ArticleIdList><ArticleId IdType="pubmed">37438003</ArticleId></ArticleIdList></Reference><Reference><Citation>MacNeill A.J., Lillywhite R., Brown C.J. The impact of surgery on global climate: a carbon footprinting study of operating theatres in three health systems. Lancet Planet Health. 2017;1(9):e381&#x2013;e388.</Citation><ArticleIdList><ArticleId IdType="pubmed">29851650</ArticleId></ArticleIdList></Reference><Reference><Citation>Waspe J., Orr T. Environmental risk assessment of propofol in wastewater: a narrative review of regulatory guidelines. Anaesthesia. 2023;78(3):337&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">36695328</ArticleId></ArticleIdList></Reference><Reference><Citation>White S., Fang L., Shelton C. Propofol waste and the aggregation of marginal gains in green anaesthesia. Anaesthesia. 2023;78(3):282&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">36695413</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernat M., Boyer A., Roche M., et al. Reducing the carbon footprint of general anaesthesia: a comparison of total intravenous anaesthesia vs. a mixed anaesthetic strategy in 47,157 adult patients. Anaesthesia. 2024;79(3):309&#x2013;317. [n/a(n/a)]</Citation><ArticleIdList><ArticleId IdType="pubmed">38205529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhopal A., Norheim O.F. Fair pathways to net-zero healthcare. Nat Med. 2023;29(5):1078&#x2013;1084.</Citation><ArticleIdList><ArticleId IdType="pubmed">37202559</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar G., Stendall C., Mistry R., Gurusamy K., Walker D. A&#xa0;comparison of total intravenous anaesthesia using propofol with sevoflurane or desflurane in ambulatory surgery: systematic review and meta-analysis. Anaesthesia. 2014;69(10):1138&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">24847783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanni A., Signori A., Alicino C., et al. Volatile anesthetics versus propofol for cardiac surgery with cardiopulmonary bypass: meta-analysis of randomized trials. Anesthesiology. 2020;132(6):1429&#x2013;1446.</Citation><ArticleIdList><ArticleId IdType="pubmed">32205551</ArticleId></ArticleIdList></Reference><Reference><Citation>Chui J., Mariappan R., Mehta J., Manninen P., Venkatraghavan L. Comparison of propofol and volatile agents for maintenance of anesthesia during elective craniotomy procedures: systematic review and meta-analysis. Can J Anesth. 2014;61(4):347&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">24482247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y., Pruna A., Turi S., et al. Propofol and survival: an updated meta-analysis of randomized clinical trials. Crit Care. 2023;27(1):139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10099692</ArticleId><ArticleId IdType="pubmed">37046269</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller D., Lewis S.R., Pritchard M.W., et al. Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2018;8(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6513211</ArticleId><ArticleId IdType="pubmed">30129968</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Q., Choi S.W., Wong S.S., Irwin M.G., Cheung C.W. Effects of intra-operative maintenance of general anaesthesia with propofol on postoperative pain outcomes - a systematic review and meta-analysis. Anaesthesia. 2016;71(10):1222&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">27506326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Feng L., Ji C., Lu K., Chen Y., Chen B. Inhalational versus propofol-based intravenous maintenance of anesthesia for emergence delirium in adults: a meta-analysis and trial sequential analysis. J&#xa0;Neurosurg Anesthesiol. 2023;35(2):177&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">35026799</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles P.S., Grocott M.P., Boney O., Moonesinghe S.R. Standardizing end points in perioperative trials: towards a core and extended outcome set. Br J Anaesth. 2016;116(5):586&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">27106961</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampman J.M., Plasmans K.Y.Q., Hermanides J., Hollmann M.W., Repping S., Sperna Weiland N.H. Influence of nitrous oxide added to general anaesthesia on postoperative mortality and morbidity: a systematic review and meta-analysis. Br J Anaesth. 2024 doi: 10.1016/j.bja.2024.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2024.02.011</ArticleId><ArticleId IdType="pubmed">38471989</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien P.A., Barkun J., de Oliveira M.L., et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638912</ArticleId></ArticleIdList></Reference><Reference><Citation>Gornall B.F., Myles P.S., Smith C.L., et al. Measurement of quality of recovery using the QoR-40: a quantitative systematic review. Br J Anaesth. 2013;111(2):161&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">23471753</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian P.T.H., Douglas G.A., Peter C.G., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Sch&#xfc;nemann H.J., Tugwell P., Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J&#xa0;Clin Epidemiol. 2011;64(4):380&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">21185693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X., Wang W., Liu J., Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa-Uva M., Head S.J., Milojevic M., et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardio Thorac Surg. 2018;53(1):5&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29029110</ArticleId></ArticleIdList></Reference><Reference><Citation>Amsterdam U.M.C. Client council. 2023. https://www.amsterdamumc.nl/nl/patientervaringen/clientenraad/clientenraad-team.htm</Citation></Reference><Reference><Citation>Yoshimura M., Shiramoto H., Morimoto Y., Koga M. Comparison of total intravenous with inhalational anesthesia in terms of postoperative delirium and complications in older patients: a nationwide population-based study. J&#xa0;Anesth. 2022;36(6):698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">36048263</ArticleId></ArticleIdList></Reference><Reference><Citation>Saller T., Hubig L., Seibold H., et al. Association between post-operative delirium and use of volatile anesthetics in the elderly: a real-world big data approach. J&#xa0;Clin Anesth. 2022;83</Citation><ArticleIdList><ArticleId IdType="pubmed">36084424</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Eckenhoff M.F., Eckenhoff R.G. Anesthesia and the old brain. Anesth Analg. 2010;110(2):421&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">19820235</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pan N., Ma Y., et al. Inhaled sevoflurane may promote progression of amnestic mild cognitive impairment: a prospective, randomized parallel-group study. Am J Med Sci. 2013;345(5):355&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">23044653</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zuylen M.L., Kampman J.M., Turgman O., et al. Prospective comparison of three methods for detecting peri-operative neurocognitive disorders in older adults undergoing cardiac and non-cardiac surgery. Anaesthesia. 2023;78(5):577&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">36632036</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles P.S., Myles D.B., Galagher W., Chew C., MacDonald N., Dennis A. Minimal clinically important difference for three quality of recovery scales. Anesthesiology. 2016;125(1):39&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">27159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgeat A., Wilder-Smith O.H., Saiah M., Rifat K. Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg. 1992;74(4):539&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">1554120</ArticleId></ArticleIdList></Reference><Reference><Citation>Schraag S., Pradelli L., Alsaleh A.J.O., et al. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18(1):162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225663</ArticleId><ArticleId IdType="pubmed">30409186</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingery W.S., Agashe G.S., Guo T.Z., et al. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology. 2002;96(2):367&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">11818770</ArticleId></ArticleIdList></Reference><Reference><Citation>Likhvantsev V.V., Landoni G., Levikov D.I., Grebenchikov O.A., Skripkin Y.V., Cherpakov R.A. Sevoflurane versus total intravenous anesthesia for isolated coronary artery bypass surgery with cardiopulmonary bypass: a randomized trial. J&#xa0;Cardiothorac Vasc Anesth. 2016;30(5):1221&#x2013;1227.</Citation><ArticleIdList><ArticleId IdType="pubmed">27431595</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass A., McCall P., Shelley B. Comment on Propofol and survival: an updated meta-analysis of randomized clinical trials. Crit Care. 2023;27(1):281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337079</ArticleId><ArticleId IdType="pubmed">37434188</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel J. Propofol versus the world: the whole is not always greater than the sum of its parts. Crit Care. 2023;27(1):208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230728</ArticleId><ArticleId IdType="pubmed">37254187</ArticleId></ArticleIdList></Reference><Reference><Citation>Knagg R., Dorey J., Evans R., Hitchman J. Sustainability in healthcare: patient and public perspectives. Anaesthesia. 2024;79(3):278&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">38205532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennington B.R.T., Politi M.C., Abdallah A.B., et al. A&#xa0;survey of surgical patients' perspectives and preferences towards general anesthesia techniques and shared-decision making. BMC Anesthesiol. 2023;23(1):277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10433576</ArticleId><ArticleId IdType="pubmed">37592215</ArticleId></ArticleIdList></Reference><Reference><Citation>White S.M., Shelton C.L. Abandoning inhalational anaesthesia. Anaesthesia. 2020;75(4):451&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">31531970</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernat M., Colombini N., Bouvet L., et al. Skills in total intravenous anaesthesia facilitate reduced volatile anaesthetic consumption. Br J Anaesth. 2023 doi: 10.1016/j.bja.2023.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2023.06.047</ArticleId><ArticleId IdType="pubmed">37451963</ArticleId></ArticleIdList></Reference><Reference><Citation>NOAA chemical sciences laboratory N. Summary of abundances, lifetimes, ODPs, REs, GWPs, and GTPs. 2022. https://csl.noaa.gov/assessments/ozone/2022/downloads/Annex_2022OzoneAssessment.pdf</Citation></Reference><Reference><Citation>Sherman J., Le C., Lamers V., Eckelman M. Life cycle greenhouse gas emissions of anesthetic drugs. Anesth Analg. 2012;114(5):1086&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">22492186</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel C.L., Eckelman M., Guido R., et al. Environmental impacts of surgical procedures: life cycle assessment of hysterectomy in the United States. Environ Sci Technol. 2015;49(3):1779&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4319686</ArticleId><ArticleId IdType="pubmed">25517602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocskai T., Loibl C., Vamos Z., et al. Cost-effectiveness of anesthesia maintained with sevoflurane or propofol with and without additional monitoring: a prospective, randomized controlled trial. BMC Anesthesiol. 2018;18(1):100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6064626</ArticleId><ArticleId IdType="pubmed">30055562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampmeier T., Rehberg S., Omar Alsaleh A.J., Schraag S., Pham J., Westphal M. Cost-Effectiveness of propofol (diprivan) versus inhalational anesthetics to maintain general anesthesia in noncardiac surgery in the United States. Value Health. 2021;24(7):939&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pubmed">34243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Commission EU  Reducing emissions from fluorinated gases and ozone-depleting substances. 2024. https://www.europarl.europa.eu/news/en/press-room/20240112IPR16757/reducing-emissions-from-fluorinated-gases-and-ozone-depleting-substances</Citation></Reference><Reference><Citation>Gov.Scott  Making the NHS more environmentally friendly. 2023. https://www.gov.scot/news/making-the-nhs-more-environmentally-friendly/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34297806</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Perioperative mortality in bariatric surgery: meta-analysis.</ArticleTitle><Pagination><StartPage>892</StartPage><EndPage>897</EndPage><MedlinePgn>892-897</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bjs/znab245</ELocationID><Abstract><AbstractText Label="BACKGROUND">Bariatric surgery is an established treatment for severe obesity; however, fewer than 1 per cent of eligible patients undergo surgery. The perceived risk of surgery may contribute to the low uptake. The aim of this study was to determine perioperative mortality associated with bariatric surgery, comparing different operation types and data sources.</AbstractText><AbstractText Label="METHODS">A literature search of Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials was conducted to identify studies published between 1 January 2014 and 31 July 2020. Inclusion criteria were studies of at least 1000 patients reporting short-term mortality after bariatric surgery. Data were collected on RCTs. Meta-analysis was performed to establish overall mortality rates across different study types. The primary outcome measure was perioperative mortality. Different operation types were compared, along with study type, in subgroup analyses. The study was registered at PROSPERO (2019: CRD 42019131632).</AbstractText><AbstractText Label="RESULTS">Some 4356 articles were identified and 58 met the inclusion criteria. Data were available on over 3.6 million patients. There were 4707 deaths. Pooled analysis showed an overall mortality rate of 0.08 (95 per cent c.i. 0.06 to 0.10; 95 per cent prediction interval 0 to 0.21) per cent. In subgroup analysis, there was no statistically significant difference between overall, 30-day, 90-day or in-hospital mortality (P&#x2009;=&#x2009;0.29). There was no significant difference in reported mortality for RCTs, large studies, national databases or registries (P&#x2009;=&#x2009;0.60). The pooled mortality rates by procedure type in ascending order were: 0.03 per cent for gastric band, 0.05 per cent for sleeve gastrectomy, 0.09 per cent for one-anastomosis gastric bypass, 0.09 per cent for Roux-en-Y gastric bypass, and 0.41 per cent for duodenal switch (P&#x2009;&lt;&#x2009;0.001 between operations).</AbstractText><AbstractText Label="CONCLUSION">Bariatric surgery is safe, with low reported perioperative mortality rates.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>A G N</ForeName><Initials>AGN</Initials><AffiliationInfo><Affiliation>Victoria Hospital Kirkcaldy, NHS Fife, Kirkcaldy, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Heartlands Hospital, Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>F P</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huppler</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Musgrove Park Hospital, Taunton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doleman</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>E M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0002-5018-3066</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollyman</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Musgrove Park Hospital, Taunton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welbourn</LastName><ForeName>R</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8228-526X</Identifier><AffiliationInfo><Affiliation>Musgrove Park Hospital, Taunton, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="N">Bariatric Surgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009767" MajorTopicYN="N">Obesity, Morbid</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Weight loss surgery helps patients with severe obesity. This study looked at the risk of dying after weight loss surgery in over 3.6 million patients. The risk was less than 1 in 1000 (0.08 per cent). The risk was lowest for gastric band and sleeve gastrectomy, then for gastric bypasses and highest for the duodenal switch operation. This shows that weight loss surgery is safe, with a low risk of dying similar to that of other common operations.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>17</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34297806</ArticleId><ArticleId IdType="doi">10.1093/bjs/znab245</ArticleId><ArticleId IdType="pii">6326873</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37352669</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN><JournalIssue CitedMedium="Internet"><Volume>201</Volume><PubDate><Year>2023</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Meta-Analysis and Clinical Features of Perioperative Takotsubo Cardiomyopathy in Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>78</StartPage><EndPage>85</EndPage><MedlinePgn>78-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2023.06.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9149(23)00380-6</ELocationID><Abstract><AbstractText>Perioperative takotsubo cardiomyopathy (pTCM) is an increasing condition defined as cardiomyopathy in the setting of emotional and physiologic stressors imposed by surgery. We aimed to classify and understand the presentation, management, and prognosis of noncardiac surgery pTCM in published cases. As such, a review of previous studies using the PubMed, Embase, Cochrane, and Web of Science databases was conducted to obtain case reports and series reporting noncardiac pTCM from inception to September 2022, and a crude analysis was conducted to classify the clinical features. Of the 1,002 studies, 96 met our inclusion criteria, of which 101 cases were extracted and included in the final systematic review. A total of 29.7% of cases occurred during general surgery and 20.8% during transplant procedures. The median age at presentation was 55 years, with a 42 to 65 interquartile range. The prevalence of hypertension and mood disorders were 22.8% and 9.9%, respectively. Before the procedures, physiologic stressors occurred more commonly than emotional stressors (20.8% and 11%, respectively). Objective findings, including ST-T-wave changes, new arrhythmias, and hypotension, were the most common initial presenting symptoms. Most cases occurred during emergence from surgery or on the first postoperative day. Mechanical circulatory support was required in 15.8% of the cases, and the all-cause in-hospital mortality was 6.9%. The ejection fraction and symptoms improved within a median of 2 weeks after diagnosis (interquartile range 1 to 6). In conclusion, the risk factors, triggers, and outcomes of pTCM appear to differ from those of classic nonperioperative TCM presentations. Future studies will help shed light on this more frequently diagnosed condition complicating some noncardiac surgical cases.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alhuarrat</LastName><ForeName>Majd Al Deen</ForeName><Initials>MAD</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, NYC Health&#xa0;+&#xa0;Hospitals/Jacobi Medical Center and. Electronic address: mhuarrat@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barzallo</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, NYC Health&#xa0;+&#xa0;Hospitals/Jacobi Medical Center and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Jiyoung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, NYC Health&#xa0;+&#xa0;Hospitals/Jacobi Medical Center and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naser</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, NYC Health&#xa0;+&#xa0;Hospitals/Jacobi Medical Center and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhuarrat</LastName><ForeName>Mohammad Rasoul</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Hashemite University College of Medicine, Zarqa, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minuti</LastName><ForeName>Aurelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Head, Research &amp; Education, D. Samuel Gottesman Library, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokkinidis</LastName><ForeName>Damianos G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Yale New Haven Hospital, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schizas</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054549" MajorTopicYN="Y">Takotsubo Cardiomyopathy</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of Competing Interest The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>18</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37352669</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2023.06.015</ArticleId><ArticleId IdType="pii">S0002-9149(23)00380-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36323600</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Obesity and outcomes in trauma - a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>469</StartPage><EndPage>480</EndPage><MedlinePgn>469-480</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2022.10.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(22)00795-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The physiological abnormalities relating to obesity and metabolic syndrome can contribute to worse outcomes following trauma especially in class 2 and 3 obesity. The aim of this systematic review was to determine whether patients with a higher class of obesity who suffer traumatic injury have a higher risk of worse outcomes including in-hospital mortality than normal-weight patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of MEDLINE, EMBASE, CENTRAL, Web of Science and CINAHL was performed for studies that reported a comparison of in-hospital obesity-related outcomes against normal-weight individuals aged 15 years and older following trauma. Single or multiple injuries from either blunt and/or penetrating trauma were included. Burn-related injuries, isolated head injury and studies focusing on orthopaedic related perioperative complications were excluded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The search yielded 7405 articles; 26 were included in this systematic review. 945,511 patients had a BMI&gt;30. A random-effects meta-analysis was performed for analysis of all four outcomes. Patients with class 3 obesity (BMI&gt;40) have significantly higher odds of in-hospital mortality than normal-BMI individuals following blunt and penetrating trauma (OR, 1.75; 95% CI, 1.39-2.19, p=&lt;0.00001), significantly longer hospital LOS (SMD, 0.23; 95% CI, 0.21-0.25; p&lt;0.00001) and significantly longer ICU LOS (SMD, 0.19; 95% CI, 0.12-0.26; p&lt;0.0001). In contrast, studies that examined blunt and penetrating trauma and classified obesity with a threshold of BMI&gt;30 found no significant difference in the odds of in-hospital mortality (OR, 0.94; 95% CI, 0.86-1.02, p=0.13).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a higher risk of in-hospital mortality in patients living with class 3 obesity following trauma when compared with individuals with normal BMI. The management of patients with obesity is complex and trauma systems should develop specific weight related pathways to manage and anticipate the complications that arise in these patients. Systematic review registration number PROSPERO registration: CRD42021234482 Level of Evidence: Level 3.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cromwell</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Surgery, St. Vincent's University Hospital, Dublin, Ireland. Electronic address: paulcromwell@rcsi.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Ian S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Department of Surgery, St. Vincent's University Hospital, Dublin, Ireland. Electronic address: reynoli@tcd.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heneghan</LastName><ForeName>Helen M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Surgery, St. Vincent's University Hospital, Dublin, Ireland. Electronic address: Helen.heneghan@svhg.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glasgow</LastName><ForeName>Simon M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Centre for Trauma Sciences, Blizard Institute of Cell and Molecular Biology, Queen Mary University of London, London, United Kingdom. Electronic address: s.glasgow@nhs.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014950" MajorTopicYN="Y">Wounds, Penetrating</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Body mass index</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword><Keyword MajorTopicYN="N">Trauma surgery</Keyword><Keyword MajorTopicYN="N">WHO obesity classes</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest All authors declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>23</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36323600</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2022.10.026</ArticleId><ArticleId IdType="pii">S0020-1383(22)00795-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39214800</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Analysis of Perioperative Factors Leading to Postoperative Pulmonary Complications, Graft Injury and Increased Postoperative Mortality in Lung Transplantation.</ArticleTitle><Pagination><StartPage>2712</StartPage><EndPage>2721</EndPage><MedlinePgn>2712-2721</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00521-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Postoperative complications such as postoperative pulmonary complications (PPCs) and other organ complications are associated with increased morbidity and mortality after successful lung transplantation and have a detrimental effect on patient recovery. The aim of this study was to investigate perioperative risk factors for in-hospital mortality and postoperative complications with a focus on PPC and graft injury in patients undergoing lung transplantation DESIGN: Single-center retrospective cohort study of 173 patients undergoing lung transplantation SETTING: University Hospital, Medical Center Freiburg.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">In the stepwise multivariate regression analysis, donor age &gt;60 years (odds ratio [OR], 1.85; 95% confidence interval [CI], 1.27-2.81), intraoperative extracorporeal membrane oxygenation (OR, 2.4; 95% CI, 1.7-3.3), transfusion of &gt;4 red blood cell concentrates (OR, 3.1; 95% CI, 1.82-5.1), mean pulmonary artery pressure of &gt;30 mmHg at the end of surgery (OR, 3.5; 95% CI, 2-6.3), the occurrence of postoperative graft injury (OR, 4.1; 95% CI, 2.8-5.9), PPCs (OR, 2.1; 95% CI, 1.7-2.6), sepsis (OR, 4.5; 95% CI, 2.8-7.3), and Kidney disease Improving Outcome grading system stage 3 acute renal failure (OR, 4.3; 95% CI, 2.4-7.7) were associated with increased in hospital mortality, whereas patients with chronic obstructive pulmonary disease had a lower in-hospital mortality (OR, 1.6; 95% CI, 1.4-1.9). The frequency and number of PPCs correlated with postoperative mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical management and risk stratification focusing on the underlying identified factors that could help to improve patient outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Axel</LastName><ForeName>Semmelmann</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany. Electronic address: axel.semmelmann@uniklinik-freiburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moneke</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Autenrieth</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baar</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loop</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="Y">Lung Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung transplantation</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">anesthesia for lung transplantation</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">postoperative pulmonary complications</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>30</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39214800</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.08.002</ArticleId><ArticleId IdType="pii">S1053-0770(24)00521-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24740486</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4626</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract</Title><ISOAbbreviation>J Gastrointest Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of laparoscopic versus open distal gastrectomy.</ArticleTitle><Pagination><StartPage>1087</StartPage><EndPage>1099</EndPage><MedlinePgn>1087-99</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11605-014-2519-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Laparoscopic distal gastrectomy has been increasingly utilized in the treatment of gastric adenocarcinoma. This study aims to compare the morbidity/mortality and postoperative outcomes of laparoscopic-assisted versus open distal gastrectomy since 2000.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search of MEDLINE and EMBASE was conducted including studies published between 2000 and present.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen studies with a total of 7,109 distal gastrectomies (3,496 lap vs 3,613 open) were included. Across all studies, postoperative morbidity rates for laparoscopic gastrectomy were lower than that of open [median (range) 10 (0-36)&#x2009;% vs 17 (0-43)&#x2009;%]. Meta-analysis of postoperative morbidity rates in prospective studies only yielded pooled odds ratio of 0.52 (95&#xa0;% CI 0.33-0.81) (P&#x2009;=&#x2009;0.004). In-hospital mortality rates were comparable between the two (range: laparoscopic 0-3.3 vs open 0-6.7&#xa0;%). The long-term oncological outcomes of resection were difficult to analyze given variable reporting but appeared similar between the two. Meta-analysis of prospective studies showed that laparoscopic-assisted distal gastrectomy was associated with significantly shorter hospital length of stay [standard mean difference (SMD)&#x2009;=&#x2009;-0.78 (95&#xa0;% CI&#x2009;=&#x2009;-1.0 to -0.56)], comparable intraoperative bleeding [SMD&#x2009;=&#x2009;0.64 (95&#xa0;% CI&#x2009;=&#x2009;-1.3-0.0430) P&#x2009;=&#x2009;0.066] and longer operative time compared to open gastrectomy [1.9 (95&#xa0;% CI 0.05-3.8) P&#x2009;=&#x2009;0.045, with P&#x2009;&lt;&#x2009;0.001].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study supports the use of laparoscopic-assisted distal gastrectomy for treatment of gastric adenocarcinoma with evidence of comparable, if not better, short-term postoperative parameters when compared to open distal gastrectomy. The long-term oncological outcomes appear similar but may require more evaluation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Qiuye</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Surgery, Westmead Hospital, PO Box 533, Wentworthville, NSW, 2145, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Tony C Y</ForeName><Initials>TC</Initials></Author><Author ValidYN="Y"><LastName>Hollands</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Arthur J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Pleass</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Emma S</ForeName><Initials>ES</Initials></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Vincent W T</ForeName><Initials>VW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Gastrointest Surg</MedlineTA><NlmUniqueID>9706084</NlmUniqueID><ISSNLinking>1091-255X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005743" MajorTopicYN="N">Gastrectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24740486</ArticleId><ArticleId IdType="doi">10.1007/s11605-014-2519-z</ArticleId><ArticleId IdType="pii">S1091-255X(23)04638-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Surg Endosc. 2005 Feb;19(2):168-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15580441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2012 Jul;256(1):39-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22664559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2009 Jun;16(6):1507-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19347407</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2012 Mar;26(3):804-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22002202</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2008 Jan;22(1):81-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17479314</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2000 Jan;14(1):27-31</Citation><ArticleIdList><ArticleId IdType="pubmed">10653231</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Surg. 2011;100(2):86-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21737383</ArticleId></ArticleIdList></Reference><Reference><Citation>J Laparoendosc Adv Surg Tech A. 2006 Apr;16(2):119-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16646700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 1999 Jan-Feb;6(1):46-56</Citation><ArticleIdList><ArticleId IdType="pubmed">10030415</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2011 Feb;35(2):357-64</Citation><ArticleIdList><ArticleId IdType="pubmed">21104250</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2005 Dec 21;11(47):7508-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16437724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Mar;251(3):417-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20160637</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2005 Mar;137(3):317-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15746786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2013 Apr;257(4):640-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23023204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2005 Feb;241(2):232-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15650632</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2008 May;22(5):1161-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18322744</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2001 Feb;44(2):207-14; discussion 214-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11227937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Surg. 2010;27(4):291-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20689290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1999 Jan;229(1):49-54</Citation><ArticleIdList><ArticleId IdType="pubmed">9923799</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2000 Jul;135(7):806-10</Citation><ArticleIdList><ArticleId IdType="pubmed">10896374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Surg. 2011;28(4):245-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21654172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2008 Nov;248(5):721-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18948798</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2006 Nov;20(11):1738-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17024529</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2009 Jun 20;122(12):1404-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19567161</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2011 Jan;25(1):140-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20535499</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Today. 2010 Mar;40(3):228-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20180075</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1999 Apr;86(4):541-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10215833</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastric Cancer. 2001;4(2):93-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11706767</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2013 Oct;37(10):2379-86</Citation><ArticleIdList><ArticleId IdType="pubmed">23783252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27919293</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>395</StartPage><MedlinePgn>395</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">395</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several studies suggest beneficial effects of perioperative statin therapy on postoperative outcome after cardiac surgery. However, recent randomized controlled trials (RCTs) show potential detrimental effects. The objective of this systematic review is to examine the association between perioperative statin therapy and clinical outcomes in cardiac surgery patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched up to 1 November 2016 for RCTs of preoperative statin therapy versus placebo or no treatment in adult cardiac surgery. Postoperative outcomes were acute kidney injury, atrial fibrillation, myocardial infarction, stroke, infections, and mortality. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using fixed-effects meta-analyses. Primary analysis was restricted to trials with low risk of bias according to Cochrane methodology, and sensitivity analyses examined whether the risk of bias of included studies was associated with different results. We performed trial sequential analysis (TSA) to test the strength of the results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included data from 23 RCTs involving 5102 patients. Meta-analysis of trials with low risk of bias showed that statin therapy was associated with an increase in acute kidney injury (314 of 1318 (23.82%) with statins versus 262 of 1319 (19.86%) with placebo; OR 1.26 (95%CI 1.05 to 1.52); p&#x2009;=&#x2009;0.01); these results were supported by TSA. No difference in postoperative atrial fibrillation, myocardial infarction, stroke, infections, or mortality was present. On sensitivity analysis, statin therapy was associated with a slight increase in hospital mortality. Meta-analysis&#xa0;including also trials with high or unclear risk of bias showed no beneficial effects of statin therapy on any postoperative outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is no evidence that statin therapy in the days prior to cardiac surgery is beneficial for patients' outcomes. Particularly, statins are not protective against postoperative atrial fibrillation, myocardial infarction, stroke, or infections. Statins are associated with a possible increased risk of acute kidney injury and a detrimental effect on hospital survival could not be excluded. Future RCTs should further evaluate the safety profile of this therapy in relation to patients' outcomes and assess the more appropriate time point for discontinuation of statins before cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capelli</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casso</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milano, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Via Olgettina 58, Milano, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cardiac anesthesia</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Statins</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27919293</ArticleId><ArticleId IdType="mid">NIHMS1054800</ArticleId><ArticleId IdType="pmc">PMC5139027</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1560-6</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1560-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>LaPar DJ, Crosby IK, Rich JB, Fonner E, Kron IL, Ailawadi G, et al. A contemporary cost analysis of postoperative morbidity after coronary artery bypass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care. Ann Thorac Surg. 2013;96:1621&#x2013;7. doi: 10.1016/j.athoracsur.2013.05.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.05.050</ArticleId><ArticleId IdType="pubmed">23972932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim LK, Looser P, Swaminathan RV, Minutello RM, Wong SC, Girardi L, et al. Outcomes in patients undergoing coronary artery bypass graft surgery in the United States based on hospital volume, 2007 to 2011. J Thorac Cardiovasc Surg. 2016;151:1686&#x2013;92. doi: 10.1016/j.jtcvs.2016.01.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.01.050</ArticleId><ArticleId IdType="pubmed">26964912</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann A, Funkat A-K, Lewandowski J, Frie M, Ernst M, Hekmat K, et al. Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2015;63:258&#x2013;69. doi: 10.1055/s-0035-1544425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1544425</ArticleId><ArticleId IdType="pubmed">26011675</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495&#x2013;502. doi: 10.1161/CIRCULATIONAHA.108.786913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.786913</ArticleId><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32. doi: 10.2215/CJN.00240605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med. 2016;374:1911&#x2013;21. doi: 10.1056/NEJMoa1602002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1602002</ArticleId><ArticleId IdType="pmc">PMC4908812</ArticleId><ArticleId IdType="pubmed">27043047</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgadottir S, Sigurdsson MI, Ingvarsdottir IL, Arnar DO, Gudbjartsson T, Almassi G, et al. Atrial fibrillation following cardiac surgery: risk analysis and long-term survival. J Cardiothorac Surg. 2012;7:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515503</ArticleId><ArticleId IdType="pubmed">22992266</ArticleId></ArticleIdList></Reference><Reference><Citation>Svircevic V, Nierich AP, Moons KGM, Brandon Bravo Bruinsma GJ, Kalkman CJ, van Dijk D. Fast-track anesthesia and cardiac surgery: a retrospective cohort study of 7989 patients. Anesth Analg. 2009;108:727&#x2013;33. doi: 10.1213/ane.0b013e318193c423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318193c423</ArticleId><ArticleId IdType="pubmed">19224776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2012;143:4&#x2013;34. doi: 10.1016/j.jtcvs.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.10.015</ArticleId><ArticleId IdType="pubmed">22172748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A, Levin R, Ruel M, Mesana TG, Solomon DH, Choudhry NK. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2007;134:932&#x2013;8. doi: 10.1016/j.jtcvs.2007.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.05.039</ArticleId><ArticleId IdType="pubmed">17903510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihos CG, Salas MJ, Santana O. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Cardiol Rev. 18:298&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">20926939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodha NR, Sellke FW. The effect of statins on perioperative inflammation in cardiac and thoracic surgery. J Thorac Cardiovasc Surg. 2015;149:1495&#x2013;501. doi: 10.1016/j.jtcvs.2015.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.02.005</ArticleId><ArticleId IdType="pubmed">25791954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol. 2003;91:1107&#x2013;9. doi: 10.1016/S0002-9149(03)00158-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(03)00158-9</ArticleId><ArticleId IdType="pubmed">12714156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Pintar T, Anton J, Lee V-V, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15364837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual DA, Arribas JM, Tornel PL, Mar&#xed;n F, Oliver C, Ahumada M, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg. 2006;81:78&#x2013;83. doi: 10.1016/j.athoracsur.2005.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.07.038</ArticleId><ArticleId IdType="pubmed">16368340</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakopoulos OJ, Choi Y-H, Haldenwang PL, Strauch J, Wittwer T, D&#xf6;rge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29:1548&#x2013;59. doi: 10.1093/eurheartj/ehn198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn198</ArticleId><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn EW, Liakopoulos OJ, Stange S, Deppe A-C, Slottosch I, Choi Y-H, et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg. 2014;45:17&#x2013;26. doi: 10.1093/ejcts/ezt181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt181</ArticleId><ArticleId IdType="pubmed">23562936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n F, Pascual DA, Rold&#xe1;n V, Arribas JM, Ahumada M, Tornel PL, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006;97:55&#x2013;60. doi: 10.1016/j.amjcard.2005.07.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.07.124</ArticleId><ArticleId IdType="pubmed">16377284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007;100:442&#x2013;4. doi: 10.1016/j.amjcard.2007.03.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.03.071</ArticleId><ArticleId IdType="pubmed">17659925</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman CI, Lucek DM, Hammond J, White CM. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin. 2007;23:1783&#x2013;90. doi: 10.1185/030079907X210570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/030079907X210570</ArticleId><ArticleId IdType="pubmed">17597556</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, et al. High-dose perioperative Atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;88. doi: 10.1001/jama.2016.0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, et al. Perioperative Rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744&#x2013;53. doi: 10.1056/NEJMoa1507750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507750</ArticleId><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S (editors).&#xa0;Cochrane Handbook for Systematic Reviews of Interventions&#xa0;Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Putzu A, Capelli B, Belletti A. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials [Internet]. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016039509. Accessed 23 Nov 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139027</ArticleId><ArticleId IdType="pubmed">27919293</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61:64&#x2013;75. doi: 10.1016/j.jclinepi.2007.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.03.013</ArticleId><ArticleId IdType="pubmed">18083463</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61:763&#x2013;9. doi: 10.1016/j.jclinepi.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JPA, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38:276&#x2013;86. doi: 10.1093/ije/dyn179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyn179</ArticleId><ArticleId IdType="pubmed">18824467</ArticleId></ArticleIdList></Reference><Reference><Citation>Almansob MAS, Xu B, Zhou L, Hu X-X, Chen W, Chang F-J, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arterioscler Thromb Vasc Biol. 2012;32:2304&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">22796581</ArticleId></ArticleIdList></Reference><Reference><Citation>Baran &#xc7;, Durdu S, Dalva K, Zaim &#xc7;, Dogan A, Ocakoglu G, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev. 2012;8:963&#x2013;71. doi: 10.1007/s12015-011-9321-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-011-9321-z</ArticleId><ArticleId IdType="pubmed">22076751</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009;57:91&#x2013;5. doi: 10.1055/s-2008-1039107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1039107</ArticleId><ArticleId IdType="pubmed">19241310</ArticleId></ArticleIdList></Reference><Reference><Citation>Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw. 2008;19:99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">18632424</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;o M, Gonz&#xe1;lez-Santos JM, L&#xf3;pez J, Garc&#xed;a B, Centeno JE, Aparicio B, et al. Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study. J Cardiovasc Surg (Torino) 2015;56:617&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">25968407</ArticleId></ArticleIdList></Reference><Reference><Citation>Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agr&#xf2; F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med. 2006;34:660&#x2013;7. doi: 10.1097/01.CCM.0000201407.89977.EA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000201407.89977.EA</ArticleId><ArticleId IdType="pubmed">16505650</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15:394&#x2013;9. doi: 10.1016/S1010-7940(99)00034-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00034-2</ArticleId><ArticleId IdType="pubmed">10371111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani MR, Kasianzadeh M, Rezaei Y, Sepehrvand N. Atorvastatin reduces the incidence of postoperative atrial fibrillation in statin-naive patients undergoing isolated heart valve surgery: a double-blind, placebo-controlled randomized trial. J Cardiovasc Pharmacol Ther. 2015;20:465&#x2013;72. doi: 10.1177/1074248414564869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248414564869</ArticleId><ArticleId IdType="pubmed">25540059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J. 2009;73:2244&#x2013;9. doi: 10.1253/circj.CJ-09-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-09-0352</ArticleId><ArticleId IdType="pubmed">19822977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg. 2008;136:1541&#x2013;8. doi: 10.1016/j.jtcvs.2008.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.06.038</ArticleId><ArticleId IdType="pubmed">19114204</ArticleId></ArticleIdList></Reference><Reference><Citation>Melina G, Angeloni E, Di Nucci G, Benedetto U, Fiorani B, Sclafani G, et al. Preoperative HMG-CoA reductase inhibitors and atrial fibrillation in patients undergoing CABG: a prospective randomised trial. Eur Hear J. 2009;30:32.</Citation></Reference><Reference><Citation>Park JH, Shim J-K, Song J-W, Soh S, Kwak Y-L. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42:1398&#x2013;407. doi: 10.1007/s00134-016-4358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4358-8</ArticleId><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, Chello M, Candura D, Pasceri V, D&#x2019;Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114:1455&#x2013;61. doi: 10.1161/CIRCULATIONAHA.106.621763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.621763</ArticleId><ArticleId IdType="pubmed">17000910</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton) 2012;17:215&#x2013;24. doi: 10.1111/j.1440-1797.2011.01546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1797.2011.01546.x</ArticleId><ArticleId IdType="pubmed">22117606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin SY, On YK, Kim JH, Shin D-H, Kim JS, Sung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 2008;156:373.</Citation><ArticleIdList><ArticleId IdType="pubmed">18657672</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaccio C, Pollari F, Casacalenda A, Alfano G, Genovese J, Covino E, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol. 2010;55:30&#x2013;8. doi: 10.1097/FJC.0b013e3181c37d4d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e3181c37d4d</ArticleId><ArticleId IdType="pubmed">19834333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Ji Q, Mei Y, Wang X, Feng J, Cai J, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. 2011;52:7&#x2013;11. doi: 10.1536/ihj.52.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.52.7</ArticleId><ArticleId IdType="pubmed">21321461</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukovic PM, Maravic-Stojkovic VR, Peric MS, Jovic MD, Cirkovic MV, Gradinac SD, et al. Steroids and statins: an old and a new anti-inflammatory strategy compared. Perfusion. 2011;26:31&#x2013;7. doi: 10.1177/0267659110385607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659110385607</ArticleId><ArticleId IdType="pubmed">20921085</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn Y-N, Park S-Y, Hwang Y, Joo H-C, Yoo K-J. Impact of high-dose statin pretreatment in patients with stable angina during off-pump coronary artery bypass. Korean J Thorac Cardiovasc Surg. 2011;44:208&#x2013;14. doi: 10.5090/kjtcs.2011.44.3.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2011.44.3.208</ArticleId><ArticleId IdType="pmc">PMC3249304</ArticleId><ArticleId IdType="pubmed">22263153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E, Alvarez FJ, Alonso O, Bustamante R, Castrodeza J, Soria S, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. J Cardiovasc Surg (Torino) 2009;50:687&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19741581</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrascal Y, Arnold RJ, De la Fuente L, Revilla A, Sevilla T, Arce N, et al. Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry). J Arrhythm Elsevier. 2016;32:191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913150</ArticleId><ArticleId IdType="pubmed">27354864</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;0:2152&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27616593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A, Ruel M, Jneid H, Ferguson TB, Hiratzka LF, Ikonomidis JS, et al. Secondary prevention after coronary artery bypass graft surgery. Circulation. 2015;131:927-964.</Citation><ArticleIdList><ArticleId IdType="pubmed">25679302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R. Perioperative statins in cardiac surgery and acute kidney injury. JAMA. 2016;315:873&#x2013;4. doi: 10.1001/jama.2016.0245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0245</ArticleId><ArticleId IdType="pubmed">26905755</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton JB, Hansen MK, Jakobsen C-J, Kshirsagar AV, Andreasen JJ, Hjortdal VE, et al. Statin initiation and acute kidney injury following elective cardiovascular surgery: a population cohort study in Denmark&#x2020;. Eur J Cardiothorac Surg. 2016;49:995&#x2013;1000. doi: 10.1093/ejcts/ezv246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv246</ArticleId><ArticleId IdType="pubmed">26188012</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton JB, Kshirsagar AV, Simpson RJ, Pate V, Jonsson Funk M, St&#xfc;rmer T, et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111:823&#x2013;8. doi: 10.1016/j.amjcard.2012.11.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.11.047</ArticleId><ArticleId IdType="pmc">PMC3637989</ArticleId><ArticleId IdType="pubmed">23273532</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar AO, Parikh CR, Coca SG, Thiessen-Philbrook H, Koyner JL, Shlipak MG, et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg. 2014;97:2081&#x2013;7. doi: 10.1016/j.athoracsur.2014.02.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.02.033</ArticleId><ArticleId IdType="pmc">PMC4068122</ArticleId><ArticleId IdType="pubmed">24725831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051&#x2013;60. doi: 10.1016/j.cjca.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.02.034</ArticleId><ArticleId IdType="pubmed">26081692</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunelli SM, Waikar SS, Bateman BT, Chang TI, Lii J, Garg AX, et al. Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012;125:1195&#x2013;204. doi: 10.1016/j.amjmed.2012.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2012.06.021</ArticleId><ArticleId IdType="pmc">PMC3597342</ArticleId><ArticleId IdType="pubmed">23062398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev. 2015;13:CD008493.</Citation><ArticleIdList><ArticleId IdType="pubmed">26270008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev. 2015;11:CD010480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference><Reference><Citation>Golomb BA, Evans MA. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8:373&#x2013;418. doi: 10.2165/0129784-200808060-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/0129784-200808060-00004</ArticleId><ArticleId IdType="pmc">PMC2849981</ArticleId><ArticleId IdType="pubmed">19159124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain V, Kapadia B, Misra P, Saxena U, Mol MJ, Erkelens DW, et al. Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism. Sci Rep. 2015;5:13823. doi: 10.1038/srep13823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13823</ArticleId><ArticleId IdType="pmc">PMC4561915</ArticleId><ArticleId IdType="pubmed">26345110</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang M-H, Paschalis A, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation. 2010;122:S66&#x2013;73. doi: 10.1161/CIRCULATIONAHA.109.927376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.927376</ArticleId><ArticleId IdType="pubmed">20837928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin antiarrhythmic effect on atrial fibrillation in statin-naive patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2016;21:167&#x2013;76. doi: 10.1177/1074248415602557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248415602557</ArticleId><ArticleId IdType="pubmed">26333596</ArticleId></ArticleIdList></Reference><Reference><Citation>Trezzi M, Blackstone EH, Sun Z, Li L, Sabik JF, Lytle BW, et al. Statin therapy is associated with fewer infections after cardiac operations. Ann Thorac Surg. 2013;95:892&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">23380476</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191&#x2013;200. doi: 10.1056/NEJMoa1401520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401520</ArticleId><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L, Roch A, Charles P-E, Penot-Ragon C, Perrin G, Roulier P, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA. 2013;310:1692&#x2013;700. doi: 10.1001/jama.2013.280031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.280031</ArticleId><ArticleId IdType="pubmed">24108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark LL, Ikonomidis JS, Crawford FA, Crumbley A, Kratz JM, Stroud MR, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg. 2006;131:679&#x2013;85. doi: 10.1016/j.jtcvs.2005.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2005.11.006</ArticleId><ArticleId IdType="pubmed">16515923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17:R2. doi: 10.1186/cc11919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11919</ArticleId><ArticleId IdType="pmc">PMC4056100</ArticleId><ArticleId IdType="pubmed">23302257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009;(1):MR000006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276556</ArticleId><ArticleId IdType="pubmed">19160345</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ. 2013;346:f880. doi: 10.1136/bmj.f880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f880</ArticleId><ArticleId IdType="pubmed">23511950</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32252112</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-1902</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Thoracic and cardiovascular surgeon</Title><ISOAbbreviation>Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Perioperative Beta-Blocker for Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>133</StartPage><EndPage>140</EndPage><MedlinePgn>133-140</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1708472</ELocationID><Abstract><AbstractText Label="BACKGROUND">This meta-analysis was conducted to evaluate the impact of perioperative use of beta-blocker (BB) on postoperative atrial fibrillation (POAF) after cardiac surgery other than isolated coronary artery bypass grafting (CABG).</AbstractText><AbstractText Label="METHODS">Five online databases were searched. Studies were included if they (1) enrolled patients who underwent cardiac surgery other than isolated CABG and (2) demonstrated the impact of perioperative use of BB on POAF based on the randomized controlled trial or adjusted analysis. The primary outcome was the occurrence rates of POAF after cardiac surgery. A meta-regression and subgroup analysis were performed according to the proportion of patients with cardiac surgery other than isolated CABG and the timing of BB use, respectively.</AbstractText><AbstractText Label="RESULTS">Thirteen articles (5 randomized and 8 nonrandomized studies: <i>n</i>&#x2009;=&#x2009;25,496) were selected. Proportion of enrolled patients undergoing cardiac surgery other than isolated CABG ranged from 7 to 100%. The BBs were used in preoperative, postoperative, and both periods in 5, 5, and 3 studies, respectively. The pooled analyses showed that the risk of POAF was significantly lower in patients with perioperative BB than those without (odds ratio, 95% confidence interval&#x2009;=&#x2009;0.56, 0.35-0.91 and 0.70, 0.55-0.91 in randomized and nonrandomized studies, respectively). The risk of POAF was lower in the BB group irrespective of the proportion of nonisolated CABG. Benefit regarding in-hospital mortality was inconclusive. Perioperative stroke and length of stay were not significantly different between BB and non-BB groups.</AbstractText><AbstractText Label="CONCLUSIONS">Perioperative use of BB is effective in preventing POAF even in patients undergoing cardiac surgery other than isolated CABG, although it did not translate into improved clinical outcomes.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sue Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, the Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Myoung-Jin</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Medical Research Collaborating Center, Seoul National University Hospital, Seoul, the Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Ho Young</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, the Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>7903387</NlmUniqueID><ISSNLinking>0171-6425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32252112</ArticleId><ArticleId IdType="doi">10.1055/s-0040-1708472</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34560218</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of the incidence of acute aortic dissections in population-based studies.</ArticleTitle><Pagination><StartPage>709</StartPage><EndPage>720</EndPage><MedlinePgn>709-720</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2021.08.080</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(21)02132-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To perform a systematic review and meta-analysis of all population-based studies reporting on incidence of acute aortic dissections (AADs).</AbstractText><AbstractText Label="METHODS">We searched the MEDLINE, EMBASE, CENTRAL, and Open Grey databases from inception to August 2020 for population-based studies reporting on the incidence of AAD. A systematic review was conducted following the PRISMA guidelines using a registered protocol (CRD42020204007). Data were pooled using a random effects model of proportions using Freeman-Tukey double arcsine transformation. The main outcome was the incidence of AAD. Secondary outcomes were incidence type A aortic dissections (TAAD) and type B aortic dissections (TBAD), the incidence of aortic dissection repair and medical management, and the incidence of in-hospital mortality. In addition, we estimated the proportion of aortic dissection repair and mortality (in hospital, overall and specific mortality according to subtype) among patients with AAD.</AbstractText><AbstractText Label="RESULTS">Thirty-three studies were included. The pooled incidence of AADs was 4.8 per 100,000 individuals/year (95% confidence interval [CI], 3.6-6.1). The incidence of TAAD was 3.0 per 100,000/year (95% CI, 1.8-4.4) and the incidence of TBAD was 1.6 per 100,000/year (95% CI, 1.1-2.2). The incidence of AAD needing repair was 1.4 per 100,000/year (95% CI, 1.0-2.0) (or 1.4 [95% CI, 1.2-1.7] for TAAD and 0.4 [95% CI, 0.2-0.7] for TBAD). The incidence of medically managed AAD was 3.4 per 100,000/year (95% CI, 2.4-4.5). The incidence of in-hospital death owing to AAD was 1.3 per 100,000 individuals/year (95% CI, 0.9-1.9), 1.0 (95% CI, 0.6-1.4; I<sup>2</sup>&#xa0;= 97%) for TAAD, and 0.3 for TBAD (95% CI, 0.2-0.4; I<sup>2</sup>&#xa0;= 96%).</AbstractText><AbstractText Label="CONCLUSIONS">A global estimate regarding the incidence rate of AADs was achieved. The incidence of AAD varied significantly between study designs and geographical regions. More accurate information on AAD epidemiology is crucial for public health decisions, clinical understanding, and healthcare management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gouveia E Melo</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Hospital Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte (CHULN), Lisboa, Portugal; Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Cardiovascular Center of the University of Lisbon (CCUL), Lisboa, Portugal. Electronic address: ryan@campus.ul.pt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mour&#xe3;o</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Lisbon, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldeira</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Cardiovascular Center of the University of Lisbon (CCUL), Lisboa, Portugal; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Servi&#xe7;o de Cardiologia, Hospital Universit&#xe1;rio de Santa Maria (CHULN), Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Servi&#xe7;o de Medicina III, Hospital Pulido Valente (CHULN), Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Hospital Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte (CHULN), Lisboa, Portugal; Cardiovascular Center of the University of Lisbon (CCUL), Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Ant&#xf3;nio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Hospital Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte (CHULN), Lisboa, Portugal; Cardiovascular Center of the University of Lisbon (CCUL), Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes E Fernandes</LastName><ForeName>Ruy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Hospital Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte (CHULN), Lisboa, Portugal; Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Cardiovascular Center of the University of Lisbon (CCUL), Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendes Pedro</LastName><ForeName>Lu&#xed;s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Hospital Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte (CHULN), Lisboa, Portugal; Faculty of Medicine, University of Lisbon, Lisboa, Portugal; Cardiovascular Center of the University of Lisbon (CCUL), Lisboa, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="N">Aortic Dissection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001014" MajorTopicYN="N">Aortic Aneurysm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute aortic dissections</Keyword><Keyword MajorTopicYN="N">Aortic dissections</Keyword><Keyword MajorTopicYN="N">Epidemiologic study</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Thoracic aortic dissections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34560218</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2021.08.080</ArticleId><ArticleId IdType="pii">S0741-5214(21)02132-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36801264</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6744</ISSN><JournalIssue CitedMedium="Internet"><Volume>260</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>American heart journal</Title><ISOAbbreviation>Am Heart J</ISOAbbreviation></Journal><ArticleTitle>Perioperative bleeding and outcomes after noncardiac surgery.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>33</EndPage><MedlinePgn>26-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahj.2023.02.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-8703(23)00043-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative bleeding is a common and potentially life-threatening complication after surgery. We sought to identify the frequency, patient characteristics, causes, and outcomes of perioperative bleeding in patients undergoing noncardiac surgery.</AbstractText><AbstractText Label="METHODS">In a retrospective cohort study of a large administrative database, adults aged &#x2265;45&#x2009;years hospitalized for noncardiac surgery in 2018 were identified. Perioperative bleeding was defined using ICD-10 diagnosis and procedure codes. Clinical characteristics, in-hospital outcomes, and first hospital readmission within 6 months were assessed by perioperative bleeding status.</AbstractText><AbstractText Label="RESULTS">We identified 2,298,757 individuals undergoing noncardiac surgery, among which 35,429 (1.54%) had perioperative bleeding. Patients with bleeding were older, less likely to be female, and more likely to have renal and cardiovascular disease. All-cause, in-hospital mortality was higher in patients with vs without perioperative bleeding (6.0% vs 1.3%; adjusted OR [aOR] 2.38, 95% CI 2.26-2.50). Patients with vs without bleeding had a prolonged inpatient length of stay (6 [IQR 3-13] vs 3 [IQR 2-6] days, P &lt; .001). Among those who were discharged alive, hospital readmission was more common within 6 months among patients with bleeding (36.0% vs 23.6%; adjusted HR 1.21, 95% CI 1.18-1.24). The risk of in-hospital death or readmission was greater in patients with vs without bleeding (39.8% vs 24.5%; aOR 1.33, 95% CI 1.29-1.38). When stratified by revised cardiac risk index , there was a stepwise increase in surgical bleeding risk with increasing perioperative cardiovascular risks.</AbstractText><AbstractText Label="CONCLUSIONS">Perioperative bleeding is reported in 1 out of every 65 noncardiac surgeries, with a higher incidence in patients at elevated cardiovascular risk. Among postsurgical inpatients with perioperative bleeding, approximately 1 of every 3 patients died during hospitalization or were readmitted within 6-months. Strategies to reduce perioperative bleeding are warranted to improve outcomes following non-cardiac surgery.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smilowitz</LastName><ForeName>Nathaniel R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY; Cardiology Section, Department of Medicine, Veterans Affairs New York Harbor Health Care System, New York, NY. Electronic address: nathaniel.smilowitz@nyulangone.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY; Department of Surgery, New York University School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL150315</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL139909</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL144993</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J</MedlineTA><NlmUniqueID>0370465</NlmUniqueID><ISSNLinking>0002-8703</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Perioperative</Keyword><Keyword MajorTopicYN="N">Readmission</Keyword><Keyword MajorTopicYN="N">Rehospitalization</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList><CoiStatement>Conflict of interest Dr Smilowitz serves on an advisory board for Abbott Vascular. The remainder of the authors report no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>21</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36801264</ArticleId><ArticleId IdType="mid">NIHMS1875184</ArticleId><ArticleId IdType="pmc">PMC10164115</ArticleId><ArticleId IdType="doi">10.1016/j.ahj.2023.02.008</ArticleId><ArticleId IdType="pii">S0002-8703(23)00043-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roshanov PS, Eikelboom JW, Sessler DI, et al. Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance. British journal of anaesthesia. 2021;126(1):163&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">32768179</ArticleId></ArticleIdList></Reference><Reference><Citation>Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study I, Spence J, LeManach Y, et al. Association between complications and death within 30 days after noncardiac surgery. CMAJ. 2019;191(30):E830&#x2013;E837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6663503</ArticleId><ArticleId IdType="pubmed">31358597</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370(16):1494&#x2013;1503.</Citation><ArticleIdList><ArticleId IdType="pubmed">24679062</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. N Engl J Med. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">36053524</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Oberweis BS, Nukala S, et al. Association Between Anemia, Bleeding, and Transfusion with Long-term Mortality Following Noncardiac Surgery. Am J Med. 2016;129(3):315&#x2013;323.e312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567997</ArticleId><ArticleId IdType="pubmed">26524702</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WC, Smith TS, Henderson WG, et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg. 2010;252(1):11&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">20505504</ArticleId></ArticleIdList></Reference><Reference><Citation>Obi AT, Park YJ, Bove P, et al. The association of perioperative transfusion with 30-day morbidity and mortality in patients undergoing major vascular surgery. J Vasc Surg. 2015;61(4):1000&#x2013;1009 e1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">25596978</ArticleId></ArticleIdList></Reference><Reference><Citation>Glance LG, Kellermann AL, Osler TM, et al. Hospital readmission after noncardiac surgery: the role of major complications. JAMA surgery. 2014;149(5):439&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">24599504</ArticleId></ArticleIdList></Reference><Reference><Citation>Redfors B, Watson BM, McAndrew T, et al. Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters. JAMA Cardiol. 2017;2(7):798&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815083</ArticleId><ArticleId IdType="pubmed">28315573</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett M, Steiner C, Andrews R, Kassed C, Nagamine M. Methodological Issues when Studying Readmissions and Revisits Using Hospital Adminstrative Data. U.S. Agency for Healthcare Research and Quality. HCUP Methods Series Report # 2011&#x2013;01 Web site. https://www.hcup-us.ahrq.gov/reports/methods/2011_01.pdf. Published 2011. Updated
March
9, 2011. Accessed
June 1, 2017.</Citation></Reference><Reference><Citation>Smilowitz NR, Gupta N, Ramakrishna H, Guo Y, Berger JS, Bangalore S. Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery. JAMA Cardiol. 2017;2(2):181&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5563847</ArticleId><ArticleId IdType="pubmed">28030663</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson C, Wissenberg M, Jorgensen ME, et al. Age-specific performance of the revised cardiac risk index for predicting cardiovascular risk in elective noncardiac surgery. Circ Cardiovasc Qual Outcomes. 2015;8(1):103&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">25587095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruetzler K, Smilowitz NR, Berger JS, et al. Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2021;144(19):e287&#x2013;e305.</Citation><ArticleIdList><ArticleId IdType="pubmed">34601955</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Gupta N, Guo Y, Berger JS, Bangalore S. Perioperative acute myocardial infarction associated with non-cardiac surgery. Eur Heart J. 2017;38(31):2409&#x2013;2417.</Citation><ArticleIdList><ArticleId IdType="pubmed">28821166</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Beckman JA, Sherman SE, Berger JS. Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery. Circulation. 2018;137(22):2332&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995321</ArticleId><ArticleId IdType="pubmed">29525764</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Gupta N, Guo Y, Beckman JA, Bangalore S, Berger JS. Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery. Heart. 2018;104(14):1180&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6102124</ArticleId><ArticleId IdType="pubmed">29305561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project. Circ Arrhythm Electrophysiol. 2012;5(5):941&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">22923275</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Angeras U, Bergqvist D, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. Journal of thrombosis and haemostasis : JTH. 2010;8(1):202&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">19878532</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736&#x2013;2747.</Citation><ArticleIdList><ArticleId IdType="pubmed">21670242</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26678152</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1569-9285</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Interactive cardiovascular and thoracic surgery</Title><ISOAbbreviation>Interact Cardiovasc Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Optimal timing for early surgery in infective endocarditis: a meta-analysis.</ArticleTitle><Pagination><StartPage>336</StartPage><EndPage>345</EndPage><MedlinePgn>336-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/icvts/ivv368</ELocationID><Abstract><AbstractText>To systematically review early surgery and the optimal timing of surgery in patients with infective endocarditis (IE), a search for foreign and domestic articles on cohort studies about the association between early surgery and infective endocarditis published from inception to January 2015 was conducted in the PubMed, EMBASE, Chinese Biomedical Literature (CBM), Wanfang and Chinese National Knowledge Infrastructure (CNKI) databases. The studies were screened according to the inclusion and exclusion criteria, the data were extracted and the quality of the method of the included studies was assessed. Then, the meta-analysis was performed using the Stata 12.0 software. Sixteen cohort studies, including 8141 participants were finally included. The results of the meta-analysis revealed that, compared with non-early surgery, early surgery in IE lowers the incidence of in-hospital mortality [odds ratio (OR) = 0.57, 95% confidence interval (CI) (0.42, 0.77); P = 0.000, I(2) = 73.1%] and long-term mortality [OR = 0.57, 95% CI (0.43, 0.77); P = 0.001, I(2) = 67.4%]. Further, performing operation within 2 weeks had a more favourable effect on long-term mortality [OR = 0.63, 95% CI (0.41, 0.97); P = 0.192, I(2) = 39.4%] than non-early surgery. In different kinds of IE, we found that early surgery for native valve endocarditis (NVE) had a lower in-hospital [OR = 0.46, 95% CI (0.31, 0.69); P = 0.001, I(2) = 73.0%] and long-term [OR = 0.57, 95% CI (0.40, 0.81); P = 0.001, I(2) = 68.9%] mortality than the non-early surgery group. However, for prosthetic valve endocarditis (PVE), in-hospital mortality did not differ significantly [OR = 0.83, 95% CI (0.65, 1.06); P = 0.413, I(2) = 0.0%] between early and non-early surgery. We concluded that early surgery was associated with lower in-hospital and long-term mortality compared with non-early surgical treatment for IE, especially in NVE. However, the optimal timing of surgery remains unclear. Additional larger prospective clinical trials will be required to clarify the optimal timing for surgical intervention and determine its efficacy in PVE.</AbstractText><CopyrightInformation>&#xa9; The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Fuxiang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The First Clinical College of Lanzhou University, Lanzhou University, Lanzhou, China Department of Cardiovascular Surgery, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The First Clinical College of Lanzhou University, Lanzhou University, Lanzhou, China Department of Cardiovascular Surgery, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China ysllfx@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ruisheng</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The First Clinical College of Lanzhou University, Lanzhou University, Lanzhou, China Department of Cardiovascular Surgery, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Hanbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The First Clinical College of Lanzhou University, Lanzhou University, Lanzhou, China Department of Cardiovascular Surgery, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Clinical College of Lanzhou University, Lanzhou University, Lanzhou, China Department of Cardiovascular Surgery, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Interact Cardiovasc Thorac Surg</MedlineTA><NlmUniqueID>101158399</NlmUniqueID><ISSNLinking>1569-9285</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004696" MajorTopicYN="N">Endocarditis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006350" MajorTopicYN="N">Heart Valve Prosthesis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006351" MajorTopicYN="N">Heart Valves</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cohort study</Keyword><Keyword MajorTopicYN="N">Early surgery</Keyword><Keyword MajorTopicYN="N">Infective endocarditis</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26678152</ArticleId><ArticleId IdType="pmc">PMC4986570</ArticleId><ArticleId IdType="doi">10.1093/icvts/ivv368</ArticleId><ArticleId IdType="pii">ivv368</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S et al. . Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">12090865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr et al. . Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010;121:1005&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3597944</ArticleId><ArticleId IdType="pubmed">20159831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794152</ArticleId></ArticleIdList></Reference><Reference><Citation>Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME et al. . Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">15956145</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al. . Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">19713420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA et al. . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">24603192</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E et al. . In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med 2013;173:1495&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">23857547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC et al. . Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012;366:2466&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">22738096</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V et al. . Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 2007;44:364&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">17205442</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V et al. . The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 2011;32:2003&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19208650</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabell CH, Abrutyn E, Fowler VG Jr., Hoen B, Miro JM, Corey GR et al. . Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 2005;150:1092&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16291004</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi S, Kaji S, Yamamuro A, Tani T, Kinoshita M, Okada Y et al. . Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg 2011;142:836&#x2013;842 e831.</Citation><ArticleIdList><ArticleId IdType="pubmed">21397271</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill EE, Herregods MC, Vanderschueren S, Claus P, Peetermans WE, Herijgers P. Outcome of patients requiring valve surgery during active infective endocarditis. Ann Thorac Surg 2008;85:1564&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18442538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourvillier B, Trouillet JL, Timsit JF, Baudot J, Chastre J, Regnier B et al. . Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med 2004;30:2046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15372147</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohara T, Nakatani S, Kokubo Y, Yamamoto H, Mitsutake K, Hanai S. Clinical predictors of in-hospital death and early surgery for infective endocarditis: results of CArdiac Disease REgistration (CADRE), a nation-wide survey in Japan. Int J Cardiol 2013;167:2688&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">22805554</ArticleId></ArticleIdList></Reference><Reference><Citation>Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L. Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes 2009;2:469&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">20031879</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A et al. . The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011;32:2027&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">19329497</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS et al. . The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 2007;115:1721&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17372170</ArticleId></ArticleIdList></Reference><Reference><Citation>Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003;290:3207&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">14693873</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Pappas P, Anstrom KJ, Abrutyn E, Fowler VG Jr., Hoen B et al. . The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J 2005;150:1086&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">16291003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang S, Tian Z, Guo L. [The impact of early surgery on long-term outcome of patients with left-sided infective endocarditis]. Zhonghua Nei Ke Za Zhi 2014;53:450&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25146512</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L, Fu Q, Yang S, Liang D, Lv X, Wei M. Clinical analysis of early surgical operation in infective endocarditis. Chin J Thorac Cardiovasc Surg 2012;28:464&#x2013;6.</Citation></Reference><Reference><Citation>Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr., Ryan T et al. . Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10770721</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">13655060</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">10861324</ArticleId></ArticleIdList></Reference><Reference><Citation>Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1557642</ArticleId><ArticleId IdType="pubmed">10861325</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S, Sardar P. Early surgery reduces mortality in patients with infective endocarditis: insight from a meta-analysis. Int J Cardiol 2013;168:3094&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23642830</ArticleId></ArticleIdList></Reference><Reference><Citation>San Roman JA, Lopez J, Revilla A, Vilacosta I, Tornos P, Almirante B et al. . Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): a multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditis. Am Heart J 2008;156:431&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18760122</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham NS, Byrne CJ, Young JM, Solomon MJ. Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol 2010;63:238&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">19716267</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36641309</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Platelet Transfusion After Cardiac Surgery.</ArticleTitle><Pagination><StartPage>528</StartPage><EndPage>538</EndPage><MedlinePgn>528-538</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2022.12.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(22)00900-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To investigate the independent association of platelet transfusion with hospital mortality and key relevant clinical outcomes in cardiac surgery.</AbstractText><AbstractText Label="DESIGN">A single-center, propensity score-matched, retrospective, cohort study.</AbstractText><AbstractText Label="SETTING">At an American tertiary teaching hospital data from the Medical Information Mart for Intensive Care III and IV databases from 2001 to 2019.</AbstractText><AbstractText Label="PARTICIPANTS">Consecutive adults undergoing coronary artery bypass graft and/or cardiac valvular surgery.</AbstractText><AbstractText Label="INTERVENTIONS">Platelet transfusion during perioperative intensive care unit (ICU) admission.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Overall, 12,043 adults met the study inclusion criteria. Of these, 1,621 (13.5%) received apheresis-leukoreduced platelets, with a median of 1.19 units per recipient (IQR: 0.93-1.19) at a median of 1.78 hours (IQR: 0.75-4.25) after ICU admission. The platelet count was measured in 1,176 patients (72.5%) before transfusion, with a median count of 120&#xa0;&#xd7;&#xa0;10<sup>9</sup>/L (IQR: 89.0-157.0), and only 53 (3.3%) had platelet counts below 50&#xa0;&#xd7;&#xa0;10<sup>9</sup>/L. After propensity matching of 1,046 platelet recipients with 1,046 controls, perioperative platelet transfusion carried no association with in-hospital mortality (odds ratio [OR]: 1.28; 99% CI: 0.49-3.35; p&#xa0;=&#xa0;0.4980). However, it was associated with a pattern of decreased odds of suspected infection (eg, respiratory infection, urinary tract infection, septicaemia, or other; OR: 0.70; 99% CI: 0.50-0.97; p&#xa0;=&#xa0;0.0050), days in the hospital (adjusted mean difference [AMD]: 0.86; 99% CI: -0.27 to 1.98; p&#xa0;=&#xa0;0.048), or days in intensive care (AMD 0.83; 99% CI: -0.15 to 1.82; p&#xa0;=&#xa0;0.0290).</AbstractText><AbstractText Label="CONCLUSIONS">Platelet transfusion was not associated with hospital mortality, but it was associated with decreased odds of suspected infection and with shorter ICU and hospital stays.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Calvin M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, The Alfred Hospital, Melbourne, Victoria, Australia. Electronic address: calvinmfletcher@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinton</LastName><ForeName>Jake V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Zhongyue</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Luke A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karamesinis</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penny-Dimri</LastName><ForeName>Jahan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramson</LastName><ForeName>Dhruvesh</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhengyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, Victoria, Australia; Department of Cardiothoracic Surgery, Monash Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Reny</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coulson</LastName><ForeName>Tim G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, The Alfred Hospital, Melbourne, Victoria, Australia; Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia; Department of Intensive Care, Austin Hospital, Melbourne, Melbourne, Victoria, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2023 Jun;37(6):1061-1062. doi: 10.1053/j.jvca.2023.02.006.</RefSource><PMID Version="1">36872113</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="Y">Platelet Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CABG, hemorrhage</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">platelets</Keyword><Keyword MajorTopicYN="N">transfusion</Keyword></KeywordList><CoiStatement>Conflicts of Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36641309</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2022.12.009</ArticleId><ArticleId IdType="pii">S1053-0770(22)00900-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24037558</PMID><DateCompleted><Year>2013</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>11</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of population-based mortality from ruptured abdominal aortic aneurysm.</ArticleTitle><Pagination><StartPage>1405</StartPage><EndPage>1413</EndPage><MedlinePgn>1405-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.9235</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A substantial proportion of patients with a ruptured abdominal aortic aneurysm (rAAA) die outside hospital. The objective of this study was to estimate the total mortality, including prehospital deaths, of patients with rAAA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a systematic review and meta-analysis following the MOOSE guidelines. The Embase, MEDLINE and Cochrane Library databases were searched. All population-based studies reporting both prehospital and in-hospital mortality in patients with rAAA were included. Studies were assessed for methodological quality and heterogeneity, and pooled estimates of mortality from rAAA were calculated using a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From a total of 3667 studies, 24 retrospective cohort studies, published between 1977 and 2012, met the inclusion criteria. The quality of included studies varied, in particular the method of determining prehospital deaths from rAAA. The estimated pooled total mortality rate was 81 (95&#xa0;per&#xa0;cent confidence interval 78 to 83) per cent. A decline in mortality was observed over time (P&#x2009;=&#x2009;0&#xb7;002); the pooled estimate of total mortality in high-quality studies before 1990 was 86 (83 to 89) per cent, compared with 74 (72 to 77) per cent since 1990. Some 32 (27 to 37) per cent of patients with rAAA died before reaching hospital. The in-hospital non-intervention rate was 40 (33 to 47) per cent, which also declined over the years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The pooled estimate of total mortality from rAAA is very high, although it has declined over the years. Most patients die outside hospital, and there is no surgical intervention in a considerable number of those who survive to reach hospital.</AbstractText><CopyrightInformation>&#xa9; 2013 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reimerink</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Academic Medical Centre, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Laan</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Koelemay</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Balm</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Legemate</LastName><ForeName>D A</ForeName><Initials>DA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001019" MajorTopicYN="N">Aortic Rupture</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24037558</ArticleId><ArticleId IdType="doi">10.1002/bjs.9235</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33795133</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Preoperative lymphopaenia, mortality, and morbidity after elective surgery: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>32</StartPage><EndPage>40</EndPage><MedlinePgn>32-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2021.02.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(21)00140-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">In the general adult population, lymphopaenia is associated with an increased risk for hospitalisation with infection and infection-related death. The quality of evidence and strength of association between perioperative lymphopaenia across different surgical procedures and mortality/morbidity has not been examined by systematic review or meta-analysis.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE, Embase, Web of Science, Google Scholar, and Cochrane databases from their inception to June 29, 2020 for observational studies reporting lymphocyte count and in-hospital mortality rate in adults. We defined preoperative lymphopaenia as a lymphocyte count 1.0-1.5&#xd7;10<sup>9</sup> L<sup>-1</sup>. Meta-analysis was performed using either fixed or random effects models. Quality was assessed using the Newcastle-Ottawa Scale. The I<sup>2</sup> index was used to quantify heterogeneity. The primary outcome was in-hospital mortality rate and mortality rate at 30 days.</AbstractText><AbstractText Label="RESULTS">Eight studies met the inclusion criteria for meta-analysis, comprising 4811 patients (age range, 46-91 yr; female, 20-79%). These studies examined preoperative lymphocyte count exclusively. Studies were of moderate to high quality overall, ranking &gt;7 using the Newcastle-Ottawa Scale. Preoperative lymphopaenia was associated with a threefold increase in mortality rate (risk ratio [RR]=3.22; 95% confidence interval [CI], 2.19-4.72; P&lt;0.01, I<sup>2</sup>=0%) and more frequent major postoperative complications (RR=1.33; 95% CI, 1.21-1.45; P&lt;0.01, I<sup>2</sup>=6%), including cardiovascular morbidity (RR=1.77; 95% CI, 1.45-2.15; P&lt;0.01, I<sup>2</sup>=0%), infections (RR=1.45; 95% CI, 1.19-1.76; P&lt;0.01, I<sup>2</sup>=0%), and acute renal dysfunction (RR=2.66; 95% CI, 1.49-4.77; P&lt;0.01, I<sup>2</sup>=1%).</AbstractText><AbstractText Label="CONCLUSION">Preoperative lymphopaenia is associated with death and complications more frequently, independent of the type of surgery.</AbstractText><AbstractText Label="PROSPERO REGISTRY NUMBER">CRD42020190702.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schroth</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Timothy F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Arroyo</LastName><ForeName>Ana Gutierrez</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henson</LastName><ForeName>Sian M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackland</LastName><ForeName>Gareth L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. Electronic address: g.ackland@qmul.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008231" MajorTopicYN="N">Lymphopenia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">death</Keyword><Keyword MajorTopicYN="N">lymphocyte</Keyword><Keyword MajorTopicYN="N">lymphopaenia</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33795133</ArticleId><ArticleId IdType="pmc">PMC8258977</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2021.02.023</ArticleId><ArticleId IdType="pii">S0007-0912(21)00140-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barnes J., Hunter J., Harris S. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: infection and sepsis. Br J Anaesth. 2019;122:500&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435904</ArticleId><ArticleId IdType="pubmed">30857606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackland G.L., Abbott T.E.F., Cain D. Preoperative systemic inflammation and perioperative myocardial injury: prospective observational multicentre cohort study of patients undergoing non-cardiac surgery. Br J Anaesth. 2019;122:180&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6354048</ArticleId><ArticleId IdType="pubmed">30686303</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards M.R., Sultan P., del Arroyo A.G. Metabolic dysfunction in lymphocytes promotes postoperative morbidity. Clin Sci (Lond) 2015;129:423&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">25891048</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien W.J., Gupta K., Itani K.M.F. Association of postoperative Infection with risk of long-term infection and mortality. JAMA Surg. 2019;155:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865239</ArticleId><ArticleId IdType="pubmed">31693076</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonesinghe S.R., Harris S., Mythen M.G. Survival after postoperative morbidity: a longitudinal observational cohort study. Br J Anaesth. 2014;113:977&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4235571</ArticleId><ArticleId IdType="pubmed">25012586</ArticleId></ArticleIdList></Reference><Reference><Citation>Warny M., Helby J., Nordestgaard B.G., Birgens H., Bojesen S.E. Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study. PLoS Med. 2018;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6211632</ArticleId><ArticleId IdType="pubmed">30383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Brass D., Mckay P., Scott F. Rational testing: investigating an incidental finding of lymphopenia. BMJ. 2014;348:g1721.</Citation><ArticleIdList><ArticleId IdType="pubmed">24591476</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar A.N., Henson S.M., Lanna A. Senescence of T Lymphocytes: implications for enhancing human immunity. Trends Immunol. 2016;37:866&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pubmed">27720177</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaulay R., Akbar A.N., Henson S.M. The role of the T cell in age-related inflammation. Age. 2013;35:563&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3636399</ArticleId><ArticleId IdType="pubmed">22252437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H., Zhang B., Huang H. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19. Clin Exp Immunol. 2020;201:76&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267633</ArticleId><ArticleId IdType="pubmed">32365221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelley O., Murphy T., Paterson H., Mannick J.A., Lederer J.A. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock. 2003;20:123&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">12865655</ArticleId></ArticleIdList></Reference><Reference><Citation>Christou N.V., Rode H., Larsen D., Loose L., Broadhead M., Meakins J.L. The walk-in anergic patient. How best to assess the risk of sepsis following elective surgery. Ann Surg. 1984;199:438&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1353363</ArticleId><ArticleId IdType="pubmed">6712320</ArticleId></ArticleIdList></Reference><Reference><Citation>Nohr C.W., Latter D.A., Meakins J.L., Christou N.V. In&#xa0;vivo and in&#xa0;vitro humoral immunity in surgical patients. Ann Surg. 1984;200:373&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1250491</ArticleId><ArticleId IdType="pubmed">6465987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord J.M., Midwinter M.J., Chen Y.F. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet. 2014;384:1455&#x2013;1465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729362</ArticleId><ArticleId IdType="pubmed">25390327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarelli M., Achilli P., Tagliabue F. Perioperative lymphocytopenia predicts mortality and severe complications after intestinal surgery. Ann Transl. 2019;7:311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6694229</ArticleId><ArticleId IdType="pubmed">31475181</ArticleId></ArticleIdList></Reference><Reference><Citation>Vulliamy P.E., Perkins Z.B., Brohi K. Persistent lymphopenia is an independent predictor of mortality in critically ill emergency general surgical patients. Eur J Trauma Emerg Surg. 2016;42:755&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">26501197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zidar D.A., Al-Kindi S.G., Liu Y. Association of lymphopenia with risk of mortality among adults in the US general population. JAMA Netw Open. 2019;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902755</ArticleId><ArticleId IdType="pubmed">31790569</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessio F.R., Kurzhagen J.T., Rabb H. Reparative T lymphocytes in organ injury. J&#xa0;Clin Invest. 2019;129:2608&#x2013;2618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6597230</ArticleId><ArticleId IdType="pubmed">31259743</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X., Wang W., Liu J., Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlan D.P. Value of lymphocyte counts as a prognostic index of survival following femoral neck fractures. Injury. 1989;20:352&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">2628333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierre-Louis W.S., Bath J., Mikkilineni S. Neutrophil to lymphocyte ratio as a predictor of outcomes after amputation. Ann Vasc Surg. 2019;54:84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">30339899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomivorotov V.V., Efremov S.M., Boboshko V.A. Preoperative total lymphocyte count in peripheral blood as a predictor of poor outcome in adult cardiac surgery. J&#xa0;Cardiothorac Vasc Anesth. 2011;25:975&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">21354824</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Daly B.J., Walsh J.C., Quinlan J.F. Serum albumin and total lymphocyte count as predictors of outcome in hip fractures. Clin Nutr. 2010;29:89&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19674819</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuo K., Kumagai K., Tanaka T. &#x2018;Physiological&#x2019; age as an outcome predictor for abdominal surgery in elderly patients. Surg Today. 1998;28:997&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">9786569</ArticleId></ArticleIdList></Reference><Reference><Citation>Seltzer M.H., Bastidas J.A., Cooper D.M., Engler P., Slocum B., Fletcher H.S. Instant nutritional assessment. JPEN J Parenter Enteral Nutr. 1979;3:157&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">573345</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolan R.D., Lim J., McSorley S.T., Horgan P.G., McMillan D.C. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci Rep. 2017;7:16717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711862</ArticleId><ArticleId IdType="pubmed">29196718</ArticleId></ArticleIdList></Reference><Reference><Citation>Norddahl G.L., Pronk C.J., Wahlestedt M. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell. 2011;8:499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">21549326</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumpey T.M., Lu X., Morken T., Zaki S.R., Katz J.M. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J&#xa0;Virol. 2000;74:6105&#x2013;6116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112109</ArticleId><ArticleId IdType="pubmed">10846094</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols J.E., Niles J.A., Roberts N.J. Human lymphocyte apoptosis after exposure to influenza A virus. J&#xa0;Virol. 2001;75:5921&#x2013;5929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114307</ArticleId><ArticleId IdType="pubmed">11390593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena L.A., Li S., Jairaman A. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 2013;38:225&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582741</ArticleId><ArticleId IdType="pubmed">23415911</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandarpurkar M., Wilson-Fritch L., Corvera S. Ian4 is required for mitochondrial integrity and T cell survival. Proc Natl Acad Sci U S A. 2003;100:10382&#x2013;10387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC193570</ArticleId><ArticleId IdType="pubmed">12930893</ArticleId></ArticleIdList></Reference><Reference><Citation>Furst D.E. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum. 2009;39:18&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">18620738</ArticleId></ArticleIdList></Reference><Reference><Citation>Cools-Lartigue J., Spicer J., McDonald B. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J&#xa0;Clin Invest. 2013;123:3446&#x2013;3458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3726160</ArticleId><ArticleId IdType="pubmed">23863628</ArticleId></ArticleIdList></Reference><Reference><Citation>Delogu G., Moretti S., Antonucci A. Apoptosis and surgical trauma. Arch Surg. 2000;135:1141&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">11030869</ArticleId></ArticleIdList></Reference><Reference><Citation>Drewry A.M., Samra N., Skrupky L.P., Fuller B.M., Compton S.M., Hotchkiss R.S. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014;42:383&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362626</ArticleId><ArticleId IdType="pubmed">25051284</ArticleId></ArticleIdList></Reference><Reference><Citation>COVIDSurg Collaborative Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396:27&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7259900</ArticleId><ArticleId IdType="pubmed">32479829</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., H&#xe9;bert H.L., Chatziperi A. Perioperative management of patients with suspected or confirmed COVID-19: review and recommendations for perioperative management from a retrospective cohort study. Br J Anaesth. 2020;125:895&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473146</ArticleId><ArticleId IdType="pubmed">33121750</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K.C., Unsinger J., Davis C.G. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. Faseb J. 2007;21:708&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">17307841</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver J.G.R., Rouse M.S., Steckelberg J.M., Badley A.D. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. Faseb J. 2004;18:1185&#x2013;1191.</Citation><ArticleIdList><ArticleId IdType="pubmed">15284218</ArticleId></ArticleIdList></Reference><Reference><Citation>Bain B.J. Ethnic and sex differences in the total and differential white cell count and platelet count. J&#xa0;Clin Pathol. 1996;49:664&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC500612</ArticleId><ArticleId IdType="pubmed">8881919</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray T.P.A., Moons K.G.M., Riley R.D. Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: a comparison of new and existing tests. Res Synth Methods. 2018;9:41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5873397</ArticleId><ArticleId IdType="pubmed">28975717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau J., Ioannidis J.P.A., Terrin N., Schmid C.H., Olkin I. The case of the misleading funnel plot. BMJ. 2006;333:597&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1570006</ArticleId><ArticleId IdType="pubmed">16974018</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois B., Jeannet R., Daix T. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5922293</ArticleId><ArticleId IdType="pubmed">29515037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32687821</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-6259</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>544</StartPage><EndPage>554</EndPage><MedlinePgn>544-554</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2020.05.104</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0003-4975(20)31153-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Postoperative atrial fibrillation (POAF) after cardiac surgery is associated with longer hospital stay and increased in-hospital death and stroke, but its long-term implications remain incompletely understood. A systematic literature review was undertaken to investigate the impact of POAF on long-term death and stroke in adult patients who undergo cardiac operations.</AbstractText><AbstractText Label="METHODS">Electronic databases (Cochrane, Embase, Ovid MEDLINE, and PubMed) were queried from inception to October 2018. Included studies compared long-term outcomes after cardiac operations in patients with and without POAF. Adjusted and unadjusted meta-analyses examined death, stroke, and major adverse cardiac and cerebrovascular events. Risk of bias was evaluated with the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="RESULTS">The inclusion criteria were met by 32 studies describing 155,575 patients who had undergone cardiac operations. POAF occurred in 36,988 patients (23.7%). Meta-analysis of 10 studies (44,367 patients) demonstrated increased 1-year death in patients with POAF (odds ratio, 2.60; 95% confidence interval, 2-3.38; P &lt; .01). Aggregate adjusted hazard of death (16 studies, n&#xa0;= 84,295) was also increased in patients with POAF (hazard ratio, 1.25; 95% confidence interval, 1.2-1.3; P &lt; .01).</AbstractText><AbstractText Label="CONCLUSIONS">This systematic review and meta-analysis identified an association between POAF and long-term death after cardiac surgery. More comprehensive POAF prevention and management, including more stringent follow-up for POAF recurrence after hospital discharge, may be indicated. The included studies used inconsistent definitions of POAF and variable exclusion criteria; however, estimates of heterogeneity are low. Differences in preoperative comorbidities, such as age, ejection fraction, and obesity, may not be fully accounted for in adjusted analyses. Future work is required to delineate mechanisms linking POAF and death in this population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanjanwala</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiac Sciences Program, St. Boniface Hospital, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Me-Linh</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Libraries, University of Manitoba, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada; Cardiac Sciences Program, St. Boniface Hospital, Winnipeg, Manitoba, Canada; Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Rakesh C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada; Cardiac Sciences Program, St. Boniface Hospital, Winnipeg, Manitoba, Canada; Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada. Electronic address: rakeshcarora@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Thorac Surg. 2021 Feb;111(2):554-555. doi: 10.1016/j.athoracsur.2020.06.104.</RefSource><PMID Version="1">32891659</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32687821</ArticleId><ArticleId IdType="doi">10.1016/j.athoracsur.2020.05.104</ArticleId><ArticleId IdType="pii">S0003-4975(20)31153-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32387492</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8473</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses</Title><ISOAbbreviation>J Perianesth Nurs</ISOAbbreviation></Journal><ArticleTitle>Adverse Outcomes Associated With Intraoperative Anesthesia Handovers: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>525</StartPage><EndPage>532.e1</EndPage><MedlinePgn>525-532.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jopan.2020.01.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1089-9472(20)30038-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Whether intraoperative handover of anesthesia care increases the risk of adverse outcomes in patients undergoing surgery remains unclear. This systematic review aimed to synthesize the evidence on the association of intraoperative anesthesia handover with delivery of patient care and patient outcomes.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This is a systematic review and meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search was conducted to identify the eligible studies examining the association between intraoperative anesthesia handover and adverse outcomes in patients receiving surgery. The cohort studies and case-control studies were included. The methodological quality of each included study was assessed using the Newcastle-Ottawa Scale. The meta-analysis across the studies was performed using Review Manager. Adjusted odds ratio (aOR) with 95% confidence intervals were used for dichotomous variables. Sensitivity analysis was conducted by removing one study each time and re-estimating the overall effect size.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Seven retrospective cohort studies with 680,155 patients were finally included. Among these participants, 139,362 patients (20.49%) had anesthesia handovers during their surgeries. In pooled analysis, the statistically significant relationship between intraoperative anesthesia handover and composite morbidity was observed (aOR 1.20 and 95% CI 1.12-1.28). However, the number of handovers was not significantly associated with composite of mortality and morbidity (aOR 1.12, 95% CI 1.00-1.25) and in-hospital mortality (aOR 1.26, 95% CI 0.96-1.67).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings suggested that each additional intraoperative anesthesia handover increased the odds of composite morbidity. It is important to improve the handover quality and avoid handovers when anesthesia providers have high-risk care events, patients having unstable status, or inadequate handover time.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jiale</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nursing, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Nurse Anesthesia, Virginia Commonwealth University, Richmond, Virginia, USA. Electronic address: jhu4@vcu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nursing, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoxue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Nursing, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Liuyun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nursing, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yiyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Nursing at University of Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallacaro</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Nurse Anesthesia, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nurse Anesthesia, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Perianesth Nurs</MedlineTA><NlmUniqueID>9610507</NlmUniqueID><ISSNLinking>1089-9472</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="Y">Anesthesiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062209" MajorTopicYN="Y">Patient Handoff</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">anesthesiology</Keyword><Keyword MajorTopicYN="N">hospital mortality</Keyword><Keyword MajorTopicYN="N">morbidity</Keyword><Keyword MajorTopicYN="N">odds ratio</Keyword><Keyword MajorTopicYN="N">patient handoff</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32387492</ArticleId><ArticleId IdType="doi">10.1016/j.jopan.2020.01.016</ArticleId><ArticleId IdType="pii">S1089-9472(20)30038-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36910538</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of thoracic endovascular aortic repair with the proximal landing zone 0.</ArticleTitle><Pagination><StartPage>1034354</StartPage><MedlinePgn>1034354</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1034354</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2023.1034354</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Thoracic endovascular aortic repair, initially intended for thoracic aortic disease treatment, has extended its application to the proximal zone of the aorta. However, the safety and surgical outcomes of extending the proximal landing zone into the ascending aorta (zone 0) in selected cases remain unknown. Thus, we performed a systematic review and meta-analysis of zone 0 thoracic endovascular aortic repair (TEVAR) to obtain a deeper understanding of its safety, outcomes, and trends over time.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A literature search was performed using PubMed, EMBASE, and Web of Science databases in accordance with the preferred reporting items for systematic reviews and meta-analyses guidelines, from January, 1997 to January, 2022. Only studies involving zone 0 TEVAR were included. The retrieved data from the eligible studies included basic study characteristics, 30-day/in-hospital mortality rate, indications, comorbidities, stent grafts, techniques, and complications. Summary effect measures of the primary outcomes were obtained by logarithmically pooling the data with an inverse variance-weighted fixed-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Fifty-three studies with 1,013 patients were eligible for analysis. The pooled 30-day/in-hospital mortality rate of zone 0 TEVAR was 7.49%. The rates of post-operative stroke, type Ia endoleak, retrograde type A aortic dissection, and spinal cord ischemia were 8.95, 9.01, 5.72, and 4.12%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Although many novel stent grafts and techniques targeting zone 0 TEVAR are being investigated, a consensus on technique and device selection in zone 0 TEVAR is yet to be established in current practice. Furthermore, the post-operative stroke rate is relatively high, while other complication rates and perioperative death rate are comparable to those of TEVAR for other aortic zones.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Zhu, Li and Lu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Longtu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of General Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoye</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of General Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qingsheng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of General Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chimney TEVAR</Keyword><Keyword MajorTopicYN="N">complications after TEVAR</Keyword><Keyword MajorTopicYN="N">endograft</Keyword><Keyword MajorTopicYN="N">fenestrated TEVAR</Keyword><Keyword MajorTopicYN="N">hybrid endovascular aortic repair</Keyword><Keyword MajorTopicYN="N">zone 0 TEVAR</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36910538</ArticleId><ArticleId IdType="pmc">PMC9998709</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2023.1034354</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Manetta F, Newman J, Mattia A. Indications for thoracic endovascular aortic repair (TEVAR): a brief review. Int J Angiol. (2018) 27:177&#x2013;84. 10.1055/s-0038-1666972</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1666972</ArticleId><ArticleId IdType="pmc">PMC6221793</ArticleId><ArticleId IdType="pubmed">30410287</ArticleId></ArticleIdList></Reference><Reference><Citation>Baikoussis NG, Antonopoulos CN, Papakonstantinou NA, Argiriou M, Geroulakos G. Endovascular stent grafting for ascending aorta diseases. J Vasc Surg. (2017) 66:1587&#x2013;601. 10.1016/j.jvs.2017.07.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2017.07.064</ArticleId><ArticleId IdType="pubmed">28830707</ArticleId></ArticleIdList></Reference><Reference><Citation>Muetterties CE, Menon R, Wheatley GR. A systematic review of primary endovascular repair of the ascending aorta. J Vasc Surg. (2018) 67:332&#x2013;42. 10.1016/j.jvs.2017.06.099</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2017.06.099</ArticleId><ArticleId IdType="pubmed">28844469</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurimoto Y, Kawaharada N, Ito T, Baba T, Ohori S, Watanabe A, et al. . Less-invasive management of left subclavian artery in stent-grafting for distal aortic arch disease. Interact Cardiovasc Thorac Surg. (2009) 8:548&#x2013;52. 10.1510/icvts.2008.192484</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2008.192484</ArticleId><ArticleId IdType="pubmed">19240060</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa R, Melissano G, Tshomba Y, Civilini E, Marone EM, Bertoglio L, et al. . Ten years of endovascular aortic arch repair. J Endovasc Ther. (2010) 17:1&#x2013;11. 10.1583/09-2884.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/09-2884.1</ArticleId><ArticleId IdType="pubmed">20199258</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt PJ, Johnson C, Hinchliffe RJ, Morgan R, Jahingiri M, Loftus IM, et al. . Outcomes of the endovascular management of aortic arch aneurysm: implications for management of the left subclavian artery. J Vasc Surg. (2010) 51:1329&#x2013;38. 10.1016/j.jvs.2009.10.131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2009.10.131</ArticleId><ArticleId IdType="pubmed">20303695</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisb&#xfc;sch P, Kotelis D, Hyhlik-D&#xfc;rr A, Hakimi M, Attigah N, B&#xf6;ckler D. Endografting in the aortic arch - does the proximal landing zone influence outcome? Eur J Vasc Endovasc Surg. (2010) 39:693&#x2013;9. 10.1016/j.ejvs.2010.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2010.03.018</ArticleId><ArticleId IdType="pubmed">20452789</ArticleId></ArticleIdList></Reference><Reference><Citation>Canaud L, Hireche K, Berthet JP, Branchereau P, Marty-An&#xe9; C, Alric P. Endovascular repair of aortic arch lesions in high-risk patients or after previous aortic surgery: midterm results. J Thorac Cardiovasc Surg. (2010) 140:52&#x2013;8. 10.1016/j.jtcvs.2009.09.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.09.022</ArticleId><ArticleId IdType="pubmed">19919865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolvenbach RR, Karmeli R, Pinter LS, Zhu Y, Lin F, Wassiljew S, et al. . Endovascular management of ascending aortic pathology. J Vasc Surg. (2011) 53:1431&#x2013;7. 10.1016/j.jvs.2010.10.133</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2010.10.133</ArticleId><ArticleId IdType="pubmed">21276685</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo N, Rodriguez-Lopez JA, Heidari P, Wheatley G, Caparrelli D, Ramaiah V, et al. . Hybrid repair of thoracic aortic lesions for zone 0 and 1 in high-risk patients. J Vasc Surg. (2012) 55:318&#x2013;25. 10.1016/j.jvs.2011.08.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2011.08.042</ArticleId><ArticleId IdType="pubmed">22047829</ArticleId></ArticleIdList></Reference><Reference><Citation>Melissano G, Tshomba Y, Bertoglio L, Rinaldi E, Chiesa R. Analysis of stroke after TEVAR involving the aortic arch. Eur J Vasc Endovasc Surg. (2012) 43:269&#x2013;75. 10.1016/j.ejvs.2011.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2011.12.009</ArticleId><ArticleId IdType="pubmed">22240331</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui D, Wada Y, Komatsu K, Fujii T, Ohashi N, Terasaki T, et al. . Innovative application of available stent grafts in Japan in aortic aneurysm treatment-significance of innovative debranching and chimney method and coil embolization procedure. Ann Vasc Dis. (2013) 6:601&#x2013;11. 10.3400/avd.oa.13-00070</Citation><ArticleIdList><ArticleId IdType="doi">10.3400/avd.oa.13-00070</ArticleId><ArticleId IdType="pmc">PMC3793182</ArticleId><ArticleId IdType="pubmed">24130616</ArticleId></ArticleIdList></Reference><Reference><Citation>Preventza O, Bakaeen FG, Cervera RD, Coselli JS. Deployment of proximal thoracic endograft in zone 0 of the ascending aorta: treatment options and early outcomes for aortic arch aneurysms in a high-risk population. Eur J Cardiothorac Surg. (2013) 44:446&#x2013;52. Discussion 452&#x2013;3. 10.1093/ejcts/ezt068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt068</ArticleId><ArticleId IdType="pubmed">23515170</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirakawa Y, Kuratani T, Shimamura K, Torikai K, Sakamoto T, Shijo T, et al. . The efficacy and short-term results of hybrid thoracic endovascular repair into the ascending aorta for aortic arch pathologies. Eur J Cardiothorac Surg. (2014) 45:298&#x2013;304. Discussion 304. 10.1093/ejcts/ezt391</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt391</ArticleId><ArticleId IdType="pubmed">23913243</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardes RC, Navarro TP, Reis FR, Lima LC, Monteiro EL, Procopio RJ, et al. . Early experience with off-the-shelf endografts using a zone 0 proximal landing site to treat the ascending aorta and arch. J Thorac Cardiovasc Surg. (2014) 148:105&#x2013;12. 10.1016/j.jtcvs.2013.07.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.07.049</ArticleId><ArticleId IdType="pubmed">24035373</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli EE, Idrees J, Greenberg RK, Johnston DR, Lytle BW. Endovascular stent grafting for ascending aorta repair in high-risk patients. J Thorac Cardiovasc Surg. (2015) 149:144&#x2013;51. 10.1016/j.jtcvs.2014.07.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.07.109</ArticleId><ArticleId IdType="pubmed">25312226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraoka A, Chikazawa G, Tamura K, Totsugawa T, Sakaguchi T, Yoshitaka H. Clinical outcomes of different approaches to aortic arch disease. J Vasc Surg. (2015) 61:88&#x2013;95. 10.1016/j.jvs.2014.06.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2014.06.121</ArticleId><ArticleId IdType="pubmed">25095745</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rango P, Cao P, Ferrer C, Simonte G, Coscarella C, Cieri E, et al. . Aortic arch debranching and thoracic endovascular repair. J Vasc Surg. (2014) 59:107&#x2013;14. 10.1016/j.jvs.2013.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2013.07.010</ArticleId><ArticleId IdType="pubmed">24001696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurimoto Y, Maruyama R, Ujihira K, Nishioka N, Hasegawa K, Iba Y, et al. . Thoracic endovascular aortic repair for challenging aortic arch diseases using fenestrated stent grafts from zone 0. Ann Thorac Surg. (2015) 100:24&#x2013;32. Discussion 32&#x2013;3. 10.1016/j.athoracsur.2015.01.071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.01.071</ArticleId><ArticleId IdType="pubmed">25986100</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandet T, Canaud L, Ozdemir BA, Ziza V, Demaria R, Albat B, et al. . Factors favoring retrograde aortic dissection after endovascular aortic arch repair. J Thorac Cardiovasc Surg. (2015) 150:136&#x2013;42. 10.1016/j.jtcvs.2015.03.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.03.042</ArticleId><ArticleId IdType="pubmed">25936469</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazavet A, Alacoque X, Marcheix B, Chaufour X, Rousseau H, Glock Y, et al. . Aortic arch aneurysm: short- and mid-term results comparing open arch surgery and the hybrid procedure&#x2020;. Eur J Cardiothorac Surg. (2016) 49:134&#x2013;40. 10.1093/ejcts/ezv024</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv024</ArticleId><ArticleId IdType="pubmed">25698156</ArticleId></ArticleIdList></Reference><Reference><Citation>Katada Y, Kondo S, Tsuboi E, Rokkaku K, Irie Y, Yokoyama H. Endovascular total arch repair using in situ fenestration for arch aneurysm and chronic type A dissection. Ann Thorac Surg. (2016) 101:625&#x2013;30. 10.1016/j.athoracsur.2015.07.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.07.032</ArticleId><ArticleId IdType="pubmed">26387722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziza V, Canaud L, Molinari N, Branchereau P, Marty-An&#xe9; C, Alric P. Thoracic endovascular aortic repair: a single center's 15-year experience. J Thorac Cardiovasc Surg. (2016) 151:1595&#x2013;603.e7. 10.1016/j.jtcvs.2015.12.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.12.030</ArticleId><ArticleId IdType="pubmed">26832207</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilimparis N, Debus ES, Oderich GS, Haulon S, Terp KA, Roeder B, et al. . International experience with endovascular therapy of the ascending aorta with a dedicated endograft. J Vasc Surg. (2016) 63:1476&#x2013;82. 10.1016/j.jvs.2015.12.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2015.12.027</ArticleId><ArticleId IdType="pubmed">26926935</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ckler D, Brunkwall DJ, Taylor PR, Mangialardi N, H&#xfc;sing J, Larzon T. Thoracic endovascular aortic repair of aortic arch pathologies with the conformable thoracic aortic graft: early and 2 year results from a European Multicentre Registry. Eur J Vasc Endovasc Surg. (2016) 51:791&#x2013;800. 10.1016/j.ejvs.2016.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2016.02.006</ArticleId><ArticleId IdType="pubmed">27107487</ArticleId></ArticleIdList></Reference><Reference><Citation>Narita H, Komori K, Usui A, Yamamoto K, Banno H, Kodama A, et al. . Postoperative outcomes of hybrid repair in the treatment of aortic arch aneurysms. Ann Vasc Surg. (2016) 34:55&#x2013;61. 10.1016/j.avsg.2015.11.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2015.11.041</ArticleId><ArticleId IdType="pubmed">27179984</ArticleId></ArticleIdList></Reference><Reference><Citation>Faure EM, Canaud L, Marty-An&#xe9; C, Alric P. Hybrid aortic arch repair for dissecting aneurysm. J Thorac Cardiovasc Surg. (2016) 152:162&#x2013;8. 10.1016/j.jtcvs.2016.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.03.020</ArticleId><ArticleId IdType="pubmed">27068438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshitake A, Hachiya T, Okamoto K, Kitahara H, Kawaguchi S, Nakatsuka S, et al. . Postoperative stroke after debranching with thoracic endovascular aortic repair. Ann Vasc Surg. (2016) 36:132&#x2013;8. 10.1016/j.avsg.2016.02.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2016.02.039</ArticleId><ArticleId IdType="pubmed">27401834</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecoraro F, Lachat M, Hofmann M, Cayne NS, Chaykovska L, Rancic Z, et al. . Mid-term results of zone 0 thoracic endovascular aneurysm repair after ascending aorta wrapping and supra-aortic debranching in high-risk patients. Interact Cardiovasc Thorac Surg. (2017) 24:882&#x2013;9. 10.1093/icvts/ivx016</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx016</ArticleId><ArticleId IdType="pubmed">28329189</ArticleId></ArticleIdList></Reference><Reference><Citation>Canaud L, Baba T, Gandet T, Narayama K, Ozdemir BA, Shibata T, et al. . Physician-modified thoracic stent-grafts for the treatment of aortic arch lesions. J Endovasc Ther. (2017) 24:542&#x2013;548. 10.1177/1526602817714206</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1526602817714206</ArticleId><ArticleId IdType="pubmed">28597717</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Shu C, Li QM, Li M, Li X, He H, et al. . First experience with the double chimney technique in the treatment of aortic arch diseases. J Vasc Surg. (2017) 66:1018&#x2013;27. 10.1016/j.jvs.2017.02.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2017.02.035</ArticleId><ArticleId IdType="pubmed">28502544</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli EE, Idrees JJ, Johnston DR, Eagleton MJ, Desai MY, Svensson LG. Zone zero thoracic endovascular aortic repair: a proposed modification to the classification of landing zones. J Thorac Cardiovasc Surg. (2018) 155:1381&#x2013;9. 10.1016/j.jtcvs.2017.11.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.11.054</ArticleId><ArticleId IdType="pubmed">29395197</ArticleId></ArticleIdList></Reference><Reference><Citation>Toya N, Ohki T, Fukushima S, Shukuzawa K, Ito E, Murakami Y, et al. . Case series of aortic arch aneurysm in patients with bovine arch treated with proximal scalloped and fenestrated stent graft. Cardiovasc Intervent Radiol. (2018) 41:1648&#x2013;53. 10.1007/s00270-018-2058-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-018-2058-1</ArticleId><ArticleId IdType="pubmed">30120530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Dai X, Noiniyom P, Luo Y, Fan H, Feng Z, et al. . Fenestrated thoracic endovascular aortic repair using physician-modified stent grafts (PMSGs) in zone 0 and zone 1 for aortic arch diseases. Cardiovasc Intervent Radiol. (2019) 42:19&#x2013;27. 10.1007/s00270-018-2079-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-018-2079-9</ArticleId><ArticleId IdType="pubmed">30327926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka A, Motoki M, Kato M, Sugai H, Okubo N. Quantification of aortic shagginess as a predictive factor of perioperative stroke and long-term prognosis after endovascular treatment of aortic arch disease. J Vasc Surg. (2019) 69:15&#x2013;23. 10.1016/j.jvs.2018.03.425</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2018.03.425</ArticleId><ArticleId IdType="pubmed">29914832</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Ding H, Jiang M, Liu Y, Huang C, Yang X, et al. . Outcomes of chimney technique for aortic arch diseases: a single-center experience with 226 cases. Clin Interv Aging. (2019) 14:1829&#x2013;40. 10.2147/CIA.S222948</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S222948</ArticleId><ArticleId IdType="pmc">PMC6818674</ArticleId><ArticleId IdType="pubmed">31749612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi T, Kubota S, Hasegawa K, Ueda H. Clinical results and medical costs of thoracic endovascular aortic repair in patients over 80 years of age. J Artif Organs. (2019) 22:61&#x2013;7. 10.1007/s10047-018-1073-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10047-018-1073-y</ArticleId><ArticleId IdType="pubmed">30311021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryomoto M, Tanaka H, Mitsuno M, Yamamura M, Sekiya N, Uemura H, et al. . A novel approach to prevent perioperative stroke in patients undergoing debranching thoracic endovascular aortic repair with a mini-cardiopulmonary bypass support. Ann Vasc Surg. (2019) 59:143&#x2013;9. 10.1016/j.avsg.2018.09.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2018.09.036</ArticleId><ArticleId IdType="pubmed">30954589</ArticleId></ArticleIdList></Reference><Reference><Citation>Piffaretti G, Grassi V, Lomazzi C, Brinkman WT, Navarro TP, Jenkins MP, et al. . Thoracic endovascular stent graft repair for ascending aortic diseases. J Vasc Surg. (2019) 70:1384&#x2013;9.e1. 10.1016/j.jvs.2019.01.075</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2019.01.075</ArticleId><ArticleId IdType="pubmed">31126763</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilimparis N, Law Y, Rohlffs F, Spanos K, Debus ES, K&#xf6;lbel T. Fenestrated endovascular repair for diseases involving the aortic arch. J Vasc Surg. (2020) 71:1464&#x2013;71. 10.1016/j.jvs.2019.06.205</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2019.06.205</ArticleId><ArticleId IdType="pubmed">32063444</ArticleId></ArticleIdList></Reference><Reference><Citation>De Le&#xf3;n AI, Cheng YT, Chen SW, Chu SY, Nan YY, Liu KS. Outcomes of type Ia endoleaks after endovascular repair of the proximal aorta. J Thorac Cardiovasc Surg. (2020) 163:2012.e6. 10.1016/j.jtcvs.2020.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.06.026</ArticleId><ArticleId IdType="pubmed">32773121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo HS, Huang JH, Chen JS. Handmade fenestrated stent grafts to preserve all supra-aortic branches in thoracic endovascular aortic repair. J Thorac Cardiovasc Surg. (2020) 160:629&#x2013;39.e1. 10.1016/j.jtcvs.2019.07.096</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.07.096</ArticleId><ArticleId IdType="pubmed">31564542</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinelli G, Ferrer C, Giudice R, Ferraresi M, Pogany G, Cao P, et al. . Long-term results of hybrid repair techniques for Kommerell's diverticulum. J Vasc Surg. (2020) 72:1213&#x2013;21. 10.1016/j.jvs.2019.11.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2019.11.052</ArticleId><ArticleId IdType="pubmed">32035782</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Alonso L, Fern&#xe1;ndez Alonso S, Mart&#xed;nez Aguilar E, Santamarta Fari&#xf1;a E, Alegret Sol&#xe9; J, Atienza Pascual M, et al. . Fenestrated and scalloped endovascular grafts in zone 0 and zone 1 for aortic arch disease. Ann Vasc Surg. (2020) 69:360&#x2013;5. 10.1016/j.avsg.2020.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.06.009</ArticleId><ArticleId IdType="pubmed">32554200</ArticleId></ArticleIdList></Reference><Reference><Citation>Chassin-Trubert L, Ozdemir BA, Roussel A, Dessertenne G, Castier Y, Ludovic C, et al. . Prevention of retrograde ascending aortic dissection by cardiac pacing during hybrid surgery for zone 0 aortic arch repair. Ann Vasc Surg. (2021) 71:48&#x2013;55. 10.1016/j.avsg.2020.08.136</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.08.136</ArticleId><ArticleId IdType="pubmed">32927033</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Wu X, Zhang X, Qin J, Zhao Z, Ye K, et al. . Clinical outcomes of distal tapered restrictive covered stent applied in endovascular treatment of aortic dissection involving zone 0. Eur J Vasc Endovasc Surg. (2021) 61:413&#x2013;21. 10.1016/j.ejvs.2020.11.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2020.11.037</ArticleId><ArticleId IdType="pubmed">33422438</ArticleId></ArticleIdList></Reference><Reference><Citation>Planer D, Elbaz-Greener G, Mangialardi N, Lindsay T, D'Onofrio A, Schelzig H, et al. . NEXUS arch: a multicenter study evaluating the initial experience with a novel aortic arch stent graft system. Ann Surg. (2021) 277:e460&#x2013;6. 10.1097/SLA.0000000000004843</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000004843</ArticleId><ArticleId IdType="pubmed">33714965</ArticleId></ArticleIdList></Reference><Reference><Citation>Dake MD, Bavaria JE, Singh MJ, Oderich G, Filinger M, Fischbein MP, et al. . Management of arch aneurysms with a single-branch thoracic endograft in zone 0. JTCVS Tech. (2021) 7:1&#x2013;6. 10.1016/j.xjtc.2021.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xjtc.2021.01.011</ArticleId><ArticleId IdType="pmc">PMC8311452</ArticleId><ArticleId IdType="pubmed">34318189</ArticleId></ArticleIdList></Reference><Reference><Citation>Seguchi R, Kiuchi R, Horikawa T, Tarui T, Sanada J, Ohtake H, et al. . Novel brain protection method for zone 0 endovascular aortic repair with selective cerebral perfusion. Ann Vasc Dis. (2021) 14:153&#x2013;8. 10.3400/avd.oa.21-00025</Citation><ArticleIdList><ArticleId IdType="doi">10.3400/avd.oa.21-00025</ArticleId><ArticleId IdType="pmc">PMC8241544</ArticleId><ArticleId IdType="pubmed">34239641</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Zhang L, Song C, Zhang H, Xia S, Li H, et al. . Long-term outcomes of thoracic endovascular repair for aortic arch dissection using customized single-branched fenestrated stent-graft. Vasc Endovascular Surg. (2021) 55:577&#x2013;585. 10.1177/15385744211010446</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15385744211010446</ArticleId><ArticleId IdType="pubmed">34036846</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Zhang L, Song C, Zhang H, Xia S, Li H, et al. . Outcomes of total endovascular aortic arch repair with surgeon-modified fenestrated stent-grafts on zone 0 landing for aortic arch pathologies. J Endovasc Ther. (2021) 2021:15266028211036478. 10.1177/15266028211036478</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15266028211036478</ArticleId><ArticleId IdType="pubmed">34427153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna L, Abdullah A, Kashef E, Riga C, Jenkins M, Bicknell C, et al. . Four-year results of the Bolton relay proximal scallop endograft in the management of thoracic and thoracoabdominal aortic pathology with unfavorable proximal landing zone. J Vasc Surg. (2021) 74:1447&#x2013;55. 10.1016/j.jvs.2021.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2021.04.027</ArticleId><ArticleId IdType="pubmed">33940076</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes JA, Wanken ZJ, Columbo JA, Kuwayama DP, Fillinger MF, Suckow BD. Procedure-associated costs and mid-term outcomes of endovascular zone 0 and zone 1 aortic arch repair. Ann Vasc Surg. (2021) 81:98&#x2013;104. 10.1016/j.avsg.2021.10.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2021.10.026</ArticleId><ArticleId IdType="pubmed">34780945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudo T, Kuratani T, Shirakawa Y, Shimamura K, Kin K, Sakamoto T, et al. . Comparison of the outcomes of total endovascular aortic arch repair between branched endograft and chimney endograft technique in zone 0 landing. J Endovasc Ther. (2021) 2021:15266028211059912. 10.1177/15266028211059912</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15266028211059912</ArticleId><ArticleId IdType="pubmed">34802327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Luo M, Fang K, Shu C. Endovascular repair for acute zone 0 intramural hematoma with most proximal tear or ulcer-like projection in the descending aorta. J Vasc Surg. (2021) 75:1561&#x2013;9. 10.1016/j.jvs.2021.12.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2021.12.055</ArticleId><ArticleId IdType="pubmed">34973400</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleshra A, Heo W, Lee KH, Kim TH, Sim HS, Sharafeldin H, et al. . Mid-term outcomes of hybrid debranching endovascular aortic arch repair in landing zones 0&#x2013;2. Vascular. (2022) 2022:17085381211068230. 10.1177/17085381211068230</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17085381211068230</ArticleId><ArticleId IdType="pubmed">35100906</ArticleId></ArticleIdList></Reference><Reference><Citation>von Allmen RS, Gahl B, Powell JT. Editor's choice - incidence of stroke following thoracic endovascular aortic repair for descending aortic aneurysm: a systematic review of the literature with meta-analysis. Eur J Vasc Endovasc Surg. (2017) 53:176&#x2013;84. 10.1016/j.ejvs.2016.10.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2016.10.025</ArticleId><ArticleId IdType="pubmed">27993454</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaolanis GI, Antonopoulos CN, Charbonneau P, Georgakarakos E, Moris D, Scali S, et al. . A systematic review and meta-analysis of stroke rates in patients undergoing Thoracic Endovascular Aortic Repair for descending thoracic aortic aneurysm and type B dissection. J Vasc Surg. (2022) 76:292&#x2013;301.e3. 10.1016/j.jvs.2022.02.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2022.02.031</ArticleId><ArticleId IdType="pubmed">35248694</ArticleId></ArticleIdList></Reference><Reference><Citation>Papakonstantinou NA, Antonopoulos CN, Baikoussis NG, Kakisis I, Geroulakos G. Frozen elephant trunk: an alternative surgical weapon against extensive thoracic aorta disease. A three-year meta-analysis. Heart Lung Circ. (2019) 28:213&#x2013;22. 10.1016/j.hlc.2018.04.306</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2018.04.306</ArticleId><ArticleId IdType="pubmed">30056013</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wang J, Premaratne S, Zhao J, Zhang WW. Meta-analysis of the outcomes of revascularization after intentional coverage of the left subclavian artery for thoracic endovascular aortic repair. J Vasc Surg. (2019) 70:1330&#x2013;40. 10.1016/j.jvs.2019.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2019.03.022</ArticleId><ArticleId IdType="pubmed">31176636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammo S, Larzon T, Hultgren R, Wanhainen A, Mani K, Resch T, et al. . Outcome after endovascular repair of ruptured descending thoracic aortic aneurysm: a national multicentre study. Eur J Vasc Endovasc Surg. (2019) 57:788&#x2013;94. 10.1016/j.ejvs.2018.10.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2018.10.029</ArticleId><ArticleId IdType="pubmed">30910493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudo T, Kuratani T, Shimamura K, Sawa Y. Determining the optimal proximal landing zone for TEVAR in the aortic arch: comparing the occurrence of the bird-beak phenomenon in zone 0 vs zones 1 and 2. J Endovasc Ther. (2020) 27:368&#x2013;76. 10.1177/1526602820914269</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1526602820914269</ArticleId><ArticleId IdType="pubmed">32242769</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida N. How to prevent spinal cord injury during endovascular repair of thoracic aortic disease. Gen Thorac Cardiovasc Surg. (2014) 62:391&#x2013;7. 10.1007/s11748-014-0395-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-014-0395-9</ArticleId><ArticleId IdType="pubmed">24696427</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Zhang S, Liu L, Lu Q, Zhang T, Jing Z. Retrograde type A aortic dissection after thoracic endovascular aortic repair: a systematic review and meta-analysis. J Am Heart Assoc. (2017) 6:e004649. 10.1161/JAHA.116.004649</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.004649</ArticleId><ArticleId IdType="pmc">PMC5634245</ArticleId><ArticleId IdType="pubmed">28939705</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuhauser B, Greiner A, Jaschke W, Chemelli A, Fraedrich G. Serious complications following endovascular thoracic aortic stent-graft repair for type B dissection. Eur J Cardiothorac Surg. (2008) 33:58&#x2013;63. 10.1016/j.ejcts.2007.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2007.10.010</ArticleId><ArticleId IdType="pubmed">18024145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramdass M. TEVAR for symptomatic Stanford B dissection: a systematic review of 30-day mortality and morbidity. Thorac Cardiovasc Surg. (2015) 63:97&#x2013;112. 10.1055/s-0034-1370760</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1370760</ArticleId><ArticleId IdType="pubmed">24752872</ArticleId></ArticleIdList></Reference><Reference><Citation>Naazie IN, Gupta JD, Azizzadeh A, Arbabi C, Zarkowsky D, Malas MB. Risk calculator predicts 30-day mortality after thoracic endovascular aortic repair for intact descending thoracic aortic aneurysms in the Vascular Quality Initiative. J Vasc Surg. (2022) 75:833&#x2013;41.e1. 10.1016/j.jvs.2021.08.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2021.08.056</ArticleId><ArticleId IdType="pubmed">34506896</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DG, Olson SL, Panthofer AM, Matsumura JS, DiMusto PD. A Frailty-based risk score predicts morbidity and mortality after elective endovascular repair of descending thoracic aortic aneurysms. Ann Vasc Surg. (2020) 67:90&#x2013;9. 10.1016/j.avsg.2019.10.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2019.10.090</ArticleId><ArticleId IdType="pubmed">31705983</ArticleId></ArticleIdList></Reference><Reference><Citation>Settepani F, Cappai A, Basciu A, Barbone A, Tarelli G. Outcome of open total arch replacement in the modern era. J Vasc Surg. (2016) 63:537&#x2013;45. 10.1016/j.jvs.2015.10.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2015.10.061</ArticleId><ArticleId IdType="pubmed">26804221</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone A, Beckmann E, Martens A, Di Marco L, Pantaleo A, Reggiani LB, et al. . Total aortic arch replacement with frozen elephant trunk technique: results from two European institutes. J Thorac Cardiovasc Surg. (2020) 159:1201&#x2013;11. 10.1016/j.jtcvs.2019.03.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.03.121</ArticleId><ArticleId IdType="pubmed">31208809</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34088614</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic Review and Meta-Analysis of the Effect of Perineural Catheters in Major Lower Limb Amputations.</ArticleTitle><Pagination><StartPage>295</StartPage><EndPage>303</EndPage><MedlinePgn>295-303</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2021.03.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(21)00240-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Controlling pain after major lower limb amputation (MLLA) is of critical importance to patients and clinicians. The aim of this systematic review and meta-analysis was to assess the effect of perineural catheters (PNCs) on post-operative pain, post-operative morphine requirement, in-hospital mortality, long term phantom limb pain, and chronic stump pain.</AbstractText><AbstractText Label="METHODS">A systematic review using PubMed, EMBASE via OVID and the Cochrane library from database inception (1946) to 20 October 2020 was performed according to PRISMA guidelines. Studies involving patients undergoing MLLA which reported on post-operative morphine requirement, pain scores, in-hospital mortality, phantom limb pain (PLP), and chronic stump pain were included. Studies comparing PNC use with epidural or wound site local anaesthetic infusions were excluded. Outcome data were extracted from individual studies and meta-analysis was performed using a random effects (Mantel-Haenszel) model for dichotomous data using an odds ratio (OR) summary statistic with 95% confidence intervals (CI), and with an inverse variance random effects model for continuous data using a standardised mean difference (SMD) summary statistic with 95% CIs. Sensitivity analyses were performed for post-operative pain scores and post-operative morphine requirement. Study quality was assessed using the Downs and Black score, and outcomes were assessed using the GRADE tool.</AbstractText><AbstractText Label="RESULTS">Ten studies reporting on 731 patients were included, with 350 patients receiving a PNC and 381 receiving standard care. PNC use is associated with a reduction in post-operative pain (SMD&#xa0;-0.30, 95% CI&#xa0;-0.58 -&#xa0;-0.01, p&#xa0;= .040, I<sup>2</sup>&#xa0;= 54%, GRADE quality of evidence: low) and post-operative morphine requirements (SMD&#xa0;-0.63, 95% CI&#xa0;-1.03 -&#xa0;-0.23, p&#xa0;= .002, I<sup>2</sup>&#xa0;= 75%, GRADE quality of evidence: moderate), although the effect of PNC on reduced post-operative morphine requirements is lost on sensitivity analysis of randomised trials only (p&#xa0;= .40). No demonstrable effect was found on in-hospital mortality, PLP, or chronic stump pain (GRADE quality of evidence: low).</AbstractText><AbstractText Label="CONCLUSION">PNC use in amputees is associated with a significant reduction in post-operative pain scores and post-operative morphine requirements, although this latter finding is lost on sensitivity analysis of randomised trials only.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2021. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laloo</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Leeds Teaching Hospitals Trust, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambler</LastName><ForeName>Graeme K</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Bristol Centre for Surgical Research, University of Bristol, Bristol, United Kingdom; North Bristol NHS Trust, Southmead Hospital, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locker</LastName><ForeName>Dafydd</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Royal Gwent Hospital, Newport, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twine</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Bristol Centre for Surgical Research, University of Bristol, Bristol, United Kingdom; North Bristol NHS Trust, Southmead Hospital, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosanquet</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Royal Gwent Hospital, Newport, United Kingdom. Electronic address: david.bosanquet@wales.nhs.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>76I7G6D29C</RegistryNumber><NameOfSubstance UI="D009020">Morphine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="N">Amputation, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000672" MajorTopicYN="N">Amputation Stumps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057785" MajorTopicYN="N">Catheters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010525" MajorTopicYN="N">Peripheral Nerves</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010591" MajorTopicYN="N">Phantom Limb</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amputation</Keyword><Keyword MajorTopicYN="N">Nerve sheath catheter</Keyword><Keyword MajorTopicYN="N">Perineural catheters</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>5</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34088614</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2021.03.008</ArticleId><ArticleId IdType="pii">S1078-5884(21)00240-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35657725</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Corticosteroids in patients undergoing cardiac surgery: A meta-analysis of 12,559 patients.</ArticleTitle><Pagination><StartPage>853</StartPage><EndPage>859</EndPage><MedlinePgn>853-859</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02676591221106324</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Corticosteroids can attenuate the inflammatory response to cardiopulmonary bypass, but their benefits on clinical outcomes are unclear. We conducted a meta-analysis to evaluate whether corticosteroid therapy affects outcomes in patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS">We searched PubMed, Embase, EBSCO and Cochrane databases from 1 January 2010 to 14 March 2022 for randomized controlled trials (RCTs) that assessed corticosteroid versus non- corticosteroid therapy in patients undergoing cardiac surgery. The primary outcome was in-hospital mortality. Secondary outcomes were renal failure, infection, delirium, intensive care unit (ICU) and hospital stay.</AbstractText><AbstractText Label="RESULTS">Four RCTs including 12,559 patients (6265 randomized to corticosteroid therapy and 6294 to non-corticosteroid therapy) were included. One-hundred and 92 of 6265 patients (3.1%) randomized to the corticosteroid group versus 221 of 6294 patients (3.5%) randomized to the non-corticosteroid group experienced death during hospitalization. Compared the control group, corticosteroid therapy did not significantly reduce in-hospital mortality, with an RR of 0.87 (0.72-1.06), <i>p</i> = .16. There was no difference in the incidence of infection (RR 0.78 (0.56-1.10), <i>p</i> = .16), delirium during hospitalization (RR 1.01 (0.90-1.14), <i>p</i> = .85), or the length of hospital stay (MD -0.13 (-0.32 to 0.05), <i>p</i> = .17). However, corticosteroid therapy significantly reduced the risk of renal failure ( RR 0.82 (0.67-0.99), <i>p</i> = .04), and the length of ICU stay (MD -0.41 (-0.65 to -0.17), <i>p</i> &lt; .01).</AbstractText><AbstractText Label="CONCLUSIONS">Corticosteroids did not significantly reduce the rates of in-hospital mortality, infection, or delirium, but reduce the incidence of renal failure and the length of ICU stay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yiyi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7727-9981</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">corticosteroid</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35657725</ArticleId><ArticleId IdType="doi">10.1177/02676591221106324</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33451954</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Esmolol in Cardiac Surgery: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>1106</StartPage><EndPage>1114</EndPage><MedlinePgn>1106-1114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2020.12.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(20)31376-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess whether the administration of the ultra-short-acting &#x3b2;-blocker esmolol in cardiac surgery could have a cardioprotective effect that translates into improved postoperative outcomes.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Single-center, double-blinded, parallel-group randomized controlled trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A tertiary care referral center.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients undergoing elective cardiac surgery with preoperative evidence of left ventricular end-diastolic diameter &gt;60 mm and/or left ventricular ejection fraction &lt;50%.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were assigned randomly to receive either esmolol (1 mg/kg as a bolus before aortic cross-clamping and 2 mg/kg mixed in the cardioplegia solution) or placebo in a 1:1 allocation ratio.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The primary composite endpoint of prolonged intensive care unit stay and/or in-hospital mortality occurred in 36/98 patients (36%) in the placebo group versus 27/102 patients (27%) in the esmolol group (p&#x202f;=&#x202f;0.13). In the esmolol group, a reduction in the maximum inotropic score during the first 24 postoperative hours was observed (10 [interquartile range 5-15] v 7 [interquartile range 5-10.5]; p&#x202f;=&#x202f;0.04), as well as a trend toward a reduction in postoperative low-cardiac-output syndrome (13/98 v 6/102; p&#x202f;=&#x202f;0.08) and the rate of hospital admission at one year (26/95 v 16/96; p&#x202f;=&#x202f;0.08). A trend toward an increase in the number of patients with ejection fraction &#x2265;60% at hospital discharge also was observed (4/95 v 11/92; p&#x202f;=&#x202f;0.06).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the present trial, esmolol as a cardioplegia adjuvant enhanced postoperative cardiac performance but did not reduce a composite endpoint of prolonged intensive care unit stay and/or mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bignami</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>No&#xe8;</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardelli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licheri</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerli</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crivellari</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Prima</LastName><ForeName>Ambra Licia</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Tomasso</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crescenzi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011412">Propanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>MDY902UXSR</RegistryNumber><NameOfSubstance UI="C036604">esmolol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011412" MajorTopicYN="Y">Propanolamines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">esmolol</Keyword><Keyword MajorTopicYN="N">&#x3b2;-blockers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33451954</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2020.12.029</ArticleId><ArticleId IdType="pii">S1053-0770(20)31376-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37495718</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Influencing factors on morbidity and mortality in intertrochanteric fractures.</ArticleTitle><Pagination><StartPage>12090</StartPage><MedlinePgn>12090</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12090</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-38667-9</ELocationID><Abstract><AbstractText>We aimed to evaluate the effect of the patient's clinical and paraclinical condition before and after surgery on short-term mortality and complication and long-term mortality. A retrospective cohort study was conducted and multivariate logistic regression was applied to determine the effect of demographic characteristics (sex, age, AO/OTA classification, height, weight, body mass index), medical history (hypertension, ischemic heart disease, diabetes mellitus, thyroid malfunction, cancer, osteoporosis, smoking) lab data (Complete blood cell, blood sugar, Blood Urea Nitrogen, Creatinine, Na, and K), surgery-related factors (Anesthesia time and type, implant, intraoperative blood transfusion, postoperative blood transfusion, and operation time), duration of admission to surgery and anticoagulant consumption on short-term mortality and complication and long-term mortality. Three hundred ten patients from November 2016 to September 2020 were diagnosed with an intertrochanteric fracture. 3.23% of patients died in hospital, 14.1% of patients confronted in-hospital complications, and 38.3% died after discharge till the study endpoint. &#x394;Number of Neutrophiles is the primary determinant for in-hospital mortality in multivariate analysis. Age and blood transfusion are the main determinants of long-term mortality, and Na before surgery is the primary variable associated with postoperative complications. Among different analytical factors Na before surgery as a biomarker presenting dehydration was the main prognostic factor for in hospital complications. In hospital mortality was mainly because of infection and long-term mortality was associated with blood transfusion.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babagoli</LastName><ForeName>Mazyar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sina University Hospital, Tehran University of Medical Sciences, Tehran, Iran. m.babagoli77@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghaseminejad Raeini</LastName><ForeName>Amirhossein</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Orthopedic Surgery Research Center, Sina University Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheykhvatan</LastName><ForeName>Mehrdad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Orthopedic Surgery Research Center, Sina University Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baghdadi</LastName><ForeName>Soroush</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Orthopaedic Surgery Department, Montefiore Medical Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafiei</LastName><ForeName>Seyyed Hossein</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Orthopedic Surgery Research Center, Sina University Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>23</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37495718</ArticleId><ArticleId IdType="pmc">PMC10372085</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-38667-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-38667-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos. Int. 1997;7(5):407&#x2013;13. doi: 10.1007/PL00004148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00004148</ArticleId><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeyemi A, Delhougne G. Incidence and economic burden of intertrochanteric fracture: A medicare claims database analysis. JBJS Open Access. 2019;4(1):e0045. doi: 10.2106/JBJS.OA.18.00045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.OA.18.00045</ArticleId><ArticleId IdType="pmc">PMC6510469</ArticleId><ArticleId IdType="pubmed">31161153</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: Morbidity, subsequent fractures, and mortality. Ther. Clin. Risk Manag. 2014;10:937&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4242696</ArticleId><ArticleId IdType="pubmed">25429224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundi S, Pindiprolu B, Simunovic N, Bhandari M. Similar mortality rates in hip fracture patients over the past 31 years. Acta Orthop. 2014;85(1):54&#x2013;9. doi: 10.3109/17453674.2013.878831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453674.2013.878831</ArticleId><ArticleId IdType="pmc">PMC3940992</ArticleId><ArticleId IdType="pubmed">24397744</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmont PJ, Jr, Garcia EJ, Romano D, Bader JO, Nelson KJ, Schoenfeld AJ. Risk factors for complications and in-hospital mortality following hip fractures: A study using the National Trauma Data Bank. Arch. Orthop. Trauma Surg. 2014;134(5):597&#x2013;604. doi: 10.1007/s00402-014-1959-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-014-1959-y</ArticleId><ArticleId IdType="pubmed">24570142</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi&#xe7;en &#xc7;, Akdemir M, T&#xfc;rken MA, &#xc7;ekok K, Ekin A, Turan AC. Analysis of risk factors affecting mortality in elderly patients operated on for hip fractures: A retrospective comparative study. Acta Orthop. Traumatol. Turc. 2021;55(6):493&#x2013;9. doi: 10.5152/j.aott.2021.21004.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/j.aott.2021.21004</ArticleId><ArticleId IdType="pmc">PMC11583227</ArticleId><ArticleId IdType="pubmed">34967737</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Chou ACC, Nadkarni N, Ng CEQ, Chong YS, Howe TS, et al. Charlson comorbidity index predicts 5-year survivorship of surgically treated hip fracture patients. Geriatr. Orthop. Surg. Rehabil. 2018;9:2151459318806442. doi: 10.1177/2151459318806442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151459318806442</ArticleId><ArticleId IdType="pmc">PMC6249653</ArticleId><ArticleId IdType="pubmed">30479849</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto IP, Ferres LFB, Boni G, Fal&#xf3;tico GG, Moraes M, Puertas EB. Does early surgical fixation of proximal femoral fractures in elderly patients affect mortality rates? Rev. Bras. Ortop. (Sao Paulo) 2019;54(4):392&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6701960</ArticleId><ArticleId IdType="pubmed">31435104</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinleye SD, Garofolo G, Culbertson MD, Homel P, Erez O. The role of BMI in hip fracture surgery. Geriatr. Orthop. Surg. Rehabil. 2018;9:2151458517747414. doi: 10.1177/2151458517747414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151458517747414</ArticleId><ArticleId IdType="pmc">PMC5813852</ArticleId><ArticleId IdType="pubmed">29468090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha YH, Lee YK, Koo KH, Wi C, Lee KH. Difference in mortality rate by type of anticoagulant in elderly patients with cardiovascular disease after hip fractures. Clin. Orthop. Surg. 2019;11(1):15&#x2013;20. doi: 10.4055/cios.2019.11.1.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.4055/cios.2019.11.1.15</ArticleId><ArticleId IdType="pmc">PMC6389530</ArticleId><ArticleId IdType="pubmed">30838103</ArticleId></ArticleIdList></Reference><Reference><Citation>Harty JA, McKenna P, Moloney D, D'Souza L, Masterson E. Anti-platelet agents and surgical delay in elderly patients with hip fractures. J. Orthop. Surg. (Hong Kong) 2007;15(3):270&#x2013;2. doi: 10.1177/230949900701500304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/230949900701500304</ArticleId><ArticleId IdType="pubmed">18162667</ArticleId></ArticleIdList></Reference><Reference><Citation>Maheshwari R, Acharya M, Monda M, Pandey R. Factors influencing mortality in patients on antiplatelet agents presenting with proximal femoral fractures. J. Orthop. Surg. (Hong Kong) 2011;19(3):314&#x2013;6. doi: 10.1177/230949901101900310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/230949901101900310</ArticleId><ArticleId IdType="pubmed">22184161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Lian X, Dou X, Bi Q, Quan R, Tong P, et al. Intertrochanteric hip fracture surgery in Chinese: Risk factors for predicting mortality. Int. J. Clin. Exp. Med. 2015;8(2):2789&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402883</ArticleId><ArticleId IdType="pubmed">25932236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan G, Nowak L, Melo L, Ward S, Atrey A, Schemitsch EH, et al. Anemia at presentation predicts acute mortality and need for readmission following geriatric hip fracture. JBJS Open Access. 2020 doi: 10.2106/JBJS.OA.20.00048.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.OA.20.00048</ArticleId><ArticleId IdType="pmc">PMC7722583</ArticleId><ArticleId IdType="pubmed">33299961</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Chen YY, Zhang L, Li YG, Wang C. Laboratory nutritional parameters predict one-year mortality in elderly patients with intertrochanteric fracture. Asia Pac. J. Clin. Nutr. 2016;25(3):457&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27440678</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges A, Torres J, S&#xe3;o Sim&#xe3;o R, Cabral AT, Pinto R. Impact of preoperative analytical values on post-operative mortality rate of intertrochanteric fractures. Acta Med. Port. 2014;27(2):218&#x2013;22. doi: 10.20344/amp.4280.</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.4280</ArticleId><ArticleId IdType="pubmed">24813490</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirel E, &#x15e;ahin A. Predictive value of blood parameters and comorbidities on three-month mortality in elderly patients with hip fracture. Cureus. 2021;13(10):e18634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576146</ArticleId><ArticleId IdType="pubmed">34765379</ArticleId></ArticleIdList></Reference><Reference><Citation>Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32&#x2013;5. doi: 10.1002/1097-0142(1950)3:1&lt;32::AID-CNCR2820030106&gt;3.0.CO;2-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(1950)3:1&lt;32::AID-CNCR2820030106&gt;3.0.CO;2-3</ArticleId><ArticleId IdType="pubmed">15405679</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: Prospective observational cohort study. BMJ. 2005;331(7529):1374. doi: 10.1136/bmj.38643.663843.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38643.663843.55</ArticleId><ArticleId IdType="pmc">PMC1309645</ArticleId><ArticleId IdType="pubmed">16299013</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain V, Halade GV. Role of neutrophils in ischemic heart failure. Pharmacol. Ther. 2020;205:107424. doi: 10.1016/j.pharmthera.2019.107424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2019.107424</ArticleId><ArticleId IdType="pmc">PMC6981275</ArticleId><ArticleId IdType="pubmed">31629005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am. J. Cardiol. 2009;103(3):333&#x2013;7. doi: 10.1016/j.amjcard.2008.09.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.09.085</ArticleId><ArticleId IdType="pubmed">19166685</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann DM, Kleinschnitz C, Gunzer M. Implications of polymorphonuclear neutrophils for ischemic stroke and intracerebral hemorrhage: Predictive value, pathophysiological consequences and utility as therapeutic target. J. Neuroimmunol. 2018;321:138&#x2013;43. doi: 10.1016/j.jneuroim.2018.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2018.04.015</ArticleId><ArticleId IdType="pubmed">29729895</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke. 2008;39(2):355&#x2013;60. doi: 10.1161/STROKEAHA.107.490128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.490128</ArticleId><ArticleId IdType="pubmed">18162626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhou C, Liu M, Zhang Y, Li H, He P, et al. Neutrophil counts and the risk of first stroke in general hypertensive adults. Hypertens. Res. 2021;44(7):830&#x2013;9. doi: 10.1038/s41440-021-00625-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-021-00625-1</ArticleId><ArticleId IdType="pubmed">33564178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang SY, Cha YH, Yoo JI, Oh T, Kim JT, Park CH, Choy WS, Ha YC, Koo KH. Blood transfusion for elderly patients with hip fracture: A Nationwide Cohort Study. J. Korean Med. Sci. 2020;35(37):e313. doi: 10.3346/jkms.2020.35.e313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e313</ArticleId><ArticleId IdType="pmc">PMC7505728</ArticleId><ArticleId IdType="pubmed">32959543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa R, Salinas JC, Navarro M, G&#xfc;emes A, Torcal J, Garc&#xed;a-Alvarez F, et al. Autologous blood transfusion as an immunomodulator in experimental sepsis. Int. J. Surg. Investig. 2000;1(5):365&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">11341592</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J. Trauma. 2003;54(5):908&#x2013;14. doi: 10.1097/01.TA.0000022460.21283.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TA.0000022460.21283.53</ArticleId><ArticleId IdType="pubmed">12777903</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumberg N, Triulzi DJ, Heal JM. Transfusion-induced immunomodulation and its clinical consequences. Transfus. Med. Rev. 1990;4(4 Suppl 1):24&#x2013;35. doi: 10.1016/S0887-7963(90)70239-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-7963(90)70239-8</ArticleId><ArticleId IdType="pubmed">2134638</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran P, Banerjee P. Iatrogenic decompensated heart failure. Curr. Heart Fail. Rep. 2020;17(2):21&#x2013;7. doi: 10.1007/s11897-020-00452-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-020-00452-4</ArticleId><ArticleId IdType="pmc">PMC7066273</ArticleId><ArticleId IdType="pubmed">32086714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Yuh Y. A paradigm shift: Perioperative iron and erythropoietin therapy for patient blood management. Hanyang Med. Rev. 2018;38:16. doi: 10.7599/hmr.2018.38.1.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.7599/hmr.2018.38.1.16</ArticleId></ArticleIdList></Reference><Reference><Citation>Voorn V, Hout A, So-Osman C, Vlieland T, Nelissen R, Van den Akker E, et al. Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty. Vox Sang. 2016;111:219&#x2013;225. doi: 10.1111/vox.12412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.12412</ArticleId><ArticleId IdType="pubmed">27314459</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzel Y, Gurcan OT, Golge UH, Dulgeroglu TC, Metineren H. Topical tranexamic acid versus autotransfusion after total knee arthroplasty. J. Orthop. Surg. (Hong Kong) 2016;24(2):179&#x2013;82. doi: 10.1177/1602400212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1602400212</ArticleId><ArticleId IdType="pubmed">27574259</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter LJ, Doleman B, Moppett IK. A systematic review of pre-operative anaemia and blood transfusion in patients with fractured hips. Anaesthesia. 2015;70(4):483&#x2013;500. doi: 10.1111/anae.12978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12978</ArticleId><ArticleId IdType="pubmed">25764405</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasab SAM, Khorramdin E. The assessment of mortality and quality of life after intertrochanteric fracture of femur in patients older than 60 at Emam Khomeini Hospital of Ahvaz. Pak. J. Med. Sci. 2017;33(4):895&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5648960</ArticleId><ArticleId IdType="pubmed">29067061</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi A, Moradi M, Emadzadeh M, Bagheri F. Comparison of the dynamic hip screw with the dynamic hip external fixator for intertrochanteric fractures: Report of a randomized controlled trial. Arch. Bone Jt. Surg. 2021;9(6):665&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8765197</ArticleId><ArticleId IdType="pubmed">35106332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Xing D, Ma X, Xu W, Wang J, Chen Y, Song D. The percutaneous compression plate versus the dynamic hip screw for treatment of intertrochanteric hip fractures: A systematic review and meta-analysis of comparative studies. Orthop. Traumatol. Surg. Res. 2012;98(7):773&#x2013;83. doi: 10.1016/j.otsr.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2012.07.004</ArticleId><ArticleId IdType="pubmed">23044466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriakopoulos E, McCormick F, Nwachukwu BU, Erickson BJ, Caravella J. In-hospital mortality risk of intertrochanteric hip fractures: A comprehensive review of the US Medicare database from 2005 to 2010. Musculoskelet. Surg. 2017;101(3):213&#x2013;218. doi: 10.1007/s12306-017-0470-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12306-017-0470-3</ArticleId><ArticleId IdType="pubmed">28255840</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh MA, Wilson JL, Schaffer NE, Olsen EC, Perdue A, Ahn J, Hake ME. Preoperative comorbidities associated with early mortality in hip fracture patients: A multicenter study. J. Am. Acad. Orthop. Surg. 2023;31(2):81&#x2013;86. doi: 10.5435/JAAOS-D-21-01055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-21-01055</ArticleId><ArticleId IdType="pubmed">36580049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper L, Bunn D, Jimoh FO, Fairweather-Tait SJ. Water-loss dehydration and aging. Mech. Ageing Dev. 2014;136&#x2013;137:50&#x2013;8. doi: 10.1016/j.mad.2013.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2013.11.009</ArticleId><ArticleId IdType="pubmed">24333321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusen JQ, van der Vet PCR, Wijdicks FJG, Link BC, Poblete B, van der Velde D, Babst R, Beeres FJP. Does preoperative hemodynamic preconditioning improve morbidity and mortality after traumatic hip fracture in geriatric patients? A retrospective cohort study. Arch. Orthop. Trauma Surg. 2021;141(9):1491&#x2013;1497. doi: 10.1007/s00402-020-03601-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-020-03601-5</ArticleId><ArticleId IdType="pubmed">32986156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindholm C, Sterner E, Romanelli M, Pina E, Torra y Bou J, Hietanen H, et al. Hip fracture and pressure ulcers&#x2014;The Pan-European Pressure Ulcer Study - intrinsic and extrinsic risk factors. Int. Wound J. 2008;5(2):315&#x2013;28. doi: 10.1111/j.1742-481X.2008.00452.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-481X.2008.00452.x</ArticleId><ArticleId IdType="pmc">PMC7951619</ArticleId><ArticleId IdType="pubmed">18494637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylinenvaara SI, Elisson O, Berg K, Zdolsek JH, Krook H, Hahn RG. Preoperative urine-specific gravity and the incidence of complications after hip fracture surgery: A prospective, observational study. Eur. J. Anaesthesiol. 2014;31(2):85&#x2013;90. doi: 10.1097/01.EJA.0000435057.72303.0e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.EJA.0000435057.72303.0e</ArticleId><ArticleId IdType="pubmed">24145802</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison RJM, Tsang B, Fishley W, Harper I, Joseph JC, Reed MR. Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty: The effectiveness of a single pre-operative dose. Bone Joint Res. 2017;6(8):499&#x2013;505. doi: 10.1302/2046-3758.68.BJR-2017-0005.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/2046-3758.68.BJR-2017-0005.R1</ArticleId><ArticleId IdType="pmc">PMC5579309</ArticleId><ArticleId IdType="pubmed">28851694</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan G, Hughes K, Barakat A, Edres K, da Assuncao R, Page P, et al. Inter- and intra-observer reliability of the new AO/OTA classification of proximal femur fractures. Injury. 2021;52(6):1434&#x2013;7. doi: 10.1016/j.injury.2020.10.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2020.10.067</ArticleId><ArticleId IdType="pubmed">33097201</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31128879</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine initiative: clinical indicators.</ArticleTitle><Pagination><StartPage>228</StartPage><EndPage>237</EndPage><MedlinePgn>228-237</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2019.04.041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(19)30297-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Clinical indicators are powerful tools to quantify the safety and quality of patient care. Their validity is often unclear and definitions extremely heterogeneous. As part of the International Standardised Endpoints in Perioperative Medicine (StEP) initiative, this study aimed to derive a set of standardised and valid clinical outcome indicators for use in perioperative clinical trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We identified clinical indicators via a systematic review of the anaesthesia and perioperative medicine literature (PubMed/OVID, EMBASE, and Cochrane Library). We performed a three-stage Delphi consensus-gaining process that involved 54 clinician-researchers worldwide. Indicators were first shortlisted and the most suitable definitions for evaluation of quality and safety interventions determined. Indicators were then assessed for validity, reliability, feasibility, and clarity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 167 clinical outcome indicators. Participation in the three Delphi rounds was 100% (n=13), 68% (n=54), and 85% (n= 6), respectively. A final list of eight outcome indicators was generated: surgical site infection at 30 days, stroke within 30 days of surgery, death within 30 days of coronary artery bypass grafting, death within 30 days of surgery, admission to the intensive care unit within 14 days of surgery, readmission to hospital within 30 days of surgery, and length of hospital stay (with or without in-hospital mortality). They were rated by the majority of experts as valid, reliable, easy to use, and clearly defined.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These clinical indicators can be confidently used as endpoints in clinical trials measuring quality, safety, and improvement in perioperative care.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="BACKGROUND">PROSPERO 2016 CRD42016042102 (http://www.crd.york.ac.uk/PROSPERO/display_record.php? ID=CRD42016042102).</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haller</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Geneva University Hospitals, Geneva, Switzerland; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: Guy.Haller@hcuge.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bampoe</LastName><ForeName>Sohail</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Perioperative Medicine, University College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Critical Care and Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Michael P W</ForeName><Initials>MPW</Initials><AffiliationInfo><Affiliation>Integrative Physiology and Critical Illness Group, Clinical and Experimental Sciences, Faculty of Medicine, University Hospital Southampton, Southampton, UK; Anaesthesia, Perioperative and Critical Care Research Group, Southampton NIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Critical Care and Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Integrated Critical Care, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>StEP-COMPAC Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DRF-2015-08-023</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="Y">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011787" MajorTopicYN="N">Quality of Health Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical indicators</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">outcome measures</Keyword><Keyword MajorTopicYN="N">patient safety</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">quality improvement</Keyword><Keyword MajorTopicYN="N">standardised endpoint</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blazeby</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boney</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diouf</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gan</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peyton</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tram&#xe8;r</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cyna</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Oliveira</LastName><ForeName>G S</ForeName><Initials>GS</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kehlet</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Botti</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boney</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Story</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gruen</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bampoe</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evered</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silbert</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eckenhoff</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eriksson</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Howell</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagele</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalu</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canet</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moller</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gin</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pelosi</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabreu</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Futier</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creagh-Brown</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbott</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcoran</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jamie Cooper</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieleman</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diouf</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIlroy</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellomo</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prowle</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Billings</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazer</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayarajah</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartoszko</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sneyd</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulman</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane-Fall</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nilsson</LastName><ForeName>U</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stevenson</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>J D J</ForeName><Initials>JDJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Klei</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrini</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buggy</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riedel</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gottumukkala</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alkhaffaf</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31128879</ArticleId><ArticleId IdType="pmc">PMC6676244</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.04.041</ArticleId><ArticleId IdType="pii">S0007-0912(19)30297-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Genovich-Richards J. Quality management organizational structures: history and trends. J&#xa0;Healthc Qual. 1994;16(22&#x2013;5):8&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10135769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15:523&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">14660535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazapis M., Gilhooly D., Smith A.F. Perioperative structure and process quality and safety indicators: a systematic review. Br J Anaesth. 2018;120:51&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397138</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint Commission of Healthcare Organizations, National library of healthcare indicators . Joint Commission on Accreditation of Healthcare Organizations; Oakbrook Terrace, IL: 1997. Health plan and network edition.</Citation><ArticleIdList><ArticleId IdType="pubmed">10158780</ArticleId></ArticleIdList></Reference><Reference><Citation>Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260:1743&#x2013;1748.</Citation><ArticleIdList><ArticleId IdType="pubmed">3045356</ArticleId></ArticleIdList></Reference><Reference><Citation>NELA Project Team  2016. www.nela.org.uk/reports Second Patient Report of the National Emergency Laparotomy Audit, Available from:</Citation></Reference><Reference><Citation>Broder M.S., Payne-Simon L., Brook R.H. Measures of surgical quality: what will patients know by 2005? J&#xa0;Eval Clin Pract. 2005;11:209&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">15869551</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller G., Myles P. Use and misuse of outcome data. Lancet. 2004;363:1912.</Citation><ArticleIdList><ArticleId IdType="pubmed">15183647</ArticleId></ArticleIdList></Reference><Reference><Citation>Copnell B., Hagger V., Wilson S.G., Evans S.M., Sprivulis P.C., Cameron P.A. Measuring the quality of hospital care: an inventory of indicators. Intern Med J. 2009;39:352&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">19323697</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesia Quality Institute Outcome definitions. Available at www.aqihq.org/AQI_Outcomes_Definitions_2015.</Citation></Reference><Reference><Citation>Australian Council on Healthcare Standards. Clinical indicators definitions. Available from: at www.achs.org.au.</Citation><ArticleIdList><ArticleId IdType="pubmed">12807289</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller G., Stoelwinder J., Myles P.S., McNeil J. Quality and safety indicators in anesthesia: a systematic review. Anesthesiology. 2009;110:1158&#x2013;1175.</Citation><ArticleIdList><ArticleId IdType="pubmed">19352148</ArticleId></ArticleIdList></Reference><Reference><Citation>Benn J., Arnold G., Wei I., Riley C., Aleva F. Using quality indicators in anaesthesia: feeding back data to improve care. Br J Anaesth. 2012;109:80&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">22661749</ArticleId></ArticleIdList></Reference><Reference><Citation>Grocott M.P. Standardisation of perioperative outcome measures. Eur J Anaesthesiol. 2015;32:83&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25536186</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell S.M., Braspenning J., Hutchinson A., Marshall M. Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care. 2002;11:358&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758017</ArticleId><ArticleId IdType="pubmed">12468698</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainz J. Developing evidence-based clinical indicators: a state of the art methods primer. Int J Qual Health Care. 2003;15:i5&#x2013;i11.</Citation><ArticleIdList><ArticleId IdType="pubmed">14660518</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Medicine. Abridged Index Medicus (AIM or &#x201c;Core Clinical&#x201d;) Journal Titles. Available from: https://www.nlm.nih.gov/bsd/aim.html.</Citation></Reference><Reference><Citation>Graham B., Regehr G., Wright J.G. Delphi as a method to establish consensus for diagnostic criteria. J&#xa0;Clin Epidemiol. 2003;56:1150&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">14680664</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J., Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2550437</ArticleId><ArticleId IdType="pubmed">7640549</ArticleId></ArticleIdList></Reference><Reference><Citation>Last J. A&#xa0;handbook sponsored by the international epidemiology association. 4th edn. Oxford University Press; New York: 2001. A&#xa0;dictionary of epidemiology,</Citation></Reference><Reference><Citation>Streiner D.L., Norman G.R. 4th edn. Oxford University Press; Oxford; New York: 2008. Health measurement scales: a practical guide to their development and use; pp. 150&#x2013;162.</Citation></Reference><Reference><Citation>McGlynn E.A., Asch S.M. Developing a clinical performance measure. Am J Prev Med. 1998;14:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9566932</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Patient Safety Initiative. Available from: http://www.euro.who.int/en/health-topics/Health-systems/patient-safety.</Citation></Reference><Reference><Citation>Koroshetz W. A&#xa0;core set of trial outcomes for every medical discipline? Br Med J. 2015;350 h85.</Citation><ArticleIdList><ArticleId IdType="pubmed">25623113</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis J.P. How to make more published research true. PLoS Med. 2014;11 e1001747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4204808</ArticleId><ArticleId IdType="pubmed">25334033</ArticleId></ArticleIdList></Reference><Reference><Citation>Boney O., Moonesinghe S.R., Myles P.S. Standardizing endpoints in perioperative research. Can J Anaesth. 2016;63:159&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">26742948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38051291</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association Between Intraoperative Landiolol Use and In-Hospital Mortality After Coronary Artery Bypass Grafting: A Nationwide Observational Study in Japan.</ArticleTitle><Pagination><StartPage>1208</StartPage><EndPage>1215</EndPage><MedlinePgn>1208-1215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006741</ELocationID><Abstract><AbstractText Label="BACKGROUND">Ischemic heart disease is a leading cause of death worldwide, and coronary artery bypass grafting (CABG) is a major treatment. Landiolol is an ultra-short-acting beta-antagonist known to prevent postoperative atrial fibrillation. However, the effectiveness of intraoperative landiolol on mortality remains unknown. This study aimed to evaluate the association between intraoperative landiolol use and the in-hospital mortality in patients undergoing CABG.</AbstractText><AbstractText Label="METHODS">To conduct this retrospective cohort study, we used data from the Japanese Diagnosis Procedure Combination inpatient database. All patients who underwent CABG during hospitalization between July 1, 2010, and March 31, 2020, were included. Patients who received intraoperative landiolol were defined as the landiolol group, whereas the other patients were defined as the control group. The primary outcome was in-hospital mortality. Propensity score matching was used to compare the landiolol and control groups.</AbstractText><AbstractText Label="RESULTS">In total, 118,506 patients were eligible for this study, including 25,219 (21%) in the landiolol group and 93,287 (79%) in the control group. One-to-one propensity score matching created 24,893 pairs. After propensity score matching, the in-hospital mortality was significantly lower in the landiolol group than that in the control group (3.7% vs 4.3%; odds ratio 0.85; 95% confidence interval 0.78 to 0.94; P = .010).</AbstractText><AbstractText Label="CONCLUSIONS">Intraoperative landiolol use was associated with decreased in-hospital mortality in patients undergoing CABG. Further randomized controlled trials are required to confirm these findings.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iwasaki</LastName><ForeName>Yudai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Perioperative Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohbe</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Mikio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Life-Saving Technique Academy of Tokyo, Foundation for Ambulance Service Development, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasabuchi</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Data Science Center, Jichi Medical University, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikumi</LastName><ForeName>Saori</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Perioperative Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiho</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Perioperative Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamauchi</LastName><ForeName>Masanori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Perioperative Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fushimi</LastName><ForeName>Kiyohide</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasunaga</LastName><ForeName>Hideo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>19AA2007 and 20AA2005</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>62NWQ924LH</RegistryNumber><NameOfSubstance UI="C077049">landiolol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>5</Day><Hour>17</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>5</Day><Hour>10</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38051291</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000006741</ArticleId><ArticleId IdType="pii">00000539-202312000-00016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blessberger H, Lewis SR, Pritchard MW, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery. Cochrane Database Syst Rev. 2019;9:CD013435.</Citation></Reference><Reference><Citation>Cork RC, Kramer TH, Dreischmeier B, Behr S, DiNardo JA. The effect of esmolol given during cardiopulmonary bypass. Anesth Analg. 1995;80:28&#x2013;40.</Citation></Reference><Reference><Citation>Sezai A, Minami K, Nakai T, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg. 2011;141:1478&#x2013;1487.</Citation></Reference><Reference><Citation>Sezai A, Nakai T, Hata M, et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. J Thorac Cardiovasc Surg. 2012;144:1241&#x2013;1248.</Citation></Reference><Reference><Citation>Engelman RM, Haag B, Lemeshow S, Angelo A, Rousou JH. Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures. J Thorac Cardiovasc Surg. 1983;86:608&#x2013;615.</Citation></Reference><Reference><Citation>Fellahi JL, Heringlake M, Knotzer J, Fornier W, Cazenave L, Guarracino F. Landiolol for managing atrial fibrillation in post-cardiac surgery. Eur Heart J Suppl. 2018;20(suppl_A):A4&#x2013;A9.</Citation></Reference><Reference><Citation>Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and &#x3b2;-blocking actions of a new ultra-short-acting &#x3b2;-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol. 1999;34:70&#x2013;77.</Citation></Reference><Reference><Citation>Kakihana Y, Nishida O, Taniguchi T, et al.; J-Land 3S Study Group. Efficacy and safety of landiolol, an ultra-short-acting &#x3b2;1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2020;8:863&#x2013;872.</Citation></Reference><Reference><Citation>Tamura T, Yatabe T, Yokoyama M. Prevention of atrial fibrillation after cardiac surgery using low-dose landiolol: a systematic review and meta-analysis. J Clin Anesth. 2017;42:1&#x2013;6.</Citation></Reference><Reference><Citation>Ikeshita K, Nishikawa K, Toriyama S, et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth. 2008;22:361&#x2013;366.</Citation></Reference><Reference><Citation>Benchimol EI, Smeeth L, Guttmann A, et al.; RECORD Working Committee. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12:e1001885.</Citation></Reference><Reference><Citation>Shigemi D, Aso S, Yasunaga H. Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan: a retrospective cohort study using a national inpatient database. BMC Pregnancy Childbirth. 2019;19:204.</Citation></Reference><Reference><Citation>Shigemi D, Ishimaru M, Matsui H, Fushimi K, Yasunaga H. Suicide attempts among pregnant and postpartum women in Japan: a nationwide retrospective cohort study. J Clin Psychiatry. 2020;81:19m12993.</Citation></Reference><Reference><Citation>Yasunaga H. Real world data in Japan: chapter II the diagnosis procedure combination database. Ann Clin Epidemiol. 2019;1:76&#x2013;79.</Citation></Reference><Reference><Citation>Riad FS, Grau-Sepulveda M, Jawitz OK, et al. Anticoagulation in new-onset postoperative atrial fibrillation: an analysis from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Heart Rhythm O2. 2022;3:325&#x2013;332.</Citation></Reference><Reference><Citation>Mahoney FI, Barthel DW. Functional evaluation: the Barthel index: a simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md Med J. 1965;14:61&#x2013;65.</Citation></Reference><Reference><Citation>Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome&#x2014;reintroduction of Japan Coma Scale: a cohort study. BMJ Open. 2013;3:e002736.</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;383.</Citation></Reference><Reference><Citation>Hurwitz EE, Simon M, Vinta SR, et al. Adding examples to the ASA-Physical Status Classification improves correct assignment to patients. Anesthesiology. 2017;126:614&#x2013;622.</Citation></Reference><Reference><Citation>Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54:522&#x2013;523.</Citation></Reference><Reference><Citation>White PD, Myers MM. The classification of cardiac diagnosis. JAMA. 1921;77:1414&#x2013;1415.</Citation></Reference><Reference><Citation>Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457&#x2013;464.</Citation></Reference><Reference><Citation>Griswold ME, Localio AR, Mulrow C. Propensity score adjustment with multilevel data: setting your sites on decreasing selection bias. Ann Intern Med. 2010;152:393&#x2013;395.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33&#x2013;38.</Citation></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083&#x2013;3107.</Citation></Reference><Reference><Citation>Leuven E, Sianesi B. psmatch2. 2003. Accessed August 8, 2020. https://www.ifs.org.uk/publications/2684 .</Citation></Reference><Reference><Citation>Miglioretti DL, Heagerty PJ. Marginal modeling of nonnested multilevel data using standard software. Am J Epidemiol. 2007;165:453&#x2013;463.</Citation></Reference><Reference><Citation>Schulte PJ, Mascha EJ. Propensity score methods: theory and practice for anesthesia research. Anesth Analg. 2018;127:1074&#x2013;1084.</Citation></Reference><Reference><Citation>Cole SR, Hern&#xe1;n MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656&#x2013;664.</Citation></Reference><Reference><Citation>Ferguson TB Jr, Coombs LP, Peterson ED; Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America [published correction appears in JAMA 2002 Jun 26;287(24):3212]. JAMA. 2002;287:2221&#x2013;2227.</Citation></Reference><Reference><Citation>Sezai A, Shiono M. The role of &#x3b2;-blockers in cardiac perioperative management. Ann Thorac Cardiovasc Surg. 2014;20:261&#x2013;266.</Citation></Reference><Reference><Citation>Yaku H, Doi K. Stroke in off-pump coronary artery bypass grafting. Ann Thorac Cadiovasc Surg. 2010;16:225&#x2013;227.</Citation></Reference><Reference><Citation>Natsue K, Takahiro M, Yuichi K. Effects of landiolol in lipopolysaccharide-induced acute kidney injury in rats and in vitro. Shock. 2019;52:e117&#x2013;e123.</Citation></Reference><Reference><Citation>Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces perioperative myocardial ischemia. Anesthesiology. 1998;88:7&#x2013;17.</Citation></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13:697&#x2013;711.</Citation></Reference><Reference><Citation>Lawton JS, Tamis-Holland JE, Bangalore S, et al. ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;2022:e21&#x2013;e129.</Citation></Reference><Reference><Citation>Motomura N, Miyata H, Tsukihara H, Takamoto S; Japan Cardiovascular Surgery Database Organization. Risk model of thoracic aortic surgery in 4707 cases from a nationwide single-race population through a web-based data entry system: the first report of 30-day and 30-day operative outcome risk models for thoracic aortic surgery. Circulation. 2008;118:S153&#x2013;S159.</Citation></Reference><Reference><Citation>Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation ( Euro SCORE). Eur J Cardiothorac Surg. 1999;16:9&#x2013;13.</Citation></Reference><Reference><Citation>Shimizu H, Okada M, Toh Y, et al.; Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery. Thoracic and cardiovascular surgeries in Japan during 2018: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2021;69:179&#x2013;212.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31347414</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0879</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Innovations (Philadelphia, Pa.)</Title><ISOAbbreviation>Innovations (Phila)</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review and Meta-Analysis of del Nido Versus Conventional Cardioplegia in Adult Cardiac Surgery.</ArticleTitle><Pagination><StartPage>385</StartPage><EndPage>393</EndPage><MedlinePgn>385-393</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1556984519863718</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Del Nido cardioplegia (DC) has been used extensively in pediatric cardiac surgery but the efficacy and safety in adults remains uncertain. Our objective was to perform a systematic review and meta-analysis comparing DC and blood cardioplegia (BC) in our primary endpoint of 30-day or in-hospital mortality as well as other efficacy and safety endpoints.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Both MEDLINE and EMBASE were searched from 1996 to 2017 for studies comparing DC and BC. Data were extracted by 2 independent investigators and aggregated in a random effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One randomized controlled trial (<i>n</i> = 89), 7 adjusted (<i>n</i> = 1,104), and 5 unadjusted observational studies (<i>n</i> = 717) were included. There was no difference in in-hospital mortality between DC and BC (relative risk:0.67, 95% confidence interval [CI]: 0.22, 2.07; <i>P</i> = 0.49). DC reduced cardioplegia volume requirements (mean difference [MD]:-1.1 L, 95% CI, -1.6, -0.6; <i>P</i> &lt; 0.0001), aortic cross-clamp time (MD: -8 minutes, 95% CI, -12, -3; <i>P</i> = 0.0004), and cardiopulmonary bypass (CPB) times (MD: -8 minutes, 95% CI, -14, -3; <i>P</i> = 0.03). DC reduced troponin release (standardized MD: -0.3, 95% CI, -0.5, -0.1; <i>P</i> = 0.001). In-hospital outcomes of stroke, atrial fibrillation, acute kidney injury/dialysis, low cardiac output state, blood transfusion, reoperation rate, postoperative left ventricular EF, intensive care unit length of stay (LOS), and in-hospital LOS were comparable between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">DC is a safe alternative to BC in routine adult cardiac surgery. Its use is associated with reduction in CPB and aortic cross-clamp times and may potentially offer improved myocardial protection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>An</LastName><ForeName>Kevin R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Ishtiaq A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Derrick Y</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ad</LastName><ForeName>Niv</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Subodh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fremes</LastName><ForeName>Stephen E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latter</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanagawa</LastName><ForeName>Bobby</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Innovations (Phila)</MedlineTA><NlmUniqueID>101257528</NlmUniqueID><ISSNLinking>1556-9845</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006324" MajorTopicYN="Y">Heart Arrest, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardioplegia</Keyword><Keyword MajorTopicYN="N">del Nido</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31347414</ArticleId><ArticleId IdType="doi">10.1177/1556984519863718</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31072705</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>General Anesthesia Versus Local Anesthesia in Carotid Endarterectomy: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>234</EndPage><MedlinePgn>219-234</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2019.03.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(19)30289-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The choice of anesthetic technique in carotid endarterectomy (CEA) has been controversial. This study compared the outcomes of general anesthesia (GA) and local anesthesia (LA) in CEA.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of comparative studies.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Hospitals.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adult patients undergoing CEA with either LA or GA.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The effects of GA and LA on CEA outcomes were compared.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">PubMed, OVID, Scopus, and Embase were searched to June 2018. Thirty-one studies with 152,376 patients were analyzed. A random effect model was used, and heterogeneity was assessed with the I<sup>2</sup> and chi-square tests. LA was associated with shorter surgical time (weighted mean difference -9.15 min [-15.55 to -2.75]; p&#x202f;=&#x202f;0.005) and less stroke (odds ratio [OR] 0.76 [0.62-0.92]; p&#x202f;=&#x202f;0.006), cardiac complications (OR 0.59 [0.47-0.73]; p &lt; 0.00001), and in-hospital mortality (OR 0.72 [0.59-0.90]; p&#x202f;=&#x202f;0.003). Transient neurologic deficit rates were similar (OR 0.69 [0.46-1.04]; p&#x202f;=&#x202f;0.07). Heterogeneity was significant for surgical time (I<sup>2</sup>&#x202f;=&#x202f;0.99, chi-square&#x202f;=&#x202f;1,336.04; p &lt; 0.00001), transient neurologic deficit (I<sup>2</sup>&#x202f;=&#x202f;0.41, chi-square&#x202f;=&#x202f;28.81; p&#x202f;=&#x202f;0.04), and cardiac complications (I<sup>2</sup>&#x202f;=&#x202f;0.42, chi-square&#x202f;=&#x202f;43.32; p&#x202f;=&#x202f;0.01) but not for stroke (I<sup>2</sup>&#x202f;=&#x202f;0.22, chi-square&#x202f;=&#x202f;30.72; p&#x202f;=&#x202f;0.16) and mortality (I<sup>2</sup>&#x202f;=&#x202f;0.00, chi-square&#x202f;=&#x202f;21.69; p&#x202f;=&#x202f;0.65). Randomized controlled trial subgroup analysis was performed, and all the aforementioned variables were not significantly different or heterogenous.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results from this study showed no inferiority of using LA to GA in patients undergoing CEA. Future investigations should be reported more systematically, preferably with randomization or propensity-matched analysis, and thus registries will facilitate investigation of this subject. Anesthetic choice in CEA should be individualized and encouraged where applicable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harky</LastName><ForeName>Amer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom. Electronic address: aaharky@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Jeffrey Shi Kai</ForeName><Initials>JSK</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kot</LastName><ForeName>Thompson Ka Ming</ForeName><Initials>TKM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanli</LastName><ForeName>Dilan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Gundogmus State Hospital, Antalya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimli</LastName><ForeName>Rashad</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belamaric</LastName><ForeName>Zlatka</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Ian Yu Young</ForeName><Initials>IYY</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bithas</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makar</LastName><ForeName>Ragai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandrasekar</LastName><ForeName>Ramasubramanyan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimitri</LastName><ForeName>Sameh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthetic technique</Keyword><Keyword MajorTopicYN="N">carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">local anesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31072705</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2019.03.029</ArticleId><ArticleId IdType="pii">S1053-0770(19)30289-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34999218</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of prophylactic closed-incision negative pressure wound therapy for vascular surgery groin wounds.</ArticleTitle><Pagination><StartPage>2086</StartPage><EndPage>2093.e9</EndPage><MedlinePgn>2086-2093.e9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2021.12.070</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(21)02750-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE">A previous meta-analysis of randomized controlled trials (RCTs) evaluating the efficacy of closed incision negative pressure wound therapy (ciNPWT) on vascular surgery groin wounds reported a reduction in surgical site infections (SSIs). Our aim was to perform a comprehensive, updated meta-analysis after the largest multicenter RCT on the subject to date reported no benefits from ciNPWT.</AbstractText><AbstractText Label="METHODS">A systematic review identified RCTs that had compared the primary outcome of the incidence of postoperative SSIs of groin incisions treated with ciNPWT or standard dressings. The secondary outcomes included wound dehiscence, a composite incidence of seroma, lymph leakage, and hematoma, the need for reoperation, in-hospital mortality, the need for readmission, and the hospital length of stay. The odds ratios (ORs) were compared across the studies using a random effects meta-analysis. The risk of bias was assessed using the Cochrane risk of bias tool, Harbord test, and trim-and-fill analysis.</AbstractText><AbstractText Label="RESULTS">Eight RCTs with 1125 incisions (ciNPWT, n&#xa0;= 555 [49.3%]; control, n&#xa0;= 570 [50.7%]) were included. The RCTs included three studies inside and five outside the United States. ciNPWT was associated with a significant reduction in the rate of SSIs (OR, 0.39; 95% confidence interval [CI], 0.24-0.63; P&#xa0;&lt; .001). No significant differences were found in the rate of wound dehiscence (OR, 1.11; 95% CI, 0.67-1.83; P&#xa0;= .68), composite incidence of seroma, lymph leak, or hematoma (OR, 0.49; 95% CI, 0.13-1.76; P&#xa0;= .27), need for reoperation (OR, 0.68; 95% CI, 0.40-1.16; P&#xa0;= .16), or need for readmission (OR, 0.60; 95% CI, 0.30-1.21; P&#xa0;= .15). It was not possible to quantitatively evaluate in-hospital mortality or the hospital length of stay. The risk of bias assessment identified a high risk of bias for participant blinding in all eight studies, a low risk for randomization and outcome reporting, and variability between studies for the other methods. We found no evidence of publication bias.</AbstractText><AbstractText Label="CONCLUSIONS">Our meta-analysis of pooled data has suggested that prophylactic use of ciNPWT for vascular groin incisions will be associated with reduced rates of SSIs. The greatest benefits were seen in the trials with higher baseline rates of SSIs in the control group.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boll</LastName><ForeName>Griffin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Vermont Medical Center, Burlington, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callas</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Biostatistics, University of Vermont, Burlington, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertges</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Vermont Medical Center, Burlington, Vt. Electronic address: daniel.bertges@uvmhealth.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006119" MajorTopicYN="N">Groin</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006406" MajorTopicYN="N">Hematoma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054843" MajorTopicYN="Y">Negative-Pressure Wound Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049291" MajorTopicYN="N">Seroma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072836" MajorTopicYN="Y">Surgical Wound</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Negative pressure wound therapy</Keyword><Keyword MajorTopicYN="N">Surgical site infections</Keyword><Keyword MajorTopicYN="N">Wound complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>9</Day><Hour>20</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34999218</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2021.12.070</ArticleId><ArticleId IdType="pii">S0741-5214(21)02750-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36781467</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Robot-assisted versus laparoscopic distal pancreatectomy: a systematic review and meta-analysis including patient subgroups.</ArticleTitle><Pagination><StartPage>4131</StartPage><EndPage>4143</EndPage><MedlinePgn>4131-4143</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-023-09894-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Robot-assisted distal pancreatectomy (RDP) has been suggested to hold some benefits over laparoscopic distal pancreatectomy (LDP) but consensus and data on specific subgroups are lacking. This systematic review and meta-analysis reports the surgical and oncological outcome and costs between RDP and LDP including subgroups with intended spleen preservation and pancreatic ductal adenocarcinoma&#xa0;(PDAC).</AbstractText><AbstractText Label="METHODS">Studies comparing RDP and LDP were included from PubMed, Cochrane Central Register, and Embase (inception-July 2022). Primary outcomes were conversion and unplanned splenectomy. Secondary outcomes were R0 resection, lymph node yield, major morbidity, operative time, intraoperative blood loss, in-hospital mortality, operative costs, total costs and hospital stay.</AbstractText><AbstractText Label="RESULTS">Overall, 43 studies with 6757 patients were included, 2514 after RDP and 4243 after LDP. RDP was associated with a longer operative time (MD&#x2009;=&#x2009;18.21, 95% CI&#xa0;2.18-34.24), less blood loss (MD&#x2009;=&#x2009;54.50, 95% CI&#xa0;&#xfeff;-&#xa0;84.49-24.50), and a lower conversion rate (OR&#x2009;=&#x2009;0.44, 95% CI&#xfeff;&#xa0;0.36-0.55) compared to LDP. In spleen-preserving procedures, RDP was associated with more Kimura procedures (OR&#x2009;=&#x2009;2.23, 95% CI&#xfeff;&#xa0;1.37-3.64) and a lower rate of unplanned splenectomies (OR&#x2009;=&#x2009;0.32, 95% CI&#xfeff;&#xa0;0.24-0.42). In patients with PDAC, RDP was associated with a higher lymph node yield (MD&#x2009;=&#x2009;3.95, 95% CI&#xa0;&#xfeff;1.67-6.23), but showed no difference in the rate of R0 resection (OR&#x2009;=&#x2009;0.96, 95% CI&#xfeff;&#xa0;0.67-1.37). RDP was associated with higher total (MD&#x2009;=&#x2009;3009.31, 95% CI&#xa0;&#xfeff;1776.37-4242.24) and operative costs (MD&#x2009;=&#x2009;3390.40, 95% CI&#xa0;&#xfeff;1981.79-4799.00).</AbstractText><AbstractText Label="CONCLUSIONS">RDP was associated with a lower conversion rate, a higher spleen preservation rate and, in patients with PDAC, a higher lymph node yield and similar R0 resection rate, as compared to LDP. The potential benefits of RDP need to be weighed against the higher total and operative costs in future randomized trials.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Ramshorst</LastName><ForeName>Tess M E</ForeName><Initials>TME</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy. t.vanramshorst@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. t.vanramshorst@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Center Amsterdam, Amsterdam, The Netherlands. t.vanramshorst@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bodegraven</LastName><ForeName>Eduard A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Center Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampedri</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasai</LastName><ForeName>Meidai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Meiwa Hospital, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Besselink</LastName><ForeName>Marc G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Center Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Abu Hilal</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012371" MajorTopicYN="Y">Robotics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010180" MajorTopicYN="N">Pancreatectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="Y">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021441" MajorTopicYN="Y">Carcinoma, Pancreatic Ductal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Distal pancreatectomy</Keyword><Keyword MajorTopicYN="N">Laparoscopy</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pancreas</Keyword><Keyword MajorTopicYN="N">Robot-assisted</Keyword><Keyword MajorTopicYN="N">Subgroups</Keyword></KeywordList><CoiStatement>Drs. Tess van Ramshorst, Drs. Eduard van Bodegraven, Mr. Pietro Zampedri, Drs. Meidai Kasai, Prof. Marc Besselink and Prof. Abu Hilal have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36781467</ArticleId><ArticleId IdType="pmc">PMC10235152</ArticleId><ArticleId IdType="doi">10.1007/s00464-023-09894-y</ArticleId><ArticleId IdType="pii">10.1007/s00464-023-09894-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lyu Y, Cheng Y, Wang B, Zhao S, Chen L. Comparison of 3 minimally invasive methods versus open distal pancreatectomy: a systematic review and network meta-analysis. Surg Laparosc Endosc Percutan Tech. 2020;31:104&#x2013;112. doi: 10.1097/SLE.0000000000000846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0000000000000846</ArticleId><ArticleId IdType="pmc">PMC8096312</ArticleId><ArticleId IdType="pubmed">32890249</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Hilal M, Richardson JR, de Rooij T, Dimovska E, Al-Saati H, Besselink MG. Laparoscopic radical &#x2018;no-touch&#x2019; left pancreatosplenectomy for pancreatic ductal adenocarcinoma: technique and results. Surg Endosc. 2016;30:3830&#x2013;3838. doi: 10.1007/s00464-015-4685-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4685-9</ArticleId><ArticleId IdType="pmc">PMC4992023</ArticleId><ArticleId IdType="pubmed">26675941</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hilst J, de Rooij T, Klompmaker S, Rawashdeh M, Aleotti F, Al-Sarireh B, Alseidi A, Ateeb Z, Balzano G, Berrevoet F, Bjornsson B, Boggi U, Busch OR, Butturini G, Casadei R, Del Chiaro M, Chikhladze S, Cipriani F, van Dam R, Damoli I, van Dieren S, Dokmak S, Edwin B, van Eijck C, Fabre JM, Falconi M, Farges O, Fernandez-Cruz L, Forgione A, Frigerio I, Fuks D, Gavazzi F, Gayet B, Giardino A, Groot Koerkamp B, Hackert T, Hassenpflug M, Kabir I, Keck T, Khatkov I, Kusar M, Lombardo C, Marchegiani G, Marshall R, Menon KV, Montorsi M, Orville M, de Pastena M, Pietrabissa A, Poves I, Primrose J, Pugliese R, Ricci C, Roberts K, Rosok B, Sahakyan MA, Sanchez-Cabus S, Sandstrom P, Scovel L, Solaini L, Soonawalla Z, Souche FR, Sutcliffe RP, Tiberio GA, Tomazic A, Troisi R, Wellner U, White S, Wittel UA, Zerbi A, Bassi C, Besselink MG, Abu Hilal M, European Consortium on Minimally Invasive Pancreatic S Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): a pan-european propensity score matched study. Ann Surg. 2019;269:10&#x2013;17. doi: 10.1097/SLA.0000000000002561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002561</ArticleId><ArticleId IdType="pubmed">29099399</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornsson B, Larsson AL, Hjalmarsson C, Gasslander T, Sandstrom P. Comparison of the duration of hospital stay after laparoscopic or open distal pancreatectomy: randomized controlled trial. Br J Surg. 2020;107:1281&#x2013;1288. doi: 10.1002/bjs.11554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.11554</ArticleId><ArticleId IdType="pubmed">32259297</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, van Dam R, Dejong C, van Duyn E, Dijkgraaf M, van Eijck C, Festen S, Gerhards M, Groot Koerkamp B, de Hingh I, Kazemier G, Klaase J, de Kleine R, van Laarhoven C, Luyer M, Patijn G, Steenvoorde P, Suker M, Abu Hilal M, Busch O, Besselink M, Dutch Pancreatic Cancer G. Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial. Ann Surg. 2019;269:2&#x2013;9. doi: 10.1097/SLA.0000000000002979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002979</ArticleId><ArticleId IdType="pubmed">30080726</ArticleId></ArticleIdList></Reference><Reference><Citation>Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, D'Angelica MI, Balduzzi A, Bassi C, Bjornsson B, Boggi U, Callery MP, Del Chiaro M, Coimbra FJ, Conrad C, Cook A, Coppola A, Dervenis C, Dokmak S, Edil BH, Edwin B, Giulianotti PC, Han HS, Hansen PD, van der Heijde N, van Hilst J, Hester CA, Hogg ME, Jarufe N, Jeyarajah DR, Keck T, Kim SC, Khatkov IE, Kokudo N, Kooby DA, Korrel M, de Leon FJ, Lluis N, Lof S, Machado MA, Demartines N, Martinie JB, Merchant NB, Molenaar IQ, Moravek C, Mou YP, Nakamura M, Nealon WH, Palanivelu C, Pessaux P, Pitt HA, Polanco PM, Primrose JN, Rawashdeh A, Sanford DE, Senthilnathan P, Shrikhande SV, Stauffer JA, Takaori K, Talamonti MS, Tang CN, Vollmer CM, Wakabayashi G, Walsh RM, Wang SE, Zinner MJ, Wolfgang CL, Zureikat AH, Zwart MJ, Conlon KC, Kendrick ML, Zeh HJ, Hilal MA, Besselink MG, International Study Group on Minimally Invasive Pancreas S The miami international evidence-based guidelines on minimally invasive pancreas resection. Ann Surg. 2020;271:1&#x2013;14. doi: 10.1097/SLA.0000000000003590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003590</ArticleId><ArticleId IdType="pubmed">31567509</ArticleId></ArticleIdList></Reference><Reference><Citation>Lof S, van der Heijde N, Abuawwad M, Al-Sarireh B, Boggi U, Butturini G, Capretti G, Coratti A, Casadei R, D'Hondt M, Esposito A, Ferrari G, Fusai G, Giardino A, Groot Koerkamp B, Hackert T, Kamarajah S, Kauffmann EF, Keck T, Marudanayagam R, Nickel F, Manzoni A, Pessaux P, Pietrabissa A, Rosso E, Salvia R, Soonawalla Z, White S, Zerbi A, Besselink MG, Abu Hilal M. Robotic versus laparoscopic distal pancreatectomy: multicentre analysis. Br J Surg. 2021;108:188&#x2013;195. doi: 10.1093/bjs/znaa039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znaa039</ArticleId><ArticleId IdType="pubmed">33711145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon J, Lee JH, Park SY, Park Y, Lee W, Song KB, Hwang DW, Kim SC. A comparison of robotic versus laparoscopic distal pancreatectomy: propensity score matching analysis. Int J Med Robot Computer Assist Surg. 2021;18(2):e2347.</Citation><ArticleIdList><ArticleId IdType="pubmed">34726827</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Martino M, Caruso R, D'Ovidio A, Nunez-Alfonsel J, Burdio Pinilla F, Quijano Collazo Y, Vicente E, Ielpo B. Robotic versus laparoscopic distal pancreatectomies: a systematic review and meta-analysis on costs and perioperative outcome. Int J Med Robot. 2021;17:e2295. doi: 10.1002/rcs.2295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcs.2295</ArticleId><ArticleId IdType="pubmed">34085371</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SB, Jia CK, Wang JR, Zhang RC, Mou YP. Do patients benefit more from robot assisted approach than conventional laparoscopic distal pancreatectomy? A meta-analysis of perioperative and economic outcomes. J Formos Med Assoc. 2019;118:268&#x2013;278. doi: 10.1016/j.jfma.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2018.05.003</ArticleId><ArticleId IdType="pubmed">29798819</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1&#x2013;9. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagnini AL, Rosok BI, Asbun HJ, Barkun J, Besselink MG, Boggi U, Conlon KC, Fingerhut A, Han HS, Hansen PD, Hogg ME, Kendrick ML, Palanivelu C, Shrikhande SV, Wakabayashi G, Zeh H, Vollmer CM, Kooby DA. Standardizing terminology for minimally invasive pancreatic resection. HPB (Oxford) 2017;19:182&#x2013;189. doi: 10.1016/j.hpb.2017.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2017.01.006</ArticleId><ArticleId IdType="pubmed">28317657</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205&#x2013;213. doi: 10.1097/01.sla.0000133083.54934.ae.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000133083.54934.ae</ArticleId><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M, International Study Group on Pancreatic S The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161:584&#x2013;591. doi: 10.1016/j.surg.2016.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2016.11.014</ArticleId><ArticleId IdType="pubmed">28040257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura W, Inoue T, Futakawa N, Shinkai H, Han I, Muto T. Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein. Surgery. 1996;120:885&#x2013;890. doi: 10.1016/S0039-6060(96)80099-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6060(96)80099-7</ArticleId><ArticleId IdType="pubmed">8909526</ArticleId></ArticleIdList></Reference><Reference><Citation>Warshaw AL. Conservation of the spleen with distal pancreatectomy. Arch Surg. 1988;123:550&#x2013;553. doi: 10.1001/archsurg.1988.01400290032004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1988.01400290032004</ArticleId><ArticleId IdType="pubmed">3358679</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603&#x2013;605. doi: 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1&#x2013;48. doi: 10.18637/jss.v036.i03.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v036.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alamino JM, Bankhead C, Heneghan C, Pidduck N, Perera R. Impact of heterogeneity and effect size on the estimation of the optimal information size: analysis of recently published meta-analyses. BMJ Open. 2017;7:e015888. doi: 10.1136/bmjopen-2017-015888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-015888</ArticleId><ArticleId IdType="pmc">PMC5695413</ArticleId><ArticleId IdType="pubmed">29122784</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfieri S, Butturini G, Boggi U, Pietrabissa A, Morelli L, Vistoli F, Damoli I, Peri A, Fiorillo C, Pugliese L, Ramera M, De Lio N, Di Franco G, Esposito A, Landoni L, Rosa F, Menghi R, Doglietto GB, Quero G. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study. Langenbecks Arch Surg. 2019;404:459&#x2013;468. doi: 10.1007/s00423-019-01786-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-019-01786-x</ArticleId><ArticleId IdType="pubmed">31055639</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimas-George M, Watson M, Salibi P, Tschuor C, Murphy KJ, Iannitti D, Baker E, Ocuin L, Vrochides D, Martinie JB. Oncologic outcomes of robotic left pancreatectomy for pancreatic adenocarcinoma a single-center comparison to laparoscopic resection. Am surg. 2020;87(1):45&#x2013;49. doi: 10.1177/0003134820949524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003134820949524</ArticleId><ArticleId IdType="pubmed">32915060</ArticleId></ArticleIdList></Reference><Reference><Citation>Benizri EI, Germain A, Ayav A, Bernard JL, Zarnegar R, Benchimol D, Bresler L, Brunaud L. Short-term perioperative outcomes after robot-assisted and laparoscopic distal pancreatectomy. J Robot Surg. 2014;8:125&#x2013;132. doi: 10.1007/s11701-013-0438-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11701-013-0438-8</ArticleId><ArticleId IdType="pubmed">27637522</ArticleId></ArticleIdList></Reference><Reference><Citation>Butturini G, Damoli I, Crepaz L, Malleo G, Marchegiani G, Daskalaki D, Esposito A, Cingarlini S, Salvia R, Bassi C. A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy. Surg Endosc. 2015;29:3163&#x2013;3170. doi: 10.1007/s00464-014-4043-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-014-4043-3</ArticleId><ArticleId IdType="pubmed">25552231</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Zhou B, Wang T, Hu X, Ye Y, Guo W. Comparative efficacy of robot-assisted and laparoscopic distal pancreatectomy: a single-center comparative study. J Healthc Eng. 2022;2022:7302222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8747902</ArticleId><ArticleId IdType="pubmed">35024102</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zhan Q, Chen JZ, Jin JB, Deng XX, Chen H, Shen BY, Peng CH, Li HW. Robotic approach improves spleen-preserving rate and shortens postoperative hospital stay of laparoscopic distal pancreatectomy: a matched cohort study. Surg Endosc. 2015;29:3507&#x2013;3518. doi: 10.1007/s00464-015-4101-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4101-5</ArticleId><ArticleId IdType="pubmed">25791063</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra A, Nassour I, Zureikat A, Paniccia A. Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma. Updat Surg. 2021;73:947&#x2013;953. doi: 10.1007/s13304-020-00927-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13304-020-00927-y</ArticleId><ArticleId IdType="pubmed">33394353</ArticleId></ArticleIdList></Reference><Reference><Citation>Daouadi M, Zureikat AH, Zenati MS, Choudry H, Tsung A, Bartlett DL, Hughes SJ, Lee KK, Moser AJ, Zeh HJ. Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg. 2013;257:128&#x2013;132. doi: 10.1097/SLA.0b013e31825fff08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31825fff08</ArticleId><ArticleId IdType="pubmed">22868357</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pastena M, Esposito A, Paiella S, Surci N, Montagnini G, Marchegiani G, Malleo G, Secchettin E, Casetti L, Ricci C, Landoni L, Bovo C, Bassi C, Salvia R. Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study. Surg Endosc. 2021;35:1420&#x2013;1428. doi: 10.1007/s00464-020-07528-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-020-07528-1</ArticleId><ArticleId IdType="pubmed">32240383</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Franco G, Peri A, Lorenzoni V, Palmeri M, Furbetta N, Guadagni S, Gianardi D, Bianchini M, Pollina LE, Melfi F, Mamone D, Milli C, Di Candio G, Turchetti G, Pietrabissa A, Morelli L. Minimally invasive distal pancreatectomy: a case-matched cost-analysis between robot-assisted surgery and direct manual laparoscopy. Surg Endosc. 2022;36:651&#x2013;662. doi: 10.1007/s00464-021-08332-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-021-08332-1</ArticleId><ArticleId IdType="pmc">PMC8741657</ArticleId><ArticleId IdType="pubmed">33534074</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran H, Ielpo B, Caruso R, Ferri V, Quijano Y, Diaz E, Fabra I, Oliva C, Olivares S, Vicente E. Does robotic distal pancreatectomy surgery offer similar results as laparoscopic and open approach? A comparative study from a single medical center. Int J Med Robot Computer Assist Surg. 2014;10:280&#x2013;285. doi: 10.1002/rcs.1569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcs.1569</ArticleId><ArticleId IdType="pubmed">24431290</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckhardt S, Schicker C, Maurer E, Fendrich V, Bartsch DK. Robotic-assisted approach improves vessel preservation in spleen-preserving distal pancreatectomy. Dig Surg. 2016;33:406&#x2013;413. doi: 10.1159/000444269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444269</ArticleId><ArticleId IdType="pubmed">27160088</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito A, Ramera M, Casetti L, De Pastena M, Fontana M, Frigerio I, Giardino A, Girelli R, Landoni L, Malleo G, Marchegiani G, Paiella S, Pea A, Regi P, Scopelliti F, Tuveri M, Bassi C, Salvia R, Butturini G. Surg Endosc. 2022;36:1&#x2013;13.</Citation></Reference><Reference><Citation>Fisher AV, Fernandes-Taylor S, Schumacher JR, Havlena JA, Wang X, Lawson EH, Ronnekleiv-Kelly SM, Winslow ER, Weber SM, Abbott DE. Analysis of 90-day cost for open versus minimally invasive distal pancreatectomy. HPB. 2019;21:60&#x2013;66. doi: 10.1016/j.hpb.2018.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2018.07.003</ArticleId><ArticleId IdType="pubmed">30076011</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh BK, Chan CY, Soh HL, Lee SY, Cheow PC, Chow PK, Ooi LL, Chung AY. A comparison between robotic-assisted laparoscopic distal pancreatectomy versus laparoscopic distal pancreatectomy. Int J Med Robot. 2017;13:e1733. doi: 10.1002/rcs.1733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcs.1733</ArticleId><ArticleId IdType="pubmed">26813478</ArticleId></ArticleIdList></Reference><Reference><Citation>Han HJ, Kang CM. Reduced port minimally invasive distal pancreatectomy: single-port laparoscopic versus robotic single-site plus one-port distal pancreatectomy. Surg Endosc. 2019;33:1091&#x2013;1099. doi: 10.1007/s00464-018-6361-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-018-6361-3</ArticleId><ArticleId IdType="pubmed">29998392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Ahmad M, Song KB, Ma CH, Kim SC, Lee YJ, Hwang DW, Lee JH, Shin SH, Kwon J, Hwang S, Park G, Park Y, Lee SJ, Park KM. Does robotic system have advantages over laparoscopic system for distal pancreatectomy? Surg Endosc Other Interv Tech. 2018;32:S349.</Citation></Reference><Reference><Citation>Ito M, Asano Y, Shimizu T, Uyama I, Horiguchi A. Comparison of standard laparoscopic distal pancreatectomy with minimally invasive distal pancreatectomy using the da Vinci S system. Hepatogastroenterology. 2014;61:493&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">24901169</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Zheng K, Zhang S, Shao Z, Cheng P, Zhang Y, Jin G, He T. Robot-assisted distal pancreatectomy improves spleen preservation rate versus laparoscopic distal pancreatectomy for benign and low-grade malignant lesions of the pancreas. Translational Cancer Res. 2020;9:5166&#x2013;5172. doi: 10.21037/tcr-19-2121.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tcr-19-2121</ArticleId><ArticleId IdType="pmc">PMC8798076</ArticleId><ArticleId IdType="pubmed">35117883</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamarajah S, Sutandi N, Sen G, Hammond J, Manas D, French J, White S. Comparative analysis of open, laparoscopic and robotic distal pancreatic resection: the United Kingdom&#x2019;s first single-centre experience. J Minim Access Surg. 2022;18:77&#x2013;83. doi: 10.4103/jmas.JMAS_163_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jmas.JMAS_163_20</ArticleId><ArticleId IdType="pmc">PMC8830579</ArticleId><ArticleId IdType="pubmed">35017396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang CM, Kim DH, Lee WJ, Chi HS. Conventional laparoscopic and robot-assisted spleen-preserving pancreatectomy: does da Vinci have clinical advantages? Surg Endosc. 2011;25:2004&#x2013;2009. doi: 10.1007/s00464-010-1504-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-010-1504-1</ArticleId><ArticleId IdType="pubmed">21136089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriger AG, Berelavichus SV, Smirnov AV, Gorin DS, Akhtanin EA. Comparative results of open robot-assisted and laparoscopic distal pancreatic resection. Khirurgiia. 2015;1:23&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">25909547</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC, Tang CN. Robotic distal pancreatectomy versus conventional laparoscopic distal pancreatectomy: a comparative study for short-term outcomes. Front med. 2015;9:356&#x2013;360. doi: 10.1007/s11684-015-0404-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-015-0404-0</ArticleId><ArticleId IdType="pubmed">26271291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SQ, Kabir T, Koh YX, Teo JY, Lee SY, Kam JH, Cheow PC, Jeyaraj PR, Chow PKH, Ooi LL, Chung AYF, Chan CY, Goh BKP. A single institution experience with robotic and laparoscopic distal pancreatectomies. Ann Hepatobiliary Pancreat Surg. 2020;24:283&#x2013;291. doi: 10.14701/ahbps.2020.24.3.283.</Citation><ArticleIdList><ArticleId IdType="doi">10.14701/ahbps.2020.24.3.283</ArticleId><ArticleId IdType="pmc">PMC7452804</ArticleId><ArticleId IdType="pubmed">32843593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Allen PJ, Sadot E, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Kingham TP. Distal pancreatectomy: a single institution&#x2019;s experience in open, laparoscopic, and robotic approaches. J Am Coll Surg. 2015;220:18&#x2013;27. doi: 10.1016/j.jamcollsurg.2014.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2014.10.004</ArticleId><ArticleId IdType="pubmed">25456783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin XC, Huang HG, Chen YC, Lu FC, Lin RG, Yang YY, Wang CF, Fang HZ. Robotic versus laparoscopic distal pancreatectomy: a retrospective single-center study. Zhonghua Wai Ke Za Zhi. 2019;57:102&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">30704212</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Liu Q, Zhao ZM, Tan XL, Gao YX, Zhao GD. Robotic versus laparoscopic distal pancreatectomy: a propensity score-matched study. J Surg Oncol. 2017;116:461&#x2013;469. doi: 10.1002/jso.24676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.24676</ArticleId><ArticleId IdType="pubmed">28628713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyman WB, Passeri M, Sastry A, Cochran A, Iannitti DA, Vrochides D, Baker EH, Martinie JB. Robotic-assisted versus laparoscopic left pancreatectomy at a high-volume, minimally invasive center. Surg Endosc. 2019;33:2991&#x2013;3000. doi: 10.1007/s00464-018-6565-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-018-6565-6</ArticleId><ArticleId IdType="pubmed">30421076</ArticleId></ArticleIdList></Reference><Reference><Citation>Magge DR, Zenati MS, Hamad A, Rieser C, Zureikat AH, Zeh HJ, Hogg ME. Comprehensive comparative analysis of cost-effectiveness and perioperative outcomes between open, laparoscopic, and robotic distal pancreatectomy. HPB. 2018;20:1172&#x2013;1180. doi: 10.1016/j.hpb.2018.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2018.05.014</ArticleId><ArticleId IdType="pubmed">31217087</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino MV, Mirabella A, Gomez Ruiz M, Komorowski AL. Robotic-assisted versus laparoscopic distal pancreatectomy: the results of a case-matched analysis from a tertiary care center. Dig Surg. 2020;37:229&#x2013;239. doi: 10.1159/000501428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000501428</ArticleId><ArticleId IdType="pubmed">31269490</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi N, Mintziras I, Wiese D, Albers MB, Maurer E, Bartsch DK. A retrospective comparison of robotic versus laparoscopic distal resection and enucleation for potentially benign pancreatic neoplasms. Surg Today. 2020;50:872&#x2013;880. doi: 10.1007/s00595-020-01966-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-020-01966-z</ArticleId><ArticleId IdType="pubmed">32016613</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu L, Zhiming Z, Xianglong T, Yuanxing G, Yong X, Rong L, Yee LW. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: a retrospective propensity score-matched study. Int J Surg. 2018;55:81&#x2013;86. doi: 10.1016/j.ijsu.2018.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2018.05.024</ArticleId><ArticleId IdType="pubmed">29802919</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoof M, Nota C, Melstrom LG, Warner SG, Woo Y, Singh G, Fong Y. Oncologic outcomes after robot-assisted versus laparoscopic distal pancreatectomy: analysis of the national cancer database. J Surg Oncol. 2018;118:651&#x2013;656. doi: 10.1002/jso.25170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.25170</ArticleId><ArticleId IdType="pmc">PMC6386178</ArticleId><ArticleId IdType="pubmed">30114321</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez M, Memeo R, Leon P, Panaro F, Tzedakis S, Perotto O, Varatharajah S, Angelis N, de, Riva P, Mutter D, Navarro F, Marescaux J, Pessaux P. Which method of distal pancreatectomy is cost-effective among open, laparoscopic, or robotic surgery? Hepatobiliary. Surg Nutr. 2018;7:345&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6230836</ArticleId><ArticleId IdType="pubmed">30498710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan CE, Ross SB, Sukharamwala PB, Sadowitz BD, Wood TW, Rosemurgy AS. Distal pancreatectomy and splenectomy: a robotic or LESS approach. JSLS. 2015;19:e2014&#x2013;00246. doi: 10.4293/JSLS.2014.00246.</Citation><ArticleIdList><ArticleId IdType="doi">10.4293/JSLS.2014.00246</ArticleId><ArticleId IdType="pmc">PMC4379862</ArticleId><ArticleId IdType="pubmed">25848192</ArticleId></ArticleIdList></Reference><Reference><Citation>Souche R, Herrero A, Bourel G, Chauvat J, Pirlet I, Guillon F, Nocca D, Borie F, Mercier G, Fabre JM. Robotic versus laparoscopic distal pancreatectomy: a French prospective single-center experience and cost-effectiveness analysis. Surg Endosc. 2018;32:3562&#x2013;3569. doi: 10.1007/s00464-018-6080-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-018-6080-9</ArticleId><ArticleId IdType="pubmed">29396754</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicente E, Nunez-Alfonsel J, Ielpo B, Ferri V, Caruso R, Duran H, Diaz E, Malave L, Fabra I, Pinna E, Isernia R, Hidalgo A, Quijano Y. A cost-effectiveness analysis of robotic versus laparoscopic distal pancreatectomy. Int J Med Robot Computer Assist Surg. 2020;16:e2080. doi: 10.1002/rcs.2080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcs.2080</ArticleId><ArticleId IdType="pubmed">32026577</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters JA, Canal DF, Wiebke EA, Dumas RP, Beane JD, Aguilar-Saavedra JR, Ball CG, House MG, Zyromski NJ, Nakeeb A, Pitt HA, Lillemoe KD, Schmidt CM. Robotic distal pancreatectomy: cost effective? Surgery. 2010;148:814&#x2013;823. doi: 10.1016/j.surg.2010.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2010.07.027</ArticleId><ArticleId IdType="pubmed">20797748</ArticleId></ArticleIdList></Reference><Reference><Citation>Xourafas D, Ashley SW, Clancy TE. Comparison of Perioperative Outcomes between Open, Laparoscopic, and Robotic Distal Pancreatectomy: an Analysis of 1815 Patients from the ACS-NSQIP Procedure-Targeted Pancreatectomy Database. J gastrointest surg. 2017;21:1442&#x2013;1452. doi: 10.1007/s11605-017-3463-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-017-3463-5</ArticleId><ArticleId IdType="pubmed">28573358</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SJ, Hwang HK, Kang CM, Lee WJ. Revisiting the potential advantage of robotic surgical system in spleen-preserving distal pancreatectomy over conventional laparoscopic approach. Annals Translational Med. 2020;8:188. doi: 10.21037/atm.2020.01.80.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2020.01.80</ArticleId><ArticleId IdType="pmc">PMC7154491</ArticleId><ArticleId IdType="pubmed">32309335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Jin J, Chen S, Gu J, Zhu Y, Qin K, Zhan Q, Cheng D, Chen H, Deng X, Shen B, Peng C. Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach? Oncotarget. 2017;8:33872&#x2013;33883. doi: 10.18632/oncotarget.17513.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.17513</ArticleId><ArticleId IdType="pmc">PMC5464919</ArticleId><ArticleId IdType="pubmed">28477012</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YH, Qin YF, Yu DD, Li X, Zhao YM, Kong DJ, Jin W, Wang H. Meta-analysis of short-term outcomes comparing robot-assisted and laparoscopic distal pancreatectomy. J Comp Eff Res. 2020;9:201&#x2013;218. doi: 10.2217/cer-2019-0124.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/cer-2019-0124</ArticleId><ArticleId IdType="pubmed">31975614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamarajah SK, Sutandi N, Robinson SR, French JJ, White SA. Robotic versus conventional laparoscopic distal pancreatic resection: a systematic review and meta-analysis. HPB. 2019;21:1107&#x2013;1118. doi: 10.1016/j.hpb.2019.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2019.02.020</ArticleId><ArticleId IdType="pubmed">30962137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrovounis G, Diamantis A, Perivoliotis K, Symeonidis D, Volakakis G, Tepetes K. Laparoscopic versus robotic peripheral pancreatectomy: a systematic review and meta-analysis. J BUON. 2020;25:2456&#x2013;2475.</Citation><ArticleIdList><ArticleId IdType="pubmed">33277870</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou JY, Xin C, Mou YP, Xu XW, Zhang MZ, Zhou YC, Lu C, Chen RG. Robotic versus laparoscopic distal pancreatectomy: a meta-analysis of short-term outcomes. PLoS ONE. 2016;11:e0151189. doi: 10.1371/journal.pone.0151189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151189</ArticleId><ArticleId IdType="pmc">PMC4790929</ArticleId><ArticleId IdType="pubmed">26974961</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilidis P, Lim C, Menahem B, Lahat E, Salloum C, Azoulay D. Robotic versus laparoscopic distal pancreatectomy&#x2014;The first meta-analysis. HPB. 2016;18:567&#x2013;574. doi: 10.1016/j.hpb.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2016.04.008</ArticleId><ArticleId IdType="pmc">PMC4925795</ArticleId><ArticleId IdType="pubmed">27346136</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang B, Feng L, Zhao J. Systematic review and meta-analysis of robotic versus laparoscopic distal pancreatectomy for benign and malignant pancreatic lesions. Surg Endosc. 2016;30:4078&#x2013;4085. doi: 10.1007/s00464-015-4723-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4723-7</ArticleId><ArticleId IdType="pubmed">26743110</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Jiang C, Feng X, Du Y, Liao W, Jin H, Liao M, Zeng Y, Huang J. Robotic versus laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Front Oncol. 2021;11:752236. doi: 10.3389/fonc.2021.752236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.752236</ArticleId><ArticleId IdType="pmc">PMC8489404</ArticleId><ArticleId IdType="pubmed">34616686</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrini GP, Lauretta A, Belluco C, Olivieri M, Forlin M, Basso S, Breda B, Bertola G, Di Benedetto F. Robotic versus laparoscopic distal pancreatectomy: an up-to-date meta-analysis. BMC Surg. 2017;17:105. doi: 10.1186/s12893-017-0301-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12893-017-0301-3</ArticleId><ArticleId IdType="pmc">PMC5680787</ArticleId><ArticleId IdType="pubmed">29121885</ArticleId></ArticleIdList></Reference><Reference><Citation>Rompianesi G, Montalti R, Ambrosio L, Troisi RI. Robotic versus laparoscopic surgery for spleen-preserving distal pancreatectomies: systematic review and meta-analysis. J Pers Med. 2021;11(6):552. doi: 10.3390/jpm11060552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11060552</ArticleId><ArticleId IdType="pmc">PMC8231987</ArticleId><ArticleId IdType="pubmed">34199314</ArticleId></ArticleIdList></Reference><Reference><Citation>Li BQ, Qiao YX, Li J, Yang WQ, Guo JC. Preservation or ligation of splenic vessels during spleen-preserving distal pancreatectomy: a meta-analysis. J Invest Surg. 2019;32:654&#x2013;669. doi: 10.1080/08941939.2018.1449918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08941939.2018.1449918</ArticleId><ArticleId IdType="pubmed">29641270</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggino L, Malleo G, Bassi C, Vollmer C. Splenectomy during distal pancreatectomy: what are we really doing? Gastroenterology. 2018;154:S&#x2013;1297. doi: 10.1016/S0016-5085(18)34251-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0016-5085(18)34251-3</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25331552</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>36</EndPage><MedlinePgn>29-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-014-0689-y</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To identify the attributable mortality of central line associated blood stream infections (CLABSI) through meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Meta-analysis of case control and cohort studies, matched and unmatched, that reported on mortality of patients with and without CLABSI was performed. MEDLINE, CENTRAL, CINAHL were searched. Non-interventional studies of all languages that reported mortality in patients with CLABSI were included. Data were extracted on patient population, study setting, design, diagnostic criteria for CLABSI, and mortality. Results from studies comparing mortality due to CLABSI were pooled using a random effects model with assessment of heterogeneity. Heterogeneity of studies was assessed with an I (2) statistic and a funnel plot was generated to assess for publication bias.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen studies were included with 1,976 CLABSI cases. Of the included studies, 17 took place in intensive care unit settings, most involved a mixed population of medical and surgical patients, and ten were matched using an illness severity index. Our findings show an odds ratio of in hospital death associated with CLABSI as 2.75 (CI 1.86-4.07) and 1.51 (CI 1.08-2.09) in the subgroup of the ten matched studies. Those studies where greater than 30 % of CLABSI were attributed to coagulase-negative Staphylococcus had an odds ratio of death of 1.64 (95 % CI 1.02-2.65) compared with 4.71 (95 % CI 1.54-14.39).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CLABSI is associated with a significantly increased risk of death supporting the use of extensive efforts to reduce these infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital (NS), University of Wisconsin Medical School, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrini</LastName><ForeName>Daniela C</ForeName><Initials>DC</Initials></Author><Author ValidYN="Y"><LastName>Safdar</LastName><ForeName>Nasia</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055499" MajorTopicYN="N">Catheter-Related Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062905" MajorTopicYN="N">Central Venous Catheters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25331552</ArticleId><ArticleId IdType="doi">10.1007/s15010-014-0689-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Intern Med. 2009 Aug 18;151(4):W65-94</Citation><ArticleIdList><ArticleId IdType="pubmed">19622512</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2003 Oct;31(6):354-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14608302</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Infect Dis. 2013 Oct;45(10):738-45</Citation><ArticleIdList><ArticleId IdType="pubmed">23826790</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2006 Aug;34(8):2084-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16763511</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2009 Jul 1;49(1):1-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19489710</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1027-30</Citation><ArticleIdList><ArticleId IdType="pubmed">10988125</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Qual. 2009 Mar-Apr;24(2):166-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19228892</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Assoc Thai. 2014 Jan;97 Suppl 1:S93-101</Citation><ArticleIdList><ArticleId IdType="pubmed">24855848</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2014 May;20(5):O318-24</Citation><ArticleIdList><ArticleId IdType="pubmed">24112305</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Dec 28;355(26):2725-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17192537</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2009 Jul;37(7):2283-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19487944</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2001 Feb;136(2):229-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11177147</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2003 Dec;31(8):475-80</Citation><ArticleIdList><ArticleId IdType="pubmed">14647110</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Care Manag (Frederick). 2008 Oct-Dec;27(4):338-49</Citation><ArticleIdList><ArticleId IdType="pubmed">19011417</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Chemother. 2014 Mar;20(3):163-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24508422</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2005 Dec 1;41(11):1591-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16267731</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 1988 Jun;16(3):128-40</Citation><ArticleIdList><ArticleId IdType="pubmed">2841893</ArticleId></ArticleIdList></Reference><Reference><Citation>Infection. 2014 Feb;42(1):31-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23821485</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 1994 Sep 19;161(6):374-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8090116</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiothorac Vasc Anesth. 2004 Jun;18(3):304-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 1999 Jun;20(6):396-401</Citation><ArticleIdList><ArticleId IdType="pubmed">10395140</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2001 Jun;163(7):1584-90</Citation><ArticleIdList><ArticleId IdType="pubmed">11401878</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2007 Jan;28(1):31-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17315338</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 May;52(9):e162-93</Citation><ArticleIdList><ArticleId IdType="pubmed">21460264</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Armed Forces India. 2014 Jan;70(1):17-21</Citation><ArticleIdList><ArticleId IdType="pubmed">24623941</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Surg. 2011 Aug;77(8):1038-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21944520</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 May 25;271(20):1598-601</Citation><ArticleIdList><ArticleId IdType="pubmed">8182812</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Qual. 2014 Jan-Feb;29(1):13-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23652336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Quimioter. 2013 Mar;26(1):21-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23546458</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1993 Jun;16(6):778-84</Citation><ArticleIdList><ArticleId IdType="pubmed">8329510</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37405729</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6262</ISSN><JournalIssue CitedMedium="Internet"><Volume>158</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA surgery</Title><ISOAbbreviation>JAMA Surg</ISOAbbreviation></Journal><ArticleTitle>Cannabis Use Disorder and Perioperative Complications.</ArticleTitle><Pagination><StartPage>935</StartPage><EndPage>944</EndPage><MedlinePgn>935-944</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamasurg.2023.2403</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Cannabis use is growing in the US and is increasingly perceived as harmless. However, the perioperative impact of cannabis use remains uncertain.</AbstractText><AbstractText Label="OBJECTIVE">To assess whether cannabis use disorder is associated with increased morbidity and mortality after major elective, inpatient, noncardiac surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This retrospective, population-based, matched cohort study used data from the National Inpatient Sample for adult patients aged 18 to 65 years who underwent major elective inpatient surgery (including cholecystectomy, colectomy, inguinal hernia repair, femoral hernia repair, mastectomy, lumpectomy, hip arthroplasty, knee arthroplasty, hysterectomy, spinal fusion, and vertebral discectomy) from January 2016 to December 2019. Data were analyzed from February to August 2022.</AbstractText><AbstractText Label="EXPOSURE">Cannabis use disorder, as defined by the presence of specific International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) diagnostic codes.</AbstractText><AbstractText Label="MAIN OUTCOME AND MEASURES">The primary composite outcome was in-hospital mortality and 7 major perioperative complications (myocardial ischemia, acute kidney injury, stroke, respiratory failure, venous thromboembolism, hospital-acquired infection, and surgical procedure-related complications) based on ICD-10 discharge diagnosis codes. Propensity score matching was performed to create a 1:1 matched cohort that was well balanced with respect to covariates, which included patient comorbidities, sociodemographic factors, and procedure type.</AbstractText><AbstractText Label="RESULTS">Among 12 422 hospitalizations, a cohort of 6211 patients with cannabis use disorder (median age, 53 years [IQR, 44-59 years]; 3498 [56.32%] male) were matched with 6211 patients without cannabis use disorder for analysis. Cannabis use disorder was associated with an increased risk of perioperative morbidity and mortality compared with hospitalizations without cannabis use disorder in adjusted analysis (adjusted odds ratio, 1.19; 95% CI, 1.04-1.37; P&#x2009;=&#x2009;.01). The outcome occurred more frequently in the group with cannabis use disorder (480 [7.73%]) compared with the unexposed group (408 [6.57%]).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this cohort study, cannabis use disorder was associated with a modest increased risk of perioperative morbidity and mortality after major elective, inpatient, noncardiac surgery. In the context of increasing cannabis use rates, our findings support preoperative screening for cannabis use disorder as a component of perioperative risk stratification. However, further research is needed to quantify the perioperative impact of cannabis use by route and dosage and to inform recommendations for preoperative cannabis cessation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Potnuru</LastName><ForeName>Paul P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonna</LastName><ForeName>Srikar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>George W</ForeName><Initials>GW</Initials><Suffix>2nd</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Surg</MedlineTA><NlmUniqueID>101589553</NlmUniqueID><ISSNLinking>2168-6254</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002189" MajorTopicYN="Y">Marijuana Abuse</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37405729</ArticleId><ArticleId IdType="pmc">PMC10323761</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2023.2403</ArticleId><ArticleId IdType="pii">2806774</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Palamar JJ, Le A, Han BH. Quarterly trends in past-month cannabis use in the United States, 2015-2019. Drug Alcohol Depend. 2021;219:108494. doi:10.1016/j.drugalcdep.2020.108494</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2020.108494</ArticleId><ArticleId IdType="pmc">PMC7855903</ArticleId><ArticleId IdType="pubmed">33434791</ArticleId></ArticleIdList></Reference><Reference><Citation>Substance Abuse and Mental Health Services Administration . Key Substance Use and Mental Health Indicators in the United States: Results From the 2019 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality; 2020.</Citation></Reference><Reference><Citation>Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43(1):195-212. doi:10.1038/npp.2017.198</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2017.198</ArticleId><ArticleId IdType="pmc">PMC5719106</ArticleId><ArticleId IdType="pubmed">28853439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasin DS, Saha TD, Kerridge BT, et al. . Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235-1242. doi:10.1001/jamapsychiatry.2015.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2015.1858</ArticleId><ArticleId IdType="pmc">PMC5037576</ArticleId><ArticleId IdType="pubmed">26502112</ArticleId></ArticleIdList></Reference><Reference><Citation>Connor JP, Stjepanovi&#x107; D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nat Rev Dis Primers. 2021;7(1):16. doi:10.1038/s41572-021-00247-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00247-4</ArticleId><ArticleId IdType="pmc">PMC8655458</ArticleId><ArticleId IdType="pubmed">33627670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapley P, Kellett S. Cannabis-based medicines and the perioperative physician. Perioper Med (Lond). 2019;8:19. doi:10.1186/s13741-019-0127-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-019-0127-x</ArticleId><ArticleId IdType="pmc">PMC6898917</ArticleId><ArticleId IdType="pubmed">31827774</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverria-Villalobos M, Todeschini AB, Stoicea N, Fiorda-Diaz J, Weaver T, Bergese SD. Perioperative care of cannabis users: a comprehensive review of pharmacological and anesthetic considerations. J Clin Anesth. 2019;57:41-49. doi:10.1016/j.jclinane.2019.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2019.03.011</ArticleId><ArticleId IdType="pubmed">30852326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SGK, Seth M, Vaduganathan M, et al. ; Blue Cross Blue Shield of Michigan Cardiovascular Consortium Investigators . Marijuana use and in-hospital outcomes after percutaneous coronary intervention in Michigan, United States. JACC Cardiovasc Interv. 2021;14(16):1757-1767. doi:10.1016/j.jcin.2021.06.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2021.06.036</ArticleId><ArticleId IdType="pmc">PMC8855440</ArticleId><ArticleId IdType="pubmed">34412793</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg MD, Ng MK, Magruder ML, Vakharia RM, Roche MW, Erez O. The association of cannabis use disorder and perioperative complications after primary total knee arthroplasty. J Am Acad Orthop Surg. 2022;30(7):313-320. doi:10.5435/JAAOS-D-21-00703</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-21-00703</ArticleId><ArticleId IdType="pubmed">35171881</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu RG, Patel S, Siddiqui N, Nunna RS, Mehta AI. Cannabis abuse and perioperative complications following inpatient spine surgery in the United States. Spine (Phila Pa 1976). 2021;46(11):734-743. doi:10.1097/BRS.0000000000004035</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000004035</ArticleId><ArticleId IdType="pubmed">33769411</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu RG, Fuentes AM, Patil SN, Chiu R, McGuire LS, Mehta AI. Cannabis abuse and perioperative complications after treatment of intracranial aneurysms: a nationwide analysis. World Neurosurg. 2022;158:e184-e195. doi:10.1016/j.wneu.2021.10.156</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.10.156</ArticleId><ArticleId IdType="pubmed">34757211</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan M, Alnahhal KI, Lingutla R, et al. . Outcomes of infrainguinal bypass in patients with cannabis vs opioid use disorder. Ann Vasc Surg. 2022;82:144-155. doi:10.1016/j.avsg.2021.10.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2021.10.069</ArticleId><ArticleId IdType="pubmed">34902470</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness B, Goel A, Elias F, Rapanos T, Mittleman MA, Ladha KS. Cannabis use disorder and perioperative outcomes in vascular surgery. J Vasc Surg. 2021;73(4):1376-1387.e3. doi:10.1016/j.jvs.2020.07.094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2020.07.094</ArticleId><ArticleId IdType="pubmed">32861869</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel A, McGuinness B, Jivraj NK, et al. . Cannabis use disorder and perioperative outcomes in major elective surgeries: a retrospective cohort analysis. Anesthesiology. 2020;132(4):625-635. doi:10.1097/ALN.0000000000003067</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003067</ArticleId><ArticleId IdType="pubmed">31789638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang BH, Saud H, Sengupta N, et al. . Effect of preoperative cannabis use on perioperative outcomes: a retrospective cohort study. Reg Anesth Pain Med. 2021;46(8):650-655. doi:10.1136/rapm-2021-102479</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2021-102479</ArticleId><ArticleId IdType="pubmed">33990440</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung F, Lee Y, Manzoor S, Hong D, Doumouras AG. Effects of perioperative cannabis use on bariatric surgical outcomes: a systematic review. Obes Surg. 2021;31(1):299-306. doi:10.1007/s11695-020-04962-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-020-04962-x</ArticleId><ArticleId IdType="pubmed">32970257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha KS, McLaren-Blades A, Goel A, et al. . Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process. Br J Anaesth. 2021;126(1):304-318. doi:10.1016/j.bja.2020.09.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.09.026</ArticleId><ArticleId IdType="pubmed">33129489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Schwenk ES, Sondekoppam RV, et al. . ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023;48(3):97-117. doi:10.1136/rapm-2022-104013</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2022-104013</ArticleId><ArticleId IdType="pubmed">36596580</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare Cost and Utilization Project (HCUP). National (Nationwide) Inpatient Sample (NIS). Agency for Healthcare Research and Quality. 2021. Accessed February 22, 2022. http://www.hcup-us.ahrq.gov/nisoverview.jsp</Citation></Reference><Reference><Citation>Durand WM, DePasse JM, Bokshan SL, Eltorai AEM, Daniels AH. Tobacco use and complications following spinal fusion: a comparison of the National Surgical Quality Improvement Program and National Inpatient Sample datasets. World Neurosurg. 2019;123:e393-e407. doi:10.1016/j.wneu.2018.11.180</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.11.180</ArticleId><ArticleId IdType="pubmed">30500580</ArticleId></ArticleIdList></Reference><Reference><Citation>Salsabili M, Kiogou S, Adam TJ. The evaluation of clinical classifications software using the National Inpatient Sample database. AMIA Jt Summits Transl Sci Proc. 2020;2020:542-551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233079</ArticleId><ArticleId IdType="pubmed">32477676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamedani AG, Blank L, Thibault DP, Willis AW. Impact of ICD-9 to ICD-10 coding transition on prevalence trends in neurology. Neurol Clin Pract. 2021;11(5):e612-e619. doi:10.1212/CPJ.0000000000001046</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000001046</ArticleId><ArticleId IdType="pmc">PMC8610531</ArticleId><ArticleId IdType="pubmed">34840874</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R, Angraal S, Couch T, et al. . Adherence to methodological standards in research using the National Inpatient Sample. JAMA. 2017;318(20):2011-2018. doi:10.1001/jama.2017.17653</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17653</ArticleId><ArticleId IdType="pmc">PMC5742631</ArticleId><ArticleId IdType="pubmed">29183077</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XI, Wang X, Speicher PJ, et al. . Reporting and guidelines in propensity score analysis: a systematic review of cancer and cancer surgical studies. J Natl Cancer Inst. 2017;109(8):djw323. doi:10.1093/jnci/djw323</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djw323</ArticleId><ArticleId IdType="pmc">PMC6059208</ArticleId><ArticleId IdType="pubmed">28376195</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare Cost and Utilization Project (HCUP) . Clinical Classifications Software for Services and Procedures. Agency for Healthcare Research and Quality. May 2021. Accessed November 3, 2022. http://www.hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccssvcproc.jsp</Citation></Reference><Reference><Citation>Zhu H, Wu LT. Multiple drug use disorder diagnoses among drug-involved hospitalizations in the United States: results from the 2016 National Inpatient Sample. Drug Alcohol Depend. 2020;213:108113. doi:10.1016/j.drugalcdep.2020.108113</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2020.108113</ArticleId><ArticleId IdType="pmc">PMC7736193</ArticleId><ArticleId IdType="pubmed">32590210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandoli G, Jelliffe-Pawlowski L, Schumacher B, et al. . Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes. Drug Alcohol Depend. 2021;225:108757. doi:10.1016/j.drugalcdep.2021.108757</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2021.108757</ArticleId><ArticleId IdType="pmc">PMC8282693</ArticleId><ArticleId IdType="pubmed">34049105</ArticleId></ArticleIdList></Reference><Reference><Citation>Southern DA, Burnand B, Droesler SE, et al. . Deriving ICD-10 codes for patient safety indicators for large-scale surveillance using administrative hospital data. Med Care. 2017;55(3):252-260. doi:10.1097/MLR.0000000000000649</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000649</ArticleId><ArticleId IdType="pubmed">27635599</ArticleId></ArticleIdList></Reference><Reference><Citation>McIsaac DI, Hamilton GM, Abdulla K, et al. . Validation of new ICD-10-based patient safety indicators for identification of in-hospital complications in surgical patients: a study of diagnostic accuracy. BMJ Qual Saf. 2020;29(3):209-216. doi:10.1136/bmjqs-2018-008852</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjqs-2018-008852</ArticleId><ArticleId IdType="pubmed">31439760</ArticleId></ArticleIdList></Reference><Reference><Citation>Copeland-Halperin LR, Herrera-Gomez LC, LaPier JR, Shank N, Shin JH. The effects of cannabis: implications for the surgical patient. Plast Reconstr Surg Glob Open. 2021;9(3):e3448. doi:10.1097/GOX.0000000000003448</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GOX.0000000000003448</ArticleId><ArticleId IdType="pmc">PMC7963514</ArticleId><ArticleId IdType="pubmed">33747688</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare Cost and Utilization Project (HCUP) . Elixhauser Comorbidity Software Refined for ICD-10-CM. Agency for Healthcare Research and Quality; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413206</ArticleId></ArticleIdList></Reference><Reference><Citation>Houchens RL, Elixhauser A. Using the HCUP Nationwide Inpatient Sample to Estimate Trends. HCUP Methods Series Report 2005-01. Agency for Healthcare Research and Quality; 2005.</Citation></Reference><Reference><Citation>White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med. 2010;29(28):2920-2931. doi:10.1002/sim.3944</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3944</ArticleId><ArticleId IdType="pubmed">20842622</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Dalton JE. A unified approach to measuring the effect size between two groups using SAS. Paper presented at: SAS Global Forum 2012; April 22, 2012; Orlando, FL. Accessed February 22, 2022. https://support.sas.com/resources/papers/proceedings12/335-2012.pdf</Citation></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107. doi:10.1002/sim.3697</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3697</ArticleId><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascha EJ, Imrey PB. Factors affecting power of tests for multiple binary outcomes. Stat Med. 2010;29(28):2890-2904. doi:10.1002/sim.4066</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4066</ArticleId><ArticleId IdType="pubmed">20862669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascha EJ, Sessler DI. Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research. Anesth Analg. 2011;112(6):1461-1471. doi:10.1213/ANE.0b013e31821796d3</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31821796d3</ArticleId><ArticleId IdType="pubmed">21543784</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober P, Vetter TR. Count data in medical research: Poisson regression and negative binomial regression. Anesth Analg. 2021;132(5):1378-1379. doi:10.1213/ANE.0000000000005398</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005398</ArticleId><ArticleId IdType="pubmed">33857979</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007;13(3):381-389. doi:10.1111/j.1365-2753.2006.00711.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2753.2006.00711.x</ArticleId><ArticleId IdType="pubmed">17518803</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424. doi:10.1080/00273171.2011.568786</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Seicean A, Seicean S, Alan N, et al. . Effect of smoking on the perioperative outcomes of patients who undergo elective spine surgery. Spine (Phila Pa 1976). 2013;38(15):1294-1302. doi:10.1097/BRS.0b013e31828e2747</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31828e2747</ArticleId><ArticleId IdType="pubmed">23462575</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Mascha EJ, Roberman D, et al. . Smoking and perioperative outcomes. Anesthesiology. 2011;114(4):837-846. doi:10.1097/ALN.0b013e318210f560</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318210f560</ArticleId><ArticleId IdType="pubmed">21372682</ArticleId></ArticleIdList></Reference><Reference><Citation>Potnuru PP, Ganduglia C, Schaefer CM, Suresh M, Eltzschig HK, Jiang Y. Impact of cesarean versus vaginal delivery on the risk of postpartum acute kidney injury: a retrospective database controlled study in 116,876 parturients. J Clin Anesth. 2022;82:110915. doi:10.1016/j.jclinane.2022.110915</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2022.110915</ArticleId><ArticleId IdType="pubmed">35969987</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Yung Y-F, Stokes M. Propensity score methods for causal inference with the PSMATCH procedure. Paper presented at: SAS Global Forum 2017; April 2-5, 2017; Orlando, FL. Accessed August 12, 2022. https://www.lexjansen.com/sesug/2017/SD-215.pdf</Citation></Reference><Reference><Citation>Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150-161. doi:10.1002/pst.433</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.433</ArticleId><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Double propensity-score adjustment: a solution to design bias or bias due to incomplete matching. Stat Methods Med Res. 2017;26(1):201-222. doi:10.1177/0962280214543508</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280214543508</ArticleId><ArticleId IdType="pmc">PMC5302082</ArticleId><ArticleId IdType="pubmed">25038071</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenis D, Nguyen TQ, Dong N, Stuart EA. It&#x2019;s all about balance: propensity score matching in the context of complex survey data. Biostatistics. 2019;20(1):147-163. doi:10.1093/biostatistics/kxx063</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxx063</ArticleId><ArticleId IdType="pmc">PMC6296318</ArticleId><ArticleId IdType="pubmed">29293896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(suppl 2):69-80. doi:10.1002/pds.3263</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3263</ArticleId><ArticleId IdType="pubmed">22552982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanutto E. A comparison of propensity score and linear regression analysis of complex survey data. J Data Sci. 2006;4:67-91. doi:10.6339/JDS.2006.04(1).233</Citation><ArticleIdList><ArticleId IdType="doi">10.6339/JDS.2006.04(1).233</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen CS, Clark AE, Thomas AM, Cook LJ. Comparing least-squares and quantile regression approaches to analyzing median hospital charges. Acad Emerg Med. 2012;19(7):866-875. doi:10.1111/j.1553-2712.2012.01388.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1553-2712.2012.01388.x</ArticleId><ArticleId IdType="pubmed">22805633</ArticleId></ArticleIdList></Reference><Reference><Citation>Staffa SJ, Kohane DS, Zurakowski D. Quantile regression and its applications: a primer for anesthesiologists. Anesth Analg. 2019;128(4):820-830. doi:10.1213/ANE.0000000000004017</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004017</ArticleId><ArticleId IdType="pubmed">30649075</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations Office on Drugs and Crime . World drug report 2022. 2022. Accessed December 3, 2022. https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2022.html</Citation></Reference><Reference><Citation>Zhong H, Thor P, Illescas A, et al. . An overview of commonly used data sources in observational research in anesthesia. Anesth Analg. 2022;134(3):548-558. doi:10.1213/ANE.0000000000005880</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005880</ArticleId><ArticleId IdType="pubmed">35180172</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell C, Rueda S, Room R, Tyndall M, Fischer B. Routes of administration for cannabis use&#x2014;basic prevalence and related health outcomes: a scoping review and synthesis. Int J Drug Policy. 2018;52:87-96. doi:10.1016/j.drugpo.2017.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugpo.2017.11.008</ArticleId><ArticleId IdType="pubmed">29277082</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey JA, Schwartz BS, Stewart WF, Adler NE. Using electronic health records for population health research: a review of methods and applications. Annu Rev Public Health. 2016;37:61-81. doi:10.1146/annurev-publhealth-032315-021353</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-032315-021353</ArticleId><ArticleId IdType="pmc">PMC6724703</ArticleId><ArticleId IdType="pubmed">26667605</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasin DS, Saxon AJ, Malte C, et al. . Trends in cannabis use disorder diagnoses in the U.S. Veterans Health Administration, 2005-2019. Am J Psychiatry. 2022;179(10):748-757. doi:10.1176/appi.ajp.22010034</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.22010034</ArticleId><ArticleId IdType="pmc">PMC9529770</ArticleId><ArticleId IdType="pubmed">35899381</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55. doi:10.1093/biomet/70.1.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xf8;rgaard M, Ehrenstein V, Vandenbroucke JP. Confounding in observational studies based on large health care databases: problems and potential solutions&#x2014;a primer for the clinician. Clin Epidemiol. 2017;9:185-193. doi:10.2147/CLEP.S129879</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S129879</ArticleId><ArticleId IdType="pmc">PMC5378455</ArticleId><ArticleId IdType="pubmed">28405173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22972525</PMID><DateCompleted><Year>2012</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>11</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis.</ArticleTitle><Pagination><StartPage>1501</StartPage><EndPage>1513</EndPage><MedlinePgn>1501-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.8868</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Only a small proportion of patients with severe Clostridium difficile infection (CDI) undergo emergency surgery, the timing and nature of which is unclear. The aim of this study was to describe the operations performed and to identify factors predictive of death following emergency surgery for CDI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of published literature was performed for studies comparing survivors and non-survivors of emergency surgery for CDI. Meta-analysis was carried out for 30-day and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall 31 studies were included, which presented data on a total of 1433 patients undergoing emergency surgery for CDI. Some 1&#xb7;1 per cent of all patients with CDI and 29&#xb7;9 per cent with severe CDI underwent emergency surgery, although rates varied between studies (0&#xb7;2-7&#xb7;6 and 2&#xb7;2-86 per cent respectively). The most commonly performed operation was total colectomy with end ileostomy (89&#xb7;0 per cent, 1247 of 1401 detailed surgical procedures). When total colectomy with end ileostomy was not performed, reoperation to resect further bowel was needed in 15&#xb7;9 per cent (20 of 126). Where described, the 30-day mortality rate was 41&#xb7;3 per cent (160 of 387). Meta-analysis of high-quality studies revealed that the strongest predictors of postoperative death were those relating to preoperative physiological status: preoperative intubation, acute renal failure, multiple organ failure and shock requiring vasopressors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This systematic review supports total colectomy with end ileostomy as the primary surgical treatment for patients with severe CDI; other surgical procedures are associated with high rates of reoperation and mortality. Less extensive surgery may have a role in selected patients with earlier-stage disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhangu</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>West Midlands Research Collaborative, c/o Professor D. Morton, Academic Department of Surgery, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK. aneelbhangu@doctors.org.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nepogodiev</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Torrance</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><CollectiveName>West Midlands Research Collaborative</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016360" MajorTopicYN="N">Clostridioides difficile</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="N">Colectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004638" MajorTopicYN="N">Emergency Treatment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004761" MajorTopicYN="N">Enterocolitis, Pseudomembranous</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Bartlett</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Battersby</LastName><ForeName>Nick</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calvert</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Futaba</LastName><ForeName>Kaori</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnstone</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laing</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marriott</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mistry</LastName><ForeName>Pritesh</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinkney</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richardson</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Royle</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whisker</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morton</LastName><ForeName>Dion</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22972525</ArticleId><ArticleId IdType="doi">10.1002/bjs.8868</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37156300</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-6143</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</Title><ISOAbbreviation>Am J Transplant</ISOAbbreviation></Journal><ArticleTitle>Intracardiac thrombosis and pulmonary thromboembolism during liver transplantation: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1227</StartPage><EndPage>1240</EndPage><MedlinePgn>1227-1240</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajt.2023.04.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1600-6135(23)00455-0</ELocationID><Abstract><AbstractText>Intracardiac thrombosis and/or pulmonary thromboembolism (ICT/PE) is a rare but devastating complication during liver transplantation. Its pathophysiology remains poorly understood, and successful treatment remains a challenge. This systematic review summarizes the available published clinical data regarding ICT/PE during liver transplantation. Databases were searched for all publications reporting on ICT/PE during liver transplantation. Data collected included its incidence, patient characteristics, the timing of diagnosis, treatment strategies, and patient outcomes. This review included 59 full-text citations. The point prevalence of ICT/PE was 1.42%. Thrombi were most often diagnosed during the neohepatic phase, particularly at allograft reperfusion. Intravenous heparin was effective in preventing early-stage thrombus from progressing further and restoring hemodynamics in 76.32% of patients it was utilized for; however, the addition of tissue plasminogen activator or sole use of tissue plasminogen activator offered diminishing returns. Despite all resuscitation efforts, the in-hospital mortality rate of an intraoperative ICT/PE was 40.42%, with nearly half of these patients dying intraoperatively. The results of our systematic review are an initial step for providing clinicians with data that can help identify higher-risk patients. The clinical implications of our results warrant the development of identification and management strategies for the timely and effective treatment of these tragic occurrences during liver transplantation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American Society of Transplantation &amp; American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores</LastName><ForeName>Antolin S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Ohio State University College of Medicine, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Nasir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Julia E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Ohio State University College of Medicine, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzsimons</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalia</LastName><ForeName>Adam A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Essandoh</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Sylvester M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Transplantation Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schenk</LastName><ForeName>Austin D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Division of Transplantation Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawyer</LastName><ForeName>Tamara R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Central Michigan University College of Medicine, Mt. Pleasant, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Manoj H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Electronic address: Manoj.Iyer@osumc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Transplant</MedlineTA><NlmUniqueID>100968638</NlmUniqueID><ISSNLinking>1600-6135</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.68</RegistryNumber><NameOfSubstance UI="D010959">Tissue Plasminogen Activator</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010959" MajorTopicYN="N">Tissue Plasminogen Activator</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">intracardiac thrombus</Keyword><Keyword MajorTopicYN="N">liver transplantation</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>19</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37156300</ArticleId><ArticleId IdType="doi">10.1016/j.ajt.2023.04.029</ArticleId><ArticleId IdType="pii">S1600-6135(23)00455-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35619178</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-8090</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of cardiothoracic surgery</Title><ISOAbbreviation>J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>The prognostic significance of postoperative hyperbilirubinemia in cardiac surgery: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>129</StartPage><MedlinePgn>129</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">129</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13019-022-01870-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hyperbilirubinemia following cardiac surgery is a common phenomenon and is of emerging interest in prognostic factor research. This systematic review and meta-analysis evaluated the association between post-operative hyperbilirubinemia (PH) and mortality and morbidity in cardiac surgery patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Ovid Medline and Ovid Embase were searched from inception to July 2020 for studies evaluating the prognostic significance of PH following cardiac surgery. Maximally adjusted odds ratios (OR) with associated confidence intervals were obtained from each study and pooled using random effects inverse variance modelling to assess in-hospital mortality. Standardised mean differences were pooled to assess Intensive Care Unit (ICU) and hospital length of stay (LOS). Qualitative analysis was performed to assess ventilation requirements and long-term mortality. Meta-regression was used to assess inter- and intra-study heterogeneity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">3251 studies satisfied the selection criteria, from which 12 studies incorporating 3876 participants were included. PH significantly predicted in-hospital mortality with a pooled OR of 7.29 (95% CI 3.53, 15.09). Multiple pre-defined covariates contributed to the prognostic significance of PH, however only aortic cross-clamp time (p&#x2009;&lt;&#x2009;0.0001) and number of transfusions (p&#x2009;=&#x2009;0.0001) were significant effect modifiers. PH significantly predicted both ICU LOS (Mean difference 1.32 [95% CI 0.04-2.6]) and hospital LOS (Mean difference 1.79 [95% CI 0.36-3.21]). Qualitative analysis suggested PH is associated with increased post-operative ventilation requirements and reduced long-term survival rates.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hyperbilirubinemia is a cost-effective, widely available prognostic marker of adverse outcomes following cardiac surgery, albeit with residual sources of heterogeneity.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raveendran</LastName><ForeName>Dev</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8987-3849</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, 300 Grattan St, Parkville, VIC, 3050, Australia. draveendran@student.unimelb.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne Medical School, University of Melbourne, Parkville, Australia. draveendran@student.unimelb.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penny-Dimri</LastName><ForeName>Jahan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Clinical Science, Monash University, Clayton, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Barwon Health, Geelong, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Reny</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, 300 Grattan St, Parkville, VIC, 3050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Clinical Science, Monash University, Clayton, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Monash Health, Clayton, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plummer</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Integrated Critical Care, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Royal Melbourne Hospital, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhengyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, 300 Grattan St, Parkville, VIC, 3050, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne Medical School, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Luke A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, 300 Grattan St, Parkville, VIC, 3050, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cardiothorac Surg</MedlineTA><NlmUniqueID>101265113</NlmUniqueID><ISSNLinking>1749-8090</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006932" MajorTopicYN="N">Hyperbilirubinemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Hyperbilirubinemia</Keyword><Keyword MajorTopicYN="N">Jaundice</Keyword><Keyword MajorTopicYN="N">Length of stay</Keyword><Keyword MajorTopicYN="N">Prognostic biomarkers</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>26</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35619178</ArticleId><ArticleId IdType="pmc">PMC9137213</ArticleId><ArticleId IdType="doi">10.1186/s13019-022-01870-2</ArticleId><ArticleId IdType="pii">10.1186/s13019-022-01870-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chu CM, Chang CH, Liaw YF, Hsieh MJ. Jaundice after open heart surgery: a prospective study. Thorax. 1984;39(1):52&#x2013;56. doi: 10.1136/thx.39.1.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.39.1.52</ArticleId><ArticleId IdType="pmc">PMC459721</ArticleId><ArticleId IdType="pubmed">6695353</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu RB, Lin FY, Chen RJ, Chou NK, Ko WJ, Chi NH, et al. Incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after heart transplantation. Eur J Cardiothorac Surg. 2007;32(6):917&#x2013;922. doi: 10.1016/j.ejcts.2007.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2007.09.013</ArticleId><ArticleId IdType="pubmed">17920286</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalopoulos A, Alivizatos P, Geroulanos S. Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepatogastroenterology. 1997;44(15):779&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">9222689</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson R, Hermodsson S, Roberts D, Waldenstrom J. Hepatic dysfunction after open-heart surgery. Scand J Thorac Cardiovasc Surg. 1984;18(3):217&#x2013;222. doi: 10.3109/14017438409109894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14017438409109894</ArticleId><ArticleId IdType="pubmed">6152078</ArticleId></ArticleIdList></Reference><Reference><Citation>Farag M, Veres G, Szabo G, Ruhparwar A, Karck M, Arif R. Hyperbilirubinaemia after cardiac surgery: the point of no return. ESC Heart Fail. 2019;6(4):694&#x2013;700. doi: 10.1002/ehf2.12447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12447</ArticleId><ArticleId IdType="pmc">PMC6676269</ArticleId><ArticleId IdType="pubmed">31095903</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardeback M, Settergren G, Brodin LA. Hepatic blood flow and right ventricular function during cardiac surgery assessed by transesophageal echocardiography. J Cardiothorac Vasc Anesth. 1996;10(3):318&#x2013;322. doi: 10.1016/S1053-0770(96)80090-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1053-0770(96)80090-5</ArticleId><ArticleId IdType="pubmed">8725410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumle B, Boldt J, Suttner SW, Piper SN, Lehmann A, Blome M. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg. 2003;75(5):1558&#x2013;1564. doi: 10.1016/S0003-4975(02)04903-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04903-2</ArticleId><ArticleId IdType="pubmed">12735579</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintar T, Collard CD. The systemic inflammatory response to cardiopulmonary bypass. Anesthesiol Clin North Am. 2003;21(3):453&#x2013;464. doi: 10.1016/S0889-8537(03)00039-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0889-8537(03)00039-7</ArticleId><ArticleId IdType="pubmed">14562560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockey E, McIntyre N, Ross DN, Brookes E, Sturridge MF. Early jaundice after open-heart surgery. Thorax. 1967;22(2):165&#x2013;169. doi: 10.1136/thx.22.2.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.22.2.165</ArticleId><ArticleId IdType="pmc">PMC471601</ArticleId><ArticleId IdType="pubmed">6033384</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastoraki A, Karatzis E, Mastoraki S, Kriaras I, Sfirakis P, Geroulanos S. Postoperative jaundice after cardiac surgery. Hepatobiliary Pancreat Dis Int. 2007;6(4):383&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">17690034</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JS, Cole FR, Gibson P, Simpson JA. Jaundice following cardiopulmonary bypass. Thorax. 1967;22(3):232&#x2013;237. doi: 10.1136/thx.22.3.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.22.3.232</ArticleId><ArticleId IdType="pmc">PMC471609</ArticleId><ArticleId IdType="pubmed">6033390</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson RG, Ellison JH, Benson JA, Jr, Starr A. Jaundice following open-heart surgery. Ann Surg. 1967;165(2):217&#x2013;224. doi: 10.1097/00000658-196702000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-196702000-00008</ArticleId><ArticleId IdType="pmc">PMC1617391</ArticleId><ArticleId IdType="pubmed">6017068</ArticleId></ArticleIdList></Reference><Reference><Citation>Arif R, Seppelt P, Schwill S, Kojic D, Ghodsizad A, Ruhparwar A, et al. Predictive risk factors for patients with cirrhosis undergoing heart surgery. Ann Thorac Surg. 2012;94(6):1947&#x2013;1952. doi: 10.1016/j.athoracsur.2012.06.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.06.057</ArticleId><ArticleId IdType="pubmed">22921237</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Hayden JA, Steyerberg EW, Moons KG, Abrams K, Kyzas PA, et al. Prognosis research strategy (PROGRESS) 2: prognostic factor research. PLoS Med. 2013;10(2):e1001380. doi: 10.1371/journal.pmed.1001380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001380</ArticleId><ArticleId IdType="pmc">PMC3564757</ArticleId><ArticleId IdType="pubmed">23393429</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170(1):W1&#x2013;W33. doi: 10.7326/M18-1377.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1377</ArticleId><ArticleId IdType="pubmed">30596876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51&#x2013;58. doi: 10.7326/M18-1376.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1376</ArticleId><ArticleId IdType="pubmed">30596875</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J, Egger M. Publication bias in meta&#x2010;analysis: prevention, assessment and adjustments. In: Rothstein H, editor. Regression methods to detect publication and other bias in meta&#x2010;analysis: John Wiley &amp; Sons, Ltd; 2005.</Citation></Reference><Reference><Citation>Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991&#x2013;996. doi: 10.1016/j.jclinepi.2007.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.010</ArticleId><ArticleId IdType="pubmed">18538991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046&#x2013;1055. doi: 10.1016/S0895-4356(01)00377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(01)00377-8</ArticleId><ArticleId IdType="pubmed">11576817</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1&#x2013;48. doi: 10.18637/jss.v036.i03.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v036.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>An Y, Xiao YB, Zhong QJ. Hyperbilirubinemia after extracorporeal circulation surgery: a recent and prospective study. World J Gastroenterol. 2006;12(41):6722&#x2013;6726. doi: 10.3748/wjg.v12.i41.6722.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v12.i41.6722</ArticleId><ArticleId IdType="pmc">PMC4125684</ArticleId><ArticleId IdType="pubmed">17075992</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins JD, Bassendine MF, Ferner R, Blesovsky A, Murray A, Pearson DT, et al. Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet. 1983;1(8334):1119&#x2013;1123. doi: 10.1016/S0140-6736(83)92863-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(83)92863-5</ArticleId><ArticleId IdType="pubmed">6133152</ArticleId></ArticleIdList></Reference><Reference><Citation>Diab M, Sponholz C, von Loeffelholz C, Scheffel P, Bauer M, Kortgen A, et al. Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients. Infection. 2017;45(6):857&#x2013;866. doi: 10.1007/s15010-017-1064-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-017-1064-6</ArticleId><ArticleId IdType="pubmed">28856632</ArticleId></ArticleIdList></Reference><Reference><Citation>Golitaleb M, Kargar F, Aghai FG, Harorani M, Jadidi A, Abkenar HB, et al. Hyperbilirubinemia after open cardiac surgery. Iran Heart J. 2017;18(2):30&#x2013;35.</Citation></Reference><Reference><Citation>Hosotsubo KK, Nishimura M, Nishimura S. Hyperbilirubinaemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomy. Crit Care. 2000;4(3):180&#x2013;187. doi: 10.1186/cc691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc691</ArticleId><ArticleId IdType="pmc">PMC29041</ArticleId><ArticleId IdType="pubmed">11056750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraev AI, Torosoff MT, Fabian T, Clement CM, Perez-Tamayo RA. Postoperative hyperbilirubinemia is an independent predictor of longterm outcomes after cardiopulmonary bypass. J Am Coll Surg. 2008;206(4):645&#x2013;653. doi: 10.1016/j.jamcollsurg.2007.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2007.11.021</ArticleId><ArticleId IdType="pubmed">18387469</ArticleId></ArticleIdList></Reference><Reference><Citation>Leacche M, Winkelmayer WC, Paul S, Lin J, Unic D, Rawn JD, et al. Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg. 2006;81(4):1385&#x2013;1392. doi: 10.1016/j.athoracsur.2005.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.10.009</ArticleId><ArticleId IdType="pubmed">16564277</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, et al. Frequency, risk factors and prognosis of postoperative hyperbilirubinemia after heart valve surgery. Cardiology. 2012;122(1):12&#x2013;19. doi: 10.1159/000338142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000338142</ArticleId><ArticleId IdType="pubmed">22652820</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Ananthanarayanan C, Vaidhya N, Malhotra A, Shah K, Sharma R. Hyperbilirubinemia after cardiac surgery: an observational study. Asian Cardiovasc Thorac Ann. 2015;23(9):1039&#x2013;1043. doi: 10.1177/0218492315607149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492315607149</ArticleId><ArticleId IdType="pubmed">26405017</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal S, Richebe P, Barandon L, Calderon J, Tafer N, Pouquet O, et al. Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery. Eur J Cardiothorac Surg. 2009;36(3):572&#x2013;579. doi: 10.1016/j.ejcts.2009.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2009.04.018</ArticleId><ArticleId IdType="pubmed">19482487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang MJ, Chao A, Huang CH, Tsai CH, Lin FY, Wang SS, et al. Hyperbilirubinemia after cardiac operation. Incidence, risk factors, and clinical significance. J Thorac Cardiovasc Surg. 1994;108(3):429&#x2013;36. doi: 10.1016/S0022-5223(94)70252-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(94)70252-7</ArticleId><ArticleId IdType="pubmed">8078336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, Gupta D, Saibaba SS, Dilip D, Kola S, Naidu MS. Hyperbilirubinemia after cardiopulmonary bypass: a prospective study. Asian Cardiovasc Thorac Ann. 1999;7(1):3&#x2013;8. doi: 10.1177/021849239900700102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/021849239900700102</ArticleId></ArticleIdList></Reference><Reference><Citation>Shardey G, Tran L, WIlliams-Spence J, Solman N, Mclaren J, Marrow N, et al. The Australian and New Zealand society of cardiac and thoracic surgeons' cardiac surgery database program annual report 2020. Australia: Monash University, Department of Epidemiology and Preventive Medicine; 2021 Decemeber Report No.: 14.</Citation></Reference><Reference><Citation>Bowdish ME, D'Agostino RS, Thourani VH, Desai N, Shahian DM, Fernandez FG, et al. The society of thoracic surgeons adult cardiac surgery database: 2020 update on outcomes and research. Ann Thorac Surg. 2020;109(6):1646&#x2013;1655. doi: 10.1016/j.athoracsur.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2020.03.003</ArticleId><ArticleId IdType="pubmed">32247780</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz GC, Renz JF. Cardiac surgery in patients with end-stage liver disease. J Cardiothorac Vasc Anesth. 2014;28(1):155&#x2013;162. doi: 10.1053/j.jvca.2012.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.09.018</ArticleId><ArticleId IdType="pubmed">23265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JJ, Nam K, Kim TK, Kim HJ, Seo JH, Hwang HY, et al. Relationship between early postoperative C-reactive protein elevation and long-term postoperative major adverse cardiovascular and cerebral events in patients undergoing off-pump coronary artery bypass graft surgery: a retrospective study. Br J Anaesth. 2014;113(3):391&#x2013;401. doi: 10.1093/bja/aeu099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu099</ArticleId><ArticleId IdType="pubmed">24829443</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikvar L, Pillgram-Larsen J, Skjaeggestad O, Arnesen H, Stromme JH. Serum cardio-specific troponin T after open heart surgery in patients with and without perioperative myocardial infarction. Scand J Clin Lab Invest. 1994;54(4):329&#x2013;335. doi: 10.3109/00365519409087530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365519409087530</ArticleId><ArticleId IdType="pubmed">7939377</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparovic H, Burcar I, Kopjar T, Vojkovic J, Gabelica R, Biocina B, et al. NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 2010;37(1):100&#x2013;105. doi: 10.1016/j.ejcts.2009.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2009.07.003</ArticleId><ArticleId IdType="pubmed">19692262</ArticleId></ArticleIdList></Reference><Reference><Citation>Preeshagul I, Gharbaran R, Jeong KH, Abdel-Razek A, Lee LY, Elman E, et al. Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries. J Cardiothorac Surg. 2013;8:176. doi: 10.1186/1749-8090-8-176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-8-176</ArticleId><ArticleId IdType="pmc">PMC3726492</ArticleId><ArticleId IdType="pubmed">23866777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CH, Hsu RB. Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality. World J Gastroenterol. 2014;20(35):12608&#x2013;12614. doi: 10.3748/wjg.v20.i35.12608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i35.12608</ArticleId><ArticleId IdType="pmc">PMC4168098</ArticleId><ArticleId IdType="pubmed">25253965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34676647</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>1-2</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>In-hospital survival after pancreatoduodenectomy is greater in high-volume hospitals versus lower-volume hospitals: a meta-analysis.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>85</EndPage><MedlinePgn>77-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.17293</ELocationID><Abstract><AbstractText Label="BACKGROUND">Variation in cut-off values for what is considered a high volume (HV) hospital has made assessments of volume-outcome relationships for pancreaticoduodenectomy (PD) challenging. Accordingly, we performed a systematic review and meta-analysis comparing in-hospital mortality after PD in hospitals above and below HV thresholds of various cut-off values.</AbstractText><AbstractText Label="METHOD">PubMed/MEDLINE, Embase and Cochrane Library were searched to 4 January 2021 for studies comparing in-hospital mortality after PD in hospitals above and below defined HV thresholds. After data extraction, risk of bias was assessed using the Downs and Black checklist. A random-effects model was used for meta-analysis, including meta-regressions. Registration: PROSPERO, CRD42021224432.</AbstractText><AbstractText Label="RESULTS">From 1855 records, 17 observational studies of moderate quality were included. Median HV cut-off was 25 PDs/year (IQR: 20-32). Overall relative risk of in-hospital mortality was 0.37 (95% CI: 0.30, 0.45), that is, 63% less in HV hospitals. All subgroup analyses found an in-hospital survival benefit in performing PDs at HV hospitals. Meta-regressions from included studies found no statistically significant associations between relative risk of in-hospital mortality and region (USA vs. non-USA; p&#xa0;=&#xa0;0.396); or 25th percentile (p&#xa0;=&#xa0;0.231), median (p&#xa0;=&#xa0;0.822) or 75th percentile (p&#xa0;=&#xa0;0.469) HV cut-off values. Significant inverse relationships were found between PD hospital volume and other outcomes.</AbstractText><AbstractText Label="CONCLUSION">In-hospital survival was significantly greater for patients undergoing PDs at HV hospitals, regardless of HV cut-off value or region. Future research is required to investigate regions where low-volume centres have specialized PD infrastructure and the potential impact on mortality.</AbstractText><CopyrightInformation>&#xa9; 2021 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kovoor</LastName><ForeName>Joshua G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0002-3880-3840</Identifier><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Ning</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3191-8688</Identifier><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tivey</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0003-2213-2576</Identifier><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandepeer</LastName><ForeName>Meegan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>Jonathan Henry W</ForeName><Initials>JHW</Initials><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarfe</LastName><ForeName>Anje</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8907-0037</Identifier><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vreugdenburg</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0003-3265-3551</Identifier><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stretton</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Adelaide Health Technology Assessment, School of Public Health, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babidge</LastName><ForeName>Wendy J</ForeName><Initials>WJ</Initials><Identifier Source="ORCID">0000-0002-7063-7192</Identifier><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anthony</LastName><ForeName>Adrian A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padbury</LastName><ForeName>Robert T A</ForeName><Initials>RTA</Initials><AffiliationInfo><Affiliation>Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery and Perioperative Medicine, Flinders Medical Centre, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maddern</LastName><ForeName>Guy J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0003-2064-181X</Identifier><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Medibank Private Limited</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061847" MajorTopicYN="Y">Hospitals, High-Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="Y">Pancreaticoduodenectomy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Whipple procedure</Keyword><Keyword MajorTopicYN="N">centralisation</Keyword><Keyword MajorTopicYN="N">pancreatoduodenectomy</Keyword><Keyword MajorTopicYN="N">postoperative mortality</Keyword><Keyword MajorTopicYN="N">volume-outcome relationships</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>22</Day><Hour>7</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34676647</ArticleId><ArticleId IdType="doi">10.1111/ans.17293</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N. Engl. J. Med. 1979; 301: 1364-9.</Citation></Reference><Reference><Citation>Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N. Engl. J. Med. 2011; 364: 2128-37.</Citation></Reference><Reference><Citation>Birkmeyer JD, Siewers AE, Finlayson EV et al. Hospital volume and surgical mortality in the United States. N. Engl. J. Med. 2002; 346: 1128-37.</Citation></Reference><Reference><Citation>Nickel F, Haney CM, Kowalewski KF et al. Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials. Ann. Surg. 2020; 271: 54-66.</Citation></Reference><Reference><Citation>Yeo CJ, Cameron JL, Sohn TA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg. 1997; 226: 248-57.</Citation></Reference><Reference><Citation>Diener MK, Knaebel HP, Heukaufer C, Antes G, Buchler MW, Seiler CM. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann. Surg. 2007; 245: 187-200.</Citation></Reference><Reference><Citation>Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann. Surg. 2006; 244: 10-5.</Citation></Reference><Reference><Citation>Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 2002; 131: 6-15.</Citation></Reference><Reference><Citation>Ho V, Heslin MJ. Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann. Surg. 2003; 237: 509-14.</Citation></Reference><Reference><Citation>Chowdhury MM, Dagash H, Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br. J. Surg. 2007; 94: 145-61.</Citation></Reference><Reference><Citation>Hata T, Motoi F, Ishida M et al. Effect of hospital volume on surgical outcomes after Pancreaticoduodenectomy: a systematic review and meta-analysis. Ann. Surg. 2016; 263: 664-72.</Citation></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021; 372: n160.</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.</Citation></Reference><Reference><Citation>Nuckles BW, Lam K, Young KA, Dove JT, Shabahang MM, Blansfield JA. Quality improvement for surgical resection of pancreatic head adenocarcinoma: hospital and surgeon predictors of higher than expected R1 resection using the National Cancer Database. Am. Surg. 2021; 87: 396-403.</Citation></Reference><Reference><Citation>Saulle R, Vecchi S, Cruciani F, Mitrova Z, Amato L, Davoli M. The combined effect of surgeon and hospital volume on health outcomes: a systematic review. Clin. Ter. 2019; 170: e148-61.</Citation></Reference><Reference><Citation>Targarona J, Pando E, Garatea R, Vavoulis A, Montoya E. Morbidity and mortality rates in relation to the &#x201c;surgeon factor&#x201d; after duodenopancreatectomy. Cir. Esp. 2007; 82: 219-23.</Citation></Reference><Reference><Citation>Targarona J, Pando E, Vavoulis A et al. Evaluation of conditioning factors of morbimortality in duodenopacreatectomy in periampullary neoplasms. Rev. Gastroenterol. Peru 2008; 28: 226-34.</Citation></Reference><Reference><Citation>Gouma DJ, De Wit LT, Van Berge Henegouwen MI, Van Gulik TH, Obertop H. Hospital experience and hospital mortality following partial pancreaticoduodenectomy in The Netherlands. Ned. Tijdschr. Geneeskd. 1997; 141: 1738-41.</Citation></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 2016; 5: 210.</Citation></Reference><Reference><Citation>Ahmad T, Bouwman RA, Grigoras I et al. Use of failure-to-rescue to identify international variation in postoperative care in low-, middle- and high-income countries: a 7-day cohort study of elective surgery. Br. J. Anaesth. 2017; 119: 258-66.</Citation></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240: 205-13.</Citation></Reference><Reference><Citation>Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 1998; 52: 377-84.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.</Citation></Reference><Reference><Citation>Adam MA, Thomas S, Youngwirth L, Pappas T, Roman SA, Sosa JA. Defining a hospital volume threshold for minimally invasive Pancreaticoduodenectomy in the United States. JAMA Surg. 2017; 152: 336-42.</Citation></Reference><Reference><Citation>Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM, Warshaw AL, Fisher ES. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 1999; 125: 250-6.</Citation></Reference><Reference><Citation>de Wilde RF, Besselink MG, van der Tweel I et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br. J. Surg. 2012; 99: 404-10.</Citation></Reference><Reference><Citation>Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann. Surg. 1995; 221: 43-9.</Citation></Reference><Reference><Citation>Gordon TA, Bowman HM, Tielsch JM, Bass EB, Burleyson GP, Cameron JL. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann. Surg. 1998; 228: 71-8.</Citation></Reference><Reference><Citation>Gouma DJ, van Geenen RC, van Gulik TM et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann. Surg. 2000; 232: 786-95.</Citation></Reference><Reference><Citation>Hunger R, Mantke R. Outcome quality beyond the mean - an analysis of 43,231 pancreatic surgical procedures related to hospital volume. Ann. Surg. 2020. https://doi.org/10.1097/SLA.0000000000004315.</Citation></Reference><Reference><Citation>Hyder O, Dodson RM, Nathan H et al. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surg. 2013; 148: 1095-102.</Citation></Reference><Reference><Citation>Imperato PJ, Nenner RP, Starr HA, Will TO, Rosenberg CR, Dearie MB. The effects of regionalization on clinical outcomes for a high risk surgical procedure: a study of the Whipple procedure in New York state. Am. J. Med. Qual. 1996; 11: 193-7.</Citation></Reference><Reference><Citation>Kim CG, Jo S, Kim JS. Impact of surgical volume on nationwide hospital mortality after pancreaticoduodenectomy. World J. Gastroenterol. 2012; 18: 4175-81.</Citation></Reference><Reference><Citation>Mackay TM, Wellner UF, van Rijssen LB et al. Variation in pancreatoduodenectomy as delivered in two national audits. Br. J. Surg. 2019; 106: 747-55.</Citation></Reference><Reference><Citation>O'Mahoney PRA, Yeo HL, Sedrakyan A et al. Centralization of pancreatoduodenectomy a decade later: impact of the volume-outcome relationship. Surgery 2016; 159: 1528-38.</Citation></Reference><Reference><Citation>Schneider EB, Hyder O, Wolfgang CL et al. Provider versus patient factors impacting hospital length of stay after pancreaticoduodenectomy. Surgery 2013; 154: 152-61.</Citation></Reference><Reference><Citation>Schneider EB, Calkins KL, Weiss MJ et al. Race-based differences in length of stay among patients undergoing pancreatoduodenectomy. Surgery 2014; 156: 528-37.</Citation></Reference><Reference><Citation>Sutton JM, Wilson GC, Wima K et al. Readmission after Pancreaticoduodenectomy: the influence of the volume effect beyond mortality. Ann. Surg. Oncol. 2015; 22: 3785-92.</Citation></Reference><Reference><Citation>Swan RZ, Niemeyer DJ, Seshadri RM et al. The impact of regionalization of pancreaticoduodenectomy for pancreatic cancer in North Carolina since 2004. Am. Surg. 2014; 80: 561-6.</Citation></Reference><Reference><Citation>Yoshioka R, Yasunaga H, Hasegawa K et al. Impact of hospital volume on hospital mortality, length of stay and total costs after pancreaticoduodenectomy. Br. J. Surg. 2014; 101: 523-9.</Citation></Reference><Reference><Citation>Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann. Intern. Med. 2002; 137: 511-20.</Citation></Reference><Reference><Citation>Post PN, Kuijpers M, Ebels T, Zijlstra F. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. Eur. Heart J. 2010; 31: 1985-92.</Citation></Reference><Reference><Citation>Holt PJ, Poloniecki JD, Gerrard D, Loftus IM, Thompson MM. Meta-analysis and systematic review of the relationship between volume and outcome in abdominal aortic aneurysm surgery. Br. J. Surg. 2007; 94: 395-403.</Citation></Reference><Reference><Citation>Richardson AJ, Pang TC, Johnston E, Hollands MJ, Lam VW, Pleass HC. The volume effect in liver surgery-a systematic review and meta-analysis. J. Gastrointest. Surg. 2013; 17: 1984-96.</Citation></Reference><Reference><Citation>Gooiker GA, van Gijn W, Wouters MW et al. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br. J. Surg. 2011; 98: 485-94.</Citation></Reference><Reference><Citation>Kanhere HA, Trochsler MI, Kanhere MH, Lord AN, Maddern GJ. Pancreaticoduodenectomy: outcomes in a low-volume, specialised Hepato Pancreato Biliary Unit. World J. Surg. 2014; 38: 1484-90.</Citation></Reference><Reference><Citation>Stevens CL, Watters DAK. Short-term outcomes of pancreaticoduodenectomy in the state of Victoria: hospital resources are more important than volume. ANZ J. Surg. 2019; 89: 1577-81.</Citation></Reference><Reference><Citation>Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: 1747-51.</Citation></Reference><Reference><Citation>Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet 2020; 395: 2008-20.</Citation></Reference><Reference><Citation>Hirst A, Philippou Y, Blazeby J et al. No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations. Ann. Surg. 2019; 269: 211-20.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39668054</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative dexmedetomidine and acute kidney injury in paediatric noncardiac surgery: a retrospective propensity score-matched analysis.</ArticleTitle><Pagination><StartPage>453</StartPage><EndPage>460</EndPage><MedlinePgn>453-460</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2024.10.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00647-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paediatric acute kidney injury (AKI) is common and linked to longer hospitalisation and mortality. We investigated whether a continuous intraoperative infusion of dexmedetomidine, which increases renal blood flow, was associated with a lower risk of postoperative AKI in paediatric patients undergoing noncardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included paediatric patients undergoing noncardiac surgery between January 2019 and July 2021. Propensity score matching, based on the participants' baseline characteristics, was used to minimise the potential bias. The primary outcome was AKI within 7 days after surgery. The secondary outcomes included ICU admission, in-hospital mortality, length of hospitalisation, intraoperative bradycardia, and hypotension. The exposure of interest was continuous intraoperative infusion of dexmedetomidine at any dosage or duration. Multivariable logistic regression and linear regression analyses were further used to adjust for residual imbalanced intraoperative factors in the matched cohort.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After propensity score matching, we identified 1858/4091 paediatric patients who had received intraoperative dexmedetomidine infusion. Intraoperative dexmedetomidine infusion was associated with a lower risk of AKI (1.4% vs 3.2%; odds ratio 0.43, 95% confidence interval 0.27-0.66; P&lt;0.001), postoperative ICU admission (odds ratio 0.35, 95% confidence interval 0.30-0.42; P&lt;0.001), and shorter hospitalisation (7 [5-10] vs 9 [6-13] days; P&lt;0.001). Intraoperative bradycardia, hypotension, and in-hospital mortality were similar between the matched groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This retrospective analysis of a single-centre paediatric noncardiac surgery cohort suggests that intraoperative dexmedetomidine infusion was associated with a lower incidence of AKI within 7 days after surgery.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ChiCTR2300069115.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Anaesthesia and Critical Care Medicine, National-Local Joint Engineering Research Center of Translational Medicine of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Haibei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Xiaoya</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Anaesthesia and Critical Care Medicine, National-Local Joint Engineering Research Center of Translational Medicine of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xuehan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Yunxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: zuoyunxia@scu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="Y">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="Y">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">intraoperative dexmedetomidine</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">paediatric patients</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>12</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39668054</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2024.10.016</ArticleId><ArticleId IdType="pii">S0007-0912(24)00647-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26119410</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Meta-Analysis of Sodium Bicarbonate Therapy for Prevention of Cardiac Surgery-Associated Acute Kidney Injury.</ArticleTitle><Pagination><StartPage>1248</StartPage><EndPage>1256</EndPage><MedlinePgn>1248-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2015.03.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(15)00133-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to determine whether or not perioperative administration of sodium bicarbonate had a preventive effect on cardiac surgery-associated acute kidney injury (CSA-AKI) as shown in randomized controlled trials.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">The authors conducted a systematic review and meta-analysis using MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and KoreaMed.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The authors searched MEDLINE, EMBASE, CENTRAL, and KoreaMed without language and date restrictions. They used both MeSH and free-text terms to identify relevant studies. Electronic searches were undertaken on July 31, 2014.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Five randomized controlled studies included in this review.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">There were no differences in the development of CSA-AKI among patients in the sodium bicarbonate group compared with those in the control group (5 trials, 1,092 patients; n = 233 of 547 in sodium bicarbonate (SB) group versus 225 of 545 in control group (SC); risk ratio (RR), 0.95; 95% confidence interval (CI), 0.74-1.22. Also, there were no statistical differences in in-hospital mortality (3 trials, 573 patients; n = 21 of 288 in SB versus 14 of 285 in SC; RR, 1.44; 95% CI, 0.76-2.72), need for renal replacement therapy (4 trials, 1,000 patients; n = 21 of 503 in SB versus 23 of 497 in SC; RR, 0.90; 95% CI, 0.50-1.60), length of stay in the intensive care unit (ICU) (hours) (4 trials, n = 969 patients, weighted men difference (WMD), 2.17; 95% CI, -1.15-5.49), and length of ventilation (hours) (4 trials, 969 patients; WMD, 0.34; 95% CI,-0.80-1.48).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative administration of sodium bicarbonate did not reduce the rate of CSA-AKI in randomized controlled trials. Therefore, use of perioperative administration of sodium bicarbonate for the prevention of CSA-AKI is questionable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jun Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Pain Medicine, Ilsan Paik Hospital, Inje University, Goyang, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyun Jung</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Preventive Medicine, College of Medicine, Korea University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Yeon</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Pain Medicine, Ilsan Paik Hospital, Inje University, Goyang, Korea. Electronic address: jy925@paik.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Hyeong sik</ForeName><Initials>Hs</Initials><AffiliationInfo><Affiliation>Preventive Medicine, College of Medicine, Korea University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Il Min</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Preventive Medicine, College of Medicine, Korea University, Seoul, Korea; Literary Arts, Brown University, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choe</LastName><ForeName>Won Joo</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Pain Medicine, Ilsan Paik Hospital, Inje University, Goyang, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Choon-Hak</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Anesthesiology and Pain Medicine, Korea University Medical Center, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8MDF5V39QO</RegistryNumber><NameOfSubstance UI="D017693">Sodium Bicarbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017693" MajorTopicYN="N">Sodium Bicarbonate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">sodium bicarbonate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26119410</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2015.03.007</ArticleId><ArticleId IdType="pii">S1053-0770(15)00133-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28647732</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9913</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>1-2</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>European neurology</Title><ISOAbbreviation>Eur Neurol</ISOAbbreviation></Journal><ArticleTitle>Perioperative Strokes Following Surgical Correction of Mitral Valves: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>70</EndPage><MedlinePgn>63-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000477164</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The primary aim of this meta-analysis was to quantify the impact of perioperative strokes on stroke-related mortality after open mitral valve (MV) procedures were performed.</AbstractText><AbstractText Label="METHODS">An electronic search of the PubMed, Embase, and the Web of Science databases was performed to retrieve articles published up to December 2015, relevant to patients undergoing MV procedures. Data were extracted from the final list of 25 studies to calculate a summary OR for 30-day stroke-related mortality.</AbstractText><AbstractText Label="RESULTS">The stroke rate in the total sample population was 1.62% (73/4,498). The 30-day all-cause mortality rate was 3.51% (158/4,498). The percentage of total deaths caused by stroke was 6.87%. The summary OR of stroke-related mortality following MV procedures was estimated to be 7.22 (95% CI 4.13-12.63, p &lt; 0.0001). A subgroup analysis was done for studies involving concomitant MV surgery and coronary artery bypass grafting. The summary estimate of the subgroup showed an OR of 8.508 (95% CI 1.552-46.622, p = 0.0136).</AbstractText><AbstractText Label="CONCLUSION">Perioperative strokes following open MV procedures may be associated with more than 7 times greater odds of 30-day stroke-related mortality. They appear to be more commonly occurring than what is reported by current literature, making further studies investigating possible mechanisms and preventive measures a priority.</AbstractText><CopyrightInformation>&#xa9; 2017 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Udesh</LastName><ForeName>Reshmi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Piruthiviraj</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Jeevanantham</LastName><ForeName>Vinodh</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Gleason</LastName><ForeName>Thomas G</ForeName><Initials>TG</Initials></Author><Author ValidYN="Y"><LastName>Badhwar</LastName><ForeName>Vinay</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Thirumala</LastName><ForeName>Parthasarathy D</ForeName><Initials>PD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Eur Neurol</MedlineTA><NlmUniqueID>0150760</NlmUniqueID><ISSNLinking>0014-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">In-hospital mortality</Keyword><Keyword MajorTopicYN="N">Mitral valve surgery</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Perioperative stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28647732</ArticleId><ArticleId IdType="doi">10.1159/000477164</ArticleId><ArticleId IdType="pii">000477164</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29909664</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1478-7083</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of the Royal College of Surgeons of England</Title><ISOAbbreviation>Ann R Coll Surg Engl</ISOAbbreviation></Journal><ArticleTitle>Predicting in-hospital mortality in older general surgical patients.</ArticleTitle><Pagination><StartPage>529</StartPage><EndPage>533</EndPage><MedlinePgn>529-533</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1308/rcsann.2018.0086</ELocationID><Abstract><AbstractText>Introduction A significant number of emergency general surgical admissions occur in older patients. Clinical decision making in this group is challenging and current risk prediction tools extrapolate data from cohorts of younger patients. This is the first UK study to examine risk factors predicting in-hospital mortality in older acute surgical patients undergoing comprehensive geriatric assessment. Methods This was a prospective study of consecutive patients aged &#x2265;75 years admitted non-electively to general surgery wards between September 2014 and February 2017 who were reviewed by an elderly medicine in-reach service. Results A total of 577 patients were included with a mean age of 82.9 years. There was a female predominance (56%). The majority were living at home alone or with carers (93%) and most were independent in basic activities of daily living (79%). Over two-thirds (69%) were mobile with no walking aids or use of a walking stick and overt here-quarters (79%) had no cognitive impairment. Seventy-seven per cent of patients were managed non-operatively. The in-hospital mortality rate was 6.9%. Female sex (p=0.031), dependence in activities of daily living (p&lt;0.001), cognitive impairment (p&lt;0.001) and incontinence (p&lt;0.001) were predictors of in-hospital mortality. ASA (American Society of Anesthesiologists) grade &#x2265;3 was also associated with increased in-hospital mortality (odds ratio: 5.3, 95% confidence interval: 2.6-10.7). Conclusions Older general surgical patients present a high level of complexity. This study highlights the predictive role of mobility, functional and cognitive impairment when assessing this population. Accurate risk stratification requires global assessment by teams experienced in care of the older patient rather than the traditional focus on co-morbidities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vilches-Moraga</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Salford Royal NHS Foundation Trust , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Salford Royal NHS Foundation Trust , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paracha</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Salford Royal NHS Foundation Trust , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Quintanilla</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Salford Royal NHS Foundation Trust , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epstein</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Salford Royal NHS Foundation Trust , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearce</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Salford Royal NHS Foundation Trust , UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann R Coll Surg Engl</MedlineTA><NlmUniqueID>7506860</NlmUniqueID><ISSNLinking>0035-8843</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004638" MajorTopicYN="N">Emergency Treatment</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015577" MajorTopicYN="N">Geriatric Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Comprehensive geriatric assessment</Keyword><Keyword MajorTopicYN="N">Emergency general surgery</Keyword><Keyword MajorTopicYN="N">Functional impairment</Keyword><Keyword MajorTopicYN="N">Older people</Keyword><Keyword MajorTopicYN="N">Perioperative care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29909664</ArticleId><ArticleId IdType="pmc">PMC6214057</ArticleId><ArticleId IdType="doi">10.1308/rcsann.2018.0086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eurostat 
Population: Structure indicators. http://appsso.eurostat.ec.europa.eu/nui/submitViewTableAction.do (cited
March
2018).</Citation></Reference><Reference><Citation>Royal College of Surgeons of England Access All Ages 2. London: RCS; 2014.</Citation></Reference><Reference><Citation>McLean RC, McCallum IJ, Dixon S, O&#x2019;Loughlin P. A 15-year retrospective analysis of the epidemiology and outcomes for elderly emergency general surgical admissions in the North East of England: a case for multidisciplinary geriatric input. Int J Surg 2016; : 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">26892599</ArticleId></ArticleIdList></Reference><Reference><Citation>Chana P, Joy M, Casey N et al. . Cohort analysis of outcomes in 69490 emergency general surgical admissions across an international benchmarking collaborative. BMJ Open 2017; : e014484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353261</ArticleId><ArticleId IdType="pubmed">28274969</ArticleId></ArticleIdList></Reference><Reference><Citation>NELA Project Team Third Patient Report of the National Emergency Laparotomy Audit (NELA). London: RCoA; 2017.</Citation></Reference><Reference><Citation>St-Louis E, Sudarshan M, Al-Habboubi M et al. . The outcomes of the elderly in acute care general surgery. Eur J Trauma Emerg Surg 2016; : 107&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">26038035</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilches-Moraga A, Fox J, Paracha A et al. . Baseline characteristics and clinical outcomes of older patients admitted as an emergency to general surgical wards. Salford-POPS &#x2013; GS. Eur Geriatr Med 2017; : 499&#x2013;504.</Citation></Reference><Reference><Citation>Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing 2012; : 142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">22345294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt J, McCormack C, Tay HS et al. . Prevalence of multimorbidity and its association with outcomes in older emergency general surgical patients: an observational study. BMJ Open 2016; : e010126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823401</ArticleId><ArticleId IdType="pubmed">27033960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangram AJ, Shifflette VK, Mitchell CD et al. . The creation of a geriatric trauma unit &#x2018;G-60&#x2019;. Am Surg 2011; : 1,144&#x2013;41,146.</Citation><ArticleIdList><ArticleId IdType="pubmed">21944622</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangram AJ, Mitchell CD, Shifflette VK et al. . Geriatric trauma service: a one-year experience. J Trauma Acute Care Surg 2012; : 119&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">22310125</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter CR, Platts-Mills TF. Evolving prehospital, emergency department, and &#x2018;inpatient&#x2019; management models for geriatric emergencies. Clin Geriatr Med 2013; : 31&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3875836</ArticleId><ArticleId IdType="pubmed">23177599</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddaert J, Cohen-Bittan J, Khiami F et al. . Postoperative admission to a dedicated geriatric unit decreases mortality in elderly patients with hip fracture. PloS One 2014; : e83795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3893076</ArticleId><ArticleId IdType="pubmed">24454708</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Pascual C, Paredes-Galan E, Vilches-Moraga A et al. . Comprehensive geriatric assessment and 2-year mortality in elderly patients hospitalized for heart failure0. Circ Cardiovasc Qual Outcomes 2014; : 251&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">24594551</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzen C, Richardson LD, Baumlin KM et al. . Redesigned geriatric emergency care may have helped reduce admissions of older adults to intensive care units. Health Aff 2015; : 788&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">25941280</ArticleId></ArticleIdList></Reference><Reference><Citation>Harari D, Hopper A, Dhesi J et al. . Proactive care of older people undergoing surgery (&#x2018;POPS&#x2019;): designing, embedding, evaluating and funding a comprehensive geriatric assessment service for older elective surgical patients. Age Ageing 2007; : 190&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">17259638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis G, Whitehead MA, Robinson D et al. . Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 2011; : d6553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203013</ArticleId><ArticleId IdType="pubmed">22034146</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge JS, Harari D, Martin FC, Dhesi JK. The impact of pre-operative comprehensive geriatric assessment on postoperative outcomes in older patients undergoing scheduled surgery: a systematic review. Anaesthesia 2014; (Suppl 1): 8&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">24303856</ArticleId></ArticleIdList></Reference><Reference><Citation>Conroy SP, Ansari K, Williams M et al. . A controlled evaluation of comprehensive geriatric assessment in the emergency department: the &#x2018;Emergency Frailty Unit&#x2019;. Age Ageing 2014; : 109&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861335</ArticleId><ArticleId IdType="pubmed">23880143</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng MA, McMillan DT, Crowell K et al. . Geriatric assessment in surgical oncology: a systematic review. J Surg Res 2015; : 265&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4267910</ArticleId><ArticleId IdType="pubmed">25091339</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorsen K, S&#xf8;reide JA, S&#xf8;reide K. What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. J Gastrointest Surg 2014; : 1,261&#x2013;1,268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057623</ArticleId><ArticleId IdType="pubmed">24610235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson I, Barrett MP, Sinha A, Chan S. Predictors of in-hospital mortality amongst octogenarians undergoing emergency general surgery: a retrospective cohort study. Int J Surg 2014; : 1,157&#x2013;1,161.</Citation><ArticleIdList><ArticleId IdType="pubmed">25229887</ArticleId></ArticleIdList></Reference><Reference><Citation>Merani S, Payne J, Padwal RS et al. . Predictors of in-hospital mortality and complications in very elderly patients undergoing emergency surgery. World J Emerg Surg 2014; : 43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105124</ArticleId><ArticleId IdType="pubmed">25050133</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist 1970; : 20&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">5420677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; : 179&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">5349366</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK, van Dyck CH, Alessi CA et al. . Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990; : 941&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">2240918</ArticleId></ArticleIdList></Reference><Reference><Citation>Desserud KF, Veen T, S&#xf8;reide K. Emergency general surgery in the geriatric patient. Br J Surg 2016; : e52&#x2013;e61.</Citation><ArticleIdList><ArticleId IdType="pubmed">26620724</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce L, Bunni J, McCarthy K, Hewitt J. Surgery in the older person: training needs for the provision of multidisciplinary care. Ann R Coll Surg Engl 2016; : 367&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5209983</ArticleId><ArticleId IdType="pubmed">27269239</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28659127</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>87</StartPage><MedlinePgn>87</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">87</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-017-0380-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hip fracture is a trauma of the elderly. The worldwide number of patients in need of surgery after hip fracture will increase in the coming years. The 30-day mortality ranges between 4 and 14%. Patients' outcome may be improved by anaesthesia technique (general vs. neuraxial anaesthesia). There is a dearth of evidence from randomised studies regarding to the optimal anaesthesia technique. However, several large non-randomised studies addressing this question have been published from the onset of 2010.</AbstractText><AbstractText Label="METHODS">To compare the 30-day mortality rate, in-hospital mortality rate and length of hospital stay after neuraxial (epidural/spinal) or general anaesthesia in hip fracture patients (&#x2265; 18&#xa0;years old) we prepared a systematic review and meta-analysis. A systematic search for appropriate retrospective observational and prospective randomised studies in Embase and PubMed databases was performed in the time-period from 01.01.2010 to 21.11.2016. Additionally a forward searching in google scholar, a level one reference list searching and a formal searching of trial registries was performed.</AbstractText><AbstractText Label="RESULTS">Twenty retrospective observational and three prospective randomised controlled studies were included. There was no difference in the 30-day mortality [OR 0.99; 95% CI (0.94 to 1.04), p&#xa0;=&#xa0;0.60] between the general and the neuraxial anaesthesia group. The in-hospital mortality [OR 0.85; 95% CI (0.76 to 0.95), p&#xa0;=&#xa0;0.004] and the length of hospital stay were significantly shorter in the neuraxial anaesthesia group [MD -0.26; 95% CI (-0.36 to -0.17); p&#xa0;&lt;&#xa0;0.00001].</AbstractText><AbstractText Label="CONCLUSION">Neuraxial anaesthesia is associated with a reduced in-hospital mortality and length of hospitalisation. However, type of anaesthesia did not influence the 30-day mortality. In future there is a need for large randomised studies to examine the association between the type of anaesthesia, post-operative complications and mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Waesberghe</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Hospital RWTH Aachen, Pauwelsstra&#xdf;e 30, 52074, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevanovic</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Hospital RWTH Aachen, Pauwelsstra&#xdf;e 30, 52074, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Hospital RWTH Aachen, Pauwelsstra&#xdf;e 30, 52074, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coburn</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7930-0270</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Hospital RWTH Aachen, Pauwelsstra&#xdf;e 30, 52074, Aachen, Germany. mcoburn@ukaachen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="Y">Anesthesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">30-day mortality</Keyword><Keyword MajorTopicYN="N">General anaesthesia</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">In-hospital mortality</Keyword><Keyword MajorTopicYN="N">Length of hospital stay</Keyword><Keyword MajorTopicYN="N">Neuraxial anaesthesia</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28659127</ArticleId><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="doi">10.1186/s12871-017-0380-9</ArticleId><ArticleId IdType="pii">10.1186/s12871-017-0380-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop. 2011;45:15&#x2013;22. doi: 10.4103/0019-5413.73656.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5413.73656</ArticleId><ArticleId IdType="pmc">PMC3004072</ArticleId><ArticleId IdType="pubmed">21221218</ArticleId></ArticleIdList></Reference><Reference><Citation>Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, et al. Meta-analysis: excess mortality after hip fracture among old women and men. Ann Intern Med. 2010;152:380&#x2013;390. doi: 10.7326/0003-4819-152-6-201003160-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-152-6-201003160-00008</ArticleId><ArticleId IdType="pmc">PMC3010729</ArticleId><ArticleId IdType="pubmed">20231569</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians . National hip Fracture Database (NHFD) annual report 2015. London: RCP; 2015.</Citation></Reference><Reference><Citation>Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2006:17:1726&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">15490120</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of Anaesthetists of Great Britain and Ireland, Griffiths R, Alper J, Beckingsale A, Goldhill D, Heyburn G, et al. Management of proximal femoral fractures 2011: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2012:6785&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22150501</ArticleId></ArticleIdList></Reference><Reference><Citation>Medin E, Goude F, Melberg HO, Tediosi F, Belicza E, Peltola M, et al. European regional differences in all-cause mortality and length of stay for hip fracture patients [abstract] Health Econ. 2015;24:53&#x2013;64. doi: 10.1002/hec.3278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.3278</ArticleId><ArticleId IdType="pubmed">26633868</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, Kopp S. Anaesthesia for hip fracture surgery in adults. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD000521. DOI: 10.1002/14651858.CD000521</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, Samuel AM, Grauer JG. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip. Bone joint J. 2015;97-B:689&#x2013;695. doi: 10.1302/0301-620X.97B5.35042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.97B5.35042</ArticleId><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields AC, Dietrich JD, Buterbaugh K, Moucha CS. Short-term complications in hip fracture surgery using spinal versus general anesthesia. Injury. 2015:46719&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25704139</ArticleId></ArticleIdList></Reference><Reference><Citation>Helwani MH, Avidan MS, Ben Abdallah A, Kaiser DJ, Clohisy JC, Hall BL, et al. Effects of regional versus general anesthesia on outcomes after total hip arthroplasty. J Bone Joint Surg Am. 2015;97:186&#x2013;193. doi: 10.2106/JBJS.N.00612.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.N.00612</ArticleId><ArticleId IdType="pubmed">25653318</ArticleId></ArticleIdList></Reference><Reference><Citation>Karademir G, Bilgin Y, Ersen A, Polat G, Buget MI, Demirel M, et al. Hip fractures in patients older than 75 years old: retrospective analysis for prognostic factors. Int J Surg. 2015;24:101&#x2013;104. doi: 10.1016/j.ijsu.2015.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2015.11.009</ArticleId><ArticleId IdType="pubmed">26563486</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaman &#xd6;, &#xd6;zkazanli G, Orak MM, Mutlu H, Caliskan G, Karakus &#xd6;, et al. Factors affecting postoperative mortality in patients older than 65 years undergoing surgery for hip fracture. Ulus Travma Acil Cerrahi Derq. 2015;21:44&#x2013;50. doi: 10.5505/tjtes.2015.02582.</Citation><ArticleIdList><ArticleId IdType="doi">10.5505/tjtes.2015.02582</ArticleId><ArticleId IdType="pubmed">25779712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SD, Park SJ, Lee DH, Jee DL. Risk factors of morbidity and mortality following hip fracture surgery. Korean J Anesthesiol. 2013;64:505&#x2013;510. doi: 10.4097/kjae.2013.64.6.505.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2013.64.6.505</ArticleId><ArticleId IdType="pmc">PMC3695247</ArticleId><ArticleId IdType="pubmed">23814650</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, Lucas S, Sadasivan K, Wendling A, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med. 2012;13:948&#x2013;956. doi: 10.1111/j.1526-4637.2012.01402.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2012.01402.x</ArticleId><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwiq JM, Zubizarreta JR, Silber JH. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA. 2014;25(311):2508&#x2013;2517. doi: 10.1001/jama.2014.6499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.6499</ArticleId><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Patorno E, Neumann MD, Schneeweiss S, Mogun H, Bateman BT. Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study. BMJ. 2014;348:g4022. doi: 10.1136/bmj.g4022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g4022</ArticleId><ArticleId IdType="pmc">PMC4073666</ArticleId><ArticleId IdType="pubmed">24972901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid RH, Shah AA, Shakoor A, Noordin S. Hip fracture surgery: does type of anesthesia matter? Biomed Res Int. Volume 2013 doi:10.1155/2013/252356</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3684036</ArticleId><ArticleId IdType="pubmed">23819114</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih Y-J, Hsieh C-H, Kang T-W, Peng S-Y, Fan K-T, Wang L-M, et al. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol. 2010;4:37&#x2013;42. doi: 10.1016/S1873-9598(10)70020-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1873-9598(10)70020-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Gill SS, Bell CM, Austin PC, Anderson GM, et al. A postoperative medical complications associated with anesthesia on older adults with dementia. J Am Geriatr Soc. 2014;62:2102&#x2013;2109. doi: 10.1111/jgs.13106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13106</ArticleId><ArticleId IdType="pubmed">25370019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevtap HS, Nurettin H, Alkin C, Necdet S. Comparison of different anesthetic techniques on postoperative outcomes in elderly patients with hip fracture. Turkiye Klinikleri J Med Sci. 2012;32:623&#x2013;629. doi: 10.5336/medsci.2011-23901.</Citation><ArticleIdList><ArticleId IdType="doi">10.5336/medsci.2011-23901</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset. Anaesthesia. 2014;69:224&#x2013;230. doi: 10.1111/anae.12542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12542</ArticleId><ArticleId IdType="pubmed">24428375</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PS, Molina CS, Greenberg SE, Thakore RV, Obremskey WT, Sethi MK. Regional Anaesthesia for hip fracture surgery is associated with significantly more peri-operative complications compared with general anaesthesia. Int Orthop. 2015;39:1321&#x2013;1327. doi: 10.1007/s00264-015-2735-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-015-2735-5</ArticleId><ArticleId IdType="pubmed">25797416</ArticleId></ArticleIdList></Reference><Reference><Citation>Brox WT, Chan PH, Cafri G, Inacio MC. Similar mortality with general or regional anesthesia in elderly hip fracture patients. Acta Orthop. 2016;87:152&#x2013;157. doi: 10.3109/17453674.2015.1128781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453674.2015.1128781</ArticleId><ArticleId IdType="pmc">PMC4812077</ArticleId><ArticleId IdType="pubmed">26986550</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung Y-C, Hsu Y-H, Chang G-M. The effect of anesthetic type on outcomes of hip fracture surgery. Medicine (Baltimore) 2016;95:e3296. doi: 10.1097/MD.0000000000003296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003296</ArticleId><ArticleId IdType="pmc">PMC4998813</ArticleId><ArticleId IdType="pubmed">27057897</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, Chien CC, Shieh JP, Chen JY, et al. Propensity score-matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology. 2015;123:136&#x2013;147. doi: 10.1097/ALN.0000000000000695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000695</ArticleId><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R, Johansen A, Wakeman R, Boulton C, et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint audit of practice (ASAP-2) Anaesthesia. 2016;71:506&#x2013;514. doi: 10.1111/anae.13415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.13415</ArticleId><ArticleId IdType="pubmed">26940645</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology. 2012;117:72&#x2013;92. doi: 10.1097/ALN.0b013e3182545e7c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182545e7c</ArticleId><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotsche P, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, Leslie MP, Baumgartner MR, Grauer JN. Postoperative length of stay and 30-day readmission after geriatric hip fracture: an analysis of 8434 patients. J Orthop Trauma. 2015;29:115&#x2013;120. doi: 10.1097/BOT.0000000000000222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOT.0000000000000222</ArticleId><ArticleId IdType="pubmed">25210835</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Lian X, Dou X, Bi Q, Quan R, Tong P, et al. Intertrochanteric hip fracture surgery in Chinese: risk factors for predicting mortality. Int J Clin Exp Med. 2015;8:2789&#x2013;2793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402883</ArticleId><ArticleId IdType="pubmed">25932236</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury. 2015;48:1562&#x2013;1566. doi: 10.1016/j.injury.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.05.004</ArticleId><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, Morau D, Bernard N, Brinquier S, et al. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med. 2012;37:433&#x2013;440. doi: 10.1097/AAP.0b013e318252e901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0b013e318252e901</ArticleId><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SA, Soltani H, Hashemi SJ, Talakoub R, Soleimani B. Comparative study of two anesthesia methods according to postoperative complications and one month mortality rate in the candidates of hip surgery. J Res Med Sci. 2011;16:323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214341</ArticleId><ArticleId IdType="pubmed">22091252</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, Luger MF, Kammerlander-Knauer U, Roth T et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter [abstract]? Osteoporos Int. 2010.; 21S555-72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemian GH, Manafi AR, Najafi F, Najafi MA. Treatment of intertrochanteric fractures in elderly high risk patients: dynamic hip screw vs. external fixation. Injury. 2014;45:568&#x2013;572. doi: 10.1016/j.injury.2013.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.11.020</ArticleId><ArticleId IdType="pubmed">24332466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel HK, Iqbal MA, Mogallapu R, Maas D, Hoffmann RG. Time to ambulation after hip fracture surgery: relation to hospitalization outcomes. J Gerontol A Biol Sci Med Sci. 2003;58:1042&#x2013;1045. doi: 10.1093/gerona/58.11.M1042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/58.11.M1042</ArticleId><ArticleId IdType="pubmed">14630887</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons National Surgical Quality Improvement Program&#xae; (ACS NSQIP&#xae;) available from https://www.facs.org/quality-programs/acs-nsqip</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fixation using Alternative Implants for the treatment of Hip fractures (FAITH) Investigators Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial. Lancet. 2017;389:1519&#x2013;1527. doi: 10.1016/S0140-6736(17)30066-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30066-1</ArticleId><ArticleId IdType="pmc">PMC5597430</ArticleId><ArticleId IdType="pubmed">28262269</ArticleId></ArticleIdList></Reference><Reference><Citation>Errando CL, Soriano-Bru JL, Peiro CM, Ubeda J. Single shot spinal anaesthesia with hypobaric bupivacaine for hip fracture repair surgery in the elderly. Randomize, double blinded comparison of 3.75 mg vs. 7.5 mg. Rev Esp Anestesiol Reanim. 2014;61:541&#x2013;548. doi: 10.1016/j.redar.2014.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redar.2014.07.001</ArticleId><ArticleId IdType="pubmed">25236946</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37101401</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-8737</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical cardiology</Title><ISOAbbreviation>Clin Cardiol</ISOAbbreviation></Journal><ArticleTitle>Analysis of perioperative corticosteroid therapy in children undergoing cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>614</EndPage><MedlinePgn>607-614</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/clc.24018</ELocationID><Abstract><AbstractText>The advantages and disadvantages of using corticosteroids in children undergoing cardiac surgery is still contentious. To examine how perioperative corticosteroids affect postoperative mortality and clinical outcomes in pediatric cardiac surgery with cardiopulmonary bypass (CPB). We used MEDLINE, EMBASE, and the Cochrane Database to conduct a comprehensive search up through January 2023. Children aged 0-18 undergoing cardiac surgery were included in the meta-analysis of randomized controlled studies comparing perioperative corticosteroids with other therapeutic therapies, placebo, or no treatment. All-cause hospital mortality was the primary endpoint of the study. Hospitalization duration was a secondary result. The Cochrane Risk of Bias Assessment Tool was used to evaluate the research quality. Ten trials and 7798 pediatric participants were included in our analysis. Children taking corticosteroids had no significant difference in all-cause in-hospital mortality using a random-effect model with relative risk (RR)&#x2009;=&#x2009;0.38, 95% confidence interval (CI)&#x2009;=&#x2009;0.16-0.91, I<sup>2</sup> &#x2009;=&#x2009;79%, p&#x2009;=&#x2009;.03 for methylprednisolone and RR&#x2009;=&#x2009;0.29, 95% CI&#x2009;=&#x2009;0.09-0.97, I<sup>2</sup> &#x2009;=&#x2009;80%, p&#x2009;=&#x2009;.04. For the secondary outcome, there was a significant difference between the corticosteroid and placebo groups, with pooled standard mean difference (SMD)&#x2009;=&#x2009;-0.86, 95% CI&#x2009;=&#x2009;-1.57 to -0.15, I<sup>2</sup> &#x2009;=&#x2009;85%, p&#x2009;=&#x2009;.02 for methylprednisolone and SMD&#x2009;=&#x2009;-0.97, 95% CI -1.90 to -0.04, I<sup>2</sup> &#x2009;=&#x2009;83%, p&#x2009;=&#x2009;.04 for dexamethasone. Perioperative corticosteroids may not improve mortality, but they reduce hospital stay compared to placebo. Further evidence from randomized controlled studies with larger samples is required for approaching at a valid conclusion.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Daliu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Gastrointestinal Surgery, Chunzhou County Hospital of Huai'an City, Huai'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yongchun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1575-1344</Identifier><AffiliationInfo><Affiliation>Pediatric Surgery, Huai'an Maternal and Child Health Care Hospital, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Cardiol</MedlineTA><NlmUniqueID>7903272</NlmUniqueID><ISSNLinking>0160-9289</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiovascular events</Keyword><Keyword MajorTopicYN="N">corticosteroids</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37101401</ArticleId><ArticleId IdType="pmc">PMC10270253</ArticleId><ArticleId IdType="doi">10.1002/clc.24018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Datzmann T, Tr&#xe4;ger K. Extracorporeal membrane oxygenation and cytokine adsorption. J Thorac Dis. 2018;10(suppl 5):S653&#x2010;S660. 10.21037/jtd.2017.10.128</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.10.128</ArticleId><ArticleId IdType="pmc">PMC5911550</ArticleId><ArticleId IdType="pubmed">29732183</ArticleId></ArticleIdList></Reference><Reference><Citation>Brix&#x2010;Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand. 2001;45(6):671&#x2010;679. 10.1034/j.1399-6576.2001.045006671</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2001.045006671</ArticleId><ArticleId IdType="pubmed">11421823</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes PJ. How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol. 2006;148(3):245&#x2010;254. 10.1038/sj.bjp.0706736</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0706736</ArticleId><ArticleId IdType="pmc">PMC1751559</ArticleId><ArticleId IdType="pubmed">16604091</ArticleId></ArticleIdList></Reference><Reference><Citation>Augoustides JGT. The inflammatory response to cardiac surgery with cardiopulmonary bypass: should steroid prophylaxis be routine? J Cardiothorac Vasc Anesth. 2012;26(5):952&#x2010;958. 10.1053/j.jvca.2012.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.05.001</ArticleId><ArticleId IdType="pubmed">22765991</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebelsiek T, Beiras&#x2010;Fernandez A, Kilger E, Mohnle P, Weis F. Routine use of corticosteroids to prevent inflammation response in cardiac surgery. Recent Patents Cardiovasc Drug Discov. 2012;7(3):170&#x2010;174. 10.2174/157489012803832829</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157489012803832829</ArticleId><ArticleId IdType="pubmed">23035828</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutinho AE, Chapman KE. The anti&#x2010;inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2&#x2010;13. 10.1016/j.mce.2010.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2010.04.005</ArticleId><ArticleId IdType="pmc">PMC3047790</ArticleId><ArticleId IdType="pubmed">20398732</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018;63(6):655&#x2010;670. 10.4187/respcare.06314</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.06314</ArticleId><ArticleId IdType="pubmed">29794202</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilpain P, Le Jeunne C. Effets anti&#x2010;inflammatoires et immunosuppresseurs des glucocortico&#xef;des. Presse Med. 2012;41(4):378&#x2010;383. 10.1016/j.lpm.2012.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2012.01.010</ArticleId><ArticleId IdType="pubmed">22361029</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford JH, Hull MS, Borasino S, et al. Adrenal insufficiency in neonates after cardiac surgery with cardiopulmonary bypass. Pediatr Anesth. 2017;27(1):77&#x2010;84. 10.1111/pan.13013</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13013</ArticleId><ArticleId IdType="pubmed">27779350</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajarski RJ, Stefanelli CB, Graziano JN, Kaciroti N, Charpie JR, Vazquez D. Adrenocortical response in infants undergoing cardiac surgery with cardiopulmonary bypass and circulatory arrest. Pediatr Crit Care Med. 2010;11(1):44&#x2010;51. 10.1097/PCC.0b013e3181a64743</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3181a64743</ArticleId><ArticleId IdType="pubmed">19451847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald EL, Preze E, Eickhoff JC, Backer CL. The effect of cardiopulmonary bypass on the hypothalamic&#x2010;pituitary&#x2010;adrenal axis in children. Pediatr Crit Care Med. 2011;12(2):190&#x2010;196. 10.1097/PCC.0b013e3181f36d17</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3181f36d17</ArticleId><ArticleId IdType="pubmed">20838356</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasir M, Goyal A, Sonthalia S. Corticosteroid adverse effects. 2022 Jul 4. StatPearls [Internet]. StatPearls Publishing; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">30285357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciriaco M, Ventrice P, Russo G, et al. Corticosteroid&#x2010;related central nervous system side effects. J Pharmacol Pharmacother. 2013;4(suppl 1):S94&#x2010;S98. 10.4103/0976-500X.120975.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0976-500X.120975</ArticleId><ArticleId IdType="pmc">PMC3853679</ArticleId><ArticleId IdType="pubmed">24347992</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long&#x2010;term systemic corticosteroid exposure: asystematic literature review. Clin Ther. 2017;39(11):2216&#x2010;2229. 10.1016/j.clinthera.2017.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2017.09.011</ArticleId><ArticleId IdType="pubmed">29055500</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289&#x2010;294. 10.1097/00004836-200110000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004836-200110000-00006</ArticleId><ArticleId IdType="pubmed">11588541</ArticleId></ArticleIdList></Reference><Reference><Citation>Mott AR, Fraser CD, Kusnoor AV, et al. The effect of short&#x2010;term prophylactic methylprednisolone on the incidence and severity of post pericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. JACC. 2001;37(6):1700&#x2010;1706. 10.1016/S0735-1097(01)01223-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01223-2</ArticleId><ArticleId IdType="pubmed">11345387</ArticleId></ArticleIdList></Reference><Reference><Citation>Checchia PA, Backer CL, Bronicki RA, et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med. 2003;31(6):1742&#x2010;1745. 10.1097/01.CCM.0000063443.32874.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000063443.32874.60</ArticleId><ArticleId IdType="pubmed">12794414</ArticleId></ArticleIdList></Reference><Reference><Citation>Heying R, Wehage E, Schumacher K, et al. Dexamethasone pretreatment provides anti&#x2010;inflammatory and myocardial protection in neonatal arterial switch operation. Ann Thorac Surg. 2012;93:869&#x2010;876. 10.1016/j.athoracsur.2011.11.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.11.059</ArticleId><ArticleId IdType="pubmed">22289904</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquali SK, Li JS, He X, et al. Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics. 2012;129(2):e385&#x2010;e391. 10.1542/peds.2011-2034</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-2034</ArticleId><ArticleId IdType="pmc">PMC3269116</ArticleId><ArticleId IdType="pubmed">22271697</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunge JJH, van Osch D, Dieleman JM, et al. Dexamethasone for the prevention of postpericardiotomy syndrome: a DExamethasone for cardiac surgery substudy. Am Heart J. 2014;168(1):126&#x2010;131. 10.1016/j.ahj.2014.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2014.03.017</ArticleId><ArticleId IdType="pubmed">24952869</ArticleId></ArticleIdList></Reference><Reference><Citation>Suominen PK, Keski&#x2010;Nisula J, Ojala T, et al. Stress&#x2010;dose corticosteroid versus placebo in neonatal cardiac operations: arandomized controlled trial. Ann Thorac Surg. 2017;104(4):1378&#x2010;1385. 10.1016/j.athoracsur.2017.01.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.01.111</ArticleId><ArticleId IdType="pubmed">28434547</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Martin RH, Buckley JR, et al. Corticosteroid therapy in neonates undergoing cardiopulmonary bypass. JACC. 2019;74(5):659&#x2010;668. 10.1016/j.jacc.2019.05.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.05.060</ArticleId><ArticleId IdType="pmc">PMC6684326</ArticleId><ArticleId IdType="pubmed">31370958</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomivorotov V, Kornilov I, Boboshko V, et al. Effect of intraoperative dexamethasone on major complications and mortality among infants undergoing cardiac surgery: the DECISION randomized clinical trial. JAMA. 2020;323(24):2485&#x2010;2492. 10.1001/jama.2020.8133</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8133</ArticleId><ArticleId IdType="pmc">PMC7312411</ArticleId><ArticleId IdType="pubmed">32573670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill KD, Kannankeril PJ, Jacobs JP, et al. Methylprednisolone for heart surgery in infants &#x2014; A randomized, controlled trial. N Engl J Med. 2022;387(23):2138&#x2010;2149. 10.1056/NEJMoa2212667</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2212667</ArticleId><ArticleId IdType="pmc">PMC9843240</ArticleId><ArticleId IdType="pubmed">36342116</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsley MM. Methylprednisolone for heart surgery in infants: findings from a large&#x2010;scale, randomized, controlled trial. J Cardiothorac Vasc Anesth. 2023:S1053&#x2010;0770(23)00063&#x2010;0. 10.1053/j.jvca.2023.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2023.02.002</ArticleId><ArticleId IdType="pubmed">36863987</ArticleId></ArticleIdList></Reference><Reference><Citation>
Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. www.handbook.cochrane.org
</Citation></Reference><Reference><Citation>Schmidt L, Shokraneh F, Steinhausen K, Adams CE. Introducing RAPTOR: RevMan parsing tool for reviewers. Syst Rev. 2019;8(1):151. 10.1186/s13643-019-1070-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-019-1070-0</ArticleId><ArticleId IdType="pmc">PMC6595567</ArticleId><ArticleId IdType="pubmed">31242929</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliavaca CB, Stein C, Colpani V, et al. Prevalence Estimates Reviews&#x2010;Systematic Review Methodology Group (PERSyst) Meta&#x2010;analysis of prevalence: I2 statistic and how to deal with heterogeneity. Res Synth Methods. 2022;13(3):363&#x2010;367. 10.1002/jrsm.1547</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1547</ArticleId><ArticleId IdType="pubmed">35088937</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown D. A review of the PubMed PICO tool: using evidence&#x2010;based practice in health education. Health Promot Pract. 2020;21(4):496&#x2010;498. 10.1177/1524839919893361</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1524839919893361</ArticleId><ArticleId IdType="pubmed">31874567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashino Y, Noguchi Y, Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol. 2005;15(6):235&#x2010;243. 10.2188/jea.15.235</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.15.235</ArticleId><ArticleId IdType="pmc">PMC7904376</ArticleId><ArticleId IdType="pubmed">16276033</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudulu DP, Gibbison B, Upton T, et al. Corticosteroids in pediatric heart surgery: myth or reality. Front Pediatr. 2018;6:112. 10.3389/fped.2018.00112</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00112</ArticleId><ArticleId IdType="pmc">PMC5920028</ArticleId><ArticleId IdType="pubmed">29732365</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavare J, Grope I, Gardovska D. Prevalence of systemic inflammatory response syndrome (SIRS) in hospitalized children: a point prevalence study. BMC Pediatr. 2009;9:25. 10.1186/1471-2431-9-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2431-9-25</ArticleId><ArticleId IdType="pmc">PMC2670291</ArticleId><ArticleId IdType="pubmed">19344519</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chakraborty RK, Burns B. Systemic inflammatory response syndrome. [Updated 2022 May 30]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK547669/
</Citation><ArticleIdList><ArticleId IdType="pubmed">31613449</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K, Weiss SL. Initial resuscitation and management of pediatric septic shock. Minerva Pediatr. 2015;67(2):141&#x2010;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4395852</ArticleId><ArticleId IdType="pubmed">25604591</ArticleId></ArticleIdList></Reference><Reference><Citation>
Levy ML, Levy DM, Manna B.
Pediatric cerebral aneurysm. [Updated 2022 Aug 8]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. 
https://www.ncbi.nlm.nih.gov/books/NBK537085/
</Citation><ArticleIdList><ArticleId IdType="pubmed">30725770</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham P, Monard C, Schneider A, Rimmel&#xe9; T. Extracorporeal blood purification in burns: for whom, why, and how? Blood Purif. 2023;52(1):17&#x2010;24. 10.1159/000525085</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000525085</ArticleId><ArticleId IdType="pmc">PMC9909620</ArticleId><ArticleId IdType="pubmed">35738240</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla BK, Teitelbaum DH. Profound systemic inflammatory response syndrome following non&#x2010;emergent intestinal surgery in children. J Pediatr Surg. 2013;48(9):1936&#x2010;1940. 10.1016/j.jpedsurg.2013.05.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2013.05.065</ArticleId><ArticleId IdType="pmc">PMC3787315</ArticleId><ArticleId IdType="pubmed">24074671</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill KD, Baldwin HS, Bichel DP, et al. Rationale and design of the STeroids to REduce systemic inflammation after infant heart surgery (STRESS) trial. Am Heart J. 2020;220:192&#x2010;202. 10.1016/j.ahj.2019.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2019.11.016</ArticleId><ArticleId IdType="pmc">PMC7008076</ArticleId><ArticleId IdType="pubmed">31855716</ArticleId></ArticleIdList></Reference><Reference><Citation>Agerskov M, Thusholdt ANW, Holm&#x2010;S&#xf8;rensen H, et al. Association of the intraoperative peripheral perfusion index with postoperative morbidity and mortality in acute surgical patients: a retrospective observational multicentre cohort study. Br J Anaesth. 2021;127(3):396&#x2010;404. 10.1016/j.bja.2021.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8451236</ArticleId><ArticleId IdType="pubmed">34226038</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Luo Q, Wu X, Jia Y, Yan F. Perioperative corticosteroid therapy in children undergoing cardiac surgery: asystematic review and meta&#x2010;analysis. Front Pediatr. 2020;8:350. 10.3389/fped.2020.00350</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00350</ArticleId><ArticleId IdType="pmc">PMC7396528</ArticleId><ArticleId IdType="pubmed">32903325</ArticleId></ArticleIdList></Reference><Reference><Citation>Elassal AA, Al&#x2010;Radi OO, Debis RS, et al. Neonatal congenital heart surgery: contemporary outcomes and risk profile. J Cardiothorac Surg. 2022;17(1):80. 10.1186/s13019-022-01830-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-022-01830-w</ArticleId><ArticleId IdType="pmc">PMC9022284</ArticleId><ArticleId IdType="pubmed">35443734</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda T, Takeuchi M, Tachibana K, Nishida T, Kagisaki K, Imanaka H. Steroids improve hemodynamics in infants with adrenal insufficiency after cardiac surgery. J Cardiothorac Vasc Anesth. 2016;30(4):936&#x2010;941. 10.1053/j.jvca.2015.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.11.025</ArticleId><ArticleId IdType="pubmed">26995098</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarizia NA, Manlhiot C, Schwartz SM, et al. Improved outcomes associated with intraoperative steroid use in high&#x2010;risk pediatric cardiac surgery. Ann Thorac Surg. 2011;91(4):1222&#x2010;1227. 10.1016/j.athoracsur.2010.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.11.005</ArticleId><ArticleId IdType="pubmed">21440149</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrascia G, Rotunno C, Guida P, et al. Perioperative steroids administration in pediatric cardiac surgery: a meta&#x2010;analysis of randomized controlled trials*. Pediatr Crit Care Med. 2014;15(5):435&#x2010;442. 10.1097/PCC.0000000000000128</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000128</ArticleId><ArticleId IdType="pubmed">24717907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37480505</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0942-0940</ISSN><JournalIssue CitedMedium="Internet"><Volume>165</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Acta neurochirurgica</Title><ISOAbbreviation>Acta Neurochir (Wien)</ISOAbbreviation></Journal><ArticleTitle>In-hospital mortality rate in subaxial cervical spinal cord injury patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2675</StartPage><EndPage>2688</EndPage><MedlinePgn>2675-2688</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00701-023-05720-5</ELocationID><Abstract><AbstractText Label="PURPOSE">To determine existing trends concerning in-hospital mortality in patients with traumatic subaxial cervical spinal cord injury (SCI) over the last four decades.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE and EMBASE to assess the role of the following factors on in-hospital mortality over the last four decades: neurological deficit, age, surgical decompression, use of computed tomography (CT) and magnetic resonance imaging (MRI), use of methylprednisolone in the acute post-injury period, and study location (developing versus developed countries).</AbstractText><AbstractText Label="RESULTS">Among 3333 papers after deduplication, 21 studies met the eligibility criteria. The mortality rate was 17.88% [95% confidence interval (CI): 12.9-22.87%]. No significant trend in mortality rate was observed over the 42-year period (meta-regression coefficient&#x2009;=&#x2009;0.317; p&#x2009;=&#x2009;0.372). Subgroup analysis revealed no significant association between acute subaxial cervical SCI-related mortality when stratified by use of surgery, administration of methylprednisolone, use of MRI and CT imaging, study design (prospective versus retrospective study), and study location. The mortality rate was significantly higher in complete SCI (20.66%, p&#x2009;=&#x2009;0.002) and American Spinal Injury Association impairment scale (AIS) A (20.57%) and B (9.28%) (p&#x2009;=&#x2009;0.028).</AbstractText><AbstractText Label="CONCLUSION">A very low level of evidence showed that in-hospital mortality in patients with traumatic subaxial cervical SCI did not decrease over the last four decades despite diagnostic and therapeutic advancements. The overall acute mortality rate following subaxial cervical SCI is 17.88%. We recommend reporting a stratified mortality rate according to key factors such as treatment paradigms, age, and severity of injury in future studies.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadeghi-Naini</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Lorestan University of Medical Sciences, Khoram-Abad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousefifard</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghodsi</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azarhomayoun</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kermanian</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Alborz University of Medical Sciences, Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golpayegani</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alizadeh</LastName><ForeName>Seyed Danial</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseini</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shokraneh</LastName><ForeName>Farhad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>King's Technology Evaluation Centre (KiTEC), School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, London Institute of Healthcare Engineering, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komlakh</LastName><ForeName>Khalil</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaccaro</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Orthopedics and Neurosurgery, Thomas Jefferson University and the Rothman Institute, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery and Spine Program, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fehlings</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Brain Institute and McEwen Centre for Regenerative Medicine, Toronto Western Hospital, University Health Network, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimi-Movaghar</LastName><ForeName>Vafa</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-7347-8767</Identifier><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Science, Tehran, Iran. v_rahimi@sina.tums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. v_rahimi@sina.tums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. v_rahimi@sina.tums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universal Scientific Education and Research Network (USERN), Tehran, Iran. v_rahimi@sina.tums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. v_rahimi@sina.tums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Visiting Professor, Spine Program, University of Toronto, Toronto, Canada. v_rahimi@sina.tums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Sina Hospital, Tehran University of Medical Sciences, Hassan-Abad Square, Imam Khomeini Ave, Tehran, 11365-3876, Iran. v_rahimi@sina.tums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Acta Neurochir (Wien)</MedlineTA><NlmUniqueID>0151000</NlmUniqueID><ISSNLinking>0001-6268</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066193" MajorTopicYN="Y">Cervical Cord</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019838" MajorTopicYN="Y">Neck Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="Y">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cervical cord</Keyword><Keyword MajorTopicYN="N">In-hospital mortalities</Keyword><Keyword MajorTopicYN="N">Regression analysis</Keyword><Keyword MajorTopicYN="N">Spinal cord injuries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>22</Day><Hour>21</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>22</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37480505</ArticleId><ArticleId IdType="doi">10.1007/s00701-023-05720-5</ArticleId><ArticleId IdType="pii">10.1007/s00701-023-05720-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackery A, Tator C, Krassioukov A (2004) A global perspective on spinal cord injury epidemiology. J Neurotrauma 21(10):1355&#x2013;1370</Citation><ArticleIdList><ArticleId IdType="pubmed">15672627</ArticleId><ArticleId IdType="doi">10.1089/neu.2004.21.1355</ArticleId></ArticleIdList></Reference><Reference><Citation>Admasu AK, Buno E (2018) Short-term outcome in subaxial spine injury patients operated on in a resource-limited setting, Addis Ababa, Ethiopia. World Neurosurg 113:e702&#x2013;e706</Citation><ArticleIdList><ArticleId IdType="pubmed">29510279</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2018.02.129</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsaleh K, Bednar D, Farrokhyar F (2017) Acute traumatic quadriplegia in adults: predictors of acute in-hospital mortality. Turk Neurosurg 27(6):942&#x2013;945</Citation><ArticleIdList><ArticleId IdType="pubmed">27651339</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Lisy K, Qureshi R, Mattis P, Mu P (2020) Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds) JBI Manual for Evidence Synthesis. JBI, . Available from https://synthesismanual.jbi.global . https://doi.org/10.46658/JBIMES-20-08</Citation></Reference><Reference><Citation>Asemota AO, Ahmed AK, Purvis TE, Passias PG, Goodwin CR, Sciubba DM (2018) Analysis of cervical spine injuries in elderly patients from 2001 to 2010 using a nationwide database: increasing incidence, overall mortality, and inpatient hospital charges. World Neurosurg 120:e114&#x2013;e130</Citation><ArticleIdList><ArticleId IdType="pubmed">30077751</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2018.07.228</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellet FD, Rashid SM, Jusabani MA, Dekker MCJ, Temu RJ (2019) The characteristics of cervical spinal cord trauma at a North Tanzanian Referral Hospital: a retrospective hospital based study. Pan Afr Med J 33:82</Citation><ArticleIdList><ArticleId IdType="pubmed">31448044</ArticleId><ArticleId IdType="pmc">6689842</ArticleId><ArticleId IdType="doi">10.11604/pamj.2019.33.82.18353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo A, Marcoux J, Radhakrishna M, Pelletier J, Goulet B (2011) The role of magnetic resonance imaging in the management of acute spinal cord injury. J Neurotrauma 28(8):1401&#x2013;1411</Citation><ArticleIdList><ArticleId IdType="pubmed">20388006</ArticleId><ArticleId IdType="pmc">3143391</ArticleId><ArticleId IdType="doi">10.1089/neu.2009.1236</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracken MB (2012) Steroids for acute spinal cord injury. Cochrane Database Syst Rev 1(1):CD001046</Citation><ArticleIdList><ArticleId IdType="pubmed">22258943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord injury study. N Engl J Med 322(20):1405&#x2013;1411</Citation><ArticleIdList><ArticleId IdType="pubmed">2278545</ArticleId><ArticleId IdType="doi">10.1056/NEJM199005173222001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain JD, Meier S, Mader L, von Groote PM, Brinkhof MWG (2015) Mortality and longevity after a spinal cord injury: systematic review and meta-analysis. Neuroepidemiology 44(3):182&#x2013;198</Citation><ArticleIdList><ArticleId IdType="pubmed">25997873</ArticleId><ArticleId IdType="doi">10.1159/000382079</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HY, Chen SS, Chiu WT et al (1997) A nationwide epidemiological study of spinal cord injury in geriatric patients in Taiwan. Neuroepidemiology 16(5):241&#x2013;247</Citation><ArticleIdList><ArticleId IdType="pubmed">9346344</ArticleId><ArticleId IdType="doi">10.1159/000109693</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra HS, Sharawat R, Vishwakarma G (2021) In-hospital mortality in people with complete acute traumatic spinal cord injury at a tertiary care center in India-a retrospective analysis. Spinal Cord 60(3):210&#x2013;215</Citation><ArticleIdList><ArticleId IdType="pubmed">34172928</ArticleId><ArticleId IdType="pmc">8231086</ArticleId><ArticleId IdType="doi">10.1038/s41393-021-00657-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu W-T, Lin H-C, Lam C, Chu S-F, Chiang Y-H, Tsai S-H (2010) Review paper: epidemiology of traumatic spinal cord injury: comparisons between developed and developing countries. Asia Pac J Public Health 22(1):9&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">20032030</ArticleId><ArticleId IdType="doi">10.1177/1010539509355470</ArticleId></ArticleIdList></Reference><Reference><Citation>Claxton AR, Wong DT, Chung F, Fehlings MG (1998) Predictors of hospital mortality and mechanical ventilation in patients with cervical spinal cord injury. Can J Anaesth 45(2):144&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pubmed">9512849</ArticleId><ArticleId IdType="doi">10.1007/BF03013253</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshvar P, Roffey DM, Brikeet YA, Tsai EC, Bailey CS, Wai EK (2013) Spinal cord injuries related to cervical spine fractures in elderly patients: factors affecting mortality. Spine J 13(8):862&#x2013;866</Citation><ArticleIdList><ArticleId IdType="pubmed">23453576</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2013.01.045</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo-Neto JS, Vidotto LEL, de Campos Gomes F, de Morais DF, Tognola WA (2017) Characteristics and clinical aspects of patients with spinal cord injury undergoing surgery. Rev Bras Ortop 52(4):479&#x2013;490</Citation><ArticleIdList><ArticleId IdType="pubmed">28884108</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehlings MG, Tetreault LA, Wilson JR et al (2017) A clinical practice guideline for the management of patients with acute spinal cord injury and central cord syndrome: recommendations on the timing (&#x2264;24 hours versus &gt;24 hours) of decompressive surgery. Global Spine J 7(3 Suppl):195S-202S</Citation><ArticleIdList><ArticleId IdType="pubmed">29164024</ArticleId><ArticleId IdType="pmc">5684850</ArticleId><ArticleId IdType="doi">10.1177/2192568217706367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehlings M, Wilson J, Tetreault L et al (2017) A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the use of methylprednisolone sodium succinate. Global Spine J. https://doi.org/10.1177/2192568217703085</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568217703085</ArticleId><ArticleId IdType="pubmed">30258760</ArticleId><ArticleId IdType="pmc">6149046</ArticleId></ArticleIdList></Reference><Reference><Citation>Fielingsdorf K, Dunn RN (2007) Cervical spine injury outcome&#x2013;a review of 101 cases treated in a tertiary referral unit. S Afr Med J 97(3):203&#x2013;207</Citation><ArticleIdList><ArticleId IdType="pubmed">17440669</ArticleId></ArticleIdList></Reference><Reference><Citation>Fred&#xf8; HL, Rizvi SAM, Rezai M, R&#xf8;nning P, Lied B, Helseth E (2016) Complications and long-term outcomes after open surgery for traumatic subaxial cervical spine fractures: a consecutive series of 303 patients. BMC Surg 16(1):56</Citation><ArticleIdList><ArticleId IdType="pubmed">27526852</ArticleId><ArticleId IdType="pmc">4986380</ArticleId><ArticleId IdType="doi">10.1186/s12893-016-0172-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhart KA (1991) Spinal cord injury outcomes in a population-based sample. J Trauma 31(11):1529&#x2013;1535</Citation><ArticleIdList><ArticleId IdType="pubmed">1942176</ArticleId><ArticleId IdType="doi">10.1097/00005373-199111000-00012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerndt SJ, Rodriguez JL, Pawlik JW, Taheri PA, Wahl WL, Micheals AJ, Papadopoulos SM (1997) Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma 42(2):279&#x2013;284</Citation><ArticleIdList><ArticleId IdType="pubmed">9042882</ArticleId><ArticleId IdType="doi">10.1097/00005373-199702000-00017</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Zhang P, Xu D, Zuo Q (2002) Cause analysis of death of patients with spinal cord injuries in the acute phase. SHAANXI Med J 31(9):778&#x2013;779</Citation></Reference><Reference><Citation>Hoque MF, Grangeon C, Reed K (1999) Spinal cord lesions in Bangladesh: an epidemiological study 1994&#x2013;1995. Spinal Cord 37(12):858&#x2013;861</Citation><ArticleIdList><ArticleId IdType="pubmed">10602529</ArticleId><ArticleId IdType="doi">10.1038/sj.sc.3100938</ArticleId></ArticleIdList></Reference><Reference><Citation>Inglis T, Banaszek D, Rivers CS et al (2020) In-hospital mortality for the elderly with acute traumatic spinal cord injury. J Neurotrauma 37(21):2332&#x2013;2342</Citation><ArticleIdList><ArticleId IdType="pubmed">32635809</ArticleId><ArticleId IdType="pmc">7585611</ArticleId><ArticleId IdType="doi">10.1089/neu.2019.6912</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakimovska VM, Biering-Sorensen F, Lidal IB, Kostovski E (2020) Epidemiological characteristics and early complications after spinal cord injury in Former Yugoslav Republic of Macedonia. Spinal Cord 58(1):86&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pubmed">31427697</ArticleId><ArticleId IdType="doi">10.1038/s41393-019-0342-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamp O, Jansen O, Lefering R, Aach M, Waydhas C, Dudda M, Schildhauer TA, Hamsen U, TraumaRegister DGU (2021) Survival among patients with severe high cervical spine injuries - a TraumaRegister DGU&#xae; database study. Scand J Trauma Resusc Emerg Med 29(1):1</Citation><ArticleIdList><ArticleId IdType="pubmed">33407690</ArticleId><ArticleId IdType="pmc">7786887</ArticleId><ArticleId IdType="doi">10.1186/s13049-020-00820-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, Perruolo E, Parati G, ESH Working Group on CV Risk in Low Resource Settings (2016) Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One 11(1):e0147601</Citation><ArticleIdList><ArticleId IdType="pubmed">26808317</ArticleId><ArticleId IdType="pmc">4725677</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0147601</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3(3):e123-130</Citation><ArticleIdList><ArticleId IdType="pubmed">21603045</ArticleId><ArticleId IdType="pmc">3090117</ArticleId></ArticleIdList></Reference><Reference><Citation>Munakomi S, Bhattarai B, Cherian I (2017) Prospective observational research on the clinical profile and outcome analysis among a cohort of patients sustaining traumatic cervical spine and cord injury in a peripheral tertiary spine care centre in Nepal. F1000Res 6:1957</Citation><ArticleIdList><ArticleId IdType="pubmed">29250317</ArticleId><ArticleId IdType="pmc">5701450</ArticleId><ArticleId IdType="doi">10.12688/f1000research.12911.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann CR, Brasil AV, Albers F (2009) Risk factors for mortality in traumatic cervical spinal cord injury: Brazilian data. J Trauma 67(1):67&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pubmed">19590310</ArticleId></ArticleIdList></Reference><Reference><Citation>Obalum DC, Giwa SO, Adekoya-Cole TO, Enweluzo GO (2009) Profile of spinal injuries in Lagos. Nigeria Spinal Cord 47(2):134&#x2013;137</Citation><ArticleIdList><ArticleId IdType="pubmed">18679400</ArticleId><ArticleId IdType="doi">10.1038/sc.2008.93</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo OA, Poluyi EO, Owolabi BS, Kanu OO, Popoola MO (2017) Surgical decompression for traumatic spinal cord injury in a tertiary center. Niger J Clin Pract 20(11):1455&#x2013;1460</Citation><ArticleIdList><ArticleId IdType="pubmed">29303132</ArticleId><ArticleId IdType="doi">10.4103/njcp.njcp_303_16</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajareya K (1996) Traumatic spinal cord injuries in Thailand: an epidemiologic study in Siriraj Hospital, 1989&#x2013;1994. Spinal Cord 34(10):608&#x2013;610</Citation><ArticleIdList><ArticleId IdType="pubmed">8896127</ArticleId><ArticleId IdType="doi">10.1038/sc.1996.108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabadi MH, Mayanna SK, Vincent AS (2013) Predictors of mortality in veterans with traumatic spinal cord injury. Spinal Cord 51(10):784&#x2013;788</Citation><ArticleIdList><ArticleId IdType="pubmed">23896672</ArticleId><ArticleId IdType="doi">10.1038/sc.2013.77</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos EAS, Filho WJS, Possatti LL, Bittencourt LRA, Fontoura EAF, Botelho RV (2009) Epidemiology of severe cervical spinal trauma in the north area of S&#xe3;o Paulo City: a 10-year prospective study. Clinical article. J Neurosurg Spine 11(1):34&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pubmed">19569938</ArticleId><ArticleId IdType="doi">10.3171/2009.3.SPINE08325</ArticleId></ArticleIdList></Reference><Reference><Citation>Selecki BR, Berry G, Kwok B, Mandryk JA, Ring IT, Sewell MF, Simpson DA, Vanderfield GK (1986) Experience with spinal injuries in New South Wales. Aust N Z J Surg 56(7):567&#x2013;576</Citation><ArticleIdList><ArticleId IdType="pubmed">3461778</ArticleId><ArticleId IdType="doi">10.1111/j.1445-2197.1986.tb07100.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao J, Zhu W, Chen X, Jia L, Song D, Zhou X, Yan W, Zhang Y (2011) Factors associated with early mortality after cervical spinal cord injury. J Spinal Cord Med 34(6):555&#x2013;562</Citation><ArticleIdList><ArticleId IdType="pubmed">22330110</ArticleId><ArticleId IdType="pmc">3237281</ArticleId><ArticleId IdType="doi">10.1179/2045772311Y.0000000024</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibahashi K, Nishida M, Okura Y, Hamabe Y (2019) Epidemiological state, predictors of early mortality, and predictive models for traumatic spinal cord injury: a multicenter nationwide cohort study. Spine (Phila Pa 1976) 44(7):479&#x2013;487</Citation><ArticleIdList><ArticleId IdType="pubmed">30234810</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000002871</ArticleId></ArticleIdList></Reference><Reference><Citation>Silberstein B, Rabinovich S (1995) Epidemiology of spinal cord injuries in Novosibirsk. Russia Paraplegia 33(6):322&#x2013;325</Citation><ArticleIdList><ArticleId IdType="pubmed">7644257</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Tetreault L, Kalsi-Ryan S, Nouri A, Fehlings MG (2014) Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol 6:309&#x2013;331</Citation><ArticleIdList><ArticleId IdType="pubmed">25278785</ArticleId><ArticleId IdType="pmc">4179833</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh DK, Chhabra A, Kumar R, Ahmad F, Yadav K, Kaif M (2018) Outcome analysis of upper versus lower cervical spine injuries. Indian J Neurotrauma 15(02/03):100&#x2013;105</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1676906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolowski MJ, Jackson AP, Haak MH, Meyer PR, Sokolowski MS (2007) Acute mortality and complications of cervical spine injuries in the elderly at a single tertiary care center. J Spinal Disord Tech 20(5):352&#x2013;356</Citation><ArticleIdList><ArticleId IdType="pubmed">17607099</ArticleId><ArticleId IdType="doi">10.1097/BSD.0b013e31802d0bc5</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro AR, Klein GR, Thaller JB, Rushton SA, Cotler JM, Albert TJ (2001) Distraction extension injuries of the cervical spine. J Spinal Disord 14(3):193&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pubmed">11389368</ArticleId><ArticleId IdType="doi">10.1097/00002517-200106000-00002</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg MEL, Castellote JM, de Pedro-Cuesta J, Mahillo-Fernandez I (2010) Survival after spinal cord injury: a systematic review. J Neurotrauma 27(8):1517&#x2013;1528</Citation><ArticleIdList><ArticleId IdType="pubmed">20486810</ArticleId><ArticleId IdType="doi">10.1089/neu.2009.1138</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Chen X, Lin Y, Tan T, Yang Z, Dayao C, Liu L, Jiang R, Zhang J (2011) Impairment of synaptic plasticity in hippocampus is exacerbated by methylprednisolone in a rat model of traumatic brain injury. Brain Res 1382:165&#x2013;172</Citation><ArticleIdList><ArticleId IdType="pubmed">21276433</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2011.01.065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32903325</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>350</StartPage><MedlinePgn>350</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">350</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2020.00350</ELocationID><Abstract><AbstractText><b>Background:</b> The benefit-risk profile of perioperative corticosteroids in pediatric patients undergoing cardiac surgery remains controversial. <b>Objective:</b> To investigate the influence of perioperative corticosteroids on the postoperative mortality and clinical outcomes in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass. <b>Methods:</b> We conducted a systematic search using MEDLINE, EMBASE, and Cochrane Database through August 31, 2019. We included randomized controlled trials comparing perioperative corticosteroids with other clinical interventions, placebo, or no treatment in children between 0 and 18 years of age undergoing cardiac surgery. The primary outcome of interest was all-cause in-hospital mortality. The secondary outcomes were length of intensive care unit stay (LOIS), duration of mechanical ventilation (DMV), postoperative insulin therapy, postoperative low cardiac output syndrome (LCOS), postoperative infection, maximal temperature (<i>T</i> <sub>max</sub>) in the first 24 h postoperatively, urine output (UO) in the first 24 h postoperatively, serum lactate at postoperative day (POD) 1, blood glucose at POD 1, vasoactive inotrope score (VIS) at POD 1, and postoperative acute kidney injury (AKI). Study quality was assessed using the Cochrane Risk of Bias Assessment Tool. <b>Results:</b> Our analysis included 17 studies and 848 pediatric patients. The data demonstrated that children receiving corticosteroids showed no significant difference on the all-cause in-hospital mortality with a fixed-effect model (RR = 0.59, 95% CI = 0.28-1.25, <i>P</i> = 0.55) compared with controls. For the secondary outcomes, corticosteroids had a statistically significant reduction on the VIS at POD1 (MD = -2.04, 95% CI = -3.96 -0.12, <i>P</i> = 0.04), while it might be significantly associated with an increased blood glucose at POD1 (MD = 1.38, 95% CI = 0.68-2.09, <i>P</i> = 0.0001) and a 2.69-fold higher risk of postoperative insulin therapy (RR = 2.69, 95% CI = 1.37-5.27, <i>P</i> = 0.004). No statistical significance was shown in other secondary outcomes. <b>Conclusion:</b> Perioperative corticosteroids might not significantly improve clinical outcomes identified as mortality, LOIS, DMV, AKI, and LCOS other than VIS at POD1. However, it might increase the blood glucose and episodes of insulin therapy. Perioperative corticosteroids to attenuate the inflammatory response are not supported by available evidence from our study. Further results from ongoing randomized controlled trials with a larger sample size are required.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Li, Luo, Wu, Jia and Yan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yinan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Center of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Qipeng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Center of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Center of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Center of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fuxia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Center of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">congenital heart defect</Keyword><Keyword MajorTopicYN="N">corticosteroid</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>9</Day><Hour>17</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32903325</ArticleId><ArticleId IdType="pmc">PMC7396528</ArticleId><ArticleId IdType="doi">10.3389/fped.2020.00350</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tarnok A, Emmrich F. Immune consequences of pediatric and adult cardiovascular surgery: report of the 7th Leipzig workshop. Cytometry Part B Clin Cytom. (2003) 54:54&#x2013;7. 10.1002/cyto.b.10018</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.b.10018</ArticleId><ArticleId IdType="pubmed">12827668</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. (2003) 75:S715&#x2013;20. 10.1016/S0003-4975(02)04701-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04701-X</ArticleId><ArticleId IdType="pubmed">12607717</ArticleId></ArticleIdList></Reference><Reference><Citation>Replogle RL, Gazzaniga AB, Gross RE. Use of corticosteroids during cardiopulmonary bypass: possible lysosome stabilization. Circulation. (1966) 33(4 Suppl.):I86&#x2013;92. 10.1161/01.CIR.33.4S1.I-86</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.33.4S1.I-86</ArticleId><ArticleId IdType="pubmed">5933603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg. (1997) 85:766&#x2013;82. 10.1097/00000539-199710000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-199710000-00011</ArticleId><ArticleId IdType="pubmed">9322454</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Bradley SM. First nights, the adrenal axis, and steroids. J Thorac Cardiovasc Surg. (2017) 153:1164&#x2013;6. 10.1016/j.jtcvs.2016.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.12.013</ArticleId><ArticleId IdType="pubmed">28131511</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhoff JJ, Chowdhury SM, Zyblewski SC, Atz AM, Bradley SM, Graham EM. Intraoperative steroid use and outcomes following the norwood procedure: an analysis of the pediatric heart network's public database. Pediatr Crit Care med. (2016) 17:30&#x2013;5. 10.1097/PCC.0000000000000541</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000541</ArticleId><ArticleId IdType="pmc">PMC4703451</ArticleId><ArticleId IdType="pubmed">26492058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. . Hydrocortisone therapy for patients with septic shock. N Engl J Med. (2008) 358:111&#x2013;24. 10.1056/NEJMoa071366</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa071366</ArticleId><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, et al. . Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. (2004) 350:1304&#x2013;13. 10.1056/NEJMoa032089</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa032089</ArticleId><ArticleId IdType="pubmed">15044641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronicki RA, Backer CL, Baden HP, Mavroudis C, Crawford SE, Green TP. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. (2000) 69:1490&#x2013;5. 10.1016/S0003-4975(00)01082-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(00)01082-1</ArticleId><ArticleId IdType="pubmed">10881828</ArticleId></ArticleIdList></Reference><Reference><Citation>Varan B, Tokel K, Mercan S, Donmez A, Aslamaci S. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose vs. low dose. Pediatr Cardiol. (2002) 23:437&#x2013;41. 10.1007/s00246-002-0118-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-002-0118-3</ArticleId><ArticleId IdType="pubmed">12170362</ArticleId></ArticleIdList></Reference><Reference><Citation>Checchia PA, Backer CL, Bronicki RA, Baden HP, Crawford SE, Green TP, et al. . Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med. (2003) 31:1742&#x2013;5. 10.1097/01.CCM.0000063443.32874.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000063443.32874.60</ArticleId><ArticleId IdType="pubmed">12794414</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder VA, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation. (2003) 107:2823&#x2013;8. 10.1161/01.CIR.0000070955.55636.25</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000070955.55636.25</ArticleId><ArticleId IdType="pubmed">12756159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando M, Park IS, Wada N, Takahashi Y. Steroid supplementation: a legitimate pharmacotherapy after neonatal open heart surgery. Ann Thorac Surg. (2005) 80:1672&#x2013;8. Discussion: 8. 10.1016/j.athoracsur.2005.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.04.035</ArticleId><ArticleId IdType="pubmed">16242437</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Ji B, Long C, Li C, Feng Z. Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass. Artif Organs. (2007) 31:571&#x2013;5. 10.1111/j.1525-1594.2007.00423.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1594.2007.00423.x</ArticleId><ArticleId IdType="pubmed">17584482</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Atz AM, Butts RJ, Baker NL, Zyblewski SC, Deardorff RL, et al. . Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: results from a randomized trial. J Thorac Cardiovasc Surg. (2011) 142:1523&#x2013;9. 10.1016/j.jtcvs.2011.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.04.019</ArticleId><ArticleId IdType="pmc">PMC3161127</ArticleId><ArticleId IdType="pubmed">21600592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronicki RA, Checchia PA, Stuart-Killion RB, Dixon DJ, Backer CL. The effects of multiple doses of glucocorticoids on the inflammatory response to cardiopulmonary bypass in children. World J Pediatr Congenit Heart Surg. (2012) 3:439&#x2013;45. 10.1177/2150135112447544</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2150135112447544</ArticleId><ArticleId IdType="pubmed">23804905</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi Tashnizi M, Soltani G, Moeinipour AA, Ayatollahi H, Tanha AS, Jarahi L, et al. . Comparison between preoperative administration of methylprednisolone with its administration before and during congenital heart surgery on serum levels of IL-6 and IL-10. Iran Red Crescent Med J. (2013) 15:147&#x2013;51. 10.5812/ircmj.8039</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ircmj.8039</ArticleId><ArticleId IdType="pmc">PMC3840835</ArticleId><ArticleId IdType="pubmed">24349746</ArticleId></ArticleIdList></Reference><Reference><Citation>Keski-Nisula J, Pesonen E, Olkkola KT, Peltola K, Neuvonen PJ, Tuominen N, et al. . Methylprednisolone in neonatal cardiac surgery: reduced inflammation without improved clinical outcome. Ann Thorac Surg. (2013) 95:2126&#x2013;32. 10.1016/j.athoracsur.2013.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.02.013</ArticleId><ArticleId IdType="pubmed">23602068</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalili M, Vesal A, Tabib A, Khani-Tafti L, Hosseini S, Totonchi Z. Single dose corticosteroid therapy after surgical repair of Fallot's tetralogy; a randomized controlled clinical trial. Res Cardiovasc Med. (2015) 4:e25500. 10.5812/cardiovascmed.25500</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/cardiovascmed.25500</ArticleId><ArticleId IdType="pmc">PMC4350157</ArticleId><ArticleId IdType="pubmed">25789260</ArticleId></ArticleIdList></Reference><Reference><Citation>Keski-Nisula J, Suominen PK, Olkkola KT, Peltola K, Neuvonen PJ, Tynkkynen P, et al. . Effect of timing and route of methylprednisolone administration during pediatric cardiac surgical procedures. Ann Thorac Surg. (2015) 99:180&#x2013;5. 10.1016/j.athoracsur.2014.08.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.08.042</ArticleId><ArticleId IdType="pubmed">25440273</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert SM, Borasino S, Dabal RJ, Cleveland DC, Hock KM, Alten JA. Postoperative hydrocortisone infusion reduces the prevalence of low cardiac output syndrome after neonatal cardiopulmonary bypass. Pediatr Crit Care Med. (2015) 16:629&#x2013;36. 10.1097/PCC.0000000000000426</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000426</ArticleId><ArticleId IdType="pubmed">25901540</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesonen EJ, Suominen PK, Keski-Nisula J, Mattila IP, Rautiainen P, Jahnukainen T. The effect of methylprednisolone on plasma concentrations of neutrophil gelatinase-associated lipocalin in pediatric heart surgery. Pediatr Crit Care Med. (2016) 17:121&#x2013;7. 10.1097/PCC.0000000000000573</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000573</ArticleId><ArticleId IdType="pubmed">26509817</ArticleId></ArticleIdList></Reference><Reference><Citation>Suominen PK, Keski-Nisula J, Ojala T, Rautiainen P, Jahnukainen T, Hastbacka J, et al. . Stress-Dose corticosteroid vs. placebo in neonatal cardiac operations: a randomized controlled trial. Ann Thorac Surg. (2017) 104:1378&#x2013;85. 10.1016/j.athoracsur.2017.01.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.01.111</ArticleId><ArticleId IdType="pubmed">28434547</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnukainen T, Keski-Nisula J, Tainio J, Valkonen H, Patila T, Jalanko H, et al. . Efficacy of corticosteroids in prevention of acute kidney injury in neonates undergoing cardiac surgery-A randomized controlled trial. Acta Anaesthesiol Scand. (2018) 62:13134. 10.1111/aas.13134</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13134</ArticleId><ArticleId IdType="pubmed">29667173</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Martin RH, Buckley JR, Zyblewski SC, Kavarana MN, Bradley SM, et al. . Corticosteroid therapy in neonates undergoing cardiopulmonary bypass: randomized controlled trial. J Am Coll Cardiol. (2019) 74:659&#x2013;68. 10.1016/j.jacc.2019.05.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.05.060</ArticleId><ArticleId IdType="pmc">PMC6684326</ArticleId><ArticleId IdType="pubmed">31370958</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian Higgins JT, Jacqueline Chandler, Miranda Cumpston, Tianjing Li, Matthew Page, Vivian Welch.
Cochrane Handbook for Systematic Reviews of Interventions. Available online at: https://training.cochrane.org/handbook/current Cochrane 2019 (accessed July, 2019).</Citation></Reference><Reference><Citation>Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. (2002) 97:215&#x2013;52. 10.1097/00000542-200207000-00030</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200207000-00030</ArticleId><ArticleId IdType="pubmed">12131125</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology. (1990) 73:661&#x2013;70. 10.1097/00000542-199010000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199010000-00012</ArticleId><ArticleId IdType="pubmed">2221435</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs ML, O'Brien SM, Jacobs JP, Mavroudis C, Lacour-Gayet F, Pasquali SK, et al. . An empirically based tool for analyzing morbidity associated with operations for congenital heart disease. J Thorac Cardiovasc Surg. (2013) 145:1046&#x2013;57.e1. 10.1016/j.jtcvs.2012.06.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.06.029</ArticleId><ArticleId IdType="pmc">PMC3824389</ArticleId><ArticleId IdType="pubmed">22835225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahle WT, Nicolson SC, Hollenbeck-Pringle D, Gaies MG, Witte MK, Lee EK, et al. . Utilizing a collaborative learning model to promote early Extubation following infant heart surgery. Pediatr Crit Care Med. (2016) 17:939&#x2013;47. 10.1097/PCC.0000000000000918</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000918</ArticleId><ArticleId IdType="pmc">PMC5053873</ArticleId><ArticleId IdType="pubmed">27513600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquali SK, Hall M, Li JS, Peterson ED, Jaggers J, Lodge AJ, et al. . Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the pediatric health information systems database. Circulation. (2010) 122:2123&#x2013;30. 10.1161/CIRCULATIONAHA.110.948737</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.948737</ArticleId><ArticleId IdType="pmc">PMC3013053</ArticleId><ArticleId IdType="pubmed">21060075</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, et al. . Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics. (2012) 129:e385&#x2013;91. 10.1542/peds.2011-2034</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-2034</ArticleId><ArticleId IdType="pmc">PMC3269116</ArticleId><ArticleId IdType="pubmed">22271697</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrascia G, Rotunno C, Guida P, Amorese L, Polieri D, Codazzi D, et al. . Perioperative steroids administration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials*. Pediatr Crit Care Med. (2014) 15:435&#x2013;42. 10.1097/PCC.0000000000000128</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000128</ArticleId><ArticleId IdType="pubmed">24717907</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarizia NA, Manlhiot C, Schwartz SM, Sivarajan VB, Maratta R, Holtby HM, et al. . Improved outcomes associated with intraoperative steroid use in high-risk pediatric cardiac surgery. Ann Thorac Surg. (2011) 91:1222&#x2013;7. 10.1016/j.athoracsur.2010.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.11.005</ArticleId><ArticleId IdType="pubmed">21440149</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ, Gill PJ, Lam S, Joffe AR. Peri-operative interventions, but not inflammatory mediators, increase risk of acute kidney injury after cardiac surgery: a prospective cohort study. Intensive Care Med. (2013) 39:934&#x2013;41. 10.1007/s00134-013-2849-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2849-4</ArticleId><ArticleId IdType="pubmed">23417202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van D, Nierich AP, Rosseel PM, et al. . Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol. (2015) 26:2947&#x2013;51. 10.1681/ASN.2014080840</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="pubmed">25952257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36273057</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-4681</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Annals of surgical oncology</Title><ISOAbbreviation>Ann Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Risk Factors and In-Hospital Outcomes of Perioperative Atrial Fibrillation for Patients with Cancer: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>711</StartPage><EndPage>721</EndPage><MedlinePgn>711-721</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1245/s10434-022-12690-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative atrial fibrillation is a common postoperative complication. Adverse consequences associated with POAF include hemodynamic instability, increased risk of stroke, extended hospital stays, and increased mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To determine the risk factors for POAF and to investigate the outcomes of POAF for patients with cancer, a systematic search of the PubMed and Cochrane Library databases was conducted from inception of the study to 1 September 2021. The inclusion criteria specified studies reporting the prevalence of POAF among patients with cancer. The study excluded articles not written in English, review articles, case reports, letters, commentaries, systematic reviews, meta-analyses, and conference abstracts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The search identified 49 studies with 201,081 patients, and the pooled prevalence of POAF was 13.5% (95% confidence interval [CI], 11.6-15.7%). Meta-analyses showed that the incidence of POAF among patients with cancer was associated with age (mean difference [MD], 4.31; 95%CI, 3.16-5.47), male sex (odds ratio [OR], 1.39; 95% CI, 1.19-1.62), chronic obstructive pulmonary disease (OR, 2.47; 95% CI, 1.71-3.56), hypertension (OR, 1.47; 95% CI, 1.23-1.75), intraoperative blood transfusion (OR, 4.58; 95% CI, 2.31-9.10), and open surgery (OR, 1.51; 95% CI, 1.26-1.81). Patients with POAF had significantly higher in-hospital mortality (OR, 4.25; 95% CI, 2.79-6.45), longer hospital stays (MD, 3.07; 95% CI, 1.63-4.51), and higher incidences of pneumonia (OR, 3.32; 95% CI, 2.85-3.86), stroke (OR, 6.57; 95% CI, 1.56-26.00), and myocardial infarction (OR, 3.00; 95% CI, 1.45-6.20) than those without POAF.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For patients with cancer, POAF is associated with an increased burden of comorbidities and worse outcomes.</AbstractText><CopyrightInformation>&#xa9; 2022. Society of Surgical Oncology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tajiri</LastName><ForeName>Kazuko</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9759-1008</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. ktajiri@east.ncc.go.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. ktajiri@east.ncc.go.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>DongZhu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murakoshi</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ieda</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KAKENHI (JP20K08396)</GrantID><Agency>Japanese Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Oncol</MedlineTA><NlmUniqueID>9420840</NlmUniqueID><ISSNLinking>1068-9265</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg Oncol. 2023 Feb;30(2):722. doi: 10.1245/s10434-022-12751-2.</RefSource><PMID Version="1">36307667</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36273057</ArticleId><ArticleId IdType="doi">10.1245/s10434-022-12690-y</ArticleId><ArticleId IdType="pii">10.1245/s10434-022-12690-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults national implications for rhythm management and stroke prevention: the an Ticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA. 2001;285:2370&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.18.2370</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger TM, Wu LQ, Shen WK. Atrial fibrillation. J Biomed Res. 2014;28:1&#x2013;17.</Citation></Reference><Reference><Citation>Lubitz SA, Yin X, Rienstra M, et al. Long-term outcomes of secondary atrial fibrillation in the community the Framingham heart study. Circulation. 2015;131:1648&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.014058</ArticleId></ArticleIdList></Reference><Reference><Citation>January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. Circulation. 2014;130:e199&#x2013;267.</Citation></Reference><Reference><Citation>Herrmann J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol. 2020;17:474&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0348-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M, Zhang Z, Tse G, et al. Association of cancer and the risk of developing atrial fibrillation: a systematic review and meta-analysis. Cardiol Res Pract. 2019;8985273.</Citation></Reference><Reference><Citation>Leiva O, Abdelhameid D, Connors JM, Cannon CP, Bhatt DL. Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis. JACC CardioOncol. 2021;3:619&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccao.2021.08.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gialdini G, Nearing K, Bhave PD, et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA. 2014;312(6):616&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.9143</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Zhao JZ, Ren KM, et al. Risk factors of atrial fibrillation occurring after radical surgery of esophageal carcinoma. J Cardiothorac Surg.. 2019;14(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-0885-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn GH, Shin DH, Byun KM, et al. The incidence and predictors of postoperative atrial fibrillation after noncardiothoracic surgery. Korean Circ J. 2009;39:100&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2009.39.3.100</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major non-cardiac surgery. Am Heart J. 2012;164:918&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2012.09.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00135</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x201c;EZR&#x201d; for medical statistics. Bone Marrow Transplant. 2013;48:452&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi H, Wakejima R, Asakawa A, et al. Postoperative atrial fibrillation in lung cancer lobectomy: analysis of risk factors and prognosis. World J Surg. 2020;44:3952&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-020-05694-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Higuchi S, Kabeya Y, Matsushita K, et al. Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy. PLoS One. 2019;14(5):e0216239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0216239</ArticleId></ArticleIdList></Reference><Reference><Citation>Muranishi Y, Sonobe M, Menju T, et al. Atrial fibrillation after lung cancer surgery: incidence, severity, and risk factors. Surg Today. 2017;47:252&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-016-1380-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale D, Martinoni A, Cipolla CM, et al. Atrial fibrillation after operation for lung cancer: clinical and prognostic significance. Ann Thorac Surg. 1999;68:1827&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(99)00712-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma JY. Atrial fibrillation after surgery for esophageal carcinoma: clinical and prognostic significance. World J Gastroenterol. 2006;21:449&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v12.i3.449</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy SC, Law S, Whooley BP, Alexandrou A, Chu KM, Wong J. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg. 2003;126:1162&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(03)00974-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperatori A, Mariscalco G, Riganti G, Rotolo N, Conti V, Dominioni L. Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg. 2012;7(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-7-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg. 2005;130:438.e1-e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2005.02.010</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack O, Zaborowski A, King S, et al. New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short- and long-term outcomes. Ann Surg. 2014;260:772&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000960</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu CW, Tung HM, Chu KW, Jim MH, Lau CP, Tse HF. Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer. Pacing Clin Electrophysiol. 2005;28:S120&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2005.00024.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyszkiewicz W, Skrzypczak M. Atrial fibrillation after surgery of the lung: clinical analysis of risk factors 1. Eur J Cardiothorac Surg. 1998;13:625&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(98)00084-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciszewski P, Tyczka J, Nadolski J, Roszak M, Dyszkiewicz W. Lower preoperative fluctuation of heart rate variability is an independent risk factor for postoperative atrial fibrillation in patients undergoing major pulmonary resection. Interact Cardiovasc Thorac Surg. 2013;17:680&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivt238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavurmaci O, Akcam TI, Ergonul AG, Turhan K, Cakan A, Cagirici U. Is the risk of postoperative atrial fibrillation predictable in patients undergoing surgery due to primary lung cancer? Heart Lung Circ. 2018;27:835&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2017.06.729</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin JH, Moon YJ, Jo JY, et al. Association between postoperatively developed atrial fibrillation and long-term mortality after esophagectomy in esophageal cancer patients: an observational study. PLoS One. 2016;11(5):e0154931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0154931</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao VP, Addae-Boateng E, Barua A, Martin-Ucar AE, Duffy JP. Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy. Eur J Cardio-Thorac Surg. 2012;42:438&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs085</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Caro A, Moradiellos FJ, Aus&#xed;n P, et al. Risk factors for atrial fibrillation after thoracic surgery. Arch Bronconeumol. 2006;42:9&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13083274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollings DD, Higgins RSD, Faber LP, et al. Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. Am J Surg. 2010;199:558&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2009.11.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells CI, Robertson JP, Campbell S, Al-Herz F, Rhind B, Young M. Impact of atrial fibrillation on long-term survival following oesophagectomy: a 21-year observational study. ANZ J Surg. 2018;88:E268&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.14054</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassoiy SP, Blackwell RH, Kothari AN, et al. New-onset postoperative atrial fibrillation predicts long-term cardiovascular events after gastrectomy. Am J Surg. 2016;211:559&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2015.10.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Passman RS, Gingold DS, Amar D, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005;79:1698&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2004.10.058</ArticleId></ArticleIdList></Reference><Reference><Citation>Stawicki SPA, Prosciak MP, Gerlach AT, et al. Atrial fibrillation after esophagectomy: an indicator of postoperative morbidity. Gen Thorac Cardiovasc Surg. 2011;59:399&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-010-0713-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Mita N, Kuroda M, Miyoshi S, Saito S. Association of preoperative right and left ventricular diastolic dysfunction with postoperative atrial fibrillation in patients undergoing lung surgery: a prospective observational study. J Cardiothorac Vasc Anesth. 2017;31:464&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2016.09.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Seesing MFJ, Scheijmans JCG, Borggreve AS, van Hillegersberg R, Ruurda JP. The predictive value of new-onset atrial fibrillation on postoperative morbidity after esophagectomy. Dis Esophagus. 2018;31(11):028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/doy028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagatsuka Y, Sugimura K, Miyata H, et al. Predictive value of preoperative echocardiographic assessment for postoperative atrial fibrillation after esophagectomy for esophageal cancer. Esophagus. 2021;18:496&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10388-020-00804-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour Z, Kochetkova EA, Santelmo N, et al. Risk factors for early mortality and morbidity after pneumonectomy: a reappraisal. Ann Thorac Surg. 2009;88:1737&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.07.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahm TS. Risk factors for an intraoperative arrhythmia during esophagectomy. Yonsei Med J. 2007;48:474&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2007.48.3.474</ArticleId></ArticleIdList></Reference><Reference><Citation>Glover JR, Velez-Cubian FO, Zhang WW, et al. Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy. J Thorac Dis. 2016;8:3614&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.12.11</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner M, Routledge T, King JE, et al. New-onset atrial fibrillation after anatomic lung resection: predictive factors, treatment and follow-up in a UK thoracic centre. Interact Cardiovasc Thorac Surg. 2017;24(2):260&#x2013;4.</Citation></Reference><Reference><Citation>Song EY, Venkat P, Fradley M, et al. Clinical factors associated with the development of postoperative atrial fibrillation in esophageal cancer patients receiving multimodality therapy before surgery. J Gastrointest Oncol. 2020;11(1):68.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jgo.2019.12.05</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar D, Zhang H, Leung DHY, Roistacher N, Kadish AH. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology. 2002;96:352&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200202000-00021</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie K, Zhang W, Fang J, et al. Prevalence and risk factors of atrial fibrillation during lung and esophageal surgery a prospective observational study. Medicine. 2018;97(30):e11549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011549</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Sawalhi S, Ding J, Vannucci J, Li Y, Odeh A, Zhao D. Perioperative risk factors for atrial fibrillation (AF) in patients underwent uniportal video-assisted thoracoscopic (VATS) pneumonectomy versus open thoracotomy: single center experience. Gen Thorac Cardiovasc Surg. 2021;69(3):487&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-020-01491-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperatori A, Mariscalco G, Riganti G, Rotolo N, Conti V, Dominioni L. Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg. 2012;7(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-7-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Feng Yang Y, Guo B, et al. The impact of atrial fibrillation on outcomes in patients undergoing radical prostatectomy. World J Urol. 2021;39:1509&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03337-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine Y, Kesler KA, Behnia M, et al. COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. Chest. 2001;120:1783&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.120.6.1783</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Zhao JZ, Ren KM, et al. Risk factors of atrial fibrillation occurring after radical surgery of esophageal carcinoma. J Cardiothorac Surg. 2019;14(1):60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-0885-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Onaitis M, D&#x2019;Amico T, Zhao Y, O&#x2019;Brien S, Harpole D. Risk factors for atrial fibrillation after lung cancer surgery: analysis of the society of thoracic surgeons general thoracic surgery database. Ann Thorac Surg. 2010;90:368&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.03.100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong LS, Ko V, Mclaughlin A, et al. Outcomes of video-assisted thoracoscopic surgery lobectomy in septuagenarians. ANZ J Surg. 2020;90(5):752&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.15788</ArticleId></ArticleIdList></Reference><Reference><Citation>Villamizar NR, Darrabie MD, Burfeind WR, et al. Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. J Thorac Cardiovasc Surg. 2009;138:419&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.04.026</ArticleId></ArticleIdList></Reference><Reference><Citation>He G, Yao T, Zhao L, et al. Atrial fibrillation and alteration of heart rate variability after video-assisted pulmonary lobectomy versus thoracotomy pulmonary lobectomy. J Cardiothorac Surg. 2020;15(1):1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01260-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang L, Shi L, Fu G, Jiang C. The role of surgery type in postoperative atrial fibrillation and in-hospital mortality in esophageal cancer patients with preserved left ventricular ejection fraction. World J Surg Oncol. 2020;18(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12957-020-02011-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Park BJ, Zhang H, Rusch VW, Amar D. Video-assisted thoracic surgery does not reduce the incidence of postoperative atrial fibrillation after pulmonary lobectomy. J Thorac Cardiovasc Surg. 2007;133:775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2006.09.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojima T, Nakamori M, Nakamura M, Katsuda M, et al. Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer. J Br Surg. 2017;104(8):1003&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10548</ArticleId></ArticleIdList></Reference><Reference><Citation>Horikoshi Y, Goyagi T, Kudo R, Kodama S, Horiguchi T, Nishikawa T. The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: a randomized controlled clinical trial. J Clin Anesth. 2017;38:111&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2017.01.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y, Kawasaki Y, Ide K, Shimizu Y, Sato S, Yokoyama J. Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial. JA Clin Rep. 2020;6(1):34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40981-020-00338-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T, Furukita Y, Yamamoto Y, et al. A randomized, open label study of the efficacy of prophylactic 24-h low-dose landiolol for atrial fibrillation in transthoracic esophagectomy. Esophagus. 2017;14:97&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10388-016-0553-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Riber LP, Christensen TD, Jensen HK, Hoejsgaard A, Pilegaard HK. Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer. Ann Thorac Surg. 2012;94(2):339&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.12.096</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisdale JE, Wroblewski HA, Wall DS, et al. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg. 2009;88:886&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.04.074</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar D, Roistacher N, Rusch VW, et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg. 2000;120:790&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2000.109538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng EP, Velez-Cubian FO, Rodriguez KL, et al. Surgical outcomes associated with postoperative atrial fibrillation after robotic-assisted pulmonary lobectomy: retrospective review of 208 consecutive cases. J Thorac Dis. 2016;8:2079&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.07.68</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa612</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu G, Versteeg HH, Verschoor AJ, et al. Atrial fibrillation and cancer: an unexplored field in cardiovascular oncology. Blood Rev. 2019;35:59&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2019.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao BC, Huang TY, Deng QW, et al. Prophylaxis against atrial fibrillation after general thoracic surgery: trial sequential analysis and network meta-analysis. Chest. 2017;151:149&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.08.1476</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Gao S. Systematic review and meta-analysis of atrial fibrillation prophylaxis after lung surgery. J Cardiovasc Pharmacol. 2016;67:351&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000351</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60601-7</ArticleId></ArticleIdList></Reference><Reference><Citation>van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJD, Demedts MGP. Amiodarone and the development of ARDS after lung surgery. Chest. 1994;105:1642&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.105.6.1642</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith HA, Kanji S, Tran DT, et al. Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study. Trials. 2021;22(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05318-1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36425088</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2167</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>OTA international : the open access journal of orthopaedic trauma</Title><ISOAbbreviation>OTA Int</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of anesthesia type on hip fracture post-surgery outcomes.</ArticleTitle><Pagination><StartPage>e204</StartPage><MedlinePgn>e204</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e204</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/OI9.0000000000000204</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To compare technical, clinical, and safety outcomes among hip fracture patients treated with procedures supplemented by general anesthesia (GA) or spinal/regional anesthesia (S/R).</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="UNASSIGNED">We searched for original studies on PubMed, Ovid MEDLINE, Ovid Embase, and Cochrane databases.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="UNASSIGNED">Studies that reported clinical outcomes in patients that underwent hip fracture surgery, had available data on type of anesthesia administered, and clinical follow-up data were selected for data extraction.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="UNASSIGNED">The primary outcomes of interest were odds of mortality, including in-hospital, 30-day, 90-day, and 1-year mortality. Various adverse events (AEs) were also compared.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="UNASSIGNED">Twenty-eight studies met our selection criteria, including 190,394 patients. A total of 107,314 (56.4%) patients were treated with procedures involving GA while 83,080 (43.6%) were treated with procedures involving S/R. There was no difference in 30-day or &gt;1-year mortality rates between the GA and SR groups; however, compared to S/R group, the GA group had a significantly higher odds of in-hospital (<i>P</i>&#x200a;=&#x200a;.004) and 90-day mortality (<i>P</i>&#x200a;=&#x200a;.004). There was no difference in odds of adverse events between the GA and the S/R group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Patients administered S/R for hip fracture procedures demonstrate lower risk of in-hospital mortality and 90-day mortality compared to patients administered GA.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="UNASSIGNED">Therapeutic level III.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leibold</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Mercy Health St. Vincent Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falbo</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Mercy Health St. Vincent Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Toledo Orthopaedic Surgeons, Toledo, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Mercy Health St. Vincent Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pederson</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Superior Medical Experts, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malpe</LastName><ForeName>Manashree</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Superior Medical Experts, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>OTA Int</MedlineTA><NlmUniqueID>101770383</NlmUniqueID><ISSNLinking>2574-2167</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">femoral neck fracture</Keyword><Keyword MajorTopicYN="N">hip fracture</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>2</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36425088</ArticleId><ArticleId IdType="pmc">PMC9580260</ArticleId><ArticleId IdType="doi">10.1097/OI9.0000000000000204</ArticleId><ArticleId IdType="pii">OTAI-D-21-00045</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997; 7:407&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005&#x2013;2025. J Bone Miner Res 2007; 22:465&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">17144789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckerman JD. Hip fracture. N Engl J Med 1996; 334:1519&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">8618608</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies IB, Mendelson DA, Kates SL, Friedman SM. The impact of comorbidity on perioperative outcomes of hip fractures in a geriatric fracture model. Geriatr Orthop Surg Rehabil 2012; 3:129&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3598442</ArticleId><ArticleId IdType="pubmed">23569706</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell L, White S. Anaesthetic management of patients with hip fractures: an update. Contin Educ Anaesth Crit Care Pain 2013; 13:179&#x2013;183.</Citation></Reference><Reference><Citation>McIsaac DI, Wijeysundera DN, Huang A, Bryson GL, van Walraven C. Association of hospital-level neuraxial anesthesia use for hip fracture surgery with outcomes: a population-based cohort study. Anesthesiology 2018; 128:480&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">28968275</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauermann WJ, Shilling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 2006; 103:1018&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">17000823</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin SC, Parker MJ, Griffiths R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth 2000; 84:450&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">10823094</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, Coburn M. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol 2017; 17:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo D, Jin C, Shan M, Zhou L, Li Y. A comparison of general versus regional anesthesia for hip fracture surgery: a meta-analysis. Int J Clin Exp Med 2015; 8:20295&#x2013;20301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4723788</ArticleId><ArticleId IdType="pubmed">26884943</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Griffiths R, Moppett IK. Standardising anaesthesia for hip fracture surgery. Anaesthesia 2016; 71:1391&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">27501337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim BG, Lee IO. Anesthetic management of geriatric patients. Korean J Anesthesiol 2020; 73:8&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7000283</ArticleId><ArticleId IdType="pubmed">31636241</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, McLoughlin L, Patterson CC, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth 2018; 120:37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, Liu Z. Comparative efficacy of Neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol 2020; 20:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int 2010; 21:555&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Soft 2010; 36:1&#x2013;48.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; 14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>van Aert RCM, van Assen M, Viechtbauer W. Statistical properties of methods based on the Q-statistic for constructing a confidence interval for the between-study variance in meta-analysis. Res Synth Methods 2019; 10:225&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590162</ArticleId><ArticleId IdType="pubmed">30589219</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, Samuel AM, Grauer JG. General versus spinal anaesthesia for patients aged 70&#x200a;years and older with a fracture of the hip. Bone Joint J 2015; 97-B:689&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigler D, Adelh&#x2298;j B, Petring OU, Pederson NO, Busch P, Kalhke P. Mental function and morbidity after acute hip surgery during spinal and general anaesthesia. Anaesthesia 1985; 40:672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">4025772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsel K, Erdil M, Gulabi D, Elmadag M, Cengiz O, Sen C. Factors affecting mortality after hip fracture surgery: a retrospective analysis of 578 patients. Eur J Orthop Surg Traumatol 2013; 23:895&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">23412231</ArticleId></ArticleIdList></Reference><Reference><Citation>Brox WT, Chan PH, Cafri G, Inacio MC. Similar mortality with general or regional anesthesia in elderly hip fracture patients. Acta Orthop 2016; 87:152&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4812077</ArticleId><ArticleId IdType="pubmed">26986550</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis FM, Laurenson VG. Spinal anaesthesia or general anaesthesia for emergency hip surgery in elderly patients. Anaesth Intensive Care 1981; 9:352&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">6797318</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis FM, Woolner DF, Frampton C, et al. Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth 1987; 59:1080&#x2013;1088.</Citation><ArticleIdList><ArticleId IdType="pubmed">3311100</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, et al. Is Anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res 2018; 476:1178&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields AC, Dieterich JD, Buterbaugh K, Moucha CS. Short-term complications in hip fracture surgery using spinal versus general anaesthesia. Injury 2015; 46:719&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pubmed">25704139</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T, Imai S, Nakadera M, Wagatsuma Y, Horiguchi H. Postoperative daily living activities of geriatric patients administered general or spinal anesthesia for hip fracture surgery: a retrospective cohort study. J Orthop Surg (Hong Kong) 2018; 26:2309499017754106.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366390</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremillet C, Jakobsson JG. Acute hip fracture surgery anaesthetic technique and 30-day mortality in Sweden 2016 and 2017: a retrospective register study. F1000Res 2018; 7:1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107981</ArticleId><ArticleId IdType="pubmed">30210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilango S, Pulle RC, Bell J, Kuys SS. General versus spinal anaesthesia and postoperative delirium in an orthogeriatric population. Australas J Ageing 2016; 35:42&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">26364948</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval KJ, Aharonoff GB, Rosenberg AD, Schmigelski C, Bernstein RL, Zuckerman JD. Hip fracture in the elderly: the effect of anesthetic technique. Orthopedics 1999; 22:31&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9925195</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med 2012; 13:948&#x2013;956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JL, Wang XL, Gong MW, et al. Comparative outcomes of peripheral nerve blocks versus general anesthesia for hip fractures in geriatric Chinese patients. Patient Prefer Adherence 2014; 8:651&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019620</ArticleId><ArticleId IdType="pubmed">24855341</ArticleId></ArticleIdList></Reference><Reference><Citation>Lon&#x10d;ari&#x107;-Katu&#x161;in M, Mi&#x161;kovi&#x107; P, Lavrnja-Skolan V, Katu&#x161;in J, Bakota B, &#x17d;uni&#x107; J. General versus spinal anaesthesia in proximal femoral fracture surgery - treatment outcomes. Injury 2017; 48:S51&#x2013;S55.</Citation><ArticleIdList><ArticleId IdType="pubmed">29122123</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie PJ, Wishart HY, Smith G. Long-term outcome after repair of fractured neck of femur. Comparison of subarachnoid and general anaesthesia. Br J Anaesth 1984; 56:581&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">6721969</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, Zubizarreta JR, Silber JH. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA 2014; 311:2508&#x2013;2517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara DA, Duff A, Berlin JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000; 92:947&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pubmed">10754613</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury 2015; 46:1562&#x2013;1566.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid RH, Shah AA, Shakoor A, Noordin S. Hip fracture surgery: does type of anesthesia matter? Biomed Res Int 2013; 2013:252356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3684036</ArticleId><ArticleId IdType="pubmed">23819114</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren AD, Stockwell MC, Reid VT. Anaesthetic techniques for surgical correction of fractured neck of femur. A comparative study of spinal and general anaesthesia in the elderly. Anaesthesia 1978; 33:10&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">626331</ArticleId></ArticleIdList></Reference><Reference><Citation>Hek&#x130;Mo&#x11e;Lu &#x15e;Ah&#x130;N S, Heybel&#x130; N, &#xc7;Olak A, et al. Comparison of different anesthetic techniques on postoperative outcomes in elderly patients with hip fracture. Turkiye Klinikleri J Med Sci 2012; 32:623&#x2013;629.</Citation></Reference><Reference><Citation>Sutcliffe AJ, Parker M. Mortality after spinal and general anaesthesia for surgical fixation of hip fractures. Anaesthesia 1994; 49:237&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">8147519</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung YC, Hsu YH, Chang GM. The effect of anesthetic type on outcomes of hip fracture surgery: a nationwide population-based study. Medicine (Baltimore) 2016; 95:e3296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4998813</ArticleId><ArticleId IdType="pubmed">27057897</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentin N, Lomholt B, Jensen JS, Hejgaard N, Kreiner S. Spinal or general anaesthesia for surgery of the fractured hip? A prospective study of mortality in 578 patients. Br J Anaesth 1986; 58:284&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">3947489</ArticleId></ArticleIdList></Reference><Reference><Citation>White IW, Chappell WA. Anaesthesia for surgical correction of fractured femoral neck. A comparison of three techniques. Anaesthesia 1980; 35:1107&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">7446914</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset. Anaesthesia 2014; 69:224&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">24428375</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R, et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint Audit of Practice (ASAP-2). Anaesthesia 2016; 71:506&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">26940645</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.</Citation></Reference><Reference><Citation>Chen DX, Yang L, Ding L, Li SY, Qi YN, Li Q. Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: a systematic review and meta-analysis. Medicine (Baltimore) 2019; 98:e18220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="pubmed">31804347</ArticleId></ArticleIdList></Reference><Reference><Citation>Haentjens P, Magaziner J, Col&#xf3;n-Emeric CS, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 2010; 152:380&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3010729</ArticleId><ArticleId IdType="pubmed">20231569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, L&#xfc; YW, Lan L, et al. Impact of diabetes on the prognosis of hip fracture: a cohort study in the Chinese population. Chin Med J (Engl) 2013; 126:813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">23489782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulcelik NE, Bayraktar M, Caglar O, Alpaslan M, Karakaya J. Mortality after hip fracture in diabetic patients. Exp Clin Endocrinol Diabetes 2011; 119:414&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">21553363</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 2005; 331:1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1309645</ArticleId><ArticleId IdType="pubmed">16299013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lienhart A, Auroy Y, P&#xe9;quignot F, et al. Survey of anesthesia-related mortality in France. Anesthesiology 2006; 105:1087&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">17122571</ArticleId></ArticleIdList></Reference><Reference><Citation>Carretta E, Bochicchio V, Rucci P, Fabbri G, Laus M, Fantini MP. Hip fracture: effectiveness of early surgery to prevent 30-day mortality. Int Orthop 2011; 35:419&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3047640</ArticleId><ArticleId IdType="pubmed">20373098</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus D, Ravi B, Wasserstein D, et al. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA 2017; 318:1994&#x2013;2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5820694</ArticleId><ArticleId IdType="pubmed">29183076</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Babu S, Dixon P, et al. Guideline for the management of hip fractures 2020: guideline by the Association of Anaesthetists. Anaesthesia 2021; 76:225&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">33289066</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CL, Chiou HY, Chou WH, Chang PY, Huang YY, Yeh HM. Leading Comorbidity associated with 30-day post-anesthetic mortality in geriatric surgical patients in Taiwan: a retrospective study from the health insurance data. BMC Geriatr 2017; 17:245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5654003</ArticleId><ArticleId IdType="pubmed">29065869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugada D, Bellini V, Lorini LF, Mariano ER. Update on selective regional analgesia for hip surgery patients. Anesthesiol Clin 2018; 36:403&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">30092937</ArticleId></ArticleIdList></Reference><Reference><Citation>Scurrah A, Shiner CT, Stevens JA, Faux SG. Regional nerve blockade for early analgesic management of elderly patients with hip fracture - a narrative review. Anaesthesia 2018; 73:769&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">29278266</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31254171</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>879</StartPage><EndPage>895</EndPage><MedlinePgn>879-895</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-019-01338-x</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">There is a lack of consensus about which endocarditis-specific preoperative characteristics have an actual impact over postoperative mortality. Our objective was the identification and quantification of these factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review of all the studies which reported factors related to in-hospital mortality after surgery for acute infective endocarditis, conducted according to PRISMA recommendations. A search string was constructed and applied on three different databases. Two investigators independently reviewed the retrieved references. Quality assessment was performed for identification of potential biases. All the variables that were included in at least two validated risk scores were meta-analyzed independently, and the pooled estimates were expressed as odds ratios (OR) with their confidence intervals (CI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The final sample consisted on 16 studies, comprising a total of 7484 patients. The overall pooled OR were statistically significant (p&#x2009;&lt;&#x2009;0.05) for: age (OR 1.03, 95% CI 1.00-1.05), female sex (OR 1.56, 95% CI 1.35-1.81), urgent or emergency surgery (OR 2.39 95% CI 1.91-3.00), previous cardiac surgery (OR 2.19, 95% CI 1.84-2.61), NYHA&#x2009;&#x2265;&#x2009;III (OR 1.84, 95% CI 1.33-2.55), cardiogenic shock (OR 4.15, 95% CI 3.06-5.64), prosthetic valve (OR 1.98, 95% CI 1.68-2.33), multivalvular affection (OR 1.35, 95% CI 1.01-1.82), renal failure (OR 2.57, 95% CI 2.15-3.06), paravalvular abscess (OR 2.39, 95% CI 1.77-3.22) and S. aureus infection (OR 2.27, 95% CI 1.89-2.73).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">After a systematic review, we identified 11 preoperative factors related to an increased postoperative mortality. The meta-analysis of each of these factors showed a significant association with an increased in-hospital mortality after surgery for active infective endocarditis. Graph summary of the Pooled Odds Ratios of the 11 preoperative factors analyzed after the systematic review and meta-analysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varela Barca</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4605-8801</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, University Hospital Ramon y Cajal, Ctra. Colmenar Viejo, km. 9.100, 28034, Madrid, Spain. lauravarela21089@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navas Elorza</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectology, University Hospital Ramon y Cajal, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Hidalgo</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University Hospital Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moya Mur</LastName><ForeName>Jose Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Ramon y Cajal, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muriel Garc&#xed;a</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Biostatistics Unit, Hospital Ramon y Cajal (IRYCIS), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Felix</LastName><ForeName>B M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Clinical Biostatistics Unit, Hospital Ramon y Cajal (IRYCIS), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miguelena Hycka</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, University Hospital Ramon y Cajal, Ctra. Colmenar Viejo, km. 9.100, 28034, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Roda</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, University Hospital Ramon y Cajal, Ctra. Colmenar Viejo, km. 9.100, 28034, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Men&#xe9;ndez</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, University Hospital Ramon y Cajal, Ctra. Colmenar Viejo, km. 9.100, 28034, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Infection. 2019 Dec;47(6):897. doi: 10.1007/s15010-019-01357-8.</RefSource><PMID Version="1">31552602</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004696" MajorTopicYN="N">Endocarditis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infective endocarditis</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Prognostic factors</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31254171</ArticleId><ArticleId IdType="doi">10.1007/s15010-019-01338-x</ArticleId><ArticleId IdType="pii">10.1007/s15010-019-01338-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Infect Dis. 2018 Mar;68:102-107</Citation><ArticleIdList><ArticleId IdType="pubmed">29382606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Cardiovasc Surg. 2012;18(3):216-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22790993</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2015 Jan 13;131(2):131-40</Citation><ArticleIdList><ArticleId IdType="pubmed">25480814</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Cardiol (Engl Ed). 2013 May;66(5):384-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24775821</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2011 Jun 16;149(3):304-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20178888</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2009 Mar 9;169(5):463-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19273776</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2016 Mar 7;37(10):840-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26685134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2008 Apr;85(4):1490-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18355567</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 2017 Sep;103(18):1435-1442</Citation><ArticleIdList><ArticleId IdType="pubmed">28432158</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2004 Feb;25(3):267-76</Citation><ArticleIdList><ArticleId IdType="pubmed">14972429</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2010 Mar 9;121(9):1141-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20212293</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2007 Jan;133(1):144-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17198801</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2007 Jan;31(1):43-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17140802</ArticleId></ArticleIdList></Reference><Reference><Citation>Asian Cardiovasc Thorac Ann. 2018 Sep;26(7):517-523</Citation><ArticleIdList><ArticleId IdType="pubmed">30185074</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Jul 21;6(7):e1000097</Citation><ArticleIdList><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiol J. 2010;17(6):566-73</Citation><ArticleIdList><ArticleId IdType="pubmed">21154258</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2015 Dec;94(49):e2000</Citation><ArticleIdList><ArticleId IdType="pubmed">26656328</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Valve Dis. 2011 Mar;20(2):223-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21560826</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorac Cardiovasc Surg. 2017 Apr;65(3):166-173</Citation><ArticleIdList><ArticleId IdType="pubmed">27074494</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Vessels. 2015 Mar;30(2):227-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24463846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellenic J Cardiol. 2019 Jan 26;:</Citation><ArticleIdList><ArticleId IdType="pubmed">30690140</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2016 Jul 14;37(27):2129-2200</Citation><ArticleIdList><ArticleId IdType="pubmed">27206819</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2019 May 1;282:24-30</Citation><ArticleIdList><ArticleId IdType="pubmed">30718134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovasc Surg. 1999 Jun;7(4):402-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10430521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2012 Oct;94(4):1204-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22771489</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2016 Nov 1;222:1001-1002</Citation><ArticleIdList><ArticleId IdType="pubmed">27526384</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1203-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20549531</ArticleId></ArticleIdList></Reference><Reference><Citation>Interact Cardiovasc Thorac Surg. 2014 Feb;18(2):169-76</Citation><ArticleIdList><ArticleId IdType="pubmed">24174123</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ J. 2008 Dec;72(12):2062-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18981596</ArticleId></ArticleIdList></Reference><Reference><Citation>Enferm Infecc Microbiol Clin. 2019 Aug - Sep;37(7):435-440</Citation><ArticleIdList><ArticleId IdType="pubmed">30470460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiol Clin. 2003 May;21(2):273-82, vii-viii</Citation><ArticleIdList><ArticleId IdType="pubmed">12874898</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2018 May 1;53(5):1049-1054</Citation><ArticleIdList><ArticleId IdType="pubmed">29228242</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellenic J Cardiol. 2014 Nov-Dec;55(6):462-74</Citation><ArticleIdList><ArticleId IdType="pubmed">25432198</ArticleId></ArticleIdList></Reference><Reference><Citation>ScientificWorldJournal. 2012;2012:307571</Citation><ArticleIdList><ArticleId IdType="pubmed">22536134</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2007 Apr;120(4):369.e1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17398233</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Sep 13;315(7109):629-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2014 Jul 15;175(1):133-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24852838</ArticleId></ArticleIdList></Reference><Reference><Citation>QJM. 2015 Mar;108(3):219-29</Citation><ArticleIdList><ArticleId IdType="pubmed">25223570</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Bras Cir Cardiovasc. 2007 Apr-Jun;22(2):192-200</Citation><ArticleIdList><ArticleId IdType="pubmed">17992324</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2011 Jan;141(1):98-106.e1-2</Citation><ArticleIdList><ArticleId IdType="pubmed">21168017</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Heart Assoc. 2017 Jul 20;6(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">28729412</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2018 Sep;24(9):985-991</Citation><ArticleIdList><ArticleId IdType="pubmed">29269091</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2000 Apr;6(4):207-12</Citation><ArticleIdList><ArticleId IdType="pubmed">11168109</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microbiol Immunol Infect. 2001 Jun;34(2):119-24</Citation><ArticleIdList><ArticleId IdType="pubmed">11456357</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2014 Sep;148(3):981-8.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">25026898</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Feb 10;342:d549</Citation><ArticleIdList><ArticleId IdType="pubmed">21310794</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Oct 18;343:d5928</Citation><ArticleIdList><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Mal Coeur Vaiss. 1993 Dec;86(12 Suppl):1825-35</Citation><ArticleIdList><ArticleId IdType="pubmed">8024388</ArticleId></ArticleIdList></Reference><Reference><Citation>Interact Cardiovasc Thorac Surg. 2018 Sep 1;27(3):317-321</Citation><ArticleIdList><ArticleId IdType="pubmed">29868857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2013 Feb 19;158(4):280-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Dis. 2018 Jun;10(6):3679-3688</Citation><ArticleIdList><ArticleId IdType="pubmed">30069366</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2017 Jan 5;356:i6460</Citation><ArticleIdList><ArticleId IdType="pubmed">28057641</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2018 Oct;24(10):1102.e7-1102.e15</Citation><ArticleIdList><ArticleId IdType="pubmed">29408350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tex Heart Inst J. 2011;38(6):667-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22199430</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Sci Monit. 2017 Jul 25;23:3617-3626</Citation><ArticleIdList><ArticleId IdType="pubmed">28740070</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2018 Dec 1;54(6):1060-1066</Citation><ArticleIdList><ArticleId IdType="pubmed">29873701</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2007 Aug;32(2):281-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17548201</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2017 Aug 15;241:97-102</Citation><ArticleIdList><ArticleId IdType="pubmed">28390740</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Jul 22;343:d4002</Citation><ArticleIdList><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 1996 Sep;62(3):932-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8784045</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1999 Jul 6;131(1):47-59</Citation><ArticleIdList><ArticleId IdType="pubmed">10391815</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2010 Jul 1;106(1):92-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20609654</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32232833</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Critical care transition programs on readmission or death: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>870</StartPage><EndPage>883</EndPage><MedlinePgn>870-883</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13591</ELocationID><Abstract><AbstractText Label="BACKGROUND">Deterioration after ICU discharge may lead to readmission or even death. Interventions (eg, critical care transition programs) have been developed to improve the clinical handover between the ICU and the ward. We conducted a systematic review with meta-analysis and trial sequential analysis (TSA) according to Cochrane Handbook and Grading of recommendations, assessment, development and evaluations (GRADE) methodology to assess the impact of these interventions on readmission and death (PROSPERO, no CRD42019121746).</AbstractText><AbstractText Label="METHODS">We searched PubMed/MEDLINE, CINAHL, AMED, PsycINFO, and the Cochrane Central Register for Controlled Trials from inception until January 2019. We included historically controlled studies that evaluated critical care transition programs in adults discharged from the ICU. Readmission and in-hospital mortality were the primary outcomes. Risk of bias, publications bias, and the quality of evidence were assessed with the ROBINS-Itool, funnel plot and GRADE, respectively.</AbstractText><AbstractText Label="RESULTS">Fifteen observational studies were included (11 in meta-analysis). All studies had at least serious risk of bias. ICU discharge within a critical care transition program modestly reduced the risk of readmission (RR 0.78; 95% CI: 0.64-0.96; TSA-adjusted 95% CI: 0.59-1.03) but not in-hospital mortality (RR 0.82; 95% CI: 0.64-1.06; TSA-adjusted 95% CI: 0.49-1.37). There was substantial heterogeneity among studies. TSA indicated lack of firm evidence. The GRADE quality of evidence on outcomes was very low.</AbstractText><AbstractText Label="CONCLUSIONS">We found no clear benefit in terms of reducing risk of readmission or death after ICU discharge, however, with overall very low certainty of evidence.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#xd6;sterlind</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7439-2711</Identifier><AffiliationInfo><Affiliation>Department of Surgical and Perioperative Sciences, Anesthesiology and Intensive Care Medicine, Sunderby Research Unit, Umea University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhardsson</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgical and Perioperative Sciences, Anesthesiology and Intensive Care Medicine, Sunderby Research Unit, Umea University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myrberg</LastName><ForeName>Tomi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8802-2321</Identifier><AffiliationInfo><Affiliation>Department of Surgical and Perioperative Sciences, Anesthesiology and Intensive Care Medicine, Sunderby Research Unit, Umea University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069341" MajorTopicYN="N">Transitional Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU follow-up</Keyword><Keyword MajorTopicYN="N">ICU liaison nurse</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">critical care outreach service</Keyword><Keyword MajorTopicYN="N">critical care transition program</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">medical emergency team</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">rapid response team</Keyword><Keyword MajorTopicYN="N">readmission</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32232833</ArticleId><ArticleId IdType="doi">10.1111/aas.13591</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Kaben A, Corr&#xea;a F, Reinhart K, et al. Readmission to a surgical intensive care unit: incidence, outcome and risk factors. Crit Care. 2008;12:R123.</Citation></Reference><Reference><Citation>The Swedish intensive care register [Internet].2019. https://www.icuregswe.org. Accessed Aug 20, 2019.</Citation></Reference><Reference><Citation>Capuzzo M, Moreno RP, Alvisi R. Admission and discharge of critically ill patients. Curr Opin Crit Care. 2010;16:499-504.</Citation></Reference><Reference><Citation>Lin F, Chaboyer W, Wallis M. A literature review of organisational, individual and teamwork factors contributing to the ICU discharge process. Aust Crit Care. 2009;22:29-43.</Citation></Reference><Reference><Citation>van Sluisveld N, Hesselink G, van der Hoeven JG, Westert G, Wollersheim H, Zegers M. Improving clinical handover between intensive care unit and general ward professionals at intensive care unit discharge. Intensive Care Med. 2015;41:589-604.</Citation></Reference><Reference><Citation>Niven DJ, Bastos JF, Stelfox HT. Critical care transition programs and the risk of readmission or death after discharge from an ICU: a systematic review and meta-analysis. Crit Care Med. 2014;42:179-187.</Citation></Reference><Reference><Citation>Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. www.handbook.cochrane.org</Citation></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, Oxman AE. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group; 2013.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.</Citation></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016:355;i4919.</Citation></Reference><Reference><Citation>McGuinness LA. robvis: an R package and web application for visualising risk-of-bias assessments [Internet]. 2019. https://github.com/mcguinlu/robvis. Accessed February 2, 2020.</Citation></Reference><Reference><Citation>Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39. https://doi.org/10.1186/s12874-017-0315-7</Citation></Reference><Reference><Citation>Thorlund K, Engstr&#xf8;m J, Wetterslev J, Brok J, Imberger G, Gluud C. User Manual for Trial Sequential Analysis (TSA). Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clinical Intervention Research. 2011;1-115. [Internet]. www.ctu.dk/tsass</Citation></Reference><Reference><Citation>McMaster University. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. Evid. Prime, Inc; 2015. www.gradepro.org. Accessed: February 10, 2020.</Citation></Reference><Reference><Citation>Baxter AD, Cardinal P, Hooper J, Patel R. Medical emergency teams at the Ottawa Hospital: the first two years. Can J Anesth. 2008;55:223-231.</Citation></Reference><Reference><Citation>Al-Rajhi A, Mardini L, Jayaraman D. The Impact of implementation of an ICU consult service on hospital-wide outcomes and ICU-specific outcomes. J Intensive Care Med. 2016;31:478-484.</Citation></Reference><Reference><Citation>Pirret AM. The role and effectiveness of a nurse practitioner led critical care outreach service. Intensive Crit Care Nurs. 2008;24:375-382.</Citation></Reference><Reference><Citation>Stelfox HT, Bastos J, Niven DJ, Bagshaw SM, Turin TC, Gao S. Critical care transition programs and the risk of readmission or death after discharge from ICU. Intensive Care Med. 2016;42:401-410.</Citation></Reference><Reference><Citation>Bergamasco E, Paula R, Tanita MT, Festti J, Queiroz Cardoso LT, Carvalho Grion CM. Analysis of readmission rates to the intensive care unit after implementation of a rapid response team in a University Hospital. Med intensiva. 2017;41:411-417.</Citation></Reference><Reference><Citation>Choi S, Lee J, Shin Y, et al. Effects of a medical emergency team follow-up programme on patients discharged from the medical intensive care unit to the general ward: a single-centre experience. J Eval Clin Pract. 2016;22:356-362.</Citation></Reference><Reference><Citation>So HM, Yan WW, Chair SY. A nurse-led critical care outreach program to reduce readmission to the intensive care unit: a quasi-experimental study with a historical control group. Aust Crit Care. 2018;32(6):494-501. https://doi.org/10.1016/j.aucc.2018.11.005</Citation></Reference><Reference><Citation>Ball C, Kirkby M, Williams S. Effect of the critical care outreach team on patient survival to discharge from hospital and readmission to critical care: non-randomised population based study. BMJ. 2003;327:1014.</Citation></Reference><Reference><Citation>Chaboyer W, Lin F, Foster M, Retallick L, Panuwatwanich K, Richards B. Redesigning the ICU nursing discharge process: a quality improvement study. Worldviews Evid Based Nurs. 2012;9(1):40-48.</Citation></Reference><Reference><Citation>Al-Qahtani S, Al-Dorzi HM, Tamim HM, et al. Impact of an intensivist-led multidisciplinary extended rapid response team on hospital-wide cardiopulmonary arrests and mortality. Crit Care Med. 2013;41:506-517.</Citation></Reference><Reference><Citation>Williams TA, Leslie G, Finn J, et al. Clinical effectiveness of a critical care nursing outreach service in facilitating discharge from the intensive care unit. Am J Crit Care. 2010;19:e63-e72.</Citation></Reference><Reference><Citation>Eliott SJ, Ernest D, Doric AG, et al. The impact of an ICU liaison nurse service on patient outcomes. Crit Care Resusc. 2008;10:296-300.</Citation></Reference><Reference><Citation>Chaboyer W, Thalib L, Foster M, Elliott D, Endacott R, Richards B. The impact of an ICU liaison nurse on discharge delay in patients after prolonged ICU stay. Anaesth Intensive Care. 2006;34:55-60.</Citation></Reference><Reference><Citation>Harrison DA, Gao H, Welch CA, Rowan KM. The effects of critical care outreach services before and after critical care: a matched-cohort analysis. J Crit Care. 2010;25:196-204.</Citation></Reference><Reference><Citation>Garcea G, Thomasset S, Mcclelland L, Leslie A, Berry DP. Impact of a critical care outreach team on critical care readmissions and mortality. Acta Anaesthesiol Scand. 2004;48:1096-1100.</Citation></Reference><Reference><Citation>Kramer AA, Higgins TL, Zimmerman JE. Intensive care unit readmissions in U.S. hospitals. Crit Care Med. 2012;40:3-10.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35258641</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-9941</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of trauma and emergency surgery : official publication of the European Trauma Society</Title><ISOAbbreviation>Eur J Trauma Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Shock index as a predictor for mortality in trauma patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2559</StartPage><EndPage>2566</EndPage><MedlinePgn>2559-2566</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00068-022-01932-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The primary aim was to determine whether a shock index (SI)&#x2009;&#x2265;&#x2009;1 in adult trauma patients was associated with increased in-hospital mortality compared to an SI&#x2009;&lt;&#x2009;1.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This systematic review including a meta-analysis was performed in accordance with the PRISMA guidelines. EMBASE, MEDLINE, and Cochrane Library were searched, and two authors independently screened articles, performed the data extraction, and assessed risk of bias. Studies were included if they reported in-hospital, 30-day, or 48-h mortality, length of stay, massive blood transfusion or ICU admission in trauma patients with SI recorded at arrival in the emergency department or trauma center. Risk of bias was assessed using the Newcastle-Ottawa Scale, and the strength and quality of the body of evidence according to GRADE. Data were pooled using a random effects model. Inter-rater reliability was assessed with Cohen's kappa.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We screened 1350 citations with an inter-rater reliability of 0.90. Thirty-eight cohort studies were included of which 14 reported the primary outcome. All studies reported a significant higher in-hospital mortality in adult trauma patients with an SI&#x2009;&#x2265;&#x2009;1 compared to those having an SI&#x2009;&lt;&#x2009;1. Twelve studies involving a total of 348,687 participants were included in the meta-analysis. The pooled risk ratio (RR) of in-hospital mortality was 4.15 (95% CI 2.96-5.83). The overall quality of evidence was low.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This systematic review found a fourfold&#xa0;increased risk of in-hospital mortality in adult trauma patients with an initial SI&#x2009;&#x2265;&#x2009;1 in the emergency department or trauma center.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vang</LastName><ForeName>Malene</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7012-8227</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Trauma Centre, Centre of Head and Orthopaedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. malene.vang.koefoed.nielsen.01@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd8;stberg</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Trauma Centre, Centre of Head and Orthopaedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinmetz</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Trauma Centre, Centre of Head and Orthopaedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Air Ambulance, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Lars S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Trauma Centre, Centre of Head and Orthopaedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Trauma Emerg Surg</MedlineTA><NlmUniqueID>101313350</NlmUniqueID><ISSNLinking>1863-9933</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="Y">Shock</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014193" MajorTopicYN="N">Trauma Centers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emergency department</Keyword><Keyword MajorTopicYN="N">Massive blood transfusion</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Shock index</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>12</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35258641</ArticleId><ArticleId IdType="doi">10.1007/s00068-022-01932-z</ArticleId><ArticleId IdType="pii">10.1007/s00068-022-01932-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geneva WHO. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000&#x2013;2016. 2018.</Citation></Reference><Reference><Citation>Sobrino J, Shafi S. Timing and causes of death after injuries. Proc (Bayl Univ Med Cent). 2013;26(2):120&#x2013;3. https://doi.org/10.1080/08998280.2013.11928934 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2013.11928934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauvar DS, Lefering R, Wade CE. Impact of Hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma Acute Care Surg. 2006;60(6):S3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ta.0000199961.02677.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacagnella RC, Souza JP, Durocher J, et al. A systematic review of the relationship between blood loss and clinical signs. PLoS&#xa0;One. 2013;8(3):e57594&#x2013;e57594. https://doi.org/10.1371/journal.pone.0057594 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057594</ArticleId><ArticleId IdType="pubmed">23483915</ArticleId><ArticleId IdType="pmc">3590203</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank M, Schmucker U, Stengel D, et al. Proper estimation of blood loss on scene of trauma: tool or tale? J Trauma Acute Care Surg. 2010;69(5):1191&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181c452e7</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLS&#x2014;Advanced Trauma Life Support Guidelines 10th Edition</Citation></Reference><Reference><Citation>Birkhahn RH, Gaeta TJ, Terry D, et al. Shock index in diagnosing early acute hypovolemia. Am J Emerg Med. 2005;23(3):323&#x2013;6. https://doi.org/10.1016/j.ajem.2005.02.029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2005.02.029</ArticleId><ArticleId IdType="pubmed">15915406</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutschler M, Nienaber U, M&#xfc;nzberg M, et al. The Shock Index revisited&#x2014;a fast guide to transfusion requirement? A retrospective analysis on 21,853 patients derived from the TraumaRegister DGU. Crit Care. 2013;17(4):R172. https://doi.org/10.1186/cc12851 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12851</ArticleId><ArticleId IdType="pubmed">23938104</ArticleId><ArticleId IdType="pmc">4057268</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandit V, Rhee P, Hashmi A, et al. Shock index predicts mortality in geriatric trauma patients: an analysis of the National Trauma Data Bank. J Trauma Acute Care Surg. 2014;76(4):1111&#x2013;5. https://doi.org/10.1097/TA.0000000000000160 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000160</ArticleId><ArticleId IdType="pubmed">24662879</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339: b2700. https://doi.org/10.1136/bmj.b2700 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId><ArticleId IdType="pmc">2714672</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, The PRISMA, et al. statement: An updated guideline for reporting systematic reviews. BMJ. 2020;2021:372. https://doi.org/10.1136/bmj.n71 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. https://doi.org/10.1186/2046-4053-4-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId><ArticleId IdType="pmc">4320440</ArticleId></ArticleIdList></Reference><Reference><Citation>Covidence&#x2014;Better systematic review management. https://www.covidence.org/ . Accessed 1 May 2021.</Citation></Reference><Reference><Citation>Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 1 May 2021.</Citation></Reference><Reference><Citation>Londo&#xf1;o J, Ni&#xf1;o C, D&#xed;az J, et al. Association of clinical hypoperfusion variables with lactate clearance and hospital mortality. Shock. 2018;50(3):286&#x2013;92. https://doi.org/10.1097/SHK.0000000000001066 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001066</ArticleId><ArticleId IdType="pubmed">29206763</ArticleId></ArticleIdList></Reference><Reference><Citation>Salottolo KM, Mains CW, Offner PJ, et al. A retrospective analysis of geriatric trauma patients: venous lactate is a better predictor of mortality than traditional vital signs. Scand J Trauma Resusc Emerg Med. 2013;21:7. https://doi.org/10.1186/1757-7241-21-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1757-7241-21-7</ArticleId><ArticleId IdType="pubmed">23410202</ArticleId><ArticleId IdType="pmc">3598961</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;hlich M, Driessen A, B&#xf6;hmer A, et al. Is the shock index based classification of hypovolemic shock applicable in multiple injured patients with severe traumatic brain injury?&#x2014;An analysis of the TraumaRegister DGU(&#xae;). Scand J Trauma Resusc Emerg Med. 2016;24(1):148. https://doi.org/10.1186/s13049-016-0340-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-016-0340-2</ArticleId><ArticleId IdType="pubmed">27955692</ArticleId><ArticleId IdType="pmc">5153863</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandarkar P, Munivenkatappa A, Roy N, et al. Pattern and distribution of shock index and age shock index score among trauma patients in towards improved trauma care outcomes (TITCO) dataset. Bull Emerg Trauma. 2018;6(4):313&#x2013;7. https://doi.org/10.29252/beat-060407 .</Citation><ArticleIdList><ArticleId IdType="doi">10.29252/beat-060407</ArticleId><ArticleId IdType="pubmed">30402519</ArticleId><ArticleId IdType="pmc">6215075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Hong KJ, Shin SD, et al. Validation of the shock index, modified shock index, and age shock index for predicting mortality of geriatric trauma patients in emergency departments. J Korean Med Sci. 2016;31(12):2026&#x2013;32. https://doi.org/10.3346/jkms.2016.31.12.2026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2016.31.12.2026</ArticleId><ArticleId IdType="pubmed">27822945</ArticleId><ArticleId IdType="pmc">5102870</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai W-H, Wu S-C, Rau C-S, et al. Systolic blood pressure lower than heart rate upon arrival at and departure from the emergency department indicates a poor outcome for adult trauma patients. Int J Environ Res Public Health. 2016. https://doi.org/10.3390/ijerph13060528 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph13060528</ArticleId><ArticleId IdType="pubmed">28029125</ArticleId><ArticleId IdType="pmc">5295262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra B, Fitzgerald M, Chan J. The utility of a shock index &#x2265; 1 as an indication for pre-hospital oxygen carrier administration in major trauma. Injury. 2014;45(1):61&#x2013;5. https://doi.org/10.1016/j.injury.2013.01.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.01.010</ArticleId><ArticleId IdType="pubmed">23391451</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J-F, Tsai Y-C, Rau C-S, et al. Systolic blood pressure lower than the heart rate indicates a poor outcome in patients with severe isolated traumatic brain injury: a cross-sectional study. Int J Surg. 2019;61:48&#x2013;52. https://doi.org/10.1016/j.ijsu.2018.11.030 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2018.11.030</ArticleId><ArticleId IdType="pubmed">30543949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono Y, Yokoyama H, Matsumoto A, et al. Is preoperative period associated with severity and unexpected death of injured patients needing emergency trauma surgery? J Anesth. 2014;28(3):381&#x2013;9. https://doi.org/10.1007/s00540-013-1727-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-013-1727-0</ArticleId><ArticleId IdType="pubmed">24141883</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Menyar A, Abdelrahman H, Alhammoud A, et al. Prognostic role of shock index in traumatic pelvic fracture: a retrospective analysis. J Surg Res. 2019;243:410&#x2013;8. https://doi.org/10.1016/j.jss.2019.05.062 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2019.05.062</ArticleId><ArticleId IdType="pubmed">31279267</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider A, Con J, Prabhakaran K, et al. Developing a simple clinical score for predicting mortality and need for ICU in trauma patients. Am Surg. 2019;85(7):733&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481908500733</ArticleId></ArticleIdList></Reference><Reference><Citation>Odom SR, Howell MD, Gupta A, et al. Extremes of shock index predicts death in trauma patients. J Emerg Trauma Shock. 2016;9(3):103&#x2013;6. https://doi.org/10.4103/0974-2700.185272 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-2700.185272</ArticleId><ArticleId IdType="pubmed">27512331</ArticleId><ArticleId IdType="pmc">4960776</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon CM, Braxton CC, Kling-Smith M, et al. Utility of the shock index in predicting mortality in traumatically injured patients. J Trauma. 2009;67(6):1426&#x2013;30. https://doi.org/10.1097/TA.0b013e3181bbf728 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181bbf728</ArticleId><ArticleId IdType="pubmed">20009697</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu WC, Powers DB, Hirshon JM, et al. Impact of trauma centre capacity and volume on the mortality risk of incoming new admissions. BMJ Mil Health. 2020. https://doi.org/10.1136/bmjmilitary-2020-001483 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmilitary-2020-001483</ArticleId><ArticleId IdType="pubmed">32474436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammers D, Conner J, Marenco C, et al. Optimal prospective predictors of mortality in austere environments. J Surg Res. 2020;255:297&#x2013;303. https://doi.org/10.1016/j.jss.2020.05.040 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2020.05.040</ArticleId><ArticleId IdType="pubmed">32585467</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab A, Burns B, Bhullar I, et al. A prehospital shock index for trauma correlates with measures of hospital resource use and mortality. Surgery. 2012;152(3):473&#x2013;6. https://doi.org/10.1016/j.surg.2012.07.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2012.07.010</ArticleId><ArticleId IdType="pubmed">22938906</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Ali S, Agarwal A, et al. Correlation of shock index and modified shock index with the outcome of adult trauma patients: a prospective study of 9860 patients. N Am J Med Sci. 2014;6(9):450&#x2013;2. https://doi.org/10.4103/1947-2714.141632 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1947-2714.141632</ArticleId><ArticleId IdType="pubmed">25317389</ArticleId><ArticleId IdType="pmc">4193151</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan-Ting C, Chin-Hsien L, Cheng-Yu L, et al. Reverse shock index multiplied by Glasgow Coma Scale (rSIG) predicts mortality in severe trauma patients with head injury. Sci Rep. 2020;10(1):2095. https://doi.org/10.1038/s41598-020-59044-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-59044-w</ArticleId><ArticleId IdType="pubmed">32034233</ArticleId><ArticleId IdType="pmc">7005840</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom O, Taylor DM, Wolfe RE, et al. Pilot study of the prevalence, outcomes and detection of occult hypoperfusion in trauma patients. Emerg Med J. 2010;27(6):470&#x2013;2. https://doi.org/10.1136/emj.2009.073254 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emj.2009.073254</ArticleId><ArticleId IdType="pubmed">20360482</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouraghaei M, Vahdati S, Moharamzadeh P, et al. The impact of prehospital emergency services on the outcome of trauma patients. Arch Trauma Res. 2020;9(3):139&#x2013;42. https://doi.org/10.4103/atr.atr_75_19 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/atr.atr_75_19</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandromme MJ, Griffin RL, Kerby JD, et al. Identifying risk for massive transfusion in the relatively normotensive patient: utility of the prehospital shock index. J Trauma. 2011;70(2):384&#x2013;90. https://doi.org/10.1097/TA.0b013e3182095a0a .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182095a0a</ArticleId><ArticleId IdType="pubmed">21307738</ArticleId></ArticleIdList></Reference><Reference><Citation>Jehan F, Con J, McIntyre M, et al. Pre-hospital shock index correlates with transfusion, resource utilization and mortality; the role of patient first vitals. Am J Surg. 2019;218(6):1169&#x2013;74. https://doi.org/10.1016/j.amjsurg.2019.08.028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2019.08.028</ArticleId><ArticleId IdType="pubmed">31540684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai W-H, Rau C-S, Hsu S-Y, et al. Using the reverse shock index at the injury scene and in the emergency department to identify high-risk patients: a cross-sectional retrospective study. Int J Environ Res Public Health. 2016;13(4):357. https://doi.org/10.3390/ijerph13040357 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph13040357</ArticleId><ArticleId IdType="pubmed">27023577</ArticleId><ArticleId IdType="pmc">4847019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheirbek T, Thomas JM, Cao J, et al. Prehospital shock index outperforms hypotension alone in predicting significant injury in trauma patients. Trauma Surg Acute Care Open. 2021;6(1): e000712. https://doi.org/10.1136/tsaco-2021-000712 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tsaco-2021-000712</ArticleId><ArticleId IdType="pubmed">33907716</ArticleId><ArticleId IdType="pmc">8051366</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottecher J, Ageron F-X, Fauch&#xe9; C, et al. Prehospital shock index and pulse pressure/heart rate ratio to predict massive transfusion after severe trauma: retrospective analysis of a large regional trauma database. J Trauma Acute Care Surg. 2016;81(4):713&#x2013;22. https://doi.org/10.1097/TA.0000000000001191 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001191</ArticleId><ArticleId IdType="pubmed">27648770</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroll R, Swift D, Tatum D, et al. Accuracy of shock index versus ABC score to predict need for massive transfusion in trauma patients. Injury. 2018;49(1):15&#x2013;9. https://doi.org/10.1016/j.injury.2017.09.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2017.09.015</ArticleId><ArticleId IdType="pubmed">29017765</ArticleId></ArticleIdList></Reference><Reference><Citation>Yumoto T, Iida A, Hirayama T, et al. Immediate screening method for predicting the necessity of massive transfusions in trauma patients: a retrospective single-center study. J Intensive Care. 2014;2(1):54. https://doi.org/10.1186/s40560-014-0054-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-014-0054-3</ArticleId><ArticleId IdType="pubmed">25705412</ArticleId><ArticleId IdType="pmc">4336277</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Serra A, Montmany-Vioque S, Rebasa-Cladera P, et al. The use of the Shock Index as a predictor of active bleeding in trauma patients. Cir Esp. 2018;96(8):494&#x2013;500. https://doi.org/10.1016/j.ciresp.2018.04.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ciresp.2018.04.004</ArticleId><ArticleId IdType="pubmed">29778416</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph B, Khan M, Truitt M, et al. Massive transfusion: the revised assessment of bleeding and transfusion (RABT) score. World J Surg. 2018;42(11):3560&#x2013;7. https://doi.org/10.1007/s00268-018-4674-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4674-y</ArticleId><ArticleId IdType="pubmed">29785693</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaussen A, Peterson EL, Mitra B, et al. Massive transfusion prediction with inclusion of the pre-hospital Shock Index. Injury. 2015;46(5):822&#x2013;6. https://doi.org/10.1016/j.injury.2014.12.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2014.12.009</ArticleId><ArticleId IdType="pubmed">25555919</ArticleId></ArticleIdList></Reference><Reference><Citation>Plewa MC, Ewing M, Vyas N, et al. A clinical rule for predicting massive transfusion in trauma victims. Ann Emerg Med. 2013;62(4 Suppl. 1):S116. https://doi.org/10.1016/j.annemergmed.2013.07.150 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2013.07.150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MJ, Park JY, Kim MK, et al. Usefulness of shock index to predict outcomes of trauma patient: a retrospective cohort study. J Trauma Inj. 2019;32(1):17&#x2013;25. https://doi.org/10.20408/jti.2018.034 .</Citation><ArticleIdList><ArticleId IdType="doi">10.20408/jti.2018.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouini S, Jebali A, Hedhli H, et al. Predictive value of shock index &#x2265; 1 in severe trauma patients in emergency department. Tunis Med. 2019;97(6):802&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31872412</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rkman J, Raatiniemi L, Set&#xe4;l&#xe4; P, et al. Shock index as a predictor for short-term mortality in helicopter emergency medical services: a registry study. Acta Anaesthesiol Scand. 2021;65(6):816&#x2013;23. https://doi.org/10.1111/aas.13765 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13765</ArticleId><ArticleId IdType="pubmed">33340090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarzaur BL, Croce MA, Fischer PE, et al. New vitals after injury: shock index for the young and age x shock index for the old. J Surg Res. 2008;147(2):229&#x2013;36. https://doi.org/10.1016/j.jss.2008.03.025 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2008.03.025</ArticleId><ArticleId IdType="pubmed">18498875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Rodr&#xed;guez F, L&#xf3;pez-Izquierdo R, Del Pozo VC, et al. Accuracy of National Early Warning Score 2 (NEWS2) in prehospital triage on in-hospital early mortality: a multi-center observational prospective cohort study. Prehosp Disaster Med. 2019;34(6):610&#x2013;8. https://doi.org/10.1017/S1049023X19005041 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1049023X19005041</ArticleId><ArticleId IdType="pubmed">31648657</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang Z, Wang Z, et al. The prognostic value of shock index for the outcomes of acute myocardial infarction patients: a systematic review and meta-analysis. Med (United States). 2017. https://doi.org/10.1097/MD.0000000000008014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000008014</ArticleId><ArticleId IdType="pubmed">30417162</ArticleId><ArticleId IdType="pmc">9165548</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton DJ, Smith TO, et al. Shock index predicts outcome in patients with suspected sepsis or community-acquired pneumonia: a systematic review. J Clin Med. 2019. https://doi.org/10.3390/jcm8081144 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8081144</ArticleId><ArticleId IdType="pubmed">31370356</ArticleId><ArticleId IdType="pmc">6723191</ArticleId></ArticleIdList></Reference><Reference><Citation>Balhara KS, Hsieh YH, Hamade B, et al. Clinical metrics in emergency medicine: the shock index and the probability of hospital admission and inpatient mortality. Emerg Med J. 2017;34(2):89&#x2013;94. https://doi.org/10.1136/emermed-2015-205532 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2015-205532</ArticleId><ArticleId IdType="pubmed">27884923</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31141306</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1478-3231</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Liver international : official journal of the International Association for the Study of the Liver</Title><ISOAbbreviation>Liver Int</ISOAbbreviation></Journal><ArticleTitle>In-Hospital mortality varies by procedure type among cirrhosis surgery admissions.</ArticleTitle><Pagination><StartPage>1394</StartPage><EndPage>1399</EndPage><MedlinePgn>1394-1399</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/liv.14156</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with cirrhosis have increased peri-operative mortality risk relative to non-cirrhotic patients, however, the impact of surgical procedure category on this risk is poorly understood.</AbstractText><AbstractText Label="METHODS">We performed a retrospective cohort study of cirrhosis surgery admissions using the National Inpatient Sample between 2012 and 2014 to estimate the adjusted odds of in-hospital mortality by surgical procedure category.</AbstractText><AbstractText Label="RESULTS">In-hospital mortality differed by surgical procedure category. Relative to major orthopedic surgeries, major abdominal surgeries had the highest odds of in-hospital mortality (odds ratio [OR] 8.27, 95% confidence interval [CI] 5.96-11.49), followed by major cardiovascular surgeries (OR 3.45, 95% CI 2.33-5.09). There was also a significant interaction term, whereby elective/non-elective admission status impacted in-hospital mortality risk differently for each surgical procedure category (P&#xa0;&lt;&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSION">In-hospital mortality varies substantially by surgical procedure type. Accounting for procedure type in models may improve risk prediction for peri-operative mortality in patients with cirrhosis.</AbstractText><CopyrightInformation>&#xa9; 2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mahmud</LastName><ForeName>Nadim</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1889-3954</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fricker</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serper</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothstein</LastName><ForeName>Kenneth D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 DK007740</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Liver Int</MedlineTA><NlmUniqueID>101160857</NlmUniqueID><ISSNLinking>1478-3223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">chronic liver disease</Keyword><Keyword MajorTopicYN="N">major abdominal</Keyword><Keyword MajorTopicYN="N">peri-operative mortality</Keyword><Keyword MajorTopicYN="N">risk stratification</Keyword></KeywordList><CoiStatement><b>Conflict of Interest:</b> The authors have no disclosures or conflicts of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31141306</ArticleId><ArticleId IdType="mid">NIHMS1032595</ArticleId><ArticleId IdType="pmc">PMC6675652</ArticleId><ArticleId IdType="doi">10.1111/liv.14156</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and non-alcoholic-steatohepatitis&#x2013;related liver transplantation waitlist additions in the United States. Hepatology 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28833326</ArticleId></ArticleIdList></Reference><Reference><Citation>Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689327</ArticleId><ArticleId IdType="pubmed">30315778</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999;29:1617&#x2013;1623.</Citation><ArticleIdList><ArticleId IdType="pubmed">10347099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoteit MA, Ghazale AH, Bain AJ, et al. Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis. World journal of gastroenterology: WJG 2008;14:1774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2695918</ArticleId><ArticleId IdType="pubmed">18350609</ArticleId></ArticleIdList></Reference><Reference><Citation>Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007;132:1261&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">17408652</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins L, Jeffries M, Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clinical Gastroenterology and Hepatology 2004;2:1123&#x2013;1128.</Citation><ArticleIdList><ArticleId IdType="pubmed">15625658</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashida N, Shoujima T, Teshima H, et al. Clinical outcome after cardiac operations in patients with cirrhosis. The Annals of thoracic surgery 2004;77:500&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">14759426</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology 2018;67:2367&#x2013;2374.</Citation><ArticleIdList><ArticleId IdType="pubmed">29315693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sam J, Nguyen GC. Protein&#x2013;calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver International 2009;29:1396&#x2013;1402.</Citation><ArticleIdList><ArticleId IdType="pubmed">19602136</ArticleId></ArticleIdList></Reference><Reference><Citation>Csikesz NG, Nguyen LN, Tseng JF, et al. Nationwide volume and mortality after elective surgery in cirrhotic patients. Journal of the American College of Surgeons 2009;208:96&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">19228510</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagg V ELIXHAUSER: Stata module to calculate Elixhauser index of comorbidity. 2015.</Citation></Reference><Reference><Citation>Menendez ME, Neuhaus V, van Dijk CN, et al. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery. Clinical Orthopaedics and Related Research&#xae; 2014;472:2878&#x2013;2886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117875</ArticleId><ArticleId IdType="pubmed">24867450</ArticleId></ArticleIdList></Reference><Reference><Citation>Houchens R, Ross D, Elixhauser A. Final report on calculating national (nationwide) inpatient sample (NIS) variances for data years 2012 and later: HCUP Methods Series Report# 2015-09 ONLINE. US Agency for Healthcare; &#x2026;, 2015.</Citation></Reference><Reference><Citation>Khera R, Angraal S, Couch T, et al. Adherence to methodological standards in research using the national inpatient sample. Jama 2017;318:2011&#x2013;2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5742631</ArticleId><ArticleId IdType="pubmed">29183077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Yim HJ, Park SM, et al. Validation of a Mayo post-operative mortality risk prediction model in Korean cirrhotic patients. Liver International 2011;31:222&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">21134111</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman LS. Surgery in the patient with liver disease. Transactions of the American Clinical and Climatological Association 2010;121:192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917124</ArticleId><ArticleId IdType="pubmed">20697561</ArticleId></ArticleIdList></Reference><Reference><Citation>Thielmann M, Mechmet A, Neuh&#xe4;user M, et al. Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery. European Journal of Cardio-Thoracic Surgery 2010;38:592&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">20413316</ArticleId></ArticleIdList></Reference><Reference><Citation>Arif R, Seppelt P, Schwill S, et al. Predictive risk factors for patients with cirrhosis undergoing heart surgery. The Annals of thoracic surgery 2012;94:1947&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pubmed">22921237</ArticleId></ArticleIdList></Reference><Reference><Citation>de Goede B, Klitsie P, Hagen S, et al. Meta-analysis of laparoscopic versus open cholecystectomy for patients with liver cirrhosis and symptomatic cholecystolithiasis. British Journal of Surgery 2013;100:209&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">23034741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiberi JV, Hansen V, El-Abbadi N, et al. Increased complication rates after hip and knee arthroplasty in patients with cirrhosis of the liver. Clinical Orthopaedics and Related Research&#xae; 2014;472:2774&#x2013;2778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117879</ArticleId><ArticleId IdType="pubmed">24993141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36001761</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Machine learning to predict adverse outcomes after cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3838</StartPage><EndPage>3845</EndPage><MedlinePgn>3838-3845</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.16842</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Machine learning (ML) models are promising tools for predicting adverse postoperative outcomes in cardiac surgery, yet have not translated to routine clinical use. We conducted a systematic review and meta-analysis to assess the predictive performance of ML approaches.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an electronic search to find studies assessing ML and traditional statistical models to predict postoperative outcomes. Our primary outcome was the concordance (C-) index of discriminative performance. Using a Bayesian meta-analytic approach we pooled the C-indices with the 95% credible interval (CrI) across multiple outcomes comparing ML methods to logistic regression (LR) and clinical scoring tools. Additionally, we performed critical difference and sensitivity analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 2792 references from the search of which 51 met inclusion criteria. Two postoperative outcomes were amenable for meta-analysis: 30-day mortality and in-hospital mortality. For 30-day mortality, the pooled C-index and 95% CrI were 0.82 (0.79-0.85), 0.80 (0.77-0.84), 0.78 (0.74-0.82) for ML models, LR, and scoring tools respectively. For in-hospital mortality, the pooled C-index was 0.81 (0.78-0.84) and 0.79 (0.73-0.84) for ML models and LR, respectively. There were no statistically significant results indicating ML superiority over LR.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In cardiac surgery patients, for the prediction of mortality, current ML methods do not have greater discriminative power over LR as measured by the C-index.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Penny-Dimri</LastName><ForeName>Jahan C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0001-8148-1237</Identifier><AffiliationInfo><Affiliation>Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergmeir</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Data Science and Artificial Intelligence, Faculty of Information Technology, Monash University, Clayton, Victoria, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Linley</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Barwon Health, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Research, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Card Surg. 2022 Nov;37(11):3846-3847. doi: 10.1111/jocs.16844.</RefSource><PMID Version="1">36001760</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">perioperative risk</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>24</Day><Hour>14</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36001761</ArticleId><ArticleId IdType="pmc">PMC9804388</ArticleId><ArticleId IdType="doi">10.1111/jocs.16842</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crawford TC, Magruder JT, Grimm JC, et al. Complications after cardiac operations: all are not created equal. Ann Thorac. 2017;103(1):32&#x2010;40. 10.1016/j.athoracsur.2016.10.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.10.022</ArticleId><ArticleId IdType="pubmed">27884410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hote M. Cardiac surgery risk scoring systems: in quest for the best. Heart Asia. 2018;10(1):e011017. 10.1136/heartasia-2018-011017</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartasia-2018-011017</ArticleId><ArticleId IdType="pmc">PMC5890060</ArticleId><ArticleId IdType="pubmed">29637928</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U, Dimagli A, Sinha S, et al. Machine learning improves mortality risk prediction after cardiac surgery: systematic review and meta&#x2010;analysis. J Thorac Cardiovasc Surg. 2020;163:2075&#x2010;2087. 10.1016/j.jtcvs.2020.07.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.07.105</ArticleId><ArticleId IdType="pubmed">32900480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripley BD. Pattern Recognition and Neural Networks. Cambridge University Press; 1996. 10.1017/cbo9780511812651</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cbo9780511812651</ArticleId></ArticleIdList></Reference><Reference><Citation>Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920&#x2010;1930. 10.1161/circulationaha.115.001593</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.115.001593</ArticleId><ArticleId IdType="pmc">PMC5831252</ArticleId><ArticleId IdType="pubmed">26572668</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta&#x2010;analysis protocols (PRISMA&#x2010;p) 2015 statement. Syst Rev. 2015;4(1):1. 10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Calster BV. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12&#x2010;22. 10.1016/j.jclinepi.2019.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.02.004</ArticleId><ArticleId IdType="pubmed">30763612</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF. QUADAS&#x2010;2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529&#x2010;536. 10.7326/0003-4819-155-8-201110180-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29&#x2010;36. 10.1148/radiology.143.1.7063747</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.143.1.7063747</ArticleId><ArticleId IdType="pubmed">7063747</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ver C. Bayesian random&#x2010;effects meta&#x2010;analysis using the bayesmeta r package. J Stat Softw. 2020;93(6):1&#x2010; 51. 10.18637/jss.v093.i06</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v093.i06</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Fawaz H, Forestier G, Weber J, Idoumghar L, Muller PA. Deep learning for time series classification: a review. Data Min Knowl Discov. 2019;33(4):917&#x2010;963.</Citation></Reference><Reference><Citation>Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882&#x2010;893. 10.1016/j.jclinepi.2005.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.01.016</ArticleId><ArticleId IdType="pubmed">16085191</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924&#x2010;926. 10.1136/bmj.39489.470347.ad</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.ad</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94&#x2010;98. 10.7861/futurehosp.6-2-94</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/futurehosp.6-2-94</ArticleId><ArticleId IdType="pmc">PMC6616181</ArticleId><ArticleId IdType="pubmed">31363513</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Wu Z, Xu X, et al. Opportunities and challenges of artificial intelligence in the medical field: current application, emerging problems, and problem&#x2010;solving strategies. J Int Med Res. 2021;49(3):030006052110001. 10.1177/03000605211000157</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605211000157</ArticleId><ArticleId IdType="pmc">PMC8165857</ArticleId><ArticleId IdType="pubmed">33771068</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati F, No&#xeb;l PA, Yang J. On the value of ML models. arXiv . Preprint posted online December 13, 2021. 10.48550/ARXIV.2112.06775</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/ARXIV.2112.06775</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;trumbelj E, Kononenko I. Explaining prediction models and individual predictions with feature contributions. Knowl Inf Syst. 2013;41(3):647&#x2010;665. 10.1007/s10115-013-0679-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10115-013-0679-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Karri R, Kawai A, Thong YJ, et al. Machine learning outperforms existing clinical scoring tools in the prediction of postoperative atrial fibrillation during intensive care unit admission after cardiac surgery. Heart Lung Circ. 2021;30(12):1929&#x2010;1937. 10.1016/j.hlc.2021.05.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2021.05.101</ArticleId><ArticleId IdType="pubmed">34215511</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny&#x2010;Dimri JC, Bergmeir C, Reid CM, Williams&#x2010;Spence J, Cochrane AD, Smith JA. Machine learning algorithms for predicting and risk profiling of cardiac surgery&#x2010;associated acute kidney injury. Semin Thorac Cardiovasc Surg. 2021;33(3):735&#x2010;745. 10.1053/j.semtcvs.2020.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2020.09.028</ArticleId><ArticleId IdType="pubmed">32979479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32882348</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>A meta-analysis of locoregional anesthesia versus general anesthesia in endovascular repair of ruptured abdominal aortic aneurysm.</ArticleTitle><Pagination><StartPage>700</StartPage><EndPage>710</EndPage><MedlinePgn>700-710</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2020.08.112</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(20)31997-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To conduct a meta-analytic review of studies investigating the effect of the anesthesia modality on perioperative mortality in endovascular repair of ruptured abdominal aortic aneurysms (REVAR).</AbstractText><AbstractText Label="METHODS">The present meta-analysis was performed in accordance with the PRISMA guidelines. Multiple electronic databases were comprehensively searched from database inception to January 2020. Eligible studies included cohort studies that reported the 30-day/in-hospital mortality rate or the multivariate adjusted odds ratio (OR) or hazard ratio of the mortality risk for patients who underwent emergency REVAR under locoregional anesthesia (LA) vs general anesthesia (GA). A random effects model was used to estimate the ORs by pooling the related data from individual studies.</AbstractText><AbstractText Label="RESULTS">A total of eight studies were included in this analysis. The first meta-analysis of seven studies that reported the 30-day/in-hospital mortality with a total of 3116 patients (867 in the LA group and 2249 in the GA group) revealed that LA was associated with a lower 30-day/in-hospital mortality than GA (16.4% vs 25.4%; unadjusted OR, 0.47; 95% confidence interval [CI], 0.32-0.68). The second meta-analysis of three of these seven studies (including 586 patients in the LA group and 1945 in the GA group) that reported the perioperative variables revealed comparable baseline characteristics but a lower 30-day/in-hospital mortality in the LA group (unadjusted OR, 0.55; 95% CI, 0.42-0.71). The third meta-analysis of the adjusted ORs or hazard ratios that were reported from four studies (including 501 patients in the LA group and 1136 in the GA group) showed a similar trend (adjusted OR,0.37; 95% CI, 0.19-0.75).</AbstractText><AbstractText Label="CONCLUSIONS">REVAR under LA is associated with a lower 30-day/in-hospital mortality than REVAR under GA. However, because the included studies may have had some observation bias, further randomized controlled trials are warranted to validate the present results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jianqing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongpeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China. Electronic address: guoweiplagh@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001019" MajorTopicYN="N">Aortic Rupture</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal aortic aneurysm</Keyword><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Aortic rupture</Keyword><Keyword MajorTopicYN="N">Endovascular aneurysm repair</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32882348</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2020.08.112</ArticleId><ArticleId IdType="pii">S0741-5214(20)31997-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37083232</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2154-8331</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Hospital practice (1995)</Title><ISOAbbreviation>Hosp Pract (1995)</ISOAbbreviation></Journal><ArticleTitle>Impact of perioperative direct oral anticoagulant assays: a multicenter cohort study.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>162</EndPage><MedlinePgn>155-162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21548331.2023.2206270</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">There is little evidence to guide the perioperative management of patients on a direct oral anticoagulant (DOAC) in the absence of a last known dose. Quantitative serum titers may be ordered, but there is little evidence supporting this.</AbstractText><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">This multi-center retrospective cohort study of consecutive surgical in-patients with a DOAC assay, performed over a five-year period, aimed to characterize preoperative DOAC assay orders and their impact on perioperative outcomes.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">Patients prescribed regular DOAC (both prophylactic and therapeutic dosing) with a preoperative DOAC assay were included. The DOAC assay titer was evaluated against endpoints. Further, patients with an assay were compared against anticoagulated patients who did not receive a preoperative DOAC assay. The primary endpoint was major bleeding. Secondary endpoints included perioperative hemoglobin change, blood transfusions, idarucizumab or prothrombin complex concentrate administration, postoperative thrombosis, in-hospital mortality and reoperation. Adjusted and unadjusted linear regression models were used for continuous data. Binary logistic models were performed for dichotomous outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">1065 patients were included, 232 had preoperative assays. Assays were ordered most commonly by Spinal (11.9%), Orthopedics (15.4%), and Neurosurgery (19.4%). For every 10 ng/ml increase in titer, the hemoglobin decreases by 0.5066&#x2009;g/L and the odds of a preoperative reversal increases by 13%. Compared to those without an assay, patients with preoperative DOAC assays had odds 1.44&#xd7; higher for major bleeding, 2.98&#xd7; higher for in-hospital mortality and 16.3&#xd7; higher for receiving anticoagulant reversal.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">A preoperative DOAC assay order was associated with worse outcomes despite increased reversal administration. However, the DOAC assay titer can reflect the patient's likelihood of bleeding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stretton</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7939-3489</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovoor</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3880-3840</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacchi</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5130-8628</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Booth</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0005-0023-6552</Identifier><AffiliationInfo><Affiliation>Central Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gluck</LastName><ForeName>Sam</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7883-517X</Identifier><AffiliationInfo><Affiliation>Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanlint</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5862-8445</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afzal</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6316-5289</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ovenden</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8075-7852</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Aashray</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8038-0378</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiothoracic Surgery, Gold Coast University Hospital, Southport, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahajan</LastName><ForeName>Rajiv</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3375-5568</Identifier><AffiliationInfo><Affiliation>Central Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2074-1685</Identifier><AffiliationInfo><Affiliation>Adelaide Health Technology Assessment, The University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-8670-4070</Identifier><AffiliationInfo><Affiliation>Central Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boey</LastName><ForeName>Jir Ping</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-0111-8575</Identifier><AffiliationInfo><Affiliation>Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddi</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4110-5055</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maddern</LastName><ForeName>Guy</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2064-181X</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Audit and Academic Surgery, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6848-3307</Identifier><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hosp Pract (1995)</MedlineTA><NlmUniqueID>101268948</NlmUniqueID><ISSNLinking>2154-8331</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="Y">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Direct oral anticoagulation</Keyword><Keyword MajorTopicYN="N">Drug monitoring</Keyword><Keyword MajorTopicYN="N">patient safety/outcomes</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">pharmacology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37083232</ArticleId><ArticleId IdType="doi">10.1080/21548331.2023.2206270</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35461781</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7533</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</Title><ISOAbbreviation>Surg Obes Relat Dis</ISOAbbreviation></Journal><ArticleTitle>Outcomes of bariatric surgery in patients with obesity and compensated liver cirrhosis.</ArticleTitle><Pagination><StartPage>727</StartPage><EndPage>737</EndPage><MedlinePgn>727-737</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.soard.2022.03.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1550-7289(22)00124-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Obesity is a major health burden worldwide and is associated with nonalcoholic fatty liver disease, which can lead to cirrhosis. Bariatric surgery is increasingly being used to treat obesity, and the number of patients with obesity and cirrhosis undergoing bariatric surgery is also rising. However, the safety and feasibility of bariatric surgery in patients with obesity and cirrhosis are controversial.</AbstractText><AbstractText Label="OBJECTIVES">In this meta-analysis, we compared postoperative complications, mortality, and weight loss between patients with and without cirrhosis undergoing bariatric surgery.</AbstractText><AbstractText Label="SETTING">An electronic search of Medline, Web of Science, and Cochrane Central Register of Controlled Trials (CENTRAL).</AbstractText><AbstractText Label="METHODS">Patient morbidity and mortality odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (CIs) were assessed. Intraoperative and overall complications, length of hospital stay, in-hospital mortality, long-term mortality, and total weight loss were recorded.</AbstractText><AbstractText Label="RESULTS">The literature search yielded 2977 articles. Eight studies were included in the analysis. Meta-analysis showed that the overall complications (OR: 2.1; 95% CI: 1.47-3.00; P &lt; .0001), postoperative bleeding (OR: 2.22; 95% CI: 1.95-2.54; P &lt; .00001), length of hospital stay (MD: .68; 95% CI: .14-1.19; P = .01), and in-hospital/90-day mortality (OR: 3.59; 95% CI: 2.84-4.54; P &lt; .00001) were significantly higher in patients with compensated cirrhosis than in patients without cirrhosis. Intraoperative complications, operation time, major complications, and long-term mortality were similar between the groups. Total weight loss was also not significantly different between the groups.</AbstractText><AbstractText Label="CONCLUSION">Bariatric surgery can be considered only in highly selected patients with obesity and compensated cirrhosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khajeh</LastName><ForeName>Elias</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aminizadeh</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eslami</LastName><ForeName>Pegah</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramouz</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulu</LastName><ForeName>Yakup</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billeter</LastName><ForeName>Adrian T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nickel</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller-Stich</LastName><ForeName>Beat Peter</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrabi</LastName><ForeName>Arianeb</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: arianeb.mehrabi@med.uni-heidelberg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Obes Relat Dis</MedlineTA><NlmUniqueID>101233161</NlmUniqueID><ISSNLinking>1550-7289</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065626" MajorTopicYN="Y">Non-alcoholic Fatty Liver Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bariatric surgery</Keyword><Keyword MajorTopicYN="N">Cirrhosis</Keyword><Keyword MajorTopicYN="N">Compensated cirrhosis</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35461781</ArticleId><ArticleId IdType="doi">10.1016/j.soard.2022.03.011</ArticleId><ArticleId IdType="pii">S1550-7289(22)00124-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29740001</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>May</Month><Day>08</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Predictors of In-Hospital Mortality among Patients with Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>7230</StartPage><MedlinePgn>7230</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7230</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-25409-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is uncertainty regarding which factors are associated with in-hospital mortality among patients with pulmonary TB (PTB). The aim of this systematic review and meta-analysis is to identify predictors of in-hospital mortality among patients with PTB.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE, EMBASE, and Global Health, for cohort and case-control studies that reported risk factors for in-hospital mortality in PTB. We pooled all factors that were assessed for an association, and presented relative associations as pooled odds ratios (ORs).</AbstractText><AbstractText Label="RESULTS">We identified 2,969 records, of which we retrieved 51 in full text; 11 cohort studies that evaluated 5,468 patients proved eligible. Moderate quality evidence suggested an association with co-morbid malignancy and in-hospital mortality (OR 1.85; 95%&#x2009;CI 1.01-3.40). Low quality evidence showed no association with positive sputum smear (OR 0.99; 95%&#x2009;CI 0.40-2.48), or male sex (OR 1.09, 95%&#x2009;CI 0.84-1.41), and very low quality evidence showed no association with diabetes mellitus (OR 1.31, 95%&#x2009;IC 0.38-4.46), and previous TB infection (OR 2.66, 95%&#x2009;CI 0.48-14.87).</AbstractText><AbstractText Label="CONCLUSION">Co-morbid malignancy was associated with increased risk of in-hospital death among pulmonary TB patients. There is insufficient evidence to confirm positive sputum smear, male sex, diabetes mellitus, and previous TB infection as predictors of in-hospital mortality in TB patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Almeida</LastName><ForeName>Carlos Podalirio Borges</ForeName><Initials>CPB</Initials><AffiliationInfo><Affiliation>Respiratory Sciences Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegelmann</LastName><ForeName>Patr&#xed;cia Klarmann</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Statistics Department and Postgraduate Program in Epidemiology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couban</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busse</LastName><ForeName>Jason Walter</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-0178-8712</Identifier><AffiliationInfo><Affiliation>Departments of Anesthesia and Health Research Methods, Evidence and Impact, and The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Denise Rossato</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0003-0230-2734</Identifier><AffiliationInfo><Affiliation>Pulmonology Division, Faculty of Medicine, Universidade Federal do Rio Grande do Sul; Hospital de Cl&#xed;nicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil. denise.rossato@terra.com.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Sciences Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. denise.rossato@terra.com.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013183" MajorTopicYN="N">Sputum</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29740001</ArticleId><ArticleId IdType="pmc">PMC5940698</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-25409-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-25409-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alavi-Naini R, Moghtaderi A, Metanat M, Mohammadi M, Zabetian M. Factors associated with mortality in tuberculosis patients. J Res Med Sci. 2013;18(1):52&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3719227</ArticleId><ArticleId IdType="pubmed">23901338</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque G, et al. Prognostic factors in tuberculosis related mortalities in hospitalized patients. Tuberc Res Treat. 2014;2014:624671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033512</ArticleId><ArticleId IdType="pubmed">24895532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57&#x2013;72. doi: 10.1016/S0140-6736(10)62173-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)62173-3</ArticleId><ArticleId IdType="pubmed">21420161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubart E, Lidgi M, Leibovitz A, Rabinovitz C, Segal R. Mortality of patients hospitalized for active tuberculosis in Israel. Isr Med Assoc J. 2007;9(12):870&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pubmed">18210928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui G, et al. High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting. PLoS One. 2014;9(3):e92077. doi: 10.1371/journal.pone.0092077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092077</ArticleId><ArticleId IdType="pmc">PMC3958438</ArticleId><ArticleId IdType="pubmed">24642794</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva DR, Menegotto DM, Schulz LF, Gazzana MB, Dalcin PT. Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis. Lung. 2010;188(1):33&#x2013;41. doi: 10.1007/s00408-009-9224-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-009-9224-9</ArticleId><ArticleId IdType="pubmed">20131479</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Global Tuberculosis Report 2015. Geneva: World Health Organization. Available at: www.who.int (2015).</Citation></Reference><Reference><Citation>Silva DR, Silva LP, Dalcin PT. Tuberculosis in hospitalized patients: clinical characteristics of patients receiving treatment within the first 24 h after admission. J Bras Pneumol. 2014;40(3):279&#x2013;285. doi: 10.1590/S1806-37132014000300011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1806-37132014000300011</ArticleId><ArticleId IdType="pmc">PMC4109200</ArticleId><ArticleId IdType="pubmed">25029651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreeramareddy CT, Panduru KV, Menten J, Van, den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis. 2009;9:91. doi: 10.1186/1471-2334-9-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-9-91</ArticleId><ArticleId IdType="pmc">PMC2702369</ArticleId><ArticleId IdType="pubmed">19519917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel NN, Merriman B, Haponik EF, Diette GB. Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality. Chest. 2004;126(4):1079&#x2013;1086. doi: 10.1378/chest.126.4.1079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.126.4.1079</ArticleId><ArticleId IdType="pubmed">15486367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel NN, Wu AW, Chang B, Diette GB. Quality of life in tuberculosis: patient and provider perspectives. Qual Life Res. 2004;13(3):639&#x2013;652. doi: 10.1023/B:QURE.0000021317.12945.f0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:QURE.0000021317.12945.f0</ArticleId><ArticleId IdType="pubmed">15130027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998;114(5):1244&#x2013;1252. doi: 10.1378/chest.114.5.1244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.114.5.1244</ArticleId><ArticleId IdType="pubmed">9823996</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton L, et al. Long-term hospitalization for tuberculosis control. Experience with a medical-psychosocial inpatient unit. JAMA. 1997;278(10):838&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pubmed">9293992</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenaway C, et al. Delay in diagnosis among hospitalized patients with active tuberculosis&#x2013;predictors and outcomes. Am J Respir Crit Care Med. 2002;165(7):927&#x2013;933. doi: 10.1164/ajrccm.165.7.2107040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.165.7.2107040</ArticleId><ArticleId IdType="pubmed">11934716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. The impact of nutritional deficit on mortality of in-patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2010;14(1):79&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">20003699</ArticleId></ArticleIdList></Reference><Reference><Citation>Faurholt-Jepsen D, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Trop Med Int Health. 2013;18(7):822&#x2013;829. doi: 10.1111/tmi.12120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.12120</ArticleId><ArticleId IdType="pubmed">23648145</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed GW, et al. Impact of diabetes and smoking on mortality in tuberculosis. PLoS One. 2013;8(2):e58044. doi: 10.1371/journal.pone.0058044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058044</ArticleId><ArticleId IdType="pmc">PMC3585219</ArticleId><ArticleId IdType="pubmed">23469139</ArticleId></ArticleIdList></Reference><Reference><Citation>Workneh MH, Bjune GA, Yimer SA. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia. Infect Dis Poverty. 2016;5(1):22. doi: 10.1186/s40249-016-0115-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-016-0115-z</ArticleId><ArticleId IdType="pmc">PMC4806519</ArticleId><ArticleId IdType="pubmed">27009088</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes CB, Hausler H, Nunn P. A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis. 1998;2(2):96&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">9562118</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss MG, Sommerfeld J, Uplekar MW. Social and cultural dimensions of gender and tuberculosis. Int J Tuberc Lung Dis. 2008;12(7):829&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">18544212</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, Bernabe-Ortiz A. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PLoS One. 2015;10(3):e0119332. doi: 10.1371/journal.pone.0119332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119332</ArticleId><ArticleId IdType="pmc">PMC4366185</ArticleId><ArticleId IdType="pubmed">25790076</ArticleId></ArticleIdList></Reference><Reference><Citation>de Faria Gomes NM, et al. Differences between Risk Factors Associated with Tuberculosis Treatment Abandonment and Mortality. Pulm Med. 2015;2015:546106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639647</ArticleId><ArticleId IdType="pubmed">26600948</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepper DJ, Schomaker M, Wilkinson RJ, de AV, Maartens G. Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study. AIDS Res Ther. 2015;12:35. doi: 10.1186/s12981-015-0076-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12981-015-0076-5</ArticleId><ArticleId IdType="pmc">PMC4596495</ArticleId><ArticleId IdType="pubmed">26448780</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng JY, et al. Initial presentations predict mortality in pulmonary tuberculosis patients&#x2013;a prospective observational study. PLoS One. 2011;6(9):e23715. doi: 10.1371/journal.pone.0023715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023715</ArticleId><ArticleId IdType="pmc">PMC3172202</ArticleId><ArticleId IdType="pubmed">21931610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CH, et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis. 2014;14:5. doi: 10.1186/1471-2334-14-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-5</ArticleId><ArticleId IdType="pmc">PMC3890594</ArticleId><ArticleId IdType="pubmed">24387757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pina JM, et al. [Excess mortality due to tuberculosis and factors associated to death in and annual cohort of patients diagnosed of tuberculosis] Rev Clin Esp. 2006;206(11):560&#x2013;565. doi: 10.1016/S0014-2565(06)72897-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-2565(06)72897-1</ArticleId><ArticleId IdType="pubmed">17265572</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida CP, et al. Predictors of in-hospital mortality among patients with pulmonary tuberculosis: a protocol of systematic review and meta-analysis of observational studies. BMJ Open. 2016;6(11):e011957. doi: 10.1136/bmjopen-2016-011957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-011957</ArticleId><ArticleId IdType="pmc">PMC5168525</ArticleId><ArticleId IdType="pubmed">27884842</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159&#x2013;174. doi: 10.2307/2529310.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2529310</ArticleId><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Ottawa Hospital Research Institute. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (2016).</Citation></Reference><Reference><Citation>Rucker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:79. doi: 10.1186/1471-2288-8-79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-8-79</ArticleId><ArticleId IdType="pmc">PMC2648991</ArticleId><ArticleId IdType="pubmed">19036172</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088&#x2013;1101. doi: 10.2307/2533446.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2533446</ArticleId><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins D, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. doi: 10.1136/bmj.328.7454.1490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.328.7454.1490</ArticleId><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, et al. GRADE guidelines: 4. Rating the quality of evidence&#x2013;study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">21247734</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, et al. GRADE guidelines 6. Rating the quality of evidence&#x2013;imprecision. J Clin Epidemiol. 2011;64(12):1283&#x2013;1293. doi: 10.1016/j.jclinepi.2011.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.01.012</ArticleId><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, et al. GRADE guidelines: 7. Rating the quality of evidence&#x2013;inconsistency. J Clin Epidemiol. 2011;64(12):1294&#x2013;1302. doi: 10.1016/j.jclinepi.2011.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.03.017</ArticleId><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, et al. GRADE guidelines: 5. Rating the quality of evidence&#x2013;publication bias. J Clin Epidemiol. 2011;64(12):1277&#x2013;1282. doi: 10.1016/j.jclinepi.2011.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.01.011</ArticleId><ArticleId IdType="pubmed">21802904</ArticleId></ArticleIdList></Reference><Reference><Citation>Erbes R, et al. Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J. 2006;27(6):1223&#x2013;1228. doi: 10.1183/09031936.06.00088105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.06.00088105</ArticleId><ArticleId IdType="pubmed">16481385</ArticleId></ArticleIdList></Reference><Reference><Citation>Horita N, et al. Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan. Int J Tuberc Lung Dis. 2013;17(1):54&#x2013;60. doi: 10.5588/ijtld.12.0476.</Citation><ArticleIdList><ArticleId IdType="doi">10.5588/ijtld.12.0476</ArticleId><ArticleId IdType="pubmed">23232005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CW, et al. Risk factors related with mortality in patient with pulmonary tuberculosis. Tuberc Respir Dis (Seoul) 2012;73(1):38&#x2013;47. doi: 10.4046/trd.2012.73.1.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.4046/trd.2012.73.1.38</ArticleId><ArticleId IdType="pmc">PMC3475478</ArticleId><ArticleId IdType="pubmed">23101023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PL, et al. Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation. Eur Respir J. 2003;22(1):141&#x2013;147. doi: 10.1183/09031936.03.00038703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.03.00038703</ArticleId><ArticleId IdType="pubmed">12882464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SM, et al. Predictive factors for mortality among non-HIV-infected patients with pulmonary tuberculosis and respiratory failure. Int J Tuberc Lung Dis. 2009;13(3):335&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">19275793</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura K, et al. Hypoalbuminemia and lymphocytopenia are predictive risk factors for in-hospital mortality in patients with tuberculosis. Intern Med. 2013;52(4):439&#x2013;444. doi: 10.2169/internalmedicine.52.8158.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.52.8158</ArticleId><ArticleId IdType="pubmed">23411698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu YJ, et al. Prognostic factors in pulmonary tuberculosis requiring mechanical ventilation for acute respiratory failure. Respirology. 2007;12(3):406&#x2013;411. doi: 10.1111/j.1440-1843.2006.01007.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2006.01007.x</ArticleId><ArticleId IdType="pubmed">17539846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Fang K, Ren DH, Sheng XL. [A study of the prognostic factors associated with mortality in critically ill patients with tuberculous] Zhonghua Jie He He Hu Xi Za Zhi. 2011;34(1):39&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">21429418</ArticleId></ArticleIdList></Reference><Reference><Citation>Who. World Health Organization. Global Tuberculosis Programme. A framework for effective tuberculosis control. WHO/TB/94. 179. Geneva, Switzerland. Available at: www.who.int (1994).</Citation></Reference><Reference><Citation>Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42(11):1592&#x2013;1595. doi: 10.1086/503917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/503917</ArticleId><ArticleId IdType="pubmed">16652317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HR, et al. Solid-organ malignancy as a risk factor for tuberculosis. Respirology. 2008;13(3):413&#x2013;419. doi: 10.1111/j.1440-1843.2008.01282.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2008.01282.x</ArticleId><ArticleId IdType="pubmed">18399865</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva FA, Matos JO, de QMF, Nucci M. Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica. 2005;90(8):1110&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">16079111</ArticleId></ArticleIdList></Reference><Reference><Citation>Balabanova Y, et al. The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res. 2006;7:44. doi: 10.1186/1465-9921-7-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-7-44</ArticleId><ArticleId IdType="pmc">PMC1440858</ArticleId><ArticleId IdType="pubmed">16556324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewan PK, et al. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis. 2004;8(5):598&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">15137537</ArticleId></ArticleIdList></Reference><Reference><Citation>Naalsund A, Heldal E, Johansen B, Kongerud J, Boe J. Deaths from pulmonary tuberculosis in a low-incidence country. J Intern Med. 1994;236(2):137&#x2013;142. doi: 10.1111/j.1365-2796.1994.tb01275.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.1994.tb01275.x</ArticleId><ArticleId IdType="pubmed">8046312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35917847</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative fluid balance and cardiac surgery-associated acute kidney injury: a multicenter prospective study.</ArticleTitle><Pagination><StartPage>688</StartPage><EndPage>694</EndPage><MedlinePgn>688-694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2022.07.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(22)00089-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recent data suggest the regime of fluid therapy intraoperatively in patients undergoing major surgeries may interfere in patient outcomes. The development of postoperative Acute Kidney Injury (AKI) has been associated with both Restrictive Fluid Balance (RFB) and Liberal Fluid Balance (LFB) during non-cardiac surgery. In patients undergoing cardiac surgery, this influence remains unclear. The study objective was to evaluate the relationship between intraoperative RFB vs. LFB and the incidence of Cardiac-Surgery-Associated AKI (CSA-AKI) and major postoperative outcomes in patients undergoing on-pump Coronary Artery Bypass Grafting (CABG).</AbstractText><AbstractText Label="METHODS">This prospective, multicenter, observational cohort study was set at two high-complexity university hospitals in Brazil. Adult patients who required postoperative intensive care after undergoing elective on-pump CABG were allocated to two groups according to their intraoperative fluid strategy (RFB or LFB) with no intervention.</AbstractText><AbstractText Label="RESULTS">The primary endpoint was CSA-AKI. The secondary outcomes were in-hospital mortality, cardiovascular complications, ICU Length of Stay (ICU-LOS), and Hospital LOS (H-LOS). After propensity score matching, 180 patients remained in each group. There was no difference in risk of CSA-AKI between the two groups (RR&#xa0;=&#xa0;1.15; 95% CI, 0.85-1.56, p&#xa0;=&#xa0;0.36). The in-hospital mortality, H-LOS and cardiovascular complications were higher in the LFB group. ICU-LOS was not significantly different between the two groups. ROCcurve analysis determined a fluid balance above 2500 mL to accurately predict in-hospital mortality.</AbstractText><AbstractText Label="CONCLUSION">Patients undergoing on-pump CABG with LFB when compared with patients with RFB present similar CSA-AKI rates and ICU-LOS, but higher in-hospital mortality, cardiovascular complications, and H-LOS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palomba</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hospital Alem&#xe3;o Oswaldo Cruz, Departamento de Medicina Intensiva, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treml</LastName><ForeName>Ricardo E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Friedrich-Schiller-University, Department of Anaesthesiology and Intensive Care Medicine, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldonazo</LastName><ForeName>Tulio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Friedrich-Schiller-University, Department of Cardiothoracic Surgery, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Henrique T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Departamento de Anestesiologia, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Brenno C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Universidade Federal do Paran&#xe1;, Departamento de Medicina Integrada, Setor de Ci&#xea;ncias da Sa&#xfa;de, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbouisson</LastName><ForeName>Luiz M S</ForeName><Initials>LMS</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Departamento de Anestesiologia, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva Junior</LastName><ForeName>Jo&#xe3;o Manoel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Departamento de Anestesiologia, S&#xe3;o Paulo, SP, Brazil. Electronic address: joao.s@usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014882" MajorTopicYN="N">Water-Electrolyte Balance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword></KeywordList><CoiStatement>Conflicts of interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35917847</ArticleId><ArticleId IdType="pmc">PMC9659999</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2022.07.006</ArticleId><ArticleId IdType="pii">S0104-0014(22)00089-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative Acute Kidney Injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant J-Y, Guinot P-G, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318:1346&#x2013;1357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M, Green J, Spiess B, et al. Measurement of blood loss in cardiac surgery: still too much. Ann Thorac Surg. 2018;105:1176&#x2013;1181.</Citation><ArticleIdList><ArticleId IdType="pubmed">29506777</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TE, Myles PS. Perioperative fluid therapy for major surgery. Anesthesiology. 2019;130:825&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">30789364</ArticleId></ArticleIdList></Reference><Reference><Citation>Corredor C, Thomson R, Al-Subaie N. Long-Term Consequences of acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">26482483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M, Riou B. Cardiopulmonary bypass&#x2013;associated acute kidney injury. Anesthesiology. 2011;114:964&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">21394005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Yared JP, Worley S, Cotman K, Paganini EP. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64:239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">12787415</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Robba C, Calabr&#xf2; L, et al. Perioperative liberal versus restrictive fluid strategies and postoperative outcomes: a systematic review and metanalysis on randomised-controlled trials in major abdominal elective surgery. Crit Care. 2021;25:205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194047</ArticleId><ArticleId IdType="pubmed">34116707</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadhan KK, Lobo DN. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc. 2010;69:488&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">20515521</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. New Engl J Med. 2018;378:2263&#x2013;2274.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil VP, Salunke BG. Fluid overload and acute kidney injury. Indian J Crit Care Med. 2020;24(Suppl 3):S94&#x2013;SS7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347067</ArticleId><ArticleId IdType="pubmed">32704211</ArticleId></ArticleIdList></Reference><Reference><Citation>Osawa EA, Rhodes A, Landoni G, et al. Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: a randomized clinical trial and systematic review. Crit Care Med. 2016;44:724&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">26646462</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(1):S31&#x2013;SS4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398292</ArticleId><ArticleId IdType="pubmed">30930717</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman M, Stamler A, Sahar G, et al. Validation of the 2000 Bernstein-Parsonnet score versus the EuroSCORE as a prognostic tool in cardiac surgery. Ann Thorac Surg. 2006;81:537&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">16427846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon JW. Hemorrhagic Shock. New Engl J Med. 2018;378:370&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">29365303</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JM, Jr, de Oliveira AM, Nogueira FA, et al. The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care. 2013;17:R288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057181</ArticleId><ArticleId IdType="pubmed">24326085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease KDIGO. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of acute kidney disease. Kidney Int. 2012;2:1&#x2013;141.</Citation></Reference><Reference><Citation>Miller TE, Roche AM, Mythen M. Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery (ERAS) Can J Anaesth. 2015;62:158&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">25391735</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Hernandez A, Parramon F, et al. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019;12:153&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612286</ArticleId><ArticleId IdType="pubmed">31303781</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Loubon C, Fern&#xe1;ndez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016;19:687&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070330</ArticleId><ArticleId IdType="pubmed">27716701</ArticleId></ArticleIdList></Reference><Reference><Citation>Protsyk V, Rasmussen BS, Guarracino F, Erb J, Turton E, Ender J. Fluid Management in cardiac surgery: results of a survey in european cardiac anesthesia departments. J Cardiothorac Vasc Anesth. 2017;31:1624&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pubmed">28778778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettig TCD, Peelen LM, Geuzebroek GSC, et al. Impact of intraoperative hypotension during cardiopulmonary bypass on acute kidney injury after coronary artery bypass grafting. J Cardioth Vasc Anesth. 2017;31:522&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">27727080</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc V, Delmas Benito L, de With E, Boerma EC. The effect of fluid overload on attributable morbidity after cardiac surgery: a retrospective study. Crit Care Res Pract. 2020;2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787830</ArticleId><ArticleId IdType="pubmed">33489370</ArticleId></ArticleIdList></Reference><Reference><Citation>Inkinen N, Pettil&#xe4; V, Lakkisto P, et al. Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: data from the FINNAKI observational study. Annals Intensive Care. 2019;9:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738365</ArticleId><ArticleId IdType="pubmed">31512003</ArticleId></ArticleIdList></Reference><Reference><Citation>Toraman F, Evrenkaya S, Yuce M, et al. Highly positive intraoperative fluid balance during cardiac surgery is associated with adverse outcome. Perfusion. 2004;19:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">15162922</ArticleId></ArticleIdList></Reference><Reference><Citation>Vretzakis G, Kleitsaki A, Stamoulis K, et al. Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial. J Cardioth Surg. 2010;5:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2845571</ArticleId><ArticleId IdType="pubmed">20181257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassinger AB, Wald EL, Goodman DM. Early postoperative fluid overload precedes acute kidney injury and is associated with higher morbidity in pediatric cardiac surgery patients. Pediatr Crit Care Med. 2014;15:131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">24366508</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein A, de Souza LV, Belettini CR, et al. Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. A prospective cohort study. Crit Care. 2012;16:R99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580649</ArticleId><ArticleId IdType="pubmed">22651844</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">20027192</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston WE. PRO: Fluid restriction in cardiac patients for noncardiac surgery is beneficial. Anesth Analg. 2006;102:340&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">16428518</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37605953</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-2035</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiovascular medicine (Hagerstown, Md.)</Title><ISOAbbreviation>J Cardiovasc Med (Hagerstown)</ISOAbbreviation></Journal><ArticleTitle>Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications.</ArticleTitle><Pagination><StartPage>612</StartPage><EndPage>624</EndPage><MedlinePgn>612-624</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2459/JCM.0000000000001533</ELocationID><Abstract><AbstractText Label="AIMS">To know the prevalence of atrial fibrillation (AF), as well as the incidence of postoperative AF (POAF) in vascular surgery for arterial diseases and its outcome implications.</AbstractText><AbstractText Label="METHODS">We performed a systematic review and meta-analysis following the PRISMA statement.</AbstractText><AbstractText Label="RESULTS">After the selection process, we analyzed 44 records (30 for the prevalence of AF history and 14 for the incidence of POAF).The prevalence of history of AF was 11.5% [95% confidence interval (CI) 1-13.3] with high heterogeneity (I2&#x200a;=&#x200a;100%). Prevalence was higher in the case of endovascular procedures. History of AF was associated with a worse outcome in terms of in-hospital death [odds ratio (OR) 3.29; 95% CI 2.66-4.06; P&#x200a;&lt;&#x200a;0.0001; I2 94%] or stroke (OR 1.61; 95% CI 1.39-1.86; P&#x200a;&lt;&#x200a;0.0001; I2 91%).The pooled incidence of POAF was 3.6% (95% CI 2-6.4) with high heterogeneity (I2&#x200a;=&#x200a;100%). POAF risk was associated with older age (mean difference 4.67&#x200a;years, 95% CI 2.38-6.96; P&#x200a;=&#x200a;0.00007). The risk of POAF was lower in patients treated with endovascular procedures as compared with an open surgical procedure (OR 0.35; 95% CI 0.13-0.91; P&#x200a;=&#x200a;0.03; I2&#x200a;=&#x200a;61%).</AbstractText><AbstractText Label="CONCLUSIONS">In the setting of vascular surgery for arterial diseases a history of AF is found overall in 11.5% of patients, more frequently in the case of endovascular procedures, and is associated with worse outcomes in terms of short-term mortality and stroke.The incidence of POAF is overall 3.6%, and is lower in patients treated with an endovascular procedure as compared with open surgery procedures. The need for oral anticoagulants for preventing AF-related stroke should be evaluated with randomized clinical trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Italian Federation of Cardiology - I.F.C. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malavasi</LastName><ForeName>Vincenzo L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muto</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceresoli</LastName><ForeName>Pietro A C M</ForeName><Initials>PACM</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menozzi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righelli</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerra</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitolo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imberti</LastName><ForeName>Jacopo F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Davide A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonini</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargiulo</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Department of Medical and Surgical Sciences, University of Bologna.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vascular Surgery Unit, IRCCS University Hospital Policlinico S. Orsola, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boriani</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Med (Hagerstown)</MedlineTA><NlmUniqueID>101259752</NlmUniqueID><ISSNLinking>1558-2027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>G.B.: small speaker's fees from Bayer, Boehringer Ingelheim, Boston, Daiichi-Sankyo, Janssen and Sanofi, not related with the current work. The other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37605953</ArticleId><ArticleId IdType="pmc">PMC10754485</ArticleId><ArticleId IdType="doi">10.2459/JCM.0000000000001533</ArticleId><ArticleId IdType="pii">01244665-202309000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maisano A, Vitolo M, Imberti JF, et al. . Atrial fibrillation in the setting of acute pneumonia: not a secondary arrhythmia. Rev Cardiovasc Med 2022; 23:176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11273968</ArticleId><ArticleId IdType="pubmed">39077611</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitolo M, Bonini N, Imberti JF, Boriani G. Atrial fibrillation in pneumonia: what clinical implications at long-term? Intern Emerg Med 2022; 23:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9780088</ArticleId><ArticleId IdType="pubmed">36550262</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrev D, Aguilar M, Heijman J, Guichard J-B, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019; 16:417&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">30792496</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A, Malavasi VL, Vitolo M, et al. . Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: a systematic review and metanalysis. Eur J Intern Med 2021; 85:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33402281</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Kim M, Krishnan U, et al. . others. Postoperative atrial fibrillation and risk of heart failure hospitalization. Eur Heart J 2022; 43:2971&#x2013;2980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9890619</ArticleId><ArticleId IdType="pubmed">35764099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gialdini G, Nearing K, Bhave PD, et al. . Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 2014; 312:616&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4277813</ArticleId><ArticleId IdType="pubmed">25117130</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldonazo T, Kirov H, Rahouma M, et al. . Atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2023; 165:94&#x2013;103. e24.</Citation><ArticleIdList><ArticleId IdType="pubmed">33952399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C. others. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42:373&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Marazzato J, Masnaghetti S, De Ponti R, et al. . Long-term survival in patients with post operative atrial fibrillation after cardiac surgery: analysis from a prospective cohort study. J Cardiovasc Dev Dis 2021; 8:169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8707624</ArticleId><ArticleId IdType="pubmed">34940524</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomani H, Mohammadpour AH, Reiner &#x17d;, Jamialahmadi T, Sahebkar A. Statin therapy in post-operative atrial fibrillation: focus on the anti-inflammatory effects. J Cardiovasc Dev Dis 2021; 8:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996747</ArticleId><ArticleId IdType="pubmed">33652637</ArticleId></ArticleIdList></Reference><Reference><Citation>Shvartz V, Le T, Kryukov Y, et al. . Colchicine for prevention of atrial fibrillation after cardiac surgery in the early postoperative period. J Clin Med 2022; 11:1387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8911341</ArticleId><ArticleId IdType="pubmed">35268478</ArticleId></ArticleIdList></Reference><Reference><Citation>Musa AF, Dillon J, Md Taib ME, et al. . Incidence and outcomes of postoperative atrial fibrillation after coronary artery bypass grafting of a randomized controlled trial: a blinded end-of-cycle analysis. Rev Cardiovasc Med 2022; 23:122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11273857</ArticleId><ArticleId IdType="pubmed">39076222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shvartz V, Le T, Enginoev S, et al. . Colchicine in cardiac surgery: the COCS randomized clinical trial. J Cardiovasc Dev Dis 2022; 9:363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9604685</ArticleId><ArticleId IdType="pubmed">36286314</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Peng X, Li Y, et al. . Colchicine for prevention of post-cardiac surgery and post-pulmonary vein isolation atrial fibrillation: a meta-analysis. Rev Cardiovasc Med 2022; 23:387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11270460</ArticleId><ArticleId IdType="pubmed">39076666</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostagno C, Cartei A, Rubbieri G, et al. . Postoperative atrial fibrillation is related to a worse outcome in patients undergoing surgery for hip fracture. Intern Emerg Med 2021; 16:333&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">32440983</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Dinnes J, D&#x2019;Amico R, et al. . Evaluating nonrandomised intervention studies. Health Technol Assessm 2003; 7:iii&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">14499048</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021.</Citation></Reference><Reference><Citation>R Studio Team. RStudio: Integrated development environment for r. Boston, MA: RStudio, PBC; 2020.</Citation></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid-Based Ment Health 2019; 22:153&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36:1&#x2013;48.</Citation></Reference><Reference><Citation>Tu JV, Wang H, Bowyer B, Green L, Fang J, Kucey D. Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario carotid endarterectomy registry. Stroke 2003; 34:2568&#x2013;2573.</Citation><ArticleIdList><ArticleId IdType="pubmed">14526040</ArticleId></ArticleIdList></Reference><Reference><Citation>Diepen S van, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation 2011; 124:289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">21709059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders RD, Bottle A, Jameson SS, et al. . Independent preoperative predictors of outcomes in orthopedic and vascular surgery: the influence of time interval between an acute coronary syndrome or stroke and the operation. Ann Surg 2012; 255:901&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">22504189</ArticleId></ArticleIdList></Reference><Reference><Citation>Harthun NL, Stukenborg GJ. Atrial fibrillation is associated with increased risk of perioperative stroke and death from carotid endarterectomy. J Vasc Surg 2010; 51:330&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">19879714</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao C-T, Tsai M-L, Wang C-Y, et al. . Outcomes and characteristics of patients undergoing percutaneous angioplasty followed by below-knee or above-knee amputation for peripheral artery disease. PLoS One 2014; 9:e111130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4212984</ArticleId><ArticleId IdType="pubmed">25354252</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Chaudhry SA, Qureshi MH, Suri MFK. Rates and predictors of 5-year survival in a national cohort of asymptomatic elderly patients undergoing carotid revascularization. Neurosurgery 2015; 76:34&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">25525692</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevilla N, Clara A, Diaz-Duran C, Ruiz-Carmona C, Iba&#xf1;ez S. Survival after endovascular abdominal aortic aneurysm repair in a population with a low incidence of coronary artery disease. World J Surg 2016; 40:1272&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">26711643</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiq F, Adil MM, Malik AA, Qureshi MH, Qureshi AI. Effect of carotid revascularization endarterectomy versus stenting trial results on the performance of carotid artery stent placement and carotid endarterectomy in the United States. Neurosurgery 2015; 77:726&#x2013;732. discussion 732.</Citation><ArticleIdList><ArticleId IdType="pubmed">26308633</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Chaudhry SA, Adil MM, et al. . The effect of atrial fibrillation on outcomes in patients undergoing carotid endarterectomy or stent placement in general practice. J Vasc Surg 2015; 61:927&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pubmed">25814367</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-L, Jimmy Juang J-M, Chou H-H, et al. . Immediate results and long-term cardiovascular outcomes of endovascular therapy in octogenarians and nonoctogenarians with peripheral arterial diseases. Clin Interv Aging 2016; 11:535&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4862757</ArticleId><ArticleId IdType="pubmed">27217735</ArticleId></ArticleIdList></Reference><Reference><Citation>Atti V, Nalluri N, Kumar V, et al. . Frequency of 30-day readmission and its causes after endovascular aneurysm intervention of abdominal aortic aneurysm (from the nationwide readmission database). Am J Cardiol 2019; 123:986&#x2013;994.</Citation><ArticleIdList><ArticleId IdType="pubmed">30598244</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-L, Tzeng I-S, Chou H-H, et al. . Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease. J Formosan Med Assoc 2020; 119:1052&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">31672435</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzaccaro D, Modafferi A, Malacrida G, Nano G. Assessment of long-term survival and stroke after carotid endarterectomy and carotid stenting in patients older than 80 years. J Vasc Surg 2019; 70:522&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">30837178</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussa Pacha H, Al-Khadra Y, Darmoch F, et al. . Comparison of in-hospital outcomes in patients having limb-revascularization with versus without atrial fibrillation. Am J Cardiol 2019; 124:1540&#x2013;1548.</Citation><ArticleIdList><ArticleId IdType="pubmed">31522770</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis PV, Lopes AI, Leite D, et al. . Major cardiac events in patients admitted to intensive care after vascular noncardiac surgery: a retrospective cohort. Semin Cardiothorac Vasc Anesth 2019; 23:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">30678531</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;cruz RT, Chong TT, Tan TF, et al. . The modified frailty index does not predict mortality after major lower extremity amputation for peripheral arterial disease in an Asian population. Ann Vasc Surg 2020; 69:298&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">32505677</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Cases C, G&#xf3;mez-Arbel&#xe1;ez D. Atrial fibrillation and surgical patients with peripheral arterial disease. Ann Vasc Surg 2020; 67:411&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">32209417</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejim B, Mathlouthi A, Weaver L, Faateh M, Arhuidese I, Malas MB. Safety of carotid artery revascularization procedures in patients with atrial fibrillation. J Vasc Surg 2020; 72:2069&#x2013;2078. e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32471737</ArticleId></ArticleIdList></Reference><Reference><Citation>Barenbrock H, Feld J, Lakomek A, et al. . Sex-related differences in outcome after endovascular revascularization for lower extremity artery disease: a single-centre analysis of a specialized vascular unit. Vasa 2022; 51:29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">34841885</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda Y, Hirano K, Yamawaki M, et al. . Atrial fibrillation is associated with femoropopliteal totally occlusive in-stent restenosis: a single-center, retrospective, observational study. J Interv Cardiol 2021; 2021:8852466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875648</ArticleId><ArticleId IdType="pubmed">33623483</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuki T, Yamaji K, Soga Y, et al. . New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication. Catheter Cardiovasc Interv 2021; 98:E395&#x2013;E402.</Citation><ArticleIdList><ArticleId IdType="pubmed">34019325</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomoi Y, Takahara M, Soga Y, et al. . Prognostic value of the CHA2DS2-VASc score after endovascular therapy for femoral popliteal artery lesions. J Atheroscler Thromb 2021; 28:1153&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592701</ArticleId><ArticleId IdType="pubmed">33487619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins BM, Kennedy KF, Giri J, et al. . Preprocedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE registry. J Am Coll Cardiol 2012; 60:1617&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pubmed">22999733</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S-H, Tsai Y-J, Chou H-H, et al. . Clinical predictors of long-term outcomes in patients with critical limb ischemia who have undergone endovascular therapy. Angiology 2014; 65:315&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">24357434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata T, Inoue T, Okada Y. Outcome of 312 Japanese patients with carotid endarterectomy and factors associated with cardiovascular events: a single-center study in Japan. J Stroke Cerebrovasc Dis 2014; 23:529&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">23721616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralevic S, Perunicic J, Lasica R, et al. . Prognostic significance of atrial fibrillation in lower limb amputee patients. Eur J Vasc Endovasc Surg 2016; 52:823&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">27789143</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrendt C-A, Heidemann F, Haustein K, Grundmann R, Debus E. Percutaneous endovascular treatment of infrainguinal PAOD. Gef&#xe4;sschirurgie 2017; 22:17&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5306226</ArticleId><ArticleId IdType="pubmed">28715513</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashitani M, Uemura Y, Mizuno A, et al. . Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease: short-term results of the TOMA-code registry. Circ J 2018; 82:1917&#x2013;1925.</Citation><ArticleIdList><ArticleId IdType="pubmed">29760308</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis P, Lopes AI, Leite D, et al. . Incidence, predictors and validation of risk scores to predict postoperative mortality after noncardiac vascular surgery, a prospective cohort study. Int J Surg 2020; 73:89&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">31843678</ArticleId></ArticleIdList></Reference><Reference><Citation>Peri&#x107; VS, Golubovi&#x107; MD, Lazarevi&#x107; MV, et al. . Predictive potential of biomarkers and risk scores for major adverse cardiac events in elderly patients undergoing major elective vascular surgery. Rev Cardiovasc Med 2021; 22:1053&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pubmed">34565107</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N, Jenkins J, Andrews G, Walker P. Using postoperative cardiac troponin-i (cTi) levels to detect myocardial ischaemia in patients undergoing vascular surgery. Cardiovasc Surg 2001; 9:254&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">11336849</ArticleId></ArticleIdList></Reference><Reference><Citation>Perzanowski C, Gandhi S, Pai RG. Incidence and predictors of atrial fibrillation after aortic repairs. Am J Cardiol 2004; 93:928&#x2013;930.</Citation><ArticleIdList><ArticleId IdType="pubmed">15050502</ArticleId></ArticleIdList></Reference><Reference><Citation>Feringa HHH, Karagiannis S, Vidakovic R, et al. . Comparison of the incidences of cardiac arrhythmias, myocardial ischemia, and cardiac events in patients treated with endovascular versus open surgical repair of abdominal aortic aneurysms. Am J Cardiol 2007; 100:1479&#x2013;1484.</Citation><ArticleIdList><ArticleId IdType="pubmed">17950812</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkel TA, Schouten O, Hoeks SE, Verhagen HJM, Bax JJ, Poldermans D. Prognosis of transient new-onset atrial fibrillation during vascular surgery. Eur J Vasc Endovasc Surg 2009; 38:683&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">19683947</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkel TA, Schouten O, Hoeks SE, et al. . Risk factors and outcome of new-onset cardiac arrhythmias in vascular surgery patients. Am Heart J 2010; 159:1108&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">20569727</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Coello P, Cook D, Xu SC, et al. . Predictors, prognosis, and management of new clinically important atrial fibrillation after noncardiac surgery: a prospective cohort study. Anesth Analg 2017; 125:162&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">28622175</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubovic M, Peric V, Stanojevic D, et al. . Potential new approaches in predicting adverse cardiac events one month after major vascular surgery. Med Princ Pract 2019; 28:63&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6558343</ArticleId><ArticleId IdType="pubmed">30391950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarevi&#x107; M, Golubovi&#x107; M, Mili&#x107; D, et al. . Preoperative levels of the soluble urokinase-type plasminogen activator receptor as predictor for new episodes of atrial fibrillation after vascular surgery. Vasc Endovasc Surg 2021; 55:461&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">33622185</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine RJ, Rosen SF, Cigarroa JE, Jackson MR, Modrall JG, Clagett GP. The clinical course of new-onset atrial fibrillation after elective aortic operations. J Am Coll Surg 2001; 193:499&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">11708506</ArticleId></ArticleIdList></Reference><Reference><Citation>Noorani A, Walsh SR, Tang TY, et al. . Atrial fibrillation following elective open abdominal aortic aneurysm repair. Int J Surg 2009; 7:24&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">19042165</ArticleId></ArticleIdList></Reference><Reference><Citation>Sposato LA, Su&#xe1;rez A, J&#xe1;uregui A, et al. . Intraoperative hypotension, new onset atrial fibrillation, and adverse outcome after carotid endarterectomy. J Neurol Sci 2011; 309:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21855089</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 2012; 164:918&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096141</ArticleId><ArticleId IdType="pubmed">23194493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothari AN, Halandras PM, Drescher M, et al. . Transient postoperative atrial fibrillation after abdominal aortic aneurysm repair increases mortality risk. J Vasc Surg 2016; 63:1240&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5110229</ArticleId><ArticleId IdType="pubmed">27005752</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco BA, Kothari AN, Halandras PM, et al. . Transient atrial fibrillation after open abdominal aortic revascularization surgery is associated with increased length of stay, mortality, and readmission rates. J Vasc Surg 2017; 66:413&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">28190713</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister F, Jacka M, Graham M, et al. . The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing noncardiac surgery: a VISION sub-study. J Thromb Haemost 2015; 13:1768&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">26270168</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MS, Lee CH, Kim J, et al. . Clinical implications of preoperative nonvalvular atrial fibrillation with respect to postoperative cardiovascular outcomes in patients undergoing noncardiac surgery. Korean Circ J 2020; 50:148&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6974665</ArticleId><ArticleId IdType="pubmed">31845556</ArticleId></ArticleIdList></Reference><Reference><Citation>So WZ, Tan FL, Tan DJH, et al. . A systematic review and meta-analysis on the impact of preexisting and new-onset atrial fibrillation on outcomes before and after liver transplantation. Digest Liver Dis 2022; 54:614&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">34896025</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrsalovi&#x107; M, Prese&#x10d;ki AV. Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: a meta-analysis of prospective studies. Clin Cardiol 2017; 40:1231&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6490667</ArticleId><ArticleId IdType="pubmed">29243858</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister F, Youngson E, Jacka M, Devereaux P. Investigators vascular events in noncardiac surgery patients cohort evaluation (VISION). A comparison of four risk models for the prediction of cardiovascular complications in patients with a history of atrial fibrillation undergoing noncardiac surgery. Anaesthesia 2020; 75:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">31282570</ArticleId></ArticleIdList></Reference><Reference><Citation>Anandasundaram B, Lane D, Apostolakis S, Lip G. The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. J Thromb Haemost 2013; 11:975&#x2013;987.</Citation><ArticleIdList><ArticleId IdType="pubmed">23441593</ArticleId></ArticleIdList></Reference><Reference><Citation>Boriani G, Vitolo M, Diemberger I, et al. . Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc Res 2021; 117:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8707734</ArticleId><ArticleId IdType="pubmed">33913486</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitolo M, Proietti M, Shantsila A, Boriani G, Lip GYH. Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes. Biomedicines 2021; 9:843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8301818</ArticleId><ArticleId IdType="pubmed">34356907</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou GA, Chalmers N, Georgiadis GS, et al. . A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013; 57:242&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">23159476</ArticleId></ArticleIdList></Reference><Reference><Citation>Boriani G, Vitolo M, Lane DA, Potpara TS, Lip GY. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. Eur J Intern Med 2021; 86:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">33518403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolben Y, Kessler A, Puris G, et al. . Management of heart failure with reduced ejection fraction: challenges in patients with atrial fibrillation, renal disease and in the elderly. Rev Cardiovasc Med 2022; 23:16.</Citation><ArticleIdList><ArticleId IdType="pubmed">35092208</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt JH, Olesen JB, Havers-Borgersen E, et al. . Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery. J Am Coll Cardiol 2018; 72:2027&#x2013;2036.</Citation><ArticleIdList><ArticleId IdType="pubmed">30336826</ArticleId></ArticleIdList></Reference><Reference><Citation>Chebbout R, Heywood EG, Drake TM, et al. . A systematic review of the incidence of and risk factors for postoperative atrial fibrillation following general surgery. Anaesthesia 2018; 73:490&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">29105078</ArticleId></ArticleIdList></Reference><Reference><Citation>Halvorsen S, Mehilli J, Cassese S, et al. . ESC Scientific Document Group. ESC Guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery: developed by the task force for cardiovascular assessment and management of patients undergoing noncardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC). Eur Heart J 2022; 43:3826&#x2013;3924.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019; 16:417&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">30792496</ArticleId></ArticleIdList></Reference><Reference><Citation>Boriani G, Diemberger I, Martignani C, Biffi M, Branzi A. The epidemiological burden of atrial fibrillation: a challenge for clinicians and healthcare systems. Eur Heart J 2006; 27:893&#x2013;894.</Citation><ArticleIdList><ArticleId IdType="pubmed">16543253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun J, Cho MS, Nam GB, et al. . Natural course of new-onset postoperative atrial fibrillation after noncardiac surgery. J Am Heart Assoc 2021; 10:e018548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8174377</ArticleId><ArticleId IdType="pubmed">33739130</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Hulme OL, Khurshid S, et al. . Initial precipitants and recurrence of atrial fibrillation. Circ Arrhythm Electrophysiol 2020; 13:e007716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7141776</ArticleId><ArticleId IdType="pubmed">32078361</ArticleId></ArticleIdList></Reference><Reference><Citation>Boriani G, Vitolo M, Imberti JF. Atrial fibrillation postcoronary or cardiac surgery: a transient inflammation-related event or the expression of a preexisting arrhythmogenic atrial substrate? Kardiol Pol 2022; 80:877&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pubmed">36062931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufano A, Lancellotti P. Atrial cardiomyopathy: pathophysiology and clinical implications. Eur J Intern Med 2022; 101:29&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">35288030</ArticleId></ArticleIdList></Reference><Reference><Citation>Maesen B, Verheule S, Zeemering S, et al. . Endomysial fibrosis, rather than overall connective tissue content, is the main determinant of conduction disturbances in human atrial fibrillation. Europace 2022; 24:1015&#x2013;1024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9282911</ArticleId><ArticleId IdType="pubmed">35348667</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichenlaub M, Mueller-Edenborn B, Minners J, et al. . Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation mapping for detection of atrial cardiomyopathy. Europace 2022; 24:1102&#x2013;1111.</Citation><ArticleIdList><ArticleId IdType="pubmed">35298612</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaakkola S, Paana T, Airaksinen J, Sipil&#xe4; J, Kyt&#xf6; V. Association of CHA2DS2-VASc score with long-term incidence of new-onset atrial fibrillation and ischemic stroke after myocardial infarction. J Clin Med 2022; 11:7090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9739941</ArticleId><ArticleId IdType="pubmed">36498665</ArticleId></ArticleIdList></Reference><Reference><Citation>Renda G, Ricci F, Patti G, et al. . CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation. Eur J Prev Cardiol 2019; 26:1987&#x2013;1997.</Citation><ArticleIdList><ArticleId IdType="pubmed">31409109</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmelreich JCL, Veelers L, Lucassen WAM, et al. . Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis. Europace 2020; 22:684&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7526764</ArticleId><ArticleId IdType="pubmed">32011689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G, Potpara T, Dagres N, et al. . ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42:373&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Imberti JF, Mei DA, Vitolo M, et al. . Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. Eur J Intern Med 2022; 101:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35525635</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Parekh S, Hooper L, et al. . Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010; 14:iii, ix&#x2013;xi, 1&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">20181324</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds M. Quantifying the risk of error when interpreting funnel plots. Syst Rev 2015; 4:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4460648</ArticleId><ArticleId IdType="pubmed">25875027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29019011</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-6713</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>General thoracic and cardiovascular surgery</Title><ISOAbbreviation>Gen Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of mechanical vs biological composite aortic root replacement, early and 1-year results.</ArticleTitle><Pagination><StartPage>70</StartPage><EndPage>76</EndPage><MedlinePgn>70-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11748-017-0845-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Composite aortic root replacement is a standard procedure for various aortic root pathologies. This systematic review was set to identify the postoperative outcomes for composite mechanical root replacement (mCRR) compared to composite biological root replacement (bCRR).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically reviewed four major databases for all papers assessing outcomes in composite root replacement. Articles selected were chosen by two reviewers. Amongst our inclusion and exclusion criteria, all pediatric populations were excluded as were studies with a cohort less than 50 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified seven studies that conformed to our inclusion criteria and incorporated 2240 patients. In-hospital mortality was higher but non-significant in the mechanical group (6.1 vs 4.2% respectively). There was no significant difference demonstrated in the risk of in-hospital stroke, late stroke and re-operation in either groups. Additionally, there was no significant difference in: endocarditis, 1-year mortality, 5-year mortality, mean cardiopulmonary or aortic cross-clamp time.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Composite mechanical root offers no superiority to composite biological root. There is a significant increase in the perioperative bleeding amongst composite mechanical root cohort. There is a need for further randomized control trail to assess the efficacy of either methods.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK. Mohamad.bashir@bartshealth.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harky</LastName><ForeName>Amer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Froghi</LastName><ForeName>Saied</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Imperial College NHS Trust, Hammersmith Hospital, Du Cane Rd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garner</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Prity</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oo</LastName><ForeName>Aung</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uppal</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Gen Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>101303952</NlmUniqueID><ISSNLinking>1863-6705</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001807" MajorTopicYN="Y">Blood Vessel Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aneurysm</Keyword><Keyword MajorTopicYN="N">Aortic root</Keyword><Keyword MajorTopicYN="N">Composite root</Keyword><Keyword MajorTopicYN="N">Valve</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29019011</ArticleId><ArticleId IdType="doi">10.1007/s11748-017-0845-2</ArticleId><ArticleId IdType="pii">10.1007/s11748-017-0845-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 1999 Nov 27;354(9193):1896-900</Citation><ArticleIdList><ArticleId IdType="pubmed">10584742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2001 May;71(5):1454-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11383782</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Valve Dis. 2001 Jul;10(4):451-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11499589</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Surg Forum. 2002;5(1):52-5; discussion 56</Citation><ArticleIdList><ArticleId IdType="pubmed">11944629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2002 Nov;74(5):S1769-72; discussion S1792-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12440662</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2003 Mar;23(3):305-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12614798</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 2003 Jul;89(7):715-21</Citation><ArticleIdList><ArticleId IdType="pubmed">12807838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 1977 Aug;24(2):140-8</Citation><ArticleIdList><ArticleId IdType="pubmed">141915</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2003 Dec;24(6):886-97</Citation><ArticleIdList><ArticleId IdType="pubmed">14643805</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2004 Sep 14;110(11):1364-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15313937</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2006 Sep;30(3):485-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16857373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen Thorac Cardiovasc Surg. 2007 Jan;55(1):6-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17444165</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2007 Jun;133(6):1455-63</Citation><ArticleIdList><ArticleId IdType="pubmed">17532939</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2007 Sep 11;116(11 Suppl):I294-300</Citation><ArticleIdList><ArticleId IdType="pubmed">17846320</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2008 Apr;135(4):878-84; discussion 884</Citation><ArticleIdList><ArticleId IdType="pubmed">18374773</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2010 Jun;37(6):1317-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20444618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2010 Dec;140(6 Suppl):S64-70; discussion S86-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21092800</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Cardiol. 2011 Mar-Apr;27(2):262.e15-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21459276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2012 Sep;94(3):737-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22626762</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean J Thorac Cardiovasc Surg. 2012 Jun;45(3):141-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22708080</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2013 Aug;44(2):337-45</Citation><ArticleIdList><ArticleId IdType="pubmed">23295449</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2013 Sep 10;128(11 Suppl 1):S253-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24030416</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2014 Oct;46(4):685-92; discussion 692</Citation><ArticleIdList><ArticleId IdType="pubmed">24497393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2015 Jan;149(1):116-22.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">24934089</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2014 Nov 1;35(41):2873-926</Citation><ArticleIdList><ArticleId IdType="pubmed">25173340</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 1968 Jul;23(4):338-9</Citation><ArticleIdList><ArticleId IdType="pubmed">5664694</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 1995 Aug;60(2 Suppl):S65-70</Citation><ArticleIdList><ArticleId IdType="pubmed">7646213</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 1996;10(3):207-13</Citation><ArticleIdList><ArticleId IdType="pubmed">8664022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28060555</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-0553</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of investigative surgery : the official journal of the Academy of Surgical Research</Title><ISOAbbreviation>J Invest Surg</ISOAbbreviation></Journal><ArticleTitle>Efficacy of N-Acetylcysteine in Preventing Acute Kidney Injury After Cardiac Surgery: A Meta-Analysis Study.</ArticleTitle><Pagination><StartPage>14</StartPage><EndPage>23</EndPage><MedlinePgn>14-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08941939.2016.1269853</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate whether perioperative N-acetylcysteine (NAC) administration reduces the risk of cardiac surgery associated acute kidney injury (CSA-AKI).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A systematic literature review (Medline, PubMed, Cochrane, Biomedical central, Google Scholar) identified 10 studies (1391 patients; 695 NAC and 696 placebo) that compared the efficacy and adverse effects of perioperative NAC administration for CSA-AKI prevention in adults undergoing elective cardiac surgery. Meta-analysis was performed using Comprehensive Meta-Analysis statistical software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in the NAC-treated and placebo groups had similar rate of CSA-AKI occurrence, change in creatinine levels, as well as the in-hospital mortality rate (RR = 0.841, 95% CI = 0.691 to 1.023, p = 0.083; pooled difference in means = -0.328, 95% CI = -0.712 to 0.056, p = 0.094; RR = 0.741, 95% CI = 0.388 to 1.418, p = 0.366, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study does not support perioperative NAC administration as a mean to reduce the risk of CSA-AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hong-Wen</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Qian-Guang</ForeName><Initials>QG</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>You-Min</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Mao-Zhi</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bing-Bing</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Invest Surg</MedlineTA><NlmUniqueID>8809255</NlmUniqueID><ISSNLinking>0894-1939</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016166">Free Radical Scavengers</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016166" MajorTopicYN="N">Free Radical Scavengers</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">N-acetylcysteine</Keyword><Keyword MajorTopicYN="N">acute kidney injury/kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery/heart surgery</Keyword><Keyword MajorTopicYN="N">coronary artery bypass</Keyword><Keyword MajorTopicYN="N">creatinine</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28060555</ArticleId><ArticleId IdType="doi">10.1080/08941939.2016.1269853</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39182102</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1465-993X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Respiratory research</Title><ISOAbbreviation>Respir Res</ISOAbbreviation></Journal><ArticleTitle>Surgery versus intrapleural fibrinolysis for management of complicated pleural infections: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>323</StartPage><MedlinePgn>323</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">323</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12931-024-02949-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Complicated pleural infection comprises of complex effusions and empyema. When tube thoracostomy is ineffective, treatment options include surgical drainage, deloculation and decortication or intrapleural fibrinolysis. We performed a systematic review and meta-analysis to examine which technique is superior in treating complicated pleural infections.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, MEDLINE and EMBASE databases were searched for studies published between January 2000 to July 2023 comparing surgery and intrapleural fibrinolysis for treatment of complicated pleural infection. The primary outcome was treatment success. Secondary outcomes included hospital length of stay, chest drain duration and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Surgical management of complicated pleural infections was more likely to be successful than intrapleural fibrinolysis (RR 1.18; 95% CI 1.02, 1.38). Surgical intervention group benefited from statistically significant shorter hospital length of stay (MD: 3.85; 95% CI 1.09, 6.62) and chest drain duration (MD: 3.42; 95% CI 1.36, 5.48). There was no observed difference between in-hospital mortality (RR: 1.00; 95% CI 0.99, 1.02).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Surgical management of complicated pleural infections results in increased likelihood of treatment success, shorter chest drain duration and hospital length of stay in the adult population compared with intrapleural fibrinolysis. In-hospital mortality did not differ. Large cohort and randomized research need to be conducted to confirm these findings.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jaewon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>George Hospital, Kogarah, Sydney, Australia. jaewon.j1.chang@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indja</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>George Hospital, Kogarah, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>George Hospital, Kogarah, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>George Hospital, Kogarah, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flynn</LastName><ForeName>Campbell D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>George Hospital, Kogarah, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Central Clinical School, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Res</MedlineTA><NlmUniqueID>101090633</NlmUniqueID><ISSNLinking>1465-9921</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="Y">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016724" MajorTopicYN="N">Empyema, Pleural</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004322" MajorTopicYN="N">Drainage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005342" MajorTopicYN="N">Fibrinolysis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010996" MajorTopicYN="N">Pleural Effusion</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complicated pleural infection</Keyword><Keyword MajorTopicYN="N">Empyema</Keyword><Keyword MajorTopicYN="N">Intrapleural fibrinolysis</Keyword><Keyword MajorTopicYN="N">Pleural effusion</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>12</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39182102</ArticleId><ArticleId IdType="pmc">PMC11344918</ArticleId><ArticleId IdType="doi">10.1186/s12931-024-02949-1</ArticleId><ArticleId IdType="pii">10.1186/s12931-024-02949-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shin JA, Chang YS, Kim TH, Haam SJ, Kim HJ, Ahn CM, et al. Surgical decortication as the first-line treatment for pleural empyema. J Thorac Cardiovasc Surg. 2013;145(4):933-9 e1. 10.1016/j.jtcvs.2012.07.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.07.035</ArticleId><ArticleId IdType="pubmed">22929218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996;89(4):285&#x2013;9. 10.1093/qjmed/89.4.285</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/89.4.285</ArticleId><ArticleId IdType="pubmed">8733515</ArticleId></ArticleIdList></Reference><Reference><Citation>Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133(2):346&#x2013;51. 10.1016/j.jtcvs.2006.09.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2006.09.038</ArticleId><ArticleId IdType="pubmed">17258562</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1682&#x2013;7. 10.1164/ajrccm.160.5.9903002</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.160.5.9903002</ArticleId><ArticleId IdType="pubmed">10556140</ArticleId></ArticleIdList></Reference><Reference><Citation>Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352(9):865&#x2013;74. 10.1056/NEJMoa042473</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa042473</ArticleId><ArticleId IdType="pubmed">15745977</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenstengel A. Pleural infection-current diagnosis and management. J Thorac Dis. 2012;4(2):186&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378219</ArticleId><ArticleId IdType="pubmed">22833824</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger HA, Morganroth ML. Immediate drainage is not required for all patients with complicated parapneumonic effusions. Chest. 1990;97(3):731&#x2013;5. 10.1378/chest.97.3.731</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.97.3.731</ArticleId><ArticleId IdType="pubmed">2306975</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleman C, Alegre J, Monasterio J, Segura RM, Armadans L, Angles A, et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond). 2003;105(5):601&#x2013;7. 10.1042/CS20030115</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20030115</ArticleId><ArticleId IdType="pubmed">12826021</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55(10):658&#x2013;60. 10.1111/j.1742-1241.2001.tb11156.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2001.tb11156.x</ArticleId><ArticleId IdType="pubmed">11777287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouros D, Antoniou KM, Chalkiadakis G, Drositis J, Petrakis I, Siafakas N. The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. Surg Endosc. 2002;16(1):151&#x2013;4. 10.1007/s00464-001-9028-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-001-9028-3</ArticleId><ArticleId IdType="pubmed">11961627</ArticleId></ArticleIdList></Reference><Reference><Citation>Luh SP, Chou MC, Wang LS, Chen JY, Tsai TP. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest. 2005;127(4):1427&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15821225</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518&#x2013;26. 10.1056/NEJMoa1012740</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1012740</ArticleId><ArticleId IdType="pubmed">21830966</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: University of Ottawa; 2000.</Citation></Reference><Reference><Citation>Luo D, Wan W, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785&#x2013;805. 10.1177/0962280216669183</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216669183</ArticleId><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Azam H, Basheer I. Is open decortication superior to fibrinolytic therapy as a first line treatment in the management of pleural empyema? Pak J Med Sci. 2016;32(2):329&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859016</ArticleId><ArticleId IdType="pubmed">27182233</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusemund F, Weber MD, Nagel W, Schneider T, Brutsche MH, Schoch OD. Characteristics of medically and surgically treated empyema patients: a retrospective cohort study. Respiration. 2013;86(4):288&#x2013;94. 10.1159/000353424</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353424</ArticleId><ArticleId IdType="pubmed">23988906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ershadi R, Vahedi M, Rafieian S. Efficacy of video-assisted thoracoscopic surgery versus intrapleural streptokinase for treatment of parapneumonic empyema with multiloculation and septation. Kardiochir Torakochirurgia Pol. 2022;19(2):86&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9290405</ArticleId><ArticleId IdType="pubmed">35891997</ArticleId></ArticleIdList></Reference><Reference><Citation>Federici S, Bedat B, Hayau J, Gonzalez M, Triponez F, Krueger T, et al. Outcome of parapneumonic empyema managed surgically or by fibrinolysis: a multicenter study. J Thorac Dis. 2021;13(11):6381&#x2013;9. 10.21037/jtd-21-1083</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-21-1083</ArticleId><ArticleId IdType="pmc">PMC8662487</ArticleId><ArticleId IdType="pubmed">34992818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermenli T, Azar C. Can intrapleural alteplase treatment be an alternative to videothoracoscopic deloculation and decortication in pleural empyema? Wideochir Inne Tech Maloinwazyjne. 2021;16(3):580&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8512508</ArticleId><ArticleId IdType="pubmed">34691309</ArticleId></ArticleIdList></Reference><Reference><Citation>Metin M, Yeginsu A, Sayar A, Alzafer S, Solak O, Ozgul A, et al. Treatment of multiloculated empyema thoracis using minimally invasive methods. Singapore Med J. 2010;51(3):242&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20428747</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad MI. Management of complicated parapneumonic effusion and empyema using different treatment modalities. Asian Cardiovasc Thorac Ann. 2012;20(2):177&#x2013;81. 10.1177/0218492311435338</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492311435338</ArticleId><ArticleId IdType="pubmed">22499966</ArticleId></ArticleIdList></Reference><Reference><Citation>Samancilar O, Akcam TI, Kaya SO, Ozturk O, Akcay O, Ceylan KC. The efficacy of VATS and intrapleural fibrinolytic therapy in parapneumonic empyema treatment. Ann Thorac Cardiovasc Surg. 2018;24(1):19&#x2013;24. 10.5761/atcs.oa.17-00153</Citation><ArticleIdList><ArticleId IdType="doi">10.5761/atcs.oa.17-00153</ArticleId><ArticleId IdType="pmc">PMC5833136</ArticleId><ArticleId IdType="pubmed">29343663</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Suarez P, Freixinet Gilart J, Hernandez Perez JM, Hussein Serhal M, Lopez Artalejo A. Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema. Med Sci Monit. 2012;18(7):443&#x2013;9.10.12659/MSM.883212</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.883212</ArticleId><ArticleId IdType="pmc">PMC3560768</ArticleId><ArticleId IdType="pubmed">22739734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire CL, Jackson AS, Vallieres E, Bograd AJ, Louie BE, Aye RW, et al. Effect of intrapleural fibrinolytic therapy vs surgery for complicated pleural infections: a randomized clinical trial. JAMA Netw Open. 2023;6(4): e237799. 10.1001/jamanetworkopen.2023.7799</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.7799</ArticleId><ArticleId IdType="pmc">PMC10098968</ArticleId><ArticleId IdType="pubmed">37043201</ArticleId></ArticleIdList></Reference><Reference><Citation>Subotic D, Lardinois D, Hojski A. Minimally invasive thoracic surgery for empyema. Breathe (Sheff). 2018;14(4):302&#x2013;10. 10.1183/20734735.025718</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/20734735.025718</ArticleId><ArticleId IdType="pmc">PMC6269178</ArticleId><ArticleId IdType="pubmed">30519296</ArticleId></ArticleIdList></Reference><Reference><Citation>Akulian J, Bedawi EO, Abbas H, Argento C, Arnold DT, Balwan A, et al. Bleeding risk with combination intrapleural fibrinolytic and enzyme therapy in pleural infection: an international, multicentre, retrospective cohort study. Chest. 2022;162(6):1384&#x2013;92. 10.1016/j.chest.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9773231</ArticleId><ArticleId IdType="pubmed">35716828</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31178357</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Non-operative Management of Type A Acute Aortic Syndromes: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>51</EndPage><MedlinePgn>41-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2018.10.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(18)30790-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">For type A acute aortic syndrome (TAAAS), the only alternative for patients who are contraindicated for open surgery or endovascular interventions is medical therapy. The objective of this study was to assess the impact of conservative treatment in patients suffering TAAAS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This systematic review and meta-analysis was performed according to the PRISMA guidelines. A systematic search was conducted on MEDLINE, Embase, and the Cochrane Library for relevant studies. Pairwise meta-analysis was conducted to compare surgical with medical intervention. Included studies were subjected to risk of bias assessment using the Newcastle-Ottawa scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-nine studies comprising 6894 patients were included. For patients with type A aortic dissection (TAAD), the pooled proportions of all cause in hospital mortality and all cause 30 day mortality were 39.1% (95% confidence interval [CI] 29.8-48.9%; I<sup>2</sup>&#xa0;=&#xa0;90.1%), and 31.1% (95% CI 8.8-59.1%; I<sup>2</sup>&#xa0;=&#xa0;95.9%), respectively. There was a significant proportion of patients who converted from medical to surgical treatment (20.7%, 95% CI 0.0-61.7%; I<sup>2</sup>&#xa0;=&#xa0;93.4%). In patients with type A intramural haematoma (IMH), the pooled proportions of all cause in hospital mortality and all cause 30 day mortality were 7.2% (95% CI 2.6-13.4%; I<sup>2</sup>&#xa0;=&#xa0;76.5%) and 15.3% (95% CI 1.1-37.9%; I<sup>2</sup>&#xa0;=&#xa0;64.1%). A significant proportion of patients converted from medical to surgical treatment (26.3%, 95% CI 12.1-43.4%; I<sup>2</sup>&#xa0;=&#xa0;90.5%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Mortality remains high for conservatively treated patients with TAAD. For patients with IMH, heterogeneity in the types of conservative treatment prohibit any firm conclusion regarding its safety and efficacy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wee</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varughese</LastName><ForeName>Rahel S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syn</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choong</LastName><ForeName>Andrew M T L</ForeName><Initials>AMTL</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore; Cardiovascular Research Institute, National University of Singapore, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Vascular Surgery, National University Heart Centre, Singapore. Electronic address: suramctl@nus.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="N">Aortic Dissection</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="N">Conservative Treatment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075204" MajorTopicYN="N">Contraindications, Procedure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Medical therapy</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Type A acute aortic syndrome</Keyword><Keyword MajorTopicYN="N">Type A aortic dissection</Keyword><Keyword MajorTopicYN="N">Type A intramural haematoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31178357</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2018.10.015</ArticleId><ArticleId IdType="pii">S1078-5884(18)30790-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37403894</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1678-9741</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>04</Day></PubDate></JournalIssue><Title>Brazilian journal of cardiovascular surgery</Title><ISOAbbreviation>Braz J Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Percutaneous Closure vs. Surgical Repair for Postinfarction Ventricular Septal Rupture: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e20220417</StartPage><MedlinePgn>e20220417</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20220417</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21470/1678-9741-2022-0417</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Ventricular septal rupture is an important high-mortality complication in the scope of myocardial infarctions. The effectiveness of different treatment modalities is still controversial. This meta-analysis compares the efficacy of percutaneous closure vs. surgical repair for the treatment of postinfarction ventricular septal rupture (PI-VSR).</AbstractText><AbstractText Label="METHODS">A meta-analysis was performed on relevant studies found through PubMed&#xae;, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (or CNKI), Wanfang Data, and VIP databases searching. The primary outcome was a comparison of in-hospital mortality between the two treatments, and the secondary outcome was documentation of one-year mortality, postoperative residual shunts, and postoperative cardiac function. Differences were expressed as odds ratios (ORs) with 95% confidence intervals (CIs) to assess the relationships between predefined surgical variables and clinical outcomes.</AbstractText><AbstractText Label="RESULTS">Qualified studies (742 patients from 12 trials) were found and investigated for this meta-analysis (459 patients in the surgical repair group, 283 patients in the percutaneous closure group). When comparing surgical repair to percutaneous closure, it was found that the former significantly reduced in-hospital mortality (OR: 0.67, 95% CI 0.48-0.96, P=0.03) and postoperative residual shunts (OR: 0.03, 95% CI 0.01-0.10, P&lt;0.00001). Surgical repair also improved postoperative cardiac function overall (OR: 3.89, 95% CI 1.10-13.74, P=0.04). However, there was no statistically significant difference in one-year mortality between the two surgical strategies (OR: 0.58, 95% CI 0.24-1.39, P=0.23).</AbstractText><AbstractText Label="CONCLUSION">We found that surgical repair appears to be a more effective therapeutic option than percutaneous closure for PI-VSR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiangyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, Gansu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cingting</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Science Center of Lanzhou University, Lanzhou University, Lanzhou, Gansu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Xinyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yongnan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, Gansu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Fengxiao</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, Gansu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Qiming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, Gansu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5026-7254</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, Gansu, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Cardiovasc Surg</MedlineTA><NlmUniqueID>101677045</NlmUniqueID><ISSNLinking>0102-7638</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018658" MajorTopicYN="Y">Ventricular Septal Rupture</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-Analysis</Keyword><Keyword MajorTopicYN="N">Myocardial Infarction</Keyword><Keyword MajorTopicYN="N">Risk Factors</Keyword><Keyword MajorTopicYN="N">Treatment Outocome</Keyword><Keyword MajorTopicYN="N">Ventricular Septal Rupture</Keyword></KeywordList><CoiStatement>No conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37403894</ArticleId><ArticleId IdType="pmc">PMC10358309</ArticleId><ArticleId IdType="doi">10.21470/1678-9741-2022-0417</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Matteucci M, Ronco D, Corazzari C, Fina D, Jiritano F, Meani P, et al. Surgical repair of postinfarction ventricular septal rupture: systematic review and meta-analysis. Ann Thorac Surg. 2021;112(1):326&#x2013;337. doi: 10.1016/j.athoracsur.2020.08.050..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2020.08.050.</ArticleId><ArticleId IdType="pubmed">33157063</ArticleId></ArticleIdList></Reference><Reference><Citation>Damluji AA, van Diepen S, Katz JN, Menon V, Tamis-Holland JE, Bakitas M, et al. Mechanical complications of acute myocardial infarction: a scientific statement from the American heart association. Circulation. 2021;144(2):e16&#x2013;e35. doi: 10.1161/CIR.0000000000000985..</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000985.</ArticleId><ArticleId IdType="pmc">PMC9364424</ArticleId><ArticleId IdType="pubmed">34126755</ArticleId></ArticleIdList></Reference><Reference><Citation>Deja MA, Szostek J, Widenka K, Szafron B, Spyt TJ, Hickey MS, et al. Post infarction ventricular septal defect - can we do better? Eur J Cardiothorac Surg. 2000;18(2):194&#x2013;201. doi: 10.1016/s1010-7940(00)00482-6..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1010-7940(00)00482-6.</ArticleId><ArticleId IdType="pubmed">10925229</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiei I, Jannati F, Jannati M. Optimal time repair of ventricular septal rupture post myocardial infarction. J Saudi Heart Assoc. 2020;32(2):288&#x2013;294. doi: 10.37616/2212-5043.1120..</Citation><ArticleIdList><ArticleId IdType="doi">10.37616/2212-5043.1120.</ArticleId><ArticleId IdType="pmc">PMC7640570</ArticleId><ArticleId IdType="pubmed">33154931</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones BM, Kapadia SR, Smedira NG, Robich M, Tuzcu EM, Menon V, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 2014;35(31):2060&#x2013;2068. doi: 10.1093/eurheartj/ehu248..</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu248.</ArticleId><ArticleId IdType="pubmed">24970335</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71..</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71.</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605. doi: 10.1007/s10654-010-9491-z..</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z.</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Velasco G, Lerma C, Arias-Mendoza A, &#xc1;lvarez-Sangabriel A, Altamirano A, Azar-Manzur F, et al. Caracter&#xed;sticas cl&#xed;nicas, modalidades de tratamiento y mortalidad en la ruptura del septum interventricular posinfarto. Arch Cardiol Mex. 2011;81(3):197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">21975233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Yinjun, Li Qiang, Li Zhanquan, et al. Treatment of acute myocardial infarction with ventricular septal perforation. Chin J Thorac Cardiovasc Surg. 2013;29(4):225&#x2013;226.</Citation></Reference><Reference><Citation>Trivedi KR, Aldebert P, Riberi A, Mancini J, Levy G, Macia JC, et al. Sequential management of post-myocardial infarction ventricular septal defects. Arch Cardiovasc Dis. 2015;108(5):321&#x2013;330. doi: 10.1016/j.acvd.2015.01.005..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2015.01.005.</ArticleId><ArticleId IdType="pubmed">25754906</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsweig AM, Wang Y, Forrest JK, Cleman MW, Minges KE, Mangi AA, et al. Ventricular septal rupture complicating acute myocardial infarction: incidence, treatment, and outcomes among medicare beneficiaries 1999-2014. Catheter Cardiovasc Interv. 2018;92(6):1104&#x2013;1115. doi: 10.1002/ccd.27576..</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27576.</ArticleId><ArticleId IdType="pubmed">29513365</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Yan, Tian Nailiang, Shen Yi, et al. Clinical characteristics and prognosis analysis of patients with acute myocardial infarction combined with ventricular septal perforation. Int J Cardiovasc Dis. 2020;47(5):311&#x2013;314.</Citation></Reference><Reference><Citation>Wang Xuewen, Zhong Jianli, Yan Hua, et al. Clinical comparison of interventional occlusion and surgical treatment for acute myocardial infarction complicated with ventricular septal rupture. Chin J Intervent Cardiol. 2020;28(10):560&#x2013;565.</Citation></Reference><Reference><Citation>Tian Xinyu, Li Pengcheng, Zhang Yanzhou, et al. Prognostic analysis of interventional therapy and surgical intervention for ventricular septal rupture. J Med Forum. 2020;41(5):37&#x2013;43.</Citation></Reference><Reference><Citation>Bhattacharya D, Sambaturu VK, Harikrishnan KN, et al. Outcome of ventricular septal rupture from a tertiary care centre in South India. Indian Heart J. 2021;73:S52.</Citation></Reference><Reference><Citation>Zheng Yago, Xie Dujiang, Tian Nailiang, et al. Clinical analysis of 50 cases of acute myocardial infarction combined with ventricular septal perforation. J Nanj Med Univer (Natural Sciences) 2021;41(3):391&#x2013;396.</Citation></Reference><Reference><Citation>Ma D, Zhang Z, Zhang S, Wang Z, Zhang G, Wang C, et al. Treatment strategies for ventricular septal rupture after myocardial infarction: a single-center experience. Front Cardiovasc Med. 2022;9:843625. doi: 10.3389/fcvm.2022.843625..</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.843625.</ArticleId><ArticleId IdType="pmc">PMC8899464</ArticleId><ArticleId IdType="pubmed">35265690</ArticleId></ArticleIdList></Reference><Reference><Citation>Giblett JP, Matetic A, Jenkins D, Ng CY, Venuraju S, MacCarthy T, et al. Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry. Eur Heart J. 2022;43(48):5020&#x2013;5032. doi: 10.1093/eurheartj/ehac511..</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac511.</ArticleId><ArticleId IdType="pubmed">36124729</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Zhenzhen. Clinical analysis of different treatment methods for ventricular septal perforation after acute myocardial infarction [thesis] Zhengzhou University; 2021.</Citation></Reference><Reference><Citation>Shah AH, Puri R, Kalra A. Management of cardiogenic shock complicating acute myocardial infarction: a review. Clin Cardiol. 2019;42(4):484&#x2013;493. doi: 10.1002/clc.23168..</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23168.</ArticleId><ArticleId IdType="pmc">PMC6712338</ArticleId><ArticleId IdType="pubmed">30815887</ArticleId></ArticleIdList></Reference><Reference><Citation>Topaz O. The enigma of optimal treatment for acute ventricular septal rupture. Am J Cardiol. 2003;92(4):419&#x2013;420. doi: 10.1016/s0002-9149(03)00660-x..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(03)00660-x.</ArticleId><ArticleId IdType="pubmed">12914872</ArticleId></ArticleIdList></Reference><Reference><Citation>Risseeuw F, Diebels I, Vandendriessche T, De Wolf D, Rodrigus IE. Percutaneous occlusion of post-myocardial infarction ventricular septum rupture. Neth Heart J. 2014;22(2):47&#x2013;51. doi: 10.1007/s12471-013-0498-4..</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-013-0498-4.</ArticleId><ArticleId IdType="pmc">PMC3967561</ArticleId><ArticleId IdType="pubmed">24287808</ArticleId></ArticleIdList></Reference><Reference><Citation>Oman Z, Kumar S, Ghani A, Sayed-Ahmad Z, Horbal P, Nasir A, et al. Percutaneous repair of post-myocardial infarction ventricular septal rupture presenting with cardiogenic shock. Am J Cardiovasc Dis. 2020;10(4):376&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675175</ArticleId><ArticleId IdType="pubmed">33224586</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldasare MD, Polyakov M, Laub GW, Costic JT, McCormick DJ, Goldberg S. Percutaneous repair of post-myocardial infarction ventricular septal defect: current approaches and future perspectives. Tex Heart Inst J. 2014;41(6):613&#x2013;619. Erratum in: Tex Heart Inst J. 2015;42(1):97. 10.14503/THIJ-13-3695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4251333</ArticleId><ArticleId IdType="pubmed">25593526</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen MM, Zhao DXM. Percutaneous Post-Myocardial Infarction Ventricular Septal Rupture Closure: A Review. Struct Heart. 2018;2(2):121&#x2013;126.</Citation></Reference><Reference><Citation>Flynn CD, Morris P, Manuel L, Matteucci M, Ronco D, Massimi G, et al. Systematic review and meta-analysis of the mechanical complications of ischemic heart disease: papillary muscle rupture, left ventricle rupture and post-infarct ventricular septal defect. Ann Cardiothorac Surg. 2022;11(3):195&#x2013;209. doi: 10.21037/acs-2022-ami-24..</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs-2022-ami-24.</ArticleId><ArticleId IdType="pmc">PMC9207690</ArticleId><ArticleId IdType="pubmed">35733707</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreyra AE, Huang MS, Wilson AC, Deng Y, Cosgrove NM, Kostis JB, et al. Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am J Cardiol. 2010;106(8):1095&#x2013;1100. doi: 10.1016/j.amjcard.2010.06.013..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2010.06.013.</ArticleId><ArticleId IdType="pubmed">20920645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco D, Corazzari C, Matteucci M, Massimi G, Di Mauro M, Ravaux JM, et al. Effects of concomitant coronary artery bypass grafting on early and late mortality in the treatment of post-infarction mechanical complications: a systematic review and meta-analysis. Ann Cardiothorac Surg. 2022;11(3):210&#x2013;225. doi: 10.21037/acs-2021-ami-19..</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs-2021-ami-19.</ArticleId><ArticleId IdType="pmc">PMC9207702</ArticleId><ArticleId IdType="pubmed">35733718</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Z, Wang Y, Ding Y, Ni R, Xiao P. Transcatheter closure for postinfarction ventricular septal defect: a meta-analysis of the current evidence. J Card Surg. 2021;36(12):4625&#x2013;4633. doi: 10.1111/jocs.15989..</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.15989.</ArticleId><ArticleId IdType="pubmed">34499370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37073747</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1699-5198</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Nutricion hospitalaria</Title><ISOAbbreviation>Nutr Hosp</ISOAbbreviation></Journal><ArticleTitle>The effect of perioperative immunonutrition on patients undergoing esophagectomy: a systematic review and updated meta-analysis.</ArticleTitle><Pagination><StartPage>839</StartPage><EndPage>847</EndPage><MedlinePgn>839-847</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.20960/nh.04371</ELocationID><Abstract><AbstractText>Background: immunonutrition has been introduced and proposed to have positive modulating effects on inflammatory and immune responses in surgical patients. This meta-analysis aimed to assess whether perioperative enteral immunonutrition (EIN) can reduce postoperative complications or reduce inflammatory responses in esophageal cancer (EC) patients undergoing esophagectomy. Methods: PubMed, Embase, Web of science, EBSCO, and Cochrane library databases were systematically searched. Randomized controlled trials (RCTs) assessing the effect of EIN before and/or after surgery in EC patients undergoing esophagectomy were identified. Two investigators independently searched articles, extracted data, and assessed the quality of included studies. Results: ten RCTs involving 1,052 patients were included in the meta-analysis, including 573 patients in the EIN group and 479 patients in the enteral nutrition (EN) group. Overall, no significant difference was observed between the two groups in the incidence of postoperative pneumonia, surgical site infection, intra-abdominal abscess, septicemia, and urinary tract infection. No significant incidence of postoperative anastomotic leakage, acute respiratory distress syndrome (ARDS), and in-hospital mortality was found. Conclusions: perioperative enteral immunonutrition did not reduce the incidence of infectious complications and anastomotic leakage in EC patients undergoing esophagectomy, nor did it reduce postoperative CRP and IL-6, but did not increase in-hospital mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery and Abdominal Hernia Surgery. The People's Hospital of Kai Zhou District.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tian-Tian</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery and Abdominal Hernia Surgery. The People's Hospital of Kai Zhou District.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhi-Liang</ForeName><Initials>ZL</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery and Abdominal Hernia Surgery. The People's Hospital of Kai Zhou District.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Zhi-Ming</ForeName><Initials>ZM</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery and Abdominal Hernia Surgery. The People's Hospital of Kai Zhou District.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chi-Fen</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery and Abdominal Hernia Surgery. The People's Hospital of Kai Zhou District.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery and Abdominal Hernia Surgery. The People's Hospital of Kai Zhou District.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Efectos de la inmunonutrici&#xf3;n perioperatoria en pacientes sometidos a esofagectom&#xed;a: revisi&#xf3;n sistem&#xe1;tica y metaan&#xe1;lisis actualizado.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Nutr Hosp</MedlineTA><NlmUniqueID>9100365</NlmUniqueID><ISSNLinking>0212-1611</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093702" MajorTopicYN="N">Immunonutrition Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="Y">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>Antecedentes: se ha introducido y propuesto la inmunonutrici&#xf3;n para regular activamente la inflamaci&#xf3;n y la respuesta inmune en pacientes quir&#xfa;rgicos. El presente metaan&#xe1;lisis fue dise&#xf1;ado para evaluar si la inmunonutrici&#xf3;n enteral perioperatoria (EIN, por sus siglas en ingl&#xe9;s) puede reducir las complicaciones postoperatorias o la inflamaci&#xf3;n en pacientes con c&#xe1;ncer de es&#xf3;fago (CE) sometidos a esofagectom&#xed;a. M&#xe9;todos: se realiz&#xf3; una b&#xfa;squeda sistem&#xe1;tica en las bases de datos de PubMed, Embase, Web of Science, EBSCO y Cochrane Library. Se evalu&#xf3; el efecto de la EIN preoperatoria y/o postoperatoria en un ensayo aleatorizado controlado (RCT) en pacientes con c&#xe1;ncer de es&#xf3;fago sometidos a esofagectom&#xed;a. Dos investigadores buscaron independientemente art&#xed;culos, extrajeron datos y evaluaron la calidad de los art&#xed;culos incluidos. Resultados: el metan&#xe1;lisis incluy&#xf3; diez ensayos controlados aleatorios en los que participaron 1.052 pacientes, de los cuales 573 fueron incluidos en el grupo EIN y 479, en el grupo de nutrici&#xf3;n enteral (NE). En general, no hubo diferencia significativa en la incidencia de neumon&#xed;a postoperatoria, infecci&#xf3;n del sitio quir&#xfa;rgico, absceso intraperitoneal, sepsis e infecci&#xf3;n del tracto urinario entre los dos grupos. No hubo diferencia significativa en la incidencia de f&#xed;stula anastom&#xf3;tica postoperatoria, s&#xed;ndrome de distr&#xe9;s respiratorio agudo (SDRA) y mortalidad hospitalaria. Conclusi&#xf3;n: la inmunonutrici&#xf3;n enteral perioperatoria no puede reducir la incidencia de complicaciones infecciosas postoperatorias y f&#xed;stulas anastom&#xf3;ticas, ni la PCR postoperatoria ni la IL-6. Pero no aument&#xf3; la mortalidad hospitalaria.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Neumon&#xed;a. Esofagectom&#xed;a. Nutrici&#xf3;n enteral. Metaan&#xe1;lisis.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>29</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37073747</ArticleId><ArticleId IdType="doi">10.20960/nh.04371</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39792052</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2474-9842</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>30</Day></PubDate></JournalIssue><Title>BJS open</Title><ISOAbbreviation>BJS Open</ISOAbbreviation></Journal><ArticleTitle>Organ-specific malperfusion in acute type A aortic dissection: epidemiological meta-analysis of incidence rates.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">zrae146</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/bjsopen/zrae146</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute type A aortic dissection is a life-threatening clinical emergency that necessitates immediate surgical intervention with an estimated mortality rate of approximately 1-2% per hour. When complicated by malperfusion, the perioperative mortality rate is reported to be increased by up to 39%. Malperfusion can affect many vascular beds with varying incidence and severity, resulting in coronary, cerebral, visceral, peripheral, renal or spinal malperfusion. The primary aim of this systematic review and meta-analysis is to investigate the epidemiology of specific types of organ malperfusion in acute type A aortic dissection and to analyse the impact on the survival outcomes associated with each malperfusion type.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases PubMed, MEDLINE and Embase were searched through to September 2024 to identify original studies that presented data on the incidence and the survival outcome of organ malperfusion in association with acute type A aortic dissection. The extracted data included patient characteristics and incidence of organ-specific malperfusion. Primary outcomes were the respective in-hospital mortality rate associated with each organ-specific malperfusion and a proportional meta-analysis was conducted to pool results. Quality assessment was performed using the modified National Institutes of Health quality assessment tool for single-arm observational studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 40 studies met the inclusion criteria, including a total of 35 361 patients. Peripheral limb malperfusion was the most prevalent with a pooled incidence of 12% (95% c.i. 10 to 14). This was followed by lower limb or iliofemoral with 11% (95% c.i. 9 to 14). Spinal malperfusion was the lowest with 1% (95% c.i. 1 to 2). The pooled mortality rate with organ malperfusion varied between 18 and 36%. Within this population the highest mortality rate was associated with mesenteric malperfusion with 36% (95% c.i. 28 to 45). Following this the highest mortality rate was found with coronary at 33% (95% c.i. 26 to 40) and cerebral at 28% (95% c.i. 24 to 33) malperfusion.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Survival during hospital admission after acute type A aortic dissection can vary depending on the presence and type of malperfusion, with mesenteric, coronary and cerebral malperfusion being associated with the highest in-hospital mortality rates. Organ-specific malperfusion syndromes should be considered when assessing the perioperative risk and surgical planning of patients undergoing surgical repair for acute type A aortic dissection.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chandiramani</LastName><ForeName>Ashwini</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, St Thomas' Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Tawil</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2111-8596</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elleithy</LastName><ForeName>Assem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Royal Blackburn Hospital, Blackburn, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakar</LastName><ForeName>Sahil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose and Throat Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajasekar</LastName><ForeName>Tharun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Liverpool Medical School, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panda</LastName><ForeName>Abinash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabry</LastName><ForeName>Haytham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haneya</LastName><ForeName>Assad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac and Thoracic Surgery, Heart Center Trier, Trier, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harky</LastName><ForeName>Amer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJS Open</MedlineTA><NlmUniqueID>101722685</NlmUniqueID><ISSNLinking>2474-9842</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001014" MajorTopicYN="N">Aortic Aneurysm</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>10</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>10</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>10</Day><Hour>10</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39792052</ArticleId><ArticleId IdType="pmc">PMC11720173</ArticleId><ArticleId IdType="doi">10.1093/bjsopen/zrae146</ArticleId><ArticleId IdType="pii">7951281</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harris &#xa0;KM, Nienaber &#xa0;CA, Peterson &#xa0;MD, Woznicki &#xa0;EM, Braverman &#xa0;AC, Trimarchi &#xa0;S &#xa0;et al. &#xa0;Early mortality in type A acute aortic dissection. JAMA Cardiol &#xa0;2022;7:1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9403853</ArticleId><ArticleId IdType="pubmed">36001309</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;sz&#xe1;ros &#xa0;I, M&#xf3;rocz &#xa0;J, Szl&#xe1;vi &#xa0;J, Schmidt &#xa0;J, Torn&#xf3;ci &#xa0;L, Nagy &#xa0;L &#xa0;et al. &#xa0;Epidemiology and clinicopathology of aortic dissection. Chest &#xa0;2000;117:1271&#x2013;1278</Citation><ArticleIdList><ArticleId IdType="pubmed">10807810</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffar-Karballai &#xa0;M, Tran &#xa0;TT, Oremakinde &#xa0;O, Zafar &#xa0;S, Harky &#xa0;A. Malperfusion in acute type A aortic dissection: management strategies. Vasc Endovascular Surg &#xa0;2021;55:721&#x2013;729</Citation><ArticleIdList><ArticleId IdType="pubmed">34039116</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang &#xa0;Y, Yang &#xa0;Y, Guo &#xa0;J, Zhang &#xa0;X, Cheng &#xa0;Y, Sun &#xa0;T &#xa0;et al. &#xa0;Risk factors for early death after surgery in patients with acute Stanford type A aortic dissection: a systematic review and meta-analysis. Int J Cardiol &#xa0;2023;377:33&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pubmed">36513283</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton &#xa0;EL, Khaja &#xa0;MS, Williams &#xa0;DM, Yang &#xa0;B. Type A aortic dissection complicated by malperfusion syndrome. Curr Opin Cardiol &#xa0;2019;34:610&#x2013;615</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7141757</ArticleId><ArticleId IdType="pubmed">31397690</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford &#xa0;TC, Beaulieu &#xa0;RJ, Ehlert &#xa0;BA, Ratchford &#xa0;EV, Black &#xa0;JH. Malperfusion syndromes in aortic dissections. Vascular Med &#xa0;2016;21:264&#x2013;273</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4876056</ArticleId><ArticleId IdType="pubmed">26858183</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandiramani &#xa0;A, Al-Tawil &#xa0;M, Rajasekar &#xa0;T, Elleithy &#xa0;A, Kakar &#xa0;S, Haneya &#xa0;A &#xa0;et al. &#xa0;Incidence rates of Penn classes and class-specific mortality in acute type A aortic dissection patients: an epidemiologic systematic review and meta-analysis. J Cardiothorac Vasc Anesth &#xa0;2024;38:1558&#x2013;1568</Citation><ArticleIdList><ArticleId IdType="pubmed">38644098</ArticleId></ArticleIdList></Reference><Reference><Citation>Page &#xa0;MJ, McKenzie &#xa0;JE, Bossuyt &#xa0;PM, Boutron &#xa0;I, Hoffmann &#xa0;TC, Mulrow &#xa0;CD &#xa0;et al. &#xa0;The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev &#xa0;2021;10:89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke &#xa0;BS, Schwartz &#xa0;TA, Pawlik &#xa0;TM. MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg &#xa0;2021;156:787.</Citation><ArticleIdList><ArticleId IdType="pubmed">33825847</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker &#xa0;TH, Migliavaca &#xa0;CB, Stein &#xa0;C, Colpani &#xa0;V, Falavigna &#xa0;M, Aromataris &#xa0;E &#xa0;et al. &#xa0;Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol &#xa0;2021;21:189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8451728</ArticleId><ArticleId IdType="pubmed">34544368</ArticleId></ArticleIdList></Reference><Reference><Citation>Augoustides &#xa0;J, Geirsson &#xa0;A, Szeto &#xa0;W, Walsh &#xa0;EK, Cornelius &#xa0;B, Pochettino &#xa0;A &#xa0;et al. &#xa0;Observational study of mortality risk stratification by ischemic presentation in patients with acute type A aortic dissection: the Penn classification. Nat Rev Cardiol &#xa0;2009;6:140&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">19065126</ArticleId></ArticleIdList></Reference><Reference><Citation>Girdauskas &#xa0;E, Kuntze &#xa0;T, Borger &#xa0;MA, Falk &#xa0;V, Mohr &#xa0;F-W. Surgical risk of preoperative malperfusion in acute type A aortic dissection. J Thorac Cardiovasc Surg &#xa0;2009;138:1363&#x2013;1369</Citation><ArticleIdList><ArticleId IdType="pubmed">19733865</ArticleId></ArticleIdList></Reference><Reference><Citation>Czerny &#xa0;M, Schoenhoff &#xa0;F, Etz &#xa0;C, Englberger &#xa0;L, Khaladj &#xa0;N, Zierer &#xa0;A &#xa0;et al. &#xa0;The impact of pre-operative malperfusion on outcome in acute type A aortic dissection: results from the GERAADA registry. J Am Coll Cardiol &#xa0;2015;65:2628&#x2013;2635</Citation><ArticleIdList><ArticleId IdType="pubmed">26088302</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsson &#xa0;E, Zindovic &#xa0;I, Bjursten &#xa0;H, Ingemansson &#xa0;R, Nozohoor &#xa0;S. Generalized ischaemia in type A aortic dissections predicts early surgical outcomes only. Interact Cardiovasc Thorac Surg &#xa0;2015;21:583&#x2013;589</Citation><ArticleIdList><ArticleId IdType="pubmed">26197811</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuhara &#xa0;S, Norton &#xa0;EL, Chaudhary &#xa0;N, Burris &#xa0;N, Shiomi &#xa0;S, Kim &#xa0;KM &#xa0;et al. &#xa0;Type A aortic dissection with cerebral malperfusion: new insights. Ann Thorac Surg &#xa0;2021;112:501&#x2013;509</Citation><ArticleIdList><ArticleId IdType="pubmed">33121966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto &#xa0;O, Saito &#xa0;Y, Nakayama &#xa0;T, Okino &#xa0;S, Sakai &#xa0;Y, Nakamura &#xa0;Y &#xa0;et al. &#xa0;Prognostic impact of branch vessel involvement on computed tomography versus clinical presentation of malperfusion in patients with type A acute aortic dissection. Am J Cardiol &#xa0;2021;152:158&#x2013;163</Citation><ArticleIdList><ArticleId IdType="pubmed">34120705</ArticleId></ArticleIdList></Reference><Reference><Citation>Immer &#xa0;FF, Grob&#xe9;ty &#xa0;V, Lauten &#xa0;A, Carrel &#xa0;TP. Does malperfusion syndrome affect early and mid-term outcome in patients suffering from acute type A aortic dissection? &#xa0;Interact Cardiovasc Thorac Surg &#xa0;2006;5:187&#x2013;190</Citation><ArticleIdList><ArticleId IdType="pubmed">17670544</ArticleId></ArticleIdList></Reference><Reference><Citation>Imura &#xa0;H, Tanoue &#xa0;M, Shibata &#xa0;M, Maruyama &#xa0;Y, Shirakawa &#xa0;M, Ochi &#xa0;M. Acute type-A aortic dissection with patent false lumen through to the abdominal aorta: effects of a conventional elephant trunk on malperfusion syndromes and narrowed true lumen. Perfusion &#xa0;2014;29:417&#x2013;424</Citation><ArticleIdList><ArticleId IdType="pubmed">24317275</ArticleId></ArticleIdList></Reference><Reference><Citation>Khachatryan &#xa0;Z, Leontyev &#xa0;S, Magomedov &#xa0;K, Haunschild &#xa0;J, Holzhey &#xa0;DM, Misfeld &#xa0;M &#xa0;et al. &#xa0;Management of aortic root in type A dissection: Bentall approach. J Card Surg &#xa0;2021;36:1779&#x2013;1785</Citation><ArticleIdList><ArticleId IdType="pubmed">33345377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura &#xa0;N, Ohnuma &#xa0;T, Itoh &#xa0;S, Sasabuchi &#xa0;Y, Asaka &#xa0;K, Shiotsuka &#xa0;J &#xa0;et al. &#xa0;Utility of the Penn classification in predicting outcomes of surgery for acute type A aortic dissection. Am J Cardiol &#xa0;2014;113:724&#x2013;730</Citation><ArticleIdList><ArticleId IdType="pubmed">24484863</ArticleId></ArticleIdList></Reference><Reference><Citation>Leontyev &#xa0;S, L&#xe9;gar&#xe9; &#xa0;JF, Borger &#xa0;MA, Buth &#xa0;KJ, Funkat &#xa0;AK, Gerhard &#xa0;J &#xa0;et al. &#xa0;Creation of a scorecard to predict in-hospital death in patients undergoing operations for acute type A aortic dissection. Ann Thorac Surg &#xa0;2016;101:1700&#x2013;1706</Citation><ArticleIdList><ArticleId IdType="pubmed">26794886</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;J, Zhou &#xa0;Y, Qin &#xa0;W, Su &#xa0;C, Huang &#xa0;F, Chen &#xa0;X. Surgical outcomes of total arch replacement with modified elephant trunk technique in type A aortic dissection: insights from single-center experience. Asian Cardiovasc Thorac Ann &#xa0;2023;31:8&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pubmed">35014890</ArticleId></ArticleIdList></Reference><Reference><Citation>Luehr &#xa0;M, Merkle-Storms &#xa0;J, Gerfer &#xa0;S, Li &#xa0;Y, Krasivskyi &#xa0;I, Vehrenberg &#xa0;J &#xa0;et al. &#xa0;Evaluation of the GERAADA score for prediction of 30-day mortality in patients with acute type A aortic dissection. Eur J Cardiothorac Surg &#xa0;2021;59:1109&#x2013;1114</Citation><ArticleIdList><ArticleId IdType="pubmed">33374014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma &#xa0;WG, Zheng &#xa0;J, Zhang &#xa0;W, Sun &#xa0;K, Ziganshin &#xa0;BA, Wang &#xa0;L-F &#xa0;et al. &#xa0;Frozen elephant trunk with total arch replacement for type A aortic dissections: does acuity affect operative mortality? &#xa0;J Thorac Cardiovasc Surg &#xa0;2014;148:963&#x2013;972</Citation><ArticleIdList><ArticleId IdType="pubmed">25043867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma &#xa0;S, Xu &#xa0;Q, Hu &#xa0;Q, Huang &#xa0;L, Wu &#xa0;D, Lin &#xa0;G &#xa0;et al. &#xa0;Post-operative uric acid: a predictor for 30-days mortality of acute type A aortic dissection repair. BMC Cardiovasc Disord &#xa0;2022;22:411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9479398</ArticleId><ArticleId IdType="pubmed">36109723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan &#xa0;I, Bianco &#xa0;V, Patel &#xa0;HJ, Arnaoutakis &#xa0;GJ, Di Eusanio &#xa0;M, Chen &#xa0;EP &#xa0;et al. &#xa0;Surgery for type A aortic dissection in patients with cerebral malperfusion: results from the International Registry of Acute Aortic Dissection. J Thorac Cardiovasc Surg &#xa0;2021;161:1713&#x2013;1720.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">31959445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang &#xa0;YF, Zhang &#xa0;GX, Liao &#xa0;ZL, Han &#xa0;L, Xu &#xa0;ZY. Surgical treatment of coronary malperfusion with acute type A aortic dissection. Chin Med J (Engl) &#xa0;2016;129:1000&#x2013;1002</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4831516</ArticleId><ArticleId IdType="pubmed">27064047</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsagakis &#xa0;K, Konorza &#xa0;T, Dohle &#xa0;DS, Kottenberg &#xa0;E, Buck &#xa0;T, Thielmann &#xa0;M &#xa0;et al. &#xa0;Hybrid operating room concept for combined diagnostics, intervention and surgery in acute type A dissection. Eur J Cardiothorac Surg &#xa0;2013;43:397&#x2013;404</Citation><ArticleIdList><ArticleId IdType="pubmed">22743082</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida &#xa0;K, Karube &#xa0;N, Yasuda &#xa0;S, Miyamoto &#xa0;T, Matsuki &#xa0;Y, Isoda &#xa0;S &#xa0;et al. &#xa0;Pathophysiology and surgical treatment of type A acute aortic dissection. Ann Vasc Dis &#xa0;2016;9:160&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027251</ArticleId><ArticleId IdType="pubmed">27738456</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;TKM, Wei &#xa0;D, Evans &#xa0;T, Ramanathan &#xa0;T, Haydock &#xa0;D. Surgery for type A aortic dissection: 14-year contemporary cohort study. Heart Lung Circ &#xa0;2020;29:1210&#x2013;1216</Citation><ArticleIdList><ArticleId IdType="pubmed">32113821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zindovic &#xa0;I, Gudbjartsson &#xa0;T, Ahlsson &#xa0;A, Fuglsang &#xa0;S, Gunn &#xa0;J, Hansson &#xa0;EC &#xa0;et al. &#xa0;Malperfusion in acute type A aortic dissection: an update from the Nordic Consortium for acute type A aortic dissection. J Thorac Cardiovasc Surg &#xa0;2019;157:1324&#x2013;1333.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">30578066</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Tawil &#xa0;M, Salem &#xa0;M, Friedrich &#xa0;C, Diraz &#xa0;S, Broll &#xa0;A, Rezahie &#xa0;N &#xa0;et al. &#xa0;Preoperative imaging signs of cerebral malperfusion in acute type A aortic dissection: influence on outcomes and prognostic implications&#x2013;a 20-year experience. J Clin Med &#xa0;2023;12:6659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10607191</ArticleId><ArticleId IdType="pubmed">37892797</ArticleId></ArticleIdList></Reference><Reference><Citation>Czerny &#xa0;M, Siepe &#xa0;M, Beyersdorf &#xa0;F, Feisst &#xa0;M, Gabel &#xa0;M, Pilz &#xa0;M &#xa0;et al. &#xa0;Prediction of mortality rate in acute type A dissection: the German registry for acute type A aortic dissection score. Eur J Cardiothorac Surg &#xa0;2020;58:700&#x2013;706</Citation><ArticleIdList><ArticleId IdType="pubmed">32492120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;W, Wang &#xa0;L, Chai &#xa0;C, Sun &#xa0;Q, Yuan &#xa0;Y, Wang &#xa0;T &#xa0;et al. &#xa0;Prognostic impact of branch vessel involvement on organ malperfusion and mid-term survival in patients with acute type A aortic dissection. Int J Cardiol &#xa0;2023;381:81&#x2013;87</Citation><ArticleIdList><ArticleId IdType="pubmed">37001645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe &#xa0;SB, Sundt &#xa0;TM &#xa0;III, Isselbacher &#xa0;EM, Cameron &#xa0;DE, Trimarchi &#xa0;S, Bekeredjian &#xa0;R &#xa0;et al. &#xa0;Survival after operative repair of acute type A aortic dissection varies according to the presence and type of preoperative malperfusion. J Thorac Cardiovasc Surg &#xa0;2022;168:37&#x2013;49.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">36333247</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagdi &#xa0;T, Atay &#xa0;Y, Engin &#xa0;C, Mahmudov &#xa0;R, Tetik &#xa0;O, Iyem &#xa0;H &#xa0;et al. &#xa0;Impact of organ malperfusion on mortality and morbidity in acute type A aortic dissections. J Card Surg &#xa0;2006;21:363&#x2013;369</Citation><ArticleIdList><ArticleId IdType="pubmed">16846414</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki &#xa0;M, Yoshino &#xa0;H, Kunihara &#xa0;T, Akutsu &#xa0;K, Shimokawa &#xa0;T, Ogino &#xa0;H &#xa0;et al. &#xa0;Risk analysis for early mortality in emergency acute type A aortic dissection surgery: experience of Tokyo acute aortic super-network. Eur J Cardiothorac Surg &#xa0;2021;60:957&#x2013;964</Citation><ArticleIdList><ArticleId IdType="pubmed">33829258</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida &#xa0;K, Karube &#xa0;N, Kasama &#xa0;K, Minami &#xa0;T, Yasuda &#xa0;S, Goda &#xa0;M &#xa0;et al. &#xa0;Early reperfusion strategy improves the outcomes of surgery for type A acute aortic dissection with malperfusion. J Thorac Cardiovasc Surg &#xa0;2018;156:483&#x2013;489</Citation><ArticleIdList><ArticleId IdType="pubmed">29548594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong &#xa0;G, Wu &#xa0;J, Chen &#xa0;Z, Zhuang &#xa0;D, Zhao &#xa0;S, Liu &#xa0;Y &#xa0;et al. &#xa0;Coronary malperfusion secondary to acute type A aortic dissection: surgical management based on a modified Neri classification. J Clin Med &#xa0;2022;11:1693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949911</ArticleId><ArticleId IdType="pubmed">35330018</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakai &#xa0;C, Izumi &#xa0;S, Haraguchi &#xa0;T, Henmi &#xa0;S, Nakayama &#xa0;S, Mikami &#xa0;T &#xa0;et al. &#xa0;Impact of time from symptom onset to operation on outcome of repair of acute type A aortic dissection with malperfusion. J Thorac Cardiovasc Surg &#xa0;2023;165:984&#x2013;991.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">33941373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishigawa &#xa0;K, Fukui &#xa0;T, Uemura &#xa0;K, Takanashi &#xa0;S, Shimokawa &#xa0;T. Preoperative renal malperfusion is an independent predictor for acute kidney injury and operative death but not associated with late mortality after surgery for acute type A aortic dissection. Eur J Cardiothorac Surg &#xa0;2020;58:302&#x2013;308</Citation><ArticleIdList><ArticleId IdType="pubmed">32182351</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita &#xa0;Y. Current surgical results of acute type A aortic dissection in Japan. Ann Cardiothorac Surg &#xa0;2016;5:368&#x2013;376</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973134</ArticleId><ArticleId IdType="pubmed">27563550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini &#xa0;D, Leone &#xa0;A, Belotti &#xa0;LM, Fortuna &#xa0;D, Gabbieri &#xa0;D, Zussa &#xa0;C &#xa0;et al. &#xa0;Acute type A aortic dissection: significance of multiorgan malperfusion. Eur J Cardiothorac Surg &#xa0;2013;43:820&#x2013;826</Citation><ArticleIdList><ArticleId IdType="pubmed">23137559</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahito &#xa0;K, Kimura &#xa0;N, Yamaguchi &#xa0;A, Aizawa &#xa0;K. Malperfusion in type A aortic dissection: results of emergency central aortic repair. Gen Thorac Cardiovasc Surg &#xa0;2019;67:594&#x2013;601</Citation><ArticleIdList><ArticleId IdType="pubmed">30729379</ArticleId></ArticleIdList></Reference><Reference><Citation>Geirsson &#xa0;A, Szeto &#xa0;WY, Pochettino &#xa0;A, McGarvey &#xa0;ML, Keane &#xa0;MG, Woo &#xa0;YJ &#xa0;et al. &#xa0;Significance of malperfusion syndromes prior to contemporary surgical repair for acute type A dissection: outcomes and need for additional revascularizations. Eur J Cardiothorac Surg &#xa0;2007;32:255&#x2013;262</Citation><ArticleIdList><ArticleId IdType="pubmed">17500002</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel &#xa0;NJ, Yarlagadda &#xa0;S, Bavaria &#xa0;JE, Freas &#xa0;AM, Kelly &#xa0;JJ, Yildiz &#xa0;M &#xa0;et al. &#xa0;Performance of the open-first repair strategy in type A aortic dissection with mesenteric malperfusion syndrome eligible for delayed repair. J Thorac Cardiovasc Surg &#xa0;2024; DOI: 10.1016/j.jtcvs.2024.07.030 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2024.07.030</ArticleId><ArticleId IdType="pmc">PMC11751134</ArticleId><ArticleId IdType="pubmed">39047861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz &#xa0;V, Muzzi &#xa0;L, Neri &#xa0;E. Analysis of current mortality risk scores for acute type A aortic dissection: the Siena experience. Asian Cardiovasc Thorac Ann &#xa0;2024;32:116&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pubmed">38317575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;X, Deng &#xa0;C, Guo &#xa0;F, Cao &#xa0;X, Yan &#xa0;Y. Relationship between the postoperative lactate dynamic levels, the acute gastrointestinal injury and the prognosis among patients who undergo surgical treatment for acute type A aortic dissection. Heliyon &#xa0;2023;9:e17128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10361332</ArticleId><ArticleId IdType="pubmed">37484280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;H, Jia &#xa0;B, Zhong &#xa0;Y, Chen &#xa0;S, Luo &#xa0;C, Qiao &#xa0;Z &#xa0;et al. &#xa0;Surgical management and outcomes of coronary artery involvement secondary to acute type A aortic dissection: a retrospective cohort study. J Thorac Dis &#xa0;2023;15:6436&#x2013;6446</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10797399</ArticleId><ArticleId IdType="pubmed">38249883</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan &#xa0;I, Brown &#xa0;JA, Serna-Gallegos &#xa0;D, Zhu &#xa0;J, Garvey &#xa0;J, Yousef &#xa0;S &#xa0;et al. &#xa0;Lower-extremity malperfusion syndrome in patients undergoing proximal aortic surgery for acute type A aortic dissection. JTCVS Open &#xa0;2023;15:1&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10556830</ArticleId><ArticleId IdType="pubmed">37808049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti &#xa0;JS, Melo &#xa0;NC, Vasconcelos &#xa0;RS. Morphometric and topographic study of coronary ostia. Arq Bras Cardiol &#xa0;2003;81:359&#x2013;362</Citation><ArticleIdList><ArticleId IdType="pubmed">14666278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahito &#xa0;K, Adachi &#xa0;H, Murata &#xa0;S, Yamaguchi &#xa0;A, Ino &#xa0;T. Coronary malperfusion due to type A aortic dissection: mechanism and surgical management. Ann Thorac Surg &#xa0;2003;76:1471&#x2013;1476</Citation><ArticleIdList><ArticleId IdType="pubmed">14602269</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito &#xa0;Y, Hashimoto &#xa0;O, Nakayama &#xa0;T, Sasaki &#xa0;H, Yumoto &#xa0;K, Oshima &#xa0;S &#xa0;et al. &#xa0;Right versus left coronary artery involvement in patients with type A acute aortic dissection. Int J Cardiol &#xa0;2023;371:49&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">36257475</ArticleId></ArticleIdList></Reference><Reference><Citation>Neri &#xa0;E, Toscano &#xa0;T, Papalia &#xa0;U, Frati &#xa0;G, Massetti &#xa0;M, Capannini &#xa0;G &#xa0;et al. &#xa0;Proximal aortic dissection with coronary malperfusion: presentation, management, and outcome. J Thorac Cardiovasc Surg &#xa0;2001;121:552&#x2013;560</Citation><ArticleIdList><ArticleId IdType="pubmed">11241091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayali &#xa0;F, Jubouri &#xa0;M, Al-Tawil &#xa0;M, Tan &#xa0;SZCP, Williams &#xa0;IM, Mohammed &#xa0;I &#xa0;et al. &#xa0;Coronary artery involvement in type A aortic dissection: fate of the coronaries. J Card Surg &#xa0;2022;37:5233&#x2013;5242</Citation><ArticleIdList><ArticleId IdType="pubmed">36177668</ArticleId></ArticleIdList></Reference><Reference><Citation>Eren &#xa0;E, Toker &#xa0;ME, Tun&#xe7;er &#xa0;A, Keles &#xa0;C, Erdogan &#xa0;HB, Anasiz &#xa0;H &#xa0;et al. &#xa0;Surgical management of coronary malperfusion due to type A aortic dissection. J Card Surg &#xa0;2007;22:2&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">17239202</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita &#xa0;Y, Minatoya &#xa0;K, Tagusari &#xa0;O, Ando &#xa0;M, Nagatsuka &#xa0;K, Kitamura &#xa0;S. Prospective comparative study of brain protection in total aortic arch replacement: deep hypothermic circulatory arrest with retrograde cerebral perfusion or selective antegrade cerebral perfusion. Ann Thorac Surg &#xa0;2001;72:72&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">11465234</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita &#xa0;Y, Miyata &#xa0;H, Motomura &#xa0;N, Takamoto &#xa0;S. A study of brain protection during total arch replacement comparing antegrade cerebral perfusion versus hypothermic circulatory arrest, with or without retrograde cerebral perfusion: analysis based on the Japan Adult Cardiovascular Surgery Database. J Thorac Cardiovasc Surg &#xa0;2015;149S65 &#xa0;S73</Citation><ArticleIdList><ArticleId IdType="pubmed">25439767</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemtob &#xa0;RA, Fuglsang &#xa0;S, Geirsson &#xa0;A, Ahlsson &#xa0;A, Olsson &#xa0;C, Gunn &#xa0;J &#xa0;et al. &#xa0;Stroke in acute type A aortic dissection: the Nordic Consortium for acute type A aortic dissection (NORCAAD). Eur J Cardiothorac Surg &#xa0;2020;58:1027&#x2013;1034</Citation><ArticleIdList><ArticleId IdType="pubmed">32688394</ArticleId></ArticleIdList></Reference><Reference><Citation>Eranki &#xa0;A, Wilson-Smith &#xa0;A, Williams &#xa0;ML, Saxena &#xa0;A, Mejia &#xa0;R. Quality of life following surgical repair of acute type A aortic dissection: a systematic review. J Cardiothorac Surg &#xa0;2022;17:118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112611</ArticleId><ArticleId IdType="pubmed">35578309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton &#xa0;JS, Moon &#xa0;MR, Liu &#xa0;J, Koerner &#xa0;DJ, Kulshrestha &#xa0;K, Damiano &#xa0;RJ &#xa0;et al. &#xa0;The profound impact of combined severe acidosis and malperfusion on operative mortality in the surgical treatment of type A aortic dissection. J Thorac Cardiovasc Surg &#xa0;2018;155:897&#x2013;904</Citation><ArticleIdList><ArticleId IdType="pubmed">29249502</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang &#xa0;B, Norton &#xa0;EL, Rosati &#xa0;CM, Wu &#xa0;X, Kim &#xa0;KM, Khaja &#xa0;MS &#xa0;et al. &#xa0;Managing patients with acute type A aortic dissection and mesenteric malperfusion syndrome: a 20-year experience. J Thorac Cardiovasc Surg &#xa0;2019;158:675&#x2013;687.e4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6570582</ArticleId><ArticleId IdType="pubmed">30711274</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang &#xa0;B, Rosati &#xa0;CM, Norton &#xa0;EL, Kim &#xa0;KM, Khaja &#xa0;MS, Dasika &#xa0;N &#xa0;et al. &#xa0;Endovascular fenestration/stenting first followed by delayed open aortic repair for acute type A aortic dissection with malperfusion syndrome. Circulation &#xa0;2018;138:2091&#x2013;2103</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6339462</ArticleId><ArticleId IdType="pubmed">30474418</ArticleId></ArticleIdList></Reference><Reference><Citation>Czerny &#xa0;M, Schmidli &#xa0;J, Adler &#xa0;S, van den Berg &#xa0;JC, Bertoglio &#xa0;L, Carrel &#xa0;T &#xa0;et al. &#xa0;Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society for Vascular Surgery (ESVS). Eur J Cardiothorac Surg &#xa0;2018;55:133&#x2013;162</Citation><ArticleIdList><ArticleId IdType="pubmed">30312382</ArticleId></ArticleIdList></Reference><Reference><Citation>Leshnower &#xa0;BG, Keeling &#xa0;WB, Duwayri &#xa0;YM, Jordan &#xa0;WD, Chen &#xa0;EP. The &#x201c;thoracic endovascular aortic repair-first&#x201d; strategy for acute type A dissection with mesenteric malperfusion: initial results compared with conventional algorithms. J Thorac Cardiovasc Surg &#xa0;2019;158:1516&#x2013;1524</Citation><ArticleIdList><ArticleId IdType="pubmed">30853232</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel &#xa0;HJ, Williams &#xa0;DM, Dasika &#xa0;NL, Suzuki &#xa0;Y, Deeb &#xa0;GM. Operative delay for peripheral malperfusion syndrome in acute type A aortic dissection: a long-term analysis. J Thorac Cardiovasc Surg &#xa0;2008;135:1288&#x2013;1296</Citation><ArticleIdList><ArticleId IdType="pubmed">18544373</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian &#xa0;S-C, Ma &#xa0;W-G, Pan &#xa0;X-D, Liu &#xa0;H, Zhang &#xa0;K, Zheng &#xa0;J &#xa0;et al. &#xa0;Renal malperfusion affects operative mortality rather than late death following acute type A aortic dissection repair. Asian J Surg &#xa0;2020;43:213&#x2013;219</Citation><ArticleIdList><ArticleId IdType="pubmed">30879906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawhney &#xa0;S, Marks &#xa0;A, Fluck &#xa0;N, Levin &#xa0;A, Prescott &#xa0;G, Black &#xa0;C. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis &#xa0;2017;69:18&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5176133</ArticleId><ArticleId IdType="pubmed">27555107</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleck &#xa0;T, Hutschala &#xa0;D, Weissl &#xa0;M, Wolner &#xa0;E, Grabenw&#xf6;ger &#xa0;M. Cerebrospinal fluid drainage as a useful treatment option to relieve paraplegia after stent-graft implantation for acute aortic dissection type B. J Thorac Cardiovasc Surg &#xa0;2002;123:1003&#x2013;1005</Citation><ArticleIdList><ArticleId IdType="pubmed">12019391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson &#xa0;CE, Yavas &#xa0;S, Segal &#xa0;MS, Schold &#xa0;JD, Tribble &#xa0;CG, Layon &#xa0;AJ &#xa0;et al. &#xa0;Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation &#xa0;2009;119:2444&#x2013;2453</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgason &#xa0;D, Helgadottir &#xa0;S, Ahlsson &#xa0;A, Gunn &#xa0;J, Hjortdal &#xa0;V, Hansson &#xa0;EC &#xa0;et al. &#xa0;Acute kidney injury after acute repair of type A aortic dissection. Ann Thorac Surg &#xa0;2021;111:1292&#x2013;1298</Citation><ArticleIdList><ArticleId IdType="pubmed">32961133</ArticleId></ArticleIdList></Reference><Reference><Citation>Medalion &#xa0;B, Bder &#xa0;O, Cohen &#xa0;AJ, Hauptman &#xa0;E, Schachner &#xa0;A. Delayed postoperative paraplegia complicating repair of type A dissection. Ann Thorac Surg &#xa0;2001;72:1389&#x2013;1391</Citation><ArticleIdList><ArticleId IdType="pubmed">11603476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu &#xa0;HK, Charlton-Ouw &#xa0;KM, Jeffress &#xa0;K, Leake &#xa0;S, Perlick &#xa0;A, Miller &#xa0;CC &#xa0;et al. &#xa0;Risk of mortality after resolution of spinal malperfusion in acute dissection. Ann Thorac Surg &#xa0;2018;106:473&#x2013;481</Citation><ArticleIdList><ArticleId IdType="pubmed">29559376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson &#xa0;SR, Romi &#xa0;F, Rekand &#xa0;T, Naess &#xa0;H. Long-term outcome after spinal cord infarctions. Acta Neurol Scand &#xa0;2014;131:253&#x2013;257</Citation><ArticleIdList><ArticleId IdType="pubmed">25346212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng &#xa0;S, Li &#xa0;X, Zhang &#xa0;Y, Liu &#xa0;C, Rao &#xa0;Y, Zhang &#xa0;Y &#xa0;et al. &#xa0;Rehabilitation report of 2 cases of spinal cord ischemic injury after intra-aortic repair. Medicine (Baltimore) &#xa0;2024;103:e38852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11272330</ArticleId><ArticleId IdType="pubmed">39058844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashir &#xa0;M, Mohammed &#xa0;I, Al-Tawil &#xa0;M, Jubouri &#xa0;M, Agbobu &#xa0;T, Chen &#xa0;EP. Frozen elephant trunk: the gold standard. Cardiovasc Diagn Ther &#xa0;2023;13:623&#x2013;627</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10315428</ArticleId><ArticleId IdType="pubmed">37405021</ArticleId></ArticleIdList></Reference><Reference><Citation>Harky &#xa0;A, Bashir &#xa0;M, Antoniou &#xa0;A, Bilal &#xa0;H. The changing surgical approach to acute type A aortic dissection. J Vis Surg &#xa0;2018;4:151</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33761539</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1833-3516</ISSN><JournalIssue CitedMedium="Print"><Volume>51</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>31</Day></PubDate></JournalIssue><Title>Diving and hyperbaric medicine</Title><ISOAbbreviation>Diving Hyperb Med</ISOAbbreviation></Journal><ArticleTitle>Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>34</StartPage><EndPage>43</EndPage><MedlinePgn>34-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.28920/dhm51.1.34-43</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Surgical intervention, broad-spectrum antibiotics and intensive care support are the standard of care in the treatment of necrotising soft-tissue infections (NSTI). Hyperbaric oxygen treatment (HBOT) may be a useful adjunctive treatment and has been used for almost 60 years, but its efficacy remains unknown and has not been systematically appraised. The aim was to systematically review and synthesise the highest level of clinical evidence available to support or refute the use of HBOT in the treatment of NSTI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The review was prospectively registered (PROSPERO; CRD42020148706). MEDLINE, EMBASE, CENTRAL and CINAHL were searched for eligible studies that reported outcomes in both HBOT treated and non-HBOT treated individuals with NSTI. In-hospital mortality was the primary outcome. Odds ratio (ORs) were pooled using random-effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The search identified 486 papers of which 31 were included in the qualitative synthesis and 21 in the meta-analyses. Meta-analysis on 48,744 patients with NSTI (1,237 (2.5%) HBOT versus 47,507 (97.5%) non-HBOT) showed in-hospital mortality was 4,770 of 48,744 patients overall (9.8%) and the pooled OR was 0.44 (95% CI 0.33-0.58) in favour of HBOT. For major amputation the pooled OR was 0.60 (95% CI 0.28-1.28) in favour of HBOT. The dose of oxygen in these studies was incompletely reported.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Meta-analysis of the non-random comparative data indicates patients with NSTI treated with HBOT have reduced odds of dying during the sentinel event and may be less likely to require a major amputation. The most effective dose of oxygen remains unclear.</AbstractText><CopyrightInformation>Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hedetoft</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, University of Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Hyperbaric Medicine, Prince of Wales Hospital, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Corresponding author: Dr Morten Hedetoft, Department of Anaesthesia, Rigshospitalet, University of Copenhagen, Blegdamsvej 8, 2100 Copenhagen, Denmark, morten.friis.fiskbaek.hedetoft@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Hyperbaric Medicine, Prince of Wales Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyldegaard</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, University of Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Diving Hyperb Med</MedlineTA><NlmUniqueID>101282742</NlmUniqueID><ISSNLinking>1833-3516</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003646" MajorTopicYN="N">Debridement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006931" MajorTopicYN="Y">Hyperbaric Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018461" MajorTopicYN="Y">Soft Tissue Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Evidence</Keyword><Keyword MajorTopicYN="N">Necrotizing infections</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>
<b>Conflict of interest and funding:</b>
 
No conflicts of interest were declared. MH was granted by Rigshospitalet&#x2019;s Research Foundation (grant no. R167-A7352-B3897), Knud and Edith Eriksen&#x2019;s Foundation, Wedellsborg Foundation and King Christian X&#x2019;s Foundation. Moreover, the study was supported by the projects of PERMIT (grant number 8113-00009B) funded by Innovation Fund Denmark and EU Horizon 2020 under the frame of ERA PerMed (project 2018-151) and PERAID (grant number 8114-00005B) funded by Innovation Fund Denmark and Nordforsk (project no. 90456).
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>24</Day><Hour>20</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33761539</ArticleId><ArticleId IdType="pmc">PMC8081587</ArticleId><ArticleId IdType="doi">10.28920/dhm51.1.34-43</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: Review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51:344&#x2013;62. doi: 10.1067/j.cpsurg.2014.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/j.cpsurg.2014.06.001</ArticleId><ArticleId IdType="pmc">PMC4199388</ArticleId><ArticleId IdType="pubmed">25069713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis Simonsen SM, Van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, et al. Cellulitis incidence in a defined population. Epidemiol Infect. 2006;134:293&#x2013;9. doi: 10.1017/S095026880500484X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S095026880500484X</ArticleId><ArticleId IdType="pmc">PMC2870381</ArticleId><ArticleId IdType="pubmed">16490133</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani AM, Best MJ, Francis CS, Allan BJ, Askari M, Panthaki ZJ. Trends in the incidence and treatment of necrotizing soft tissue infections: An analysis of the national hospital discharge survey. J Burn Care Res. 2014;35:449&#x2013;454. doi: 10.1097/BCR.0000000000000010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BCR.0000000000000010</ArticleId><ArticleId IdType="pubmed">25144805</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen MB, Skrede S, Perner A, Arnell P, Nekludov M, Bruun T, et al. Patient&#x2019;s characteristics and outcomes in necrotising soft-tissue infections: Results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Med. 2019;45:1241&#x2013;51. doi: 10.1007/s00134-019-05730-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05730-x</ArticleId><ArticleId IdType="pubmed">31440795</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2018;378:971. doi: 10.1056/NEJMc1800049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1800049</ArticleId><ArticleId IdType="pubmed">29514033</ArticleId></ArticleIdList></Reference><Reference><Citation>Young MH, Aronoff DM, Engleberg NC. Necrotizing fasciitis: Pathogenesis and treatment. Expert Rev Anti Infect Ther. 2005;3:279&#x2013;94. doi: 10.1586/14787210.3.2.279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.3.2.279</ArticleId><ArticleId IdType="pubmed">15918785</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen RJ, Musser JM. Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol. 2010;5:1&#x2013;31. doi: 10.1146/annurev-pathol-121808-102135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-121808-102135</ArticleId><ArticleId IdType="pubmed">19737105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt TK, Zederfeldt B, Goldstick TK. Oxygen and healing. Am J Surg. 1969;118:521&#x2013;5. doi: 10.1016/0002-9610(69)90174-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(69)90174-3</ArticleId><ArticleId IdType="pubmed">4898193</ArticleId></ArticleIdList></Reference><Reference><Citation>Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2020;26:8&#x2013;17. doi: 10.1016/j.cmi.2019.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2019.06.031</ArticleId><ArticleId IdType="pubmed">31284035</ArticleId></ArticleIdList></Reference><Reference><Citation>Brummelkamp WH, Hogendijk J, Boerema I. Treatment of anaerobic infections (clostridial myositis) by drenching the tissues with oxygen under high atmospheric pressure. Surgery. 1961;49:299&#x2013;302. doi: 10.5555/uri:pii:0039606061902641.</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/uri:pii:0039606061902641</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh CR, Pietrobon R, Freiberger JJ, Chew ST, Rajgor D, Gandhi M, et al. Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. Intensive Care Med. 2012;38:1143&#x2013;51. doi: 10.1007/s00134-012-2558-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2558-4</ArticleId><ArticleId IdType="pubmed">22527074</ArticleId></ArticleIdList></Reference><Reference><Citation>Levett D, Bennett MH, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database Syst Rev. 2015;1(1):CD007937. doi: 10.1002/14651858.CD007937.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007937.pub2</ArticleId><ArticleId IdType="pmc">PMC6516968</ArticleId><ArticleId IdType="pubmed">25879088</ArticleId></ArticleIdList></Reference><Reference><Citation>Faun&#xf8; Thrane J, Ovesen T. Scarce evidence of efficacy of hyperbaric oxygen therapy in necrotizing soft tissue infection: A systematic review. Infect Dis (Lond). 2019;51:485&#x2013;92. doi: 10.1080/23744235.2019.1597983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2019.1597983</ArticleId><ArticleId IdType="pubmed">30985236</ArticleId></ArticleIdList></Reference><Reference><Citation>

US National Library of Medicine
.
 Clinical Trials.
[cited 2020 May 05].
Available from:
https://clinicaltrials.gov.
</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008&#x2013;12. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wells G,
Shea B,
O&#x2019;Connell D,
Peterson J,
Welch V,
Losos M,
et al..
The Newcastle-Ottawa Scale (Nos) for assessing the quality of nonrandomised studies in meta-analyses.
Ottawa (ON), Canada:
Ottawa Hospital Research Institute.
[cited 2020 May 05].
Available from:
http://www.ohri.ca/programs/clinicalepidemiology/oxford.asp.
</Citation></Reference><Reference><Citation>Sterne JAc, Hern&#xe1;n MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Aasen AO, Ruud TE, Haffner J, Raeder M, Solheim K, Stadaas JO, et al. [Surgical treatment of necrotizing fasciitis]. Tidsskr Nor Laegeforen. 1989;109:2768&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">2815006</ArticleId></ArticleIdList></Reference><Reference><Citation>Anheuser P, Muhlstadt S, Kranz J, Schneidewind L, Steffens J, Fornara P. Significance of hyperbaric oxygenation in the treatment of Fournier&#x2019;s Gangrene: A comparative study. Urol Int. 2018;101:467&#x2013;71. doi: 10.1159/000493898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493898</ArticleId><ArticleId IdType="pubmed">30326483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayan F, Sunamak O, Paksoy SM, Polat SS, As A, Sakoglu N, et al. Fournier&#x2019;s gangrene: A retrospective clinical study on forty-one patients. ANZ J Surg. 2005;75:1055&#x2013;8. doi: 10.1111/j.1445-2197.2005.03609.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-2197.2005.03609.x</ArticleId><ArticleId IdType="pubmed">16398810</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DR, Davis NL, Lepawsky M, Cunningham J, Kortbeek J. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167:485&#x2013;9. doi: 10.1016/0002-9610(94)90240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(94)90240-2</ArticleId><ArticleId IdType="pubmed">8185032</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahm P, Roland FH, Vaslef SN, Moon RE, Price DT, Georgiade GS, et al. Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology. 2000;56:31&#x2013;5. doi: 10.1016/s0090-4295(00)00604-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0090-4295(00)00604-x</ArticleId><ArticleId IdType="pubmed">10869615</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaney B, Frawley G, Frawley L, Pilcher DV. Necrotising soft tissue infections: The effect of hyperbaric oxygen on mortality. Anaesth Intensive Care. 2015;43:685&#x2013;92. doi: 10.1177/0310057X1504300604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1504300604</ArticleId><ArticleId IdType="pubmed">26603791</ArticleId></ArticleIdList></Reference><Reference><Citation>George ME, Rueth NM, Skarda DE, Chipman JG, Quickel RR, Beilman GJ. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt). 2009;10:21&#x2013;8. doi: 10.1089/sur.2007.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2007.085</ArticleId><ArticleId IdType="pubmed">18991520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan Z, Mullins RF, Friedman BC, Shaver JR, Brandigi C, Alam B, et al. Treating necrotizing fasciitis with or without hyperbaric oxygen therapy. Undersea Hyperb Med. 2010;37:115&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">20462144</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollabaugh RS, Dmochowski RR, Hickerson WL, Cox CE. Fournier&#x2019;s gangrene: Therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg. 1998;101:94&#x2013;100. doi: 10.1097/00006534-199801000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006534-199801000-00016</ArticleId><ArticleId IdType="pubmed">9427921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung MC, Chou CL, Cheng LC, Ho CH, Niu KC, Chen HL, et al. The role of hyperbaric oxygen therapy in treating extensive Fournier&#x2019;s Gangrene. Urol Sci. 2015;27:148&#x2013;53. doi: 10.1016/j.urols.2015.06.294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urols.2015.06.294</ArticleId></ArticleIdList></Reference><Reference><Citation>Krenk L, Nielsen HU, Christensen ME. Necrotizing fasciitis in the head and neck region: An analysis of standard treatment effectiveness. Eur Arch Otorhinolaryngol. 2007;264:917&#x2013;22. doi: 10.1007/s00405-007-0275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-007-0275-3</ArticleId><ArticleId IdType="pubmed">17340128</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Zhou X, Liu LF, Qi F, Chen JB, Zu XB. Hyperbaric oxygen therapy as an adjuvant therapy for comprehensive treatment of Fournier&#x2019;s gangrene. Urol Int. 2015;94:453&#x2013;8. doi: 10.1159/000366137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000366137</ArticleId><ArticleId IdType="pubmed">25677386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao JC, Carron MA, Fountain KR, Stachler RJ, Yoo GH, Mathog RH, et al. Craniocervical necrotizing fasciitis with and without thoracic extension: Management strategies and outcome. Am J Otolaryngol. 2009;30:17&#x2013;23. doi: 10.1016/j.amjoto.2007.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2007.12.007</ArticleId><ArticleId IdType="pubmed">19027508</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey PR, Sakran JV, Mills AM, Sarani B, Aufhauser DD, Sims CA, et al. Hyperbaric oxygen therapy in necrotizing soft tissue infections. J Surg Res. 2012;177:146&#x2013;51. doi: 10.1016/j.jss.2012.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2012.03.016</ArticleId><ArticleId IdType="pubmed">22487383</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehl AA, Filho DCN, Mantovani LM, Grippa MM, Berger R, Krauss D, et al. Management of Fournier&#x2019;s gangrene: Experience of a university hospital of Curitiba. Rev Col Bras Cir. 2010;37:435&#x2013;41. doi: 10.1590/S0100-69912010000600010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-69912010000600010</ArticleId><ArticleId IdType="pubmed">21340259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mindrup SR, Kealey GP, Fallon B. Hyperbaric oxygen for the treatment of Fournier&#x2019;s gangrene. J Urol. 2005;173:1975&#x2013;7. doi: 10.1097/01.ju.0000158129.56571.05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ju.0000158129.56571.05</ArticleId><ArticleId IdType="pubmed">15879795</ArticleId></ArticleIdList></Reference><Reference><Citation>Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108:847&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">2237764</ArticleId></ArticleIdList></Reference><Reference><Citation>Shupak A, Shoshani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S. Necrotizing fasciitis: An indication for hyperbaric oxygenation therapy? Surgery. 1995: 118; 873- 8. doi: 10.1016/S0039-6060(05)80278-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6060(05)80278-8</ArticleId><ArticleId IdType="pubmed">7482275</ArticleId></ArticleIdList></Reference><Reference><Citation>Faun&#xf8; Thrane J, Pikelis A, Ovesen T. Hyperbaric oxygen may only be optional in head and neck necrotizing fasciitis: A retrospective analysis of 43 cases and review of the literature. Infect Dis (Lond). 2017;49:792&#x2013;8. doi: 10.1080/23744235.2017.1342142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2017.1342142</ArticleId><ArticleId IdType="pubmed">28644692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg. 2004;139:1339&#x2013;45. doi: 10.1001/archsurg.139.12.1339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.139.12.1339</ArticleId><ArticleId IdType="pubmed">15611459</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw JJ, Psoinos C, Emhoff TA, Shah SS, Santry HP. Not just full of hot air: Hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect (Larchmt). 2014;15:328&#x2013;35. doi: 10.1089/sur.2012.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2012.135</ArticleId><ArticleId IdType="pmc">PMC4696431</ArticleId><ArticleId IdType="pubmed">24786980</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanagan CE, Daramola OO, Maisel RH, Adkinson C, Odland RM. Surgical debridement and adjunctive hyperbaric oxygen in cervical necrotizing fasciitis. Otolaryngol Head Neck Surg. 2009;140:730&#x2013;4. doi: 10.1016/j.otohns.2009.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otohns.2009.01.014</ArticleId><ArticleId IdType="pubmed">19393420</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzilai A, Zaaroor M, Toledano C. Necrotizing fasciitis: Early awareness and principles of treatment. Isr J Med Sci. 1985;21:127&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">3156822</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo K, Gong W, Zheng T, Hong Z, Wu X, Ren H, et al. Clinical parameters and outcomes of necrotizing soft tissue infections secondary to gastrointestinal fistulas. BMC Infect Dis. 2019;19:597. doi: 10.1186/s12879-019-4248-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4248-0</ArticleId><ArticleId IdType="pmc">PMC6617561</ArticleId><ArticleId IdType="pubmed">31288746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ersan Y, &#xd6;zg&#xfc;ltekin R, Cetinkale O, Celik V, Ayan F, Cercel A. Fournier-Gangr&#xe4;n. Langenbecks Arch Chir. 1995;380:139&#x2013;43. doi: 10.1007/BF00207718. (Ger).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00207718</ArticleId><ArticleId IdType="pubmed">7791483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayetto K, Cheng A, Sambrook P. Necrotizing fasciitis as a complication of odontogenic infection: A review of management and case series. Aust Dent J. 2017;62:317&#x2013;22. doi: 10.1111/adj.12508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/adj.12508</ArticleId><ArticleId IdType="pubmed">28241379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferretti M, Saji AA, Phillips J. Fournier&#x2019;s gangrene: A review and outcome comparison from 2009 to 2016. Adv Wound Care (New Rochelle). 2017;6:289&#x2013;95. doi: 10.1089/wound.2017.0730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/wound.2017.0730</ArticleId><ArticleId IdType="pmc">PMC5592842</ArticleId><ArticleId IdType="pubmed">28894636</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieg A, Dizdar L, Verde PE, Knoefel WT. Predictors of mortality for necrotizing soft-tissue infections: A retrospective analysis of 64 cases. Langenbecks Arch Surg. 2014;399:333&#x2013;41. doi: 10.1007/s00423-014-1162-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-014-1162-1</ArticleId><ArticleId IdType="pubmed">24413760</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisel RH, Karlen R. Cervical necrotizing fasciitis. Laryngoscope. 1994;104:795&#x2013;8. doi: 10.1288/00005537-199407000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1288/00005537-199407000-00003</ArticleId><ArticleId IdType="pubmed">8022239</ArticleId></ArticleIdList></Reference><Reference><Citation>Creta M, Longo M, Arcaniolo D, Giannella R, Cai T, Cicalese A, et al. Hyperbaric oxygen therapy reduces mortality in patients with Fournier&#x2019;s gangrene. Results from a multi-institutional observational study. Minerva Urol Nefrol. 2020;72:223&#x2013;8. doi: 10.23736/S0393-2249.20.03696-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0393-2249.20.03696-6</ArticleId><ArticleId IdType="pubmed">32083420</ArticleId></ArticleIdList></Reference><Reference><Citation>
Higgins JPT,
Thomas J,
Chandler J,
Cumpston M,
Li T,
Page MJ, editors.
Cochrane handbook for systematic reviews of interventions, version 6.0 (Updated July 2019).
Cochrane; 
2019.
[cited 2020 May 05].
Available from:
https://training.cochrane.org/cochrane-handbook-systematic-reviews-interventions.
</Citation></Reference><Reference><Citation>

The Centre for Evidence-Based Medicine.

Number needed to treat (NNT).
[cited 2020 May 05].
Available from:
https://www.cebm.net/2014/03/number-needed-to-treat-nnt/.
</Citation></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Hoboken (NJ): Wiley Publishers; 2018.</Citation></Reference><Reference><Citation>Linde K, Scholz M, Melchart D, Willich SN. Should systematic reviews include non-randomized and uncontrolled studies? The case of acupuncture for chronic headache. J Clin Epidemiol. 2002;55:77&#x2013;85. doi: 10.1016/s0895-4356(01)00422-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0895-4356(01)00422-x</ArticleId><ArticleId IdType="pubmed">11781125</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol (1985). 2009;106:988&#x2013;95. doi: 10.1152/japplphysiol.91004.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.91004.2008</ArticleId><ArticleId IdType="pmc">PMC2660252</ArticleId><ArticleId IdType="pubmed">18845776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratzenhofer-Komenda B, Offner A, Ofner P, Klemen H, Prause G, Smolle-J&#xfc;tiner FM, et al. Arterial oxygen tension increase 2&#x2013;3 h after hyperbaric oxygen therapy: A prospective observational study. Acta Anaesthesiol Scand. 2007;51:68&#x2013;73. doi: 10.1111/j.1399-6576.2006.01197.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2006.01197.x</ArticleId><ArticleId IdType="pubmed">17229230</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallinger S, Dorner GT, Wenzel R, Graselli U, Findl O, Eichler HG, et al. Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina. Invest Ophthalmol Vis Sci. 2000;41:864&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10711705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird AD, Telfer AB. The effect of oxygen at 1 and 2 atmospheres on resting forearm blood flow. Surg Gynecol Obstet. 1966;123:260&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">5913479</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill AL, Bell CNA. Hyperbaric oxygen: Its uses, mechanisms of action and outcomes. QJM. 2004;97:385&#x2013;95. doi: 10.1093/qjmed/hch074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hch074</ArticleId><ArticleId IdType="pubmed">15208426</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom SR, Mendiguren I, Hardy K, Bolotin T, Fisher D, Nebolon M, et al. Inhibition of human neutrophil b2-integrin-dependent adherence by hyperbaric O2 . Am J Physiol. 1997;272:C770&#x2013;7. doi: 10.1152/ajpcell.1997.272.3.C770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1997.272.3.C770</ArticleId><ArticleId IdType="pubmed">9124510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima FL, Joazeiro PP, Lancellotti M, Hollada LMD, Lima BDA, Linares E, et al. Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages. Future Microbiol. 2015;10:179&#x2013;89. doi: 10.2217/fmb.14.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.14.111</ArticleId><ArticleId IdType="pubmed">25689530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bumah VV, Whelan HT, Masson-Meyers DS, Quirk B, Buchmann E, Enwemeka CS. The bactericidal effect of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus (MRSA). Lasers Med Sci. 2015;30:1153&#x2013;9. doi: 10.1007/s10103-015-1722-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-015-1722-9</ArticleId><ArticleId IdType="pmc">PMC4535990</ArticleId><ArticleId IdType="pubmed">25700768</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerche CJ, Christophersen LJ, Kolpen M, Nielsen PR, Tr&#xf8;strup H, Thomsen K, et al. Hyperbaric oxygen therapy augments tobramycin efficacy in experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents. 2017;50:406&#x2013;12. doi: 10.1016/j.ijantimicag.2017.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2017.04.025</ArticleId><ArticleId IdType="pubmed">28669832</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemens N, Chakrakodi B, Shambat SM, Morgan M, Bergsten H, Hyldegaard O, et al. Biofilm in group A streptococcal necrotizing soft tissue infections. JCI insight. 2016;1(10):e87882. doi: 10.1172/jci.insight.87882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.87882</ArticleId><ArticleId IdType="pmc">PMC5033946</ArticleId><ArticleId IdType="pubmed">27699220</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen P&#xd8;, M&#xf8;ller SA, Lerche CJ, Moser C, Bjarnsholt T, Ciofu O, et al. Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: Not just hot air. Biofilm. 2019;1:100008. doi: 10.1016/j.bioflm.2019.100008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioflm.2019.100008</ArticleId><ArticleId IdType="pmc">PMC7798444</ArticleId><ArticleId IdType="pubmed">33447795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hills BA. A role for oxygen-induced osmosis in hyperbaric oxygen therapy. Med Hypotheses. 1999;52:259&#x2013;63. doi: 10.1054/mehy.1997.0640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/mehy.1997.0640</ArticleId><ArticleId IdType="pubmed">10362286</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver LK. UHMS: Hyperbaric oxygen therapy indications, 13th ed. North Palm Beach (FL): Best Publishing Company; 2014.</Citation></Reference><Reference><Citation>Capes JP, Tomaszewski C. Prophylaxis against middle ear barotrauma in US hyperbaric oxygen therapy centers. Am J Emerg Med. 1996;14:645&#x2013;8. doi: 10.1016/S0735-6757(96)90079-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-6757(96)90079-0</ArticleId><ArticleId IdType="pubmed">8906761</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa DA, Ganilha JS, Barata PC, Guerreiro FG. Seizure frequency in more than 180,000 treatment sessions with hyperbaric oxygen therapy &#x2013; a single centre 20-year analysis. Diving Hyperb Med. 2019;49:167&#x2013;74. doi: 10.28920/dhm49.3167-174.</Citation><ArticleIdList><ArticleId IdType="doi">10.28920/dhm49.3167-174</ArticleId><ArticleId IdType="pmc">PMC6884101</ArticleId><ArticleId IdType="pubmed">31523791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kot J. Staffing and training issues in critical care hyperbaric medicine. Diving Hyperb Med. 2015;45:47&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">25964039</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu D, Ratzenhofer-Komendailha B, Kot J. Hyperbaric oxygen therapy for intensive care patients: position statement by the European Committee for Hyperbaric Medicine. Diving Hyperb Med. 2015;45:42&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25964038</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37736801</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2614</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of clinical monitoring and computing</Title><ISOAbbreviation>J Clin Monit Comput</ISOAbbreviation></Journal><ArticleTitle>Electrocardiogram alterations in non-traumatic brain injury: a systematic review.</ArticleTitle><Pagination><StartPage>407</StartPage><EndPage>414</EndPage><MedlinePgn>407-414</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10877-023-01075-5</ELocationID><Abstract><AbstractText>The presence of abnormal electrocardiograms in individuals without known organic heart disease is one of the most common manifestations of cardiac dysfunction occurring during acute non traumatic brain injury. The primary goal of the present review is to provide an overview of the available data and literature regarding the presence of new-onset electrocardiographic (ECG) alterations in acute non traumatic brain injury. The secondary aim is to identify the incidence of ECG alterations and consider the prognostic significance of new-onset ECG changes in this setting. To do so, English language articles from January 2000 to January 2022 were included from PubMed using the following keywords: "electrocardiogram and subarachnoid hemorrhage", "electrocardiogram and intracranial hemorrhage", "Q-T interval and subarachnoid hemorrhage ", "Q-T interval and intracranial bleeding ", "Q-T interval and intracranial hemorrhage", and "brain and heart- interaction in stroke". Of 3162 papers, 27 original trials looking at electrocardiogram alterations in acute brain injury were included following the PRISMA guideline. ECG abnormalities associated with acute brain injury could potentially predict poor patient outcomes. They could even herald the future development of neurogenic pulmonary edema (NPE), delayed cerebral ischemia (DCI), and even in-hospital death. In particular, patients with SAH are at increased risk of having severe ventricular dysrhythmias. These may contribute to a high mortality rate and to poor functional outcome at 3&#xa0;months. The current data on ECG QT dispersion and mortality appear less clearly associated. While some patients demonstrated poor outcomes, others showed no relationship with poor outcomes or increased in-hospital mortality. Observing ECG alterations carefully after cerebral damage is important in the critical care of these patients as it can expose preexisting myocardial disease and change prognosis.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Longhitano</LastName><ForeName>Yaroslava</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bottinelli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, "Maggiore Della Carit&#xe0;" University Hospital, Corso Mazzini18, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappalardo</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Anesthesiology, AON SS. Antonio E Biagio E Cesare Arrigo H, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maj</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiac Anesthesiology, AON SS. Antonio E Biagio E Cesare Arrigo H, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Audo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, AON SS. Antonio E Biagio E Cesare Arrigo H, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srejic</LastName><ForeName>Una</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pain Medicine, and Critical Care, University of California, San Diego, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasulo</LastName><ForeName>Frank Anthony</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pain Medicine, and Critical Care, Spedali Civili, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanza</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Italian Society of Pre-Hospital Emergency Medicine (SIS-118), Consultant in Anesthesia and Critical Care and Consultant in Internal and Emergency Medicine, Taranto, EU, Italy. christian.zanza@live.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Monit Comput</MedlineTA><NlmUniqueID>9806357</NlmUniqueID><ISSNLinking>1387-1307</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="Y">Brain Injuries</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013345" MajorTopicYN="N">Subarachnoid Hemorrhage</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011654" MajorTopicYN="N">Pulmonary Edema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain&#x2013;heart interaction</Keyword><Keyword MajorTopicYN="N">Electrocardiogram</Keyword><Keyword MajorTopicYN="N">Intracranial bleeding</Keyword><Keyword MajorTopicYN="N">Intracranial hemorrhage</Keyword><Keyword MajorTopicYN="N">Q-T dispersion</Keyword><Keyword MajorTopicYN="N">Q-T interval</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Subarachnoid hemorrhage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37736801</ArticleId><ArticleId IdType="doi">10.1007/s10877-023-01075-5</ArticleId><ArticleId IdType="pii">10.1007/s10877-023-01075-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longhitano Y, Iannuzzi F, Bonatti G, Zanza C, Messina A, Godoy D, Dabrowski W, Xiuyun L, Czosnyka M, Pelosi P, Badenes R, Robba C. Cerebral autoregulation in non-brain injured patients: a systematic review. Front Neurol. 2021;12:732176. https://doi.org/10.3389/fneur.2021.732176 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.732176</ArticleId><ArticleId IdType="pubmed">34899560</ArticleId><ArticleId IdType="pmc">8660115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanza C, Piccolella F, Racca F, Romenskaya T, Longhitano Y, Franceschi F, Savioli G, Bertozzi G, De Simone S, Cipolloni L, La Russa R. Ketamine in acute brain injury: current opinion following cerebral circulation and electrical activity. Healthcare (Basel). 2022;10(3):566. https://doi.org/10.3390/healthcare10030566.PMID:35327044;PMCID:PMC8949520 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10030566.PMID:35327044;PMCID:PMC8949520</ArticleId><ArticleId IdType="pubmed">35327044</ArticleId></ArticleIdList></Reference><Reference><Citation>Byer E, Ashman R, Toth LA. Electrocardiograms with large, upright T waves and long Q-T intervals. Am Heart J. 1947;33(6):796&#x2013;806. https://doi.org/10.1016/0002-8703(47)90025-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(47)90025-2</ArticleId><ArticleId IdType="pubmed">20242366</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke. 1979;10(3):253&#x2013;9. https://doi.org/10.1161/01.str.10.3.253 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.str.10.3.253</ArticleId><ArticleId IdType="pubmed">462510</ArticleId></ArticleIdList></Reference><Reference><Citation>Macmillan CS, Andrews PJ, Struthers AD. QTc dispersion as a marker for medical complications after severe subarachnoid haemorrhage. Eur J Anaesthesiol. 2003;20(7):537&#x2013;42. https://doi.org/10.1017/s0265021503000851 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0265021503000851</ArticleId><ArticleId IdType="pubmed">12884986</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers PJ, Wijdicks EF, Hasan D, Vermeulen M, Wever EF, Frericks H, van Gijn J. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke. 1989;20(9):1162&#x2013;7. https://doi.org/10.1161/01.str.20.9.1162 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.str.20.9.1162</ArticleId><ArticleId IdType="pubmed">2772976</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo J, Huang L, Peng J, Ocak U, Zhang J, Zhang JH. Autonomic disturbances in acute cerebrovascular disease. Neurosci Bull. 2019;35(1):133&#x2013;44. https://doi.org/10.1007/s12264-018-0299-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-018-0299-2</ArticleId><ArticleId IdType="pubmed">30311072</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L, Tian G, Leung H, Soo YOY, Chen X, Ip VHL, Mok VCT, Chu WCW, Wong KS, Leung TWH. Autonomic dysfunction predicts clinical outcomes after acute ischemic stroke: a prospective observational study. Stroke. 2018;49(1):215&#x2013;8. https://doi.org/10.1161/STROKEAHA.117.019312 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.019312</ArticleId><ArticleId IdType="pubmed">29203690</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos AH, Korantzopoulos P, Tsivgoulis G, Kyritsis AP, Kosmidou M, Giannopoulos S. Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesions. Int J Cardiol. 2013;167(2):328&#x2013;34. https://doi.org/10.1016/j.ijcard.2012.06.107 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.06.107</ArticleId><ArticleId IdType="pubmed">22809542</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Huang CH, Kuo HY, Chan CM, Chen JH, Chen WL. The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: early risk prognostication. Am J Emerg Med. 2012;30(5):732&#x2013;6. https://doi.org/10.1016/j.ajem.2011.05.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2011.05.003</ArticleId><ArticleId IdType="pubmed">21641747</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf3;voa R, Cavichio L, de Almeida AL, Viotti D, Ferreira C, Galv&#xe3;o L, Pimenta J. Electrocardiographic abnormalities in neurological diseases. Arq Bras Cardiol. 2003;80(4):351&#x2013;8. https://doi.org/10.1590/s0066-782x2003000400001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0066-782x2003000400001</ArticleId><ArticleId IdType="pubmed">12754557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T, Azuma A, Sawada T, Sugihara H, Kuribayashi T, Satoh M, Shimizu Y, Nakagawa M. Electrocardiographic score as a predictor of mortality after subarachnoid hemorrhage. Circ J. 2002;66(6):567&#x2013;70. https://doi.org/10.1253/circj.66.567 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.66.567</ArticleId><ArticleId IdType="pubmed">12074275</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuels MA. The brain-heart connection. Circulation. 2007;116(1):77&#x2013;84. https://doi.org/10.1161/CIRCULATIONAHA.106.678995 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.678995</ArticleId><ArticleId IdType="pubmed">17606855</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniele O, Caravaglios G, Fierro B, Natal&#xe8; E. Stroke and cardiac arrhythmias. J Stroke Cerebrovasc Dis. 2002;11(1):28&#x2013;33. https://doi.org/10.1053/jscd.2002.123972 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jscd.2002.123972</ArticleId><ArticleId IdType="pubmed">17903852</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr YL, Lim N, Amaral AC, Ghosn I, Carvalho FB, Renard M, Vincent JL. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol. 2004;96(3):369&#x2013;73. https://doi.org/10.1016/j.ijcard.2003.07.027 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2003.07.027</ArticleId><ArticleId IdType="pubmed">15301889</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https://doi.org/10.1136/bmj.n160 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n160</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId><ArticleId IdType="pmc">8005925</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui S, Katoh H, Tsuzuki N, Ishihara S, Otani N, Ooigawa H, Toyooka T, Ohnuki A, Miyazawa T, Nawashiro H, Shima K. Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage. Crit Care. 2003;7(3):R7&#x2013;12. https://doi.org/10.1186/cc2160 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2160</ArticleId><ArticleId IdType="pubmed">12793884</ArticleId><ArticleId IdType="pmc">270671</ArticleId></ArticleIdList></Reference><Reference><Citation>Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 1990;63(6):342&#x2013;4. https://doi.org/10.1136/hrt.63.6.342.PMID:2375895;PMCID:PMC1024518 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.63.6.342.PMID:2375895;PMCID:PMC1024518</ArticleId><ArticleId IdType="pubmed">2375895</ArticleId><ArticleId IdType="pmc">1024518</ArticleId></ArticleIdList></Reference><Reference><Citation>Colkesen AY, Sen O, Giray S, Acil T, Ozin B, Muderrisoglu H. Correlation between QTc interval and clinical severity of subarachnoid hemorrhage depends on the QTc formula used. Pacing Clin Electrophysiol. 2007;30(12):1482&#x2013;6. https://doi.org/10.1111/j.1540-8159.2007.00895.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2007.00895.x</ArticleId><ArticleId IdType="pubmed">18070302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Kato M, Yoshimoto T. QT intervals and QT dispersion in patients with subarachnoid hemorrhage. J Anesth. 2001;15(2):74&#x2013;7. https://doi.org/10.1007/s005400170030 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s005400170030</ArticleId><ArticleId IdType="pubmed">14566526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KW, Okin PM, Kligfield P, Stein KM, Lerman BB. Precordial QT dispersion and inducible ventricular tachycardia. Am Heart J. 1997;134(6):1005&#x2013;13. https://doi.org/10.1016/s0002-8703(97)70019-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-8703(97)70019-x</ArticleId><ArticleId IdType="pubmed">9424059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Qi S. Electrocardiographic abnormalities predict adverse clinical outcomes in patients with subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2016;25(11):2653&#x2013;9. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.07.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2016.07.011</ArticleId><ArticleId IdType="pubmed">27476337</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuiling WJ, Algra A, de Weerd AW, Leemans P, Rinkel GJ. ECG abnormalities in predicting secondary cerebral ischemia after subarachnoid haemorrhage. Acta Neurochir (Wien). 2006;148(8):853&#x2013;8. https://doi.org/10.1007/s00701-006-0808-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-006-0808-3</ArticleId><ArticleId IdType="pubmed">16791433</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt JM, Sow D, Crimmins M, Albers D, Agarwal S, Claassen J, Connolly ES, Elkind MS, Hripcsak G, Mayer SA. Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage. Neurocrit Care. 2014;20(3):382&#x2013;9. https://doi.org/10.1007/s12028-014-9966-y.PMID:24610353;PMCID:PMC4436968 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-014-9966-y.PMID:24610353;PMCID:PMC4436968</ArticleId><ArticleId IdType="pubmed">24610353</ArticleId><ArticleId IdType="pmc">4436968</ArticleId></ArticleIdList></Reference><Reference><Citation>Togha M, Sharifpour A, Ashraf H, Moghadam M, Sahraian MA. Electrocardiographic abnormalities in acute cerebrovascular events in patients with/without cardiovascular disease. Ann Indian Acad Neurol. 2013;16(1):66&#x2013;71. https://doi.org/10.4103/0972-2327.107710.PMID:23661966;PMCID:PMC3644785 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-2327.107710.PMID:23661966;PMCID:PMC3644785</ArticleId><ArticleId IdType="pubmed">23661966</ArticleId><ArticleId IdType="pmc">3644785</ArticleId></ArticleIdList></Reference><Reference><Citation>Loggini A, Mansour A, El Ammar F, Tangonan R, Kramer CL, Goldenberg FD, Lazaridis C. Inversion of T waves on admission is associated with mortality in spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2021;30(6):105776. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105776 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2021.105776</ArticleId><ArticleId IdType="pubmed">33839377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim GM, Macdonald RL. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2012;43(8):2102&#x2013;7. https://doi.org/10.1161/STROKEAHA.112.658153 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.112.658153</ArticleId><ArticleId IdType="pubmed">22678087</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong YS, Kim HD. Clinically significant cardiac arrhythmia in patients with aneurysmal subarachnoid hemorrhage. J Cerebrovasc Endovasc Neurosurg. 2012;14(2):90&#x2013;4. https://doi.org/10.7461/jcen.2012.14.2.90 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7461/jcen.2012.14.2.90</ArticleId><ArticleId IdType="pubmed">23210034</ArticleId><ArticleId IdType="pmc">3471254</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen H, Fogh Christensen A, Boysen G. Abnormalities on ECG and telemetry predict stroke outcome at 3&#xa0;months. J Neurol Sci. 2005;234(1&#x2013;2):99&#x2013;103. https://doi.org/10.1016/j.jns.2005.03.039 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.03.039</ArticleId><ArticleId IdType="pubmed">15935384</ArticleId></ArticleIdList></Reference><Reference><Citation>Stead LG, Gilmore RM, Bellolio MF, Vaidyanathan L, Weaver AL, Decker WW, Brown RD. Prolonged QTc as a predictor of mortality in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2009;18(6):469&#x2013;74. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.02.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2009.02.006</ArticleId><ArticleId IdType="pubmed">19900651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroiwa T, Morita H, Tanabe H, Ohta T. Significance of ST segment elevation in electrocardiograms in patients with ruptured cerebral aneurysms. Acta Neurochir (Wien). 1995;133(3&#x2013;4):141&#x2013;6. https://doi.org/10.1007/BF01420064 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01420064</ArticleId><ArticleId IdType="pubmed">8748756</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pasquale G, Pinelli G, Andreoli A, Manini G, Grazi P, Tognetti F. Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol. 1987;59(6):596&#x2013;600. https://doi.org/10.1016/0002-9149(87)91176-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(87)91176-3</ArticleId><ArticleId IdType="pubmed">3825900</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Parra A, Shimbo D, Fernandez A, Schmidt JM, Peter P, Claassen J, Wartenberg KE, Rincon F, Badjatia N, Naidech A, Connolly ES, Mayer SA. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis. 2008;26(1):71&#x2013;8. https://doi.org/10.1159/000135711 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000135711</ArticleId><ArticleId IdType="pubmed">18525201</ArticleId><ArticleId IdType="pmc">2909703</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Kaffashi F, Loparo KA, Jacono FJ. The use of heart rate variability for the early detection of treatable complications after aneurysmal subarachnoid hemorrhage. J Clin Monit Comput. 2013;27(4):385&#x2013;93. https://doi.org/10.1007/s10877-013-9467-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-013-9467-0</ArticleId><ArticleId IdType="pubmed">23615846</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangiskakis JM, Hravnak M, Crago EA, Tanabe M, Kip KE, Gorcsan J 3rd, Horowitz MB, Kassam AB, London B. Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit Care. 2009;10(3):287&#x2013;94. https://doi.org/10.1007/s12028-009-9188-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-009-9188-x</ArticleId><ArticleId IdType="pubmed">19184553</ArticleId><ArticleId IdType="pmc">3673292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar JM, Salciccioli L. Prognostic value of QT dispersion in acute stroke. Int J Cardiol. 2008;129(1):1&#x2013;2. https://doi.org/10.1016/j.ijcard.2008.04.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2008.04.003</ArticleId><ArticleId IdType="pubmed">18573552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanci V, G&#xfc;l S, Dogan SM, Turan IO, Kalayci M, A&#xe7;ikg&#xf6;z B. Evaluation of P wave and corrected QT dispersion in subarachnoid haemorrhage. Anaesth Intensive Care. 2010;38(1):128&#x2013;32. https://doi.org/10.1177/0310057X1003800121 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1003800121</ArticleId><ArticleId IdType="pubmed">20191788</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Feng-He DU, Tian JP. The electrocardiographic changes in acute brain injury patients. Chin Med J (Engl). 2012;125(19):3430&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">23044301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederman YS, Balucani C, Lazar J, Steinberg L, Gugger J, Levine SR. Relationship between QT interval dispersion in acute stroke and stroke prognosis: a systematic review. J Stroke Cerebrovasc Dis. 2014;23(10):2467&#x2013;78. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.06.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2014.06.004</ArticleId><ArticleId IdType="pubmed">25282188</ArticleId><ArticleId IdType="pmc">4256166</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WL, Huang CH, Chen JH, Tai HC, Chang SH, Wang YC. ECG abnormalities predict neurogenic pulmonary edema in patients with subarachnoid hemorrhage. Am J Emerg Med. 2016;34(1):79&#x2013;82. https://doi.org/10.1016/j.ajem.2015.09.032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2015.09.032</ArticleId><ArticleId IdType="pubmed">26472508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinomiya T, Terao Y, Miura K, Higashijima U, Tanise T, Fukusaki M, Sumikawa K. QTc interval and neurological outcomes in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;13(3):347&#x2013;54. https://doi.org/10.1007/s12028-010-9411-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-010-9411-9</ArticleId><ArticleId IdType="pubmed">20652444</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsuzaki M, Takasusuki T, Kimura Y, Yamaguchi S. Assessment of the ECG T-Wave in patients With subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2021;33(1):58&#x2013;64. https://doi.org/10.1097/ANA.0000000000000624 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000624</ArticleId><ArticleId IdType="pubmed">31290770</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahar KK, Pahadiya HR, Barupal KG, Mathur CP, Lakhotia M. The QT dispersion and QTc dispersion in patients presenting with acute neurological events and its impact on early prognosis. J Neurosci Rural Pract. 2016;7(1):61&#x2013;6. https://doi.org/10.4103/0976-3147.172173 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0976-3147.172173</ArticleId><ArticleId IdType="pubmed">26933346</ArticleId><ArticleId IdType="pmc">4750342</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommargren CE, Zaroff JG, Banki N, Drew BJ. Electrocardiographic repolarization abnormalities in subarachnoid hemorrhage. J Electrocardiol. 2002;35(Suppl):257&#x2013;62. https://doi.org/10.1054/jelc.2002.37187 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/jelc.2002.37187</ArticleId><ArticleId IdType="pubmed">12539136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziabari SMZ, Akhundzadeh N, Shakiba M, Keshavarz P. The Relationship between QT interval and intra-hospital mortality in patients with spontaneous intracranial hemorrhage. Adv J Emerg Med. 2019;4(2):e25. https://doi.org/10.22114/ajem.v0i0.190 .</Citation><ArticleIdList><ArticleId IdType="doi">10.22114/ajem.v0i0.190</ArticleId><ArticleId IdType="pubmed">32322793</ArticleId><ArticleId IdType="pmc">7163270</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Bilt I, Hasan D, van den Brink R, Cramer MJ, van der Jagt M, van Kooten F, Meertens J, van den Berg M, Groen R, Ten Cate F, Kamp O, G&#xf6;tte M, Horn J, Groeneveld J, Vandertop P, Algra A, Visser F, Wilde A, Rinkel G, SEASAH (Serial Echocardiography After Subarachnoid Hemorrhage) Investigators. Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: relationship with outcome. Neurology. 2014;82(4):351&#x2013;8. https://doi.org/10.1212/WNL.0000000000000057 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000057</ArticleId><ArticleId IdType="pubmed">24363132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjalmarsson C, Bergfeldt L, Bokemark L, Manhem K, Andersson B. Electrocardiographic abnormalities and elevated cTNT at admission for intracerebral hemorrhage: predictors for survival? Ann Noninvasive Electrocardiol. 2013;18(5):441&#x2013;9. https://doi.org/10.1111/anec.12056 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12056</ArticleId><ArticleId IdType="pubmed">24047488</ArticleId><ArticleId IdType="pmc">6931947</ArticleId></ArticleIdList></Reference><Reference><Citation>von Rennenberg R, Krause T, Herm J, Hellwig S, Scheitz JF, Endres M, Haeusler KG, Nolte CH. Heart rate variability and recurrent stroke and myocardial infarction in patients with acute mild to moderate stroke. Front Neurol. 2021;12:772674. https://doi.org/10.3389/fneur.2021.772674 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.772674</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Ding YH, Zhang JH, Lei H. ECG change of acute subarachnoid hemorrhagic patients. Acta Neurochir Suppl. 2011;111:357&#x2013;9. https://doi.org/10.1007/978-3-7091-0693-8_60 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-7091-0693-8_60</ArticleId><ArticleId IdType="pubmed">21725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern&#xe1;n MA, Hopewell S, Hr&#xf3;bjartsson A, Junqueira DR, J&#xfc;ni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366):l4898. https://doi.org/10.1136/bmj.l4898 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28381375</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1499-3872</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Hepatobiliary &amp; pancreatic diseases international : HBPD INT</Title><ISOAbbreviation>Hepatobiliary Pancreat Dis Int</ISOAbbreviation></Journal><ArticleTitle>Superior mesenteric artery first approach versus standard pancreaticoduodenectomy: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>127</StartPage><EndPage>138</EndPage><MedlinePgn>127-138</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The superior mesenteric artery (SMA) first approach was proposed recently as a new modification of the standard pancreaticoduodenectomy. Increasing evidence showed that a periadventiceal dissection of the SMA with early transection of the inflow during pancreaticoduodenectomy associates better early perioperative results, and setup the scene for long-term oncological benefits. The objectives of the current study are to compare the operative results and long-term oncological outcomes of SMA first approach pancreaticoduodenectomy (SMA-PD) with standard pancreaticoduodenectomy (S-PD).</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Electronic search of the PubMed/MEDLINE, EMBASE, Web of Science and Cochrane Library was performed until July 2015. We considered randomized controlled trials (RCTs) and non-randomized comparative studies (NRCSs) comparing SMA-PD with S-PD to be eligible if they included patients with periampullary cancers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of one RCT and thirteen NRCSs met the inclusion criteria, involving 640 patients with SMA-PD and 514 patients with S-PD. The SMA-PD was associated with less intraoperative bleeding, less blood transfusions and higher rate of associated venous resections. The pancreatic fistula and delayed gastric emptying had a significantly lower rate in the SMA-PD group. There were no differences between the two approaches regarding overall complications, major complication rates and in-hospital mortality. There was no difference regarding R0 resection rate, and one-, two- or three-year overall survival. The SMA-PD was associated with a lower local, hepatic and extrahepatic metastatic rate.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The SMA-PD is associated with better perioperative outcomes, such as blood loss, transfusion requirements, pancreatic fistula, and delayed gastric emptying. Although the one-, two- or three-year overall survival rate is not superior, the SMA-PD has a lower local and metastatic recurrence rate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Negoi</LastName><ForeName>Ionut</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>General Surgery Department, Emergency Hospital of Bucharest, Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania. negoiionut@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hostiuc</LastName><ForeName>Sorin</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Runcanu</LastName><ForeName>Alexandru</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Negoi</LastName><ForeName>Ruxandra Irina</ForeName><Initials>RI</Initials></Author><Author ValidYN="Y"><LastName>Beuran</LastName><ForeName>Mircea</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Hepatobiliary Pancreat Dis Int</MedlineTA><NlmUniqueID>101151457</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018589" MajorTopicYN="N">Gastroparesis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017538" MajorTopicYN="N">Mesenteric Artery, Superior</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010185" MajorTopicYN="N">Pancreatic Fistula</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28381375</ArticleId><ArticleId IdType="doi">10.1016/s1499-3872(16)60134-0</ArticleId><ArticleId IdType="pii">S1499-3872(16)60134-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30763714</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Neutrophil to lymphocyte ratio and mortality in spinal epidural abscess.</ArticleTitle><Pagination><StartPage>1180</StartPage><EndPage>1185</EndPage><MedlinePgn>1180-1185</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2019.02.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(19)30054-3</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT">Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio have been previously identified as markers for overall survival in oncology but remain heretofore unexplored in spinal epidural abscess (SEA).</AbstractText><AbstractText Label="PURPOSE">The purpose of this study was to determine the impact of these routinely collected assessments on 90-day mortality in SEA.</AbstractText><AbstractText Label="STUDY DESIGN/SETTING">Retrospective, case-control study.</AbstractText><AbstractText Label="PATIENT SAMPLE">Patients 18 years or older diagnosed with SEA at 2 academic medical centers and 3 community hospitals.</AbstractText><AbstractText Label="OUTCOME MEASURES">Ninety-day postdischarge and in-hospital mortality.</AbstractText><AbstractText Label="METHODS">Complete blood count with differential obtained on the day immediately preceding or on the day of admission was used to calculate platelet to lymphocyte and neutrophil to lymphocyte ratios. Multivariate analyses were used to determine if these ratios were independent risk factors for 90-day mortality.</AbstractText><AbstractText Label="RESULTS">For 1,053 SEA patients included in the study, the rate of 90-day mortality was 134 (12.7%). The rate of 90-day mortality with neutrophil to lymphocyte ratio (&#x2265;8) was (20.5%) compared to (8.1%) with neutrophil to lymphocyte ratio &lt;8. Neutrophil to lymphocyte ratio was positively associated with bacteremia, elevated erythrocyte sedimentation rate, and concurrent systemic infections (endocarditis, meningitis) and negatively associated with duration of symptoms prior to presentation. On multivariate analysis, elevated neutrophil to lymphocyte remained an independent risk factor for 90-day mortality (odds ratio=2.62, 95% confidence interval=1.66-4.17, p&lt;.001). Platelet to lymphocyte ratio was not associated with 90-day mortality.</AbstractText><AbstractText Label="CONCLUSIONS">Absolute neutrophil to lymphocyte ratio is a routinely collected but overlooked biomarker in patients with spinal epidural abscess that is a novel independent risk factor for 90-day mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karhade</LastName><ForeName>Aditya V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Kush C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Akash A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University of California, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogink</LastName><ForeName>Paul T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Sandra B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwab</LastName><ForeName>Joseph H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA. Electronic address: jhschwab@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020802" MajorTopicYN="N">Epidural Abscess</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Neutrophil to lymphocyte ratio</Keyword><Keyword MajorTopicYN="N">Platelet to lymphocyte ratio</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Spinal epidural abscess</Keyword><Keyword MajorTopicYN="N">Spine surgery</Keyword><Keyword MajorTopicYN="N">Survival</Keyword><Keyword MajorTopicYN="N">Systemic inflammation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30763714</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2019.02.005</ArticleId><ArticleId IdType="pii">S1529-9430(19)30054-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28027892</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Venous Arterialisation for Salvage of Critically Ischaemic Limbs: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>387</StartPage><EndPage>402</EndPage><MedlinePgn>387-402</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2016.11.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(16)30574-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Critical limb ischaemia (CLI) is the end stage of peripheral artery disease (PAD) and is associated with high amputation and mortality rates and poor quality of life. For CLI patients with no revascularisation options, venous arterialisation could be a last resort for limb salvage.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To review the literature on the clinical effectiveness of venous arterialisation for lower limb salvage in CLI patients with no revascularisation options.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Different databases were searched for papers published between January 1966 and January 2016. The criteria for eligible articles were studies describing outcomes of venous arterialisation, published in English, human studies, and with the full text available. Additionally, studies were excluded if they did not report limb salvage, wound healing or amputation as outcome measures. The primary outcome measure was post-operative limb salvage at 12 months. Secondary outcome measures were 30 day or in-hospital mortality, survival, patency, technical success, and wound healing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen articles met the inclusion criteria. The included studies described 768 patients. According to the MINORS score, methodological quality was moderate to poor. The estimated pooled limb salvage rate at one year was 75% (0.75, 95% CI 0.70-0.81). Thirty day or in-hospital mortality was reported in 12 studies and ranged from 0 to 10%. Overall survival was reported in 10 studies and ranged from 54% to 100% with a mean follow-up ranging from 5 to 60 months. Six studies reported on patency of the venous arterialisations performed, with a range of 59-71% at 12 months.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this systematic review on venous arterialisation in patients with non-reconstructable critical limb ischaemia, the pooled proportion of limb salvage at 12 months was 75%. Venous arterialisation could be a valuable treatment option in patients facing amputation of the affected limb; however, the current evidence is of low quality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schreve</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands. Electronic address: m.a.schreve@nwz.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vos</LastName><ForeName>C G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Surgery, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vahl</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Surgery, OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>J P P M</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kum</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Changi General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Borst</LastName><ForeName>G J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, UMCU, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xdc;nl&#xfc;</LastName><ForeName>&#xc7;</ForeName><Initials>&#xc7;</Initials><AffiliationInfo><Affiliation>Department of Surgery, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="N">Amputation, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023821" MajorTopicYN="Y">Limb Salvage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014654" MajorTopicYN="N">Vascular Patency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical limb ischaemia</Keyword><Keyword MajorTopicYN="N">Limb salvage</Keyword><Keyword MajorTopicYN="N">Venous arterialisation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28027892</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2016.11.007</ArticleId><ArticleId IdType="pii">S1078-5884(16)30574-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33831530</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>The Initial Experience on Branched and Fenestrated Endografts in the Aortic Arch. A Systematic Review.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>44</EndPage><MedlinePgn>29-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2021.03.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(21)00287-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Branched and fenestrated endografts (fEVAR/bEVAR) are complex techniques used to treat thoracic aorta pathologies involving the aortic arch. This systematic review aims to determine all the reported results regarding these techniques in the aortic arch, in order to describe their clinical outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of the literature was performed, considering all articles published until October 2019. PubMed, Cochrane database resources were used. The protocol of the study was previously registered in the Prospero database (CRD42020147037). Primary exclusion criteria included opinion articles, merely technique descriptions, articles without the follow-up of at least 1 month, studies conducted on animals, mixed treatments, and ongoing trials without published data. Included variables were study design, aortic pathology, type of endovascular technique (fEVAR/bEVAR), endograft manufacturing, number of fenestrations/branches and type of bridge stents. Technical success, complications during surgery and follow-up were also described.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From a total of 164 articles, 29 (28 retrospective, 1 prospective) were analyzed with a total of 693 cases (341 fEVAR and 352 bEVAR). The most common indications for repair were aneurysm (54.8%) and dissection (40%). Only fEVAR and bEVAR were considered, but different endograft materials and techniques were used and, therefore, reported upon in the current review. Zenith Alpha Thoracic Endovascular Graft was the most representative (24% of cases). Custom made, off-the-shelf, physician modified and in situ fenestrated endografts were also used in 39%, 22.4%, 18.6% and 18.9% of cases, respectively. Bridge stents were implanted in the 50.5% of cases. Technical success rate was 96%. The main intraoperative complication was the endoleak (5.2%) followed by stroke (4.8%). The in-hospital mortality was 2.5%. The mean follow-up was 18.5 months. The mortality related to the main operation during follow-up was 3.2% and not directly related to the main operation was 11.3%. During the follow-up, 92 cases (13.3%) in total had to undergo through a reintervention, 46.7% with endovascular repair and 26.1% with open surgical repair (the rest were not specified).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">published experience with bEVAR and fEVAR in the aortic arch showed acceptable short-term effectiveness and safety. More well-conducted prospective clinical studies with long term follow-up, combined with comparative meta-analysis, are needed to elucidate the real benefit of those endovascular techniques in the aortic arch pathology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blanco Amil</LastName><ForeName>Carla Lorena</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain. Electronic address: c.blanco.amil@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mestres Alomar</LastName><ForeName>Gaspar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarnaccia</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luoni</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yugueros Castellnou</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vigliotti</LastName><ForeName>Rossella Chiara</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramses</LastName><ForeName>Rafic</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riambau</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Cardiovascular Institute, Hospital Cl&#xed;nic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="N">Aortic Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001807" MajorTopicYN="Y">Blood Vessel Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019233" MajorTopicYN="N">Retreatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of Interest V. Riambau: Consultant for TERUMO AORTIC AND MEDTRONIC CO-FOUNDER AND STOCKHOLDER OF AORTYX SPEAKER AGREEMENT FOR LIFETECH RESEARCH GRANT FROM WL.GORE AND ASSOCIATES PROCTOR FOR TERUMO AORTIC, MEDTRONIC, WL GORE AND ASSOCIATES, LIFETECH, COOK MEDICAL, MICROPORT, JOTEC/Cryolife G. Mestres: Receives speaker's fees from WL.GORE AND ASSOCIATES</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>8</Day><Hour>20</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33831530</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2021.03.024</ArticleId><ArticleId IdType="pii">S0890-5096(21)00287-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36556021</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Central versus Peripheral Postcardiotomy Veno-Arterial Extracorporeal Membrane Oxygenation: Systematic Review and Individual Patient Data Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7406</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11247406</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It is unclear whether peripheral arterial cannulation is superior to central arterial cannulation for postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was conducted using PubMed, Scopus, and Google Scholar to identify studies on postcardiotomy VA-ECMO for the present individual patient data (IPD) meta-analysis. Analysis was performed according to the intention-to-treat principle.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The investigators of 10 studies agreed to participate in the present IPD meta-analysis. Overall, 1269 patients were included in the analysis. Crude rates of in-hospital mortality after central versus peripheral arterial cannulation for VA-ECMO were 70.7% vs. 63.7%, respectively (adjusted OR 1.38, 95% CI 1.08-1.75). Propensity score matching yielded 538 pairs of patients with balanced baseline characteristics and operative variables. Among these matched cohorts, central arterial cannulation VA-ECMO was associated with significantly higher in-hospital mortality compared to peripheral arterial cannulation VA-ECMO (64.5% vs. 70.8%, <i>p</i> = 0.027). These findings were confirmed by aggregate data meta-analysis, which showed that central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation (OR 1.35, 95% CI 1.04-1.76, I<sup>2</sup> 21%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients requiring postcardiotomy VA-ECMO, central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation. This increased risk is of limited magnitude, and further studies are needed to confirm the present findings and to identify the mechanisms underlying the potential beneficial effects of peripheral VA-ECMO.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biancari</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5028-8186</Identifier><AffiliationInfo><Affiliation>Heart and Lung Center, Helsinki University Hospital, Haartmaninkatu 4, P.O. Box 340, 00029 Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, South-Karelia Central Hospital, University of Helsinki, 53130 Lappeenranta, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaserer</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9105-8328</Identifier><AffiliationInfo><Affiliation>Institute of Anesthesiology, University and University Hospital Zurich, 8091 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrotti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8582-242X</Identifier><AffiliationInfo><Affiliation>Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggieri</LastName><ForeName>Vito G</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic and Vascular Surgery, Robert Debr&#xe9; University Hospital, 51100 Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sung-Min</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-5132-0958</Identifier><AffiliationInfo><Affiliation>Divisions of Neurosciences, Critical Care and Cardiac Surgery, Departments of Neurology, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Jin Kook</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Divisions of Neurosciences, Critical Care and Cardiac Surgery, Departments of Neurology, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dal&#xe9;n</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5352-5132</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welp</LastName><ForeName>Henryk</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4216-6223</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, M&#xfc;nster University Hospital, 48149 M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf3;nsson</LastName><ForeName>Kristj&#xe1;n</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6689-6976</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragnarsson</LastName><ForeName>Sigurdur</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University of Lund, 10392 Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez P&#xe9;rez</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Puerta de Hierro University Hospital, 29222 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatti</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9996-6133</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Cardio-Thoracic and Vascular Department, University Hospital of Trieste, 34128 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhamees</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Prince Sultan Cardiac Center, Al Hassa 36441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loforte</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3689-0477</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, S. Orsola Hospital, University of Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lechiancole</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiothoracic Department, University Hospital of Udine, 33100 Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosato</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6690-5537</Identifier><AffiliationInfo><Affiliation>Center for Global Health, Italian National Institute, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadaccio</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN 13400, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettinari</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2611-9566</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiore</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7962-7276</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, H&#xf4;pitaux Universitaires Henri Mondor, Assistance Publique-H&#xf4;pitaux de Paris, 94000 Creteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe4;kikallio</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, South-Karelia Central Hospital, University of Helsinki, 53130 Lappeenranta, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahli</LastName><ForeName>Sebastian D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0002-2030-0313</Identifier><AffiliationInfo><Affiliation>Institute of Anesthesiology, University and University Hospital Zurich, 8091 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L'Acqua</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0533-8284</Identifier><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Centro Cardiologico Monzino, 20138 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arafat</LastName><ForeName>Amr A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Adult Cardiac Surgery, Prince Sultan Cardiac Center, Riyadh 12611, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Tanta University, Tanta 31527, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albabtain</LastName><ForeName>Monirah A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiology Clinical Pharmacy, Prince Sultan Cardiac Center, Riyadh 12611, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlBarak</LastName><ForeName>Mohammed M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Prince Sultan Cardiac Center, Riyadh 12611, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laimoud</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5069-2813</Identifier><AffiliationInfo><Affiliation>Cardiac Surgical Intensive Care Department, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care Medicine Department, Cairo University, Cairo 12613, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djordjevic</LastName><ForeName>Ilija</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5810-8626</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University Hospital Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasivskyi</LastName><ForeName>Ihor</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0573-8218</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University Hospital Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samalavicius</LastName><ForeName>Robertas</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesia, Vilnius University Hospital Santaros Klinikos, 08410 Vilnius, Lithuania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Emergency Medicine, Medical Faculty, Vilnius University, 03101 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puodziukaite</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesia, Vilnius University Hospital Santaros Klinikos, 08410 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso-Fernandez-Gatta</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4363-8835</Identifier><AffiliationInfo><Affiliation>Cardiology Department, University Hospital of Salamanca, Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Salamanca, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER-CV Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilhelm</LastName><ForeName>Markus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Clinic for Cardiac Surgery, University Heart Center, University and University Hospital Zurich, 8091 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariscalco</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine and Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester LE2 9QP, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL157610</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 HL165486</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECMO</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">central</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">peripheral</Keyword><Keyword MajorTopicYN="N">postcardiotomy</Keyword></KeywordList><CoiStatement>Alexander Kaserer received honoraria for lecturing from Bayer AG Switzerland and CSL Behring GmbH. Sung-Min Cho is supported by a grant from NIH NHLBI K23HL157610 and Hyperfine, Inc. for the SAFE MRI ECMO study. The other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36556021</ArticleId><ArticleId IdType="pmc">PMC9785985</ArticleId><ArticleId IdType="doi">10.3390/jcm11247406</ArticleId><ArticleId IdType="pii">jcm11247406</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kowalewski M., Zieli&#x144;ski K., Brodie D., MacLaren G., Whitman G., Raffa G.M., Boeken U., Shekar K., Chen Y.S., Bermudez C., et al. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock-analysis of the extracorporeal life support organization registry. Crit. Care Med. 2021;49:1107&#x2013;1117. doi: 10.1097/CCM.0000000000004695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004695</ArticleId><ArticleId IdType="pmc">PMC8217275</ArticleId><ArticleId IdType="pubmed">33729722</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancari F., Dal&#xe9;n M., Fiore A., Ruggieri V.G., Saeed D., J&#xf3;nsson K., Gatti G., Zipfel S., Perrotti A., Bounader K., et al. Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation. J. Thorac. Cardiovasc. Surg. 2020;159:1844&#x2013;1854. doi: 10.1016/j.jtcvs.2019.06.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.06.039</ArticleId><ArticleId IdType="pubmed">31358340</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancari F., Perrotti A., Dal&#xe9;n M., Guerrieri M., Fiore A., Reichart D., Dell&#x2019;Aquila A.M., Gatti G., Ala-Kokko T., Kinnunen E.M., et al. Meta-analysis of the outcome after postcardiotomy venoarterial extracorporeal membrane oxygenation in adult patients. J. Cardiothorac. Vasc. Anesth. 2018;32:1175&#x2013;1182. doi: 10.1053/j.jvca.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2017.08.048</ArticleId><ArticleId IdType="pubmed">29158060</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles C., Hiesinger W. Postcardiotomy shock extracorporeal membrane oxygenation: Peripheral or central? JTCVS Open. 2021;8:66&#x2013;69. doi: 10.1016/j.xjon.2021.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xjon.2021.10.020</ArticleId><ArticleId IdType="pmc">PMC9390509</ArticleId><ArticleId IdType="pubmed">36004095</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariscalco G., Salsano A., Fiore A., Dal&#xe9;n M., Ruggieri V.G., Saeed D., J&#xf3;nsson K., Gatti G., Zipfel S., Dell&#x2019;Aquila A.M., et al. Peripheral versus central extracorporeal membrane oxygenation for postcardiotomy shock: Multicenter registry, systematic review, and meta-analysis. J. Thorac. Cardiovasc. Surg. 2020;160:1207&#x2013;1216.e44. doi: 10.1016/j.jtcvs.2019.10.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.10.078</ArticleId><ArticleId IdType="pubmed">31864699</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffa G.M., Kowalewski M., Brodie D., Ogino M., Whitman G., Meani P., Pilato M., Arcadipane A., Delnoij T., Natour E., et al. Meta-analysis of peripheral or central extracorporeal membrane oxygenation in postcardiotomy and non-postcardiotomy shock. Ann. Thorac. Surg. 2019;107:311&#x2013;321. doi: 10.1016/j.athoracsur.2018.05.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.05.063</ArticleId><ArticleId IdType="pubmed">29959943</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P.R., Flo Forner A., Marin-Cuartas M., Lehmann S., Saeed D., Ginther A., Borger M.A., Ender J. 30-Day perioperative mortality following venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock in patients with normal preoperative ejection fraction. Interact. Cardiovasc. Thorac. Surg. 2021;32:817&#x2013;824. doi: 10.1093/icvts/ivaa323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivaa323</ArticleId><ArticleId IdType="pmc">PMC8691502</ArticleId><ArticleId IdType="pubmed">33417704</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A., Kurlansky P., Ning Y., Sanchez J., Fried J., Witer L.J., Kaku Y., Takayama H., Naka Y., Takeda K. Early venoarterial extracorporeal membrane oxygenation improves outcomes in post-cardiotomy shock. J. Artif. Organs. 2021;24:7&#x2013;14. doi: 10.1007/s10047-020-01212-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10047-020-01212-w</ArticleId><ArticleId IdType="pubmed">32926268</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastan A.J., Dege A., Mohr M., Doll N., Falk V., Walther T., Mohr F.W. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J. Thorac. Cardiovasc. Surg. 2010;139:302&#x2013;311. doi: 10.1016/j.jtcvs.2009.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.10.043</ArticleId><ArticleId IdType="pubmed">20106393</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute  Study Quality Assessment Tools.  [(accessed on 1 October 2022)]; Available online:  https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.</Citation></Reference><Reference><Citation>Al-Kawaz M., Shou B., Prokupets R., Whitman G., Geocadin R., Cho S.M. Mild hypothermia and neurologic outcomes in patients undergoing venoarterial extracorporeal membrane oxygenation. J. Card. Surg. 2022;37:825&#x2013;830. doi: 10.1111/jocs.16308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.16308</ArticleId><ArticleId IdType="pmc">PMC8891050</ArticleId><ArticleId IdType="pubmed">35152478</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhijab F.A., Tantawy T.M., Ismail H.H., AlBarrak M., Adam A.I., Belghith M., Hassan E., Pragliola C., Albabtain M.A., Arafat A.A. Venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock: The impact of cannulation strategy on survival. Perfusion. 2022. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02676591221114954</ArticleId><ArticleId IdType="pubmed">35841146</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Fernandez-Gatta M., Merchan-Gomez S., Gonzalez-Cebrian M., Diego-Nieto A., Alzola E., Toranzo-Nieto I., Barrio A., Martin-Herrero F., Sanchez P.L. Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival. Artif. Organs. 2021;45:717&#x2013;725. doi: 10.1111/aor.13899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.13899</ArticleId><ArticleId IdType="pubmed">33377185</ArticleId></ArticleIdList></Reference><Reference><Citation>Djordjevic I., Deppe A.-C., Sabashnikov A., Kuhn E., Eghbalzadeh K., Merkle J., Gerfer S., Gaisendrees C., Ivanov B., Moellenbeck L., et al. Concomitant ECMO and IABP support in postcardiotomy cardiogenic shock patients. Heart Lung Circ. 2021;30:1533&#x2013;1539. doi: 10.1016/j.hlc.2021.03.276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2021.03.276</ArticleId><ArticleId IdType="pubmed">33903028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-P&#xe9;rez F.J., &#xc1;lvarez-Avell&#xf3; J.M., Forteza A., G&#xf3;mez-Bueno M., Gonz&#xe1;lez A., L&#xf3;pez-Ibor J.V., Silva-Melchor L., Goicolea J., Mart&#xed;n C.E., Iranzo R., et al. Initial outcomes of a multidisciplinary network for the care of patients with cardiogenic shock. Rev. Esp. Cardiol. 2021;74:33&#x2013;43. doi: 10.1016/j.recesp.2020.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2020.01.019</ArticleId><ArticleId IdType="pubmed">32448727</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#x2019;Acqua C., De Tisi C., Lerva G., Ballotta A. Postcardiotomy VA ECMO in adult patients: Italian single center experience in 2021. Int. J. Artif. Organs. 2022;45:799&#x2013;800. doi: 10.1177/03913988221112685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03913988221112685</ArticleId><ArticleId IdType="pmc">PMC9465498</ArticleId><ArticleId IdType="pubmed">35822880</ArticleId></ArticleIdList></Reference><Reference><Citation>Laimoud M., Alanazi M. The clinical significance of blood lactate levels in evaluation of adult patients with veno-arterial extracorporeal membrane oxygenation. Egypt. Hear. J. 2020;72:74. doi: 10.1186/s43044-020-00108-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43044-020-00108-7</ArticleId><ArticleId IdType="pmc">PMC7588953</ArticleId><ArticleId IdType="pubmed">33108534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahli S.D., Kaserer A., Braun J., Halbe M., Dahlem Y., Spahn M.A., R&#xf6;ssler J., Kr&#xfc;ger B., Maisano F., Spahn D.R., et al. Predictors associated with mortality of extracorporeal life support therapy for acute heart failure: Single-center experience with 679 patients. J. Thorac. Dis. 2022;14:1960&#x2013;1971. doi: 10.21037/jtd-21-1770.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-21-1770</ArticleId><ArticleId IdType="pmc">PMC9264083</ArticleId><ArticleId IdType="pubmed">35813709</ArticleId></ArticleIdList></Reference><Reference><Citation>Samalavicius R., Norkiene I., Scupakova N., Sabliauskas J., Urbonas K., Andrijauskas P., Jankuviene A., Puodziukaite L., Zorinas A., Janusauskas V. Evaluation of risk factors for adverse outcome in extracorporeal membrane oxygenation-supported elderly postcardiotomy patients. Perfusion. 2020;35((Suppl. S1)):50&#x2013;56. doi: 10.1177/0267659120907746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659120907746</ArticleId><ArticleId IdType="pubmed">32397883</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupprecht L., Lunz D., Philipp A., Lubnow M., Schmid C. Pitfalls in percutaneous ECMO cannulation. Heart Lung Vessel. 2015;7:320&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4712035</ArticleId><ArticleId IdType="pubmed">26811838</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic D., Hamouda K., Penov K., Bening C., Sayed S., Gietzen C., Leyh R.G., Aleksic I. Central versus peripheral arterial cannulation for veno-arterial extracorporeal membrane oxygenation in post-cardiotomy patients. ASAIO J. 2021;67:67&#x2013;73. doi: 10.1097/MAT.0000000000001202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000001202</ArticleId><ArticleId IdType="pubmed">33346992</ArticleId></ArticleIdList></Reference><Reference><Citation>Merritt-Genore H., Schwabe M., Luksan A., Ryan T., Lyden E., Moulton M. Postcardiotomy extracorporeal membrane oxygenator: No longer a bridge to no where? J. Card. Surg. 2020;35:2208&#x2013;2215. doi: 10.1111/jocs.14715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.14715</ArticleId><ArticleId IdType="pubmed">32720339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalampokas N., Sipahi N.F., Aubin H., Akhyari P., Petrov G., Albert A., Westenfeld R., Lichtenberg A., Saeed D. Postcardiotomy veno-arterial extracorporeal membrane oxygenation: Does the cannulation technique influence the outcome? Front. Cardiovasc. Med. 2021;8:658412. doi: 10.3389/fcvm.2021.658412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.658412</ArticleId><ArticleId IdType="pmc">PMC8382236</ArticleId><ArticleId IdType="pubmed">34434969</ArticleId></ArticleIdList></Reference><Reference><Citation>Djordjevic I., Eghbalzadeh K., Sabashnikov A., Deppe A.C., Kuhn E., Merkle J., Weber C., Ivanov B., Ghodsizad A., Rustenbach C. Central vs. peripheral venoarterial ECMO in postcardiotomy cardiogenic shock. J. Card. Surg. 2020;35:1037&#x2013;1042. doi: 10.1111/jocs.14526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.14526</ArticleId><ArticleId IdType="pubmed">32227395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnunen E.M., Juvonen T., Airaksinen K.E., Heikkinen J., Kettunen U., Mariscalco G., Biancari F. Clinical significance and determinants of the universal definition of perioperative bleeding classification in patients undergoing coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 2014;148:1640&#x2013;1646. doi: 10.1016/j.jtcvs.2014.07.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.07.040</ArticleId><ArticleId IdType="pubmed">25260277</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng W., Li R., Lihua E., Zha N. Postoperative acute kidney injury and early and long-term mortality in acute aortic dissection patients: A meta-analysis. Medicine. 2021;100:e23426. doi: 10.1097/MD.0000000000023426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000023426</ArticleId><ArticleId IdType="pmc">PMC7808523</ArticleId><ArticleId IdType="pubmed">33466119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28706862</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2225-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Annals of cardiothoracic surgery</Title><ISOAbbreviation>Ann Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Flexible band versus rigid ring annuloplasty for tricuspid regurgitation: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>194</StartPage><EndPage>203</EndPage><MedlinePgn>194-203</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/acs.2017.05.05</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Up to 20% of patients have pre-discharge residual moderate to severe tricuspid regurgitation (TR) after tricuspid repair. Reoperations for recurrent TR carry high mortality rates, which emphasizes the importance of identifying the optimal technique for the surgical management of TR. The present study is a systematic review and meta-analysis that aims to compare short and long term survival and freedom from TR of flexible band ring versus rigid ring for annuloplasty of TR.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic review and meta-analysis of comparative studies to evaluate these procedures. A systematic search of the literature was performed from six electronic databases. Pooled meta-analysis was conducted using odds ratio (OR) and weighted mean difference (WMD).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The rates of in-hospital mortality were not different between the two groups, with cumulative rates of 6.9% for flexible band and 7.3% for rigid ring (OR: 0.92; 95% CI: 0.49-1.71). Rates of stroke were also similar with 1.7% of flexible band and 1.3% of rigid rings suffering a perioperative stroke (OR: 1.29; 95% CI: 0.74-2.23). Rigid ring had significantly better freedom from grade &#x2265;2 TR at 5 years (OR: 0.44; 95% CI: 0.20-0.99) and overall (P=0.005). There was no significant difference in overall rates of reoperation (P=0.232) and survival (P=0.086) between flexible band and rigid ring.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Both rigid ring and flexible band offer acceptable outcomes for the treatment of TR. Compared to flexible band, rates of TR are stable after rigid ring annuloplasty and long term freedom from TR are superior for rigid ring devices. Large prospective randomized trials are required in order to validate these findings and assess for improvements in patient survival.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal North Shore Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Tristan D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Cardiothorac Surg</MedlineTA><NlmUniqueID>101605877</NlmUniqueID><ISSNLinking>2225-319X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Flexible band</Keyword><Keyword MajorTopicYN="N">rigid ring</Keyword><Keyword MajorTopicYN="N">tricuspid regurgitation</Keyword></KeywordList><CoiStatement>Conflicts of Interest: The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28706862</ArticleId><ArticleId IdType="pmc">PMC5494420</ArticleId><ArticleId IdType="doi">10.21037/acs.2017.05.05</ArticleId><ArticleId IdType="pii">acs-06-03-194</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goldstone AB, Howard JL, Cohen JE, et al. Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: implications for future guidelines. J Thorac Cardiovasc Surg 2014;148:2802-9. 10.1016/j.jtcvs.2014.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.08.001</ArticleId><ArticleId IdType="pubmed">25218532</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mauro M, Bezante GP, Di Baldassarre A, et al. Functional tricuspid regurgitation: an underestimated issue. Int J Cardiol 2013;168:707-15. 10.1016/j.ijcard.2013.04.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.04.043</ArticleId><ArticleId IdType="pubmed">23647591</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-9. 10.1067/mhj.2002.123575</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mhj.2002.123575</ArticleId><ArticleId IdType="pubmed">12228791</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405-9. 10.1016/j.jacc.2003.09.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2003.09.036</ArticleId><ArticleId IdType="pubmed">15013122</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes MJ, Barlow JB. Management of tricuspid valve regurgitation. Heart 2007;93:271-6. 10.1136/hrt.2006.095281</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2006.095281</ArticleId><ArticleId IdType="pmc">PMC1861404</ArticleId><ArticleId IdType="pubmed">17228081</ArticleId></ArticleIdList></Reference><Reference><Citation>Filsoufi F, Anyanwu AC, Salzberg SP, et al. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg 2005;80:845-50. 10.1016/j.athoracsur.2004.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2004.12.019</ArticleId><ArticleId IdType="pubmed">16122441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S, Gillinov AM, McCarthy PM, et al. Echocardiographic follow-up of tricuspid annuloplasty with a new three-dimensional ring in patients with functional tricuspid regurgitation. J Am Soc Echocardiogr 2007;20:1236-42. 10.1016/j.echo.2007.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2007.03.006</ArticleId><ArticleId IdType="pubmed">17588715</ArticleId></ArticleIdList></Reference><Reference><Citation>Navia JL, Nowicki ER, Blackstone EH, et al. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg 2010;139:1473-82.e5. 10.1016/j.jtcvs.2010.02.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2010.02.046</ArticleId><ArticleId IdType="pubmed">20394950</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004;127:674-85. 10.1016/j.jtcvs.2003.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2003.11.019</ArticleId><ArticleId IdType="pubmed">15001895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeganathan R, Armstrong S, Al-Alao B, et al. The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg 2013;95:119-24. 10.1016/j.athoracsur.2012.08.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.08.058</ArticleId><ArticleId IdType="pubmed">23103002</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Gu C, Men X, et al. Repair of functional tricuspid regurgitation: comparison between suture annuloplasty and rings annuloplasty. Ann Thorac Surg 2014;97:1286-92. 10.1016/j.athoracsur.2013.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.10.037</ArticleId><ArticleId IdType="pubmed">24370203</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolari A, Barili F, Pilozzi A, et al. Ring or suture annuloplasty for tricuspid regurgitation? A meta-analysis review. Ann Thorac Surg 2014;98:2255-63. 10.1016/j.athoracsur.2014.06.100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.06.100</ArticleId><ArticleId IdType="pubmed">25443026</ArticleId></ArticleIdList></Reference><Reference><Citation>Starck CT, Kempfert J, Falk V. Tricuspid valve interventions: surgical techniques and outcomes. EuroIntervention 2015;11 Suppl W:W128-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">26384178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfannmuller B, Doenst T, Eberhardt K, et al. Increased risk of dehiscence after tricuspid valve repair with rigid annuloplasty rings. J Thorac Cardiovasc Surg 2012;143:1050-5. 10.1016/j.jtcvs.2011.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.06.019</ArticleId><ArticleId IdType="pubmed">21798563</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. 10.1371/journal.pmed.1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan K, Tian DH, Cao C, et al. Systematic review and meta-analysis: techniques and a guide for the academic surgeon. Annals of Cardiothoracic Surgery 2015;4:112-22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384252</ArticleId><ArticleId IdType="pubmed">25870806</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyot P, Ades AE, Ouwens MJ, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012;12:9. 10.1186/1471-2288-12-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-12-9</ArticleId><ArticleId IdType="pmc">PMC3313891</ArticleId><ArticleId IdType="pubmed">22297116</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti G, Dell'Angela L, Morosin M, et al. Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation: two different patterns of right heart reverse remodelling. Interact Cardiovasc Thorac Surg 2016;23:79-89. 10.1093/icvts/ivw047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivw047</ArticleId><ArticleId IdType="pmc">PMC4986730</ArticleId><ArticleId IdType="pubmed">26993479</ArticleId></ArticleIdList></Reference><Reference><Citation>Izutani H, Nakamura T, Kawachi K. Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation. Heart Int 2010;5:e13. 10.4081/hi.2010.e13</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/hi.2010.e13</ArticleId><ArticleId IdType="pmc">PMC3184685</ArticleId><ArticleId IdType="pubmed">21977298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Liu X, Wang X, et al. Comparison of outcomes of tricuspid annuloplasty with 3D-rigid versus flexible prosthetic ring for functional tricuspid regurgitation secondary to rheumatic mitral valve disease. J Thorac Dis 2016;8:3087-95. 10.21037/jtd.2016.11.97</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.11.97</ArticleId><ArticleId IdType="pmc">PMC5179467</ArticleId><ArticleId IdType="pubmed">28066587</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 2009;53:401-8. 10.1016/j.jacc.2008.09.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.09.048</ArticleId><ArticleId IdType="pubmed">19179197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti G, Marciano F, Antonini-Canterin F, et al. Tricuspid valve annuloplasty with a flexible prosthetic band. Interact Cardiovasc Thorac Surg 2007;6:731-5. 10.1510/icvts.2007.156786</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2007.156786</ArticleId><ArticleId IdType="pubmed">17766276</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung SH, Je HG, Song JM, et al. Outcomes following use of a modified Duran ring tricuspid valve reconstruction procedure for secondary tricuspid regurgitation. Circ J 2010;74:925-30. 10.1253/circj.CJ-09-0845</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-09-0845</ArticleId><ArticleId IdType="pubmed">20339192</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu TY, Wang JG, Meng X. Is a rigid tricuspid annuloplasty ring superior to a flexible band when correcting secondary tricuspid regurgitation? Interact Cardiovasc Thorac Surg 2013;17:1009-14. 10.1093/icvts/ivt363</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivt363</ArticleId><ArticleId IdType="pmc">PMC3829493</ArticleId><ArticleId IdType="pubmed">23962851</ArticleId></ArticleIdList></Reference><Reference><Citation>Galinanes M, Duarte J, de Caleya DF, et al. Fracture of the Carpentier-Edwards ring in tricuspid position: a report of three cases. Ann Thorac Surg 1986;42:74-6. 10.1016/S0003-4975(10)61840-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(10)61840-1</ArticleId><ArticleId IdType="pubmed">3729619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay HR, Hammond GL. Fracture of a prosthetic tricuspid annular ring. J Thorac Cardiovasc Surg 1982;83:635.</Citation><ArticleIdList><ArticleId IdType="pubmed">7062774</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukmawan R, Watanabe N, Ogasawara Y, et al. Geometric changes of tricuspid valve tenting in tricuspid regurgitation secondary to pulmonary hypertension quantified by novel system with transthoracic real-time 3-dimensional echocardiography. J Am Soc Echocardiogr 2007;20:470-6. 10.1016/j.echo.2006.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2006.10.001</ArticleId><ArticleId IdType="pubmed">17484985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ton-Nu TT, Levine RA, Handschumacher MD, et al. Geometric determinants of functional tricuspid regurgitation: insights from 3-dimensional echocardiography. Circulation 2006;114:143-9. 10.1161/CIRCULATIONAHA.106.611889</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.611889</ArticleId><ArticleId IdType="pubmed">16818811</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinn SH, Dayan V, Schaff HV, et al. Outcomes of ring versus suture annuloplasty for tricuspid valve repair in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2016;152:406-15.e3. 10.1016/j.jtcvs.2016.04.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.04.068</ArticleId><ArticleId IdType="pubmed">27260957</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35460890</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Coverage of the Coeliac Artery During Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>828</StartPage><EndPage>837</EndPage><MedlinePgn>828-837</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2022.02.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(22)00134-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To investigate the clinical impact of coeliac artery (CA) coverage during thoracic endovascular aortic repair (TEVAR).</AbstractText><AbstractText Label="METHODS">This systematic review and meta-analysis was conducted according to the PRISMA guidelines. Electronic databases were searched from 1989 to 2020 for studies reporting visceral ischaemia, spinal cord ischaemia (SCI), 30 day/in hospital mortality, endoleaks, re-intervention, and caudal stent graft migration following CA coverage in patients undergoing TEVAR. Meta-analysis was conducted using random effects modelling. The quality of the evidence was graded using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach.</AbstractText><AbstractText Label="RESULTS">Fifteen observational studies with 236 patients (108 male, age range 61.3 - 79 years) were included. The pooled visceral ischaemia rate was 13% with significant heterogeneity between studies (95% confidence intervals [CI] 4 - 24; I<sup>2</sup>&#xa0;= 72%, p &lt; .001). The SCI rate was 5% (95% CI 2 - 9; I<sup>2</sup>&#xa0;= 0%); the 30 day/in hospital mortality was 4% (95% CI 1 - 7; I<sup>2</sup>&#xa0;= 0%); the overall endoleak rate was 21% (95% CI 13 - 29; I<sup>2</sup>&#xa0;= 35%) with a 5% (95% CI 0 - 13; I<sup>2</sup>&#xa0;= 38%) rate of type Ib and 2% (95% CI 0 - 8; I<sup>2</sup>&#xa0;= 43%) rate of type II endoleak from retrograde CA flow. The re-intervention rate was 13% (95% CI 6 - 22; I<sup>2</sup>&#xa0;= 54%); the caudal stent graft migration rate was 3% (95% CI 0 - 9, I<sup>2</sup>&#xa0;= 0%). The certainty of the body of evidence was judged to be very low for all outcomes.</AbstractText><AbstractText Label="CONCLUSION">CA coverage during TEVAR is associated with high rates of visceral ischaemia, spinal cord ischaemia, 30 day/in hospital mortality, endoleaks, and re-intervention. Although the literature is of poor quality and questions remain over effects estimates, there is evidence that CA coverage should be avoided if at all possible, during TEVAR.</AbstractText><AbstractText Label="REGISTRATION">PROSPERO registration number 244084.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hanna</LastName><ForeName>Lydia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK; Department of Surgery and Cancer, Imperial College London, UK. Electronic address: l.hanna@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agbeko</LastName><ForeName>Anita E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoako</LastName><ForeName>Joachim K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashrafian</LastName><ForeName>Hutan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Imperial College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sounderajah</LastName><ForeName>Viknesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK; Department of Surgery and Cancer, Imperial College London, UK; Institute of Global Health Innovation, Imperial College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK; Department of Surgery and Cancer, Imperial College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibbs</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK; Department of Surgery and Cancer, Imperial College London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="Y">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002445" MajorTopicYN="N">Celiac Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057867" MajorTopicYN="N">Endoleak</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020760" MajorTopicYN="Y">Spinal Cord Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">30 day mortality</Keyword><Keyword MajorTopicYN="N">Coeliac artery coverage</Keyword><Keyword MajorTopicYN="N">Endoleak</Keyword><Keyword MajorTopicYN="N">Scallop endografts</Keyword><Keyword MajorTopicYN="N">Spinal cord ischaemia</Keyword><Keyword MajorTopicYN="N">Thoracic endovascular aortic repair</Keyword><Keyword MajorTopicYN="N">Visceral ischaemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35460890</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2022.02.026</ArticleId><ArticleId IdType="pii">S1078-5884(22)00134-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38750417</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis on mortality rate following total pelvic exenteration in cancer patients.</ArticleTitle><Pagination><StartPage>593</StartPage><MedlinePgn>593</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">593</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-024-12377-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Total pelvic exenteration (TPE), an en bloc resection is an ultraradical operation for malignancies, and refers to the removal of organs inside the pelvis, including female reproductive organs, lower urological organs and involved parts of the digestive system. The aim of this meta-analysis is to estimate the intra-operative mortality, in-hospital mortality, 30- and 90-day mortality rate and overall mortality rate (MR) following TPE in colorectal, gynecological, urological, and miscellaneous cancers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a systematic review and meta-analysis in which three international databases including Medline through PubMed, Scopus and Web of Science on November 2023 were searched. To screen and select relevant studies, retrieved articles were entered into Endnote software. The required information was extracted from the full text of the retrieved articles by the authors. Effect measures in this study was the intra-operative, in-hospital, and 90-day and overall MR following TPE. All analyzes are performed using Stata software version 16 (Stata Corp, College Station, TX).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this systematic review, 1751 primary studies retrieved, of which 98 articles (5343 cases) entered into this systematic review. The overall mortality rate was 30.57% in colorectal cancers, 25.5% in gynecological cancers and 12.42% in Miscellaneous. The highest rate of mortality is related to the overall mortality rate of colorectal cancers. The MR in open surgeries was higher than in minimally invasive surgeries, and also in primary advanced cancers, it was higher than in recurrent cancers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In conclusion, it can be said that performing TPE in a specialized surgical center with careful patient eligibility evaluation is a viable option for advanced malignancies of the pelvic organs.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Esmailzadeh</LastName><ForeName>Arezoo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5999-9590</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fakhari</LastName><ForeName>Mohammad Sadegh</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-0350-447X</Identifier><AffiliationInfo><Affiliation>Student Research Committee, Arak University of Medical Sciences, Arak, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saedi</LastName><ForeName>Nafise</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8187-5738</Identifier><AffiliationInfo><Affiliation>Fellowship of Perinatology, Department of Gynecologic Oncology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shokouhi</LastName><ForeName>Nasim</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4746-8087</Identifier><AffiliationInfo><Affiliation>Fellowship of Female Pelvic Medicine and Reconstructive Surgery, Yas Women Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almasi-Hashiani</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4434-561X</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Arak University of Medical Sciences, Arak, Iran. amiralmasi2007@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Traditional and Complementary Medicine Research Center, Arak University of Medical Sciences, Arak, Iran. amiralmasi2007@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010385" MajorTopicYN="Y">Pelvic Exenteration</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005833" MajorTopicYN="N">Genital Neoplasms, Female</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal neoplasms</Keyword><Keyword MajorTopicYN="N">Gynecological neoplasms</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Total pelvic exenteration</Keyword><Keyword MajorTopicYN="N">Urologic neoplasms</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38750417</ArticleId><ArticleId IdType="pmc">PMC11095034</ArticleId><ArticleId IdType="doi">10.1186/s12885-024-12377-5</ArticleId><ArticleId IdType="pii">10.1186/s12885-024-12377-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1(2):177&#x2013;83. doi: 10.1002/1097-0142(194807)1:2&lt;177::AID-CNCR2820010203&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(194807)1:2&lt;177::AID-CNCR2820010203&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">18875031</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleth Nielsen CK, S&#xf8;rensen MM, Christensen HK, Funder JA. Complications and survival after total pelvic exenteration. Eur J Surg Oncol. 2022;48(6):1362&#x2013;7. doi: 10.1016/j.ejso.2021.12.472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2021.12.472</ArticleId><ArticleId IdType="pubmed">34998633</ArticleId></ArticleIdList></Reference><Reference><Citation>Miri SR, Akhavan S, Mousavi AS, Hashemi SR, Sheikhhasan S, Almasi-Hashiani A, Sadegh Fakhari M, Esmailzadeh A. A systematic review on overall survival and disease-free survival following total pelvic exenteration. Asian Pac J cancer Prevention: APJCP. 2022;23(4):1137&#x2013;45. doi: 10.31557/APJCP.2022.23.4.1137.</Citation><ArticleIdList><ArticleId IdType="doi">10.31557/APJCP.2022.23.4.1137</ArticleId><ArticleId IdType="pmc">PMC9375624</ArticleId><ArticleId IdType="pubmed">35485668</ArticleId></ArticleIdList></Reference><Reference><Citation>Straubhar AM, Chi AJ, Zhou QC, Iasonos A, Filippova OT, Leitao MM, Jr, Awowole IO, Abu-Rustum NR, Broach VA, Jewell EL, et al. Pelvic exenteration for recurrent or persistent gynecologic malignancies: clinical and histopathologic factors predicting recurrence and survival in a modern cohort. Gynecol Oncol. 2021;163(2):294&#x2013;8. doi: 10.1016/j.ygyno.2021.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2021.08.033</ArticleId><ArticleId IdType="pmc">PMC8585715</ArticleId><ArticleId IdType="pubmed">34518053</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh I, Nasir I, Gani A, Mureb A, Dowsett D, Haywood R, Rosich Medina A, Al Kadhi O, Parvaiz A, Kapur S. Robotic total pelvic exenteration &#x2013; a video vignette. Colorectal Dis. 2021;23(7):1946&#x2013;1946. doi: 10.1111/codi.15700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.15700</ArticleId><ArticleId IdType="pubmed">33928742</ArticleId></ArticleIdList></Reference><Reference><Citation>Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99(1):153&#x2013;9. doi: 10.1016/j.ygyno.2005.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2005.05.034</ArticleId><ArticleId IdType="pubmed">16054678</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003) Gynecol Oncol. 2006;101(2):261&#x2013;8. doi: 10.1016/j.ygyno.2005.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2005.10.011</ArticleId><ArticleId IdType="pubmed">16426668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrou NC, Pearson JM, Averette HE. Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations. Surg Oncol Clin N Am. 2005;14(2):289&#x2013;300. doi: 10.1016/j.soc.2004.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soc.2004.11.011</ArticleId><ArticleId IdType="pubmed">15817240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhman Y, Nougaret S, Micc&#xf2; M, Scelzo C, Vargas HA, Sosa RE, Sutton EJ, Chi DS, Hricak H, Sala E. Role of MR Imaging and FDG PET/CT in selection and follow-up of patients treated with pelvic exenteration for gynecologic malignancies. Radiographics: Rev Publication Radiological Soc North Am Inc. 2015;35(4):1295&#x2013;313. doi: 10.1148/rg.2015140313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.2015140313</ArticleId><ArticleId IdType="pmc">PMC4959795</ArticleId><ArticleId IdType="pubmed">26172364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ter&#xe1;n-Porcayo MA, Zeichner-Gancz I, del-Castillo RA, Beltr&#xe1;n-Ortega A, Solorza-Luna G. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico. Med Oncol (Northwood Lond Engl) 2006;23(2):219&#x2013;23. doi: 10.1385/MO:23:2:219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/MO:23:2:219</ArticleId><ArticleId IdType="pubmed">16720922</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna-Perez P, Rodriguez DF, Flores D, Delgado S, Labastida S. Morbidity and mortality following preoperative radiation therapy and total pelvic exenteration for primary rectal adenocarcinoma. Surg Oncol. 1995;4(6):295&#x2013;301. doi: 10.1016/S0960-7404(10)80041-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-7404(10)80041-6</ArticleId><ArticleId IdType="pubmed">8809951</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo P, Ravindran B, Katz J, Paty P, Guillem J, Cohen AM. Urinary diversion after total pelvic exenteration for rectal cancer. Ann Surg Oncol. 1999;6(8):732&#x2013;8. doi: 10.1007/s10434-999-0732-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10434-999-0732-x</ArticleId><ArticleId IdType="pubmed">10622500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamat AM, Huang SF, Bermejo CE, Rosser CJ, Pettaway CA, Pisters PW, Guitreau D, Pisters LL. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol. 2003;170(5):1868&#x2013;71. doi: 10.1097/01.ju.0000091656.94825.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ju.0000091656.94825.90</ArticleId><ArticleId IdType="pubmed">14532795</ArticleId></ArticleIdList></Reference><Reference><Citation>Katory M, McLean R, Paez E, Kucukmetin A, Naik R. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: a 9 year consecutive single-centre cohort study. Int J Surg (London England) 2017;43:38&#x2013;45. doi: 10.1016/j.ijsu.2017.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2017.05.037</ArticleId><ArticleId IdType="pubmed">28529192</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute JB, The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party*. Supporting Document for the Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Austr&#xe1;lia: Joanna Briggs Institute 2014:2019&#x2009;&#x2013;&#x2009;2005.</Citation></Reference><Reference><Citation>Peters MD, Godfrey CM, McInerney P, Soares CB, Khalil H, Parker D. The Joanna Briggs Institute reviewers&#x2019; manual 2015: methodology for JBI scoping reviews. 2015.</Citation></Reference><Reference><Citation>Ingiulla W, Cosmi EV. Pelvic exenteration for advanced carcinoma of the cervix. Some reflections on 241 cases. Am J Obstet Gynecol. 1967;99(8):1083&#x2013;6. doi: 10.1016/0002-9378(67)90347-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(67)90347-X</ArticleId><ArticleId IdType="pubmed">6065302</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton WN, Jr, Flanagan WC., Jr Pelvic exenteration in the treatment of advanced malignancy of the vulva. Am J Obstet Gynecol. 1973;117(6):774&#x2013;81. doi: 10.1016/0002-9378(73)90492-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(73)90492-4</ArticleId><ArticleId IdType="pubmed">4745176</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlen JR, Piver MS. Reduction of mortality and morbidity associated with pelvic exenteration. Gynecol Oncol. 1975;3(2):164&#x2013;7. doi: 10.1016/0090-8258(75)90076-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-8258(75)90076-1</ArticleId><ArticleId IdType="pubmed">1183867</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckhauser FE, Lindenauer SM, Morley GW. Pelvic exenteration for advanced rectal carcinoma. Am J Surg. 1979;138(3):412&#x2013;4. doi: 10.1016/0002-9610(79)90274-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(79)90274-5</ArticleId><ArticleId IdType="pubmed">474878</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledesma EJ, Bruno S, Mittelman A. Total pelvic exenteration in colorectal disease: a 20-year experience. Ann Surg. 1981;194(6):701&#x2013;3. doi: 10.1097/00000658-198112000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-198112000-00007</ArticleId><ArticleId IdType="pmc">PMC1345381</ArticleId><ArticleId IdType="pubmed">7305482</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T, Tominaga T, Itoh I. Results of pelvic exenteration. World J Surg. 1981;5(5):749&#x2013;50. doi: 10.1007/BF01657946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01657946</ArticleId><ArticleId IdType="pubmed">7331370</ArticleId></ArticleIdList></Reference><Reference><Citation>Boey J, Wong J, Ong GB. Pelvic exenteration for locally advanced colorectal carcinoma. Ann Surg. 1982;195(4):513&#x2013;8. doi: 10.1097/00000658-198204000-00022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-198204000-00022</ArticleId><ArticleId IdType="pmc">PMC1352537</ArticleId><ArticleId IdType="pubmed">6175286</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi H, Morimoto T, Yasue M, Kato K, Yamada E, Suzuki R. Total pelvic exenteration for advanced carcinoma of the lower colon. J Surg Oncol. 1985;28(1):59&#x2013;62. doi: 10.1002/jso.2930280114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.2930280114</ArticleId><ArticleId IdType="pubmed">3968889</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuevas HR, Torres A, Garza MDL, Hernandez D, Herrera L. Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases. J Surg Oncol. 1988;38(2):121&#x2013;5. doi: 10.1002/jso.2930380214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.2930380214</ArticleId><ArticleId IdType="pubmed">3288809</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung RS, Moffat FL, Falk RE. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer. 1993;72(6):1853&#x2013;8. doi: 10.1002/1097-0142(19930915)72:6&lt;1853::AID-CNCR2820720611&gt;3.0.CO;2-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(19930915)72:6&lt;1853::AID-CNCR2820720611&gt;3.0.CO;2-V</ArticleId><ArticleId IdType="pubmed">7689919</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SY, Wang YN, Zhu WQ, Gu WL, Fu H. Total pelvic exenteration for locally advanced rectal carcinoma. Dis Colon Rectum. 1994;37(2):172&#x2013;4. doi: 10.1007/BF02047542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02047542</ArticleId><ArticleId IdType="pubmed">8306839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MJ, Standiford SB, Skibba JL. Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Archives of surgery (Chicago, Ill: 1960) 1994, 129(4):390&#x2013;395; discussion 395&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">8154965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardi A, Bolton JS, Hicks TC, Skenderis BS. 2nd: total pelvic exenteration with or without sacral resection in patients with recurrent colorectal cancer. South Med J. 1994;87(3):363&#x2013;9. doi: 10.1097/00007611-199403000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007611-199403000-00013</ArticleId><ArticleId IdType="pubmed">7510906</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodhouse CR, Plail RO, Schlesinger PE, Shepherd JE, Hendry WF, Breach NM. Exenteration as palliation for patients with advanced pelvic malignancy. Br J Urol. 1995;76(3):315&#x2013;20. doi: 10.1111/j.1464-410X.1995.tb07707.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-410X.1995.tb07707.x</ArticleId><ArticleId IdType="pubmed">7551839</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna-Perez P. Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma. Ann Surg Oncol. 1996;3(6):526&#x2013;33. doi: 10.1007/BF02306084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02306084</ArticleId><ArticleId IdType="pubmed">8915483</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg. 1996;83(1):32&#x2013;5. doi: 10.1002/bjs.1800830109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.1800830109</ArticleId><ArticleId IdType="pubmed">8653356</ArticleId></ArticleIdList></Reference><Reference><Citation>Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg. 2000;190(1):78&#x2013;83. doi: 10.1016/S1072-7515(99)00229-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1072-7515(99)00229-X</ArticleId><ArticleId IdType="pubmed">10625236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HS, Sheen-Chen SM. Total pelvic exenteration for primary local advanced colorectal cancer. World J Surg. 2001;25(12):1546&#x2013;9. doi: 10.1007/s00268-001-0167-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-001-0167-4</ArticleId><ArticleId IdType="pubmed">11775189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiig JN, Poulsen JP, Larsen S, Br&#xe6;ndengen M, Waehre H, Giercksky KE. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg. 2002;168(1):42&#x2013;8. doi: 10.1080/110241502317307562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/110241502317307562</ArticleId><ArticleId IdType="pubmed">12022371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum. 2003;46(4):474&#x2013;80. doi: 10.1007/s10350-004-6585-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10350-004-6585-2</ArticleId><ArticleId IdType="pubmed">12682540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez RE, Shoup M, Cohen AM, Paty PB, Guillem J, Wong WD. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum. 2003;46(12):1619&#x2013;25. doi: 10.1007/BF02660766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02660766</ArticleId><ArticleId IdType="pubmed">14668586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakuda JT, Lamont JP, Chu DZ, Paz IB. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg. 2003;186(6):660&#x2013;4. doi: 10.1016/j.amjsurg.2003.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2003.08.011</ArticleId><ArticleId IdType="pubmed">14672775</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitelli CE, Crenca F, Fortunato L, Di Nardo A, Farina M, Mustacciuoli G. Pelvic exenterative procedures for locally advanced or recurrent colorectal carcinoma in a community hospital. Tech Coloproctol. 2003;7(3):159&#x2013;63. doi: 10.1007/s10151-003-0028-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10151-003-0028-2</ArticleId><ArticleId IdType="pubmed">14628159</ArticleId></ArticleIdList></Reference><Reference><Citation>Houvenaeghel G, Moutardier V, Karsenty G, Bladou F, Lelong B, Buttarelli M, Delpero JR. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol. 2004;92(2):680&#x2013;3. doi: 10.1016/j.ygyno.2003.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2003.11.003</ArticleId><ArticleId IdType="pubmed">14766266</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum. 2004;47(12):2047&#x2013;53. doi: 10.1007/s10350-004-0714-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10350-004-0714-9</ArticleId><ArticleId IdType="pubmed">15657653</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibovici D, Pagliaro L, Rosser CJ, Pisters LL. Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy. J Urol. 2005;173(3):781&#x2013;3. doi: 10.1097/01.ju.0000152394.32858.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ju.0000152394.32858.14</ArticleId><ArticleId IdType="pubmed">15711269</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen DQ, McGregor AD, Freites O, Carr ND, Beynon J, El-Sharkawi AM, Lucas MG. Exenterative pelvic surgery&#x2013;eleven year experience of the Swansea Pelvic Oncology Group. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2005;31(10):1180&#x2013;4. doi: 10.1016/j.ejso.2005.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2005.07.007</ArticleId><ArticleId IdType="pubmed">16126362</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wilt JH, van Leeuwen DH, Logmans A, Verhoef C, Kirkels WJ, Vermaas M, Ansink AC. Pelvic exenteration for primary and recurrent gynaecological malignancies. Eur J Obstet Gynecol Reprod Biol. 2007;134(2):243&#x2013;8. doi: 10.1016/j.ejogrb.2006.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2006.07.025</ArticleId><ArticleId IdType="pubmed">16950559</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Choi HJ, Jeong SY, Chung J, Park JK, Park SY. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: analysis of risk factors predicting recurrence and survival. J Surg Oncol. 2007;96(7):560&#x2013;8. doi: 10.1002/jso.20847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.20847</ArticleId><ArticleId IdType="pubmed">17708548</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermaas M, Ferenschild FT, Verhoef C, Nuyttens JJ, Marinelli AW, Wiggers T, Kirkels WJ, Eggermont AM, de Wilt JH. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2007;33(4):452&#x2013;8. doi: 10.1016/j.ejso.2006.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2006.09.021</ArticleId><ArticleId IdType="pubmed">17071043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells BJ, Stotland P, Ko MA, Al-Sukhni W, Wunder J, Ferguson P, Lipa J, Last L, Smith AJ, Swallow CJ. Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol. 2007;14(2):390&#x2013;5. doi: 10.1245/s10434-006-9119-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-006-9119-4</ArticleId><ArticleId IdType="pubmed">17063304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungar L, Palfalvi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol. 2008;111(2 Suppl):S9&#x2013;12. doi: 10.1016/j.ygyno.2008.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2008.07.041</ArticleId><ArticleId IdType="pubmed">18775558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH. Total pelvic exenteration for primary and recurrent malignancies. World J Surg. 2009;33(7):1502&#x2013;8. doi: 10.1007/s00268-009-0066-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-009-0066-7</ArticleId><ArticleId IdType="pmc">PMC2691931</ArticleId><ArticleId IdType="pubmed">19421811</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggioni A, Roviglione G, Landoni F, Zanagnolo V, Peiretti M, Colombo N, Bocciolone L, Biffi R, Minig L, Morrow CP. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114(1):64&#x2013;8. doi: 10.1016/j.ygyno.2009.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2009.03.029</ArticleId><ArticleId IdType="pubmed">19411097</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntambekar S, Agarwal G, Puntambekar S, Sathe R, Patil A. Stretching the limits of laparoscopy in gynecological oncology: technical feasibility of doing a laparoscopic total pelvic exenteration for palliation in advanced cervical cancer. Int J Biomedical Science: IJBS. 2009;5(1):17. doi: 10.59566/IJBS.2009.5017.</Citation><ArticleIdList><ArticleId IdType="doi">10.59566/IJBS.2009.5017</ArticleId><ArticleId IdType="pmc">PMC3614755</ArticleId><ArticleId IdType="pubmed">23675109</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahn M, Weiss C, Bader P, Frohneberg D, Studer UE, Burkhard FC. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival. Urol Int. 2010;85(1):16&#x2013;22. doi: 10.1159/000296300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000296300</ArticleId><ArticleId IdType="pubmed">20299775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoucas E, Frederiksen S, Lydrup ML, M&#xe5;nsson W, Gustafson P, Alberius P. Pelvic exenteration for advanced and recurrent malignancy. World J Surg. 2010;34(9):2177&#x2013;84. doi: 10.1007/s00268-010-0637-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-010-0637-7</ArticleId><ArticleId IdType="pubmed">20512493</ArticleId></ArticleIdList></Reference><Reference><Citation>Chokshi RJ, Fowler J, Cohn D, Bahnson R, Lumbley J, Martin EW., Jr A single-institution approach to total pelvic exenteration. Am Surg. 2011;77(12):1629&#x2013;39. doi: 10.1177/000313481107701234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481107701234</ArticleId><ArticleId IdType="pubmed">22273221</ArticleId></ArticleIdList></Reference><Reference><Citation>Domes TS, Colquhoun PH, Taylor B, Izawa JI, House AA, Luke PP, Izawa JI. Total pelvic exenteration for rectal cancer: outcomes and prognostic factors. Can J Surg J canadien de chirurgie. 2011;54(6):387&#x2013;93. doi: 10.1503/cjs.014010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cjs.014010</ArticleId><ArticleId IdType="pmc">PMC3238342</ArticleId><ArticleId IdType="pubmed">21939606</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es GC, Baiocchi G, Ferreira FO, Kumagai LY, Fallopa CC, Aguiar S, Rossi BM, Soares FA, Lopes A. Palliative pelvic exenteration for patients with gynecological malignancies. Arch Gynecol Obstet. 2011;283(5):1107&#x2013;12. doi: 10.1007/s00404-010-1544-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-010-1544-8</ArticleId><ArticleId IdType="pubmed">20563730</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitulescu G, Gluck G, St&#xee;ngu C. Radical surgical treatement in pelvic advanced cancer. Annals Fundeni Hosp. 2011;16(3&#x2013;4):87&#x2013;106.</Citation></Reference><Reference><Citation>Baiocchi G, Guimaraes GC, Rosa Oliveira RA, Kumagai LY, Faloppa CC, Aguiar S, Begnami MD, Soares FA, Lopes A. Prognostic factors in pelvic exenteration for gynecological malignancies. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2012;38(10):948&#x2013;54. doi: 10.1016/j.ejso.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2012.07.002</ArticleId><ArticleId IdType="pubmed">22818842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhrt MP, Chokshi RJ, Arrese D, Martin EW., Jr Retrospective review of pelvic malignancies undergoing total pelvic exenteration. World J Surg Oncol. 2012;10:110. doi: 10.1186/1477-7819-10-110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7819-10-110</ArticleId><ArticleId IdType="pmc">PMC3465228</ArticleId><ArticleId IdType="pubmed">22703863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramamurthy R, Duraipandian A. Morbidity and outcome of pelvic exenteration in locally advanced pelvic malignancies. Indian J Surg Oncol. 2012;3(3):231&#x2013;5. doi: 10.1007/s13193-012-0129-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13193-012-0129-3</ArticleId><ArticleId IdType="pmc">PMC3444588</ArticleId><ArticleId IdType="pubmed">23997512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, Park SY. Pelvic exenteration for recurrent cervical cancer: ten-year experience at national cancer center in Korea. J Gynecologic Oncol. 2012;23(4):242&#x2013;50. doi: 10.3802/jgo.2012.23.4.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3802/jgo.2012.23.4.242</ArticleId><ArticleId IdType="pmc">PMC3469859</ArticleId><ArticleId IdType="pubmed">23094127</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ger L, Nilsson PJ, R&#xe5;destad AF. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2013;23(4):755&#x2013;62. doi: 10.1097/IGC.0b013e318287a874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IGC.0b013e318287a874</ArticleId><ArticleId IdType="pubmed">23407096</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan KK, Pal S, Lee PJ, Rodwell L, Solomon MJ. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca&#x2013;a single institution&#x2019;s experience over 16 years. Colorectal Disease: Official J Association Coloproctology Great Br Irel. 2013;15(10):1227&#x2013;31. doi: 10.1111/codi.12306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.12306</ArticleId><ArticleId IdType="pubmed">23714581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda T, Koyama F, Nakagawa T, Nakamura S, Nishigori N, Inoue T, Kawasaki K, Obara S, Nakamoto T, Fujii H, et al. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies. Gan Kagaku Ryoho Cancer Chemother. 2013;40(12):2433&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24394136</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne T, Solomon MJ, Lee P, Young JM, Stalley P, Harrison JD, Austin KK. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Dis Colon Rectum. 2014;57(10):1153&#x2013;61. doi: 10.1097/DCR.0000000000000196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000000196</ArticleId><ArticleId IdType="pubmed">25203370</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathiraja P, Sandhu H, Instone M, Haldar K, Kehoe S. Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered? Arch Gynecol Obstet. 2014;289:657&#x2013;62. doi: 10.1007/s00404-013-3023-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-013-3023-5</ArticleId><ArticleId IdType="pubmed">24026090</ArticleId></ArticleIdList></Reference><Reference><Citation>Petruzziello A, Kondo W, Hatschback SB, Guerreiro JA, Filho FP, Vendrame C, Luz M, Ribeiro R. Surgical results of pelvic exenteration in the treatment of gynecologic cancer. World J Surg Oncol. 2014;12:279. doi: 10.1186/1477-7819-12-279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7819-12-279</ArticleId><ArticleId IdType="pmc">PMC4167277</ArticleId><ArticleId IdType="pubmed">25200866</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Nagase S, Kaiho-Sakuma M, Nagai T, Kurosawa H, Toyoshima M, Tokunaga H, Otsuki T, Utsunomiya H, Takano T, et al. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer. Int J Clin Oncol. 2014;19(1):133&#x2013;8. doi: 10.1007/s10147-013-0534-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10147-013-0534-9</ArticleId><ArticleId IdType="pubmed">23404487</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin KY, Ng DW, Tan GH, Teo MC. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer. J Gastrointest cancer. 2014;45(3):291&#x2013;7. doi: 10.1007/s12029-014-9586-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12029-014-9586-y</ArticleId><ArticleId IdType="pubmed">24563189</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#x259;p&#xee;lna ME, Moldovan B, Szabo B. Pelvic exenteration - our initial experience in 15 cases. Eur J Gynaecol Oncol. 2015;36(2):142&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">26050350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghouti L, Pereira P, Filleron T, Humeau M, Guimbaud R, Selves J, Carrere N. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure? A single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010. Am J Surg. 2015;209(2):352&#x2013;62. doi: 10.1016/j.amjsurg.2014.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2014.01.008</ArticleId><ArticleId IdType="pubmed">25524284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusters M, Austin KK, Solomon MJ, Lee PJ, Nieuwenhuijzen GA, Rutten HJ. Survival after pelvic exenteration for T4 rectal cancer. Br J Surg. 2015;102(1):125&#x2013;31. doi: 10.1002/bjs.9683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9683</ArticleId><ArticleId IdType="pubmed">25451182</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Palacios E, Diestro MD, De Santiago J, Hern&#xe1;ndez A, Zapardiel I. Pelvic exenteration in Gynecologic Cancer: La Paz University Hospital Experience. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2015;25(6):1109&#x2013;14. doi: 10.1097/IGC.0000000000000435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IGC.0000000000000435</ArticleId><ArticleId IdType="pubmed">25853383</ArticleId></ArticleIdList></Reference><Reference><Citation>Rombouts AJ, Koh CE, Young JM, Masya L, Roberts R, De-Loyde K, de Wilt JH, Solomon MJ. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer? Dis Colon Rectum. 2015;58(1):65&#x2013;73. doi: 10.1097/DCR.0000000000000213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000000213</ArticleId><ArticleId IdType="pubmed">25489696</ArticleId></ArticleIdList></Reference><Reference><Citation>Koda K, Shuto K, Matsuo K, Kosugi C, Mori M, Hirano A, Hiroshima Y, Tanaka K. Layer-oriented total pelvic exenteration for locally advanced primary colorectal cancer. Int J Colorectal Dis. 2016;31(1):59&#x2013;66. doi: 10.1007/s00384-015-2353-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-015-2353-0</ArticleId><ArticleId IdType="pubmed">26255259</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt AM, Imesch P, Fink D, Egger H. Pelvic exenterations for Advanced and recurrent endometrial Cancer: clinical outcomes of 40 patients. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2016;26(4):716&#x2013;21. doi: 10.1097/IGC.0000000000000678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IGC.0000000000000678</ArticleId><ArticleId IdType="pubmed">26937752</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew MH, Yeh YT, Toh EL, Sumarli SA, Chew GK, Lee LS, Tan MH, Hennedige TP, Ng SY, Lee SK, et al. Critical evaluation of contemporary management in a new pelvic exenteration unit: the first 25 consecutive cases. World J Gastrointest Oncol. 2017;9(5):218&#x2013;27. doi: 10.4251/wjgo.v9.i5.218.</Citation><ArticleIdList><ArticleId IdType="doi">10.4251/wjgo.v9.i5.218</ArticleId><ArticleId IdType="pmc">PMC5434389</ArticleId><ArticleId IdType="pubmed">28567186</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslim EJ, Chew MH, Chew GK, Lee LS. Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy. ANZ J Surg. 2018;88(9):896&#x2013;900. doi: 10.1111/ans.14689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.14689</ArticleId><ArticleId IdType="pubmed">29895098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemans JAW, Rothbarth J, Kirkels WJ, Boormans JL, van Meerten E, Nuyttens J, Madsen EVE, Verhoef C, Burger JWA. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2018;44(10):1548&#x2013;54. doi: 10.1016/j.ejso.2018.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2018.06.033</ArticleId><ArticleId IdType="pubmed">30075979</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Ma SQ, Tan XJ, Zhong S, Wu M. Pelvic exenteration for recurrent and persistent cervical Cancer. Chin Med J. 2018;131(13):1541&#x2013;8. doi: 10.4103/0366-6999.235111.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.235111</ArticleId><ArticleId IdType="pmc">PMC6032675</ArticleId><ArticleId IdType="pubmed">29941707</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta AM, Hellawell G, Burling D, Littler S, Antoniou A, Jenkins JT. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes. Tech Coloproctol. 2018;22(9):663&#x2013;71. doi: 10.1007/s10151-018-1852-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10151-018-1852-8</ArticleId><ArticleId IdType="pubmed">30306276</ArticleId></ArticleIdList></Reference><Reference><Citation>Romeo A, Gonzalez MI, Jaunarena J, Zubieta ME, Favre G, Tejerizo JC. Pelvic exenteration for gynecologic malignancies: postoperative complications and oncologic outcomes. Actas Urol Esp. 2018;42(2):121&#x2013;5. doi: 10.1016/j.acuro.2017.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acuro.2017.05.004</ArticleId><ArticleId IdType="pubmed">28911880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizzarri N, Chiantera V, Ercoli A, Fagotti A, Tortorella L, Conte C, Cappuccio S, Di Donna MC, Gallotta V, Scambia G, et al. Minimally invasive pelvic exenteration for gynecologic malignancies: a multi-institutional Case Series and Review of the literature. J Minim Invasive Gynecol. 2019;26(7):1316&#x2013;26. doi: 10.1016/j.jmig.2018.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmig.2018.12.019</ArticleId><ArticleId IdType="pubmed">30611973</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gregorio N, de Gregorio A, Ebner F, Friedl TWP, Huober J, Hefty R, Wittau M, Janni W, Widschwendter P. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases. Arch Gynecol Obstet. 2019;300(1):161&#x2013;8. doi: 10.1007/s00404-019-05154-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-019-05154-4</ArticleId><ArticleId IdType="pubmed">31011878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiiski J, R&#xe4;ikk&#xf6;nen K, Vuento MH, Hy&#xf6;ty MK, Kallio J, Kuokkanen HO, Kaartinen IS. Transverse myocutaneous Gracilis flap reconstruction is feasible after pelvic exenteration: 12-year surgical and oncological results. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2019;45(9):1632&#x2013;7. doi: 10.1016/j.ejso.2019.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2019.04.021</ArticleId><ArticleId IdType="pubmed">31060762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lago V, Poveda I, Padilla-Iserte P, Sim&#xf3;n-Sanz E, Garc&#xed;a-Granero &#xc1;, Pontones JL, Matute L, Domingo S. Pelvic exenteration in gynecologic cancer: complications and oncological outcome. Gynecol Surg 2019, 16(1).</Citation></Reference><Reference><Citation>Lee P, Tan WJ, Brown KGM, Solomon MJ. Addressing the empty pelvic syndrome following total pelvic exenteration: does mesh reconstruction help? Colorectal Disease: Official J Association Coloproctology Great Br Irel. 2019;21(3):365&#x2013;9. doi: 10.1111/codi.14523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.14523</ArticleId><ArticleId IdType="pubmed">30548166</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedyalkov K, Magunska N, Bechev B, Kostov I. Survival rate and complications after different types of pelvic exenteration for gynecological cancer. Eur J Gynaecol Oncol. 2019;40(1):69&#x2013;73.</Citation></Reference><Reference><Citation>Rema P, Suchetha S, Mathew AP, George P, Mathew A, Thomas S. Pelvic exenterations for Cervical Cancer Recurrences&#x2014;a safe option in Indian scenario. Indian J Surg. 2019;81(6):537&#x2013;42. doi: 10.1007/s12262-018-1853-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12262-018-1853-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeda S, Furukawa S, Sato T, Ueda M, Kamo N, Endo Y, Kojima M, Nomura S, Kataoka M, Fujita S, et al. Pelvic exenteration as potential cure and Symptom Relief in Advanced and recurrent Gynaecological Cancer. Anticancer Res. 2019;39(10):5631&#x2013;7. doi: 10.21873/anticanres.13759.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.13759</ArticleId><ArticleId IdType="pubmed">31570460</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorella L, Casarin J, Mara KC, Weaver AL, Multinu F, Glaser GE, Cliby WA, Scambia G, Mariani A, Kumar A. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol. 2019;152(1):151&#x2013;6. doi: 10.1016/j.ygyno.2018.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2018.10.036</ArticleId><ArticleId IdType="pubmed">30414740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewandowska A, Szubert S, Koper K, Koper A, Cwynar G, Wicherek L. Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer. World J Surg Oncol 2020, 18(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7469312</ArticleId><ArticleId IdType="pubmed">32878646</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuech JJ, Pinson J, Nouhaud FX, Wood G, Clavier T, Sabourin JC, Di Fiore F, Monge M, Papet E, Coget J. Total pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for rectal cancer with associate peritoneal metastases: Surgical strategies to optimize safety. Cancers. 2020;12(11):1&#x2013;14. doi: 10.3390/cancers12113478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12113478</ArticleId><ArticleId IdType="pmc">PMC7700214</ArticleId><ArticleId IdType="pubmed">33238384</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigneswaran HT, Schwarzman LS, Madueke IC, David SML, Nordenstam J, Moreira D, Abern MR. Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US. Annals of surgical oncology 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33105501</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogner A, Fritzmann J, M&#xfc;ssle B, Huber J, Dobroschke J, Bork U, Wolk S, Distler M, Weitz J, Welsch T et al. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome. Int J Colorectal Dis 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279979</ArticleId><ArticleId IdType="pubmed">33677655</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KGM, Ansari N, Solomon MJ, Austin KKS, Hamilton AER, Young CJ. Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases. Colorectal Dis. 2021;23(1):186&#x2013;91. doi: 10.1111/codi.15378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.15378</ArticleId><ArticleId IdType="pubmed">32978813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanao H, Aoki Y, Omi M, Nomura H, Tanigawa T, Okamoto S, Chang EJ, Kurita T, Netsu S, Matoda M et al. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome. Gynecologic oncology 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33423805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ter Glane L, Hegele A, Wagner U, Boekhoff J. Pelvic exenteration for recurrent or advanced gynecologic malignancies&#x2013;analysis of outcome and complications. Gynecologic Oncol Rep. 2021;36:100757. doi: 10.1016/j.gore.2021.100757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gore.2021.100757</ArticleId><ArticleId IdType="pmc">PMC8059060</ArticleId><ArticleId IdType="pubmed">33898694</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahman GO, Das N, Chandrasekaran TV, Khot U, Drew PJ, Bose P, Vet JN, Tofazzal N, Roberts S, Lutchman Singh K. Pelvic exenteration for the treatment of locally advanced vulvar cancer in south west wales. Cancers. 2022;14(7):1767. doi: 10.3390/cancers14071767.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14071767</ArticleId><ArticleId IdType="pmc">PMC8997009</ArticleId><ArticleId IdType="pubmed">35406539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouraoui I, Bouaziz H, Tounsi N, Ben Romdhane R, Hechiche M, Slimane M, Rahal K. Survival after pelvic exenteration for cervical cancer. J Obstet Gynecol India. 2022;72(1):66&#x2013;71. doi: 10.1007/s13224-021-01502-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13224-021-01502-0</ArticleId><ArticleId IdType="pmc">PMC8804146</ArticleId><ArticleId IdType="pubmed">35125740</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidopoulos D, Pergialiotis V, Aggelou K, Thomakos N, Alexakis N, Stamatakis E, Rodolakis A. Pelvic exenteration for gynecologic malignancies: the experience of a tertiary center from Greece. Surg Oncol. 2022;40:101702. doi: 10.1016/j.suronc.2021.101702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suronc.2021.101702</ArticleId><ArticleId IdType="pubmed">35065392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen CKP, S&#xf8;rensen MM, Christensen HK, Funder JA. Complications and survival after total pelvic exenteration. Eur J Surg Oncol. 2022;48(6):1362&#x2013;7. doi: 10.1016/j.ejso.2021.12.472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2021.12.472</ArticleId><ArticleId IdType="pubmed">34998633</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KG, Solomon MJ, Koh CE. Pelvic exenteration surgery: the evolution of radical surgical techniques for advanced and recurrent pelvic malignancy. Dis Colon Rectum. 2017;60(7):745&#x2013;54. doi: 10.1097/DCR.0000000000000839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000000839</ArticleId><ArticleId IdType="pubmed">28594725</ArticleId></ArticleIdList></Reference><Reference><Citation>Diver EJ, Rauh-Hain JA, Del Carmen MG. Total pelvic exenteration for gynecologic malignancies. International Journal of Surgical Oncology 2012, 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3376473</ArticleId><ArticleId IdType="pubmed">22720150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroon HM, Dudi-Venkata N, Bedrikovetski S, Thomas M, Kelly M, Aalbers A, Aziz NA, Abraham-Nordling M, Akiyoshi T, Alberda W. Palliative pelvic exenteration: a systematic review of patient-centered outcomes. Eur J Surg Oncol. 2019;45(10):1787&#x2013;95. doi: 10.1016/j.ejso.2019.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2019.06.011</ArticleId><ArticleId IdType="pubmed">31255441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G. Guidelines for perioperative care in gynecologic/oncology: enhanced recovery after surgery (ERAS) society recommendations&#x2014;2019 update. Int J Gynecologic Cancer 2019, 29(4).</Citation><ArticleIdList><ArticleId IdType="pubmed">30877144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferron G, Querleu D, Martel P, Letourneur B, Souli&#xe9; M. Laparoscopy-assisted vaginal pelvic exenteration. Gynecol Oncol. 2006;100(3):551&#x2013;5. doi: 10.1016/j.ygyno.2005.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2005.09.027</ArticleId><ArticleId IdType="pubmed">16249020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogura A, Akiyoshi T, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M. Safety of laparoscopic pelvic exenteration with urinary diversion for colorectal malignancies. World J Surg. 2016;40:1236&#x2013;43. doi: 10.1007/s00268-015-3364-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-015-3364-2</ArticleId><ArticleId IdType="pubmed">26643513</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K, Cai L, Yao L, Zhang Z, Zhang C, Wang X, Tang J, Li X, He Z, Zhou L. Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases. World J Surg Oncol. 2015;13(1):1&#x2013;9. doi: 10.1186/s12957-015-0715-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12957-015-0715-2</ArticleId><ArticleId IdType="pmc">PMC4608103</ArticleId><ArticleId IdType="pubmed">26472147</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokharkar A, Kammar P, D&#x2019;Souza A, Bhamre R, Sugoor P, Saklani A. Laparoscopic pelvic exenteration for locally advanced rectal Cancer, technique and short-term outcomes. J Laparoendoscopic Adv Surg Techniques. 2018;28(12):1489&#x2013;94. doi: 10.1089/lap.2018.0147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2018.0147</ArticleId><ArticleId IdType="pubmed">29741977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichihara M, Uemura M, Ikeda M, Miyake M, Kato T, Hamakawa T, Maeda S, Hama N, Nishikawa K, Miyamoto A. Safety and feasibility of laparoscopic pelvic exenteration for locally advanced or recurrent colorectal cancer. Surg Laparosc Endosc Percutan Tech. 2019;29(5):389&#x2013;92. doi: 10.1097/SLE.0000000000000699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0000000000000699</ArticleId><ArticleId IdType="pubmed">31335481</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Tominaga T, Akazawa Y, Sawai T, Nagayasu T. Feasibility of laparoscopic-assisted transanal pelvic exenteration in locally advanced rectal cancer with anterior invasion. Tech Coloproctol. 2021;25:69&#x2013;74. doi: 10.1007/s10151-020-02324-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10151-020-02324-4</ArticleId><ArticleId IdType="pubmed">32815047</ArticleId></ArticleIdList></Reference><Reference><Citation>Rios-Doria E, Filippova OT, Straubhar AM, Chi A, Awowole I, Sandhu J, Broach V, Mueller JJ, Gardner GJ, Jewell EL. A modern-day experience with Brunschwig&#x2019;s operation: outcomes associated with pelvic exenteration. Gynecol Oncol. 2022;167(2):277&#x2013;82. doi: 10.1016/j.ygyno.2022.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2022.08.017</ArticleId><ArticleId IdType="pmc">PMC10204127</ArticleId><ArticleId IdType="pubmed">36064678</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkia R, Tailor A, Ellis P, Madhuri T, Scala A, Read J, Perry M, Patil K, Blackburn A, Butler-Manuel S. Minimally invasive pelvic exenteration for gynaecological malignancy: a single-centre case series and review of the literature. Eur J Obstet Gynecol Reproductive Biology. 2022;274:56&#x2013;61. doi: 10.1016/j.ejogrb.2022.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2022.05.003</ArticleId><ArticleId IdType="pubmed">35584578</ArticleId></ArticleIdList></Reference><Reference><Citation>Quyn AJ, Murthy S, Gould L, Said H, Tiernan J, Sagar P, Antoniou A, Jenkins I, Burns EM. Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma. Colorectal Dis. 2023;25(11):2131&#x2013;8. doi: 10.1111/codi.16736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.16736</ArticleId><ArticleId IdType="pubmed">37753947</ArticleId></ArticleIdList></Reference><Reference><Citation>Naha U, Khurshudyan A, Vigneswaran HT, Mima M, Abern MR, Moreira DM. Perioperative outcomes in male patients undergoing cystectomy, radical colorectal procedure or total pelvic exenteration. Translational Androl Urol. 2023;12(11):1631. doi: 10.21037/tau-23-266.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tau-23-266</ArticleId><ArticleId IdType="pmc">PMC10719775</ArticleId><ArticleId IdType="pubmed">38106684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralston C, Hainsworth A, de Naurois J, Schizas A, George M. Is an uncomplicated postoperative recovery following total pelvic exenteration a more important prognostic factor than achieving R0 in the first 2 years? Colorectal Dis 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38071402</ArticleId></ArticleIdList></Reference><Reference><Citation>Saqib SU, Raza MZ, Twigg J, Altan O, Bajwa AA. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration. Langenbeck&#x2019;s Archives Surg. 2023;409(1):9. doi: 10.1007/s00423-023-03206-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-023-03206-7</ArticleId><ArticleId IdType="pubmed">38102305</ArticleId></ArticleIdList></Reference><Reference><Citation>Beppu N, Ito K, Otani M, Imada A, Matsubara T, Song J, Kimura K, Kataoka K, Kuwahara R, Horio Y. Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies. Tech Coloproctol 2023:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37878167</ArticleId></ArticleIdList></Reference><Reference><Citation>Valstad H, Eyjolfsdottir B, Wang Y, Kristensen G, Skeie-Jensen T, Lindemann K. Pelvic exenteration for vulvar cancer: postoperative morbidity and oncologic outcome&#x2013;A single center retrospective analysis. Eur J Surg Oncol. 2023;49(9):106958. doi: 10.1016/j.ejso.2023.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2023.06.010</ArticleId><ArticleId IdType="pubmed">37349160</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26873043</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Endovascular repair or open repair for ruptured abdominal aortic aneurysm: a Cochrane systematic review.</ArticleTitle><Pagination><StartPage>e008391</StartPage><MedlinePgn>e008391</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e008391</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2015-008391</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Emergency endovascular aneurysm repair (eEVAR) may improve outcomes for patients with ruptured abdominal aortic aneurysm (RAAA). The study aim was to compare the outcomes for eEVAR with conventional open surgical repair for the treatment of RAAA.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A systematic review of relevant publications was performed. Randomised controlled trials (RCTs) comparing eEVAR with open surgical repair for RAAA were included.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">3 RCTs were included, with a total of 761 patients with RAAA.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Meta-analysis was performed with fixed-effects models with ORs and 95% CIs for dichotomous data and mean differences with 95% CIs for continuous data.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOME MEASURES" NlmCategory="METHODS">Primary outcome was short-term mortality. Secondary outcome measures included aneurysm-specific and general complication rates, quality of life and economic analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall risk of bias was low. There was no difference between the 2 interventions on 30-day (or in-hospital) mortality, OR 0.91 (95% CI 0.67 to 1.22; p=0.52). 30-day complications included myocardial infarction, stroke, composite cardiac complications, renal complications, severe bowel ischaemia, spinal cord ischaemia, reoperation, amputation and respiratory failure. Reporting was incomplete, and no robust conclusion was drawn. For complication outcomes that did include at least 2 studies in the meta-analysis, there was no clear evidence to support a difference between eEVAR and open repair. Longer term outcomes and cost per patient were evaluated in only a single study, thus precluding definite conclusions.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Outcomes between eEVAR and open repair, specifically 30-day mortality, are similar. However, further high-quality trials are required, as the paucity of data currently limits the conclusions.</AbstractText><CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Badger</LastName><ForeName>S A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Mater Misericordiae University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harkin</LastName><ForeName>D W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Belfast Vascular Centre, Royal Victoria Hospital, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>P H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Belfast Vascular Centre, Royal Victoria Hospital, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>P K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Belfast Vascular Centre, Royal Victoria Hospital, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kee</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Public Health, Queens University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forster</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001019" MajorTopicYN="N">Aortic Rupture</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26873043</ArticleId><ArticleId IdType="pmc">PMC4762122</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2015-008391</ArticleId><ArticleId IdType="pii">bmjopen-2015-008391</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conway AM, Malkawi AH, Hinchliffe RJ et al. . First-year results of a national abdominal aortic aneurysm screening programme in a single centre. Br J Surg 2012;99:73&#x2013;7. 10.1002/bjs.7685</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.7685</ArticleId><ArticleId IdType="pubmed">21928466</ArticleId></ArticleIdList></Reference><Reference><Citation>Anon. NHS Abdominal Aortic Aneurysm Screening Programme
2013. 
http://aaa.screening.nhs.uk</Citation></Reference><Reference><Citation>Alsac JM, Kobeiter H, Becquemin JP et al. . Endovascular repair for ruptured AAA: a literature review. Acta Chir Belg 2005;105:134&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15906902</ArticleId></ArticleIdList></Reference><Reference><Citation>Korhonen SJ, Ylonen K, Biancari F et al. , Finnvasc Study Group. Glasgow Aneurysm Score as a predictor of immediate outcome after surgery for ruptured abdominal aortic aneurysm. Br J Surg 2004;91:1449&#x2013;52. 10.1002/bjs.4634</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.4634</ArticleId><ArticleId IdType="pubmed">15499653</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary WD, Crow P, Foy C et al. . Comparison of POSSUM scoring and the Hardman Index in selection of patients for repair of ruptured abdominal aortic aneurysm. Br J Surg 2003;90:421&#x2013;5. 10.1002/bjs.4061</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.4061</ArticleId><ArticleId IdType="pubmed">12673742</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinterseher I, Saeger HD, Koch R et al. . Quality of life and long-term results after ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2004;28:262&#x2013;9. 10.1016/j.ejvs.2004.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2004.06.006</ArticleId><ArticleId IdType="pubmed">15288629</ArticleId></ArticleIdList></Reference><Reference><Citation>Tambyraja AL, Fraser SC, Murie JA et al. . Quality of life after repair of ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2004;28:229&#x2013;33. 10.1016/j.ejvs.2004.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2004.03.024</ArticleId><ArticleId IdType="pubmed">15288624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorham TJ, Taylor J, Raptis S. Endovascular treatment of abdominal aortic aneurysm. Br J Surg 2004;91:815&#x2013;27. 10.1002/bjs.4611</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.4611</ArticleId><ArticleId IdType="pubmed">15227687</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh RM, Forbes JF, Fowkes FG et al. . Early elective open surgical repair of small abdominal aortic aneurysms is not recommended: results of the UK Small Aneurysm Trial. Steering Committee. Eur J Vasc Endovasc Surg 1998;16:462&#x2013;4. 10.1016/S1078-5884(98)80234-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1078-5884(98)80234-7</ArticleId><ArticleId IdType="pubmed">9894483</ArticleId></ArticleIdList></Reference><Reference><Citation>Veith FJ, Ohki T, Lipsitz EC et al. . Treatment of ruptured abdominal aortic aneurysms with stent grafts: a new gold standard? Semin Vasc Surg 2003;16:171&#x2013;5. 10.1016/S0895-7967(03)00003-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-7967(03)00003-6</ArticleId><ArticleId IdType="pubmed">12920689</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton HA, Buxton MJ, Day NE et al. . Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360:1531&#x2013;9. 10.1016/S0140-6736(02)11522-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)11522-4</ArticleId><ArticleId IdType="pubmed">12443589</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott RA, Ashton HA, Kay DN. Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over 6 years. Br J Surg 1991;78:1122&#x2013;5. 10.1002/bjs.1800780929</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.1800780929</ArticleId><ArticleId IdType="pubmed">1933203</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P, Buth J, Eurostar et al. . What is the future for registries on endovascular aneurysm repair and who should be responsible? Eur J Vasc Endovasc Surg 2005;30:343&#x2013;5. 10.1016/j.ejvs.2005.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2005.07.014</ArticleId><ArticleId IdType="pubmed">16143280</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SM, Beard JD, Ireland M et al. , Vascular Society of Great Britain and Ireland; British Society of Interventional Radiology. Results from the prospective registry of endovascular treatment of abdominal aortic aneurysms (RETA): mid-term results to five years. Eur J Vasc Endovasc Surg 2005;29:563&#x2013;70. 10.1016/j.ejvs.2005.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2005.03.012</ArticleId><ArticleId IdType="pubmed">15878530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WA, Herniese CM, Tayyarah M et al. . Impact of endovascular repair on early outcomes of ruptured abdominal aortic aneurysms. J Vasc Surg 2004;40:211&#x2013;15. 10.1016/j.jvs.2004.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2004.05.006</ArticleId><ArticleId IdType="pubmed">15297812</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh RM, Brown LC, Kwong GP et al. , EVAR trial participants. Comparison of Endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 2004;364:843&#x2013;8. 10.1016/S0140-6736(04)16979-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16979-1</ArticleId><ArticleId IdType="pubmed">15351191</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinssen M, Verhoeven ELG, Buth J et al. . A randomized controlled trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004;351:1607&#x2013;18. 10.1056/NEJMoa042002</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa042002</ArticleId><ArticleId IdType="pubmed">15483279</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachat ML, Pfammatter T, Wizke HJ et al. . Endovascular repair with bifurcated stent-grafts under local anaesthesia to improve outcome of ruptured aortoiliac aneurysms. Eur J Vasc Endovasc Surg 2002;23:528&#x2013;36. 10.1053/ejvs.2002.1622</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejvs.2002.1622</ArticleId><ArticleId IdType="pubmed">12093070</ArticleId></ArticleIdList></Reference><Reference><Citation>EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 2005;365:2179&#x2013;86. 10.1016/S0140-6736(05)66627-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)66627-5</ArticleId><ArticleId IdType="pubmed">15978925</ArticleId></ArticleIdList></Reference><Reference><Citation>EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 2005;365:2187&#x2013;92. 10.1016/S0140-6736(05)66628-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)66628-7</ArticleId><ArticleId IdType="pubmed">15978926</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown LC, Powell JT, Thompson SG et al. . The UK Endovascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy. Health Technol Assess 2012;16:1&#x2013;218. 10.3310/hta16090</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta16090</ArticleId><ArticleId IdType="pubmed">22381040</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam DJ, Mohan IV, Stuart WP et al. . Community and hospital outcome from ruptured abdominal aortic aneurysm within the catchment area of a regional vascular surgical service. J Vasc Surg 1999;30:922&#x2013;8. 10.1016/S0741-5214(99)70018-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(99)70018-2</ArticleId><ArticleId IdType="pubmed">10550191</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber TS, Harward TR, Flynn TC et al. . Operative mortality rates after elective infrarenal aortic reconstructions. J Vasc Surg 1995;22:287&#x2013;93; discussion 293&#x2013;4 10.1016/S0741-5214(95)70143-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(95)70143-5</ArticleId><ArticleId IdType="pubmed">7674472</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay TF, Luo XP, Lehotay DC et al. . Ruptured abdominal aortic aneurysm, a &#x201c;two-hit&#x201d; ischaemia/reperfusion injury: evidence from an analysis of oxidative products. J Vasc Surg 1999;30:219&#x2013;28. 10.1016/S0741-5214(99)70131-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(99)70131-X</ArticleId><ArticleId IdType="pubmed">10436441</ArticleId></ArticleIdList></Reference><Reference><Citation>Bown MJ, Nicholson ML, Bell PR et al. . The systemic inflammatory response syndrome, organ failure and mortality after abdominal aortic aneurysm repair. J Vasc Surg 2003;37:600&#x2013;6. 10.1067/mva.2003.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mva.2003.39</ArticleId><ArticleId IdType="pubmed">12618699</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris LM, Faggioli GL, Fiedler R et al. . Ruptured abdominal aortic aneurysms: factors affecting mortality rates. J Vasc Surg 1991;14:812&#x2013;18; discussion 819&#x2013;20 10.1067/mva.1991.33494</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mva.1991.33494</ArticleId><ArticleId IdType="pubmed">1960812</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumen RM, Hendriks T, van der Ven-Jongekrijg J et al. . Cytokine patterns in patients after major vascular surgery, haemorrhagic shock and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218:769&#x2013;76. 10.1097/00000658-199312000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199312000-00011</ArticleId><ArticleId IdType="pmc">PMC1243073</ArticleId><ArticleId IdType="pubmed">8257227</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuypers PWM, Gardien M, Buth J et al. . Randomized study comparing cardiac response in endovascular and open aortic aneurysm repair. Br J Surg 2001;88:1059&#x2013;65. 10.1046/j.0007-1323.2001.01834.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0007-1323.2001.01834.x</ArticleId><ArticleId IdType="pubmed">11488790</ArticleId></ArticleIdList></Reference><Reference><Citation>Peppelenbosch N, Yilmaz N, van Marrewijk C et al. . Emergency treatment of acute symptomatic or ruptured abdominal aortic aneurysm. Outcome of a prospective intent-to-treat by EVAR protocol. Eur J Vasc Endovasc Surg 2003;26:303&#x2013;10. 10.1053/ejvs.2002.1972</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejvs.2002.1972</ArticleId><ArticleId IdType="pubmed">14509895</ArticleId></ArticleIdList></Reference><Reference><Citation>van Sambeek MR, van Dijk LC, Hendriks JM et al. . Endovascular versus conventional open repair of acute abdominal aortic aneurysm: feasibility and preliminary results. J Endovasc Ther 2002;9:443&#x2013;8. 10.1583/1545-1550(2002)009&lt;0443:EVCORO&gt;2.0.CO;2</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/1545-1550(2002)009&lt;0443:EVCORO&gt;2.0.CO;2</ArticleId><ArticleId IdType="pubmed">12223004</ArticleId></ArticleIdList></Reference><Reference><Citation>Makar RR, Badger SA, O'Donnell ME et al. . The inflammatory response to ruptured abdominal aortic aneurysm is altered by endovascular repair. Intern J Vasc Med 2013;2013:482728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3865732</ArticleId><ArticleId IdType="pubmed">24363936</ArticleId></ArticleIdList></Reference><Reference><Citation>Makar RR, Badger SA, O'Donnell ME et al. . The impact of endovascular repair of ruptured abdominal aortic aneurysm on gastrointestinal and renal function. Intern J Vasc Med 2014:178323 10.1155/2014/178323</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/178323</ArticleId><ArticleId IdType="pmc">PMC3927867</ArticleId><ArticleId IdType="pubmed">24616809</ArticleId></ArticleIdList></Reference><Reference><Citation>Badger S, Bedenis R, Blair PH et al. . Endovascular treatment of ruptured abdominal aortic aneurysm. Cochrane Database Syst Rev 2014;7:CD005261 10.1002/14651858.CD005261.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD005261.pub3</ArticleId><ArticleId IdType="pubmed">25042123</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillon M, Cardwell C, Blair PH et al. . Endovascular treatment of ruptured abdominal aortic aneurysm. Cochrane Database Syst Rev 2007;(1):CD005261 10.1002/14651858.CD005261.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD005261.pub2</ArticleId><ArticleId IdType="pubmed">17253551</ArticleId></ArticleIdList></Reference><Reference><Citation> The Cochrane library.  http:www.thecochranelibrary.com.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, Sterne JAC, eds. 
Cochrane Handbook for Systematic Review of Interventions Version 5.1.0 (updated March 2011). Chapter 8: assessing risk of bias in included studies. http://www.cochranehandbook.org.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JT et al. . Measuring inconsistency in meta-analyses. BJM 2003;327:557&#x2013;60. 10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinchliffe RJ, Bruijstens L, MacSweeney STR et al. . A randomised trial of endovascular and open surgery for ruptured abdominal aortic aneurysm&#x2014;results of a pilot study and lessons learned for future studies. Eur J Vasc Endovasc Surg 2006;32:506&#x2013;13; discussion 514&#x2013;15 10.1016/j.ejvs.2006.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2006.05.016</ArticleId><ArticleId IdType="pubmed">16887369</ArticleId></ArticleIdList></Reference><Reference><Citation>Anon. Acute endovascular treatment to improve outcome of ruptured aorto-iliac aneurysms. The AJAX trial
2009. 
http://controlled-trials.com/mrct/trial/229677/ajax</Citation></Reference><Reference><Citation>Balm R.2005.  Acute endovascular treatment to improve outcome of ruptured aortoiliac aneurysms.  http://www.controlled-trials.com/ISRCTN66212637/ISRCTN66212637.</Citation></Reference><Reference><Citation>Balm R.2012.   http://www.cxvascular.com/cx-latest-news/cx-latest-news/ajax-confirms-no-difference-between-evar-and-open-repair-for-ruptured-aneurysms.</Citation></Reference><Reference><Citation>Hoornweg LL, Balm R, Legemate DA et al. . Amsterdam Acute Aneurysm Trial: background, design, and methods. Vascular 2006;14:130&#x2013;5. 10.2310/6670.2006.00027</Citation><ArticleIdList><ArticleId IdType="doi">10.2310/6670.2006.00027</ArticleId><ArticleId IdType="pubmed">16956484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoornweg LL, Wisselink W, Vahl A et al. . Amsterdam-Acute-Aneurysm-Trial-Collaborators. The Amsterdam Acute Aneurysm Trial: suitability and application rate for endovascular repair of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2007;33:679&#x2013;83. 10.1016/j.ejvs.2006.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2006.12.011</ArticleId><ArticleId IdType="pubmed">17276096</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimerink JJ, Hoornweg LL, Vahl AC et al. . Endovascular repair versus open repair of ruptured abdominal aortic aneurysms: a multicenter randomized controlled trial. Ann Surg 2013;258:248&#x2013;56. 10.1097/SLA.0b013e31828d4b76</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31828d4b76</ArticleId><ArticleId IdType="pubmed">23549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell JT, Thompson SG, Thompson MM et al. . The Immediate Management of the Patient with Rupture: Open Versus Endovascular repair (IMPROVE) aneurysm trial&#x2014;ISRCTN 48334791 IMPROVE trialists. Acta Chir Belg 2009;109:678&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">20184048</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell JT, Hinchliffe RJ, Thompson MM et al. . Improve trial investigators. Observations from the IMPROVE trial concerning the clinical care of patients with ruptured abdominal aortic aneurysm. Br J Surg 2014;101:216&#x2013;24; discussion 224 10.1002/bjs.9410</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9410</ArticleId><ArticleId IdType="pmc">PMC4164272</ArticleId><ArticleId IdType="pubmed">24469620</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research. IMPROVE: can eEVAR reduce mortality from ruptured AAA? Protocol. National Health Institute for Health Research: Evaluation, Trials and Studies Coordinating Centre; 
http://www.hta.ac.uk/protocols/200700370064.pdf</Citation></Reference><Reference><Citation>Powell JT, Sweeting MJ, Thompson MM et al. . Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial. BMJ 2014;348:f7661 10.1136/bmj.f7661</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f7661</ArticleId><ArticleId IdType="pubmed">24418950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodel SG, Meerwaldt R, Beuk RJ et al. . Endovascular treatment of ruptured abdominal aortic aneurysm: is there a long-term benefit at follow-up? J Cardiovasc Surg 2012;53:83&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22231534</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser JJ, Bosch JL, Hunink MG et al. . Endovascular repair versus open surgery in patients with ruptured abdominal aortic aneurysms: clinical outcomes with 1-year follow-up. J Vasc Surg 2006;44:1148&#x2013;55. 10.1016/j.jvs.2006.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2006.08.018</ArticleId><ArticleId IdType="pubmed">17145414</ArticleId></ArticleIdList></Reference><Reference><Citation>Anon. Ruptured aorta-iliac aneurysms: endo vs surgery (ECAR). Clinicaltrials.gov 2007; NCT00577616. http://clinicaltrials.gov/ct2/show/NCT00577616?term=ECAR&amp;rank=1</Citation></Reference><Reference><Citation>Desgranges P.2008.  Ruptured aorta-iliac aneurysms: endo vs. surgery (ECAR)  http://clinicaltrials.gov/ct2/show/NCT00577616?term=stable+and+aortic&amp;rank=2.</Citation></Reference><Reference><Citation>Desgranges P, Kobeiter H, Castier Y et al. . The Endovasculaire vs Chirurgie dans les Anevrysmes Rompus PROTOCOL trial update. J Vasc Surg 2010;51:267&#x2013;70. 10.1016/j.jvs.2009.10.128</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2009.10.128</ArticleId><ArticleId IdType="pubmed">20117503</ArticleId></ArticleIdList></Reference><Reference><Citation>Resch T, Malina M, Lindblad B et al. . Endovascular repair of ruptured abdominal aortic aneurysms: logistics and short-term results. J Endovasc Ther 2003;10:440&#x2013;6. 10.1583/1545-1550(2003)010&lt;0440:ERORAA&gt;2.0.CO;2</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/1545-1550(2003)010&lt;0440:ERORAA&gt;2.0.CO;2</ArticleId><ArticleId IdType="pubmed">12932153</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhoeven EL, Prins TR, van den Dungen JJ et al. . Endovascular repair of acute AAAs under local anaesthesia with bifurcated endografts: a feasibility study. J Endovasc Ther 2002;9:729&#x2013;35. 10.1583/1545-1550(2002)009&lt;0729:EROAAU&gt;2.0.CO;2</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/1545-1550(2002)009&lt;0729:EROAAU&gt;2.0.CO;2</ArticleId><ArticleId IdType="pubmed">12546571</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser JJ, van Sambeek MRHM, Hamza TH et al. . Ruptured abdominal aortic aneurysms: endovascular repair versus open surgery&#x2014;systematic review. Radiology 2007;245:122&#x2013;9. 10.1148/radiol.2451061204</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2451061204</ArticleId><ArticleId IdType="pubmed">17885185</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi H, Umemoto T. A meta-analysis of randomized and risk-adjusted observational studies of endovascular versus open repair for ruptured abdominal aortic aneurysm. Vasc Endovasc Surg 2012;45:717&#x2013;19. 10.1177/1538574411418010</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574411418010</ArticleId><ArticleId IdType="pubmed">22262115</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Chen L, Xiao Y-B. Emergent endovascular versus open surgery repair for ruptured abdominal aortic aneurysms: a meta-analysis. PLoS ONE 2014;9:e87465 10.1371/journal.pone.0087465</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087465</ArticleId><ArticleId IdType="pmc">PMC3909181</ArticleId><ArticleId IdType="pubmed">24498112</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou GA, Georgiadis GS, Antoniou SA et al. . Endovascular repair for ruptured abdominal aortic aneurysm confers an early survival benefit over open repair. J Vasc Surg 2013;58:1091&#x2013;105. 10.1016/j.jvs.2013.07.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2013.07.109</ArticleId><ArticleId IdType="pubmed">24075109</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30703671</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairment and postoperative outcomes in patients undergoing primary total hip arthroplasty: A systematic review.</ArticleTitle><Pagination><StartPage>65</StartPage><EndPage>76</EndPage><MedlinePgn>65-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2019.01.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(18)31667-2</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">Total hip arthroplasty (THA) is a common surgical procedure in the elderly. Varying degrees of cognitive impairment (CI) are frequently seen in this patient population. To date, there has been no systematic review of the literature specifically examining the impact of CI on outcomes after elective THA. The aim of this systematic review was to identify studies that compare the postoperative outcomes of patients with and without CI after undergoing elective primary THA.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">We conducted a systematic review of prospective and retrospective studies. A systematic literature review was conducted by searching MEDLINE, PubMed, and Embase from between January 1, 1997 and January 1, 2018. A total of 234 articles were reviewed and 22 studies were selected.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Operating room and short-term and long-term postoperative recovery up to 2&#x202f;years.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients with CI who underwent an elective primary THA that required general anesthesia with a comparator group of patients who did not have dementia.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients who underwent elective primary total hip arthroplasty.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Outcomes included post-operative delirium (POD), mortality and other complications, discharge disposition, length of stay (LOS), mortality, short-term (30&#x202f;days) and long-term (1&#x202f;month-2&#x202f;years) complications.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">22 studies with 5,705,302 participants were included in the systematic review. Sample sizes varied greatly, ranging from 14 to 2,924,995 participants. There was an association between patients with CI and an increase in POD, in-hospital mortality, complications during hospitalization, non-routine disposition, LOS, mortality between 1&#x202f;month to 2&#x202f;years, and worse postoperative functional status.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We demonstrate that there are strong associations between patients with pre-existing CI undergoing THA and increased POD, hospital mortality, hospital complications, and hospital LOS. We report good quality evidence linking complications after THA to preexisting CI. Screening for CI can improve care and better predict the risk of developing postoperative complications such as delirium. Further investigations can address perioperative factors that can help reduce complications and show the utility of more widespread assessment of preoperative cognitive impairment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viramontes</LastName><ForeName>Octavio</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan Erfe</LastName><ForeName>Betty M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Internal Medicine Program, Department of Medicine, Queens Hospital Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erfe</LastName><ForeName>J Mark</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brovman</LastName><ForeName>Ethan Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA; Center for Perioperative Research, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boehme</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bader</LastName><ForeName>Angela M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urman</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA; Center for Perioperative Research, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: rurman@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Delirium</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30703671</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2019.01.024</ArticleId><ArticleId IdType="pii">S0952-8180(18)31667-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28962938</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Prevention of atrial fibrillation after cardiac surgery using low-dose landiolol: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>6</EndPage><MedlinePgn>1-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2017.07.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(17)30644-X</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">Atrial fibrillation (AF) is associated with mortality after cardiac surgery. Several studies have reported that landiolol might help to prevent postoperative AF. The objective of this study was to investigate whether low-dose landiolol is useful in terms of balance of benefit and risk.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">We conducted a meta-analysis after systematically searching the PubMed, the Cochrane library and the ICHUSHI to identify randomized, controlled trials investigating the preventive effect of landiolol on incidence of AF after cardiac surgery.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Six randomized trial with 571 patients were included.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The primary outcome was incidence of AF after surgery, while secondary outcomes were mortality and complications.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Incidence of AF within 1week after surgery was significantly lower in the landiolol group than in the control group (odds ratio, 0.27; 95% confidence interval, 0.18-0.42; p&lt;0.001). Three of the 6 studies reported data regarding in-hospital mortality and complications, showing no significant differences between groups (0.7 vs 3.0%; OR, 0.45; 95% CI, 0.07-2.74; p=0.39; and 4.5 vs 9.7%; OR, 0.45; 95% CI, 0.16-1.23; p=0.12, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our systematic review revealed that low-dose landiolol might help to prevent AF after cardiac surgery and further large trials are needed to evaluate safety because mortality and morbidity rate were very low in included studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tamura</LastName><ForeName>Takahiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku City, Kochi 783-8505, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yatabe</LastName><ForeName>Tomoaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku City, Kochi 783-8505, Japan. Electronic address: yatabe@kochi-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Masataka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku City, Kochi 783-8505, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009025">Morpholines</NameOfSubstance></Chemical><Chemical><RegistryNumber>62NWQ924LH</RegistryNumber><NameOfSubstance UI="C077049">landiolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance UI="D014508">Urea</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009025" MajorTopicYN="N">Morpholines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014508" MajorTopicYN="N">Urea</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Landiolol</Keyword><Keyword MajorTopicYN="N">Short-acting beta-blocker</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28962938</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2017.07.009</ArticleId><ArticleId IdType="pii">S0952-8180(17)30644-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35155550</PMID><DateRevised><Year>2022</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-875X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in surgery</Title><ISOAbbreviation>Front Surg</ISOAbbreviation></Journal><ArticleTitle>Antithrombotic Therapy in Spinal Surgery Does Not Impact Patient Safety-A Single Center Cohort Study.</ArticleTitle><Pagination><StartPage>791713</StartPage><MedlinePgn>791713</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">791713</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fsurg.2021.791713</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Antithrombotic therapy is common in older patients to avoid thromboembolic events. Careful planning is required, particularly in the perioperative environment. There are no clearly date guidelines on the best timing for interrupting the use of anticoagulation in the case of spinal surgery. This study evaluates early per procedural clinical outcomes in patients whose antithrombotic therapy was interrupted for spinal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective cohort study. All patients who underwent dorsal instrumentation from January 1, 2019 to December 31, 2020 were included. In group A, vitamin K antagonists (VKA) were suspended for 5 days and direct oral anticoagulants (DOAC) for 3 days. In group B, antiplatelet agents (APA) were paused for at least 7 days before surgery to prevent perioperative bleeding. Patients not taking anticoagulation medication were gathered into control group C. We analyzed demographic data, ASA status, blood loss, comorbidities, duration of surgery, blood transfusion, length of hospital stay, complications, thromboembolism, and 30 day in-hospital mortality. Multivariate analyses from the three groups were further analyzed and conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 217 patients were operated and included. Twenty-eight patients taking VKA/DOAC (group A), 37 patients using APA (group B), and 152 patients without anticoagulation (group C) underwent spinal surgery. Those using anticoagulants were significantly older and often with multimorbidity, but did not differ significantly in procedural bleeding, time of surgery, length of hospital stay, complication rate, thromboembolism, or 30 day in-hospital mortality (<i>p</i> &gt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data show that dorsal instrumentation safely took place in patients whose antithrombotic therapy was interrupted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Banat, Wach, Salemdawod, Bara, Shabo, Scorzin, M&#xfc;ller, Vatter and Eichhorn.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banat</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wach</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salemdawod</LastName><ForeName>Abdallah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bara</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shabo</LastName><ForeName>Ehab</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scorzin</LastName><ForeName>Jasmin E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Inselspital, Bern University Hospital, Bern University, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vatter</LastName><ForeName>Hartmut</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichhorn</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Surg</MedlineTA><NlmUniqueID>101645127</NlmUniqueID><ISSNLinking>2296-875X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antithrombotic therapy</Keyword><Keyword MajorTopicYN="N">optimizing surgical planning</Keyword><Keyword MajorTopicYN="N">patient safety</Keyword><Keyword MajorTopicYN="N">spinal complications</Keyword><Keyword MajorTopicYN="N">spinal surgery</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35155550</ArticleId><ArticleId IdType="pmc">PMC8825487</ArticleId><ArticleId IdType="doi">10.3389/fsurg.2021.791713</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. (2013) 368:2113&#x2013;24. 10.1056/NEJMra1206531</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1206531</ArticleId><ArticleId IdType="pubmed">23718166</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Soh S, Shim JK. Dual Antiplatelet Therapy and Non-Cardiac Surgery: Evolving Issues and Anesthetic Implications. Korean J Anesthesiol. (2017) 70:13&#x2013;21. 10.4097/kjae.2017.70.1.13</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2017.70.1.13</ArticleId><ArticleId IdType="pmc">PMC5296381</ArticleId><ArticleId IdType="pubmed">28184261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato ET, Goto S, Giugliano RP. Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation. Ageing Res Rev. (2019) 49:115&#x2013;24. 10.1016/j.arr.2018.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2018.10.006</ArticleId><ArticleId IdType="pubmed">30359765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulkifly H, Lip GYH, Lane DA. Epidemiology of atrial fibrillation. Int J Clin Pract. (2018) 72:e13070. 10.1111/ijcp.13070</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13070</ArticleId><ArticleId IdType="pubmed">29493854</ArticleId></ArticleIdList></Reference><Reference><Citation>Trouillier H, Birkenmaier C, Kluzik J, Kauschke T, Refior HJ. Operative treatment for degenerative lumbar spinal canal stenosis. Acta Orthop Belg. (2004) 70:337&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">15481418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambakidis NC, Feiz-Erfan I, Klopfenstein JD, Sonntag VKH. Indications for surgical fusion of the cervical and lumbar motion segment. Spine. (2005) 30(16 Suppl):S2&#x2013;6. 10.1097/01.brs.0000174509.31291.26</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.brs.0000174509.31291.26</ArticleId><ArticleId IdType="pubmed">16103830</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojo Y, Ito M, Suda K, Oda I, Yoshimoto H, Abumi K. A multicenter study on accuracy and complications of freehand placement of cervical pedicle screws under lateral fluoroscopy in different pathological conditions: CT-based evaluation of more than 1,000 screws. Eur Spine J. (2014) 23:2166&#x2013;74. 10.1007/s00586-014-3470-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-014-3470-0</ArticleId><ArticleId IdType="pubmed">25047653</ArticleId></ArticleIdList></Reference><Reference><Citation>Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. . Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. (2012) 141(2 Suppl):e326S&#x2212;50S. 10.1378/chest.11-2298</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2298</ArticleId><ArticleId IdType="pmc">PMC3278059</ArticleId><ArticleId IdType="pubmed">22315266</ArticleId></ArticleIdList></Reference><Reference><Citation>Oscarsson A, Gupta A, Fredrikson M, J&#xe4;rhult J, Nystr&#xf6;m M, Pettersson E, et al. . To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. (2010) 104:305&#x2013;12. 10.1093/bja/aeq003</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq003</ArticleId><ArticleId IdType="pubmed">20150346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SB, Cho KJ, Moon KH, Jung JH, Jung SJ. Does low-dose aspirin increase blood loss after spinal fusion surgery? Spine J. (2011) 11:303&#x2013;7. 10.1016/j.spinee.2011.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2011.02.006</ArticleId><ArticleId IdType="pubmed">21474081</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Ahn Y, Choi BS, Choi K-T, Lee K, Kim SH, et al. . Antithrombotic effects of aspirin on 1- or 2-level lumbar spinal fusion surgery: a comparison between 2 groups discontinuing aspirin use before and after 7 days prior to surgery. Spine. (2013) 38:1561&#x2013;5. 10.1097/BRS.0b013e31829a84d2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31829a84d2</ArticleId><ArticleId IdType="pubmed">23680836</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively?: Clinical impact of aspirin withdrawal syndrome. Ann Surg. (2012) 255:811&#x2013;9. 10.1097/SLA.0b013e318250504e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318250504e</ArticleId><ArticleId IdType="pubmed">22470078</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak H, Unterberg M. Oral anticoagulants: management of elective and emergency surgery. Anasthesiol Intensivmed Notfallmed Schmerzther. (2018) 53:543&#x2013;50. 10.1055/s-0043-111006</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-111006</ArticleId><ArticleId IdType="pubmed">30036900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner J, Wiegering A, Germer C-T. Perioperative management of patients facing long-term medication. Chirurg. (2018) 89:89. 10.1007/s00104-017-0574-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00104-017-0574-1</ArticleId><ArticleId IdType="pubmed">29426983</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw JR, Li N, Vanassche T, Coppens M, Spyropoulos AC, Syed S, et al. . Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Adv. (2020) 4:3520&#x2013;7. 10.1182/bloodadvances.2020002335</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020002335</ArticleId><ArticleId IdType="pmc">PMC7422107</ArticleId><ArticleId IdType="pubmed">32756938</ArticleId></ArticleIdList></Reference><Reference><Citation>Godier A, Dincq AS, Martin AC, Radu A, Leblanc I, Antona M, et al. . Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study. Eur Heart J. (2017) 38:2431&#x2013;9. 10.1093/eurheartj/ehx403</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx403</ArticleId><ArticleId IdType="pubmed">28821169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, et al. . Patient blood management: recommendations from the 2018 frankfurt consensus conference. JAMA. (2019) 321:983&#x2013;97. 10.1001/jama.2019.0554</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0554</ArticleId><ArticleId IdType="pubmed">30860564</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, McKittrick T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med. (1995) 122:40&#x2013;2. 10.7326/0003-4819-122-1-199501010-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-122-1-199501010-00006</ArticleId><ArticleId IdType="pubmed">7985894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. (1997) 336:1506&#x2013;11. 10.1056/NEJM199705223362107</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199705223362107</ArticleId><ArticleId IdType="pubmed">9154771</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson BJG, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest. (2005) 127:922&#x2013;7. 10.1378/chest.127.3.922</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.127.3.922</ArticleId><ArticleId IdType="pubmed">15764777</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel JB, Marhefka GD, Weitz HH. Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review. Hosp Pract. (2013) 41:79&#x2013;88. 10.3810/hp.2013.02.1013</Citation><ArticleIdList><ArticleId IdType="doi">10.3810/hp.2013.02.1013</ArticleId><ArticleId IdType="pubmed">23466970</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwenhuis HK, Albada J, Banga JD, Sixma JJ. Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. Blood. (1991) 78:2337&#x2013;43. 10.1182/blood.V78.9.2337.bloodjournal7892337</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V78.9.2337.bloodjournal7892337</ArticleId><ArticleId IdType="pubmed">1657248</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest. (1995) 108(4 Suppl):276S&#x2212;90S. 10.1378/chest.108.4_Supplement.276S</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.108.4_Supplement.276S</ArticleId><ArticleId IdType="pubmed">7555182</ArticleId></ArticleIdList></Reference><Reference><Citation>Torn M, Rosendaal FR. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol. (2003) 123:676&#x2013;82. 10.1046/j.1365-2141.2003.04652.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2003.04652.x</ArticleId><ArticleId IdType="pubmed">14616972</ArticleId></ArticleIdList></Reference><Reference><Citation>Omran H, Bauersachs R, R&#xfc;benacker S, Goss F, Hammerstingl C. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the National Multicentre BNK Online BRiDging REgistRy (BORDER). Thromb Haemost. (2012) 108:65&#x2013;73. 10.1160/TH11-12-0827</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH11-12-0827</ArticleId><ArticleId IdType="pubmed">22534746</ArticleId></ArticleIdList></Reference><Reference><Citation>Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, et al. . Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. (2019) 179:1469&#x2013;78. 10.1001/jamainternmed.2019.2431</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2019.2431</ArticleId><ArticleId IdType="pmc">PMC6686768</ArticleId><ArticleId IdType="pubmed">31380891</ArticleId></ArticleIdList></Reference><Reference><Citation>Perioperative Management of Patients Receiving Anticoagulants &#x2013; UpToDate. Available online at: https://www.uptodate.com/contents/perioperative-management-of-patients-receiving-anticoagulants?search=bridging%20anticoagulation&amp;source=search_result&amp;selectedTitle=1~26&amp;usage_type=default&amp;display_rank=1 (accessed May 16, 2021).</Citation></Reference><Reference><Citation>Doherty J. U., Gluckman T. J., Hucker W. J., Januzzi J. L., Ortel T. L., Saxonhouse S. J., et al. . ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the american college of cardiology clinical expert consensus document task force. J. Am. Coll. Cardiol. 69, 871&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pubmed">28081965</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, et al. . Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial. Circulation. (2012) 126:343&#x2013;8. 10.1161/CIRCULATIONAHA.111.090464</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.090464</ArticleId><ArticleId IdType="pubmed">22700854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwood MW, Douketis JD, Patel MR, Piccini JP, Hellkamp AS, Lokhnygina Y, et al. . Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation. (2014) 129:1850&#x2013;9. 10.1161/CIRCULATIONAHA.113.005754</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.005754</ArticleId><ArticleId IdType="pmc">PMC4206548</ArticleId><ArticleId IdType="pubmed">24552831</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, et al. . Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood. (2014) 124:3692&#x2013;8. 10.1182/blood-2014-08-595496</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-08-595496</ArticleId><ArticleId IdType="pmc">PMC4263979</ArticleId><ArticleId IdType="pubmed">25320240</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo HC, Liu FL, Chen JT, Cherng YG, Tam KW, Tai YH. Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: a systematic review and meta-analysis. Clin Cardiol. (2020) 43:441&#x2013;9. 10.1002/clc.23336</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23336</ArticleId><ArticleId IdType="pmc">PMC7244304</ArticleId><ArticleId IdType="pubmed">31944351</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, et al. . Aspirin in patients undergoing noncardiac surgery. N Engl J Med. (2014) 370:1494&#x2013;503. 10.1056/NEJMoa1401105</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401105</ArticleId><ArticleId IdType="pubmed">24679062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Wang J-W, Zhang L, Feng X-M. Outcomes of oblique lateral interbody fusion for adult spinal deformity: a systematic review and meta-analysis. Global Spine J. (2021) 12:142&#x2013;54. 10.1177/2192568220979145</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568220979145</ArticleId><ArticleId IdType="pmc">PMC8965311</ArticleId><ArticleId IdType="pubmed">33438462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tram J, Srinivas S, Wali AR, Lewis CS, Pham MH. Decompression surgery versus interspinous devices for lumbar spinal stenosis: a systematic review of the literature. Asian Spine J. (2020) 14:526&#x2013;42. 10.31616/asj.2019.0105</Citation><ArticleIdList><ArticleId IdType="doi">10.31616/asj.2019.0105</ArticleId><ArticleId IdType="pmc">PMC7435320</ArticleId><ArticleId IdType="pubmed">31906617</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Cao H, Chen Y, Jiao G. Risk factors for venous thromboembolism following spinal surgery: a meta-analysis. Medicine. (2020) 99:e20954. 10.1097/MD.0000000000020954</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000020954</ArticleId><ArticleId IdType="pmc">PMC7373537</ArticleId><ArticleId IdType="pubmed">32702835</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24967162</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2225-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Annals of cardiothoracic surgery</Title><ISOAbbreviation>Ann Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Management of complicated and uncomplicated acute type B dissection. A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>234</StartPage><EndPage>246</EndPage><MedlinePgn>234-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2225-319X.2014.05.08</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The management of acute type B dissection represents a clinical challenge. We undertook a systematic review of the available literature regarding medical, surgical and endovascular treatments of acute type B aortic dissection and combined the eligible studies into a meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An extensive electronic health database search was performed on all articles published from January 2006 up to November 2013 describing the management of acute type B aortic dissection. Studies including less than 15 patients were excluded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ACUTE COMPLICATED TYPE B DISSECTION: overall, 2,531 patients were treated with endovascular repair (TEVAR) and the pooled rate for 30-day/in-hospital mortality was 7.3%. The pooled estimates for cerebrovascular events, spinal cord ischemia (SCI) and total neurologic events were 3.9%, 3.1% and 7.3%, respectively. A total of 1,276 patients underwent open surgical repair and the pooled rate for 30-day/in-hospital mortality was 19.0%. The pooled rate for cerebrovascular events was 6.8%, for SCI 3.3% and for total neurologic complications 9.8%. Acute uncomplicated type B dissection: outcome of 2,347 patients who underwent conservative medical management were analyzed. The pooled 30-day/in-hospital mortality rate was 2.4%. The pooled rate for cerebrovascular events was 1%, for SCI 0.8% and for overall neurologic complications 2%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Endovascular repair provides a superior 30-day/in-hospital survival for acute complicated type B aortic dissection compared to surgical aortic reconstruction. However, open repair still has a significant role as endovascular repair is not applicable in all patients and there remains concerns regarding the durability of this technique. TEVAR seems to have a more favorable outcome regarding aortic remodeling and the aortic-specific survival rate when compared with medical therapy alone. Randomized controlled trials focusing on the prognostic factors of early and late complications in uncomplicated type B dissections are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moulakakis</LastName><ForeName>Konstantinos G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>1 Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece ; 2 The Collaborative Research Group, Macquarie University, Sydney, Australia ; 3 Vascular Unit, 2nd Clinic of Surgery, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mylonas</LastName><ForeName>Spyridon N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>1 Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece ; 2 The Collaborative Research Group, Macquarie University, Sydney, Australia ; 3 Vascular Unit, 2nd Clinic of Surgery, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalainas</LastName><ForeName>Ilias</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>1 Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece ; 2 The Collaborative Research Group, Macquarie University, Sydney, Australia ; 3 Vascular Unit, 2nd Clinic of Surgery, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakisis</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1 Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece ; 2 The Collaborative Research Group, Macquarie University, Sydney, Australia ; 3 Vascular Unit, 2nd Clinic of Surgery, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotsis</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>1 Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece ; 2 The Collaborative Research Group, Macquarie University, Sydney, Australia ; 3 Vascular Unit, 2nd Clinic of Surgery, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liapis</LastName><ForeName>Christos D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>1 Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece ; 2 The Collaborative Research Group, Macquarie University, Sydney, Australia ; 3 Vascular Unit, 2nd Clinic of Surgery, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Cardiothorac Surg</MedlineTA><NlmUniqueID>101605877</NlmUniqueID><ISSNLinking>2225-319X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Type B aortic dissection</Keyword><Keyword MajorTopicYN="N">acute</Keyword><Keyword MajorTopicYN="N">endovascular</Keyword><Keyword MajorTopicYN="N">medical treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24967162</ArticleId><ArticleId IdType="pmc">PMC4052408</ArticleId><ArticleId IdType="doi">10.3978/j.issn.2225-319X.2014.05.08</ArticleId><ArticleId IdType="pii">acs-03-03-234</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coady MA, Ikonomidis JS, Cheung AT, et al. Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation 2010;121:2780-804</Citation><ArticleIdList><ArticleId IdType="pubmed">20530003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fattori R, Cao P, De Rango P, et al. Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol 2013;61:1661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">23500232</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg 2009;37:149-59</Citation><ArticleIdList><ArticleId IdType="pubmed">19097813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai TT, Evangelista A, Nienaber CA, et al. Long-term survival in patients presenting with type A acute aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2006;114:I350-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16820599</ArticleId></ArticleIdList></Reference><Reference><Citation>Nienaber CA, Kische S, Rousseau H, et al. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv 2013;6:407-16</Citation><ArticleIdList><ArticleId IdType="pubmed">23922146</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Tommaso L, Monaco M, Mottola M, et al. Major complications following endovascular surgery of descending thoracic aorta. Interact Cardiovasc Thorac Surg 2006;5:705-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17670690</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Yei F, Zhou L, et al. Endovascular stent-grafts treatment in acute aortic dissection (type B): clinical outcomes during early, late, or chronic phases. Catheter Cardiovasc Interv 2006;68:319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">16821238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zuo J, Yang L, et al. Endovascular stent-graft treatment of thoracic aortic dissection. Interact Cardiovasc Thorac Surg 2006;5:688-91</Citation><ArticleIdList><ArticleId IdType="pubmed">17670684</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing QM, Han YL, Wang XZ, et al. Endovascular stent-grafts for acute and chronic type B aortic dissection: comparison of clinical outcomes. Chin Med J (Engl) 2008;121:2213-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19080319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayer D, Bratby M, Brooks M, et al. Aortic morphology following endovascular repair of acute and chronic type B aortic dissection: implications for management. Eur J Vasc Endovasc Surg 2008;36:522-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18692416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez JA, Olsen DM, Lucas L, et al. Aortic remodeling after endografting of thoracoabdominal aortic dissection. J Vasc Surg 2008;47:1188-94</Citation><ArticleIdList><ArticleId IdType="pubmed">18440180</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ckler D, Hyhlik-D&#xfc;rr A, Hakimi M, et al. Type B aortic dissections: treating the many to benefit the few? J Endovasc Ther 2009;16Suppl 1:I80-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19317582</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CM, da Fonseca JH, de Souza JA, et al. Endovascular treatment of type B aortic dissection: the challenge of late success. Ann Thorac Surg 2009;87:1360-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19379864</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad MF, Crawford RS, Kwolek CJ, et al. Aortic remodeling after endovascular repair of acute complicated type B aortic dissection. J Vasc Surg 2009;50:510-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19497701</ArticleId></ArticleIdList></Reference><Reference><Citation>Guangqi C, Xiaoxi L, Wei C, et al. Endovascular repair of Stanford type B aortic dissection: early and mid-term outcomes of 121 cases. Eur J Vasc Endovasc Surg 2009;38:422-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19524463</ArticleId></ArticleIdList></Reference><Reference><Citation>Feezor RJ, Martin TD, Hess PJ, Jr, et al. Early outcomes after endovascular management of acute, complicated type B aortic dissection. J Vasc Surg 2009;49:561-6; discussion 566-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19268759</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning BJ, Dias N, Manno M, et al. Endovascular treatment of acute complicated type B dissection: morphological changes at midterm follow-up. J Endovasc Ther 2009;16:466-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19702338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze DY, van den Bosch MA, Dake MD, et al. Factors portending endoleak formation after thoracic aortic stent-graft repair of complicated aortic dissection. Circ Cardiovasc Interv 2009;2:105-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20031703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemelli-Steingruber I, Chemelli A, Strasak A, et al. Endovascular repair or medical treatment of acute type B aortic dissection? A comparison. Eur J Radiol 2010;73:175-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18996662</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsios S, Schuermann K, Maatz W, et al. Complicated acute type B dissections: a single-center experience with endovascular treatment. Thorac Cardiovasc Surg 2010;58:280-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20680904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeeshan A, Woo EY, Bavaria JE, et al. Thoracic endovascular aortic repair for acute complicated type B aortic dissection: superiority relative to conventional open surgical and medical therapy. J Thorac Cardiovasc Surg 2010;140:S109-15; discussion S142-S146.</Citation><ArticleIdList><ArticleId IdType="pubmed">21092775</ArticleId></ArticleIdList></Reference><Reference><Citation>Torsello GB, Torsello GF, Osada N, et al. Midterm results from the TRAVIATA registry: treatment of thoracic aortic disease with the valiant stent graft. J Endovasc Ther 2010;17:137-50</Citation><ArticleIdList><ArticleId IdType="pubmed">20426628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunt ME, Egorova NN, Moskowitz AJ. Propensity score-matched analysis of open surgical and endovascular repair for type B aortic dissection. Int J Vasc Med 2011;2011:364046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3180776</ArticleId><ArticleId IdType="pubmed">21961067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JD, Huang JF, Zuo KQ, et al. Emergency endovascular repair of complicated Stanford type B aortic dissections within 24 hours of symptom onset in 30 cases. J Thorac Cardiovasc Surg 2011;141:926-31</Citation><ArticleIdList><ArticleId IdType="pubmed">20599231</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell S, Geotchues A, Beavers F, et al. Endovascular management of acute aortic dissections. J Vasc Surg 2011;54:1283-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21958570</ArticleId></ArticleIdList></Reference><Reference><Citation>Steuer J, Eriksson MO, Nyman R, et al. Early and long-term outcome after thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissection. Eur J Vasc Endovasc Surg 2011;41:318-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21194985</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtue Registry Investigators The VIRTUE Registry of type B thoracic dissections--study design and early results. Eur J Vasc Endovasc Surg 2011;41:159-66</Citation><ArticleIdList><ArticleId IdType="pubmed">20952217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipfel B, Czerny M, Funovics M, et al. Endovascular treatment of patients with types A and B thoracic aortic dissection using Relay thoracic stent-grafts: results from the RESTORE Patient Registry. J Endovasc Ther 2011;18:131-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21521051</ArticleId></ArticleIdList></Reference><Reference><Citation>Fattori R, Montgomery D, Lovato L, et al. Survival after endovascular therapy in patients with type B aortic dissection: a report from the International Registry of Acute Aortic Dissection (IRAD). JACC Cardiovasc Interv 2013;6:876-82</Citation><ArticleIdList><ArticleId IdType="pubmed">23968705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrlich MP, Rousseau H, Heijmen R, et al. Midterm results after endovascular treatment of acute, complicated type B aortic dissection: the Talent Thoracic Registry. J Thorac Cardiovasc Surg 2013;145:159-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22329980</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin YL, Deng G, Li TX, et al. Treatment of acute type-B aortic dissection: thoracic endovascular aortic repair or medical management alone? JACC Cardiovasc Interv 2013;6:185-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23428012</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu C, Fang K, Luo M, et al. Emergency endovascular stent-grafting for acute type B aortic dissection with symptomatic malperfusion. Int Angiol 2013;32:483-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23903307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna JM, Andersen ND, Ganapathi AM, et al. Five-year results for endovascular repair of acute complicated type B aortic dissection. J Vasc Surg 2014;59:96-106</Citation><ArticleIdList><ArticleId IdType="pubmed">24094903</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson DA, Patel HJ, Williams DM, et al. Early open and endovascular thoracic aortic repair for complicated type B aortic dissection. Ann Thorac Surg 2013;96:23-30; discussion 230</Citation><ArticleIdList><ArticleId IdType="pubmed">23477564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobocinski J, Dias NV, Berger L, et al. Endograft repair of complicated acute type B aortic dissections. Eur J Vasc Endovasc Surg 2013;45:468-74</Citation><ArticleIdList><ArticleId IdType="pubmed">23433951</ArticleId></ArticleIdList></Reference><Reference><Citation>Winnerkvist A, Lockowandt U, Rasmussen E, et al. A prospective study of medically treated acute type B aortic dissection. Eur J Vasc Endovasc Surg 2006;32:349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16753315</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrera AL, Miller CC, Goodrick J, et al. Update on outcomes of acute type B aortic dissection. Ann Thorac Surg 2007;83:S842-5; discussion S846-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17257938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada S, Akutsu K, Tamori Y, et al. Usefulness of fibrinogen/fibrin degradation product to predict poor one-year outcome of medically treated patients with acute type B aortic dissection. Am J Cardiol 2008;101:1341-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18435968</ArticleId></ArticleIdList></Reference><Reference><Citation>Niino T, Hata M, Sezai A, et al. Optimal clinical pathway for the patient with type B acute aortic dissection. Circ J 2009;73:264-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19106462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Kubo N, Ako J, et al. Determinants of long-term mortality in patients with type B acute aortic dissection. Am J Hypertens 2009;22:371-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19197250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitai T, Kaji S, Yamamuro A, et al. Impact of new development of ulcer-like projection on clinical outcomes in patients with type B aortic dissection with closed and thrombosed false lumen. Circulation 2010;122:S74-80</Citation><ArticleIdList><ArticleId IdType="pubmed">20837929</ArticleId></ArticleIdList></Reference><Reference><Citation>Dick F, Hirzel C, Immer FF, et al. Quality of life after acute type B dissection in the era of thoracic endovascular aortic repair. Vasa 2010;39:219-28</Citation><ArticleIdList><ArticleId IdType="pubmed">20737380</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbade J, Jenniches M, Borger MA, et al. Outcome of patients suffering from acute type B aortic dissection: a retrospective single-centre analysis of 135 consecutive patients. Eur J Cardiothorac Surg 2010;38:285-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20381372</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyahara S, Mukohara N, Fukuzumi M, et al. Long-term follow-up of acute type B aortic dissection: ulcer-like projections in thrombosed false lumen play a role in late aortic events. J Thorac Cardiovasc Surg 2011;142:e25-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21439577</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkwall J. ADSORB was totally underpowered but still shows that AD should be treated. Critical issues in aortic endografting Nuremberg, Germany, 2013.</Citation></Reference><Reference><Citation>Lu Q. Comparison of Endovascular and Medical Therapy in Uncomplicated Stanford Type B Aortic Dissection. Critical issues in aortic endografting Nuremberg, Germany, 2013.</Citation></Reference><Reference><Citation>Trimarchi S, Nienaber CA, Rampoldi V, et al. Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2006;114:I357-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16820600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozinovski J, Coselli JS. Outcomes and survival in surgical treatment of descending thoracic aorta with acute dissection. Ann Thorac Surg 2008;85:965-70; discussion 970-1</Citation><ArticleIdList><ArticleId IdType="pubmed">18291179</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimokawa T, Horiuchi K, Ozawa N, et al. Outcome of surgical treatment in patients with acute type B aortic dissection. Ann Thorac Surg 2008;86:103-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18573406</ArticleId></ArticleIdList></Reference><Reference><Citation>Murashita T, Ogino H, Matsuda H, et al. Clinical outcome of emergency surgery for complicated acute type B aortic dissection. Circ J 2012;76:650-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22185715</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami T, Imoto K, Uchida K, et al. Clinical outcomes of emergency surgery for acute type B aortic dissection with rupture. Eur J Cardiothorac Surg 2013;44:360-4; discussion 364-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23324797</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkwall J, Lammer J, Verhoeven E, et al. ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta. Eur J Vasc Endovasc Surg 2012;44:31-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22575291</ArticleId></ArticleIdList></Reference><Reference><Citation>Nienaber CA, Rousseau H, Eggebrecht H, et al. Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial. Circulation 2009;120:2519-28</Citation><ArticleIdList><ArticleId IdType="pubmed">19996018</ArticleId></ArticleIdList></Reference><Reference><Citation>Marui A, Mochizuki T, Koyama T, et al. Degree of fusiform dilatation of the proximal descending aorta in type B acute aortic dissection can predict late aortic events. J Thorac Cardiovasc Surg 2007;134:1163-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17976444</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JM, Kim SD, Kim JH, et al. Long-term predictors of descending aorta aneurysmal change in patients with aortic dissection. J Am Coll Cardiol 2007;50:799-804</Citation><ArticleIdList><ArticleId IdType="pubmed">17707186</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarchi S, Eagle KA, Nienaber CA, et al. Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2010;122:1283-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20837896</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29944524</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Ketamine as a Rapid Sequence Induction Agent in the Trauma Population: A Systematic Review.</ArticleTitle><Pagination><StartPage>504</StartPage><EndPage>510</EndPage><MedlinePgn>504-510</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000003568</ELocationID><Abstract><AbstractText>The choice of drug used to facilitate endotracheal intubation in trauma patients during rapid sequence induction (RSI) may have an impact on survival. Ketamine is commonly used in the hemodynamically unstable trauma patient although it has been associated with side effects. This review sought to investigate whether ketamine should be preferred over other induction agents for RSI in trauma patients. PubMed, Embase, and the Cochrane Library were systematically searched on September 19, 2016 for studies reporting RSI of adult trauma patients with ketamine compared with another induction agent (etomidate, propofol, thiopental, or midazolam). No language restrictions were applied. The primary outcome was 30-day mortality, and secondary outcomes included information on blood transfusions, length of hospital stay, and hospital mortality. Risk of bias was assessed using the Cochrane Risk of Bias assessment tool for randomized trials and the Risk of Bias in Non-Randomized Studies of Interventions for nonrandomized studies of intervention. A total of 4 studies were included. A cohort study from 1976 compared thiopental (n = 26) with ketamine (n = 14) for RSI in trauma patients. The primary outcome was number of blood transfusions, and no significant difference was found. Risk of bias was judged to be serious. A randomized controlled trial from 2009 compared etomidate (n = 57) with ketamine (n = 47) and found no significant difference in 28-day mortality (odds ratio [OR], 0.8 [0.4-2.0]). The trial was judged to have a low risk of bias. Two cohort studies from 2015 and 2017 also compared etomidate (n = 116 and n = 526) with ketamine (n = 145 and n = 442). No significant difference in hospital mortality between the groups was observed (OR, 1.11 [0.38-3.27] and OR, 1.41 [0.91-2.16], respectively). Both studies were judged to have a moderate risk of bias, thus excluding the possibility of a meaningful meta-analysis. The study from 2017 also reported number of units of blood transfused during the first 48 hours after trauma and length of hospital stay. No significant differences were observed (OR, 1.14 [0.87-1.49] and OR, 1.1 [0.95-1.27], respectively). Extremely few studies have compared induction agents for RSI in trauma patients. No significant differences have been found in mortality, length of hospital stay, or number of blood transfusions after induction with ketamine compared to other induction agents, but a clinically relevant benefit or harm cannot be excluded.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baekgaard</LastName><ForeName>Josefine S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Center of Head and Orthopedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eskesen</LastName><ForeName>Trine G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Center of Head and Orthopedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sillesen</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Gastroenterology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Lars S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Center of Head and Orthopedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinmetz</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Center of Head and Orthopedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009104" MajorTopicYN="N">Multiple Trauma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079603" MajorTopicYN="N">Rapid Sequence Induction and Intubation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29944524</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003568</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36639122</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2241-5955</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><PubDate><Year>2023</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese</Title><ISOAbbreviation>Hellenic J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Robotic vs other surgery techniques for mitral valve repair and/or replacement: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>16</StartPage><EndPage>25</EndPage><MedlinePgn>16-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hjc.2022.12.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1109-9666(22)00185-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Mitral valve repair or replacement (MVr/R) are procedures that aim to correct mitral regurgitation. The three techniques, namely conventional, minimally invasive, and robotic each present their advantages and setbacks. Previous studies had compared each technique with the other but mostly focused on two techniques. In this systematic review and meta-analysis, we attempt to compare all three techniques, to provide a reference for the clinical selection of the best surgical scheme.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The literature search was performed in databases including PubMed, Scopus, Google Scholar, EBSCOHost, Wiley, ProQuest, and Embase, up to June 1<sup>st</sup>, 2022. Critical appraisal of studies was performed using Newcastle Ottawa Scale converted by Agency for Healthcare Research and Quality (AHRQ). We used bayesian network meta-analysis and conventional meta-analysis (random effects model) to rank and analyze pooled odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI). Forest plots of pooled effect estimates comparing each treatment and ranking panel using Surface Under the Cumulative Ranking (SUCRA) were used for the intervention measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 18 studies with 60,331 patients were included in this systematic review and meta-analysis. Hospital stay was significantly lower in the group with robotic procedure compared to the conventional interventions in terms of ICU stay and overall length of stay. The mean difference of length of hospital stay days of the conventional group was 2.27 (1.31-3.30) days and of the minimally invasive -0.364 (-2.31-1.53) days compared to the robotic group. The robotic procedure was associated with longer cross-clamp and cardiopulmonary bypass (CPB) times. Nevertheless, the robotic procedure was associated with lower infection (OR = 0.60 [95% CI 0.50-0.73)] rates and in-hospital mortality compared to conventional techniques (OR=0.53 [95% CI 0.40-0.70)] but not the minimally invasive techniques (OR = 1.74 [95% CI 0.48-6.31]).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Robotic surgery showed more favorable surgical outcomes, including hospital stay, post-operational complications and in-hospital mortality, although it was associated with longer cross-clamp time and CPB time compared to other interventions. However, its high cost is a difficult consideration for its widespread clinical implementation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Husen</LastName><ForeName>Theresia Feline</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Indonesia, Pondok Cina, Beji, Depok City, West Java, 16424, Indonesia. Electronic address: felinetheresia@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohar</LastName><ForeName>Kelvin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Indonesia, Pondok Cina, Beji, Depok City, West Java, 16424, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelica</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Indonesia, Pondok Cina, Beji, Depok City, West Java, 16424, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saputro</LastName><ForeName>Bryanna Infinita Laviashna</ForeName><Initials>BIL</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Indonesia, Pondok Cina, Beji, Depok City, West Java, 16424, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Hellenic J Cardiol</MedlineTA><NlmUniqueID>101257381</NlmUniqueID><ISSNLinking>1109-9666</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008944" MajorTopicYN="Y">Mitral Valve Insufficiency</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mitral valve</Keyword><Keyword MajorTopicYN="N">conventional sternotomy</Keyword><Keyword MajorTopicYN="N">minimally-invasive surgery</Keyword><Keyword MajorTopicYN="N">robotic surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36639122</ArticleId><ArticleId IdType="doi">10.1016/j.hjc.2022.12.011</ArticleId><ArticleId IdType="pii">S1109-9666(22)00185-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31108081</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>In-Hospital Mortality After Spinal Surgery in Hemodialysis Patients: An 11-Year Population-Based Study.</ArticleTitle><Pagination><StartPage>e667</StartPage><EndPage>e675</EndPage><MedlinePgn>e667-e675</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2018.10.119</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(18)32417-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with end-stage renal disease (ESRD) are at an increased risk of surgical mortality. We aimed to investigate the factors associated with in-hospital mortality in patients with ESRD who underwent spinal surgery, which remains to be determined.</AbstractText><AbstractText Label="MATERIAL AND METHODS">An age- and sex-matched cohort study was conducted using the Taiwan Longitudinal Health Insurance Database between January 2000 and December 2012. Kaplan-Meier curves were plotted with log-rank test to compare the differences between these 2 groups. The Cox proportional hazard model was used to estimate the hazard ratio of in-hospital mortality adjusted with potential confounding.</AbstractText><AbstractText Label="RESULTS">In total, 4109 participants with pre-existing ESRD and 8218 patients without ESRD were included. The in-hospital mortality in ESRD (10.17%) was greater than without ESRD (1.39%). Spinal surgery patients with pre-existing ESRD had a 6.78-fold increase in-hospital mortality risk compared with those without ESRD. Spinal surgery patients with ESRD of any age, male or female, and comorbidities experienced a greater incidence of hospital mortality. In patients with ESRD, operations on spinal cords and spinal canal structures had the greatest hospital mortality (14.87%) compared with spinal fusion (3.46%) or excision or destruction of intervertebral disc (3.01%). Kaplan-Meier survival curves showed that patients with ESRD experienced greater hospital mortality than patients without ESRD in all 3 spinal surgery methods (log rank P &lt; 0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">Spinal surgery patients with ESRD have greater in-hospital mortality than patients without ESRD. Age, sex, history of comorbidities, and types of surgical methods were associated with greater in-hospital mortality among patients with ESRD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eric Nyam</LastName><ForeName>Tee-Tau</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Chi-Mei Medical Center, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Sher-Wei</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Chi-Mei Medical Center, Chiali, Tainan, Taiwan; Department of Nursing, Min-Hwei College of Health Care Management, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Chung-Han</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan; Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Jen-Chieh</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Chi-Mei Medical Center, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jhi-Joung</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chio</LastName><ForeName>Chung-Ching</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Chi-Mei Medical Center, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Jinn-Rung</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Chi-Mei Medical Center, Tainan, Taiwan; Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan. Electronic address: kuojinnrung@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Che-Chuan</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Chi-Mei Medical Center, Tainan, Taiwan; Center for General Education, Southern Taiwan University of Science and Technology, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age</Keyword><Keyword MajorTopicYN="N">Comorbidity</Keyword><Keyword MajorTopicYN="N">End-stage renal disease</Keyword><Keyword MajorTopicYN="N">Hemodialysis</Keyword><Keyword MajorTopicYN="N">Hospital mortality</Keyword><Keyword MajorTopicYN="N">Spinal surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31108081</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2018.10.119</ArticleId><ArticleId IdType="pii">S1878-8750(18)32417-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32106856</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7819</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>World journal of surgical oncology</Title><ISOAbbreviation>World J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of video-assisted thoracoscopic surgery segmentectomy versus lobectomy for stage I non-small cell lung cancer.</ArticleTitle><Pagination><StartPage>44</StartPage><MedlinePgn>44</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">44</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12957-020-01814-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Whether video-assisted thoracoscopic surgery (VATS) segmentectomy and VATS lobectomy provide similar perioperative and oncological outcomes in stage I non-small cell lung cancer (NSCLC) is still controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Meta-analysis of 12 studies comparing outcomes after VATS lobectomy and VATS segmentectomy for stage I NSCLC. Data were analyzed by the RevMan 5.3 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Disease-free survival (HR 1.19, 95% CI 0.89 to 1.33, P = 0.39), overall survival (HR 1.11, 95% CI 0.89 to 1.38, P = 0.36), postoperative complications (OR = 1.10, 95% CI 0.69 to 1.75, P = 0.7), intraoperative blood loss (MD = 3.87, 95% CI - 10.21 to 17.94, P = 0.59), operative time (MD = 10.89, 95% CI - 13.04 to 34.82, P = 0.37), air leak &gt; 5&#x2009;days (OR = 1.20, 95% CI 0.66 to 2.17, P = 0.55), and in-hospital mortality (OR = 1.67, 95% CI 0.39 to 7.16, P = 0.49) were comparable between the groups. Postoperative hospital stay (MD = - 0.69, 95% CI - 1.19 to - 0.19, P = 0.007) and number of dissected lymph nodes (MD = - 6.44, 95%CI - 9.49 to - 3.40, P &lt; 0.0001) were significantly lower in VATS segmentectomy patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VATS segmentectomy and VATS lobectomy provide similar oncological and perioperative outcomes for stage I NSCLC patients. This systematic review was registered on PROSPERO and can be accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID = CRD42019133398.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Weibiao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenxiong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jianyong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Guangmiao</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yu'ang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jianjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dongliang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Jinhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yiping</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5087-7113</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China. weiyip2000@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Surg Oncol</MedlineTA><NlmUniqueID>101170544</NlmUniqueID><ISSNLinking>1477-7819</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011013" MajorTopicYN="N">Pneumonectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020775" MajorTopicYN="N">Thoracic Surgery, Video-Assisted</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung cancer</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">NSCLC</Keyword><Keyword MajorTopicYN="N">VATS segmentectomy</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32106856</ArticleId><ArticleId IdType="pmc">PMC7047378</ArticleId><ArticleId IdType="doi">10.1186/s12957-020-01814-x</ArticleId><ArticleId IdType="pii">10.1186/s12957-020-01814-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007;48(2):214&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">17268017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615&#x2013;622. doi: 10.1016/0003-4975(95)00537-u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(95)00537-u</ArticleId><ArticleId IdType="pubmed">7677489</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione A, Ligabue T, Luzzi L, et al. Comparison between segmentectomy and larger resection of stage IA non-small cell lung carcinoma. J Cardiovasc Surg (Torino). 2004;45(1):67&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">15041941</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada M, Koike T, Higashiyama M, et al. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132(4):769&#x2013;775. doi: 10.1016/j.jtcvs.2006.02.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2006.02.063</ArticleId><ArticleId IdType="pubmed">17000286</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiraishi T, Shirakusa T, Iwasaki A, et al. Video-assisted thoracoscopic surgery (VATS) segmentectomy for small peripheral lung cancer tumors: intermediate results. Surg Endosc. 2004;18(11):1657&#x2013;1662. doi: 10.1007/s00464-003-9269-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-003-9269-4</ArticleId><ArticleId IdType="pubmed">16237587</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins BZ, Harpole DH, Mangum JH, et al. Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach. Ann Thorac Surg. 2007;84(4):1107&#x2013;1112. doi: 10.1016/j.athoracsur.2007.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2007.05.013</ArticleId><ArticleId IdType="pubmed">17888955</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuchert MJ, Pettiford BF, Pennathur AF, et al. Anatomic segmentectomy for stage I non-small-cell lung cancer: comparison of video-assisted thoracic surgery versus open approach. J Thorac Cardiovasc Surg. 2009;138(6):1318-25.e1. doi: 10.1016/j.jtcvs.2009.08.028.</Citation><ArticleIdList><ArticleId IdType="pubmed">19931665</ArticleId></ArticleIdList></Reference><Reference><Citation>Leshnower BG, Miller DF, Fernandez F, et al. Video-assisted thoracoscopic surgery segmentectomy: a safe and effective procedure. Ann Thorac Surg. 2010;89(5):1571&#x2013;1576. doi: 10.1016/j.athoracsur.2010.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.01.061</ArticleId><ArticleId IdType="pubmed">20417779</ArticleId></ArticleIdList></Reference><Reference><Citation>Tierney JF, Stewart LF, Ghersi DF, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi: 10.1186/1745-6215-8-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-8-16</ArticleId><ArticleId IdType="pmc">PMC1920534</ArticleId><ArticleId IdType="pubmed">17555582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang Y, Kang CH, Kim HS, et al. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy on the patients with non-small cell lung cancer: a propensity score matching study. European journal of cardio-thoracic surgery : Eur J Cardiothorac Surg. 2015;48(2):273&#x2013;278. doi: 10.1093/ejcts/ezu422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezu422</ArticleId><ArticleId IdType="pubmed">25406426</ArticleId></ArticleIdList></Reference><Reference><Citation>Echavarria MF, Cheng AM, Velez-Cubian FO, et al. Comparison of pulmonary function tests and perioperative outcomes after robotic-assisted pulmonary lobectomy vs segmentectomy. Am J Surg. 2016;212(6):1175&#x2013;1182. doi: 10.1016/j.amjsurg.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg</ArticleId><ArticleId IdType="pubmed">27823756</ArticleId></ArticleIdList></Reference><Reference><Citation>Landreneau RJ, Normolle DP, Christie NA, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. Journal of clinical oncology. J Clin Oncol. 2014;32(23):2449&#x2013;2455. doi: 10.1200/JCO.2013.50.8762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2013.50.8762</ArticleId><ArticleId IdType="pmc">PMC4121502</ArticleId><ArticleId IdType="pubmed">24982447</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura H, Taniguchi Y, Miwa K, et al. Comparison of the surgical outcomes of thoracoscopic lobectomy, segmentectomy, and wedge resection for clinical stage I non-small cell lung cancer. Thorac Cardiovasc Surg. 2011;59(3):137&#x2013;141. doi: 10.1055/s-0030-1250377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1250377</ArticleId><ArticleId IdType="pubmed">21480132</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman M, Labbouz S, Valtzoglou V, et al. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes. Eur J Surg Oncol. 2019;45(5):845&#x2013;850. doi: 10.1016/j.ejso.2018.10.534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2018.10.534</ArticleId><ArticleId IdType="pubmed">30409440</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro M, Weiser TS, Wisnivesky JP, et al. Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer. J Thorac Cardiovasc Surg. 2009;137(6):1388&#x2013;1393. doi: 10.1016/j.jtcvs.2009.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.02.009</ArticleId><ArticleId IdType="pubmed">19464454</ArticleId></ArticleIdList></Reference><Reference><Citation>Song CY, Sakai T, Kimura D, et al. Comparison of perioperative and oncological outcomes between video-assisted segmentectomy and lobectomy for patients with clinical stage IA non-small cell lung cancer: a propensity score matching study. J Thorac Dis. 2018;10(8):4891-4901. doi: 10.21037/jtd.2018.07.133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6129932</ArticleId><ArticleId IdType="pubmed">30233863</ArticleId></ArticleIdList></Reference><Reference><Citation>Soukiasian HJ, Hong E, McKenna RJ., Jr Video-assisted thoracoscopic trisegmentectomy and left upper lobectomy provide equivalent survivals for stage IA and IB lung cancer. J Thorac Cardiovasc Surg. 2012;144(3):S23&#x2013;S26. doi: 10.1016/j.jtcvs.2012.05.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.05.071</ArticleId><ArticleId IdType="pubmed">22898524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsubokawa N, Tsutani Y, Miyata Y, et al. Segmentectomy versus lobectomy for radiologically pure solid clinical T1a-bN0M0 lung cancer. World J Surg. 2018;42(8):2493&#x2013;2501. doi: 10.1007/s00268-018-4514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4514-0</ArticleId><ArticleId IdType="pubmed">29423740</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang BY, Tu CC, Liu CY, et al. Single-incision thoracoscopic lobectomy and segmentectomy with radical lymph node dissection. Ann Thorac Surg. 2013;96(3):977&#x2013;982. doi: 10.1016/j.athoracsur.2013.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.05.002</ArticleId><ArticleId IdType="pubmed">23870694</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Tokuishi K, Anami K, et al. Thoracoscopic segmentectomy for T1 classification of non-small cell lung cancer: a single center experience. Eur J Cardiothorac Surg. 2012;42(1):83&#x2013;88. doi: 10.1093/ejcts/ezr254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezr254</ArticleId><ArticleId IdType="pubmed">22228839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong C, Fang W, Mao T, et al. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer. Ann Thorac Surg. 2012;94(2):362&#x2013;367. doi: 10.1016/j.athoracsur.2012.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.04.047</ArticleId><ArticleId IdType="pubmed">22727321</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedetti B, Bertolaccini L, Rocco R, et al. Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis. 2017;9(6):1615-1623. doi: 10.21037/jtd.2017.05.79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506148</ArticleId><ArticleId IdType="pubmed">28740676</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q, Huang J, Ding Z, et al. Meta-analysis for curative effect of lobectomy and segmentectomy on non-small cell lung cancer. Int J Clin Exp Med. 2014;7(9):2599&#x2013;2604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4211765</ArticleId><ArticleId IdType="pubmed">25356115</ArticleId></ArticleIdList></Reference><Reference><Citation>Altorki NK, Yip R, Hanaoka T, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147(2):754&#x2013;762. doi: 10.1016/j.jtcvs.2013.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.09.065</ArticleId><ArticleId IdType="pubmed">24280722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtsuka T, Nomori HF, Horio HF, et al. Is major pulmonary resection by video-assisted thoracic surgery an adequate procedure in clinical stage I lung cancer? Chest. 2004;125(5):1742&#x2013;1746. doi: 10.1378/chest.125.5.1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.125.5.1742</ArticleId><ArticleId IdType="pubmed">15136385</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Wang H, Zhou D, et al. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for stage I nonsmall cell lung cancer: a meta-analysis. J Cancer Res Ther. 2016;12(2):926-31. doi: 10.4103/0973-1482.174181.</Citation><ArticleIdList><ArticleId IdType="pubmed">27461676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Wang H, Mao T, et al. Pulmonary function changes after different extent of pulmonary resection under video-assisted thoracic surgery. J Thorac Dis. 2018;10(4):2331-2337. doi: 10.21037/jtd.2018.03.163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5949488</ArticleId><ArticleId IdType="pubmed">29850138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sienel W, Stremmel CF, Kirschbaum AF, et al. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins--implications for patient selection for segmentectomy. Eur J Cardiothorac Surg. 2007;31(3):522&#x2013;527. doi: 10.1016/j.ejcts.2006.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2006.12.018</ArticleId><ArticleId IdType="pubmed">17229574</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao C, Chandrakumar D, Gupta S, et al. Could less be more? A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection. Lung Cancer. 2015;89(2):121&#x2013;132. doi: 10.1016/j.lungcan.2015.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lungcan.2015.05.010</ArticleId><ArticleId IdType="pubmed">26033208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedetti B, Bertolaccini L, Rocco R, et al. Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis. 2017;9(6):1615-1623. doi: 10.21037/jtd.2017.05.79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506148</ArticleId><ArticleId IdType="pubmed">28740676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao F, Ye P, Yang Y, et al. Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis. Eur J Cardiothorac Surg. 2014;46(1):1&#x2013;7. doi: 10.1093/ejcts/ezt554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt554</ArticleId><ArticleId IdType="pubmed">24321996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Li M, Yin R, et al. Comparison of the oncologic outcomes of anatomic segmentectomy and lobectomy for early-stage non-small cell lung cancer. Ann Thorac Surg. 2015;99(2):728&#x2013;737. doi: 10.1016/j.athoracsur.2014.08.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.08.080</ArticleId><ArticleId IdType="pubmed">25497073</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenan RJ, Landreneau RF, Maley R, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004;78(1):228&#x2013;233. doi: 10.1016/j.athoracsur.2004.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2004.01.024</ArticleId><ArticleId IdType="pubmed">15223434</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Ucar AE, Nakas AF, Pilling JF, et al. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg. 2005;27(4):675&#x2013;679. doi: 10.1016/j.ejcts.2005.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.01.006</ArticleId><ArticleId IdType="pubmed">15784373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto K, Nomori HF. Mori TF, et al. Quantification of the impact of segmentectomy on pulmonary function by perfusion single-photon-emission computed tomography and multidetector computed tomography. doi: J Thorac Cardiovasc Surg. 2009;137(5):1200&#x2013;1205. doi: 10.1016/j.jtcvs.2008.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.10.028</ArticleId><ArticleId IdType="pubmed">19379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Takizawa T, Haga MF, Yagi NF, et al. Pulmonary function after segmentectomy for small peripheral carcinoma of the lung. J Thorac Cardiovasc Surg. 1999;118(3):536&#x2013;541. doi: 10.1016/S0022-5223(99)70193-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(99)70193-5</ArticleId><ArticleId IdType="pubmed">10469972</ArticleId></ArticleIdList></Reference><Reference><Citation>Charloux A, Quoix E. Lung segmentectomy: does it offer a real functional benefit over lobectomy? Eur Respir Rev. 2017;26(146). pii: 170079. doi: 10.1183/16000617.0079-2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9488724</ArticleId><ArticleId IdType="pubmed">29070582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda K, Tanaka TF, Hayashi MF, et al. Computed tomography-defined functional lung volume after segmentectomy versus lobectomy. Eur J Cardiothorac Surg. 2010;37(6):1433&#x2013;1437. doi: 10.1016/j.ejcts.2010.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.01.002</ArticleId><ArticleId IdType="pubmed">20153214</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada H, Okada MF. akamoto TF, et al. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg. 2005;80(6):2041&#x2013;2045. doi: 10.1016/j.athoracsur.2005.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.06.010</ArticleId><ArticleId IdType="pubmed">16305841</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler JP, Loring SF, Patz SF, et al. Evidence for adult lung growth in humans. N Engl J Med. 2012;367(3):244&#x2013;247. doi: 10.1056/NEJMoa1203983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1203983</ArticleId><ArticleId IdType="pmc">PMC3422892</ArticleId><ArticleId IdType="pubmed">22808959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizobuchi T, Wada HF, Sakairi YF, et al. Spirometric and radiological evaluation of the remnant lung long after major pulmonary resection: can compensatory phenomena be recognized in clinical cases? Surg Today. 2014;44(9):1735&#x2013;1743. doi: 10.1007/s00595-013-0702-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-013-0702-6</ArticleId><ArticleId IdType="pubmed">23982195</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Morimoto J, Mizobuchi T, et al. Does segmentectomy really preserve the pulmonary function better than lobectomy for patients with early-stage lung cancer? Surg Today. 2017;47(4):463&#x2013;469. doi: 10.1007/s00595-016-1387-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-016-1387-4</ArticleId><ArticleId IdType="pubmed">27484067</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyasaka Y, Oh SF, Takahashi NF, et al. Postoperative complications and respiratory function following segmentectomy of the lung - comparison of the methods of making an inter-segmental plane. Interact Cardiovasc Thorac Surg. 2011;12(3):426&#x2013;429. doi: 10.1510/icvts.2010.253989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.253989</ArticleId><ArticleId IdType="pubmed">21081556</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27503847</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Surgical Valvotomy Versus Balloon Valvuloplasty for Congenital Aortic Valve Stenosis: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e003931</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.116.003931</ELocationID><Abstract><AbstractText Label="BACKGROUND">Optimal initial treatment for congenital aortic valve stenosis in children remains unclear between balloon aortic valvuloplasty (BAV) and surgical aortic valvotomy (SAV).</AbstractText><AbstractText Label="METHODS AND RESULTS">We performed a contemporary systematic review and meta-analysis to compare survival in children with congenital aortic valve stenosis. Secondary outcomes included frequency of at least moderate regurgitation at hospital discharge as well as rates of aortic valve replacement and reintervention. Single- and dual-arm studies were identified by a search of PubMed (Medline), Embase, and the Cochrane database. Overall 2368 patients from 20 studies were included in the analysis, including 1835 (77%) in the BAV group and 533 (23%) in the SAV group. There was no difference between SAV and BAV in hospital mortality (OR=0.98, 95% CI 0.5-2.0, P=0.27, I(2)=22%) or frequency of at least moderate aortic regurgitation at discharge (OR=0.58, 95% CI 0.3-1.3, P=0.09, I(2)=54%). Kaplan-Meier analysis showed no difference in long-term survival or freedom from aortic valve replacement but significantly more reintervention in the BAV group (10-year freedom from reintervention of 46% [95% CI 40-52] for BAV versus 73% [95% CI 68-77] for SAV, P&lt;0.001). Results were unchanged in a sensitivity analysis restricted to infants (&lt;1&#xa0;year of age).</AbstractText><AbstractText Label="CONCLUSIONS">Although higher rates of reintervention suggest improved outcomes with SAV, indications for reintervention may vary depending on initial intervention. When considering the benefits of a less-invasive approach, and clinical equipoise with respect to more clinically relevant outcomes, these findings support the need for a randomized controlled trial.</AbstractText><CopyrightInformation>&#xa9; 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Garick D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI ghill@chw.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ginde</LastName><ForeName>Salil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rios</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frommelt</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Kevin D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Pediatrics, Duke University, Durham, NC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000055</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000151" MajorTopicYN="Y">congenital</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063126" MajorTopicYN="Y">Balloon Valvuloplasty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aortic surgery</Keyword><Keyword MajorTopicYN="N">aortic valve stenosis</Keyword><Keyword MajorTopicYN="N">balloon aortic valvuloplasty</Keyword><Keyword MajorTopicYN="N">congenital heart defects</Keyword><Keyword MajorTopicYN="N">meta&#x2010;analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27503847</ArticleId><ArticleId IdType="pmc">PMC5015309</ArticleId><ArticleId IdType="doi">10.1161/JAHA.116.003931</ArticleId><ArticleId IdType="pii">JAHA.116.003931</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCrindle BW, Blackstone EH, Williams WG, Sittiwangkul R, Spray TL, Azakie A, Jonas RA. Are outcomes of surgical versus transcatheter balloon valvotomy equivalent in neonatal critical aortic stenosis? Circulation. 2001;104:I152&#x2013;I158.</Citation><ArticleIdList><ArticleId IdType="pubmed">11568048</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JW, Rodefeld MD, Ruzmetov M, Eltayeb O, Yurdakok O, Turrentine MW. Surgical valvuloplasty versus balloon aortic dilation for congenital aortic stenosis: are evidence&#x2010;based outcomes relevant? Ann Thorac Surg. 2012;94:146&#x2013;153; discussion 153&#x2010;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">22537535</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui J, Brizard CP, Galati JC, Iyengar AJ, Hutchinson D, Konstantinov IE, Wheaton GR, Ramsay JM, d'Udekem Y. Surgical valvotomy and repair for neonatal and infant congenital aortic stenosis achieves better results than interventional catheterization. J Am Coll Cardiol. 2013;62:2134&#x2013;2140.</Citation><ArticleIdList><ArticleId IdType="pubmed">23954309</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexiou C, Chen Q, Langley SM, Salmon AP, Keeton BR, Haw MP, Monro JL. Is there still a place for open surgical valvotomy in the management of aortic stenosis in children? The view from Southampton. Eur J Cardiothorac Surg. 2001;20:239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">11463538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhabra MS, Dhillon R, Bhudia S, Sethia B, Miller P, Stumper O, Wright JG, De Giovanni JV, Barron DJ, Brawn WJ. Surgical aortic valvotomy in infancy: impact of leaflet morphology on long&#x2010;term outcomes. Ann Thorac Surg. 2003;76:1412&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pubmed">14602259</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespo D, Miro J, Vobecky SJ, Poirier N, Lapierre C, Zhao NN, Dahdah N. Experience in a single centre with percutaneous aortic valvoplasty in children, including those with associated cardiovascular lesions. Cardiol Young. 2009;19:372&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">19519967</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshershari H, Alehan D, Demircin M, Pasaoglu I, Bilgic A. Surgical outcome of congenital valvar aortic stenosis. Turk J Pediatr. 2002;44:304&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">12458805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewert P, Bertram H, Breuer J, Dahnert I, Dittrich S, Eicken A, Emmel M, Fischer G, Gitter R, Gorenflo M, Haas N, Kitzmuller E, Koch A, Kretschmar O, Lindinger A, Michel&#x2010;Behnke I, Nuernberg JH, Peuster M, Walter K, Zartner P, Uhlemann F. Balloon valvuloplasty in the treatment of congenital aortic valve stenosis&#x2014;a retrospective multicenter survey of more than 1000 patients. Int J Cardiol. 2011;149:182&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">20153064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidi&#x2010;Manesh L, Tibby SM, Herman R, Rosenthal E, Qureshi SA, Krasemann T. Influence of balloon size on aortic regurgitation in neonates undergoing balloon aortic valvuloplasty&#x2014;a retrospective study over an 11&#x2010;year period. J&#xa0;Interv Cardiol. 2013;26:200&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">23406402</ArticleId></ArticleIdList></Reference><Reference><Citation>Han RK, Gurofsky RC, Lee KJ, Dipchand AI, Williams WG, Smallhorn JF, McCrindle BW. Outcome and growth potential of left heart structures after neonatal intervention for aortic valve stenosis. J Am Coll Cardiol. 2007;50:2406&#x2013;2414.</Citation><ArticleIdList><ArticleId IdType="pubmed">18154967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochstrasser L, Ruchat P, Sekarski N, Hurni M, von Segesser LK. Long&#x2010;term outcome of congenital aortic valve stenosis: predictors of reintervention. Cardiol Young. 2015;25:893&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">24983130</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindal RC, Saxena A, Kothari SS, Juneja R, Shrivastava S. Congenital severe aortic stenosis with congestive heart failure in late childhood and adolescence: effect on left ventricular function after balloon valvuloplasty. Catheter Cardiovasc Interv. 2000;51:168&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">11025569</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DW, Raviele AA, Vincent RN. Use of a 3 French system for balloon aortic valvuloplasty in infants. Catheter Cardiovasc Interv. 2005;66:254&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">16127701</ArticleId></ArticleIdList></Reference><Reference><Citation>Latiff HA, Sholler GF, Cooper S. Balloon dilatation of aortic stenosis in infants younger than 6&#xa0;months of age: intermediate outcome. Pediatr Cardiol. 2003;24:17&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">12370791</ArticleId></ArticleIdList></Reference><Reference><Citation>Loomba RS, Bowman JL, Cao Y, Tweddell J, Dearani JA, Simpson PM, Cetta F, Pelech AN. Is aortic valve leaflet morphology predictive of outcome in pediatric aortic valve stenosis? Congenit Heart Dis. 2015;10:552&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">26219421</ArticleId></ArticleIdList></Reference><Reference><Citation>McElhinney DB, Lock JE, Keane JF, Moran AM, Colan SD. Left heart growth, function, and reintervention after balloon aortic valvuloplasty for neonatal aortic stenosis. Circulation. 2005;111:451&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">15687133</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto T, Sinzobahamvya N, Wetter J, Kallenberg R, Brecher AM, Asfour B, Urban AE. Twenty years experience of surgical aortic valvotomy for critical aortic stenosis in early infancy. Eur J Cardiothorac Surg. 2006;30:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">16725339</ArticleId></ArticleIdList></Reference><Reference><Citation>Prijic SM, Vukomanovic VA, Stajevic MS, Bjelakovic BB, Zdravkovic MD, Sehic IN, Kosutic JL. Balloon dilation and surgical valvotomy comparison in non&#x2010;critical congenital aortic valve stenosis. Pediatr Cardiol. 2015;36:616&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">25388630</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson BV, Brzezinska&#x2010;Rajszys G, Weber HS, Ksiazyk J, Fricker FJ, Fischer DR, Ettedgui JA. Balloon aortic valvotomy through a carotid cutdown in infants with severe aortic stenosis: results of the multi&#x2010;centric registry. Cardiol Young. 2000;10:225&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">10824903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi RI, Manica JL, Petraco R, Scott M, Piazza L, Machado PM. Balloon aortic valvuloplasty for congenital aortic stenosis using the femoral and the carotid artery approach: a 16&#x2010;year experience from a single center. Catheter Cardiovasc Interv. 2011;78:84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">21234922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan&#x2010;Meier survival curves. BMC Med Res Methodol. 2012;12:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3313891</ArticleId><ArticleId IdType="pubmed">22297116</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamlou T, Shen I, Alsoufia B, Burch G, Reller M, Silberbach M, Ungerleider RM. The influence of valve physiology on outcome following aortic valvotomy for congenital bicuspid valve in children: 30&#x2010;year results from a single institution. Eur J Cardiothorac Surg. 2005;27:81&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">15621475</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich O, Tax P, Marek J, Razek V, Gilik J, Tomek V, Chaloupecky V, Bartakova H, Skovranek J. Long term results of percutaneous balloon valvoplasty of congenital aortic stenosis: independent predictors of outcome. Heart. 2004;90:70&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1768014</ArticleId><ArticleId IdType="pubmed">14676248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37052065</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Cardiac dysfunction in patients affected by subarachnoid haemorrhage affects in-hospital mortality: A systematic review and metanalysis.</ArticleTitle><Pagination><StartPage>442</StartPage><EndPage>449</EndPage><MedlinePgn>442-449</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000001829</ELocationID><Abstract><AbstractText Label="BACKGROUND">Subarachnoid haemorrhage (SAH) is a life-threatening condition with associated brain damage. Moreover, SAH is associated with a massive release of catecholamines, which may promote cardiac injury and dysfunction, possibly leading to haemodynamic instability, which in turn may influence a patient's outcome.</AbstractText><AbstractText Label="OBJECTIVES">To study the prevalence of cardiac dysfunction (as assessed by echocardiography) in patients with SAH and its effect on clinical outcomes.</AbstractText><AbstractText Label="DESIGN">Systematic review of observational studies.</AbstractText><AbstractText Label="DATA SOURCES">We performed a systematic search over the last 20&#x200a;years on MEDLINE and EMBASE databases.</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA">Studies reporting echocardiography findings in adult patients with SAH admitted to intensive care. Primary outcomes were in-hospital mortality and poor neurological outcome according to the presence or absence of cardiac dysfunction.</AbstractText><AbstractText Label="RESULTS">We included a total of 23 studies (4 retrospective) enrolling 3511 patients. The cumulative frequency of cardiac dysfunction was 21% (725 patients), reported as regional wall motion abnormality in the vast majority of studies (63%). Due to the heterogeneity of clinical outcome data reporting, a quantitative analysis was carried out only for in-hospital mortality. Cardiac dysfunction was associated with a higher in-hospital mortality [odds ratio 2.69 (1.64 to 4.41); P &#x200a;&lt;&#x200a;0.001; I2 = 63%]. The GRADE of evidence assessment resulted in very low certainty of evidence.</AbstractText><AbstractText Label="CONCLUSION">About one in five patients with SAH develops cardiac dysfunction, which seems to be associated with higher in-hospital mortality. The consistency of cardiac and neurological data reporting is lacking, reducing the comparability of the studies in this field.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy (AM, LC, FV, MC), Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy (AM, MC), Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA (YL, CZ), IRCCS Ospedale Policlinico San Martino (CR), Dipartimento di Medicina E Chirurgia, Universita' Degli Studi di Perugia, Perugia (GC) and Department of Anaesthesia and Intensive Care, A.O.U. 'Policlinico-San Marco', Catania, Italy (FS).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhitano</LastName><ForeName>Yaroslava</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zanza</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Villa</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Cammarota</LastName><ForeName>Gianmaria</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Robba</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013345" MajorTopicYN="Y">Subarachnoid Hemorrhage</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37052065</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000001829</ArticleId><ArticleId IdType="pii">00003643-202306000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lerch C, Yonekawa Y, Muroi C, et al. Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2006; 5:85&#x2013;92.</Citation></Reference><Reference><Citation>Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet 2017; 389:655&#x2013;666.</Citation></Reference><Reference><Citation>Nieuwkamp DJ, Setz LE, Algra A, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009; 8:635&#x2013;642.</Citation></Reference><Reference><Citation>Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008; 118:397&#x2013;409.</Citation></Reference><Reference><Citation>Mrozek S, Constantin JM, Geeraerts T. Brain-lung crosstalk: Implications for neurocritical care patients. World J Crit Care Med 2015; 4:163&#x2013;178.</Citation></Reference><Reference><Citation>Scheitz JF, Nolte CH, Doehner W, et al. Stroke-heart syndrome: clinical presentation and underlying mechanisms. Lancet Neurol 2018; 17:1109&#x2013;1120.</Citation></Reference><Reference><Citation>Scheitz JF, Sposato LA, Schulz-Menger J, et al. Stroke-heart syndrome: recent advances and challenges. J Am Heart Assoc 2022; 11:e026528.</Citation></Reference><Reference><Citation>Lee VH, Oh JK, Mulvagh SL, Wijdicks EF. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2006; 5:243&#x2013;249.</Citation></Reference><Reference><Citation>Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke 1999; 30:780&#x2013;786.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; 14:135.</Citation></Reference><Reference><Citation>Ahmadian A, Mizzi A, Banasiak M, et al. Cardiac manifestations of subarachnoid hemorrhage. Heart Lung Vessel 2013; 5:168&#x2013;178.</Citation></Reference><Reference><Citation>Huang S, Sanfilippo F, Herpain A, et al. Systematic review and literature appraisal on methodology of conducting and reporting critical-care echocardiography studies: a report from the European Society of Intensive Care Medicine PRICES expert panel. Ann Intensive Care 2020; 10:49.</Citation></Reference><Reference><Citation>Zhang L, Wang Z, Qi S. Cardiac troponin elevation and outcome after subarachnoid hemorrhage: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2015; 24:2375&#x2013;2384.</Citation></Reference><Reference><Citation>van der Bilt I, Hasan D, van den Brink R, et al. SEASAH (Serial Echocardiography After Subarachnoid Hemorrhage) Investigators. Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: relationship with outcome. Neurology 2014; 82:351&#x2013;358.</Citation></Reference><Reference><Citation>Taccone FS, Citerio G. Participants in the International Multidisciplinary Consensus Conference on Multimodality M. Advanced monitoring of systemic hemodynamics in critically ill patients with acute brain injury. Neurocrit Care 2014; 21: (Suppl 2): S38&#x2013;63.</Citation></Reference><Reference><Citation>Banki NM, Kopelnik A, Dae MW, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 2005; 112:3314&#x2013;3319.</Citation></Reference><Reference><Citation>Singh T, Khan H, Gamble DT, et al. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation 2022; 145:1002&#x2013;1019.</Citation></Reference><Reference><Citation>Messina A, Villa F, Cecconi M. Challenges in the hemodynamic management of acute nontraumatic neurological injuries. Curr Opin Crit Care 2022; 28:138&#x2013;144.</Citation></Reference><Reference><Citation>Zaroff JG, Leong J, Kim H, et al. Cardiovascular predictors of long-term outcomes after nontraumatic subarachnoid hemorrhage. Neurocrit Care 2012; 17:374&#x2013;381.</Citation></Reference><Reference><Citation>Crago EA, Kerr ME, Kong Y, et al. The impact of cardiac complications on outcome in the SAH population. Acta Neurol Scand 2004; 110:248&#x2013;253.</Citation></Reference><Reference><Citation>Banki N, Kopelnik A, Tung P, et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg 2006; 105:15&#x2013;20.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.</Citation></Reference><Reference><Citation>Sanfilippo F, Huang S, Herpain A, et al. The PRICES statement: an ESICM expert consensus on methodology for conducting and reporting critical care echocardiography research studies. Intensive Care Med 2021; 47:1&#x2013;13.</Citation></Reference><Reference><Citation>Slim K, Nini E, Forestier D, et al. Methodological index for nonrandomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003; 73:712&#x2013;716.</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018; 27:1785&#x2013;1805.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539&#x2013;1558.</Citation></Reference><Reference><Citation>Chalouhi N, Daou B, Okabe T, et al. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study. J Neurosurg 2016; 125:730&#x2013;736.</Citation></Reference><Reference><Citation>Cinotti R, Piriou N, Launey Y, et al. Speckle tracking analysis allows sensitive detection of stress cardiomyopathy in severe aneurysmal subarachnoid hemorrhage patients. Intensive Care Med 2016; 42:173&#x2013;182.</Citation></Reference><Reference><Citation>Cremers CH, van der Bilt IA, van der Schaaf IC, et al. Relationship between cardiac dysfunction and cerebral perfusion in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2016; 24:202&#x2013;206.</Citation></Reference><Reference><Citation>Huang WJ, Chen WW, Zhang X. Comparison of cerebral-cardiac syndrome caused by nonaneurysmal or aneurysmal subarachnoid hemorrhage. Eur Rev Med Pharmacol Sci 2014; 18:3737&#x2013;3742.</Citation></Reference><Reference><Citation>Jangra K, Grover VK, Bhagat H, et al. Evaluation of the effect of aneurysmal clipping on electrocardiography and echocardiographic changes in patients with subarachnoid hemorrhage: a prospective observational study. J Neurosurg Anesthesiol 2017; 29:335&#x2013;340.</Citation></Reference><Reference><Citation>Junttila E, Vaara M, Koskenkari J, et al. Repolarization abnormalities in patients with subarachnoid and intracerebral hemorrhage: predisposing factors and association with outcome. Anesth Analg 2013; 116:190&#x2013;197.</Citation></Reference><Reference><Citation>Jyotsna M, Prasad V, Indrani G, et al. Importance of detection of segmental wall motion abnormalities of left ventricle in nontraumatic subarachnoid hemorrhage: a prospective study. Echocardiography 2010; 27:496&#x2013;500.</Citation></Reference><Reference><Citation>Kagiyama N, Sugahara M, Crago EA, et al. Neurocardiac injury assessed by strain imaging is associated with in-hospital mortality in patients with subarachnoid hemorrhage. JACC Cardiovasc Imaging 2020; 13:535&#x2013;546.</Citation></Reference><Reference><Citation>Kilbourn KJ, Levy S, Staff I, et al. Clinical characteristics and outcomes of neurogenic stress cadiomyopathy in aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 2013; 115:909&#x2013;914.</Citation></Reference><Reference><Citation>Kothavale A, Banki NM, Kopelnik A, et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocritical Care 2006; 4:199&#x2013;205.</Citation></Reference><Reference><Citation>Moussouttas M, Huynh TT, Khoury J, et al. Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage. Cerebrovasc Dis 2012; 33:173&#x2013;181.</Citation></Reference><Reference><Citation>Papanikolaou J, Makris D, Karakitsos D, et al. Cardiac and central vascular functional alterations in the acute phase of aneurysmal subarachnoid hemorrhage. Crit Care Med 2012; 40:223&#x2013;232.</Citation></Reference><Reference><Citation>Salem R, Vallee F, Depret F, et al. Subarachnoid hemorrhage induces an early and reversible cardiac injury associated with catecholamine release: one-week follow-up study. Crit Care 2014; 18:558.</Citation></Reference><Reference><Citation>Sharma AK, Singh D, Mahajan B, et al. Prospective analysis of role of hsTnT and NT-proBNP in prediction of neurogenic stress cardiomyopathy in patients with aneurysmal subarachnoid haemorrhage. Neurol India 2021; 69:944&#x2013;949.</Citation></Reference><Reference><Citation>Sugimoto K, Yamada A, Inamasu J, et al. Electrocadiographic scoring helps predict left ventricular wall motion abnormality commonly observed after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2018; 27:3148&#x2013;3154.</Citation></Reference><Reference><Citation>van der Bilt IA, Hasan D, van den Brink RB, et al. SEASAH (Serial Echocardiography After Subarachnoid Hemorrhage) Investigators. Time course and risk factors for myocardial dysfunction after aneurysmal subarachnoid hemorrhage. Neurosurgery 2015; 76:700&#x2013;705.</Citation></Reference><Reference><Citation>Temes RE, Tessitore E, Schmidt JM, et al. Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage. Neurocrit Care 2010; 13:359&#x2013;365.</Citation></Reference><Reference><Citation>Bihorac A, Ozrazgat-Baslanti T, Mahanna E, et al. Long-term outcomes for different forms of stress cardiomyopathy after surgical treatment for subarachnoid hemorrhage. Anesth Analg 2016; 122:1594&#x2013;1602.</Citation></Reference><Reference><Citation>Dalla K, Bech-Hanssen O, Oras J, et al. Speckle tracking-vs conventional echocardiography for the detection of myocardial injury-a study on patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand 2019; 63:365&#x2013;372.</Citation></Reference><Reference><Citation>Inamasu J, Ganaha T, Nakae S, et al. Therapeutic outcomes for patients with aneurysmal subarachnoid hemorrhage complicated by Takotsubo cardiomyopathy. Acta Neurochir (Wien) 2016; 158:885&#x2013;893.</Citation></Reference><Reference><Citation>Sugimoto K, Inamasu J, Kato Y, et al. Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients. Neurosurg Rev 2013; 36:259&#x2013;266.</Citation></Reference><Reference><Citation>Sanfilippo F, Messina A, Cecconi M, et al. Ten answers to key questions for fluid management in intensive care. Med Intensiva 2020; 12:30338&#x2013;30347.</Citation></Reference><Reference><Citation>Messina A, Greco M, Cecconi M. What should I use next if clinical evaluation and echocardiographic haemodynamic assessment is not enough? Curr Opin Crit Care 2019; 25:259&#x2013;265.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33643529</PMID><DateRevised><Year>2021</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1948-5204</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>World journal of gastrointestinal oncology</Title><ISOAbbreviation>World J Gastrointest Oncol</ISOAbbreviation></Journal><ArticleTitle>Outcomes of curative esophageal cancer surgery in elderly: A meta-analysis.</ArticleTitle><Pagination><StartPage>131</StartPage><EndPage>146</EndPage><MedlinePgn>131-146</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4251/wjgo.v13.i2.131</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">An increasing number of older patients is undergoing curative, surgical treatment of esophageal cancer. Previous meta-analyses have shown that older patients suffered from more postoperative morbidity and mortality compared to younger patients, which may lead to patient selection based on age. However, only studies including patients that underwent open esophagectomy were included. Therefore, it remains unknown whether there is an association between age and outcome in patients undergoing minimally invasive esophagectomy.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To perform a systematic review on age and postoperative outcome in esophageal cancer patients undergoing esophagectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Studies comparing older with younger patients with primary esophageal cancer undergoing curative esophagectomy were included. Meta-analysis of studies using a 75-year age threshold are presented in the manuscript, studies using other age thresholds in the Supplementary material. MEDLINE, Embase and the Cochrane Library were searched for articles published between 1995 and 2020. Risk of bias was assessed with the Newcastle-Ottawa Scale. Primary outcomes were anastomotic leak, pulmonary and cardiac complications, delirium, 30- and 90-d, and in-hospital mortality. Secondary outcomes included pneumonia and 5-year overall survival.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies (4847 patients) using an age threshold of 75 years were included for meta-analysis with 755 older and 4092 younger patients. Older patients (9.05%) had higher rates of 90-d mortality compared with younger patients (3.92%), (confidence interval = 1.10-5.56). In addition, older patients (9.45%) had higher rates of in-hospital mortality compared with younger patients (3.68%), (confidence interval = 1.01-5.91). In the subgroup of 2 studies with minimally invasive esophagectomy, older and younger patients had comparable 30-d, 90-d and in-hospital mortality rates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Older patients undergoing curative esophagectomy for esophageal cancer have a higher postoperative mortality risk. Minimally invasive esophagectomy may be important for minimizing mortality in older patients.</AbstractText><CopyrightInformation>&#xa9;The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baranov</LastName><ForeName>Nikolaj S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud University Medical Center, Nijmegen 6525GA, the Netherlands. nikolaj.baranov@radboudumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slootmans</LastName><ForeName>Cettela</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud University Medical Center, Nijmegen 6525GA, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Workum</LastName><ForeName>Frans</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud University Medical Center, Nijmegen 6525GA, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klarenbeek</LastName><ForeName>Bastiaan R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud University Medical Center, Nijmegen 6525GA, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoon</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Radboud University Medical Center, Nijmegen 6525GA, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosman</LastName><ForeName>Camiel</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboud University Medical Center, Nijmegen 6525GA, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>World J Gastrointest Oncol</MedlineTA><NlmUniqueID>101532470</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical outcome</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Esophageal cancer</Keyword><Keyword MajorTopicYN="N">Minimally invasive esophagectomy</Keyword><Keyword MajorTopicYN="N">Open esophagectomy</Keyword><Keyword MajorTopicYN="N">Perioperative mortality</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>1</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33643529</ArticleId><ArticleId IdType="pmc">PMC7896422</ArticleId><ArticleId IdType="doi">10.4251/wjgo.v13.i2.131</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374:1196&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2810516</ArticleId><ArticleId IdType="pubmed">19801098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlottmann F, Strassle PD, Nayyar A, Herbella FAM, Cairns BA, Patti MG. Postoperative outcomes of esophagectomy for cancer in elderly patients. J Surg Res. 2018;229:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">29937021</ArticleId></ArticleIdList></Reference><Reference><Citation>Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887&#x2013;1892.</Citation><ArticleIdList><ArticleId IdType="pubmed">22552194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carr&#xe8;re N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G F&#xe9;d&#xe9;ration de Recherche en Chirurgie (FRENCH) and French Eso-Gastric Tumors (FREGAT) Working Group. Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer. N Engl J Med. 2019;380:152&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625052</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA, Kroese CC, Haj Mohammad N, Mook S, Vleggaar FP, Borel Rinkes IHM, Ruurda JP, van Hillegersberg R. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial. Ann Surg. 2019;269:621&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">30308612</ArticleId></ArticleIdList></Reference><Reference><Citation>Haverkamp L, Seesing MF, Ruurda JP, Boone J, V Hillegersberg R. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus. 2017;30:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27001442</ArticleId></ArticleIdList></Reference><Reference><Citation>Markar SR, Karthikesalingam A, Thrumurthy S, Ho A, Muallem G, Low DE. Systematic review and pooled analysis assessing the association between elderly age and outcome following surgical resection of esophageal malignancy. Dis Esophagus. 2013;26:250&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">22591068</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Liu S, Guo W, Zhang Y, Li H. Clinical outcomes of oesophagectomy in elderly versus relatively younger patients: a meta-analysis. Interact Cardiovasc Thorac Surg. 2019;29:897&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">31765482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Lopez V, G&#xf3;mez-Ruiz AJ, Eshmuminov D, Cascales-Campos PA, Alconchel F, Arevalo-Perez J, Robles Campos R, Parrilla Paricio P. Surgical oncology in patients aged 80 years and older is associated with increased postoperative morbidity and mortality: A systematic review and meta-analysis of literature over 25 years. Surg Oncol. 2020;33:81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">32561103</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott A, Shridhar R, Hoffe S, Almhanna K, Doepker M, Saeed N, Meredith K. Robotic assisted Ivor Lewis esophagectomy in the elderly patient. J Gastrointest Oncol. 2015;6:31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4294822</ArticleId><ArticleId IdType="pubmed">25642335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Liu G, Wei S, Liu H. Short- and long-term outcomes of minimally invasive esophagectomy in elderly patients with esophageal squamous cell carcinoma. J BUON. 2017;22:1540&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pubmed">29332350</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranov NS, van Workum F, van der Maas J, Kouwenhoven E, van Det M, van den Wildenberg FJH, Polat F, Nieuwenhuijzen GAP, Luyer MDP, Rosman C. The Influence of Age on Complications and Overall Survival After Ivor Lewis Totally Minimally Invasive Esophagectomy. J Gastrointest Surg. 2019;23:1293&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6591183</ArticleId><ArticleId IdType="pubmed">30565069</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos DM, Tugwell P.  The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. [cited 25 January 2021]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp .</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol . 2014;14:, 135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrer M, Cuijpers P, Furukawa TA, Ebert DD. Doing Meta-Analysis in R: A Hands-on Guide. 2019.</Citation></Reference><Reference><Citation>Team R.  R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austra, 2010. Available from: https://www.bibsonomy.org/bibtex/2b73bfa376907e90089cf7434f67bfd53/yevb0 .</Citation></Reference><Reference><Citation>Akutsu Y, Shuto K, Uesato M, Hoshino I, Matsubara H. [The problems of surgery in aged esophageal cancer] Nihon Ronen Igakkai Zasshi. 2009;46:313&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">19713659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Omae K, Kodera Y. Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis. BMC Surg. 2019;19:143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792188</ArticleId><ArticleId IdType="pubmed">31615499</ArticleId></ArticleIdList></Reference><Reference><Citation>Klevebro F, Garritano S, Scandavini CM, Shetye A, Coppola A, Kamiya S, Nilsson M, Lundell L, Rouvelas I. Surgical outcomes of oesophagectomy or gastrectomy due to cancer for patients &#x2265;75 years of age: a single-centre cohort study. ANZ J Surg. 2019;89:228&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">30151854</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CW, Wu HR, Xu GW, Xiong R, Xu MQ, Xie MR. Analysis of short- and long-term outcomes after esophagectomy in elderly cancer patients. hongguo Zhongliu Linchuang. 2018;45:508&#x2013;512.</Citation></Reference><Reference><Citation>Matsumoto Y, Kimura K, Zhou Q, Sasaki K, Saiki T, Moriyama M, Saijo Y. Treatments and outcomes of older patients with esophageal cancer: Comparison with younger patients. Mol Clin Oncol. 2019;11:383&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713945</ArticleId><ArticleId IdType="pubmed">31475066</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweigert M, Solymosi N, Dubecz A, Stadlhuber RJ, Ofner D, Stein HJ. Current outcome of esophagectomy in the very elderly: experience of a German high-volume center. Am Surg. 2013;79:754&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">23896240</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Li H, Jia C, Ma X, Guo W, Li H. Clinicopathological features and prognosis of patients &lt;45 years old with esophageal adenocarcinoma comparing to other age groups. J Thorac Dis. 2016;8:2724&#x2013;2729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5107463</ArticleId><ArticleId IdType="pubmed">27867547</ArticleId></ArticleIdList></Reference><Reference><Citation>Horne ZD, Wegner RE, Colonias A, Weksler B, Glaser SM, Kalash R, Beriwal S. Drivers of 30- and 90-day Postoperative Death After Neoadjuvant Chemoradiation for Esophageal Cancer. Ann Thorac Surg. 2020;109:921&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">31846643</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhavan A, Kamarajah SK, Navidi M, Wahed S, Immanuel A, Hayes N, Griffin SM, Phillips AW. The impact of age on patients undergoing transthoracic esophagectomy for cancer. Dis Esophagus. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32556151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagergren J, Bottai M, Santoni G. Patient Age and Survival After Surgery for Esophageal Cancer. Ann Surg Oncol. 2021;28:159&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7752878</ArticleId><ArticleId IdType="pubmed">32468352</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gestel YR, Lemmens VE, de Hingh IH, Steevens J, Rutten HJ, Nieuwenhuijzen GA, van Dam RM, Siersema PD. Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients. Ann Surg Oncol. 2013;20:371&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">22987098</ArticleId></ArticleIdList></Reference><Reference><Citation>Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44:1055&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918092</ArticleId><ArticleId IdType="pubmed">25142482</ArticleId></ArticleIdList></Reference><Reference><Citation>Backemar L, Lagergren P, Johar A, Lagergren J. Impact of co-morbidity on mortality after oesophageal cancer surgery. Br J Surg. 2015;102:1097&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">26059747</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita K, Watanabe M, Mine S, Fukudome I, Okamura A, Yuda M, Hayami M, Imamura Y. The impact of the Charlson comorbidity index on the prognosis of esophageal cancer patients who underwent esophagectomy with curative intent. Surg Today. 2018;48:632&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pubmed">29383595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pultrum BB, Bosch DJ, Nijsten MW, Rodgers MG, Groen H, Slaets JP, Plukker JT. Extended esophagectomy in elderly patients with esophageal cancer: minor effect of age alone in determining the postoperative course and survival. Ann Surg Oncol. 2010;17:1572&#x2013;1580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2868167</ArticleId><ArticleId IdType="pubmed">20180031</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31286916</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2482</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC surgery</Title><ISOAbbreviation>BMC Surg</ISOAbbreviation></Journal><ArticleTitle>The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis.</ArticleTitle><Pagination><StartPage>84</StartPage><MedlinePgn>84</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">84</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12893-019-0540-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although pancreaticoduodenectomy with vein resection (PDVR) is widely performed in selected patients with indications, its benefits remain controversial. In this meta-analysis, we evaluate the safety and efficacy of PDVR in comparison to standard pancreaticoduodenectomy (PD).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Embase, and Cochrane as well as the Chinese National Knowledge Infrastructure, Weipu, and Wanfang databases for studies that evaluate the value of PVDR. The data of the patients who underwent PD or PDVR were analyzed using Review Manager and STATA software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In comparison with the PD group, the PDVR group had a lower R0 resection rate and higher rates of complications such as biliary fistula, reoperation rate, delayed gastric emptying, cardiopulmonary abnormalities, hemorrhage, in-hospital mortality, 30-day mortality. The blood loss, duration of operation, total hospital stay is higher in PDVR group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared to standard PD, PDVR was associated with a greater risk of some specific complications and increase the mortality rate, total hospital stay time, combine with vein resection have a lower R0 resection rate. Therefore, combine with vascular resection for pancreatic cancer needs to be carefully selected by the surgeon.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary-Pancreatic Surgery, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, 130033, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Lingjun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yanlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of general surgery, Xi'an No.4 Hospital, Xi'an, 710000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hanwen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary-Pancreatic Surgery, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, 130033, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary-Pancreatic Surgery, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, 130033, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chao</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7658-9136</Identifier><AffiliationInfo><Affiliation>Department of Hepatobiliary-Pancreatic Surgery, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, 130033, China. linchao@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Surg</MedlineTA><NlmUniqueID>100968567</NlmUniqueID><ISSNLinking>1471-2482</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021441" MajorTopicYN="N">Carcinoma, Pancreatic Ductal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008642" MajorTopicYN="N">Mesenteric Veins</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011169" MajorTopicYN="N">Portal Vein</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019043" MajorTopicYN="N">Vascular Neoplasms</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pancreatic cancer</Keyword><Keyword MajorTopicYN="N">Pancreaticoduodenectomy</Keyword><Keyword MajorTopicYN="N">Vein resection</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31286916</ArticleId><ArticleId IdType="pmc">PMC6615269</ArticleId><ArticleId IdType="doi">10.1186/s12893-019-0540-6</ArticleId><ArticleId IdType="pii">10.1186/s12893-019-0540-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuzillet C, Gaujoux S, Williet N, Bachet JB, Bauguion L, Colson Durand L, et al. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) Dig Liver Dis. 2018;50(12):1257&#x2013;1271. doi: 10.1016/j.dld.2018.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2018.08.008</ArticleId><ArticleId IdType="pubmed">30219670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducreux M, Cuhna AS, Caramella C, Hollebecque A, Burtin P, Goere D, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v56&#x2013;v68. doi: 10.1093/annonc/mdv295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdv295</ArticleId><ArticleId IdType="pubmed">26314780</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleive D, Sahakyan MA, Berstad AE, Verbeke CS, Gladhaug IP, Edwin B, et al. Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy. Br J Surg. 2017;104(11):1558&#x2013;1567. doi: 10.1002/bjs.10603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10603</ArticleId><ArticleId IdType="pubmed">28815556</ArticleId></ArticleIdList></Reference><Reference><Citation>Podda M, Thompson J, Kulli CTG, Tait IS. Vascular resection in pancreaticoduodenectomy for periampullary cancers. A 10 year retrospective cohort study. Int J Surg. 2017;39:37&#x2013;44. doi: 10.1016/j.ijsu.2017.01.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2017.01.042</ArticleId><ArticleId IdType="pubmed">28110027</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsoner K, Langeder R, Csengeri D, Sodeck G, Mischinger HJ, Kornprat P. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk? Wien Klin Wochenschr. 2016;128(15&#x2013;16):566&#x2013;572. doi: 10.1007/s00508-016-1024-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-016-1024-7</ArticleId><ArticleId IdType="pmc">PMC5010594</ArticleId><ArticleId IdType="pubmed">27363995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Wakamatsu S, et al. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer. Eur J Surg Oncol. 2017;43(6):1068&#x2013;1075. doi: 10.1016/j.ejso.2017.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2017.03.020</ArticleId><ArticleId IdType="pubmed">28427822</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon D, McFarland K, Velanovich V, Martin RC., 2nd Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation. Surgery. 2014;156(4):910&#x2013;920. doi: 10.1016/j.surg.2014.06.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2014.06.058</ArticleId><ArticleId IdType="pubmed">25239345</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin RC, 2nd, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg. 2015;262(3):486&#x2013;494. doi: 10.1097/SLA.0000000000001441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001441</ArticleId><ArticleId IdType="pubmed">26258317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciato G, Mercantini P, Petrucciani N, Giaccaglia V, Nigri G, Ravaioli M, et al. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol. 2009;16(4):817&#x2013;825. doi: 10.1245/s10434-008-0281-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-008-0281-8</ArticleId><ArticleId IdType="pubmed">19156463</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, et al. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg. 2012;255(1):103&#x2013;108. doi: 10.1097/SLA.0b013e318237872e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318237872e</ArticleId><ArticleId IdType="pubmed">22156923</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004;8(8):935&#x2013;949. doi: 10.1016/j.gassur.2004.09.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gassur.2004.09.046</ArticleId><ArticleId IdType="pubmed">15585381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg. 2003;186(2):149&#x2013;153. doi: 10.1016/S0002-9610(03)00173-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(03)00173-9</ArticleId><ArticleId IdType="pubmed">12885608</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata C, Kobari M, Tsuchiya T, Arai K, Anzai R, Takahashi M, et al. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg. 2001;25(8):1002&#x2013;1005. doi: 10.1007/s00268-001-0070-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-001-0070-z</ArticleId><ArticleId IdType="pubmed">11571964</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605. doi: 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med. 2010;29(12):1282&#x2013;1297. doi: 10.1002/sim.3602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3602</ArticleId><ArticleId IdType="pubmed">19408255</ArticleId></ArticleIdList></Reference><Reference><Citation>Addeo P, Velten M, Averous G, Faitot F, Nguimpi-Tambou M, Nappo G, et al. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: depth of invasion matters. Surgery. 2017;162(2):264&#x2013;274. doi: 10.1016/j.surg.2017.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2017.03.008</ArticleId><ArticleId IdType="pubmed">28576385</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktekin A, Kucuk M, Odabasi M, Muftuoglu T, Gurleyik G, Ozkara S, et al. The importance of invasion and resection of superior mesenteric and portal veins in adenocarcinoma of the pancreas. Hepatogastroenterology. 2013;60(125):1194&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">23803382</ArticleId></ArticleIdList></Reference><Reference><Citation>Banz VM, Croagh D, Coldham C, Taniere P, Buckels J, Isaac J, et al. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas. Eur J Surg Oncol. 2012;38(1):72&#x2013;79. doi: 10.1016/j.ejso.2011.08.134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2011.08.134</ArticleId><ArticleId IdType="pubmed">22054617</ArticleId></ArticleIdList></Reference><Reference><Citation>Beane JD, House MG, Pitt SC, Zarzaur B, Kilbane EM, Hall BL, et al. Pancreatoduodenectomy with venous or arterial resection: a NSQIP propensity score analysis. HPB (Oxford) 2017;19(3):254&#x2013;263. doi: 10.1016/j.hpb.2016.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2016.11.013</ArticleId><ArticleId IdType="pubmed">28038967</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrere N, Sauvanet A, Goere D, Kianmanesh R, Vullierme MP, Couvelard A, et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg. 2006;30(8):1526&#x2013;1535. doi: 10.1007/s00268-005-0784-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-005-0784-4</ArticleId><ArticleId IdType="pubmed">16855797</ArticleId></ArticleIdList></Reference><Reference><Citation>Castleberry AW, White RR, De La Fuente SG, Clary BM, Blazer DG, 3rd, McCann RL, et al. The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol. 2012;19(13):4068&#x2013;4077. doi: 10.1245/s10434-012-2585-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-012-2585-y</ArticleId><ArticleId IdType="pubmed">22932857</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty KD, Hsu JT, Liu KH, Yeh CN, Yeh TS, Hwang TL, et al. Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma. World J Gastroenterol. 2010;16(8):997&#x2013;1002. doi: 10.3748/wjg.v16.i8.997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v16.i8.997</ArticleId><ArticleId IdType="pmc">PMC2828606</ArticleId><ArticleId IdType="pubmed">20180240</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung TT, Poon RT, Chok KS, Chan AC, Tsang SH, Dai WC, et al. Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability. World J Gastroenterol. 2014;20(46):17448&#x2013;17455. doi: 10.3748/wjg.v20.i46.17448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i46.17448</ArticleId><ArticleId IdType="pmc">PMC4265604</ArticleId><ArticleId IdType="pubmed">25516657</ArticleId></ArticleIdList></Reference><Reference><Citation>Elberm H, Ravikumar R, Sabin C, Abu Hilal M, Al-Hilli A, Aroori S, et al. Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: a multivariable analysis from the UK vascular resection for pancreatic cancer study group. Eur J Surg Oncol. 2015;41(11):1500&#x2013;1507. doi: 10.1016/j.ejso.2015.08.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2015.08.158</ArticleId><ArticleId IdType="pubmed">26346183</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Zhang L, He T, Ding J, Zhang H, Chen G, et al. Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis. PLoS One. 2013;8(8):e70340. doi: 10.1371/journal.pone.0070340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070340</ArticleId><ArticleId IdType="pmc">PMC3732270</ArticleId><ArticleId IdType="pubmed">23936411</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg. 1996;224(3):342&#x2013;347. doi: 10.1097/00000658-199609000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199609000-00010</ArticleId><ArticleId IdType="pmc">PMC1235378</ArticleId><ArticleId IdType="pubmed">8813262</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard TJ, Villanustre N, Moore SA, DeWitt J, LeBlanc J, Maglinte D, et al. Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head. J Gastrointest Surg. 2003;7(8):1089&#x2013;1095. doi: 10.1016/j.gassur.2003.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gassur.2003.07.010</ArticleId><ArticleId IdType="pubmed">14675720</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J, Choi DW, Choi SH, Heo JS, Jang KT. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma. ANZ J Surg. 2015;85(4):264&#x2013;269. doi: 10.1111/ans.12502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.12502</ArticleId><ArticleId IdType="pubmed">24641800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneoka Y, Yamaguchi A, Isogai M. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery. 2009;145(4):417&#x2013;425. doi: 10.1016/j.surg.2008.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2008.12.009</ArticleId><ArticleId IdType="pubmed">19303991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly KJ, Winslow E, Kooby D, Lad NL, Parikh AA, Scoggins CR, et al. Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of &#x201c;borderline resectable disease&#x201d;? J Gastrointest Surg. 2013;17(7):1209&#x2013;1217. doi: 10.1007/s11605-013-2178-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-013-2178-5</ArticleId><ArticleId IdType="pubmed">23620151</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosaki I, Hatakeyama K, Minagawa M, Sato D. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor. J Gastrointest Surg. 2008;12(5):907&#x2013;918. doi: 10.1007/s11605-007-0387-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-007-0387-5</ArticleId><ArticleId IdType="pubmed">17968629</ArticleId></ArticleIdList></Reference><Reference><Citation>Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg. 1998;85(5):611&#x2013;617. doi: 10.1046/j.1365-2168.1998.00641.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2168.1998.00641.x</ArticleId><ArticleId IdType="pubmed">9635805</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin RC, 2nd, Scoggins CR, Egnatashvili V, Staley CA, McMasters KM, Kooby DA. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg. 2009;144(2):154&#x2013;159. doi: 10.1001/archsurg.2008.547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2008.547</ArticleId><ArticleId IdType="pubmed">19221327</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon VG, Puri VC, Annamalai AA, Tuli R, Nissen NN. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience. Am Surg. 2013;79(10):1064&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">24160800</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, et al. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma. J Surg Oncol. 2013;107(4):414&#x2013;421. doi: 10.1002/jso.23229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.23229</ArticleId><ArticleId IdType="pubmed">22886567</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Pancreaticoduodenectomy with en bloc portal vein resection for pancreatic carcinoma with suspected portal vein involvement. World J Surg. 2004;28(6):602&#x2013;608. doi: 10.1007/s00268-004-7250-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-004-7250-6</ArticleId><ArticleId IdType="pubmed">15366753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar R, Sabin C, Abu Hilal M, Bramhall S, White S, Wigmore S, et al. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study. J Am Coll Surg. 2014;218(3):401&#x2013;411. doi: 10.1016/j.jamcollsurg.2013.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2013.11.017</ArticleId><ArticleId IdType="pubmed">24484730</ArticleId></ArticleIdList></Reference><Reference><Citation>Roch AM, House MG, Cioffi J, Ceppa EP, Zyromski NJ, Nakeeb A, et al. Significance of portal vein invasion and extent of invasion in patients undergoing Pancreatoduodenectomy for pancreatic adenocarcinoma. J Gastrointest Surg. 2016;20(3):479&#x2013;487. doi: 10.1007/s11605-015-3005-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-015-3005-y</ArticleId><ArticleId IdType="pubmed">26768008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgroi MD, Narayan RR, Lane JS, Demirjian A, Kabutey NK, Fujitani RM, et al. Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma. J Vasc Surg. 2015;61(2):475&#x2013;480. doi: 10.1016/j.jvs.2014.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2014.09.003</ArticleId><ArticleId IdType="pubmed">25441672</ArticleId></ArticleIdList></Reference><Reference><Citation>Toomey P, Hernandez J, Morton C, Duce L, Farrior T, Villadolid D, et al. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg. 2009;75(9):804&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">19774952</ArticleId></ArticleIdList></Reference><Reference><Citation>Turley RS, Peterson K, Barbas AS, Ceppa EP, Paulson EK, Blazer DG, 3rd, et al. Vascular surgery collaboration during pancreaticoduodenectomy with vascular reconstruction. Ann Vasc Surg. 2012;26(5):685&#x2013;692. doi: 10.1016/j.avsg.2011.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2011.11.009</ArticleId><ArticleId IdType="pubmed">22305864</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Gill AJ, Neale M, Puttaswamy V, Gananadha S, Pavlakis N, et al. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2014;21(6):1937&#x2013;1947. doi: 10.1245/s10434-014-3554-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-014-3554-4</ArticleId><ArticleId IdType="pubmed">24558067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WL, Ye S, Yan S, Shen Y, Zhang M, J W, et al. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Hepatobiliary Pancreat Dis Int. 2015;14(4):429&#x2013;435. doi: 10.1016/S1499-3872(15)60400-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1499-3872(15)60400-3</ArticleId><ArticleId IdType="pubmed">26256089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Li LX, Fan H, Kou JT, Li XL, Lang R, et al. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy. J Int Med Res. 2016;44(6):1339&#x2013;1348. doi: 10.1177/0300060516665708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060516665708</ArticleId><ArticleId IdType="pmc">PMC5536759</ArticleId><ArticleId IdType="pubmed">28322103</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8&#x2013;13. doi: 10.1016/j.surg.2005.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2005.05.001</ArticleId><ArticleId IdType="pubmed">16003309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell R, Ao BT, Ironside N, Bartlett A, Windsor JA, Pandanaboyana S. Meta-analysis and cost effective analysis of portal-superior mesenteric vein resection during pancreatoduodenectomy: impact on margin status and survival. Surg Oncol. 2017;26(1):53&#x2013;62. doi: 10.1016/j.suronc.2016.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suronc.2016.12.007</ArticleId><ArticleId IdType="pubmed">28317585</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovinazzo F, Turri G, Katz MH, Heaton N, Ahmed I. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br J Surg. 2016;103(3):179&#x2013;191. doi: 10.1002/bjs.9969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9969</ArticleId><ArticleId IdType="pubmed">26663252</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Yang Q, Chen L, Sun Q, Zhou D, Ye S, et al. Pancreatoduodenectomy combined with portal-superior mesenteric vein resection and reconstruction with interposition grafts for cancer: a meta-analysis. Oncotarget. 2017;8(46):81520&#x2013;81528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655306</ArticleId><ArticleId IdType="pubmed">29113411</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu XZ, Li J, Fu DL, Di Y, Yang F, Hao SJ, et al. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis. Eur J Surg Oncol. 2014;40(4):371&#x2013;378. doi: 10.1016/j.ejso.2014.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2014.01.010</ArticleId><ArticleId IdType="pubmed">24560302</ArticleId></ArticleIdList></Reference><Reference><Citation>Roder JD, Stein HJ, Siewert JR. Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg. 1996;171(1):170&#x2013;174. doi: 10.1016/S0002-9610(99)80094-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(99)80094-4</ArticleId><ArticleId IdType="pubmed">8554135</ArticleId></ArticleIdList></Reference><Reference><Citation>van Geenen RC, ten Kate FJ, de Wit LT, van Gulik TM, Obertop H, Gouma DJ. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery. 2001;129(2):158&#x2013;163. doi: 10.1067/msy.2001.110221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/msy.2001.110221</ArticleId><ArticleId IdType="pubmed">11174708</ArticleId></ArticleIdList></Reference><Reference><Citation>Friess H, Kleeff J, Fischer L, Muller M, Buchler MW. Surgical standard therapy for cancer of the pancreas. Chirurg. 2003;74(3):183&#x2013;190. doi: 10.1007/s00104-003-0620-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00104-003-0620-z</ArticleId><ArticleId IdType="pubmed">12647074</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller SA, Hartel M, Mehrabi A, Welsch T, Martin DJ, Hinz U, et al. Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg. 2009;13(4):784&#x2013;792. doi: 10.1007/s11605-008-0791-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-008-0791-5</ArticleId><ArticleId IdType="pubmed">19137380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(8):1028&#x2013;1061. doi: 10.6004/jnccn.2017.0131.</Citation><ArticleIdList><ArticleId IdType="doi">10.6004/jnccn.2017.0131</ArticleId><ArticleId IdType="pubmed">28784865</ArticleId></ArticleIdList></Reference><Reference><Citation>Esnaola NF, Chaudhary UB, O'Brien P, Garrett-Mayer E, Camp ER, Thomas MB, et al. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014;88(4):837&#x2013;844. doi: 10.1016/j.ijrobp.2013.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijrobp.2013.12.030</ArticleId><ArticleId IdType="pmc">PMC4120643</ArticleId><ArticleId IdType="pubmed">24606850</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz MH, Crane CH, Varadhachary G. Management of borderline resectable pancreatic cancer. Semin Radiat Oncol. 2014;24(2):105&#x2013;112. doi: 10.1016/j.semradonc.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semradonc.2013.11.006</ArticleId><ArticleId IdType="pubmed">24635867</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz MH, Shi Q, Ahmad SA, Herman JM, Marsh Rde W, Collisson E, et al. Preoperative modified FOLFIRINOX treatment followed by Capecitabine-based Chemoradiation for borderline Resectable pancreatic cancer: Alliance for clinical trials in oncology trial A021101. JAMA Surg. 2016;151(8):e161137. doi: 10.1001/jamasurg.2016.1137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.1137</ArticleId><ArticleId IdType="pmc">PMC5210022</ArticleId><ArticleId IdType="pubmed">27275632</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31957798</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1442-2050</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</Title><ISOAbbreviation>Dis Esophagus</ISOAbbreviation></Journal><ArticleTitle>Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">doz089</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/dote/doz089</ELocationID><Abstract><AbstractText>Anastomotic leaks (AL) are a major complication after esophagectomy. This meta-analysis aimed to determine identify risks factors for AL (preoperative, intra-operative, and post-operative factors) and assess the consequences to outcome on patients who developed an AL. This systematic review was performed according to PRISMA guidelines, and eligible studies were identified through a search of PubMed, Scopus, and Cochrane CENTRAL databases up to 31 December 2018. A meta-analysis was conducted with the use of random-effects modeling and prospectively registered with the PROSPERO database (Registration CRD42018130732). This review identified 174 studies reporting outcomes of 74,226 patients undergoing esophagectomy. The overall pooled AL rates were 11%, ranging from 0 to 49% in individual studies. Majority of studies were from Asia (n&#xa0;=&#x2009;79). In pooled analyses, 23 factors were associated with AL (17 preoperative and six intraoperative). AL were associated with adverse outcomes including pulmonary (OR: 4.54, CI95%: 2.99-6.89, P&#xa0;&lt;&#x2009;0.001) and cardiac complications (OR: 2.44, CI95%: 1.77-3.37, P&#xa0;&lt;&#x2009;0.001), prolonged hospital stay (mean difference: 15&#xa0;days, CI95%: 10-21&#xa0;days, P&#xa0;&lt;&#x2009;0.001), and in-hospital mortality (OR: 5.91, CI95%: 1.41-24.79, P&#xa0;=&#x2009;0.015). AL are a major complication following esophagectomy accounting for major morbidity and mortality. This meta-analysis identified modifiable risk factors for AL, which can be a target for interventions to reduce AL rates. Furthermore, identification of both modifiable and non-modifiable risk factors will facilitate risk stratification and prediction of AL enabling better perioperative planning, patient counseling, and informed consent.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamarajah</LastName><ForeName>Sivesh K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary, Pancreatic and Transplant Surgery, Freeman Hospital, Newcastle University NHS Foundation Trust Hospitals, Newcastle Upon Tyne, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cellular Medicine, University of Newcastle, Newcastle Upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tharmaraja</LastName><ForeName>Thahesh</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bharwada</LastName><ForeName>Yashvi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bundred</LastName><ForeName>James R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nepogodiev</LastName><ForeName>Dmitri</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Academic Surgery and College of Medical and Dental Sciences, Institute of Translational Medicine, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Richard P T</ForeName><Initials>RPT</Initials><AffiliationInfo><Affiliation>Department of Upper Gastrointestinal Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Pritam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Trent Oesophago-Gastric Unit, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Ewen A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Upper Gastrointestinal Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Esophagus</MedlineTA><NlmUniqueID>8809160</NlmUniqueID><ISSNLinking>1120-8694</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="Y">Anastomotic Leak</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020379" MajorTopicYN="N">Risk Adjustment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">esophageal cancer</Keyword><Keyword MajorTopicYN="N">esophagectomy</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31957798</ArticleId><ArticleId IdType="doi">10.1093/dote/doz089</ArticleId><ArticleId IdType="pii">5709700</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33134945</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2639-8028</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Critical care explorations</Title><ISOAbbreviation>Crit Care Explor</ISOAbbreviation></Journal><ArticleTitle>Timing of Intubation and In-Hospital Mortality in Patients With Coronavirus Disease 2019.</ArticleTitle><Pagination><StartPage>e0254</StartPage><MedlinePgn>e0254</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0254</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCE.0000000000000254</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To examine whether increasing time between admission and intubation was associated with mortality in patients with coronavirus disease 2019 who underwent mechanical ventilation.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study of patients with severe acute respiratory syndrome coronavirus 2 infection who were admitted between January 30, 2020, and April 30, 2020, and underwent intubation and mechanical ventilation prior to May 1, 2020. Patients were followed up through August 15, 2020.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Five hospitals within the Mount Sinai Health System in New York City, NY.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Adult patients with severe acute respiratory syndrome coronavirus 2 infection who underwent intubation and mechanical ventilation.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Tracheal intubation and mechanical ventilation.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The primary outcome was in-hospital mortality. A hospital-stratified time-varying Cox model was used to evaluate the effect of time from admission to intubation on in-hospital death. A total of 755 adult patients out of 5,843 admitted with confirmed severe acute respiratory syndrome coronavirus 2 infection underwent tracheal intubation and mechanical ventilation during the study period. The median age of patients was 65 years (interquartile range, 56-72 yr) and 64% were male. As of the time of follow-up, 121 patients (16%) who were intubated and mechanically ventilated had been discharged home, 512 (68%) had died, 113 (15%) had been discharged to a skilled nursing facility, and 9 (1%) remained in the hospital. The median time from admission to intubation was 2.3 days (interquartile range, 0.6-6.3 d). Each additional day between hospital admission and intubation was significantly associated with higher in-hospital death (adjusted hazard ratio, 1.03; 95% CI, 1.01-1.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients with coronavirus disease 2019 who were intubated and mechanically ventilated, intubation earlier in the course of hospital admission may be associated with improved survival.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hyman</LastName><ForeName>Jaime B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leibner</LastName><ForeName>Evan S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Institute for Critical Care Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Pranai</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory Institute, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egorova</LastName><ForeName>Natalia N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassily-Marcus</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Critical Care Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohli-Seth</LastName><ForeName>Roopa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Critical Care Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arvind</LastName><ForeName>Varun</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Helena L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hung-Mo</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Respiratory Institute, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Healthcare Delivery Science, Icahn Institute for Data Science and Genomic Technology, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Explor</MedlineTA><NlmUniqueID>101746347</NlmUniqueID><ISSNLinking>2639-8028</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus disease 2019 infection</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019 pandemic</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">intubation</Keyword><Keyword MajorTopicYN="N">mechanical ventilation</Keyword><Keyword MajorTopicYN="N">respiratory failure</Keyword></KeywordList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33134945</ArticleId><ArticleId IdType="pmc">PMC7587418</ArticleId><ArticleId IdType="doi">10.1097/CCE.0000000000000254</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8:475&#x2013;481</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Del Sorbo L, Goligher EC, et al. An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017; 195:1253&#x2013;1263</Citation><ArticleIdList><ArticleId IdType="pubmed">28459336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395:1054&#x2013;1062</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: A systematic review and meta-analysis of observational studies. Anaesthesia. 2020; 75:1340&#x2013;1349</Citation><ArticleIdList><ArticleId IdType="pubmed">32602561</ArticleId></ArticleIdList></Reference><Reference><Citation>Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA. 2020; 323:1839&#x2013;1841</Citation><ArticleIdList><ArticleId IdType="pubmed">32215647</ArticleId></ArticleIdList></Reference><Reference><Citation>Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010; 29:1037&#x2013;1057</Citation><ArticleIdList><ArticleId IdType="pubmed">20087875</ArticleId></ArticleIdList></Reference><Reference><Citation>Kangelaris KN, Ware LB, Wang CY, et al. Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome. Crit Care Med. 2016; 44:120&#x2013;129</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4774861</ArticleId><ArticleId IdType="pubmed">26474112</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: A systematic review and meta-analysis. Intensive Care Med. 2019; 45:563&#x2013;572</Citation><ArticleIdList><ArticleId IdType="pubmed">30888444</ArticleId></ArticleIdList></Reference><Reference><Citation>Auld SC, Caridi-Scheible M, Blum JM, et al. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med. 2020; 48:e799&#x2013;e804</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255393</ArticleId><ArticleId IdType="pubmed">32452888</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323:1574&#x2013;1581</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. ; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323:2052&#x2013;2059</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel JH, Tomashek KM, Dodd LE, et al. ; ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020. October 8 [online ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et al. ; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19 - preliminary report. New Engl J Med. 2020. July 17 [online ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, mortality, bleeding and pathology among patients hospitalized with COVID-19: A single health system study. J Am Coll Cardiol. 2020; 76:1815&#x2013;1826</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449655</ArticleId><ArticleId IdType="pubmed">32860872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39064116</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>14</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The Outcomes of Surgical Pulmonary Embolectomy for Pulmonary Embolism: A Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4076</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13144076</ELocationID><Abstract><AbstractText><b>Objectives:</b> The purpose of this study is to assess the efficacy, short- and long-term cardiovascular and non-cardiovascular mortalities and postoperative morbidities of surgical pulmonary embolectomy (SPE) for patients with massive or submassive pulmonary embolism. Methods: A comprehensive literature review was performed to identify articles reporting SPE for pulmonary embolism. The outcomes included in-hospital and long-term mortality in addition to postoperative morbidities. The random effect inverse variance method was used. Cumulative meta-analysis, leave-one-out sensitivity analysis, subgroup analysis and meta-regression were performed. <b>Results:</b> Among the 1949 searched studies in our systematic literature search, 78 studies met our inclusion criteria, including 6859 cases. The mean age ranged from 42 to 65 years. The percentage of males ranged from 25.6% to 86.7%. The median rate of preoperative cardiac arrest was 27.6%. The percentage of contraindications to preoperative systemic thrombolysis was 30.4%. The preoperative systemic thrombolysis use was 11.5%. The in-hospital mortality was estimated to be 21.96% (95% CI: 19.21-24.98); in-hospital mortality from direct cardiovascular causes was estimated to be 16.05% (95% CI: 12.95-19.73). With a weighted median follow-up of 3.05 years, the late cardiovascular and non-cardiovascular mortality incidence rates were 0.39 and 0.90 per person-year, respectively. The incidence of pulmonary bleeding, gastrointestinal bleeding, surgical site bleeding, non-surgical site bleeding and wound complications was 0.62%, 4.70%, 4.84%, 5.80% and 7.2%, respectively. Cumulative meta-analysis showed a decline in hospital mortality for SPE from 42.86% in 1965 to 20.56% in 2024. Meta-regression revealed that the publication year and male sex were associated with lower in-hospital mortality, while preoperative cardiac arrest, the need for inotropes or vasopressors and preoperative mechanical ventilation were associated with higher in-hospital mortality. <b>Conclusions</b>: This study demonstrates acceptable perioperative mortality rates and late cardiovascular and non-cardiovascular mortality in patients who undergo SPE for massive or submassive pulmonary embolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahouma</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8678-2060</Identifier><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Weill Cornell Medicine, New York, NY 10065, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Thani</LastName><ForeName>Shaikha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Weill Cornell Medicine, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Haitham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ain Shams University Hospital, Ain Shams University, Cairo 11517, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmoud</LastName><ForeName>Alzahraa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Beni Suef University, Beni Suef 2721562, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairallah</LastName><ForeName>Sherif</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Weill Cornell Medicine, New York, NY 10065, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenouda</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>New York Institute of Technology, New York, NY 10023, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sultan</LastName><ForeName>Batool</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Rak Medical and Health Sciences University, Ras al Khaimah 11172, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Laila</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2772-9814</Identifier><AffiliationInfo><Affiliation>Weill Cornell Medicine, Doha 24144, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alomari</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3330-7239</Identifier><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makey</LastName><ForeName>Ian A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haney</LastName><ForeName>John C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0009-0001-4002-0909</Identifier><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mick</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Weill Cornell Medicine, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Sayed Ahmed</LastName><ForeName>Magdy M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgery Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hospital mortality</Keyword><Keyword MajorTopicYN="N">pulmonary bleeding</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">surgical pulmonary embolectomy</Keyword><Keyword MajorTopicYN="N">thrombolysis</Keyword></KeywordList><CoiStatement>All authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39064116</ArticleId><ArticleId IdType="pmc">PMC11278425</ArticleId><ArticleId IdType="doi">10.3390/jcm13144076</ArticleId><ArticleId IdType="pii">jcm13144076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goldhaber S.Z. Surgical Pulmonary Embolectomy: The Resurrection of an Almost Discarded Operation. Tex. Heart Inst. J. 2013;40:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3568292</ArticleId><ArticleId IdType="pubmed">23468580</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.-J., Harjola V.-P., Huisman M.V., Humbert M., Jennings C.S., Jim&#xe9;nez D., et al. 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respiratory Society (ERS) Eur. Heart J. 2020;41:543&#x2013;603. doi: 10.1093/eurheartj/ehz405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz405</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffett L., Castellucci L.A., Forgie M.A. Pulmonary Embolism: Update on Management and Controversies. BMJ. 2020;370:m2177. doi: 10.1136/bmj.m2177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2177</ArticleId><ArticleId IdType="pubmed">32759284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra R., Bajaj N.S., Arora P., Arora G., Crosland W.A., McGiffin D.C., Ahmed M.I. Surgical Embolectomy for Acute Pulmonary Embolism: Systematic Review and Comprehensive Meta-Analyses. Ann. Thorac. Surg. 2017;103:982&#x2013;990. doi: 10.1016/j.athoracsur.2016.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.11.016</ArticleId><ArticleId IdType="pubmed">28159170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Shea B., O&#x2019;Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses.  [(accessed on 5 July 2024)].  Available online:  https://web.archive.org/web/20210716121605id_/http://www3.med.unipmn.it/dispense_ebm/2009-2010/Corso%20Perfezionamento%20EBM_Faggiano/NOS_oxford.pdf.</Citation></Reference><Reference><Citation>Hartman A.R., Manetta F., Lessen R., Pekmezaris R., Kozikowski A., Jahn L., Akerman M., Lesser M.L., Glassman L.R., Graver M., et al. Acute Surgical Pulmonary Embolectomy: A 9-Year Retrospective Analysis. Tex. Heart Inst. J. 2015;42:25&#x2013;29. doi: 10.14503/THIJ-13-3877.</Citation><ArticleIdList><ArticleId IdType="doi">10.14503/THIJ-13-3877</ArticleId><ArticleId IdType="pmc">PMC4378038</ArticleId><ArticleId IdType="pubmed">25873794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed P., Khan A.A., Smith A., Pagala M., Abrol S., Cunningham J.N., Vaynblat M. Expedient Pulmonary Embolectomy for Acute Pulmonary Embolism: Improved Outcomes. Interact. Cardiovasc. Thorac. Surg. 2008;7:591&#x2013;594. doi: 10.1510/icvts.2008.176735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2008.176735</ArticleId><ArticleId IdType="pubmed">18469011</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani F., Munir M.B., Aljohani S., Tarabishy A., Almustafa A., Alkhouli M. Surgical Thrombectomy for Pulmonary Embolism: Updated Performance Rates and Outcomes. Tex. Heart Inst. J. 2019;46:172&#x2013;174. doi: 10.14503/THIJ-18-6751.</Citation><ArticleIdList><ArticleId IdType="doi">10.14503/THIJ-18-6751</ArticleId><ArticleId IdType="pmc">PMC6827469</ArticleId><ArticleId IdType="pubmed">31708697</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirghofran A.A., Emami Nia A., Javan R. Surgical Embolectomy in Acute Massive Pulmonary Embolism. Asian Cardiovasc. Thorac. Ann. 2007;15:149&#x2013;153. doi: 10.1177/021849230701500214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/021849230701500214</ArticleId><ArticleId IdType="pubmed">17387199</ArticleId></ArticleIdList></Reference><Reference><Citation>Argyriou A., Vohra H., Chan J., Ahmed E.M., Rajakaruna C., Angelini G.D., Fudulu D.P. Incidence and Outcomes of Surgical Pulmonary Embolectomy in the UK. Br. J. Surg. 2024;111:znae003. doi: 10.1093/bjs/znae003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znae003</ArticleId><ArticleId IdType="pmc">PMC11167207</ArticleId><ArticleId IdType="pubmed">38230762</ArticleId></ArticleIdList></Reference><Reference><Citation>Azari A., Bigdelu L., Moravvej Z. Surgical Embolectomy in the Management of Massive and Sub-Massive Pulmonary Embolism: The Results of 30 Consecutive Ill Patients. ARYA Atheroscler. 2015;11:208&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568195</ArticleId><ArticleId IdType="pubmed">26405455</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett N.A., Byrne A., Delaney A., Hibbert M., Ramakrishnan N. Management of Massive Pulmonary Embolism: A Retrospective Single-Centre Cohort Study. Crit. Care Resusc. 2010;12:242&#x2013;247. doi: 10.1016/S1441-2772(23)01343-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1441-2772(23)01343-1</ArticleId><ArticleId IdType="pubmed">21143084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer E., Laske A., Segesser L., Carrel T., Turina M. Early and Late Results after Surgery for Massive Pulmonary Embolism. Thorac. Cardiovasc. Surg. 1991;39:353&#x2013;356. doi: 10.1055/s-2007-1019998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1019998</ArticleId><ArticleId IdType="pubmed">1788840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett J.M., Pretorius M., Ahmad R.M., Eagle S.S. Hemodynamic Instability in Patients Undergoing Pulmonary Embolectomy: Institutional Experience. J. Clin. Anesth. 2015;27:207&#x2013;213. doi: 10.1016/j.jclinane.2014.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2014.10.007</ArticleId><ArticleId IdType="pubmed">25544262</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger R.L. Pulmonary Embolectomy with Preoperative Circulatory Support. Ann. Thorac. Surg. 1973;16:217&#x2013;227. doi: 10.1016/S0003-4975(10)64989-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(10)64989-2</ArticleId><ArticleId IdType="pubmed">4728607</ArticleId></ArticleIdList></Reference><Reference><Citation>Biglioli P., Alamanni F., Spirito R., Arena V. From deep venous thrombosis to pulmonary embolism. Cardiologia. 1991;36:195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">1841770</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf8;ttzauw J., Vejlsted H., Albrechtsen O. Pulmonary Embolectomy Using Extracorporeal Circulation. Thorac. Cardiovasc. Surg. 1981;29:320&#x2013;322. doi: 10.1055/s-2007-1023507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1023507</ArticleId><ArticleId IdType="pubmed">6179211</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulafendis D., Bastounis E., Panayiotopoulos Y.P., Papalambros E.L. Pulmonary Embolectomy (Answered and Unanswered Questions) Int. Angiol. J. Int. Union Angiol. 1991;10:187&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">1765724</ArticleId></ArticleIdList></Reference><Reference><Citation>Caleb M.G. Massive Pulmonary Embolism with Haemodynamic Collapse. Singap. Med. J. 2002;43:25&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">12008772</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke D.B., Abrams L.D. Pulmonary Embolectomy: A 25 Year Experience. J. Thorac. Cardiovasc. Surg. 1986;92:442&#x2013;445. doi: 10.1016/S0022-5223(19)35798-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)35798-8</ArticleId><ArticleId IdType="pubmed">3747572</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauphine C., Omari B. Pulmonary Embolectomy for Acute Massive Pulmonary Embolism. Ann. Thorac. Surg. 2005;79:1240&#x2013;1244. doi: 10.1016/j.athoracsur.2004.08.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2004.08.081</ArticleId><ArticleId IdType="pubmed">15797055</ArticleId></ArticleIdList></Reference><Reference><Citation>De Weese J.A. The Role of Pulmonary Embolectomy in Venous Thromboembolism. J. Cardiovasc. Surg. 1976;17:348&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">939777</ArticleId></ArticleIdList></Reference><Reference><Citation>DiChiacchio L., Pasrija C., Boulos F.M., Ramani G., Jeudy J., Deatrick K.B., Griffith B.P., Kon Z.N. Occult Chronic Thromboembolic Disease in Patients Presenting for Surgical Pulmonary Embolectomy. Ann. Thorac. Surg. 2019;108:1183&#x2013;1188. doi: 10.1016/j.athoracsur.2019.03.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2019.03.088</ArticleId><ArticleId IdType="pubmed">31055039</ArticleId></ArticleIdList></Reference><Reference><Citation>Digonnet A., Moya-Plana A., Aubert S., Flecher E., Bonnet N., Leprince P., Pavie A., Gandjbakhch I. Acute Pulmonary Embolism: A Current Surgical Approach. Interdiscip. CardioVascular Thorac. Surg. 2007;6:27&#x2013;29. doi: 10.1510/icvts.2006.141366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2006.141366</ArticleId><ArticleId IdType="pubmed">17669761</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerge H., Schoendube F., Vo&#xdf; M., Seipelt R., Messmer B. Surgical Therapy of Fulminant Pulmonary Embolism: Early and Late Results. Thorac. Cardiovasc. Surg. 1999;47:9&#x2013;13. doi: 10.1055/s-2007-1013100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1013100</ArticleId><ArticleId IdType="pubmed">10218613</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohle K., Dohle D.-S., El Beyrouti H., Buschmann K., Emrich A.L., Brendel L., Vahl C.-F. Short- and Long-Term Outcomes for the Surgical Treatment of Acute Pulmonary Embolism. Innov. Surg. Sci. 2018;3:271&#x2013;276. doi: 10.1515/iss-2018-0024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/iss-2018-0024</ArticleId><ArticleId IdType="pmc">PMC6604590</ArticleId><ArticleId IdType="pubmed">31579791</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman J.J., Okiwelu N., Anvardeen K., Joshi P., Murphy B., Sanders L.H., Newman M.A., Passage J. Surgical Pulmonary Embolectomy: Experience in a Series of 37 Consecutive Cases. Heart Lung Circ. 2016;25:1240&#x2013;1244. doi: 10.1016/j.hlc.2016.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2016.03.010</ArticleId><ArticleId IdType="pubmed">27423976</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrera A.S., Platt M.R., Mills L.J. Pulmonary Embolectomy for Massive Pulmonary Embolism. Tex. Med. 1981;77:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">7209806</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorov S.A., Pichugin V.V., Chiginev V.A., Brichkin Y.D., Kulkarni S.V., Tselousova L.M., Kalinina M.L., Taranov E.V., Domnin S.E. Domnin Possibilities and Perspectives of Retrograde Pulmonary Artery Perfusion as a Component of Surgical Treatment of Pulmonary Embolism. Opera Med. Physiol. 2022;9:95&#x2013;102. doi: 10.24412/2500-2295-2022-2-95-102.</Citation><ArticleIdList><ArticleId IdType="doi">10.24412/2500-2295-2022-2-95-102</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford D.M., Alford W.C., Burrus G.R., Stoney W.S., Thomas C.S. Pulmonary Embolectomy. Ann. Thorac. Surg. 1981;32:28&#x2013;32. doi: 10.1016/S0003-4975(10)61369-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(10)61369-0</ArticleId><ArticleId IdType="pubmed">7247558</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray H.H., Morgan J.M., Paneth M., Miller G.A. Pulmonary Embolectomy for Acute Massive Pulmonary Embolism: An Analysis of 71 Cases. Heart. 1988;60:196&#x2013;200. doi: 10.1136/hrt.60.3.196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.60.3.196</ArticleId><ArticleId IdType="pmc">PMC1216553</ArticleId><ArticleId IdType="pubmed">3179135</ArticleId></ArticleIdList></Reference><Reference><Citation>Greelish J.P., Leacche M., Solenkova N.S., Ahmad R.M., Byrne J.G. Improved Midterm Outcomes for Type A (Central) Pulmonary Emboli Treated Surgically. J. Thorac. Cardiovasc. Surg. 2011;142:1423&#x2013;1429. doi: 10.1016/j.jtcvs.2010.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2010.12.030</ArticleId><ArticleId IdType="pubmed">21481423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajizadeh R., Ghaffari S., Habibzadeh A., Safaei N., Mohammadi K., Ranjbar A., Ghodratizadeh S. Outcome of Surgical Embolectomy in Patients with Massive Pulmonary Embolism with and without Cardiopulmonary Resuscitation. Pol. J. Thorac. Cardiovasc. Surg. 2017;4:241&#x2013;244. doi: 10.5114/kitp.2017.72228.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/kitp.2017.72228</ArticleId><ArticleId IdType="pmc">PMC5767774</ArticleId><ArticleId IdType="pubmed">29354176</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig K., Franke D., Fenn K. Pulmonary embolectomy (report on 3 personal cases) VASA Z. Gefasskrankh. 1974;3:342&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">4422163</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakob H., Vahl C., Lange R., Micek M., Tanzeem A., Hagl S. Modified Surgical Concept for Fulminant Pulmonary Embolism. Eur. J. Cardio-Thorac. Surg. 1995;9:557&#x2013;561. doi: 10.1016/S1010-7940(05)80005-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(05)80005-3</ArticleId><ArticleId IdType="pubmed">8562100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaumin P., Moriau M., el Gariani A., Rubay J., Baele P., Dautrebande J., Goenen M., Servaye-Kestens Y., Ponlot R. Pulmonary embolectomy. Clinical experience. Acta Chir. Belg. 1986;86:123&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">3716721</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling W.B., Sundt T., Leacche M., Okita Y., Binongo J., Lasajanak Y., Aklog L., Lattouf O.M. Outcomes After Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus: A Multi-Institutional Study. Ann. Thorac. Surg. 2016;102:1498&#x2013;1502. doi: 10.1016/j.athoracsur.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.05.004</ArticleId><ArticleId IdType="pubmed">27373187</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling W.B., Leshnower B.G., Lasajanak Y., Binongo J., Guyton R.A., Halkos M.E., Thourani V.H., Lattouf O.M. Midterm Benefits of Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus on Right Ventricular Function. J. Thorac. Cardiovasc. Surg. 2016;152:872&#x2013;878. doi: 10.1016/j.jtcvs.2015.11.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.11.042</ArticleId><ArticleId IdType="pubmed">26992603</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury E., Rabinov M., Davis B.B., Stirling G.R. Pulmonary Embolectomy in the Management of Massive Pulmonary Embolism. Australas. J. Card. Thorac. Surg. 1992;1:25&#x2013;26. doi: 10.1016/1037-2091(92)90008-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1037-2091(92)90008-E</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieny R., Charpentier A., Kieny M.T. What Is the Place of Pulmonary Embolectomy Today? J. Cardiovasc. Surg. 1991;32:549&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">1939313</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinov I.E., Saxena P., Koniuszko M.D., Alvarez J., Newman M.A.J. Acute Massive Pulmonary Embolism with Cardiopulmonary Resuscitation: Management and Results. Tex. Heart Inst. J. 2007;34:41&#x2013;45; discussion 45&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1847913</ArticleId><ArticleId IdType="pubmed">17420792</ArticleId></ArticleIdList></Reference><Reference><Citation>Laas J., Schmid C., Albes J.M., Borst H.G. Surgical aspects of fulminant pulmonary embolism. Z. Kardiol. 1993;82((Suppl. S2)):25&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">8328205</ArticleId></ArticleIdList></Reference><Reference><Citation>Leacche M., Unic D., Goldhaber S.Z., Rawn J.D., Aranki S.F., Couper G.S., Mihaljevic T., Rizzo R.J., Cohn L.H., Aklog L., et al. Modern Surgical Treatment of Massive Pulmonary Embolism: Results in 47 Consecutive Patients after Rapid Diagnosis and Aggressive Surgical Approach. J. Thorac. Cardiovasc. Surg. 2005;129:1018&#x2013;1023. doi: 10.1016/j.jtcvs.2004.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2004.10.023</ArticleId><ArticleId IdType="pubmed">15867775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehnert P., M&#xf8;ller C.H., Carlsen J., Grande P., Steinbr&#xfc;chel D.A. Surgical Treatment of Acute Pulmonary Embolism&#x2014;A 12-Year Retrospective Analysis. Scand. Cardiovasc. J. 2012;46:172&#x2013;176. doi: 10.3109/14017431.2011.642811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14017431.2011.642811</ArticleId><ArticleId IdType="pubmed">22369435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund O., Nielsen T., Schifter S., Roenne K. Treatment of Pulmonary Embolism with Full-Dose Heparin, Streptokinase or Embolectomy&#x2014;Results and Indications. Thorac. Cardiovasc. Surg. 1986;34:240&#x2013;246. doi: 10.1055/s-2007-1020420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1020420</ArticleId><ArticleId IdType="pubmed">2429392</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekan R., Saunders P.C., Yu C.J., Brown K.A., Gass A.L., Spielvogel D., Lansman S.L. Peripheral Extracorporeal Membrane Oxygenation: Comprehensive Therapy for High-Risk Massive Pulmonary Embolism. Ann. Thorac. Surg. 2012;94:104&#x2013;108. doi: 10.1016/j.athoracsur.2012.03.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.03.052</ArticleId><ArticleId IdType="pubmed">22542068</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall L., Mundy J., Garrahy P., Christopher S., Wood A., Griffin R., Shah P. Surgical Pulmonary Embolectomy: Mid-term Outcomes. ANZ J. Surg. 2012;82:822&#x2013;826. doi: 10.1111/j.1445-2197.2012.06190.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-2197.2012.06190.x</ArticleId><ArticleId IdType="pubmed">22943165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattox K.L., Feldtman R.W., Beall A.C., DeBAKEY M.E. Pulmonary Embolectomy for Acute Massive Pulmonary Embolism. Ann. Surg. 1982;195:726&#x2013;731. doi: 10.1097/00000658-198206000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-198206000-00008</ArticleId><ArticleId IdType="pmc">PMC1352667</ArticleId><ArticleId IdType="pubmed">7082065</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer G., Tamisier D., Sors H., Stern M., Vouh&#xe9; P., Makowski S., Neveux J.-Y., Leca F., Even P. Pulmonary Embolectomy: A 20-Year Experience at One Center. Ann. Thorac. Surg. 1991;51:232&#x2013;236. doi: 10.1016/0003-4975(91)90792-O.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(91)90792-O</ArticleId><ArticleId IdType="pubmed">1989537</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyns B., Sergeant P., Flameng W., Daenen W. Surgery for Massive Pulmonary Embolism. Acta Cardiol. 1992;47:487&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">1441856</ArticleId></ArticleIdList></Reference><Reference><Citation>Minakawa M., Fukuda I., Miyata H., Motomura N., Takamoto S., Taniguchi S., Daitoku K., Kondo N., Japan Cardiovascular Surgery Database Organization Outcomes of Pulmonary Embolectomy for Acute Pulmonary Embolism. Circ. J. 2018;82:2184&#x2013;2190. doi: 10.1253/circj.CJ-18-0371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-18-0371</ArticleId><ArticleId IdType="pubmed">29952349</ArticleId></ArticleIdList></Reference><Reference><Citation>Mkalaluh S., Szczechowicz M., Karck M., Szabo G. Twenty-Year Results of Surgical Pulmonary Thromboembolectomy in Acute Pulmonary Embolism. Scand. Cardiovasc. J. 2019;53:98&#x2013;103. doi: 10.1080/14017431.2019.1600013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017431.2019.1600013</ArticleId><ArticleId IdType="pubmed">30919668</ArticleId></ArticleIdList></Reference><Reference><Citation>Neely R.C., Byrne J.G., Gosev I., Cohn L.H., Javed Q., Rawn J.D., Goldhaber S.Z., Piazza G., Aranki S.F., Shekar P.S., et al. Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients. Ann. Thorac. Surg. 2015;100:1245&#x2013;1252. doi: 10.1016/j.athoracsur.2015.03.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.03.111</ArticleId><ArticleId IdType="pubmed">26165484</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcomb G., Wilson B.L., White R.J., Goldman B., Lachant N.A., Lachant D.J. An Untapped Resource: Characteristics of Thrombus Recovered from Intermediate or High Risk Pulmonary Embolus Patients. Cardiovasc. Pathol. 2022;57:107392. doi: 10.1016/j.carpath.2021.107392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2021.107392</ArticleId><ArticleId IdType="pubmed">34718141</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne Z.J., Rossi P., Aucar J., Dharamsy S., Cook S., Wheatley B. Surgical Pulmonary Embolectomy in a Community Hospital. Am. J. Surg. 2014;207:337&#x2013;341. doi: 10.1016/j.amjsurg.2013.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2013.10.011</ArticleId><ArticleId IdType="pubmed">24418179</ArticleId></ArticleIdList></Reference><Reference><Citation>Panholzer B., Gravert H., Borzikowsky C., Huenges K., Schoettler J., Schoeneich F., Attmann T., Haneya A., Frank D., Cremer J., et al. Outcome after Surgical Embolectomy for Acute Pulmonary Embolism. J. Cardiovasc. Med. 2022;23:519&#x2013;523. doi: 10.2459/JCM.0000000000001349.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001349</ArticleId><ArticleId IdType="pubmed">35905002</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Lim S.-H., Hong Y.S., Park S., Lee C.J., Lee S.O. Acute Pulmonary Thromboembolism: 14 Years of Surgical Experience. Korean J. Thorac. Cardiovasc. Surg. 2019;52:78&#x2013;84. doi: 10.5090/kjtcs.2019.52.2.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2019.52.2.78</ArticleId><ArticleId IdType="pmc">PMC6493267</ArticleId><ArticleId IdType="pubmed">31089444</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasrija C., Shah A., Sultanik E., Rouse M., Ghoreishi M., Bittle G.J., Boulos F., Griffith B.P., Kon Z.N. Minimally Invasive Surgical Pulmonary Embolectomy: A Potential Alternative to Conventional Sternotomy. Innov. Technol. Tech. Cardiothorac. Vasc. Surg. 2017;12:406&#x2013;410. doi: 10.1097/imi.0000000000000439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/imi.0000000000000439</ArticleId><ArticleId IdType="pubmed">29219944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasrija C., Kronfli A., Rouse M., Raithel M., Bittle G.J., Pousatis S., Ghoreishi M., Gammie J.S., Griffith B.P., Sanchez P.G., et al. Outcomes after Surgical Pulmonary Embolectomy for Acute Submassive and Massive Pulmonary Embolism: A Single-Center Experience. J. Thorac. Cardiovasc. Surg. 2018;155:1095&#x2013;1106.e2. doi: 10.1016/j.jtcvs.2017.10.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.10.139</ArticleId><ArticleId IdType="pubmed">29452460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Chen L., Chen D., Qiu H., Huang Z., Dai X., Huang X., Lin F., Chen H. Clinical Outcomes of Acute Pulmonary Embolectomy as the First-Line Treatment for Massive and Submassive Pulmonary Embolism: A Single-Centre Study in China. J. Cardiothorac. Surg. 2020;15:321. doi: 10.1186/s13019-020-01364-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01364-z</ArticleId><ArticleId IdType="pmc">PMC7576708</ArticleId><ArticleId IdType="pubmed">33087152</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore K.S., Weightman W., Passage J., Joshi P., Sanders L., Newman M. Risk Stratification Using Serum Lactate in Patients Undergoing Surgical Pulmonary Embolectomy. J. Cardiothorac. Surg. 2020;35:1531&#x2013;1538. doi: 10.1111/jocs.14652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.14652</ArticleId><ArticleId IdType="pubmed">32598529</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas J., Bircks W., Nier H., Schneider E., Tarbiat S. Lungenembolie. DMW&#x2014;Dtsch. Med. Wochenschr. 1975;100:1239&#x2013;1243. doi: 10.1055/s-0028-1106363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1106363</ArticleId><ArticleId IdType="pubmed">1132337</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa Y., Choi S., Lee J., Kwon J., Moon S., Jo K., Wang Y., Kim S., Kim P., Jung H. Off-Pump Open Pulmonary Embolectomy for Patients with Major Pulmonary Embolism. Heart Surg. Forum. 2007;10:E304&#x2013;E308. doi: 10.1532/HSF98.20071043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/HSF98.20071043</ArticleId><ArticleId IdType="pubmed">17599880</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi R., Ansarin K. Surgical Embolectomy in Treating Acute Massive Pulmonary Embolism. J. Pak. Med. Assoc. 2013;63:969&#x2013;972.</Citation></Reference><Reference><Citation>Sareyyupoglu B., Greason K.L., Suri R.M., Keegan M.T., Dearani J.A., Sundt T.M. A More Aggressive Approach to Emergency Embolectomy for Acute Pulmonary Embolism. Mayo Clin. Proc. 2010;85:785&#x2013;790. doi: 10.4065/mcp.2010.0250.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2010.0250</ArticleId><ArticleId IdType="pmc">PMC2931613</ArticleId><ArticleId IdType="pubmed">20810792</ArticleId></ArticleIdList></Reference><Reference><Citation>Satter P. Pulmonary Embolectomy. Indication and Results. Ann. Radiol. 1980;23:321&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">7387088</ArticleId></ArticleIdList></Reference><Reference><Citation>Saylam A., Melo J.Q., Ahmad A., Chapman R.D., Wood J.A., Starr A. Pulmonary Embolectomy. West. J. Med. 1978;128:377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1238147</ArticleId><ArticleId IdType="pubmed">664640</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiomi D., Kiyama H., Shimizu M., Yamada M., Shimada N., Takahashi A., Kaki N. Surgical Embolectomy for High-Risk Acute Pulmonary Embolism Is Standard Therapy. Interdiscip. CardioVascular Thorac. Surg. 2017;25:297&#x2013;301. doi: 10.1093/icvts/ivx091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx091</ArticleId><ArticleId IdType="pubmed">28472317</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo S., Grasso M.A., Tesler U.F. Retrograde Pulmonary Perfusion Improves Results in Pulmonary Embolectomy for Massive Pulmonary Embolism. Tex. Heart Inst. J. 2006;33:473&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1764971</ArticleId><ArticleId IdType="pubmed">17215973</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalpaert G., Suy R., Daenen W., Flameng W., Sergeant P., Nevelsteen A., Lauwers P., De Geest H., Van Elst F. Surgical Treatment of Acute, Massive Lung Embolism. Results and Follow-Up. Acta Chir. Belg. 1986;86:118&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">3716720</ArticleId></ArticleIdList></Reference><Reference><Citation>Stulz P., Schlapfer R., Feer R., Habicht J., Gradel E. Decision Making in the Surgical Treatment of Massive Pulmonary Embolism. Eur. J. Cardio-Thorac. Surg. 1994;8:188&#x2013;193. doi: 10.1016/1010-7940(94)90113-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1010-7940(94)90113-9</ArticleId><ArticleId IdType="pubmed">8031561</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H., Okada K., Matsumori M., Kano H., Kitagawa A., Okita Y. Aggressive Surgical Treatment of Acute Pulmonary Embolism with Circulatory Collapse. Ann. Thorac. Surg. 2012;94:785&#x2013;791. doi: 10.1016/j.athoracsur.2012.03.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.03.101</ArticleId><ArticleId IdType="pubmed">22698769</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi S., Fukuda W., Fukuda I., Watanabe K.-I., Saito Y., Nakamura M., Sakuma M. Outcome of Pulmonary Embolectomy for Acute Pulmonary Thromboembolism: Analysis of 32 Patients from a Multicentre Registry in Japan. Interact. Cardiovasc. Thorac. Surg. 2012;14:64&#x2013;67. doi: 10.1093/icvts/ivr018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivr018</ArticleId><ArticleId IdType="pmc">PMC3420282</ArticleId><ArticleId IdType="pubmed">22108928</ArticleId></ArticleIdList></Reference><Reference><Citation>Thielmann M., Pasa S., Wendt D., Price V., Marggraf G., Neuhauser M., Piotrowski A., Jakob H. Prognostic Significance of Cardiac Troponin I on Admission for Surgical Treatment of Acute Pulmonary Embolism: A Single-Centre Experience over More than 10 Years. Eur. J. Cardiothorac. Surg. 2012;42:951&#x2013;957. doi: 10.1093/ejcts/ezs122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs122</ArticleId><ArticleId IdType="pubmed">22491666</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnier E., Hill J.D., Kerth W.J., Gerbode F. Massive Pulmonary Embolism. Am. J. Surg. 1973;125:611&#x2013;622. doi: 10.1016/0002-9610(73)90148-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(73)90148-7</ArticleId><ArticleId IdType="pubmed">4699205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullmann M., Hemmer W., Hannekum A. The Urgent Pulmonary Embolectomy: Mechanical Resuscitation in the Operating Theatre Determines the Outcome. Thorac. Cardiovasc. Surg. 1999;47:5&#x2013;8. doi: 10.1055/s-2007-1013099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1013099</ArticleId><ArticleId IdType="pubmed">10218612</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra H.A., Whistance R.N., Mattam K., Kaarne M., Haw M.P., Barlow C.W., Tsang G.M.K., Livesey S.A., Ohri S.K. Early and Late Clinical Outcomes of Pulmonary Embolectomy for Acute Massive Pulmonary Embolism. Ann. Thorac. Surg. 2010;90:1747&#x2013;1752. doi: 10.1016/j.athoracsur.2010.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.08.002</ArticleId><ArticleId IdType="pubmed">21095299</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossschulte K., Stiller H., Eisenreich F. Emergency Embolectomy by the Transsternal Approach in Acute Pulmonary Embolism. Surgery. 1965;58:317&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">14316491</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M.-Y., Liu Y.-C., Tseng Y.-H., Chang Y.-S., Lin P.-J., Wu T.-I. Pulmonary Embolectomy in High-Risk Acute Pulmonary Embolism: The Effectiveness of a Comprehensive Therapeutic Algorithm Including Extracorporeal Life Support. Resuscitation. 2013;84:1365&#x2013;1370. doi: 10.1016/j.resuscitation.2013.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2013.03.032</ArticleId><ArticleId IdType="pubmed">23583612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili K., Fleisher A.G., Lehrman S.G., Axelrod H.I., Lafaro R.J., Sarabu M.R., Zias E.A., Moggio R.A. Open Pulmonary Embolectomy for Treatment of Major Pulmonary Embolism. Ann. Thorac. Surg. 2004;77:819&#x2013;823. doi: 10.1016/j.athoracsur.2003.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2003.08.008</ArticleId><ArticleId IdType="pubmed">14992879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavuz S., Toktas F., Goncu T., Eris C., Gucu A., Ay D., Erdolu B., Tenekecioglu E., Karaagac K., Vural H., et al. Surgical Embolectomy for Acute Massive Pulmonary Embolism. Int. J. Clin. Exp. Med. 2014;7:5362&#x2013;5375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307492</ArticleId><ArticleId IdType="pubmed">25664045</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrabi K., Zolghadrasli A., Ostovan M.A., Azimifar A., Malekmakan L. Residual Pulmonary Hypertension after Retrograde Pulmonary Embolectomy: Long-Term Follow-up of 30 Patients with Massive and Submassive Pulmonary Embolism. Interact. Cardiovasc. Thorac. Surg. 2013;17:242&#x2013;246. doi: 10.1093/icvts/ivt210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivt210</ArticleId><ArticleId IdType="pmc">PMC3715199</ArticleId><ArticleId IdType="pubmed">23677779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieli&#x144;ski D., Zygier M., Dyk W., Wojdyga R., Wr&#xf3;bel K., Pirsztuk E., Szostakiewicz K., Szatkowski P., Darocha S., Kurzyna M., et al. Acute Pulmonary Embolism with Coexisting Right Heart Thrombi in Transit-Surgical Treatment of 20 Consecutive Patients. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 2023;63:ezad022. doi: 10.1093/ejcts/ezad022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezad022</ArticleId><ArticleId IdType="pubmed">36661312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic A., Shah A.S., Conte J.V., Yuh D.D. Nationwide Outcomes of Surgical Embolectomy for Acute Pulmonary Embolism. J. Thorac. Cardiovasc. Surg. 2013;145:373&#x2013;377. doi: 10.1016/j.jtcvs.2012.01.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.01.066</ArticleId><ArticleId IdType="pubmed">22341655</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein P.D., Alnas M., Beemath A., Patel N.R. Outcome of Pulmonary Embolectomy. Am. J. Cardiol. 2007;99:421&#x2013;423. doi: 10.1016/j.amjcard.2006.08.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.08.050</ArticleId><ArticleId IdType="pubmed">17261411</ArticleId></ArticleIdList></Reference><Reference><Citation>Poterucha T.J., Bergmark B., Aranki S., Kaneko T., Piazza G. Surgical Pulmonary Embolectomy. Circulation. 2015;132:1146&#x2013;1151. doi: 10.1161/CIRCULATIONAHA.115.015916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.015916</ArticleId><ArticleId IdType="pubmed">26391295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32109743</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>251</Volume><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Associations Between Perioperative Crystalloid Volume and Adverse Outcomes in Five Surgical Populations.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>32</EndPage><MedlinePgn>26-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2019.12.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(19)30860-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Optimal administration of fluids is an important part of enhanced recovery after surgery (ERAS) protocols. We sought to examine the relationship between perioperative crystalloid volume and adverse outcomes in five common types of surgical procedures with ERAS fluid guidelines in place where large randomized controlled trials have not been conducted: breast reconstruction, bariatric, major urologic, gynoncologic, and head and neck oncologic procedures.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study included patients who had undergone any one of the aforementioned procedures within any facility in a large multihospital alliance (Premier, Inc, Charlotte, NC) between 2008 and 2014. We used multivariable generalized additive models to examine relationships between the total crystalloid volume (TCV) on the day of surgery and a composite adverse outcome of prolonged (&gt;75th percentile) hospital or intensive care unit stay or in-hospital mortality. Models were constructed separately within each surgical category and adjusted for demographic, clinical, and hospital characteristics. Informed consent requirements were waived because deidentified data were used.</AbstractText><AbstractText Label="RESULTS">We identified 83,685 patients within 312 US hospitals undergoing breast reconstruction (n&#xa0;=&#xa0;8738), bariatric surgery (n&#xa0;=&#xa0;8067), major urologic surgery (n&#xa0;=&#xa0;28,654), gynoncologic surgery (n&#xa0;=&#xa0;34,559), and head/neck oncology surgery (n&#xa0;=&#xa0;3667). There was significant patient-independent variation in TCV. Probabilities of adverse outcomes increased at a TCV below 3 L and above 6 L for all types of surgeries except bariatric surgery, where larger volumes were associated with progressively better outcomes.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Relationships between TCV and adverse outcomes were generally J shaped with higher volumes (&gt;6 L) associated with increased risk. As per current ERAS guidelines, it is important to avoid excessive crystalloid volume in most surgical procedures except for bariatric surgery.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Fangyu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Hospital, Durham, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasouli</LastName><ForeName>Mohammad R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Hospital, Durham, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Alan R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Social Work, North Carolina State University Raleigh, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>Tetsu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Hospital, Durham, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartz</LastName><ForeName>Raquel R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Hospital, Durham, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Hospital, Durham, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haines</LastName><ForeName>Krista L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Surgery, Duke University Hospital, Durham, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghunathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Hospital, Durham, North Carolina; Anesthesiology Service Durham VA Medical Center, Durham, North Carolina; Department of Anesthesiology, Critical Care and Perioperative Epidemiologic Research (CAPER) Unit, Duke University, Durham, North Carolina. Electronic address: Karthik.Raghunathan@duke.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Surg Res. 2021 Jan;257:167-168. doi: 10.1016/j.jss.2020.07.068.</RefSource><PMID Version="1">32829001</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080482" MajorTopicYN="Y">Enhanced Recovery After Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAPER</Keyword><Keyword MajorTopicYN="N">Crystalloid</Keyword><Keyword MajorTopicYN="N">ERAS</Keyword><Keyword MajorTopicYN="N">Fluids</Keyword><Keyword MajorTopicYN="N">Perioperative outcomes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32109743</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2019.12.013</ArticleId><ArticleId IdType="pii">S0022-4804(19)30860-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37670106</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4626</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract</Title><ISOAbbreviation>J Gastrointest Surg</ISOAbbreviation></Journal><ArticleTitle>Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors-a Systematic Review and Meta-analysis of Surgery-Associated Morbidity.</ArticleTitle><Pagination><StartPage>2611</StartPage><EndPage>2627</EndPage><MedlinePgn>2611-2627</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11605-023-05789-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pancreatic benign, cystic, and neuroendocrine neoplasms are increasingly detected and recommended for surgical treatment. In multiorgan resection pancreatoduodenectomy or parenchyma-sparing, local extirpation is a challenge for decision-making regarding surgery-related early and late postoperative morbidity.</AbstractText><AbstractText Label="METHODS">PubMed, Embase, and Cochrane Libraries were searched for studies reporting early surgery-related complications following pancreatoduodenectomy (PD) and duodenum-preserving total (DPPHRt) or partial (DPPHRp) pancreatic head resection for benign tumors. Thirty-four cohort studies comprising data from 1099 patients were analyzed. In total, 654 patients underwent DPPHR and 445 patients PD for benign tumors. This review and meta-analysis does not need ethical approval.</AbstractText><AbstractText Label="RESULTS">Comparing DPPHRt and PD, the need for blood transfusion (OR 0.20, 95% CI 0.10-0.41, p&lt;0.01), re-intervention for serious surgery-related complications (OR 0.48, 95% CI 0.31-0.73, p&lt;0.001), and re-operation for severe complications (OR 0.50, 95% CI 0.26-0.95, p=0.04) were significantly less frequent following DPPHRt. Pancreatic fistula B+C (19.0 to 15.3%, p=0.99) and biliary fistula (6.3 to 4.3%; p=0.33) were in the same range following PD and DPPHRt. In-hospital mortality after DPPHRt was one of 350 patients (0.28%) and after PD eight of 445 patients (1.79%) (OR 0.32, 95% CI 0.10-1.09, p=0.07). Following DPPHRp, there was no mortality among the 192 patients.</AbstractText><AbstractText Label="CONCLUSION">DPPHR for benign pancreatic tumors is associated with significantly fewer surgery-related, serious, and severe postoperative complications and lower in-hospital mortality compared to PD. Tailored use of DPPHRt or DPPHRp contributes to a reduction of surgery-related complications. DPPHR has the potential to replace PD for benign tumors and premalignant cystic and neuroendocrine neoplasms of the pancreatic head.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beger</LastName><ForeName>Hans G</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>c/o University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. hans@beger-ulm.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Epidemiology and Medical Biometry, Ulm University, Ulm, Germany. hans@beger-ulm.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Oncologic, Endocrine and Minimal Invasive Surgery, Donau-Klinikum Neu-Ulm, Neu-Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poch</LastName><ForeName>Bertram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Gastrointest Surg</MedlineTA><NlmUniqueID>9706084</NlmUniqueID><ISSNLinking>1091-255X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010180" MajorTopicYN="N">Pancreatectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="Y">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004386" MajorTopicYN="N">Duodenum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018358" MajorTopicYN="Y">Neuroendocrine Tumors</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010181" MajorTopicYN="Y">Pancreatic Cyst</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Benign pancreatic head tumors</Keyword><Keyword MajorTopicYN="N">Cystic and neuroendocrine neoplasms of the pancreas</Keyword><Keyword MajorTopicYN="N">Duodenum-preserving pancreatic head resection</Keyword><Keyword MajorTopicYN="N">Pancreatoduodenectomy</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37670106</ArticleId><ArticleId IdType="pmc">PMC10661729</ArticleId><ArticleId IdType="doi">10.1007/s11605-023-05789-4</ArticleId><ArticleId IdType="pii">S1091-255X(24)00048-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mavroeidis VK, Russell TB, Clark J, Adebayo D, Bowles M, Briggs C, Denson J, Aroori S. Pancreatoduodenectomy for suspected malignancy: nonmalignant histology confers increased risk of serious morbidity. Ann R Coll Surg Engl. 2022;000:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10149251</ArticleId><ArticleId IdType="pubmed">35904332</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes SA, Lillemoe KD, Kaufman HS, Sauter PK, Yeo CJ, Talamini MA, et al. Pancreaticoduodenectomy for Benign Disease. Am J Surgery. 1996;171:131&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8554127</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg. 2015;19:1072&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">25801594</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimptsch U, Krautz C, Weber GF, Mansky T, Gr&#xfc;tzmann R. Nationwide in-hospital mortality following pancreatic surgery in Germany is higher than anticipated. Ann Surg. 2016;264:1082&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">26978570</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Peneva IS, Evison F, Sahdra S, Mirza DF, Charnley RM, Savage R, Moss PA, Roberts KJ. Ninety day mortality following pancreatoduodenectomy in England: has the optimum centre volume been identified? HPB. 2018;20:1012&#x2013;1020.</Citation><ArticleIdList><ArticleId IdType="pubmed">29895441</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid-Lombardo KM, Thomsen K, Harmsen WS, Farnell MB. Long-term anastomotic complications after pancreaticoduodenectomy for benign diseases. J Gastrointest Surg. 2007;11:1704&#x2013;1711.</Citation><ArticleIdList><ArticleId IdType="pubmed">17929105</ArticleId></ArticleIdList></Reference><Reference><Citation>Krautz C, Nimptsch U, Weber GF, Mansky T, Gr&#xfc;tzmann R. Effect of hospital volume on in-hospital morbidity and mortality following pancreatic surgery in Germany. Ann Surg. 2018;267:411&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">28379871</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan S, Martin AN, Turrentine FE, Bauer TW, Adams RB, Zaydfudim VM. Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death. J Surg Res. 2018;231:304&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8246070</ArticleId><ArticleId IdType="pubmed">30278945</ArticleId></ArticleIdList></Reference><Reference><Citation>Firkins SA, Hart PA, Porter K, Chiang C, Cloyd JM, Dillhoff M, et al. Incidence and Risk Factors for New-Onset Diabetes Mellitus After Surgical Resection of Pancreatic Cystic Lesions: A MarketScan Study. Pancreas. 2022;51:427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388590</ArticleId><ArticleId IdType="pubmed">35858183</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholten L, Mungroop TH, Haijtink SA, Issa Y, van Rijssen LB, Koerkamp BG, et al. New-onset diabetes after pancreatoduodenectomy: a systematic review and meta-analysis. Surgery. 2018;164:6&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">29779868</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger HG, Mayer B, Poch B. Long-Term Metabolic Morbidity and Steatohepatosis following Standard Pancreatic Resections and Parenchyma-Sparing, Local Extirpations for Benign Tumor - A Systematic Review and Meta-Analysis. Ann Surg. 2022;275:54&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">33630451</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas AS, Huang Y, Kwon W, Schrope BA, Sugahara K, Chabot JA, et al. Prevalence and Risk Factors for Pancreatic Insufficiency After Partial Pancreatectomy. J Gastrointest Surg. 2022;26:1425&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">35318597</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreasi V, Partelli S, Capurso G, Muffatti F, Balzano G, Crippa S, et al. Long-term pancreatic functional impairment after surgery for neuroendocrine neoplasms. J Clin Med. 2019;8:1611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6832294</ArticleId><ArticleId IdType="pubmed">31623399</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger HG, Mayer B, Poch B. Resection of the duodenum causes long-term endocrine and exocrine dysfunction after Whipple procedure for benign tumors-A systematic review and meta-analysis. HPB. 2020;22:809&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">31983660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kromrey ML, B&#xfc;low R, H&#xfc;bner J, Paperlein C, Lerch MM, Ittermann T, et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018;67:138&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">28877981</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Rel Can. 2008;2008(15):409&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693313</ArticleId><ArticleId IdType="pubmed">18508996</ArticleId></ArticleIdList></Reference><Reference><Citation>Rold&#xe1;n J, Harrison J, Qadan M, Bolm L, Baba T, Brugge WR et al. Evolving trends in pancreatic cystic tumors: a 3-decade single-center experience with 1290 resections. Ann Surg 2021, online ahead of print;. 10.1097/SLA.0000000000005142</Citation><ArticleIdList><ArticleId IdType="pubmed">34353996</ArticleId></ArticleIdList></Reference><Reference><Citation>Talamini MA, Moesinger R, Yeo CJ, Poulose B, Hruban RH, Cameron JL, et al. Cystadenomas of the pancreas: is enucleation an adequate operation? Ann Surg. 1998;227:896&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1191400</ArticleId><ArticleId IdType="pubmed">9637553</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger HG, Nasseri M, B&#xfc;cherl ES. Surgical technic in partial doudenal resection. Chirurg. 1969;40:523&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">5354002</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger HG, Witte C, Krautzberger W, Bittner R. Erfahrung mit einer das Duodenum erhaltenden Pankreaskopfresektion bei chronischer Pankreatitis. Chirurg. 1980;51:303&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">7408575</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacono C, Verlato G, Ruzzenente A, Campagnaro T, Bacchelli C, Bortolasi L, et al. Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. Br J Surg. 2013;100:873&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pubmed">23640664</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P. Pancreatic insufficiency after different resections for benign tumors. Br J Surg. 2008;95:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">18041022</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda H, Takada T, Toyota N, Amano H, Yoshida M, Takada Y, et al. Limited pancreatectomy: significance of postoperative maintenance of pancreatic exocrine function. J Hepatobiliary Pancreat Surg. 2000;7(5):466&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">11180872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K, Takada T. Duodenum preservation in pancreatic head resection to maintain pancreatic exocrine function (determined by pancreatic function diagnostant test and cholecystokinin secretion) J Hepatobiliary Pancreatic Surg. 2005;12:123&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">15868075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn YJ, Kim SW, Park YC, Jang JY, Yoon YS, et al. Duodenal-preserving resection of the head of the pancreas and pancreatic head resection with second-portion duodenectomy for benign lesions, low-grade malignancies, and early carcinoma involving the periampullary region. Arch Surg. 2003;138:162&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">12578411</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips ME. Pancreatic exocrine insufficiency following pancreatic resection. Pancreatology. 2015;15:449&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">26145836</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger HG, Siech M, Poch B, Mayer B, Schoenberg MH. Limited surgery for benign tumors of the pancreas: a systematic review. World J Surg. 2015;39:1557&#x2013;1566.</Citation><ArticleIdList><ArticleId IdType="pubmed">25691214</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati L, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analysis: The PRISMA statement. Ann Intern Med. 2009;151:265&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxford Center for Evidence-Based Medicine. available at https://www.cebm.net/index.aspx?o=5653 accessed October 2020.</Citation></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. Clinical Epidemiology 2016. Available from: http://www. ohri. ca/programs/clinical_epidemiology/oxford. asp.</Citation></Reference><Reference><Citation>Cai Y, Zheng Z, Gao P, Li Y, Peng B. Laparoscopic duodenum-preserving total pancreatic head resection using real-time indocyanine green fluorescence imaging. Surg Endoscopy. 2021;35:1355&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">32221750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong D, Cheng J, Wu W, Liu X, Zheng X. How to perform total laparoscopic duodenum-preserving pancreatic head resection safely and efficiently with innovative techniques. Ann Surg Oncol. 2021;28:3209&#x2013;3216.</Citation><ArticleIdList><ArticleId IdType="pubmed">33123857</ArticleId></ArticleIdList></Reference><Reference><Citation>Snajdauf J, Rygl M, Petru O, Nahlovsky J, Frybova B, Durilova M, et al. Indications and outcomes of duodenum-preserving resection of the pancreatic head in children. Pediatr Surg Int. 2019;35:449&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">30386905</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Li GL, Wei JX, Yang WB, Shang CZ, Chen YJ, et al. Laparoscopic duodenum-preserving total pancreatic head resection: a novel surgical approach for benign or low-grade malignant tumors. Surg Endosc. 2019;33:633&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">30456509</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanetto AC, Lico V, Allagio R, Pedrazzoli S, Pasquali C. Duodenum-preserving pancreatic head resection for treatment of neuroendocrine pancreatic tumors of the head of the pancreas. Pancreatology. 2016;16:S65&#x2013;S66.</Citation></Reference><Reference><Citation>Yuan CH, Tao M, Jia YM, Xiong JW, Zhang TL, Xiu DR, et al. Duodenum-preserving resection and Roux-en-Y pancreatic jejunostomy in benign pancreatic head tumors. World J Gastrointest. 2014;20:16786&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248228</ArticleId><ArticleId IdType="pubmed">25469053</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas E, Matsuoka L, Alexopoulos S, Selby R, Parekh D. Laparoscopic hand-assisted parenchymal-sparing resections for presumed side-branch intraductal papillary mucinous neoplasms. J Laparoend Adv Surg Tech. 2015;25:668&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">26200132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov IA, Smirnov AV, Chzhao AV. Duodenum-preserving pancreatic head resection and resection of the head of the pancreas combined with segmental duodenectomy. HPB. 2014;16(Suppl.2):594&#x2013;595.</Citation></Reference><Reference><Citation>Tsuchikawa T, Hirano S, Tanaka E, Kato K, Matsumot J, Nakamura T, et al. Modified duodenum-preserving pancreas head resection for low-grade malignant lesion in the pancreatic head. Pancreatology. 2013;13:170&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">23561975</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R, Hatori T, Suzuki S, Oshima N, Kimijima A, Izumo W, et al. The treatment strategy of non-functioning pancreatic neuroendocrine tumor. Pancreatology. 2013;4:S74&#x2013;S75.</Citation></Reference><Reference><Citation>Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kobayashi S, et al. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms. J Hepatobiliary Pancreat Sci. 2010;17:798&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">19727540</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger HG, Gansauge F, Siech M, Schwarz M, Poch B. Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas. J Hepatobiliary Pancreat Surg. 2008;15:149&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">18392707</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong JX, Wang CY, Tao J, Zhang SH. Indication and choice of operation technique for duodenum-preserving resection of pancreatic head: 22 cases reports. Zhonghua wai ke za zhi [Chinese Journal of Surgery] 2007;45:24&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">17403284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Cruz L, Olvera C, L&#xf3;pez-Boado MA, Bollo J, Romero J, Comas J. Organ-preserving resection of the pancreaticoduodenal region in the treatment of intraductal papillary mucinous tumors. Cir Esp. 2006;80:295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">17192205</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami Y, Uemura K, Yokoyama Y, Sasaki M, Morifuji M, Hayashidani Y, et al. Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg. 2004;8:713&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">15358333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano S, Kondo S, Ambo Y, Tanaka E, Morikawa T, Okushiba S, et al. Outcome of duodenum-preserving resection of the head of the pancreas for intraductal papillary-mucinous neoplasm. Dig Surg. 2004;21:242&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">15237258</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada T, Yasuda H, Amano H. Yoshida M.A duodenum-preserving and bile duct-preserving total pancreatic head resection with associated pancreatic duct-to-duct anastomosis. J Gastrointest Surg. 2004;8:220&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">15036200</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi K, Yokohata K, Nakano K, Ohtani K, Ogawa Y, Chijiiwa K, Tanaka M. Which is a less invasive pancreatic head resection: PD, PPPD, or DPPHR? Digest Dis Sci. 2001;46:282&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">11281176</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaji S, Kawarada Y. Pancreatic head resection with second-portion duodenectomy for benign lesions, low-grade malignancies, and early stage carcinomas involving the pancreatic head region. Am J Surg. 2001;181:172&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">11425061</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaizumi T, Hanyu F, Suzuki M, Nakasako T, Harada N, Hatori T. Clinical experience with duodenum-preserving total resection of the head of the pancreas with pancreaticocholedochoduodenostomy. J Hepatobiliary Pancreat Surg. 1995;2:38&#x2013;44.</Citation></Reference><Reference><Citation>Harada N. Digestive functions and secretion of gastrointestinal hormones after duodenum-preserving pancreas head resection. Jpn J Gastroenterol Surg. 1994;27:781&#x2013;788.</Citation></Reference><Reference><Citation>Chen X, Chen W, Zhang Y, An Y, Zhang X. Short-term outcomes of laparoscopic duodenum-preserving total pancreatic head resection compared with laparoscopic pancreaticoduodenectomy for the management of pancreatic-head benign or low-grade malignant lesions. Med Sci Monitor. 2020;26:e927248&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519948</ArticleId><ArticleId IdType="pubmed">32935663</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin H, Yang S, Yang H, W., Cheng, H., Chang, X., et al. Duodenum-preserving pancreas head resection in the treatment of pediatric benign and low-grade malignant pancreatic tumors. HPB. 2020;22:306&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">31409540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Jin JB, Zhan Q, Deng XX, Peng CH, Shen BY, et al. Robot-assisted duodenum-preserving pancreatic head resection with pancreaticogastrostomy for benign or premalignant pancreatic head lesions: a single-centre experience. Int J Med Robot. 2018;14:e1903.</Citation><ArticleIdList><ArticleId IdType="pubmed">29498195</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wu W, Zhang T, Liao Q, Zhao Y, Dai M. Comparison of long-term benefits of organ-preserving pancreatectomy techniques for benign or low-grade malignant tumors at the pancreatic head. Medicine (Baltimore) 2017;96:51(e9420).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5758269</ArticleId><ArticleId IdType="pubmed">29390567</ArticleId></ArticleIdList></Reference><Reference><Citation>Perinel J, Adham M. Short-and long-term outcomes of pancreatectomy with or without biliary tract and duodenum preservation for benign and borderline neoplasms. Dig Surg. 2014;31:233&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">25277317</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JZ, Huang XY, Wang HC, Zhen Q. Duodenum-preserving pancreatic head resection versus pancreaticoduodenectomy for benign pancreatic neoplasms. HPB. 2013;15(Suppl.2):540.</Citation></Reference><Reference><Citation>Gong DJ, Zhang JM, Mao GJ, Xu LT, Wu RJ, Yu S, et al. Duodenum-preserving pancreatic head resection vs. pancreatoduodenectomy for benign lesions and low-grade malignancies of the pancreatic head. Hepatogastroenterology. 2013;60:19&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">22773304</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrazzoli S, Canton SA, Sperti C. Duodenum-preserving versus pylorus-preserving pancreatic head resection for benign and premalignant lesions. J Hepatobiliary Pancreat Sci. 2011;18:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">20694480</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Kanda M, Kodera Y, Nagai S, Sahin TT, Kanzaki A, et al. Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic head. Pancreas. 2011;40:1258&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pubmed">21705943</ArticleId></ArticleIdList></Reference><Reference><Citation>Busquets J, Fabregat J, Borobia FG, Jorba R, Valls C, Serrano T, et al. Organ-preserving surgery for benign lesions and low-grade malignancies of the pancreatic head: a matched case-control study. Surg Today. 2010;40:125&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">20107951</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiguchi A, Miyakawa S, Ishihara S, Ito M, Asano Y, Furusawa K, et al. Surgical design and outcome of duodenum-preserving pancreatic head resection for benign or low-grade malignant tumors. J Hepatobiliary Pancreat Sci. 2010;17:792&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19894017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Jang JY, Hwang DW, Lee KU, Kim SW. Clinical efficacy of organ-preserving pancreatectomy for benign or low-grade malignant potential lesion. J Korean Med Sci. 2010;25(1):97&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2800014</ArticleId><ArticleId IdType="pubmed">20052354</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspelund G, Topazian MD, Lee JH, Andersen DK. Improved outcomes for benign disease with limited pancreatic head resection. J Gastrointest Surg. 2005;9:400&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">15749604</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. &amp; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">16003309</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149:680&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">21316725</ArticleId></ArticleIdList></Reference><Reference><Citation>Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS) Surgery. 2007;142:761&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pubmed">17981197</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638912</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher RH, Flechter SW, Flechter GS. Clinical epidemiology: The essentials. Lipponcott Williams &amp; Wilkins; 2019.</Citation></Reference><Reference><Citation>Aizpuru M, Starlinger P, Nagorney DM, Smoot RL, Truty MJ, Kendrick ML, et al. Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesions. HPB. 2022;24:1416&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pubmed">35140056</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, et al. Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg. 2005;242:781&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1409869</ArticleId><ArticleId IdType="pubmed">16327488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroon VJ, Daamen LA, Tseng DS J, Roele-de Vreugd A, Busch OR, et al. Pancreatic exocrine insufficiency following pancreatoduodenectomy: A prospective bi-center study. Pancreatology 2022. online ahead of print. 10.1016/j.pan.2022.08.002</Citation><ArticleIdList><ArticleId IdType="pubmed">35961936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata K, Nakata B, Amano R, Yamazoe S, Kimura K, Hirakawa K. Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients. J Gastrointest Surg. 2014;18:1597&#x2013;1603.</Citation><ArticleIdList><ArticleId IdType="pubmed">25002020</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreasi V, Partelli S, Capurso G, Muffatti F, Balzano G, Crippa S, et al. Long-term pancreatic functional impairment after surgery for neuroendocrine neoplasms. Journal of. Clinical Medicine. 2019;8:1611. doi: 10.3390/jcm8101611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8101611</ArticleId><ArticleId IdType="pmc">PMC6832294</ArticleId><ArticleId IdType="pubmed">31623399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C, Xu B, Mou Y, Zhou Y, Jin W, Xia T, et al. Laparoscopic duodenum&#x2013;preserving pancreatic head resection with real-time indocyanine green guidance of different dosage and timing: enhanced safety with visualized biliary duct and its long-term metabolic morbidity. Langenbecks Arch Surg. 2022;407:2823&#x2013;2832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640461</ArticleId><ArticleId IdType="pubmed">35854048</ArticleId></ArticleIdList></Reference><Reference><Citation>Osayi SN, Wendling MR, Drosdeck JM, Chaudhry UI, Perry KA, Noria SF, et al. Near-infrared fluorescent cholangiography facilitates identification of biliary anatomy during laparoscopic cholecystectomy. Surg Endosc. 2015;29:368&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4415528</ArticleId><ArticleId IdType="pubmed">24986018</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger H, Krautzberger W, Bittner R, B&#xfc;chler M, Limmer J. Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis. Surgery. 1985;97:467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">3983823</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaiber U, Alldinger I, Probst P, Bruckner T, Contin P, K&#xf6;ninger J, et al. Duodenum-preserving pancreatic head resection: 10-year follow-up of a randomized controlled trial comparing the Beger procedure with the Berne modification. Surgery. 2016;160:127&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">27106794</ArticleId></ArticleIdList></Reference><Reference><Citation>Soejima Y, Toshima T, Motomura T, Yokota T, Joko K, Oshiro Y, et al. Technical feasibility and oncological legitimacy of enucleation of intraductal papillary mucinous neoplasm located at the pancreatic head or uncinate process. Anticancer Res. 2017;37:321&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">28011509</ArticleId></ArticleIdList></Reference><Reference><Citation>Jilesen AP, van Eijck CH, Busch OR, van Gulik TM, Gouma DJ, Van Dijkum EJ. Postoperative outcomes of enucleation and standard resections in patients with a pancreatic neuroendocrine tumor. World J Surg. 2016;40:715&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4746212</ArticleId><ArticleId IdType="pubmed">26608956</ArticleId></ArticleIdList></Reference><Reference><Citation>Duconseil P, Marchese U, Ewald J, Giovannini M, Mokart D, Delpero JR, et al. A pancreatic zone at higher risk of fistula after enucleation. World J Surg Onc. 2018;16:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6116563</ArticleId><ArticleId IdType="pubmed">30157952</ArticleId></ArticleIdList></Reference><Reference><Citation>Heeger K, Falconi M, Partelli S, Waldmann J, Crippa S, Fendrich V, et al. Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors. Langenbeck's Arch Surg. 2014;399:315&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">24522434</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger HG, Mayer B, Poch B. Long-term oncologic outcome after duodenum-preserving pancreatic head resection for benign tumors, cystic neoplasms and neuroendocrine tumors. Systematic review and meta-analysis. (to be published 4/2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11164799</ArticleId><ArticleId IdType="pubmed">38578553</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30737881</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1478-596X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The international journal of medical robotics + computer assisted surgery : MRCAS</Title><ISOAbbreviation>Int J Med Robot</ISOAbbreviation></Journal><ArticleTitle>Robotic-assisted minimally invasive esophagectomy versus the conventional minimally invasive one: A meta-analysis and systematic review.</ArticleTitle><Pagination><StartPage>e1988</StartPage><MedlinePgn>e1988</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/rcs.1988</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Conventional video-assisted minimally invasive esophagectomy (MIE) is safe and associated with low rates of morbidity and mortality, but the two-dimensional monitor reduces eye-hand harmony and viewing yield. Robotic-assisted minimally invasive esophagectomy (RAMIE) with its virtual reality simulators offers a realistic three-dimensional environment that facilitates dissection in the narrow working space, but it is expensive and requires longer operative time. Therefore, the aim of this meta-analysis was to assess the safety and feasibility of RAMIE versus MIE in patients with esophageal cancer.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">PubMed, EMBASE, Cochrane library, and Chinese Biomedical Literature databases were systematically searched up to 21 September 2018 for case-controlled studies that compared RAMIE with MIE.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">Eight case-controlled studies involving 1862 patients (931 under RAMIE and 931 under MIE) were considered. No statistically significant difference between the two techniques was observed regarding R0 resection rate (OR&#xa0;=&#xa0;1.1174, P&#xa0;=&#xa0;0.8647), conversion to open (OR&#xa0;=&#xa0;0.7095, P&#xa0;=&#xa0;0.7519), 30-day mortality rate (OR&#xa0;=&#xa0;0.8341, P&#xa0;=&#xa0;0.7696), 90-day mortality rate (OR&#xa0;=&#xa0;0.3224, P&#xa0;=&#xa0;0.3329), in-hospital mortality rate (OR&#xa0;=&#xa0;0.3733, P&#xa0;=&#xa0;0.3895), postoperative complications, number of harvested lymph nodes (mean difference [MD]&#xa0;=&#xa0;0.8216, P&#xa0;=&#xa0;0.2039), operation time (MD&#xa0;=&#xa0;24.3655&#xa0;min, P&#xa0;=&#xa0;0.2402), and length of stay in hospitals (LOS) (MD&#xa0;=&#xa0;-5.0228&#xa0;day, P&#xa0;=&#xa0;0.1342). The meta-analysis showed that RAMIE was associated with a significantly fewer estimated blood loss (EBL) (MD&#xa0;=&#xa0;-33.2268&#xa0;mL, P&#xa0;=&#xa0;0.0075). And the vocal cord palsy rate was higher in the MIE group compared with RAMIE, and the difference was significant (OR&#xa0;=&#xa0;0.5696, P&#xa0;=&#xa0;0.0447).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis indicated that RAMIE and MIE display similar feasibility and safety when used in esophagectomy. However, randomized controlled studies with larger sample sizes are needed to evaluate the benefit and harm in patients with esophageal cancer undergoing RAMIE.</AbstractText><CopyrightInformation>&#xa9; 2019 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Dacheng</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4213-3544</Identifier><AffiliationInfo><Affiliation>Department of Clinical Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Gansu Province People's Hospital, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institution of Clinical Research and Evidence Based Medicine, Gansu Province People's Hospital, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Second Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Division, Hong Kong Baptist University, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Gansu Province People's Hospital, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Second Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Tiankang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institution of Clinical Research and Evidence Based Medicine, Gansu Province People's Hospital, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kehu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institution of Clinical Research and Evidence Based Medicine, Gansu Province People's Hospital, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gou</LastName><ForeName>Yunjiu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Gansu Province People's Hospital, Lanzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Med Robot</MedlineTA><NlmUniqueID>101250764</NlmUniqueID><ISSNLinking>1478-5951</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014741" MajorTopicYN="N">Video Recording</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014826" MajorTopicYN="N">Vocal Cord Paralysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30737881</ArticleId><ArticleId IdType="doi">10.1002/rcs.1988</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35450507</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Surgical <i>versus</i> medical treatment for infective endocarditis in patients on dialysis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>706</StartPage><EndPage>713</EndPage><MedlinePgn>706-713</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2064756</ELocationID><Abstract><AbstractText>Infective endocarditis (IE) is a serious infection and causes significant morbidity and mortality. However, the benefit of surgery for endocarditis besides antibiotic treatment in dialysis patients remains controversial. We performed a systematic review of studies published between 1960 and February 2022. Meta-analysis was conducted with a random-effects model to explore the in-hospital, 30, 60, 90, 180-d, and 1-year mortality rates in adult dialysis patients with IE. Sensitivity analysis, subgroup analysis, and meta-regression were performed to explore potential sources of heterogeneity. Confidence of evidence was evaluated by the GRADE system. Thirteen studies were included. The pooled odds ratio of in-hospital mortality was 0.62 (95% confidence interval [CI]: 0.30-1.28, <i>p</i>&#x2009;=&#x2009;.17), with moderate heterogeneity (<i>I</i><sup>2</sup> = 62%, <i>p</i>&#x2009;&lt;&#x2009;.01). Three studies reported 30-d mortality, and the pooled odds ratio for surgery compared with medical treatment was even lower (0.36; 95% CI: 0.22-0.61, <i>p</i>&#x2009;&lt;&#x2009;.01), with low heterogeneity (<i>I</i><sup>2</sup> = 0%, <i>p</i>&#x2009;=&#x2009;.86). With studies on fewer than 30 patients excluded, the sensitivity analysis revealed a low odds ratio of in-hospital mortality for surgery <i>versus</i> medical treatment (0.52; 95% CI: 0.27-0.99, <i>p</i>&#x2009;=&#x2009;.047), with moderate heterogeneity (<i>I</i><sup>2</sup> = 63%, <i>p</i>&#x2009;&lt;&#x2009;.01). Subgroup analysis revealed no significant differences between any two comparator subgroups. Based on a very low strength of evidence, compared with medical treatment, surgical treatment for IE in patients on dialysis is not associated with lower in-hospital mortality. When studies on fewer than 30 patients were excluded, surgical treatment was associated with better survival.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ting</LastName><ForeName>Sze-Wen</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0002-8057-771X</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, New Taipei City Municipal Tucheng Hospital, New Taipei City, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jia-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Kidney Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Tao-Han</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Kidney Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, ROC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, New Taipei City Municipal Tucheng Hospital, New Taipei City, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>George</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5908-403X</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Kidney Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, ROC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004696" MajorTopicYN="Y">Endocarditis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004697" MajorTopicYN="Y">Endocarditis, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dialysis</Keyword><Keyword MajorTopicYN="N">infective endocarditis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">valve replacement surgery</Keyword><Keyword MajorTopicYN="N">valvuloplasty</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests. SW Ting and JJ Chen participated in conceptualization, methodology, validation, and original draft preparation. G Kuo and TH Lee performed software programing and developed the supporting algorithms. JJ Chen, TH Lee, and G Kuo performed formal analysis. SW Ting, JJ Chen, and G Kuo performed the investigation and data curation. All authors read and approved the final manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35450507</ArticleId><ArticleId IdType="pmc">PMC9037223</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2022.2064756</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chang CH, Fan PC, Kuo G, et al. . Infection in advanced chronic kidney disease and subsequent adverse outcomes after dialysis initiation: a nationwide cohort study. Sci Rep. 2020;10(1):2938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7031239</ArticleId><ArticleId IdType="pubmed">32076027</ArticleId></ArticleIdList></Reference><Reference><Citation>Raza S, Hussain ST, Rajeswaran J, et al. . Value of surgery for infective endocarditis in dialysis patients. J Thorac Cardiovasc Surg. 2017;154(1):61&#x2013;70.e66.</Citation><ArticleIdList><ArticleId IdType="pubmed">28633210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Chmielewski M, Honda H, et al. . Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526&#x2013;1533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4571158</ArticleId><ArticleId IdType="pubmed">18701615</ArticleId></ArticleIdList></Reference><Reference><Citation>Akar H, Akar GC, Carrero JJ, et al. . Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol. 2011;6(1):218&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">21115624</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersson GB, Hussain ST.. Current AATS guidelines on surgical treatment of infective endocarditis. Ann Cardiothorac Surg. 2019;8(6):630&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6892713</ArticleId><ArticleId IdType="pubmed">31832353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SA, Roques F, Sharples LD, et al. . EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">22378855</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien SM, Feng L, He X, et al. . The society of thoracic surgeons 2018 adult cardiac surgery risk models: part 2-Statistical methods and results. Ann Thorac Surg. 2018;105(5):1419&#x2013;1428.</Citation><ArticleIdList><ArticleId IdType="pubmed">29577924</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahian DM, Jacobs JP, Badhwar V, et al. . The society of thoracic surgeons 2018 adult cardiac surgery risk models: part 1-background, design considerations, and model development. Ann Thorac Surg. 2018;105(5):1411&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pubmed">29577925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia N, Agrawal S, Garg A, et al. . Trends and outcomes of infective endocarditis in patients on dialysis. Clin Cardiol. 2017;40(7):423&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6490541</ArticleId><ArticleId IdType="pubmed">28300288</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamsrizi P, Gladstone BP, Carrara E, et al. . Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and Meta-analysis. BMJ Open. 2020;10(1):e030266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7044956</ArticleId><ArticleId IdType="pubmed">31964661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, et al. . 
GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group; 2013. https://www.guidelinedevelopment.org/handbook</Citation></Reference><Reference><Citation>McMaster University and Evidence Prime . GRADEpro GDT: GRADEpro guideline development tool. 2021. Available from: gradepro.org</Citation></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G.. How to perform a Meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: a language and environment for statistical computing. Vienna, Austria: R Core Team; 
2019. Available from: https://www.R-project.org/</Citation></Reference><Reference><Citation>Durante-Mangoni E, Pafundi PC, Ravasio V, et al. . Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort. Infection 2016;44(4):467&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">26780903</ArticleId></ArticleIdList></Reference><Reference><Citation>Pericas JM, Llopis J, Jimenez-Exposito MJ, et al. . Infective endocarditis in patients on chronic hemodialysis. J Am Coll Cardiol. 2021;77(13):1629&#x2013;1640.</Citation><ArticleIdList><ArticleId IdType="pubmed">33795037</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroudi S, Qazi RA, Lentine KL, et al. . Infective endocarditis in haemodialysis patients: 16-year experience at one institution. NDT Plus. 2008;1(4):253&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4421220</ArticleId><ArticleId IdType="pubmed">25983896</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou MT, Wang JJ, Wu WS, et al. . Epidemiologic features and long-term outcome of dialysis patients with infective endocarditis in Taiwan. Int J Cardiol. 2015;179:465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">25465808</ArticleId></ArticleIdList></Reference><Reference><Citation>Doulton T, Sabharwal N, Cairns HS, et al. . Infective endocarditis in dialysis patients: new challenges and old. Kidney Int. 2003;64(2):720&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pubmed">12846771</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DA, McGill LA, Rathod KS, et al. . Characteristics and outcomes of dialysis patients with infective endocarditis. Nephron Clin Pract. 2013;123(3&#x2013;4):151&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">23887311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamalakannan D, Pai RM, Johnson LB, et al. . Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg. 2007;83(6):2081&#x2013;2086.</Citation><ArticleIdList><ArticleId IdType="pubmed">17532401</ArticleId></ArticleIdList></Reference><Reference><Citation>Liau SK, Kuo G, Chen CY, et al. . In-hospital and long-term outcomes of infective endocarditis in chronic dialysis patients. IJGM. 2021;14:425&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886777</ArticleId><ArticleId IdType="pubmed">33603449</ArticleId></ArticleIdList></Reference><Reference><Citation>Nori US, Manoharan A, Thornby JI, et al. . Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant. 2006;21(8):2184&#x2013;2190.</Citation><ArticleIdList><ArticleId IdType="pubmed">16644778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekik S, Trabelsi I, Hentati M, et al. . Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis. Clin Exp Nephrol. 2009;13(4):350&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">19381757</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson DL, Fowler VG, Sexton DJ, et al. . Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis. 1997;30(4):521&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">9328367</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell R, Steinberg JP, Jacob JT.. Predictors of mortality in End-Stage renal disease patients with infective endocarditis. Open Forum Infect Dis. 2015;2(1):860.</Citation></Reference><Reference><Citation>Birkmeyer JD, Stukel TA, Siewers AE, et al. . Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349(22):2117&#x2013;2127.</Citation><ArticleIdList><ArticleId IdType="pubmed">14645640</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez AA, Dimick JB, Birkmeyer JD, et al. . Understanding the volume-outcome effect in cardiovascular surgery: the role of failure to rescue. JAMA Surg. 2014;149(2):119&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4016988</ArticleId><ArticleId IdType="pubmed">24336902</ArticleId></ArticleIdList></Reference><Reference><Citation>Preston L, Turner J, Booth A, et al. . Is there a relationship between surgical case volume and mortality in congenital heart disease services? A rapid evidence review. BMJ Open. 2015;5(12):e009252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4691785</ArticleId><ArticleId IdType="pubmed">26685029</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Zhang Z, Wang H, et al. . The relation between volume and outcome of transcatheter and surgical aortic valve replacement: a systematic review and Meta-Analysis. Cardiovasc Ther. 2020;2020(2601340):2601340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7189304</ArticleId><ArticleId IdType="pubmed">32395180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirji SA, McCarthy E, Kim D, et al. . Relationship between hospital surgical aortic valve replacement volume and transcatheter aortic valve replacement outcomes. JACC Cardiovasc. Interv. 2020;13(3):335&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8858441</ArticleId><ArticleId IdType="pubmed">32029250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan G, Norris KC, Xin W, et al. . Facility size, race and ethnicity, and mortality for in-center hemodialysis. J Am Soc Nephrol. 2013;24(12):2062&#x2013;2070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839547</ArticleId><ArticleId IdType="pubmed">23970120</ArticleId></ArticleIdList></Reference><Reference><Citation>Fareed N. Size matters: a meta-analysis on the impact of hospital size on patient mortality. Int J Evid Based Healthc. 2012;10(2):103&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">22672599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey TM, Herbert MA, Ryan WH, et al. . Influence of surgeon volume on outcomes with aortic valve replacement. Ann Thorac Surg. 2012;93(4):1107&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">22226491</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36741847</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Transcatheter mitral valve replacement versus redo surgery for mitral prosthesis failure: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1058576</StartPage><MedlinePgn>1058576</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1058576</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.1058576</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Transcatheter mitral valve replacement (TMVR) has emerged as an alternative to redo surgery. TMVR compared with redo surgical mitral valve replacement (SMVR) in patients with mitral prosthesis failure remains limited. In this study, we performed a meta-analysis to assess the outcomes of TMVR (including valve-in-valve and valve-in-ring) versus redo surgery for mitral prosthesis failure.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We comprehensively searched the PubMed, Embase, and Cochrane library databases according to predetermined inclusion and exclusion criteria, and then we extracted data. We compared the outcomes of TMVR and redo SMVR for mitral prosthesis failure in terms of the in-hospital mortality, stroke, renal dysfunction, vascular complication, pacemaker implantation, exploration for bleeding, paravalvular leak, mean mitral valve gradient, 30-day mortality, and 1-year mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Nine retrospective cohort studies and a total of 3,038 patients were included in this analysis. Compared with redo SMVR for mitral prosthesis failure, TMVR was associated with lower in-hospital mortality [odds ratios (OR): 0.44; 95% confidence interval (CI): 0.30-0.64; <i>P</i> &lt; 0.001], stroke (OR: 0.44; 95% CI: 0.29-0.67; <i>P</i> = 0.0001), renal dysfunction (OR: 0.52; 95% CI: 0.37-0.75; <i>P</i> = 0.0003), vascular complication (OR: 0.58; 95% CI: 0.43-0.78; <i>P</i> = 0.004), pacemaker implantation (OR: 0.23; 95% CI: 0.15-0.36; <i>P</i> &lt; 0.00001), and exploration for bleeding (OR: 0.24; 95% CI: 0.06-0.96; <i>P</i> = 0.04). Conversely, redo SMVR had lower paravalvular leak (OR: 22.12; 95% CI: 2.81-174.16; <i>P</i> = 0.003). There was no difference in mean mitral valve gradient (MD: 0.04; 95% CI: -0.47 to 0.55; <i>P</i> = 0.87), 30-day mortality (OR: 0.65; 95% CI: 0.36-1.17; <i>P</i> = 0.15), and 1-year mortality (OR: 0.96; 95% CI: 0.63-1.45; <i>P</i> = 0.84).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In patients with mitral prosthesis failure, TMVR is associated with lower in-hospital mortality and lower occurrence of postoperative complications, except for paravalvular leak. TMVR offers a viable alternative to the conventional redo surgery in selected patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Zhou, Li, Chen and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jiawei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuehuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mitral prosthesis failure</Keyword><Keyword MajorTopicYN="N">redo</Keyword><Keyword MajorTopicYN="N">surgical mitral valve replacement</Keyword><Keyword MajorTopicYN="N">transcatheter mitral valve replacement (TMVR)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>3</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36741847</ArticleId><ArticleId IdType="pmc">PMC9889358</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.1058576</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>C&#xf4;t&#xe9; N, Pibarot P, Clavel M. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr Opin Cardiol. (2017) 32:123&#x2013;9. 10.1097/HCO.0000000000000372</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000372</ArticleId><ArticleId IdType="pubmed">28067715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylotte D, Osnabrugge R, Martucci G, Lange R, Kappetein A, Piazza N. Failing surgical bioprosthesis in aortic and mitral position. Eurointervention. (2013) 9:S77&#x2013;83. 10.4244/EIJV9SSA15</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJV9SSA15</ArticleId><ArticleId IdType="pubmed">24025964</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra H, Whistance R, Roubelakis A, Burton A, Barlow C, Tsang G, et al. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact Cardiovasc Thorac Surg. (2012) 14:575&#x2013;9. 10.1093/icvts/ivs005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivs005</ArticleId><ArticleId IdType="pmc">PMC3735849</ArticleId><ArticleId IdType="pubmed">22294560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta A, Yazdchi F, Alexis S, Percy E, Premkumar A, Hirji S, et al. Reoperative mitral surgery versus transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. (2021) 10:e019854. 10.1161/JAHA.120.019854</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.019854</ArticleId><ArticleId IdType="pmc">PMC8174229</ArticleId><ArticleId IdType="pubmed">33686870</ArticleId></ArticleIdList></Reference><Reference><Citation>Javadikasgari H, Chemtob R, Gillinov A, Pettersson G, Lowry A, Desai M, et al. Outcomes of mitral valve re-replacement for bioprosthetic structural valve deterioration. J Thorac Cardiovasc Surg. (2022) 163:1804&#x2013;12. 10.1016/j.jtcvs.2020.08.067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.08.067</ArticleId><ArticleId IdType="pubmed">33059934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic A, Acker M, Gleason T, Sultan I, Vemulapalli S, Thibault D, et al. Clinical outcomes of mitral valve reoperations in the united states: an analysis of the society of thoracic surgeons national database. Ann Thorac Surg. (2019) 107:754&#x2013;9. 10.1016/j.athoracsur.2018.08.083</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.08.083</ArticleId><ArticleId IdType="pubmed">30365952</ArticleId></ArticleIdList></Reference><Reference><Citation>Murzi M, Berti S, Gasbarri T, Trianni G, Maffei S, Solinas M, et al. Transapical transcatheter mitral valve-in-valve implantation versus minimally invasive surgery for failed mitral bioprostheses. Interact Cardiovasc Thorac Surg. (2017) 25:57&#x2013;61. 10.1093/icvts/ivx067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx067</ArticleId><ArticleId IdType="pubmed">28387805</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S, Whisenant B, Bleiziffer S, Delgado V, Dhoble A, Schofer N, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. (2019) 40:441&#x2013;51. 10.1093/eurheartj/ehy590</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy590</ArticleId><ArticleId IdType="pubmed">30357365</ArticleId></ArticleIdList></Reference><Reference><Citation>Whisenant B, Kapadia S, Eleid M, Kodali S, McCabe J, Krishnaswamy A, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol. (2020) 5:1245. 10.1001/jamacardio.2020.2974</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.2974</ArticleId><ArticleId IdType="pmc">PMC7391176</ArticleId><ArticleId IdType="pubmed">32745164</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman M, Al-Hijji M, Kawsara A, Patel B, Alkhouli M. Comparative outcomes of mitral valve in valve implantation versus redo mitral valve replacement for degenerated bioprotheses. Am J Cardiol. (2020) 132:175&#x2013;6. 10.1016/j.amjcard.2020.06.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.06.064</ArticleId><ArticleId IdType="pmc">PMC8393531</ArticleId><ArticleId IdType="pubmed">32723558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahid S, Ullah W, Hashem A, Khan M, Gowda S, Vishnevsky A, et al. Transcatheter valve-in-valve implantation versus redo surgical mitral valve replacement in patients with failed mitral bioprostheses. Eurointervention. (2022) 18:824&#x2013;35. 10.4244/EIJ-D-22-00437</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-22-00437</ArticleId><ArticleId IdType="pmc">PMC9724889</ArticleId><ArticleId IdType="pubmed">36106346</ArticleId></ArticleIdList></Reference><Reference><Citation>Szlapka M, Hausmann H, Timm J, Bauer A, Metz D, Pohling D, et al. Transcatheter mitral valve implantation versus conventional redo surgery for degenerated mitral valve prostheses and rings in a multicenter registry. J Thorac Cardiovasc Surg. (2022) S0022-5223(22)00831-5. 10.1016/j.jtcvs.2022.07.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2022.07.032</ArticleId><ArticleId IdType="pubmed">36088142</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill J, Zahra F, Retzer E. In-hospital outcomes and predictors of mortality for redo surgical mitral valve replacement versus transcatheter mitral valve-in-valve replacement. Am J Cardiol. (2022) 176:89&#x2013;95. 10.1016/j.amjcard.2022.04.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2022.04.023</ArticleId><ArticleId IdType="pubmed">35644696</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehaffey H, Hawkins R, Schubert S, Fonner C, Yarboro L, Quader M, et al. Contemporary outcomes in reoperative mitral valve surgery. Heart. (2018) 104:652&#x2013;6. 10.1136/heartjnl-2017-312047</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2017-312047</ArticleId><ArticleId IdType="pubmed">28982718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zia Khan M, Zahid S, Khan M, Kichloo A, Jamal S, Mannan Khan Minhas A, et al. Redo surgical mitral valve replacement versus transcatheter mitral valve in valve from the national inpatient sample. J Am Heart Assoc. (2021) 10:e020948. 10.1161/JAHA.121.020948</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.020948</ArticleId><ArticleId IdType="pmc">PMC8649266</ArticleId><ArticleId IdType="pubmed">34459226</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero M, Salinger M, Pursnani A, Pearson P, Lampert M, Levisay J, et al. Transseptal transcatheter mitral valve-in-valve: a step by step guide from preprocedural planning to postprocedural care. Catheter Cardiovasc Interv. (2018) 92:E185&#x2013;96. 10.1002/ccd.27128</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27128</ArticleId><ArticleId IdType="pubmed">28557344</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero M, Vemulapalli S, Xiang Q, Wang D, Eleid M, Cabalka A, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States. Circ Cardiovas Interv. (2020) 13:e008425. 10.1161/CIRCINTERVENTIONS.119.008425</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.119.008425</ArticleId><ArticleId IdType="pubmed">32138529</ArticleId></ArticleIdList></Reference><Reference><Citation>Schamroth Pravda N, Mishaev R, Levi A, Witberg G, Shapira Y, Orvin K, et al. Five-year outcomes of patients with mitral structural valve deterioration treated with transcatheter valve in valve implantation &#x2013; a single center prospective registry. Front Cardiovasc Med. (2022) 9:883242. 10.3389/fcvm.2022.883242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.883242</ArticleId><ArticleId IdType="pmc">PMC9086553</ArticleId><ArticleId IdType="pubmed">35557522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahid S, Ullah W, Khan M, Sarvepalli D, Inayat A, Salman F, et al. Meta-analysis comparing valve in valve transcatheter mitral valve replacement versus redo surgical mitral valve replacement for degenerating bioprosthetic valves. Am J Cardiol. (2021) 149:155&#x2013;6. 10.1016/j.amjcard.2021.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2021.03.005</ArticleId><ArticleId IdType="pubmed">33736998</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins S, Williamson K, Davidson M, Donahue B. Long-term mortality associated with acute kidney injury in children following congenital cardiac surgery. Paediatr Anaesth. (2014) 24:919&#x2013;26. 10.1111/pan.12419</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12419</ArticleId><ArticleId IdType="pubmed">24823449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko T, Piccirillo B, Golwala H, Trzcinka A, Nyman C, Shook D, et al. Balloon fracture of a surgical mitral bioprosthesis during valve-in-valve transcatheter mitral valve replacement: first-in-human report. Circ Cardiovasc Interv. (2018) 11:e6273. 10.1161/CIRCINTERVENTIONS.117.006273</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.117.006273</ArticleId><ArticleId IdType="pubmed">29311291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamioka N, Corrigan F, Iturbe J, Caughron H, Lerakis S, Thourani V, et al. Mitral bioprosthetic valve fracture: bailout procedure for undersized bioprosthesis during mitral valve-in-valve procedure with paravalvular leak closure. JACC Cardiovasc Interv. (2018) 11:e21&#x2013;2. 10.1016/j.jcin.2017.10.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2017.10.047</ArticleId><ArticleId IdType="pubmed">29413254</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. (2017) 38:2739&#x2013;91. 10.1093/eurheartj/ehx391</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx391</ArticleId><ArticleId IdType="pubmed">28886619</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V, Burwash I, Lam B, Auyeung T, Tran A, Mesana T, et al. Clinical and echocardiographic impact of functional tricuspid regurgitation repair at the time of mitral valve replacement. Ann Thorac Surg. (2009) 88:1209&#x2013;15. 10.1016/j.athoracsur.2009.06.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.06.034</ArticleId><ArticleId IdType="pubmed">19766809</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi G, Solinas M, Bevilacqua S, Glauber M. Which patient undergoing mitral valve surgery should also have the tricuspid repair? Interact Cardiovasc Thorac Surg. (2009) 9:1009&#x2013;20. 10.1510/icvts.2009.217570</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2009.217570</ArticleId><ArticleId IdType="pubmed">19778956</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard T, Lloyd J, Crestanello J, Thaden J, Alkhouli M, Guerrero M, et al. Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration. Catheter Cardiovasc Interv. (2022) 99:1659&#x2013;65. 10.1002/ccd.30059</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.30059</ArticleId><ArticleId IdType="pubmed">35019211</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wei P, Liu Y, Ma J, Wu H, Tan T, et al. Trends in redo mitral procedure for treating mitral bioprostheses failure: a single center&#x2019;s experience. Ann Transl Med. (2021) 9:1306. 10.21037/atm-21-3118</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-3118</ArticleId><ArticleId IdType="pmc">PMC8422140</ArticleId><ArticleId IdType="pubmed">34532443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubarevich A, Szczechowicz M, Zhigalov K, Marx P, Lind A, J&#xe1;nosi R, et al. Transapical transcatheter mitral valve implantation in patients with degenerated mitral bioprostheses or failed ring annuloplasty. Ann Cardiothorac Surg. (2021) 10:674&#x2013;82. 10.21037/acs-2021-tviv-fs-67</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs-2021-tviv-fs-67</ArticleId><ArticleId IdType="pmc">PMC8505924</ArticleId><ArticleId IdType="pubmed">34733695</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetto F, Purita P, Malerba M, Barbierato M, Pascotto A, Mangino D, et al. Surgical redo versus transseptal or transapical transcatheter mitral valve-in-valve implantation for failed mitral valve bioprosthesis. Catheter Cardiovasc Interv. (2021) 97:714&#x2013;22. 10.1002/ccd.29324</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.29324</ArticleId><ArticleId IdType="pubmed">33048438</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamioka N, Babaliaros V, Morse M, Frisoli T, Lerakis S, Iturbe J, et al. Comparison of clinical and echocardiographic outcomes after surgical redo mitral valve replacement and transcatheter mitral valve-in-valve therapy. JACC Cardiovasc Interv. (2018) 11:1131&#x2013;8. 10.1016/j.jcin.2018.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2018.03.011</ArticleId><ArticleId IdType="pubmed">29929633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37237276</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative outcomes in different anesthesia techniques for patients undergoing hip fracture surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>184</StartPage><MedlinePgn>184</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">184</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-023-02150-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Previous studies of the perioperative effects of general and regional anesthesia in adult patients undergoing effects of different anesthesia techniques on patients undergoing hip fracture surgery have not produced consistent results. The aim of this systematic review and meta-analysis was to compare the hip fracture surgery.</AbstractText><AbstractText Label="METHODS">We performed a systematic review and meta-analysis to compare the effects of general anesthesia with regional anesthesia on in-hospital mortality, 30-day mortality, postoperative pneumonia, and delirium in adult hip fracture patients (&#x2265;&#x2009;18&#xa0;years). Between January 1, 2022, and March 31, 2023, a systematic search was performed for retrospective observational and prospective randomized controlled studies in PubMed, Ovid Medline, Cochrane Library, and Scopus.</AbstractText><AbstractText Label="RESULTS">Twenty-one studies including 363,470 patients showed higher in-hospital mortality in the general anesthesia group compared with regional anesthesia (OR&#x2009;=&#x2009;1.21; 95% CI 1.13-1.29; P&#x2009;&lt;&#x2009;0.001, n&#x2009;=&#x2009;191,511). The 30-day mortality (OR&#x2009;=&#x2009;1.00; 95% CI 0.96-1.05; P&#x2009;=&#x2009;0.95, n&#x2009;=&#x2009;163,811), the incidence of postoperative pneumonia (OR&#x2009;=&#x2009;0.93; 95% CI 0.82-1.06; P&#x2009;=&#x2009;0.28, n&#x2009;=&#x2009;36,743) and the occurrence of postoperative delirium in the two groups (OR&#x2009;=&#x2009;0.94; 95% CI 0.74-1.20; P&#x2009;=&#x2009;0.61, n&#x2009;=&#x2009;2861) had no significant difference.</AbstractText><AbstractText Label="CONCLUSION">Regional anesthesia is associated with reduced in-hospital mortality. However, the type of anesthesia did not affect the occurrence of 30-day mortality, postoperative pneumonia, and delirium. A large number of randomized studies are needed in the future to examine the relationship between type of anesthesia, postoperative complications, and mortality.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ma</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Haibiao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Urology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Huayong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Wuhua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China. tuesdaymorninggz@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delirium</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Hip fractures</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pneumonia</Keyword><Keyword MajorTopicYN="N">Regional anesthesia</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37237276</ArticleId><ArticleId IdType="pmc">PMC10224302</ArticleId><ArticleId IdType="doi">10.1186/s12871-023-02150-9</ArticleId><ArticleId IdType="pii">10.1186/s12871-023-02150-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang C, Feng J, Wang S, et al. Incidence of and trends in hip fracture among adults in urban China: A nationwide retrospective cohort study. PLoS Med. 2020;17(8):e1003180. doi: 10.1371/journal.pmed.1003180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003180</ArticleId><ArticleId IdType="pmc">PMC7410202</ArticleId><ArticleId IdType="pubmed">32760065</ArticleId></ArticleIdList></Reference><Reference><Citation>National Hip Fracture Database.Annual report, The National Hip Fracture Database (nhfd.co.uk), 2020. Available from. (Accessed 21 April 2022)</Citation></Reference><Reference><Citation>Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop. 2011;45(1):15&#x2013;22. doi: 10.4103/0019-5413.73656.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5413.73656</ArticleId><ArticleId IdType="pmc">PMC3004072</ArticleId><ArticleId IdType="pubmed">21221218</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, et al. Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery: The RAGA Randomized Trial [published correction appears in. &#xa0;JAMA. 2022;327(12):1188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, et al. Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults. N Engl J Med. 2021;385(22):2025&#x2013;2035. doi: 10.1056/NEJMoa2113514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2113514</ArticleId><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi: 10.1136/bmj.n160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n160</ArticleId><ArticleId IdType="pmc">PMC8005925</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, Samuel AM, Grauer JG. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip.&#xa0;Bone Joint J. 2015; 97-B(5): 689&#x2013;695</Citation><ArticleIdList><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounet B, Choquet O, Swisser F, et al. Impact of multiple nerves blocks anaesthesia on intraoperative hypotension and mortality in hip fracture surgery intermediate-risk elderly patients: A propensity score-matched comparison with spinal and general anaesthesia. Anaesth Crit Care Pain Med. 2021;40(4):100924. doi: 10.1016/j.accpm.2021.100924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2021.100924</ArticleId><ArticleId IdType="pubmed">34217841</ArticleId></ArticleIdList></Reference><Reference><Citation>Brox WT, Chan PH, Cafri G, Inacio MC. Similar mortality with general or regional anesthesia in elderly hip fracture patients. Acta Orthop. 2016;87(2):152&#x2013;157. doi: 10.3109/17453674.2015.1128781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453674.2015.1128781</ArticleId><ArticleId IdType="pmc">PMC4812077</ArticleId><ArticleId IdType="pubmed">26986550</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, et al. Propensity Score-matched Comparison of Postoperative Adverse Outcomes between Geriatric Patients Given a General or a Neuraxial Anesthetic for Hip Surgery: A Population-based Study. Anesthesiology. 2015;123(1):136&#x2013;147. doi: 10.1097/ALN.0000000000000695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000695</ArticleId><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Patorno E, Neuman MD, Schneeweiss S, Mogun H, Bateman BT. Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study. BMJ. 2014;348:g4022. doi: 10.1136/bmj.g4022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g4022</ArticleId><ArticleId IdType="pmc">PMC4073666</ArticleId><ArticleId IdType="pubmed">24972901</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields AC, Dieterich JD, Buterbaugh K, Moucha CS. Short-term complications in hip fracture surgery using spinal versus general anaesthesia. Injury. 2015;46(4):719&#x2013;723. doi: 10.1016/j.injury.2015.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.02.002</ArticleId><ArticleId IdType="pubmed">25704139</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SM, Soltani H, Hashemi SJ, Talakoub R, Soleimani B. Comparative study of two anesthesia methods according to postoperative complications and one month mortality rate in the candidates of hip surgery. J Res Med Sci. 2011;16(3):323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214341</ArticleId><ArticleId IdType="pubmed">22091252</ArticleId></ArticleIdList></Reference><Reference><Citation>Helwani MA, Avidan MS, Ben Abdallah A, et al. Effects of regional versus general anesthesia on outcomes after total hip arthroplasty: a retrospective propensity-matched cohort study. J Bone Joint Surg Am. 2015;97(3):186&#x2013;193. doi: 10.2106/JBJS.N.00612.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.N.00612</ArticleId><ArticleId IdType="pubmed">25653318</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med. 2012;13(7):948&#x2013;956. doi: 10.1111/j.1526-4637.2012.01402.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2012.01402.x</ArticleId><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, Ludwig JM, Fleisher LA. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology. 2012;117(1):72&#x2013;92. doi: 10.1097/ALN.0b013e3182545e7c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182545e7c</ArticleId><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, Zubizarreta JR, Silber JH. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA. 2014;311(24):2508&#x2013;2517. doi: 10.1001/jama.2014.6499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.6499</ArticleId><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures.&#xa0; A pilot randomised controlled trial of 322 patients. Injury. 2015;46(8):1562&#x2013;1566. doi: 10.1016/j.injury.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.05.004</ArticleId><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff TA, Henderson WG, Stoner TJ, Khuri SF, Dohm M, Hutt E. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am. 2008;90(1):34&#x2013;42. doi: 10.2106/JBJS.G.00065.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.G.00065</ArticleId><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Gill SS, Bell CM, et al. Postoperative medical complications associated with anesthesia in older adults with dementia. J Am Geriatr Soc. 2014;62(11):2102&#x2013;2109. doi: 10.1111/jgs.13106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13106</ArticleId><ArticleId IdType="pubmed">25370019</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih JY, Hsieh CH, Kang TW, et al. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol. 2010;4:37&#x2013;42. doi: 10.1016/S1873-9598(10)70020-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1873-9598(10)70020-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung YC, Hsu YH, Chang GM. The Effect of Anesthetic Type on Outcomes of Hip Fracture Surgery: A Nationwide Population-Based Study. Medicine (Baltimore) 2016;95(14):e3296. doi: 10.1097/MD.0000000000003296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003296</ArticleId><ArticleId IdType="pmc">PMC4998813</ArticleId><ArticleId IdType="pubmed">27057897</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery.&#xa0;An observational audit of 65&#xa0;535 patients in a national dataset. Anaesthesia. 2014;69(3):224&#x2013;230. doi: 10.1111/anae.12542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12542</ArticleId><ArticleId IdType="pubmed">24428375</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R, et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint Audit of Practice (ASAP-2) Anaesthesia. 2016;71(5):506&#x2013;514. doi: 10.1111/anae.13415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.13415</ArticleId><ArticleId IdType="pubmed">26940645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood RJ, White SM. Anaesthesia for 1131 patients undergoing proximal femoral fracture repair: a retrospective, observational study of effects on blood pressure, fluid administration and perioperative anaemia. Anaesthesia. 2011;66(11):1017&#x2013;1022. doi: 10.1111/j.1365-2044.2011.06854.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2011.06854.x</ArticleId><ArticleId IdType="pubmed">21851345</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol. 2011;11:41. doi: 10.1186/1471-2288-11-41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-11-41</ArticleId><ArticleId IdType="pmc">PMC3102034</ArticleId><ArticleId IdType="pubmed">21473747</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.&#xa0;BMJ. 2011; 343</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.&#xa0;BMJ. 2016; 355</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int. 2010;21(Suppl 4):S555&#x2013;S572. doi: 10.1007/s00198-010-1399-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-010-1399-7</ArticleId><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, Kopp S. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev. 2016;2(2):CD000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, Coburn M. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis.&#xa0;BMC Anesthesiol. 2017; 17(1): 87</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell CM, McLoughlin L, Patterson CC, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis Br J Anaesth. 2018;120(1):37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilango S, Pulle RC, Bell J, Kuys SS. General versus spinal anaesthesia and postoperative delirium in an orthogeriatric population. Australas J Ageing. 2016;35(1):42&#x2013;47. doi: 10.1111/ajag.12212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajag.12212</ArticleId><ArticleId IdType="pubmed">26364948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200&#x2013;207. doi: 10.7326/0003-4819-158-3-201302050-00583.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-3-201302050-00583</ArticleId><ArticleId IdType="pmc">PMC5114123</ArticleId><ArticleId IdType="pubmed">23295957</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31864699</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>160</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Peripheral versus central extracorporeal membrane oxygenation for postcardiotomy shock: Multicenter registry, systematic review, and meta-analysis.</ArticleTitle><Pagination><StartPage>1207</StartPage><EndPage>1216.e44</EndPage><MedlinePgn>1207-1216.e44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2019.10.078</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(19)32376-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">We hypothesized that cannulation strategy in venoarterial extracorporeal membrane oxygenation (VA-ECMO) could play a crucial role in the perioperative survival of patients affected by postcardiotomy shock.</AbstractText><AbstractText Label="METHODS">Between January 2010 and March 2018, 781 adult patients receiving VA-ECMO for postcardiotomy shock at 19 cardiac surgical centers were retrieved from the Postcardiotomy Veno-arterial Extracorporeal Membrane Oxygenation study registry. A parallel systematic review and meta-analysis (PubMed/MEDLINE, Embase, and Cochrane Library) through December 2018 was also accomplished.</AbstractText><AbstractText Label="RESULTS">Central and peripheral VA-ECMO cannulation were performed in 245 (31.4%) and 536 (68.6%) patients, respectively. Main indications for the institution VA-ECMO were failure to wean from cardiopulmonary bypass (38%) and heart failure following cardiopulmonary bypass weaning (48%). The doubly robust analysis after inverse probability treatment weighting by propensity score demonstrated that central VA-ECMO was associated with greater hospital mortality (odds ratio 1.54; 95% confidence interval, 1.09-2.18), reoperation for bleeding/tamponade (odds ratio, 1.96; 95% confidence interval, 1.37-2.81), and transfusion of more than 9 RBC units (odds ratio, 2.42; 95% confidence interval, 1.59-3.67). The systematic review provided a total of 2491 individuals with postcardiotomy shock treated with VA-ECMO. Pooled prevalence of in-hospital/30-day mortality in overall patient population was 66.6% (95% confidence interval, 64.7-68.4%), and pooled unadjusted risk ratio analysis confirmed that patients undergoing peripheral VA-ECMO had a lower in-hospital/30-day mortality than patients undergoing central cannulation (risk ratio, 0.92; 95% confidence interval, 0.87-0.98). Adjustments for important confounders did not alter our results.</AbstractText><AbstractText Label="CONCLUSIONS">In patients with postcardiotomy shock treated with VA-ECMO, central cannulation was associated with greater in-hospital mortality than peripheral cannulation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mariscalco</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom. Electronic address: giovannimariscalco@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salsano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiore</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Henri Mondor University Hospital, AP-HP, Paris-Est University, Cr&#xe9;teil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dal&#xe9;n</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggieri</LastName><ForeName>Vito G</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic and Vascular Surgery, Robert Debr&#xe9; University Hospital, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeed</LastName><ForeName>Diyar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, University Hospital of Dusseldorf, Dusseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf3;nsson</LastName><ForeName>Kristj&#xe1;n</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatti</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zipfel</LastName><ForeName>Svante</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hamburg University Heart Center, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dell'Aquila</LastName><ForeName>Angelo M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, M&#xfc;nster University Hospital, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrotti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loforte</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, S. Orsola Hospital, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livi</LastName><ForeName>Ugolino</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Cardiothoracic Department, University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pol</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Clinical and Experimental Medicine, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadaccio</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettinari</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburgl, Genk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragnarsson</LastName><ForeName>Sigurdur</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University of Lund, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhamees</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Prince Sultan Cardiac Center, Al Hassa, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Dean</LastName><ForeName>Zein</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bounader</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biancari</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Heart Center, Turku University Hospital and University of Turku, Turku, Finland; Department of Surgery, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PC-ECMO group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2020 Nov;160(5):1218-1219. doi: 10.1016/j.jtcvs.2019.11.063.</RefSource><PMID Version="1">31926726</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2020 Nov;160(5):1220-1221. doi: 10.1016/j.jtcvs.2019.10.132.</RefSource><PMID Version="1">31928828</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2020 Nov;160(5):1217-1218. doi: 10.1016/j.jtcvs.2019.10.180.</RefSource><PMID Version="1">31987618</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="N">Shock</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECMO</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">postcardiotomy</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Dashey</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yusuff</LastName><ForeName>Hakeem</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porter</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sampson</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harvey</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Settembre</LastName><ForeName>Nicla</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fux</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amr</LastName><ForeName>Gilles</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lichtenberg</LastName><ForeName>Artur</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jeppsson</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabrielli</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reichart</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welp</LastName><ForeName>Henryk</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chocron</LastName><ForeName>Sidney</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorentino</LastName><ForeName>Mariafrancesca</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lechiancole</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Netuka</LastName><ForeName>Ivan</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Keyzer</LastName><ForeName>Dieter</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strauven</LastName><ForeName>Maarten</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xe4;lve</LastName><ForeName>Kristiina</ForeName><Initials>K</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31864699</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2019.10.078</ArticleId><ArticleId IdType="pii">S0022-5223(19)32376-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40884710</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7322</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Heart failure reviews</Title><ISOAbbreviation>Heart Fail Rev</ISOAbbreviation></Journal><ArticleTitle>Infective endocarditis complicated by shock: a systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10741-025-10556-5</ELocationID><Abstract><AbstractText>Infective endocarditis (IE) complicated by septic or cardiogenic shock is linked to a marked increase in morbidity and mortality rates. This systematic review and meta-analysis sought to evaluate clinical outcomes, identify prognostic factors, and assess the effects of valve surgical intervention in patients with infective endocarditis complicated by shock. Systematic searches were performed in PubMed, Cochrane Library, and Google Scholar databases, following PRISMA and MOOSE guidelines. Included were observational studies published from January 2015 to May 2025 that reported on adult patients with infective endocarditis complicated by septic or cardiogenic shock. A random-effects model was utilized for data synthesis (restricted maximum likelihood with Hartung-Knapp adjustment), and meta-regression was conducted to assess sources of heterogeneity. Seven observational studies were included (n&#x2009;=&#x2009;183-255,838). In-hospital mortality among patients with shock was 62.3% (95% CI 48.3-74.5%). Compared with IE without shock, the pooled odds ratio for in-hospital mortality (HK-REML) was 5.83 (95% CI 1.35-25.23; 95% prediction interval 0.26-129.69), with substantial heterogeneity (I<sup>2</sup>&#x2009;=&#x2009;90.3%). Valve surgical intervention was associated with reduced mortality, particularly in cardiogenic shock. Staphylococcus aureus was the most common pathogen in available microbiological data. Shock was frequently accompanied by acute kidney injury, neurological complications, and multiorgan dysfunction. Infective endocarditis complicated by shock carries an extremely poor prognosis, with pooled mortality exceeding 60%. Prompt recognition of shock, timely initiation of appropriate antimicrobial therapy, hemodynamic stabilization, and early valve surgery are crucial to improve outcomes in this high-risk population. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: CRD420250652570.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xee;r&#xee;ianu-Masgras</LastName><ForeName>Roxana-Bianca</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd, 050474, Bucharest, Romania. roxana-bianca.masgras@drd.umfcd.ro.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mebazaa</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Critical Care, Lariboisi&#xe8;re Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savarese</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoica</LastName><ForeName>Emanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>1, Department of Cardiology, Emergency Institute for Cardiovascular Diseases "C.C.Iliescu", 258 Fundeni St, 022328, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geavlete</LastName><ForeName>Oliviana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd, 050474, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1, Department of Cardiology, Emergency Institute for Cardiovascular Diseases "C.C.Iliescu", 258 Fundeni St, 022328, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrosy</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antohi</LastName><ForeName>Elena-Laura</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd, 050474, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1, Department of Cardiology, Emergency Institute for Cardiovascular Diseases "C.C.Iliescu", 258 Fundeni St, 022328, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yilmaz</LastName><ForeName>Mehmet Birhan</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, Dokuz Eyl&#xfc;l University, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radu</LastName><ForeName>Razvan-Ilie</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd, 050474, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1, Department of Cardiology, Emergency Institute for Cardiovascular Diseases "C.C.Iliescu", 258 Fundeni St, 022328, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamo</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Cardiology, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Beth A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>UMR-S 942 (MASCOT), Universit&#xe9; Paris Cit&#xe9;, INSERM, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Momentum Research Inc, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Heart Initiative, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biegus</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Clinical Department of Intensive Cardiac Care, Institute of Heart Diseases, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotter</LastName><ForeName>Gad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UMR-S 942 (MASCOT), Universit&#xe9; Paris Cit&#xe9;, INSERM, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Momentum Research Inc, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Heart Initiative, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Javed</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Baylor Scott and White Research Institute, Dallas, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Mississippi Medical Center, Jackson, MS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Sean P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chioncel</LastName><ForeName>Ovidiu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd, 050474, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1, Department of Cardiology, Emergency Institute for Cardiovascular Diseases "C.C.Iliescu", 258 Fundeni St, 022328, Bucharest, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Fail Rev</MedlineTA><NlmUniqueID>9612481</NlmUniqueID><ISSNLinking>1382-4147</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Clinical outcomes</Keyword><Keyword MajorTopicYN="N">Infective endocarditis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval: This article does not contain any studies with human participants or animals performed by any of the authors. Consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40884710</ArticleId><ArticleId IdType="doi">10.1007/s10741-025-10556-5</ArticleId><ArticleId IdType="pii">10.1007/s10741-025-10556-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075&#x2013;128.</Citation></Reference><Reference><Citation>Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, Hirsch GA, Mehta JL (2015) Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 65(19):2070&#x2013;2076</Citation><ArticleIdList><ArticleId IdType="pubmed">25975469</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlton EW, Cullen L, Than M, Gamble J, Khattab A, Greaves K (2015) A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin. Heart 101(13):1041&#x2013;1046</Citation><ArticleIdList><ArticleId IdType="pubmed">25691511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir T, Uddin M, Qureshi WT, Regmi N, Tleyjeh IM, Saydain G (2022) Predictors of complications secondary to infective endocarditis and their associated outcomes: a large cohort study from the National Emergency Database (2016&#x2013;2018). Infect Dis Ther 11(1):305&#x2013;321</Citation><ArticleIdList><ArticleId IdType="pubmed">34817839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostaghim AS, Lo HYA, Khardori N (2017) A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital. SAGE Open Med 5:2050312117741772</Citation><ArticleIdList><ArticleId IdType="pubmed">29163950</ArticleId><ArticleId IdType="pmc">5692128</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajani R, Klein JL (2020) Infective endocarditis: a contemporary update. Clin Med (Lond) 20(1):31&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">31941729</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajinovic V, Ivancic S, Gezman P, Barsic B (2018) Association between cardiac surgery and mortality among patients with infective endocarditis complicated by sepsis and septic shock. Shock 49(5):536&#x2013;542</Citation><ArticleIdList><ArticleId IdType="pubmed">28991051</ArticleId></ArticleIdList></Reference><Reference><Citation>Peric&#xe0;s JM, Hern&#xe1;ndez-Meneses M, Mu&#xf1;oz P, Mart&#xed;nez-Sell&#xe9;s M, &#xc1;lvarez-Uria A, de Alarc&#xf3;n A, Guti&#xe9;rrez-Carretero E, Goenaga MA, Zarauza MJ, Falces C, Rodr&#xed;guez-Esteban M, Hidalgo-Tenorio C, Hern&#xe1;ndez-Cabrera M, Mir&#xf3; JM (2021) Characteristics and outcome of acute heart failure in infective endocarditis: focus on cardiogenic shock. Clin Infect Dis 73(5):765&#x2013;774</Citation><ArticleIdList><ArticleId IdType="pubmed">33560404</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmos C, Vilacosta I, Fern&#xe1;ndez C, L&#xf3;pez J, Sarri&#xe1; C, Ferrera C, Revilla A, Silva J, Vivas D, Gonz&#xe1;lez I, San Rom&#xe1;n JA (2013) Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J 34(26):1999&#x2013;2006</Citation><ArticleIdList><ArticleId IdType="pubmed">23060453</ArticleId></ArticleIdList></Reference><Reference><Citation>Peric&#xe0;s JM, Hern&#xe1;ndez-Meneses M, Mu&#xf1;oz P, &#xc1;lvarez-Ur&#xed;a A, Pinilla-Llorente B, de Alarc&#xf3;n A, Reviejo K, Fari&#xf1;as MC, Falces C, Goikoetxea-Agirre J, G&#xe1;lvez-Acebal J, Hidalgo-Tenorio C, G&#xf3;mez-Nebreda E, Miro JM (2021) Outcomes and risk factors of septic shock in patients with infective endocarditis: a prospective cohort study. Open Forum Infect Dis 8(6):ofab119</Citation><ArticleIdList><ArticleId IdType="pubmed">34189153</ArticleId><ArticleId IdType="pmc">8232381</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzi L, Sperandeo L, Forzano I, et al (2024) Contemporary evidence and practice on right heart catheterization in patients with acute or chronic heart failure. Diagnostics (Basel) 14(2):136. https://doi.org/10.3390/diagnostics14020136</Citation></Reference><Reference><Citation>Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293(24):3012&#x2013;3021</Citation><ArticleIdList><ArticleId IdType="pubmed">15972563</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques A, Cruz I, Caldeira D, Alegria S, Gomes AC, Broa AL, Jo&#xe3;o I, Pereira H (2020) Risk factors for in-hospital mortality in infective endocarditis. Arq Bras Cardiol 114(1):1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">31751437</ArticleId><ArticleId IdType="pmc">7025303</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelsomino S, Maessen JG, van der Veen F, Livi U, Renzulli A, Luc&#xe0; F, Carella R, Crudeli E, Rubino A, Rostagno C, Russo C, Borghetti V, Beghi C, De Bonis M, Gensini GF, Lorusso R (2012) Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. Ann Thorac Surg 93(5):1469&#x2013;1476</Citation><ArticleIdList><ArticleId IdType="pubmed">22342063</ArticleId></ArticleIdList></Reference><Reference><Citation>Handa K, Yoshioka D, Toda K, Yokoyama JY, Samura T, Suzuki K, Miyagawa S, Matsumiya G, Sakaguchi T, Fukuda H, Sawa Y (2020) Surgical results for infective endocarditis complicated with cardiogenic shock. Circ J 84(6):926&#x2013;934</Citation><ArticleIdList><ArticleId IdType="pubmed">32295976</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71</Citation><ArticleIdList><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2024) Cochrane handbook for systematic reviews of interventions version 6.5. Cochrane 2024. Available from https://www.cochrane.org/handbook</Citation></Reference><Reference><Citation>Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603&#x2013;605</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, Roen K, Duffy S (2006) Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version 1(1):b92</Citation></Reference><Reference><Citation>Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1&#x2013;48</Citation></Reference><Reference><Citation>Hartung J, Knapp G (2001) On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat Med 20(12):1771&#x2013;1782</Citation><ArticleIdList><ArticleId IdType="pubmed">11406840</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Higgins JP, Deeks JJ (2011) Interpretation of random effects meta-analyses. Bmj 342:d549</Citation><ArticleIdList><ArticleId IdType="pubmed">21310794</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557&#x2013;560</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId><ArticleId IdType="pmc">192859</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W, Cheung MW (2010) Outlier and influence diagnostics for meta-analysis. Res Synth Methods 1(2):112&#x2013;125</Citation><ArticleIdList><ArticleId IdType="pubmed">26061377</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21(11):1559&#x2013;1573</Citation><ArticleIdList><ArticleId IdType="pubmed">12111920</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54(10):1046&#x2013;1055</Citation><ArticleIdList><ArticleId IdType="pubmed">11576817</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting . Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283(15):2008&#x2013;2012</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, Tugwell P (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.</Citation></Reference><Reference><Citation>Motoc A, Kessels J, Roosens B, Lacor P, Van de Veire N, De Sutter J, Magne J, Droogmans S, Cosyns B (2023) Impact of the initial clinical presentation on the outcome of patients with infective endocarditis. Cardiol J 30(3):385&#x2013;390</Citation><ArticleIdList><ArticleId IdType="pubmed">34240402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lnu S, Jamal A, Raza MA, Umar Z, Ahmad S, Alvi W, Khattak LZ, Ajmal A, Ullah N, Khan K (2025) Infective endocarditis in septic shock: results from an observational multicenter study. Cureus 17(2):e78927</Citation><ArticleIdList><ArticleId IdType="pubmed">40092000</ArticleId><ArticleId IdType="pmc">11909614</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioncel O, Vinereanu D, Datcu M, Ionescu DD, Capalneanu R, Brukner I, Dorobantu M, Ambrosy A, Macarie C, Gheorghiade M (2011) The Romanian acute heart failure syndromes (RO-AHFS) registry. Am Heart journal. 162(1):142&#x2013;153 (e1)</Citation></Reference><Reference><Citation>Becher PM, Go&#xdf;ling A, Fluschnik N, Schrage B, Seiffert M, Schofer N, Blankenberg S, Kirchhof P, Westermann D, Kalbacher D (2024) Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019. Clin Res Cardiol 113(2):205&#x2013;215</Citation><ArticleIdList><ArticleId IdType="pubmed">36094574</ArticleId></ArticleIdList></Reference><Reference><Citation>Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F, D&#x2019;Aiello I, Picchi A, De Sensi F, Habib G (2017) Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther 7(1):27&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">28164010</ArticleId><ArticleId IdType="pmc">5253443</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P (2011) Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis 11(1):48</Citation><ArticleIdList><ArticleId IdType="pubmed">21345185</ArticleId><ArticleId IdType="pmc">3051911</ArticleId></ArticleIdList></Reference><Reference><Citation>Abegaz TM, Bhagavathula AS, Gebreyohannes EA, Mekonnen AB, Abebe TB (2017) Short- and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis. BMC Cardiovasc Disord 17(1):291</Citation><ArticleIdList><ArticleId IdType="pubmed">29233094</ArticleId><ArticleId IdType="pmc">5728061</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, Caselli S, Doenst T, Ederhy S, Erba PA, Foldager D, Fosb&#xf8;l EL, Kovac J, Mestres CA, Miller OI, Miro JM, Pazdernik M, Pizzi MN, Quintana E, Rasmussen TB, Risti&#x107; AD, Rod&#xe9;s-Cabau J, Sionis A, Z&#xfc;hlke LJ, Borger MA (2023) 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 44(39):3948&#x2013;4042</Citation><ArticleIdList><ArticleId IdType="pubmed">37622656</ArticleId></ArticleIdList></Reference><Reference><Citation>Malvindi PG, Luthra S, Zingale A, Bifulco O, Berretta P, Pierri MD, Ohri SK, Di Eusanio M (2024) Surgical repair and replacement for native mitral valve infective endocarditis. J Cardiovasc Med (Hagerstown) 25(4):334&#x2013;341</Citation><ArticleIdList><ArticleId IdType="pubmed">38407841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj A, Kumar S, Salas de Armas IA, Nascimbene A, Nathan S, Kar B, Gregoric ID (2022) Pre- and post-operative mechanical circulatory support in surgical repair of post-acute myocardial infarction mechanical complications. Ann Cardiothorac Surg 11(3):304&#x2013;309</Citation><ArticleIdList><ArticleId IdType="pubmed">35733711</ArticleId><ArticleId IdType="pmc">9207699</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilotra NA, Stevens GR (2014) Temporary mechanical circulatory support: a review of the options, indications, and outcomes. Clin Med Insights Cardiol 8(Suppl 1):75&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pubmed">25674024</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso R, Lo Coco V, Ravaux JM, Mariani S (2022) The use of mechanical circulatory support in post-acute myocardial infarction mechanical complications. Ann Cardiothorac Surg 11(3):325&#x2013;327</Citation><ArticleIdList><ArticleId IdType="pubmed">35733721</ArticleId><ArticleId IdType="pmc">9207683</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobreiro DI, Sampaio RO, Siciliano RF, Brazil CV, Branco CE, Lopes AS, Tarasoutchi F, Strabelli TM (2019) Early diagnosis and treatment in infective endocarditis: challenges for a better prognosis. Arquivos Brasileiros de Cardiologia 112(2):201&#x2013;3</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34929644</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2653</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia</Title><ISOAbbreviation>J Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Impact of age on mortality and complications in patients with Ankylosing Spondylitis spine fractures.</ArticleTitle><Pagination><StartPage>188</StartPage><EndPage>197</EndPage><MedlinePgn>188-197</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jocn.2021.11.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0967-5868(21)00590-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this retrospective cohort study was to study the impact of age on in-hospital complications and mortality following surgery for Ankylosing Spondylitis (AS) associated spine fractures.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We extracted data from the Nationwide Inpatient Sample (NIS) database (1998-2018) using ICD-9/10 codes. Patients with a primary diagnosis of AS associated spine fractures who underwent fusion surgery were included. Complications and in-hospital mortality were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total cohort of 8526 patients was identified. Overall, the median age of the cohort was 69&#xa0;years. AS associated fractures were equally distributed among cervical and thoracolumbar regions. Overall, complications were noted in 48% of patients and pulmonary complications were the most common (32%) followed by renal (13%) and infection (12%). Complications were seen in 57.3% of patients&#xa0;&#x2265;&#xa0;70&#xa0;years of age compared to 38.4% of patients&#xa0;&lt;&#xa0;70&#xa0;years of age (p&#xa0;&lt;&#xa0;.0001). Also, 9.9 % of patients&#xa0;&#x2265;&#xa0;70&#xa0;years of age had in-hospital mortality compared to 3.1 % of patients&#xa0;&lt;&#xa0;70&#xa0;years of age (p&#xa0;&lt;&#xa0;.0001). Based on surgical approaches, elderly patients (&#x2265;70&#xa0;years) who underwent anterior, posterior, and anterior&#xa0;+&#xa0;posterior approaches had 19.8%, 7.4% and 16.4% in-hospital mortality compared to 5.3%, 2.2% and 7.4% respectively for patients&#xa0;&lt;&#xa0;70&#xa0;years.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Elderly patients (&#x2265;70&#xa0;years of age) were 3.2 times more likely to have in-hospital mortality and higher complications compared to younger patients (57% vs. 38%). Cervical compared to thoracolumbar fractures and anterior compared to posterior surgical approaches were associated with higher complications and in-hospital mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Mayur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Louisville, 200 Abraham Flexner Hwy, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Louisville, 200 Abraham Flexner Hwy, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dengzhi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Louisville, 200 Abraham Flexner Hwy, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugiliweneza</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Louisville, 200 Abraham Flexner Hwy, Louisville, KY 40202, USA; Kentucky Spinal Cord Injury Research Center, School of Medicine, University of Louisville, Louisville, KY, USA; Department of Health Management and Systems Science, School of Public Health and Information Science, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boakye</LastName><ForeName>Maxwell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Louisville, 200 Abraham Flexner Hwy, Louisville, KY 40202, USA; Kentucky Spinal Cord Injury Research Center, School of Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drazin</LastName><ForeName>Doniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pacific Northwest University of Health Sciences, Yakima, WA, USA. Electronic address: ddrazin@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Clin Neurosci</MedlineTA><NlmUniqueID>9433352</NlmUniqueID><ISSNLinking>0967-5868</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002574" MajorTopicYN="N">Cervical Vertebrae</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013167" MajorTopicYN="Y">Spondylitis, Ankylosing</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ankylosing Spondylitis</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Fracture</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">National trends</Keyword><Keyword MajorTopicYN="N">Nationwide inpatient sample</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Spine</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>20</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34929644</ArticleId><ArticleId IdType="doi">10.1016/j.jocn.2021.11.035</ArticleId><ArticleId IdType="pii">S0967-5868(21)00590-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33632610</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Editor's Choice - Systematic Review and Meta-Analysis of the Effect of Weekend Admission on Outcomes for Ruptured Abdominal Aortic Aneurysms: A Call for an Equitable Seven Day Vascular Service.</ArticleTitle><Pagination><StartPage>767</StartPage><EndPage>778</EndPage><MedlinePgn>767-778</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2020.12.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(21)00001-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE">"The weekend effect" of higher patient mortality when presenting at a weekend compared with a weekday has been established for several conditions. The aim of this study was to investigate whether a weekend effect exists for the emergency condition of ruptured abdominal aortic aneurysm.</AbstractText><AbstractText Label="DATA SOURCES">A review of the literature was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines (PROSPERO registration number CRD42020157484). MEDLINE, EMBASE and CINAHL were searched using the Healthcare Databases Advanced Search interface developed by NICE.</AbstractText><AbstractText Label="REVIEW METHODS">The prognostic factor of interest was weekend admission. The primary outcome of interest was all cause peri-operative mortality, with a secondary outcome of hospital length of stay. A random effects meta-analysis was performed, and the results were reported as summary odds ratio (OR) and 95% confidence interval (CI).</AbstractText><AbstractText Label="RESULTS">Twelve observational cohort studies published between 2001 and 2019 comprising 14 patient cohorts with a total of 95 856 patients were eligible for quantitative synthesis. Patients presenting on a weekend had a significantly higher risk of unadjusted in hospital mortality (OR 1.20, 95% CI 1.10 - 1.31, p &lt; .001). Both the unadjusted 30 day mortality risk (OR 1.16, 95% CI 0.98 - 1.39, p&#xa0;= .090) and unadjusted 90 day mortality risk (OR 1.12, 95% CI 0.90 - 1.40, p&#xa0;= .30) were higher for those presenting at a weekend, but neither reached statistical significance. There was a significantly greater risk of combined unadjusted in hospital, 30 and 90 day mortality for those presenting at a weekend (OR 1.17, 95% CI 1.09 - 1.27, p &lt; .001). Hospital length of stay was not statistically different between groups.</AbstractText><AbstractText Label="CONCLUSION">There is an association between weekend admission and higher mortality in patients presenting with ruptured abdominal aortic aneurysm.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leatherby</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Vascular &amp; Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Northern Care Alliance NHS Group, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Madison R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Tameside Hospital, Tameside and Glossop NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Vascular &amp; Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Northern Care Alliance NHS Group, Manchester, UK; Division of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Manchester, UK. Electronic address: antoniou.ga@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2021 Oct;62(4):660. doi: 10.1016/j.ejvs.2021.06.042.</RefSource><PMID Version="1">34456117</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001019" MajorTopicYN="N">Aortic Rupture</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="N">Conservative Treatment</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004638" MajorTopicYN="N">Emergency Treatment</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Ruptured abdominal aortic aneurysm</Keyword><Keyword MajorTopicYN="N">Weekend effect</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33632610</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2020.12.022</ArticleId><ArticleId IdType="pii">S1078-5884(21)00001-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32151576</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-6259</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Surgical Pulmonary Embolectomy Outcomes for Acute Pulmonary Embolism.</ArticleTitle><Pagination><StartPage>1072</StartPage><EndPage>1080</EndPage><MedlinePgn>1072-1080</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2020.01.075</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0003-4975(20)30345-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute pulmonary embolism (PE) is associated with significant mortality. Surgical embolectomy is a viable treatment option; however, it remains controversial as a result of variable outcomes. This review investigates patient outcomes after surgical embolectomy for acute PE.</AbstractText><AbstractText Label="METHODS">An electronic search was performed to identify articles reporting surgical embolectomy for treatment of PE. 32 studies were included comprising 936 patients. Demographic, perioperative, and outcome data were extracted and pooled for systematic review.</AbstractText><AbstractText Label="RESULTS">Mean patient age was 56.3 years (95% confidence interval [CI], 52.5, 60.1), and 50% were male (95% CI, 46, 55); 82% had right ventricular dysfunction (95% CI, 62, 93), 80% (95% CI, 67, 89) had unstable hemodynamics, and 9% (95% CI, 5, 16) experienced cardiac arrest. Massive PE and submassive PE were present in 83% (95% CI, 43, 97)] and 13% (95% CI, 2, 56) of patients, respectively. Before embolectomy, 33% of patients (95% CI, 14, 60) underwent systemic thrombolysis, and 14% (95% CI, 8, 24) underwent catheter embolectomy. Preoperatively, 47% of patients were ventilated (95% CI, 26; 70), and 36% had percutaneous cardiopulmonary support (95% CI, 11, 71). Mean operative time and mean cardiopulmonary bypass time were 170 minutes (95% CI, 101, 239) and 56 minutes (95% CI, 42, 70), respectively. Intraoperative mortality was 4% (95% CI, 2, 8). Mean hospital and intensive care unit stay were 10 days (95% CI, 6, 14) and 2 days (95% CI, 1, 3), respectively. Mean postoperative systolic pulmonary artery pressure (sPAP) was significantly decreased from the preoperative period (sPAP 57.8, mm Hg; 95% CI, 53, 62.7) to the postoperative period (sPAP, 31.3 mm Hg; 24.9, 37.8); P &lt; .01). In-hospital mortality was 16% (95% CI, 12, 21). Overall survival at 5 years was 73% (95% CI, 64, 81).</AbstractText><AbstractText Label="CONCLUSIONS">Surgical embolectomy is an acceptable treatment option with favorable outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jae Hwan</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Malley</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maynes</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Antonio</LastName><ForeName>Nicholas D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mellado</LastName><ForeName>Mart&#xed;n</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Frances M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Division of Critical Care, Pulmonary/Allergy, and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galanis</LastName><ForeName>Taki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Thomas Jefferson Vascular Center, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonsalves</LastName><ForeName>Carin F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Division of Vascular and Interventional Radiology, Thomas Jefferson University Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marhefka</LastName><ForeName>Gregary D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awsare</LastName><ForeName>Bharat K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Division of Critical Care, Pulmonary/Allergy, and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merli</LastName><ForeName>Geno J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Thomas Jefferson Vascular Center, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tchantchaleishvili</LastName><ForeName>Vakhtang</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: vakhtang.tchantchaleishvili@jefferson.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Thorac Surg. 2020 Sep;110(3):1080-1081. doi: 10.1016/j.athoracsur.2020.03.042.</RefSource><PMID Version="1">32315644</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Thorac Surg. 2021 Jul;112(1):344. doi: 10.1016/j.athoracsur.2020.08.112.</RefSource><PMID Version="1">33253668</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Thorac Surg. 2021 Jul;112(1):344-345. doi: 10.1016/j.athoracsur.2020.11.084.</RefSource><PMID Version="1">33621548</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017128" MajorTopicYN="N">Embolectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32151576</ArticleId><ArticleId IdType="doi">10.1016/j.athoracsur.2020.01.075</ArticleId><ArticleId IdType="pii">S0003-4975(20)30345-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33773889</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Predicting Readmission to Intensive Care After Cardiac Surgery Within Index Hospitalization: A Systematic Review.</ArticleTitle><Pagination><StartPage>2166</StartPage><EndPage>2179</EndPage><MedlinePgn>2166-2179</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2021.02.056</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(21)00191-9</ELocationID><Abstract><AbstractText>Readmission to the cardiac intensive care unit after cardiac surgery has significant implications for both patients and healthcare providers. Identifying patients at risk of readmission potentially could improve outcomes. The objective of this systematic review was to identify risk factors and clinical prediction models for readmission within a single hospitalization to intensive care after cardiac surgery. PubMed, MEDLINE, and EMBASE databases were searched to identify candidate articles. Only studies that used multivariate analyses to identify independent predictors were included. There were 25 studies and five risk prediction models identified. The overall rate of readmission pooled across the included studies was 4.9%. In all 25 studies, in-hospital mortality and duration of hospital stay were higher in patients who experienced readmission. Recurring predictors for readmission were preoperative renal failure, age &gt;70, diabetes, chronic obstructive pulmonary disease, preoperative left ventricular ejection fraction &lt;30%, type and urgency of surgery, prolonged cardiopulmonary bypass time, prolonged postoperative ventilation, postoperative anemia, and neurologic dysfunction. The majority of readmissions occurred due to respiratory and cardiac complications. Four models were identified for predicting readmission, with one external validation study. As all models developed to date had limitations, further work on larger datasets is required to develop clinically useful models to identify patients at risk of readmission to the cardiac intensive care unit after cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kimani</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Sciences, University of Manchester, ERC, Manchester University Hospital Foundation Trust, Manchester, UK. Electronic address: linda.kimani@manchester.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howitt</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Sciences, University of Manchester, ERC, Manchester University Hospital Foundation Trust, Manchester, UK; Department of Cardiothoracic Anaesthesia and Critical Care, Wythenshawe Hospital, Manchester University Hospital Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tennyson</LastName><ForeName>Charlene</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Blackpool Victoria Hospital, Blackpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Templeton</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and Critical Care, Wythenshawe Hospital, Manchester University Hospital Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCollum</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Sciences, University of Manchester, ERC, Manchester University Hospital Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Stuart W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Sciences, University of Manchester, ERC, Manchester University Hospital Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PG/16/80/32411</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="Y">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">readmission to intensive care</Keyword><Keyword MajorTopicYN="N">risk prediction model</Keyword></KeywordList><CoiStatement>Conflict of Interest All the authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>28</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33773889</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2021.02.056</ArticleId><ArticleId IdType="pii">S1053-0770(21)00191-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35419440</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Appropriate Timing of Coronary Artery Bypass Graft Surgery for Acute Myocardial Infarction Patients: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>794925</StartPage><MedlinePgn>794925</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">794925</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.794925</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Currently, percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are commonly used in the treatment of coronary atherosclerotic heart disease. But the optimal timing for CABG after acute myocardial infarction (AMI) is still controversial. The purpose of this article was to evaluate the optimal timing for CABG in AMI.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched the PubMed, Embase, and Cochrane library databases for documents that met the requirements. The primary outcome was in-hospital mortality. The secondary outcomes were perioperative myocardial infarction (MI) incidence and cerebrovascular accident incidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The search strategy produced 1,742 studies, of which 19 studies (including data from 113,984 participants) were included in our analysis. In total, 14 studies compared CABG within 24 h with CABG late 24 h after AMI and five studies compared CABG within 48 h with CABG late 48 h after AMI. The OR of in-hospital mortality between early 24 h CABG and late 24 h CABG group was 2.65 (95%CI: 1.96 to 3.58; <i>P</i> &lt; 0.00001). In the undefined ST segment elevation myocardial infarction (STEMI)/non-ST segment elevation myocardial infarction (NSTEMI) subgroup, the mortality in the early 24 h CABG group (OR: 3.88; 95%CI: 2.69 to 5.60; <i>P</i> &lt; 0.00001) was significantly higher than the late 24 h CABG group. Similarly, in the STEMI subgroup, the mortality in the early 24 h CABG group (OR: 2.62; 95% CI: 1.58 to 4.35; <i>P</i> = 0.0002) was significantly higher than that in the late 24 h CABG group. However, the mortality of the early 24 h CABG group (OR: 1.24; 95%CI: 0.83 to 1.85; <i>P</i> = 0.29) was not significantly different from that of the late 24 h CABG group in the NSTEMI group. The OR of in-hospital mortality between early 48 h CABG and late 48 h CABG group was 1.91 (95%CI: 1.11 to 3.29; <i>P</i> = 0.02). In the undefined STEMI/NSTEMI subgroup, the mortality in the early 48 h CABG group (OR: 2.84; 95%CI: 1.31 to 6.14; <i>P</i> &lt; 0.00001) was higher than the late 48 h CABG group. The OR of perioperative MI and cerebrovascular accident between early CABG and late CABG group were 1.38 (95%CI: 0.41 to 4.72; <i>P</i> = 0.60) and 1.31 (95%CI: 0.72 to 2.39; <i>P</i> = 0.38), respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The risk of early CABG could be higher in STEMI patients, and CABG should be delayed until 24 h later as far as possible. However, the timing of CABG does not affect mortality in NSTEMI patients. There was no statistical difference in perioperative MI and cerebrovascular accidents between early and late CABG.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Lang, Qin and Meng.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Qianlei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Chaoyi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronary artery bypass graft</Keyword><Keyword MajorTopicYN="N">early surgery</Keyword><Keyword MajorTopicYN="N">late surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>5</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35419440</ArticleId><ArticleId IdType="pmc">PMC8995744</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.794925</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. (2019) 40:87&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. (2012) 367:2375&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">23121323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul TK, Fields BL, Riggins SL, Dacumos GC, Wyatt DA, Jones CR. Coronary artery bypass grafting within 30 days of an acute myocardial infarction. Ann Thorac Surg. (1995) 59:1169&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">7733715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Murrell HK, Strony J, Cmolik B, Nair R, Lesnefsky E, et al. Risk analysis of coronary bypass surgery after acute myocardial infarction. Surgery. (1997) 122:675&#x2013;81. 10.1016/s0039-6060(97)90073-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0039-6060(97)90073-8</ArticleId><ArticleId IdType="pubmed">9347842</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SV, de Lemos JA, Jessen ME, Brilakis ES, Ohman EM, Chen AY, et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the national cardiovascular data registry ACTION registry-GWTG (acute coronary treatment and intervention outcomes network registry-get with the guidelines). JACC Cardiovasc Interv. (2010) 3:419&#x2013;27. 10.1016/j.jcin.2010.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2010.01.012</ArticleId><ArticleId IdType="pubmed">20398870</ArticleId></ArticleIdList></Reference><Reference><Citation>Davierwala PM, Verevkin A, Leontyev S, Misfeld M, Borger MA, Mohr FW. Does timing of coronary artery bypass surgery affect early and long-term outcomes in patients with non-ST-segment-elevation myocardial infarction? Circulation. (2015) 132:731&#x2013;40. 10.1161/CIRCULATIONAHA.115.015279</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.015279</ArticleId><ArticleId IdType="pubmed">26304664</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AN, Sabbagh S, Ittaman S, Abrich V, Narayan A, Austin B, et al. Outcome of early revascularization surgery in patients with ST-elevation myocardial infarction. J Interv Cardiol. (2015) 28:14&#x2013;23. 10.1111/joic.12177</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joic.12177</ArticleId><ArticleId IdType="pubmed">25664508</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakopoulos OJ, Slottosch I, Wendt D, Welp H, Schiller W, Martens S, et al. Surgical revascularization for acute coronary syndromes: a report from the North Rhine-Westphalia surgical myocardial infarction registry. Eur J Cardiothorac Surg. (2020) 58:1137&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">33011789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco V, Kilic A, Gleason TG, Aranda-Michel E, Wang Y, Navid F, et al. Timing of coronary artery bypass grafting after acute myocardial infarction may not influence mortality and readmissions. J Thorac Cardiovasc Surg. (2021) 161:2056&#x2013;64.e2054. 10.1016/j.jtcvs.2019.11.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.11.061</ArticleId><ArticleId IdType="pubmed">31952832</ArticleId></ArticleIdList></Reference><Reference><Citation>Voisine P, Mathieu P, Doyle D, Perron J, Baillot R, Raymond G, et al. Influence of time elapsed between myocardial infarction and coronary artery bypass grafting surgery on operative mortality. Eur J Cardiothorac Surg. (2006) 29:319&#x2013;23. 10.1016/j.ejcts.2005.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.12.021</ArticleId><ArticleId IdType="pubmed">16439152</ArticleId></ArticleIdList></Reference><Reference><Citation>Thielmann M, Neuhauser M, Marr A, Herold U, Kamler M, Massoudy P, et al. Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial infarction. Ann Thorac Surg. (2007) 84:17&#x2013;24. 10.1016/j.athoracsur.2007.03.086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2007.03.086</ArticleId><ArticleId IdType="pubmed">17588374</ArticleId></ArticleIdList></Reference><Reference><Citation>Creswell LL, Moulton MJ, Cox JL, Rosenbloom M. Revascularization after acute myocardial infarction. Ann Thorac Surg. (1995) 60:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">7598589</ArticleId></ArticleIdList></Reference><Reference><Citation>Braxton JH, Hammond GL, Letsou GV, Franco KL, Kopf GS, Elefteriades JA, et al. Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction. Circulation. (1995) 92(9 Suppl):II66&#x2013;8. 10.1161/01.cir.92.9.66</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.92.9.66</ArticleId><ArticleId IdType="pubmed">7586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bana A, Yadava OP, Ghadiok R, Selot N. Myocardial revascularisation after acute myocardial infarction. Int J Cardiol. (1999) 69:209&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">10549845</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DC, Oz MC, Weinberg AD, Lin SX, Ting W. Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg. (2001) 71:1197&#x2013;204. 10.1016/s0003-4975(01)02425-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0003-4975(01)02425-0</ArticleId><ArticleId IdType="pubmed">11308159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DC, Oz MC, Weinberg AD, Ting W. Appropriate timing of surgical intervention after transmural acute myocardial infarction. J Thorac Cardiovasc Surg. (2003) 125:115&#x2013;9; discussion 119&#x2013;20. 10.1067/mtc.2003.75</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2003.75</ArticleId><ArticleId IdType="pubmed">12538993</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss ES, Chang DD, Joyce DL, Nwakanma LU, Yuh DD. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. J Thorac Cardiovasc Surg. (2008) 135:503&#x2013;11, 511.e501&#x2013;3. 10.1016/j.jtcvs.2007.10.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.10.042</ArticleId><ArticleId IdType="pubmed">18329460</ArticleId></ArticleIdList></Reference><Reference><Citation>Filizcan U, Kurc E, Cetemen S, Soylu O, Aydogan H, Bayserke O, et al. Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting. Angiology. (2011) 62:68&#x2013;73. 10.1177/0003319710369103</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003319710369103</ArticleId><ArticleId IdType="pubmed">20462895</ArticleId></ArticleIdList></Reference><Reference><Citation>Assmann A, Boeken U, Akhyari P, Lichtenberg A. Appropriate timing of coronary artery bypass grafting after acute myocardial infarction. Thorac Cardiovasc Surg. (2012) 60:446&#x2013;51. 10.1055/s-0032-1304542</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1304542</ArticleId><ArticleId IdType="pubmed">22549759</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols EL, McCullough JN, Ross CS, Kramer RS, Westbrook BM, Klemperer JD, et al. Optimal timing from myocardial infarction to coronary artery bypass grafting on hospital mortality. Ann Thorac Surg. (2017) 103:162&#x2013;71. 10.1016/j.athoracsur.2016.05.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.05.116</ArticleId><ArticleId IdType="pubmed">27570160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemaire A, Vagaonescu T, Ikegami H, Volk L, Verghis N, Lee LY. Delay in coronary artery bypass grafting for STEMI patients improves hospital morbidity and mortality. J Cardiothorac Surg. (2020) 15:86. 10.1186/s13019-020-01134-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01134-x</ArticleId><ArticleId IdType="pmc">PMC7216497</ArticleId><ArticleId IdType="pubmed">32398141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HL, Liu K. Timing of coronary artery bypass graft surgery for acute myocardial infarction patients: a meta-analysis. Int J Cardiol. (2014) 177:53&#x2013;6. 10.1016/j.ijcard.2014.09.127</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2014.09.127</ArticleId><ArticleId IdType="pubmed">25499339</ArticleId></ArticleIdList></Reference><Reference><Citation>Applebaum R, House R, Rademaker A, Garibaldi A, Davis Z, Guillory J, et al. Coronary artery bypass grafting within thirty days of acute myocardial infarction. Early and late results in 406 patients. J Thorac Cardiovasc Surg. (1991) 102:745&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">1943193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sintek CF, Pfeffer TA, Khonsari S. Surgical revascularization after acute myocardial infarction. Does timing make a difference? J Thorac Cardiovasc Surg. (1994) 107:1317&#x2013;21; discussion 1321&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">8176975</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. (1997) 96:778&#x2013;84. 10.1161/01.cir.96.3.778</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.96.3.778</ArticleId><ArticleId IdType="pubmed">9264482</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietil&#xe4; K, Harmoinen A, P&#xf6;yh&#xf6;nen L, Ruosteenoja R. C-reactive protein in subendocardial and transmural myocardial infarcts. Clin Chem. (1986) 32:1596&#x2013;7. 10.1093/clinchem/32.8.1596a</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/32.8.1596a</ArticleId><ArticleId IdType="pubmed">3731470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest. (1998) 113:1290&#x2013;5. 10.1378/chest.113.5.1290</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.113.5.1290</ArticleId><ArticleId IdType="pubmed">9596308</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin WH, Lu TH, Chen KC, Cheng CF, Lee JC, Liang FW, et al. The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15years in a Taiwanese population. Int J Cardiol. (2016) 209:103&#x2013;13. 10.1016/j.ijcard.2016.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.02.022</ArticleId><ArticleId IdType="pubmed">26889592</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigel F, Krakowski G, Nudy M, Foy A. Systematic review of bias in non-randomized studies on the optimal timing of coronary artery bypass grafting following acute coronary syndrome. J Am Coll Cardiol. (2021) 77:145.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36669936</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2531-0437</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Pulmonology</Title><ISOAbbreviation>Pulmonology</ISOAbbreviation></Journal><ArticleTitle>Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study).</ArticleTitle><Pagination><StartPage>457</StartPage><EndPage>468</EndPage><MedlinePgn>457-468</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pulmoe.2022.11.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2531-0437(22)00260-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The risk of barotrauma associated with different types of ventilatory support is unclear in COVID-19 patients. The primary aim of this study was to evaluate the effect of the different respiratory support strategies on barotrauma occurrence; we also sought to determine the frequency of barotrauma and the clinical characteristics of the patients who experienced this complication.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This multicentre retrospective case-control study from 1 March 2020 to 28 February 2021 included COVID-19 patients who experienced barotrauma during hospital stay. They were matched with controls in a 1:1 ratio for the same admission period in the same ward of treatment. Univariable and multivariable logistic regression (OR) were performed to explore which factors were associated with barotrauma and in-hospital death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 200 cases and 200 controls. Invasive mechanical ventilation was used in 39.3% of patients in the barotrauma group, and in 20.1% of controls (p&lt;0.001). Receiving non-invasive ventilation (C-PAP/PSV) instead of conventional oxygen therapy (COT) increased the risk of barotrauma (OR 5.04, 95% CI 2.30 - 11.08, p&lt;0.001), similarly for invasive mechanical ventilation (OR 6.24, 95% CI 2.86-13.60, p&lt;0.001). High Flow Nasal Oxygen (HFNO), compared with COT, did not significantly increase the risk of barotrauma. Barotrauma frequency occurred in 1.00% [95% CI 0.88-1.16] of patients; these were older (p=0.022) and more frequently immunosuppressed (p=0.013). Barotrauma was shown to be an independent risk for death (OR 5.32, 95% CI 2.82-10.03, p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">C-PAP/PSV compared with COT or HFNO increased the risk of barotrauma; otherwise HFNO did not. Barotrauma was recorded in 1.00% of patients, affecting mainly patients with more severe COVID-19 disease. Barotrauma was independently associated with mortality.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">this case-control study was prospectively registered in clinicaltrial.gov as NCT04897152 (on 21 May 2021).</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vetrugno</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care Medicine and Emergency, SS. Annunziata Hospital, Chieti, Italy; Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy. Electronic address: luigi.vetrugno@unich.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castaldo</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pulmonology Unit, Department of Cardiothoracic Surgery, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantin</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pulmonology Unit, Department of Cardiothoracic Surgery, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deana</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Palermo, Italy; Department of Anesthesia Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forfori</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, AOUP-Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cammarota</LastName><ForeName>Gianmaria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Service 2, University Hospital of Perugia, Perugia, Italy; Department of Medicine and Surgery, Universiy of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grieco</LastName><ForeName>Domenico Luca</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Catholic University of The Sacred Heart, Rome, Italy; Department of Anesthesia, Emergency and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isola</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care, Padua University Hospital, Padua, Italy; Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggiore</LastName><ForeName>Salvatore Maurizio</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care Medicine and Emergency, SS. Annunziata Hospital, Chieti, Italy; Department of Innovative Technologies in Medicine and Dentistry, Gabriele d'Annunzio University of Chieti Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Health Sciences, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chetta</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Confalonieri</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy; University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Martino</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pneumologia e Unit&#xe0; di Terapia Semi Intensiva Respiratoria, AO Umberto I Mauriziano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francisi</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease "S. Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luzzati</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meini</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>U.O. Medicina Interna, Felice Lotti Hospital, Azienda USL Toscana Nord-Ovest, Pontedera, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scozzafava</LastName><ForeName>Mariano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory High Dependecy Unit - General Hospital Lodi, Lodi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sozio</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tascini</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Udine, Udine, Italy; Infectious Diseases Division, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassi</LastName><ForeName>Flavio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patruno</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Pulmonology Unit, Department of Cardiothoracic Surgery, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Italian COVI-MIX Study Group</CollectiveName><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care Medicine and Emergency, SS. Annunziata Hospital, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Robertis</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Service 2, University Hospital of Perugia, Perugia, Italy; Department of Medicine and Surgery, Universiy of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldieri</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Hospital Santa Croce e Carle, Cuneo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baratella</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy; University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoletti</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant'Orsola, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boscolo</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgazzi</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catalanotti</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant'Orsola, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Confalonieri</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy; University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcione</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, University of Turin, Infectious Diseases, City of Health and Sciences, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rosa</LastName><ForeName>Francesco Giuseppe</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Cardinal Massaia Hospital, Asti, Italy; Infectious Diseases Unit, Cardinal Massaia Hospital, Asti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Simoni</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bono</LastName><ForeName>Valerio Del</ForeName><Initials>VD</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Hospital Santa Croce e Carle, Cuneo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tria</LastName><ForeName>Roberta Di</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Pneumologia e Unit&#xe0; di Terapia Semi Intensiva Respiratoria, AO Umberto I Mauriziano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forlani</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacobbe</LastName><ForeName>Daniele Roberto</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Health Sciences, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granozzi</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant'Orsola, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labate</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Health Sciences, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lococo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lupia</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Cardinal Massaia Hospital, Asti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matellon</LastName><ForeName>Carola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrabi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Diagnostics and Public Health Department, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morosi</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease "S. Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongodi</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mura</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>U.O. Medicina Interna, Felice Lotti Hospital, Azienda USL Toscana Nord-Ovest, Pontedera, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nava</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical, Integrated and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy; Respiratory and Critical Care Unit, Sant Orsola University Hospital, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pol</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettenuzzo</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quyen</LastName><ForeName>Nguyen Hoang</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rescigno</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UOC Malattie Infettive ad Indirizzo&#xa0;Neurologico, AORN Ospedali dei Colli, P.O. "D. Cotugno", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righi</LastName><ForeName>Elda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruaro</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy; University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salton</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy; University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scabini</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, University of Turin, Infectious Diseases, City of Health and Sciences, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarda</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, "Santa Maria degli Angeli" Hospital, Pordenone, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sibani</LastName><ForeName>Marcella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tacconelli</LastName><ForeName>Evelina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tartaglione</LastName><ForeName>Gennaro</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, "Santa Maria degli Angeli" Hospital, Pordenone, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tazza</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant'Orsola, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vania</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Health Integrated Agency of Friuli Centrale, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viale</LastName><ForeName>Pierluigi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant'Orsola, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vianello</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visentin</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccon</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, "Santa Maria degli Angeli" Hospital, Pordenone, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04897152</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pulmonology</MedlineTA><NlmUniqueID>101723786</NlmUniqueID><ISSNLinking>2531-0429</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001469" MajorTopicYN="Y">Barotrauma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute respiratory failure</Keyword><Keyword MajorTopicYN="N">Barotrauma</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">High flow nasal cannula</Keyword><Keyword MajorTopicYN="N">Invasive mechanical ventilation</Keyword><Keyword MajorTopicYN="N">Pneumothorax</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36669936</ArticleId><ArticleId IdType="pmc">PMC9684110</ArticleId><ArticleId IdType="doi">10.1016/j.pulmoe.2022.11.002</ArticleId><ArticleId IdType="pii">S2531-0437(22)00260-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anzueto A., Frutos-Vivar F., Esteban A., Alia I., Brochard L., Stewart T., et al. Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Med. 2004;30(4):612&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">14991090</ArticleId></ArticleIdList></Reference><Reference><Citation>Udi J., Lang C.N., Zotzmann V., Krueger K., Fluegler A., Bamberg F., et al. Incidence of barotrauma in patients with COVID-19 pneumonia during prolonged invasive mechanical ventilation - a case-control study. J Intensive Care Med. 2021;36(4):477&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">32959730</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness G., Zhan C., Rosenberg N., Azour L., Wickstrom M., Mason D.M., et al. Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology. 2020;297(2):E252&#x2013;EE62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336751</ArticleId><ArticleId IdType="pubmed">32614258</ArticleId></ArticleIdList></Reference><Reference><Citation>Miro O., Llorens P., Jimenez S., Pinera P., Burillo-Putze G., Martin A., et al. Frequency, risk factors, clinical characteristics, and outcomes of spontaneous pneumothorax in patients with coronavirus disease 2019: a case-control, emergency medicine-based multicenter study. Chest. 2021;159(3):1241&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7678420</ArticleId><ArticleId IdType="pubmed">33227276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini J.J., Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329&#x2013;2330.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Cattaneo E., Florio G., Ippolito M., Zanella A., Cortegiani A., et al. Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review. Crit Care. 2021;25(1):115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980724</ArticleId><ArticleId IdType="pubmed">33743812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun R., Liu H., Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol. 2020;21(5):541&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183834</ArticleId><ArticleId IdType="pubmed">32207255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Vega J.M., Parra Gordo M.L., Diez Tascon A., Ossaba Velez S. Pneumomediastinum and spontaneous pneumothorax as an extrapulmonary complication of COVID-19 disease. Emerg Radiol. 2020;27(6):727&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286744</ArticleId><ArticleId IdType="pubmed">32524296</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieco D.L., Menga L.S., Eleuteri D., Antonelli M. Patient self-inflicted lung injury: implications for acute hypoxemic respiratory failure and ARDS patients on non-invasive support. Minerva Anestesiol. 2019;85(9):1014&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pubmed">30871304</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P., et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>EDC C. Castor Electronic Data Capture. Available at: https://castoredc.com2019.</Citation></Reference><Reference><Citation>WHO. Living guidance for clinical management of COVID-19. 2021: Available at: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-clinical-21-2.</Citation></Reference><Reference><Citation>Haimovich A.D., Ravindra N.G., Stoytchev S., Young H.P., Wilson F.P., van Dijk D., et al. Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76(4):442&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373004</ArticleId><ArticleId IdType="pubmed">33012378</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight S.R., Ho A., Pius R., Buchan I., Carson G., Drake T.M., et al. Risk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116472</ArticleId><ArticleId IdType="pubmed">32907855</ArticleId></ArticleIdList></Reference><Reference><Citation>Salaffi F., Carotti M., Tardella M., Borgheresi A., Agostini A., Minorati D., et al. The role of a chest computed tomography severity score in coronavirus disease 2019 pneumonia. Medicine. 2020;99(42):e22433. (Baltimore)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571935</ArticleId><ArticleId IdType="pubmed">33080676</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">2841893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M.R., Watson R.L., Thetford J.T., Wong J.I., Kamangar N. High incidence of barotrauma in patients with severe coronavirus disease 2019. J Intensive Care Med. 2021;36(6):646&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967021</ArticleId><ArticleId IdType="pubmed">33722090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayazi S., Zebarjadi J., Grubic A.D., Tahmasbi H., Ayazi K., Jobe BA. Pneumothorax as the presenting manifestation of COVID-19. J Thorac Dis. 2020;12(12):7488&#x2013;7493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797865</ArticleId><ArticleId IdType="pubmed">33447436</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradi F., Isirdi A., Malacarne P., Santori G., Barbieri G., Romei C., et al. Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for COVID-19 pneumonia: an exploratory pilot study. Minerva Anestesiol. 2021;87(4):432&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">33594871</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradi F., Vetrugno L., Orso D., Bove T., Schreiber A., Boero E., et al. Diaphragmatic thickening fraction as a potential predictor of response to continuous positive airway pressure ventilation in Covid-19 pneumonia: a single-center pilot study. Respir Physiol Neurobiol. 2021;284</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664482</ArticleId><ArticleId IdType="pubmed">33197604</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieco D.L., Maggiore S.M., Roca O., Spinelli E., Patel B.K., Thille A.W., et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261815</ArticleId><ArticleId IdType="pubmed">34232336</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T., Turrini C., Eronia N., Grasselli G., Volta C.A., Bellani G., et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">27997805</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimi C., Pierucci P., Renda T., Pisani L., Carlucci A. High-flow nasal cannula and COVID-19: a clinical review. Respir Care. 2022;67(2):227&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">34521762</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins G.D., Ji C., Connolly B.A., Couper K., Lall R., Baillie J.K., et al. Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial. JAMA. 2022;327(6):546&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787685</ArticleId><ArticleId IdType="pubmed">35072713</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimi C., Noto A., Madotto F., Ippolito M., Nolasco S., Campisi R., et al. High Flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxemia: a randomised controlled trial. Thorax. 2022 doi: 10.1136/thoraxjnl-2022-218806. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2022-218806</ArticleId><ArticleId IdType="pubmed">35580898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T., Suzuki T., Maeda M., Iwamoto S., Hirayama M., Yamada Y., et al. Pulmonary barotrauma following nasal high-flow therapy in a patient with bronchiolitis obliterans syndrome. Am J Case Rep. 2019;20:1619&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858625</ArticleId><ArticleId IdType="pubmed">31680117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalewajska M., Feret W., Wojczynski L., Witkiewicz W., Wisniewska M., Kotfis K. Spontaneous pneumothorax in COVID-19 patients treated with high-flow nasal cannula outside the ICU: a case series. Int J Environ Res Public Health. 2021;18(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7926594</ArticleId><ArticleId IdType="pubmed">33672281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.H., Duan J., Han X., Liu X., Zhou J., Wang X., et al. High incidence and mortality of pneumothorax in critically Ill patients with COVID-19. Heart Lung. 2021;50(1):37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556825</ArticleId><ArticleId IdType="pubmed">33138976</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A., Todaro G., Valsecchi G., Losiggio R., Palumbo D., Landoni G., et al. Barotrauma in coronavirus disease 2019 patients undergoing invasive mechanical ventilation: a systematic literature review. Crit Care Med. 2022;50(3):491&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8855757</ArticleId><ArticleId IdType="pubmed">34637421</ArticleId></ArticleIdList></Reference><Reference><Citation>Slutsky A.S., Ranieri V.M. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126&#x2013;2136.</Citation><ArticleIdList><ArticleId IdType="pubmed">24283226</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E., Del Sorbo L., Goligher E.C., Hodgson C.L., Munshi L., Walkey A.J., et al. An official american thoracic society/european society of intensive care medicine/society of critical care medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pubmed">28459336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumello D., Brochard L., Marini J.J., Slutsky A.S., Mancebo J., Ranieri V.M., et al. Respiratory support in patients with acute respiratory distress syndrome: an expert opinion. Crit Care. 2017;21(1):240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5596474</ArticleId><ArticleId IdType="pubmed">28899408</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute Respiratory Distress Syndrome N. Brower R.G., Matthay M.A., Morris A., Schoenfeld D., Thompson B.T., et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301&#x2013;1308.</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruces P., Retamal J., Hurtado D.E., Erranz B., Iturrieta P., Gonzalez C., et al. A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection. Crit Care. 2020;24(1):494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7416996</ArticleId><ArticleId IdType="pubmed">32778136</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammarota G., Vaschetto R., Turucz E., Dellapiazza F., Colombo D., Blando C., et al. Influence of lung collapse distribution on the physiologic response to recruitment maneuvers during noninvasive continuous positive airway pressure. Intensive Care Med. 2011;37(7):1095&#x2013;1102. doi: 10.1007/s00134-011-2239-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2239-8</ArticleId><ArticleId IdType="pubmed">21567113</ArticleId></ArticleIdList></Reference><Reference><Citation>Deana C., Verriello L., Pauletto G., Corradi F., Forfori F., Cammarota G., et al. Insights into neurological dysfunction of critically ill COVID-19 patients. Trends Anaesth Crit Care. 2021;36:30&#x2013;38. doi: 10.1016/j.tacc.2020.09.00.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tacc.2020.09.00</ArticleId><ArticleId IdType="pmc">PMC7490585</ArticleId><ArticleId IdType="pubmed">38620281</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehmani R., Salazar J., Sharma S., et al. COVID-19 associated spontaneous barotrauma: a literature review. F1000Research. 2021;10:412. doi: 10.12688/f1000research.52381.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52381.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Koukaki E., Rovina N., Tzannis K., Sotiropoulou Z., Loverdos K., Koutsoukou A., et al. Fungal infections in the ICU during the COVID-19 Era: descriptive and comparative analysis of 178 patients. J Fungi. 2022;8(8):881. doi: 10.3390/jof8080881. (Basel)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof8080881</ArticleId><ArticleId IdType="pmc">PMC9410292</ArticleId><ArticleId IdType="pubmed">36012869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C.M., Leung Y.Y., Hui J.Y., Hung I.F., Chan V.L., Leung W.S., et al. Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome. Eur Respir J. 2004;23(6):802&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">15218989</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy D.J., Lane A.S., Flynn P.W., Seppelt I.M. Tension pneumomediastinum: a literal form of chest tightness. J Intensive Care Soc. 2017;18(1):52&#x2013;56. doi: 10.1177/1751143716662665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1751143716662665</ArticleId><ArticleId IdType="pmc">PMC5606356</ArticleId><ArticleId IdType="pubmed">28979537</ArticleId></ArticleIdList></Reference><Reference><Citation>Beitler J.R., Malhotra A., Thompson B.T. Ventilator-induced lung injury. Clin Chest Med. 2016;37(4):633&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131805</ArticleId><ArticleId IdType="pubmed">27842744</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternoster G., Bertini P., Belletti A., Landoni G., Gallotta S., Palumbo D., et al. Venovenous extracorporeal membrane oxygenation in awake non-intubated patients with COVID-19 ARDS at high risk for barotrauma. J Cardiothorac Vasc Anesth. 2022;36(8 Pt B):2975&#x2013;2982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926433</ArticleId><ArticleId IdType="pubmed">35537972</ArticleId></ArticleIdList></Reference><Reference><Citation>Zantah M., Dominguez Castillo E., Townsend R., Dikengil F., Criner G.J. Pneumothorax in COVID-19 disease- incidence and clinical characteristics. Respir Res. 2020;21(1):236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492794</ArticleId><ArticleId IdType="pubmed">32938445</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect. 2020;80(6):607&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinelli A.W., Ingle T., Newman J., Nadeem I., Jackson K., Lane N.D., et al. COVID-19 and pneumothorax: a multicentre retrospective case series. Eur Respir J. 2020;56(5):002697..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487269</ArticleId><ArticleId IdType="pubmed">32907891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kangas-Dick A., Gazivoda V., Ibrahim M., Sun A., Shaw J.P., Brichkov I., et al. Clinical characteristics and outcome of pneumomediastinum in patients with COVID-19 pneumonia. J Laparoendosc Adv Surg Tech A. 2021;31(3):273&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">32936034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazivoda V.P., Ibrahim M., Kangas-Dick A., Sun A., Silver M., Wiesel O. Outcomes of barotrauma in critically Ill COVID-19 patients with severe pneumonia. J Intensive Care Med. 2021;36(10):1176&#x2013;1183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221250</ArticleId><ArticleId IdType="pubmed">34151633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26286073</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Late Rupture of Abdominal Aortic Aneurysm After Previous Endovascular Repair: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>734</StartPage><EndPage>744</EndPage><MedlinePgn>734-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1526602815601405</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To report a systematic literature review of late rupture of abdominal aortic aneurysm (AAA) after endovascular aneurysm repair (EVAR) and the results of a pooled analysis of causes, treatment, and outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic information sources and bibliographic reference lists were interrogated using a combination of free text and controlled vocabulary searches; 11 articles were ultimately identified that fulfilled the inclusion criteria. The articles reported a total of 190 patients who were included in the qualitative and quantitative synthesis. Mortality within 30 days or during the admission with aneurysm rupture was a primary endpoint; major perioperative morbidity was a secondary endpoint. A meta-analysis was performed for 30-day/in-hospital mortality using the random effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 152 ruptures occurred after 16,974 EVAR procedures reported by 8 of the case series, giving an incidence of 0.9% [95% confidence interval (CI) 0.77 to 1.05]. The mean time to rupture was 37 months. Twenty-nine percent (95% CI 20 to 39) of the patients had at least one previous secondary endovascular intervention following the initial EVAR, and 37% (95% CI 30 to 45) were not compliant with surveillance. Type I and III endoleaks were the predominant causes of rupture. Open surgical treatment was undertaken in 61% (95% CI 53 to 68) of the patients who underwent treatment. The pooled estimate for perioperative mortality was 32% (95% CI 24 to 41). A significantly lower mortality was found with endovascular treatment than open surgical management (p=0.027).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Graft-related endoleaks appear to be the predominant causes of late aneurysm rupture. Quality of and compliance with post-EVAR surveillance are important factors in late rupture; a large proportion of late ruptures are amenable to endovascular treatment.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2015.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK antoniou.ga@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiadis</LastName><ForeName>George S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>Stavros A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital of Heraklion, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neequaye</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torella</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallabhaneni</LastName><ForeName>S Rao</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Endovasc Ther. 2015 Oct;22(5):745-7. doi: 10.1177/1526602815601837.</RefSource><PMID Version="1">26392477</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001019" MajorTopicYN="N">Aortic Rupture</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057867" MajorTopicYN="N">Endoleak</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">abdominal aortic aneurysm</Keyword><Keyword MajorTopicYN="N">aneurysm rupture</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">conversion</Keyword><Keyword MajorTopicYN="N">endoleak</Keyword><Keyword MajorTopicYN="N">endovascular aneurysm repair</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">open repair</Keyword><Keyword MajorTopicYN="N">secondary interventions</Keyword><Keyword MajorTopicYN="N">stent-graft</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26286073</ArticleId><ArticleId IdType="doi">10.1177/1526602815601405</ArticleId><ArticleId IdType="pii">1526602815601405</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34609988</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Oxygen Saturation and Postoperative Mortality in Patients With Acute Ischemic Stroke Treated by Endovascular Thrombectomy.</ArticleTitle><Pagination><StartPage>369</StartPage><EndPage>379</EndPage><MedlinePgn>369-379</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005763</ELocationID><Abstract><AbstractText Label="BACKGROUND">Monitored anesthesia care (MAC) and general anesthesia (GA) with endotracheal intubation are the 2 most used techniques for patients with acute ischemic stroke (AIS) undergoing endovascular thrombectomy. We aimed to test the hypothesis that increased arterial oxygen concentration during reperfusion period is a mechanism underlying the association between use of GA (versus MAC) and increased risk of in-hospital mortality.</AbstractText><AbstractText Label="METHODS">In this retrospective cohort study, data were collected at the Cleveland Clinic between 2013 and 2018. To assess the potential mediation effect of time-weighted average oxygen saturation (Spo2) in first postoperative 48 hours between the association between GA versus MAC and in-hospital mortality, we assessed the association between anesthesia type and post-operative Spo2 tertiles (exposure-mediator relationship) through a cumulative logistic regression model and assessed the association between Spo2 and in-hospital mortality (mediator-outcome relationship) using logistic regression models. Confounding factors were adjusted for using propensity score methods. Both significant exposure-mediator and significant mediator-outcome relationships are needed to suggest potential mediation effect.</AbstractText><AbstractText Label="RESULTS">Among 358 patients included in the study, 104 (29%) patients received GA and 254 (71%) received MAC, with respective hospital mortality rate of 19% and 5% (unadjusted P value &lt;.001). GA patients were 1.6 (1.2, 2.1) (P &lt; .001) times more likely to have a higher Spo2 tertile as compared to MAC patients. Patients with higher Spo2 tertile had 3.8 (2.1, 6.9) times higher odds of mortality than patients with middle Spo2 tertile, while patients in the lower Spo2 tertile did not have significant higher odds compared to the middle tertile odds ratio (OR) (1.8 [0.9, 3.4]; overall P &lt; .001). The significant exposure-mediator and mediator-outcome relationships suggest that Spo2 may be a mediator of the relationship between anesthetic method and mortality. However, the estimated direct effect of GA versus MAC on mortality (ie, after adjusting for Spo2; OR [95% confidence interval {CI}] of 2.1 [0.9-4.9]) was close to the estimated association ignoring Spo2 (OR [95% CI] of 2.2 [1.0-5.1]), neither statistically significant, suggesting that Spo2 had at most a modest mediator role.</AbstractText><AbstractText Label="CONCLUSIONS">GA was associated with a higher Spo2 compared to MAC among those treated by endovascular thrombectomy for AIS. Spo2 values that were higher than the middle tertile were associated with higher odds of mortality. However, GA was not significantly associated with higher odds of death. Spo2 at most constituted a modest mediator role in explaining the relationship between GA versus MAC and mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farag</LastName><ForeName>Ehab</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology &amp; Pain Management Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology &amp; Pain Management Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Lerner Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascha</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology &amp; Pain Management Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Lerner Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toth</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurointerventional Radiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argalious</LastName><ForeName>Maged</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manlapaz</LastName><ForeName>Mariel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Joao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, The Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebrahim</LastName><ForeName>Zeyd</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Muhammad Shazam</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurointerventional Radiology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="N">Ischemic Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089382" MajorTopicYN="N">Oxygen Saturation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>17</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34609988</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005763</ArticleId><ArticleId IdType="pii">00000539-202202000-00021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen CJ, Ding D, Starke RM, et al. Endovascular vs medical management of acute ischemic stroke. Neurology. 2015;85:1980&#x2013;1990.</Citation></Reference><Reference><Citation>Davis MJ, Menon BK, Baghirzada LB, et al.; Calgary Stroke Program. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012;116:396&#x2013;405.</Citation></Reference><Reference><Citation>Abou-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke. 2010;41:1175&#x2013;1179.</Citation></Reference><Reference><Citation>Nichols C, Carrozzella J, Yeatts S, Tomsick T, Broderick J, Khatri P. Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? J Neurointerv Surg. 2010;2:67&#x2013;70.</Citation></Reference><Reference><Citation>Abou-Chebl A, Zaidat OO, Castonguay AC, et al. North American SOLITAIRE Stent-Retriever Acute Stroke Registry: choice of anesthesia and outcomes. Stroke. 2014;45:1396&#x2013;1401.</Citation></Reference><Reference><Citation>John S, Thebo U, Gomes J, et al. Intra-arterial therapy for acute ischemic stroke under general anesthesia versus monitored anesthesia care. Cerebrovasc Dis. 2014;38:262&#x2013;267.</Citation></Reference><Reference><Citation>Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2015;36:525&#x2013;529.</Citation></Reference><Reference><Citation>Cappellari M, Pracucci G, Forlivesi S, et al. General anesthesia versus conscious sedation and local anesthesia during thrombectomy for acute ischemic stroke. Stroke. 2020;51:2036&#x2013;2044.</Citation></Reference><Reference><Citation>Pryor KO, Berger MM. The elusive promise of perioperative hyperoxia. Br J Anaesth. 2015;115:344&#x2013;346.</Citation></Reference><Reference><Citation>Sj&#xf6;berg F, Singer M. The medical use of oxygen: a time for critical reappraisal. J Intern Med. 2013;274:505&#x2013;528.</Citation></Reference><Reference><Citation>Kallet RH, Branson RD. Should oxygen therapy be tightly regulated to minimize hyperoxia in critically ill patients? Respir Care. 2016;61:801&#x2013;817.</Citation></Reference><Reference><Citation>Rincon F, Kang J, Maltenfort M, et al. Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med. 2014;42:387&#x2013;396.</Citation></Reference><Reference><Citation>Schulte PJ, Mascha EJ. Propensity score methods: theory and practice for anesthesia research. Anesth Analg. 2018;127:1074&#x2013;1084.</Citation></Reference><Reference><Citation>Imai K, Ratkovic M. Covariate balancing propensity score. J R Stat Soc Series B Stat Methodol. 2014;76:243&#x2013;263.</Citation></Reference><Reference><Citation>Mascha EJ, Dalton JE, Kurz A, Saager L. Statistical grand rounds: understanding the mechanism: mediation analysis in randomized and nonrandomized studies. Anesth Analg. 2013;117:980&#x2013;994.</Citation></Reference><Reference><Citation>Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003&#x2013;2011.</Citation></Reference><Reference><Citation>Broderick JP, Palesch YY, Demchuk AM, et al.; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893&#x2013;903.</Citation></Reference><Reference><Citation>Seder DB, Riker RR, Jagoda A, Smith WS, Weingart SD. Emergency neurological life support: airway, ventilation, and sedation. Neurocrit Care. 2012;17(suppl 1):S4&#x2013;S20.</Citation></Reference><Reference><Citation>O&#x2019;Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008;63(suppl 6):vi1&#x2013;vi68.</Citation></Reference><Reference><Citation>Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018;391:1693&#x2013;1705.</Citation></Reference><Reference><Citation>Roffe C, Nevatte T, Sim J, et al.; Stroke Oxygen Study Investigators and the Stroke OxygenStudy Collaborative Group. Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the stroke oxygen study randomized clinical trial. JAMA. 2017;318:1125&#x2013;1135.</Citation></Reference><Reference><Citation>Singhal AB, Benner T, Roccatagliata L, et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36:797&#x2013;802.</Citation></Reference><Reference><Citation>Kongebro EK, Jorgensen LN, Siersma VD, Meyhoff CS. Association between perioperative hyperoxia and cerebrovascular complications after laparotomy-a post-hoc follow-up study. Acta Anaesthesiol Scand. 2019;63:164&#x2013;170.</Citation></Reference><Reference><Citation>Helmerhorst HJ, Schultz MJ, van der Voort PH, de Jonge E, van Westerloo DJ. Bench-to-bedside review: the effects of hyperoxia during critical illness. Crit Care. 2015;19:284.</Citation></Reference><Reference><Citation>Watson NA, Beards SC, Altaf N, Kassner A, Jackson A. The effect of hyperoxia on cerebral blood flow: a study in healthy volunteers using magnetic resonance phase-contrast angiography. Eur J Anaesthesiol. 2000;17:152&#x2013;159.</Citation></Reference><Reference><Citation>Schiffman HJ, Olufs ZPG, Lasarev MR, Wassarman DA, Perouansky M. Ageing and genetic background influence anaesthetic effects in a D. melanogaster model of blunt trauma with brain injury&#x2020;. Br J Anaesth. 2020;125:77&#x2013;86.</Citation></Reference><Reference><Citation>Knafl GJ, Knafl KA, Grey M, Dixon J, Deatrick JA, Gallo AM. Incorporating nonlinearity into mediation analyses. BMC Med Res Methodol. 2017;17:45.</Citation></Reference><Reference><Citation>MacKinnon DP. Introduction to Statistical Mediation Analysis. 2008.Psychology Press;</Citation></Reference><Reference><Citation>Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods. 2010;15:309&#x2013;334.</Citation></Reference><Reference><Citation>Imai K, Keele L, Tingley D, Yamamoto T. Unpacking the black box of causality: learning about causal mechanisms from experimental and observational studies. Am Polit Sci Rev. 2011;105:765&#x2013;789.</Citation></Reference><Reference><Citation>Albert JM. Mediation analysis via potential outcomes models. Stat Med. 2008;27:1282&#x2013;1304.</Citation></Reference><Reference><Citation>Albert JM. Distribution-free mediation analysis for nonlinear models with confounding. Epidemiology. 2012;23:879&#x2013;888.</Citation></Reference><Reference><Citation>Albert JM, Nelson S. Generalized causal mediation analysis. Biometrics. 2011;67:1028&#x2013;1038.</Citation></Reference><Reference><Citation>Campbell BCV, van Zwam WH, Goyal M, et al.; HERMES collaborators. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 2018;17:47&#x2013;53.</Citation></Reference><Reference><Citation>McTaggart RA, Ansari SA, Goyal M, et al.; Standards and Guidelines Committee of the Society of NeuroInterventional Surgery (SNIS). Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg. 2017;9:316&#x2013;323.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35914987</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Comparison of surgical stabilization of rib fractures vs epidural analgesia on in-hospital outcomes.</ArticleTitle><Pagination><StartPage>32</StartPage><EndPage>38</EndPage><MedlinePgn>32-38</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2022.07.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(22)00516-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Surgical stabilization of rib fractures (SSRF) improves functional outcomes compared to controls, partly due to reduction in pain. We investigated the impact of early SSRF on pulmonary complications, mortality, and length of stay compared to non-operative analgesia with epidural analgesia (EA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort study of the Trauma Quality Improvement Program (TQIP) 2017 dataset for adults with rib fractures, excluding those with traumatic brain injury or death within twenty-four hours. Early SSRF and EA occurred within 72&#xa0;h, and we excluded those who received both or neither intervention. Our primary outcome was a composite of pulmonary complications including acute respiratory distress syndrome (ARDS) or ventilator-associated pneumonia (VAP). Additional outcomes included unplanned endotracheal intubation, in-hospital mortality, and hospital and intensive care unit (ICU) length of stay (LOS) for those surviving to discharge. Multiple logistic and linear regressions were controlled for variables including age, sex, flail chest (FC), injury severity, additional procedures, and medical comorbidities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 1,024 and 1,109 patients undergoing early SSRF and EA, respectively. SSRF patients were more severely injured with higher rates of FC (42.8&#xa0;vs 13.3%, p&lt;0.001), Injury Severity Score (ISS) &gt; 16 (56.9&#xa0;vs 36.1%, p&lt;0.001), and Abbreviated Injury Scale (AIS) Thorax &gt; 3 (33.3&#xa0;vs 12.2%, p&lt;0.001). Overall, 49 (2.3%) of patients developed ARDS or VAP, 111 (5.2%) required unplanned intubation, and 58 (2.7%) expired prior to discharge. On multivariable analysis, SSRF was not associated with the primary composite outcome (OR: 1.65, 95%CI: 0.85-3.21). Early SSRF significantly predicted decreased risk of unplanned intubation (OR:0.59, 95%CI: 0.38-0.92) compared with early EA alone, however, was not a significant predictor of in-hospital mortality (OR: 1.27, 95%CI: 0.68-2.39). SSRF was associated with significantly longer hospital (Exp(&#x3b2;): 1.06, 95%CI: 1.00-1.12, p&#xa0;=&#xa0;0.047) and ICU LOS (Exp(&#x3b2;): 1.17, 95%CI: 1.08-1.27, p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Aside from unplanned intubation, we observed no statistically significant difference in the adjusted odds of in-hospital pulmonary morbidity or mortality for patients undergoing early SSRF compared with early EA. Chest wall injury patients may benefit from referral to trauma centers where both interventions are available and appropriate surgical candidates may receive timely intervention.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tindal</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Trauma and Critical Care Surgery, Department of Surgery, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of Trauma and Critical Care Surgery, Department of Surgery, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lueckel</LastName><ForeName>Stephanie N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Division of Trauma and Critical Care Surgery, Department of Surgery, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheirbek</LastName><ForeName>Tareq</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Trauma and Critical Care Surgery, Department of Surgery, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012253" MajorTopicYN="Y">Rib Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015360" MajorTopicYN="Y">Analgesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005409" MajorTopicYN="Y">Flail Chest</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chest wall injury</Keyword><Keyword MajorTopicYN="N">Rib fractures</Keyword><Keyword MajorTopicYN="N">Surgical stabilization of rib fractures</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>1</Day><Hour>22</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35914987</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2022.07.038</ArticleId><ArticleId IdType="pii">S0020-1383(22)00516-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19608798</PMID><DateCompleted><Year>2009</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials.</ArticleTitle><Pagination><StartPage>320</StartPage><EndPage>330</EndPage><MedlinePgn>320-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ane.0b013e3181aa084c</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cell salvage may be used during cardiac surgery to avoid allogeneic blood transfusion. It has also been claimed to improve patient outcomes by removing debris from shed blood, which may increase the risk of stroke or neurocognitive dysfunction. In this study, we sought to determine the overall safety and efficacy of cell salvage in cardiac surgery by performing a systematic review and meta-analysis of published randomized controlled trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search was undertaken to identify all randomized trials of cell saver use during cardiac surgery. MEDLINE, Cochrane Library, EMBASE, and abstract databases were searched up to November 2008. All randomized trials comparing cell saver use and no cell saver use in cardiac surgery and reporting at least one predefined clinical outcome were included. The random effects model was used to calculate the odds ratios (OR, 95% confidence intervals [CI]) and the weighted mean differences (WMD, 95% CI) for dichotomous and continuous variables, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-one randomized trials involving 2282 patients were included in the meta-analysis. During cardiac surgery, the use of an intraoperative cell saver reduced the rate of exposure to any allogeneic blood product (OR 0.63, 95% CI: 0.43-0.94, P = 0.02) and red blood cells (OR 0.60, 95% CI: 0.39-0.92, P = 0.02) and decreased the mean volume of total allogeneic blood products transfused per patient (WMD -256 mL, 95% CI: -416 to -95 mL, P = 0.002). There was no difference in hospital mortality (OR 0.65, 95% CI: 0.25-1.68, P = 0.37), postoperative stroke or transient ischemia attack (OR 0.59, 95% CI: 0.20-1.76, P = 0.34), atrial fibrillation (OR 0.92, 95% CI: 0.69-1.23, P = 0.56), renal dysfunction (OR 0.86, 95% CI: 0.41-1.80, P = 0.70), infection (OR 1.25, 95% CI: 0.75-2.10, P = 0.39), patients requiring fresh frozen plasma (OR 1.16, 95% CI: 0.82-1.66, P = 0.40), and patients requiring platelet transfusions (OR 0.90, 95% CI: 0.63-1.28, P = 0.55) between cell saver and noncell saver groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Current evidence suggests that the use of a cell saver reduces exposure to allogeneic blood products or red blood cell transfusion for patients undergoing cardiac surgery. Subanalyses suggest that a cell saver may be beneficial only when it is used for shed blood and/or residual blood or during the entire operative period. Processing cardiotomy suction blood with a cell saver only during cardiopulmonary bypass has no significant effect on blood conservation and increases fresh frozen plasma transfusion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guyan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bainbridge</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Janet</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Davy</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001793" MajorTopicYN="N">Blood Preservation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>52</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>7</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19608798</ArticleId><ArticleId IdType="doi">10.1213/ane.0b013e3181aa084c</ArticleId><ArticleId IdType="pii">109/2/320</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30676348</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review of the Impact of Surgical Special Care Units on Patient Outcomes and Health Care Resource Utilization.</ArticleTitle><Pagination><StartPage>533</StartPage><EndPage>542</EndPage><MedlinePgn>533-542</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000003942</ELocationID><Abstract><AbstractText>Perioperative intermediate care units (termed surgical special care units) have been widely implemented across health systems because they are believed to improve surveillance and management of high-risk surgical patients. Our objective was to conduct a systematic review to investigate the effects of a 3-level model of perioperative care delivery (ie, ward, surgical special care unit, or intensive care unit) compared to a 2-level model of care (ie, ward, intensive care unit) on postoperative outcomes. Our protocol was registered with PROSPERO, the international prospective register of systematic reviews (CRD42015025155). Randomized controlled studies and nonrandomized comparator studies were included. We performed a systematic search of Medline, Cumulative Index to Nursing and Allied Health Literature, Embase, and the Cochrane library (inception - 11/2017). The primary outcome was mortality; secondary outcomes included length of stay and hospital costs. We identified 1995 citations with our search, and 21 studies met eligibility criteria (2 randomized controlled studies and 19 nonrandomized comparator studies; 44,134 patients in total). Surgical special care units were characterized by continuous monitoring (12 studies), the absence of mechanical ventilation (8 studies), nurse-to-patient ratios (range, 1:2-1:4), and number of beds (median: 5; range: 3-33). Thirteen studies reported on mortality. Notable findings included no observed difference in overall in-hospital mortality, but an apparent increase in intensive care unit mortality in a 3-level model of care. This may reflect a decanting of lower acuity patients from the intensive care unit to the surgical special care unit. No significant difference was found in hospital length of stay; however, 2 studies demonstrated reductions in hospital costs with the implementation of a surgical special care unit. Significant clinical and methodological heterogeneity precluded pooled analysis. Given the prevalence of surgical special care units, the results of our review suggest that additional methodologically rigorous investigations are needed to understand the effect of these units on the surgical population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendis</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Gavin M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIsaac</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Ottawa Hospital Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>Dean A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Ottawa Hospital Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Surgery &amp; Epidemiology and Department of Community Medicine, The University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wunsch</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montroy</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Ottawa Hospital Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chass&#xe9;</LastName><ForeName>Micha&#xeb;l</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine (Critical Care), University of Montreal Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turgeon</LastName><ForeName>Alexis F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Division of Critical Care Medicine, Universit&#xe9; Laval, and CHU de Qu&#xe9;bec - Universit&#xe9; Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology-Emergency-Critical Care Medicine, Universit&#xe9; Laval, Qu&#xe9;bec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Lauralyn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Ottawa Hospital Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonald</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Manitoba, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Homer</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>Sonia D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Memorial University of Newfoundland, St John's, Newfoundland, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCartney</LastName><ForeName>Colin J L</ForeName><Initials>CJL</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Ottawa Hospital Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorr</LastName><ForeName>Risa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Learning Services, The Ottawa Hospital, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denault</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of Anesthesia and Critical Care, Montreal Heart Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Ottawa Hospital Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Canadian Perioperative Anesthesia Clinical Trials Group (PACT)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2019 Mar;128(3):396-398. doi: 10.1213/ANE.0000000000003999.</RefSource><PMID Version="1">30789408</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30676348</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003942</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36401716</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1970-9366</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Internal and emergency medicine</Title><ISOAbbreviation>Intern Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>162</EndPage><MedlinePgn>151-162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11739-022-03142-2</ELocationID><Abstract><AbstractText>Cardiac surgery in Jehovah's Witnesses (JW) patients who refuse blood transfusion is challenging requiring dedicated strategies. We aimed to analyze non-selected JW patients undergoing cardiac surgery and to compare with matched controls both perioperative outcomes and long-term survival. We retrospectively analyzed JW patients undergoing cardiac surgery from January 2016 to March 2021 and compared them with matched controls. The primary outcome was a composite of in-hospital perioperative adverse events and in-hospital mortality. The secondary outcome was all-cause mortality at long-term follow-up. A total of 113 JW patients and 113 controls were included. Baseline clinical characteristics, including laboratory parameters were comparable. Overall, there were no statistical differences between JW vs controls in terms of in-hospital mortality (2.7% vs 1.8%, p&#x2009;=&#x2009;1.00) but mortality was remarkably high (40%) in JW patients with post-op hemoglobin&#x2009;&lt;&#x2009;8&#xa0;g/dl. Logistic regression analysis found that the JW group was not associated with a higher occurrence of the composite outcome (adjusted odds ratio 0.91, 95% confidence interval [CI] 0.54-1.57). After a median follow-up of 1397 [IQR 922.7-1723.5] days, JW patients were not associated with a significantly higher all-cause mortality (adjusted hazard ratio 0.77, 95% CI 0.24-2.42). Cardiac surgery can be safely performed in non-anemic JW patients despite the refusal of blood transfusions. Favorable clinical outcomes can be achieved by the use of specific perioperative strategies for bloodless surgery with no differences as compared to control patients except in JW patients with a very low level of post-operative hemoglobin not supported by immediate transfusions.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Societ&#xe0; Italiana di Medicina Interna (SIMI).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Nanni</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Vitolo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imberti</LastName><ForeName>Jacopo F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girolami</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonini</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valenti</LastName><ForeName>Anna Chiara</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cimato</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Hesperia Hospital, Modena, Italy. dottpaolocimato@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Villa Torri Hospital, GVM Care &amp; Research, Bologna, Italy. dottpaolocimato@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Boriani</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9820-4815</Identifier><AffiliationInfo><Affiliation>Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Intern Emerg Med</MedlineTA><NlmUniqueID>101263418</NlmUniqueID><ISSNLinking>1828-0447</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033221" MajorTopicYN="Y">Jehovah's Witnesses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bloodless surgery</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Jehovah&#x2019;s Witnesses</Keyword><Keyword MajorTopicYN="N">Patient blood management</Keyword><Keyword MajorTopicYN="N">Transfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>19</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36401716</ArticleId><ArticleId IdType="doi">10.1007/s11739-022-03142-2</ArticleId><ArticleId IdType="pii">10.1007/s11739-022-03142-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Official Website of Jehovah&#x2019;s Witnesses. https://www.jw.org/en/ . Accessed July 1, 2022. Accessed.</Citation></Reference><Reference><Citation>Rashid M, Kromah F, Cooper C (2021) Blood transfusion and alternatives in jehovah&#x2019;s witness patients. Curr Opin Anaesthesiol 34(2):125&#x2013;130. https://doi.org/10.1097/aco.0000000000000961</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aco.0000000000000961</ArticleId></ArticleIdList></Reference><Reference><Citation>Rollins KE, Contractor U, Inumerable R, Lobo DN (2016) Major abdominal surgery in jehovah&#x2019;s witnesses. Ann R Coll Surg Engl 98(8):532&#x2013;537. https://doi.org/10.1308/rcsann.2016.0210</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/rcsann.2016.0210</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamson JW (2008) New blood, old blood, or no blood? N Engl J Med 358(12):1295&#x2013;1296. https://doi.org/10.1056/NEJMe0800520</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe0800520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper L, Ford K, Miller E (2013) Preparing a jehovah&#x2019;s witness for major elective surgery. BMJ 346:f1588. https://doi.org/10.1136/bmj.f1588</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f1588</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubouri M, Hedayat F, Abrar S, Mellor SL, Brown LJ, Harky A (2022) Optimising bloodless cardiovascular surgery for jehovah&#x2019;s witnesses and beyond. Coron Artery Dis 31(1):52&#x2013;60. https://doi.org/10.1097/mca.0000000000001050</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mca.0000000000001050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G (2013) Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 96(2):478&#x2013;485. https://doi.org/10.1016/j.athoracsur.2013.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.03.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyke C, Aronson S, Dietrich W, Hofmann A, Karkouti K, Levi M et al (2014) Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg 147(5):1458&#x2013;63.e1. https://doi.org/10.1016/j.jtcvs.2013.10.070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.10.070</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ et al (2006) Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 81(5):1650&#x2013;1657. https://doi.org/10.1016/j.athoracsur.2005.12.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.12.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi G, Busti F, Girelli D (2020) Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine. Intern Emerg Med 15(4):559&#x2013;561. https://doi.org/10.1007/s11739-020-02278-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02278-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta I, Mantovan G, Consonni D, Brambilla AM, Materia M, Porzio M et al (2020) Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department. Intern Emerg Med 15(4):629&#x2013;634. https://doi.org/10.1007/s11739-019-02223-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-019-02223-z</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney S, Guinn N, Roberson R, Broomer B, White W, Hill S (2014) Jehovah&#x2019;s witnesses and cardiac surgery: a single institution&#x2019;s experience. Transfusion 54(10 Pt 2):2745&#x2013;2752. https://doi.org/10.1111/trf.12696</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.12696</ArticleId></ArticleIdList></Reference><Reference><Citation>Pompei E, Tursi V, Guzzi G, Vendramin I, Ius F, Muzzi R et al (2010) Mid-term clinical outcomes in cardiac surgery of jehovah&#x2019;s witnesses. J Cardiovasc Med (Hagerstown) 11(3):170&#x2013;174. https://doi.org/10.2459/JCM.0b013e3283330752</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0b013e3283330752</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinakis S, Van der Linden P, Tortora R, Massaut J, Pierrakos C, Wauthy P (2016) Outcomes from cardiac surgery in jehovah&#x2019;s witness patients: experience over twenty-one years. J Cardiothorac Surg 11(1):67. https://doi.org/10.1186/s13019-016-0455-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-016-0455-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Wauthy P, Pierrakos C, Chebli L, Tortora R (2019) Long-term survival and quality of life in jehovah&#x2019;s witnesses after cardiac surgery: a case control study. BMC Cardiovasc Disord 19(1):73. https://doi.org/10.1186/s12872-019-1061-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-019-1061-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasques F, Kinnunen EM, Pol M, Mariscalco G, Onorati F, Biancari F (2016) Outcome of jehovah&#x2019;s witnesses after adult cardiac surgery: systematic review and meta-analysis of comparative studies. Transfusion 56(8):2146&#x2013;2153. https://doi.org/10.1111/trf.13657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.13657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R et al (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16(1):9&#x2013;13. https://doi.org/10.1016/s1010-7940(99)00134-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1010-7940(99)00134-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam G, West M, Berg G (2005) Additive and logistic EuroSCORE performance in high risk patients. Interact Cardiovasc Thorac Surg 4(4):299&#x2013;303. https://doi.org/10.1510/icvts.2004.104042</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2004.104042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahba A, Milojevic M, Boer C, De Somer F, Gudbjartsson T, van den Goor J et al (2020) 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Eur J Cardiothorac Surg 57(2):210&#x2013;251. https://doi.org/10.1093/ejcts/ezz267</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezz267</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123(23):2736&#x2013;2747. https://doi.org/10.1161/circulationaha.110.009449</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.110.009449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis CT, Murphy MC, Cooley DA (1991) Risk factors for cardiac operations in adult jehovah&#x2019;s witnesses. Ann Thorac Surg 51(3):448&#x2013;450. https://doi.org/10.1016/0003-4975(91)90862-k</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(91)90862-k</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattakos G, Koch CG, Brizzio ME, Batizy LH, Sabik JF, Blackstone EH et al (2012) Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med 172(15):1154&#x2013;1160. https://doi.org/10.1001/archinternmed.2012.2449</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2012.2449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskar B, Jack RK, Mullany D, Fraser J (2010) Comparison of outcome in jehovah&#x2019;s witness patients in cardiac surgery: an Australian experience. Heart Lung Circ 19(11):655&#x2013;659. https://doi.org/10.1016/j.hlc.2010.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2010.07.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamou SC, White T, Barnett S, Boyce SW, Corso PJ, Lefrak EA (2006) Comparisons of cardiac surgery outcomes in jehovah&#x2019;s versus Non-jehovah&#x2019;s witnesses. Am J Cardiol 98(9):1223&#x2013;1225. https://doi.org/10.1016/j.amjcard.2006.05.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.05.055</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes G, Nuche JM, Sarraj A, Cobiella J, Orts M, Martin G et al (2007) Bloodless cardiac surgery in jehovah&#x2019;s witnesses: outcomes compared with a control group. Rev Esp Cardiol 60(7):727&#x2013;731</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13108278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander S, Singer-Englar T, Nishihara K, Esmailian F, Patel JK, Kobashigawa JA et al (2021) Heart transplant in jehovah&#x2019;s witness patients: a case-control study. J Heart Lung Transplant 40(7):575&#x2013;579. https://doi.org/10.1016/j.healun.2021.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2021.03.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosengart TK, Helm RE, DeBois WJ, Garcia N, Krieger KH, Isom OW (1997) Open heart operations without transfusion using a multimodality blood conservation strategy in 50 jehovah&#x2019;s witness patients: implications for a &#x201c;bloodless&#x201d; surgical technique. J Am Coll Surg 184(6):618&#x2013;629</Citation></Reference><Reference><Citation>Chambault AL, Brown LJ, Mellor S, Harky A (2021) Outcomes of cardiac surgery in jehovah&#x2019;s witness patients: a review. Perfusion 36(7):661&#x2013;671. https://doi.org/10.1177/0267659120980375</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659120980375</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaislic CD, Dalibon N, Ponzio O, Ba M, Jugan E, Lagneau F et al (2012) Outcomes in cardiac surgery in 500 consecutive Jehovah&#x2019;s witness patients: 21&#xa0;year experience. J Cardiothorac Surg 7:95. https://doi.org/10.1186/1749-8090-7-95</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-7-95</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka A, Ota T, Uriel N, Asfaw Z, Onsager D, Lonchyna VA et al (2015) Cardiovascular surgery in jehovah&#x2019;s witness patients: the role of preoperative optimization. J Thorac Cardiovasc Surg 150(4):976&#x2013;983. https://doi.org/10.1016/j.jtcvs.2015.06.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.06.059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R et al (2019) Patient blood management: recommendations from the 2018 frankfurt consensus conference. JAMA 321(10):983&#x2013;997. https://doi.org/10.1001/jama.2019.0554</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0554</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein A, Agarwal S, Cholley B, Fassl J, Griffin M, Kaakinen T et al (2022) A review of European guidelines for patient blood management with a particular emphasis on antifibrinolytic drug administration for cardiac surgery. J Clin Anesth 78:110654. https://doi.org/10.1016/j.jclinane.2022.110654</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2022.110654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagano D, Milojevic M, Meesters MI, Benedetto U, Bolliger D, von Heymann C et al (2017) 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg 53(1):79&#x2013;111. https://doi.org/10.1093/ejcts/ezx325</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezx325</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K et al (2017) Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 377(22):2133&#x2013;2144. https://doi.org/10.1056/NEJMoa1711818</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1711818</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD et al (2006) Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34(6):1608&#x2013;1616. https://doi.org/10.1097/01.CCM.0000217920.48559.D8</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000217920.48559.D8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogervorst EK, Rosseel PM, van de Watering LM, Brand A, Bentala M, van der Bom JG et al (2016) intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. J Cardiothorac Vasc Anesth 30(2):363&#x2013;372. https://doi.org/10.1053/j.jvca.2015.10.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.10.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson JL, Noveck H, Berlin JA, Gould SA (2002) Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 42(7):812&#x2013;818. https://doi.org/10.1046/j.1537-2995.2002.00123.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1537-2995.2002.00123.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S et al (2014) An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 54(10 Pt 2):2688&#x2013;2695. https://doi.org/10.1111/trf.12565</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.12565</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinn NR, Roberson RS, White W, Cowper PA, Broomer B, Milano C et al (2015) Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study. Transfusion 55(12):2791&#x2013;2798. https://doi.org/10.1111/trf.13246</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.13246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28859398</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1442-2050</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</Title><ISOAbbreviation>Dis Esophagus</ISOAbbreviation></Journal><ArticleTitle>Component analysis of enhanced recovery pathways for esophagectomy.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/dote/dox090</ELocationID><Abstract><AbstractText>The objective of this systematic review is to identify key components of enhanced recovery protocols (ERP) that lead to improved length of hospital stay (LOS) following esophagectomy. Relevant electronic databases were searched for studies comparing clinical outcome from esophagectomy followed by a conventional pathway versus ERP. Relevant outcome measures were compared and metaregression was performed to identify the key ERP components associated with reduced in LOS. Thirteen publications were included, ERP was associated with no changes in in-hospital mortality, total complications, anastomotic leak, or pulmonary complications compared with a conventional pathway, however LOS was reduced in the ERP group. Metaregression identified that immediate extubation was associated with reduced LOS (OR = -0.51, 95%CI -0.77 to -0.25; P&#xa0;&lt;&#xa0;0.01). Several postoperative factors were associated with a significant reduction in length of hospital stay, and in order of most important were (i) gastrograffin swallow &#x2264;5 days (OR = -4.27, 95%CI -4.50 to -4.03); (ii) mobilization on postoperative day &#x2264;1 (OR = -2.49, 95%CI -2.63 to -2.34); (iii) removal of urinary catheter &#x2264;2 days (OR = -0.99, 95%CI -1.15 to -0.84); (iv) oral intake with at least sips of fluid &#x2264;1 day (OR = -0.96, 95%CI -1.24 to -0.68); (v) enteral diet with feeding jejunostomy or gastrostomy &#x2264;&#xa0;1 day (OR = -0.57, 95%CI -0.80 to -0.35) and (vi) epidural removal &#x2264;&#xa0;4 days (OR = -0.17, 95%CI -0.27 to -0.07). Several core ERP components and principles appear to be associated with LOS reduction. These elements should form a part of the core ERP for the specialty, while surgical teams incorporate other elements through an iterative process.</AbstractText><CopyrightInformation>&#xa9; The Authors 2017. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Markar</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Malietzis</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Athanasiou</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Moorthy</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Esophagus</MedlineTA><NlmUniqueID>8809160</NlmUniqueID><ISSNLinking>1120-8694</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>3X9MR4N98U</RegistryNumber><NameOfSubstance UI="D003974">Diatrizoate Meglumine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015360" MajorTopicYN="N">Analgesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003974" MajorTopicYN="N">Diatrizoate Meglumine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004326" MajorTopicYN="N">Drinking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004434" MajorTopicYN="N">Early Ambulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004750" MajorTopicYN="N">Enteral Nutrition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014546" MajorTopicYN="N">Urinary Catheterization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">esophageal cancer</Keyword><Keyword MajorTopicYN="N">esophageal cancer surgery</Keyword><Keyword MajorTopicYN="N">supportive care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28859398</ArticleId><ArticleId IdType="doi">10.1093/dote/dox090</ArticleId><ArticleId IdType="pii">4001440</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33479993</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2724-7031</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>La Tunisie medicale</Title><ISOAbbreviation>Tunis Med</ISOAbbreviation></Journal><ArticleTitle>Quality indicators of hip fracture management. A systematic review.</ArticleTitle><Pagination><StartPage>913</StartPage><EndPage>925</EndPage><MedlinePgn>913-925</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify standards and quality indicators of hip fracture management from the medical literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a "systematic review" on the topic of quality indicators of hip fracture management using PubMed database, during 15 years from 2001 to 2015. The collected publications were studied by two readers to extract the different quality indicators of hip fracture management. These indicators were stratified according to their type (process or outcome) and to the time of health care (pre, per or post-operative).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 41 articles were included in the study: The analysis of these articles highlighted a predominance of Anglo-Saxon papers, an increasing rate of publication over time, a dominance of evaluative studies and a multiplicity of guidelines. A total of 46 quality indicators were identified through these articles. Two third were classified as procedural items and 60% were about post-operative hip fracture management. The most assessed indicators and standards, among those related to the preoperative care, were time to surgery (34%) and patient clinical condition assessment (11%). During the operation time, the most assessed indicator was the proportion of patients who have had spinal anesthesia (73%). For the postoperative care, the most common&#xa0; indicators and standards were length of hospital stay (12%), osteoporosis treatment prescription (8%), mattresses use to prevent pressure ulcer (7%), pressure sores occurring (7%) and in hospital mortality (7%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This systematic review allowed to identify the main indicators recommended to evaluate the management of hip fracture. The continuous monitoring of these indicators should be generalized in maghrebian countries using strategic dashboards in all hospitals and clinics treating this pathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zemni</LastName><ForeName>Imen</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Meriem</LastName><ForeName>Kacem</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Khelil</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Safer</LastName><ForeName>Mouna</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Zoghlami</LastName><ForeName>Chokri</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ben Abdelaziz</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Tunisia</Country><MedlineTA>Tunis Med</MedlineTA><NlmUniqueID>0413766</NlmUniqueID><ISSNLinking>0041-4131</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019984" MajorTopicYN="Y">Quality Indicators, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33479993</ArticleId><ArticleId IdType="pii">/article-medicale-tunisie.php?article=3805</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29936992</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>229</Volume><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Multidisciplinary strategies in bloodless medicine and surgery for patients undergoing pancreatectomy.</ArticleTitle><Pagination><StartPage>208</StartPage><EndPage>215</EndPage><MedlinePgn>208-215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2018.04.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(18)30248-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Bloodless pancreatic surgery (BPS) is rarely performed and/or reported. We aim to characterize perioperative and anesthetic strategies in BPS.</AbstractText><AbstractText Label="MATERIALS AND METHODS">A literature search was performed on MEDLINE looking for case reports/case series using search terms ("Jehovah's Witness" [All Fields]) AND ("Pancreatic Surgery" [All Fields] OR "Pancreaticoduodenectomy" [All Fields] OR "Distal Pancreatectomy" [All Fields]). Data regarding categorical variables are reported as proportions and quantitative continuous variables as medians with ranges or means with standard deviation. Forty-one patients requiring BPS are reported in the literature with three additional cases from our institution (n&#xa0;=&#xa0;44). The data analyzed included clinicopathologic factors, BPS strategies, patient complications, and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">The most common procedure and diagnosis were pancreaticoduodenectomy (n&#xa0;=&#xa0;34, 77.3%) and pancreatic ductal adenocarcinoma (n&#xa0;=&#xa0;12, 27.3%), respectively. Transfusion reduction strategies in BPS fell into three categories: preoperative, intraoperative, and postoperative. Preoperative strategies included iron supplementation (n&#xa0;=&#xa0;24, 54.5%) and erythropoietin administration (n&#xa0;=&#xa0;14, 41.2%). Intraoperative strategies included acute normovolemic hemodilution (n&#xa0;=&#xa0;30, 68%) and cell saver (n&#xa0;=&#xa0;4, 9.1%). Postoperative strategies included erythropoietin (n&#xa0;=&#xa0;16, 48.5%) and iron supplementation (n&#xa0;=&#xa0;16, 48.5%). Complications occurred in 21 (60%) patients. There was no in-hospital mortality among the 44 patients in this cohort.</AbstractText><AbstractText Label="CONCLUSIONS">A broad spectrum of bloodless medicine and surgery practices were used based on patient selection, multidisciplinary practice, and preference. With careful perioperative and anesthetic management, BPS can be performed with good outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khalili</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morano</LastName><ForeName>William F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marconcini</LastName><ForeName>Luiz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Hematology &amp; Oncology, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaikh</LastName><ForeName>Mohammad F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleeson</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Styler</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology &amp; Oncology, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zebrower</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowne</LastName><ForeName>Wilbur B</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania. Electronic address: wbb28@drexel.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057668" MajorTopicYN="N">Bloodless Medical and Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021441" MajorTopicYN="N">Carcinoma, Pancreatic Ductal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033183" MajorTopicYN="Y">Interdisciplinary Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033221" MajorTopicYN="N">Jehovah's Witnesses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010180" MajorTopicYN="N">Pancreatectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057240" MajorTopicYN="N">Patient Preference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bloodless Surgery and Medicine</Keyword><Keyword MajorTopicYN="N">Jehovah&#x2019;s Witness</Keyword><Keyword MajorTopicYN="N">Pancreatic Surgery</Keyword><Keyword MajorTopicYN="N">Pancreaticoduodenectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29936992</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2018.04.009</ArticleId><ArticleId IdType="pii">S0022-4804(18)30248-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38418761</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Comparing perioperative outcomes between regional anesthesia and general anesthesia in patients undergoing hip fracture surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>849</StartPage><EndPage>869</EndPage><MedlinePgn>849-869</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-024-02696-3</ELocationID><Abstract><AbstractText Label="PURPOSE">Nearly all patients with hip fractures undergo surgical treatment. The use of different anesthesia techniques during surgery may influence the clinical outcomes. The optimal anesthetic technique for patients undergoing hip fracture surgery is still controversial. We performed this updated systematic review and meta-analysis to compare clinical outcomes of patients undergoing hip fracture surgery with different anesthesia techniques.</AbstractText><AbstractText Label="SOURCE">Articles published from 2000 to May 2023 were included from MEDLINE, Embase, Web of Science, and the Cochrane Library. We included randomized controlled trials and observational studies comparing general anesthesia (GA) with regional anesthesia (RA) for the outcomes of 30-day mortality, 90-day mortality, in-hospital mortality, perioperative complications, length of hospital stay, and length of surgery in patients undergoing hip fracture surgery. Subgroup analyses were performed for the outcomes based on study design (randomized controlled trials or observational studies). We used a random-effects model for all analyses.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">In this meta-analysis, we included 12 randomized controlled trials. There was no difference in postoperative 30-day mortality between the two groups (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.44 to 1.74; I<sup>2</sup>&#x2009;=&#x2009;0%). The incidence of intraoperative hypotension was lower in patients who received RA vs GA (OR, 0.52; 95% CI, 0.38 to 0.72; I<sup>2</sup>&#x2009;=&#x2009;0%). No significant differences were observed in 90-day mortality, in-hospital mortality, postoperative delirium, pneumonia, myocardial infarction, venous thromboembolism, length of surgery, and length of hospital stay.</AbstractText><AbstractText Label="CONCLUSION">In this updated systematic review and meta-analysis, RA did not reduce postoperative 30-day mortality in hip fracture surgery patients compared to GA. Fewer patients receiving RA had intraoperative hypotension than those receiving GA did. Apart from intraoperative hypotension, the data showed no differences in complications between the two anesthetic techniques.</AbstractText><AbstractText Label="STUDY REGISTRATION">PROSPERO (CRD42023411854); registered 7 April 2023.</AbstractText><CopyrightInformation>&#xa9; 2024. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Jianan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Huihong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jianhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wenzhou</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Wenjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shaoguang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wenjie</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Weidong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Anjing</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yanbo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Yingfeng Road, 33th Haizhu District, Guangzhou, 510000, China. sysuchenybo3@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>A2021280</GrantID><Agency>Medical Research Foundation of Guangdong Province</Agency><Country/></Grant><Grant><GrantID>SYS-Q-202105</GrantID><Agency>Sun Yat-sen Clinical Research Cultivation Program</Agency><Country/></Grant><Grant><GrantID>YXQH202213</GrantID><Agency>Sun Yat-sen Scientific Research Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><VernacularTitle>Comparaison des issues p&#xe9;riop&#xe9;ratoires entre l&#x2019;anesth&#xe9;sie r&#xe9;gionale et l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale chez la patient&#xe8;le b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie de fracture de la hanche : une revue syst&#xe9;matique et une m&#xe9;ta-analyse.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="UNLABELLED">R&#xe9;SUM&#xe9;: OBJECTIF: Presque toutes les personnes ayant subi une fracture de la hanche se font op&#xe9;rer. L&#x2019;utilisation de diff&#xe9;rentes techniques d&#x2019;anesth&#xe9;sie pendant la chirurgie peut influencer les issues cliniques. La technique d&#x2019;anesth&#xe9;sie optimale pour la patient&#xe8;le b&#xe9;n&#xe9;ficiant de chirurgie de fracture de la hanche est encore controvers&#xe9;e. Nous avons r&#xe9;alis&#xe9; cette mise &#xe0; jour par revue syst&#xe9;matique et m&#xe9;ta-analyse pour comparer les issues cliniques des personnes b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie de fracture de la hanche avec diff&#xe9;rentes techniques d&#x2019;anesth&#xe9;sie.</AbstractText><AbstractText Label="SOURCES" NlmCategory="METHODS">Les articles publi&#xe9;s de 2000 &#xe0; mai 2023 ont &#xe9;t&#xe9; inclus &#xe0; partir des bases de donn&#xe9;es MEDLINE, Embase, Web of Science et Cochrane Library. Nous avons inclus des &#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es et des &#xe9;tudes observationnelles comparant l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale (AG) &#xe0; l&#x2019;anesth&#xe9;sie r&#xe9;gionale (AR) pour les issues de mortalit&#xe9; &#xe0; 30 jours, de mortalit&#xe9; &#xe0; 90 jours, de mortalit&#xe9; intrahospitali&#xe8;re, de complications p&#xe9;riop&#xe9;ratoires, de dur&#xe9;e de s&#xe9;jour &#xe0; l&#x2019;h&#xf4;pital et de dur&#xe9;e de la chirurgie pour les personnes b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie de fracture de la hanche. Des analyses de sous-groupes ont &#xe9;t&#xe9; r&#xe9;alis&#xe9;es pour les issues en fonction de la m&#xe9;thodologie utilis&#xe9;e (&#xe9;tude randomis&#xe9;e contr&#xf4;l&#xe9;e ou &#xe9;tude observationnelle). Un mod&#xe8;le &#xe0; effets al&#xe9;atoires a &#xe9;t&#xe9; utilis&#xe9; pour toutes les analyses.</AbstractText><AbstractText Label="CONSTATATIONS PRINCIPALES" NlmCategory="UNASSIGNED">Dans cette m&#xe9;ta-analyse, nous avons inclus 12 &#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es. Il n&#x2019;y avait pas de diff&#xe9;rence dans la mortalit&#xe9; postop&#xe9;ratoire &#xe0; 30 jours entre les deux groupes (rapport de cotes [RC], 0,88; intervalle de confiance &#xe0; 95&#xa0;% [IC], 0,44 &#xe0; 1,74; I<sup>2</sup>&#x2009;=&#x2009;0&#xa0;%). L&#x2019;incidence d&#x2019;hypotension perop&#xe9;ratoire &#xe9;tait plus faible chez les patient&#xb7;es ayant re&#xe7;u une AR vs une AG (RC, 0,52; IC 95&#xa0;%, 0,38 &#xe0; 0,72; I<sup>2</sup>&#x2009;=&#x2009;0&#xa0;%). Aucune diff&#xe9;rence significative n&#x2019;a &#xe9;t&#xe9; observ&#xe9;e dans les issues de mortalit&#xe9; &#xe0; 90 jours, de mortalit&#xe9; intrahospitali&#xe8;re, de delirium postop&#xe9;ratoire, de pneumonie, d&#x2019;infarctus du myocarde, de thromboembolie veineuse, de dur&#xe9;e de la chirurgie, et de dur&#xe9;e du s&#xe9;jour &#xe0; l&#x2019;h&#xf4;pital.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dans cette revue syst&#xe9;matique avec m&#xe9;ta-analyse, l&#x2019;anesth&#xe9;sie r&#xe9;gionale n&#x2019;a pas r&#xe9;duit la mortalit&#xe9; postop&#xe9;ratoire &#xe0; 30 jours chez les personnes ayant b&#xe9;n&#xe9;fici&#xe9; d&#x2019;une chirurgie de fracture de la hanche par rapport &#xe0; l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale. Une proportion moindre de patient&#xb7;es ayant re&#xe7;u une AR pr&#xe9;sentaient une hypotension perop&#xe9;ratoire par rapport aux personnes ayant re&#xe7;u une AG. En dehors de l&#x2019;hypotension perop&#xe9;ratoire, les donn&#xe9;es n&#x2019;ont montr&#xe9; aucune diff&#xe9;rence dans les complications entre les deux techniques anesth&#xe9;siques. ENREGISTREMENT DE L&#x2019;&#xe9;TUDE: PROSPERO (CRD42023411854); enregistr&#xe9;e le 7 avril 2023.</AbstractText><CopyrightInformation>&#xa9; 2024. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">hip fracture surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">regional anesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38418761</ArticleId><ArticleId IdType="doi">10.1007/s12630-024-02696-3</ArticleId><ArticleId IdType="pii">10.1007/s12630-024-02696-3</ArticleId></ArticleIdList><ReferenceList><Title>Reference</Title><Reference><Citation>Zhang YW, Lu PP, Li YJ, et al. Prevalence, characteristics, and associated risk factors of the elderly with hip fractures: a cross-sectional analysis of NHANES 2005&#x2013;2010. Clin Interv Aging 2021; 16: 177&#x2013;85. https://doi.org/10.2147/cia.s291071</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/cia.s291071</ArticleId><ArticleId IdType="pubmed">33542622</ArticleId><ArticleId IdType="pmc">7851483</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YW, Cao MM, Li YJ, et al. Dietary protein intake in relation to the risk of osteoporosis in middle-aged and older individuals: a cross-sectional study. J Nutr Health Aging 2022; 26: 252&#x2013;8. https://doi.org/10.1007/s12603-022-1748-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-022-1748-1</ArticleId><ArticleId IdType="pubmed">35297468</ArticleId></ArticleIdList></Reference><Reference><Citation>Flikweert ER, Wendt KW, Diercks RL, et al. Complications after hip fracture surgery: are they preventable? Eur J Trauma Emerg Surg 2018; 44: 573&#x2013;80. https://doi.org/10.1007/s00068-017-0826-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00068-017-0826-2</ArticleId><ArticleId IdType="pubmed">28795198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Gao L. Association between general anesthesia and the occurrence of cerebrovascular accidents in hip fracture patients. J Healthc Eng 2021; https://doi.org/10.1155/2021/7271136</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7271136</ArticleId><ArticleId IdType="pubmed">35419184</ArticleId><ArticleId IdType="pmc">8719998</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Chan PH, Zohman GL, et al. Impact of anesthesia on hospital mortality and morbidities in geriatric patients following emergency hip fracture surgery. J Orthop Trauma 2018; 32: 116&#x2013;23. https://doi.org/10.1097/bot.0000000000001035</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bot.0000000000001035</ArticleId><ArticleId IdType="pubmed">29461445</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, et al. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res 2018; 476: 1178&#x2013;88. https://doi.org/10.1007/s11999.0000000000000147</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999.0000000000000147</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId><ArticleId IdType="pmc">6263607</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, et al. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med 2021; 385: 2025&#x2013;35. https://doi.org/10.1056/nejmoa2113514</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2113514</ArticleId><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, et al. Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the RAGA randomized trial. JAMA 2022; 327: 50&#x2013;8. https://doi.org/10.1001/jama.2021.22647</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.22647</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, Coburn M. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol 2017; 17: 87. https://doi.org/10.1186/s12871-017-0380-9</Citation></Reference><Reference><Citation>Patel V, Champaneria R, Dretzke J, Yeung J. Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review. BMJ Open 2018; 8: e020757. https://doi.org/10.1136/bmjopen-2017-020757</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-020757</ArticleId><ArticleId IdType="pubmed">30518580</ArticleId><ArticleId IdType="pmc">6286489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, Liu Z. Comparative efficacy of neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol 2020; 20: 162. https://doi.org/10.1186/s12871-020-01074-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01074-y</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId><ArticleId IdType="pmc">7325684</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhushan S, Huang X, Duan Y, Xiao Z. The impact of regional versus general anesthesia on postoperative neurocognitive outcomes in elderly patients undergoing hip fracture surgery: a systematic review and meta-analysis. Int J Surg 2022; 105: 106854. https://doi.org/10.1016/j.ijsu.2022.106854</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2022.106854</ArticleId><ArticleId IdType="pubmed">36031067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor SK, Hamal PB, Tomassini S, Yeung J, Whitehouse MR, Matharu GS. Clinical effectiveness and safety of spinal anaesthesia compared with general anaesthesia in patients undergoing hip fracture surgery using a consensus-based core outcome set and patient-and public-informed outcomes: a systematic review and meta-analysis of randomised controlled trials. Br J Anaesth 2022; 129: 788&#x2013;800. https://doi.org/10.1016/j.bja.2022.07.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.07.031</ArticleId><ArticleId IdType="pubmed">36270701</ArticleId><ArticleId IdType="pmc">9642835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DX, Yang L, Ding L, Li SY, Qi YN, Li Q. Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: a systematic review and meta-analysis. Medicine (Baltimore) 2019; 98: e18220. https://doi.org/10.1097/md.0000000000018220</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000018220</ArticleId><ArticleId IdType="pubmed">31804347</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, McLoughlin L, Patterson CC, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth 2018; 120: 37&#x2013;50. https://doi.org/10.1016/j.bja.2017.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.09.002</ArticleId><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Babu S, Dixon P, et al. Guideline for the management of hip fractures 2020: guideline by the Association of Anaesthetists. Anaesthesia 2021; 76: 225&#x2013;37. https://doi.org/10.1111/anae.15291</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15291</ArticleId><ArticleId IdType="pubmed">33289066</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097. https://doi.org/10.1371/journal.pmed.1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId><ArticleId IdType="pmc">2707599</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928. https://doi.org/10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId><ArticleId IdType="pmc">3196245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Wells G, Shea B, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014: Available from URL: https://api.semanticscholar.org/CorpusID:79550924 (accessed October 2023).</Citation></Reference><Reference><Citation>Shi J, Luo D, Wan X, et al. Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat Methods Med Res 2023; 32: 1338&#x2013;60. https://doi.org/10.1177/09622802231172043</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09622802231172043</ArticleId><ArticleId IdType="pubmed">37161735</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Luo D, Wan X, et al. Detecting the skewness of data from the sample size and the five-number summary. Stat Methods Med Res 2020; 32: 1338&#x2013;60. https://doi.org/10.1177/09622802231172043</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09622802231172043</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Luo D, Weng H, et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods 2020; 11: 641&#x2013;54. https://doi.org/10.1002/jrsm.1429</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1429</ArticleId><ArticleId IdType="pubmed">32562361</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018; 27: 1785&#x2013;805. https://doi.org/10.1177/0962280216669183</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216669183</ArticleId><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; 14: 135. https://doi.org/10.1186/1471-2288-14-135</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId><ArticleId IdType="pmc">4383202</ArticleId></ArticleIdList></Reference><Reference><Citation>Titler S, Dexter F, Epstein RH. Percentages of cases in operating rooms of sufficient duration to accommodate a 30-minute breast milk pumping session by anesthesia residents or nurse anesthetists. Cureus 2021; 13: e12519. https://doi.org/10.7759/cureus.12519</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12519</ArticleId><ArticleId IdType="pubmed">33564523</ArticleId><ArticleId IdType="pmc">7863080</ArticleId></ArticleIdList></Reference><Reference><Citation>Strum DP, May JH, Vargas LG. Modeling the uncertainty of surgical procedure times: comparison of log-normal and normal models. Anesthesiology 2000; 92: 1160&#x2013;67. https://doi.org/10.1097/00000542-200004000-00035</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200004000-00035</ArticleId><ArticleId IdType="pubmed">10754637</ArticleId></ArticleIdList></Reference><Reference><Citation>van Aert RC, Jackson D. A new justification of the Hartung-Knapp method for random-effects meta-analysis based on weighted least squares regression. Res Synth Methods 2019; 10: 515&#x2013;27. https://doi.org/10.1002/jrsm.1356</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1356</ArticleId><ArticleId IdType="pubmed">31111673</ArticleId><ArticleId IdType="pmc">6973024</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003; 22: 2693&#x2013;710. https://doi.org/10.1002/sim.1482</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1482</ArticleId><ArticleId IdType="pubmed">12939780</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara DA, Duff A, Berlin JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000; 92: 947&#x2013;57. https://doi.org/10.1097/00000542-200004000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200004000-00011</ArticleId><ArticleId IdType="pubmed">10754613</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SM, Soltani H, Hashemi SJ, Talakoub R, Soleimani B. Comparative study of two anesthesia methods according to postoperative complications and one month mortality rate in the candidates of hip surgery. J Res Med Sci 2011; 16: 323&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">22091252</ArticleId><ArticleId IdType="pmc">3214341</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, Ludwig JM, Fleisher LA. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology 2012; 117: 72&#x2013;92. https://doi.org/10.1097/aln.0b013e3182545e7c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0b013e3182545e7c</ArticleId><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med 2012; 13: 948&#x2013;56. https://doi.org/10.1111/j.1526-4637.2012.01402.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2012.01402.x</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid RH, Shah AA, Shakoor A, Noordin S. Hip fracture surgery: does type of anesthesia matter? Biomed Res Int 2013; 2013: 252356. https://doi.org/10.1155/2013/252356</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/252356</ArticleId><ArticleId IdType="pubmed">23819114</ArticleId><ArticleId IdType="pmc">3684036</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, Zubizarreta JR, Silber JH. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA 2014; 311: 2508&#x2013;17. https://doi.org/10.1001/jama.2014.6499</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.6499</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId><ArticleId IdType="pmc">4344128</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JL, Wang XL, Gong MW, et al. Comparative outcomes of peripheral nerve blocks versus general anesthesia for hip fractures in geriatric Chinese patients. Patient Prefer Adherence 2014; 8: 651&#x2013;9. https://doi.org/10.2147/ppa.s61903</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ppa.s61903</ArticleId><ArticleId IdType="pubmed">24855341</ArticleId><ArticleId IdType="pmc">4019620</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65,535 patients in a national dataset. Anaesthesia 2014; 69: 224&#x2013;30. https://doi.org/10.1111/anae.12542</Citation></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, Samuel AM, Grauer JG. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip. Bone Joint J 2015; 97: 689&#x2013;95. https://doi.org/10.1302/0301-620x.97b5.35042</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620x.97b5.35042</ArticleId><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, et al. Propensity score-matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology 2015; 123: 136&#x2013;47. https://doi.org/10.1097/aln.0000000000000695</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000000695</ArticleId><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields AC, Dieterich JD, Buterbaugh K, Moucha CS. Short-term complications in hip fracture surgery using spinal versus general anaesthesia. Injury 2015; 46: 719&#x2013;23. https://doi.org/10.1016/j.injury.2015.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.02.002</ArticleId><ArticleId IdType="pubmed">25704139</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury 2015; 46: 1562&#x2013;6. https://doi.org/10.1016/j.injury.2015.05.004</Citation></Reference><Reference><Citation>Brox WT, Chan PH, Cafri G, Inacio MC. Similar mortality with general or regional anesthesia in elderly hip fracture patients. Acta Orthop 2016; 87: 152&#x2013;7. https://doi.org/10.3109/17453674.2015.1128781</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453674.2015.1128781</ArticleId><ArticleId IdType="pubmed">26986550</ArticleId><ArticleId IdType="pmc">4812077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilango S, Pulle RC, Bell J, Kuys SS. General versus spinal anaesthesia and postoperative delirium in an orthogeriatric population. Australas J Ageing 2016; 35: 42&#x2013;7. https://doi.org/10.1111/ajag.12212</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajag.12212</ArticleId><ArticleId IdType="pubmed">26364948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lon&#x10d;ari&#x107;-Katu&#x161;in M, Mi&#x161;kovi&#x107; P, Lavrnja-Skolan V, Katu&#x161;in J, Bakota B, &#x17d;uni&#x107; J. General versus spinal anaesthesia in proximal femoral fracture surgery&#x2014;treatment outcomes. Injury 2017; 48: S51&#x2013;5. https://doi.org/10.1016/s0020-1383(17)30740-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0020-1383(17)30740-4</ArticleId><ArticleId IdType="pubmed">29122123</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Samara E, Petrou A, Korompilias A, Chalkias A, Papadopoulos G. The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general vs spinal anesthesia. Injury 2018; 49: 2221&#x2013;6. https://doi.org/10.1016/j.injury.2018.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.09.023</ArticleId><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn EJ, Kim HJ, Kim KW, Choi HR, Kang H, Bang SR. Comparison of general anaesthesia and regional anaesthesia in terms of mortality and complications in elderly patients with hip fracture: a nationwide population-based study. BMJ Open 2019; 9: e029245. https://doi.org/10.1136/bmjopen-2019-029245</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-029245</ArticleId><ArticleId IdType="pubmed">31501111</ArticleId><ArticleId IdType="pmc">6738684</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi T, Maeda T, Imatoh T, Babazono A. Comparison of regional with general anesthesia on mortality and perioperative length of stay in older patients after hip fracture surgery. Int J Qual Health Care 2019; 31: 669&#x2013;76. https://doi.org/10.1093/intqhc/mzy233</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzy233</ArticleId><ArticleId IdType="pubmed">30452640</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan L, McKeever TM, Nightingale J, Deakin DE, Moppett IK. Spinal or general anaesthesia for surgical repair of hip fracture and subsequent risk of mortality and morbidity: a database analysis using propensity score-matching. Anaesthesia 2020; 75: 1173&#x2013;9. https://doi.org/10.1111/anae.15042</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15042</ArticleId><ArticleId IdType="pubmed">32337715</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S, Kim SH, Park KK, Kim SJ, Bae JC, Choi YS. Effects of anesthesia techniques on outcomes after hip fracture surgery in elderly patients: a prospective, randomized, controlled trial. J Clin Med 2020; 9: 1605. https://doi.org/10.3390/jcm9061605</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061605</ArticleId><ArticleId IdType="pubmed">32466360</ArticleId><ArticleId IdType="pmc">7355551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehsani R, Motlagh SD, Zaman B, Kashani SS, Ghodraty MR. Effect of general versus spinal anesthesia on postoperative delirium and early cognitive dysfunction in elderly patients. Anesth Pain Med 2020; 10: e101815. https://doi.org/10.5812/aapm.101815</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/aapm.101815</ArticleId><ArticleId IdType="pubmed">33134142</ArticleId><ArticleId IdType="pmc">7539056</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounet B, Choquet O, Swisser F, et al. Impact of multiple nerves blocks anaesthesia on intraoperative hypotension and mortality in hip fracture surgery intermediate-risk elderly patients: a propensity score-matched comparison with spinal and general anaesthesia. Anaesth Crit Care Pain Med 2021; 40: 100924. https://doi.org/10.1016/j.accpm.2021.100924</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2021.100924</ArticleId><ArticleId IdType="pubmed">34217841</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Liu Y, Yuan Y, et al. Effects of general versus subarachnoid anaesthesia on circadian melatonin rhythm and postoperative delirium in elderly patients undergoing hip fracture surgery: a prospective cohort clinical trial. EBioMedicine 2021; 70: 103490. https://doi.org/10.1016/j.ebiom.2021.103490</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103490</ArticleId><ArticleId IdType="pubmed">34280784</ArticleId><ArticleId IdType="pmc">8318871</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T, Imai S, Shimoda S, Maruo K, Nakadera M, Horiguchi H. Aspiration pneumonia and anesthesia techniques in hip fracture surgery in elderly patients: a retrospective cohort study using administrative data. J Orthop Surg (Hong Kong) 2022; 30. https://doi.org/10.1177/10225536221078622</Citation></Reference><Reference><Citation>Guo LS, Wang LN, Xiao JB, Zhong M, Zhao GF. Association between anesthesia technique and complications after hip surgery in the elderly population. World J Clin Cases 2022; 10: 2721&#x2013;32. https://doi.org/10.12998/wjcc.v10.i9.2721</Citation></Reference><Reference><Citation>Matharu GS, Shah A, Hawley S, et al. The influence of mode of anaesthesia on perioperative outcomes in people with hip fracture: a prospective cohort study from the National Hip Fracture Database for England, Wales and Northern Ireland. BMC Med 2022; 20: 319. https://doi.org/10.1186/s12916-022-02517-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02517-8</ArticleId><ArticleId IdType="pubmed">36154933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad Ismail A, Forssten MP, Bass GA, et al. Mode of anesthesia is not associated with outcomes following emergency hip fracture surgery: a population-level cohort study. Trauma Surg Acute Care Open 2022; 7: e000957. https://doi.org/10.1136/tsaco-2022-000957</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tsaco-2022-000957</ArticleId><ArticleId IdType="pubmed">36148316</ArticleId><ArticleId IdType="pmc">9486374</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodkey DL, Pezzi A, Hymes R. Effects of spinal anesthesia in geriatric hip fracture: a propensity-matched study. J Orthop Trauma 2022; 36: 234&#x2013;8. https://doi.org/10.1097/bot.0000000000002273</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bot.0000000000002273</ArticleId><ArticleId IdType="pubmed">34561407</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonin M, Delsuc C, Meuret P, et al. Hypobaric unilateral spinal anesthesia versus general anesthesia for hip fracture surgery in the elderly: a randomized controlled trial. Anesth Analg 2022; 135: 1262&#x2013;70. https://doi.org/10.1213/ane.0000000000006208</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000006208</ArticleId><ArticleId IdType="pubmed">36135347</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A, Pina G, Figueiredo E, Magalh&#xe3;es J, Assun&#xe7;&#xe3;o J. General versus regional anaesthesia for hip fracture surgery&#x2014;impact on mortality and length of stay. Anaesthesiol Intensive Ther 2022; 54: 103&#x2013;7. https://doi.org/10.5114/ait.2022.114251</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2022.114251</ArticleId><ArticleId IdType="pubmed">35579280</ArticleId><ArticleId IdType="pmc">10156514</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra F, Marsan A, Fraschini G, Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2003; 20: 640&#x2013;6. https://doi.org/10.1017/s0265021503001030</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0265021503001030</ArticleId><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>David ME, Aharonoff GB, Karp A, Capla EL, Zuckerman JD, Koval KJ. Effect of postoperative delirium on outcome after hip fracture. Clin Orthop Relat Res 2004; 422: 195&#x2013;200. https://doi.org/10.1097/01.blo.0000128649.59959.0c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.blo.0000128649.59959.0c</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppenstein D, Zohar E, Ramaty E, Shabat S, Fredman B. The effects of general vs spinal anesthesia on frontal cerebral oxygen saturation in geriatric patients undergoing emergency surgical fixation of the neck of femur. J Clin Anesth 2005; 17: 431&#x2013;8. https://doi.org/10.1016/j.jclinane.2004.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2004.09.013</ArticleId><ArticleId IdType="pubmed">16171663</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff TA, Henderson WG, Stoner TJ, Khuri SF, Dohm M, Hutt E. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am 2008; 90: 34&#x2013;42. https://doi.org/10.2106/jbjs.g.00065</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/jbjs.g.00065</ArticleId><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih YJ, Hsieh CH, Kang TW, Peng SY, Fan KT, Wang LM. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol 2010; 4: 37&#x2013;42. https://doi.org/10.1016/S1873-9598(10)70020-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1873-9598(10)70020-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood RJ, White SM. Anaesthesia for 1131 patients undergoing proximal femoral fracture repair: a retrospective, observational study of effects on blood pressure, fluid administration and perioperative anaemia. Anaesthesia 2011; 66: 1017&#x2013;22. https://doi.org/10.1111/j.1365-2044.2011.06854.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2011.06854.x</ArticleId><ArticleId IdType="pubmed">21851345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin S, Heybeli N, Colak A, et al. Comparison of different anesthetic techniques on postoperative outcomes in elderly patients with hip fracture. Turkiye Klinikleri J Med Sci 2012; 32: 623&#x2013;9. https://doi.org/10.5336/medsci.2011-23901</Citation><ArticleIdList><ArticleId IdType="doi">10.5336/medsci.2011-23901</ArticleId></ArticleIdList></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, et al. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med 2012; 37: 433&#x2013;40. https://doi.org/10.1097/aap.0b013e318252e901</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aap.0b013e318252e901</ArticleId><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaca S, Ayhan E, Kesmezacar H, Uysal O. Hip fracture mortality: is it affected by anesthesia techniques? Anesthesiol Res Pract 2012; https://doi.org/10.1155/2012/708754</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/708754</ArticleId><ArticleId IdType="pubmed">22291699</ArticleId><ArticleId IdType="pmc">3265054</ArticleId></ArticleIdList></Reference><Reference><Citation>Seung DK, Park SJ, Lee DH, Jee DL. Risk factors of morbidity and mortality following hip fracture surgery. Korean J Anesthesiol 2013; 64: 505&#x2013;10. https://doi.org/10.4097/kjae.2013.64.6.505</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2013.64.6.505</ArticleId></ArticleIdList></Reference><Reference><Citation>Elisabetta P, Neuman MD, Schneeweiss S, Mogun H, Bateman BT. Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study. BMJ 2014; 348: g4022. https://doi.org/10.1136/bmj.g4022</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g4022</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Gill SS, Bell CM, et al. Postoperative medical complications associated with anesthesia in older adults with dementia. J Am Geriatr Soc 2014; 62: 2102&#x2013;9. https://doi.org/10.1111/jgs.13106</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13106</ArticleId><ArticleId IdType="pubmed">25370019</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaman &#xd6;, &#xd6;zkazanl&#x131; G, Orak MM, et al. Factors affecting postoperative mortality in patients older than 65 years undergoing surgery for hip fracture. Ulus Travma Acil Cerrahi Derg 2015; 21: 44&#x2013;50. https://doi.org/10.5505/tjtes.2015.02582</Citation><ArticleIdList><ArticleId IdType="doi">10.5505/tjtes.2015.02582</ArticleId><ArticleId IdType="pubmed">25779712</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PS, Molina CS, Greenberg SE, Thakore RV, Obremskey WT, Sethi MK. Regional anaesthesia for hip fracture surgery is associated with significantly more perioperative complications compared with general anaesthesia. Int Orthop 2015; 39: 1321&#x2013;7. https://doi.org/10.1007/s00264-015-2735-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-015-2735-5</ArticleId><ArticleId IdType="pubmed">25797416</ArticleId></ArticleIdList></Reference><Reference><Citation>Iftikhar A, Asim KM, Victoria A. Influence of anaesthesia on mobilisation following hip fracture surgery: an observational study. J Orthop Trauma Rehabil 2016; 22: 41&#x2013;7. https://doi.org/10.1016/j.jotr.2016.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jotr.2016.05.001</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R, et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint Audit of Practice (ASAP-2). Anaesthesia 2016; 71: 506&#x2013;14. https://doi.org/10.1111/anae.13415</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.13415</ArticleId><ArticleId IdType="pubmed">26940645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung YC, Hsu YH, Chang GM. The effect of anesthetic type on outcomes of hip fracture surgery: a nationwide population-based study. Medicine (Baltimore) 2016; 95: e3296. https://doi.org/10.1097/md.0000000000003296</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000003296</ArticleId><ArticleId IdType="pubmed">27057897</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi M, Sedighinejad A, Nabi BN, et al. Is spinal anesthesia with low dose lidocaine better than sevoflorane anesthesia in patients undergoing hip fracture surgery. Arch Bone Jt Surg 2017; 5: 226&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28913379</ArticleId><ArticleId IdType="pmc">5592363</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremillet C, Jakobsson JG. Acute hip fracture surgery anaesthetic technique and 30-day mortality in Sweden 2016 and 2017: a retrospective register study. F1000Res 2018; 7: 1009. https://doi.org/10.12688/f1000research.15363.2</Citation></Reference><Reference><Citation>Meuret P, Bouvet L, Villet B, Hafez M, Allaouchiche B, Boselli E. Hypobaric unilateral spinal anaesthesia versus general anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim 2018; 46: 121&#x2013;30. https://doi.org/10.5152/tjar.2018.90699</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/tjar.2018.90699</ArticleId><ArticleId IdType="pubmed">29744247</ArticleId><ArticleId IdType="pmc">5937458</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein ER, Boyer RB, White RS, et al. Improved outcomes for spinal versus general anesthesia for hip fracture surgery: a retrospective cohort study of the National Surgical Quality Improvement Program. Reg Anesth Pain Med 2023; https://doi.org/10.1136/rapm-2022-104217</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2022-104217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, Kopp S. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2016; 2: CD000521. https://doi.org/10.1002/14651858.cd000521.pub3</Citation></Reference><Reference><Citation>Zuo D, Jin C, Shan M, Zhou L, Li Y. A comparison of general versus regional anesthesia for hip fracture surgery: a meta-analysis. Int J Clin Exp Med 2015; 8: 20295&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">26884943</ArticleId><ArticleId IdType="pmc">4723788</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibold C, Falbo R, Gupta A, Miller R, Pederson JM, Malpe M. A systematic review and meta-analysis of anesthesia type on hip fracture post-surgery outcomes. OTA Int 2022; 5: e204. https://doi.org/10.1097/oi9.0000000000000204</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/oi9.0000000000000204</ArticleId><ArticleId IdType="pubmed">36425088</ArticleId><ArticleId IdType="pmc">9580260</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhas L, Perlas A, Tierney S, Chan VW, Beattie S. The effect of anesthetic technique on mortality and major morbidity after hip fracture surgery: a retrospective, propensity-score matched-pairs cohort study. Reg Anesth Pain Med 2019; 44: 847&#x2013;53. https://doi.org/10.1136/rapm-2019-100417</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2019-100417</ArticleId><ArticleId IdType="pubmed">31300593</ArticleId></ArticleIdList></Reference><Reference><Citation>Elie M, Cole MG, Primeau FJ, Bellavance F. Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998; 13: 204&#x2013;12. https://doi.org/10.1046/j.1525-1497.1998.00047.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.1998.00047.x</ArticleId><ArticleId IdType="pubmed">9541379</ArticleId><ArticleId IdType="pmc">1496920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho MH, Nealon J, Igwe E, et al. Postoperative delirium in older patients: a systematic review of assessment and incidence of postoperative delirium. Worldviews Evid Based Nurs 2021; 18: 290&#x2013;301. https://doi.org/10.1111/wvn.12536</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/wvn.12536</ArticleId><ArticleId IdType="pubmed">34482593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry K, Quinn TJ, Evans J, et al. Evaluation of delirium screening tools in geriatric medical inpatients: a diagnostic test accuracy study. Age Ageing 2016; 45: 832&#x2013;37. https://doi.org/10.1093/ageing/afw130</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afw130</ArticleId><ArticleId IdType="pubmed">27503794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao MM, Zhang YW, Sheng RW, et al. General anesthesia versus regional anesthesia in the elderly patients undergoing hip fracture surgeries: a systematic review and meta-analysis of randomized clinical trials. World J Surg 2023; 47: 1444&#x2013;56. https://doi.org/10.1007/s00268-023-06949-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-023-06949-y</ArticleId><ArticleId IdType="pubmed">36826487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindman BJ, Gold CJ, Ray E, et al. Surgeon-specific treatment selection bias and heterogeneous perioperative practices in an observational spine surgery study. a statistical tutorial with implications for analysis of observational studies of perioperative interventions. World Neurosurg 2023; 173: e168&#x2013;79. https://doi.org/10.1016/j.wneu.2023.02.027</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36912515</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>The correlation of intraoperative oliguria with acute kidney injury after noncardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>449</StartPage><EndPage>457</EndPage><MedlinePgn>449-457</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000000284</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) occurs commonly after major surgery and is correlated with increased in-hospital morbidity and mortality. There is no consensus on whether intraoperative oliguria affects postoperative AKI. We conducted a meta-analysis to systematically assess the correlation of intraoperative oliguria with postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, Web of Science, and Cochrane Library databases were searched to identify reports on the relationship between intraoperative oliguria and postoperative AKI. Quality was assessed using the Newcastle-Ottawa Scale. The primary outcomes were the unadjusted and multivariate-adjusted odds ratios (ORs) for intraoperative oliguria to correlate with postoperative AKI. The secondary outcomes included intraoperative urine output in the AKI and non-AKI groups, the demand for postoperative renal replacement therapy (RRT), in-hospital mortality, and length of hospital stay in the oliguria and non-oliguria groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine eligible studies with 18&#xa0;473 patients were included. The meta-analysis revealed that patients with intraoperative oliguria had a considerably greater risk of postoperative AKI (unadjusted OR: 2.03, 95% CI: 1.60-2.58, I2 =63%, P &lt;0.00001; multivariate-adjusted OR: 2.00, 95% CI: 1.64-2.44, I2 =40%, P &lt;0.00001). Further subgroup analysis did not find differences between different oliguria criteria or surgical types. Furthermore, the AKI group's pooled intraoperative urine output was less (mean differences: -0.16, 95% CI: -0.26 to -0.07, P &lt;0.001). Intraoperative oliguria was associated with increased demand for postoperative RRT (risk ratios: 4.71, 95% CI: 2.83-7.84, P &lt;0.001) and in-hospital mortality (risk ratios: 1.83, 95% CI: 1.24-2.69, P =0.002), but not with prolonged length of hospital stay (mean differences: 0.55, 95% CI: -0.27 to 1.38, P =0.19).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intraoperative oliguria was significantly associated with a higher incidence of postoperative AKI, as well as increased in-hospital mortality and demand for postoperative RRT, but not with prolonged hospitalization.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3899-0145</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Manyu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3897-1622</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Nannan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qulian</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-5636-8491</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Wangyuan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4813-2806</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Centre for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="Y">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36912515</ArticleId><ArticleId IdType="pmc">PMC10389605</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000000284</ArticleId><ArticleId IdType="pii">01279778-202303000-00030</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garg AX, Kurz A, Sessler DI, et al. . Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA 2014;312:2254&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">25399007</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekkesin AI, et al. . Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 2014;207:53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM, et al. . Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 2016;42:521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365&#x2013;3370.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara ST, Bellomo R. Postoperative renal dysfunction after noncardiac surgery. Curr Opin Crit Care 2017;23:440&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28820797</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Mugawar M, Herbison GP, et al. . Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2013;9:CD003590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154582</ArticleId><ArticleId IdType="pubmed">24027097</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I. Perioperative acute kidney injury. Br J Anaesth 2015;115(Suppl 2):ii3&#x2013;ii14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26658199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. . Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007;107:892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Zagli G, Tuccinardi G, et al. . Postoperative acute kidney injury in high-risk patients undergoing major abdominal surgery. J Crit Care 2016;35:120&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">27481746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. . Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009;110:505&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, et al. . Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg 2016;122:1912&#x2013;1920.</Citation><ArticleIdList><ArticleId IdType="pubmed">27195635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M, et al. . Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS(R)) Society Recommendations: 2018. World J Surg 2019;43:659&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">30426190</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael JC, Keller DS, Baldini G, et al. . Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons. Dis Colon Rectum 2017;60:761&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">28682962</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014;10:37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiba A, Uchino S, Fujii T, et al. . Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg 2018;127:1229&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pubmed">29933276</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Beck-Schimmer B, Breitenstein S, et al. . Novel prediction score including pre- and intraoperative parameters best predicts acute kidney injury after liver surgery. World J Surg 2013;37:2618&#x2013;2628.</Citation><ArticleIdList><ArticleId IdType="pubmed">23959337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizota T, Yamamoto Y, Hamada M, et al. . Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth 2017;119:1127&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Mcilroy DR, Bellomo R, et al. . Importance of intraoperative oliguria during major abdominal surgery: findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial. Br J Anaesth 2019;122:726&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916001</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng ZT, Mu DL. Impact of oliguria during lung surgery on postoperative acute kidney injury. Beijing Da Xue Xue Bao Yi Xue Ban 2020;53:188&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7867982</ArticleId><ArticleId IdType="pubmed">33550355</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JW, Kim KR, Jung Y, et al. . Role of intraoperative oliguria in risk stratification for postoperative acute kidney injury in patients undergoing colorectal surgery with an enhanced recovery protocol: a propensity score matching analysis. PLoS One 2020;15:e0231447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164643</ArticleId><ArticleId IdType="pubmed">32302336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao BC, Lei SH, Yang X, et al. . Assessment of prognostic value of intraoperative oliguria for postoperative acute kidney injury: a retrospective cohort study. Br J Anaesth 2021;126:799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">33342539</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert RA, Roizen MF, Hamilton WK, et al. . Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization. Surgery 1984;95:707&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">6427960</ArticleId></ArticleIdList></Reference><Reference><Citation>Knos GB, Berry AJ, Isaacson IJ, et al. . Intraoperative urinary output and postoperative blood urea nitrogen and creatinine levels in patients undergoing aortic reconstructive surgery. J Clin Anesth 1989;1:181&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">2627385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Koyner JL, Hoste E, et al. . Update on perioperative acute kidney injury. Anesth Analg 2018;127:1236&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Levy A, Cattan A, et al. . Acute kidney injury in pancreatic surgery; association with urine output and intraoperative fluid administration. Am J Surg 2017;214:246&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">28223046</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio R, Gameiro J, Amaro S, et al. . Intraoperative oliguria does not predict postoperative acute kidney injury in major abdominal surgery: a cohort analysis. J Bras Nefrol 2021;43:9&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8061965</ArticleId><ArticleId IdType="pubmed">32779689</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Mckenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 2021;88:105906.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, et al. . World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 2013;8:1482&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al. . Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018;27:1785&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, et al. . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zou W. Research progress in influence of perioperative hypotension on postoperative outcome of patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2021;46:84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10878287</ArticleId><ArticleId IdType="pubmed">33678641</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S, Zou W. Effect of the intraoperative use of the Hypotension Prediction Index on postoperative hypotension in the postanaesthesia care unit. Comment on Br J Anaesth 2021; 127: 681&#x2013;8. Br J Anaesth 2022;128:E340&#x2013;E341.</Citation><ArticleIdList><ArticleId IdType="pubmed">35331545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sear JW. Kidney dysfunction in the postoperative period. Br J Anaesth 2005;95:20&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15531622</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, et al. . Determinants of postoperative acute kidney injury. Crit Care 2009;13:R79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Liu YL, Licari E, et al. . Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care 2011;15:R172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387614</ArticleId><ArticleId IdType="pubmed">21771324</ArticleId></ArticleIdList></Reference><Reference><Citation>Small RG, Witt RE. Major and minor surgery. JAMA 1965;191:180&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">14233251</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Malhotra R, Bouchard J, et al. . Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int 2011;80:760&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">21716258</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinni P, Cruz DN, Gramaticopolo S, et al. . Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol 2011;77:1072&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">21597441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Liu K. Pathophysiology of AKI. Best Pract Res Clin Anaesthesiol 2017;31:305&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">29248138</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis 2016;67:872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>du Toit L, Biccard BM. The relationship between intraoperative oliguria and acute kidney injury. Br J Anaesth 2019;122:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">30961912</ArticleId></ArticleIdList></Reference><Reference><Citation>Egal M, de Geus HR, van Bommel J, et al. . Targeting oliguria reversal in perioperative restrictive fluid management does not influence the occurrence of renal dysfunction: a systematic review and meta-analysis. Eur J Anaesthesiol 2016;33:425&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">26840829</ArticleId></ArticleIdList></Reference><Reference><Citation>Egal M, Erler NS, de Geus HR, et al. . Targeting oliguria reversal in goal-directed hemodynamic management does not reduce renal dysfunction in perioperative and critically ill patients: a systematic review and meta-analysis. Anesth Analg 2016;122:173&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">26505575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006;333:420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1553510</ArticleId><ArticleId IdType="pubmed">16861256</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I, Paskaleva R, Eid L, et al. . Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: a randomized controlled trial. Arch Surg 2012;147:228&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106246</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SJ, Lehner GF, Forni LG, et al. . Oliguria in critically ill patients: a narrative review. J Nephrol 2018;31:855&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6244549</ArticleId><ArticleId IdType="pubmed">30298272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambhampati G, Ross EA, Alsabbagh MM, et al. . Perioperative fluid balance and acute kidney injury. Clin Exp Nephrol 2012;16:730&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">22457087</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisanevich V, Felsenstein I, Almogy G, et al. . Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005;103:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15983453</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Garzotto F, Piccinni P, et al. . Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013;17:R14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057508</ArticleId><ArticleId IdType="pubmed">23347825</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Schetz M. Does this critically ill patient with oliguria need more fluids, a vasopressor, or neither? Intensive Care Med 2017;43:907&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">28293703</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Prowle J, Joannidis M, et al. . Fluid management in acute kidney injury. Intensive Care Med 2017;43:807&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">28470347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yang R, Xu J, et al. . Effects of intraoperative fluid management on postoperative outcomes after lobectomy. Ann Thorac Surg 2019;107:1663&#x2013;1669.</Citation><ArticleIdList><ArticleId IdType="pubmed">30641068</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37652847</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Vasodilator and Inodilator Drugs in Cardiac Surgery: A Systematic Review With Bayesian Network Meta-Analysis.</ArticleTitle><Pagination><StartPage>2261</StartPage><EndPage>2271</EndPage><MedlinePgn>2261-2271</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2023.07.041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(23)00533-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The authors performed a systematic review to evaluate the effect of pharmacologic therapy on pulmonary hypertension in the perioperative setting of elective cardiac surgery (PROSPERO CRD42023321041).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review of randomized controlled trials with a Bayesian network meta-analysis.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The authors searched biomedical databases for randomized controlled trials on the perioperative use of inodilators and pulmonary vasodilators in adult cardiac surgery, with in-hospital mortality as the primary outcome and duration of ventilation, length of stay in the intensive care unit, stage 3 acute kidney injury, cardiogenic shock requiring mechanical support, and change in mean pulmonary artery pressure as secondary outcomes.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Twenty-eight studies randomizing 1,879 patients were included.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Catecholamines and noncatecholamine inodilators, arterial pulmonary vasodilators, vasodilators, or their combination were considered eligible interventions compared with placebo or standard care.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Ten studies reported in-hospital mortality and assigned 855 patients to 12 interventions. Only inhaled prostacyclin use was supported by a statistically discernible improvement in mortality, with a number-needed-to-treat estimate of at least 3.3, but a wide credible interval (relative risk 1.26&#xa0;&#xd7;&#xa0;10<sup>-17</sup> - 0.7). Inhaled prostacyclin and nitric oxide were associated with a reduction in intensive care unit stay, and none of the included interventions reached a statistically evident difference compared to usual care or placebo in the other secondary clinical outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Inhaled prostacyclin was the only pharmacologic intervention whose use is supported by a statistically discernible improvement in mortality in the perioperative cardiac surgery setting as treatment of pulmonary hypertension. However, available evidence has significant limitations, mainly the low number of events and imprecision.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sardo</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy. Electronic address: salvatore.sardo@unica.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripodi</LastName><ForeName>Vincenzo Francesco</ForeName><Initials>VF</Initials><AffiliationInfo><Affiliation>Department of Human Pathology, Unit of Anesthesia and Intensive Care, University Hospital of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerzoni</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musu</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncological and Oral Science, University of Palermo, Palermo, Italy; Department of Anesthesia, Intensive Care, and Emergency, University Hospital "Policlinico Paolo Giaccone", Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">pulmonary hypertension</Keyword><Keyword MajorTopicYN="N">vasodilator</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37652847</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2023.07.041</ArticleId><ArticleId IdType="pii">S1053-0770(23)00533-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38735057</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-2300</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of international medical research</Title><ISOAbbreviation>J Int Med Res</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of perioperative melatonin for postoperative delirium in patients undergoing surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3000605241239854</StartPage><MedlinePgn>3000605241239854</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">03000605241239854</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/03000605241239854</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the efficacy and safety of perioperative melatonin and melatonin agonists in preventing postoperative delirium (POD).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic search for randomized controlled trials (RCTs) published through December 2022. The primary outcome was efficacy based on the incidence of POD (POD-I). Secondary outcomes included efficacy and safety according to the length of hospital or intensive care unit stay, in-hospital mortality, and adverse events. Subgroup analyses of POD-I were based on the type and dose of drug (low- and high-dose melatonin, ramelteon), the postoperative period (early or late), and the type of surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the analysis (16 RCTs, 1981 patients), POD-I was lower in the treatment group than in the control group (risk ratio [RR]&#x2009;=&#x2009;0.57). POD-I was lower in the high-dose melatonin group than in the control group (RR&#x2009;=&#x2009;0.41), whereas no benefit was observed in the low-dose melatonin and ramelteon groups. POD-I was lower in the melatonin group in the early postoperative period (RR&#x2009;=&#x2009;0.35) and in patients undergoing cardiopulmonary surgery (RR&#x2009;=&#x2009;0.54).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Perioperative melatonin or melatonin agonist treatment suppressed POD without severe adverse events, particularly at higher doses, during the early postoperative period, and after cardiopulmonary surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hye Won</ForeName><Initials>HW</Initials><Identifier Source="ORCID">0000-0003-3770-6675</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.</Affiliation><Identifier Source="RINGGOLD">37997</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Ji Su</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.</Affiliation><Identifier Source="RINGGOLD">37997</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yoon Ji</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0003-3031-357X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, College of Medicine, Korea University Ansan Hospital, Gyeonggi-do Province, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Woo</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.</Affiliation><Identifier Source="RINGGOLD">37997</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Hae Sun</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.</Affiliation><Identifier Source="RINGGOLD">37997</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hyun Ju</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0003-3150-6840</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.</Affiliation><Identifier Source="RINGGOLD">37997</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Yoo Kyung</ForeName><Initials>YK</Initials><Identifier Source="ORCID">0000-0002-3491-1430</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.</Affiliation><Identifier Source="RINGGOLD">37997</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Int Med Res</MedlineTA><NlmUniqueID>0346411</NlmUniqueID><ISSNLinking>0300-0605</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>JL5DK93RCL</RegistryNumber><NameOfSubstance UI="D008550">Melatonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>901AS54I69</RegistryNumber><NameOfSubstance UI="C495910">ramelteon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007192">Indenes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008550" MajorTopicYN="Y">Melatonin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007192" MajorTopicYN="N">Indenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delirium</Keyword><Keyword MajorTopicYN="N">melatonin</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">perioperative treatment</Keyword><Keyword MajorTopicYN="N">postoperative</Keyword><Keyword MajorTopicYN="N">ramelteon</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe authors declare that they have no conflicting interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>19</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>15</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38735057</ArticleId><ArticleId IdType="pmc">PMC11089947</ArticleId><ArticleId IdType="doi">10.1177/03000605241239854</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jin Z, Hu J, Ma D. Postoperative delirium: perioperative assessment, risk reduction, and management. Br J Anaesth 2020; 125: 492&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">32798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Young J, Inouye SK. Delirium in older people. Bmj 2007; 334: 842&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1853193</ArticleId><ArticleId IdType="pubmed">17446616</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarbrick C, Partridge J. Evidence&#x2010;based strategies to reduce the incidence of postoperative delirium: a narrative review. Anaesthesia 2022; 77: 92&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">35001376</ArticleId></ArticleIdList></Reference><Reference><Citation>Salluh JI, Wang H, Schneider EB, et al.. Outcome of delirium in critically ill patients: systematic review and meta-analysis. Bmj 2015; 350: h2538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4454920</ArticleId><ArticleId IdType="pubmed">26041151</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiely DK, Marcantonio ER, Inouye SK, et al.. Persistent delirium predicts greater mortality. J Am Geriatr Soc 2009; 57: 55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744464</ArticleId><ArticleId IdType="pubmed">19170790</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazemi AK, Gowd AK, Carmouche JJ, et al.. Prevention and management of postoperative delirium in elderly patients following elective spinal surgery. Clin Spine Surg 2017; 30: 112&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">28141603</ArticleId></ArticleIdList></Reference><Reference><Citation>Noah AM, Almghairbi D, Evley R, et al.. Preoperative inflammatory mediators and postoperative delirium: systematic review and meta-analysis. Br J Anaesth 2021; 127: 424&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">34218905</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker CK, Gales MA. Melatonin receptor agonists for delirium prevention. Ann Pharmacother 2017; 51: 72&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">27539735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos E, Pati&#xf1;o P, Reiter RJ, et al.. Ischemic brain injury: new insights on the protective role of melatonin. Free Radic Biol Med 2017; 104: 32&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">28065781</ArticleId></ArticleIdList></Reference><Reference><Citation>Marseglia L, D&#x2019;Angelo G, Manti S, et al.. Analgesic, anxiolytic and anaesthetic effects of melatonin: new potential uses in pediatrics. Int J Mol Sci 2015; 16: 1209&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307299</ArticleId><ArticleId IdType="pubmed">25569095</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito E, Paterniti I, Mazzon E, et al.. Melatonin reduces hyperalgesia associated with inflammation. J Pineal Res 2010; 49: 321&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">20666977</ArticleId></ArticleIdList></Reference><Reference><Citation>Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005; 9: 11&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">15649735</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;genur I, Ocak U, Altunpinar O, et al.. Disturbances in melatonin, cortisol and core body temperature rhythms after major surgery. World J Surg 2007; 31: 290&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">17180564</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigeta H, Yasui A, Nimura Y, et al.. Postoperative delirium and melatonin levels in elderly patients. Am J Surg 2001; 182: 449&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">11754849</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili A, Fanoodi A, Ebrahimi A, et al.. The Efficacy of Melatonin and Clonidine in Preventing Emergence Delirium in the Elderly Undergoing Orthopedic Surgery, Neurosurgery, and General Surgery: A Placebo-controlled Randomized Clinical Trial. J Kermanshah Univ Med Sci 2022; 26: e128831.</Citation></Reference><Reference><Citation>Fazel MR, Mofidian S, Mahdian M, et al.. The effect of melatonin on prevention of postoperative delirium after lower limb fracture surgery in elderly patients: a randomized double blind clinical trial. Int J Burns Trauma 2022; 12: 161&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9490153</ArticleId><ArticleId IdType="pubmed">36160675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadeh FJ, Janatmakan F, Shafaeebejestan E, et al.. Effect of melatonin on delirium after on-pump coronary artery bypass graft surgery: a randomized clinical trial. Iran J Med Sci 2021; 46: 120&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7966933</ArticleId><ArticleId IdType="pubmed">33753956</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. Effects of Melatonin on Postoperative Delirium After PCI in Elderly Patients: A Randomized, Single-Center, Double-Blind, Placebo-Controlled Trial. Heart Surg Forum 2021; 24: E893&#x2013;E897.</Citation><ArticleIdList><ArticleId IdType="pubmed">34730495</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh ES, Leoutsakos JM, Rosenberg PB, et al.. Effects of Ramelteon on the prevention of postoperative delirium in older patients undergoing orthopedic surgery: The RECOVER randomized controlled trial. Am J Geriatr Psychiatry 2021; 29: 90&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8809889</ArticleId><ArticleId IdType="pubmed">32532654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford AH, Flicker L, Kelly R, et al.. The Healthy Heart&#x2010;Mind trial: randomized controlled trial of melatonin for prevention of delirium. J Am Geriatr Soc 2020; 68: 112&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">31595489</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta PK, Verma R, Kohli M, et al.. The effect of ramelteon on postoperative delirium in elderly patients: A randomised double-blind study. Journal of Clinical &amp; Diagnostic Research 2019; 13: 15.</Citation></Reference><Reference><Citation>Jaiswal SJ, Vyas AD, Heisel AJ, et al.. Ramelteon for prevention of postoperative delirium: a randomized controlled trial in patients undergoing elective pulmonary thromboendarterectomy. Crit Care Med 2019; 47: 1751&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6861685</ArticleId><ArticleId IdType="pubmed">31567351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasnavieh FH, Rezaeipandari H, Hadadzadeh M, et al.. Effect of Melatonin on Incidence Rate of Delirium in Elderly Patients Undergoing Open-Heart Surgery without a Pump: A Clinical Trial. Elderly Health Journal 2019; 5: 32&#x2013;39.</Citation></Reference><Reference><Citation>Abbasi S, Farsaei S, Ghasemi D, et al.. Potential role of exogenous melatonin supplement in delirium prevention in critically ill patients: a double-blind randomized pilot study. Iran J Pharm Res 2018; 17: 1571&#x2013;1580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6269584</ArticleId><ArticleId IdType="pubmed">30568713</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Naggar DI, Sharaf SI, Nasr El-Din DA, et al.. A study of the prophylactic and curative effect of melatonin on postoperative delirium after coronary artery bypass grafting surgery in elderly patients. The Egyptian Journal of Hospital Medicine 2018; 72: 4919&#x2013;4926.</Citation></Reference><Reference><Citation>De Jonghe A, Van Munster BC, Goslings JC, et al.. Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial. Cmaj 2014; 186: E547&#x2013;E556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4188685</ArticleId><ArticleId IdType="pubmed">25183726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen MV, Madsen MT, Andersen LT, et al.. Effect of melatonin on cognitive function and sleep in relation to breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Int J Breast Cancer 2014; 2014: 416531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4160608</ArticleId><ArticleId IdType="pubmed">25328711</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta K, Kishi Y, Wada K, DELIRIA-J Group et al.. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 2014; 71: 397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">24554232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickkholgh A, Schneider H, Sobirey M, et al.. The use of high&#x2010;dose melatonin in liver resection is safe: first clinical experience. J Pineal Res 2011; 50: 381&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21480979</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan SS. Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly. Saudi J Anaesth 2010; 4: 169&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2980663</ArticleId><ArticleId IdType="pubmed">21189854</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, et al.. Cochrane handbook for systematic reviews of interventions. John Wiley &amp; Sons, 2019.</Citation></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. Bmj 2021; 372: n160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005925</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald JM, Adamis D, Trzepacz PT, et al.. Delirium: a disturbance of circadian integrity? Med Hypotheses 2013; 81: 568&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pubmed">23916192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellapart J, Boots R. Potential use of melatonin in sleep and delirium in the critically ill. Br J Anaesth 2012; 108: 572&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">22419624</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin AJ, Keifer JC, Davies MF, et al.. Melatonin secretion after surgery. Lancet 2000; 356: 1244&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">11072950</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rooij SE, Van Munster BC. Melatonin deficiency hypothesis in delirium: a synthesis of current evidence. Rejuvenation Res 2013; 16: 273&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">23597050</ArticleId></ArticleIdList></Reference><Reference><Citation>Harps&#xf8;e NG, Andersen LPH, G&#xf6;genur I, et al.. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol 2015; 71: 901&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">26008214</ArticleId></ArticleIdList></Reference><Reference><Citation>Di WL, Kadva A, Johnston A, et al.. Variable bioavailability of oral melatonin. N Engl J Med 1997; 336: 1028&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">9091795</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Weaver DR, Jin X, et al.. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19: 91&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">9247266</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer DN. A review of ramelteon in the treatment of sleep disorders. Neuropsychiatr Dis Treat 2008; 4: 69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2515902</ArticleId><ArticleId IdType="pubmed">18728808</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata R, Omasa M, Fujimoto R, et al.. Efficacy of Ramelteon for delirium after lung cancer surgery. Interact Cardiovasc Thorac Surg 2017; 24: 8&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">27624354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng KT, Teoh WY, Khor AJ. The effect of melatonin on delirium in hospitalised patients: A systematic review and meta-analyses with trial sequential analysis. J Clin Anesth 2020; 59: 74&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">31279283</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Chen J, Wang Z. Meta&#x2010;analysis of factors which influence delirium following cardiac surgery. J Card Surg 2012; 27: 481&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">22784203</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo SC, Ahn HS, Shin R, et al.. Risk factors of elderly patients with postoperative delirium following major abdominal surgery for cancer. Korean J Clin Oncol 2020; 16: 104&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9942723</ArticleId><ArticleId IdType="pubmed">36945720</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Yuan L, Ji M, et al.. The effect of melatonin on early postoperative cognitive decline in elderly patients undergoing hip arthroplasty: a randomized controlled trial. J Clin Anesth 2017; 39: 77&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">28494914</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Wu J, Qin Z, et al.. Melatonin and its analogues for the prevention of postoperative delirium: A systematic review and meta&#x2010;analysis. J Pineal Res 2020; 68: e12644.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145098</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell AM, Axon DR, Martin JR, et al.. Melatonin for the prevention of postoperative delirium in older adults: a systematic review and meta-analysis. BMC Geriatr 2019; 19: 272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6796479</ArticleId><ArticleId IdType="pubmed">31619178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CM, Zhou LY. Melatonin and melatonergic agents for the prevention of postoperative delirium: A meta-analysis of randomized placebo-controlled trials. Asian J Surg 2022; 45: 27&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">34092473</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson TN, Dunn CL, Adams JC, et al.. Tryptophan supplementation and postoperative delirium&#x2014;a randomized controlled trial. J Am Geriatr Soc 2014; 62: 1764&#x2013;1771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172657</ArticleId><ArticleId IdType="pubmed">25112175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi Y, Mihara T, Taguri M, et al.. Melatonin receptor agonist for the prevention of postoperative delirium in elderly patients: a randomized, double-blind, placebo-controlled trial. Intensive care medicine. Springer 233 SPRING ST, NEW YORK, NY 10013 USA, 2014, pp. S246&#x2013;S246.</Citation></Reference><Reference><Citation>Artemiou P, Bily B, Bilecova-Rabajdova M, et al.. Melatonin treatment in the prevention of postoperative delirium in cardiac surgery patients. Kardiochir Torakochirurgia Pol 2015; 12: 126&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550034</ArticleId><ArticleId IdType="pubmed">26336494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vural EM, Van Munster BC, De Rooij SE. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature. Drugs Aging 2014; 31: 441&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">24802882</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20621432</PMID><DateCompleted><Year>2010</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>36 Suppl 1</Volume><PubDate><Year>2010</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider?</ArticleTitle><Pagination><StartPage>S27</StartPage><EndPage>S35</EndPage><MedlinePgn>S27-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2010.06.024</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To conduct a systematic review of the literature on the volume-outcome relationship for the surgical treatment of breast cancer with consideration of the methodological quality of the available evidence and to perform a meta-analysis on the studies of considered good quality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search was done to identify all articles examining the effects of hospital or surgeon volume on clinical outcome of the surgical treatment of breast cancer. Reviews, opinion articles and surveys were excluded. All articles were critically appraised on methodological quality and risk of bias. After strict inclusion, meta-analysis assuming a random effects model was done to estimate the effect of higher hospital or surgeon volume on patient outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found 12 studies of good methodological quality which could be included for meta-analysis. The results showed a significant association between high volume providers and an improved survival. The association is the most robust for surgeon volume (HR 0.80 (0.71-0.90) and RR 0.85 (0.80-0.90). In addition there is an effect of hospital volume on the in-hospital mortality, although the mortality was very low (0.1-0.2%). Results of meta-analysis were heterogeneous. Sensitivity analysis showed a larger effect size for studies also adjusting for comorbidity for both studies on hospital and surgeon volume. The data were not suggestive for publication bias.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results show that survival after breast cancer surgery is significantly associated with high volume providers.</AbstractText><CopyrightInformation>Copyright (c) 2010 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gooiker</LastName><ForeName>G A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Gijn</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Post</LastName><ForeName>P N</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>van de Velde</LastName><ForeName>C J H</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Tollenaar</LastName><ForeName>R A E M</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Wouters</LastName><ForeName>M W J M</ForeName><Initials>MW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>36</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20621432</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2010.06.024</ArticleId><ArticleId IdType="pii">S0748-7983(10)00200-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32746729</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6817</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</Title><ISOAbbreviation>Otolaryngol Head Neck Surg</ISOAbbreviation></Journal><ArticleTitle>Predictors of Complications Occurrence Associated With Emergency Surgical Tracheotomy.</ArticleTitle><Pagination><StartPage>346</StartPage><EndPage>352</EndPage><MedlinePgn>346-352</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0194599820947001</ELocationID><Abstract><AbstractText Label="OBJECTIVE">In emergency airway management, the occurrence of surgical tracheotomy complications is increased and may be fatal for the patient. However, the factors that play a role in complication occurrence and lead to lethal outcome are not known. The objective of this study was to determine predictors associated with the occurrence of complications and mortality after emergency surgical tracheostomy.</AbstractText><AbstractText Label="STUDY DESIGN">Retrospective study with a systematic review of the literature.</AbstractText><AbstractText Label="SETTING">Tertiary medical academic center.</AbstractText><AbstractText Label="SUBJECTS AND METHODS">We included 402 adult patients who underwent emergency surgical tracheostomy under local anesthesia due to upper airway obstruction. Demographic, clinical, complication occurrence, and mortality data were collected. For statistical analysis, univariable and multivariable logistic regression methods were used.</AbstractText><AbstractText Label="RESULTS">In multivariable analysis, significant positive predictors of complication occurrence were previously performed tracheotomy (odds ratio [OR] 3.67, 95% confidence interval [CI], 0.75-17.88), neck pathology (OR 2.05, 95% CI 1.1-1.77), and tracheotomy performed outside the operating room (OR 5.88, 95% CI, 1.58-20). General in-hospital mortality was 4%, but lethal outcome as a direct result of tracheotomy complications occurred in only 4 patients (1%) because of intraoperative and postoperative complications.</AbstractText><AbstractText Label="CONCLUSION">The existence of neck pathology and situations in which tracheotomy was performed outside the operating room in uncontrolled conditions were significant prognostic factors for complication occurrence. Tracheotomy-related mortality was greater in patients with intraoperative and early postoperative complications. Clinicians should be aware of the increased risk in specific cases, to prepare, prevent, or manage unwanted outcomes in further treatment and care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jotic</LastName><ForeName>Ana D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milovanovic</LastName><ForeName>Jovica P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivic</LastName><ForeName>Aleksandar S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folic</LastName><ForeName>Miljan M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krejovic-Trivic</LastName><ForeName>Sanja B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radin</LastName><ForeName>Zorana Z</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>General Hospital "Dr Djordje Joanovi&#x107;," Zrenjanin, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buta</LastName><ForeName>Marko N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Medical Faculty, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Oncology and Radiology, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milicic</LastName><ForeName>Biljana R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Otolaryngol Head Neck Surg</MedlineTA><NlmUniqueID>8508176</NlmUniqueID><ISSNLinking>0194-5998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="N">Airway Obstruction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="Y">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014140" MajorTopicYN="N">Tracheotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">emergency surgical tracheotomy</Keyword><Keyword MajorTopicYN="N">predictors</Keyword><Keyword MajorTopicYN="N">tracheostomy complication</Keyword><Keyword MajorTopicYN="N">tracheostomy-related mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32746729</ArticleId><ArticleId IdType="doi">10.1177/0194599820947001</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24425619</PMID><DateCompleted><Year>2014</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1262</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Apr</Month></PubDate></JournalIssue><Title>International journal of colorectal disease</Title><ISOAbbreviation>Int J Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Surgery for ischemic colitis: outcome and risk factors for in-hospital mortality.</ArticleTitle><Pagination><StartPage>493</StartPage><EndPage>503</EndPage><MedlinePgn>493-503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00384-013-1819-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Surgery for ischemic colitis is associated with high perioperative morbidity and mortality, but the risk factors for mortality and major surgical complications are unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective single institution cohort study of all patients undergoing colorectal surgery for histologically proven ischemic colitis between 2004 and 2010, we evaluated surgical outcomes and risk factors for in-hospital mortality and major surgical complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">For the 100 patients included in the study, in-hospital mortality was 54 %; major surgical complications, defined as anastomotic leakage or rectal stump and stoma complications, occurred in 16 %. In the multivariable analysis, hospital death was more likely in patients with right-sided (odds ratio [OR] 3.8; 95 % confidence interval [CI] 1.2, 12; P&#x2009;=&#x2009;0.022) or pan-colonic ischemia (OR 11; 95 % CI 2.8, 39; P&#x2009;&lt;&#x2009;0.001), both relative to left-sided ischemia. Decreased preoperative pH level (OR 2.5 per 0.1 decrease; 95 % CI 1.5, 4.1; P&#x2009;&lt;&#x2009;0.001) and prior cardiac or aortic surgery (OR 2.4; 95 % CI 0.82, 6.8; P&#x2009;=&#x2009;0.109) were further important risk factors for in-hospital mortality. Major postoperative surgical complications were more likely in patients with ischemic alterations at the resection margin of the histological specimen (OR 3.7; 95 % CI 1.2, 11; P&#x2009;=&#x2009;0.022).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Colonic resection for ischemic colitis is associated with high in-hospital mortality, especially in patients with right-sided or pan-colonic ischemia. In patients developing acidosis, early laparotomy is essential. Since resection margins' affection seems to be underestimated upon surgery, resections should be performed wide enough within healthy tissue.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Genstorfer</LastName><ForeName>J&#xf6;rg</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital Basel, Basel, Switzerland, jgenstorfer@gmx.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;fer</LastName><ForeName>Juliane</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kettelhack</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Oertli</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int J Colorectal Dis</MedlineTA><NlmUniqueID>8607899</NlmUniqueID><ISSNLinking>0179-1958</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Colorectal Dis. 2014 Nov;29(11):1439. doi: 10.1007/s00384-014-1911-1.</RefSource><PMID Version="1">24898590</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017091" MajorTopicYN="N">Colitis, Ischemic</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24425619</ArticleId><ArticleId IdType="doi">10.1007/s00384-013-1819-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Colorectal Dis. 2012 Nov;14(11):e751-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22776101</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1994 Jun;167(6):575-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8209931</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chir (Paris). 1997 Aug;134(3):103-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9378792</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2010 Oct;105(10):2245-52; quiz 2253</Citation><ArticleIdList><ArticleId IdType="pubmed">20531399</ArticleId></ArticleIdList></Reference><Reference><Citation>Helv Chir Acta. 1991 Feb;57(5):777-82</Citation><ArticleIdList><ArticleId IdType="pubmed">1864748</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Surg. 1989 Jun;55(6):378-80</Citation><ArticleIdList><ArticleId IdType="pubmed">2729775</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2010 Sep;53(9):1287-94</Citation><ArticleIdList><ArticleId IdType="pubmed">20706072</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2000 Jan;95(1):195-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10638582</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Exp Med Biol. 1996;388:45-51</Citation><ArticleIdList><ArticleId IdType="pubmed">8798793</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Clin North Am. 1992 Feb;72(1):203-29</Citation><ArticleIdList><ArticleId IdType="pubmed">1731384</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Clin. 1995 Apr;11(2):479-512</Citation><ArticleIdList><ArticleId IdType="pubmed">7788542</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2008 Sep 21;14(35):5361-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18803347</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2007 Dec 30;26(30):5512-28</Citation><ArticleIdList><ArticleId IdType="pubmed">18058845</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1997 Dec;40(12):1448-54</Citation><ArticleIdList><ArticleId IdType="pubmed">9407984</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2008 Dec 28;14(48):7302-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19109863</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2004 Feb;47(2):180-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15043287</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2007 Oct;102(10):2247-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17561968</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2003 Oct;134(4):624-9; discussion 629-30</Citation><ArticleIdList><ArticleId IdType="pubmed">14605623</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Vasc Endovasc Surg. 1997 Jun;13(6):531-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9236705</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2006 Aug;30(8):1579-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16865320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Vasc Surg. 2011 Jul;25(5):612-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21724100</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2009 May;24(5):569-76</Citation><ArticleIdList><ArticleId IdType="pubmed">19221768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirurg. 2006 Dec;77(12):1152-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16565824</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliment Pharmacol Ther. 2004 Apr 1;19(7):729-38</Citation><ArticleIdList><ArticleId IdType="pubmed">15043513</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2011 Apr;149(4):585-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21247611</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vasc Surg. 1998 Sep;28(3):404-11; discussion 411-2</Citation><ArticleIdList><ArticleId IdType="pubmed">9737449</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2010 Oct;12(10):1018-25</Citation><ArticleIdList><ArticleId IdType="pubmed">19681979</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1985 Dec;120(12):1368-70</Citation><ArticleIdList><ArticleId IdType="pubmed">4062543</ArticleId></ArticleIdList></Reference><Reference><Citation>Angiology. 1998 Apr;49(4):267-73</Citation><ArticleIdList><ArticleId IdType="pubmed">9555929</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2000 May;118(5):954-68</Citation><ArticleIdList><ArticleId IdType="pubmed">10784596</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenbecks Arch Surg. 2008 Jul;393(4):507-12</Citation><ArticleIdList><ArticleId IdType="pubmed">18286300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleve Clin J Med. 2003 Nov;70(11):920-1, 925-6, 928-30 passim</Citation><ArticleIdList><ArticleId IdType="pubmed">14650467</ArticleId></ArticleIdList></Reference><Reference><Citation>J Craniomaxillofac Surg. 2006 Jan;34(1):25-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16343915</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1992 Aug;35(8):726-30</Citation><ArticleIdList><ArticleId IdType="pubmed">1643995</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2003 Feb 28;22(4):639-59</Citation><ArticleIdList><ArticleId IdType="pubmed">12590419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirurg. 2003 May;74(5):413-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12748789</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Gynecol Obstet. 1963 Jan;116:53-60</Citation><ArticleIdList><ArticleId IdType="pubmed">13968597</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2008;12(2):R44</Citation><ArticleIdList><ArticleId IdType="pubmed">18384672</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Gastroenterol. 1998 Sep;27(2):122-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9754772</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Surg Res. 2008;41(3):303-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18797169</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2006 Mar;30(3):457-61</Citation><ArticleIdList><ArticleId IdType="pubmed">16479348</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1989 Jun;32(6):500-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2791788</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2006 Feb;10(1):R22</Citation><ArticleIdList><ArticleId IdType="pubmed">16507145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Vasc Surg. 2005 May;19(3):328-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15818455</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Cardiol. 2006 Jun;61(3):301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Anasthesiol Intensivmed Notfallmed Schmerzther. 1994 Feb;29(1):23-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8142565</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1993 Aug;166(2):231-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8352421</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 1996 Dec;49(12):1373-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8970487</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosthet Orthot Int. 1995 Dec;19(3):139-47</Citation><ArticleIdList><ArticleId IdType="pubmed">8927524</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40054789</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis comparing single-stage versus multistaged approaches for endovascular repair of extensive thoracoabdominal aortic aneurysms.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>285.e2</EndPage><MedlinePgn>275-285.e2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2025.01.234</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(25)00356-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to perform a systematic review and meta-analysis comparing the outcomes of single-stage vs multistaged fenestrated-branched endovascular aortic repair (FB-EVAR) for extensive thoracoabdominal aortic aneurysms (TAAAs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Embase, and Cochrane databases were searched from inception to March 2024. This study was registered in PROSPERO (CRD42024567099) and followed the PRISMA guidelines. Inclusion was restricted to original studies comparing single-stage vs multistaged FB-EVAR for reported patients evaluated as extensive TAAAs (Crawford/Safi extent I-III and V). A multistaged approach consisted of aneurysm exclusion besides FB-EVAR using one or more staging strategies, including temporary aneurysm sac perfusion, first stage thoracic endovascular aortic repair, unintentional open surgical or endovascular proximal thoracic aortic repair, and minimally invasive staged segmental artery coil embolization. Endpoints evaluated included permanent and any spinal cord injury (SCI), 30-day or in-hospital mortality, acute kidney injury, cardiac, cerebrovascular, and bowel complications. A random effects meta-analysis was performed using pooled odds ratios (ORs) with 95% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four cohort studies involving 1949 patients treated by elective FB-EVAR were included, including 1097 patients (56.28%) treated by the multistaged approach. The most frequently used staging strategy was thoracic endovascular aortic repair in 404 patients (37%). Multistaged repairs significantly reduced permanent SCI events (OR, 0.37; 95% CI, 0.23-0.58; P &lt; .0001), any SCI events (OR, 0.51; 95% CI, 0.29-0.93; P = .03), and 30-day or in-hospital mortality (OR, 0.57; 95% CI, 0.38-0.85; P = .006). Additionally, the multistaged approach was associated with lower risk of acute kidney injury (OR, 0.67; 95% CI, 0.51-0.89; P = .005), although there were no significant differences observed for cardiac, cerebrovascular, or bowel complications.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Multistaged FB-EVAR for elective extensive TAAA repair significantly reduces the risks of permanent and any SCI events, 30-day or in-hospital mortality, and acute kidney injury.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Godeiro Fernandez</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Escola Bahiana de Medicina e Sa&#xfa;de P&#xfa;blica, Salvador, Brazil. Electronic address: miguelfernandez212@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pimentel-Junior</LastName><ForeName>Dilson</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidade Federal Fluminense, Niter&#xf3;i, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias-Neto</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Angiology and Vascular Surgery, USL S&#xe3;o Jo&#xe3;o EPE, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiter Kanamori</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Advanced Aortic Research Program, Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center at Houston, John P. and Kathrine G. McGovern Medical School, Houston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumgardt Barbosa Lima</LastName><ForeName>Guilherme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flor&#xea;ncio de Mesquita</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro Mastra Fontoura</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prajiante Bertolino</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidade Estadual de Maring&#xe1;, Maring&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsargyris</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, General Hospital &amp; Paracelsus Medical University, N&#xfc;rnberg, Germany; 2(nd) Department of Vascular Surgery, Athens University Medical School, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito Queiroz</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Ana Nery, Centro de Doen&#xe7;as da Aorta, Universidade Federal da Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Luccia</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C Mendes</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S Oderich</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Advanced Aortic Research Program, Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center at Houston, John P. and Kathrine G. McGovern Medical School, Houston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvajal Mulatti</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="Y">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094624" MajorTopicYN="N">Aortic Aneurysm, Thoracoabdominal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001807" MajorTopicYN="N">Blood Vessel Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endovascular aneurysm repair</Keyword><Keyword MajorTopicYN="N">FB-EVAR</Keyword><Keyword MajorTopicYN="N">Fenestrated-branched endovascular aneurysm repair</Keyword><Keyword MajorTopicYN="N">Spinal cord injury</Keyword><Keyword MajorTopicYN="N">Thoracoabdominal aortic aneurysm</Keyword></KeywordList><CoiStatement>Disclosures G.C.M. is a consultant for E. Tamussino and Medtronic. G.S.O. has received consulting fees and grants from Cook Medical, W. L. Gore &amp; Associates, Centerline Biomedical, and GE Healthcare. B.C.M. reports consulting fees and research grants from Cook Medical and W. L. Gore &amp; Associates and membership on the scientific advisory board of Medtronic. A.K. received travel grants and speaker fees from W. L. Gore &amp; Associates, Cook Medical, Bentley, and Artivion, and proctor fees from Cook Medical. A.B.Q. is a consultant at Cook Medical.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>24</Day><Hour>11</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>9</Day><Hour>15</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40054789</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2025.01.234</ArticleId><ArticleId IdType="pii">S0741-5214(25)00356-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23263644</PMID><DateCompleted><Year>2013</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1509</StartPage><EndPage>1520</EndPage><MedlinePgn>1509-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-012-2661-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The possible advantages of laparoscopic (assisted) total gastrectomy (LTG) versus open total gastrectomy (OTG) have not been reviewed systematically. The aim of this study was to systematically review the short-term outcomes of LTG versus OTG in the treatment of gastric cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of PubMed, Cochrane, CINAHL, and Embase was conducted. All original studies comparing LTG with OTG were included for critical appraisal. Data describing short-term outcomes were pooled and analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of eight original studies that compared LTG (n = 314) with OTG (n = 384) in patients with gastric cancer fulfilled quality criteria and were selected for review and meta-analysis. LTG compared with OTG was associated with a significant reduction of intraoperative blood loss (weighted mean difference = 227.6 ml; 95 % CI 144.3-310.9; p &lt; 0.001), a reduced risk of postoperative complications (risk ratio = 0.51; 95 % CI 0.33-0.77), and shorter hospital stay (weighted mean difference 4.0 = days; 95 % CI 1.4-6.5; p &lt; 0.001). These benefits were at the cost of longer operative time (weighted mean difference = 55.5 min; 95 % CI 24.8-86.2; p &lt; 0.001). In-hospital mortality rates were comparable for LTG (0.9 %) and OTG (1.8 %) (risk ratio = 0.68; 95 % CI 0.20-2.36).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LTG shows better short term outcomes compared with OTG in eligible patients with gastric cancer. Future studies should evaluate 30- and 60-day mortality, radicality of resection, and long-term follow-up in LTG versus OTG, preferably in randomized trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haverkamp</LastName><ForeName>Leonie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands. l.haverkamp@umcutrecht.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weijs</LastName><ForeName>Teus J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>van der Sluis</LastName><ForeName>Pieter C</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>van der Tweel</LastName><ForeName>Ingeborg</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Ruurda</LastName><ForeName>Jelle P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>van Hillegersberg</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015986" MajorTopicYN="N">Confounding Factors, Epidemiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005743" MajorTopicYN="N">Gastrectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015983" MajorTopicYN="N">Selection Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23263644</ArticleId><ArticleId IdType="doi">10.1007/s00464-012-2661-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Surg Laparosc Endosc Percutan Tech. 2009 Aug;19(4):277-84</Citation><ArticleIdList><ArticleId IdType="pubmed">19692873</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2008 Sep;22(9):1997-2002</Citation><ArticleIdList><ArticleId IdType="pubmed">18594925</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc Percutan Tech. 2005 Dec;15(6):309-14</Citation><ArticleIdList><ArticleId IdType="pubmed">16340559</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2009 May;23(5):991-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18806941</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2005 Apr 20;5:13</Citation><ArticleIdList><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2006 Dec 21;12(47):7676-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17171799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2005 Jan;241(1):27-39</Citation><ArticleIdList><ArticleId IdType="pubmed">15621988</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2008 Aug;22(8):1781-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18437472</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2004 Sep;91(9):1111-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15449261</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg Oncol. 2009 Mar;35(3):281-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18342480</ArticleId></ArticleIdList></Reference><Reference><Citation>J Korean Surg Soc. 2011 Apr;80(4):245-50</Citation><ArticleIdList><ArticleId IdType="pubmed">22066043</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2010 Nov;211(5):677-86</Citation><ArticleIdList><ArticleId IdType="pubmed">20869270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2011 May;253(5):900-11</Citation><ArticleIdList><ArticleId IdType="pubmed">21394009</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatogastroenterology. 2010 Nov-Dec;57(104):1589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">21443126</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2012 Mar;26(3):804-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22002202</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Robot. 2011 Dec;7(4):452-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21984205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Enferm Dig. 2011 Mar;103(3):133-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21434716</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2010 Jun;14(6):958-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20354807</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2005 Jul;19(7):933-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15920691</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2005 Dec 21;11(47):7508-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16437724</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2012 May;26(5):1377-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22083338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2012 Feb;255(2):216-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22241289</ArticleId></ArticleIdList></Reference><Reference><Citation>J Laparoendosc Adv Surg Tech A. 2008 Aug;18(4):572-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18721007</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2009 Nov;33(11):2389-95</Citation><ArticleIdList><ArticleId IdType="pubmed">19760315</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108</Citation><ArticleIdList><ArticleId IdType="pubmed">15761078</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Surg. 2011;28(3):157-62</Citation><ArticleIdList><ArticleId IdType="pubmed">21540602</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2008 Apr;22(4):980-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17690934</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2010 Mar;24(3):610-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19688399</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2005 Sep;92(9):1055-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16106468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2009 Jun;249(6):927-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19474671</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc. 1994 Apr;4(2):146-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8180768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatogastroenterology. 2011 Mar-Apr;58(106):659-62</Citation><ArticleIdList><ArticleId IdType="pubmed">21661448</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2011 Jan;98(1):50-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20799296</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2010 Nov;24(11):2860-70</Citation><ArticleIdList><ArticleId IdType="pubmed">20419322</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2010 Nov;24(11):2739-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20364352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Wai Ke Za Zhi. 2008 Jan 1;46(1):21-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18509996</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2009 Nov;23(11):2416-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19266232</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28752257</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-086X</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cardiovascular and interventional radiology</Title><ISOAbbreviation>Cardiovasc Intervent Radiol</ISOAbbreviation></Journal><ArticleTitle>What is the Best Revascularization Strategy for Acute Occlusive Arterial Mesenteric Ischemia: Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>36</EndPage><MedlinePgn>27-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00270-017-1749-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Acute mesenteric ischemia (AMI) is a life-threatening disease that leads to bowel infarction and death. The optimal management of AMI remains controversial. The present meta-analysis aimed to estimate the prognostic impact of surgical (SG) versus endovascular or hybrid intervention (EV) as the first-line treatment for acute arterial occlusive mesenteric ischemia and to assess whether endovascular strategy was actually effective in reducing bowel resection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Scopus and the Cochrane Library databases were searched. There have been no randomized controlled trials comparing SG versus EV for the treatment of AMI. We undertook this systematic review and meta-analysis according to MOOSE (Meta-analysis of Observational Studies in Epidemiology) guidelines, assessing the included study quality with the Newcastle-Ottawa scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies comparing EV versus SG as first strategy for the treatment of AMI were selected for the analyses, reporting of 3020 patients. EV was associated with a reduced risk of in-hospital mortality (RR 0.68; 95% CI 0.59-0.79; fixed-effects analysis; p&#xa0;&lt;&#xa0;0.0001; I <sup>2</sup>&#xa0;=&#xa0;4.9%; &#x3c4; <sup>2</sup>&#xa0;=&#xa0;0.025). Pooled prevalence of mortality was 19% for EV and 34% for SG. EV also showed a benefit impact on risk of bowel resection and second-look laparotomy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present meta-analysis outlines that endovascular revascularization strategy seems to offer advantages in terms of in-hospital mortality and morbidity in case of arterial occlusive AMI. A multidisciplinary team consisting of radiologists, interventional radiologists, cardiovascular and general surgeons comes out to be essential to tailor the right procedure to the patient and improve the outcomes associated with AMI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salsano</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiology and Interventional Radiology, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. giancarlo.salsano@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salsano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sportelli</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrocelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Radiology and Interventional Radiology, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahmane</LastName><ForeName>M'ahmed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology and Interventional Radiology, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinella</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pane</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mambrini</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palombo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santini</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, IRCCS San Martino-IST University Hospital, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Intervent Radiol</MedlineTA><NlmUniqueID>8003538</NlmUniqueID><ISSNLinking>0174-1551</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065666" MajorTopicYN="N">Mesenteric Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute mesenteric ischemia</Keyword><Keyword MajorTopicYN="N">First-line treatment</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28752257</ArticleId><ArticleId IdType="doi">10.1007/s00270-017-1749-3</ArticleId><ArticleId IdType="pii">10.1007/s00270-017-1749-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30037741</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Editor's Choice - Aortic Re-operation After Replacement of the Proximal Aorta: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>515</StartPage><EndPage>523</EndPage><MedlinePgn>515-523</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2018.06.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(18)30397-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE/BACKGROUND" NlmCategory="OBJECTIVE">The aim was to estimate risk of aortic re-operation, and re-operative morbidity and mortality, following replacement of the proximal aorta for aneurysm or dissection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement and the Meta-Analysis of Observational Studies in Epidemiology guidelines. A comprehensive literature review was performed to identify all articles reporting aortic re-operation after proximal aortic replacement. The proximal aorta was defined as extending to the origin of the brachiocephalic trunk. The incidence rate for aortic re-operation (IRAR) was calculated, and stratified based on presence/absence of connective tissue disorders, as well as initial surgical indication. Pooled in hospital mortality and post-operative complication rates were estimated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 7821 patients who underwent proximal aortic replacement from 47 studies were included: 8.3% (n&#xa0;=&#xa0;649) had Marfan syndrome (MS). During a weighted mean follow up of 4.7&#xa0;&#xb1;&#xa0;0.3 years, 11.5% (n&#xa0;=&#xa0;903) underwent aortic re-operation. Mean weighted time between initial surgery and re-operation was 5.2&#xa0;&#xb1;&#xa0;0.2 years. IRAR was 2.4% per person-year (PPY) (confidence interval [CI] 2.1-2.8%). Patients with MFS had a threefold higher IRAR (6.0% PPY, CI 4.1-8.8%) than did patients without a connective tissue disorders (2.3% PPY, CI 1.9-2.7%; p&#xa0;&lt;&#xa0;.001). IRAR was 2.5% PPY (CI 2.1-3.0%) after operation for dissection and 1.3% PPY (CI 0.9-2.0%) after operation for aneurysm (p&#xa0;=&#xa0;.004 for subgroup differences). IRAR proximal and distal to the left subclavian artery was 1.2% PPY (CI 1.0-1.5%) and 1.3% PPY (CI 1.1-1.6%), respectively. The pooled in hospital mortality and complication rates after re-operation were 14.31% (CI 11.28-17.99%) and 18.08% (CI 10.54-29.25%), respectively. On meta-regression, initial operation for dissection was the only significant predictor of aortic re-operation (beta&#xa0;=&#xa0;.030, p&#xa0;=&#xa0;.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Aortic re-operation occurs at a mean rate of 2.4% per person-year in the five years after proximal aortic replacement and is strongly associated with initial operation for dissection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gaudino</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA. Electronic address: mfg9004@med.cornell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardi</LastName><ForeName>Leonard N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahouma</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonard</LastName><ForeName>Jeremy R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Franco</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine (Cardiology), Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abouarab</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwann</LastName><ForeName>Alexandra N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scuderi</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demetres</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Samuel J. Wood Library and C.V. Starr Biomedical Information Centre, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devereux</LastName><ForeName>Richard B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Medicine (Cardiology), Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benedetto</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinsaft</LastName><ForeName>Jonathan W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Medicine (Cardiology), Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="N">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001011" MajorTopicYN="N">Aorta</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="Y">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aneurysm</Keyword><Keyword MajorTopicYN="N">Aorta</Keyword><Keyword MajorTopicYN="N">Dissection</Keyword><Keyword MajorTopicYN="N">Surgical grafting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30037741</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2018.06.038</ArticleId><ArticleId IdType="pii">S1078-5884(18)30397-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34665474</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Slow gait speed is associated with worse postoperative outcomes in cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>197</StartPage><EndPage>204</EndPage><MedlinePgn>197-204</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.16089</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Frailty is associated with poorer outcomes in cardiac surgery, but the heterogeneity in frailty assessment tools makes it difficult to ascertain its true impact in cardiac surgery. Slow gait speed is a simple, validated, and reliable marker of frailty. We performed a systematic review and meta-analysis to examine the effect of slow gait speed on postoperative cardiac surgical patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMED, MEDLINE, and EMBASE databases were searched from January 2000 to August 2021 for studies comparing slow gait speed and "normal" gait speed. Primary outcome was in-hospital mortality. Secondary outcomes were composite mortality and major morbidity, AKI, stroke, deep sternal wound infection, prolonged ventilation, discharge to a healthcare facility, and ICU length of stay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were seven eligible studies with 36,697 patients. Slow gait speed was associated with increased likelihood of in-hospital mortality (risk ratio [RR]: 2.32; 95% confidence interval [CI]: 1.87-2.87). Additionally, they were more likely to suffer from composite mortality and major morbidity (RR: 1.52; 95% CI: 1.38-1.66), AKI (RR: 2.81; 95% CI: 1.44-5.49), deep sternal wound infection (RR: 1.77; 95% CI: 1.59-1.98), prolonged ventilation &gt;24&#x2009;h (RR: 1.97; 95% CI: 1.48-2.63), reoperation (RR: 1.38; 95% CI: 1.05-1.82), institutional discharge (RR: 2.08; 95% CI: 1.61-2.69), and longer ICU length of stay (MD: 21.69; 95% CI: 17.32-26.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Slow gait speed is associated with poorer outcomes in cardiac surgery. Frail patients are twofold more likely to die during hospital admission than nonfrail counterparts and are at an increased risk of developing various perioperative complications.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jaewon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2698-6571</Identifier><AffiliationInfo><Affiliation>The Royal Melbourne Hospital, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nathalie</LastName><ForeName>Janice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyenhuy</LastName><ForeName>Minhtuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Western Hospital, Footscray, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ruiwen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Concord Repatriation General Hospital, Concord West, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saxena</LastName><ForeName>Akshat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery and Transplantation, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072797" MajorTopicYN="N">Walking Speed</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">frailty</Keyword><Keyword MajorTopicYN="N">gait speed</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>19</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34665474</ArticleId><ArticleId IdType="doi">10.1111/jocs.16089</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156.</Citation></Reference><Reference><Citation>Lee JA, Yanagawa B, An KR, et al. Frailty and pre-frailty in cardiac surgery: a systematic review and meta-analysis of 66,448 patients. J Cardiothorac Surg. 2021;16(1):184.</Citation></Reference><Reference><Citation>Sepehri A, Beggs T, Hassan A, et al. The impact of frailty on outcomes after cardiac surgery: a systematic review. J Thorac Cardiovasc Surg. 2014;148(6):3110-3117.</Citation></Reference><Reference><Citation>Purser JL, Kuchibhatla MN, Fillenbaum GG, Harding T, Peterson ED, Alexander KP. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc. 2006;54(11):1674-1681.</Citation></Reference><Reference><Citation>Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well-functioning older people&#x2212;results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53(10):1675-1680.</Citation></Reference><Reference><Citation>GA Wells BS, O'Connell D, Peterson J, Welch V, Losos M &amp; Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses University of Ottawa: University of Ottawa; 2000. Accessed August 21, 2021. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</Citation></Reference><Reference><Citation>Luo DWX, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Statist Methods Med Res. 2018;27(6):1785-1805.</Citation></Reference><Reference><Citation>Afilalo J, Eisenberg MJ, Morin JF, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56(20):1668-1676.</Citation></Reference><Reference><Citation>Lim S, Jacques F, Babaki S, et al. Preoperative physical frailty assessment among octogenarians undergoing cardiac surgery: upgrading the &#x201c;eyeball&#x201d; test. J Thorac Cardiovasc Surg. Forthcoming.</Citation></Reference><Reference><Citation>Afilalo J, Kim S, O'Brien S, et al. Gait speed and operative mortality in older adults following cardiac surgery. JAMA Cardiol. 2016;1(3):314-321.</Citation></Reference><Reference><Citation>Afilalo J, Sharma A, Zhang S, et al. Gait speed and 1-year mortality following cardiac surgery: a landmark analysis from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. J Am Heart Assoc. 2018;7(23):e010139.</Citation></Reference><Reference><Citation>Bergquist CS, Jackson EA, Thompson MP, et al. Understanding the association between frailty and cardiac surgical outcomes. Ann Thorac Surg. 2018;106(5):1326-1332.</Citation></Reference><Reference><Citation>Clark K, Leathers T, Rotich D, et al. Gait speed is not associated with vasogenic shock or cardiogenic shock following cardiac surgery, but is associated with increased hospital length of stay. Crit Care Res Pract. 2018;2018:1538587.</Citation></Reference><Reference><Citation>Hobbs RD, Norton EL, Wu X, et al. Gait speed is a preoperative indicator of postoperative events after elective proximal aortic surgery. J Thorac Cardiovasc Surg. 2020</Citation></Reference><Reference><Citation>Hogan DB, Maxwell CJ, Afilalo J, et al. A scoping review of frailty and acute care in middle-aged and older individuals with recommendations for future research. Can Geriatr J. 2017;20(1):22-37.</Citation></Reference><Reference><Citation>King SJ, Raine KA, Peel NM, Hubbard RE. Interventions for frail older inpatients: a systematic review of frailty measures and reported outcomes in randomised controlled trials. Australas J Ageing. 2021;40(2):129-144.</Citation></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute dialysis quality initiative w. acute renal failure&#x2212;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212.</Citation></Reference><Reference><Citation>Koh LY, Hwang NC. Frailty in cardiac surgery. J Cardiothorac Vasc Anesth. 2019;33(2):521-531.</Citation></Reference><Reference><Citation>Li Z, Ding X. The incremental predictive value of frailty measures in elderly patients undergoing cardiac surgery: a systematic review. Clin Cardiol. 2018;41(8):1103-1110.</Citation></Reference><Reference><Citation>Boreskie KF, Hay JL, Kehler DS, et al. Prehabilitation: the right medicine for older frail adults anticipating transcatheter aortic valve replacement, coronary artery bypass graft, and other cardiovascular care. Clin Geriatr Med. 2019;35(4):571-585.</Citation></Reference><Reference><Citation>McCann M, Stamp N, Ngui A, Litton E. Cardiac prehabilitation. J Cardiothorac Vasc Anesth. 2019;33(8):2255-2265.</Citation></Reference><Reference><Citation>Waite I, Massey T, Baghai M, Wendler O, Deshpande R, Greenwood S. Home-based preoperative rehabilitation (PREHAB) to improve physical function and reduce hospital length of stay for frail patients undergoing cardiac surgery. Physiotherapy. 2017;103(suppl 1):e117.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36452913</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Postoperative Complications and In-Hospital Mortality Following Surgery for Cervical Spinal Cord Injury.</ArticleTitle><Pagination><StartPage>e31960</StartPage><MedlinePgn>e31960</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e31960</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.31960</ELocationID><Abstract><AbstractText>Background and objective The operative priority in the setting of traumatic cervical spinal cord injury (SCI) is to decompress the injured spinal cord and stabilize the vertebral column. Currently, there is a relative paucity of evidence regarding associations of patient and surgical factors with in-hospital mortality following traumatic SCI. In light of this, the aim of this study was to investigate the correlation of injury, patient, and surgical factors with in-hospital morbidity and mortality. Methods The study was designed as a retrospective cohort study. The electronic medical records (EMR) at a single tertiary centre in Australia were retrospectively reviewed over a five-year period (2016-2021). All adults who were admitted to undergo&#xa0;emergency surgery for cervical SCI were identified and reviewed for patient factors (age, sex, comorbidities), injury factors [injury severity score (ISS), American Spinal Cord Injury Association (ASIA) classification], and surgical factors (anterior/posterior/360 instrumentation, greater than five levels instrumented, operative time). Factors were correlated to in-hospital complications (infection, pressure injury, ventilator dependency, venous thromboembolism, stroke) and in-hospital mortality by using univariate analysis and multivariable logistic regression models. Results A total of 92 patients were identified from the EMR. The median patient age was 54.5&#xa0;years [interquartile range (IQR): 2.5];&#xa0;77&#xa0;(82.2%) of the participants were male. The median ASIA classification was C4 ASIA C. In-hospital mortality following surgery was 6.5% (n=6). Of these patients, the primary cause of death was respiratory failure in 83.3% (n=5). In-hospital mortality was associated with anticoagulation (p=0.01), coronary disease (p=0.012), complete injury (p=0.011), and ventilator dependency (p&lt;0.001). Postoperative pneumonia was associated with complete injury (p=0.009) and polytrauma (p=0.002). Ventilator dependency was associated with complete injuries (p&lt;0.001) and polytrauma (p&lt;0.001). A logistic regression analysis found complete neurological injury to be significant in predicting in-hospital mortality [odds ratio (OR): 184.53, 95% confidence interval (CI): 2.41-14106.65, p=0.018, R<sup>2</sup>=0.58]. Conclusion To improve surgical outcomes in patients with traumatic cervical SCI, a concerted effort must be made to prevent postoperative complications. Cardiovascular comorbidities present significant risk factors for patients. Patient age appears to insignificantly influence postoperative complication rates; however, this finding may have been influenced by selection bias. Postoperative respiratory complications, especially in patients with complete neurological deficits, can be particularly devastating.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, Wilton et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilton</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Orthopaedics, Northern Sydney Local Health District, Sydney, AUS.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">australia</Keyword><Keyword MajorTopicYN="N">cervical spinal cord injury</Keyword><Keyword MajorTopicYN="N">early postoperative complication</Keyword><Keyword MajorTopicYN="N">inhospital mortality</Keyword><Keyword MajorTopicYN="N">logistic regression model</Keyword><Keyword MajorTopicYN="N">spinal cord injury</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36452913</ArticleId><ArticleId IdType="pmc">PMC9703390</ArticleId><ArticleId IdType="doi">10.7759/cureus.31960</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Estimating the incidence and prevalence of traumatic spinal cord injury in Australia. New PW, Baxter D, Farry A, Noonan VK. Arch Phys Med Rehabil. 2015;96:76&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">25218255</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and patterns of spinal cord injury in Australia. O'Connor P. Accid Anal Prev. 2002;34:405&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">12067103</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal cord injury facts and figures at a glance. National Spinal Cord Injury Statistical Center. J Spinal Cord Med. 2013;36:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555099</ArticleId><ArticleId IdType="pubmed">23433327</ArticleId></ArticleIdList></Reference><Reference><Citation>Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Front Neurol. 2019;10:282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439316</ArticleId><ArticleId IdType="pubmed">30967837</ArticleId></ArticleIdList></Reference><Reference><Citation>Central nervous system injury and nicotinamide adenine dinucleotide phosphate oxidase: oxidative stress and therapeutic targets. von Leden RE, Yauger YJ, Khayrullina G, Byrnes KR. J Neurotrauma. 2017;34:755&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5335782</ArticleId><ArticleId IdType="pubmed">27267366</ArticleId></ArticleIdList></Reference><Reference><Citation>Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Oyinbo CA. https://pubmed.ncbi.nlm.nih.gov/21731081/ Acta Neurobiol Exp (Wars) 2011;71:281&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">21731081</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute spinal cord injury, part I: pathophysiologic mechanisms. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS. Clin Neuropharmacol. 2001;24:254&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">11586110</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervical spine injuries with acute traumatic spinal cord injury: spinal surgery adverse events and their association with neurological and functional outcome. Liebscher T, Ludwig J, L&#xfc;bstorf T, et al. Spine (Phila Pa 1976) 2022;47:0&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8654254</ArticleId><ArticleId IdType="pubmed">34027924</ArticleId></ArticleIdList></Reference><Reference><Citation>Factors associated with early mortality after cervical spinal cord injury. Shao J, Zhu W, Chen X, et al. J Spinal Cord Med. 2011;34:555&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3237281</ArticleId><ArticleId IdType="pubmed">22330110</ArticleId></ArticleIdList></Reference><Reference><Citation>In-hospital mortality in people with complete acute traumatic spinal cord injury at a tertiary care center in India-a retrospective analysis. Chhabra HS, Sharawat R, Vishwakarma G. Spinal Cord. 2022;60:210&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8231086</ArticleId><ArticleId IdType="pubmed">34172928</ArticleId></ArticleIdList></Reference><Reference><Citation>A new scale for predicting the risk of in-hospital mortality in patients with traumatic spinal cord injury. Gong Y, Du J, Hao D, et al. Front Neurol. 2022;13:894273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9204840</ArticleId><ArticleId IdType="pubmed">35720092</ArticleId></ArticleIdList></Reference><Reference><Citation>A systematic review of intensive cardiopulmonary management after spinal cord injury. Casha S, Christie S. J Neurotrauma. 2011;28:1479&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3143388</ArticleId><ArticleId IdType="pubmed">20030558</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of pulmonary embolism after the first 3 months of spinal cord injury. Alabed S, de Heredia LL, Naidoo A, Belci M, Hughes RJ, Meagher TM. Spinal Cord. 2015;53:835&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">26099210</ArticleId></ArticleIdList></Reference><Reference><Citation>Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Cardenas DD, Hoffman JM, Kirshblum S, McKinley W. Arch Phys Med Rehabil. 2004;85:1757&#x2013;1763.</Citation><ArticleIdList><ArticleId IdType="pubmed">15520970</ArticleId></ArticleIdList></Reference><Reference><Citation>Secondary conditions following spinal cord injury in a population-based sample. Johnson RL, Gerhart KA, McCray J, Menconi JC, Whiteneck GG. Spinal Cord. 1998;36:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">9471138</ArticleId></ArticleIdList></Reference><Reference><Citation>Pressure ulcer risk factors in persons with SCI: Part I: acute and rehabilitation stages. G&#xe9;lis A, Dupeyron A, Legros P, Bena&#xef;m C, Pelissier J, Fattal C. Spinal Cord. 2009;47:99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">18762807</ArticleId></ArticleIdList></Reference><Reference><Citation>Determinants of in-hospital death after acute spinal cord injury: a population-based study. Selassie AW, Varma A, Saunders LL, Welldaregay W. Spinal Cord. 2013;51:48&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">22847652</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictors of early mortality after traumatic spinal cord injury: a population-based study. Varma A, Hill EG, Nicholas J, Selassie A. Spine (Phila Pa 1976) 2010;35:778&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">20228715</ArticleId></ArticleIdList></Reference><Reference><Citation>In-hospital mortality for the elderly with acute traumatic spinal cord injury. Inglis T, Banaszek D, Rivers CS, et al. J Neurotrauma. 2020;37:2332&#x2013;2342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585611</ArticleId><ArticleId IdType="pubmed">32635809</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervical spine injuries in the elderly: acute postoperative mortality. Jackson AP, Haak MH, Khan N, Meyer PR. Spine (Phila Pa 1976) 2005;30:1524&#x2013;1527.</Citation><ArticleIdList><ArticleId IdType="pubmed">15990667</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiological state, predictors of early mortality, and predictive models for traumatic spinal cord injury: a multicenter nationwide cohort study. Shibahashi K, Nishida M, Okura Y, Hamabe Y. Spine (Phila Pa 1976) 2019;44:479&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">30234810</ArticleId></ArticleIdList></Reference><Reference><Citation>The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data. Badhiwala JH, Wilson JR, Witiw CD, et al. Lancet Neurol. 2021;20:117&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">33357514</ArticleId></ArticleIdList></Reference><Reference><Citation>Immediate spinal cord decompression for cervical spinal cord injury: feasibility and outcome. Papadopoulos SM, Selden NR, Quint DJ, Patel N, Gillespie B, Grube S. J Trauma. 2002;52:323&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">11834996</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesia duration as an independent risk factor for early postoperative complications in adults undergoing elective ACDF. Phan K, Kim JS, Kim JH, Somani S, Di'Capua J, Dowdell JE, Cho SK. Global Spine J. 2017;7:727&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5721997</ArticleId><ArticleId IdType="pubmed">29238635</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of anterior and posterior approaches in cervical spinal cord injuries. Brodke DS, Anderson PA, Newell DW, Grady MS, Chapman JR. J Spinal Disord Tech. 2003;16:229&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">12792335</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of anterior and posterior approaches for treatment of traumatic cervical dislocation combined with spinal cord injury: minimum 10-year follow-up. Ren C, Qin R, Wang P, Wang P. Sci Rep. 2020;10:10346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316727</ArticleId><ArticleId IdType="pubmed">32587305</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Bureau of Statistics: Snapshot of New South Wales. Australian Bureau of Statistics: Canberra, ABS.  [
Nov;
2022 
]. 2022. https://www.abs.gov.au/articles/snapshot-nsw-2021 https://www.abs.gov.au/articles/snapshot-nsw-2021</Citation></Reference><Reference><Citation>Australian Institute of Health and Welfare. Australian Institute of Health and Welfare: Australian Family of Health and Related Classifications - ICD-10-AM. 2022.  [
Nov;
2022 
]. 2022. https://www.aihw.gov.au/suicide-self-harm-monitoring/data/technical-notes/codes-and-classifications p. 0.https://www.aihw.gov.au/suicide-self-harm-monitoring/data/technical-notes/codes-and-classifications</Citation></Reference><Reference><Citation>The impact of confounder selection criteria on effect estimation. Mickey RM, Greenland S. Am J Epidemiol. 1989;129:125&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">2910056</ArticleId></ArticleIdList></Reference><Reference><Citation>Variable selection strategies and its importance in clinical prediction modelling. Chowdhury MZ, Turin TC. Fam Med Community Health. 2020;8:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7032893</ArticleId><ArticleId IdType="pubmed">32148735</ArticleId></ArticleIdList></Reference><Reference><Citation>Multicollinearity and misleading statistical results. Kim JH. Korean J Anesthesiol. 2019;72:558&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900425</ArticleId><ArticleId IdType="pubmed">31304696</ArticleId></ArticleIdList></Reference><Reference><Citation>Baseline predictors of in-hospital mortality after acute traumatic spinal cord injury: data from a level I trauma center. Blex C, Kreutztr&#xe4;ger M, Ludwig J, et al. Sci Rep. 2022;12:11420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9259676</ArticleId><ArticleId IdType="pubmed">35794189</ArticleId></ArticleIdList></Reference><Reference><Citation>Development and validation of predictors of respiratory insufficiency and mortality scores: simple bedside additive scores for prediction of ventilation and in-hospital mortality in acute cervical spine injury. Durga P, Sahu BP, Mantha S, Ramachandran G. Anesth Analg. 2010;110:134&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">19933524</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality and longevity after a spinal cord injury: systematic review and meta-analysis. Chamberlain JD, Meier S, Mader L, von Groote PM, Brinkhof MW. Neuroepidemiology. 2015;44:182&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">25997873</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for mortality after spinal cord injury in the USA. Cao Y, Krause JS, DiPiro N. Spinal Cord. 2013;51:413&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">23380680</ArticleId></ArticleIdList></Reference><Reference><Citation>Recent trends in mortality and causes of death among persons with spinal cord injury. DeVivo MJ, Krause JS, Lammertse DP. Arch Phys Med Rehabil. 1999;80:1411&#x2013;1419.</Citation><ArticleIdList><ArticleId IdType="pubmed">10569435</ArticleId></ArticleIdList></Reference><Reference><Citation>Stability of predictors of mortality after spinal cord injury. Krause JS, Saunders LL, Zhai Y. Spinal Cord. 2012;50:281&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3321101</ArticleId><ArticleId IdType="pubmed">22231541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervical injuries in Sweden, a national survey of patient data from 1987 to 1999. Brolin K, von Holst H. Inj Control Saf Promot. 2002;9:40&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">12462163</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of traumatic spinal cord injury in Canada. Pickett GE, Campos-Benitez M, Keller JL, Duggal N. Spine (Phila Pa 1976) 2006;31:799&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">16582854</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal cord injuries in Ilorin, Nigeria. Solagberu BA. West Afr J Med. 2002;21:230&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">12744575</ArticleId></ArticleIdList></Reference><Reference><Citation>Traumatic spinal cord injury in Victoria, 2007-2016. Beck B, Cameron PA, Braaf S, et al. Med J Aust. 2019;210:360&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">31055854</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of traumatic spinal cord injuries in Finland over a 30-year period. Ahoniemi E, Alaranta H, Hokkinen EM, Valtonen K, Kautiainen H. Spinal Cord. 2008;46:781&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">18542095</ArticleId></ArticleIdList></Reference><Reference><Citation>The changing face of major trauma in the UK. Kehoe A, Smith JE, Edwards A, Yates D, Lecky F. Emerg Med J. 2015;32:911&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4717354</ArticleId><ArticleId IdType="pubmed">26598629</ArticleId></ArticleIdList></Reference><Reference><Citation>Major trauma in older persons. Beck B, Cameron P, Lowthian J, Fitzgerald M, Judson R, Gabbe BJ. BJS Open. 2018;2:310&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156159</ArticleId><ArticleId IdType="pubmed">30263982</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbidity and mortality of traumatic cervical spinal cord injuries in a geriatric cohort. Wilson KV, McDonnell JM, O'Malley S, et al. Ir J Med Sci. 2022;3:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510192</ArticleId><ArticleId IdType="pubmed">36151362</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostic coding accuracy for traumatic spinal cord injuries. Hagen EM, Rekand T, Gilhus NE, Gronning M. Spinal Cord. 2009;47:367&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">18839007</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical coders' perspectives on pressure injury coding in acute care services in Victoria, Australia. Weller CD, Turnour L, Connelly E, Banaszak-Holl J, Team V. Front Public Health. 2022;10:893482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198603</ArticleId><ArticleId IdType="pubmed">35719639</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical documentation requirements for the accurate coding of hospital-acquired urinary tract infections in Australia. Liu S, Kim D, Penfold S, Doric A. Aust Health Rev. 2022;2:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36223718</ArticleId></ArticleIdList></Reference><Reference><Citation>Accuracy of ICD-9-CM codes in hospital morbidity data, Victoria: implications for public health research. MacIntyre CR, Ackland MJ, Chandraraj EJ, Pilla JE. Aust N Z J Public Health. 1997;21:477&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">9343891</ArticleId></ArticleIdList></Reference><Reference><Citation>Accuracy of injury coding in Victorian hospital morbidity data. MacIntyre CR, Ackland MJ, Chandraraj EJ. https://pubmed.ncbi.nlm.nih.gov/9489199/ Aust N Z J Public Health. 1997;21:779&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">9489199</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal cord injury without radiologic abnormalities in adults: a systematic review. Boese CK, Lechler P. J Trauma Acute Care Surg. 2013;75:320&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pubmed">23702634</ArticleId></ArticleIdList></Reference><Reference><Citation>The adult spinal cord injury without radiographic abnormalities syndrome: magnetic resonance imaging and clinical findings in adults with spinal cord injuries having normal radiographs and computed tomography studies. Kasimatis GB, Panagiotopoulos E, Megas P, Matzaroglou C, Gliatis J, Tyllianakis M, Lambiris E. J Trauma. 2008;65:86&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">18580514</ArticleId></ArticleIdList></Reference><Reference><Citation>The relationship between statistical power and predictor distribution in multilevel logistic regression: a simulation-based approach. Olvera Astivia OL, Gadermann A, Guhn M. BMC Med Res Methodol. 2019;19:97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6507150</ArticleId><ArticleId IdType="pubmed">31072299</ArticleId></ArticleIdList></Reference><Reference><Citation>Multicollinearity in regression analyses conducted in epidemiologic studies. Vatcheva KP, Lee M, McCormick JB, Rahbar MH. Epidemiology (Sunnyvale) 2016;6:3&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888898</ArticleId><ArticleId IdType="pubmed">27274911</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluation of Cox's model and logistic regression for matched case-control data with time-dependent covariates: a simulation study. Leffondr&#xe9; K, Abrahamowicz M, Siemiatycki J. Stat Med. 2003;22:3781&#x2013;3794.</Citation><ArticleIdList><ArticleId IdType="pubmed">14673938</ArticleId></ArticleIdList></Reference><Reference><Citation>Empirical comparisons of proportional hazards, poisson, and logistic regression modeling of occupational cohort data. Callas PW, Pastides H, Hosmer DW. Am J Ind Med. 1998;33:33&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">9408527</ArticleId></ArticleIdList></Reference><Reference><Citation>External validation of a Cox prognostic model: principles and methods. Royston P, Altman DG. BMC Med Res Methodol. 2013;13:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667097</ArticleId><ArticleId IdType="pubmed">23496923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bias in surgical research. Paradis C. Ann Surg. 2008;248:180&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">18650626</ArticleId></ArticleIdList></Reference><Reference><Citation>Variations in practice patterns among neurosurgeons and orthopaedic surgeons in the management of spinal disorders. Hussain M, Nasir S, Moed A, Murtaza G. Asian Spine J. 2011;5:208&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3230647</ArticleId><ArticleId IdType="pubmed">22164314</ArticleId></ArticleIdList></Reference><Reference><Citation>Development of a machine learning algorithm for predicting in-hospital and 1-year mortality after traumatic spinal cord injury. Fallah N, Noonan VK, Waheed Z, et al. Spine J. 2022;22:329&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">34419627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37432902</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9042</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>23-24</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of neurotrauma</Title><ISOAbbreviation>J Neurotrauma</ISOAbbreviation></Journal><ArticleTitle>Role of Frailty Status in Prediction of Clinical Outcomes of Traumatic Spinal Injury: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>2453</StartPage><EndPage>2468</EndPage><MedlinePgn>2453-2468</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/neu.2023.0008</ELocationID><Abstract><AbstractText>Although many frailty tools have been used to predict traumatic spinal injury (TSI) outcomes, identifying predictors of outcomes after TSI in the aged population is difficult. Frailty, age, and TSI association are interesting topics of discussion in geriatric literature. However, the association between these variables are yet to be clearly elucidated. We conducted a systematic review to investigate the association between frailty and TSI outcomes. The authors searched Medline, EMBASE, Scopus, and Web of Science for relevant studies. Studies with observational designs that assessed baseline frailty status in individuals suffering from TSI published from inception until 26th March 2023 were included. Length of hospital stay (LoS), adverse events (AEs), and mortality were the outcomes of interest. Of the 2425 citations, 16 studies involving 37,640 participants were included. The modified frailty index (mFI) was the most common tool used to assess frailty. Meta-analysis was employed only in studies that used mFI for measuring frailty. Frailty was significantly associated with increased in-hospital or 30-day mortality (pooled odds ratio [OR]: 1.93 [1.19; 3.11]), non-routine discharge (pooled OR: 2.44 [1.34; 4.44]), and AEs or complications (pooled OR: 2.00 [1.14; 3.50]). However, no significant relationship was found between frailty and LoS (pooled OR: 3.02 [0.86; 10.60]). Heterogeneity was observed across multiple factors, including age, injury level, frailty assessment tool, and spinal cord injury characteristics. In conclusion, although there is limited data concerning using frailty scales to predict short-term outcomes after TSI, the results showed that frailty status may be a predictor of in-hospital mortality, AEs, and unfavorable discharge destination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rohollahi</LastName><ForeName>Faramarz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farahbakhsh</LastName><ForeName>Farzin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kankam</LastName><ForeName>Samuel Berchi</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>Aynaz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korkorian</LastName><ForeName>Rojin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobabi</LastName><ForeName>Sepehr</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moarrefdezfouli</LastName><ForeName>Azin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molavi</LastName><ForeName>Shervin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Benjamin M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zipser</LastName><ForeName>Carl M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laufer</LastName><ForeName>Ilya</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, NYU Grossman School of Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrop</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Carle Foundation Hospital, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Carle Illinois College of Medicine, University of Illinois Urbana Champaign, Champaign, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Spine and Peripheral Nerve Surgery, Departments of Neurological and Orthopedic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Allan R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of California, Davis, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimi-Movaghar</LastName><ForeName>Vafa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurotrauma</MedlineTA><NlmUniqueID>8811626</NlmUniqueID><ISSNLinking>0897-7151</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013124" MajorTopicYN="Y">Spinal Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">frailty</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">spinal cord injury</Keyword><Keyword MajorTopicYN="N">trauma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>13</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37432902</ArticleId><ArticleId IdType="doi">10.1089/neu.2023.0008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40034144</PMID><DateRevised><Year>2025</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Comparison of the effects of perioperative fentanyl and morphine use on the short-term prognosis of patients with cardiac surgery in the ICU.</ArticleTitle><Pagination><StartPage>1453835</StartPage><MedlinePgn>1453835</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1453835</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2024.1453835</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="UNASSIGNED">This study aimed to analyze the effects of perioperative morphine and fentanyl use on delirium, length of ICU stay, and in-hospital mortality after cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This cohort study retrieved the data of 4,596 patients admitted to ICU after cardiac surgery in MIMIC-IV database from 2008 to 2019. The primary outcome was postoperative delirium. The secondary outcomes were length of ICU stay, and in-hospital mortality. To compare the effects of perioperative fentanyl and morphine use on postoperative delirium, length of ICU stay, and in-hospital mortality, univariate, two-way stepwise, as well as multivariable Logistic regression, linear regression, and Cox proportional hazards models was respectively used. Odd ratio (OR), &#x3b2; coefficient, hazard ratio (HR), and respective confidence interval (CI) were calculated. Subgroup analysis was conducted in terms of age, use of extracorporeal circulation, midazolam, dexmedetomidine or surgery type.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In total, the data of 4,596 patients were analyzed including 2,589 morphine user and 2007 fentanyl user. We found that the risk of postoperative delirium was reduced in patients with cardiac surgery undergoing perioperative morphine relative to perioperative fentanyl (OR = 0.62, 95%CI: 0.40-0.96). Perioperative morphine use was negatively correlated with the length of ICU stay in patients with cardiac surgery in comparison to patients with perioperative fentanyl use (&#x3b2; = -0.72, 95%CI: -1.06, -0.39). Relative to patients who had perioperative fentanyl, patients who had perioperative morphine were associated with reduced risk of in-hospital mortality in patients with cardiac surgery after adjusting for respective confounding factors (HR = 0.35, 95%CI: 0.13-0.91).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Perioperative morphine use was related to lower risk of delirium and in-hospital mortality as well as shortened length of ICU stay in these patients. The findings might offer a reference for perioperative anesthesia management in patients receiving cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Zhong, Sui, Zi and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Jingtao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sui</LastName><ForeName>Runqian</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zi</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Anbiao</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">delirium</Keyword><Keyword MajorTopicYN="N">fentanyl</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">morphine</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>4</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>4</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>4</Day><Hour>4</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40034144</ArticleId><ArticleId IdType="pmc">PMC11873745</ArticleId><ArticleId IdType="doi">10.3389/fphar.2024.1453835</ArticleId><ArticleId IdType="pii">1453835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ball L., Costantino F., Pelosi P. (2016). Postoperative complications of patients undergoing cardiac surgery. Curr. Opin. Crit. care 22 (4), 386&#x2013;392. 10.1097/mcc.0000000000000319</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mcc.0000000000000319</ArticleId><ArticleId IdType="pubmed">27309972</ArticleId></ArticleIdList></Reference><Reference><Citation>Bencsics A., Elenkov I. J., Vizi E. S. (1997). Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: involvement of the sympathetic nervous system. J. Neuroimmunol. 73 (1-2), 1&#x2013;6. 10.1016/s0165-5728(96)00163-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(96)00163-4</ArticleId><ArticleId IdType="pubmed">9058753</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentley J. B., Borel J. D., Nenad R. E., Jr., Gillespie T. J. (1982). Age and fentanyl pharmacokinetics. Anesth. analgesia 61 (12), 968&#x2013;971. 10.1213/00000539-198212000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-198212000-00002</ArticleId><ArticleId IdType="pubmed">7149300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilfinger T. V., Fimiani C., Stefano G. B. (1998). Morphine's immunoregulatory actions are not shared by fentanyl. Int. J. Cardiol. 64 (Suppl. 1), S61&#x2013;S66. 10.1016/s0167-5273(98)00037-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-5273(98)00037-0</ArticleId><ArticleId IdType="pubmed">9687094</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilfinger T. V., Kushnerik V., Bundz S., Liu Y., Stefano G. B. (1996). Evidence for morphine downregulating immunocytes during cardiopulmonary bypass in a porcine model. Int. J. Cardiol. 53 (Suppl. l), S39&#x2013;S46. 10.1016/0167-5273(96)02574-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5273(96)02574-0</ArticleId><ArticleId IdType="pubmed">8793592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta F., Lauretta M. P., Borozdina A., Mizikov V. M., Rosa G. (2013). Postoperative delirium: risk factors, diagnosis and perioperative care. Minerva Anestesiol. 79 (9), 1066&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">23511351</ArticleId></ArticleIdList></Reference><Reference><Citation>Botea M. O., Lungeanu D., Petrica A., Sandor M. I., Huniadi A. C., Barsac C., et al. (2023). Perioperative analgesia and patients' satisfaction in spinal anesthesia for cesarean section: fentanyl versus morphine. J. Clin. Med. 12 (19), 6346. 10.3390/jcm12196346</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12196346</ArticleId><ArticleId IdType="pmc">PMC10573232</ArticleId><ArticleId IdType="pubmed">37834990</ArticleId></ArticleIdList></Reference><Reference><Citation>Casamento A., Neto A. S., Lawrence M., Chudleigh L., Browne E., Taplin C., et al. (2023). Delirium in ventilated patients receiving fentanyl and morphine for analgosedation: findings from the analgesic trial. J. Crit. care 77, 154343. 10.1016/j.jcrc.2023.154343</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2023.154343</ArticleId><ArticleId IdType="pubmed">37235918</ArticleId></ArticleIdList></Reference><Reference><Citation>Casamento A. J., Serpa Neto A., Young M., Lawrence M., Taplin C., Eastwood G. M., et al. (2021). A phase ii cluster-crossover randomized trial of fentanyl versus morphine for analgosedation in mechanically ventilated patients. Am. J. Respir. Crit. care Med. 204 (11), 1286&#x2013;1294. 10.1164/rccm.202106-1515OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202106-1515OC</ArticleId><ArticleId IdType="pubmed">34543581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Hao Q., Sun R., Zhang Y., Fu H., Liu S., et al. (2023). Predictive value of the geriatric nutrition risk index for postoperative delirium in elderly patients undergoing cardiac surgery. CNS Neurosci. and Ther. 30, e14343. 10.1111/cns.14343</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.14343</ArticleId><ArticleId IdType="pmc">PMC10848042</ArticleId><ArticleId IdType="pubmed">37408469</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischman R. J., Frazer D. G., Daya M., Jui J., Newgard C. D. (2010). Effectiveness and safety of fentanyl compared with morphine for out-of-Hospital analgesia. Prehospital Emerg. care 14 (2), 167&#x2013;175. 10.3109/10903120903572301</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10903120903572301</ArticleId><ArticleId IdType="pmc">PMC2924527</ArticleId><ArticleId IdType="pubmed">20199230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xe4;ssdorf J., Weber N. C., Obal D., Toma O., M&#xfc;llenheim J., Kojda G., et al. (2005). Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB. Anesth. analgesia 101 (4), 934&#x2013;941. Epub 2005/09/30. 10.1213/01.ane.0000172130.70274.84</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000172130.70274.84</ArticleId><ArticleId IdType="pubmed">16192499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu A. M., Shan Z. M., Zhang Z. J., Li H. P. (2021). Comparative efficacy of fentanyl and morphine in patients with or at risk for acute respiratory distress syndrome: a propensity score-matched cohort study. Drugs R&amp;D 21 (2), 149&#x2013;155. 10.1007/s40268-021-00338-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40268-021-00338-3</ArticleId><ArticleId IdType="pmc">PMC8054845</ArticleId><ArticleId IdType="pubmed">33876394</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson A. E. W., Bulgarelli L., Shen L., Gayles A., Shammout A., Horng S., et al. (2023). Mimic-iv, a freely accessible electronic health record dataset. Sci. data 10 (1), 1. 10.1038/s41597-022-01899-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-022-01899-x</ArticleId><ArticleId IdType="pmc">PMC9810617</ArticleId><ArticleId IdType="pubmed">36596836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalogeropoulos A. S., Redwood S. R., Allen C. J., Hurrell H., Chehab O., Rajani R., et al. (2022). A 20-year journey in transcatheter aortic valve implantation: evolution to current eminence. Front. Cardiovasc Med. 9, 971762. 10.3389/fcvm.2022.971762</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.971762</ArticleId><ArticleId IdType="pmc">PMC9719928</ArticleId><ArticleId IdType="pubmed">36479570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H. S., Czuczman G. J., Nicholson W. K., Pham L. D., Richman J. M. (2008). Pain levels within 24 hours after ufe: a comparison of morphine and fentanyl patient-controlled analgesia. Cardiovasc. interventional radiology 31 (6), 1100&#x2013;1107. 10.1007/s00270-008-9430-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-008-9430-5</ArticleId><ArticleId IdType="pubmed">18797963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuntz M. T., Pereira L. M., Matte G. S., Connor K., Staffa S. J., DiNardo J. A., et al. (2021). Sequestration of midazolam, fentanyl, and morphine by an ex vivo cardiopulmonary bypass circuit. ASAIO J. (Am. Soc. Artif. Intern. Organs 1992) 67 (12), 1342&#x2013;1348. 10.1097/mat.0000000000001506</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mat.0000000000001506</ArticleId><ArticleId IdType="pubmed">34415712</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey A. S., Stevens L. A., Schmid C. H., Zhang Y. L., Castro A. F., 3rd, Feldman H. I., et al. (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150 (9), 604&#x2013;612. 10.7326/0003-4819-150-9-200905050-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>McNichols B., Spratt J. R., George J., Rizzi S., Manning E. W., Park K. (2021). Coronary artery bypass: review of surgical techniques and impact on long-term revascularization outcomes. Cardiol. Ther. 10 (1), 89&#x2013;109. 10.1007/s40119-021-00211-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-021-00211-z</ArticleId><ArticleId IdType="pmc">PMC8126527</ArticleId><ArticleId IdType="pubmed">33515370</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Mart&#xed;nez L. M., Gonz&#xe1;lez-Espinosa C., Cruz S. L. (2014). Dissociation of immunosuppressive and nociceptive effects of fentanyl, but not morphine, after repeated administration in mice: fentanyl-induced sensitization to lps. Brain, Behav. Immun. 42, 60&#x2013;64. 10.1016/j.bbi.2014.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2014.06.011</ArticleId><ArticleId IdType="pubmed">24975593</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan M. M., Tran A., Wescom R. L., Bobeck E. N. (2020). Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray. Eur. J. pain (London, Engl.) 24 (3), 617&#x2013;624. 10.1002/ejp.1513</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1513</ArticleId><ArticleId IdType="pubmed">31785128</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy G. S., Szokol J. W., Marymont J. H., Avram M. J., Vender J. S. (2007). The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesth. analgesia 104 (6), 1334&#x2013;1342. 10.1213/01.ane.0000264108.47280.f5</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000264108.47280.f5</ArticleId><ArticleId IdType="pubmed">17513621</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy G. S., Szokol J. W., Marymont J. H., Greenberg S. B., Avram M. J., Vender J. S., et al. (2009). Morphine-based cardiac anesthesia provides superior early recovery compared with fentanyl in elective cardiac surgery patients. Anesth. analgesia 109 (2), 311&#x2013;319. 10.1213/ane.0b013e3181a90adc</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181a90adc</ArticleId><ArticleId IdType="pubmed">19608797</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittams A. P., Iddawela S., Zaidi S., Tyson N., Harky A. (2022). Scoring systems for risk stratification in patients undergoing cardiac surgery. J. Cardiothorac. Vasc. Anesth. 36 (4), 1148&#x2013;1156. 10.1053/j.jvca.2021.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2021.03.005</ArticleId><ArticleId IdType="pubmed">33836964</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A., Grieco D. L., Bevilacqua F., Anzellotti G. M., Scarano A., Scambia G., et al. (2017). Continuous intravenous analgesia with fentanyl or morphine after gynecological surgery: a cohort study. J. Anesth. 31 (1), 51&#x2013;57. 10.1007/s00540-016-2268-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-016-2268-0</ArticleId><ArticleId IdType="pubmed">27743121</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarenmaa E., Huttunen P., Lepp&#xe4;luoto J., Meretoja O., Fellman V. (1999). Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: a randomized trial. J. Pediatr. 134 (2), 144&#x2013;150. 10.1016/s0022-3476(99)70407-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(99)70407-5</ArticleId><ArticleId IdType="pubmed">9931520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanson G., Khlopenyuk Y., Milocco S., Sartori M., Dreas L., Fabiani A. (2018). Delirium after cardiac surgery. Incidence, phenotypes, predisposing and precipitating risk factors, and effects. Heart and lung. 47 (4), 408&#x2013;417. 10.1016/j.hrtlng.2018.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2018.04.005</ArticleId><ArticleId IdType="pubmed">29751986</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa-Uva M., Head S. J., Milojevic M., Collet J. P., Landoni G., Castella M., et al. (2018). 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur. J. cardio-thoracic Surg. 53 (1), 5&#x2013;33. 10.1093/ejcts/ezx314</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezx314</ArticleId><ArticleId IdType="pubmed">29029110</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez A., Knoppert D. C., Lee D. S., Pletsch D., Seabrook J. A. (2010). Opioid infusions in the neonatal intensive care unit. J. Pediatr. Pharmacol. Ther. 15 (2), 142&#x2013;146. 10.5863/1551-6776-15.2.142</Citation><ArticleIdList><ArticleId IdType="doi">10.5863/1551-6776-15.2.142</ArticleId><ArticleId IdType="pmc">PMC3018177</ArticleId><ArticleId IdType="pubmed">22477805</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor N. M., Lacoumenta S., Hall G. M. (1997). Fentanyl and the interleukin-6 response to surgery. Anaesthesia 52 (2), 112&#x2013;115. 10.1111/j.1365-2044.1997.65-az0063.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.1997.65-az0063.x</ArticleId><ArticleId IdType="pubmed">9059091</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dorp E. L., Romberg R., Sarton E., Bovill J. G., Dahan A. (2006). Morphine-6-glucuronide: morphine's successor for postoperative pain relief? Anesth. analgesia 102 (6), 1789&#x2013;1797. 10.1213/01.ane.0000217197.96784.c3</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000217197.96784.c3</ArticleId><ArticleId IdType="pubmed">16717327</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatraman R., Pushparani A., Balaji R., Nandhini P. (2021). Comparison of low dose intravenous fentanyl and morphine infusion for postoperative analgesia in spine fusion surgeries - a randomized control trial. Braz. J. Anesthesiol. (Elsevier) 71 (4), 339&#x2013;344. 10.1016/j.bjane.2020.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjane.2020.12.013</ArticleId><ArticleId IdType="pmc">PMC9373321</ArticleId><ArticleId IdType="pubmed">34229859</ArticleId></ArticleIdList></Reference><Reference><Citation>Welters I. D., Menzebach A., Goumon Y., Langefeld T. W., Teschemacher H., Hempelmann G., et al. (2000). Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J. Neuroimmunol. 111 (1-2), 139&#x2013;145. 10.1016/s0165-5728(00)00401-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(00)00401-x</ArticleId><ArticleId IdType="pubmed">11063831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L., Shi H., Wang X., Duan Q., Ge P., Shao Y. (2022). Elevated blood urea nitrogen to serum albumin ratio is an adverse prognostic predictor for patients undergoing cardiac surgery. Front. Cardiovasc. Med. 9, 888736. 10.3389/fcvm.2022.888736</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.888736</ArticleId><ArticleId IdType="pmc">PMC9114352</ArticleId><ArticleId IdType="pubmed">35600476</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">23977592</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2225-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>Annals of cardiothoracic surgery</Title><ISOAbbreviation>Ann Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of hybrid aortic arch replacement.</ArticleTitle><Pagination><StartPage>247</StartPage><EndPage>260</EndPage><MedlinePgn>247-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2225-319X.2013.05.06</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Evolution in the endovascular era has influenced the management of aortic arch pathologies. Several studies have described the use of a combined endovascular and open surgical approach to the treatment of arch diseases. Hybrid repair of arch pathologies has been considered as a less invasive method, and is therefore an appealing option for high-risk patients who are unsuitable for open repairs. The aim of the present meta-analysis was to assess the efficacy of hybrid techniques in patients with aortic arch pathologies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Extensive electronic literature search was undertaken to identify all articles published up to December 2012 that described hybrid aortic arch repair with intrathoracic supra-aortic branch revascularisation and subsequent stent graft deployment. Eligible studies were divided into two groups: group I included studies on the aortic arch debranching procedure and group II included studies that reported an elephant trunk technique (either "frozen" or stented). Separate meta-analyses were conducted in order to assess technical success, stroke, spinal cord ischemia (SCI), renal failure requiring dialysis, and cardiac and pulmonary complications rate, as well as 30-day/in-hospital mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-six studies were eligible for the present meta-analysis: 26 studies with a total of 956 patients reported aortic arch debranching procedures, and 20 studies with 1,316 patients performed either 'frozen' or stented elephant trunk technique. The pooled estimate for 30-day/in-hospital mortality was 11.9% for the arch debranching group and 9.5% for the elephant trunk group. Cerebrovascular events of any severity were found to have occurred postoperatively at a pooled rate of 7.6% and 6.2%, while irreversible spinal cord injury symptoms were present in a pooled estimate of 3.6% and 5.0% in the arch debranching and elephant trunk group, respectively. Renal failure requiring dialysis occurred at 5.7% and 3.8% in both groups, while cardiac complications rate was 6.0% in the arch debranching cohort and pulmonary complication was 19.7% in the elephant trunk cohort.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hybrid arch techniques provide a safe alternative to open repair with acceptable short- and mid-term results. However, stroke and mortality rates remain noteworthy. Future prospective trials that compare open conventional techniques with the hybrid method or the entirely endovascular methods are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moulakakis</LastName><ForeName>Konstantinos G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece; ; The Systematic Review Unit, The Collaborative Research (CORE) Group, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mylonas</LastName><ForeName>Spyridon N</ForeName><Initials>SN</Initials></Author><Author ValidYN="Y"><LastName>Markatis</LastName><ForeName>Fotis</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Kotsis</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kakisis</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Liapis</LastName><ForeName>Christos D</ForeName><Initials>CD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Cardiothorac Surg</MedlineTA><NlmUniqueID>101605877</NlmUniqueID><ISSNLinking>2225-319X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic arch</Keyword><Keyword MajorTopicYN="N">debranching</Keyword><Keyword MajorTopicYN="N">frozen elephant trunk</Keyword><Keyword MajorTopicYN="N">hybrid</Keyword><Keyword MajorTopicYN="N">stented elephant trunk</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23977592</ArticleId><ArticleId IdType="pmc">PMC3741846</ArticleId><ArticleId IdType="doi">10.3978/j.issn.2225-319X.2013.05.06</ArticleId><ArticleId IdType="pii">acs-02-03-247</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bachet J, Guilmet D, Goudot B, et al. Antegrade cerebral perfusion with cold blood: a 13-year experience. Ann Thorac Surg 1999;67:1874-8; discussion 1891-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10391330</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Eusanio M, Schepens MA, Morshuis WJ, et al. Separate grafts or en bloc anastomosis for arch vessels reimplantation to the aortic arch. Ann Thorac Surg 2004;77:2021-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15172258</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Xiong J, Liu X, et al. Endovascular chimney technique of aortic arch pathologies: a systematic review. Ann Vasc Surg 2012;26:1014-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22944571</ArticleId></ArticleIdList></Reference><Reference><Citation>Czerny M, Weigang E, Sodeck G, et al. Targeting landing zone 0 by total arch rerouting and TEVAR: midterm results of a transcontinental registry. Ann Thorac Surg 2012;94:84-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22595468</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt PJ, Johnson C, Hinchliffe RJ, et al. Outcomes of the endovascular management of aortic arch aneurysm: implications for management of the left subclavian artery. J Vasc Surg 2010;51:1329-38</Citation><ArticleIdList><ArticleId IdType="pubmed">20303695</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Qi R, Zhu J, Liu Y, et al. Total arch replacement combined with stented elephant trunk implantation: a new &#x201c;standard&#x201d; therapy for type a dissection involving repair of the aortic arch? Circulation 2011;123:971-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21339481</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakob H, Tsagakis K, Pacini D, et al. The International E-vita Open Registry: data sets of 274 patients. J Cardiovasc Surg (Torino) 2011;52:717-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21894139</ArticleId></ArticleIdList></Reference><Reference><Citation>Borst HG, Walterbusch G, Schaps D. Extensive aortic replacement using &#x201c;elephant trunk&#x201d; prosthesis. Thorac Cardiovasc Surg 1983;31:37-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6189250</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell RS, Ishimaru S, Ehrlich MP, et al. First International Summit on Thoracic Aortic Endografting: roundtable on thoracic aortic dissection as an indication for endografting. J Endovasc Ther 2002;9Suppl 2:II98-105</Citation><ArticleIdList><ArticleId IdType="pubmed">12166849</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N.Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen ND, Williams JB, Hanna JM, et al. Results with an algorithmic approach to hybrid repair of the aortic arch. J Vasc Surg 2013;57:655-67; discussion 666-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718888</ArticleId><ArticleId IdType="pubmed">23186868</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou GA, Mireskandari M, Bicknell CD, et al. Hybrid repair of the aortic arch in patients with extensive aortic disease. Eur J Vasc Endovasc Surg 2010;40:715-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20920861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavaria J, Milewski RK, Baker J, et al. Classic hybrid evolving approach to distal arch aneurysms: toward the zone zero solution. J Thorac Cardiovasc Surg 2010;140:S77-80; discussion S86-91.</Citation><ArticleIdList><ArticleId IdType="pubmed">21092802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron P, Mangialardi N, Costa P, et al. Great vessel management for endovascular exclusion of aortic arch aneurysms and dissections. Eur J Vasc Endovasc Surg 2006;32:38-45</Citation><ArticleIdList><ArticleId IdType="pubmed">16520069</ArticleId></ArticleIdList></Reference><Reference><Citation>Canaud L, Hireche K, Berthet JP, et al. Endovascular repair of aortic arch lesions in high-risk patients or after previous aortic surgery: midterm results. J Thorac Cardiovasc Surg 2010;140:52-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19919865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YC, Cheng SW, Ting AC, et al. Supra-aortic hybrid endovascular procedures for complex thoracic aortic disease: single center early to midterm results. J Vasc Surg 2008;48:571-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18639423</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa R, Melissano G, Tshomba Y, et al. Ten years of endovascular aortic arch repair. J Endovasc Ther 2010;17:1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">20199258</ArticleId></ArticleIdList></Reference><Reference><Citation>Donas KP, Rancic Z, Lachat M, et al. Novel sutureless telescoping anastomosis revascularization technique of supra-aortic vessels to simplify combined open endovascular procedures in the treatment of aortic arch pathologies. J Vasc Surg 2010;51:836-41</Citation><ArticleIdList><ArticleId IdType="pubmed">20347679</ArticleId></ArticleIdList></Reference><Reference><Citation>Deriu G, Grego F, Frigatti P, et al. Unusual inflow sources and device introduction sites in aortic arch debranching. J Cardiovasc Surg (Torino) 2012;53:143-51</Citation><ArticleIdList><ArticleId IdType="pubmed">22456635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrero E, Ferri M, Viazzo A, et al. Is total debranching a safe procedure for extensive aortic-arch disease? A single experience of 27 cases. Eur J Cardiothorac Surg 2012;41:177-82</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241089</ArticleId><ArticleId IdType="pubmed">21820909</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisb&#xfc;sch P, Kotelis D, M&#xfc;ller-Eschner M, et al. Complications after aortic arch hybrid repair. J Vasc Surg 2011;53:935-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21215585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi G, Vanelli P, Mangini A, et al. Hybrid aortic arch repair procedure: reinforcement of the aorta for a safe and durable landing zone. Eur J Vasc Endovasc Surg 2010;40:709-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20870433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottardi R, Funovics M, Eggers N, et al. Supra-aortic transposition for combined vascular and endovascular repair of aortic arch pathology. Ann Thorac Surg 2008;86:1524-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19049743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes GC, Daneshmand MA, Balsara KR, et al. &#x201c;Hybrid&#x201d; repair of aneurysms of the transverse aortic arch: midterm results. Ann Thorac Surg 2009;88:1882-7; discussion 1887-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19932255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingrund JC, Nasser F, Jesus-Silva SG, et al. Hybrid procedures for complex thoracic aortic diseases. Rev Bras Cir Cardiovasc 2010;25:303-10</Citation><ArticleIdList><ArticleId IdType="pubmed">21103737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi H, Ishiguchi T, Ohta T, et al. Partial debranching hybrid stent graft for distal aortic arch aneurysms. Surg Today 2012;42:765-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22318637</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CW, Beaver TM, Klodell CT, Jr, et al. Arch debranching versus elephant trunk procedures for hybrid repair of thoracic aortic pathologies. Ann Thorac Surg 2011;91:465-71</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010941</ArticleId><ArticleId IdType="pubmed">21256293</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotfi S, Clough RE, Ali T, et al. Hybrid repair of complex thoracic aortic arch pathology: long-term outcomes of extra-anatomic bypass grafting of the supra-aortic trunk. Cardiovasc Intervent Radiol 2013;36:46-55</Citation><ArticleIdList><ArticleId IdType="pubmed">22526104</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Jing Z, Zhao Z, et al. Endovascular stent graft repair of aortic dissection type B extending to the aortic arch. Eur J Vasc Endovasc Surg 2011;42:456-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21788141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Yang HY, Zou JJ, et al. Management with the insufficient proximal landing zone for endovascular repair in aortic dissection. Chin Med J (Engl) 2011;124:3003-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22040544</ArticleId></ArticleIdList></Reference><Reference><Citation>Murashita T, Matsuda H, Domae K, et al. Less invasive surgical treatment for aortic arch aneurysms in high-risk patients: a comparative study of hybrid thoracic endovascular aortic repair and conventional total arch replacement. J Thorac Cardiovasc Surg 2012;143:1007-13</Citation><ArticleIdList><ArticleId IdType="pubmed">21783209</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh HM, Inglese L. Combined surgical and endovascular treatment of aortic arch aneurysms. J Vasc Surg 2006;44:460-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16950417</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo N, Rodriguez-Lopez JA, Heidari P, et al. Hybrid repair of thoracic aortic lesions for zone 0 and 1 in high-risk patients. J Vasc Surg 2012;55:318-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22047829</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigang E, Parker J, Czerny M, et al. Endovascular aortic arch repair after aortic arch de-branching. Ann Thorac Surg 2009;87:603-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19161789</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraki H, Hagl C, Khaladj N, et al. The frozen elephant trunk technique for treatment of thoracic aortic aneurysms. Ann Thorac Surg 2007;83:S819-23; discussion S824-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17257934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Huang F, Xu M, et al. The stented elephant trunk procedure combined total arch replacement for Debakey I aortic dissection: operative result and follow-up. Interact Cardiovasc Thorac Surg 2010;11:594-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20716557</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores J, Kunihara T, Shiiya N, et al. Extensive deployment of the stented elephant trunk is associated with an increased risk of spinal cord injury. J Thorac Cardiovasc Surg 2006;131:336-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16434262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofferberth SC, Newcomb AE, Yii MY, et al. Hybrid proximal surgery plus adjunctive retrograde endovascular repair in acute DeBakey type I dissection: superior outcomes to conventional surgical repair. J Thorac Cardiovasc Surg 2013;145:349-54; discussion 354-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23142120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman A, Damberg AL, Sch&#xe4;lte G, et al. Thoracic stent graft sizing for frozen elephant trunk repair in acute type A dissection. J Thorac Cardiovasc Surg 2013;145:964-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22507842</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim J, Moon MR, Rubin BG, et al. Hybrid repair of distal arch aortic aneurysms: endovascular elephant trunk completion. Ann Vasc Surg 2011;25:598-604</Citation><ArticleIdList><ArticleId IdType="pubmed">21131174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaharada N, Kurimoto Y, Ito T, et al. Hybrid treatment for aortic arch and proximal descending thoracic aneurysm: experience with stent grafting for second-stage elephant trunk repair. Eur J Cardiothorac Surg 2009;36:956-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19589693</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima B, Roselli EE, Soltesz EG, et al. Modified and &#x201c;reverse&#x201d; frozen elephant trunk repairs for extensive disease and complications after stent grafting. Ann Thorac Surg 2012;93:103-9; discussion 109</Citation><ArticleIdList><ArticleId IdType="pubmed">22088418</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi H, Mitsuno M, Tanaka H, et al. Spinal cord injury in patients undergoing total arch replacement: a cautionary note for use of the long elephant technique. J Thorac Cardiovasc Surg 2011;142:1084-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21616508</ArticleId></ArticleIdList></Reference><Reference><Citation>Pochettino A, Brinkman WT, Moeller P, et al. Antegrade thoracic stent grafting during repair of acute DeBakey I dissection prevents development of thoracoabdominal aortic aneurysms. Ann Thorac Surg 2009;88:482-9; discussion 489-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19632398</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi E, Gu T, Yu L, et al. Repair of Stanford type A aortic dissection with ascending aorta and hemiarch replacement combined with stent-graft elephant trunk technique by using innominate cannulation. J Thorac Cardiovasc Surg 2011;142:1458-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21458010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimamura K, Kuratani T, Matsumiya G, et al. Long-term results of the open stent-grafting technique for extended aortic arch disease. J Thorac Cardiovasc Surg 2008;135:1261-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18544367</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimamura K, Kuratani T, Matsumiya G, et al. Hybrid endovascular aortic arch repair using branched endoprosthesis: the second-generation &#x201c;branched&#x201d; open stent-grafting technique. J Thorac Cardiovasc Surg 2009;138:46-52; discussion 52-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19577055</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha M, Pichlmaier M, Martens A, et al. Total aortic arch replacement with a novel four-branched frozen elephant trunk graft: first-in-man results. Eur J Cardiothorac Surg 2013;43:406-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22653445</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida N, Katayama A, Tamura K, et al. Frozen elephant trunk technique and partial remodeling for acute type A aortic dissection. Eur J Cardiothorac Surg 2011;40:1066-71</Citation><ArticleIdList><ArticleId IdType="pubmed">21511488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao HP, Zhu JM, Ma WG, et al. Total arch replacement with stented elephant trunk technique for acute type B aortic dissection involving the aortic arch. Ann Thorac Surg 2012;93:1517-22</Citation><ArticleIdList><ArticleId IdType="pubmed">22443864</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U, Melina G, Angeloni E, et al. Current results of open total arch replacement versus hybrid thoracic endovascular aortic repair for aortic arch aneurysm: a meta-analysis of comparative studies. J Thorac Cardiovasc Surg 2013;145:305-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23040321</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19918168</PMID><DateCompleted><Year>2011</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-3686</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>American journal of therapeutics</Title><ISOAbbreviation>Am J Ther</ISOAbbreviation></Journal><ArticleTitle>Outcomes of nonemergent percutaneous coronary intervention with and without on-site surgical backup: a meta-analysis.</ArticleTitle><Pagination><StartPage>e22</StartPage><EndPage>e28</EndPage><MedlinePgn>e22-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MJT.0b013e3181bc0f5a</ELocationID><Abstract><AbstractText>Despite major advances in percutaneous coronary intervention (PCI) techniques, the current guidelines recommend against elective PCI at hospitals without on-site cardiac surgery backup. Nonetheless, an increasing number of hospitals without on-site cardiac surgery in the United States have developed programs for elective PCI. Studies evaluating outcome in this setting have yielded mixed results, leaving the question unanswered. Hence, a meta-analysis comparing outcomes of nonemergent PCI in hospitals with and without on-site surgical backup was performed. A systematic review of literature identified four studies involving 6817 patients. Three clinical end points were extracted from each study and included in-hospital death, myocardial infarction, and the need for emergency coronary artery bypass grafting. The studies were homogenous for each outcome studied. Therefore, the combined relative risks (RRs) across all the studies and the 95% confidence intervals (CIs) were computed using the Mantel-Haenszel fixed-effect model. A two-sided alpha error less than 0.05 was considered to be statistically significant. Compared with facilities with on-site surgical backup, the risk of in-hospital death (RR, 2.7; CI, 0.6-12.9; P = 0.18), nonfatal myocardial infarction (RR, 1.3; CI, 0.7- 2.2; P = 0.29), and need of emergent coronary artery bypass grafting (RR, 0.46; CI, 0.06- 3.1; P = 0.43) was similar in those lacking on-site surgical backup. The present meta-analysis suggests that there is no difference in the outcome with regard to risk of nonfatal myocardial infarction, need for emergency coronary artery bypass grafting, and the risk of death in patients undergoing elective PCI in hospitals with and without on-site cardiac surgery backup.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Param Puneet</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chicago Medical School, Rosalind Franklin University of Medicine &amp; Science, North Chicago, IL 60064, USA. drparamsingh@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Mukesh</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bedi</LastName><ForeName>Updesh Singh</ForeName><Initials>US</Initials></Author><Author ValidYN="Y"><LastName>Adigopula</LastName><ForeName>Sasikanth</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sarabjeet</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kodumuri</LastName><ForeName>Vamsi</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Molnar</LastName><ForeName>Janos</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Aziz</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Rohit</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Khosla</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ther</MedlineTA><NlmUniqueID>9441347</NlmUniqueID><ISSNLinking>1075-2765</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015906" MajorTopicYN="N">Angioplasty, Balloon, Coronary</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19918168</ArticleId><ArticleId IdType="doi">10.1097/MJT.0b013e3181bc0f5a</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25511567</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Non-radical resection versus bypass procedure for pancreatic cancer - a consecutive series and systematic review.</ArticleTitle><Pagination><StartPage>220</StartPage><EndPage>227</EndPage><MedlinePgn>220-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2014.11.041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(14)01261-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Most survival studies comparing non-radical resections to bypass surgery in patients with pancreatic cancer often do not differentiate between an R1 and R2 resection. The aim of this study was to evaluate whether non-radical R1 and R2 resections have better postoperative outcomes and survival compared to a palliative bypass.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single center cohort study was performed analyzing mortality, morbidity and 1-year survival after R1 (tumor cells within 1&#xa0;mm from the circumferential margin), R2 and bypass surgery in patients with pancreatic cancer. For the systematic review, studies were identified comparing R1 or R2 resections with bypass, in patients with pancreatic cancer. Postoperative outcomes were compared including the cohort study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The cohort study (n=405) showed higher morbidity rates after R1 (n=191) and R2 (n=11) resections compared to bypass (52% and 73% vs. 34%, p&#xa0;&lt;&#xa0;0.01). In-hospital mortality did not differ (overall 1.7%). 1-year survival rates were 71%, 46% and 32% after R1, R2 resection and bypass (p=0.6 between R2 and bypass). The systematic review identified 8 studies, after including the cohort study 1535 patients were analyzed. Increased morbidity after R1-R2 resection (48%) compared to bypass (30-34%) was found. Median survival was 14-18 months after R1 resection vs. 9-13 months after bypass and 8.5-11.5 months after R2 resection vs. 7.5-10.7 months after bypass.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An R2 resection should be avoided in patients with pancreatic cancer due to its poor prognosis. Survival benefit after an R1 resection, as compared to bypass surgery, justifies a resection despite the increased morbidity rate.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tol</LastName><ForeName>J A M G</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: j.tol@amc.uva.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eshuis</LastName><ForeName>W J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besselink</LastName><ForeName>M G H</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Gulik</LastName><ForeName>T M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>O R C</ForeName><Initials>OR</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouma</LastName><ForeName>D J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Surg Oncol. 2016 Apr;42(4):581-3. doi: 10.1016/j.ejso.2015.12.015.</RefSource><PMID Version="1">26868166</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015390" MajorTopicYN="Y">Gastric Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006500" MajorTopicYN="N">Hepatic Duct, Common</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007583" MajorTopicYN="N">Jejunum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="Y">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018365" MajorTopicYN="N">Neoplasm, Residual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="Y">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Oncology</Keyword><Keyword MajorTopicYN="N">Palliative treatment</Keyword><Keyword MajorTopicYN="N">Pancreatic cancer</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25511567</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2014.11.041</ArticleId><ArticleId IdType="pii">S0748-7983(14)01261-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19453310</PMID><DateCompleted><Year>2009</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>6</Issue><PubDate><Year>2009</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis on the effect of dopexamine on in-hospital mortality.</ArticleTitle><Pagination><StartPage>589</StartPage><EndPage>594</EndPage><MedlinePgn>589-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-2044.2009.05896.x</ELocationID><Abstract><AbstractText>The objective of the study was to determine whether dopexamine alters in-hospital mortality. The following databases were searched, Embase (1974-July 2007), Medline (1950-July 2007), CINAHL, PubMed and Cochrane Clinical Register of Controlled Trials (CENTRAL). Two reviewers independently checked the quality of the studies and extracted data. Six randomised controlled trials totalling 935 patients were included. Mortality was not significantly different with dopexamine treatment (relative risk 0.75, 95% confidence interval 0.48-1.18, p = 0.22). In conclusion, dopexamine does not improve in-hospital mortality in patients undergoing major abdominal surgery and in the critically ill.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gopal</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Medicine, New Cross Hospital, Wolverhampton, UK. shameer.gopal@nhs.net</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayakumar</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>P N</ForeName><Initials>PN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000318">Adrenergic beta-Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014665">Vasodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>398E7Z7JB5</RegistryNumber><NameOfSubstance UI="C046318">dopexamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesia. 2009 Jun;64(6):585-8. doi: 10.1111/j.1365-2044.2009.05965.x.</RefSource><PMID Version="1">19453309</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesia. 2009 Nov;64(11):1258; author reply 1259. doi: 10.1111/j.1365-2044.2009.06111.x.</RefSource><PMID Version="1">19825065</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000318" MajorTopicYN="N">Adrenergic beta-Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014665" MajorTopicYN="N">Vasodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>19</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>6</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19453310</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2044.2009.05896.x</ArticleId><ArticleId IdType="pii">ANA5896</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28040677</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-734X</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title><ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery: does the 'obesity paradox' really exist?</ArticleTitle><Pagination><StartPage>817</StartPage><EndPage>828</EndPage><MedlinePgn>817-828</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezw386</ELocationID><Abstract><AbstractText>The paradoxical benefit of obesity, the 'obesity paradox', has been recently identified in surgical populations. Our goal was to evaluate by a systematic review with meta-analysis the prognostic role of body mass index (BMI) and to identify whether the 'obesity paradox' exists in lung cancer surgery. Comprehensive literature retrieval was conducted in PubMed to identify the eligible articles. The odds ratios (OR) and hazard ratios (HR) with the corresponding 95% confidence intervals (CI) were used to synthesize in-hospital and long-term survival outcomes, respectively. The heterogeneity level and publication bias between studies were also estimated. Finally, 25 observational studies with 78 143 patients were included in this review. The pooled analyses showed a significantly better long-term survival rate in patients with higher BMI, but no significant benefit of increased BMI was found for in-hospital morbidity. The pooled analyses also showed that overall morbidity (OR: 0.84; 95% CI: 0.73-0.98; P&#x2009; = &#x2009; 0.025) and in-hospital mortality (OR: 0.78; 95% CI: 0.63-0.98; P&#x2009; = &#x2009; 0.031) were significantly decreased in obese patients. Obesity could be a strong predictor of the favourable long-term prognosis of lung cancer patients (HR: 0.69; 95% CI: 0.56-0.86; P&#x2009; = &#x2009; 0.001). The robustness of these pooled estimates was strong. No publication bias was detected. In summary, obesity has favourable effects on in-hospital outcomes and long-term survival of surgical patients with lung cancer. The 'obesity paradox' does have the potential to exist in lung cancer surgery.</AbstractText><CopyrightInformation>&#xa9; The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuangjiang</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Heng</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lunxu</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Che</LastName><ForeName>Guowei</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Cardiothorac Surg</MedlineTA><NlmUniqueID>8804069</NlmUniqueID><ISSNLinking>1010-7940</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="Y">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013510" MajorTopicYN="N">Pulmonary Surgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Body mass index</Keyword><Keyword MajorTopicYN="N">Lung cancer surgery</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28040677</ArticleId><ArticleId IdType="doi">10.1093/ejcts/ezw386</ArticleId><ArticleId IdType="pii">ezw386</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31487905</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2103</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu11092103</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac surgery is associated with oxidative stress and systemic inflammation, which both contribute to postoperative organ dysfunction. Vitamin C is a pleiotropic, antioxidant, and potentially organ-protective micronutrient. Past clinical trials and meta-analyses have focused predominantly on occurrence of postoperative atrial fibrillation. Therefore, we investigated the influence of perioperative vitamin C administration on clinically relevant parameters closer related to the patient's recovery, especially organ function, and overall outcomes after cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized controlled trials (RCTs) comparing perioperative vitamin C administration versus placebo or standard of care in adult patients undergoing cardiac surgery were identified through systematic searches in Pubmed, EMBASE, and CENTRAL on 23 November 2018. Published and unpublished data were included. Assessed outcomes include organ function after cardiac surgery, adverse events, in-hospital mortality, intensive care unit, and hospital length-of-stay. Data was pooled only when appropriate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19 RCTs with 2008 patients were included in this meta-analysis. Vitamin C significantly decreased the incidence of atrial fibrillation (<i>p</i> = 0.008), ventilation time (<i>p</i> &lt; 0.00001), ICU length-of-stay (<i>p</i> = 0.004), and hospital length-of-stay (<i>p</i> &lt; 0.0001). However, on average, vitamin C had no significant effects on in-hospital mortality (<i>p</i> = 0.76), or on the incidence of stroke (<i>p</i> = 0.82). High statistical heterogeneity was observed in most analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Vitamin C impacts clinically and economically important outcomes, such as ICU and hospital length-of-stay, duration of mechanical ventilation and lowers the incidence of atrial fibrillation. Due to missing reports on organ dysfunction, this meta-analysis cannot answer the question, if vitamin C can improve single- or multiorgan function after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Aileen</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7013-3357</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany. ahill@ukaachen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany. ahill@ukaachen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany. ahill@ukaachen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clasen</LastName><ForeName>Kai C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendt</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majoros</LastName><ForeName>&#xc1;d&#xe1;m G</ForeName><Initials>&#xc1;G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Student of the Medical Faculty RWTH Aachen University, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoppe</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adhikari</LastName><ForeName>Neill K J</ForeName><Initials>NKJ</Initials><Identifier Source="ORCID">0000-0003-4038-5382</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyland</LastName><ForeName>Daren K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, CA K7L 2V7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benstoem</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany. cbenstoem@ukaachen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany. cbenstoem@ukaachen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nutrients. 2020 Dec 21;12(12):E3910. doi: 10.3390/nu12123910.</RefSource><PMID Version="1">33371532</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antioxidant</Keyword><Keyword MajorTopicYN="N">ascorbic acid</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">organ dysfunction</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">reperfusion injury</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">vitamin</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31487905</ArticleId><ArticleId IdType="pmc">PMC6769534</ArticleId><ArticleId IdType="doi">10.3390/nu11092103</ArticleId><ArticleId IdType="pii">nu11092103</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Levy J.H., Tanaka K.A. Inflammatory Response to Cardiopulmonary Bypass. Ann. Thorac. Surg. 2003;75:S715&#x2013;S720. doi: 10.1016/S0003-4975(02)04701-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04701-X</ArticleId><ArticleId IdType="pubmed">12607717</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard H. Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2013;27:983&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">23276596</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis R.C., Brown J.R., Fitzgerald D., Likosky D.S., Shore-Lesserson L., Baker R.A., Hammon J.W. Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: A critical review of the evidence base. J. Extra Corp. Technol. 2014;46:197&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4566828</ArticleId><ArticleId IdType="pubmed">26357785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A., Wendt S., Benstoem C., Neubauer C., Meybohm P., Langlois P., Adhikari N.K., Heyland D.K., Stoppe C. Vitamin c to improve organ dysfunction in cardiac surgery patients-review and pragmatic approach. Nutrients. 2018;10:974. doi: 10.3390/nu10080974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10080974</ArticleId><ArticleId IdType="pmc">PMC6115862</ArticleId><ArticleId IdType="pubmed">30060468</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoppe C., McDonald B., Benstoem C., Elke G., Meybohm P., Whitlock R., Fremes S., Fowler R., Lamarche Y., Jiang X., et al. Evaluation of persistent organ dysfunction plus death as a novel composite outcome in cardiac surgical patients. J. Cardiothorac. Vasc. Anesth. 2016;30:30&#x2013;38. doi: 10.1053/j.jvca.2015.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.07.035</ArticleId><ArticleId IdType="pubmed">26847748</ArticleId></ArticleIdList></Reference><Reference><Citation>Frei B., Stocker R., England L., Ames B.N. Ascorbate: The most effective antioxidant in human blood plasma. Adv. Exp. Med. Biol. 1990;264:155&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">2244489</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudemans-van Straaten H.M., Spoelstra-de Man A.M., de Waard M.C. Vitamin c revisited. Crit. Care. 2014;18:460. doi: 10.1186/s13054-014-0460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0460-x</ArticleId><ArticleId IdType="pmc">PMC4423646</ArticleId><ArticleId IdType="pubmed">25185110</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger M.M., Oudemans-van Straaten H.M. Vitamin c supplementation in the critically ill patient. Curr. Opin. Clin. Nutr. Metab. Care. 2015;18:193&#x2013;201. doi: 10.1097/MCO.0000000000000148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000148</ArticleId><ArticleId IdType="pubmed">25635594</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A.C., Maggini S. Vitamin c and immune function. Nutrients. 2017;9:1211. doi: 10.3390/nu9111211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111211</ArticleId><ArticleId IdType="pmc">PMC5707683</ArticleId><ArticleId IdType="pubmed">29099763</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoelstra-de Man A.M.E., Elbers P.W.G., Oudemans-van Straaten H.M. Making sense of early high-dose intravenous vitamin c in ischemia/reperfusion injury. Crit. Care. 2018;22:70. doi: 10.1186/s13054-018-1996-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-1996-y</ArticleId><ArticleId IdType="pmc">PMC5861638</ArticleId><ArticleId IdType="pubmed">29558975</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker W.L., Coleman C.I. Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery. Am. J. Health Syst. Pharm. 2016;73:2056&#x2013;2066. doi: 10.2146/ajhp160066.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp160066</ArticleId><ArticleId IdType="pubmed">27806938</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos E., Bagos P., Papadimitriou M., Rizos I., Patsouris E., &#x3a4;oumpoulis I. Vitamin c for the prevention of postoperative atrial fibrillation after cardiac surgery: A meta-analysis. Adv. Pharm. Bull. 2016;6:243. doi: 10.15171/apb.2016.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/apb.2016.033</ArticleId><ArticleId IdType="pmc">PMC4961983</ArticleId><ArticleId IdType="pubmed">27478787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemilae H., Suonsyrjae T. Vitamin c for preventing atrial fibrillation in high risk patients: A systematic review and meta-analysis. BMC Cardiovasc. Disord. 2017;17:49. doi: 10.1186/s12872-017-0478-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-017-0478-5</ArticleId><ArticleId IdType="pmc">PMC5286679</ArticleId><ArticleId IdType="pubmed">28143406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Yuan L., Wang H., Li C., Cai J., Hu Y., Ma C. Efficacy and safety of vitamin c for atrial fibrillation after cardiac surgery: A meta-analysis with trial sequential analysis of randomized controlled trials. Int. J. Surg. 2017;37:58&#x2013;64. doi: 10.1016/j.ijsu.2016.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2016.12.009</ArticleId><ArticleId IdType="pubmed">27956113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi R., Li Z.H., Chen D., Wu Q.C., Zhou X.L., Tie H.T. Sole and combined vitamin c supplementation can prevent postoperative atrial fibrillation after cardiac surgery: A systematic review and meta-analysis of randomized controlled trials. Clin. Cardiol. 2018;41:871&#x2013;878. doi: 10.1002/clc.22951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.22951</ArticleId><ArticleId IdType="pmc">PMC6489881</ArticleId><ArticleId IdType="pubmed">29603289</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Green S., editors. Cochrane Handbook for Systematic Reviews of Interventions.  [(accessed on 23 November 2018)];2011  The Cochrane Collaboration. Available online:  http://handbook.cochrane.org.</Citation></Reference><Reference><Citation>Deeks J.J., Higgins J.P.T., Altman D.G. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration and John Wiley &amp; Sons Ltd.; Chichester, England: 2008. [(accessed on 23 November 2018)]. Analysing data and undertaking meta-analyses; pp. 243&#x2013;296. (Cochrane Book Series). Available online:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470712184.ch9</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghpour A., Alizadehasl A., Kyavar M., Sadeghi T., Moludi J., Gholizadeh F., Totonchi Z., Ghadrdoost B. Impact of vitamin c supplementation on post-cardiac surgery icu and hospital length-of-stay. Anesth. Pain Med. 2015;5:e25337. doi: 10.5812/aapm.25337.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/aapm.25337</ArticleId><ArticleId IdType="pmc">PMC4350190</ArticleId><ArticleId IdType="pubmed">25789244</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed K.A.M.D., Hany M.E.M.D., Moataz E.R.M.D., Hani M.M.M.S.C. Role of ascorbic acid in reduction of the incidence of the atrial fibrillation in patients under b-blocker and undergoing coronary artery bypass graft operation in early post-operative period. J. Egypt. Soc. Cardio Thorac. Surg. 2017;25:198&#x2013;203.</Citation></Reference><Reference><Citation>Bakr H., Elsayegh T., Fatah M.A.E. Role of ascorbic acid and statin in reduction of the incidence of the atrial fibrillation in patients under b-blocker and undergoing coronary artery bypass graft operation in early post-operative period. J. Saudi Heart Assoc. 2015;27:299&#x2013;300. doi: 10.1016/j.jsha.2015.05.183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsha.2015.05.183</ArticleId></ArticleIdList></Reference><Reference><Citation>Healy R.M., Day D., van Gorder C. Ascorbic acid utilization for atrial-fibrillation prophylaxis post coronary-artery-bypass graft and valve replacement surgeries: An interim analysis of a prospective, randomized study. Pharmacotherapy. 2010;30:445e&#x2013;446e.</Citation></Reference><Reference><Citation>Van Wagoner D.R., Palumbo R., Li J., Carnes C.A., Gillinov A., McCarthy P.M., Chung M.K. Supplemental Vitamin C Did Not Reduce the Incidence of Atrial Arrhythmia following Cardiac Bypass Surgery.  [(accessed on 4 December 2016)];Heart Rhythm Soc. 2003  Available online:  http://www.mv.helsinki.fi/home/hemila/CAF/vanWagoner2003.pdf.</Citation></Reference><Reference><Citation>Antonic M., Lipovec R., Gregorcic F., Juric P., Kosir G. Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients. J. Cardiol. 2016;69:98&#x2013;102. doi: 10.1016/j.jjcc.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2016.01.010</ArticleId><ArticleId IdType="pubmed">26917198</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonic M. Effect of ascorbic acid on postoperative acute kidney injury in coronary artery bypass graft patients: A pilot study. Heart Surg. Forum. 2017;20:E214&#x2013;E218. doi: 10.1532/hsf.1811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/hsf.1811</ArticleId><ArticleId IdType="pubmed">29087285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjordahl P.M., Helmer S.D., Gosnell D.J., Wemmer G.E., O&#x2019;Hara W.W., Milfeld D.J. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am. J. Surg. 2012;204:862&#x2013;867. doi: 10.1016/j.amjsurg.2012.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2012.03.012</ArticleId><ArticleId IdType="pubmed">23022248</ArticleId></ArticleIdList></Reference><Reference><Citation>Colby J.A., Chen W.T., Baker W.L., Coleman C.I., Reinhart K., Kluger J., White C.M. Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. Am. J. Health Syst. Pharm. 2011;68:1632&#x2013;1639. doi: 10.2146/ajhp100703.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp100703</ArticleId><ArticleId IdType="pubmed">21856809</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani M.R., Majidi N., Rahmani A., Asgari B., Rezaei Y. Effect of oral vitamin c on atrial fibrillation development after isolated coronary artery bypass grafting surgery: A prospective randomized clinical trial. Cardiol. J. 2014;21:492&#x2013;499. doi: 10.5603/CJ.a2013.0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2013.0154</ArticleId><ArticleId IdType="pubmed">24293167</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirag K., Askar F.Z., Uyar M., Cevik A., Ozmen D., Mutaf I., Bayindir O. The protective effects of high dose ascorbic acid and diltiazem on myocardial ischaemia-reperfusion injury. Middle East J. Anaesthesiol. 2001;16:67&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">11281049</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan P.C., Kramer R.S. Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery, nct00953212.  [(accessed on 23 November 2018)];ClinicalTrials.Gov. 2012  Available online:  https://clinicaltrials.gov/ct2/show/NCT00953212.</Citation></Reference><Reference><Citation>Eslami M., Badkoubeh R.S., Mousavi M., Radmehr H., Salehi M., Tavakoli N., Avadi M.R. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex. Heart Inst. J. 2007;34:268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1995047</ArticleId><ArticleId IdType="pubmed">17948074</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouybar R., Kabgani H., Kamalipour H., Shahbazi S., Allahyary E., Rasouli M., Akhlagh S.H., Shafa M., Ghazinoor M., Moeinvaziri M.T., et al. The perioperative effect of ascorbic acid on inflammatory response in coronary artery bypass graft surgery; a randomized controlled trial coronary artery bypass graft surgery. Int. Cardiovasc. Res. J. 2012;6:13&#x2013;17.</Citation></Reference><Reference><Citation>Knodell R.G., Tate M.A., Akl B.F., Wilson J.W. Vitamin c prophylaxis for posttransfusion hepatitis: Lack of effect in a controlled trial. Am. J. Clin. Nutr. 1981;34:20&#x2013;23. doi: 10.1093/ajcn/34.1.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/34.1.20</ArticleId><ArticleId IdType="pubmed">7446455</ArticleId></ArticleIdList></Reference><Reference><Citation>Papoulidis P., Ananiadou O., Chalvatzoulis E., Ampatzidou F., Koutsogiannidis C., Karaiskos T., Madesis A., Drossos G. The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: A single-center experience&#x2013;a pilot study. Interact. Cardiovasc. Thorac. Surg. 2011;12:121&#x2013;124. doi: 10.1510/icvts.2010.240473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.240473</ArticleId><ArticleId IdType="pubmed">21098510</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos E. Vitamin C for Prophylaxis of Post-Operative Atrial Fibrillation in on-Pump Cardiac Surgery Procedures, nct01107730.  [(accessed on 23 November 2018)];ClincalTrials Gov. 2015  Available online:  https://clinicaltrials.gov/ct2/show/NCT00953212.</Citation></Reference><Reference><Citation>Safaei N., Babaei H., Azarfarin R., Jodati A.R., Yaghoubi A., Sheikhalizadeh M.A. Comparative effect of grape seed extract (vitis vinifera) and ascorbic acid in oxidative stress induced by on-pump coronary artery bypass surgery. Ann. Cardiac. Anaesth. 2017;20:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5290695</ArticleId><ArticleId IdType="pubmed">28074795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarzaeem M., Shayan N. Vitamin c in prevention of atrial fibrillation after coronary artery bypass graft: Double blind randomized clinical trial. Tehran Univ. Med. J. 2014;71:2014.</Citation></Reference><Reference><Citation>Geng J., Qian J., Si W., Cheng H., Ji F., Shen Z. The clinical benefits of perioperative antioxidant vitamin therapy in patients undergoing cardiac surgery: A meta-analysis. Interact. Cardiovasc. Thoracic. Surg. 2017;25:966&#x2013;974. doi: 10.1093/icvts/ivx178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx178</ArticleId><ArticleId IdType="pubmed">28645181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemilae H. Vitamin c and infections. Nutrients. 2017;9:339. doi: 10.3390/nu9040339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9040339</ArticleId><ArticleId IdType="pmc">PMC5409678</ArticleId><ArticleId IdType="pubmed">28353648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali-Hassan-Sayegh S., Mirhosseini S.J., Rezaeisadrabadi M., Dehghan H.R., Sedaghat-Hamedani F., Kayvanpour E., Popov A.F., Liakopoulos O.J. Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: An updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials. Interact. Cardiovasc. Thoracic. Surg. 2014;18:646&#x2013;654. doi: 10.1093/icvts/ivu020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu020</ArticleId><ArticleId IdType="pubmed">24556447</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoppe C., Ney J., Lomivorotov V.V., Efremov S.M., Benstoem C., Hill A., Nesterova E., Laaf E., Goetzenich A., McDonald B., et al. Prediction of prolonged icu stay in cardiac surgery patients as a useful method to identify nutrition risk in cardiac surgery patients: A post hoc analysis of a prospective observational study. JPEN. J. Parenter. Enteral Nutr. 2019;43:768&#x2013;779. doi: 10.1002/jpen.1486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.1486</ArticleId><ArticleId IdType="pmc">PMC7379574</ArticleId><ArticleId IdType="pubmed">30506711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali- Hasan- Al- Saegh S., Mirhosseini S.J., Tahernejad M., Mahdavi P., Shahidzadeh A., Karimi-Bondarabadi A.A., Dehghan A.M., Rahimizadeh E., Haddad F., Ghodratipour Z., et al. Impact of antioxidant supplementations on cardio-renal protection in cardiac surgery: An updated and comprehensive meta-analysis and systematic review. Cardiovasc. Ther. 2016;34:360&#x2013;370. doi: 10.1111/1755-5922.12207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12207</ArticleId><ArticleId IdType="pubmed">27344977</ArticleId></ArticleIdList></Reference><Reference><Citation>Baines M., Shenkin A. Use of antioxidants in surgery: A measure to reduce postoperative complications. Curr. Opin. Clin. Nutr. Metab. Care. 2002;5:665&#x2013;670. doi: 10.1097/00075197-200211000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00075197-200211000-00009</ArticleId><ArticleId IdType="pubmed">12394642</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnes C.A., Chung M.K., Nakayama T., Nakayama H., Baliga R.S., Piao S., Kanderian A., Pavia S., Hamlin R.L., McCarthy P.M., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 2001;89:e32&#x2013;e38. doi: 10.1161/hh1801.097644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hh1801.097644</ArticleId><ArticleId IdType="pubmed">11557745</ArticleId></ArticleIdList></Reference><Reference><Citation>Das D., Sen C., Goswami A. Effect of vitamin c on adrenal suppression by etomidate induction in patients undergoing cardiac surgery: A randomized controlled trial. Ann. Car. Anaesth. 2016;19:410. doi: 10.4103/0971-9784.185522.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.185522</ArticleId><ArticleId IdType="pmc">PMC4971968</ArticleId><ArticleId IdType="pubmed">27397444</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingchao H., Zhiduan Q., Liye H., Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac. Cardiovasc. Surg. 1994;42:276&#x2013;278. doi: 10.1055/s-2007-1016504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1016504</ArticleId><ArticleId IdType="pubmed">7863489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebade A., Taha W.S., Saleh R.H., Fawzy F. Ascorbic acid versus magnesium for the prevention of atrial fibrillation after coronary artery bypass grafting surgery. Egypt. J. Cardiothorac. Anesth. 2014;8:59. doi: 10.4103/1687-9090.143259.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1687-9090.143259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Benjo A.M., Pamidimukala C.K., Javed F., Garcia W., Macedo F.Y., Garcia D.C., Santana O., Nascimeto F.O., Pierce M., et al. Vitamin c decreases atrial fibrillation in cardiac surgery patients but vitamin e may decrease response: A randomized-controlled trial meta-analysis. Circ. Cardiovasc. Qual. Outcomes. 2013;6 doi: 10.1161/circoutcomes.6.suppl_1.A288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circoutcomes.6.suppl_1.A288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.C. Changes of creatine phosphokinase and malondialdehyde in the serum and clinical use of large doses of vitamin c following open heart surgery. Zhonghua Wai Ke Za zhi [Chin. J. Surg.] 1990;28:16&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">2364809</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Li G. Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation. Int. J. Cardiol. 2010;145:140&#x2013;142. doi: 10.1016/j.ijcard.2009.06.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2009.06.054</ArticleId><ArticleId IdType="pubmed">19616323</ArticleId></ArticleIdList></Reference><Reference><Citation>Moludi J., Keshavarz S., Pakzad R., Sedghi N., Sadeghi T., Alimoradi F. Effect of vitamin c supplementation in the prevention of atrial fibrillation. Tehran Univ. Med. J. 2016;73:791&#x2013;797.</Citation></Reference><Reference><Citation>Oktar G.L., Sinci V., Kalaycioglu S., Soncul H., G&#xf6;kg&#xf6;z L., Halit V., Ers&#xf6;z A. Biochemical and hemodynamic effects of ascorbic acid and alpha-tocopherol in coronary artery surgery. Scand. J. Clin. Lab. Invest. 2001;61:621&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">11768322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasoli S., Kourliouros A., Harling L., Athanasiou T. Does prophylactic therapy with antioxidant vitamins have an effect on atrial fibrillation following cardiac surgery? Interact. Cardiovasc. Thorac. Surg. 2011;13:82&#x2013;85. doi: 10.1510/icvts.2011.268326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2011.268326</ArticleId><ArticleId IdType="pubmed">21525032</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo R., Cereceda M., Castillo R., Asenjo R., Zamorano J., Araya J., Castillo-Koch R., Espinoza J., Larra&#xed;n E. Prevention of atrial fibrillation following cardiac surgery: Basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol. Ther. 2008;118:104&#x2013;127. doi: 10.1016/j.pharmthera.2008.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2008.01.005</ArticleId><ArticleId IdType="pubmed">18346791</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo R., Cereceda M., Castillo R., Asenjo R., Zamorano J., Araya J., Castillo-Koch R., Espinoza J., Larra&#xed;n E. Use of vitamins c and e as a prophylactic therapy to prevent postoperative atrial fibrillation. Int. J. Cardiol. 2009;138:221&#x2013;228. doi: 10.1016/j.ijcard.2009.04.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2009.04.043</ArticleId><ArticleId IdType="pubmed">19446899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebrova T.I., Shipulin V.M., Afanas&#x2019;ev S.A., Vorob&#x2019;eva E.V., Ki&#x12d;ko O.G. The experience of the application of ascorbinic acid as antioxidant after coronary artery surgery with use of cardiopulmonary bypass. Kardiologiia. 2012;52:73&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">22839718</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto T., Paajanen H., Mets&#xe4;-Ketel&#xe4; T., Harmoinen A., Nordback I., Tarkka M. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann. Thorac. Surg. 1995;59:1519&#x2013;1523. doi: 10.1016/0003-4975(95)00197-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(95)00197-S</ArticleId><ArticleId IdType="pubmed">7771834</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadikhah J., Golzari S.E.J., Sabermarouf B., karimzadeh I., Tizro P., Khanli H.M., Ghabili K. Efficacy of combination therapy of statin and vitamin c in comparison with statin in the prevention of post-cabg atrial fibrillation. Adv. Pharm. Bull. 2014;4:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3885376</ArticleId><ArticleId IdType="pubmed">24409416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37200964</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Postoperative short-term mortality between insulin-treated and non-insulin-treated patients with diabetes after non-cardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1142490</StartPage><MedlinePgn>1142490</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1142490</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2023.1142490</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Diabetes mellitus is an independent risk factor for postoperative complications. It has been reported that insulin-treated diabetes is associated with increased postoperative mortality compared to non-insulin-treated diabetes after cardiac surgery; however, it is unclear whether this finding is applicable to non-cardiac surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">We aimed to assess the effects of insulin-treated and non-insulin-treated diabetes on short-term mortality after non-cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Our study was a systematic review and meta-analysis of observational studies. PubMed, CENTRAL, EMBASE, and ISI Web of Science databases were searched from inception to February 22, 2021. Cohort or case-control studies that provided information on postoperative short-term mortality in insulin-treated diabetic and non-insulin-treated diabetic patients were included. We pooled the data with a random-effects model. The Grading of Recommendations, Assessment, Development, and Evaluation system was used to rate the quality of evidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Twenty-two cohort studies involving 208,214 participants were included. Our study suggested that insulin-treated diabetic patients was associated with a higher risk of 30-day mortality than non-insulin-treated diabetic patients [19 studies with 197,704 patients, risk ratio (RR) 1.305; 95% confidence interval (CI), 1.127 to 1.511; <i>p</i> &lt; 0.001]. The studies were rated as very low quality. The new pooled result only slightly changed after seven simulated missing studies were added using the trim-and-fill method (RR, 1.260; 95% CI, 1.076-1.476; <i>p</i> = 0.004). Our results also showed no significant difference between insulin-treated diabetes and non-insulin-treated diabetes regarding in-hospital mortality (two studies with 9,032 patients, RR, 0.970; 95% CI, 0.584-1.611; <i>p</i> = 0.905).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Very-low-quality evidence suggests that insulin-treated diabetes was associated with increased 30-day mortality after non-cardiac surgery. However, this finding is non-definitive because of the influence of confounding factors.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021246752, identifier: CRD42021246752.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Jiang, Wang, Sun, Zhao, Zhou, Bi, Luo and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Jiang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rao</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yilin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Jiangjiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ailin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shiyong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">hypoglycemic regimens</Keyword><Keyword MajorTopicYN="N">insulin</Keyword><Keyword MajorTopicYN="N">non-cardiac surgery</Keyword><Keyword MajorTopicYN="N">postoperative mortality</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>16</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37200964</ArticleId><ArticleId IdType="pmc">PMC10185903</ArticleId><ArticleId IdType="doi">10.3389/fmed.2023.1142490</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nyberg ST, Fransson EI, Heikkila K, Ahola K, Alfredsson L, Bjorner JB, et al. . Job strain as a risk factor for type 2 diabetes: a pooled analysis of 124,808 men and women. Diabetes Care. (2014) 37:2268&#x2013;75. 10.2337/dc13-2936</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-2936</ArticleId><ArticleId IdType="pmc">PMC4113178</ArticleId><ArticleId IdType="pubmed">25061139</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser JC, Provenzano B, Mongkolpun W, Halenarova K, Cnop M. Perioperative management of oral glucose-lowering drugs in the patient with type 2 diabetes. Anesthesiology. (2020) 133:430&#x2013;8. 10.1097/ALN.0000000000003237</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003237</ArticleId><ArticleId IdType="pubmed">32667156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. (2012) 380:2095&#x2013;128. 10.1016/S0140-6736(12)61728-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61728-0</ArticleId><ArticleId IdType="pmc">PMC10790329</ArticleId><ArticleId IdType="pubmed">23245604</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. . IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. (2018) 138:271&#x2013;81. 10.1016/j.diabres.2018.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2018.02.023</ArticleId><ArticleId IdType="pubmed">29496507</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AH, Mitchell AE, Mitchell IM, A. 15-year study of the changing demographics and infection risk in a new UK cardiac surgery unit. Interact Cardiovasc Thorac Surg. (2012) 15:390&#x2013;4. 10.1093/icvts/ivs278</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivs278</ArticleId><ArticleId IdType="pmc">PMC3422967</ArticleId><ArticleId IdType="pubmed">22718465</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman JD, Wilcox T, Smilowitz NR, Berger JS. Influence of diabetes on trends in perioperative cardiovascular events. Diabetes Care. (2018) 41:1268&#x2013;74. 10.2337/dc17-2046</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-2046</ArticleId><ArticleId IdType="pmc">PMC5961401</ArticleId><ArticleId IdType="pubmed">29618572</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannini P, Ciavarella A, Olmi R, Flammini M, Moroni A, Galuppi V, et al. . Diabetes as pro-infective risk factor in total hip replacement. Acta Diabetol Lat. (1984) 21:275&#x2013;80. 10.1007/BF02642901</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02642901</ArticleId><ArticleId IdType="pubmed">6516693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Muir R, Johnston R, Carter E, Bowden G, Wilson-MacDonald J. Diabetes is predictive of longer hospital stay and increased rate of complications in spinal surgery in the UK. Ann R Coll Surg Engl. (2013) 95:275&#x2013;9. 10.1308/003588413X13511609958299</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/003588413X13511609958299</ArticleId><ArticleId IdType="pmc">PMC4132503</ArticleId><ArticleId IdType="pubmed">23676813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-de-Andres A, Hernandez-Barrera V, Martinez-Huedo MA, Villanueva-Martinez M, Jimenez-Trujillo I, Jimenez-Garcia R. Type 2 diabetes and in-hospital complications after revision of total hip and knee arthroplasty. PLoS ONE. (2017) 12:e0183796. 10.1371/journal.pone.0183796</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183796</ArticleId><ArticleId IdType="pmc">PMC5570305</ArticleId><ArticleId IdType="pubmed">28837689</ArticleId></ArticleIdList></Reference><Reference><Citation>Worley N, Buza J, Jalai CM, Poorman GW, Day LM, Vira S, et al. . Diabetes as an independent predictor for extended length of hospital stay and increased adverse post-operative events in patients treated surgically for cervical spondylotic myelopathy. Int J Spine Surg. (2017) 11:10. 10.14444/4010</Citation><ArticleIdList><ArticleId IdType="doi">10.14444/4010</ArticleId><ArticleId IdType="pmc">PMC5537976</ArticleId><ArticleId IdType="pubmed">28765794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzetti RM, Lupariello D, Venditto T, Guzzini M, Ponzo A, De Carli A, et al. . The role of diabetes mellitus and BMI in the surgical treatment of ankle fractures. Diabetes Metab Res Rev. (2018) 34. 10.1002/dmrr.2954</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.2954</ArticleId><ArticleId IdType="pubmed">29031012</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JW, Ahn J, Raspovic KM, Liu GT, Nakonezny PA, Lavery LA, et al. . Increased rates of readmission, reoperation, and mortality following open reduction and internal fixation of ankle fractures are associated with diabetes mellitus. J Foot Ankle Surg. (2019) 58:470&#x2013;4. 10.1053/j.jfas.2018.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jfas.2018.09.023</ArticleId><ArticleId IdType="pubmed">30760411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-de-Andres A, Perez-Farinos N, de Miguel-Diez J, Hernandez-Barrera V, Jimenez-Trujillo I, Mendez-Bailon M, et al. . Type 2 diabetes and postoperative pneumonia: An observational, population-based study using the Spanish Hospital Discharge Database, 2001-2015. PLoS ONE. (2019) 14:e0211230. 10.1371/journal.pone.0211230</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0211230</ArticleId><ArticleId IdType="pmc">PMC6364970</ArticleId><ArticleId IdType="pubmed">30726277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma CM, Liu Q, Li ML Ji MJ, Zhang JD, Zhang BH, et al. . The effects of type 2 diabetes and postoperative pneumonia on the mortality in inpatients with surgery. Diabetes Metab Syndr Obes. (2019) 12:2507&#x2013;13. 10.2147/DMSO.S232039</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S232039</ArticleId><ArticleId IdType="pmc">PMC6890188</ArticleId><ArticleId IdType="pubmed">31819576</ArticleId></ArticleIdList></Reference><Reference><Citation>Golinvaux NS, Varthi AG, Bohl DD, Basques BA, Grauer JN. Complication rates following elective lumbar fusion in patients with diabetes: insulin dependence makes the difference. Spine. (2014) 39:1809&#x2013;16. 10.1097/BRS.0000000000000506</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000000506</ArticleId><ArticleId IdType="pubmed">25010098</ArticleId></ArticleIdList></Reference><Reference><Citation>Traven SA, Reeves RA, Walton ZJ, Woolf SK, Slone HS. Insulin dependence is associated with increased medical complications and mortality after shoulder arthroscopy. Arthroscopy. (2019) 35:1316&#x2013;21. 10.1016/j.arthro.2018.11.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2018.11.059</ArticleId><ArticleId IdType="pubmed">30979624</ArticleId></ArticleIdList></Reference><Reference><Citation>Munnee K, Bundhun PK, Quan H, Tang Z. Comparing the clinical outcomes between insulin-treated and non-insulin-treated patients with type 2 diabetes mellitus after coronary artery bypass surgery: a systematic review and meta-analysis. Medicine. (2016) 95:e3006. 10.1097/MD.0000000000003006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003006</ArticleId><ArticleId IdType="pmc">PMC4998895</ArticleId><ArticleId IdType="pubmed">26962814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundhun PK Li N, Chen MH. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis. Cardiovasc Diabetol. (2015) 14:135. 10.1186/s12933-015-0300-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0300-6</ArticleId><ArticleId IdType="pmc">PMC4597459</ArticleId><ArticleId IdType="pubmed">26446829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolliger D, Seeberger MD, Lurati Buse G, Christen P, Seeberger E, Ruppen W, et al. . The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study. Anaesthesia. (2012) 67:149&#x2013;57. 10.1111/j.1365-2044.2011.06963.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2011.06963.x</ArticleId><ArticleId IdType="pubmed">22066687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. . Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. (1999) 100:1043&#x2013;9. 10.1161/01.CIR.100.10.1043</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.100.10.1043</ArticleId><ArticleId IdType="pubmed">10477528</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamanos E, Sivrikoz E, Beale E, Chan L, Inaba K, Demetriades D. Effect of diabetes on outcomes in patients undergoing emergent cholecystectomy for acute cholecystitis. World J Surg. (2013) 37:2257&#x2013;64. 10.1007/s00268-013-2086-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-013-2086-6</ArticleId><ArticleId IdType="pubmed">23677561</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu A, Wei C, Robinson HN, Sobrio SA, Liu J, Sculco TP, et al. . Postoperative complications and impact of diabetes mellitus severity on revision total knee arthroplasty. J Knee Surg. (2020) 33:228&#x2013;34. 10.1055/s-0038-1677542</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1677542</ArticleId><ArticleId IdType="pubmed">30650440</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard-Murali S, Nasser H, Ivanics T, Shakaroun D, Genaw J. Perioperative outcomes of Roux-en-Y gastric bypass and sleeve gastrectomy in patients with diabetes mellitus: an analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database. Obes Surg. (2020) 30:111&#x2013;8. 10.1007/s11695-019-04175-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-019-04175-x</ArticleId><ArticleId IdType="pmc">PMC7223599</ArticleId><ArticleId IdType="pubmed">31598899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanninen M, McAlister FA, Bakal JA, van Diepen S, Ezekowitz JA. Neither diabetes nor glucose-lowering drugs are associated with mortality after noncardiac surgery in patients with coronary artery disease or heart failure. Can J Cardiol. (2013) 29:423&#x2013;8. 10.1016/j.cjca.2012.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2012.07.004</ArticleId><ArticleId IdType="pubmed">22985785</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeger RV, Seeberger MD, Keller U, Pfisterer ME, Filipovic M. Oral hypoglycemics: increased postoperative mortality in coronary risk patients. Cardiology. (2007) 107:296&#x2013;301. 10.1159/000099065</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000099065</ArticleId><ArticleId IdType="pubmed">17264509</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh C-C, Liao C-C, Chang Y-C, Jeng L-B, Yang H-R, Shih C-C, et al. . Adverse outcomes after noncardiac surgery in patients with diabetes: a nationwide population-based retrospective cohort study. Diabetes Care. (2013) 36:3216&#x2013;21. 10.2337/dc13-0770</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-0770</ArticleId><ArticleId IdType="pmc">PMC3781492</ArticleId><ArticleId IdType="pubmed">23990518</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. (2000) 283:2008&#x2013;12. 10.1001/jama.283.15.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells BS, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed February 1, 2021).</Citation></Reference><Reference><Citation>Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. (2011) 106:1911&#x2013;21; quiz 22. 10.1038/ajg.2011.301</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2011.301</ArticleId><ArticleId IdType="pmc">PMC3741453</ArticleId><ArticleId IdType="pubmed">21912438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zhang D, Feng N, Chen G, Liu J, Chen G, et al. . Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis. Gastroenterology. (2014) 147:1031&#x2013;42. 10.1053/j.gastro.2014.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2014.08.005</ArticleId><ArticleId IdType="pubmed">25127680</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. (2000) 56:455&#x2013;63. 10.1111/j.0006-341X.2000.00455.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0006-341X.2000.00455.x</ArticleId><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al. . Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. (2004) 4:38. 10.1186/1472-6963-4-38</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-4-38</ArticleId><ArticleId IdType="pmc">PMC545647</ArticleId><ArticleId IdType="pubmed">15615589</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelrod DA, Upchurch GR Jr, DeMonner S, Stanley JC, Khuri S, Daley J, et al. . Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. J Vasc Surg. (2002) 35:894&#x2013;901. 10.1067/mva.2002.123681</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mva.2002.123681</ArticleId><ArticleId IdType="pubmed">12021704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallaert JB, Nolan BW, Adams J, Stanley AC, Eldrup-Jorgensen J, Cronenwett JL, et al. . The impact of diabetes on postoperative outcomes following lower-extremity bypass surgery. J Vasc Surg. (2012) 56:1317&#x2013;23. 10.1016/j.jvs.2012.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2012.04.011</ArticleId><ArticleId IdType="pmc">PMC3564014</ArticleId><ArticleId IdType="pubmed">22819754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker EJ, Valentijn TM, van de Luijtgaarden KM, Hoeks SE, Voute MT, Goncalves FB, et al. . Type 2 diabetes mellitus, independent of insulin use, is associated with an increased risk of cardiac complications after vascular surgery. Anaesth Intens Care. (2013) 41:584&#x2013;90. 10.1177/0310057X1304100515</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1304100515</ArticleId><ArticleId IdType="pubmed">23977908</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio S, Clements JM, Grauf D, Merchant AM. Outcomes of diabetic and nondiabetic patients undergoing general and vascular surgery. ISRN Surg. (2013) 2013:963930. 10.1155/2013/963930</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/963930</ArticleId><ArticleId IdType="pmc">PMC3888764</ArticleId><ArticleId IdType="pubmed">24455308</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Vaca E, Lovecchio F, Ver Halen JP, Hansen NM, Kim JY. Differential impact of non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus on breast reconstruction outcomes. Breast Cancer Res Treat. (2014) 146:429&#x2013;38. 10.1007/s10549-014-3024-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-014-3024-5</ArticleId><ArticleId IdType="pubmed">24961932</ArticleId></ArticleIdList></Reference><Reference><Citation>Haltmeier T, Benjamin E, Beale E, Inaba K, Demetriades D. Insulin-treated patients with diabetes mellitus undergoing emergency abdominal surgery have worse outcomes than patients treated with oral agents. World J Surg. (2016) 40:1575&#x2013;82. 10.1007/s00268-016-3469-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-016-3469-2</ArticleId><ArticleId IdType="pubmed">26913730</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Souza J, Aggarwal A, Kim JY. Insulin dependence as an independent predictor of perioperative morbidity after ventral hernia repair: a National Surgical Quality Improvement Program analysis of 45,759 patients. Am J Surg. (2016) 211:11&#x2013;7. 10.1016/j.amjsurg.2014.08.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2014.08.046</ArticleId><ArticleId IdType="pubmed">26542188</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu MC, Boddapati V, Dines DM, Warren RF, Dines JS, Gulotta LV. The impact of insulin dependence on short-term postoperative complications in diabetic patients undergoing total shoulder arthroplasty. J Shoulder Elbow Surg. (2017) 26:2091&#x2013;6. 10.1016/j.jse.2017.05.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2017.05.027</ArticleId><ArticleId IdType="pubmed">28739297</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson DC, Shin JI, Andelman SM, Olujimi V, Parsons BO. Increased risk of 30-day postoperative complications for diabetic patients following open reduction-internal fixation of proximal humerus fractures: an analysis of 1391 patients from the American College of Surgeons National Surgical Quality Improvement Program database. JSES Open Access. (2017) 1:19&#x2013;24. 10.1016/j.jses.2017.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jses.2017.03.006</ArticleId><ArticleId IdType="pmc">PMC6340826</ArticleId><ArticleId IdType="pubmed">30675534</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan K, Kim JS, Lee N, Kothari P, Cho SK. Impact of insulin dependence on perioperative outcomes following anterior cervical discectomy and fusion. Spine. (2017) 42:456&#x2013;64. 10.1097/BRS.0000000000001829</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000001829</ArticleId><ArticleId IdType="pubmed">27488292</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb ML, Golinvaux NS, Ibe IK, Bovonratwet P, Ellman MS, Grauer JN. Comparison of perioperative adverse event rates after total knee arthroplasty in patients with diabetes: insulin dependence makes a difference. J Arthroplasty. (2017) 32:2947&#x2013;51. 10.1016/j.arth.2017.04.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2017.04.032</ArticleId><ArticleId IdType="pubmed">28559194</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Capua J, Lugo-Fagundo N, Somani S, Kim JS, Phan K, Lee NJ, et al. . Diabetes mellitus as a risk factor for acute postoperative complications following elective adult spinal deformity surgery. Global Spine J. (2018) 8:615&#x2013;21. 10.1177/2192568218761361</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568218761361</ArticleId><ArticleId IdType="pmc">PMC6125929</ArticleId><ArticleId IdType="pubmed">30202716</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepan JG, Boddapati V, Sacks HA, Fu MC, Osei DA, Fufa DT. Insulin dependence is associated with increased risk of complications after upper extremity surgery in diabetic patients. J Hand Surg Am. (2018) 43:745&#x2013;54 e4. 10.1016/j.jhsa.2018.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhsa.2018.06.006</ArticleId><ArticleId IdType="pubmed">29954628</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothof AB, O'Donnell TFX, Swerdlow NJ, Liang P, Li C, Varkevisser RRB, et al. . Risk of insulin-dependent diabetes mellitus in patients undergoing carotid endarterectomy. J Vasc Surg. (2019) 69:814&#x2013;23. 10.1016/j.jvs.2018.05.250</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2018.05.250</ArticleId><ArticleId IdType="pubmed">30714571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamidi IS Li L, Jones JW, Lee R, Rana MS, Reilly BK. Impact of diabetes mellitus following tonsillectomy in adults: A National Surgical Quality Improvement Program Analysis. Ann Otol Rhinol Laryngol. (2021) 130:682&#x2013;8. 10.1177/0003489420967041</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003489420967041</ArticleId><ArticleId IdType="pubmed">33094637</ArticleId></ArticleIdList></Reference><Reference><Citation>Selemon NA, Gu A, Malahias MA, Fassihi SC, Chen AZ, Adriani M, et al. . Insulin-dependent diabetes mellitus is an independent risk factor for postoperative complications in aseptic revision total hip arthroplasty. Hip Int. (2022) 32:213&#x2013;20. 10.1177/1120700020945221</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1120700020945221</ArticleId><ArticleId IdType="pubmed">32750266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kebaish KJ, Puvanesarajah V, Rao S, Zhang B, Ottesen TD, Grauer JN, et al. . Diabetes status affects odds of body mass index-dependent adverse outcomes after total hip arthroplasty. J Am Acad Orthop Surg. (2021) 29:71&#x2013;7. 10.5435/JAAOS-D-20-00028</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-20-00028</ArticleId><ArticleId IdType="pubmed">32404681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TC, Lee YL, Chen JC, Chen CH, Ho PS. Impact of type 2 diabetes on postoperative outcome after hip fracture: nationwide population-based study in Taiwan. BMJ Open Diabetes Res Care. (2020) 8:e000843. 10.1136/bmjdrc-2019-000843</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2019-000843</ArticleId><ArticleId IdType="pmc">PMC7039587</ArticleId><ArticleId IdType="pubmed">32086279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting CT, Chen RC, Chen CC, Liu MH, Chu D, Kuo NW. Diabetes worsens the surgical outcomes in cirrhotic patients with hepatocellular carcinoma. Tohoku J Exp Med. (2012) 227:73&#x2013;81. 10.1620/tjem.227.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1620/tjem.227.73</ArticleId><ArticleId IdType="pubmed">22688467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortved M, Petersen PB, Jorgensen CC, Kehlet H, Lundbeck Foundation Centre for Fast-track H, Knee Replacement Collaborative Group. Postoperative morbidity and mortality in diabetic patients after fast-track hip and knee arthroplasty: a prospective follow-up cohort of 36,762 procedures. Anesth Analg. (2021) 133:115&#x2013;22. 10.1213/ANE.0000000000005248</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005248</ArticleId><ArticleId IdType="pubmed">33234944</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi C, Miccoli R, Daniele G, Penno G, Del Prato S. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes Diabetes Care. (2009) 32(Suppl. 2):S342&#x2013;8. 10.2337/dc09-S336</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-S336</ArticleId><ArticleId IdType="pmc">PMC2811446</ArticleId><ArticleId IdType="pubmed">19875578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassem SA, Raz I. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity or mortality? No Diabetes Care. (2009) 32(Suppl. 2):S337&#x2013;41. 10.2337/dc09-S335</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-S335</ArticleId><ArticleId IdType="pmc">PMC2811474</ArticleId><ArticleId IdType="pubmed">19875577</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, Ding X, Li L, Wang T, Kan Q, Wang L, et al. . Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Crit Care. (2019) 23:50. 10.1186/s13054-019-2346-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2346-4</ArticleId><ArticleId IdType="pmc">PMC6379943</ArticleId><ArticleId IdType="pubmed">30777119</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrezk R, Jackson N, Al Rezk M, Elashoff R, Weintraub N, Elashoff D, et al. . Derivation and validation of a geriatric-sensitive perioperative cardiac risk index. J Am Heart Assoc. (2017) 6:e006648. 10.1161/JAHA.117.006648</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.006648</ArticleId><ArticleId IdType="pmc">PMC5721761</ArticleId><ArticleId IdType="pubmed">29146612</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta PK, Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ, et al. . Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. (2011) 124:381&#x2013;7. 10.1161/CIRCULATIONAHA.110.015701</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.015701</ArticleId><ArticleId IdType="pubmed">21730309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, et al. . Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. (2013) 217:833&#x2013;42 e1-3. 10.1016/j.jamcollsurg.2013.07.385</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2013.07.385</ArticleId><ArticleId IdType="pmc">PMC3805776</ArticleId><ArticleId IdType="pubmed">24055383</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34954261</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Safety and effectiveness of adding fentanyl or sufentanil to spinal anesthesia: systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>198</StartPage><EndPage>216</EndPage><MedlinePgn>198-216</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2021.10.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(21)00409-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Spinal infusions of either fentanyl or sufentanil have been reported in international reports, articles, and scientific events worldwide. This study aimed to determine whether intrathecal fentanyl or sufentanil offers safety in mortality and perioperative adverse events.</AbstractText><AbstractText Label="METHODS">MEDLINE (via PubMed), EMBASE, CENTRAL (Cochrane library databases), gray literature, hand-searching, and clinicaltrials.gov were systematically searched. Randomized controlled trials with no language, data, or status restrictions were included, comparing the effectiveness and safety of adding spinal lipophilic opioid to local anesthetics (LAs). Data were pooled using the random-effects models or fixed-effect models based on heterogeneity.</AbstractText><AbstractText Label="RESULTS">The initial search retrieved 4469 records; 3241 records were eligible, and 3152 articles were excluded after reading titles and abstracts, with a high agreement rate (98.6%). After reading the full texts, 76 articles remained. Spinal fentanyl and sufentanil significantly reduced postoperative pain and opioid consumption, increased analgesia and pruritus. Fentanyl, but not sufentanil, significantly reduced both postoperative nausea and vomiting, and postoperative shivering; compared to LAs alone. The analyzed studies did not report any case of in-hospital mortality related to spinal lipophilic opioids. The rate of respiratory depression was 0.7% and 0.8% when spinal fentanyl or sufentanil was added and when it was not, respectively. Episodes of respiratory depression were rare, uneventful, occurred intraoperatively, and were easily manageable.</AbstractText><AbstractText Label="CONCLUSION">There is moderate to high quality certainty that there is evidence regarding the safety and effectiveness of adding lipophilic opioids to LAs in spinal anesthesia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Sociedade Brasileira de Anestesiologia. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fonseca</LastName><ForeName>Neuber Martins</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Universidade Federal de Uberl&#xe2;ndia (UFU), Faculdade de Medicina, Disciplina de Anestesiologia, Uberl&#xe2;ndia, MG, Brazil; Universidade Federal de Uberl&#xe2;ndia (UFU), Faculdade de Medicina, CET, Uberl&#xe2;ndia, MG, Brazil; Sociedade Brasileira de Anestesiologia, Brazil; Comit&#xea; para o Estudo do Equipamento Respirat&#xf3;rio e Anestesia de ABNT, Brazil; Revista Brasileira de Anestesiologia, Brazil. Electronic address: neubermf@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimar&#xe3;es</LastName><ForeName>Gabriel Magalh&#xe3;es Nunes</ForeName><Initials>GMN</Initials><AffiliationInfo><Affiliation>Universidade de Bras&#xed;lia (UnB), Faculdade de Medicina, Departamento de Cl&#xed;nica Cir&#xfa;rgica, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontes</LastName><ForeName>Jo&#xe3;o Paulo Jord&#xe3;o</ForeName><Initials>JPJ</Initials><AffiliationInfo><Affiliation>Complexo Hospitalar Santa Genoveva de Uberl&#xe2;ndia, Departamento de Anestesiologia, Uberl&#xe2;ndia, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azi</LastName><ForeName>Liana Maria Torres de Ara&#xfa;jo</ForeName><Initials>LMTA</Initials><AffiliationInfo><Affiliation>Universidade Federal da Bahia (UFBA), Faculdade de Medicina, Departamento de Anestesiologia e Cirurgia, Salvador, BA, Brazil; Complexo Hospitalar Universit&#xe1;rio Professor Edgard Santos, Salvador, BA, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de &#xc1;vila Oliveira</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universidade Federal de Uberl&#xe2;ndia (UFU), Faculdade de Medicina, Disciplina de Cirurgia Vascular, Uberl&#xe2;ndia, MG, Brazil; Universidade Federal de Uberl&#xe2;ndia (UFU), Departamento de Cirurgia, Uberl&#xe2;ndia, MG, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>AFE2YW0IIZ</RegistryNumber><NameOfSubstance UI="D017409">Sufentanil</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="Y">Fentanyl</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017409" MajorTopicYN="N">Sufentanil</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia, spinal</Keyword><Keyword MajorTopicYN="N">Drug-related side effects and adverse reactions</Keyword><Keyword MajorTopicYN="N">Fentanyl</Keyword><Keyword MajorTopicYN="N">Safety</Keyword><Keyword MajorTopicYN="N">Sufentanil</Keyword></KeywordList><CoiStatement>Conflicts of interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>19</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>26</Day><Hour>20</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34954261</ArticleId><ArticleId IdType="pmc">PMC10068557</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2021.10.010</ArticleId><ArticleId IdType="pii">S0104-0014(21)00409-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Finch JS, DeKornfeld TJ. Clinical investigation of the analgesic potency and respiratory depressant activity of fentanyl, a new narcotic analgesic. J Clin Pharmacol J New Drugs. 1967;7:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">4951240</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SW, Maguire PA, Davies MF, et al. Evidence for mu1-opioid receptor involvement in fentanyl-mediated respiratory depression. Eur J Pharmacol. 1996;312:241&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">8894602</ArticleId></ArticleIdList></Reference><Reference><Citation>Willette RN, Doorley BM, Sapru HN. Activation of cholinergic mechanisms in the medulla oblongata reverse intravenous opioid-induced respiratory depression. J Pharmacol Exp Ther. 1987;240:352&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">3806396</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehling M, Tryba M. Risks and side-effects of intrathecal morphine combined with spinal anaesthesia: a meta-analysis. Anaesthesia. 2009;64:643&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">19462494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Sun H, Sun W-T, et al. Efficacy and safety of intrathecal morphine for pain control after spinal surgery: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25:2674&#x2013;2684.</Citation><ArticleIdList><ArticleId IdType="pubmed">33829454</ArticleId></ArticleIdList></Reference><Reference><Citation>Uppal V, Retter S, Casey M, et al. Efficacy of intrathecal fentanyl for cesarean delivery: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Anesth Analg. 2020;130:111&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">30633056</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;pping DM, Elia N, Marret E, et al. Opioids added to local anesthetics for single-shot intrathecal anesthesia in patients undergoing minor surgery: a meta-analysis of randomized trials. Pain. 2012;153:784&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">22230804</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, et&#xa0;al., Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. 2020 at &lt;https://doi.org/10.1002/9781119536604&gt;</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A, Asthana V, Sharma J, et al. Efficacy of lipophilic vs lipophobic opioids in addition to hyperbaric bupivacaine for patients undergoing lower segment caeserean section. Anesth Essays Res. 2016;10:420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062202</ArticleId><ArticleId IdType="pubmed">27746526</ArticleId></ArticleIdList></Reference><Reference><Citation>Akan B, Yagan O, Bilal B, et al. Comparison of levobupivacaine alone and in combination with fentanyl and sufentanil in patients undergoing transurethral resection of the prostate. J Res Med Sci Off J Isfahan Univ Med Sci. 2013;18:378&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810569</ArticleId><ArticleId IdType="pubmed">24174940</ArticleId></ArticleIdList></Reference><Reference><Citation>Asokumar B, Newman LM, McCarthy RJ, et al. Intrathecal bupivacaine reduces pruritus and prolongs duration of fentanyl analgesia during labor: a prospective, randomized controlled trial. Anesth Analg. 1998;87:1309&#x2013;1315.</Citation><ArticleIdList><ArticleId IdType="pubmed">9842818</ArticleId></ArticleIdList></Reference><Reference><Citation>Atallah MM, Shorrab AA, Abdel Mageed YM, et al. Low-dose bupivacaine spinal anaesthesia for percutaneous nephrolithotomy: the suitability and impact of adding intrathecal fentanyl. Acta Anaesthesiol Scand. 2006;50:798&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">16879461</ArticleId></ArticleIdList></Reference><Reference><Citation>Atallah MM, Helal MA, Shorrab AA. Hypobaric bupivacaine spinal anesthesia for cystoscopic intervention: the impact of adding fentanyl. Middle East J Anaesthesiol. 2003;17:415&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">14740594</ArticleId></ArticleIdList></Reference><Reference><Citation>Attri J, Kaur G, Kaur S, et al. Comparison of levobupivacaine and levobupivacaine with fentanyl in infraumbilical surgeries under spinal anaesthesia. Anesth Essays Res. 2015;9:178&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4563977</ArticleId><ArticleId IdType="pubmed">26417124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-David B, Solomon E, Levin H, et al. Intrathecal fentanyl with small-dose dilute bupivacaine: better anesthesia without prolonging recovery. Anesth Analg. 1997;85:560&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">9296409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-David B, Frankel R, Arzumonov T, et al. Minidose bupivacaine-fentanyl spinal anesthesia for surgical repair of hip fracture in the aged. Anesthesiology. 2000;92:6&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">10638892</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidikar M, Mudakanagoudar M, Santhosh MCB. Comparison of intrathecal levobupivacaine and levobupivacaine plus fentanyl for cesarean section. Anesth Essays Res. 2017;11:495&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490141</ArticleId><ArticleId IdType="pubmed">28663648</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas B, Rudra A, Bose B, et al. Intrathecal fentanyl with hyperbaric bupivacaine improves analgesia during caesarean delivery and in early postoperative period. Indian J Anaesth. 2002;46:469.</Citation></Reference><Reference><Citation>Chandra BJ, Kusum MB, Anurup P, et al. Intrathecal bupivacaine with 5&#x3bc;g of sufentanil or 25&#x3bc;g fentanyl for caesarean delivery in pregnancy induced hypertension. J Anaesthesiol Clin Pharmacol. 2008;24:420.</Citation></Reference><Reference><Citation>Chilvers CR, Vaghadia H, Mitchell GW, et al. Small-dose hypobaric lidocaine-fentanyl spinal anesthesia for short duration outpatient laparoscopy. II. Optimal fentanyl dose. Anesth Analg. 1997;84:65&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">8989001</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan CM, Kendall JB, Barclay PM, et al. Comparison of intrathecal fentanyl and diamorphine in addition to bupivacaine for caesarean section under spinal anaesthesia. Br J Anaesth. 2002;89:452&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">12402725</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlgren G, Hultstrand C, Jakobsson J, et al. Intrathecal sufentanil, fentanyl, or placebo added to bupivacaine for cesarean section. Anesth Analg. 1997;85:1288&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pubmed">9390596</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai D, Bumiya P, Upadhyay M. Spinal anesthesia with low dose bupivacaine and fentanyl for femur surgeries in elderly patients. J Anes Cri Open Access. 2019;11:60&#x2013;64.</Citation></Reference><Reference><Citation>Farzi F, Mirmansouri A, Naderi Nabi B, et al. Comparing the effect of adding fentanyl, sufentanil, and placebo with intrathecal bupivacaine on duration of analgesia and complications of spinal anesthesia in patients undergoing cesarean section. Anesthesiol Pain Med. 2017;7:e12738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5903220</ArticleId><ArticleId IdType="pubmed">29696107</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauchan S, Thapa C, Prasai A, et al. Effects of intrathecal fentanyl as an adjunct to hyperbaric bupivacaine in spinal anesthesia for elective caesarean section. Nepal Med Coll J NMCJ. 2014;16:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25799801</ArticleId></ArticleIdList></Reference><Reference><Citation>Girgin NK, Gurbet A, Turker G, et al. The combination of low-dose levobupivacaine and fentanyl for spinal anaesthesia in ambulatory inguinal herniorrhaphy. J Int Med Res. 2008;36:1287&#x2013;1292.</Citation><ArticleIdList><ArticleId IdType="pubmed">19094438</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Sampley S, Kathuria S, et al. Intrathecal sufentanil or fentanyl as adjuvants to low dose bupivacaine in endoscopic urological procedures. J Anaesthesiol Clin Pharmacol. 2013;29:509&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3819846</ArticleId><ArticleId IdType="pubmed">24249989</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurbet A, Turker G, Girgin NK, et al. Combination of ultra-low dose bupivacaine and fentanyl for spinal anaesthesia in out-patient anorectal surgery. J Int Med Res. 2008;36:964&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">18831889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassani V, Movassaghi G, Safaian R, et al. Bupivacaine-sufentanil versus bupivacaine-fentanyl in spinal anesthesia of patients undergoing lower extremity surgery. Anesthesiol Pain Med. 2014;4:e12091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4013506</ArticleId><ArticleId IdType="pubmed">24829879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoda MQ, Saeed S, Afshan G, et al. Haemodynamic effects of intrathecal bupivacaine for surgical repair of hip fracture. J Pak Med Assoc. 2007;57:245&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">17571481</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt CO, Naulty JS, Bader AM, et al. Perioperative analgesia with subarachnoid fentanyl-bupivacaine for cesarean delivery. Anesthesiology. 1989;71:535&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">2679237</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain K, Grover VK, Mahajan R, et al. Effect of varying doses of fentanyl with low dose spinal bupivacaine for caesarean delivery in patients with pregnancy-induced hypertension. Int J Obstet Anesth. 2004;13:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">15477049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kararmaz A, Kaya S, Turhanoglu S, et al. Low-dose bupivacaine-fentanyl spinal anaesthesia for transurethral prostatectomy. Anaesthesia. 2003;58:526&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">12846615</ArticleId></ArticleIdList></Reference><Reference><Citation>Khezri MB, Rezaei M, Delkhosh Reihany M, et al. Comparison of postoperative analgesic effect of intrathecal clonidine and fentanyl added to bupivacaine in patients undergoing cesarean section: a prospective randomized double-blind study. Pain Res Treat. 2014;2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932201</ArticleId><ArticleId IdType="pubmed">24649361</ArticleId></ArticleIdList></Reference><Reference><Citation>Korhonen AM, Valanne JV, Jokela RM, et al. Intrathecal hyperbaric bupivacaine 3 mg&#xa0;+&#xa0;fentanyl 10 &#x3bc;g for outpatient knee arthroscopy with tourniquet. Acta Anaesthesiol Scand. 2003;47:342&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">12648202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuberan A, Jain K, Bagga R, et al. The effect of spinal hyperbaric bupivacaine-fentanyl or hyperbaric bupivacaine on uterine tone and fetal heart rate in labouring women: a randomised controlled study. Anaesthesia. 2018;73:832&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">29582422</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuusniemi KS, Pihlajam&#xe4;ki KK, Pitk&#xe4;nen MT, et al. The use of bupivacaine and fentanyl for spinal anesthesia for urologic surgery. Anesth Analg. 2000;91:1452&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pubmed">11093999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauretti GR, Mattos AL, Reis MP, et al. Combined intrathecal fentanyl and neostigmine: therapy for postoperative abdominal hysterectomy pain relief. J Clin Anesth. 1998;10:291&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">9667344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YY, Muchhal K, Chan CK, et al. Levobupivacaine and fentanyl for spinal anaesthesia: a randomized trial. Eur J Anaesthesiol. 2005;22:899&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">16318658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJ, Kim SH, Jung JD, et al. The effects of intrathecal fentanyl for spinal anesthesia in lower extremity surgery. Korean J Anesthesiol. 2009;56:280&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Chung KH, Lee JY, et al. Comparison of fentanyl and sufentanil added to 0.5% hyperbaric bupivacaine for spinal anesthesia in patients undergoing cesarean section. Korean J Anesthesiol. 2011;60:103&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049877</ArticleId><ArticleId IdType="pubmed">21390165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan R, Grover V, Jain K, et al. Intrathecal fentanyl with low dose hyperbaric bupivacaine for caesarean delivery in patients with pregnancy induced hypertension. J Anaesthesiol Clin Pharmacol. 2005;21:51&#x2013;58.</Citation></Reference><Reference><Citation>Makwana J, Tn S, Khande A, et al. Comparison between hyperbaric Bupivacaine and hyperbaric Bupivacaine plus Fentanyl intrathecally in major gynaecological surgeries. Int J Med Sci Public Health. 2014;3:319.</Citation></Reference><Reference><Citation>Martin R, Tsen LC, Tzeng G, et al. Anesthesia for in vitro fertilization: the addition of fentanyl to 1.5% lidocaine. Anesth Analg. 1999;88:523&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">10071998</ArticleId></ArticleIdList></Reference><Reference><Citation>Martyr JW, Clark MX. Hypotension in elderly patients undergoing spinal anaesthesia for repair of fractured neck of femur. A comparison of two different spinal solutions. Anaesth Intensive Care. 2001;29:501&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">11669431</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeta S, Upadya M, Gosain A, et al. A prospective randomized controlled study comparing intrathecal bupivacaine combined with fentanyl and sufentanil in abdominal and lower limb surgeries. Anesth Essays Res. 2015;9:149&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4563967</ArticleId><ArticleId IdType="pubmed">26417119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozdogan Ozyilkan N, Kocum A, Sener M, et al. Comparison of intrathecal levobupivacaine combined with sufentanil, fentanyl, or placebo for elective caesarean section: A prospective, randomized, double-blind, controlled study. Curr Ther Res - Clin Exp. 2013;75:64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898189</ArticleId><ArticleId IdType="pubmed">24465046</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer CM, Voulgaropoulos D, Alves D. Subarachnoid fentanyl augments lidocaine spinal anesthesia for cesarean delivery. Reg Anesth. 1995;20:389&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">8519715</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajbhandari D, Mahato MP, Dahal P, et al. The comparison of effectiveness of different doses of fentanyl added to hyperbaric bupivacaine for spinal anaesthesia in emergency appendectomy: the comparison of effectiveness of different doses of fentanyl added to hyperbaric bupivacaine for spinal anaesthesia in emergency appendectomy. Medico Res Chron. 2020;7:240&#x2013;249.</Citation></Reference><Reference><Citation>Randalls B, Broadway JW, Browne DA, et al. Comparison of four subarachnoid solutions in a needle-through-needle technique for elective caesarean section. Br J Anaesth. 1991;66:314&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">2015147</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadegh A, Tazeh-kand NF, Eslami B. Intrathecal fentanyl for prevention of shivering in spinal anesthesia in cesarean section. Med J Islam Repub Iran. 2012;26:85&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587896</ArticleId><ArticleId IdType="pubmed">23483276</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahriari A, Khooshideh M. Intrathecal fentanyl added to lidocaine for cesarean delivery under spinal anesthesia - A randomised clinical trial. Middle East J Anesthesiol. 2007;19:397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">17684879</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim SM, Park JH, Hyun DM, et al. The effects of adjuvant intrathecal fentanyl on postoperative pain and rebound pain for anorectal surgery under saddle anesthesia. Korean J Anesthesiol. 2018;71:213&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995019</ArticleId><ArticleId IdType="pubmed">29684993</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H, Yang J, Thornton K, et al. Intrathecal fentanyl prolongs sensory bupivacaine spinal block. Can J Anaesth J Can Anesth. 1995;42:987&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">8590509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung TY, Kim MS, Cho CK, et al. Clinical effects of intrathecal fentanyl on shoulder tip pain in laparoscopic total extraperitoneal inguinal hernia repair under spinal anaesthesia: a double-blind, prospective, randomized controlled trial. J Int Med Res. 2013;41:1160&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">23839277</ArticleId></ArticleIdList></Reference><Reference><Citation>Techanivate A, Urusopone P, Kiatgungwanglia P, et al. Intrathecal fentanyl in spinal anesthesia for appendectomy. J Med Assoc Thail Chotmaihet Thangphaet. 2004;87:525&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">15222523</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi P, Srivastava A. Comparision of bupivacaine alone and its combination with different doses of fentanyl in spinal anesthesia for cesarean section: a prospective randomized study. Indian J Public Health Res Dev. 2013;4:19.</Citation></Reference><Reference><Citation>Unal D, Ozdogan L, Ornek HD, et al. Selective spinal anaesthesia with low-dose bupivacaine and bupivacaine&#xa0;+&#xa0;fentanyl in ambulatory arthroscopic knee surgery. J Pak Med Assoc. 2012;62:313&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">22755270</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkata HG, Pasupuleti S, Pabba UG, et al. A randomized controlled prospective study comparing a low dose bupivacaine and fentanyl mixture to a conventional dose of hyperbaric bupivacaine for cesarean section. Saudi J Anaesth. 2015;9:122&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374214</ArticleId><ArticleId IdType="pubmed">25829897</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Peng X, Zhan L, et al. Effects of intrathecal bupivacaine and bupivacaine plus fentanyl in elderly patients undergoing total hip arthroplasty. J Coll Physicians Surg Pak. 2019;29:1133&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pubmed">31839082</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigl W, Bierylo A, Wielgus M, et al. Analgesic efficacy of intrathecal fentanyl during the period of highest analgesic demand after cesarean section A randomized controlled study. Med U S. 2016;95:e3827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4998444</ArticleId><ArticleId IdType="pubmed">27310958</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Guo Q, Wang E, et al. Spinal anesthesia with low dose sufentanil-bupivacaine in transurethral resection of the prostate. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006;31:925&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pubmed">17213598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zohar E, Noga Y, Rislick U, et al. Intrathecal anesthesia for elderly patients undergoing short transurethral procedures: a dose-finding study. Anesth Analg. 2007;104:552&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">17312207</ArticleId></ArticleIdList></Reference><Reference><Citation>Shende D, Cooper GM, Bowden MI. The influence of intrathecal fentanyl on the characteristics of subarachnoid block for caesarean section. Anaesthesia. 1998;53:706&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">9771182</ArticleId></ArticleIdList></Reference><Reference><Citation>Seewal R, Shende D, Kashyap L, et al. Effect of addition of various doses of fentanyl intrathecally to 0.5% hyperbaric bupivacaine on perioperative analgesia and subarachnoid-block characteristics in lower abdominal surgery: a dose-response study. Reg Anesth Pain Med. 2007;32:20&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">17196488</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyhan T&#xd6;, &#x15e;ent&#xfc;rk E, &#x15e;enbecerir N, et al. Spinal anesthesia in cesarean section with different combinations of bupivacaine and fentanyl. Agri. 2006;18:37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">16783667</ArticleId></ArticleIdList></Reference><Reference><Citation>Sert&#xf6;z N, Aysel I, Uyar M. The effects of sufentanil added to low-dose hyperbaric bupivacaine in unilateral spinal anaesthesia for outpatients undergoing knee arthroscopy. Agri. 2014;26:158&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">25551811</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdollahpour A, Azadi R, Bandari R, et al. Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiol Pain Med. 2015;5:e23565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4602227</ArticleId><ArticleId IdType="pubmed">26473100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayd&#x131;n F, Akan B, Susleyen C, et al. Comparison of bupivacaine alone and in combination with sufentanil in patients undergoing arthroscopic knee surgery. Knee Surg Sports Traumatol Arthrosc. 2011;19:1915&#x2013;1919.</Citation><ArticleIdList><ArticleId IdType="pubmed">22005905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang YS, Chung KH, Lee JH, et al. Comparison of clinical effects according to the dosage of sufentanil added to 0.5% hyperbaric bupivacaine for spinal anesthesia in patients undergoing cesarean section. Korean J Anesthesiol. 2012;63:321&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3483490</ArticleId><ArticleId IdType="pubmed">23115684</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga A de F de A, Braga FS da S, Pot&#xe9;rio GMB, et al. Sufentanil added to hyperbaric bupivacaine for subarachnoid block in caesarean section. Eur J Anaesthesiol. 2003;20:631&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932064</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga AA, Frias JAF, Braga FS, et al. Spinal anesthesia for cesarean section. Use of hyperbaric bupivacaine (10mg) combined with different adjuvants. Rev Bras Anestesiol. 2012;62:775&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pubmed">23176986</ArticleId></ArticleIdList></Reference><Reference><Citation>Demiraran Y, Ozdemir I, Kocaman B, et al. Intrathecal sufentanil (1.5&#x3bc;g) added to hyperbaric bupivacaine (0.5%) for elective cesarean section provides adequate analgesia without need for pruritus therapy. J Anesth. 2006;20:274&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">17072691</ArticleId></ArticleIdList></Reference><Reference><Citation>Derakhshan P, Imani F, Koleini ZS, et al. Comparison of adding sufentanil and low-dose epinephrine to bupivacaine in spinal anesthesia: a randomized, double-blind, clinical trial. Anesthesiol Pain Med. 2018;8:e69600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6252044</ArticleId><ArticleId IdType="pubmed">30538940</ArticleId></ArticleIdList></Reference><Reference><Citation>Doger C, Y&#xfc;ksel BE, Canoler O, et al. Effects of intrathecal bupivacaine and bupivacaine plus sufentanil in elderly patients undergoing transurethral resection. Niger J Clin Pract. 2014;17:149&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">24553022</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadoni R, Vermeulen H, Noorduin H, et al. Intrathecal sufentanil as a supplement to subarachnoid anaesthesia with lignocaine. Br J Anaesth. 1987;59:1523&#x2013;1527.</Citation><ArticleIdList><ArticleId IdType="pubmed">2892517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur M, Katyal S, Kathuria S, et al. A comparative evaluation of intrathecal bupivacaine alone, sufentanil or butorphanol in combination with bupivacaine for endoscopic urological surgery. Saudi J Anaesth. 2011;5:202&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139316</ArticleId><ArticleId IdType="pubmed">21804804</ArticleId></ArticleIdList></Reference><Reference><Citation>Olofsson C, Nyg&#xe5;rds EB, Bjersten AB, et al. Low-dose bupivacaine with sufentanil prevents hypotension after spinal anesthesia for hip repair in elderly patients. Acta Anaesthesiol Scand. 2004;48:1240&#x2013;1244.</Citation><ArticleIdList><ArticleId IdType="pubmed">15504182</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyas N, Sahu DK, Parampill R. Comparative study of intrathecal sufentanil bupivacaine versus intrathecal bupivacaine in patients undergoing elective cesarean section. J Anaesthesiol Clin Pharmacol. 2010;26:488&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3087272</ArticleId><ArticleId IdType="pubmed">21547176</ArticleId></ArticleIdList></Reference><Reference><Citation>Waxler B, Mondragon SA, Patel SN, et al. Intrathecal lidocaine and sufentanil shorten postoperative recovery after outpatient rectal surgery. Can J Anaesth J Can Anesth. 2004;51:680&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">15310635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakkim A, Kirubahar R, Kanna V, et al. Comparative study of 0.5% hyperbaric bupivacaine with sufentanil and 0.5% hyperbaric bupivacaine for spinal anesthesia. Int J Res Med Sci. 2015;3:3367&#x2013;3371.</Citation></Reference><Reference><Citation>Ngiam SK, Chong JL. The addition of intrathecal sufentanil and fentanyl to bupivacaine for caesarean section. Singapore Med J. 1998;39:290&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">9885688</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya B, Acharya K, Sigdel S, et al. Effect of low dose bupivacaine and fentanyl during elective cesarean section. J Anesth Clin Res. 2019;10:1&#x2013;6.</Citation></Reference><Reference><Citation>Walsh KH, Murphy C, Iohom G, et al. Comparison of the effects of two intrathecal anaesthetic techniques for transurethral prostatectomy on haemodynamic and pulmonary function. Eur J Anaesthesiol. 2003;20:560&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">12884990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamber EA, Viscomi CM. Intrathecal lipophilic opioids as adjuncts to surgical spinal anesthesia. Reg Anesth Pain Med. 1999;24:255&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">10338179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Zhang C, Yan J, et al. Sufentanil and bupivacaine combination versus bupivacaine alone for spinal anesthesia during cesarean delivery: a meta-analysis of randomized trials. PloS One. 2016;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4816294</ArticleId><ArticleId IdType="pubmed">27032092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge D, Martin J, Arango M, et al. Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet Lond Engl. 2012;380:1075&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">22998717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko S, Goldstein DH, VanDenKerkhof EG. Definitions of &#x201c;respiratory depression&#x201d; with intrathecal morphine postoperative analgesia: a review of the literature. Can J Anaesth J Can Anesth. 2003;50:679&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">12944442</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmell JP, Lair TR, Nauman B. The role of intrathecal drugs in the treatment of acute pain. Anesth Analg. 2005;101:S30&#x2013;S43.</Citation><ArticleIdList><ArticleId IdType="pubmed">16334491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauchat JR, Weiniger CF, Sultan P, et al. Society for Obstetric Anesthesia and Perinatology Consensus Statement: monitoring recommendations for prevention and detection of respiratory depression associated with administration of neuraxial morphine for cesarean delivery analgesia. Anesth Analg. 2019;129:458&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">31082964</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts GW, Bekker TB, Carlsen HH, et al. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg. 2005;101:1343&#x2013;1348.</Citation><ArticleIdList><ArticleId IdType="pubmed">16243992</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuipers PW, Kamphuis ET, Venrooij GE van, et al. Intrathecal opioids and lower urinary tract function. Anesthesiology. 2004;100:1497&#x2013;1503.</Citation><ArticleIdList><ArticleId IdType="pubmed">15166570</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmelz M. Opioid-induced pruritus. Mechanisms and treatment regimens. Anaesthesist. 2009;58:61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">19132330</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo Locks G de. Incidence of shivering after cesarean section under spinal anesthesia with or without intrathecal sufentanil: a randomized study. Rev Bras Anestesiol. 2012;62:676&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">22999400</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi C, Lenhardt R, Ozaki M, et al. Opioids inhibit febrile responses in humans, whereas epidural analgesia does not: an explanation for hyperthermia during epidural analgesia. Anesthesiology. 2001;94:218&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">11176084</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SW, Hauben M, Aronson JK. Paradoxical and bidirectional drug effects. Drug Saf. 2012;35:173&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">22272687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27688630</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0972-5229</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine</Title><ISOAbbreviation>Indian J Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Systematic review of statins in sepsis: There is no evidence of dose response.</ArticleTitle><Pagination><StartPage>534</StartPage><EndPage>541</EndPage><MedlinePgn>534-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0972-5229.190366</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Sepsis is a common cause of morbidity and mortality and is associated with significant costs to the healthcare organizations. We performed a systematic review and meta-analysis to assess whether high or low-dose statin therapy improved mortality in patients with sepsis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The trials analyzed in this study were multicenter or single center randomized control studies using statins for sepsis in a hospital setting. The patients included were adults with suspected or confirmed infection.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">This study found eight randomized controlled trials where participants were given either a statin or placebo daily for 14-28 days, the duration of their illness, or until their death or discharge, which ever occurred first.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOMES MEASURED" NlmCategory="UNASSIGNED">This meta-analysis measured the effect of statin therapy on in hospital and 28 days mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In unselected patients, there was no demonstrable difference in the 28 days mortality (relative risk [RR] 0.88 95% confidence interval [CI], 0.70-1.12 and P = 0.16). There was also no significant difference between statin versus placebo for in-hospital mortality (RR 0.98 95% CI, 0.85-1.14 P = 0.36). When the studies where divided into low-dose and high-dose groups, there were no statistically significant differences for in-hospital mortality between low-dose statin versus placebo for (RR 0.81 CI 0.44-1.49 P = 0.27) or high-dose statin versus placebo (RR 0.99 95% CI 0.85-1.16, P = 0.28). There was no significant difference in adverse effects between the high- and low-dose groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this meta-analysis, we found that the use of statins did not significantly improve either in-hospital mortality or 28-day mortality in patients with sepsis. In the low-dose group, there were fewer quality multicenter studies; hence, conclusions based on the results of this subgroup are limited.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moody</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tunnicliffe</LastName><ForeName>Bill</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Zahid</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manji</LastName><ForeName>Mav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudibande</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitehouse</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snelson</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veenith</LastName><ForeName>Tonny</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen Elizabeth Medical Centre, Birmingham, B15 2TH, UK; Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK; School of Immunity and Infection, University of Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Crit Care Med</MedlineTA><NlmUniqueID>101208863</NlmUniqueID><ISSNLinking>0972-5229</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">High dose</Keyword><Keyword MajorTopicYN="N">low dose</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">statin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27688630</ArticleId><ArticleId IdType="pmc">PMC5027747</ArticleId><ArticleId IdType="doi">10.4103/0972-5229.190366</ArticleId><ArticleId IdType="pii">IJCCM-20-534</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006;34:344&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. Inpatient care for septicemia or sepsis: A challenge for patients and hospitals. NCHS Data Brief. 2011;62:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142805</ArticleId></ArticleIdList></Reference><Reference><Citation>Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. 2006.  [Last cited on 2016 Jul 24].  Available from: http://www.ncbi.nlm.nih.gov/pubmed/24199255 .</Citation><ArticleIdList><ArticleId IdType="pubmed">24199255</ArticleId></ArticleIdList></Reference><Reference><Citation>Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins: Panacea for sepsis? Lancet Infect Dis. 2006;6:242&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16554249</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2694580</ArticleId><ArticleId IdType="pubmed">15822172</ArticleId></ArticleIdList></Reference><Reference><Citation>Merx MW, Liehn EA, Graf J, van de Sandt A, Schaltenbrand M, Schrader J, et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation. 2005;112:117&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">15998696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 2006;32:75&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16283159</ArticleId></ArticleIdList></Reference><Reference><Citation>Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: Multiple modifications at multiple levels. Lancet Infect Dis. 2007;7:358&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17448939</ArticleId></ArticleIdList></Reference><Reference><Citation>Drage SM, Barber VS, Young JD. Statins and sepsis: Panacea or pandora's box? Lancet Infect Dis. 2007;7:80.</Citation><ArticleIdList><ArticleId IdType="pubmed">17251076</ArticleId></ArticleIdList></Reference><Reference><Citation>De Loecker I, Preiser JC. Statins in the critically ill. Ann Intensive Care. 2012;2:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488539</ArticleId><ArticleId IdType="pubmed">22709377</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood J, Mason JC. Statins and the vascular endothelial inflammatory response. Trends Immunol. 2007;28:88&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839264</ArticleId><ArticleId IdType="pubmed">17197237</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L, Roch A, Charles PE, Penot-Ragon C, Perrin G, Roulier P, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: A randomized clinical trial. JAMA. 2013;310:1692&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart TN. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference><Reference><Citation>Review Manager (RevMan) [Computer Program] Copenhagen: The Nordic Cochrane Centre; 2014. The Cochrane Collaboration.</Citation></Reference><Reference><Citation>Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] The Cochrane Collaboration. 2011.  [Last accessed on 2016 Sep 07].  Available from http://handbook.cochrane.org .</Citation></Reference><Reference><Citation>Hsu I, Spinler SA, Johnson NE. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacother. 1995;29:743&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">8520093</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) Am J Cardiol. 2003;92:152&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12860216</ArticleId></ArticleIdList></Reference><Reference><Citation>Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: A randomized double-blind placebo controlled clinical trial. Intensive Care Med. 2009;35:1255&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19205663</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JM, Snaith C, Thickett DR, Linhartova L, Melody T, Hawkey P, et al. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial) Crit Care. 2012;16:R231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672620</ArticleId><ArticleId IdType="pubmed">23232151</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford RH, Shear CL, Chremos AN, Dujovne C, Downton M, Franklin FA, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med. 1991;151:43&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1985608</ArticleId></ArticleIdList></Reference><Reference><Citation>Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11961152</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer JA. Learning from the cerivastatin experience. Lancet. 2001;358:1383&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11705478</ArticleId></ArticleIdList></Reference><Reference><Citation>McAuley DF, Laffey JG, O'Kane CM, Perkins GD, Mullan B, Trinder TJ, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371:1695&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">25268516</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande A, Pasupuleti V, Rothberg MB. Statin therapy and mortality from sepsis: A meta-analysis of randomized trials. Am J Med. 2015;128:410&#x2013;7.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">25526798</ArticleId></ArticleIdList></Reference><Reference><Citation>Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004;110:880&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15289367</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhas BB, Ashmi H, Bhat BV. Sepsis genomics: Stepping forward toward sepsis prevention.? Int J Adv Med Health Res. 2014;1:8&#x2013;15.</Citation></Reference><Reference><Citation>Kruger PS, Harward ML, Jones MA, Joyce CJ, Kostner KM, Roberts MS, et al. Continuation of statin therapy in patients with presumed infection: A randomized controlled trial. Am J Respir Crit Care Med. 2011;183:774&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20959555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger P, Bailey M, Bellomo R, Cooper DJ, Harward M, Higgins A, et al. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med. 2013;187:743&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23348980</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, et al. A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study) Am J Respir Crit Care Med. 2011;183:620&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20870757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39336487</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Anesthesia's Influence on Postoperative In-Hospital Morbidity-Mortality in Proximal Femoral Fractures in the Elderly.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1446</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina60091446</ELocationID><Abstract><AbstractText><i>Background and Objectives:</i> The incidence of proximal femoral fractures (PFFs) is rising, causing significant morbidity and mortality. Regional anesthesia (RA)'s benefits include the avoidance of intubation and mechanical ventilation, decreased blood loss, and improved analgesia. General anesthesia (GA) offers improved hemodynamic stability. This study examines the in-hospital post-surgical morbidity and mortality seen in PFFs in a cohort of the elderly undergoing GA or RA. <i>Materials and Methods:</i> This is a retrospective cohort study of 319 PFF patients older than 65 years over a single year. <i>Results:</i> In total, 73.7% of patients underwent GA. The patient characteristics were identical between groups, except for smoking. Hypertension was the most frequent comorbidity, followed by hyperlipidemia, NIDDM, and IHD. The overall patient complication rate was 11.4%. Pneumonia was the most common complication (5.1% in GA, 8.4% in RA). A total of 0.9% of patients required ICU admission. Overall, the in-hospital mortality rate was 2.3%, with no statistically significant difference between GA and RA. The GA and RA cohorts were similar in terms of their patient demographics, medical history, and preoperative parameters. In total, 73% of surgeries were under GA. No statistically significant differences were found in total anesthesia time or complication rates. <i>Conclusions:</i> We did not find a difference between general and spinal anesthesia regarding complication rates, anesthesia time, or morbidity. General anesthesia remains best suited for patients receiving anticoagulation treatment and undergoing semi-urgent surgery, but, other than that, the mode of anesthesia administered remains up to the anesthesiologist's preference.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hershkovich</LastName><ForeName>Oded</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-2975-9152</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Wolfson Medical Center, Affiliated to the Sackler School of Medicine, Holon 5822012, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tetroashvili</LastName><ForeName>Inga</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Wolfson Medical Center, Affiliated to the Sackler School of Medicine, Holon 5822012, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Adam Lee</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Trauma Unit, Wolfson Medical Center, Affiliated to the Sackler School of Medicine, Holon 5822012, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lotan</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7968-7906</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Wolfson Medical Center, Affiliated to the Sackler School of Medicine, Holon 5822012, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005264" MajorTopicYN="Y">Femoral Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="N">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000092526" MajorTopicYN="N">Proximal Femoral Fractures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">femur</Keyword><Keyword MajorTopicYN="N">fracture</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39336487</ArticleId><ArticleId IdType="pmc">PMC11434477</ArticleId><ArticleId IdType="doi">10.3390/medicina60091446</ArticleId><ArticleId IdType="pii">medicina60091446</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brauer C.A., Coca-Perraillon M., Cutler D.M., Rosen A.B. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302:1573&#x2013;1579. doi: 10.1001/jama.2009.1462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1462</ArticleId><ArticleId IdType="pmc">PMC4410861</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnea R., Weiss Y., Korek-Abadi I., Shemer J. The epidemiology and economic burden of hip fractures in Israel. Isr. J. Health Policy Res. 2018;7:38. doi: 10.1186/s13584-018-0235-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-018-0235-y</ArticleId><ArticleId IdType="pmc">PMC6090924</ArticleId><ArticleId IdType="pubmed">30068383</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa T., Dennison E., Leufkens H., Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29:517&#x2013;522. doi: 10.1016/S8756-3282(01)00614-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S8756-3282(01)00614-7</ArticleId><ArticleId IdType="pubmed">11728921</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman M.D., Fleisher L.A., Even-Shoshan O., Mi L., Silber J.H. Non-operative care for hip fracture in the elderly: The influence of race, income, and comorbidities. Med. Care. 2010;48:314. doi: 10.1097/MLR.0b013e3181ca4126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3181ca4126</ArticleId><ArticleId IdType="pmc">PMC4882126</ArticleId><ArticleId IdType="pubmed">20355262</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche J.J.W., Wenn R.T., Sahota O., Moran C.G. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: Prospective observational cohort study. BMJ. 2005;331:1374. doi: 10.1136/bmj.38643.663843.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38643.663843.55</ArticleId><ArticleId IdType="pmc">PMC1309645</ArticleId><ArticleId IdType="pubmed">16299013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence V.A., Hilsenbeck S.G., Noveck H., Poses R.M., Carson J.L. Medical complications and outcomes after hip fracture repair. Arch. Intern. Med. 2002;162:2053&#x2013;2057. doi: 10.1001/archinte.162.18.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.18.2053</ArticleId><ArticleId IdType="pubmed">12374513</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff T.A., Henderson W.G., Stoner T.J., Khuri S.F., Dohm M., Hutt E. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J. Bone Jt. Surg. 2008;90:34&#x2013;42. doi: 10.2106/JBJS.G.00065.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.G.00065</ArticleId><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M., Johansen A.J.B. Hip fracture. BMJ. 2006;333:27&#x2013;30. doi: 10.1136/bmj.333.7557.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.333.7557.27</ArticleId><ArticleId IdType="pmc">PMC1488757</ArticleId><ArticleId IdType="pubmed">16809710</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaupre L.A., Jones C.A., Saunders L.D., Johnston D.W.C., Buckingham J., Majumdar S.R. Best practices for elderly hip fracture patients. J. Gen. Intern. Med. 2005;20:1019&#x2013;1025. doi: 10.1111/j.1525-1497.2005.00219.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1497.2005.00219.x</ArticleId><ArticleId IdType="pmc">PMC1490246</ArticleId><ArticleId IdType="pubmed">16307627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers A., Walker N., Schug S., McKee A., Kehlet H., Van Zundert A., Sage D., Futter M., Saville G., Clark T.J.B. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials. BMJ. 2000;321:1493. doi: 10.1136/bmj.321.7275.1493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.321.7275.1493</ArticleId><ArticleId IdType="pmc">PMC27550</ArticleId><ArticleId IdType="pubmed">11118174</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M.J., Handoll H.H., Griffiths R. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst. Rev. 2001;4:CD000521.</Citation><ArticleIdList><ArticleId IdType="pubmed">11687085</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell B.G., Spitz W., Porter J. Association of increasing use of spinal anesthesia in hip fracture repair with treating an aging patient population. JAMA Surg. 2020;155:167&#x2013;168. doi: 10.1001/jamasurg.2019.4471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.4471</ArticleId><ArticleId IdType="pmc">PMC6902104</ArticleId><ArticleId IdType="pubmed">31746959</ArticleId></ArticleIdList></Reference><Reference><Citation>Berggren D., Gustafson Y., Eriksson B., Bucht G., Hansson L., Reiz S., Winblad B. Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesthesia Analg. 1987;66:497&#x2013;504. doi: 10.1213/00000539-198706000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-198706000-00003</ArticleId><ArticleId IdType="pubmed">3578861</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis F.M., McDermott E., Hickton C., Wells E., Heaton D.C., Laurenson V.G., Gillespie W.J., Foate J. Influence of spinal and general anaesthesia on haemostasis during total hip arthroplasty. Br. J. Anaesth. 1987;59:561&#x2013;571. doi: 10.1093/bja/59.5.561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/59.5.561</ArticleId><ArticleId IdType="pubmed">3107600</ArticleId></ArticleIdList></Reference><Reference><Citation>Juelsgaard P., Sand N.P.R., Felsby S., Dalsgaard J., Jakobsen K.B., Brink O., Carlsson P.S., Thygesen K. Perioperative myocardial ischaemia in patients undergoing surgery for fractured hip randomized to incremental spinal, single-dose spinal or general anaesthesia. Eur. J. Anaesthesiol. 1998;15:656&#x2013;663. doi: 10.1097/00003643-199811000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003643-199811000-00006</ArticleId><ArticleId IdType="pubmed">9884850</ArticleId></ArticleIdList></Reference><Reference><Citation>Mckenzie P., Wishart H., Dewar K., Gray I., Smith G. Comparison of the effects of spinal anaesthesia and general anaesthesia on postoperative oxygenation and perioperative mortality. Br. J. Anaesth. 1980;52:49&#x2013;54. doi: 10.1093/bja/52.1.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/52.1.49</ArticleId><ArticleId IdType="pubmed">6769450</ArticleId></ArticleIdList></Reference><Reference><Citation>Racle J., Benkhadra A., Poy J., Gleizal B., Gaudray A. Comparative study of general and spinal anesthesia in elderly women in hip surgery. Ann. Fr. D&#x2019;anesthesie Reanim. 1986;5:24&#x2013;30. doi: 10.1016/S0750-7658(86)80118-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0750-7658(86)80118-6</ArticleId><ArticleId IdType="pubmed">3706840</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman M.D., Silber J.H., Elkassabany N.M., Ludwig J.M., Fleisher L.A. Comparative Effectiveness of Regional versus General Anesthesia for Hip Fracture Surgery in Adults. Anesthesiology. 2012;117:72&#x2013;92. doi: 10.1097/ALN.0b013e3182545e7c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182545e7c</ArticleId><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman M.D., Feng R., Carson J.L., Gaskins L.J., Dillane D., Sessler D.I., Sieber F., Magaziner J., Marcantonio E.R., Mehta S., et al. Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults. N. Engl. J. Med. 2021;385:2025&#x2013;2035. doi: 10.1056/NEJMoa2113514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2113514</ArticleId><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkmen S., Mutlu M., Karslioglu B. Does Anesthesia Type Affect Mortality Rates in Delayed Femoral Neck Fracture Surgery? A Retrospective Study. Eurasian J. Med. Investig. 2022;6:217&#x2013;221. doi: 10.14744/ejmi.2022.41628.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/ejmi.2022.41628</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao M., Zhang Y., Sheng R., Gao W., Kang Q., Gao Y., Qiu X., Rui Y. General anesthesia versus regional anesthesia in the elderly patients undergoing hip fracture surgeries: A systematic review and meta-analysis of randomized clinical trials. World J. Surg. 2023;47:1444&#x2013;1456. doi: 10.1007/s00268-023-06949-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-023-06949-y</ArticleId><ArticleId IdType="pubmed">36826487</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Chen J., Shi H., Li J., Zeng G., Liu W., Hu W., Li S., Gao W., Song W. Comparing perioperative outcomes between regional anesthesia and general anesthesia in patients undergoing hip fracture surgery: A systematic review and meta-analysis. Can. J. Anesth/J. Can. Anesth. 2024;71:849&#x2013;869. doi: 10.1007/s12630-024-02696-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-024-02696-3</ArticleId><ArticleId IdType="pubmed">38418761</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35953796</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2482</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC surgery</Title><ISOAbbreviation>BMC Surg</ISOAbbreviation></Journal><ArticleTitle>Management of intra-thoracic anastomotic leakages after esophagectomy: updated systematic review and meta-analysis of endoscopic vacuum therapy versus stenting.</ArticleTitle><Pagination><StartPage>309</StartPage><MedlinePgn>309</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">309</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12893-022-01764-z</ELocationID><Abstract><AbstractText>Despite a significant decrease of surgery-related mortality and morbidity, anastomotic leakage still occurs in a significant number of patients after esophagectomy. The two main endoscopic treatments in case of anastomotic leakage are self-expanding metal stents (SEMS) and the endoscopic vacuum therapy (EVT). It is still under debate, if one method is superior to the other. Therefore, we performed a systematic review and meta-analysis of the existing literature to compare the effectiveness and the related morbidity of SEMS and EVT in the treatment of esophageal leakage. We systematically searched for studies comparing SEMS and EVT to treat anastomotic leak after esophageal surgery. Predefined endpoints including outcome, treatment success, endoscopy, treatment duration, re-operation rate, intensive care and hospitalization time, stricture rate, morbidity and mortality were assessed and included in the meta-analysis. Seven retrospective studies including 338 patients matched the inclusion criteria. Compared to stenting, EVT was significantly associated with higher healing (OR 2.47, 95% CI [1.30 to 4.73]), higher number of endoscopic changes (pooled median difference of 3.57 (95% CI [2.24 to 4.90]), shorter duration of treatment (pooled median difference -&#xa0;11.57&#xa0;days; 95% CI [-&#xa0;17.45 to -&#xa0;5.69]), and stricture rate (OR 0.22, 95% CI [0.08 to 0.62]). Hospitalization and intensive care unit duration, in-hospital mortality rate, rate of major and treatment related complications, of surgical revisions and of esophago-tracheal fistula failed to show significant differences between the two groups. Our analysis indicates a high potential for EVT, but because of the retrospective design of the included studies with potential biases, these results must be interpreted with caution. More robust prospective randomized trials should further investigate the potential of the two procedures.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scognamiglio</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany. p.scognamiglio@uke.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeh</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melling</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kantowski</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Interdisciplinary Endoscopy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichelmann</LastName><ForeName>Ann-Kathrin</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>General, Visceral and Transplantation Surgery, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chon</LastName><ForeName>Seung-Hun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Cancer Surgery, University Hospital Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Sourani</LastName><ForeName>Nader</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department for General and Visceral Surgery, University Hospital, Klinikum Oldenburg A&#xf6;R, Oldenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;n</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf6;ller</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izbicki</LastName><ForeName>Jakob R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tachezy</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Surg</MedlineTA><NlmUniqueID>100968567</NlmUniqueID><ISSNLinking>1471-2482</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003251" MajorTopicYN="N">Constriction, Pathologic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016099" MajorTopicYN="N">Endoscopy, Gastrointestinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054843" MajorTopicYN="Y">Negative-Pressure Wound Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anastomotic leakage</Keyword><Keyword MajorTopicYN="N">Endoscopic stenting</Keyword><Keyword MajorTopicYN="N">Esophagectomy</Keyword><Keyword MajorTopicYN="N">Vacuum therapy</Keyword></KeywordList><CoiStatement>All authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35953796</ArticleId><ArticleId IdType="pmc">PMC9367146</ArticleId><ArticleId IdType="doi">10.1186/s12893-022-01764-z</ArticleId><ArticleId IdType="pii">10.1186/s12893-022-01764-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barbour AP, Cormack OMM, Baker PJ, Hirst J, Krause L, Brosda S, et al. Long-term health-related quality of life following esophagectomy: a nonrandomized comparison of thoracoscopically assisted and open surgery. Ann Surg. 2017;265(6):1158&#x2013;1165. doi: 10.1097/SLA.0000000000001899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001899</ArticleId><ArticleId IdType="pubmed">27429022</ArticleId></ArticleIdList></Reference><Reference><Citation>Haverkamp L, Seesing MF, Ruurda JP, Boone J, Hillegersberg RV. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus. 2017;30(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27001442</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE. Evolution in surgical management of esophageal cancer. Dig Dis. 2013;31(1):21&#x2013;29. doi: 10.1159/000343650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343650</ArticleId><ArticleId IdType="pubmed">23797119</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, et al. Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med. 2019;380(2):152&#x2013;162. doi: 10.1056/NEJMoa1805101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1805101</ArticleId><ArticleId IdType="pubmed">30625052</ArticleId></ArticleIdList></Reference><Reference><Citation>Messager M, Pasquer A, Duhamel A, Caranhac G, Piessen G, Mariette C, et al. Laparoscopic gastric mobilization reduces postoperative mortality after esophageal cancer surgery: a French nationwide study. Ann Surg. 2015;262(5):817&#x2013;822. doi: 10.1097/SLA.0000000000001470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001470</ArticleId><ArticleId IdType="pubmed">26583671</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE, Kuppusamy MK, Alderson D, Cecconello I, Chang AC, Darling G, et al. Benchmarking complications associated with esophagectomy. Ann Surg. 2019;269(2):291&#x2013;298. doi: 10.1097/SLA.0000000000002611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002611</ArticleId><ArticleId IdType="pubmed">29206677</ArticleId></ArticleIdList></Reference><Reference><Citation>Markar S, Gronnier C, Duhamel A, Mabrut JY, Bail JP, Carrere N, et al. The impact of severe anastomotic leak on long-term survival and cancer recurrence after surgical resection for esophageal malignancy. Ann Surg. 2015;262(6):972&#x2013;980. doi: 10.1097/SLA.0000000000001011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001011</ArticleId><ArticleId IdType="pubmed">26469952</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198(1):42&#x2013;50. doi: 10.1016/j.jamcollsurg.2003.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2003.08.007</ArticleId><ArticleId IdType="pubmed">14698310</ArticleId></ArticleIdList></Reference><Reference><Citation>Whooley BP, Law S, Alexandrou A, Murthy SC, Wong J. Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer. Am J Surg. 2001;181(3):198&#x2013;203. doi: 10.1016/S0002-9610(01)00559-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(01)00559-1</ArticleId><ArticleId IdType="pubmed">11376570</ArticleId></ArticleIdList></Reference><Reference><Citation>Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg. 2011;28(1):29&#x2013;35. doi: 10.1159/000322014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000322014</ArticleId><ArticleId IdType="pubmed">21293129</ArticleId></ArticleIdList></Reference><Reference><Citation>Crestanello JA, Deschamps C, Cassivi SD, Nichols FC, Allen MS, Schleck C, et al. Selective management of intrathoracic anastomotic leak after esophagectomy. J Thorac Cardiovasc Surg. 2005;129(2):254&#x2013;260. doi: 10.1016/j.jtcvs.2004.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2004.10.024</ArticleId><ArticleId IdType="pubmed">15678033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooszen JAH, Goense L, Gisbertz SS, Ruurda JP, van Hillegersberg R, van Berge Henegouwen MI. Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer. Br J Surg. 2018;105(5):552&#x2013;560. doi: 10.1002/bjs.10728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10728</ArticleId><ArticleId IdType="pmc">PMC5900725</ArticleId><ArticleId IdType="pubmed">29412450</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin SM, Lamb PJ, Dresner SM, Richardson DL, Hayes N. Diagnosis and management of a mediastinal leak following radical oesophagectomy. Br J Surg. 2001;88(10):1346&#x2013;1351. doi: 10.1046/j.0007-1323.2001.01918.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0007-1323.2001.01918.x</ArticleId><ArticleId IdType="pubmed">11578290</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE. Diagnosis and management of anastomotic leaks after esophagectomy. J Gastrointest Surg. 2011;15(8):1319&#x2013;1322. doi: 10.1007/s11605-011-1511-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-011-1511-0</ArticleId><ArticleId IdType="pubmed">21557015</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmes D, Bruwer M, Bader FG, Betzler M, Becker H, Bruch HP, et al. Diagnostic evaluation, surgical technique, and perioperative management after esophagectomy: consensus statement of the German Advanced Surgical Treatment Study Group. Langenbecks Arch Surg. 2011;396(6):857&#x2013;866. doi: 10.1007/s00423-011-0818-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-011-0818-3</ArticleId><ArticleId IdType="pubmed">21713594</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkyilmaz A, Eroglu A, Aydin Y, Tekinbas C, MuharremErol M, Karaoglanoglu N. The management of esophagogastric anastomotic leak after esophagectomy for esophageal carcinoma. Dis Esophagus. 2009;22(2):119&#x2013;126. doi: 10.1111/j.1442-2050.2008.00866.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2050.2008.00866.x</ArticleId><ArticleId IdType="pubmed">18847447</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimminger PP, Goense L, Gockel I, Bergeat D, Bertheuil N, Chandramohan SM, et al. Diagnosis, assessment, and management of surgical complications following esophagectomy. Ann N Y Acad Sci. 2018;1434(1):254&#x2013;273. doi: 10.1111/nyas.13920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13920</ArticleId><ArticleId IdType="pubmed">29984413</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LW, Hofstetter W, Swisher SG, Roth JA. Management of intrathoracic leaks following esophagectomy. Adv Surg. 2006;40:173&#x2013;190. doi: 10.1016/j.yasu.2006.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yasu.2006.05.010</ArticleId><ArticleId IdType="pubmed">17163101</ArticleId></ArticleIdList></Reference><Reference><Citation>Messager M, Warlaumont M, Renaud F, Marin H, Branche J, Piessen G, et al. Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. Eur J Surg Oncol. 2017;43(2):258&#x2013;269. doi: 10.1016/j.ejso.2016.06.394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2016.06.394</ArticleId><ArticleId IdType="pubmed">27396305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasari BV, Neely D, Kennedy A, Spence G, Rice P, Mackle E, et al. The role of esophageal stents in the management of esophageal anastomotic leaks and benign esophageal perforations. Ann Surg. 2014;259(5):852&#x2013;860. doi: 10.1097/SLA.0000000000000564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000564</ArticleId><ArticleId IdType="pubmed">24509201</ArticleId></ArticleIdList></Reference><Reference><Citation>Persson S, Rouvelas I, Irino T, Lundell L. Outcomes following the main treatment options in patients with a leaking esophagus: a systematic literature review. Dis Esophagus. 2017;30(12):1&#x2013;10. doi: 10.1093/dote/dox108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/dox108</ArticleId><ArticleId IdType="pubmed">28881894</ArticleId></ArticleIdList></Reference><Reference><Citation>Pournaras DJ, Hardwick RH, Safranek PM, Sujendran V, Bennett J, Macaulay GD, et al. Endoluminal vacuum therapy (E-Vac): a treatment option in oesophagogastric surgery. World J Surg. 2018;42(8):2507&#x2013;2511. doi: 10.1007/s00268-018-4463-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4463-7</ArticleId><ArticleId IdType="pmc">PMC6060786</ArticleId><ArticleId IdType="pubmed">29372375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent B, Griffin SM, Jones R, Wahed S, Immanuel A, Hayes N. Management and outcomes of anastomotic leaks after oesophagectomy. Br J Surg. 2016;103(8):1033&#x2013;1038. doi: 10.1002/bjs.10175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10175</ArticleId><ArticleId IdType="pubmed">27146631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehn F, Loske G, Schiffmann L, Gock M, Klar E. Endoscopic vacuum therapy for various defects of the upper gastrointestinal tract. Surg Endosc. 2017;31(9):3449&#x2013;3458. doi: 10.1007/s00464-016-5404-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-016-5404-x</ArticleId><ArticleId IdType="pubmed">28078463</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgilio E, Ceci D, Cavallini M. Surgical endoscopic vacuum-assisted closure therapy (EVAC) in treating anastomotic leakages after major resective surgery of esophageal and gastric cancer. Anticancer Res. 2018;38(10):5581&#x2013;5587. doi: 10.21873/anticanres.12892.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.12892</ArticleId><ArticleId IdType="pubmed">30275175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Esquivel R, Raju GS. Endoscopic closure of acute esophageal perforations. Curr Gastroenterol Rep. 2013;15(5):321. doi: 10.1007/s11894-013-0321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-013-0321-9</ArticleId><ArticleId IdType="pubmed">23558969</ArticleId></ArticleIdList></Reference><Reference><Citation>Mennigen R, Colombo-Benkmann M, Senninger N, Laukoetter M. Endoscopic closure of postoperative gastrointestinal leakages and fistulas with the Over-the-Scope Clip (OTSC) J Gastrointest Surg. 2013;17(6):1058&#x2013;1065. doi: 10.1007/s11605-013-2156-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-013-2156-y</ArticleId><ArticleId IdType="pubmed">23400507</ArticleId></ArticleIdList></Reference><Reference><Citation>Scognamiglio P, Reeh M, Karstens K, Bellon E, Kantowski M, Schon G, et al. Endoscopic vacuum therapy versus stenting for postoperative esophago-enteric anastomotic leakage: systematic review and meta-analysis. Endoscopy. 2020;52(8):632&#x2013;642. doi: 10.1055/a-1149-1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1149-1741</ArticleId><ArticleId IdType="pubmed">32316043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausa E, Asti E, Aiolfi A, Bianco F, Bonitta G, Bonavina L. Comparison of endoscopic vacuum therapy versus endoscopic stenting for esophageal leaks: systematic review and meta-analysis. Dis Esophagus. 2018 doi: 10.1093/dote/doy060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/doy060</ArticleId><ArticleId IdType="pubmed">29939229</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Sohn H, Steele R, Benedetti A. Two-sample aggregate data metaanalysis of medians. 2018. ArXiv e-prints https://arxiv.org/abs/1809.01278.</Citation></Reference><Reference><Citation>RC T. A language and environment for statistical computing. R Foundation for Statistical Computing 2019. https://www.R-project.org/.</Citation></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2019;36:1&#x2013;48.</Citation></Reference><Reference><Citation>McGrath S, Zhao X, Steele R, Benedetti A. Metamedian: meta-analysis of medians. R package version 0.1.4. 2019. https://CRAN.R-project.org/package=metamedian.</Citation></Reference><Reference><Citation>Berlth F, Bludau M, Plum PS, Herbold T, Christ H, Alakus H, et al. Self-expanding metal stents versus endoscopic vacuum therapy in anastomotic leak treatment after oncologic gastroesophageal surgery. J Gastrointest Surg. 2019;23(1):67&#x2013;75. doi: 10.1007/s11605-018-4000-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-018-4000-x</ArticleId><ArticleId IdType="pubmed">30374816</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangewitz M, Voigtlander T, Helfritz FA, Lankisch TO, Winkler M, Klempnauer J, et al. Endoscopic closure of esophageal intrathoracic leaks: stent versus endoscopic vacuum-assisted closure, a retrospective analysis. Endoscopy. 2013;45(6):433&#x2013;438. doi: 10.1055/s-0032-1326435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1326435</ArticleId><ArticleId IdType="pubmed">23733727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang JJ, Jeong YS, Park YS, Yoon H, Shin CM, Kim N, et al. Comparison of endoscopic vacuum therapy and endoscopic stent implantation with self-expandable metal stent in treating postsurgical gastroesophageal leakage. Medicine (Baltimore) 2016;95(16):e3416. doi: 10.1097/MD.0000000000003416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003416</ArticleId><ArticleId IdType="pmc">PMC4845835</ArticleId><ArticleId IdType="pubmed">27100431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mennigen R, Harting C, Lindner K, Vowinkel T, Rijcken E, Palmes D, et al. Comparison of endoscopic vacuum therapy versus stent for anastomotic leak after esophagectomy. J Gastrointest Surg. 2015;19(7):1229&#x2013;1235. doi: 10.1007/s11605-015-2847-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-015-2847-7</ArticleId><ArticleId IdType="pubmed">25967140</ArticleId></ArticleIdList></Reference><Reference><Citation>Schniewind B, Schafmayer C, Voehrs G, Egberts J, von Schoenfels W, Rose T, et al. Endoscopic endoluminal vacuum therapy is superior to other regimens in managing anastomotic leakage after esophagectomy: a comparative retrospective study. Surg Endosc. 2013;27(10):3883&#x2013;3890. doi: 10.1007/s00464-013-2998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-013-2998-0</ArticleId><ArticleId IdType="pubmed">23708716</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichelmann AK, Ismail S, Merten J, Slepecka P, Palmes D, Laukotter MG, et al. Economic burden of endoscopic vacuum therapy compared to alternative therapy methods in patients with anastomotic leakage after esophagectomy. J Gastrointest Surg. 2021;25(10):2447&#x2013;2454. doi: 10.1007/s11605-021-04955-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-021-04955-w</ArticleId><ArticleId IdType="pmc">PMC8523444</ArticleId><ArticleId IdType="pubmed">33629233</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Sourani N, Miftode S, Bockhorn M, Arlt A, Meinhardt C. Endoscopic management of anastomotic leakage after esophageal surgery: ten year analysis in a Tertiary University Center. Clin Endosc. 2022;55(1):58&#x2013;66. doi: 10.5946/ce.2021.099.</Citation><ArticleIdList><ArticleId IdType="doi">10.5946/ce.2021.099</ArticleId><ArticleId IdType="pmc">PMC8831416</ArticleId><ArticleId IdType="pubmed">34645084</ArticleId></ArticleIdList></Reference><Reference><Citation>do Monte Junior ES, de Moura DTH, Ribeiro IB, Hathorn KE, Farias GFA, Turiani CV, et al. Endoscopic vacuum therapy versus endoscopic stenting for upper gastrointestinal transmural defects: systematic review and meta-analysis. Dig Endosc. 2021;33(6):892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">33300634</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambertz R, Holscher AH, Bludau M, Leers JM, Gutschow C, Schroder W. Management of tracheo- or bronchoesophageal fistula after ivor-lewis esophagectomy. World J Surg. 2016;40(7):1680&#x2013;1687. doi: 10.1007/s00268-016-3470-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-016-3470-9</ArticleId><ArticleId IdType="pubmed">26913731</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidenhagen R, Hartl WH, Gruetzner KU, Eichhorn ME, Spelsberg F, Jauch KW. Anastomotic leakage after esophageal resection: new treatment options by endoluminal vacuum therapy. Ann Thorac Surg. 2010;90(5):1674&#x2013;1681. doi: 10.1016/j.athoracsur.2010.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.07.007</ArticleId><ArticleId IdType="pubmed">20971288</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Q, Zhou S, Song Y, Xun X, Liu N, Liu L. Treatment of intrathoracic anastomotic leak after esophagectomy with the sump drainage tube. J Cardiothorac Surg. 2021;16(1):46. doi: 10.1186/s13019-021-01429-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-021-01429-7</ArticleId><ArticleId IdType="pmc">PMC7988901</ArticleId><ArticleId IdType="pubmed">33757562</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske G, Schorsch T, Muller C. Intraluminal and intracavitary vacuum therapy for esophageal leakage: a new endoscopic minimally invasive approach. Endoscopy. 2011;43(6):540&#x2013;544. doi: 10.1055/s-0030-1256345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1256345</ArticleId><ArticleId IdType="pubmed">21448855</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske G, Muller CT. Tips and tricks for endoscopic negative pressure therapy. Chirurg. 2019;90(Suppl 1):7&#x2013;14. doi: 10.1007/s00104-018-0725-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00104-018-0725-z</ArticleId><ArticleId IdType="pmc">PMC6347589</ArticleId><ArticleId IdType="pubmed">30280205</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske G, Schorsch T, Rucktaeschel F, Schulze W, Riefel B, van Ackeren V, et al. Open-pore film drainage (OFD): a new multipurpose tool for endoscopic negative pressure therapy (ENPT) Endosc Int Open. 2018;6(7):E865&#x2013;E871. doi: 10.1055/a-0599-5886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0599-5886</ArticleId><ArticleId IdType="pmc">PMC6031437</ArticleId><ArticleId IdType="pubmed">29978007</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moura DTH, Hirsch BS, Do Monte Junior ES, McCarty TR, de Medeiros FS, Thompson CC, et al. Cost-effective modified endoscopic vacuum therapy for the treatment of gastrointestinal transmural defects: step-by-step process of manufacturing and its advantages. VideoGIE. 2021;6(12):523&#x2013;528. doi: 10.1016/j.vgie.2021.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vgie.2021.08.002</ArticleId><ArticleId IdType="pmc">PMC8645785</ArticleId><ArticleId IdType="pubmed">34917860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chon SH, Tox U, Lorenz F, Rieck I, Wagner BJ, Kleinert R, et al. A novel hybrid stent with endoscopic vacuum therapy for treating leaks of the upper gastrointestinal tract. Visc Med. 2021;37(5):403&#x2013;409. doi: 10.1159/000512320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512320</ArticleId><ArticleId IdType="pmc">PMC8543322</ArticleId><ArticleId IdType="pubmed">34722723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamarajah SK, Lin A, Tharmaraja T, Bharwada Y, Bundred JR, Nepogodiev D, et al. Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis. Dis Esophagus. 2020;33(3):doz089. doi: 10.1093/dote/doz089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/doz089</ArticleId><ArticleId IdType="pubmed">31957798</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo-Grueso M, Bolton N, Brown R. Endoscopic vacuum therapy via pharyngostomy: novel access for management of upper gastrointestinal defects. Am Surg. 2021 doi: 10.1177/00031348211041567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00031348211041567</ArticleId><ArticleId IdType="pubmed">34459263</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske G, Liedke M, Schloricke E, Herrmann T, Rucktaeschel F. Endoscopic negative-pressure therapy for duodenal leakage using new open-pore film and polyurethane foam drains with the pull-through technique. Endoscopy. 2017;49(12):E300&#x2013;E302. doi: 10.1055/s-0043-119346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-119346</ArticleId><ArticleId IdType="pubmed">28946171</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller J, Goerdt AM, Muller CT, Loske G. Endoscopic negative pressure therapy for a broad rectal fistula using pull-through open-pore film and polyurethane foam drains. Endoscopy. 2021 doi: 10.1055/a-1519-6825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1519-6825</ArticleId><ArticleId IdType="pubmed">34243203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler C, Vetter D, Schmidt HM, Muller PC, Morell B, Raptis D, et al. Preemptive endoluminal vacuum therapy to reduce anastomotic leakage after esophagectomy: a game-changing approach? Dis Esophagus. 2019;32(7):doy126. doi: 10.1093/dote/doy126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/doy126</ArticleId><ArticleId IdType="pubmed">30596963</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann PA, Mennigen R, Palmes D, Senninger N, Vowinkel T, Laukoetter MG. Pre-emptive endoscopic vacuum therapy for treatment of anastomotic ischemia after esophageal resections. Endoscopy. 2017;49(5):498&#x2013;503. doi: 10.1055/s-0042-123188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-123188</ArticleId><ArticleId IdType="pubmed">28107761</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske G, Muller J, Schulze W, Riefel B, Muller CT. Pre-emptive active drainage of reflux (PARD) in Ivor-Lewis oesophagectomy with negative pressure and simultaneous enteral nutrition using a double-lumen open-pore film drain (dOFD) Surg Endosc. 2022;36(3):2208&#x2013;2216. doi: 10.1007/s00464-021-08933-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-021-08933-w</ArticleId><ArticleId IdType="pmc">PMC8847238</ArticleId><ArticleId IdType="pubmed">34973079</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltin C, Kron F, Urbanski A, Zander T, Kron A, Berlth F, et al. The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy. PLoS ONE. 2019;14(8):e0221406. doi: 10.1371/journal.pone.0221406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221406</ArticleId><ArticleId IdType="pmc">PMC6713440</ArticleId><ArticleId IdType="pubmed">31461487</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachezy M, Chon SH, Rieck I, Kantowski M, Christ H, Karstens K, et al. Endoscopic vacuum therapy versus stent treatment of esophageal anastomotic leaks (ESOLEAK): study protocol for a prospective randomized phase 2 trial. Trials. 2021;22(1):377. doi: 10.1186/s13063-021-05315-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05315-4</ArticleId><ArticleId IdType="pmc">PMC8170795</ArticleId><ArticleId IdType="pubmed">34078426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38467037</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1533-4023</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiovascular pharmacology</Title><ISOAbbreviation>J Cardiovasc Pharmacol</ISOAbbreviation></Journal><ArticleTitle>N-Acetylcysteine to Reduce Mortality for Patients Requiring Cardiac Catheterization or Cardiac Surgery: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>580</StartPage><EndPage>587</EndPage><MedlinePgn>580-587</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/FJC.0000000000001551</ELocationID><Abstract><AbstractText>Multimers of von Willebrand factor play a critical role in various processes inducing morbidity and mortality in cardiovascular-risk patients. With the ability to reduce von Willebrand factor multimers, N-acetylcysteine (NAC) could reduce mortality in patients undergoing coronary catheterization or cardiac surgery. However, its impact in perioperative period has never been studied so far in regard of its potential cardiovascular benefits. Then, 4 databases were searched for randomized controlled trials that compared in-hospital mortality between an experimental group, with NAC, and a control group without NAC, in patients undergoing coronary catheterization or cardiac surgery. The primary efficacy outcome was in-hospital mortality. Secondary outcomes were the occurrence of thrombotic events, major cardiovascular events, myocardial infarction, and contrast-induced nephropathy. The safety outcome was occurrence of hemorrhagic events. Nineteen studies totaling 3718 patients were included. Pooled analysis demonstrated a reduction of in-hospital mortality associated with NAC: odds ratio, 0.60; 95% confidence interval, 0.39-0.92; P = 0.02. The occurrence of secondary outcomes was not significantly reduced with NAC except for contrast-induced nephropathy. No difference was reported for hemorrhagic events. Subgroup analyses revealed a life-saving effect of NAC in a dose-dependent manner with reduction of in-hospital mortality for the NAC high-dose group, but not for the NAC standard-dose (&lt;3500-mg) group. In conclusion, without being able to conclude on the nature of the mechanism involved, our review suggests a benefit of NAC in cardiovascular-risk patients in perioperative period in terms of mortality and supports prospective confirmatory studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gakuba</LastName><ForeName>Clement</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6523-3954</Identifier><AffiliationInfo><Affiliation>d&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, CHU de Caen Normandie, Caen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d&#xe9;partement PhIND &#xab; Physiopathology and imaging of Neurological Disorders &#xbb;, Institut Blood and Brain @ Caen-Normandie, Normandie Univ, UNICAEN, INSERM, U1237, Cyceron, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumitrascu</LastName><ForeName>Alexandru-Daniel</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>d&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, CHU de Caen Normandie, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsan</LastName><ForeName>Pierre-Emmanuel</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>d&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, CHU de Caen Normandie, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legallois</LastName><ForeName>Damien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>d&#xe9;partement de Cardiologie, CHU de Caen Normandie, EA4650 (SEILIRM), FHU REMOD-VHF,Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanouz</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>d&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, CHU de Caen Normandie, Caen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d&#xe9;partement PhIND &#xab; Physiopathology and imaging of Neurological Disorders &#xbb;, Institut Blood and Brain @ Caen-Normandie, Normandie Univ, UNICAEN, INSERM, U1237, Cyceron, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vivien</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>d&#xe9;partement PhIND &#xab; Physiopathology and imaging of Neurological Disorders &#xbb;, Institut Blood and Brain @ Caen-Normandie, Normandie Univ, UNICAEN, INSERM, U1237, Cyceron, Caen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d&#xe9;partement de Recherche Clinique, CHU de Caen Normandie, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez de Lizarrondo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>d&#xe9;partement PhIND &#xab; Physiopathology and imaging of Neurological Disorders &#xbb;, Institut Blood and Brain @ Caen-Normandie, Normandie Univ, UNICAEN, INSERM, U1237, Cyceron, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauberti</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>d&#xe9;partement PhIND &#xab; Physiopathology and imaging of Neurological Disorders &#xbb;, Institut Blood and Brain @ Caen-Normandie, Normandie Univ, UNICAEN, INSERM, U1237, Cyceron, Caen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d&#xe9;partement de Radiologie diagnostique et interventionnelle, CHU de Caen Normandie, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerasuolo</LastName><ForeName>Damiano</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>d&#xe9;partement de sant&#xe9; publique, Centre hospitalier universitaire de Caen, Caen, France; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM U1086, ANTICIPE, Caen, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Pharmacol</MedlineTA><NlmUniqueID>7902492</NlmUniqueID><ISSNLinking>0160-2446</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiovasc Pharmacol. 2024 Jun 01;83(6):534-536. doi: 10.1097/FJC.0000000000001558.</RefSource><PMID Version="1">38547513</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="Y">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="Y">Acetylcysteine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>19</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>17</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38467037</ArticleId><ArticleId IdType="doi">10.1097/FJC.0000000000001551</ArticleId><ArticleId IdType="pii">00005344-202406000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Castro-Dominguez YS, Wang Y, Minges KE, et al. Predicting in-hospital mortality in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2021;78:216&#x2013;229.</Citation></Reference><Reference><Citation>Mazzeffi M, Zivot J, Buchman T, et al. In-hospital mortality after cardiac surgery: patient characteristics, timing, and association with postoperative length of intensive care unit and hospital stay. Ann Thorac Surg. 2014;97:1220&#x2013;1225.</Citation></Reference><Reference><Citation>Chen J, Chung DW. Inflammation, von Willebrand factor, and ADAMTS13. Blood. 2018;132:141&#x2013;147.</Citation></Reference><Reference><Citation>Spiel AO, Gilbert JC, Jilma B. Von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117:1449&#x2013;1459.</Citation></Reference><Reference><Citation>Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395&#x2013;424.</Citation></Reference><Reference><Citation>Chen J, Reheman A, Gushiken FC, et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest. 2011;121:593&#x2013;603.</Citation></Reference><Reference><Citation>Martinez de Lizarrondo S, Gakuba C, Herbig BA, et al. Potent thrombolytic effect of N-acetylcysteine on arterial thrombi. Circulation. 2017;136:646&#x2013;660.</Citation></Reference><Reference><Citation>Lillicrap D. Thrombolytic potential of N -acetylcysteine. Circulation. 2017;136:661&#x2013;663.</Citation></Reference><Reference><Citation>HIGGINS JP, GREEN S. Cochrane Handbook for Systematic Reviews of Interventions . The COCHRANE COLLABORATION:London, UK;2011.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation></Reference><Reference><Citation>Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int. 2006;69:S11&#x2013;S15.</Citation></Reference><Reference><Citation>Babic A, Tokalic R, Am&#xed;lcar Silva Cunha J, et al. Assessments of attrition bias in Cochrane systematic reviews are highly inconsistent and thus hindering trial comparability. BMC Med Res Methodol. 2019;19:76.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation></Reference><Reference><Citation>Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.</Citation></Reference><Reference><Citation>Biernacka-Fia&#x142;kowska B, Szuksztul M, Su&#x15b;lik W, et al. Intravenous N-acetylcysteine for the PRevention of Contrast-induced nephropathy&#x2014;a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial. Postep W Kardiol Interwencyjnej. 2018;14:59&#x2013;66.</Citation></Reference><Reference><Citation>Carbonell N, Blasco M, Sanju&#xe1;n R, et al. Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. Int J Cardiol. 2007;115:57&#x2013;62.</Citation></Reference><Reference><Citation>Tossios P, Bloch W, Huebner A, et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg. 2003;126:1513&#x2013;1520.</Citation></Reference><Reference><Citation>Carbonell N, Sanju&#xe1;n R, Blasco M, et al. N-acetylcysteine: short-term clinical benefits after coronary angiography in high-risk renal patients. Rev Esp Cardiol. 2010;63:12&#x2013;19.</Citation></Reference><Reference><Citation>Jaffery Z, Verma A, White CJ, et al. A randomized trial of intravenous N-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. Catheter Cardiovasc Interv. 2012;79:921&#x2013;926.</Citation></Reference><Reference><Citation>Kim JC, Hong SW, Shim JK, et al. Effect of N-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery. Acta Anaesthesiol Scand. 2011;55:452&#x2013;459.</Citation></Reference><Reference><Citation>Orhan G, Yapici N, Yuksel M, et al. Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels. 2006;21:42&#x2013;47.</Citation></Reference><Reference><Citation>Ozaydin M, Icli A, Yucel H, et al. Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. Eur Heart J. 2013;34:597&#x2013;604.</Citation></Reference><Reference><Citation>Pasupathy S, Tavella R, Grover S, et al. Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment&#x2013;elevation myocardial infarction reduces myocardial infarct size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]). Circulation. 2017;136:894&#x2013;903.</Citation></Reference><Reference><Citation>Santana-Santos E, Gowdak LHW, Gaiotto FA, et al. High dose of N-acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization. Ann Thorac Surg. 2014;97:1617&#x2013;1623.</Citation></Reference><Reference><Citation>Sisillo E, Ceriani R, Bortone F, et al. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008;36:81&#x2013;86.</Citation></Reference><Reference><Citation>Park SH, Jeong MH, Park IH, et al. Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2016;212:100&#x2013;106.</Citation></Reference><Reference><Citation>Miner SES, Dzavik V, Nguyen-Ho P, et al. N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up. Am Heart J. 2004;148:690&#x2013;695.</Citation></Reference><Reference><Citation>Kazemi B, Akbarzadeh F, Safaei N, et al. Prophylactic high-dose oral-N-acetylcysteine does not prevent atrial fibrillation after heart surgery: a prospective double blind placebo-controlled randomized clinical trial. Pacing Clin Electrophysiol. 2013;36:1211&#x2013;1219.</Citation></Reference><Reference><Citation>Hafiz AM, Jan MF, Mori N, et al. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies. Catheter Cardiovasc Interv. 2012;79:929&#x2013;937.</Citation></Reference><Reference><Citation>Gomes VO, Poli De Figueredo CE, Caramori P, et al. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart. 2005;91:774&#x2013;778.</Citation></Reference><Reference><Citation>Amini S, Robabi HN, Tashnizi MA, et al. Selenium, vitamin c and n-acetylcysteine do not reduce the risk of acute kidney injury after off-pump cabg: a randomized clinical trial. Braz J Cardiovasc Surg. 2018;33:129&#x2013;134.</Citation></Reference><Reference><Citation>Adabag AS, Ishani A, Koneswaran S, et al. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J. 2008;155:1143&#x2013;1149.</Citation></Reference><Reference><Citation>Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773&#x2013;2782.</Citation></Reference><Reference><Citation>Guo Z, Liu J, Lei L, et al. Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2020;10:e039009.</Citation></Reference><Reference><Citation>Biondi-Zoccai GGL, Lotrionte M, Abbate A, et al. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. BMJ (Clinical Research Ed.). 2006;332:202&#x2013;209.</Citation></Reference><Reference><Citation>Pereira JEG, El Dib R, Braz LG, et al. N-acetylcysteine use among patients undergoing cardiac surgery: a systematic review and meta-analysis of randomized trials. PLoS One. 2019;14:e0213862.</Citation></Reference><Reference><Citation>Fishbane S. N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol. 2008;3:281&#x2013;287.</Citation></Reference><Reference><Citation>Cepaityte D, Leivaditis K, Varouktsi G, et al. N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients&#x2014;focus on the antioxidant and anti-inflammatory properties. Int Urol Nephrol. 2023;55:1481&#x2013;1492.</Citation></Reference><Reference><Citation>Khan SA, Campbell AM, Lu Y, et al. N-acetylcysteine for cardiac protection during coronary artery reperfusion: a systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2021;8:752939.</Citation></Reference><Reference><Citation>Valerio V, Keceli G, Moschetta D, et al. Enduring reactive oxygen species emission causes aberrant protein S-glutathionylation transitioning human aortic valve cells from a sclerotic to a stenotic phenotype. Antioxid Redox Signaling. 2022;37:1051&#x2013;1071.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24012233</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2013</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-1608</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Best practice &amp; research. Clinical anaesthesiology</Title><ISOAbbreviation>Best Pract Res Clin Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Monitoring respiration: what the clinician needs to know.</ArticleTitle><Pagination><StartPage>209</StartPage><EndPage>223</EndPage><MedlinePgn>209-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpa.2013.06.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1521-6896(13)00039-6</ELocationID><Abstract><AbstractText>A recent large prospective cohort study showed an unexpectedly high in-hospital mortality after major non-cardiac surgery in Europe, as well as a high incidence of postoperative pulmonary complications. The direct effect of postoperative respiratory complications on mortality is still under investigation, for intensive care unit (ICU) and in the perioperative period. Although respiratory monitoring has not been actually proven to affect in-hospital mortality, it plays an important role in patient care, leading to appropriate setting of ventilatory support as well as risk stratification. The aim of this article is to provide an overview of various respiratory monitoring techniques including the role of conventional and most recent methods in the perioperative period and in critically ill patients. The most recent techniques proposed for bedside respiratory monitoring, including lung imaging, are presented and discussed, comparing them to those actually considered as gold standards.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino-IST, Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy. lorenzo.ball@email.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutherasan</LastName><ForeName>Yuda</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Best Pract Res Clin Anaesthesiol</MedlineTA><NlmUniqueID>101121446</NlmUniqueID><ISSNLinking>1753-3740</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="N">Point-of-Care Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="N">Respiratory Mechanics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">lung physiology</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">respiratory monitoring</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24012233</ArticleId><ArticleId IdType="doi">10.1016/j.bpa.2013.06.004</ArticleId><ArticleId IdType="pii">S1521-6896(13)00039-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35979735</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>External validation of a surgical mortality risk prediction model for inpatient noncardiac surgery in an Australian private health insurance dataset.</ArticleTitle><Pagination><StartPage>2873</StartPage><EndPage>2880</EndPage><MedlinePgn>2873-2880</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.17946</ELocationID><Abstract><AbstractText Label="BACKGROUND">We previously conducted a systematic review to identify surgical mortality risk prediction tools suitable for adapting in the Australian context and identified the Surgical Outcome Risk Tool (SORT) as an ideal model. The primary aim was to investigate the external validity of SORT for predicting in-hospital mortality in a large Australian private health insurance dataset.</AbstractText><AbstractText Label="METHODS">A cohort study using a prospectively collected Australian private health insurance dataset containing over 2 million deidentified records. External validation was conducted by applying the predictive equation for SORT to the complete case analysis dataset. Model re-estimation (recalibration) was performed by logistic regression.</AbstractText><AbstractText Label="RESULTS">The complete case analysis dataset contained 161&#x2009;277 records. In-hospital mortality was 0.2% (308/161277). The mean estimated risk given by SORT was 0.2% and the median (IQR) was 0.01% (0.003%-0.08%). Discrimination was high (c-statistic 0.96) and calibration was accurate over the range 0%-10%, beyond which mortality was over-predicted but confidence intervals included or closely approached the perfect prediction line. Re-estimation of the equation did not improve over-prediction. Model diagnostics suggested the presence of outliers or highly influential values.</AbstractText><AbstractText Label="CONCLUSION">The low perioperative mortality rate suggests the dataset was not representative of the overall Australian surgical population, primarily due to selection bias and classification bias. Our results suggest SORT may significantly under-predict 30-day mortality in this dataset. Given potential differences in perioperative mortality, private health insurance status and hospital setting should be considered as covariables when a locally validated national surgical mortality risk prediction model is developed.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. ANZ Journal of Surgery published by John Wiley &amp; Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reilly</LastName><ForeName>Jennifer Richelle</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-7109-8493</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Darren</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1490-0547</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Wendy Ann</ForeName><Initials>WA</Initials><Identifier Source="ORCID">0000-0002-0137-2688</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Alfred Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabbe</LastName><ForeName>Belinda Jane</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0001-7096-7688</Identifier><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul Stewart</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0002-3324-5456</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Australian and New Zealand College of Anaesthetists, Project Grant and PhD Scholarship</Agency><Country/></Grant><Grant><Agency>Australian Government, Research Training Program (RTP) Scholarship</Agency><Country/></Grant><Grant><Agency>Australian Society of Anaesthetists, Jackson Rees Research Scholarship</Agency><Country/></Grant><Grant><Agency>Faculty of Medicine, Nursing and Health Sciences, Monash University, Graduate Excellence Scholarship</Agency><Country/></Grant><Grant><Agency>National Health and Medical Research Council, Practitioner Fellowship</Agency><Country/></Grant><Grant><Agency>Australian and New Zealand College of Anaesthetists</Agency><Country/></Grant><Grant><Agency>Australian Society of Anaesthetists</Agency><Country/></Grant><Grant><Agency>National Health and Medical Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="Y">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007348" MajorTopicYN="Y">Insurance, Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">risk</Keyword><Keyword MajorTopicYN="N">risk score</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>18</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35979735</ArticleId><ArticleId IdType="doi">10.1111/ans.17946</ArticleId><ArticleId IdType="pmc">PMC9804688</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peden CJ, Stephens T, Martin G et al. A national quality improvement programme to improve survival after emergency abdominal surgery: the EPOCH stepped&#x2010;wedge cluster RCT. Health Services Deliv. Res. 2019; 7: 1&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">31577397</ArticleId></ArticleIdList></Reference><Reference><Citation>Story DA, Shelton A, Jones D, Heland M, Belomo R. Austin health Post&#x2010;operative surveillance team I. audit of co&#x2010;management and critical care outreach for high risk postoperative patients (the POST audit). Anaesth. Intensive Care 2013; 41: 793&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24180722</ArticleId></ArticleIdList></Reference><Reference><Citation>Swart M, Carlisle JB, Goddard J. Using predicted 30 day mortality to plan postoperative colorectal surgery care: a cohort study. Br. J. Anaesth. 2017; 118: 100&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">28039247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd C, Proctor L, Au M, Story D, Edwards S, Ludbrook G. Incidence of early major adverse events after surgery in moderate&#x2010; risk patients: early postoperative adverse events. Br. J. Anaesth. 2020; 124: e9&#x2013;e10. 10.1016/j.bja.2019.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.10.002</ArticleId><ArticleId IdType="pubmed">31706578</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D, Boyle L, Soakell&#x2010;Ho M et al. National risk prediction model for perioperative mortality in non&#x2010;cardiac surgery. Br. J. Surg. 2019; 106: 1549&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">31386174</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly JR, Gabbe BJ, Brown WA, Hodgson CL, Myles PS. Systematic review of perioperative mortality risk prediction models for adults undergoing inpatient non&#x2010;cardiac surgery. ANZ J. Surg. 2021; 91: 860&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">32935458</ArticleId></ArticleIdList></Reference><Reference><Citation>Protopapa KL, Simpson JC, Smith NC, Moonesinghe SR. Development and validation of the surgical outcome risk tool (SORT). Br. J. Surg. 2014; 101: 1774&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4240514</ArticleId><ArticleId IdType="pubmed">25388883</ArticleId></ArticleIdList></Reference><Reference><Citation>Glance LG, Lustik SJ, Hannan EL et al. The surgical mortality probability model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann. Surg. 2012; 255: 696&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">22418007</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Manach Y, Collins G, Rodseth R et al. Preoperative score to predict postoperative mortality (POSPOM) derivation and validation. Anesthesiology 2016; 124: 570&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26655494</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. J. Clin. Epidemiol. 2015; 68: 134&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25579640</ArticleId></ArticleIdList></Reference><Reference><Citation>Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941; 2: 281&#x2013;4.</Citation></Reference><Reference><Citation>Australian Consortium for Classification Development . The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD&#x2010;10&#x2010;AM/ACHI/ACS), 10th edn. Darlinghurst, NSW: Independent Hospital Pricing Authority, 2017.</Citation></Reference><Reference><Citation>Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation and Updating, 2nd edn. Switzerland: Springer Nature, 2019.</Citation></Reference><Reference><Citation>RStudio Team. RStudio: Integrated Development for R. 1.1.442 ed. Boston: PBC, 2020.</Citation></Reference><Reference><Citation>Van Calster B, McLernon DJ, van Smeden M et al. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019; 17: 230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6912996</ArticleId><ArticleId IdType="pubmed">31842878</ArticleId></ArticleIdList></Reference><Reference><Citation>Field A, Miles J, Field Z. Discovering Statistics Using R. London: SAGE Publications Ltd, 2012.</Citation></Reference><Reference><Citation>Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW. A calibration hierarchy for risk models was defined: from utopia to empirical data. J. Clin. Epidemiol. 2016; 74: 167&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">26772608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sv B, Groothuis&#x2010;Oudshoorn K. Mice: multivariate imputation by chained equations in R. J. Stat. Softw. 2011; 45: 1&#x2013;67. 10.18637/jss.v045.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v045.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly JR, Wong D, Heritier S, Brown WA, Richards T, Bell M. Hospital costs and factors associated with &#x201c;days alive and at home after surgery&#x201d;. Med. J. Aust. 10.5694/mja2.51658</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.51658</ArticleId><ArticleId IdType="pmc">PMC9796479</ArticleId><ArticleId IdType="pubmed">35852009</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW. Validation in prediction research: the waste by data splitting. J. Clin. Epidemiol. 2018; 103: 131&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">30063954</ArticleId></ArticleIdList></Reference><Reference><Citation>Watters DA, Babidge WJ, Kiermeier A, McCulloch GA, Maddern GJ. Perioperative mortality rates in Australian public hospitals: the influence of age gender and urgency. World J. Surg. 2016; 40: 2591&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27255941</ArticleId></ArticleIdList></Reference><Reference><Citation>International Surgical Outcomes Study Group . Global patient outcomes after elective surgery: prospective cohort study in 27 low&#x2010;, middle&#x2010; and high&#x2010;income countries. Br. J. Anaesth. 2016; 117: 601&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5091334</ArticleId><ArticleId IdType="pubmed">27799174</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse RM, Moreno RP, Bauer P et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet 2012; 380: 1059&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Bureau of Statistics . Patient experiences in Australia. In: Summary of Findings. Canberra: ABS, 2019; 2017&#x2013;8.</Citation></Reference><Reference><Citation>Australian Institute of Health and Welfare . Australia's Hospitals at a Glance 2018&#x2013;19. Canberra: AIHW, 2020.</Citation></Reference><Reference><Citation>Gutierrez CS, Passos SC, Castro SMJ et al. Few and feasible preoperative variables can identify high&#x2010;risk surgical patients: derivation and validation of the ex&#x2010;care risk model. Br. J. Anaesth. 2021; 126: 525&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">33127046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong DJN, Harris S, Sahni A et al. Developing and validating subjective and objective risk&#x2010;assessment measures for predicting mortality after major surgery: an international prospective cohort study. PLoS Med. 2020; 17: e1003253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561094</ArticleId><ArticleId IdType="pubmed">33057333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37674585</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1687-6962</ISSN><JournalIssue CitedMedium="Print"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Anesthesiology research and practice</Title><ISOAbbreviation>Anesthesiol Res Pract</ISOAbbreviation></Journal><ArticleTitle>Association between Intraoperative Early Warning Score and Mortality and In-Hospital Stay in Lower Gastrointestinal Spontaneous Perforation.</ArticleTitle><Pagination><StartPage>8910198</StartPage><MedlinePgn>8910198</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8910198</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2023/8910198</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Early warning scores (EWSs) can be easily calculated from physiological indices; however, the extent to which intraoperative EWSs and the corresponding changes are associated with patient prognosis is unknown. In this study, we investigated whether EWS and the corresponding time-related changes are associated with patient outcomes during the anesthetic management of lower gastrointestinal perforation.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a single-center, retrospective cohort study conducted at a tertiary emergency care center. Adult patients who underwent surgery for spontaneous lower gastrointestinal perforations between September 1, 2012, and December 31, 2019, were included. The National Early Warning Score (NEWS) and Modified Early Warning Score (MEWS) were calculated based on the intraoperative physiological indices, and the associations with in-hospital death and length of hospital stay were investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 101 patients were analyzed. The median age was 70&#x2009;years, and there were 11 cases of in-hospital death (mortality rate: 10.9%). There was a significant association between the intraoperative maximum NEWS and in-hospital death (odds ratio (OR): 1.60, 95% confidence interval (CI): 1.10-2.32, <i>p</i>=0.013) and change from initial to maximum NEWS (OR: 1.60, 95% CI: 1.07-2.40, <i>p</i>=0.023) in the crude analysis. However, when adjustments were made for confounding factors, no statistically significant associations were found. Other intraoperative EWS values and changes were not significantly associated with the investigated outcomes. The preoperative sepsis-related organ failure assessment score and the intraoperative base excess value were significantly associated with in-hospital death.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">No clear association was observed between EWSs and corresponding changes and in-hospital death in cases of lower gastrointestinal perforation. The preoperative sepsis-related organ failure assessment score and intraoperative base excess value were significantly associated with in-hospital death.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Kazuya Takada et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takada</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagamine</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0443-5007</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuo</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seike</LastName><ForeName>Takumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horikawa</LastName><ForeName>Hanako</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumiya</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyashita</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goto</LastName><ForeName>Takahisa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6331-0119</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiol Res Pract</MedlineTA><NlmUniqueID>101532982</NlmUniqueID><ISSNLinking>1687-6962</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>4</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37674585</ArticleId><ArticleId IdType="pmc">PMC10480023</ArticleId><ArticleId IdType="doi">10.1155/2023/8910198</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barie P. S., Hydo L. J., Fischer E. Development of multiple organ dysfunction syndrome in critically ill patients with perforated viscus. Predictive value of Apache severity scoring. Archives of Surgery . 1996;131(1):37&#x2013;43. doi: 10.1001/archsurg.1996.01430130039007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1996.01430130039007</ArticleId><ArticleId IdType="pubmed">8546575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnen J. M., Mustard R. A., Oxholm S. E., Schouten B. D. Apache II score and abdominal sepsis: a prospective study. Archives of Surgery . 1988;123(2):225&#x2013;229. doi: 10.1001/archsurg.1988.01400260113014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1988.01400260113014</ArticleId><ArticleId IdType="pubmed">3124798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M., Catena F., Ansaloni L., et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World Journal of Emergency Surgery . 2012;7(1):p. 36. doi: 10.1186/1749-7922-7-36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-7922-7-36</ArticleId><ArticleId IdType="pmc">PMC3539964</ArticleId><ArticleId IdType="pubmed">23190741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya A., Yasunaga H., Tsutsumi Y., Kawahara T., Matsui H., Fushimi K. Nationwide observational study of mortality from complicated intra-abdominal infections and the role of bacterial cultures. British Journal of Surgery . 2019;106(5):606&#x2013;615. doi: 10.1002/bjs.11095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.11095</ArticleId><ArticleId IdType="pubmed">30883708</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T., Kita R., Masui H., et al. Prediction of mortality in patients with colorectal perforation based on routinely available parameters: a retrospective study. World Journal of Emergency Surgery . 2015;10(1):p. 24. doi: 10.1186/s13017-015-0020-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-015-0020-y</ArticleId><ArticleId IdType="pmc">PMC4513392</ArticleId><ArticleId IdType="pubmed">26213564</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong D. S., Kim Y. H., Kim K. J. Surgical outcomes and risk factors in patients who underwent emergency colorectal surgery. Ann. Coloproctol. . 2017;33(6):239&#x2013;244. doi: 10.3393/ac.2017.33.6.239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3393/ac.2017.33.6.239</ArticleId><ArticleId IdType="pmc">PMC5768479</ArticleId><ArticleId IdType="pubmed">29354607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann B., Junger A., R&#xf6;hrig R., et al. Intra-operative tachycardia and peri-operative outcome. Langenbeck&#x2019;s Archives of Surgery . 2003;388(4):255&#x2013;260. doi: 10.1007/s00423-003-0398-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-003-0398-y</ArticleId><ArticleId IdType="pubmed">12920601</ArticleId></ArticleIdList></Reference><Reference><Citation>Monk T. G., Bronsert M. R., Henderson W. G., et al. Association between intraoperative hypotension and hypertension and 30-day postoperative mortality in noncardiac surgery. Anesthesiology . 2015;123(2):307&#x2013;319. doi: 10.1097/ALN.0000000000000756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000756</ArticleId><ArticleId IdType="pubmed">26083768</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbe C. P., Kruger M., Rutherford P., Gemmel L. Validation of a modified early warning score in medical admissions. QJM . 2001;94(10):521&#x2013;526. doi: 10.1093/qjmed/94.10.521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/94.10.521</ArticleId><ArticleId IdType="pubmed">11588210</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the Assessment of Acute-Illness Severity in the NHS . London, UK: RCP; 2017.</Citation></Reference><Reference><Citation>Royal College of Physicians. London, UK: RCP; 2012. National early warning score (news)&#x2013;standardising the assessment of acute-illness severity in the NHS. Report of a Working Party.</Citation></Reference><Reference><Citation>Prytherch D. R., Smith G. B., Schmidt P. E., Featherstone P. I. ViEWS-Towards a national early warning score for detecting adult inpatient deterioration. Resuscitation . 2010;81(8):932&#x2013;937. doi: 10.1016/j.resuscitation.2010.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2010.04.014</ArticleId><ArticleId IdType="pubmed">20637974</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith G. B., Prytherch D. R., Meredith P., Schmidt P. E., Featherstone P. I. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation . 2013;84(4):465&#x2013;470. doi: 10.1016/j.resuscitation.2012.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2012.12.016</ArticleId><ArticleId IdType="pubmed">23295778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs C., Jarvis S. W., Prytherch D. R., et al. Comparison of the national early warning score in non-elective medical and surgical patients. British Journal of Surgery . 2016;103(10):1385&#x2013;1393. doi: 10.1002/bjs.10267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10267</ArticleId><ArticleId IdType="pubmed">27487317</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson C., Maclean F., Bell C., et al. Early warning systems in the UK: variation in content and implementation strategy has implications for a NHS early warning system. Clinical Medicine . 2011;11(5):424&#x2013;427. doi: 10.7861/clinmedicine.11-5-424.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.11-5-424</ArticleId><ArticleId IdType="pmc">PMC4954231</ArticleId><ArticleId IdType="pubmed">22034697</ArticleId></ArticleIdList></Reference><Reference><Citation>Keep J. W., Messmer A. S., Sladden R., et al. National early warning score at Emergency Department triage may allow earlier identification of patients with severe sepsis and septic shock: a retrospective observational study. Emergency Medicine Journal . 2016;33(1):37&#x2013;41. doi: 10.1136/emermed-2014-204465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2014-204465</ArticleId><ArticleId IdType="pubmed">25971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L., Rhodes A., Alhazzani W., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine . 2021;47(11):1181&#x2013;1247. doi: 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin N., Horton D., Sanford M., et al. Failure of vital sign normalization is more strongly associated than single measures with mortality and outcomes. The American Journal of Emergency Medicine . 2020;38(12):2516&#x2013;2523. doi: 10.1016/j.ajem.2019.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2019.12.024</ArticleId><ArticleId IdType="pmc">PMC6938586</ArticleId><ArticleId IdType="pubmed">31864869</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J. L., Moreno R., Takala J., et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure: on behalf of the working group on sepsis-related problems of the European society of intensive care medicine (see contributors to the project in the appendix) Intensive Care Medicine . 1996;22(7):707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M. E., Pompei P., Ales K. L., MacKenzie C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases . 1987;40(5):373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi T., Katsumata K., Katayanagi S., et al. Examination of prognostic factors in patients undergoing surgery for colorectal perforation: a case controlled study. International Journal of Surgery . 2014;12(6):566&#x2013;571. doi: 10.1016/j.ijsu.2014.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.03.021</ArticleId><ArticleId IdType="pubmed">24709571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamikawa Y., Hayashi H. Predicting in-hospital mortality among non-trauma patients based on vital sign changes between prehospital and in-hospital: an observational cohort study. PLoS One . 2019;14(1) doi: 10.1371/journal.pone.0211580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0211580</ArticleId><ArticleId IdType="pmc">PMC6355016</ArticleId><ArticleId IdType="pubmed">30703160</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartkowiak B., Snyder A. M., Benjamin A., et al. Validating the electronic cardiac arrest risk triage (eCART) score for risk stratification of surgical inpatients in the postoperative setting: retrospective cohort study. Annals of Surgery . 2019;269(6):1059&#x2013;1063. doi: 10.1097/SLA.0000000000002665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002665</ArticleId><ArticleId IdType="pmc">PMC6610875</ArticleId><ArticleId IdType="pubmed">31082902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler D. I., Warner D., Warner M. Temperature monitoring and perioperative thermoregulation. Anesthesiology . 2008;109(2):318&#x2013;338. doi: 10.1097/ALN.0b013e31817f6d76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31817f6d76</ArticleId><ArticleId IdType="pmc">PMC2614355</ArticleId><ArticleId IdType="pubmed">18648241</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi C., Kim J. S., Lenhardt R., et al. Alfentanil reduces the febrile response to interleukin-2 in humans. Critical Care Medicine . 2000;28(5):1295&#x2013;1300. doi: 10.1097/00003246-200005000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200005000-00006</ArticleId><ArticleId IdType="pubmed">10834668</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi C., Lenhardt R., Sessler D. I., et al. Desflurane reduces the febrile response to administration of interleukin-2. Anesthesiology . 1998;88(5):1162&#x2013;1169. doi: 10.1097/00000542-199805000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199805000-00005</ArticleId><ArticleId IdType="pubmed">9605674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellett J., Kim A. Validation of an abbreviated VitalpacTM early warning score (ViEWS) in 75,419 consecutive admissions to a Canadian regional hospital. Resuscitation . 2012;83(3):297&#x2013;302. doi: 10.1016/j.resuscitation.2011.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2011.08.022</ArticleId><ArticleId IdType="pubmed">21907689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton T. O., Quinn A., Fletcher S. J. Perioperative metabolic acidosis: the bradford anaesthetic department acidosis study. Journal of the Intensive Care Society . 2019;20(1):11&#x2013;17. doi: 10.1177/1751143718772792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1751143718772792</ArticleId><ArticleId IdType="pmc">PMC6376579</ArticleId><ArticleId IdType="pubmed">30792757</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller M. H., Shah K., Bendix J., et al. Risk factors in patients surgically treated for peptic ulcer perforation. Scandinavian Journal of Gastroenterology . 2009;44(2):145&#x2013;152. doi: 10.1080/00365520802401261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365520802401261</ArticleId><ArticleId IdType="pubmed">18785067</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobin S. P., Maitra S., Baidya D. K., Subramaniam R., Prasad G., Seenu V. Role of serial lactate measurement to predict 28-day mortality in patients undergoing emergency laparotomy for perforation peritonitis: prospective observational study. Journal of Intensive Care . 2019;7(1):p. 58. doi: 10.1186/s40560-019-0418-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-019-0418-9</ArticleId><ArticleId IdType="pmc">PMC6907168</ArticleId><ArticleId IdType="pubmed">31890220</ArticleId></ArticleIdList></Reference><Reference><Citation>Noritomi D. T., Soriano F. G., Kellum J. A., et al. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Critical Care Medicine . 2009;37(10):2733&#x2013;2739. doi: 10.1097/ccm.0b013e3181a59165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0b013e3181a59165</ArticleId><ArticleId IdType="pubmed">19885998</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28803772</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative Statins Do Not Prevent Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>2086</StartPage><EndPage>2092</EndPage><MedlinePgn>2086-2092</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2017.04.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(17)30430-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate whether perioperative statins reduce the risk of acute kidney injury (AKI) after cardiac surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of randomized trials.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Perioperative management in hospitals that perform cardiac surgery.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adult patients undergoing cardiac surgery.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">PubMed, EMBASE, and the Cochrane Library databases were searched for randomized trials. Random-effects meta-analyses were performed to compare the effects of statins versus placebo/control. Trial sequential analysis was conducted to confirm the results.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The primary outcome was incidence of postoperative AKI. Eight trials enrolling 3,204 patients were included. The statin arms and the control arms were comparable in incidence of postoperative AKI (risk ratio [RR] = 1.02, 95% confidence interval [CI] = 0.82-1.28), need for renal replacement therapy (RR = 1.09, 95% CI = 0.45-2.66), mechanical ventilation duration (mean difference [MD] = 24.84 min, 95% CI = -55.53-105.20), intensive care unit length of stay (MD = 0.04 days, 95% CI = -3.13-3.20), hospital length of stay (MD = -0.08 days, 95% CI = -0.31-0.15), and in-hospital mortality (RR = 3.76, 95% CI = 0.93-15.14). Trial sequential analysis confirmed that it is unlikely that perioperative statin therapy could achieve a 20% or more relative risk reduction in AKI incidence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients undergoing cardiac surgery, perioperative statin treatment did not reduce the risk of AKI. Statin therapy should not be initiated to prevent AKI following cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Pu</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: liukexuan507@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2017 Dec;31(6):2093-2095. doi: 10.1053/j.jvca.2017.06.003.</RefSource><PMID Version="1">28939318</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">statin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28803772</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2017.04.038</ArticleId><ArticleId IdType="pii">S1053-0770(17)30430-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34872284</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2224-5839</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of palliative medicine</Title><ISOAbbreviation>Ann Palliat Med</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of different mask ventilation schemes on management of general anesthesia in patients with respiratory failure.</ArticleTitle><Pagination><StartPage>11587</StartPage><EndPage>11597</EndPage><MedlinePgn>11587-11597</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/apm-21-2709</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Difficulty in mask ventilation is one of the more dangerous factors in general anesthesia. The traditional mask has some problems, such as air leakage and facial skin compression injury. The head cover is a new interactive non-invasive ventilation (NIV) model. NIV studies comparing hoods and masks have all been single-center and small-sample randomized trials, and extensive clinical studies are lacking.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a computerized search in the databases of PubMed, Embase, Medline, Chinese Biomedical Literature (CBM), and others for randomized controlled trials (RCTs) on the effect of hoods and masks on patients with respiratory failure published since their establishment to March 2021. The quality of the included literature was assessed using the Cochrane Systematic Review Manual, and the data was analyzed using Review Manager 5.3 to assess the risk of bias.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 9 articles were included, involving 462 patients, with 233 patients in the hood group and 229 patients in the face mask group. The results of meta-analysis showed the comparative endotracheal intubation rate of the hood group and the mask group [odds ratio (OR) =0.26; 95% confidence interval (CI): 0.14 to 0.47; Z=4.48; P&lt;0.00001], the complications rate (OR =0.54; 95% CI: 0.31 to 0.97; Z=2.08; P=0.04) was statistically considerable, although there was no considerable difference in in-hospital mortality (OR =0.56; 95% CI: 0.28 to 1.14; Z=1.59; P=0.11).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">NIV with a hood can reduce the rate of endotracheal intubation and the incidence of related complications in patients with acute respiratory failure (ARF), which has considerable advantages in contrast to the traditional mask.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xinchuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiangkui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Jiyue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Palliat Med</MedlineTA><NlmUniqueID>101585484</NlmUniqueID><ISSNLinking>2224-5820</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="Y">Noninvasive Ventilation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hood</Keyword><Keyword MajorTopicYN="N">mask</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">non-invasive ventilation (NIV)</Keyword><Keyword MajorTopicYN="N">respiratory failure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>7</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34872284</ArticleId><ArticleId IdType="doi">10.21037/apm-21-2709</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35117499</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2219-6803</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Translational cancer research</Title><ISOAbbreviation>Transl Cancer Res</ISOAbbreviation></Journal><ArticleTitle>McKeown or Ivor Lewis minimally invasive esophagectomy: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1518</StartPage><EndPage>1527</EndPage><MedlinePgn>1518-1527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/tcr.2020.01.45</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Minimally invasive esophagectomy (MIE) is increasingly accepted in many countries. McKeown esophagectomy and Ivor Lewis esophagectomy are two protocols commonly used for MIE, but which one provides more benefit to the patients remains matter of controversy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All records in PubMed, Embase, Medline, The Cochrane Library, Wanfang Database, China National Knowledge Infrastructure (CNKI) and Chinese VIP Information till May 2019 were systematically retrieved to compare the cohort studies of McKeown esophagectomy and Ivor Lewis esophagectomy. A meta-analysis of the extracted data was performed using the Review Manager 5.3 and Stata 15 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The meta-analysis included 23 cohort studies in which a total of 4,933 patients were enrolled. The results revealed that minimally invasive McKeown esophagectomy (MIME) was superior to minimally invasive Ivor Lewis esophagectomy (MILE) in hospital cost, but inferior to it in operating time, length of hospital stay, in-hospital mortality, 30-day mortality, 90-day mortality, anastomotic leakage, anastomotic leakage requiring surgery, anastomotic stenosis, recurrent laryngeal nerve (RLN) injury, chylothorax, pulmonary complications and total complications. There were no statistical differences between MIME and MILE in blood loss, detected number of lymph nodes, blood transfusion rate, R0 resection rate, re-operation rate, drainage duration, length of the stay in intensive care unit (ICU), 1-year mortality, lung infection, cardiac arrhythmia and delayed gastric emptying.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Except for the cost, MILE is superior to MIME in several aspects, and may represent a better choice for MIE. The results of the present study should be interpreted with caution since the meta-analysis is based on nonrandom cohort studies which may have a selection bias.</AbstractText><CopyrightInformation>2020 Translational Cancer Research. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingpu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jingfeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Dengyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kankan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Chunzhi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Spinal Orthopedics, General Hospital of Pingmei Shenma Medical Group, Pingdingshan 467000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Transl Cancer Res</MedlineTA><NlmUniqueID>101585958</NlmUniqueID><ISSNLinking>2218-676X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ivor Lewis esophagectomy</Keyword><Keyword MajorTopicYN="N">McKeown esophagectomy</Keyword><Keyword MajorTopicYN="N">Minimally invasive esophagectomy (MIE)</Keyword><Keyword MajorTopicYN="N">cervical anastomosis</Keyword><Keyword MajorTopicYN="N">intrathoracic anastomosis</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2020.01.45). The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35117499</ArticleId><ArticleId IdType="pmc">PMC8798823</ArticleId><ArticleId IdType="doi">10.21037/tcr.2020.01.45</ArticleId><ArticleId IdType="pii">tcr-09-03-1518</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Torre LA, Siegel RL, Ward EM, et al. Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev 2016;25:16-27. 10.1158/1055-9965.EPI-15-0578</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-15-0578</ArticleId><ArticleId IdType="pubmed">26667886</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi C, Shridhar R, Huston J, et al. Esophagectomy from then to now. J Gastrointest Oncol 2018;9:903-9. 10.21037/jgo.2018.08.15</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jgo.2018.08.15</ArticleId><ArticleId IdType="pmc">PMC6219976</ArticleId><ArticleId IdType="pubmed">30505593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet 2017;390:2383-96. 10.1016/S0140-6736(17)31462-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31462-9</ArticleId><ArticleId IdType="pubmed">28648400</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med 2014;371:2499-509. 10.1056/NEJMra1314530</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1314530</ArticleId><ArticleId IdType="pubmed">25539106</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisbertz SS, Hagens ERC, Ruurda JP, et al. The evolution of surgical approach for esophageal cancer. Ann N Y Acad Sci 2018;1434:149-55. 10.1111/nyas.13957</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13957</ArticleId><ArticleId IdType="pubmed">30191569</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Su Q, Ren Z, et al. Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis. Onco Targets Ther 2018;11:6057-69. 10.2147/OTT.S169488</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S169488</ArticleId><ArticleId IdType="pmc">PMC6157998</ArticleId><ArticleId IdType="pubmed">30275710</ArticleId></ArticleIdList></Reference><Reference><Citation>van Workum F, Berkelmans GH, Klarenbeek BR, et al. McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis. J Thorac Dis 2017;9:S826-33. 10.21037/jtd.2017.03.173</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.03.173</ArticleId><ArticleId IdType="pmc">PMC5538973</ArticleId><ArticleId IdType="pubmed">28815080</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Liu X, Wang R, et al. Minimally invasive esophagectomy for esophageal cancer according to the location of the tumor: Experience of 251 patients. Ann Med Surg (Lond) 2017;17:54-60. 10.1016/j.amsu.2017.03.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2017.03.038</ArticleId><ArticleId IdType="pmc">PMC5388933</ArticleId><ArticleId IdType="pubmed">28417001</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. Minimally invasive Ivor-Lewis Vs McKeown esophagectomy in the treatment of lower thoracic esophageal cancer. J MED Theor Prac 2017;30:3189-91.</Citation></Reference><Reference><Citation>Lin J, Kang M, Lin J, et al. Short-term efficacy comparison between Ivor-Lewis approach and McKeown approach in minimally invasive esophagectomy. Zhonghua Wei Chang Wai Ke Za Zhi 2014;17:888-91.</Citation><ArticleIdList><ArticleId IdType="pubmed">25273657</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Q. Clinical Analysis of Minimal Invasive McKeown and Ivor-Lewis Surgery in the Treatment of Middle-Lower Section Esophageal Cancer. Medical Innovation of China 2016;13:17-20.</Citation></Reference><Reference><Citation>Wu H, Xie M, Liu C, et al. A retrospective study of short-term outcomes of minimally invasive Ivor-Lewis esophagectomy and McKeown esophagectomy for thoracic middle-lower esophageal carcinoma. Chin J Thorac Cardiovasc Surg 2014;30:649-52.</Citation></Reference><Reference><Citation>Hou X, Ren Z, Yang B, et al. Comparison of short-term therapeutic efficacy between minimally invasive Ivor-Lewis esophagectomy and Mckeown esophagectomy for esophageal cancer. Biomed Res 2017;28:5321-6.</Citation></Reference><Reference><Citation>Rong B. Comparison of Ivor-Lewis approach and Mckeown approach in treating mid-thoracic esophageal cancer. Chin J Clin Healthc 2018;21:497-500</Citation></Reference><Reference><Citation>Wei H. The comparison of the clinical curative effect of Ivor-Lewis and McKeown operation in totally endoscopic esophagectomy. Chin J Thorac Cardiovasc Surg 2016;32:495-8.</Citation></Reference><Reference><Citation>Tang X. Short-term effects of full-endoscopic Ivor-lews and Mckeown operations on treatment of thoracic middle-lower segment esophageal carcinoma. Medical Journal of National Defending Forces in Southwest China 2016;26:1173-5.</Citation></Reference><Reference><Citation>Brown AM, Pucci MJ, Berger AC, et al. A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown. Surg Endosc 2018;32:204-11. 10.1007/s00464-017-5660-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-017-5660-4</ArticleId><ArticleId IdType="pubmed">28643075</ArticleId></ArticleIdList></Reference><Reference><Citation>van Workum F, Slaman AE, van Berge Henegouwen MI, et al. Propensity Score-Matched Analysis Comparing Minimally Invasive Ivor Lewis Versus Minimally Invasive Mckeown Esophagectomy. Ann Surg 2020;271:128-33. 10.1097/SLA.0000000000002982</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002982</ArticleId><ArticleId IdType="pubmed">30102633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y. Feasibility, safety and short-term efficacy of thoracoscopy and laparoscopy combined with Ivor-Lewis surgery for middle and lower esophageal carcinoma. Hainan Med J 2017;28:576-7.</Citation></Reference><Reference><Citation>Nguyen NT, Hinojosa MW, Smith BR, et al. Minimally invasive esophagectomy: lessons learned from 104 operations. Ann Surg 2008;248:1081-91. 10.1097/SLA.0b013e31818b72b5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31818b72b5</ArticleId><ArticleId IdType="pubmed">19092354</ArticleId></ArticleIdList></Reference><Reference><Citation>Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 2012;256:95-103. 10.1097/SLA.0b013e3182590603</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3182590603</ArticleId><ArticleId IdType="pmc">PMC4103614</ArticleId><ArticleId IdType="pubmed">22668811</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HM, Gisbertz SS, Moons J, et al. Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients. Ann Surg 2017;266:814-21. 10.1097/SLA.0000000000002445</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002445</ArticleId><ArticleId IdType="pubmed">28796646</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z, Zhenya S, Lei W. Esophageal-gastric anastomosis in radical resection of esophageal cancer under thoracoscopy combined with laparoscopy. J Coll Physicians Surg Pak 2014;24:754-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25327921</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, An ZY. Control study of the short-term efficacy of Ivor-Lewis and McKeown operation by thoracoscopy and laparoscopy in esophageal squamous cell carcinoma. Chinese Journal of the Frontiers of Medical Science (Electronic Version) 2016;8:57-60.</Citation></Reference><Reference><Citation>Ling F. Short-term effects of full-endoscopic Ivor-lews Vs Mckeown esophagectomy on treatment of thoracic middle-lower segment esophageal carcinoma. Shandong Med J 2018;58:45-47.</Citation></Reference><Reference><Citation>Zhang L, Chen M, Zhang Y. The effect of minimally invasive esophagectomy Mckeown and Ivor-Lewis on pulmonary function in patients with esophageal carcinoma. Oncology Progress 2018;16:1604-7.</Citation></Reference><Reference><Citation>Ren W. Influence of Lvor-Lewis and McKeown surgery For middle and lower esophageal carcinoma in immune pain response, digestive function and prognosis. Pract J Clin Med 2018;15:246-8.</Citation></Reference><Reference><Citation>Chang T, Hsiao PN, Tsai MY, et al. Perioperative management and outcomes of minimally invasive esophagectomy: case study of a high-volume tertiary center in Taiwan. J Thorac Dis 2018;10:1670-6. 10.21037/jtd.2018.01.147</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2018.01.147</ArticleId><ArticleId IdType="pmc">PMC5906220</ArticleId><ArticleId IdType="pubmed">29707319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai C. A comparison of short-term outcomes and quality of life between Ivor-Lewis and McKeown minimally invasive esophagectomy. Shandong University, 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703672</ArticleId><ArticleId IdType="pubmed">26793358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei S. Short-term efficacy of purse sting forceps Ivor-Lewis approach and McKeown approach in minially invasive esophagectomy for middle-lower section esophageal cancer. Anhui Medical University, 2016.</Citation></Reference><Reference><Citation>Inokuchi M, Kojima K, Kato K, et al. Risk factors for post-operative pulmonary complications after gastrectomy for gastric cancer. Surg Infect (Larchmt) 2014;15:314-21. 10.1089/sur.2013.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2013.031</ArticleId><ArticleId IdType="pubmed">24796353</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholtemeijer MG, Seesing MFJ, Brenkman HJF, et al. Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis 2017;9:S868-78. 10.21037/jtd.2017.06.92</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.06.92</ArticleId><ArticleId IdType="pmc">PMC5538987</ArticleId><ArticleId IdType="pubmed">28815085</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37499940</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Efficacy of perioperative prophylactic administration of corticosteroids in pediatric cardiac surgeries using cardiopulmonary bypass: a systematic review with meta-analysis.</ArticleTitle><Pagination><StartPage>101281</StartPage><MedlinePgn>101281</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2023.101281</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(23)00089-9</ELocationID><Abstract><AbstractText>An updated systematic review with meta-analysis comparing perioperative prophylactic administration of corticosteroids with placebo in pediatric cardiac surgeries using cardiopulmonary bypass was conducted. The Cochrane Central Register of Controlled Trials and MEDLINE (via PubMed) were searched for relevant randomized controlled trials published between January 1, 2000, and February 14, 2023. The primary outcome was postoperative in-hospital mortality. Secondary outcomes were duration of mechanical ventilation, length of intensive care unit and hospital stay, postoperative low cardiac output syndrome, and adverse events. A total of 11 studies were included in the meta-analysis. Corticosteroid administration did not decrease postoperative in-hospital mortality compared with placebo (relative risk, 0.69; 95% confidence interval, 0.40-1.17). Subgroup analyses according to the type of corticosteroids and neonates revealed that corticosteroids did not decrease postoperative in-hospital mortality. In the trial sequential analysis, the last point in the z-curve was within the futility borders. Although the duration of mechanical ventilation (mean difference, -5.54&#x2009;h; 95% confidence interval (CI), -9.75 - -1.34) and incidence of low cardiac output syndrome (relative risk, 0.75; 95% CI, 0.59 - 0.96) decreased with corticosteroid administration, it did not affect the length of intensive care unit (mean difference, -0.28 days; 95% CI, -0.74 - 0.17) and hospital stay (mean difference, -0.59 days; 95% CI, -1.31 - 0.14). In conclusion, perioperative prophylactic corticosteroid administration in pediatric cardiac surgeries using cardiopulmonary bypass did not decrease postoperative in-hospital mortality compared with placebo. According to the trial sequential analysis results, additional randomized controlled trials assessing mortality are not required. PROSPERO REGISTRY NUMBER: CRD 42023391789.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Soci&#xe9;t&#xe9; fran&#xe7;aise d'anesth&#xe9;sie et de r&#xe9;animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takeshita</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Osaka Prefectural Hospital Organization, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan. Electronic address: t-k-s-t@koto.kpu-m.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Yasufumi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Kinki University Faculty of Medicine, 377-2 Ohnohigashi, Sayama, Osaka 589-8511, Japan; Outcomes Research Consortium, 9500 Euclid Avenue, P77, Cleveland, OH 44195, USA. Electronic address: nakajima@koto.kpu-m.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tachibana</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Osaka Prefectural Hospital Organization, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan. Electronic address: tatty0329@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeuchi</LastName><ForeName>Muneyuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibeshinmachi, Suita, Osaka 564-8565, Japan. Electronic address: mutake1017@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shime</LastName><ForeName>Nobuaki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, 1-3-2 Kagamiyama, Higashihiroshima, Hiroshima 739-8511, Japan. Electronic address: shime@koto.kpu-m.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="N">Cardiac Output, Low</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Confidence intervals</Keyword><Keyword MajorTopicYN="N">Corticosteroid</Keyword><Keyword MajorTopicYN="N">Myocardial adverse events</Keyword><Keyword MajorTopicYN="N">Pediatrics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37499940</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2023.101281</ArticleId><ArticleId IdType="pii">S2352-5568(23)00089-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39382630</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-191X</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of cardiovascular surgery</Title><ISOAbbreviation>J Cardiovasc Surg (Torino)</ISOAbbreviation></Journal><ArticleTitle>Does performing cardiac surgery after hours impact postoperative outcomes? A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>523</StartPage><EndPage>532</EndPage><MedlinePgn>523-532</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0021-9509.24.13154-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">There has been concern regarding the safety of cardiac surgical intervention during off-hours. Sleep deprivation, resource limitations, and an increased case urgency have been postulated to increase off-hours surgical risk, although outcomes are inconsistent in the existing literature. In this systematic review and meta-analysis, we review the literature comparing patients undergoing cardiac surgery during on and off-hours.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">PubMed and Embase were systematically searched for literature published from January 2000-September 2023, comparing outcomes of patients undergoing cardiac surgery during on and off-hours. Overall, 3540 manuscript titles and abstracts were screened and 11 articles were included.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Overall aggregate analysis indicated no significant differences in rates of in-hospital mortality(OR 1.04; 95% CI, 0.41-2.63; P=0.93) and perioperative morbidity, including stroke (P=0.52), reoperation (P=0.92), major bleeding (P=0.10), and renal complications (P=0.55). Composite rates of sternal wound infection favored on-hours surgery (P=0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although inferior outcomes in patients undergoing cardiac surgery during off-hours have been noted, aggregate analysis largely revealed equivalent perioperative morbidity and mortality during on and off-hours surgery, although with the exclusion of one outlier study in-hospital mortality and reoperation favored on-hours surgery. Heterogeneity in outcomes is likely multifactorial, with surgical staff fatigue, patient preoperative risk, clinical setting, and resource limitations all contributing. Further investigation is required directly comparing emergent cardiac surgical intervention during on-hours and off-hours controlling for baseline surgical risk to elucidate the true impact of timing of surgery on postoperative outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AL, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Andari</LastName><ForeName>Ryaan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AL, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fialka</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AL, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagendran</LastName><ForeName>Jeevan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AL, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AL, Canada - srmeyer@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>J Cardiovasc Surg (Torino)</MedlineTA><NlmUniqueID>0066127</NlmUniqueID><ISSNLinking>0021-9509</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039602" MajorTopicYN="N">After-Hours Care</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>9</Day><Hour>16</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39382630</ArticleId><ArticleId IdType="doi">10.23736/S0021-9509.24.13154-0</ArticleId><ArticleId IdType="pii">S0021-9509.24.13154-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35151565</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Outcomes After Bidirectional Glenn Shunt in a Tertiary-Care Pediatric Hospital in South Africa.</ArticleTitle><Pagination><StartPage>1573</StartPage><EndPage>1581</EndPage><MedlinePgn>1573-1581</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2022.01.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(22)00004-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Large data sets have been published on short- and long-term outcomes following bidirectional Glenn surgery (BDG), or partial cavopulmonary connection, in high-income countries. Data from low-income and middle-income countries are few and often limited to the immediate postoperative period. The primary outcome was any in-hospital postoperative complication, assessed according to predefined criteria, in children who underwent BDG surgery at Red Cross War Memorial Children's Hospital.</AbstractText><AbstractText Label="DESIGN">A retrospective cohort study.</AbstractText><AbstractText Label="SETTING">A tertiary teaching hospital.</AbstractText><AbstractText Label="PARTICIPANTS">The study authors identified 61 children (&lt;18 years of age) who underwent BDG over 8 years. The median age of patients undergoing BDG was 2.5 years (interquartile range, 1.4-5.5 years).</AbstractText><AbstractText Label="INTERVENTIONS">BDG surgery.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Thirty-five patients (57.4%) had a postoperative complication, with some patients (17 of 61, 27.9%) having more than 1 complication. The most frequent complications were infective (29.5%). Univariate analysis found that postoperative complications were associated with the use of nitric oxide (p&#xa0;=&#xa0;0.004) and a longer duration of anesthesia (p&#xa0;=&#xa0;0.045) and surgery (p&#xa0;=&#xa0;0.004). Patients with complications spent longer in the pediatric intensive care unit (ICU) (p &lt; 0.001) and in the hospital (p &lt; 0.012). On multivariate analysis, a priori risk factors based on previous studies were not found to be statistically significant. A total of 37.3% of patients completed their single-ventricle palliation, and 30.5% of patients were lost to follow-up.</AbstractText><AbstractText Label="CONCLUSIONS">Important findings were the older age at which the BDG was performed compared to high-income countries, an acceptable mortality rate of 3.3%, infection being the most common complication, the association of a complication with increased ICU and hospital lengths of stay, and the high rate of patients lost to follow-up.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Heidi M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Division of Paediatric Anaesthesia, Department of Anaesthesia &amp; Perioperative Medicine, Faculty of Health Sciences, University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa. Electronic address: heids_meyer@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marange-Chikuni</LastName><ForeName>Danai</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Sally Mugabe Central Hospital, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anaesthesia</LastName><ForeName>MMed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Sally Mugabe Central Hospital, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Z&#xfc;hlke</LastName><ForeName>Liesl</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Paediatric Cardiology, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roussow</LastName><ForeName>Beyra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Paediatric Critical Care, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Human</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chris Barnard Division of Cardiothoracic Surgery and Cardiovascular Research Unit, Department of Surgery, Faculty of Health Sciences, University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Chris Barnard Division of Cardiothoracic Surgery and Cardiovascular Research Unit, Department of Surgery, Faculty of Health Sciences, University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/S005242/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2022 Jun;36(6):1582-1583. doi: 10.1053/j.jvca.2022.02.020.</RefSource><PMID Version="1">35304045</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018729" MajorTopicYN="Y">Fontan Procedure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006776" MajorTopicYN="N">Hospitals, Pediatric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bidirectional Glenn shunt</Keyword><Keyword MajorTopicYN="N">cardiac anesthesia</Keyword><Keyword MajorTopicYN="N">congenital heart disease</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">incidence rate</Keyword><Keyword MajorTopicYN="N">univentricular hearts</Keyword></KeywordList><CoiStatement>Conflict of Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>13</Day><Hour>20</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35151565</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2022.01.003</ArticleId><ArticleId IdType="pii">S1053-0770(22)00004-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34263619</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2224-5839</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of palliative medicine</Title><ISOAbbreviation>Ann Palliat Med</ISOAbbreviation></Journal><ArticleTitle>The incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after cardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>7247</StartPage><EndPage>7257</EndPage><MedlinePgn>7247-7257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/apm-21-410</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of the present systematic review was to evaluate the incidence, risk factors, and outcome of hyperbilirubinemia after cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Population, Interventions, Comparators, Outcomes, and Study design (PICOS) framework was employed to develop the search strategy, and the findings are reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. PubMed, Embase, and the Cochrane Library were systematically searched for studies that provided data on the incidence, risk factors, and outcomes of hyperbilirubinemia in cardiac surgery patients from January 1960 to May 2020. Publication bias was graphically explored through funnel plots, and the Newcastle-Ottawa quality assessment scale (NOS) was used to evaluate the quality of the included studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies with 6,100 patients were included in our systematic review. The pooled incidence of hyperbilirubinemia was 23% [95% confidence interval (CI), 0.13-0.32]. Preoperative factors, including right atrial pressure [mean difference (MD), 4.65; 95% CI, 4.43-4.88], total bilirubin (TB) concentration (MD, 0.72; 95% CI, 0.65-0.79), alkaline phosphatase (MD, 27.38; 95% CI, 12.94-41.82), and alanine aminotransferase (MD, 12.02; 95% CI, 10.73-13.31), and intraoperative factors, including cardiopulmonary bypass (CPB) time (MD, 1.57; 95% CI, 0.52-2.63), aortic cross-clamping (ACC) time (MD, 11.82; 95% CI, 9.50-14.14), and the amount of blood transfused (MD, 3.77; 95% CI, 0.68-6.85), were the most robust risk factors for hyperbilirubinemia after cardiac surgery. Additionally, postoperative hyperbilirubinemia was associated with increased in-hospital mortality [odds ratio (OR), 9.9; 95% CI, 5.00-19.60, P&lt;0.0001].</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Hyperbilirubinemia was common and was associated with increased in-hospital mortality. Preoperative high right atrial pressure, high TB concentration, prolonged CPB and ACC time, and a large amount of blood transfused were the commonly observed risk factors for postoperative hyperbilirubinemia in cardiac surgery patients. Addressing these risk factors may be helpful to lower the occurrence of postoperative hyperbilirubinemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaolan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Shiren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiangmei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China; State Key Laboratory of Kidney Disease, Department of Nephrology, Chinese People's Liberation Army General Hospital and Military Medical Postgraduate College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Palliat Med</MedlineTA><NlmUniqueID>101585484</NlmUniqueID><ISSNLinking>2224-5820</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006932" MajorTopicYN="N">Hyperbilirubinemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hyperbilirubinemia</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass (CPB)</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>15</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34263619</ArticleId><ArticleId IdType="doi">10.21037/apm-21-410</ArticleId><ArticleId IdType="pii">apm-21-410</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35072938</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1878-7649</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European geriatric medicine</Title><ISOAbbreviation>Eur Geriatr Med</ISOAbbreviation></Journal><ArticleTitle>Mortality and complication rates in nonagenarians and octogenarians undergoing total hip and knee arthroplasty: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>725</StartPage><EndPage>733</EndPage><MedlinePgn>725-733</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s41999-022-00610-y</ELocationID><Abstract><AbstractText Label="PURPOSE">Advancing age is a significant risk factor for the development of perioperative complications and mortality in patients undergoing total hip or knee arthroplasty (THA or TKA) due to their compromised health status and the associated medical comorbidities. The purpose of this review is to identify if nonagenarians having a THA or TKA are associated with a higher incidence of mortality and morbidity compared to octogenarians.</AbstractText><AbstractText Label="METHODS">Medline, Scopus, and the Cochrane library were searched for relevant studies. The primary outcome of the review was the incidence of mortality. The secondary outcomes were the 30-day readmission, the perioperative complications, and the length of hospital stay (LOS).</AbstractText><AbstractText Label="RESULTS">Six studies with 479,630 patients were included in the review. No difference between nonagenarians and octogenarians was detected regarding the in-hospital mortality, the 30-day readmission rate, and the LOS. However, nonagenarians were associated with a greater 1-year mortality rate (OR: 2.4; 95% CI 1.91-3.01, P&#x2009;&lt;&#x2009;0.001; I<sup>2</sup>&#x2009;=&#x2009;0%) and increased odds of perioperative complications (OR: 1.6; 95% CI 1.48-1.72, P&#x2009;&lt;&#x2009;0.001; I<sup>2</sup>&#x2009;=&#x2009;0%). This finding was unchanged after adjusting for baseline characteristics (OR<sub>adj</sub>: 1.68; 95% CI 1.53-1.84, P&#x2009;&lt;&#x2009;0.001; I<sup>2</sup>&#x2009;=&#x2009;0%).</AbstractText><AbstractText Label="CONCLUSION">Although nonagenarians undergoing TKA or THA can achieve the same clinical benefit as octogenarians, they have a higher risk of perioperative complications and 1-year mortality. Therefore, meticulous preoperative screening, proper patient selection and optimization of comorbidities are essential to minimize any postoperative side effects in patients over 90&#xa0;years of age.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to European Geriatric Medicine Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kitridis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6063-8650</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, 1st Orthopaedic Department, "George Papanikolaou" Hospital, Aristotle University of Thessaloniki, 55210, Thessalon&#xed;ki, Greece. dkitridis@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsikopoulos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5923-4782</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics, Harrogate and District Foundation Trust, Lancaster Park Road, Harrogate, HG2 7SX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Givissis</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8649-1159</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, 1st Orthopaedic Department, "George Papanikolaou" Hospital, Aristotle University of Thessaloniki, 55210, Thessalon&#xed;ki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalidis</LastName><ForeName>Byron</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1305-2734</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, 1st Orthopaedic Department, "George Papanikolaou" Hospital, Aristotle University of Thessaloniki, 55210, Thessalon&#xed;ki, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Eur Geriatr Med</MedlineTA><NlmUniqueID>101533694</NlmUniqueID><ISSNLinking>1878-7649</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088642" MajorTopicYN="N">Nonagenarians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087742" MajorTopicYN="N">Octogenarians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Nonagenarians</Keyword><Keyword MajorTopicYN="N">Octogenarians</Keyword><Keyword MajorTopicYN="N">Total hip arthroplasty</Keyword><Keyword MajorTopicYN="N">Total knee arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>24</Day><Hour>12</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35072938</ArticleId><ArticleId IdType="doi">10.1007/s41999-022-00610-y</ArticleId><ArticleId IdType="pii">10.1007/s41999-022-00610-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murphy BPd&#x2019;S, Dowsey MM, Choong PFM (2018) The Impact of advanced age on the outcomes of primary total hip and knee arthroplasty for osteoarthritis: a systematic review. JBJS Rev. https://doi.org/10.2106/JBJS.RVW.17.00077</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.RVW.17.00077</ArticleId><ArticleId IdType="pubmed">29485516</ArticleId></ArticleIdList></Reference><Reference><Citation>Miric A, Inacio MCS, Kelly MP, Namba RS (2014) Can total knee arthroplasty be safely performed among nonagenarians? An evaluation of morbidity and mortality within a total joint replacement registry. J Arthroplasty 29:1635&#x2013;1638. https://doi.org/10.1016/j.arth.2014.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2014.03.014</ArticleId><ArticleId IdType="pubmed">24767951</ArticleId></ArticleIdList></Reference><Reference><Citation>National life tables-life expectancy in the UK: 2018 to 2020 data. Off Natl Stat UK 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/bulletins/nationallifetablesunitedkingdom/2018to2020#national-life-tables-life-expectancy-in-the-uk-2018-to-2020-data . Accessed 17 Oct 2021</Citation></Reference><Reference><Citation>Dugdale EM, Tybor D, Kain M, Smith EL (2019) Comparing inpatient complication rates between octogenarians and nonagenarians following primary and revision total hip arthroplasty in a Nationally Representative Sample 2010&#x2013;2014. Geriatr (Basel, Switzerland). https://doi.org/10.3390/geriatrics4040055</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics4040055</ArticleId></ArticleIdList></Reference><Reference><Citation>Badley EM, Wang PP (1998) Arthritis and the aging population: projections of arthritis prevalence in Canada 1991 to 2031. J Rheumatol 25:138&#x2013;144</Citation><ArticleIdList><ArticleId IdType="pubmed">9458217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Jt Surg Am. https://doi.org/10.2106/JBJS.F.00222</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.F.00222</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy BPd&#x2019;S, Dowsey MM, Spelman T, Choong PFM (2018) What Is the impact of advancing age on the outcomes of total hip arthroplasty? J Arthroplasty 33:1101-1107.e1. https://doi.org/10.1016/j.arth.2017.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2017.11.010</ArticleId><ArticleId IdType="pubmed">29208330</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanjayan SK, Swamy GN, Yellu S, Yallappa S, Abuzakuk T, Straw R (2014) In-hospital complications following primary total hip and knee arthroplasty in octogenarian and nonagenarian patients. J Orthop Traumatol 15:29&#x2013;33. https://doi.org/10.1007/s10195-013-0262-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10195-013-0262-y</ArticleId><ArticleId IdType="pubmed">23989856</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuppiah SV, Banaszkiewicz PA, Ledingham WM (2008) The mortality, morbidity and cost benefits of elective total knee arthroplasty in the nonagenarian population. Int Orthop 32:339&#x2013;343. https://doi.org/10.1007/s00264-007-0324-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-007-0324-y</ArticleId><ArticleId IdType="pubmed">17333185</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmar CJ, Barth P, Lonner JH, Lotke PA (1999) Total knee arthroplasty in patients 90 years of age and older. J Arthroplasty 14:911&#x2013;914. https://doi.org/10.1016/S0883-5403(99)90002-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0883-5403(99)90002-5</ArticleId><ArticleId IdType="pubmed">10614879</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauregui JJ, Boylan MR, Kapadia BH, Naziri Q, Maheshwari AV, Mont MA (2015) Total joint arthroplasty in nonagenarians: what are the risks? J Arthroplasty 30:2102&#x2013;5.e1. https://doi.org/10.1016/j.arth.2015.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.06.028</ArticleId><ArticleId IdType="pubmed">26169454</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner D, Tadros BJ, Bray E, Elsherbiny M, Stafford G (2016) Clinical outcome following primary total hip or knee replacement in nonagenarians. Ann R Coll Surg Engl 98:258&#x2013;264. https://doi.org/10.1308/rcsann.2016.0095</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/rcsann.2016.0095</ArticleId><ArticleId IdType="pubmed">26924477</ArticleId><ArticleId IdType="pmc">5226032</ArticleId></ArticleIdList></Reference><Reference><Citation>Deirmengian C, Austin M, Deirmengian G (2011) Hip replacement in the very elderly: selecting a suitable candidate. Aging Health 7:803&#x2013;811. https://doi.org/10.2217/ahe.11.70</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ahe.11.70</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalidis B, Kitridis D, Givissis P (2020) Tibial tubercle osteotomy in revision total knee arthroplasty: a systematic review. World J Orthop 11:294&#x2013;303. https://doi.org/10.5312/WJO.V11.I6.294</Citation><ArticleIdList><ArticleId IdType="doi">10.5312/WJO.V11.I6.294</ArticleId><ArticleId IdType="pubmed">32572366</ArticleId><ArticleId IdType="pmc">7298452</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId><ArticleId IdType="pmc">2714657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wylde V, Beswick AD, Dennis J, Gooberman-Hill R (2017) Post-operative patient-related risk factors for chronic pain after total knee replacement: a systematic review. BMJ Open 7:1&#x2013;12. https://doi.org/10.1136/bmjopen-2017-018105</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-018105</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557&#x2013;560. https://doi.org/10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId><ArticleId IdType="pmc">192859</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Deeks J (2008) Chapter 9: analysing data and undertaking meta-analyses. In: Higgins J, Green S (eds) Cochrane Handb. Syst. Rev. Interv. Willey, Chichester, pp 243&#x2013;296</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470712184</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkani AL, Dilworth B, Ong K, Baykal D, Lau E, Mackin TN et al (2017) High risk of readmission in octogenarians undergoing primary hip arthroplasty. Clin Orthop Relat Res 475:2878&#x2013;2888. https://doi.org/10.1007/s11999-017-5241-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-017-5241-9</ArticleId><ArticleId IdType="pubmed">28083755</ArticleId><ArticleId IdType="pmc">5670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Miric A, Inacio MCS, Kelly MP, Namba RS (2015) Are nonagenarians too old for total hip arthroplasty? An evaluation of morbidity and mortality within a total joint replacement registry. J Arthroplasty 30:1324&#x2013;1327. https://doi.org/10.1016/j.arth.2015.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.03.008</ArticleId><ArticleId IdType="pubmed">25820118</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EL, Dugdale EM, Tybor D, Kain M (2019) Comparing inpatient complication rates between octogenarians and nonagenarians following primary and revision total knee arthroplasty in a nationally representative sample, 2010&#x2013;2014. Geriatr. https://doi.org/10.3390/geriatrics4010003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics4010003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang C, Hagar A, Gordon M, Talmo CT, Mattingly DA, Smith EL (2021) Differences in hospital costs among octogenarians and nonagenarians following primary total joint arthroplasty. Geriatr. https://doi.org/10.3390/geriatrics6010026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics6010026</ArticleId></ArticleIdList></Reference><Reference><Citation>Yohe N, Weisberg MD, Ciminero M, Mannino A, Erez O, Saleh A (2020) Complications and readmissions after total hip replacement in octogenarians and nonagenarians. Geriatr Orthop Surg Rehabil 11:2151459320940959. https://doi.org/10.1177/2151459320940959</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151459320940959</ArticleId><ArticleId IdType="pubmed">32742739</ArticleId><ArticleId IdType="pmc">7375711</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfonso DT, Howell RD, Strauss EJ, Di Cesare PE (2007) Total hip and knee arthroplasty in nonagenarians. J Arthroplasty 22:807&#x2013;811. https://doi.org/10.1016/j.arth.2006.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2006.10.016</ArticleId><ArticleId IdType="pubmed">17826269</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JF, Stoyanov V, Shafqat A, Lui DF, Mulhall KJ (2012) Total joint arthroplasty in nonagenarians&#x2014;a retrospective review of complications and resource use. Acta Orthop Belg 78:745&#x2013;750</Citation><ArticleIdList><ArticleId IdType="pubmed">23409570</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagneaux L, Amundson AW, Larson DR, Pagnano MW, Berry DJ, Abdel MP (2020) Contemporary mortality rate and outcomes in nonagenarians undergoing primary total hip arthroplasty. J Arthroplasty 36:1373&#x2013;1379. https://doi.org/10.1016/j.arth.2020.10.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2020.10.040</ArticleId><ArticleId IdType="pubmed">33199094</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez Alcaraz J, Pardo Garc&#xed;a JM, Sevilla Fern&#xe1;ndez J, Delgado D&#xed;az E, Moreno Beamud JA (2021) Primary total hip arthroplasty in elderly patients over 85 years old: risks, complications and medium-long term results [Artroplastia total primaria de cadera en pacientes mayores de 85 a&#xf1;os: riesgos, complicaciones y resultados a medio-largo plazo]. Rev Esp Cir Ortop Traumatol 65:13&#x2013;23. https://doi.org/10.1016/j.recot.2020.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recot.2020.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AB, Gill G (2002) Total knee arthroplasty in nonagenarians. J Arthroplasty 17:681&#x2013;684. https://doi.org/10.1054/arth.2002.32175</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/arth.2002.32175</ArticleId><ArticleId IdType="pubmed">12216019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezgin EA, Robertsson O, W-Dahl A, Lidgren L (2019) Nonagenarians qualify for total knee arthroplasty: a report on 329 patients from the Swedish Knee Arthroplasty Register 2000&#x2013;2016. Acta Orthop 90:53&#x2013;59. https://doi.org/10.1080/17453674.2018.1530173</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17453674.2018.1530173</ArticleId><ArticleId IdType="pubmed">30334634</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorgul K, Novicoff WM, Saleh KJ (2010) American Society of Anesthesiologist Physical Status score may be used as a comorbidity index in hip fracture surgery. J Arthroplasty 25:134&#x2013;137. https://doi.org/10.1016/j.arth.2010.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2010.04.010</ArticleId><ArticleId IdType="pubmed">20537857</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauh MA, Krackow KA (2004) In-hospital deaths following elective total joint arthroplasty. Orthopedics 27:407&#x2013;411. https://doi.org/10.3928/0147-7447-20040401-18</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/0147-7447-20040401-18</ArticleId><ArticleId IdType="pubmed">15101485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36053160</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1839</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International angiology : a journal of the International Union of Angiology</Title><ISOAbbreviation>Int Angiol</ISOAbbreviation></Journal><ArticleTitle>Mortality and neurologic complications after repair of aortic arch pathology with elephant trunk procedures: a systematic review with meta-analysis.</ArticleTitle><Pagination><StartPage>372</StartPage><EndPage>381</EndPage><MedlinePgn>372-381</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0392-9590.22.04924-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Frozen elephant trunk (FET) technique was developed as an alternative to the conventional elephant trunk (cET) procedure for the repair of complex aortic arch pathology. However, short term results between these different procedures are sparsely described. This systematic review with meta-analysis aimed to compare short term outcomes between FET and cET in the repair of aortic arch pathology.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">PubMed, Web of Science and Scopus electronic databases were searched for studies comparing performance of FET and cET procedures in patients with aortic arch pathology. The primary outcome of interest was early mortality, defined as 30-day or in-hospital mortality. Secondary outcomes were stroke, and spinal cord ischemia (SCI). Meta-analysis utilizing the random-effects model was performed using Review Manager (RevMan) software, version 5.4.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Ten studies, comprising 1481 patients with aortic arch pathology, were included. Meta-analysis demonstrated statistically significant reduction of early mortality (odds ratio [OR], 0.63; 95% CI, 0.41-0.97) in the FET group. For neurologic outcomes, no significant differences were noted in stroke risk between both groups (OR, 1.21; 95% CI, 0.83-1.75), but an increased risk of SCI was present in FET patients (OR, 2.07; 95% CI, 1.05-4.10).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FET appears to be associated with a significant lower early mortality, at costs of greater SCI risk. Larger studies are needed to provide confident recommendations towards preferential use of either procedure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Afonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery and Physiology, Faculty of Medicine of Porto University, Porto, Portugal - jafonso.ferreira@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira-Pinto</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Angiology and Vascular Surgery, S&#xe3;o Jo&#xe3;o Hospital And University Center, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansilha</LastName><ForeName>Armando</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Angiology and Vascular Surgery, S&#xe3;o Jo&#xe3;o Hospital And University Center, Porto, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Int Angiol</MedlineTA><NlmUniqueID>8402693</NlmUniqueID><ISSNLinking>0392-9590</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="Y">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020760" MajorTopicYN="Y">Spinal Cord Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36053160</ArticleId><ArticleId IdType="doi">10.23736/S0392-9590.22.04924-0</ArticleId><ArticleId IdType="pii">S0392-9590.22.04924-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33227479</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Zone 1 Aortic Arch Hybrid Endovascular Repair with Extra-anatomical Bypass: A Meta-analysis.</ArticleTitle><Pagination><StartPage>601</StartPage><EndPage>609</EndPage><MedlinePgn>601-609</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2020.10.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(20)30957-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this meta-analysis is to determine the morbidity and mortality outcomes of adult patients with aortic arch disease managed with extra-anatomical bypass avoiding median sternotomy and cardiopulmonary bypass, with simultaneous or staged hybrid zone 1 endovascular aortic repair.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic literature searches of the MEDLINE, EMBASE, and Cochrane databases were carried out to identify relevant studies on zone 1 hybrid arch repair. Extracted data were analyzed by random effects models. Primary outcomes included 30-day or in-hospital mortality. Longitudinal survival was analyzed up to 7&#xa0;years from date of operation. Secondary outcomes included in-hospital morbidity, as well as late endoleak and reintervention.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty studies incorporating 348 patients were included. In-hospital or 30-day mortality was 10.1% (95% confidence interval, 6.7-14.9%). Overall operative technical success was 89.8% (83.7-93.8%). Early type 1 endoleak rate was 14.0% (7.4-24.7%). Stroke prevalence was 9.5% (6.1-14.3%). Spinal cord paraplegia prevalence was 3.8% (1.9-7.6%). Retrograde aortic dissection prevalence was 4.1% (1.5-10.6%). Survival at 1&#xa0;year postoperatively was 77.2% (66.1-85.4%). Survival at 3&#xa0;years postoperatively was 73.7% (59.2-84.4%). Survival beyond 4&#xa0;years postoperatively (range 58-80&#xa0;months) was 65.9% (53.6-76.4%). Late type 1 endoleak prevalence was 11.8% (5.5-23.7%). Overall rate of reintervention was 11.6% (6.4-20.1%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Zone 1 hybrid repair has evidence for satisfactory short- and long-term morbidity/mortality outcomes and may be considered as an alternative approach to aortic arch disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bayfield</LastName><ForeName>Nicholas Gr</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore; Department of Cardiothoracic Surgery, Fiona Stanley Hospital, Perth, Australia. Electronic address: Nicholas.Bayfield@health.wa.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Miny</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore; Systematic Review Unit, Dean's Office, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayfield</LastName><ForeName>Anna-Louise E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore; School of Medicine, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choong</LastName><ForeName>Andrew Mtl</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore; Cardiovascular Research Institute, National University of Singapore, Singapore, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Division of Vascular Surgery, National University Heart Centre, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="N">Aortic Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019233" MajorTopicYN="N">Retreatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>23</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33227479</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2020.10.010</ArticleId><ArticleId IdType="pii">S0890-5096(20)30957-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36347195</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>The effectiveness of positive airway pressure therapy in reducing postoperative adverse outcomes in surgical patients with obstructive sleep apnea: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>110993</StartPage><MedlinePgn>110993</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2022.110993</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(22)00351-8</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Obstructive sleep apnea (OSA) is prevalent in surgical patients and is associated with an increased risk of adverse perioperative events.</AbstractText><AbstractText Label="STUDY OBJECTIVE">To determine the effectiveness of positive airway pressure (PAP) therapy in reducing the risk of postoperative complications in patients with OSA undergoing surgery.</AbstractText><AbstractText Label="DESIGN">Systematic review and meta-analysis searching Medline and other databases from inception to October 17, 2021. The search terms included: "positive airway pressure," "surgery," "post-operative," and "obstructive sleep apnea." The inclusion criteria were: 1) adult patients with OSA undergoing surgery; (2) patients using preoperative and/or postoperative PAP; (3) at least one postoperative outcome reported; (4) control group (patients with OSA undergoing surgery without preoperative and/or postoperative PAP therapy); and (5) English language articles.</AbstractText><AbstractText Label="PATIENTS">Twenty-seven studies included 30,514 OSA patients undergoing non-cardiac surgery and 837 OSA patients undergoing cardiac surgery.</AbstractText><AbstractText Label="INTERVENTION">PAP therapy MAIN RESULTS: In patients with OSA undergoing non-cardiac surgery, PAP therapy was associated with a decreased risk of postoperative respiratory complications (2.3% vs 3.6%; RR: 0.72, 95% CI: 0.51-1.00, asymptotic P&#xa0;=&#xa0;0.05) and unplanned ICU admission (0.12% vs 4.1%; RR: 0.44, 95% CI: 0.19-0.99, asymptotic P&#xa0;=&#xa0;0.05). No significant differences were found for all-cause complications (11.6% vs 14.4%; RR: 0.89, 95% CI: 0.74-1.06, P&#xa0;=&#xa0;0.18), postoperative cardiac and neurological complications, in-hospital length of stay, and in-hospital mortality between the two groups. In patients with OSA undergoing cardiac surgery, PAP therapy was associated with decreased postoperative cardiac complications (33.7% vs 50%; RR: 0.63, 95% CI: 0.51-0.77, P&#xa0;&lt;&#xa0;0.0001), and postoperative atrial fibrillation (40.1% vs 66.7%; RR: 0.59, 95% CI 0.45-0.77, P&#xa0;&lt;&#xa0;0.0001).</AbstractText><AbstractText Label="CONCLUSION">In patients with OSA undergoing non-cardiac surgery, PAP therapy was associated with a 28% reduction in the risk of postoperative respiratory complications and 56% reduction in unplanned ICU admission. In patients with OSA undergoing cardiac surgery, PAP therapy decreased the risk of postoperative cardiac complications and atrial fibrillation by 37% and 41%, respectively.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2022. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berezin</LastName><ForeName>Linor</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagappa</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, London Health Sciences Centre and St. Joseph Healthcare, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poorzargar</LastName><ForeName>Khashayar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saripella</LastName><ForeName>Aparna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariaratnam</LastName><ForeName>Jennita</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butris</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englesakis</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Library &amp; Information Services, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Department of Anesthesia &amp; Perioperative Medicine, London Health Sciences Centre and St. Joseph Healthcare, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. Electronic address: frances.chung@uhn.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Anesth. 2023 Aug;87:111085. doi: 10.1016/j.jclinane.2023.111085.</RefSource><PMID Version="1">37129975</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="Y">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse outcomes</Keyword><Keyword MajorTopicYN="N">Obstructive sleep apnea</Keyword><Keyword MajorTopicYN="N">Positive airway pressure</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest FC reports research support from the University Health Network Foundation, consultant to Takeda Pharma, Up-to-Date royalties, STOP-Bang proprietary to University Health Network. MN reports grants from the Academic Medical Organization of Southwestern Ontario Opportunity Fund, Ontario Ministry of Health and Long-term Care Innovation Fund, and Lawson Research Fund. All other authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>18</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36347195</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2022.110993</ArticleId><ArticleId IdType="pii">S0952-8180(22)00351-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39580405</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2466</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC pulmonary medicine</Title><ISOAbbreviation>BMC Pulm Med</ISOAbbreviation></Journal><ArticleTitle>Electrical impedance tomography guided positive end-expiratory pressure titration in critically ill and surgical adult patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>582</StartPage><MedlinePgn>582</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">582</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12890-024-03394-y</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Electrical impedance tomography (EIT) has been used to titrate positive end-expiratory pressure (PEEP). This study aims to develop a comprehensive view of the efficacy and long-term prognosis of EIT-guided PEEP compared to other conventional approaches in various clinical scenarios, including patients with acute respiratory distress syndrome (ARDS), hypoxemic acute respiratory failure (hARF) and patients undergoing surgery under general anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The literature search was conducted in&#xa0;PubMed,&#xa0;Web&#xa0;of&#xa0;Science,&#xa0;Embase, and Cochrane&#xa0;Library, from inception&#xa0;to&#xa0;July 30, 2023 (ARDS/hARF) and October 5, 2023 (surgery). The Cochrane risk of bias assessment and the methodological index for non-randomized studies were used for quality appraisal. The main outcomes were PEEP level, PaO<sub>2</sub>/FiO<sub>2</sub> ratio, lung/respiratory system compliance (C<sub>L</sub>/C<sub>rs</sub>), driving pressure (&#x394;P), in-hospital mortality, and postoperative pulmonary complications (PPCs) in surgical studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four randomized controlled trials (RCTs), one historical control study, and six before-after studies of ARDS/hARF, as well as eight surgical RCTs, were&#xa0;retrieved.&#xa0;Subgroup analysis has been carried out and analysis of before-after studies was performed separately. Diverse PEEP strategies were adopted in the included studies, such as low/high PEEP-FiO<sub>2</sub>-table of ARDS-net, pressure-volume loop, and transpulmonary pressure. In ARDS/hARF studies, the EIT strategy did not result in considerably enhanced respiratory system mechanics, including comparable PaO<sub>2</sub>/FiO<sub>2</sub> ratios, comparable &#x394;P, and increased C<sub>L</sub>/C<sub>rs</sub>. As for long-term prognosis, the rough overall meta-analysis showed decreased in-hospital mortality (risk ratio RR&#x2009;=&#x2009;1.54, 95% CI&#x2009;=&#x2009;(1.09, 2.18), P&#x2009;=&#x2009;0.01). In patients undergoing general anesthesia surgery, the EIT group demonstrated increased PaO<sub>2</sub>/FiO<sub>2</sub> ratio, C<sub>L</sub>/C<sub>rs</sub>, and decreased &#x394;P versus the fixed 4 or 5 cmH<sub>2</sub>O PEEP. In postoperative prognosis, incidence of PPCs was generally comparable between the two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The EIT-derived PEEP setting strategy might be associated with potential benefits in respiratory outcomes and prognosis in ARDS/hARF and surgical patients. Current data is insufficient to provide solid evidence.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yelin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Huaiwu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. tjmuhhw@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frerichs</LastName><ForeName>In&#xe9;z</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Medical Center of Schleswig-Holstein Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. icu_longyun@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhanqi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Complex Severe and Rare Diseases, Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. zhanqi.zhao@gzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, China. zhanqi.zhao@gzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Technical Medicine, Furtwangen University, Villingen-Schwenningen, Germany. zhanqi.zhao@gzhmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022-PUMCH-D-005</GrantID><Agency>National High-Level Hospital Clinical Research Funding</Agency><Country/></Grant><Grant><GrantID>82272249</GrantID><Agency>National Outstanding Youth Science Fund Project of National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2022YFC2404805</GrantID><Agency>National key research and development program</Agency><Country/></Grant><Grant><GrantID>2021-I2M-1-062</GrantID><Agency>CAMS Innovation Fund for Medical Sciences from Chinese Academy of Medical Sciences</Agency><Country/></Grant><Grant><GrantID>No. Z201100005520051</GrantID><Agency>Beijing Municipal Science and Technology Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pulm Med</MedlineTA><NlmUniqueID>100968563</NlmUniqueID><ISSNLinking>1471-2466</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="Y">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014054" MajorTopicYN="Y">Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">Electrical impedance tomography</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Hypoxemic acute respiratory failure</Keyword><Keyword MajorTopicYN="N">Positive end-expiratory pressure</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Systematic&#xa0;review,&#xa0;meta-analysis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>23</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39580405</ArticleId><ArticleId IdType="pmc">PMC11585246</ArticleId><ArticleId IdType="doi">10.1186/s12890-024-03394-y</ArticleId><ArticleId IdType="pii">10.1186/s12890-024-03394-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Slutsky AS, Vincent J-L, Rubenfeld GD, Thompson B, Taylor; Ranieri, V. Marco,. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573&#x2013;82. 10.1007/s00134-012-2682-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">22926653</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428&#x2013;37. 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallet RH, Branson RD. Respiratory controversies in the critical care setting. Do the NIH ARDS Clinical Trials Network PEEP/FIO2 tables provide the best evidence-based guide to balancing PEEP and FIO2 settings in adults?. Respir Care. 2007;52(4):461&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">17417980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumello D, Carlesso E, Cadringher P, et al. Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. Am J Respir Crit Care Med. 2008;178(4):346&#x2013;55. 10.1164/rccm.200710-1589OC.</Citation><ArticleIdList><ArticleId IdType="pubmed">18451319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintado MC, de Pablo R, Trascasa M, et al. Individualized PEEP setting in subjects with ARDS: a randomized controlled pilot study. Respir Care. 2013;58(9):1416&#x2013;23. 10.4187/respcare.02068.</Citation><ArticleIdList><ArticleId IdType="pubmed">23362167</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso S, Terragni P, Mascia L, et al. Airway pressure-time curve profile (stress index) detects tidal recruitment/hyperinflation in experimental acute lung injury. Crit Care Med. 2004;32(4):1018&#x2013;27. 10.1097/01.ccm.0000120059.94009.ad.</Citation><ArticleIdList><ArticleId IdType="pubmed">15071395</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotti S, Mascheroni D, Caironi P, et al. Recruitment and derecruitment during acute respiratory failure: a clinical study. Am J Respir Crit Care Med. 2001;164(1):131&#x2013;40. 10.1164/ajrccm.164.1.2007011.</Citation><ArticleIdList><ArticleId IdType="pubmed">11435251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T, Yoshida T, Bellani G, et al. Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives. Intensive Care Med. 2016;42(9):1360&#x2013;73. 10.1007/s00134-016-4400-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">27334266</ArticleId></ArticleIdList></Reference><Reference><Citation>He H, Chi Y, Yang Y, et al. Early individualized positive end-expiratory pressure guided by electrical impedance tomography in acute respiratory distress syndrome: a randomized controlled clinical trial. Crit Care. 2021;25(1):230. Published 2021 Jun 30. 10.1186/s13054-021-03645-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8243615</ArticleId><ArticleId IdType="pubmed">34193224</ArticleId></ArticleIdList></Reference><Reference><Citation>Frerichs I, Amato MB, van Kaam AH, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2017;72(1):83&#x2013;93. 10.1136/thoraxjnl-2016-208357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5329047</ArticleId><ArticleId IdType="pubmed">27596161</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaro S, Mauri T, B&#xf6;hm SH, et al. Variation of poorly ventilated lung units (silent spaces) measured by electrical impedance tomography to dynamically assess recruitment. Crit Care. 2018;22(1):26. Published 2018 Jan 31. 10.1186/s13054-017-1931-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793388</ArticleId><ArticleId IdType="pubmed">29386048</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez JV, Munroe E, Weirauch AJ, et al. Electric impedance tomography-guided PEEP titration reduces mechanical power in ARDS: a randomized crossover pilot trial. Crit Care. 2023;27(1):21. Published 2023 Jan 17. 10.1186/s13054-023-04315-x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843117</ArticleId><ArticleId IdType="pubmed">36650593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu HJ, Chang HT, Zhao Z, et al. Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve: a randomized trial in moderate to severe ARDS. Physiol Meas. 2021;42(1):014002. Published 2021 Feb 6. 10.1088/1361-6579/abd679</Citation><ArticleIdList><ArticleId IdType="pubmed">33361553</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzo G, Spadaro S, Dalla Corte F, et al. Personalized Positive End-Expiratory Pressure in Acute Respiratory Distress Syndrome: Comparison Between Optimal Distribution of Regional Ventilation and Positive Transpulmonary Pressure. Crit Care Med. 2020;48(8):1148&#x2013;56. 10.1097/CCM.0000000000004439.</Citation><ArticleIdList><ArticleId IdType="pubmed">32697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Chang MY, Chang MY, et al. Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve in severe acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):7. Published 2019 Jan 17. 10.1186/s13613-019-0484-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6336593</ArticleId><ArticleId IdType="pubmed">30656479</ArticleId></ArticleIdList></Reference><Reference><Citation>Somhorst P, van der Zee P, Endeman H, Gommers D. PEEP-FiO2 table versus EIT to titrate PEEP in mechanically ventilated patients with COVID-19-related ARDS. Crit Care. 2022;26(1):272. Published 2022 Sep 12. 10.1186/s13054-022-04135-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465137</ArticleId><ArticleId IdType="pubmed">36096837</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibot S, Conrad M, Courte G, Cravoisy A. Positive End-Expiratory Pressure Setting in COVID-19-Related Acute Respiratory Distress Syndrome: Comparison Between Electrical Impedance Tomography, PEEP/FiO2 Tables, and Transpulmonary Pressure. Front Med (Lausanne). 2021;8:720920. Published 2021 Dec 22. 10.3389/fmed.2021.720920</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727370</ArticleId><ArticleId IdType="pubmed">35004712</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher T, Buchholz V, Hassel D, et al. Individualization of PEEP and tidal volume in ARDS patients with electrical impedance tomography: a pilot feasibility study. Ann Intensive Care. 2021;11(1):89. Published 2021 Jun 2. 10.1186/s13613-021-00877-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8171998</ArticleId><ArticleId IdType="pubmed">34080074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sella N, Zarantonello F, Andreatta G, Gagliardi V, Boscolo A, Navalesi P. Positive end-expiratory pressure titration in COVID-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FiO2 tables. Crit Care. 2020;24(1):540. Published 2020 Sep 1. 10.1186/s13054-020-03242-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7459241</ArticleId><ArticleId IdType="pubmed">32873337</ArticleId></ArticleIdList></Reference><Reference><Citation>Heines SJH, Strauch U, van de Poll MCG, Roekaerts PMHJ, Bergmans DCJJ. Clinical implementation of electric impedance tomography in the treatment of ARDS: a single centre experience. J Clin Monit Comput. 2019;33(2):291&#x2013;300. 10.1007/s10877-018-0164-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420412</ArticleId><ArticleId IdType="pubmed">29845479</ArticleId></ArticleIdList></Reference><Reference><Citation>Eronia N, Mauri T, Maffezzini E, et al. Bedside selection of positive end-expiratory pressure by electrical impedance tomography in hypoxemic patients: a feasibility study. Ann Intensive Care. 2017;7(1):76. 10.1186/s13613-017-0299-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519511</ArticleId><ArticleId IdType="pubmed">28730554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Fu Y, Piao X, et al. Individualised positive end-expiratory pressure titrated intra-operatively by electrical impedance tomography optimises pulmonary mechanics and reduces postoperative atelectasis: A randomised controlled trial. Eur J Anaesthesiol. 2023;40(11):805&#x2013;16. 10.1097/EJA.0000000000001901.</Citation><ArticleIdList><ArticleId IdType="pubmed">37789753</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Yu K, Yang JJ, et al. Effect of individualized positive end-expiratory pressure based on electrical impedance tomography guidance on pulmonary ventilation distribution in patients who receive abdominal thermal perfusion chemotherapy. Front Med (Lausanne). 2023;10:1198720. Published 2023 Sep 5. 10.3389/fmed.2023.1198720</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10507689</ArticleId><ArticleId IdType="pubmed">37731718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha J, Yu YJ, Li GR, et al. Lung protection effect of EIT-based individualized protective ventilation strategy in patients with partial pulmonary resection. Eur Rev Med Pharmacol Sci. 2023;27(12):5459&#x2013;67. 10.26355/eurrev_202306_32782.</Citation><ArticleIdList><ArticleId IdType="pubmed">37401282</ArticleId></ArticleIdList></Reference><Reference><Citation>Girrbach F, Petroff D, Schulz S, et al. Individualised positive end-expiratory pressure guided by electrical impedance tomography for robot-assisted laparoscopic radical prostatectomy: a prospective, randomised controlled clinical trial. Br J Anaesth. 2020;125(3):373&#x2013;82. 10.1016/j.bja.2020.05.041.</Citation><ArticleIdList><ArticleId IdType="pubmed">32665059</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber J, Gutjahr J, Schmidt J, et al. Effect of individualized PEEP titration guided by intratidal compliance profile analysis on regional ventilation assessed by electrical impedance tomography - a randomized controlled trial. BMC Anesthesiol. 2020;20(1):42. Published 2020 Feb 20. 10.1186/s12871-020-00960-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7033933</ArticleId><ArticleId IdType="pubmed">32079526</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Huang C, Xu M, et al. PEEP guided by electrical impedance tomography during one-lung ventilation in elderly patients undergoing thoracoscopic surgery. Ann Transl Med. 2019;7(23):757. 10.21037/atm.2019.11.95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6989968</ArticleId><ArticleId IdType="pubmed">32042773</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira SM, Tucci MR, Morais CCA, et al. Individual Positive End-expiratory Pressure Settings Optimize Intraoperative Mechanical Ventilation and Reduce Postoperative Atelectasis. Anesthesiology. 2018;129(6):1070&#x2013;81. 10.1097/ALN.0000000000002435.</Citation><ArticleIdList><ArticleId IdType="pubmed">30260897</ArticleId></ArticleIdList></Reference><Reference><Citation>Nestler C, Simon P, Petroff D, et al. Individualized positive end-expiratory pressure in obese patients during general anaesthesia: a randomized controlled clinical trial using electrical impedance tomography. Br J Anaesth. 2017;119(6):1194&#x2013;205. 10.1093/bja/aex192.</Citation><ArticleIdList><ArticleId IdType="pubmed">29045567</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178&#x2013;89. 10.1016/j.jclinepi.2021.03.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789819</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration's tool for assessing the risk of bias in randomised trials. BMJ. 2011;343:d5928. Published 2011 Oct 18. 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>lim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological Index for Non-Randomized Studies (MINORS): developement and validation of a new instrument. ANZ J Surg. 2003;73(9):712&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">12956787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2&#x2013;10. 10.1111/jebm.12141.</Citation><ArticleIdList><ArticleId IdType="pubmed">25594108</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021;398(10300):622&#x2013;37. 10.1016/S0140-6736(21)00439-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248927</ArticleId><ArticleId IdType="pubmed">34217425</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data [published correction appears in Lancet Respir Med. 2016;4(6):e34]. Lancet Respir Med. 2016;4(4):272&#x2013;280. 10.1016/S2213-2600(16)00057-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K, Vidal Melo MF, McLean DJ, et al. Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ. 2015;351:h3646. Published 2015 Jul 14. 10.1136/bmj.h3646</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501577</ArticleId><ArticleId IdType="pubmed">26174419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Steinmann D, Frerichs I, Guttmann J, M&#xf6;ller K. PEEP titration guided by ventilation homogeneity: a feasibility study using electrical impedance tomography. Crit Care. 2010;14(1):R8. 10.1186/cc8860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875520</ArticleId><ArticleId IdType="pubmed">20113520</ArticleId></ArticleIdList></Reference><Reference><Citation>Perier F, Tuffet S, Maraffi T, et al. Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome. Crit Care. 2020;24(1):678. Published 2020 Dec 7. 10.1186/s13054-020-03414-3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7719729</ArticleId><ArticleId IdType="pubmed">33287864</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36436787</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Effect of continuous infusion of hypertonic saline solution on survival of patients with brain injury: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>101177</StartPage><MedlinePgn>101177</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2022.101177</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(22)00158-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">The objective was to determine the effects of continuous infusion of hypertonic saline solutions on outcomes of patients with brain injury.</AbstractText><AbstractText Label="METHODS">Preferred Reported Items for Systemic Reviews and Meta-Analysis guidelines were followed. We searched the MEDLINE and COCHRANE clinical trials register (through December 2021) and reference lists of articles. We included all clinical trials conducted in brain-injured patients hospitalized in intensive care units evaluating continuous infusion of hypertonic saline solution (osmolarity above 308 mOsm/L). Two reviewers extracted data that were checked by two others. The primary outcome was the in-hospital mortality rate. The main secondary outcomes were the rates of intracranial hypertension, an unfavorable neurological outcome at day 90, and adverse events.</AbstractText><AbstractText Label="RESULTS">We identified 23 clinical trials reporting the use of continuous infusion of hypertonic saline solution in brain-injured patients. The primary outcome was available in 10 studies (n&#x2009;=&#x2009;1883 patients). The odds ratio (OR) for in-hospital death with the intervention was 0.68 (95% confidence interval (CI), 0.54-0.85, I<sup>2</sup>&#x2009;=&#x2009;0%). In the subgroup of studies including only traumatic brain-injured patients (7 studies, n&#x2009;=&#x2009;1521 patients), the OR for the primary outcome was 0.74 (95%CI 0.57-0.95) with the intervention. The OR for intracranial hypertension and unfavorable neurological outcome at day 90 were 0.66 (95%CI 0.49-0.88, I<sup>2</sup>&#x2009;=&#x2009;42%, n&#x2009;=&#x2009;787 patients) and 0.61 (95%CI 0.46-0.81, I<sup>2</sup>&#x2009;=&#x2009;15%, n&#x2009;=&#x2009;956 patients), respectively. Regarding safety, the OR of acute kidney injury and severe hypernatremia were 0.82 (95%CI 0.47-1.44, I<sup>2</sup>&#x2009;=&#x2009;0%) and 3.38 (95%CI 2.16-5.27, I<sup>2</sup>&#x2009;=&#x2009;24%).</AbstractText><AbstractText Label="CONCLUSIONS">Continuous hypertonic saline solution infusion reduced in-hospital mortality without increasing the risk of unfavorable neurological outcome at day 90 in brain-injured patients hospitalized in intensive care units. Given the inclusion of observational and heterogeneous studies, further randomized studies are needed before developing recommendations for implementation at the bedside.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION">PROSPERO CRD42021221367. Registered 13 May 2021.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Soci&#xe9;t&#xe9; fran&#xe7;aise d'anesth&#xe9;sie et de r&#xe9;animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hourmant</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, INSERM CIC 0004 Immunologie Et Infectiologie, Nantes, F-44093 France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huard</LastName><ForeName>Donatien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, INSERM CIC 0004 Immunologie Et Infectiologie, Nantes, F-44093 France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demeure Dit Latte</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, INSERM CIC 0004 Immunologie Et Infectiologie, Nantes, F-44093 France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouras</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, INSERM CIC 0004 Immunologie Et Infectiologie, Nantes, F-44093 France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asehnoune</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, INSERM CIC 0004 Immunologie Et Infectiologie, Nantes, F-44093 France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirrachio</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roquilly</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, INSERM CIC 0004 Immunologie Et Infectiologie, Nantes, F-44093 France. Electronic address: antoine.roquilly@chu-nantes.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012462">Saline Solution, Hypertonic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012462" MajorTopicYN="N">Saline Solution, Hypertonic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="Y">Brain Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019586" MajorTopicYN="Y">Intracranial Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006257" MajorTopicYN="N">Head</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain injury</Keyword><Keyword MajorTopicYN="N">Hypertonic saline solution</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Saline infusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>27</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36436787</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2022.101177</ArticleId><ArticleId IdType="pii">S2352-5568(22)00158-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30502311</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Noninvasive Ventilation After Thoracoabdominal Aortic Surgery: A Pilot Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>1639</StartPage><EndPage>1645</EndPage><MedlinePgn>1639-1645</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2018.10.041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(18)31013-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the beneficial effects of noninvasive ventilation in treating postoperative pulmonary complications in patients undergoing thoracoabdominal aortic aneurysm (TAAA) open repair surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Randomized controlled trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">University tertiary-care hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Forty patients who underwent elective TAAA open repair.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomized to the "noninvasive ventilation" group, receiving 2-hour cycles of noninvasive ventilation every 8 hours for at least 3 days in addition to the best available postoperative treatment currently in use at the authors' institution versus the "standard" group, not receiving noninvasive ventilation treatment MEASUREMENTS AND MAIN RESULTS: The primary outcome of clinical worsening, described as a composite outcome of need for therapeutic noninvasive ventilation, need for mechanical ventilation owing to respiratory causes, need for intensive care unit admission owing to respiratory causes, and in-hospital mortality, occurred in 2 (11%) patients in the noninvasive ventilation group versus 12 (57%) in the standard group (p&#x202f;=&#x202f;0.002; relative risk 0.18; 95% confidence interval 0.047-0.72).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Noninvasive ventilation is a promising, affordable, and easy-to-use tool to prevent postoperative respiratory complications after TAAA open surgical repair.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mamo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leggieri</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olper</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardelli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalessandro</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponzetta</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Humanitas Clinical and Research Center, Rozzano Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2019 Jun;33(6):1646-1647. doi: 10.1053/j.jvca.2019.01.034.</RefSource><PMID Version="1">30765213</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3219-3220. doi: 10.1053/j.jvca.2019.07.149.</RefSource><PMID Version="1">31444043</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3220-3221. doi: 10.1053/j.jvca.2019.07.146.</RefSource><PMID Version="1">31495680</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="N">Noninvasive Ventilation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">noninvasive ventilation</Keyword><Keyword MajorTopicYN="N">postoperative respiratory complications</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword><Keyword MajorTopicYN="N">thoracoabdominal aortic aneurysm</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30502311</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2018.10.041</ArticleId><ArticleId IdType="pii">S1053-0770(18)31013-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37481517</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Neuraxial versus general anesthesia in elderly patients undergoing hip fracture surgery and the incidence of postoperative delirium: a systematic review and stratified meta-analysis.</ArticleTitle><Pagination><StartPage>250</StartPage><MedlinePgn>250</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">250</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-023-02196-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Evidence-based effect of anesthetic regimens on postoperative delirium (POD) incidence after hip fracture surgery is still debated. Randomized trials have reported inconsistent contradictory results largely attributed to small sample size, use of outdated drugs and techniques, and inconsistent definitions of adverse outcomes. The primary objective of this meta-analysis was to investigate the impact of different anesthesia regimens on POD, cognitive impairment, and associated complications including mortality, duration of hospital stay, and rehabilitation capacity.</AbstractText><AbstractText Label="METHODS">We identified randomized controlled trials (RCTs) published from 2000 to December 2021, in English and non-English language, comparing the effect of neuraxial anesthesia (NA) versus general anesthesia (GA) in elderly patients undergoing hip fracture surgery, from PubMed, EMBASE, Google Scholar, Web of Science and the Cochrane Library database. They were included if POD incidence, cognitive impairment, mortality, duration of hospital stay, or rehabilitation capacity were reported as at least one of the outcomes. Study protocols, case reports, audits, editorials, commentaries, conference reports, and abstracts were excluded. Two investigators (KYC and TXY) independently screened studies for inclusion and performed data extraction. The risk of bias was assessed using the Cochrane Collaboration risk-of-bias tool. The quality of the evidence for each outcome according to the GRADE working group criteria. The odds ratio (OR) and 95% confidence intervals (CI) were calculated to assess the pooled data.</AbstractText><AbstractText Label="RESULTS">A total of 10 RCTs with 3968 patients were included in the present analysis. No significant differences were found in the incidence of POD comparing NA vs GA [OR 1.10, 95% CI (0.89 to 1.37)], with or without including patients with a pre-existing condition of dementia or delirium, POD incidence from postoperative day 2-7 [OR 0.31, 95% CI (0.06 to -1.63)], in mini-mental state examination (MMSE) score [OR 0.07, 95% CI (-0.22 to 0.36)], or other neuropsychological test results. NA appeared to have a shorter duration of hospital stay, especially in patients without pre-existing dementia or delirium, however the observed effect did not reach statistical significance [OR -0.23, 95% CI (-0.46 to 0.01)]. There was no difference in other outcomes, including postoperative pain control, discharge to same preadmission residence [OR 1.05, 95% CI (0.85 to 1.31)], in-hospital mortality [OR 1.98, 95% CI (0.20 to 19.25)], 30-day [OR 1.03, 95% CI (0.47 to 2.25)] or 90-day mortality [OR 1.08, 95% CI (0.53-2.24)].</AbstractText><AbstractText Label="CONCLUSIONS">No significant differences were detected in incidence of POD, nor in other delirium-related outcomes between NA and GA groups and in subgroup analyses. NA appeared to be associated with a shorter hospital stay, especially in patients without pre-existing dementia, but the observed effect did not reach statistical significance. Further larger prospective randomized trials investigating POD incidence and its duration and addressing long-term clinical outcomes are indicated to rule out important differences between different methods of anesthesia for hip surgery.</AbstractText><AbstractText Label="TRIAL REGISTRATION">10.17605/OSF.IO/3DJ6C.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Karis Yui-Lam</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Tertiary Hospital in Kowloon, 30 Gascoigne Road, Hong Kong, Hong Kong. cyl983@ha.org.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Timothy Xianyi</ForeName><Initials>TX</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Tertiary Hospital in Kowloon, 30 Gascoigne Road, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>David Yew-Chuan</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Tertiary Hospital in Kowloon, 30 Gascoigne Road, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>So</LastName><ForeName>Eric Hang-Kwong</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Tertiary Hospital in Kowloon, 30 Gascoigne Road, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Neuraxial anesthesia</Keyword><Keyword MajorTopicYN="N">Postoperative delirium</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>23</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>22</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37481517</ArticleId><ArticleId IdType="pmc">PMC10362612</ArticleId><ArticleId IdType="doi">10.1186/s12871-023-02196-9</ArticleId><ArticleId IdType="pii">10.1186/s12871-023-02196-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Od&#xe9;n A, McCloskey EV, Johansson H, Kanis JA. Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int. 2013;92:42&#x2013;49. doi: 10.1007/s00223-012-9666-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-012-9666-6</ArticleId><ArticleId IdType="pubmed">23135744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285&#x2013;289. doi: 10.1007/BF01623184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01623184</ArticleId><ArticleId IdType="pubmed">1421796</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Handoll HH, Griffiths R. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev. 2004;2017:CD000521.</Citation><ArticleIdList><ArticleId IdType="pubmed">15494999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DX, Yang L, Ding L, Li SY, Qi YN, Li Q. Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: a systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e18220. doi: 10.1097/MD.0000000000018220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000018220</ArticleId><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="pubmed">31804347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, Liu Z. Comparative efficacy of neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol. 2020;20:162. doi: 10.1186/s12871-020-01074-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01074-y</ArticleId><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, Coburn M. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17:87. doi: 10.1186/s12871-017-0380-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-017-0380-9</ArticleId><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, Zohman GL, Diekmann GR, Maletis GB, et al. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res. 2018;476:1178&#x2013;1188. doi: 10.1007/s11999.0000000000000147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999.0000000000000147</ArticleId><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Choi P, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;2014:CD010108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087466</ArticleId><ArticleId IdType="pubmed">24464831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn EJ, Kim HJ, Kim KW, Choi HR, Kang H, Bang SR. Comparison of general anaesthesia and regional anaesthesia in terms of mortality and complications in elderly patients with hip fracture: a nationwide population-based study. BMJ Open. 2019;9:e029245. doi: 10.1136/bmjopen-2019-029245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-029245</ArticleId><ArticleId IdType="pmc">PMC6738684</ArticleId><ArticleId IdType="pubmed">31501111</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, Ludwig JM, Fleisher LA. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology. 2012;117:72&#x2013;92. doi: 10.1097/ALN.0b013e3182545e7c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182545e7c</ArticleId><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, Chien CC, Shieh JP, Chen JY, et al. Propensity score-matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology. 2015;123:136&#x2013;147. doi: 10.1097/ALN.0000000000000695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000695</ArticleId><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih Y-J, Hsieh C-H, Kang T-W, Peng S-Y, Fan K-T, Wang L-M. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol. 2010;4:37&#x2013;42. doi: 10.1016/S1873-9598(10)70020-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1873-9598(10)70020-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields AC, Dieterich JD, Buterbaugh K, Moucha CS. Short-term complications in hip fracture surgery using spinal versus general anaesthesia. Injury. 2015;46:719&#x2013;723. doi: 10.1016/j.injury.2015.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.02.002</ArticleId><ArticleId IdType="pubmed">25704139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Yin Y, Jin M, Li B. The risk factors for postoperative delirium in adult patients after hip fracture surgery: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021;36:3&#x2013;14. doi: 10.1002/gps.5408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5408</ArticleId><ArticleId IdType="pubmed">32833302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J, Zhang P, Liang X, Wu Z, Wang J, Liang Y. Association between dementia and mortality in the elderly patients undergoing hip fracture surgery: a meta-analysis. J Orthop Surg Res. 2018;13:298. doi: 10.1186/s13018-018-0988-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-018-0988-6</ArticleId><ArticleId IdType="pmc">PMC6260652</ArticleId><ArticleId IdType="pubmed">30470251</ArticleId></ArticleIdList></Reference><Reference><Citation>Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, Van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443&#x2013;451. doi: 10.1001/jama.2010.1013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1013</ArticleId><ArticleId IdType="pubmed">20664045</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V, Champaneria R, Dretzke J, Yeung J. Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review. BMJ Open. 2018;8:e020757. doi: 10.1136/bmjopen-2017-020757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-020757</ArticleId><ArticleId IdType="pmc">PMC6286489</ArticleId><ArticleId IdType="pubmed">30518580</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, Gaskins LJ, Dillane D, Sessler DI, et al. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med. 2021;385:2025&#x2013;2035. doi: 10.1056/NEJMoa2113514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2113514</ArticleId><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, Wu J, Jiang C, Daniels J, et al. Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the RAGA randomized trial. JAMA. 2022;327:50&#x2013;58. doi: 10.1001/jama.2021.22647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.22647</ArticleId><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitani K, Higuchi A, Asahi T, Yoshida H. Postoperative delirium after general anesthesia vs. spinal anesthesia in geriatric patients. Masui. 2003;52:972&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">14531256</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Savovi&#x107; J, Page MJ, Elbers RG, Sterne JA. Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: Wiley; 2019. pp. 205&#x2013;228.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383&#x2013;94. doi: 10.1016/j.jclinepi.2010.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. 2013. https://gdt.gradepro.org/app/handbook/handbook.html&#xa0;. Updated October 2013.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139&#x2013;145. doi: 10.1016/j.cct.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2015.09.002</ArticleId><ArticleId IdType="pmc">PMC4639420</ArticleId><ArticleId IdType="pubmed">26343745</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Li T, Deeks JJ. Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch V, editors. Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: Wiley; 2019. pp. 143&#x2013;176.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101&#x2013;105. doi: 10.1136/bmj.323.7304.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.323.7304.101</ArticleId><ArticleId IdType="pmc">PMC1120714</ArticleId><ArticleId IdType="pubmed">11451790</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;cker G, Schwarzer G, Carpenter JR, Binder H, Schumacher M. Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis. Biostatistics. 2011;12:122&#x2013;142. doi: 10.1093/biostatistics/kxq046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxq046</ArticleId><ArticleId IdType="pubmed">20656692</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17:39. doi: 10.1186/s12874-017-0315-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0315-7</ArticleId><ArticleId IdType="pmc">PMC5397700</ArticleId><ArticleId IdType="pubmed">28264661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren W-X, Wu R-R. Effect of general and sub-arachnoid anesthesia on the incidence of postoperative delirium and cognitive impairments in elderly Chinese patients. Trop J Pharm Res. 2021;20:433&#x2013;439. doi: 10.4314/tjpr.v20i2.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/tjpr.v20i2.30</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Fang P, Fang Y, Lu Y, Xu G, Liu X. Comparison of effects between combined lumbar-sacral plexus block plus general anesthesia and unilateral spinal anesthesia in elderly patients undergoing hip fracture surgery: a pilot randomized controlled trial. Evid Based Complement Alternat Med. 2021;2021:6685497. doi: 10.1155/2021/6685497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6685497</ArticleId><ArticleId IdType="pmc">PMC8105098</ArticleId><ArticleId IdType="pubmed">34012474</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S, Kim SH, Park KK, Kim SJ, Bae JC, Choi YS. Effects of anesthesia techniques on outcomes after hip fracture surgery in elderly patients: a prospective, randomized, controlled trial. J Clin Med. 2020;9:1605. doi: 10.3390/jcm9061605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061605</ArticleId><ArticleId IdType="pmc">PMC7355551</ArticleId><ArticleId IdType="pubmed">32466360</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Samara E, Petrou A, Korompilias A, Chalkias A, Papadopoulos G. The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general vs spinal anesthesia. Injury. 2018;49:2221&#x2013;2226. doi: 10.1016/j.injury.2018.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.09.023</ArticleId><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. a pilot randomised controlled trial of 322 patients. Injury. 2015;46:1562&#x2013;6. doi: 10.1016/j.injury.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.05.004</ArticleId><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SM, Soltani H, Hashemi SJ, Talakoub R, Soleimani B. Comparative study of two anesthesia methods according to postoperative complications and one month mortality rate in the candidates of hip surgery. J Res Med Sci. 2011;16:323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214341</ArticleId><ArticleId IdType="pubmed">22091252</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, Marsan A, Fraschini G, Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20:640&#x2013;646. doi: 10.1097/00003643-200308000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003643-200308000-00009</ArticleId><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Ellenberg SS, Sieber F, Sessler DI, Magaziner J, et al. Pain, analgesic use, and patient satisfaction with spinal versus general anesthesia for hip fracture surgery : a randomized clinical trial. Ann Intern Med. 2022;175:952&#x2013;960. doi: 10.7326/M22-0320.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M22-0320</ArticleId><ArticleId IdType="pubmed">35696684</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigler D, Adelh&#xf8;j B, Petring OU, Pederson NO, Busch P, Kalhke P. Mental function and morbidity after acute hip surgery during spinal and general anaesthesia. Anaesthesia. 1985;40:672&#x2013;676. doi: 10.1111/j.1365-2044.1985.tb10949.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.1985.tb10949.x</ArticleId><ArticleId IdType="pubmed">4025772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei LA, Fearing MA, Sternberg EJ, Inouye SK. The confusion assessment method: a systematic review of current usage. J Am Geriatr Soc. 2008;56:823&#x2013;830. doi: 10.1111/j.1532-5415.2008.01674.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2008.01674.x</ArticleId><ArticleId IdType="pmc">PMC2585541</ArticleId><ArticleId IdType="pubmed">18384586</ArticleId></ArticleIdList></Reference><Reference><Citation>Pompei P, Foreman M, Rudberg MA, Inouye SK, Braund V, Cassel CK. Delirium in hospitalized older persons: outcomes and predictors. J Am Geriatr Soc. 1994;42:809&#x2013;815. doi: 10.1111/j.1532-5415.1994.tb06551.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.1994.tb06551.x</ArticleId><ArticleId IdType="pubmed">8046190</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020;11:CD.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8130997</ArticleId><ArticleId IdType="pubmed">33238043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouzopoulos G, Vasiliadis G, Lasanianos N, Nikolaras G, Morakis E, Kaminaris M. Fascia iliaca block prophylaxis for hip fracture patients at risk for delirium: a randomized placebo-controlled study. J Orthop Traumatol. 2009;10:127&#x2013;133. doi: 10.1007/s10195-009-0062-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10195-009-0062-6</ArticleId><ArticleId IdType="pmc">PMC2744739</ArticleId><ArticleId IdType="pubmed">19690943</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Parker MJ, Griffiths R, Kopp SL. Peripheral nerve blocks for hip fractures: a Cochrane review. Anesth Analg. 2018;126:1695&#x2013;1704. doi: 10.1213/ANE.0000000000002489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002489</ArticleId><ArticleId IdType="pubmed">28991122</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber FE, Zakriya KJ, Gottschalk A, Blute MR, Lee HB, Rosenberg PB, et al. Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair. Mayo Clin Proc. 2010;85:18&#x2013;26. doi: 10.4065/mcp.2009.0469.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2009.0469</ArticleId><ArticleId IdType="pmc">PMC2800291</ArticleId><ArticleId IdType="pubmed">20042557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber FE, Neufeld KJ, Gottschalk A, Bigelow GE, Oh ES, Rosenberg PB, et al. Effect of depth of sedation in older patients undergoing hip fracture repair on postoperative delirium: the STRIDE randomized clinical trial. JAMA Surg. 2018;153:987&#x2013;995. doi: 10.1001/jamasurg.2018.2602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2018.2602</ArticleId><ArticleId IdType="pmc">PMC6583071</ArticleId><ArticleId IdType="pubmed">30090923</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006;102:1267&#x2013;1273. doi: 10.1213/01.ane.0000199156.59226.af.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000199156.59226.af</ArticleId><ArticleId IdType="pubmed">16551935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor SK, Hamal PB, Tomassini S, Yeung J, Whitehouse MR, Matharu GS. Clinical effectiveness and safety of spinal anaesthesia compared with general anaesthesia in patients undergoing hip fracture surgery using a consensus-based core outcome set and patient-and public-informed outcomes: a systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. 2022;129:788&#x2013;800. doi: 10.1016/j.bja.2022.07.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.07.031</ArticleId><ArticleId IdType="pmc">PMC9642835</ArticleId><ArticleId IdType="pubmed">36270701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowark A, Adam C, Ahrens J, Bajbouj M, Bollheimer C, Borowski M, et al. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia. BMJ Open. 2018;8:e023609. doi: 10.1136/bmjopen-2018-023609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-023609</ArticleId><ArticleId IdType="pmc">PMC6196806</ArticleId><ArticleId IdType="pubmed">30341135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37400892</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-8090</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of cardiothoracic surgery</Title><ISOAbbreviation>J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Outcomes of valve-sparing aortic root replacement in patients with bicuspid aortic valve and tricuspid aortic valve: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>206</StartPage><MedlinePgn>206</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">206</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13019-023-02329-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Valve-sparing aortic root replacement (VSARR) is a safe and effective surgical procedure to treat aortic root aneurysm. This meta-analysis aimed to investigate how this procedure might differ in patients with bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Meta-analysis with meta-regression and systematic review.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Systematic search in the following databases: PubMed, Cochrane Central Register of Controlled Trials, and Embase.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">All observational studies of VSARR in patients with BAV or TAV were included in our study. Studies were included without any restrictions on language or publication date. A trial sequential analysis and a post-hoc meta-regression was performed on the main outcomes.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">Eleven articles met the inclusion criteria. A total of 1138 patients in BAV group, and 2125 patients in TAV group. No significant differences in gender and age were observed between BAV and TAV patients. BAV and TAV patients showed no differences in in-hospital mortality rate [0.00% vs. 1.93%; RR (95% CI) 0.33 (0.09, 1.26), I<sup>2</sup>&#x2009;=&#x2009;0%, P&#x2009;=&#x2009;0.11] and the rate of in-hospital reoperation [5.64% vs. 5.99%; RR (95% CI) 1.01(0.59, 1.73), I<sup>2</sup>&#x2009;=&#x2009;33%, P&#x2009;=&#x2009;0.98]. The overall long-term mortality rate of BAV patients was better than that of TAV patients [1.63% vs. 8.15%; RR (95% CI) 0.34 (0.13, 0.86), I<sup>2</sup>&#x2009;=&#x2009;0%, P&#x2009;=&#x2009;0.02]. During the follow-up observation period, patients in TAV group showed small but no statistic advantage in 3-year, 5-year, and over 10-year incidences of reintervention. Regarding the secondary endpoints, the two groups showed similar aortic cross-clamping time and total cardiopulmonary bypass time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The VSARR techniques yielded similar clinical outcomes in both BAV and TAV patients. Although patients with BAV might have a higher incidence of reinterventions after initial VSARR, it is still a safe and effective approach to treat aortic root dilation with or without aortic valve insufficiency. TAV patients showed small but no statistic advantage in long-term (over 10&#xa0;years) reintervention rate, which means, patients with BAV may face a higher risk of reintervention in the clinic.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Yiding</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ruixi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Chaoyi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery and Cardiovascular Surgery Research Laboratory, West China Hospital, Sichuan University, 37th Guoxue Road, Chengdu, 610041, China. qinchaoyi@wchscu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cardiothorac Surg</MedlineTA><NlmUniqueID>101265113</NlmUniqueID><ISSNLinking>1749-8090</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082882" MajorTopicYN="Y">Bicuspid Aortic Valve Disease</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006349" MajorTopicYN="Y">Heart Valve Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001011" MajorTopicYN="N">Aorta</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014261" MajorTopicYN="N">Tricuspid Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bicuspid aortic valve</Keyword><Keyword MajorTopicYN="N">Reimplantation</Keyword><Keyword MajorTopicYN="N">Remodeling</Keyword><Keyword MajorTopicYN="N">Tricuspid aortic valve</Keyword><Keyword MajorTopicYN="N">Valve-sparing aortic root replacement</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>4</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37400892</ArticleId><ArticleId IdType="pmc">PMC10318800</ArticleId><ArticleId IdType="doi">10.1186/s13019-023-02329-8</ArticleId><ArticleId IdType="pii">10.1186/s13019-023-02329-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>David TE. Aortic root aneurysms: remodeling or composite replacement? Ann Thorac Surg. 1997;64:1564&#x2013;1568. doi: 10.1016/S0003-4975(97)01026-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(97)01026-6</ArticleId><ArticleId IdType="pubmed">9386768</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokashi SA, Rosinski BF, Desai MY, Griffin BP, Hammer DF, Kalahasti V, Johnston DR, Rajeswaran J, Roselli EE, Blackstone EH, Svensson LG. Aortic root replacement with bicuspid valve reimplantation: Are outcomes and valve durability comparable to those of tricuspid valve reimplantation? J Thorac Cardiovasc Surg. 2022;163:51&#x2013;63. doi: 10.1016/j.jtcvs.2020.02.147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.02.147</ArticleId><ArticleId IdType="pubmed">32684389</ArticleId></ArticleIdList></Reference><Reference><Citation>David TE, David CM, Feindel CM, Manlhiot C. Reimplantation of the aortic valve at 20 years. J Thorac Cardiovasc Surg. 2017;153:232&#x2013;238. doi: 10.1016/j.jtcvs.2016.10.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.10.081</ArticleId><ArticleId IdType="pubmed">27923487</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotz S, Stock S, Sievers HH, Diwoky M, Petersen M, Stierle U, Richardt D. Survival and reoperation pattern after 20 years of experience with aortic valve-sparing root replacement in patients with tricuspid and bicuspid valves. J Thorac Cardiovasc Surg. 2018;155:1403&#x2013;1411. doi: 10.1016/j.jtcvs.2017.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.12.039</ArticleId><ArticleId IdType="pubmed">29338868</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Liang M, Huang S, Wu Z. Reimplantation versus remodeling in valve-sparing surgery for aortic root aneurysms: a meta-analysis. J Thorac Dis. 2020;12:4742&#x2013;4753. doi: 10.21037/jtd-20-1407.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-20-1407</ArticleId><ArticleId IdType="pmc">PMC7578473</ArticleId><ArticleId IdType="pubmed">33145047</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafers HJ, Raddatz A, Schmied W, Takahashi H, Miura Y, Kunihara T, Aicher D. Reexamining remodeling. J Thorac Cardiovasc Surg. 2015;149:S30&#x2013;S36. doi: 10.1016/j.jtcvs.2014.09.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.09.048</ArticleId><ArticleId IdType="pubmed">25439784</ArticleId></ArticleIdList></Reference><Reference><Citation>David TE, David CM, Ouzounian M, Feindel CM, Lafreniere-Roula M. A progress report on reimplantation of the aortic valve. J Thorac Cardiovasc Surg. 2021;161:890&#x2013;899. doi: 10.1016/j.jtcvs.2020.07.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.07.121</ArticleId><ArticleId IdType="pubmed">33008570</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Qual Report Meta Anal Lancet. 1999;354:1896&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pubmed">10584742</ArticleId></ArticleIdList></Reference><Reference><Citation>D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Aicher D, Langer F, Lausberg H, Bierbach B, Schafers HJ. Aortic root remodeling: ten-year experience with 274 patients. J Thorac Cardiovasc Surg. 2007;134:909&#x2013;915. doi: 10.1016/j.jtcvs.2007.05.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.05.052</ArticleId><ArticleId IdType="pubmed">17903506</ArticleId></ArticleIdList></Reference><Reference><Citation>Malvindi PG, Raffa GM, Basciu A, Citterio E, Cappai A, Ornaghi D, Tarelli G, Settepani F. Bicuspidy does not affect reoperation risk following aortic valve reimplantation. Interact Cardiovasc Thorac Surg. 2012;14:717&#x2013;720. doi: 10.1093/icvts/ivs059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivs059</ArticleId><ArticleId IdType="pmc">PMC3352725</ArticleId><ArticleId IdType="pubmed">22389000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvitting JP, Kari FA, Fischbein MP, Liang DH, Beraud AS, Stephens EH, Mitchell RS, Miller DC. David valve-sparing aortic root replacement: equivalent mid-term outcome for different valve types with or without connective tissue disorder. J Thorac Cardiovasc Surg. 2013;145:117&#x2013;126. doi: 10.1016/j.jtcvs.2012.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.09.013</ArticleId><ArticleId IdType="pmc">PMC6382393</ArticleId><ArticleId IdType="pubmed">23083792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavaria JE, Desai N, Szeto WY, Komlo C, Rhode T, Wallen T, Vallabhajosyula P. Valve-sparing root reimplantation and leaflet repair in a bicuspid aortic valve: comparison with the 3-cusp David procedure. J Thorac Cardiovasc Surg. 2015;149:S22&#x2013;S28. doi: 10.1016/j.jtcvs.2014.10.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.10.103</ArticleId><ArticleId IdType="pubmed">25500099</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin CE, Garcia Montero C, Serrano SF, Gonzalez A, Mingo S, Monivas V, Centeno J, Forteza A. The influence of Marfans and bicuspid valves on outcomes following aortic valve reimplantation. J Card Surg. 2017;32:604&#x2013;612. doi: 10.1111/jocs.13206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.13206</ArticleId><ArticleId IdType="pubmed">28929526</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha ML, Beckmann E, Abd Alhadi F, Krueger H, Meyer-Bockenkamp F, Bertele S, Koigeldiyev N, Kaufeld T, Fleissner F, Korte W, Schmitto J, Cebotari S, Harringer W, Haverich A, Martens A. Elective David I procedure has excellent long-term results: 20-year single-center experience. Ann Thorac Surg. 2018;105:731&#x2013;738. doi: 10.1016/j.athoracsur.2017.08.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.08.040</ArticleId><ArticleId IdType="pubmed">29198631</ArticleId></ArticleIdList></Reference><Reference><Citation>Karciauskas D, Mizariene V, Jakuska P, Ereminiene E, Orda P, Ordiene R, Vaskelyte JJ, Nedzelskiene I, Kinduris S, Benetis R. Early and long-term results of aortic valve sparing aortic root reimplantation surgery for bicuspid and tricuspid aortic valves. Perfusion. 2019;34:482&#x2013;489. doi: 10.1177/0267659119831926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659119831926</ArticleId><ArticleId IdType="pubmed">30823866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzounian M, Feindel CM, Manlhiot C, David C, David TE. Valve-sparing root replacement in patients with bicuspid versus tricuspid aortic valves. J Thorac Cardiovasc Surg. 2019;158:1&#x2013;9. doi: 10.1016/j.jtcvs.2018.10.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2018.10.151</ArticleId><ArticleId IdType="pubmed">31248507</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyahara S, Karliova I, Giebels C, Schneider U, Matsushima S, Schafers HJ. Aortic root remodeling in bicuspid and tricuspid aortic valves-long-term results. Indian J Thorac Cardiovasc Surg. 2020;36:81&#x2013;87. doi: 10.1007/s12055-019-00798-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12055-019-00798-y</ArticleId><ArticleId IdType="pmc">PMC7525473</ArticleId><ArticleId IdType="pubmed">33061188</ArticleId></ArticleIdList></Reference><Reference><Citation>David TE. Current readings: aortic valve-sparing operations. Semin Thorac Cardiovasc Surg. 2014;26:231&#x2013;238. doi: 10.1053/j.semtcvs.2014.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2014.10.002</ArticleId><ArticleId IdType="pubmed">25527017</ArticleId></ArticleIdList></Reference><Reference><Citation>Sef D, Bahrami T, Raja SG, Klokocovnik T. Current trends in minimally invasive valve-sparing aortic root replacement-Best available evidence. J Card Surg. 2022;37:1684&#x2013;1690. doi: 10.1111/jocs.16453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.16453</ArticleId><ArticleId IdType="pubmed">35348237</ArticleId></ArticleIdList></Reference><Reference><Citation>David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. 1992;103:617&#x2013;21. doi: 10.1016/S0022-5223(19)34942-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)34942-6</ArticleId><ArticleId IdType="pubmed">1532219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarsam MA, Yacoub M. Remodeling of the aortic valve anulus. J Thorac Cardiovasc Surg. 1993;105:435&#x2013;438. doi: 10.1016/S0022-5223(19)34225-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)34225-4</ArticleId><ArticleId IdType="pubmed">8445922</ArticleId></ArticleIdList></Reference><Reference><Citation>Schill MR, Kachroo P. Surgical options for aortic root aneurysm disease: which procedure, which patient. Curr Opin Cardiol. 2021;36:683&#x2013;688. doi: 10.1097/HCO.0000000000000902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000902</ArticleId><ArticleId IdType="pubmed">34354008</ArticleId></ArticleIdList></Reference><Reference><Citation>David TE, Ivanov J, Armstrong S, Feindel CM, Webb GD. Aortic valve-sparing operations in patients with aneurysms of the aortic root or ascending aorta. Ann Thorac Surg. 2002;74:S1758&#x2013;61. doi: 10.1016/S0003-4975(02)04135-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04135-8</ArticleId><ArticleId IdType="pubmed">12440659</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra HA, Whistance RN, De Kerchove L, Punjabi P, El Khoury G. Valve-preserving surgery on the bicuspid aortic valve. Eur J Cardiothorac Surg. 2013;43:888&#x2013;898. doi: 10.1093/ejcts/ezs664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs664</ArticleId><ArticleId IdType="pubmed">23293321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashikhmina E, Sundt TM, 3rd, Dearani JA, Connolly HM, Li Z, Schaff HV. Repair of the bicuspid aortic valve: a viable alternative to replacement with a bioprosthesis. J Thorac Cardiovasc Surg. 2010;139:1395&#x2013;1401. doi: 10.1016/j.jtcvs.2010.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2010.02.035</ArticleId><ArticleId IdType="pubmed">20392456</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson LG, Al Kindi AH, Vivacqua A, Pettersson GB, Gillinov AM, Mihaljevic T, Roselli EE, Sabik JF, 3rd, Griffin B, Hammer DF, Rodriguez L, Williams SJ, Blackstone EH, Lytle BW. Long-term durability of bicuspid aortic valve repair. Ann Thorac Surg. 2014;97:1539&#x2013;47. doi: 10.1016/j.athoracsur.2013.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.11.036</ArticleId><ArticleId IdType="pubmed">24680032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra K, Wagh K, Wei JW, McPherson L, Binongo JN, Leshnower BG, Chen EP. Regurgitant bicuspid aortopathy: is valve-sparing root replacement equivalent to Bentall procedure? Ann Thorac Surg. 2021;112:737&#x2013;745. doi: 10.1016/j.athoracsur.2020.08.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2020.08.074</ArticleId><ArticleId IdType="pubmed">33197424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kari FA, Doll KN, Hemmer W, Liebrich M, Sievers HH, Richardt D, Reichenspurner H, Detter C, Siepe M, Czerny M, Beyersdorf F. Survival and freedom from aortic valve-related reoperation after valve-sparing aortic root replacement in 1015 patients. Interact Cardiovasc Thorac Surg. 2016;22:431&#x2013;438. doi: 10.1093/icvts/ivv354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivv354</ArticleId><ArticleId IdType="pubmed">26718320</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhwani M, de Kerchove L, Glineur D, Rubay J, Vanoverschelde JL, Noirhomme P, El Khoury G. Repair of regurgitant bicuspid aortic valves: a systematic approach. J Thorac Cardiovasc Surg. 2010;140:276&#x2013;284. doi: 10.1016/j.jtcvs.2009.11.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.11.058</ArticleId><ArticleId IdType="pubmed">20488466</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafers HJ, Aicher D, Langer F, Lausberg HF. Preservation of the bicuspid aortic valve. Ann Thorac Surg. 2007;83:S740&#x2013;5. doi: 10.1016/j.athoracsur.2006.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2006.11.017</ArticleId><ArticleId IdType="pubmed">17257919</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafers HJ, Aicher D. Root remodeling for aortic root dilatation. Ann Cardiothorac Surg. 2013;2:113&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3741821</ArticleId><ArticleId IdType="pubmed">23977567</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocol R, Bis J, Malinowski M, Ciosek J, Hudziak D, Morkisz L, Jasinski M, Deja MA. Comparison of bicuspid and tricuspid aortic valve repair. Eur J Cardiothorac Surg. 2021;59:1183&#x2013;1190. doi: 10.1093/ejcts/ezaa462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezaa462</ArticleId><ArticleId IdType="pmc">PMC8244631</ArticleId><ArticleId IdType="pubmed">33367683</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabhajosyula P, Komlo C, Szeto WY, Wallen TJ, Desai N, Bavaria JE. Root stabilization of the repaired bicuspid aortic valve: subcommissural annuloplasty versus root reimplantation. Ann Thorac Surg. 2014;97:1227&#x2013;1234. doi: 10.1016/j.athoracsur.2013.10.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.10.071</ArticleId><ArticleId IdType="pubmed">24418204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Cho YH, Sung K, Kim WS, Park KH, Jeong DS, Park PW, Lee YT. Clinical outcomes of root reimplantation and bentall procedure: propensity score matching analysis. Ann Thorac Surg. 2018;106:539&#x2013;547. doi: 10.1016/j.athoracsur.2018.02.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.02.057</ArticleId><ArticleId IdType="pubmed">29596818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethancourt CN, Blitzer D, Yamabe T, Zhao Y, Nguyen S, Nitta S, Kelebeyev S, Borger MA, Kurlansky PA, George I, Smith C, Takayama H. Valve-sparing root replacement versus bio-bentall: inverse propensity weighting of 796 patients. Ann Thorac Surg. 2022;113:1529&#x2013;1535. doi: 10.1016/j.athoracsur.2021.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2021.05.044</ArticleId><ArticleId IdType="pubmed">34116001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37276351</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Epidemiology, Resistance Profiles, and Outcomes of Bloodstream Infections in Community-Onset Sepsis in the United States.</ArticleTitle><Pagination><StartPage>1148</StartPage><EndPage>1158</EndPage><MedlinePgn>1148-1158</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000005870</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe frequency of positive blood cultures, patterns of pathogens' characteristics and their resistance profile in patients with blood cultures drawn due to a presumed diagnosis of community-onset sepsis, and to examine the association between blood culture-positive pathogens and hospital mortality.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING">Two hundred one U.S. hospitals from 2016 to 2020 using the Premier Healthcare Database.</AbstractText><AbstractText Label="SUBJECTS">Adult patients presenting with community-onset sepsis who had blood cultures collected within 2 days of hospital admission. We defined sepsis using the U.S. Centers for Disease Control Adult Sepsis Event Surveillance criteria.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">We identified 147,061 patients with community-onset sepsis. The number of blood culture-positive sepsis episodes was 21,167 (14%) and the number of nonblood culture-positive sepsis episodes was 20,326 (14%). Among patients with blood culture-positive sepsis, Gram-negative rods were isolated in 55% of patients, Gram-positive cocci were isolated in 47%. Of those, methicillin-resistant Staphylococcus aureus (MRSA) was 11%, ceftriaxone-resistant Enterobacterales /extended-spectrum &#x3b2;-lactamase was 7%, and carbapenem-resistant Enterobacterales was 1.3%. The crude in-hospital mortality was 17% for culture-negative sepsis, 13% for nonblood culture-positive sepsis, and 17% for blood culture-positive sepsis. In multilevel logistic regression models, compared with culture-negative sepsis, blood culture-positive sepsis (adjusted odds ratio [aOR], 0.89; 95% CI, 0.85-0.94) and nonblood culture-positive sepsis (aOR, 0.82; 95% CI, 0.78-0.87) were associated with lower odds of in-hospital mortality. Acinetobacter species, Pseudomonas aeruginosa , methicillin-sensitive Staphylococcus aureus , and MRSA were associated with higher in-hospital mortality, whereas Escherichia coli , Klebsiella species, Proteus species, and Streptococcus species were associated with lower in-hospital mortality.</AbstractText><AbstractText Label="CONCLUSIONS">In patients hospitalized with community-onset sepsis, the prevalence of blood culture-positive sepsis was 14%. Among positive blood culture sepsis resistant organisms were infrequent. Compared with culture-negative sepsis, blood culture-positive sepsis and nonblood culture-positive sepsis were associated with lower in-hospital mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>Tetsu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chihara</LastName><ForeName>Shingo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, Department of Internal Medicine, Virginia Mason Medical Center, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costin</LastName><ForeName>Blair</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treggiari</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartz</LastName><ForeName>Raquel R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghunathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Anesthesiology Service Division, Durham VA Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2023 Sep 1;51(9):1261-1263. doi: 10.1097/CCM.0000000000005918.</RefSource><PMID Version="1">37589517</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="Y">Bacterial Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="Y">Cross Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055624" MajorTopicYN="N">Methicillin-Resistant Staphylococcus aureus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Treggiari received funding from Edwards Lifesciences. Dr. Bartz received funding from The Difficult Airway. The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>19</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>14</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37276351</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005870</ArticleId><ArticleId IdType="pii">00003246-202309000-00006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al.: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47:1181&#x2013;1247</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801&#x2013;810</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention: Sepsis. 2022. Available at: https://www.cdc.gov/sepsis/what-is-sepsis.html . Accessed February 11, 2022</Citation></Reference><Reference><Citation>Kethireddy S, Bilgili B, Sees A, et al.; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Culture-negative septic shock compared with culture-positive septic shock: A retrospective cohort study. Crit Care Med. 2018; 46:506&#x2013;512</Citation></Reference><Reference><Citation>Gupta S, Sakhuja A, Kumar G, et al.: Culture-negative severe sepsis: Nationwide trends and outcomes. Chest. 2016; 150:1251&#x2013;1259</Citation></Reference><Reference><Citation>Rhee C, Kadri SS, Dekker JP, et al.; CDC Prevention Epicenters Program: Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020; 3:e202899</Citation></Reference><Reference><Citation>Rhee C, Wang R, Zhang Z, et al.; CDC Prevention Epicenters Program: Epidemiology of hospital-onset versus community-onset sepsis in U.S. hospitals and association with mortality: A retrospective analysis using electronic clinical data. Crit Care Med. 2019; 47:1169&#x2013;1176</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention: Hospital Toolkit for Adult Sepsis Surveillance. 2018. Available at: https://www.cdc.gov/sepsis/pdfs/Sepsis-Surveillance-Toolkit-Mar-2018_508.pdf . Accessed February 9, 2022</Citation></Reference><Reference><Citation>Rahmel T, Schmitz S, Nowak H, et al.: Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare. PLoS One. 2020; 15:e0228952</Citation></Reference><Reference><Citation>Moore BJ, White S, Washington R, et al.: Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: The AHRQ elixhauser comorbidity index. Med Care. 2017; 55:698&#x2013;705</Citation></Reference><Reference><Citation>Kadri SS, Lai YL, Warner S, et al.; forming the National Insititutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI): Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: A retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021; 21:241&#x2013;251</Citation></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, et al.; CDC Prevention Epicenter Program: Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017; 318:1241&#x2013;1249</Citation></Reference><Reference><Citation>Phua J, Ngerng W, See K, et al.: Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013; 17:R202</Citation></Reference><Reference><Citation>Ljungstrom L, Andersson R, Jacobsson G: Incidences of community onset severe sepsis, sepsis-3 sepsis, and bacteremia in Sweden - a prospective population-based study. PLoS One. 2019; 14:e0225700</Citation></Reference><Reference><Citation>Sigakis MJG, Jewell E, Maile MD, et al.: Culture-negative and culture-positive sepsis: A comparison of characteristics and outcomes. Anesth Analg. 2019; 129:1300&#x2013;1309</Citation></Reference><Reference><Citation>Cheng MP, Stenstrom R, Paquette K, et al.: Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: A diagnostic study. Ann Intern Med. 2019; 171:547&#x2013;554</Citation></Reference><Reference><Citation>Yang L, Lin Y, Wang J, et al.: Comparison of clinical characteristics and outcomes between positive and negative blood culture septic patients: A retrospective cohort study. Infect Drug Resist. 2021; 14:4191&#x2013;4205</Citation></Reference><Reference><Citation>Scheer CS, Fuchs C, Grundling M, et al.: Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: A prospective clinical cohort study. Clin Microbiol Infect. 2019; 25:326&#x2013;331</Citation></Reference><Reference><Citation>Hantrakun V, Somayaji R, Teparrukkul P, et al.: Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: A prospective observational study (Ubon-sepsis). PLoS One. 2018; 13:e0204509</Citation></Reference><Reference><Citation>Mellhammar L, Kahn F, Whitlow C, et al.: Bacteremic sepsis leads to higher mortality when adjusting for confounders with propensity score matching. Sci Rep. 2021; 11:6972</Citation></Reference><Reference><Citation>Nannan Panday RS, Lammers EMJ, Alam N, et al.: An overview of positive cultures and clinical outcomes in septic patients: A sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. Crit Care. 2019; 23:182</Citation></Reference><Reference><Citation>Chou EH, Mann S, Hsu TC, et al.: Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study. PLoS One. 2020; 15:e0227752</Citation></Reference><Reference><Citation>Vincent JL, Sakr Y, Singer M, et al.; EPIC III Investigators: Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020; 323:1478&#x2013;1487</Citation></Reference><Reference><Citation>Umemura Y, Ogura H, Takuma K, et al.; Japanese Association for Acute Medicine (JAAM) Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome Sepsis and Trauma (FORECAST) Study Group: Current spectrum of causative pathogens in sepsis: A prospective nationwide cohort study in Japan. Int J Infect Dis. 2021; 103:343&#x2013;351</Citation></Reference><Reference><Citation>Paquette K, Sweet D, Stenstrom R, et al.: Neither blood culture positivity nor time to positivity is associated with mortality among patients presenting with severe manifestations of sepsis: The FABLED cohort study. Open Forum Infect Dis. 2021; 8:ofab321</Citation></Reference><Reference><Citation>Abe T, Ogura H, Kushimoto S, et al.; JAAM FORECAST group: Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan. J Intensive Care. 2019; 7:28</Citation></Reference><Reference><Citation>Cosgrove SE, Sakoulas G, Perencevich EN, et al.: Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis. 2003; 36:53&#x2013;59</Citation></Reference><Reference><Citation>Timbrook TT, Morton JB, McConeghy KW, et al.: The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: A systematic review and meta-analysis. Clin Infect Dis. 2017; 64:15&#x2013;23</Citation></Reference><Reference><Citation>Tsalik EL, Bonomo RA, Fowler VG Jr: New molecular diagnostic approaches to bacterial infections and antibacterial resistance. Annu Rev Med. 2018; 69:379&#x2013;394</Citation></Reference><Reference><Citation>Pfaller MA, Carvalhaes CG, Smith CJ, et al.: Bacterial and fungal pathogens isolated from patients with bloodstream infection: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017). Diagn Microbiol Infect Dis. 2020; 97:115016</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25906096</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>16</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Outcome of frozen elephant trunk technique for acute type A aortic dissection: as systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e694</StartPage><MedlinePgn>e694</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e694</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000000694</ELocationID><Abstract><AbstractText>Acute aortic dissections of Stanford type A require emergency surgery repair and present challenges to surgeons. The frozen elephant technique is one of several approaches used to treat aortic arch dissection. The purpose of this meta-analysis was to investigate the clinical effectiveness of the frozen elephant technique for treating acute type A aortic dissection.Medline, Cochrane, Google Scholar, and ClinicalTrials.gov databases were searched up to March 31, 2014, for studies that assessed the use of frozen elephant trunk technique for treating acute type A aortic dissection. The primary outcome was in-hospital mortality. Secondary outcomes included rate of stroke, spinal cord injury, renal failure, and reoperations for bleeding.Eleven studies were included in the analysis that encompassed 881 patients. The mean age ranged from 45.4 to 66.8 years, and the proportion of the population that was male ranged from 45 to 85%. The overall in-hospital mortality rate was 8%. The rate of stroke, spinal cord injury, renal failure, and frequency of reoperations for bleeding were 3, 4, 5, and 5, respectively. Sensitivity analysis indicates that the findings are robust and there was no publication bias.These findings indicate that the frozen elephant techniques does not bring unacceptable mortality or morbidity risk for treating acute type A aortic dissection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hui-Han</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>From the Division of Cardiovascular Surgery (HHL, CFW, PCL, MLL), China Medical University Hospital, Taichung; and Department of Surgery (SFL), National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Shou-Fu</ForeName><Initials>SF</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ching-Feng</ForeName><Initials>CF</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ping-Chun</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ming-Li</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="N">Aortic Dissection</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001014" MajorTopicYN="N">Aortic Aneurysm</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051437" MajorTopicYN="N">Renal Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25906096</ArticleId><ArticleId IdType="pmc">PMC4602692</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000000694</ArticleId><ArticleId IdType="pii">00005792-201504040-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wiesenfarth JM.
Acute Aortic Dissection. http://emedicine.medscape.com/article/756835-overview
Accessed October 6, 2014.</Citation></Reference><Reference><Citation>Hiratzka LF, Bakris GL, Beckman JA, et al. 2010&#x200a;ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol 2010; 55:e27&#x2013;e129.</Citation><ArticleIdList><ArticleId IdType="pubmed">20359588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Qi R, Zhu J, et al. Total arch replacement combined with stented elephant trunk implantation: a new &#x201c;standard&#x201d; therapy for type a dissection involving repair of the aortic arch? Circulation 2011; 123:971&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pubmed">21339481</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakob H, Tsagakis K, Pacini D, et al. The International E-vita Open Registry: data sets of 274 patients. J Cardiovasc Surg 2011; 52:717&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pubmed">21894139</ArticleId></ArticleIdList></Reference><Reference><Citation>Borst HG, Walterbusch G, Schaps D. Extensive aortic replacement using &#x201c;elephant trunk&#x201d; prosthesis. Thorac Cardiovasc Surg 1983; 31:37&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">6189250</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinemann MK, Buehner B, Jurmann MJ, et al. Use of the &#x201c;elephant trunk technique&#x201d; in aortic surgery. Ann Thorac Surg 1995; 60:2&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7598596</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrera AL, Miller CC, 3rd, Porat EE, et al. Staged repair of extensive aortic aneurysms. Ann Thorac Surg 2002; 74:S1803&#x2013;S1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">12440669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, Ohnishi K, Kaneko M, et al. New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation 1996; 94 suppl 9:II188&#x2013;II193.</Citation><ArticleIdList><ArticleId IdType="pubmed">8901744</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian DH, Wan B, Di Eusanio M, et al. A systematic review and meta-analysis on the safety and efficacy of the frozen elephant trunk technique in aortic arch surgery. Ann Cardiothorac Surg 2013; 2:581&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791206</ArticleId><ArticleId IdType="pubmed">24109565</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao P, De Rango P, Czerny M, et al. Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases. J Thorac Cardiovasc Surg 2012; 144:1286&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pubmed">22789301</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulakakis KG, Mylonas SN, Markatis F, et al. A systematic review and meta-analysis of hybrid aortic arch replacement. Ann Cardiothorac Surg 2013; 2:247&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3741846</ArticleId><ArticleId IdType="pubmed">23977592</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151:W65&#x2013;W94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622512</ArticleId></ArticleIdList></Reference><Reference><Citation>Moga C, Guo B, Schopflocher D, et al. Development of a quality appraisal tool for case series studies using a modified Delphi technique. Edmonton, Alberta, Canada: Institute of Health Economics; 2012.</Citation></Reference><Reference><Citation>Roselli EE, Rafael A, Soltesz EG, et al. Simplified frozen elephant trunk repair for acute DeBakey type I dissection. J Thorac Cardiovasc Surg 2013; 145 suppl 3:S197&#x2013;S201.</Citation><ArticleIdList><ArticleId IdType="pubmed">23260435</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman A, Damberg AL, Schalte G, et al. Thoracic stent graft sizing for frozen elephant trunk repair in acute type A dissection. J Thorac Cardiovasc Surg 2013; 145:964&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">22507842</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida N, Katayama A, Tamura K, et al. Frozen elephant trunk technique and partial remodeling for acute type A aortic dissection. Eur J Cardiothorac Surg 2011; 40:1066&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">21511488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K, Uchida N, Katayama A, et al. The frozen elephant trunk technique for retrograde acute type A aortic dissection. J Thorac Cardiovasc Surg 2014; 148:561&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">24252940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pochettino A, Brinkman WT, Moeller P, et al. Antegrade thoracic stent grafting during repair of acute DeBakey I dissection prevents development of thoracoabdominal aortic aneurysms. Ann Thorac Surg 2009; 88:482&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">19632398</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Huang F, Xu M, et al. The stented elephant trunk procedure combined total arch replacement for Debakey I aortic dissection: operative result and follow-up. Interact Cardiovasc Thorac Surg 2010; 11:594&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">20716557</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi E, Gu T, Yu L, et al. Repair of Stanford type A aortic dissection with ascending aorta and hemiarch replacement combined with stent-graft elephant trunk technique by using innominate cannulation. J Thorac Cardiovasc Surg 2011; 142:1458&#x2013;1463.</Citation><ArticleIdList><ArticleId IdType="pubmed">21458010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen K, Tang H, Jing R, et al. Application of triple-branched stent graft for Stanford type A aortic dissection: potential risks. Eur J Cardiothorac Surg 2012; 41:e12&#x2013;e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22223699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma WG, Zhu JM, Zheng J, et al. Sun's procedure for complex aortic arch repair: total arch replacement using a tetrafurcate graft with stented elephant trunk implantation. Ann cardiothorac Surg 2013; 2:642&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791186</ArticleId><ArticleId IdType="pubmed">24109575</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z, Meng W, Zhu D, et al. Treatment strategies for left subclavian artery during total arch replacement combined with stented elephant trunk implantation. J Thorac Cardiovasc Surg 2014; 147:639&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">23523037</ArticleId></ArticleIdList></Reference><Reference><Citation>Karck M, Kamiya H. Progress of the treatment for extended aortic aneurysms: is the frozen elephant trunk technique the next standard in the treatment of complex aortic disease including the arch? Eur J Cardiothorac Surg 2008; 33:1007&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">18406159</ArticleId></ArticleIdList></Reference><Reference><Citation>Leontyev S, Borger MA, Etz CD, et al. Experience with the conventional and frozen elephant trunk techniques: a single-centre study. Eur J Cardiothorac Surg 2013; 44:1076&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">23677901</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Eusanio M, Borger M, Petridis FD, et al. Conventional versus frozen elephant trunk surgery for extensive disease of the thoracic aorta. J Cardiovasc Med (Hagerstown) 2014; 15:803&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">23867913</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28040765</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1569-9285</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Interactive cardiovascular and thoracic surgery</Title><ISOAbbreviation>Interact Cardiovasc Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Classification and outcomes of extended arch repair for acute Type A aortic dissection: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>450</StartPage><EndPage>459</EndPage><MedlinePgn>450-459</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/icvts/ivw355</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Distal extent of repair in patients undergoing surgery for acute Type A aortic dissection (ATAAD) is controversial. Emerging hybrid techniques involving open and endovascular surgery have been reported in small numbers by select individual centres. A systematic review and meta-analysis was performed to investigate the outcomes following extended arch repair for ATAAD. A classification system is proposed of the different techniques to facilitate discussion and further investigation.</AbstractText><AbstractText Label="METHODS">Using Ovid MEDLINE, 38 studies were identified reporting outcomes for 2140 patients. Studies were categorized into four groups on the basis of extent of surgical aortic resection and the method of descending thoracic aortic stent graft deployment; during circulatory arrest (frozen stented elephant trunk) or with normothermic perfusion and use of fluoroscopy (warm stent graft): (I) surgical total arch replacement, (II) total arch and frozen stented elephant trunk, (III) hemiarch and frozen stented elephant trunk and (IV) total arch and warm stent graft. Perioperative event rates were obtained for each of the four groups and the entire cohort using pooled summary estimates. Linearized rates of late mortality and reoperation were calculated.</AbstractText><AbstractText Label="RESULTS">Overall pooled hospital mortality for extended arch techniques was 8.6% (95% CI 7.2-10.0). Pooled data categorized by surgical technique resulted in hospital mortality of 11.9% for total arch, 8.6% total arch and frozen stented elephant trunk, 6.3% hemiarch and frozen stented elephant trunk and 5.5% total arch and 'warm stent graft'. Overall incidence of stroke for the entire cohort was 5.7% (95% CI 3.6-8.2). Rate of spinal cord ischaemia was 2.0% (95% CI 1.2-3.0). Pooled linearized rate of late mortality was 1.66%/pt-yr (95% CI 1.34-2.07) with linearized rate of re-operation of 1.62%/pt-yr (95% CI 1.24-2.05).</AbstractText><AbstractText Label="CONCLUSIONS">Perioperative results of extended arch procedures are encouraging. Further follow-up is required to see if long-term complications are reduced with these emerging techniques. The proposed classification system will facilitate future comparison of short- and long-term results of different techniques of extended arch repair for ATAAD.</AbstractText><CopyrightInformation>&#xa9; The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Holly N</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Toronto Western Hospital EW 1-433, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boodhwani</LastName><ForeName>Munir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouzounian</LastName><ForeName>Maral</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saczkowski</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hospital of the Sacred Heart of Montreal and the University of Montreal, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herget</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Imaging, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appoo</LastName><ForeName>Jehangir J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Interact Cardiovasc Thorac Surg</MedlineTA><NlmUniqueID>101158399</NlmUniqueID><ISSNLinking>1569-9285</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="N">Aortic Dissection</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aorta</Keyword><Keyword MajorTopicYN="N">Aortic dissection</Keyword><Keyword MajorTopicYN="N">Aortic repair</Keyword><Keyword MajorTopicYN="N">Extended arch</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28040765</ArticleId><ArticleId IdType="doi">10.1093/icvts/ivw355</ArticleId><ArticleId IdType="pii">ivw355</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17245171</PMID><DateCompleted><Year>2007</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-4932</ISSN><JournalIssue CitedMedium="Print"><Volume>245</Volume><Issue>2</Issue><PubDate><Year>2007</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma.</ArticleTitle><Pagination><StartPage>187</StartPage><EndPage>200</EndPage><MedlinePgn>187-200</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Comparison of effectiveness between the pylorus-preserving pancreaticoduodenectomy ("pylorus-preserving Whipple" [PPW]) and the classic Whipple (CW) procedure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search (Medline, Embase, Cochrane Library, Biosis, Science Citation Index, Ovid Journals) was performed to identify all eligible articles. Randomized controlled trials (RCTs) comparing PPW versus CW for periampullary and pancreatic carcinoma were eligible for inclusion. The methodologic quality of included studies was evaluated independently by 2 authors. Quantitative data on perioperative parameters (blood loss, transfusion, operation time, and length of hospital stay), mortality, morbidity, and survival were extracted from included studies for meta-analysis. Pooled estimates of overall treatment effect were calculated using a random effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 1235 abstracts were retrieved and checked for eligibility and 6 RCTs finally included. The critical appraisal revealed vast heterogeneity with respect to methodologic quality and outcome parameters. The comparison of overall in-hospital mortality (odds ratio, 0.49; 95% CI, 0.17 to 1.40; P = 0.18), morbidity (odds ratio 0.89; 95% CI, 0.48 to 1.62; P = 0.69), and survival (hazard ratio, 0.74; 95% CI, 0.52 to 1.07; P = 0.11) showed no significant difference. However, operating time (weighted mean difference, -68.26 minutes; 95% CI, -105.70 to -30.83; P = 0.0004), and intraoperative blood loss (weighted mean difference, -766 mL; 95% CI, -965.26 to -566.74; P = 0.00001) were significantly reduced in the PPW group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Hence, in the absence of relevant differences in mortality, morbidity, and survival, the PPW seems to be as effective as the CW. Given obvious clinical and methodological interstudy heterogeneity, efforts should be intensified in the future to perform high quality RCTs of complex surgical interventions on the basis of well defined outcome parameters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diener</LastName><ForeName>Markus K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>University of Heidelberg, Department of General, Visceral and Trauma Surgery, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knaebel</LastName><ForeName>Hanns-Peter</ForeName><Initials>HP</Initials></Author><Author ValidYN="Y"><LastName>Heukaufer</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Antes</LastName><ForeName>Gerd</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>B&#xfc;chler</LastName><ForeName>Markus W</ForeName><Initials>MW</Initials></Author><Author ValidYN="Y"><LastName>Seiler</LastName><ForeName>Christoph M</ForeName><Initials>CM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014670" MajorTopicYN="Y">Ampulla of Vater</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011708" MajorTopicYN="N">Pylorus</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>2</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2007</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17245171</ArticleId><ArticleId IdType="pmc">PMC1876989</ArticleId><ArticleId IdType="doi">10.1097/01.sla.0000242711.74502.a9</ArticleId><ArticleId IdType="pii">00000658-200702000-00006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973&#x2013;1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766&#x2013;2792.</Citation><ArticleIdList><ArticleId IdType="pubmed">12173348</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">15661684</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 1996;83:625&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">8689203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg. 1995;221:721&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1234702</ArticleId><ArticleId IdType="pubmed">7794076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: state-of-the-art care. CA Cancer J Clin. 2000;50:241&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">10986966</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchler MW, Wagner M, Schmied BM, et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg. 2003;138:1310&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pubmed">14662530</ArticleId></ArticleIdList></Reference><Reference><Citation>Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1358031</ArticleId><ArticleId IdType="pubmed">2322039</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1191017</ArticleId><ArticleId IdType="pubmed">9339931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi C, Falconi M, Salvia R, et al. Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg. 2001;18:453&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">11799295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1421271</ArticleId><ArticleId IdType="pubmed">11088073</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27:324&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">12607060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kausch W. Das Carcinom der Papilla duodeni und seine radikale Entfernung. Beitr klin Chir. 1912;78:439&#x2013;486.</Citation></Reference><Reference><Citation>Whipple AO. Treatment of carcinoma of the ampulla of Vater. Ann Surg. 1935;102:763&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1391173</ArticleId><ArticleId IdType="pubmed">17856666</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson K. Carcinoma of the ampulla of Vater: successful radical resection. Br J Surg. 1944;31:368&#x2013;373.</Citation></Reference><Reference><Citation>Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation. Ann Surg. 1980;192:306&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1344905</ArticleId><ArticleId IdType="pubmed">7416828</ArticleId></ArticleIdList></Reference><Reference><Citation>Trede M, Carter DC. Surgery of the Pancreas. Edinburgh: Churchill Livingstone, 1993.</Citation></Reference><Reference><Citation>Seiler CA, Wagner M, Sadowski C, et al. Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg. 2000;4:443&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">11077317</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson RC, Bliouras N, Cooper MJ, et al. Gastric emptying and enterogastric reflux after conservative and conventional pancreatoduodenectomy. Surgery. 1993;114:82&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">8102817</ArticleId></ArticleIdList></Reference><Reference><Citation>Horstmann O, Markus PM, Ghadimi MB, et al. Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection. Pancreas. 2004;28:69&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">14707733</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenger FA, Jacobi CA, Haubold K, et al. Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma: preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy. Chirurg. 1999;70:1454&#x2013;1459.</Citation><ArticleIdList><ArticleId IdType="pubmed">10637702</ArticleId></ArticleIdList></Reference><Reference><Citation>Warshaw AL, Torchiana DL. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. Surg Gynecol Obstet. 1985;160:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">3964962</ArticleId></ArticleIdList></Reference><Reference><Citation>Roder JD, Stein HJ, Huttl W, et al. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg. 1992;79:152&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">1348201</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YC, Kim SW, Jang JY, et al. Factors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy. J Am Coll Surg. 2003;196:859&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pubmed">12788421</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari M, Devereaux PJ, Montori V, et al. Users&#x2019; guide to the surgical literature: how to use a systematic literature review and meta-analysis. Can J Surg. 2004;47:60&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3211813</ArticleId><ArticleId IdType="pubmed">14997929</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Green S (Eds). Cochrane Handbook of Systematic Reviews of Interventions, 4. 2.5 [updated May 2005]. Chichester, UK: John Wiley &amp; Sons, 2005.</Citation></Reference><Reference><Citation>Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">7823387</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pubmed">10584742</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815&#x2013;2834.</Citation><ArticleIdList><ArticleId IdType="pubmed">9921604</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med. 1987;6:341&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">3616287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PW, Shan YS, Lin YJ, et al. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology. 2005;52:1601&#x2013;1604.</Citation><ArticleIdList><ArticleId IdType="pubmed">16201125</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg. 2005;92:547&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">15800958</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran KT, Smeenk HG, van Eijck CH, et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg. 2004;240:738&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356476</ArticleId><ArticleId IdType="pubmed">15492552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloechle C, Broering DC, Latuske C, et al. Prospective randomized study to evaluate quality of life after partial pancreatoduodenectomy according to Whipple versus pylorus preserving pancreatoduodenectomy according to Longmire-Traverso for periampullary carcinoma. Dtsch Gesellschaft Chir. 1999;(suppl 1):661&#x2013;664.</Citation></Reference><Reference><Citation>Paquet K-J. Vergleich der partiellen Duodenopankreatektomie (Whipple-Operation) mit der pyloruserhaltenden Zephaloduodenopankreatektomie: eine prospektive kontrollierte, randomisierte Langzeitstudie. Chir Gastroenterol. 1998;14:54&#x2013;58.</Citation></Reference><Reference><Citation>Bassi C, Stocken DD, Olah A, et al. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg. 2005;22:353&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">16293966</ArticleId></ArticleIdList></Reference><Reference><Citation>Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1422135</ArticleId><ArticleId IdType="pubmed">11729382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca F, Giulianotti PC, Balestracci T, et al. Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery. 1997;122:553&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">9308613</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD. Meta-analysis: potentials and promise. BMJ. 1997;315:1371&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127866</ArticleId><ArticleId IdType="pubmed">9432250</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulrow CD. Rationale for systematic reviews. BMJ. 1994;309:597&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2541393</ArticleId><ArticleId IdType="pubmed">8086953</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">16003309</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229:613&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1420805</ArticleId><ArticleId IdType="pubmed">10235519</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1422589</ArticleId><ArticleId IdType="pubmed">12192322</ArticleId></ArticleIdList></Reference><Reference><Citation>Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138:618&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">16269290</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell RH Jr. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treat Rev. 2005;31:328&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">15905037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">15122610</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TC, Sohn TA, Cameron JL, et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg. 2003;7:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12559179</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg. 2003;27:709&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">12732998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg. 1999;86:603&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">10361177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998;228:508&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1191525</ArticleId><ArticleId IdType="pubmed">9790340</ArticleId></ArticleIdList></Reference><Reference><Citation>Berge Henegouwen MI, Moojen TM, van Gulik TM, et al. Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status. Br J Surg. 1998;85:922&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">9692564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou FF, Sheen-Chen SM, Chen YS, et al. Postoperative morbidity and mortality of pancreaticoduodenectomy for periampullary cancer. Eur J Surg. 1996;162:477&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">8817225</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan MF, Pisters PW, Posner M, et al. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994;220:436&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1234412</ArticleId><ArticleId IdType="pubmed">7944656</ArticleId></ArticleIdList></Reference><Reference><Citation>Friess H, Klempa I, Hermanek P, et al. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany. Digestion. 1994;55(suppl 1):35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">8132135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi C, Falconi M, Lombardi D, et al. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy: Italian Study Group. Digestion. 1994;55(suppl 1):41&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">8132136</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone PA, Sindelar WF. Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial. Pancreas. 1993;8:535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302788</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery: risk factors influencing the short-term results. Ann Surg. 1993;217:356&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1242802</ArticleId><ArticleId IdType="pubmed">7682052</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchler M, Friess H. Prevention of postoperative complications following pancreatic surgery. Digestion. 1993;54(suppl 1):41&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">8103013</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37182608</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic Review of the Effect of Cerebrospinal Fluid Drainage on Outcomes After Endovascular Descending Thoracic/Thoraco-Abdominal Aortic Aneurysm Repair.</ArticleTitle><Pagination><StartPage>501</StartPage><EndPage>512</EndPage><MedlinePgn>501-512</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2023.05.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(23)00367-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study aimed to investigate whether prophylactic use of cerebrospinal fluid (CSF) drainage in endovascular descending thoracic aortic aneurysm (DTAA) and thoraco-abdominal aortic aneurysm (TAAA) repair contributes to a lower rate of post-operative spinal cord ischaemia (SCI).</AbstractText><AbstractText Label="DATA SOURCES">MEDLINE, Embase, and CINAHL.</AbstractText><AbstractText Label="REVIEW METHODS">A literature review was conducted in accordance with PRISMA guidelines (PROSPERO registration no. CRD42021245893). Risk of bias was assessed through the Newcastle-Ottawa scale (NOS), and the certainty of evidence was graded using the GRADE approach. A proportion meta-analysis was conducted to calculate the pooled rate and 95% confidence interval (CI) of both early and late onset SCI. Pooled outcome estimates were calculated using the odds ratio (OR) and associated 95% CI. The primary outcome was SCI, both early and lateonset. Secondary outcomes were complications of CSF drainage, length of hospital stay, and peri-operative (30 day or in hospital) mortality rates.</AbstractText><AbstractText Label="RESULTS">Twenty-eight observational, retrospective studies were included, reporting 4 814 patients (2 599 patients with and 2 215 without CSF drainage). The NOS showed a moderate risk of bias. The incidence of SCI was similar in patients with CSF drainage (0.05, 95% CI 0.03 &#x2012; 0.08) and without CSF drainage (0.05, 95% CI 0.00 &#x2012; 0.14). No significant decrease in SCI was found when using CSF drainage (OR 0.67, 95% CI 0.29 &#x2012; 1.55, p&#xa0;= .35). The incidence rate of CSF drainage related complication was 0.10 (95% CI 0.04 &#x2012; 0.19). The 30 day and in hospital mortality rate with CSF drainage was 0.08 (95% CI 0.05 &#x2012; 0.12). The 30 day and in hospital mortality rate without CSF drainage and comparison with late mortality and length of hospital stay could not be determined due to lack of data. The quality of evidence was considered very low.</AbstractText><AbstractText Label="CONCLUSION">Pre-operative CSF drainage placement was not related to a favourable outcome regarding SCI rate in endovascular TAAA and DTAA repair. Due to the low quality of evidence, no clear recommendation on pre-operative use of CSF drainage placement can be made.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frankort</LastName><ForeName>Jelle</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, European Vascular Centre Aachen-Maastricht, RWTH Aachen, Aachen, Germany; Department of Vascular Surgery, European Vascular Centre Maastricht-Aachen, MUMC Maastricht, Maastricht, The Netherlands. Electronic address: jelle.frankort@live.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mees</LastName><ForeName>Barend</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, European Vascular Centre Maastricht-Aachen, MUMC Maastricht, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doukas</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, European Vascular Centre Aachen-Maastricht, RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keszei</LastName><ForeName>Andr&#xe0;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Translational &amp; Clinical Research Aachen (CTC-A), University Hospital RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontopodis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Medical School, University of Crete, Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, Manchester University NHS Foundation Trust, Manchester, UK; Division of Cardiovascular Sciences, School of Medical Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, European Vascular Centre Aachen-Maastricht, RWTH Aachen, Aachen, Germany; Department of Vascular Surgery, European Vascular Centre Maastricht-Aachen, MUMC Maastricht, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gombert</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, European Vascular Centre Aachen-Maastricht, RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="Y">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004322" MajorTopicYN="N">Drainage</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065634" MajorTopicYN="N">Cerebrospinal Fluid Leak</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094624" MajorTopicYN="Y">Aortic Aneurysm, Thoracoabdominal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020760" MajorTopicYN="Y">Spinal Cord Ischemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cerebrospinal fluid drainage</Keyword><Keyword MajorTopicYN="N">Descending thoracic aortic aneurysm repair</Keyword><Keyword MajorTopicYN="N">Spinal cord ischaemia</Keyword><Keyword MajorTopicYN="N">Thoraco-abdominal aortic aneurysm repair</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37182608</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2023.05.006</ArticleId><ArticleId IdType="pii">S1078-5884(23)00367-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34622441</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Rapid Evaluation of Coronavirus Illness Severity (RECOILS) in intensive care: Development and validation of a prognostic tool for in-hospital mortality.</ArticleTitle><Pagination><StartPage>65</StartPage><EndPage>75</EndPage><MedlinePgn>65-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13991</ELocationID><Abstract><AbstractText Label="BACKGROUND">The prediction of in-hospital mortality for ICU patients with COVID-19 is fundamental to treatment and resource allocation. The main purpose was to develop an easily implemented score for such prediction.</AbstractText><AbstractText Label="METHODS">This was an observational, multicenter, development, and validation study on a national critical care dataset of COVID-19 patients. A systematic literature review was performed to determine variables possibly important for COVID-19 mortality prediction. Using a logistic multivariable model with a LASSO penalty, we developed the Rapid Evaluation of Coronavirus Illness Severity (RECOILS) score and compared its performance against published scores.</AbstractText><AbstractText Label="RESULTS">Our development (validation) cohort consisted of 1480 (937) adult patients from 14 (11) Dutch ICUs admitted between March 2020 and April 2021. Median age was 65 (65) years, 31% (26%) died in hospital, 74% (72%) were males, average length of ICU stay was 7.83 (10.25) days and average length of hospital stay was 15.90 (19.92) days. Age, platelets, PaO2/FiO2 ratio, pH, blood urea nitrogen, temperature, PaCO2, Glasgow Coma Scale (GCS) score measured within +/-24&#xa0;h of ICU admission were used to develop the score. The AUROC of RECOILS score was 0.75 (CI 0.71-0.78) which was higher than that of any previously reported predictive scores (0.68 [CI 0.64-0.71], 0.61 [CI 0.58-0.66], 0.67 [CI 0.63-0.70], 0.70 [CI 0.67-0.74] for ISARIC 4C Mortality Score, SOFA, SAPS-III, and age, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">Using a large dataset from multiple Dutch ICUs, we developed a predictive score for mortality of COVID-19 patients admitted to ICU, which outperformed other predictive scores reported so far.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ple&#x10d;ko</LastName><ForeName>Drago</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5433-196X</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mathematics, Seminar for Statistics, ETH Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Seminar for Statistics, ETH Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;rtensson</LastName><ForeName>Johan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8739-7896</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dam</LastName><ForeName>Tariq A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Entjes</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Admiraal De Ruyter Ziekenhuis, Goes, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rettig</LastName><ForeName>Thijs C D</ForeName><Initials>TCD</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Amphia Ziekenhuis, Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dongelmans</LastName><ForeName>Dave A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boelens</LastName><ForeName>Age D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Antonius Ziekenhuis Sneek, Sneek, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigter</LastName><ForeName>Sander</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, St. Antonius Hospital, Nieuwegein, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hendriks</LastName><ForeName>Stefaan H A</ForeName><Initials>SHA</Initials><AffiliationInfo><Affiliation>Intensive Care, Albert Schweitzerziekenhuis, Dordrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jong</LastName><ForeName>Remko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Intensive Care, Bovenij Ziekenhuis, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamps</LastName><ForeName>Marlijn J A</ForeName><Initials>MJA</Initials><AffiliationInfo><Affiliation>Intensive Care, Catharina Ziekenhuis Eindhoven, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karakus</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Diakonessenhuis Hospital, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gommers</LastName><ForeName>Diederik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramnarain</LastName><ForeName>Dharmanand</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Intensive Care, ETZ Tilburg, Tilburg, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wils</LastName><ForeName>Evert-Jan</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Franciscus Gasthuis &amp; Vlietland, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achterberg</LastName><ForeName>Sefanja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ICU, Haaglanden Medisch Centrum, Den Haag, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowitzky</LastName><ForeName>Ralph</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Intensive Care, HagaZiekenhuis, Den Haag, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Tempel</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Ikazia Ziekenhuis Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jager</LastName><ForeName>Cornelis P C</ForeName><Initials>CPC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nooteboom</LastName><ForeName>Fleur G C A</ForeName><Initials>FGCA</Initials><AffiliationInfo><Affiliation>Intensive Care, Laurentius Ziekenhuis, Roermond, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oostdijk</LastName><ForeName>Evelien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ICU, Maasstad Ziekenhuis Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koetsier</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Intensive Care, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornet</LastName><ForeName>Alexander D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reidinga</LastName><ForeName>Auke C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>ICU, SEH, BWC, Martiniziekenhuis, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ruijter</LastName><ForeName>Wouter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Northwest Clinics, Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosman</LastName><ForeName>Rob J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>ICU, OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenzel</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urlings-Strop</LastName><ForeName>Louise C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Intensive Care, Reinier de Graaf Gasthuis, Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jong</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Slingeland Ziekenhuis, Doetinchem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smit</LastName><ForeName>Ellen G M</ForeName><Initials>EGM</Initials><AffiliationInfo><Affiliation>Intensive Care, Spaarne Gasthuis, Haarlem en Hoofddorp, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cremer</LastName><ForeName>Olaf L</ForeName><Initials>OL</Initials><AffiliationInfo><Affiliation>Intensive Care, UMC Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehagnoul-Schipper</LastName><ForeName>D Jannet</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Intensive Care, VieCuri Medisch Centrum, Venlo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faber</LastName><ForeName>Harald J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>ICU, WZA, Assen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lens</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ICU, ICU, IJsselland Ziekenhuis, Capelle aan den IJssel, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunnekreef</LastName><ForeName>Gert B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Ziekenhuisgroep Twente, Almelo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Festen-Spanjer</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Intensive Care, Ziekenhuis Gelderse Vallei, Ede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dormans</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive care, Zuyderland MC, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bruin</LastName><ForeName>Daan P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Pacmed, Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalisang</LastName><ForeName>Robbert C A</ForeName><Initials>RCA</Initials><AffiliationInfo><Affiliation>Pacmed, Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vonk</LastName><ForeName>Sebastiaan J J</ForeName><Initials>SJJ</Initials><AffiliationInfo><Affiliation>Pacmed, Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haan</LastName><ForeName>Martin E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleuren</LastName><ForeName>Lucas M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thoral</LastName><ForeName>Patrick J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbers</LastName><ForeName>Paul W G</ForeName><Initials>PWG</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation Centre, Department of Medicine and Radiology, The University of Melbourne.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#2017-110</GrantID><Agency>Personalized Health and Related Technologies (PHRT)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">corona virus</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">mechanical ventilation</Keyword><Keyword MajorTopicYN="N">respiratory failure</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34622441</ArticleId><ArticleId IdType="pmc">PMC8652966</ArticleId><ArticleId IdType="doi">10.1111/aas.13991</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO
. WHO COVID&#x2010;19 situation reports. 2020; https://www.who.int/emergencies/diseases/novel&#x2010;coronavirus&#x2010;2019/situation&#x2010;reports
</Citation></Reference><Reference><Citation>
Johns Hopkins University
. Johns Hopkins Coronavirus Resource Center. 2020; https://coronavirus.jhu.edu/map.html
</Citation></Reference><Reference><Citation>Baud D, Qi X, Nielsen&#x2010;Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID&#x2010;19 infection. Lancet Infect Dis. 2020;20:773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118515</ArticleId><ArticleId IdType="pubmed">32171390</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory&#x2010;confirmed coronavirus disease 2019 &#x2010; COVID&#x2010;NET, 14 States, March 1&#x2013;30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458&#x2010;464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;reide K, Hallet J, Matthews JB, et al. Immediate and long&#x2010;term impact of the COVID&#x2010;19 pandemic on delivery of surgical services. Br J Surg. 2020;107:1250&#x2010;1261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267363</ArticleId><ArticleId IdType="pubmed">32350857</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar A, Saini D, Roy S, et al. Cancer care delivery challenges amidst coronavirus disease&#x2013;19 (COVID&#x2010;19) outbreak: specific precautions for cancer patients and cancer care providers to prevent spread. Asian Pac J Cancer Prev. 2020;21:569&#x2010;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437319</ArticleId><ArticleId IdType="pubmed">32212779</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Shamsi HO, Alhazzani W, Alhuraiji A, et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID&#x2010;19) pandemic: an international collaborative group. Oncologist. 2020;25:e936&#x2010;e945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7288661</ArticleId><ArticleId IdType="pubmed">32243668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Suarez&#x2010;Sipmann F, Mellado&#x2010;Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID&#x2010;19 are similar to other causes of ARDS. Intensive Care Med. 2020;46:2200&#x2010;2211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387884</ArticleId><ArticleId IdType="pubmed">32728965</ArticleId></ArticleIdList></Reference><Reference><Citation>Du RH, Liu LM, Yin W, et al. Hospitalization and critical care of 109 decedents with COVID&#x2010;19 pneumonia in Wuhan, China. Ann Am Thorac Soc. 2020;17:839&#x2010;846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328178</ArticleId><ArticleId IdType="pubmed">32255382</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID&#x2010;19&#x2010;associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201&#x2010;1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834127</ArticleId><ArticleId IdType="pubmed">32861276</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID&#x2010;19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180:1345&#x2010;1355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7364371</ArticleId><ArticleId IdType="pubmed">32667669</ArticleId></ArticleIdList></Reference><Reference><Citation>Galloway JB, Norton S, Barker RD, et al. A clinical risk score to identify patients with COVID&#x2010;19 at high risk of critical care admission or death: an observational cohort study. J Infect. 2020;81:282&#x2010;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258846</ArticleId><ArticleId IdType="pubmed">32479771</ArticleId></ArticleIdList></Reference><Reference><Citation>Auld SC, Caridi&#x2010;Scheible M, Blum JM, et al. ICU and ventilator mortality among critically Ill adults with coronavirus disease 2019. Crit Care Med. 2020;48:e799&#x2010;e804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255393</ArticleId><ArticleId IdType="pubmed">32452888</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid&#x2010;19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116472</ArticleId><ArticleId IdType="pubmed">32907855</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenguer J, Ryan P, Rodr&#xed;guez&#x2010;Ba&#xf1;o J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID&#x2010;19 in Spain. Clin Microbiol Infect. 2020;26:1525&#x2010;1536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399713</ArticleId><ArticleId IdType="pubmed">32758659</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson RJ, Hunter J, Dutton J, et al. Clinical characteristics and outcomes of critically ill patients with COVID&#x2010;19 admitted to an intensive care unit in London: a prospective observational cohort study. PLoS One. 2020;15:e0243710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737956</ArticleId><ArticleId IdType="pubmed">33320904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando&#x2010;Vivas P, Doidge J, Thomas K, et al. Prognostic factors for 30&#x2010;day mortality in critically Ill patients with coronavirus disease 2019: an observational cohort study. Crit Care Med. 2021;49:102&#x2010;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737692</ArticleId><ArticleId IdType="pubmed">33116052</ArticleId></ArticleIdList></Reference><Reference><Citation>Turcotte JJ, Meisenberg BR, MacDonald JH, et al. Risk factors for severe illness in hospitalized Covid&#x2010;19 patients at a regional hospital. PLoS One. 2020;15:e0237558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423129</ArticleId><ArticleId IdType="pubmed">32785285</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause M, Douin DJ, Kim KK, Fernandez&#x2010;Bustamante A, Bartels K. Characteristics and outcomes of mechanically ventilated COVID&#x2010;19 patients&#x2010;an observational cohort study. J Intensive Care Med. 2021;36:271&#x2010;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7468669</ArticleId><ArticleId IdType="pubmed">32873103</ArticleId></ArticleIdList></Reference><Reference><Citation>Santus P, Radovanovic D, Saderi L, et al. Severity of respiratory failure at admission and in&#x2010;hospital mortality in patients with COVID&#x2010;19: a prospective observational multicentre study. BMJ Open. 2020;10:e043651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7549463</ArticleId><ArticleId IdType="pubmed">33040020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically Ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436. doi: 10.1001/jamainternmed.2020.3596</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3596</ArticleId><ArticleId IdType="pmc">PMC7364338</ArticleId><ArticleId IdType="pubmed">32667668</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID&#x2010;19 in New York City: a prospective cohort study. Lancet (London, England). 2020;395:1763&#x2010;1770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu PP, Tian RH, Luo S, et al. Risk factors for adverse clinical outcomes with COVID&#x2010;19 in China: a multicenter, retrospective, observational study. Theranostics. 2020;10:6372&#x2010;6383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255028</ArticleId><ArticleId IdType="pubmed">32483458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachtigall I, Lenga P, J&#xf3;&#x17a;wiak K, et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID&#x2010;19 in Germany: an observational study. Clin Microbiol Infect. 2020;26:1663&#x2010;1669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434317</ArticleId><ArticleId IdType="pubmed">32822883</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase N, Plovsing R, Christensen S, et al. Characteristics, interventions, and longer term outcomes of COVID&#x2010;19 ICU patients in Denmark&#x2013;A nationwide, observational study. Acta Anaesthesiol Scand. 2021;65:68&#x2010;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929715</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd1;amendys&#x2010;Silva SA, Alvarado&#x2010;&#xc1;vila PE, Dom&#xed;nguez&#x2010;Cherit G, et al. Outcomes of patients with COVID&#x2010;19 in the intensive care unit in Mexico: a multicenter observational study. Heart Lung. 2021;50:28&#x2010;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577687</ArticleId><ArticleId IdType="pubmed">33138974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang H, Qiao R, et al. Thrombo&#x2010;inflammatory features predicting mortality in patients with COVID&#x2010;19: the FAD&#x2010;85 score. J Int Med Res. 2020;48:300060520955037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511832</ArticleId><ArticleId IdType="pubmed">32960106</ArticleId></ArticleIdList></Reference><Reference><Citation>Allenbach Y, Saadoun D, Maalouf G, et al. Development of a multivariate prediction model of intensive care unit transfer or death: a French prospective cohort study of hospitalized COVID&#x2010;19 patients. PLoS One. 2020;15:e0240711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571674</ArticleId><ArticleId IdType="pubmed">33075088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Ng M, Xu S, et al. Development and validation of prognosis model of mortality risk in patients with COVID&#x2010;19. Epidemiol Infect. 2020;148:e168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426607</ArticleId><ArticleId IdType="pubmed">32746957</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Abudurexiti S, An MM, Cao D, Wei J, Gong P. Risk factors associated with 28&#x2010;day all&#x2010;cause mortality in older severe COVID&#x2010;19 patients in Wuhan, China: a retrospective observational study. Sci Rep. 2020;10:22369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755901</ArticleId><ArticleId IdType="pubmed">33353956</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid&#x2010;19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID&#x2010;19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201:1372&#x2010;1379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258652</ArticleId><ArticleId IdType="pubmed">32242738</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS&#x2010;CoV&#x2010;2 pneumonia in Wuhan, China: a single&#x2010;centered, retrospective, observational study. Lancet Respir Med. 2020;8:475&#x2010;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow DS, Glavis&#x2010;Bloom J, Soun JE, et al. Development and external validation of a prognostic tool for COVID&#x2010;19 critical disease. PLoS One. 2020;15:e0242953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725393</ArticleId><ArticleId IdType="pubmed">33296357</ArticleId></ArticleIdList></Reference><Reference><Citation>Fominskiy EV, Scandroglio AM, Monti G, et al. Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID&#x2010;19 patients with acute kidney injury and renal replacement therapy. Blood Purif. 2021;50:102&#x2010;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445373</ArticleId><ArticleId IdType="pubmed">32659757</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloisio E, Chibireva M, Serafini L, et al. A comprehensive appraisal of laboratory biochemistry tests as major predictors of COVID&#x2010;19 severity. Arch Pathol Lab Med. 2020;144:1457&#x2010;1464.</Citation><ArticleIdList><ArticleId IdType="pubmed">32649222</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil&#x2010;Rodrigo A, Miro O, Pinera P, et al. Analysis of clinical characteristics and outcomes in patients with COVID&#x2010;19 based on a series of 1000 patients treated in Spanish emergency departments. Emergencias Rev La Soc Esp Med Emergencias. 2020;32:233&#x2010;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">32692000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Zhang Z, Yu M, Tao Y, Xie M. 15&#x2010;day mortality and associated risk factors for hospitalized patients with COVID&#x2010;19 in Wuhan, China: an ambispective observational cohort study. Intensive Care Med. 2020;46:1472&#x2010;1474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7176814</ArticleId><ArticleId IdType="pubmed">32328724</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett N, Ple&#x10d;ko D, Ukor I&#x2010;F, Meinshausen N, B&#xfc;hlmann P. ricu: R&#x2019;s Interface to intensive care data. J Stat Softw. arXiv Preprint arXiv:2108.00796. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10268223</ArticleId><ArticleId IdType="pubmed">37318234</ArticleId></ArticleIdList></Reference><Reference><Citation>Team, R. C. &amp; others . R: A language and environment for statistical computing. 2013.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31804347</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>49</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e18220</StartPage><MedlinePgn>e18220</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18220</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000018220</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous meta-analyses assessing anesthetic techniques in adult patients undergoing hip fractures surgery are available. However, whether the anesthetic technique is associated with risk of mortality and complications in geriatric patients with hip fractures remains unclear. This study was conducted to assess postoperative outcomes of anesthesia technique in geriatric patients undergoing hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cochrane Library, PubMed, EMBASE, MEDLINE, CNKI, and CBM were searched from inception up to May 25, 2018. Observational studies and randomized controlled trials (RCTs) that assessed the perioperative outcomes of technique of anesthesia (general or regional [epidural/spinal/neuraxial]) in geriatric patients (&#x2265;60 years old) undergoing hip fracture surgery were included. Two investigators independently screened studies for inclusion and performed data extraction. Heterogeneity was assessed by the I and Chi-square tests. The odds ratio (OR) of the dichotomous data, mean difference (MD) of continuous data, and 95% confidence intervals (CI) were calculated to assess the pooled data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven retrospective and 2 RCTs were included. There was no difference in 30-day mortality (OR&#x200a;=&#x200a;0.96; 95% CI 0.86-1.08; P&#x200a;=&#x200a;.51) between the general and regional anesthesia groups. In-hospital mortality (OR&#x200a;=&#x200a;1.26; 95% CI 1.17-1.36; P&#x200a;&lt;&#x200a;.001), acute respiratory failure (OR&#x200a;=&#x200a;2.66; 95% CI 2.34-3.02; P&#x200a;&lt;&#x200a;.001), length of hospital stay (MD&#x200a;=&#x200a;0.33; 95% CI 0.24-0.42; P&#x200a;&lt;&#x200a;.001), and readmission (OR&#x200a;=&#x200a;1.09; 95% CI 1.01-1.18; P&#x200a;=&#x200a;.03) were significantly reduced in the regional anesthesia group. Pneumonia (OR&#x200a;=&#x200a;0.99; 95% CI 0.91-1.07; P&#x200a;=&#x200a;.79), heart failure (OR&#x200a;=&#x200a;0.97; 95% CI 0.86-1.09; P&#x200a;=&#x200a;.62), acute myocardial infraction (OR&#x200a;=&#x200a;1.07; 95% CI 0.99-1.16; P&#x200a;=&#x200a;.10), acute renal failure (OR&#x200a;=&#x200a;1.32; 95% CI 0.97-1.79; P&#x200a;=&#x200a;.07), cerebrovascular accident (OR&#x200a;=&#x200a;1.08; 95% CI 0.82-1.42; P&#x200a;=&#x200a;.58), postoperative delirium (OR&#x200a;=&#x200a;1.51; 95% CI 0.16-13.97; P&#x200a;=&#x200a;.72), and deep vein thrombosis/pulmonary embolism (OR&#x200a;=&#x200a;1.42; 95% CI 0.84-2.38; P&#x200a;=&#x200a;.19) were similar between the two anesthetic techniques.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">General anesthesia is associated with increased risk of in-hospital mortality, acute respiratory failure, longer hospital stays, and higher readmission. There is evidence to suggest that regional anesthesia is associated with improved perioperative outcomes. Large RCTs are needed to explore the most optimal anesthetic techniques for geriatric patients with hip fractures before drawing final conclusions.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42018093582.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dong Xu</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shi Yue</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Ya Na</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31804347</ArticleId><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000018220</ArticleId><ArticleId IdType="pii">00005792-201912060-00046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;5:407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes WC, Myers ER, Robinovitch SN, et al. Etiology and prevention of age-related hip fractures. Bone 1996;18:77&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">8717551</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis EM, van der Velde R, Moon RJ, et al. Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone 2016;87:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890652</ArticleId><ArticleId IdType="pubmed">26968752</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, et al. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol 2017;17:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, McLoughlin L, Patterson CC, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth 2018;120:37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Alper J, Beckingsale A, et al. Management of proximal femoral fractures 2011: association of anaesthetists of Great Britain and Ireland. Anaesthesia 2012;67:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22150501</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A, Boulton C, Hertz K, et al. The National Hip Fracture Database (NHFD) &#x2013; using a national clinical audit to raise standards of nursing care. Int J Orthop Trauma Nurs 2017;26:3&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28237620</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer CA, Coca-Perraillon M, Cutler DM, et al. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410861</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Gill SS, Bell CM, et al. Postoperative medical complications associated with anesthesia in older adults with dementia. J Am Geriatr Soc 2014;62:2102&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25370019</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, et al. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res 2018;476:1178&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, Martone AM, Marzetti E, et al. Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip fractured patients. Front Aging Neurosci 2014;6:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4236534</ArticleId><ArticleId IdType="pubmed">25477815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, et al. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA 2014;24:2508&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury 2015;46:1562&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int 2010;21:555&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara DA, Duff A, Berlin JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000;92:947&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">10754613</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson RL, Kopp SL, Burkle CM, et al. Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: a systematic review of comparative-effectiveness research. Br J Anaesth 2016;116:163&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">26787787</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset. Anaesthesia 2014;69:224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">24428375</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Altermatt F, Barry J, et al. International fragility fracture network delphi consensus statement on the principles of anaesthesia for patients with hip fracture. Anaesthesia 2018;73:863&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">29508382</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation> Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle&#x2013;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Available at:  http://wwwohrica/programs/clinicalepidemiology/oxfordasp. [Accessed May 5, 2012]</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekimo&#x11f;lu &#x15e;S, Heybeli N, &#xc7;olak A, et al. Comparison of different anesthetic techniques on postoperative outcomes in elderly patients with hip fracture. Turkiye Klin J Med Sci 2012;32:623&#x2013;9.</Citation></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, et al. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med 2012;37:433&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med 2012;13:948&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, et al. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip. Bone Jt J 2015;97-B:689&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, et al. Propensity score &#x2013; matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology 2015;123:136&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Chan PH, Zohman GL, et al. Impact of anesthesia on hospital mortality and morbidities in geriatric patients following emergency hip fracture surgery. J Orthop Trauma 2018;32:116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29461445</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, et al. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2003;20:640&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T, Imai S, Nakadera M, et al. Postoperative daily living activities of geriatric patients administered general or spinal anesthesia for hip fracture surgery: a retrospective cohort study. J Orthop Surg (Hong Kong) 2018;26:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366390</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff TA, Henderson WG, Stoner TJ, et al. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am 2008;90:34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih YJ, Hsieh CH, Kang TW, et al. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol 2010;4:37&#x2013;42.</Citation></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, et al. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2016;2:CD000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, et al. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology 2012;117:72&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber FE, Gottshalk A, Zakriya KJ, et al. General anesthesia occurs frequently in elderly patients during propofol-based sedation and spinal anesthesia. J Clin Anesth 2010;22:179&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">20400003</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Poeran J, Zubizarreta N, et al. Do hospitals performing frequent neuraxial anesthesia for hip and knee replacements have better outcomes? Anesthesiology 2018;129:428&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">29878899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak JC, Cameron ID, March LM. Evidence-based guidelines for the management of hip fractures in older persons: an update. Med J Aust 2010;192:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowark A, Adam C, Ahrens J, et al. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia. BMJ Open 2018;8:e023609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196806</ArticleId><ArticleId IdType="pubmed">30341135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39696003</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Ramelteon exposure and survival of critically Ill sepsis patients: a retrospective study from MIMIC-IV.</ArticleTitle><Pagination><StartPage>454</StartPage><MedlinePgn>454</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">454</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-024-02851-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effect of ramelteon, a melatonin receptor agonist, on survival in septic patients remains unknown. The purpose of this retrospective cohort study was to explore the relationship between ramelteon exposure and survival outcomes in septic patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from septic patients admitted to the intensive care unit (ICU) were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, with patients categorized into ramelteon exposure and non-exposure groups based on the use of ramelteon. The primary outcome was 30-day mortality, and secondary outcomes included 90-day mortality, in-hospital mortality, length of ICU stay, and hospital stay. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were employed to address confounding variables. Kaplan-Meier (K-M) analysis and Cox proportional hazards regression models for stepwise regression were utilized to assess the impact of ramelteon exposure on survival.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study included 22,152 unexposed patients and 2,708 exposed patients, resulting in 2,607 matched pairs after PSM. Following PSM, ramelteon exposure was associated with significantly lower in-hospital mortality (11.6% vs.19.7%, p&#x2009;&lt;&#x2009;0.001), 30-day mortality (13.4% vs. 23.2%, p&#x2009;&lt;&#x2009;0.001), and 90-day mortality (22.1% vs. 30%, p&#x2009;&lt;&#x2009;0.001).K-M curves demonstrated a significant difference in 30-day and 90-day mortality between the two groups (P&#x2009;&lt;&#x2009;0.001), irrespective of PSM application. Both PSM (hazard ratio [HR]&#x2009;=&#x2009;0.53, 95% confidence intervals [CIs] 0.47-0.61, p&#x2009;&lt;&#x2009;0.001) and IPTW models (HR&#x2009;=&#x2009;0.59, 95% CI 0.50-0.70, p&#x2009;&lt;&#x2009;0.001) indicated a significant positive effect of ramelteon usage on 30-day mortality among septic patients compared to the non-exposure group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This exploratory, retrospective study suggests an association between ramelteon exposure and reduced 30-day and 90-day mortality in septic patients compared with the non-exposure group. Considering the limitations of the retrospective design and the potential for unmeasured confounding, well-designed prospective studies and randomized controlled trials will be needed to confirm these findings.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Han</LastName><ForeName>Yun-Yang</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tian</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, 510280, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. liukexuan705@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>901AS54I69</RegistryNumber><NameOfSubstance UI="C495910">ramelteon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007192">Indenes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007192" MajorTopicYN="Y">Indenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">MIMIC-IV</Keyword><Keyword MajorTopicYN="N">Melatonin</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Ramelteon</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Authorization for this investigation was granted by the Massachusetts Institute of Technology (MIT) and Beth Israel Deaconess Medical Center (BIDMC) institutional review boards, with informed consent waived. Database access was granted to a researcher (HYY) who completed the Collaborative Institutional Training Initiative test (name ID: 10112186, record ID: 42408105). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39696003</ArticleId><ArticleId IdType="pmc">PMC11653545</ArticleId><ArticleId IdType="doi">10.1186/s12871-024-02851-9</ArticleId><ArticleId IdType="pii">10.1186/s12871-024-02851-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA-J AM MED ASSOC. 2016;315(8):801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. CRIT CARE. 2020;24(1):239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YC, Yao Y, Yu MM, Gao YL, Qi AL, Jiang TY, Chen ZS, Shou ST, Chai YF. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis. BMC INFECT DIS. 2022;22(1):564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210671</ArticleId><ArticleId IdType="pubmed">35729526</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AD, MacCallum NS, Harris S, Brealey DA, Palmer E, Hetherington J, Shi S, Perez-Suarez D, Ercole A, Watkinson PJ et al: Descriptors of Sepsis Using the Sepsis-3 Criteria: A Cohort Study in Critical Care Units Within the U.K. National Institute for Health Research Critical Care Health Informatics Collaborative. CRIT CARE MED 2021, 49(11):1883&#x2013;1894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508729</ArticleId><ArticleId IdType="pubmed">34259454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J CLIN SLEEP MED. 2017;13(2):307&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5263087</ArticleId><ArticleId IdType="pubmed">27998379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox ME, Burry L, Englesakis M, Coman B, Daou M, van Haren FM, Ely EW, Bosma KJ, Knauert MP. Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review. Thorax. 2024;79(10):988&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">38350730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA PSYCHIAT. 2014;71(4):397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">24554232</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto M. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS NEUROSCI THER. 2009;15(1):32&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2871175</ArticleId><ArticleId IdType="pubmed">19228178</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpsoe NG, Andersen LP, Gogenur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. EUR J CLIN PHARMACOL. 2015;71(8):901&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26008214</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim A, Tolbert D, Cao C. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. J CLIN PHARMACOL. 2006;46(2):140&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16432265</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, Chen S, Peng Y, Hardeland R, Xia Y. Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights. FRONT IMMUNOL. 2021;12: 683879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201398</ArticleId><ArticleId IdType="pubmed">34135911</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Luo X, Li J, Lei Y, Zeng F, Huang X, Lan Y, Yang F. Melatonin: A window into the organ-protective effects of sepsis. BIOMED PHARMACOTHER. 2022;154: 113556.</Citation><ArticleIdList><ArticleId IdType="pubmed">35994818</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang L, Du N, Yin X, Shao H, Yang L. Ramelteon Ameliorates LPS-Induced Hyperpermeability of the Blood-Brain Barrier (BBB) by Activating Nrf2. Inflammation. 2021;44(5):1750&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">33876343</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Wang J, Wang D, Guo L, Yu D. Melatonin Receptor Agonist Ramelteon Suppresses LPS-Induced Neuroinflammation in Astrocytes. ACS CHEM NEUROSCI. 2021;12(9):1498&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Zhang Y, Lu D, Huang T, Yan K, Wang W, Gao J. Ramelteon protects against human pulmonary microvascular endothelial cell injury induced by lipopolysaccharide (LPS) via activating nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. Bioengineered. 2022;13(1):1518&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805948</ArticleId><ArticleId IdType="pubmed">34986734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton SS, Magagnoli J, Cummings TH, Hardin JW. Melatonin use and the risk of 30-day mortality among US veterans with sepsis: A retrospective study. J PINEAL RES. 2022;73(2): e12811.</Citation><ArticleIdList><ArticleId IdType="pubmed">35652450</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink T, Glas M, Wolf A, Kleber A, Reus E, Wolff M, Kiefer D, Wolf B, Rensing H, Volk T, et al. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. CRIT CARE MED. 2014;42(1):e22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">24145838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikimi M, Numaguchi A, Takahashi K, Miyagawa Y, Matsui K, Higashi M, Makishi G, Matsui S, Matsuda N. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial. CRIT CARE MED. 2018;46(7):1099&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6012040</ArticleId><ArticleId IdType="pubmed">29595562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Mikkelsen EM, Cronin-Fenton D, Kristensen NR, Pham TM, Pedersen L, Petersen I. Missing data and multiple imputation in clinical epidemiological research. CLIN EPIDEMIOL. 2017;9:157&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358992</ArticleId><ArticleId IdType="pubmed">28352203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Kim HJ, Lonjon G, Zhu Y. Balance diagnostics after propensity score matching. ANN TRANSL MED. 2019;7(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351359</ArticleId><ArticleId IdType="pubmed">30788363</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Vico A, Lardone PJ, Naji L, Fernandez-Santos JM, Martin-Lacave I, Guerrero JM, Calvo JR. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J PINEAL RES. 2005;39(4):400&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16207296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wang L, Xie W, Hu S, Zhou H, Zhu P, Zhu H. Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway. J CELL PHYSIOL. 2020;235(3):2847&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">31535369</ArticleId></ArticleIdList></Reference><Reference><Citation>Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. MED CLIN N AM. 2020;104(4):573&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">32505253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi SM, Nabavi SF, Sureda A, Xiao J, Dehpour AR, Shirooie S, Silva AS, Baldi A, Khan H, Daglia M. Anti-inflammatory effects of Melatonin: A mechanistic review. CRIT REV FOOD SCI. 2019;59(sup1):S4&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">29902071</ArticleId></ArticleIdList></Reference><Reference><Citation>Galano A, Reiter RJ. Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection. J PINEAL RES. 2018;65(1): e12514.</Citation><ArticleIdList><ArticleId IdType="pubmed">29888508</ArticleId></ArticleIdList></Reference><Reference><Citation>Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J CLIN INVEST. 2006;116(4):984&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1421348</ArticleId><ArticleId IdType="pubmed">16585964</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecon E, Izabelle C, Poder SL, Real F, Zhu A, Tu L, Ghigna MR, Klonjkowski B, Bomsel M, Jockers R, et al. Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2. J PINEAL RES. 2022;72(1): e12772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646885</ArticleId><ArticleId IdType="pubmed">34586649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameri A, Frouz AM, Ziaei A, Vatankhah M, Safa O, Kamali M, Fathalipour M, Mahmoodi M, Hassanipour S. Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial. Inflammopharmacology. 2023;31(1):265&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9676876</ArticleId><ArticleId IdType="pubmed">36401728</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PY, Wu JY, Liu TH, Tsai YW, Chen PT, Liao CT, Toh HS. The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. FRONT MED-LAUSANNE. 2023;10:1171294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10166833</ArticleId><ArticleId IdType="pubmed">37181363</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai S, Kadomura S, Miyai T, Kashiwagi H, Sato Y, Sugawara M, Takekuma Y. Using Japanese big data to investigate novel factors and their high-risk combinations that affect vancomycin-induced nephrotoxicity. BRIT J CLIN PHARMACO. 2022;88(7):3241&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">35106797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingren MS, Starr ME, Saito H. Divergent Sepsis Pathophysiology in Older Adults. ANTIOXID REDOX SIGN. 2021;35(16):1358&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905233</ArticleId><ArticleId IdType="pubmed">34210173</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C, Wang F, Zhang YT, Wei SZ, Liu JY, Sun HY, Wang GH, Liu CF. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20(6): e13375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208780</ArticleId><ArticleId IdType="pubmed">33964119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu GC, Peng CK, Liao WI, Pao HP, Huang KL, Chu SJ. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production. RESP RES. 2020;21(1):65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7059294</ArticleId><ArticleId IdType="pubmed">32143642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathes AM, Kubulus D, Waibel L, Weiler J, Heymann P, Wolf B, Rensing H. Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat. CRIT CARE MED. 2008;36(10):2863&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18766086</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroethoff M, Christoph I, Behmenburg F, Raupach A, Bunte S, Senpolat S, Heinen A, Hollmann MW, Mathes A, Huhn R. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels. J CARDIOVASC PHARM. 2018;72(2):106&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">29787401</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23810260</PMID><DateCompleted><Year>2014</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Clinical outcomes of single versus staged hybrid repair for thoracoabdominal aortic aneurysm.</ArticleTitle><Pagination><StartPage>1192</StartPage><EndPage>1200</EndPage><MedlinePgn>1192-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2013.04.061</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(13)00886-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We investigated the outcomes of hybrid repair of thoracoabdominal aortic aneurysms and performed meta-analyses and meta-regressions to assess whether the number of stages during hybrid repair is associated with mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Review methods were according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The primary outcome was 30-day mortality. Secondary outcomes of procedural and clinical success were reported descriptively. Meta-analyses, meta-regressions, and logistic regressions were performed to estimate the odds ratio (OR) describing the association between the staging of the operation and in-hospital death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 19 studies of 660 patients. Procedures were single-staged in 288 patients and staged in 372. Perioperative mortality ranged from 0% to 44.4%, and spinal cord ischemia ranged from 0% to 15.3%. After a mean follow-up of 26 months (range, 6-88.5 months), the overall mortality was 20.8%. The meta-regression of all studies' summary data (OR, 0.64; 95% confidence interval [CI], 0.19-2.16; P = .45; I(2) = 0.42) and a meta-regression where mortality rates in four studies were stratified by operative staging (OR, 0.57; 95% CI, 0.24-1.36; P = .19; I(2) = 0.38) supported a two-stage procedure but failed to reach statistical significance. Logistic regressions of individual patient data from a single center demonstrated evidence that a staged procedure was safer (adjusted OR, 0.04; 95% CI, 0.00-0.96; P &lt; .05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hybrid repair of thoracoabdominal aortic aneurysms may reduce early morbidity and mortality even in a group considered high risk for open surgery but still carries risks of perioperative complications. This study suggested advantages to a staged procedure, but statistically significant evidence is lacking. Prospective data are still needed to optimize hybrid repair and best define its role.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canaud</LastName><ForeName>Ludovic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, St George's Vascular Institute, London, United Kingdom. Electronic address: ludoviccanaud@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karthikesalingam</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Cresswell</LastName><ForeName>Lynne</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cliff</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Markar</LastName><ForeName>S Sheraz</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Maytham</LastName><ForeName>Gary</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Matt</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_U105260558</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UP_1302/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23810260</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2013.04.061</ArticleId><ArticleId IdType="pii">S0741-5214(13)00886-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35999113</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>New-Onset Atrial Fibrillation in Patients Undergoing Liver Transplantation: Retrospective Analysis of Risk Factors and Outcomes.</ArticleTitle><Pagination><StartPage>4100</StartPage><EndPage>4107</EndPage><MedlinePgn>4100-4107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2022.07.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(22)00527-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The authors aimed to identify predictors of new-onset postoperative atrial fibrillation (POAF) during the initial 90 days following liver transplantation, and to assess the association between POAF in-hospital and 1-year mortality.</AbstractText><AbstractText Label="DESIGN">A retrospective cohort study.</AbstractText><AbstractText Label="SETTING">At a university hospital between 2005 and 2017.</AbstractText><AbstractText Label="PATIENTS">Adults without a history of preoperative atrial fibrillation who underwent orthotopicliver transplantation.</AbstractText><AbstractText Label="MEASUREMENT AND MAIN RESULTS">The authors assessed the univariate association between new-onset of POAF in the postoperative period and each potential factor through a logistic regression model. Moreover, they explored predictors for POAF through stepwise selection. Finally, the authors assessed the relationship between POAF and in-hospital and 1-year mortality using logistic regression models, and whether the duration of atrial fibrillation was associated with in-hospital and 1-year mortality. Among 857 patients, 89 (10.4%) developed POAF. Using only preoperative variables, pulmonary hypertension, age, Model for End-Stage Liver Disease (MELD) score, and White race were identified as the most important predictors. Model discrimination was 0.75 (95% CI: 0.69-0.80), and incorporating intraoperative variables was 0.77 (95% CI: 0.72-0.82). In-hospital mortality was observed in 7.2% (6/83) of patients with new-onset of POAF, and in 2.8% (22/768) without, with confounder-adjusted odds ratio (OR) 1.00 (97.5% CI: 0.29,3.45; p&#xa0;=&#xa0;0.996). One-year mortality was 22.4% (20/89) in patients who developed POAF and 8.3% (64/768) in patients who did not, confounder-adjusted OR 2.64 (97.5% CI: 1.35-5.16; p&#xa0;=&#xa0;0.001). The duration of POAF did not affect long-term postoperative mortality.</AbstractText><AbstractText Label="CONCLUSION">Preoperative, mostly unmodifiable comorbidities are important risk factors for new-onset POAF after liver transplantation. The POAF was not associated with in-hospital mortality, but with increased 1-year mortality. Once developed, the duration of POAF did not affect long-term mortality after a liver transplant.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rivas</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of OUTCOMES RESEARCH, Cleveland Clinic, Cleveland, OH; Department of Anesthesia, Hospital Clinic of Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>Kazunari</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Liver Transplant, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiayi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of OUTCOMES RESEARCH, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintini</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Liver Transplant, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maheshwari</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of OUTCOMES RESEARCH, Cleveland Clinic, Cleveland, OH; Department of General Anesthesia, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turan</LastName><ForeName>Alparslan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of OUTCOMES RESEARCH, Cleveland Clinic, Cleveland, OH; Department of General Anesthesia, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fares</LastName><ForeName>Maan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cywinski</LastName><ForeName>Jacek B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of OUTCOMES RESEARCH, Cleveland Clinic, Cleveland, OH; Department of General Anesthesia, Cleveland Clinic, Cleveland, OH. Electronic address: CYWINSJ@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058625" MajorTopicYN="Y">End Stage Liver Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">liver transplant</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">postoperative outcomes</Keyword><Keyword MajorTopicYN="N">predictors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>22</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35999113</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2022.07.013</ArticleId><ArticleId IdType="pii">S1053-0770(22)00527-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22261931</PMID><DateCompleted><Year>2012</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction.</ArticleTitle><Pagination><StartPage>469</StartPage><EndPage>476</EndPage><MedlinePgn>469-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.8689</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Use of self-expanding metallic stents (SEMS) as a bridge to surgery has been suggested as an alternative management for acute malignant left-sided colonic obstruction, as emergency surgery has a high risk of morbidity and mortality. This meta-analysis evaluated high-quality evidence comparing preoperative SEMS with emergency surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Relevant randomized clinical trials (RCTs) were identified from the Cochrane Central Register of Controlled Trials, MEDLINE, Embase and PubMed (1990-2011). Primary outcomes were primary anastomosis, stoma and in-hospital mortality rates. Secondary outcomes included anastomotic leak, 30-day reoperation and surgical-site infection rates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four RCTs with 234 patients were included. Technical and clinical success rates for stenting were 70&#xb7;7 per cent (82 of 116) and 69&#xb7;0 per cent (80 of 116) respectively. The clinical perforation rate was 6&#xb7;9 per cent (8 of 116) and the silent perforation rate 14 per cent (11 of 77). SEMS intervention resulted in significantly higher successful primary anastomosis (risk ratio (RR) 1&#xb7;58, 95 per cent confidence interval 1&#xb7;22 to 2&#xb7;04; P &lt; 0&#xb7;001) and lower overall stoma (RR 0&#xb7;71, 0&#xb7;56 to 0&#xb7;89; P = 0&#xb7;004) rates. There was no difference in primary anastomosis, permanent stoma, in-hospital mortality, anastomotic leak, 30-day reoperation and surgical-site infection rates. Three trials were stopped prematurely, one because the emergency surgery group had a significantly increased anastomotic leak rate, and two others because of stent-related complications and increased 30-day morbidity following SEMS management.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Technical and clinical success rates for stenting were lower than expected. SEMS is associated with a high incidence of clinical and silent perforation. However, as a bridge to surgery, SEMS has higher successful primary anastomosis and lower overall stoma rates, with no significant difference in complications or mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>C J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Royal Victoria Hospital, 274 Grosvenor Road, Belfast BT12 6BA, UK. cjtan99@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dasari</LastName><ForeName>B V M</ForeName><Initials>BV</Initials></Author><Author ValidYN="Y"><LastName>Gardiner</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Surg. 2012 Oct;99(10):1462; author reply 1462-3. doi: 10.1002/bjs.8925.</RefSource><PMID Version="1">22961530</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Br J Surg. 2012 Oct;99(10):1464; author reply 1464-5. doi: 10.1002/bjs.8929.</RefSource><PMID Version="1">22961534</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003108" MajorTopicYN="N">Colonic Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003125" MajorTopicYN="N">Colostomy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004638" MajorTopicYN="N">Emergency Treatment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007415" MajorTopicYN="N">Intestinal Obstruction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22261931</ArticleId><ArticleId IdType="doi">10.1002/bjs.8689</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37160444</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Prevalence of preoperative opioid usage and its impact on postoperative outcomes: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>532</StartPage><EndPage>538</EndPage><MedlinePgn>532-538</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-023-03198-0</ELocationID><Abstract><AbstractText Label="PURPOSE">Preoperative opioid treatment increases postoperative adverse events. This study was aimed to analyze preoperative opioid prevalence in countries with low opioid consumption. Additionally, the effect of low opioid usage on postoperative outcomes was also investigated.</AbstractText><AbstractText Label="METHODS">We conducted this single center retrospective cohort analysis in a Japanese university-affiliated hospital to investigate opioid usage and its impact on the duration of postoperative hospitalization and in-hospital mortality. Adult patients who underwent general anesthesia between 2015 and 2020 were included. We extracted the patients' characteristics, surgical information and postoperative outcomes. Subgroup analysis to address opioid dose effect was performed in high and low dose opioid subgroups.</AbstractText><AbstractText Label="RESULTS">Among 20,306 inpatients, 535 (2.63%) patients used opioids preoperatively. Tramadol was the most frequently used opioid. The median morphine equivalent (MME) dose was 15&#xa0;mg/day. Median duration of hospitalization was 18 and 9&#xa0;days in the opioid and non-opioid groups, and in-hospital mortality was 2.06% and 0.42%. Multivariable regression analysis demonstrated that preoperative opioid use was associated with a longer duration of hospitalization and in-hospital mortality. Subgroup analysis demonstrated longer durations of hospitalization in both high (&gt;&#x2009;30&#xa0;mg/day MME) and low (&#x2264;&#x2009;30&#xa0;mg/day MME) dose opioid groups, while higher in-hospital mortality was seen only in the high dose opioid group.</AbstractText><AbstractText Label="CONCLUSIONS">Preoperative opioid usage was one-tenth of the United States average. Despite its low prevalence and small dosage, preoperative opioid usage was associated with poor postoperative outcomes. Dedicated perioperative interventions to prevent opioid-associated adverse events should be developed even in countries with low opioid consumption.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s) under exclusive licence to Japanese Society of Anesthesiologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oya</LastName><ForeName>Rina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pain Management and Palliative Care Medicine, Kyoto Prefectural University of Medicine, Kajiicho 465, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pain Management and Palliative Care Medicine, Kyoto Prefectural University of Medicine, Kajiicho 465, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oya</LastName><ForeName>Kiyofumi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Peace Home Care Clinic, 16-21 Oiwake-cho, Otsu, Shiga, 520-0064, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirakawa</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pain Management and Palliative Care Medicine, Kyoto Prefectural University of Medicine, Kajiicho 465, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Chika</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pain Management and Palliative Care Medicine, Kyoto Prefectural University of Medicine, Kajiicho 465, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amaya</LastName><ForeName>Fumimasa</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-2934-0845</Identifier><AffiliationInfo><Affiliation>Department of Pain Management and Palliative Care Medicine, Kyoto Prefectural University of Medicine, Kajiicho 465, Kamigyo-ku, Kyoto, 602-0841, Japan. ama@koto.kpu-m.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>78185-58-7</RegistryNumber><NameOfSubstance UI="C020415">MME</NameOfSubstance></Chemical><Chemical><RegistryNumber>76I7G6D29C</RegistryNumber><NameOfSubstance UI="D009020">Morphine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="Y">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="Y">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Opioid</Keyword><Keyword MajorTopicYN="N">Postoperative</Keyword><Keyword MajorTopicYN="N">Preoperative</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37160444</ArticleId><ArticleId IdType="doi">10.1007/s00540-023-03198-0</ArticleId><ArticleId IdType="pii">10.1007/s00540-023-03198-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-2559</ArticleId><ArticleId IdType="pubmed">25581257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cron DC, Englesbe MJ, Bolton CJ, Joseph MT, Carrier KL, Moser SE, Waljee JF, Hilliard PE, Kheterpal S, Brummett CM. Preoperative opioid use is independently associated with increased costs and worse outcomes after major abdominal surgery. Ann Surg. 2017;265:695&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001901</ArticleId><ArticleId IdType="pubmed">27429021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghian S, Karimi A, Dowlatshahi S, Ahmadi SH, Davoodi S, Marzban M, Movahedi N, Abbasi K, Tazik M, Fathollahi MS. The association of opium dependence and postoperative complications following coronary artery bypass graft surgery: a propensity-matched study. J Opioid Manag. 2009;5:365&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="doi">10.5055/jom.2009.0036</ArticleId><ArticleId IdType="pubmed">20073410</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam VK, Couch KS, McNish S, Amdur RL. Relationship between opioid treatment and rate of healing in chronic wounds. Wound Repair Regen. 2017;25:120&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/wrr.12496</ArticleId><ArticleId IdType="pubmed">27865036</ArticleId><ArticleId IdType="pmc">5357171</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez ME, Ring D, Bateman BT. Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery. Clin Orthop Relat Res. 2015;473:2402&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-015-4173-5</ArticleId><ArticleId IdType="pubmed">25694266</ArticleId><ArticleId IdType="pmc">4457771</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrantes F, Luan FL, Kommareddi M, Alazem K, Yaqub T, Roth RS, Sung RS, Cibrik DM, Song P, Samaniego M. A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk. Kidney Int. 2013;84:390&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.136</ArticleId><ArticleId IdType="pubmed">23615503</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyland SJ, Brockhaus KK, Vincent WR, Spence NZ, Lucki MM, Howkins MJ, Cleary RK. Perioperative pain management and opioid stewardship: a practical guide. Healthcare (Basel). 2021;9:333. https://doi.org/10.3390/healthcare9030333 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9030333</ArticleId><ArticleId IdType="pubmed">33809571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilliard PE, Waljee J, Moser S, Metz L, Mathis M, Goesling J, Cron D, Clauw DJ, Englesbe M, Abecasis G, Brummett CM. Prevalence of preoperative opioid use and characteristics associated with opioid use among patients presenting for surgery. JAMA Surg. 2018;153:929&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2018.2102</ArticleId><ArticleId IdType="pubmed">29998303</ArticleId><ArticleId IdType="pmc">6233789</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholten W, Christensen AE, Olesen AE, Drewes AM. Analyzing and benchmarking global consumption statistics for opioid analgesics 2015: inequality continues to increase. J Pain Palliat Care Pharmacother. 2020;34:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15360288.2019.1686098</ArticleId><ArticleId IdType="pubmed">31755794</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayawardana S, Forman R, Johnston-Webber C, Campbell A, Berterame S, de Joncheere C, Aitken M, Mossialos E. Global consumption of prescription opioid analgesics between 2009&#x2013;2019: a country-level observational study. EClinicalMedicine. 2021;42:101198. https://doi.org/10.1016/j.eclinm.2021.101198 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101198</ArticleId><ArticleId IdType="pubmed">34820610</ArticleId><ArticleId IdType="pmc">8599097</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi E, Kobayashi T, Dexter E, Marino M, Maeno T, Deyo RA. Comparison of opioid prescribing patterns in the United States and Japan: primary care physicians&#x2019; attitudes and perceptions. J Am Board Family Med. 2017;30:248&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2017.02.160299</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S, Kobayashi F, Nishihara M, Arai Y-CP, Ikemoto T, Kawai T, Inoue M, Hasegawa T, Ushida T. Chronic pain in the japanese community&#x2014;prevalence, characteristics and impact on quality of life. PLoS&#xa0;One. 2015;10:e0129262. https://doi.org/10.1371/journal.pone.0129262 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129262</ArticleId><ArticleId IdType="pubmed">26076135</ArticleId><ArticleId IdType="pmc">4467865</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010;11:1230&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2010.07.002</ArticleId><ArticleId IdType="pubmed">20797916</ArticleId></ArticleIdList></Reference><Reference><Citation>Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015;350:g6380. https://doi.org/10.1136/bmj.g6380 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g6380</ArticleId><ArticleId IdType="pubmed">25561513</ArticleId><ArticleId IdType="pmc">6882374</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sainsbury A, Seebass G, Bansal A, Young JB. Reliability of the Barthel Index when used with older people. Age Ageing. 2005;34:228&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afi063</ArticleId><ArticleId IdType="pubmed">15863408</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasunaga H. Real world data in Japan: chapter II the diagnosis procedure combination database. Ann Clin Epidemiol. 2019;1:76&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.37737/ace.1.3_76</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins JM, Hern&#xe1;n MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200009000-00011</ArticleId><ArticleId IdType="pubmed">10955408</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart EA, Lee BK, Leacy FP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8 Suppl):S84-S90. e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.01.013</ArticleId><ArticleId IdType="pubmed">23849158</ArticleId><ArticleId IdType="pmc">3713509</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards DA, Hedrick TL, Jayaram J, Argoff C, Gulur P, Holubar SD, Gan TJ, Mythen MG, Miller TE, Shaw AD, Thacker JKM, McEvoy MD, Group P-W. American society for enhanced recovery and perioperative quality initiative joint consensus statement on perioperative management of patients on preoperative opioid therapy. Anesth Analg. 2019;129(2):553&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004018</ArticleId><ArticleId IdType="pubmed">30768461</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkow ND, McLellan AT. Opioid abuse in chronic pain-misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1507771</ArticleId><ArticleId IdType="pubmed">27028915</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R, Chou LN, Kuo YF, Raji MA. Long-term opioid therapy in older cancer survivors: a retrospective cohort study. J Am Geriatr Soc. 2019;67:945&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15945</ArticleId><ArticleId IdType="pubmed">31026356</ArticleId><ArticleId IdType="pmc">6645777</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyachi T, Ozaki A, Saito H, Sawano T, Tanimoto T, Crump A. Opioids: a &#x201c;crisis&#x201d; of too much or not enough - or simply how rich you are and where you live? Eur J Pain. 2021;25:1181&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1767</ArticleId><ArticleId IdType="pubmed">33822443</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiels CA, Habermann EB, Hooten WM, Jeffery MM. Chronic use of tramadol after acute pain episode: cohort study. BMJ. 2019;365:l1849. https://doi.org/10.1136/bmj.l1849 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l1849</ArticleId><ArticleId IdType="pubmed">31088782</ArticleId><ArticleId IdType="pmc">6514531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C, Dubreuil M, LaRochelle MR, Lu N, Wei J, Choi HK, Lei G, Zhang Y. Association of tramadol with all-cause mortality among patients with osteoarthritis. JAMA. 2019;321:969&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.1347</ArticleId><ArticleId IdType="pubmed">30860559</ArticleId><ArticleId IdType="pmc">6439672</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam VK, Fernandez SJ, Evans KK, Mcnish S, Banerjee AN, Couch KS, Mete M, Shara N. Postoperative wound dehiscence: predictors and associations. Wound Repair Regen. 2015;23:184&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/wrr.12268</ArticleId><ArticleId IdType="pubmed">25683272</ArticleId><ArticleId IdType="pmc">4587566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita GP, Lundorff L, Pimenta CADM, Sj&#xf8;gren P. The cognitive effects of opioids in cancer: a systematic review. Support Care Cancer. 2009;17:11&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-008-0497-y</ArticleId><ArticleId IdType="pubmed">18762994</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherrer JF, Salas J, Sullivan MD, Schneider FD, Bucholz KK, Burroughs T, Copeland L, Ahmedani B, Lustman PJ. The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med. 2016;91:110&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2016.08.003</ArticleId><ArticleId IdType="pubmed">27497660</ArticleId><ArticleId IdType="pmc">5050125</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;derberg KC, Laflamme L, M&#xf6;ller J. Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs. 2013;27:155&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-013-0038-1</ArticleId><ArticleId IdType="pubmed">23345030</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa D, Farney RJ, Chung F, Prasad A, Lam D, Wong J. Chronic opioid use and central sleep apnea. Anesth Analg. 2015;120:1273&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000672</ArticleId><ArticleId IdType="pubmed">25988636</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34846684</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-6713</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>General thoracic and cardiovascular surgery</Title><ISOAbbreviation>Gen Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Incidence and risk factors of acute cholecystitis after cardiovascular surgery.</ArticleTitle><Pagination><StartPage>611</StartPage><EndPage>618</EndPage><MedlinePgn>611-618</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11748-021-01751-w</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Acute cholecystitis is a complication in critically ill patients. However, a few studies have described its incidence, risk factors, and mortality in patients who underwent cardiovascular surgery. We investigated the incidence, perioperative predictors, and clinical features of acute cholecystitis after cardiovascular surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study examined 7013 patients who underwent cardiovascular surgery between October 2000 and March 2019 at a tertiary care hospital. We collected preoperative, intraoperative, and postoperative data from our database and electronic medical records. The primary outcome was the incidence of postoperative cholecystitis until hospital discharge. A multivariable logistic regression analysis to estimate perioperative predictors of acute cholecystitis was conducted. We described the clinical characteristics of patients complicated with acute cholecystitis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 7013 patients, 51 (0.7%) developed acute cholecystitis. Logistic regression analysis found that circulatory arrest (odds ratio [OR] 1.97; 95% confidence interval [CI] 1.04-3.74; P&#x2009;=&#x2009;0.037) and intraoperative massive transfusion (OR 2.03; 95% CI 1.03-4.01; P&#x2009;=&#x2009;0.041) were associated with the incidences of cholecystitis. In-hospital mortality was significantly higher in the cholecystitis group than in the non-cholecystitis group (13.7% vs 3.9%, P&#x2009;=&#x2009;0.004). Aortic disease was more frequent in the cholecystitis group (54.9% vs 38.6%, P&#x2009;=&#x2009;0.021). The median time of acute cholecystitis onset from surgery was 12.5&#xa0;days (interquartile range 7.0-27.75). Twenty-six patients (51.0%) developed asymptomatic cholecystitis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Approximately 1% of patients who underwent cardiovascular surgery developed postoperative cholecystitis; half of them were asymptomatic. Since cholecystitis is associated with high mortality, it is a complication after cardiovascular surgery that needs to be considered.</AbstractText><CopyrightInformation>&#xa9; 2021. The Japanese Association for Thoracic Surgery.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamei</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9150-1529</Identifier><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Okayama, 710-8602, Japan. junk19860816@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuriyama</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Okayama, 710-8602, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimamoto</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Okayama, 710-8602, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komiya</LastName><ForeName>Tatsuhiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Okayama, 710-8602, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Gen Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>101303952</NlmUniqueID><ISSNLinking>1863-6705</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Gen Thorac Cardiovasc Surg. 2022 Apr;70(4):416. doi: 10.1007/s11748-022-01782-x.</RefSource><PMID Version="1">35094256</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002764" MajorTopicYN="Y">Cholecystitis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041881" MajorTopicYN="Y">Cholecystitis, Acute</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute cholecystitis</Keyword><Keyword MajorTopicYN="N">Cardiovascular surgery</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Postoperative complication</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>30</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34846684</ArticleId><ArticleId IdType="doi">10.1007/s11748-021-01751-w</ArticleId><ArticleId IdType="pii">10.1007/s11748-021-01751-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Laurila J, Syrjala H, Laurila PA, Saarnio J, Ala-Kokko TI. Acute acalculous cholecystitis in critically ill patients. Acta Anaesthesiol Scand. 2004;48(8):986&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0001-5172.2004.00426.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelinka LE, Schmidhammer R, Hamid L, Mauritz W, Redl H. Acute acalculous cholecystitis after trauma: a prospective study. J Trauma. 2003;55(2):323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TA.0000054648.26933.21</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh K, Goutos I, Dheansa B. Acute acalculous cholecystitis in burns: a review. J Burn Care Res. 2018;39(5):724&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jbcr/irx055</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue T, Mishima Y. Postoperative acute cholecystitis: a collective review of 494 cases in Japan. Jpn J Surg. 1988;18(1):35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02470844</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman JL, Schenker S. Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol. 2010;8(1):15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2009.08.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg. 1998;64(5):471&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9585788</ArticleId></ArticleIdList></Reference><Reference><Citation>McChesney JA, Northup PG, Bickston SJ. Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology. Dig Dis Sci. 2003;48(10):1960&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1026118320460</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlando R 3rd, Gleason E, Drezner AD. Acute acalculous cholecystitis in the critically ill patient. Am J Surg. 1983;145(4):472&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(83)90042-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Rady MY, Kodavatiganti R, Ryan T. Perioperative predictors of acute cholecystitis after cardiovascular surgery. Chest. 1998;114(1):76&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.114.1.76</ArticleId></ArticleIdList></Reference><Reference><Citation>Passage J, Joshi P, Mullany DV. Acute cholecystitis complicating cardiac surgery: case series involving more than 16,000 patients. Ann Thorac Surg. 2007;83(3):1096&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2006.09.048</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, O&#x2019;Farrell R, Yau TM, Beattie WS, Reducing Bleeding in Cardiac Surgery Research G. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth. 2006;53(8):781&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03022795</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaney M, Stark PC, Suh M, Triulzi DJ, Hess JR, Steiner ME, et al. Massive transfusion in cardiac surgery: the impact of blood component ratios on clinical outcomes and survival. Anesth Analg. 2017;124(6):1777&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001926</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jhbp.515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg. 2016;11:25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-016-0082-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis? JAMA. 2003;289(1):80&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.1.80</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuks D, Mouly C, Robert B, Hajji H, Yzet T, Regimbeau JM. Acute cholecystitis: preoperative CT can help the surgeon consider conversion from laparoscopic to open cholecystectomy. Radiology. 2012;263(1):128&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.12110460</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa Y, Abe S, Yoshimura Y, Uchida T, Kim C, Kuroda Y, et al. Clinical characteristics of biliary tract infection and acalculous cholecystitis after cardiovascular surgery. Kyobu Geka. 2014;67(12):1039&#x2013;43 (discussion 43&#x2013;6).</Citation><ArticleIdList><ArticleId IdType="pubmed">25391463</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurila JJ, Ala-Kokko TI, Laurila PA, Saarnio J, Koivukangas V, Syrjala H, et al. Histopathology of acute acalculous cholecystitis in critically ill patients. Histopathology. 2005;47(5):485&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2559.2005.02238.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson B, Nilsson J, Brandt J, Hoglund P, Andersson R. Gastrointestinal complications after cardiac surgery. Br J Surg. 2005;92(3):326-33.</Citation></Reference><Reference><Citation>Filsoufi F, Rahmanian PB, Castillo JG, Scurlock C, Legnani PE, Adams DH. Predictors and outcome of gastrointestinal complications in patients undergoing cardiac surgery. Ann Surg. 2007;246(2):323-9.</Citation></Reference><Reference><Citation>Kumral E, Yuksel M, Buket S, Yagdi T, Atay Y, Guzelant A. Neurologic complications after deep hypothermic circulatory arrest: types, predictors, and timing. Tex Heart Inst J. 2001;28(2):83&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11453137</ArticleId><ArticleId IdType="pmc">101145</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo M, Salandin V, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107(6):1489&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(94)70429-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper WA, Duarte IG, Thourani VH, Nakamura M, Wang NP, Brown WM 3rd, et al. Hypothermic circulatory arrest causes multisystem vascular endothelial dysfunction and apoptosis. Ann Thorac Surg. 2000;69(3):696&#x2013;702 (discussion 3).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(99)01524-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Croome KP, Kiaii B, Fox S, Quantz M, McKenzie N, Novick RJ. Comparison of gastrointestinal complications in on-pump versus off-pump coronary artery bypass grafting. Can J Surg. 2009;52(2):125&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19399207</ArticleId><ArticleId IdType="pmc">2663510</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Dubois MJ, Schmartz D, Koch M, Ducart A, Barvais L, et al. Microcirculatory alterations in cardiac surgery: effects of cardiopulmonary bypass and anesthesia. Ann Thorac Surg. 2009;88(5):1396&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg EF, Grinnan GL, Smith L. Acalculous cholecystitis in Viet Nam casualties. Ann Surg. 1970;171(1):152&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-197001000-00022</ArticleId></ArticleIdList></Reference><Reference><Citation>Toursarkissian B, Kearney PA, Holley DT, Cheung R, Fried A, Strodel WE. Biliary sludging in critically ill trauma patients. South Med J. 1995;88(4):420&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007611-199504000-00007</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen SR, Sheldon GF. Acute acalculous cholecystitis: a complication of hyperalimentation. Am J Surg. 1979;138(6):814&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(79)90302-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Guglielmi FW, Regano N, Mazzuoli S, Fregnan S, Leogrande G, Guglielmi A, et al. Cholestasis induced by total parenteral nutrition. Clin Liver Dis. 2008;12(1):97&#x2013;110 (viii).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cld.2007.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A, Shirai Y, Ohzeki H, Hayashi J, Eguchi S. Acute acalculous cholecystitis after cardiovascular surgery. Surg Today. 1997;27(10):907&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02388137</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35900307</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Percutaneous coronary intervention versus coronary artery bypass graft surgery in dialysis-dependent patients: A pooled meta-analysis of reconstructed time-to-event data.</ArticleTitle><Pagination><StartPage>3365</StartPage><EndPage>3373</EndPage><MedlinePgn>3365-3373</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.16805</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">&#x3a4;&#x3bf; perform a systematic review with meta-analysis of published data comparing outcomes between a percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in dialysis-dependent patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Scopus, and Cochrane databases for studies including dialysis-dependent patients who underwent either CABG or PCI. This meta-analysis follows the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. We conducted one-stage and two-stage meta-analysis with Kaplan-Meier-derived individual patient data&#xa0;for overall survival and meta-analysis with the random-effects model for the in-hospital mortality and repeat revascularization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve studies met our eligibility criteria, including 13,651 and 28,493 patients were identified in the CABG and PCI arms, respectively. Patients who underwent CABG had overall improved survival compared with those who underwent PCI at the one-stage meta-analysis (hazard ratio [HR]: 1.12, 95% confidence interval [CI]: 1.09-1.16, p&#x2009;&lt;&#x2009;.0001) and the two-stage meta-analysis (HR: 1.15, 95% CI: 1.08-1.23, p&#x2009;&lt;&#x2009;.001, I<sup>2</sup> &#x2009;=&#x2009;30.0%). Landmark analysis suggested that PCI offers better survival before the 8.5 months of follow-up (HR: 0.96, 95% CI: 0.92-0.99, p&#x2009;=&#x2009;.043), while CABG offers an advantage after this timepoint (HR: 1.3, 95% CI: 1.22-1.32, p&#x2009;&lt;&#x2009;.001). CABG was associated with increased odds for in-hospital mortality (odds ratio [OR]: 1.70, 95% CI: 1.50-1.92, p&#x2009;&lt;&#x2009;.001, I<sup>2</sup> &#x2009;=&#x2009;0.0%) and decreased odds for repeat revascularization (OR: 0.22, 95% CI: 0.14-0.34, p&#x2009;&lt;&#x2009;.001, I<sup>2</sup> &#x2009;=&#x2009;58.08%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In dialysis-dependent patients, CABG was associated with long-term survival but a higher risk for early mortality. The risk for repeat revascularization was higher with PCI.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tasoudis</LastName><ForeName>Panagiotis T</ForeName><Initials>PT</Initials><Identifier Source="ORCID">0000-0001-7735-9474</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, School of Health Sciences, University of Thessaly, Larisa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varvoglis</LastName><ForeName>Dimitrios N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, School of Health Sciences, University of Thessaly, Larisa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzoumas</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doulamis</LastName><ForeName>Ilias P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzani</LastName><ForeName>Aspasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;</LastName><ForeName>Michel Pompeu</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0001-5356-2996</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampaktsis</LastName><ForeName>Polydoros N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiology, New York University Langone Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1392-4558</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Cardiocentro Ticino, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Card Surg. 2022 Oct;37(10):3374-3375. doi: 10.1111/jocs.16803.</RefSource><PMID Version="1">35900306</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054855" MajorTopicYN="Y">Drug-Eluting Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgical procedures</Keyword><Keyword MajorTopicYN="N">cardiovascular surgical procedures</Keyword><Keyword MajorTopicYN="N">coronary artery bypass</Keyword><Keyword MajorTopicYN="N">myocardial revascularization</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35900307</ArticleId><ArticleId IdType="doi">10.1111/jocs.16805</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Collins AJ, Foley RN, Gilbertson DT, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int&#xa0;Suppl. 2015;5(1):2-7. doi:10.1038/kisup.2015.2</Citation></Reference><Reference><Citation>Raine AE, Margreiter R, Brunner FP, et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol&#xa0;Dial Transplant. 1992;7(suppl 2):7-35.</Citation></Reference><Reference><Citation>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305. doi:10.1056/nejmoa041031</Citation></Reference><Reference><Citation>Ishimura E, Shoji T, Emoto M, et al. Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis. 2001;38(4):S186-S190. doi:10.1053/ajkd.2001.27440</Citation></Reference><Reference><Citation>Farkouh ME, Sidhu MS, Brooks MM, et al. Impact of chronic kidney disease on outcomes of myocardial revascularization in patients with diabetes. J Am Coll Cardiol. 2019;73(4):400-411. doi:10.1016/j.jacc.2018.11.044</Citation></Reference><Reference><Citation>Wang Z, Gong Y, Fan F, et al. Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis. Ren Fail. 2020;42(1):107-112. doi:10.1080/0886022X.2019.1710187</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71</Citation></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/BMJ.I4919</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control&#xa0;Clin Trials. 1986;7(3):177-188. doi:10.1016/0197-2456(86)90046-2</Citation></Reference><Reference><Citation>Wei Y, Royston P. Reconstructing time-to-event data from published Kaplan-Meier curves. Stata J. 2017;17(4):786-802.</Citation></Reference><Reference><Citation>Guyot P, Ades AE, Ouwens MJNM, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12(1):9. doi:10.1186/1471-2288-12-9</Citation></Reference><Reference><Citation>Yeates A, Hawley C, Mundy J, Pinto N, Haluska B, Shah P. Treatment outcomes for ischemic heart disease in dialysis-dependent patients. Asian Cardiovasc&#xa0;Thorac&#xa0;Ann. 2012;20(3):281-291. doi:10.1177/0218492312437383</Citation></Reference><Reference><Citation>Aoki J, Ikari Y, Sugimoto T, Fukuda S, Hara K. Clinical outcome of percutaneous transluminal coronary rotational atherectomy in patients with end-stage renal disease. Circ J. 2003;67(7):617-621. doi:10.1253/circj.67.617</Citation></Reference><Reference><Citation>Baek CH, Kim SO, Park SJ, Lee JW, Kim SB, Kim KM. Propensity-matched comparison of drug-eluting stent implantation and coronary artery bypass graft surgery in chronic hemodialysis patients. J Nephrol. 2014;27(1):87-93. doi:10.1007/s40620-013-0023-2</Citation></Reference><Reference><Citation>Chou CL, Hsieh TC, Wang CH, et al. Long-term outcomes of dialysis patients after coronary revascularization: a population-based cohort study in Taiwan. Arch Med Res. 2014;45(2):188-194. doi:10.1016/j.arcmed.2014.01.009</Citation></Reference><Reference><Citation>Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106(17):2207-2211. doi:10.1161/01.CIR.0000035248.71165.EB</Citation></Reference><Reference><Citation>Ivens K, Gradaus F, Heering P, et al. Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol Nephrol. 2001;32(4):717-723. doi:10.1023/A:1015067611958</Citation></Reference><Reference><Citation>Kumada Y, Ishii H, Aoyama T, et al. Long-term clinical outcomes after coronary artery bypass graft versus everolimus-eluting stent implantation in chronic hemodialysis patients. Coron Artery Dis. 2018;29(6):489-494. doi:10.1097/MCA.0000000000000628</Citation></Reference><Reference><Citation>Manabe S, Shimokawa T, Fukui T, et al. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome? J Card Surg. 2009;24(3):234-239. doi:10.1111/j.1540-8191.2008.00789.x</Citation></Reference><Reference><Citation>Marui A, Kimura T, Nishiwaki N, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2. Am J Cardiol. 2014;114(4):555-561. doi:10.1016/j.amjcard.2014.05.034</Citation></Reference><Reference><Citation>Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013;127(18):1861-1869. doi:10.1161/CIRCULATIONAHA.112.001264</Citation></Reference><Reference><Citation>Terazawa S, Tajima K, Takami Y, et al. Early and late outcomes of coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stents for dialysis patients. J Card Surg. 2012;27(3):281-287. doi:10.1111/j.1540-8191.2012.01444.x</Citation></Reference><Reference><Citation>M&#xf6;ckel M, Searle J, Baberg HT, et al. Revascularisation of patients with end-stage renal disease on chronic haemodialysis: bypass surgery versus PCI-analysis of routine statutory health insurance data. Open Heart. 2016;3(2):000464. doi:10.1136/openhrt-2016-000464</Citation></Reference><Reference><Citation>Sunagawa G, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Murashita T. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg. 2010;89(6):1896-1900. doi:10.1016/j.athoracsur.2010.02.080</Citation></Reference><Reference><Citation>Shroff GR, Solid CA, Herzog CA. Impact of acute coronary syndromes on survival of dialysis patients following surgical or percutaneous coronary revascularization in the United States. Eur Heart J Acute Cardiovasc Care. 2016;5(3):205-213. doi:10.1177/2048872615574106</Citation></Reference><Reference><Citation>Krishnaswami A, McCulloch CE, Tawadrous M, et al. Coronary artery bypass grafting and percutaneous coronary intervention in patients with end-stage renal disease. Eur J Cardiothorac Surg. 2015;47(5):e193-e198. doi:10.1093/ejcts/ezv104</Citation></Reference><Reference><Citation>Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol. 2012;23(12):2042-2049. doi:10.1681/ASN.2012060554</Citation></Reference><Reference><Citation>Agirbasli M, Weintraub WS, Chang GL, et al. Outcome of coronary revascularization in patients on renal dialysis. Am J Cardiol. 2000;86(4):395-399. doi:10.1016/S0002-9149(00)00953-X</Citation></Reference><Reference><Citation>Simsir SA, Kohlman-Trigoboff D, Flood R, Lindsay J, Smith BM. A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis. Vascular. 1998;6(5):500-505. doi:10.1177/096721099800600513</Citation></Reference><Reference><Citation>Rinehart AL, Herzog CA, Collins AJ M, Flack J, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis. 1995;25(2):281-290. doi:10.1016/0272-6386(95)90010-1</Citation></Reference><Reference><Citation>Kumada Y, Ishii H, Aoyama T, et al. Long-term clinical outcome after surgical or percutaneous coronary revascularization in hemodialysis patients. Circ J. 2014;78(4):986-992. doi:10.1253/circj.CJ-13-1357</Citation></Reference><Reference><Citation>Sun LY, Gaudino M, Chen RJ, Bader Eddeen A, Ruel M. Long-term outcomes in patients with severely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting. JAMA Cardiol. 2020;5(6):631-641. doi:10.1001/jamacardio.2020.0239</Citation></Reference><Reference><Citation>Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375-2384. doi:10.1056/NEJMoa1211585</Citation></Reference><Reference><Citation>Best PJM, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39(7):1113-1119. doi:10.1016/S0735-1097(02)01745-X</Citation></Reference><Reference><Citation>Zheng H, Xue S, Lian F, Huang RT, Hu ZL, Wang Yyi. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease. Eur J Cardiothorac Surg. 2013;43(3):459-467. doi:10.1093/ejcts/ezs360</Citation></Reference><Reference><Citation>Wang Y, Zhu S, Gao P, Zhang Q. Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: a meta-analysis. Eur J Intern Med. 2017;43(2016):28-35. doi:10.1016/j.ejim.2017.04.002</Citation></Reference><Reference><Citation>Koyanagi T, Nishida H, Kitamura M, et al. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg. 1996;61(6):1793-1796. doi:10.1016/0003-4975(96)00170-1</Citation></Reference><Reference><Citation>Rollino C, Formica M, Minelli M, et al. Outcome of dialysis patients submitted to coronary revascularization. Ren Fail. 2000;22(5):605-611. doi:10.1081/JDI-100100901</Citation></Reference><Reference><Citation>Johnson DW, Dent H, Hawley CM, et al. Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am&#xa0;Soc&#xa0;Nephrol. 2009;4(10):1620-1628. doi:10.2215/CJN.01750309</Citation></Reference><Reference><Citation>Suehiro S, Shibata T, Hattori K, et al. Early and long-term results of coronary artery bypass grafting in dialysis patients. Jpn J Thorac Cardiovasc Surg. 2001;49(11):660-665. doi:10.1007/BF02912475</Citation></Reference><Reference><Citation>Doulamis IP, Tzani A, Tzoumas A, Iliopoulos DC, Kampaktsis PN, Briasoulis A. Percutaneous coronary intervention with drug eluting stents versus coronary artery bypass graft surgery in patients with advanced chronic kidney disease: a systematic review and meta-analysis. Semin Thorac Cardiovasc Surg. 2020;33:958-969. doi:10.1053/j.semtcvs.2020.11.005</Citation></Reference><Reference><Citation>Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. 2014;35(40):2821-2830. doi:10.1093/eurheartj/ehu213</Citation></Reference><Reference><Citation>Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972. doi:10.1056/NEJMoa0804626</Citation></Reference><Reference><Citation>Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55(5):432-440. doi:10.1016/j.jacc.2009.10.014</Citation></Reference><Reference><Citation>Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285-1295. doi:10.1056/NEJMoa041365</Citation></Reference><Reference><Citation>Charytan DM, Desai M, Mathur M, et al. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016;90(2):411-421. doi:10.1016/j.kint.2016.03.033</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34482453</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-4681</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Annals of surgical oncology</Title><ISOAbbreviation>Ann Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses.</ArticleTitle><Pagination><StartPage>1358</StartPage><EndPage>1373</EndPage><MedlinePgn>1358-1373</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1245/s10434-021-10734-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to identify preoperative patient-related prognostic factors for anastomotic leakage, mortality, and major complications in patients undergoing oncological esophagectomy.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Esophagectomy is a high-risk procedure with an incidence of major complications around 25% and short-term mortality around 4%.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched the Medline and Embase databases for studies investigating the associations between patient-related prognostic factors and anastomotic leakage, major postoperative complications (Clavien-Dindo&#x2009;&#x2265;&#x2009;IIIa), and/or 30-day/in-hospital mortality after esophagectomy for cancer.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-nine eligible studies identifying 37 prognostic factors were included. Cardiac comorbidity was associated with anastomotic leakage, major complications, and mortality. Male sex and diabetes were prognostic factors for anastomotic leakage and major complications. Additionally, American Society of Anesthesiologists (ASA) score&#x2009;&gt;&#x2009;III and renal disease were associated with anastomotic leakage and mortality. Pulmonary comorbidity, vascular comorbidity, hypertension, and adenocarcinoma tumor histology were identified as prognostic factors for anastomotic leakage. Age&#x2009;&gt;&#x2009;70&#xa0;years, habitual alcohol usage, and body mass index (BMI) 18.5-25&#xa0;kg/m<sup>2</sup> were associated with increased risk for mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Various patient-related prognostic factors are associated with anastomotic leakage, major postoperative complications, and postoperative mortality following oncological esophagectomy. This knowledge may define case-mix adjustment models used in benchmarking or auditing and may assist in selection of patients eligible for surgery or tailored perioperative care.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Kooten</LastName><ForeName>Robert T</ForeName><Initials>RT</Initials><Identifier Source="ORCID">0000-0001-9633-7289</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. r.t.van_kooten@lumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voeten</LastName><ForeName>Daan M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyerberg</LastName><ForeName>Ewout W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartgrink</LastName><ForeName>Henk H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Berge Henegouwen</LastName><ForeName>Mark I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Hillegersberg</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tollenaar</LastName><ForeName>Rob A E M</ForeName><Initials>RAEM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wouters</LastName><ForeName>Michel W J M</ForeName><Initials>MWJM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Dutch Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Oncol</MedlineTA><NlmUniqueID>9420840</NlmUniqueID><ISSNLinking>1068-9265</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="Y">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>M.I.v.B.H. is consultant for Mylan, Johnson &amp; Johnson, Alesi Surgical, and Medtronic, and received research grants from Olympus and Stryker. R.v.H. is consultant for Medtronic and proctoring surgeon for Intuitive Surgical Inc. and trains other surgeons in robot-assisted minimally invasive esophagectomy. For the remaining authors no conflicts of interest were declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>5</Day><Hour>21</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34482453</ArticleId><ArticleId IdType="pmc">PMC8724192</ArticleId><ArticleId IdType="doi">10.1245/s10434-021-10734-3</ArticleId><ArticleId IdType="pii">10.1245/s10434-021-10734-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394&#x2013;424. doi: 10.3322/caac.21492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21492</ArticleId><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruol A, Castoro C, Portale G, et al. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009;144(3):247&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">19289664</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074&#x2013;2084.</Citation><ArticleIdList><ArticleId IdType="pubmed">22646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Busweiler LA, Henneman D, Dikken JL, et al. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer. Eur J Surg Oncol. 2017;43(10):1962&#x2013;1969.</Citation><ArticleIdList><ArticleId IdType="pubmed">28797755</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelsattar ZM, Habermann E, Borah BJ, Moriarty JP, Rojas RL, Blackmon SH. Understanding failure to rescue after esophagectomy in the United States. Ann Thorac Surg. 2020;109(3):865&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">31706867</ArticleId></ArticleIdList></Reference><Reference><Citation>Voeten DM, van der Werf LR, van Sandick JW, van Hillegersberg R, van Berge Henegouwen MI. Length of hospital stay after uncomplicated esophagectomy. Hospital variation shows room for nationwide improvement. Surg Endosc. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8523439</ArticleId><ArticleId IdType="pubmed">33104919</ArticleId></ArticleIdList></Reference><Reference><Citation>Aurello P, Berardi G, Moschetta G, et al. Recurrence following anastomotic leakage after surgery for carcinoma of the distal esophagus and gastroesophageal junction: a systematic review. Anticancer Res. 2019;39(4):1651&#x2013;1660.</Citation><ArticleIdList><ArticleId IdType="pubmed">30952703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashok A, Niyogi D, Ranganathan P, et al. The enhanced recovery after surgery (ERAS) protocol to promote recovery following esophageal cancer resection. Surg Today. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7098920</ArticleId><ArticleId IdType="pubmed">32048046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouters MW, Jansen-Landheer ML, van de Velde CJ. The Quality of Cancer Care initiative in the Netherlands. Eur J Surg Oncol. 2010;36(Suppl 1):S3&#x2013;s13.</Citation><ArticleIdList><ArticleId IdType="pubmed">20576399</ArticleId></ArticleIdList></Reference><Reference><Citation>Marang-van de Mheen PJ, Dijs-Elsinga J, Otten W, et al. The relative importance of quality of care information when choosing a hospital for surgical treatment: a hospital choice experiment. Med Decis Making. 2011;31(6):816&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pubmed">22067430</ArticleId></ArticleIdList></Reference><Reference><Citation>Waljee J, McGlinn EP, Sears ED, Chung KC. Patient expectations and patient-reported outcomes in surgery: a systematic review. Surgery. 2014;155(5):799&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4170731</ArticleId><ArticleId IdType="pubmed">24787107</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: the problem with small sample size. JAMA. 2004;292(7):847&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pubmed">15315999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary PD, McNeil BJ. Patient satisfaction as an indicator of quality care. Inquiry. 1988;25(1):25&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">2966123</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, C&#xf4;t&#xe9; P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexiou C, Beggs D, Salama FD, Brackenbury ET, Morgan WE. Surgery for esophageal cancer in elderly patients: the view from Nottingham. J. Thorac Cadiovasc Surg. 1998;116(4):545&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">9766581</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama T, Atsumi Y, Hara K, Tamagawa H, et al. Risk factors for postoperative anastomosis leak after esophagectomy for esophageal cancer. Vivo. 2020;34(2):857&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7157851</ArticleId><ArticleId IdType="pubmed">32111795</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkelmans GH, Kouwenhoven EA, Smeets BJ, et al. Diagnostic value of drain amylase for detecting intrathoracic leakage after esophagectomy. World J Gastroenterol. 2015;21(30):9118&#x2013;9125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4533043</ArticleId><ArticleId IdType="pubmed">26290638</ArticleId></ArticleIdList></Reference><Reference><Citation>Borggreve AS, Goense L, van Rossum PSN, van Hillegersberg R, de Jong PA, Ruurda JP. Generalized cardiovascular disease on a preoperative CT scan is predictive for anastomotic leakage after esophagectomy. Eur J Surg Oncol. 2018;44(5):587&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">29452856</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Werf LR, Busweiler LAD, van Sandick JW, van Berge Henegouwen MI, Wijnhoven BPL. Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG). Ann Surg. 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30676381</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Daele E, Van de Putte D, Ceelen W, Van Nieuwenhove Y, Pattyn P. Risk factors and consequences of anastomotic leakage after Ivor Lewis oesophagectomy&#x2020;. Interactive Cardiovasc Thorac Surg. 2016;22(1):32&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">26433973</ArticleId></ArticleIdList></Reference><Reference><Citation>Filip B, Scarpa M, Cavallin F, Cagol M, et al. Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol. 2015;41(6):787&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pubmed">25890494</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjederholt KT, Okholm C, Svendsen LB, Achiam MP, Kirkegard J, Mortensen FV. Ketorolac and other NSAIDs increase the risk of anastomotic leakage after surgery for GEJ cancers: a cohort study of 557 patients. J Gastrointest Surg. 2018;22(4):587&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">29134504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh SE, Yu A, Kubicek GJ, et al. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy? Int J Radiat Oncol Biol Phys. 2011;80(5):1372&#x2013;1376.</Citation><ArticleIdList><ArticleId IdType="pubmed">21106309</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Xu G, Wang C, Wang D. Evaluation of preoperative risk factors and postoperative indicators for anastomotic leak of minimally invasive McKeown esophagectomy: a single-center retrospective analysis. J Cardiothorac Surg. 2019;14(1):46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6394086</ArticleId><ArticleId IdType="pubmed">30819240</ArticleId></ArticleIdList></Reference><Reference><Citation>Goense L, van Rossum PSN, Weijs TJ, et al. Aortic calcification increases the risk of anastomotic leakage after Ivor-Lewis esophagectomy. Ann Thorac Surg. 2016;102(1):247&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooszen JAH, Goense L, Gisbertz SS, Ruurda JP, van Hillegersberg R, van Berge Henegouwen MI. Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer. Br J Surg. 2018;105(5):552&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5900725</ArticleId><ArticleId IdType="pubmed">29412450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall BR, Flores LE, Parshall ZS, Shostrom VK, Are C, Reames BN. Risk factors for anastomotic leak after esophagectomy for cancer: A NSQIP procedure-targeted analysis. J Surg Oncol. 2019;120(4):661&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">31292967</ArticleId></ArticleIdList></Reference><Reference><Citation>Harustiak T, Pazdro A, Snajdauf M, Stolz A, Lischke R. Anastomotic leak and stricture after hand-sewn versus linear-stapled intrathoracic oesophagogastric anastomosis: single-centre analysis of 415 oesophagectomies. Eur J Cardiothorac Surg. 2016;49(6):1650&#x2013;1659.</Citation><ArticleIdList><ArticleId IdType="pubmed">26574497</ArticleId></ArticleIdList></Reference><Reference><Citation>Harustiak T, Pazdro A, Snajdauf M, Stolz A, Lischke R. The Surgical Apgar Score in esophagectomy. J Thorac Cardiovasc Surg. 2015;150(4):806&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pubmed">26234458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassis ES, Kosinski AS, Ross P, Jr, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013;96(6):1919&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pubmed">24075499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathiravetpillai N, Koeter M, van der Sangen MJ, et al. Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma. Eur J Surg Oncol. 2016;42(8):1183&#x2013;1190.</Citation><ArticleIdList><ArticleId IdType="pubmed">27134188</ArticleId></ArticleIdList></Reference><Reference><Citation>Klevebro F, Elliott JA, Slaman A, et al. Cardiorespiratory comorbidity and postoperative complications following esophagectomy: a European multicenter cohort study. Ann Surg Oncol. 2019;26(9):2864&#x2013;2873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682565</ArticleId><ArticleId IdType="pubmed">31183640</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeter M, van der Sangen MJ, Hurkmans CW, Luyer MD, Rutten HJ, Nieuwenhuijzen GA. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy. Radiat Oncol. 2015;10:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4369843</ArticleId><ArticleId IdType="pubmed">25884226</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyanagi K, Ozawa S, Oguma J, et al. Blood flow speed of the gastric conduit assessed by indocyanine green fluorescence: New predictive evaluation of anastomotic leakage after esophagectomy. Medicine. 2016;95(30):e4386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5265869</ArticleId><ArticleId IdType="pubmed">27472732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruhlikava I, Kirkegard J, Mortensen FV, Kjaer DW. Impact of body mass index on complications and survival after surgery for esophageal and gastro-esophageal-junction cancer. Scand J Surg. 2017;106(4):305&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">28737095</ArticleId></ArticleIdList></Reference><Reference><Citation>Markar SR, Low DE. Physiology, not chronology, dictates outcomes after esophagectomy for esophageal cancer: outcomes in patients 80 years and older. Ann Surg Oncol. 2013;20(3):1020&#x2013;1026.</Citation><ArticleIdList><ArticleId IdType="pubmed">23117475</ArticleId></ArticleIdList></Reference><Reference><Citation>McBee PJ, Walters RW, Nandipati KC. Obesity is associated with significantly more anastomotic leaks after minimally invasive esophagectomy: a NSQIP database study. Ann Surg Oncol. 2020;27(9):3208&#x2013;3217.</Citation><ArticleIdList><ArticleId IdType="pubmed">32356272</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki Y, Toyokawa T, Kubo N, et al. C-reactive protein indicates early stage of postoperative infectious complications in patients following minimally invasive esophagectomy. World J Surg. 2017;41(3):796&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">27878351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitzman B, Schipper PH, Edwards MA, Kim S, Ferguson MK. Complications after esophagectomy are associated with extremes of body mass index. Ann Thorac Surg. 2018;106(4):973&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">29936024</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyawaki Y, Sato H, Fujiwara N, Sugita H, et al. Evaluation of the Associations between Gastric Tube Preparation Methods and the Incidence of Cervical Anastomotic Leakage after Esophagectomy for Thoracic Esophageal Cancer. Vol 37. Switzerland (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">30939466</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy CC, Incalcaterra JR, Albright HW, Correa AM, Swisher SG, Hofstetter WL. Pretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center. J Oncol Pract. 2013;9(5):233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">23943906</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura A, Watanabe M, Mine S, Nishida K, Kurogochi T, Imamura Y. Spirometric lung age predicts postoperative pneumonia after esophagectomy. World J Surg. 2016;40(10):2412&#x2013;2418.</Citation><ArticleIdList><ArticleId IdType="pubmed">27146051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutegard M, Lagergren P, Johar A, Lagergren J. Time shift in early postoperative mortality after oesophagectomy for cancer. Ann Surg Oncol. 2015;22(9):3144&#x2013;3149.</Citation><ArticleIdList><ArticleId IdType="pubmed">25649859</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutegard M, Lagergren P, Rouvelas I, Lagergren J. Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study. Ann Surg Oncol. 2012;19(1):99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">21769467</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Tanaka K, Ebihara Y, et al. Novel prognostic score of postoperative complications after transthoracic minimally invasive esophagectomy for esophageal cancer: a retrospective cohort study of 90 consecutive patients. Esophagus. 2019;16(2):155&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">30178429</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem AI, Thau MR, Strom TJ, et al. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center. Dis Esophag. 2017;30(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149640</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Nakatani E, Higashizono K, Nagai E, et al. Size of the thoracic inlet predicts cervical anastomotic leak after retrosternal reconstruction after esophagectomy for esophageal cancer. Surgery. 2020;168(3):558&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">32611514</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpa M, Filip B, Cavallin F, et al. Esophagectomy in elderly patients: which is the best prognostic score? Dis Esophag. 2016;29(6):589&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pubmed">25873285</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlottmann F, Strassle PD, Nayyar A, Herbella FAM, Cairns BA, Patti MG. Postoperative outcomes of esophagectomy for cancer in elderly patients. J Surg Res. 2018;229:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">29937021</ArticleId></ArticleIdList></Reference><Reference><Citation>Shichinohe T, Uemura S, Hirano S, Hosokawa M. Impact of preoperative skeletal muscle mass and nutritional status on short-and long-term outcomes after esophagectomy for esophageal cancer: a retrospective observational study: impact of psoas muscle mass and body mass on esophagectomy. Ann Surg Oncol. 2019;26(5):1301&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">30725311</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260(2):259&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">24743609</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Werf LR, Dikken JL, van der Willik EM, van Berge Henegouwen MI, Nieuwenhuijzen GAP, Wijnhoven BPL. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: a nationwide study. Eur J Cancer. 2018;91:76&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">29353163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Liu G, Wei S, Liu H. Short- and long-term outcomes of minimally invasive esophagectomy in elderly patients with esophageal squamous cell carcinoma. J BUON. 2017;22(6):1540&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pubmed">29332350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Deeb AP, Iannuzzi JC, Rickles AS, Monson JR, Fleming FJ. Tobacco smoking and postoperative outcomes after colorectal surgery. Ann Surg. 2013;258(2):296&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">23059503</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheingraber S, Dobbert D, Schmiedel P, Seliger E, Dralle H. Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery. Surg Today. 2005;35(10):846&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">16175466</ArticleId></ArticleIdList></Reference><Reference><Citation>Goense L, Meziani J, Ruurda JP, van Hillegersberg R. Impact of postoperative complications on outcomes after oesophagectomy for cancer. Br J Surg. 2019;106(1):111&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">30370938</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SJ, Wang ZQ, Li YJ, et al. Diabetes mellitus and risk of anastomotic leakage after esophagectomy: a systematic review and meta-analysis. Dis Esophag. 2017;30(6):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">28475743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ri M, Aikou S, Seto Y. Obesity as a surgical risk factor. Ann Gastroenterol Surg. 2018;2(1):13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881295</ArticleId><ArticleId IdType="pubmed">29863119</ArticleId></ArticleIdList></Reference><Reference><Citation>Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234(3):360&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1422027</ArticleId><ArticleId IdType="pubmed">11524589</ArticleId></ArticleIdList></Reference><Reference><Citation>Goense L, van Dijk WA, Govaert JA, van Rossum PS, Ruurda JP, van Hillegersberg R. Hospital costs of complications after esophagectomy for cancer. Eur J Surg Oncol. 2017;43(4):696&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">28012715</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang ZD, Gu HY, Zhu J, et al. The application of enhanced recovery after surgery for upper gastrointestinal surgery: meta-analysis. BMC Surg. 2020;20(1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942370</ArticleId><ArticleId IdType="pubmed">31900149</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppedal K, M&#xf8;ller AM, Pedersen B, T&#xf8;nnesen H. Preoperative alcohol cessation prior to elective surgery. Cochrane Database Syst Rev. 2012(7):Cd008343.</Citation><ArticleIdList><ArticleId IdType="pubmed">22786514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungqvist O, de Boer HD, Balfour A, et al. Opportunities and challenges for the next phase of Enhanced Recovery after surgery: a review. JAMA Surg. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33881466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevo Y, Arjah S, Katz A, et al. ERAS 2.0: Continued refinement of an established enhanced recovery protocol for esophagectomy. Ann Surg Oncol. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33774774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H, Xu J, You J, Qin H, Ma H. Effects of enteral nutrition support combined with enhanced recovery after surgery on the nutritional status, immune function, and prognosis of patients with esophageal cancer after Ivor-Lewis operation. J Thorac Dis. 2020;12(12):7337&#x2013;7345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797812</ArticleId><ArticleId IdType="pubmed">33447423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai A, Suehiro K, Watanabe R, et al. Impact of intraoperative goal-directed fluid therapy on major morbidity and mortality after transthoracic oesophagectomy: a multicentre, randomised controlled trial. Br J Anaesth. 2020;125(6):953&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pubmed">33092805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka K, Takeuchi H, Mizusawa J, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg. 2017;265(6):1152&#x2013;1157.</Citation><ArticleIdList><ArticleId IdType="pubmed">27280509</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogura M, Takeuchi H, Kawakubo H, et al. Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma. Surgery. 2013;154(3):512&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">23972657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedenne L, Michel P, Bouch&#xe9; O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pubmed">17401004</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23(10):2310&#x2013;2317.</Citation><ArticleIdList><ArticleId IdType="pubmed">15800321</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger JC, Loughney L, Tully R, et al. Perioperative prehabilitation and rehabilitation in esophagogastric malignancies: a systematic review. Dis Esophagus. 2019;32(9).</Citation><ArticleIdList><ArticleId IdType="pubmed">31206582</ArticleId></ArticleIdList></Reference><Reference><Citation>Argudo N, Rod&#xf3;-Pin A, Mart&#xed;nez-Llorens J, et al. Feasibility, tolerability, and effects of exercise-based prehabilitation after neoadjuvant therapy in esophagogastric cancer patients undergoing surgery: an interventional pilot study. Dis Esophagus. 2021;34(4).</Citation><ArticleIdList><ArticleId IdType="pubmed">32940327</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeters P, Bozzetti F, Cynober L, Elia M, Shenkin A, Sobotka L. Meta-analysis is not enough: the critical role of pathophysiology in determining optimal care in clinical nutrition. Clin Nutr. 2016;35(3):748&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pubmed">26615913</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenhagen E, van Vulpen JK, van Hillegersberg R, May AM, Siersema PD. Nutrition in peri-operative esophageal cancer management. Expert Rev Gastroenterol Hepatol. 2017;11(7):663&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pubmed">28454509</ArticleId></ArticleIdList></Reference><Reference><Citation>Weenk M, Koeneman M, van de Belt TH, Engelen L, van Goor H, Bredie SJH. Wireless and continuous monitoring of vital signs in patients at the general ward. Resuscitation. 2019;136:47&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">30685546</ArticleId></ArticleIdList></Reference><Reference><Citation>Downey C, Randell R, Brown J, Jayne DG. Continuous versus intermittent vital signs monitoring using a wearable, wireless patch in patients admitted to surgical wards: pilot cluster randomized controlled trial. J Med Internet Res. 2018;20(12):e10802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6305881</ArticleId><ArticleId IdType="pubmed">30538086</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck N, van Bommel AC, Eddes EH, van Leersum NJ, Tollenaar RA, Wouters MW. The Dutch Institute for Clinical Auditing: achieving Codman's dream on a nationwide basis. Ann Surg. 2020;271(4):627&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">31972639</ArticleId></ArticleIdList></Reference><Reference><Citation>Busweiler LA, Wijnhoven BP, van Berge Henegouwen MI, et al. Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit. Br J Surg. 2016;103(13):1855&#x2013;1863.</Citation><ArticleIdList><ArticleId IdType="pubmed">27704530</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Hayden JA, Steyerberg EW, et al. Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med. 2013;10(2):e1001380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3564757</ArticleId><ArticleId IdType="pubmed">23393429</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Kievit J, de Mol Van Otterloo JC, van Bockel JH, Eijkemans MJ, Habbema JD. Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data. Arch Intern Med. 1995;155(18):1998&#x2013;2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">7575054</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34330644</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-2574</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>HPB : the official journal of the International Hepato Pancreato Biliary Association</Title><ISOAbbreviation>HPB (Oxford)</ISOAbbreviation></Journal><ArticleTitle>Pushing the limit of liver regeneration - Safety and survival after monosegment-ALPPS: systematic review and individual patient data meta-analysis.</ArticleTitle><Pagination><StartPage>353</StartPage><EndPage>358</EndPage><MedlinePgn>353-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hpb.2021.06.427</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1365-182X(21)00609-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has expanded and spearheaded development in hepatobiliary surgery. Monosegment-ALPPS tests liver regeneration limits and may present as the last feasible curative treatment option.</AbstractText><AbstractText Label="METHODS">Electronic databases (MEDLINE, Web of Science, Google Scholar, Cochrane Library and WHO International Clinical Trials Registry Platform) were searched for publications on mono-ALPPS using a predefined strategy without date or language restrictions. Individual patient data was extracted and analyzed.</AbstractText><AbstractText Label="RESULTS">237 publications were identified. 19 patients were identified to have undergone mono-ALPPS. Primarily, mono-ALPPS has been utilized as curative treatment for CRLM (17 of 19 cases). Successful mono-ALPPS was possible in FLR above 8% SLV. All patients received either chemotherapy alone or in combination with radiotherapy prior to surgery. 8 of 19 patients experienced PHLF grade A or B. There was no in-hospital mortality described. Recurrent disease has occurred in 7 of 19 patients and 3 have died during follow-up.</AbstractText><AbstractText Label="CONCLUSION">Mono-ALPPS is an experimental procedure that provides a reasonably safe opportunity to curatively treat extensive liver malignancies in patients with FLR as low as 8% SLV. PHLF is the most prevalent complication in mono-ALPPS. Mono-ALPPS should be evaluated in a multicentral study setting.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murtha-Lemekhova</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplantation Surgery, Ruprecht Karl University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Juri</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplantation Surgery, Ruprecht Karl University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplantation Surgery, Ruprecht Karl University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterkenburg</LastName><ForeName>Anthe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplantation Surgery, Ruprecht Karl University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Probst</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplantation Surgery, Ruprecht Karl University, Heidelberg, Germany; Study Center of the German Surgical Society (SDGC), Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplantation Surgery, Ruprecht Karl University, Heidelberg, Germany. Electronic address: katrin.hoffmann@med.uni-heidelberg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>HPB (Oxford)</MedlineTA><NlmUniqueID>100900921</NlmUniqueID><ISSNLinking>1365-182X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006498" MajorTopicYN="N">Hepatectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008026" MajorTopicYN="N">Ligation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="Y">Liver Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008115" MajorTopicYN="Y">Liver Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011169" MajorTopicYN="N">Portal Vein</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34330644</ArticleId><ArticleId IdType="doi">10.1016/j.hpb.2021.06.427</ArticleId><ArticleId IdType="pii">S1365-182X(21)00609-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26385669</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative hospital mortality at a tertiary paediatric institution.</ArticleTitle><Pagination><StartPage>608</StartPage><EndPage>615</EndPage><MedlinePgn>608-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aev286</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Research in postoperative mortality is scarce. Insight into mortality and cause of death might improve and innovate perioperative care. The objective for this study was to report the 24-hour and 30-day overall, and surgery and anaesthesia-related, in-hospital mortality at a tertiary paediatric hospital.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients &lt;18 yr old who underwent anaesthesia with or without surgery between January 1, 2006, and December 31, 2012, at the Wilhelmina Children's Hospital, Utrecht, The Netherlands, were included in this retrospective cohort study. Causes of death within 30 days were identified and tabulated into four major categories according to principal cause.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 45,182 anaesthetics were administered during this 7-yr period. The all-cause 24-hour hospital mortality was 13.1 per 10,000 anaesthetics (95% CI: 9.9-16.8) and the all-cause 30-day in-hospital mortality was 41.6 per 10,000 anaesthetics (95% CI: 35.9-48.0). In total five patients were partially contributable to anaesthesia (30-day mortality: 1.1/10,000, 95% CI: 0.4-2.6) and four patients were partially contributable to surgery (30-day mortality: 0.9/10,000, 95% CI: 0.2-2.3). Mortality was higher in neonates and infants, children with ASA physical status III and IV, and emergency- and cardiothoracic surgery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Neonates and infants, children with ASA physical status III or poorer, and emergency- and cardiothoracic surgery are associated with a higher postoperative mortality. Anaesthesia- or surgery-related complications contribute to mortality in only a small amount of the deaths, indicating the relative safety of paediatric surgical and anaesthetic procedures.</AbstractText><CopyrightInformation>&#xa9; The Author 2015. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Bruin</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands Present affiliation: Department of Surgery, Amstelland Hospital, Amstelveen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasma</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Werff</LastName><ForeName>D B M</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schouten</LastName><ForeName>T A N J</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haas</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Paediatric Cardiothoracic Surgery, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Zee</LastName><ForeName>D C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Wolfswinkel</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Graaff</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands Brain Center Rudolph Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands j.c.degraaff-2@umcutrecht.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006776" MajorTopicYN="N">Hospitals, Pediatric</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">child mortality</Keyword><Keyword MajorTopicYN="N">hospital mortality</Keyword><Keyword MajorTopicYN="N">infants, paediatrics, surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26385669</ArticleId><ArticleId IdType="doi">10.1093/bja/aev286</ArticleId><ArticleId IdType="pii">S0007-0912(17)31121-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17137805</PMID><DateCompleted><Year>2007</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-5884</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2007</Year><Month>Mar</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Relation between hospital volume and outcome of elective surgery for abdominal aortic aneurysm: a systematic review.</ArticleTitle><Pagination><StartPage>285</StartPage><EndPage>292</EndPage><MedlinePgn>285-92</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Our aim was to analyse the relation between hospital volume and peri-operative mortality in abdominal aortic aneurysm surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">The Medline, Embase and Cochrane databases were searched to identify all population based studies reporting on the volume outcome relationship published between 1966 and 2006. Two independent observers performed methodological quality assessment and data extraction. Outcome was 30-day or in-hospital mortality in relation to hospital volume.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four articles were included. Overall peri-operative mortality ranged from 2.3 to 9.9%. The cut-off values for a high- or low-volume hospital appeared to range from 8 to 50 operations annually. The peri-operative mortality in low volume hospitals (LVH) ranged from 3.0 to 13.8% (median 6.2%) and from 1.8 to 7.4% in high volume hospitals (HVH) (median 4.3%). In 14 studies a significantly lower mortality was found in HVH as opposed to LVH; in 10 articles no such difference between HVH and LVH could be proved.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We found some evidence for a relation between the volume of AAA surgery and peri-operative mortality. There seems to be a nonsignificant trend in favour of high volume hospitals. However we could not derive an unequivocal volume threshold for safely performing AAA surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Henebiens</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hilversum Hospital, Hilversum, The Netherlands. mkoelemay@tergooiziekenhuizen.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Broek</LastName><ForeName>Th A A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>Vahl</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Koelemay</LastName><ForeName>M J W</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2007 Sep;34(3):379-80. doi: 10.1016/j.ejvs.2007.04.021.</RefSource><PMID Version="1">17574880</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011787" MajorTopicYN="N">Quality of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>48</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>12</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>4</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>12</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17137805</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2006.10.010</ArticleId><ArticleId IdType="pii">S1078-5884(06)00586-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29457334</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>Establishing a successful perioperative geriatric service in an Australian acute surgical unit.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>611</EndPage><MedlinePgn>607-611</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.14411</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this study was to assess the impact of a perioperative geriatric service (PGS) in an acute surgical unit (ASU) on patient and organizational outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Single centre retrospective cohort study. Inclusion criteria were patients over the age of 65 admitted to the ASU between January and June 2014 (pre-PGS) and 2015 (post-PGS). Chart reviews were performed to identify outcomes of interest including in-hospital morbidity and mortality, length of stay (LOS), 30-day representation and mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Geriatric admissions increased by 32% over the two study periods (154 pre-PGS and 203 post-PGS). Surgical intervention increased by 11% (P = 0.01). Significantly more medical complications (14% versus 33%, P &lt; 0.001) were identified after the implementation of the PGS. Recognition of delirium in the over 80s also increased by 57%. Rate of surgical complications was unchanged over the study (28% pre-PGS and 34% post-PGS, P = 0.6). In-hospital (&lt;1%, P = 0.5) and 30-day mortality (&lt;1%, P = 0.6) remained low, as did 30-day representation (10% versus 8%, P = 0.5). A trend towards decreased LOS of 1 day was identified after the implementation of the PGS (P = 0.07).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study demonstrated successful implementation of a PGS into an ASU. This multi-disciplinary approach has been effective in maintaining low numbers of surgical complications, in-hospital mortality, LOS and patient representations despite an increased number of medical complications. This likely reflects more timely recognition and intervention of medically unwell patients with the PGS.</AbstractText><CopyrightInformation>&#xa9; 2018 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Styan</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Surgery, Logan Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Griffith University, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Skyle</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0696-8501</Identifier><AffiliationInfo><Affiliation>Division of Surgery, Logan Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Griffith University, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleury</LastName><ForeName>Aisling</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Surgery, Logan Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Griffith University, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGowan</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Surgery, Logan Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wullschleger</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Surgery, Logan Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Griffith University, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005853" MajorTopicYN="N">Geriatrics</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009936" MajorTopicYN="N">Organizational Innovation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016730" MajorTopicYN="N">Program Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011793" MajorTopicYN="N" Type="Geographic">Queensland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013043" MajorTopicYN="N">Specialties, Surgical</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013503" MajorTopicYN="N">Surgery Department, Hospital</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute surgical unit</Keyword><Keyword MajorTopicYN="N">general surgery</Keyword><Keyword MajorTopicYN="N">geriatric</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29457334</ArticleId><ArticleId IdType="doi">10.1111/ans.14411</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27927246</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7819</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>World journal of surgical oncology</Title><ISOAbbreviation>World J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis.</ArticleTitle><Pagination><StartPage>304</StartPage><MedlinePgn>304</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">304</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Open esophagectomy (OE) is associated with significant morbidity and mortality. Minimally invasive oesophagectomy (MIO) reduces complications in resectable esophageal cancer. The aim of this study is to explore the superiority of MIO in reducing complications and in-hospital mortality than OE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Embase, Science Citation Index, Wanfang, and Wiley Online Library were thoroughly searched. Odds ratio (OR)/weighted mean difference (WMD) with a 95% confidence interval (CI) was used to assess the strength of association.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-seven studies containing 15,790 cases of resectable esophageal cancer were included. MIO had less intraoperative blood loss, short hospital stay, and high operative time (P&#x2009;&lt;&#x2009;0.05) than OE. MIO also had reduced incidence of total complications; (OR&#x2009;=&#x2009;0.700, 95% CI&#x2009;=&#x2009;0.626&#x2009;~&#x2009;0.781, P <sub>V</sub> &#x2009;&lt;&#x2009;0.05), pulmonary complications (OR&#x2009;=&#x2009;0.527, 95% CI&#x2009;=&#x2009;0431&#x2009;~&#x2009;0.645, P <sub>V</sub> &#x2009;&lt;&#x2009;0.05), cardiovascular complications (OR&#x2009;=&#x2009;0.770, 95% CI&#x2009;=&#x2009;0.681&#x2009;~&#x2009;0.872, P <sub>V</sub> &#x2009;&lt;&#x2009;0.05), and surgical technology related (STR) complications (OR&#x2009;=&#x2009;0.639, 95% CI&#x2009;=&#x2009;0.522&#x2009;~&#x2009;0.781, P <sub>V</sub> &#x2009;&lt;&#x2009;0.05), as well as lower in-hospital mortality (OR&#x2009;=&#x2009;0.668, 95% CI&#x2009;=&#x2009;0.539&#x2009;~&#x2009;0.827, P <sub>V</sub> &#x2009;&lt;&#x2009;0.05). However, the number of harvested lymph nodes, intensive care unit (ICU) stay, gastrointestinal complications, anastomotic leak (AL), and recurrent laryngeal nerve palsy (RLNP) had no significant difference.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MIO is superior to OE in terms of perioperative complications and in-hospital mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yibulayin</LastName><ForeName>Waresijiang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Tumor Hospital of Xinjiang Medical University, Urumqi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abulizi</LastName><ForeName>Sikandaer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Tumor Hospital of Xinjiang Medical University, Urumqi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Tumor Hospital of Xinjiang Medical University, Urumqi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Tumor Hospital of Xinjiang Medical University, Urumqi, China. yuan2559052@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Surg Oncol</MedlineTA><NlmUniqueID>101170544</NlmUniqueID><ISSNLinking>1477-7819</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Minimally invasive esophagectomy</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Open esophagectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27927246</ArticleId><ArticleId IdType="pmc">PMC5143462</ArticleId><ArticleId IdType="doi">10.1186/s12957-016-1062-7</ArticleId><ArticleId IdType="pii">10.1186/s12957-016-1062-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69&#x2013;90. doi: 10.3322/caac.20107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.20107</ArticleId><ArticleId IdType="pubmed">21296855</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33&#x2013;64. doi: 10.3322/canjclin.49.1.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/canjclin.49.1.33</ArticleId><ArticleId IdType="pubmed">10200776</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweigert M, Dubecz A, Stadlhuber RJ, Muschweck H, Stein HJ. Treatment of intrathoracic esophageal anastomotic leaks by means of endoscopic stent implantation. Interact Cardiovasc Thorac Surg. 2011;12:147&#x2013;151. doi: 10.1510/icvts.2010.247866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.247866</ArticleId><ArticleId IdType="pubmed">21106566</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M, Nakanoko T, Fujinaka Y, Kubo N, Yamashita N, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Shirabe K, Maehara Y. In-hospital mortality after a surgical resection for esophageal cancer: analyses of the associated factors and historical changes. Ann Surg Oncol. 2011;18:1757&#x2013;1765. doi: 10.1245/s10434-010-1502-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-010-1502-5</ArticleId><ArticleId IdType="pubmed">21207167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, Ten KF, van Dekken H, Obertop H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662&#x2013;1669. doi: 10.1056/NEJMoa022343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022343</ArticleId><ArticleId IdType="pubmed">12444180</ArticleId></ArticleIdList></Reference><Reference><Citation>Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernando HC. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360107</ArticleId><ArticleId IdType="pubmed">14530720</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimick JB, Staiger DO, Birkmeyer JD. Are mortality rates for different operations related?: implications for measuring the quality of noncardiac surgery. Med Care. 2006;44:774&#x2013;778. doi: 10.1097/01.mlr.0000215898.33228.c7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000215898.33228.c7</ArticleId><ArticleId IdType="pmc">PMC2121187</ArticleId><ArticleId IdType="pubmed">16862040</ArticleId></ArticleIdList></Reference><Reference><Citation>Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381&#x2013;390. doi: 10.1002/bjs.1800670602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.1800670602</ArticleId><ArticleId IdType="pubmed">6155968</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppo T, Jobe BA, Hunter JG. Minimally invasive esophagectomy: The evolution and technique of minimally invasive surgery for esophageal cancer. World J Surg. 2011;35:1454&#x2013;63. doi: 10.1007/s00268-011-1049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-011-1049-z</ArticleId><ArticleId IdType="pubmed">21409606</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Weber JM, Karl RC, Meredith KL. Minimally invasive surgery for esophageal cancer: review of the literature and institutional experience. Cancer Control. 2013;20:130&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">23571703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkaria IS, Rizk NP. Robotic-assisted minimally invasive esophagectomy: the Ivor Lewis approach. Thorac Surg Clin. 2014;24:211&#x2013;222. doi: 10.1016/j.thorsurg.2014.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thorsurg.2014.02.010</ArticleId><ArticleId IdType="pubmed">24780426</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Journo XB, Thomas PA. Current management of esophageal cancer. J Thorac Dis. 2014;6(Suppl 2):S253&#x2013;S264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4032955</ArticleId><ArticleId IdType="pubmed">24868443</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhamija A, Dhamija A, Hancock J, McCloskey B, Kim AW, Detterbeck FC, Boffa DJ. Minimally invasive oesophagectomy more expensive than open despite shorter length of stay. Eur J Cardiothorac Surg. 2014;45:904&#x2013;909. doi: 10.1093/ejcts/ezt482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt482</ArticleId><ArticleId IdType="pubmed">24092502</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhage RJ, Hazebroek EJ, Boone J, Van Hillegersberg R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir. 2009;64:135&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">19365314</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Ma X, Yang S, Zhu X, Qin W, Xiang J, Lerut T, Li H. Combined thoracoscopic-laparoscopic esophagectomy versus open esophagectomy: a meta-analysis of outcomes. Surg Endosc. 2016;18(9):5&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26659248</ArticleId></ArticleIdList></Reference><Reference><Citation>Markar SR, Arya S, Karthikesalingam A, Hanna GB. Technical factors that affect anastomotic integrity following esophagectomy: systematic review and meta-analysis. Ann Surg Oncol. 2013;20:4274&#x2013;4281. doi: 10.1245/s10434-013-3189-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-013-3189-x</ArticleId><ArticleId IdType="pubmed">23943033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Ma G, Li X, Li J, Yan Y, Liu P, He J, Ren Y. Is minimally invasive esophagectomy effective for preventing anastomotic leakages after esophagectomy for cancer?A systematic review and meta-analysis. World J Surg Oncol. 2015;13:269. doi: 10.1186/s12957-015-0661-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12957-015-0661-z</ArticleId><ArticleId IdType="pmc">PMC4560054</ArticleId><ArticleId IdType="pubmed">26338060</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemmill EH, McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg. 2007;94:1461&#x2013;1467. doi: 10.1002/bjs.6015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.6015</ArticleId><ArticleId IdType="pubmed">17973268</ArticleId></ArticleIdList></Reference><Reference><Citation>Biere SS, Cuesta MA, van der Peet DL. Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis. Minerva Chir. 2009;64:121&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">19365313</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagpal K, Ahmed K, Vats A, Yakoub D, James D, Ashrafian H, Darzi A, Moorthy K, Athanasiou T. Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc. 2010;24:1621&#x2013;1629. doi: 10.1007/s00464-009-0822-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-009-0822-7</ArticleId><ArticleId IdType="pubmed">20108155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgourakis G, Gockel I, Radtke A, Musholt TJ, Timm S, Rink A, Tsiamis A, Karaliotas C, Lang H. Minimally invasive versus open esophagectomy: meta-analysis of outcomes. Dig Dis Sci. 2010;55:3031&#x2013;3040. doi: 10.1007/s10620-010-1153-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-010-1153-1</ArticleId><ArticleId IdType="pubmed">20186484</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler N, Collins S, Memon B, Memon MA. Minimally invasive oesophagectomy: current status and future direction. Surg Endosc. 2011;25:2071&#x2013;2083. doi: 10.1007/s00464-010-1511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-010-1511-2</ArticleId><ArticleId IdType="pubmed">21298548</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantoc MM, Cox MR, Eslick GD. Does minimally invasive esophagectomy (MIE) provide for comparable oncologic outcomes to open techniques? A systematic review. J Gastrointest Surg. 2012;16:486&#x2013;494. doi: 10.1007/s11605-011-1792-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-011-1792-3</ArticleId><ArticleId IdType="pubmed">22183862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Zhang L, Wang H, Ma X, Shi B, Chen W, He J, Wang K, Liu P, Ren Y. Superiority of minimally invasive oesophagectomy in reducing in-hospital mortality of patients with resectable oesophageal cancer: a meta-analysis. PLoS One. 2015;10:e132889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4509855</ArticleId><ArticleId IdType="pubmed">26196135</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantoc M, Cox MR, Eslick GD. Evidence to support the use of minimally invasive esophagectomy for esophageal cancer: a meta-analysis. Arch Surg. 2012;147:768&#x2013;776. doi: 10.1001/archsurg.2012.1326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2012.1326</ArticleId><ArticleId IdType="pubmed">22911078</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumer E, Perry K, Melvin WS. Minimally invasive esophagectomy for esophageal cancer: evolution and review. Surg Laparosc Endosc Percutan Tech. 2012;22:383&#x2013;386. doi: 10.1097/SLE.0b013e31826295a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0b013e31826295a4</ArticleId><ArticleId IdType="pubmed">23047377</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Baba Y, Nagai Y, Baba H. Minimally invasive esophagectomy for esophageal cancer: an updated review. Surg Today. 2013;43:237&#x2013;244. doi: 10.1007/s00595-012-0300-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-012-0300-z</ArticleId><ArticleId IdType="pubmed">22926551</ArticleId></ArticleIdList></Reference><Reference><Citation>Uttley L, Campbell F, Rhodes M, Cantrell A, Stegenga H, Lloyd-Jones M. Minimally invasive oesophagectomy versus open surgery: is there an advantage? Surg Endosc. 2013;27:724&#x2013;731. doi: 10.1007/s00464-012-2546-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-012-2546-3</ArticleId><ArticleId IdType="pubmed">23052523</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs M, Macefield RC, Elbers RG, Sitnikova K, Korfage IJ, Smets EM, Henselmans I, van Berge HM, de Haes JC, Blazeby JM, Sprangers MA. Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery. Qual Life Res. 2014;23:1097&#x2013;1115. doi: 10.1007/s11136-013-0545-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-013-0545-z</ArticleId><ArticleId IdType="pubmed">24129668</ArticleId></ArticleIdList></Reference><Reference><Citation>Biere SS, van Berge HM, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887&#x2013;1892. doi: 10.1016/S0140-6736(12)60516-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60516-9</ArticleId><ArticleId IdType="pubmed">22552194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">13655060</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654&#x2013;2664. doi: 10.1001/jama.298.22.2654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.22.2654</ArticleId><ArticleId IdType="pubmed">18073361</ArticleId></ArticleIdList></Reference><Reference><Citation>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studiesinmeta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 2 Dec 2016.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Follette DM, Wolfe BM, Schneider PD, Roberts P, Goodnight JJ. Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg. 2000;135:920&#x2013;925. doi: 10.1001/archsurg.135.8.920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.135.8.920</ArticleId><ArticleId IdType="pubmed">10922253</ArticleId></ArticleIdList></Reference><Reference><Citation>Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H. A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg. 2003;90:108&#x2013;113. doi: 10.1002/bjs.4022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.4022</ArticleId><ArticleId IdType="pubmed">12520585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunisaki C, Hatori S, Imada T, Akiyama H, Ono H, Otsuka Y, Matsuda G, Nomura M, Shimada H. Video-assisted thoracoscopic esophagectomy with a voice-controlled robot: the AESOP system. Surg Laparosc Endosc Percutan Tech. 2004;14:323&#x2013;327. doi: 10.1097/01.sle.0000148468.74546.9a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sle.0000148468.74546.9a</ArticleId><ArticleId IdType="pubmed">15599295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernabe KQ, Bolton JS, Richardson WS. Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case&#x2013;control study. Surg Endosc. 2005;19:334&#x2013;337. doi: 10.1007/s00464-004-8807-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-004-8807-z</ArticleId><ArticleId IdType="pubmed">15959707</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Broek WT, Makay O, Berends FJ, Yuan JZ, Houdijk AP, Meijer S, Cuesta MA. Laparoscopically assisted transhiatal resection for malignancies of the distal esophagus. Surg Endosc. 2004;18:812&#x2013;817. doi: 10.1007/s00464-003-9173-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-003-9173-y</ArticleId><ArticleId IdType="pubmed">15216864</ArticleId></ArticleIdList></Reference><Reference><Citation>Braghetto I, Csendes A, Cardemil G, Burdiles P, Korn O, Valladares H. Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc. 2006;20:1681&#x2013;1686. doi: 10.1007/s00464-006-0009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-006-0009-4</ArticleId><ArticleId IdType="pubmed">16960662</ArticleId></ArticleIdList></Reference><Reference><Citation>Bresadola V, Terrosu G, Cojutti A, Benzoni E, Baracchini E, Bresadola F. Laparoscopic versus open gastroplasty in esophagectomy for esophageal cancer: a comparative study. Surg Laparosc Endosc Percutan Tech. 2006;16:63&#x2013;67. doi: 10.1097/00129689-200604000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00129689-200604000-00001</ArticleId><ArticleId IdType="pubmed">16773002</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiraishi T, Kawahara K, Shirakusa T, Yamamoto S, Maekawa T. Risk analysis in resection of thoracic esophageal cancer in the era of endoscopic surgery. Ann Thorac Surg. 2006;81:1083&#x2013;1089. doi: 10.1016/j.athoracsur.2005.08.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.08.057</ArticleId><ArticleId IdType="pubmed">16488728</ArticleId></ArticleIdList></Reference><Reference><Citation>Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007;245:232&#x2013;240. doi: 10.1097/01.sla.0000225093.58071.c6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000225093.58071.c6</ArticleId><ArticleId IdType="pmc">PMC1876975</ArticleId><ArticleId IdType="pubmed">17245176</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzoni E, Terrosu G, Bresadola V, Uzzau A, Intini S, Noce L, Cedolini C, Bresadola F, De Anna D. A comparative study of the transhiatal laparoscopic approach versus laparoscopic gastric mobilisation and right open transthoracic esophagectomy for esophageal cancer management. J Gastrointestin Liver Dis. 2007;16:395&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">18193121</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabian T, Martin JT, McKelvey AA, Federico JA. Minimally invasive esophagectomy: a teaching hospital's first year experience. Dis Esophagus. 2008;21:220&#x2013;225. doi: 10.1111/j.1442-2050.2007.00783.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2050.2007.00783.x</ArticleId><ArticleId IdType="pubmed">18430102</ArticleId></ArticleIdList></Reference><Reference><Citation>Parameswaran R, Veeramootoo D, Krishnadas R, Cooper M, Berrisford R, Wajed S. Comparative experience of open and minimally invasive esophagogastric resection. World J Surg. 2009;33:1868&#x2013;1875. doi: 10.1007/s00268-009-0116-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-009-0116-1</ArticleId><ArticleId IdType="pubmed">19609827</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha AK, Sutton CD, Sue-Ling H, Dexter SP, Sarela AI. Comparison of oncological outcomes after laparoscopic transhiatal and open esophagectomy for T1 esophageal adenocarcinoma. Surg Endosc. 2009;23:119&#x2013;124. doi: 10.1007/s00464-008-0065-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-008-0065-z</ArticleId><ArticleId IdType="pubmed">18626700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingg U, McQuinn A, DiValentino D, Esterman AJ, Bessell JR, Thompson SK, Jamieson GG, Watson DI. Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg. 2009;87:911&#x2013;919. doi: 10.1016/j.athoracsur.2008.11.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.11.060</ArticleId><ArticleId IdType="pubmed">19231418</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham TH, Perry KA, Dolan JP, Schipper P, Sukumar M, Sheppard BC, Hunter JG. Comparison of perioperative outcomes after combined thoracoscopic-laparoscopic esophagectomy and open Ivor-Lewis esophagectomy. Am J Surg. 2010;199:594&#x2013;598. doi: 10.1016/j.amjsurg.2010.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.01.005</ArticleId><ArticleId IdType="pubmed">20466101</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry KA, Enestvedt CK, Pham T, Welker M, Jobe BA, Hunter JG, Sheppard BC. Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage I esophageal adenocarcinoma. Arch Surg. 2009;144:679&#x2013;684. doi: 10.1001/archsurg.2009.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2009.113</ArticleId><ArticleId IdType="pubmed">19620549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamouda AH, Forshaw MJ, Tsigritis K, Jones GE, Noorani AS, Rohatgi A, Botha AJ. Perioperative outcomes after transition from conventional to minimally invasive Ivor-Lewis esophagectomy in a specialized center. Surg Endosc. 2010;24:865&#x2013;869. doi: 10.1007/s00464-009-0679-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-009-0679-9</ArticleId><ArticleId IdType="pubmed">19730947</ArticleId></ArticleIdList></Reference><Reference><Citation>Safranek PM, Cubitt J, Booth MI, Dehn TC. Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg. 2010;97:1845&#x2013;1853. doi: 10.1002/bjs.7231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.7231</ArticleId><ArticleId IdType="pubmed">20922782</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoppmann SF, Prager G, Langer FB, Riegler FM, Kabon B, Fleischmann E, Zacherl J. Open versus minimally invasive esophagectomy: a single-center case controlled study. Surg Endosc. 2010;24:3044&#x2013;3053. doi: 10.1007/s00464-010-1083-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-010-1083-1</ArticleId><ArticleId IdType="pubmed">20464423</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder W, Holscher AH, Bludau M, Vallbohmer D, Bollschweiler E, Gutschow C. Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg. 2010;34:738&#x2013;743. doi: 10.1007/s00268-010-0403-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-010-0403-x</ArticleId><ArticleId IdType="pubmed">20098986</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, et al. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus. 2011;24:147&#x2013;152. doi: 10.1111/j.1442-2050.2010.01113.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2050.2010.01113.x</ArticleId><ArticleId IdType="pubmed">21040152</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger AC, Bloomenthal A, Weksler B, Evans N, Chojnacki KA, Yeo CJ, Rosato EL. Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy. J Am Coll Surg. 2011;212:560&#x2013;566. doi: 10.1016/j.jamcollsurg.2010.12.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.12.042</ArticleId><ArticleId IdType="pubmed">21463789</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Cheng JW, Lin MT, Huang PM, Chen JS, Lee YC. Is there any benefit to incorporating a laparoscopic procedure into minimally invasive esophagectomy? The impact on perioperative results in patients with esophageal cancer. World J Surg. 2011;35:790&#x2013;797. doi: 10.1007/s00268-011-0955-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-011-0955-4</ArticleId><ArticleId IdType="pubmed">21327605</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafteux P, Moons J, Coosemans W, Decaluwe H, Decker G, De Leyn P, Van Raemdonck D, Lerut T. Minimally invasive oesophagectomy: a valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinoma. Eur J Cardiothorac Surg. 2011;40:1455&#x2013;1463.</Citation><ArticleIdList><ArticleId IdType="pubmed">21514837</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki M, Miyata H, Fujiwara Y, Takiguchi S, Nakajima K, Kurokawa Y, Mori M, Doki Y. Minimally invasive esophagectomy for esophageal cancer: comparative analysis of open and hand-assisted laparoscopic abdominal lymphadenectomy with gastric conduit reconstruction. J Surg Oncol. 2011;104:623&#x2013;628. doi: 10.1002/jso.21991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.21991</ArticleId><ArticleId IdType="pubmed">21695699</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas KW, Biere SS, Scheepers JJ, Gisbertz SS, Van-der-Peet DL, Cuesta MA. Laparoscopic versus open transhiatal esophagectomy for distal and junction cancer. Rev Esp Enferm Dig. 2012;104:197&#x2013;202. doi: 10.4321/S1130-01082012000400005.</Citation><ArticleIdList><ArticleId IdType="doi">10.4321/S1130-01082012000400005</ArticleId><ArticleId IdType="pubmed">22537368</ArticleId></ArticleIdList></Reference><Reference><Citation>Briez N, Piessen G, Torres F, Lebuffe G, Triboulet JP, Mariette C. Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. Br J Surg. 2012;99:1547&#x2013;1553. doi: 10.1002/bjs.8931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.8931</ArticleId><ArticleId IdType="pubmed">23027071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinjo Y, Kurita N, Nakamura F, Okabe H, Tanaka E, Kataoka Y, Itami A, Sakai Y, Fukuhara S. Effectiveness of combined thoracoscopic-laparoscopic esophagectomy: comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc. 2012;26:381&#x2013;390. doi: 10.1007/s00464-011-1883-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-011-1883-y</ArticleId><ArticleId IdType="pubmed">21898014</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamidanna R, Bottle A, Aylin P, Faiz O, Hanna GB. Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg. 2012;255:197&#x2013;203. doi: 10.1097/SLA.0b013e31823e39fa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31823e39fa</ArticleId><ArticleId IdType="pubmed">22173202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sihag S, Wright CD, Wain JC, Gaissert HA, Lanuti M, Allan JS, Mathisen DJ, Morse CR. Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre. Eur J Cardiothorac Surg. 2012;42:430&#x2013;437. doi: 10.1093/ejcts/ezs031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs031</ArticleId><ArticleId IdType="pubmed">22345284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaram A, Geronimo JC, Willer BL, Hoshino M, Torgersen Z, Juhasz A, Lee TH, Mittal SK. Survival and quality of life after minimally invasive esophagectomy: a single-surgeon experience. Surg Endosc. 2012;26:168&#x2013;176. doi: 10.1007/s00464-011-1850-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-011-1850-7</ArticleId><ArticleId IdType="pubmed">21853394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujimoto H, Takahata R, Nomura S, Yaguchi Y, Kumano I, Matsumoto Y, Yoshida K, Horiguchi H, Hiraki S, Ono S, et al. Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications. Surgery. 2012;151:667&#x2013;673. doi: 10.1016/j.surg.2011.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2011.12.006</ArticleId><ArticleId IdType="pubmed">22244180</ArticleId></ArticleIdList></Reference><Reference><Citation>Javidfar J, Bacchetta M, Yang JA, Miller J, D'Ovidio F, Ginsburg ME, Gorenstein LA, Bessler M, Sonett JR. The use of a tailored surgical technique for minimally invasive esophagectomy. J Thorac Cardiovasc Surg. 2012;143:1125&#x2013;1129. doi: 10.1016/j.jtcvs.2012.01.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.01.071</ArticleId><ArticleId IdType="pubmed">22500593</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey L, Khan O, Willows E, Somers S, Mercer S, Toh S. Open and laparoscopically assisted oesophagectomy: a prospective comparative study. Eur J Cardiothorac Surg. 2013;43:268&#x2013;273. doi: 10.1093/ejcts/ezs314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs314</ArticleId><ArticleId IdType="pubmed">22753051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikawa H, Miyata G, Miyazaki S, Onodera K, Kamei T, Hoshida T, Kikuchi H, Kanba R, Nakano T, Akaishi T, Satomi S. Esophagectomy using a thoracoscopic approach with an open laparotomic or hand-assisted laparoscopic abdominal stage for esophageal cancer: analysis of survival and prognostic factors in 315 patients. Ann Surg. 2013;257:873&#x2013;885. doi: 10.1097/SLA.0b013e31826c87cd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31826c87cd</ArticleId><ArticleId IdType="pubmed">23001081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitagawa H, Namikawa T, Iwabu J, Akimori T, Okabayashi T, Sugimoto T, Mimura T, Kobayashi M, Hanazaki K. Efficacy of laparoscopic gastric mobilization for esophagectomy: comparison with open thoraco-abdominal approach. J Laparoendosc Adv Surg Tech A. 2013;23:452&#x2013;455. doi: 10.1089/lap.2012.0377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2012.0377</ArticleId><ArticleId IdType="pubmed">23560659</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble F, Kelly JJ, Bailey IS, Byrne JP, Underwood TJ. A prospective comparison of totally minimally invasive versus open Ivor Lewis esophagectomy. Dis Esophagus. 2013;26:263&#x2013;271. doi: 10.1111/j.1442-2050.2012.01356.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2050.2012.01356.x</ArticleId><ArticleId IdType="pubmed">23551569</ArticleId></ArticleIdList></Reference><Reference><Citation>Parameswaran R, Titcomb DR, Blencowe NS, Berrisford RG, Wajed SA, Streets CG, Hollowood AD, Krysztopik R, Barham CP, Blazeby JM. Assessment and comparison of recovery after open and minimally invasive esophagectomy for cancer: an exploratory study in two centers. Ann Surg Oncol. 2013;20:1970&#x2013;1977. doi: 10.1245/s10434-012-2848-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-012-2848-7</ArticleId><ArticleId IdType="pubmed">23306956</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeno S, Takahashi Y, Moroga T, Kawahara K, Yamashita Y, Ohtaki M. Retrospective study using the propensity score to clarify the oncologic feasibility of thoracoscopic esophagectomy in patients with esophageal cancer. World J Surg. 2013;37:1673&#x2013;1680. doi: 10.1007/s00268-013-2008-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-013-2008-7</ArticleId><ArticleId IdType="pubmed">23539192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo N, Ohira M, Yamashita Y, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Shibutani M, Yamazoe S, Kimura K, et al. The impact of combined thoracoscopic and laparoscopic surgery on pulmonary complications after radical esophagectomy in patients with resectable esophageal cancer. Anticancer Res. 2014;34:2399&#x2013;2404.</Citation><ArticleIdList><ArticleId IdType="pubmed">24778050</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider C, Boddy AP, Fukuta J, Groom WD, Streets CG. Predicting blood transfusion in patients undergoing minimally invasive oesophagectomy. Int J Surg. 2014;12:1342&#x2013;1347. doi: 10.1016/j.ijsu.2014.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.10.016</ArticleId><ArticleId IdType="pubmed">25448656</ArticleId></ArticleIdList></Reference><Reference><Citation>Daiko H, Fujita T. Laparoscopic assisted versus open gastric pull-up following thoracoscopic esophagectomy: A cohort study. Int J Surg. 2015;19:61&#x2013;66. doi: 10.1016/j.ijsu.2015.04.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2015.04.040</ArticleId><ArticleId IdType="pubmed">25986060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauppi J, Rasanen J, Sihvo E, Huuhtanen R, Nelskyla K, Salo J. Open versus minimally invasive esophagectomy: clinical outcomes for locally advanced esophageal adenocarcinoma. Surg Endosc. 2015;29:2614&#x2013;2619. doi: 10.1007/s00464-014-3978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-014-3978-8</ArticleId><ArticleId IdType="pubmed">25480610</ArticleId></ArticleIdList></Reference><Reference><Citation>Law S. Minimally invasive techniques for oesophageal cancer surgery. Best Pract Res Clin Gastroenterol. 2006;20:925&#x2013;940. doi: 10.1016/j.bpg.2006.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2006.03.011</ArticleId><ArticleId IdType="pubmed">16997170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BF, Zhu CC, Wang CG, Ma DH, Lin J, Zhang B, Kong M. Clinical comparative study of minimally invasive esophagectomy versus open esophagectomy for esophageal carcinoma. Zhonghua Wai Ke Za Zhi. 2010;48:1206&#x2013;1209.</Citation><ArticleIdList><ArticleId IdType="pubmed">21055206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Wang Y, Chen L, Zhao Y. Comparison of open three-field and minimally-invasive esophagectomy for esophageal cancer. Interact Cardiovasc Thorac Surg. 2011;12:366&#x2013;369. doi: 10.1510/icvts.2010.258632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.258632</ArticleId><ArticleId IdType="pubmed">21186282</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Zhang Y, Tan L, Feng M, Wang H, Khan MA, Liang M, Wang Q. Extensive mediastinal lymphadenectomy during minimally invasive esophagectomy: optimal results from a single center. J Gastrointest Surg. 2012;16:715&#x2013;721. doi: 10.1007/s11605-012-1824-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-012-1824-7</ArticleId><ArticleId IdType="pubmed">22258878</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu BX, Li Y, Qin JJ, Zhang RX, Liu XB, Sun HB, Liu SL. Comparison of thoraco-laparoscopic and open three-field subtotal esophagectomy for esophageal cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15:938&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">22990928</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao T, Fang WT, Gu ZT, Yao F, Guo XF, Chen WH. Comparative study of perioperative complications and lymphadenectomy between minimally invasive esophagectomy and open procedure. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15:922&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pubmed">22990924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Tan LJ, Li JP, Shen YX, Zhang Y, Feng MX, Wang Q. Evaluation of safety of video-assisted thoracoscopic esophagectomy for esophageal carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15:926&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pubmed">22990925</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu J, Yuan Z, Zhang B, Li N, Lyu F, Mao Y, Xue Q, Gao S, Zhao J, Wang D, et al. Comparative study of minimally invasive versus open esophagectomy for esophageal cancer in a single cancer center. Chin Med J (Engl) 2014;127:747&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pubmed">24534234</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F, Li Y, Ma H, Yan M, Zhang R. Comparison of outcomes of open and minimally invasive esophagectomy in 183 patients with cancer. J Thorac Dis. 2014;6:1218&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178093</ArticleId><ArticleId IdType="pubmed">25276363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Xu M, Guo M, Mei X, Liu C. Analysis of postoperative quality of life in patients with middle thoracic esophageal carcinoma undergoing minimally invasive Ivor-Lewis esophagectomy. Zhonghua Wei Chang Wai Ke Za Zhi. 2014;17:915&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">25273663</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yang J, Peng J, Jiang H. Case-matched analysis of combined thoracoscopic-laparoscopic versus open esophagectomy for esophageal squamous cell carcinoma. Int J Clin Exp Med. 2015;8:13516&#x2013;13523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4612974</ArticleId><ArticleId IdType="pubmed">26550289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Lyu B, Zhu W, Chen J, He J, Tang S. A retrospective cohort comparison of esophageal carcinoma between thoracoscopic and laparoscopic esophagectomy and open esophagectomy. Zhonghua Wai Ke Za Zhi. 2015;53:378&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">26082255</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Shen Y, Tan L, Feng M, Wang H, Xi Y, Wang Q. Is minimally invasive esophagectomy beneficial to elderly patients with esophageal cancer? Surg Endosc. 2015;29:925&#x2013;930. doi: 10.1007/s00464-014-3753-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-014-3753-x</ArticleId><ArticleId IdType="pubmed">25249141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallner G, Zgodzinski W, Masiak-Segit W, Skoczylas T, Dabrowski A. Minimally invasive surgery for esophageal cancer - benefits and controversies. Kardiochir Torakochirurgia Pol. 2014;11:151&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4283863</ArticleId><ArticleId IdType="pubmed">26336413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002;123:661&#x2013;669. doi: 10.1067/mtc.2002.120350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2002.120350</ArticleId><ArticleId IdType="pubmed">11986593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinugasa S, Tachibana M, Yoshimura H, Ueda S, Fujii T, Dhar DK, Nakamoto T, Nagasue N. Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy. J Surg Oncol. 2004;88:71&#x2013;77. doi: 10.1002/jso.20137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.20137</ArticleId><ArticleId IdType="pubmed">15499604</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont P, Wihlm JM, Hentz JG, Roeslin N, Lion R, Morand G. Respiratory complications after surgical treatment of esophageal cancer. A study of 309 patients according to the type of resection. Eur J Cardiothorac Surg. 1995;9:539&#x2013;543. doi: 10.1016/S1010-7940(05)80001-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(05)80001-6</ArticleId><ArticleId IdType="pubmed">8562096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauvanet A, Mariette C, Thomas P, Lozac'H P, Segol P, Tiret E, Delpero JR, Collet D, Leborgne J, Pradere B, et al. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg. 2005;201:253&#x2013;262. doi: 10.1016/j.jamcollsurg.2005.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2005.02.002</ArticleId><ArticleId IdType="pubmed">16038824</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico TA. Outcomes after surgery for esophageal cancer. Gastrointest Cancer Res. 2007;1:188&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2632530</ArticleId><ArticleId IdType="pubmed">19262708</ArticleId></ArticleIdList></Reference><Reference><Citation>Gex G, Gerstel E, Righini M, LE Gal G, Aujesky D, Roy PM, Sanchez O, Verschuren F, Rutschmann OT, Perneger T, Perrier A. Is atrial fibrillation associated with pulmonary embolism? J Thromb Haemost. 2012;10:347&#x2013;351. doi: 10.1111/j.1538-7836.2011.04608.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2011.04608.x</ArticleId><ArticleId IdType="pubmed">22212132</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidenhagen R, Hartl WH, Gruetzner KU, Eichhorn ME, Spelsberg F, Jauch KW. Anastomotic leakage after esophageal resection: new treatment options by endoluminal vacuum therapy. Ann Thorac Surg. 2010;90:1674&#x2013;1681. doi: 10.1016/j.athoracsur.2010.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.07.007</ArticleId><ArticleId IdType="pubmed">20971288</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, Brennan MF, Rusch VW. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42&#x2013;50. doi: 10.1016/j.jamcollsurg.2003.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2003.08.007</ArticleId><ArticleId IdType="pubmed">14698310</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38956401</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Impact of surgical specialization on emergency upper gastrointestinal surgery outcomes: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1941</StartPage><EndPage>1949</EndPage><MedlinePgn>1941-1949</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/wjs.12267</ELocationID><Abstract><AbstractText Label="BACKGROUND">Emergency presentations make up a large proportion of a general surgeon's workload. Patients who have emergency surgery carry a higher rate of mortality and complications. We aim to review the impact of surgical subspecialization on patients following upper gastrointestinal (UGI) emergency surgery.</AbstractText><AbstractText Label="METHODS">A systematic search of Ovid Embase, Ovid MEDLINE, and Cochrane databases using a predefined search strategy was completed reviewing studies published from 1st of January 1990 to August 27, 2023. The study was prospectively registered with PROSPERO (CRD42022359326). Studies were reviewed for the following outcomes: 30-day mortality, in-hospital mortality, conversion to open, length of stay, return to theater, and readmission.</AbstractText><AbstractText Label="RESULTS">Of 5181 studies, 24 articles were selected for full text review. Of these, seven were eligible and included in this study. There was a statistically significant improvement in 30-day mortality favoring UGI specialists (OR 0.71 [95% CI 0.55-0.92 and p&#xa0;=&#xa0;0.009]) and in-hospital mortality (OR 0.29 [95% CI 0.14-0.60 and p&#xa0;=&#xa0;0009]). There was a high degree of study heterogeneity in 30-day mortality; however, a low degree of heterogeneity within in-hospital mortality. There was no statistical significance when considering conversion to open and insufficient data to allow meta-analysis for return to theater or readmission rates.</AbstractText><AbstractText Label="CONCLUSION">In emergency UGI surgery, there was improved 30-day and in-hospital mortality for UGI specialists. Therefore, surgeons should consider early involvement of a subspecialist team to improve patient outcomes.</AbstractText><CopyrightInformation>&#xa9; 2024 International Society of Surgery/Soci&#xe9;t&#xe9; Internationale de Chirurgie (ISS/SIC).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbaro</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2992-8999</Identifier><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunjo</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asokan</LastName><ForeName>Gayatri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanhere</LastName><ForeName>Akshay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuan</LastName><ForeName>Li Lian</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trochsler</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Upper Gastrointestinal Surgery, The Royal Adelaide Hospital, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanhere</LastName><ForeName>Harsh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Upper Gastrointestinal Surgery, The Royal Adelaide Hospital, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maddern</LastName><ForeName>Guy J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>The University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="Y">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013043" MajorTopicYN="N">Specialties, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041742" MajorTopicYN="N">Upper Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">esophagus</Keyword><Keyword MajorTopicYN="N">gastrointestinal</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">stomach</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>3</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38956401</ArticleId><ArticleId IdType="doi">10.1002/wjs.12267</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Pearce, L., S. R. Smith, E. Parkin, C. Hall, J. Kennedy, and A. Macdonald. 2016. &#x201c;Emergency General Surgery: Evolution of a Subspecialty by Stealth.&#x201d; World Journal of Emergency Surgery 11(1): 2. https://doi.org/10.1186/s13017&#x2010;015&#x2010;0058&#x2010;x.</Citation></Reference><Reference><Citation>Ramsay, G., J. M. Wohlgemut, and J. O. Jansen. 2019. &#x201c;Twenty&#x2010;year Study of In&#x2010;Hospital and Postdischarge Mortality Following Emergency General Surgical Admission.&#x201d; BJS Open 3(5): 713&#x2013;721. https://doi.org/10.1002/bjs5.50187.</Citation></Reference><Reference><Citation>Chana, P., M. Joy, N. Casey, D. Chang, E. M. Burns, S. Arora, A. W. Darzi, O. D. Faiz, and C. J. Peden. 2017. &#x201c;Cohort Analysis of Outcomes in 69 490 Emergency General Surgical Admissions across an International Benchmarking Collaborative.&#x201d; BMJ Open 7(3): e014484. https://doi.org/10.1136/bmjopen&#x2010;2016&#x2010;014484.</Citation></Reference><Reference><Citation>Guy, S., and C. Lisec. 2018. &#x201c;Emergency Laparotomy Outcomes Before and after the Introduction of an Acute Surgical Unit.&#x201d; International Journal of Surgery Open 10: 61&#x2013;65. https://doi.org/10.1016/j.ijso.2017.12.001.</Citation></Reference><Reference><Citation>Saunders, D. I., D. Murray, A. C. Pichel, S. Varley, and C. j. Peden. 2012. &#x201c;Variations in Mortality after Emergency Laparotomy: The First Report of the UK Emergency Laparotomy Network.&#x201d; British Journal of Anaesthesia 109(3): 368&#x2013;375. https://doi.org/10.1093/bja/aes165.</Citation></Reference><Reference><Citation>Akinbami, F., R. Askari, J. Steinberg, M. Panizales, and S. O. Rogers, Jr. 2011. &#x201c;Factors Affecting Morbidity in Emergency General Surgery.&#x201d; Americas Journal of Surgery 201(4): 456&#x2013;462. https://doi.org/10.1016/j.amjsurg.2010.11.007.</Citation></Reference><Reference><Citation>Baimas&#x2010;George, M., S. W. Ross, T. Hetherington, M. Kowalkowski, H. Wang, K. Thompson, K. Cunningham, B. D. Matthews, A. K. May, and C. E. Reinke. 2022. &#x201c;The Physiology of Failure: Identifying Risk Factors for Mortality in Emergency General Surgery Patients Using a Regional Health System Integrated Electronic Medical Record.&#x201d; Journal of Trauma and Acute Care Surgery 93(3): 409&#x2013;417. https://doi.org/10.1097/ta.0000000000003618.</Citation></Reference><Reference><Citation>Brown, L. R., R. C. McLean, D. Perren, P. O'Loughlin, and I. J. D. McCallum. 2019. &#x201c;Evaluating the Effects of Surgical Subspecialisation on Patient Outcomes Following Emergency Laparotomy: A Retrospective Cohort Study.&#x201d; International Journal of Surgery 62: 67&#x2013;73. https://doi.org/10.1016/j.ijsu.2019.01.010.</Citation></Reference><Reference><Citation>Chowdhury, M. M., H. Dagash, and A. Pierro. 2007. &#x201c;A Systematic Review of the Impact of Volume of Surgery and Specialization on Patient Outcome.&#x201d; British Journal of Surgery 94(2): 145&#x2013;161. https://doi.org/10.1002/bjs.5714.</Citation></Reference><Reference><Citation>Page, M. J., J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, et&#xa0;al. 2021. &#x201c;The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews.&#x201d; BMJ 372: n71. https://doi.org/10.1136/bmj.n71.</Citation></Reference><Reference><Citation>Wells, G. S. B., D. O&#x2019;Connell, J. Peterson, V. Welch, M. Losos, and P. Tugwell. 2021. &#x201c;The Newcastle&#x2010;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#x2010;Analyses.&#x201d; https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Boyd&#x2010;Carson, H., B. Doleman, P. J. J. Herrod, I. D. Anderson, J. P. Williams, J. N. Lund, G. M. Tierney, et&#xa0;al. 2019. &#x201c;Association between Surgeon Special Interest and Mortality after Emergency Laparotomy.&#x201d; British Journal of Surgery 106(7): 940&#x2013;948. https://doi.org/10.1002/bjs.11146.</Citation></Reference><Reference><Citation>Johnson, C. H. N., R. C. McLean, I. McCallum, D. Perren, and A. W. Phillips. 2019. &#x201c;An Evaluation of the Epidemiology, Management and Outcomes for Perforated Peptic Ulcers across the North of England over 15 Years: A Retrospective Cohort Study.&#x201d; International Journal of Surgery 64: 24&#x2013;32. https://doi.org/10.1016/j.ijsu.2019.03.005.</Citation></Reference><Reference><Citation>Khan, O. A., E. R. McGlone, S. J. Mercer, S. S. Somers, and S. K. C. Toh. 2015. &#x201c;Outcomes Following Major Emergency Gastric Surgery: The Importance of Specialist Surgeons.&#x201d; Acta Chirurgica Belgica 115(2): 131&#x2013;135. https://doi.org/10.1080/00015458.2015.11681082.</Citation></Reference><Reference><Citation>Robson, A. J., J. M. J. Richards, N. Ohly, S. J. Nixon, and S. Paterson&#x2010;Brown. 2008. &#x201c;The Effect of Surgical Subspecialization on Outcomes in Peptic Ulcer Disease Complicated by Perforation and Bleeding.&#x201d; World Journal of Surgery 32(7): 1456&#x2013;1461. https://doi.org/10.1007/s00268&#x2010;007&#x2010;9444&#x2010;1.</Citation></Reference><Reference><Citation>Barrow, E., I. D. Anderson, S. Varley, Ac Pichel, Cj Peden, Di Saunders, and D. Murray. 2013. &#x201c;Current UK Practice in Emergency Laparotomy.&#x201d; Annals of the Royal College of Surgeons of England 95(8): 599&#x2013;603. https://doi.org/10.1308/003588413x13629960048433.</Citation></Reference><Reference><Citation>Hallam, S., M. Bickley, L. Phelan, M. Dilworth, and Dm Bowley. 2020. &#x201c;Does Declared Surgeon Specialist Interest Influence the Outcome of Emergency Laparotomy?&#x201d; Annals of the Royal College of Surgeons of England 102(6): 437&#x2013;441. https://doi.org/10.1308/rcsann.2020.0098.</Citation></Reference><Reference><Citation>Mocan, L. 2021. &#x201c;Surgical Management of Gastric Cancer: A Systematic Review.&#x201d; Journal of Clinical Medicine 10(12): 2557. https://doi.org/10.3390/jcm10122557.</Citation></Reference><Reference><Citation>Markar, S. R., A. Karthikesalingam, S. Thrumurthy, and D. E. Low. 2012. &#x201c;Volume&#x2010;outcome Relationship in Surgery for Esophageal Malignancy: Systematic Review and Meta&#x2010;Analysis 2000&#x2010;2011.&#x201d; Journal of Gastrointestinal Surgery 16(5): 1055&#x2013;1063. https://doi.org/10.1007/s11605&#x2010;011&#x2010;1731&#x2010;3.</Citation></Reference><Reference><Citation>Markar, S. R., H. Mackenzie, A. Askari, O. Faiz, and G. B. Hanna. 2017. &#x201c;Effect of Esophageal Cancer Surgeon Volume on Management and Mortality from Emergency Upper Gastrointestinal Conditions: Population&#x2010;Based Cohort Study.&#x201d; Annals of Surgery 266(5): 847&#x2013;853. https://doi.org/10.1097/sla.0000000000002387.</Citation></Reference><Reference><Citation>Archampong, D., D. Borowski, P. Wille&#x2010;Jorgensen, et&#xa0;al. 2012. &#x201c;Workload and Surgeon's Specialty for Outcome after Colorectal Cancer Surgery.&#x201d; Cochrane Database of Systematic Reviews. CD005391.</Citation></Reference><Reference><Citation>Oliphant, R., G. A. Nicholson, P. G. Horgan, R. G. Molloy, D. C. McMillan, and D. S. Morrison. 2013. &#x201c;Contribution of Surgical Specialization to Improved Colorectal Cancer Survival.&#x201d; British Journal of Surgery 100(10): 1388&#x2013;1395. https://doi.org/10.1002/bjs.9227.</Citation></Reference><Reference><Citation>Abelson, J. S., J. D. Spiegel, C. Afaneh, J. Mao, A. Sedrakyan, and H. L. Yeo. 2017. &#x201c;Evaluating Cumulative and Annual Surgeon Volume in Laparoscopic Cholecystectomy.&#x201d; Surgery 161(3): 611&#x2013;617. https://doi.org/10.1016/j.surg.2016.08.027.</Citation></Reference><Reference><Citation>Ballal, M., G. David, S. Willmott, D. J. Corless, M. Deakin, and J. P. Slavin. 2009. &#x201c;Conversion after Laparoscopic Cholecystectomy in England.&#x201d; Surgical Endoscopy 23(10): 2338&#x2013;2344. https://doi.org/10.1007/s00464&#x2010;009&#x2010;0338&#x2010;1.</Citation></Reference><Reference><Citation>Fischer, C., S. J. Alvarico, B. Wildner, M. Schindl, and J. Simon. 2023. &#x201c;The Relationship of Hospital and Surgeon Volume Indicators and Post&#x2010;operative Outcomes in Pancreatic Surgery: a Systematic Literature Review, Meta&#x2010;Analysis and Guidance for Valid Outcome Assessment.&#x201d; HPB (Oxford) 25(4): 387&#x2013;399. https://doi.org/10.1016/j.hpb.2023.01.008.</Citation></Reference><Reference><Citation>Huo, Y. R., K. Phan, D. L. Morris, and W. Liauw. 2017. &#x201c;Systematic Review and a Meta&#x2010;Analysis of Hospital and Surgeon Volume/outcome Relationships in Colorectal Cancer Surgery.&#x201d; Journal of Gastrointestinal Oncology 8(3): 534&#x2013;546. https://doi.org/10.21037/jgo.2017.01.25.</Citation></Reference><Reference><Citation>Fedeli, U., E. Schievano, and M. Lisiero. 2012. &#x201c;Mortality after Esophageal and Gastric Cancer Resection.&#x201d; World Journal of Surgery 36(11): 2630&#x2013;2636. https://doi.org/10.1007/s00268&#x2010;012&#x2010;1724&#x2010;8.</Citation></Reference><Reference><Citation>Havens, J. M., A. B. Peetz, W. S. Do, Z. Cooper, E. Kelly, R. Askari, G. Reznor, and A. Salim. 2015. &#x201c;The Excess Morbidity and Mortality of Emergency General Surgery.&#x201d; Journal of Trauma and Acute Care Surgery 78(2): 306&#x2013;311. https://doi.org/10.1097/ta.0000000000000517.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38523141</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Identifying factors predicting outcomes after major trauma in older patients: Prognostic systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>478</StartPage><EndPage>487</EndPage><MedlinePgn>478-487</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000004320</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Trauma is the most common cause of morbidity and mortality in older people, and it is important to determine the predictors of outcomes after major trauma in older people.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Embase, and Web of Science were searched, and manual search of relevant papers since 1987 to February 2023 was performed. Random-effects meta-analyses were performed. The primary outcome of interest was mortality, and secondary outcomes were medical complications, length of stay, discharge destination, readmission, and intensive care requirement.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 6,064 studies in the search strategy, 136 studies qualified the inclusion criteria. Forty-three factors, ranging from demographics to patient factors, admission measurements, and injury factors, were identified as potential predictors. Mortality was the commonest outcome investigated, and increasing age was associated with increased risk of in-hospital mortality (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03-1.07) along with male sex (OR, 1.40; 95% CI, 1.24-1.59). Comorbidities of heart disease (OR, 2.59; 95% CI, 1.41-4.77), renal disease (OR, 2.52; 95% CI, 1.79-3.56), respiratory disease (OR, 1.40; 95% CI, 1.09-1.81), diabetes (OR, 1.35; 95% CI, 1.03-1.77), and neurological disease (OR, 1.42; 95% CI, 0.93-2.18) were also associated with increased in-hospital mortality risk. Each point increase in the Glasgow Coma Scale lowered the risk of in-hospital mortality (OR, 0.85; 95% CI, 0.76-0.95), while each point increase in Injury Severity Score increased the risk of in-hospital mortality (OR, 1.07; 95% CI, 1.04-1.09). There were limited studies and substantial variability in secondary outcome predictors; however, medical comorbidities, frailty, and premorbid living condition appeared predictive for those outcomes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This review was able to identify potential predictors for older trauma patients. The identification of these factors allows for future development of risk stratification tools for clinicians.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Systematic Review and Meta-Analysis; Level III.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iddagoda</LastName><ForeName>Mayura Thilanka</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>From the Perioperative Service (M.T.I., C.M., C.E.-B., L.F.), Royal Perth Hospital; and University of Western Australia (M.T.I., M.T., C.E.-B., L.F.), Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trevenen</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Meaton</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Etherton-Beer</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Flicker</LastName><ForeName>Leon</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="Y">Wounds and Injuries</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>0</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38523141</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000004320</ArticleId><ArticleId IdType="pii">01586154-202409000-00021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Noncommunicable diseases country profiles 2014. 2014. Published 2014. Available at: https://www.who.int/publications/i/item/9789241507509 . Accessed February 10, 2024.</Citation></Reference><Reference><Citation>Victorino GP, Chong TJ, Pal JD. Trauma in the elderly patient. Arch Surg . 2003;138(10):1093&#x2013;1098.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg . 2021;88:105906.</Citation></Reference><Reference><Citation>Sammy I, Lecky F, Sutton A, Leaviss J, O&#x2019;Cathain A. Factors affecting mortality in older trauma patients&#x2014;a systematic review and meta-analysis. Injury . 2016;47(6):1170&#x2013;1183.</Citation></Reference><Reference><Citation>Ahmadi S, Sarveazad A, Babahajian A, Ahmadzadeh K, Yousefifard M. Comparison of Glasgow Coma Scale and full outline of UnResponsiveness score for prediction of in-hospital mortality in traumatic brain injury patients: a systematic review and meta-analysis. Eur J Trauma Emerg Surg . 2023;49(4):1693&#x2013;1706.</Citation></Reference><Reference><Citation>Azarhomayoun A, Aghasi M, Mousavi N, Shokraneh F, Vaccaro AR, Haj Mirzaian A, et al. Mortality rate and predicting factors of traumatic thoracolumbar spinal cord injury; a systematic review and meta-analysis. Bull Emerg Trauma . 2018;6(3):181&#x2013;194.</Citation></Reference><Reference><Citation>Xiong C, Hanafy S, Chan V, Hu ZJ, Sutton M, Escobar M, et al. Comorbidity in adults with traumatic brain injury and all-cause mortality: a systematic review. BMJ Open . 2019;9(11):e029072.</Citation></Reference><Reference><Citation>Alqarni AG, Gladman JRF, Obasi AA, Ollivere B. Does frailty status predict outcome in major trauma in older people? A systematic review and meta-analysis. Age Ageing . 2023;52(5):afad073.</Citation></Reference><Reference><Citation>Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev . 2021;10(1):39.</Citation></Reference><Reference><Citation>Iddagoda MT, Flicker L. Clinical systematic reviews&#x2014;a brief overview. BMC Med Res Methodol . 2023;23(1):226.</Citation></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ . 2016;355:i4919.</Citation></Reference><Reference><Citation>Abdelfattah A, Core MD, Cannada LK, Watson JT. Geriatric high-energy polytrauma with orthopedic injuries: clinical predictors of mortality. Geriatr Orthop Surg Rehabil . 2014;5(4):173&#x2013;177.</Citation></Reference><Reference><Citation>Akella K, Joshi G, Young D, Tatarian L, Ibrahim S, Boden B, et al. Atrial fibrillation is independently associated with increased morbidity and mortality in elderly trauma patients. Chest . 2019;156(4 Supplement):A314.</Citation></Reference><Reference><Citation>Alexander JQ, Gutierrez CJ, Mariano MC, Vander Laan T, Gaspard DJ, Carpenter CL, et al. Blunt chest trauma in the elderly patient: how cardiopulmonary disease affects outcome. Am Surg . 2000;66(9):855&#x2013;857.</Citation></Reference><Reference><Citation>Ang D, Kurek S, McKenney M, Norwood S, Kimbrell B, Barquist E, et al. Outcomes of geriatric trauma patients on preinjury anticoagulation: a multicenter study. Am Surg . 2017;83(6):527&#x2013;535.</Citation></Reference><Reference><Citation>Ang D, Norwood S, Barquist E, McKenney M, Kurek S, Kimbrell B, et al. Geriatric outcomes for trauma patients in the state of Florida after the advent of a large trauma network. J Trauma Acute Care Surg . 2014;77(1):155&#x2013;160 discussion 60.</Citation></Reference><Reference><Citation>Auckley ED, Sharma D, Henry M, Kaplan SJ, Pham TN, Reed M, et al. Prospective measurement of sarcopenia with masseter muscle ultrasound in elderly trauma patients. J Am Geriatr Soc . 2020;68:S319.</Citation></Reference><Reference><Citation>Bakhos C, O'Connor J, Kyriakides T, Abou-Nukta F, Bonadies J. Vital capacity as a predictor of outcome in elderly patients with rib fractures. J Trauma . 2006;61(1):131&#x2013;134.</Citation></Reference><Reference><Citation>Bala M, Willner D, Klauzni D, Bdolah-Abram T, Rivkind AI, Gazala MA, et al. Pre-hospital and admission parameters predict in-hospital mortality among patients 60 years and older following severe trauma. Scand J Trauma Resusc Emerg Med . 2013;21:91.</Citation></Reference><Reference><Citation>Barletta JF, Hall S, Sucher JF, Dzandu JK, Haley M, Mangram AJ. The impact of pre-injury direct oral anticoagulants compared to warfarin in geriatric G-60 trauma patients. Eur J Trauma Emerg Surg . 2017;43(4):445&#x2013;449.</Citation></Reference><Reference><Citation>Barry R, Modarresi M, Duran R, Denning D, Wilson S, Thompson E, et al. The impact of obesity on outcomes in geriatric blunt trauma. Am Surg . 2019;85(2):188&#x2013;195.</Citation></Reference><Reference><Citation>Bauer J, Harrison G, Grandhi R, Voronovich Z, Puccio A, Okonkwo DO. Pre-morbid and hospital course factors affecting intracranial hemorrhage expansion and mortality in the elderly post traumatic brain injury. J Neurotrauma . 2012;29(10):A44&#x2013;A45.</Citation></Reference><Reference><Citation>Bauman Z, Hommel D, Gassner M, Horst H, Blyden D, Kather R, et al. 689: Older trauma patients are associated with a greater risk of inpatient harms. Crit Care Med . 2013;41:A169.</Citation></Reference><Reference><Citation>Bennett KM, Scarborough JE, Vaslef SN, Shapiro ML, Brooks K. Are all geriatric trauma patients the same? A comparison of post-injury outcomes and resource utilization for the elderly versus super-elderly. J Surg Res . 2010;158(2):290&#x2013;291.</Citation></Reference><Reference><Citation>Brooks SE, Mukherjee K, Gunter OL, Guillamondegui OD, Jenkins JM, Miller RS, et al. Do models incorporating comorbidities outperform those incorporating vital signs and injury pattern for predicting mortality in geriatric trauma? J Am Coll Surg . 2014;219(5):1020&#x2013;1027.</Citation></Reference><Reference><Citation>Broos PL, D'Hoore A, Vanderschot P, Rommens PM, Stappaerts KH. Multiple trauma in elderly patients. Factors influencing outcome: importance of aggressive care. Injury . 1993;24(6):365&#x2013;368.</Citation></Reference><Reference><Citation>Brown CV, Rix K, Klein AL, Ford B, Teixeira PG, Aydelotte J, et al. A comprehensive investigation of comorbidities, mechanisms, injury patterns, and outcomes in geriatric blunt trauma patients. Am Surg . 2016;82(11):1055&#x2013;1062.</Citation></Reference><Reference><Citation>Bryant MK, Reynolds K, Brittain C, Patel Z, Reid TDS, Maine RG, et al. Does level of blood alcohol content affect clinical outcomes after trauma in older adult patients? Am Surg . 2020;86(9):1106&#x2013;1112.</Citation></Reference><Reference><Citation>Caglar A, Sert ET, Mutlu H. Impact of chronic medical conditions on mortality in geriatric trauma, 10-year analysis of a single centre in Turkey. Acta Chir Belg . 2021;122(4):253&#x2013;259.</Citation></Reference><Reference><Citation>Callaway DW, Shapiro NI, Donnino MW, Baker C, Rosen CL. Serum lactate and base deficit as predictors of mortality in normotensive elderly blunt trauma patients. J Trauma . 2009;66(4):1040&#x2013;1044.</Citation></Reference><Reference><Citation>Camilloni L, Farchi S, Giorgi Rossi P, Chini F, Borgia P. Mortality in elderly injured patients: the role of comorbidities. Int J Inj Control Saf Promot . 2008;15(1):25&#x2013;31.</Citation></Reference><Reference><Citation>Caterino JM, Brown NV, Hamilton MW, Ichwan B, Khaliqdina S, Evans DC, et al. Effect of geriatric-specific trauma triage criteria on outcomes in injured older adults: a statewide retrospective cohort study. J Am Geriatr Soc . 2016;64(10):1944&#x2013;1951.</Citation></Reference><Reference><Citation>Cevik Y, Dogan NO, Das M, Karakayali O, Delice O, Kavalci C. Evaluation of geriatric patients with trauma scores after motor vehicle trauma. Am J Emerg Med . 2013;31(10):1453&#x2013;1456.</Citation></Reference><Reference><Citation>Cheung A, Haas B, Ringer TJ, McFarlan A, Wong CL. Canadian study of health and aging clinical frailty scale: does it predict adverse outcomes among geriatric trauma patients? J Am Coll Surg . 2017;225(5):658&#x2013;665.e3.</Citation></Reference><Reference><Citation>Clark DE, DeLorenzo MA, Lucas FL, Cushing BM. Initial presentation of older injured patients to high-volume hospitals is not associated with lower 30-day mortality in Medicare data. Crit Care Med . 2007;35(8):1829&#x2013;1836.</Citation></Reference><Reference><Citation>Ramirez M, Chang D, Coimbra R, Kobayashi L. Disparity in trauma outcomes in elderly minorities in California. J Am Coll Surg . 2011;213(3):S118.</Citation></Reference><Reference><Citation>Collins CE, Santry PH, Witkowski ER, Flahive JM, Anderson AF Jr. Impact of pre-injury warfarin use on hospital mortality in elderly united states residents with torso trauma. J Thromb Haemost . 2013;11:825&#x2013;826.</Citation></Reference><Reference><Citation>Couch AP, Ho K, Darwood R, Hsu JM. Lean psoas area does not correlate with clinical outcomes in moderately to severely injured older people. Australas J Ageing . 2018;37(1):E7&#x2013;E11.</Citation></Reference><Reference><Citation>Curtis E, Romanowski K, Sen S, Hill A, Cocanour C. Frailty score on admission predicts mortality and discharge disposition in elderly trauma patients over the age of 65 y. J Surg Res . 2018;230:13&#x2013;19.</Citation></Reference><Reference><Citation>Daneshvar P, Roffey DM, Brikeet YA, Tsai EC, Bailey CS, Wai EK. Spinal cord injuries related to cervical spine fractures in elderly patients: factors affecting mortality. Spine J . 2013;13(8):862&#x2013;866.</Citation></Reference><Reference><Citation>Davis JS, Prescott AT, Varas RP, Quintana OD, Rosales O, Pizano LR, et al. A new algorithm to allow early prediction of mortality in elderly burn patients. Burns . 2012;38(8):1114&#x2013;1118.</Citation></Reference><Reference><Citation>de Vries R, Reininga IHF, de Graaf MW, Heineman E, El Moumni M, Wendt KW. Older polytrauma: mortality and complications. Injury . 2019;50(8):1440&#x2013;1447.</Citation></Reference><Reference><Citation>DeMaria EJ, Kenney PR, Merriam MA, Casanova LA, Gann DS. Survival after trauma in geriatric patients. Ann Surg . 1987;206(6):738&#x2013;743.</Citation></Reference><Reference><Citation>Dunham CM, Chance EA, Hileman BM, Flowers LL, Ransom KJ, Puet TA. Geriatric preinjury activities of daily living function is associated with Glasgow Coma Score and discharge disposition: a retrospective, consecutive cohort study. J Trauma Nurs . 2015;22(1):6&#x2013;13.</Citation></Reference><Reference><Citation>Duvall DB, Zhu X, Elliott AC, Wolf SE, Rhodes RL, Paulk ME, et al. Injury severity and comorbidities alone do not predict futility of care after geriatric trauma. J Palliat Med . 2015;18(3):246&#x2013;250.</Citation></Reference><Reference><Citation>Ebbeling L, Grabo DJ, Shashaty M, Dua R, Sonnad SS, Sims CA, et al. Psoas: lumbar vertebra index: central sarcopenia independently predicts morbidity in elderly trauma patients. Eur J Trauma Emerg Surg . 2014;40(1):57&#x2013;65.</Citation></Reference><Reference><Citation>Efron DT, Sorock G, Haut ER, Chang D, Schneider E, Mackenzie E, et al. Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients. J Trauma . 2008;64(1):66&#x2013;73; discussion 73-4.</Citation></Reference><Reference><Citation>Evans DC, Cook CH, Christy JM, Murphy CV, Gerlach AT, Eiferman D, et al. Comorbidity-polypharmacy scoring facilitates outcome prediction in older trauma patients. J Am Geriatr Soc . 2012;60(8):1465&#x2013;1470.</Citation></Reference><Reference><Citation>Fairchild B, Webb TP, Xiang Q, Tarima S, Brasel KJ. Sarcopenia and frailty in elderly trauma patients. World J Surg . 2015;39(2):373&#x2013;379.</Citation></Reference><Reference><Citation>Fletcher B, Bradburn E, Baker C, Collier B, Hamill M, Shaver K. Pretrauma functional independence measure score predicts survival in geriatric trauma. Am Surg . 2017;83(6):559&#x2013;563.</Citation></Reference><Reference><Citation>Fox ED, Heffernan DS, Adams CA, Miner TJ, Connolly MD, Gregg SC, et al. Not all comorbidities are the same: the impact of specific comorbidities on mortality in critically ill geriatric trauma patients. J Am Coll Surg . 2013;217(3):S59.</Citation></Reference><Reference><Citation>Fox ED, Monaghan SF, Chamberlain CJ, Machan JT, Cioffi WG, Gravenstein S, et al. Early neutrophilia is predictive of higher mortality in moderately to severely injured geriatric trauma patients. Shock . 2012;37:46&#x2013;47.</Citation></Reference><Reference><Citation>Garwe T, Albrecht RM, Stoner JA, Mitchell S, Motghare P. Hypoalbuminemia at admission is associated with increased incidence of in-hospital complications in geriatric trauma patients. Am J Surg . 2016;212(1):109&#x2013;115.</Citation></Reference><Reference><Citation>Guiab K, Evans T, Saadat G, Starr F, Bokhari F. Can the 5-item modified frailty index predict outcomes in geriatric trauma? A national database study. J Am Geriatr Soc . 2021;69:S210.</Citation></Reference><Reference><Citation>Haines K, Zens T, Jung HS, Agarwal S. 499: Socioeconomics, race, and ethnicity determine outcomes in elderly ventilated trauma patients. Crit Care Med . 2018;46(1):234.</Citation></Reference><Reference><Citation>Hamidi M, Zeeshan M, Leon-Risemberg V, Nikolich-Zugich J, Hanna K, Kulvatunyou N, et al. Frailty as a prognostic factor for the critically ill older adult trauma patients. Am J Surg . 2019;218(3):484&#x2013;489.</Citation></Reference><Reference><Citation>Harrington DT, Phillips B, Machan J, Zacharias N, Velmahos GC, Rosenblatt MS, et al. Factors associated with survival following blunt chest trauma in older patients: results from a large regional trauma cooperative. Arch Surg . 2010;145(5):432&#x2013;437.</Citation></Reference><Reference><Citation>Heydari F, Golban M, Majidinejad S. Traumatic brain injury in older adults presenting to the emergency department: epidemiology, outcomes and risk factors predicting the prognosis. Adv J Emerg Med . 2019;4(2):e19.</Citation></Reference><Reference><Citation>Schneider EB, Hirani SA, Hambridge HL, Haut ER, Carlini AR, Castillo RC, et al. Beating the weekend trend: increased mortality in older adult traumatic brain injury (TBI) patients admitted on weekends. J Surg Res . 2012;177(2):295&#x2013;300.</Citation></Reference><Reference><Citation>Hohle R, Wothe J, Vail Harmon J, Vakayil VR. Massive blood transfusion after geriatric trauma: effect of blood ratio on mortality. J Am Coll Surg . 2020;231(4):S322.</Citation></Reference><Reference><Citation>Holler E, Meagher AD, Ortiz D, Mohanty S, Newnum A, Perkins A, et al. Preinjury functional Independence is not associated with discharge location in older trauma patients. J Surg Res . 2021;266:413&#x2013;420.</Citation></Reference><Reference><Citation>Holmes M, Garver M, Albrecht L, Arbabi S, Pham TN. Comparison of two comorbidity scoring systems for older adults with traumatic injuries. J Am Coll Surg . 2014;219(4):631&#x2013;637.</Citation></Reference><Reference><Citation>Horst HM, Obeid FN, Sorensen VJ, Bivins BA. Factors influencing survival of elderly trauma patients. Crit Care Med . 1986;14(8):681&#x2013;684.</Citation></Reference><Reference><Citation>Housley BC, Stawicki SP, Evans DC, Jones C. Comorbidity-polypharmacy score predicts readmission in older trauma patients. J Surg Res . 2015;199(1):237&#x2013;243.</Citation></Reference><Reference><Citation>Hwang F, McGreevy CM, Pentakota SR, Verde D, Park JH, Berlin A, et al. Sarcopenia is predictive of functional outcomes in older trauma patients. Cureus . 2019;11(11):e6154.</Citation></Reference><Reference><Citation>Hranjec T, Sawyer RG, Young JS, Swenson BR, Calland JF. Mortality factors in geriatric blunt trauma patients: creation of a highly predictive statistical model for mortality using 50,765 consecutive elderly trauma admissions from the National Sample Project. Am Surg . 2012;78(12):1369&#x2013;1375.</Citation></Reference><Reference><Citation>Hu P, Uhlich R, White J, Kerby J, Bosarge P. Sarcopenia measured using masseter area predicts early mortality following severe traumatic brain injury. J Neurotrauma . 2018;35(20):2400&#x2013;2406.</Citation></Reference><Reference><Citation>Jebri R, Mac V, Carlier M, Christian M. Prognostic factors of poor outcome in geriatric traumatology patients in the emergency department. West J Emerg Med . 2019;20:S16.</Citation></Reference><Reference><Citation>Jiang L, Zheng Z, Zhang M. The incidence of geriatric trauma is increasing and comparison of different scoring tools for the prediction of in-hospital mortality in geriatric trauma patients. World J Emerg Surg . 2020;15(1):59.</Citation></Reference><Reference><Citation>Jones K, Sharp C, Mangram AJ, Dunn EL. The effects of preinjury clopidogrel use on older trauma patients with head injuries. Am J Surg . 2006;192(6):743&#x2013;745.</Citation></Reference><Reference><Citation>Joseph B, Orouji Jokar T, Hassan A, Azim A, Mohler MJ, Kulvatunyou N, et al. Redefining the association between old age and poor outcomes after trauma: the impact of frailty syndrome. J Trauma Acute Care Surg . 2017;82(3):575&#x2013;581.</Citation></Reference><Reference><Citation>Joseph B, Pandit V, Rhee P, Aziz H, Sadoun M, Wynne J, et al. Predicting hospital discharge disposition in geriatric trauma patients: is frailty the answer? J Trauma Acute Care Surg . 2014;76(1):196&#x2013;200.</Citation></Reference><Reference><Citation>Kamata K, Abe T, Aoki M, Deshpande G, Saitoh D, Tokuda Y. Dynamic vital signs may predict in-hospital mortality in elderly trauma patients. Medicine (Baltimore) . 2020;99(25):e20741.</Citation></Reference><Reference><Citation>Keller JM, Sciadini MF, Sinclair E, O'Toole RV. Geriatric trauma: demographics, injuries, and mortality. J Orthop Trauma . 2012;26(9):e161&#x2013;e165.</Citation></Reference><Reference><Citation>Kennedy DM, Cipolle MD, Pasquale MD, Wasser T. Impact of preinjury warfarin use in elderly trauma patients. J Trauma . 2000;48(3):451&#x2013;453.</Citation></Reference><Reference><Citation>Khan M, O'Keeffe T, Jehan F, Kulvatunyou N, Kattaa A, Gries L, et al. The impact of Glasgow Coma Scale&#x2014;age prognosis score on geriatric traumatic brain injury outcomes. J Surg Res . 2017;216:109&#x2013;114.</Citation></Reference><Reference><Citation>Khokhar B, Simoni-Wastila L, Slejko JF, Perfetto E, Zhan M, Smith GS. In-hospital mortality following traumatic brain injury among older Medicare beneficiaries, comparing statin users with nonusers. J Pharm Technol . 2017;33(6):225&#x2013;236.</Citation></Reference><Reference><Citation>Kim SY, Hong KJ, Shin SD, Ro YS, Ahn KO, Kim YJ, et al. Validation of the shock index, modified shock index, and age shock index for predicting mortality of geriatric trauma patients in emergency departments. J Korean Med Sci . 2016;31(12):2026&#x2013;2032.</Citation></Reference><Reference><Citation>Kirshenbom D, Ben-Zaken Z, Albilya N, Niyibizi E, Bala M. Older age, comorbid illnesses, and injury severity affect immediate outcome in elderly trauma patients. J Emerg Trauma Shock . 2017;10(3):146&#x2013;150.</Citation></Reference><Reference><Citation>Peck KA, Calvo RY, Schechter MS, Sise CB, Kahl JE, Shackford MC, et al. The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury. J Trauma Acute Care Surg . 2014;76(2):431&#x2013;436.</Citation></Reference><Reference><Citation>Lai K, Anantha RV, Fawcett V, Tsang B, Kim M, Widder S. Early predictors of discharge to home among severely injured geriatric patients: a single-system retrospective cohort study. Trauma . 2022;24(2):154&#x2013;163.</Citation></Reference><Reference><Citation>Lalwani S, Gera S, Sawhney C, Mathur P, Lalwani P, Misra MC. Mortality profile of geriatric trauma at a level 1 trauma center. J Emerg Trauma Shock . 2020;13(4):269&#x2013;273.</Citation></Reference><Reference><Citation>Lank PM, Crandall ML. Outcomes for older trauma patients in the emergency department screening positive for alcohol, cocaine, or marijuana use. Am J Drug Alcohol Abuse . 2014;40(2):118&#x2013;124.</Citation></Reference><Reference><Citation>Lee H, Tan C, Tran V, Mathew J, Fitzgerald M, Leong R, et al. The utility of the modified frailty index in outcome prediction for elderly patients with acute traumatic subdural hematoma. J Neurotrauma . 2020;37(23):2499&#x2013;2506.</Citation></Reference><Reference><Citation>Lenell S, Nyholm L, Lew&#xe9;n A, Enblad P. Clinical outcome and prognostic factors in elderly traumatic brain injury patients receiving neurointensive care. Acta Neurochir . 2019;161(6):1243&#x2013;1254.</Citation></Reference><Reference><Citation>Liu HT, Wu SC, Tsai CH, Li C, Chou SE, Su WT, et al. Association between geriatric nutritional risk index and mortality in older trauma patients in the intensive care unit. Nutrients . 2020;12(12):3861.</Citation></Reference><Reference><Citation>Lowe J, Bigham C. Does Psoas Lumbar Vertebral Index (PLVI) have any prognostic value in the elderly population with major trauma? In: Critical Care Conference: 38th International Symposium on Intensive Care and Emergency Medicine, ISICEM, March 20&#x2013;23, 2018, Brussels, Belgium. 2018;22(Suppl 1).</Citation></Reference><Reference><Citation>Leskovan JJ, Justiniano CF, Bach JA, Cook CH, Lindsey DE, Eiferman DS, et al. Anion gap as a predictor of trauma outcomes in the older trauma population: correlations with injury severity and mortality. Am Surg . 2013;79(11):1203&#x2013;1206.</Citation></Reference><Reference><Citation>Maghsoudi H, Ghaffari A. Aetiology and outcome of elderly burn patients in Tabriz, Iran. Ann Burns Fire Disasters . 2009;22(3):115&#x2013;120.</Citation></Reference><Reference><Citation>Malekpour M, Bridgham K, Jaap K, Erwin R, Widom K, Rapp M, et al. The effect of sarcopenia on outcomes in geriatric blunt trauma. Am Surg . 2017;83(11):1203&#x2013;1208.</Citation></Reference><Reference><Citation>Martin JT, Alkhoury F, O'Connor JA, Kyriakides TC, Bonadies JA. &#x2018;Normal&#x2019; vital signs belie occult hypoperfusion in geriatric trauma patients. Am Surg . 2010;76(1):65&#x2013;69.</Citation></Reference><Reference><Citation>Matsushima K, Schaefer EW, Won EJ, Armen SB, Indeck MC, Soybel DI. Positive and negative volume-outcome relationships in the geriatric trauma population. JAMA Surg . 2014;149(4):319&#x2013;326.</Citation></Reference><Reference><Citation>Menendez ME, Ring D, Harris MB, Cha TD. Predicting in-hospital mortality in elderly patients with cervical spine fractures: a comparison of the Charlson and Elixhauser comorbidity measures. Spine (Phila Pa 1976) . 2015;40(11):809&#x2013;815.</Citation></Reference><Reference><Citation>Miller PR, Chang MC, Hoth JJ, Hildreth AN, Wolfe SQ, Gross JL, et al. Predicting mortality and independence at discharge in the aging traumatic brain injury population using data available at admission. J Am Coll Surg . 2017;224(4):680&#x2013;685.</Citation></Reference><Reference><Citation>Min L, Burruss S, Morley E, Mody L, Hiatt JR, Cryer H, et al. A simple clinical risk nomogram to predict mortality-associated geriatric complications in severely injured geriatric patients. J Trauma Acute Care Surg . 2013;74(4):1125&#x2013;1132.</Citation></Reference><Reference><Citation>Min L, Cherry-Bukowiec J, Hickey K, Dubin L, Khan F, Chan C, et al. Vulnerable Elders-13 score predicts complications and death in acute trauma. J Am Geriatr Soc . 2018;66:S156.</Citation></Reference><Reference><Citation>Mock K, Keeley J, Moazzez A, Plurad DS, Putnam B, Kim DY. Predictors of mortality in trauma patients aged 80 years or older. Am Surg . 2016;82(10):926&#x2013;929.</Citation></Reference><Reference><Citation>Morris RS, Tignanelli CJ, deRoon-Cassini T, Laud P, Sparapani R. Improved prediction of older adult discharge after trauma using a novel machine learning paradigm. J Surg Res . 2022;270:39&#x2013;48.</Citation></Reference><Reference><Citation>Mubang RN, Stoltzfus JC, Cohen MS, Hoey BA, Stehly CD, Evans DC, et al. Comorbidity-polypharmacy score as predictor of outcomes in older trauma patients: a retrospective validation study. World J Surg . 2015;39(8):2068&#x2013;2075.</Citation></Reference><Reference><Citation>Mulvey HE, Haslam RD, Laytin AD, Diamond CA, Sims CA. Unplanned ICU admission is associated with worse clinical outcomes in geriatric trauma patients. J Surg Res . 2020;245:13&#x2013;21.</Citation></Reference><Reference><Citation>Neideen T, Lam M, Brasel KJ. Preinjury beta blockers are associated with increased mortality in geriatric trauma patients. J Trauma . 2008;65(5):1016&#x2013;1020.</Citation></Reference><Reference><Citation>Neville AL, Nemtsev D, Manasrah R, Bricker SD, Putnam BA. Mortality risk stratification in elderly trauma patients based on initial arterial lactate and base deficit levels. Am Surg . 2011;77(10):1337&#x2013;1341.</Citation></Reference><Reference><Citation>Nishimura T, Naito H, Fujisaki N, Ishihara S, Nakao A, Nakayama S. The psoas muscle index as a predictor of mortality and morbidity of geriatric trauma patients: experience of a major trauma center in Kobe. Surg Today . 2020;50(9):1016&#x2013;1023.</Citation></Reference><Reference><Citation>Nossaman VE, Larsen BE, DiGiacomo JC, Manuelyan Z, Afram R, Shukry S, et al. Mortality is predicted by comorbidity polypharmacy score but not Charlson comorbidity index in geriatric trauma patients. Am J Surg . 2018;216(1):42&#x2013;45.</Citation></Reference><Reference><Citation>O'Neill S, Brady RR, Kerssens JJ, Parks RW. Mortality associated with traumatic injuries in the elderly: a population based study. Arch Gerontol Geriatr . 2012;54(3):e426&#x2013;e430.</Citation></Reference><Reference><Citation>Ohm C, Mina A, Howells G, Bair H, Bendick P. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma . 2005;58(3):518&#x2013;522.</Citation></Reference><Reference><Citation>Olufajo OA, Metcalfe D, Rios-Diaz A, Lilley E, Havens JM, Kelly E, et al. Does hospital experience rather than volume improve outcomes in geriatric trauma patients? J Am Coll Surg . 2016;223(1):32&#x2013;40.e1.</Citation></Reference><Reference><Citation>Oreskovich MR, Howard JD, Copass MK, Carrico CJ. Geriatric trauma: injury patterns and outcome. J Trauma . 1984;24(7):565&#x2013;572.</Citation></Reference><Reference><Citation>Ostermann RC, Joestl J, Tiefenboeck TM, Lang N, Platzer P, Hofbauer M. Risk factors predicting prognosis and outcome of elderly patients with isolated traumatic brain injury. J Orthop Surg Res . 2018;13(1):277.</Citation></Reference><Reference><Citation>Pagin M, Mabire C, Cotton M, Zingg T, Carron PN. Retrospective analysis of geriatric major trauma patients admitted in the shock room of a Swiss academic hospital: characteristics and prognosis. J Clin Med . 2020;9(5):1343.</Citation></Reference><Reference><Citation>Pandit V, Joseph B, Rhee PM, Aziz H, Kulvatunyou N, Wynne JL, et al. Frailty is superior to age in predicting outcomes in geriatric trauma patients: A prospective analysis. J Am Coll Surg . 2013;217(3):S59.</Citation></Reference><Reference><Citation>Pandit V, Rhee P, Hashmi A, Kulvatunyou N, Tang A, Khalil M, et al. Shock index predicts mortality in geriatric trauma patients: an analysis of the National Trauma Data Bank. J Trauma Acute Care Surg . 2014;76(4):1111&#x2013;1115.</Citation></Reference><Reference><Citation>Pecheva M, Phillips M, Hull P, Carrothers A OR, Queally JM. The impact of frailty in major trauma in older patients. Injury . 2020;51(7):1536&#x2013;1542.</Citation></Reference><Reference><Citation>Penasco Y, Gonzalez-Castro A, Rodriguez-Borregan JC, Munoz C, Llorca J. Evoluci&#xf3;n de la mortalidad en el traumatismo tor&#xe1;cico grave del paciente anciano [Evolution of mortality in severe chest trauma in the elderly patient]. Rev Calidad Asistencial . 2016;31(4):204&#x2013;211.</Citation></Reference><Reference><Citation>Pe&#xf1;asco Y, Gonz&#xe1;lez-Castro A, Rodr&#xed;guez-Borreg&#xe1;n JC, Llorca J. Base excess, a useful marker in the prognosis of chest trauma in the geriatric population. Rev Esp Anestesiol Reanim . 2017;64(5):250&#x2013;256.</Citation></Reference><Reference><Citation>Phung ET, Hebert RS, Chow E, Toevs C. Does the palliative performance score correlate with mortality in the geriatric trauma population? J Am Geriatr Soc . 2015;63:S106.</Citation></Reference><Reference><Citation>Prabhakaran K, Gogna S, Klein J, Latifi R, Rhee P. Trauma center designation impacts outcomes in geriatric trauma. J Am Coll Surg . 2020;231(4):S333&#x2013;S334.</Citation></Reference><Reference><Citation>Pracht EE, Langland-Orban B, Flint L. Survival advantage for elderly trauma patients treated in a designated trauma center. J Trauma . 2011;71(1):69&#x2013;77.</Citation></Reference><Reference><Citation>Proksch DM, Kelley KM, White S, Burgess JR. Identification of sarcopenia in elderly trauma patients: the value of clinical competency and experience. Am Surg . 2022;88(3):339&#x2013;342.</Citation></Reference><Reference><Citation>Ravindranath S, Ho KM, Rao S, Nasim S, Burrell M. Validation of the geriatric trauma outcome scores in predicting outcomes of elderly trauma patients. Injury . 2021;52(2):154&#x2013;159.</Citation></Reference><Reference><Citation>Rickard F, Ibitoye S, Deakin H, Walton B, Thompson J, Shipway D, et al. The clinical frailty scale predicts adverse outcome in older people admitted to a UK major trauma Centre. Age Ageing . 2021;50(3):891&#x2013;897.</Citation></Reference><Reference><Citation>Rogers FB, Morgan ME, Brown CT, Vernon TM, Bresz KE, Cook AD, et al. Geriatric trauma mortality: does trauma center level matter? Am Surg . 2021;87(12):1965&#x2013;1971.</Citation></Reference><Reference><Citation>Rohr K. Alcohol use and injury-related outcomes in older rural trauma patients. Prairie Rose . 2007;76(4):6&#x2013;11.</Citation></Reference><Reference><Citation>Romanowski KS, Barsun A, Pamlieri TL, Greenhalgh DG, Sen S. Frailty score on admission predicts outcomes in elderly burn injury. J Burn Care Res . 2015;36(1):1&#x2013;6.</Citation></Reference><Reference><Citation>Ronning P, Helseth E, Skaansar O, Tverdal C, Andelic N, Bhatnagar R, et al. Impact of preinjury antithrombotic therapy on 30-day mortality in older patients hospitalized with traumatic brain injury (TBI). Front Neurol . 2021;12:650695.</Citation></Reference><Reference><Citation>Rupprecht H, Heppner HJ, Wohlfart K, Turkoglu A. The geriatric polytrauma: risk profile and prognostic factors. Ulus Travma Acil Cerrahi Derg . 2017;23(2):156&#x2013;162.</Citation></Reference><Reference><Citation>Sadarangani T, Squires A. Frailty as a predictive factor in geriatric trauma patient outcomes. J Clin Outcomes Manag . 2014;21(9):396&#x2013;397.</Citation></Reference><Reference><Citation>Tawab Saljuqi A, Khurrum M, Hanna K, Bible L, Asmar S, Chehab M, et al. Impact of race and ethnicity on health outcomes among geriatric trauma patients. J Am Coll Surg . 2020;231(4):e144&#x2013;e145.</Citation></Reference><Reference><Citation>Salottolo KM, Mains CW, Offner PJ, Bourg PW, Bar-Or D. A retrospective analysis of geriatric trauma patients: venous lactate is a better predictor of mortality than traditional vital signs. Scand J Trauma Resusc Emerg Med . 2013;21:7.</Citation></Reference><Reference><Citation>Savioli G, Ceresa IF, Macedonio S, Gerosa S, Belliato M, Luzzi S, et al. Major trauma in elderly patients: worse mortality and outcomes in an Italian trauma center. J Emerg Trauma Shock . 2021;14(2):98&#x2013;103.</Citation></Reference><Reference><Citation>Scheetz LJ. Differences in survival, length of stay, and discharge disposition of older trauma patients admitted to trauma centers and nontrauma center hospitals. J Nurs Scholarsh . 2005;37(4):361&#x2013;366.</Citation></Reference><Reference><Citation>Scherer J, Kalbas Y, Ziegenhain F, Neuhaus V, Lefering R, Teuben M, et al. The GERtality score: the development of a simple tool to help predict in-hospital mortality in geriatric trauma patients. J Clin Med . 2021;10(7):1362.</Citation></Reference><Reference><Citation>Schneider EB, Efron DT, MacKenzie EJ, Rivara FP, Nathens AB, Jurkovich GJ. Premorbid statin use is associated with improved survival and functional outcomes in older head-injured individuals. J Trauma . 2011;71(4):815&#x2013;819.</Citation></Reference><Reference><Citation>Stephen AH, Heffernan DS, Monaghan SF, Adams CA Jr., Cioffi WG. The presence, but not the degree of systemic inflammatory response syndrome (SIRS) in elderly trauma patients is predictive of mortality. J Surg Res . 2010;158(2):351&#x2013;352.</Citation></Reference><Reference><Citation>Su WT, Tsai CH, Huang CY, Chou SE, Li C, Hsu SY, et al. Geriatric nutritional risk index as a prognostic factor for mortality in elderly patients with moderate to severe traumatic brain injuries. Risk Manag Healthc Policy . 2021;14:2465&#x2013;2474.</Citation></Reference><Reference><Citation>Thompson A, Gida S, Nassif Y, Hope C, Brooks A. The impact of frailty on trauma outcomes using the clinical frailty scale. Eur J Trauma Emerg Surg . 2022;48(2):1271&#x2013;1276.</Citation></Reference><Reference><Citation>Ubeda A, Alonso L, Esquinas AM. Base excess, a useful marker in the prognosis of chest trauma in the geriatric population. Rev Esp Anestesiol Reanim (Engl Ed) . 2018;65(1):64&#x2013;65.</Citation></Reference><Reference><Citation>van Aalst JA, Morris JA Jr., Yates HK, Miller RS, Bass SM. Severely injured geriatric patients return to independent living: a study of factors influencing function and independence. J Trauma . 1991;31(8):1096&#x2013;1101; discussion 1101-2.</Citation></Reference><Reference><Citation>Wallace JD, Calvo RY, Brill J, Lewis P, Sise M, Shackford S, et al. Masseter muscle a measure of sarcopenia and mortality in geriatric trauma patients. J Am Geriatr Soc . 2016;64:S12.</Citation></Reference><Reference><Citation>Wan X, Zhao K, Wang S, Zhang H, Zeng L, Wang Y, et al. Is it reliable to predict the outcome of elderly patients with severe traumatic brain injury using the IMPACT prognostic calculator? World Neurosurg . 2017;103:584&#x2013;590.</Citation></Reference><Reference><Citation>Watts HF, Kerem Y, Kulstad EB. Evaluation of the revised trauma and injury severity scores in elderly trauma patients. J Emerg Trauma Shock . 2012;5(2):131&#x2013;134.</Citation></Reference><Reference><Citation>Wilson MS, Konda SR, Seymour RB, Karunakar MA; Carolinas Trauma Network Research Group. Early predictors of mortality in geriatric patients with trauma. J Orthop Trauma . 2016;30(9):e299&#x2013;e304.</Citation></Reference><Reference><Citation>Wu SC, Rau CS, Kuo PJ, Liu HT, Hsu SY, Hsieh CH. Significance of blood transfusion units in determining the probability of mortality among elderly trauma patients based on the geriatric trauma outcome scoring system: a cross-sectional analysis based on trauma registered data. Int J Environ Res Public Health . 2018;15(10):2285.</Citation></Reference><Reference><Citation>Yadollahi M, Mahmoudi A, Niakan M, Dashti MF. Evaluating risk factors of geriatric trauma mortality by logistic regression: a cross-sectional study in 2011&#x2013;2016. Iran Red Crescent Med J . 2018;20(5): (no pagination).</Citation></Reference><Reference><Citation>Yeates EO, Grigorian A, Kuza CM, Nguyen NT, Inaba K, Dolich M, et al. The DEPARTS score: a novel tool for predicting discharge disposition in geriatric trauma patients. Am Surg . 2023;89(3):447&#x2013;451.</Citation></Reference><Reference><Citation>Zhao F, Tang B, Liu X, Weng W, Wang B, Wang Y, et al. Development and validation of the geriatric trauma frailty index for geriatric trauma patients based on electronic hospital records. Age Ageing . 2022;51(1):afab186.</Citation></Reference><Reference><Citation>Ferrera PC, Bartfield JM, D'Andrea CC. Geriatric trauma: outcomes of elderly patients discharged from the ED. J Emerg Med . 1999;17(7):629&#x2013;632.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37741720</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Outcomes following perioperative red blood cell transfusion in patients undergoing elective major abdominal surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1002</StartPage><EndPage>1013</EndPage><MedlinePgn>1002-1013</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2023.08.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(23)00484-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative red blood cell transfusion is a double-edged sword for surgical patients. While transfusion of red cells can increase oxygen delivery by increasing haemoglobin levels, its impact on short- and long-term postoperative outcomes, particularly in patients undergoing elective major abdominal surgery, is unclear.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review and meta-analysis on the effect of perioperative blood transfusions on postoperative outcomes in elective major abdominal surgery. PubMed, Cochrane, and Scopus databases were searched for studies with data collected between January 1, 2000 and June 6, 2020. The primary outcome was short-term mortality, including all-cause 30-day or in-hospital mortality. Secondary outcomes included long-term all-cause mortality, any morbidity, infectious complications, overall survival, and recurrence-free survival. No randomised controlled trials were found. Thirty-nine observational studies were identified, of which 37 were included in the meta-analysis.</AbstractText><AbstractText Label="RESULTS">Perioperative blood transfusion was associated with short-term all-cause mortality (odds ratio [OR] 2.72, 95% confidence interval [CI] 1.89-3.91, P&lt;0.001), long-term all-cause mortality (hazard ratio 1.35, 95% CI 1.09-1.67, P=0.007), any morbidity (OR 2.18, 95% CI 1.81-2.64, P&lt;0.001), and infectious complications (OR 1.90, 95% CI 1.60-2.26, P&lt;0.001). Perioperative blood transfusion remained associated with short-term mortality in the sensitivity analysis after excluding studies that did not control for preoperative anaemia (OR 2.27, 95% CI 1.59-3.24, P&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Perioperative blood transfusion in patients undergoing elective major abdominal surgery is associated with poorer short- and long-term postoperative outcomes. This highlights the need to implement patient blood management strategies to manage and preserve the patient's own blood and reduce the need for red blood cell transfusion.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO (CRD42021254360).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Fraser J D</ForeName><Initials>FJD</Initials><AffiliationInfo><Affiliation>School of Health, University of the Sunshine Coast, Sippy Downs, QLD, Australia. Electronic address: fraser.morris@research.usc.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fung</LastName><ForeName>Yoke-Lin</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>School of Health, University of the Sunshine Coast, Sippy Downs, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craswell</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Health, University of the Sunshine Coast, Sippy Downs, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="Y">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="Y">Anemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaemia</Keyword><Keyword MajorTopicYN="N">elective surgery</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">patient blood management</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">red blood cell transfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>23</Day><Hour>21</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37741720</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2023.08.032</ArticleId><ArticleId IdType="pii">S0007-0912(23)00484-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39618849</PMID><DateRevised><Year>2024</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2153-8174</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Reviews in cardiovascular medicine</Title><ISOAbbreviation>Rev Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>The Incidence, Risk Factors, and Hospital Mortality of Prolonged Mechanical Ventilation among Cardiac Surgery Patients: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>409</StartPage><MedlinePgn>409</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">409</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.31083/j.rcm2511409</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Prolonged mechanical ventilation (PMV) is a common complication after cardiac surgery and is considered a risk factor for poor outcomes. However, the incidence and in-hospital mortality of PMV among cardiac surgery patients reported in studies vary widely, and risk factors are controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched four databases (Web of Science, Cochrane Library, PubMed, and EMBASE) for English-language articles from inception to October 2023. The odds ratio (OR), 95% confidence interval (CI), PMV incidence, and in-hospital mortality were extracted. Statistical data analysis was performed using Stata software. We calculated the fixed or random effects model according to the heterogeneity. The quality of each study was appraised by two independent reviewers using the Newcastle-Ottawa scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Thirty-two studies were included. The incidence of PMV was 20%. Twenty-one risk factors were pooled, fifteen risk factors were found to be statistically significant (advanced age, being female, ejection fraction &lt;50, body mass index (BMI), BMI &gt;28 kg/m<sup>2</sup>, New York Heart Association Class &#x2265;&#x2162;, chronic obstructive pulmonary disease, chronic renal failure, heart failure, arrhythmia, previous cardiac surgery, higher white blood cell count, creatinine, longer cardiopulmonary bypass (CPB) time, and CPB &gt;120 min). In addition, PMV was associated with increased in-hospital mortality (OR, 14.13, 95% CI, 12.16-16.41, I<sup>2</sup> = 90.3%, <i>p</i> &lt; 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The PMV incidence was 20%, and it was associated with increased in-hospital mortality. Fifteen risk factors were identified. More studies are needed to prevent PMV more effectively according to these risk factors.</AbstractText><AbstractText Label="THE PROSPERO REGISTRATION" NlmCategory="UNASSIGNED">This systematic review and meta-analysis was recorded at PROSPERO (CRD42021273953, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=273953).</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 The Author(s). Published by IMR Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiaoying</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, 350005 Fuzhou, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nursing, Jingmen Peoples Hospital, 448001 Jingmen, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nursing, Women and Children's Hospital, School of Medicine, Xiamen University, 361005 Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shurong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, 350005 Fuzhou, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lingyu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liangwan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yanjuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Rev Cardiovasc Med</MedlineTA><NlmUniqueID>100960007</NlmUniqueID><ISSNLinking>1530-6550</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgical patients</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">prolonged mechanical ventilation</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>5</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39618849</ArticleId><ArticleId IdType="pmc">PMC11607491</ArticleId><ArticleId IdType="doi">10.31083/j.rcm2511409</ArticleId><ArticleId IdType="pii">S1530-6550(24)01525-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology . 2020;76:2982&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Lin Y, Peng Y, Huang X, Zhang X, Chen L, et al. Admission Hyperglycemia in Acute Type A Aortic Dissection Predicts for a Prolonged Duration of Mechanical Ventilation. International Heart Journal . 2022;63:106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">35034919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko HK, Liu CY, Ho LI, Chen PK, Shie HG. Predictors of delayed extubation following lung resection: Focusing on preoperative pulmonary function and incentive spirometry. Journal of the Chinese Medical Association: JCMA . 2021;84:368&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">33784264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberberg MD, de Wit M, Pirone JR, Shorr AF. Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery. Critical Care Medicine . 2008;36:1451&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pubmed">18434911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberberg MD, de Wit M, Shorr AF. Accuracy of previous estimates for adult prolonged acute mechanical ventilation volume in 2020: update using 2000-2008 data. Critical Care Medicine . 2012;40:18&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">21926594</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient Numbers and Healthcare Cost of Prolonged Mechanical V entilation in Taiwan since 2015&#x2013;2019. 2019.  [(Accessed: 15 September 2020)].  Available at:
 https://news.ltn.com.tw/news/life/paper/1399672
.</Citation></Reference><Reference><Citation>Papathanasiou M, Mincu RI, Lortz J, Horacek M, Koch A, Pizanis N, et al. Prolonged mechanical ventilation after left ventricular assist device implantation: risk factors and clinical implications. ESC Heart Failure . 2019;6:545&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487691</ArticleId><ArticleId IdType="pubmed">30861636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumus F, Polat A, Yektas A, Totoz T, Bagci M, Erentug V, et al. Prolonged mechanical ventilation after CABG: risk factor analysis. Journal of Cardiothoracic and Vascular Anesthesia . 2015;29:52&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25620139</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Li N, Li Y, Song Z, Zhao A. Risk Factors for Postoperative Prolonged Ventilation Time in Acute Type A Aortic Dissection Patients Received Modified Aortic Root Procedure. The Heart Surgery Forum . 2019;22:E476&#x2013;E480.</Citation><ArticleIdList><ArticleId IdType="pubmed">31895033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu H, Lai HC, Liu TJ. Factors causing prolonged mechanical ventilation and peri-operative morbidity after robot-assisted coronary artery bypass graft surgery. Heart and Vessels . 2019;34:44&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30006655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AD, Fowler RA, Burns KEA, Rose L, Pinto RL, Scales DC. Long-Term Outcomes and Health Care Utilization after Prolonged Mechanical Ventilation. Annals of the American Thoracic Society . 2017;14:355&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">28033033</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh HZ, Shaw M, Al-Rawi O, Yates J, Pullan DM, Chalmers JAC, et al. Outcomes and predictors of prolonged ventilation in patients undergoing elective coronary surgery. Interactive Cardiovascular and Thoracic Surgery . 2012;15:51&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380973</ArticleId><ArticleId IdType="pubmed">22495507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartz RR, Ferreira RG, Schroder JN, Davies J, Liu WW, Camara A, et al. Prolonged pulmonary support after cardiac surgery: incidence, risk factors and outcomes: a retrospective cohort study. Journal of Critical Care . 2015;30:940&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">26205187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge M, Wang Z, Chen T, Cheng Y, Ye J, Lu L, et al. Risk factors for and outcomes of prolonged mechanical ventilation in patients received DeBakey type I aortic dissection repairment. Journal of Thoracic Disease . 2021;13:735&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7947516</ArticleId><ArticleId IdType="pubmed">33717545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V, Rao V, Manlhiot C, Boruvka A, Fremes S, W&#x105;sowicz M. A derived and validated score to predict prolonged mechanical ventilation in patients undergoing cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery . 2017;153:108&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">27665221</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotto RF, Ferreira FB, Col&#xf3;simo FC, Silva GS, Sousa AG, Braile DM. Independent predictors of prolonged mechanical ventilation after coronary artery bypass surgery. Revista Brasileira de Cirurgia Cardiovascular . 2012;27:520&#x2013;528. (In English, Portuguese)</Citation><ArticleIdList><ArticleId IdType="pubmed">23515724</ArticleId></ArticleIdList></Reference><Reference><Citation>Engle J, Safi HJ, Miller CC, 3rd, Campbell MP, Harlin SA, Letsou GV, et al. The impact of diaphragm management on prolonged ventilator support after thoracoabdominal aortic repair. Journal of Vascular Surgery . 1999;29:150&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">9882799</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern H, Redlich U, Hotz H, von Heymann C, Grosse J, Konertz W, et al. Risk factors for prolonged ventilation after cardiac surgery using APACHE II, SAPS II, and TISS: comparison of three different models. Intensive Care Medicine . 2001;27:407&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">11396286</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;gar&#xe9; JF, Hirsch GM, Buth KJ, MacDougall C, Sullivan JA. Preoperative prediction of prolonged mechanical ventilation following coronary artery bypass grafting. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery . 2001;20:930&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">11675177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Quasney MW, Tolley EA, Wunderink RG. Clinical relevance of angiotensin-converting enzyme gene polymorphisms to predict risk of mechanical ventilation after coronary artery bypass graft surgery. Critical Care Medicine . 2004;32:922&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pubmed">15071379</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan K, Patil S, Lesley N, Ninan B. Predictors of prolonged mechanical ventilation after on-pump coronary artery bypass grafting. Annals of Cardiac Anaesthesia . 2006;9:31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Q, Chen L, Zhang Y, Fang N, Cheng W, Li L. Predictors of prolonged mechanical ventilation after aortic arch surgery with deep hypothermic circulatory arrest plus antegrade selective cerebral perfusion. Journal of Cardiothoracic and Vascular Anesthesia . 2009;23:495&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">19054693</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirzad M, Karimi A, Ahmadi SH, Marzban M, Tazik M, Aramin H. Predictors and early outcome of prolonged mechanical ventilation in contemporary heart valve surgery. Monaldi Archives for Chest Disease = Archivio Monaldi per Le Malattie Del Torace. Monaldi Archives for Chest Disease = Archivio Monaldi per Le Malattie Del Torace . 2010;74:22&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">20925175</ArticleId></ArticleIdList></Reference><Reference><Citation>Christian K, Engel AM, Smith JM. Predictors and outcomes of prolonged ventilation after coronary artery bypass graft surgery. The American Surgeon . 2011;77:942&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pubmed">21944364</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui MMA, Paras I, Jalal A. Risk factors of prolonged mechanical ventilation following open heart surgery: what has changed over the last decade? Cardiovascular Diagnosis and Therapy . 2012;2:192&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839186</ArticleId><ArticleId IdType="pubmed">24282717</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise ES, Stonko DP, Glaser ZA, Garcia KL, Huang JJ, Kim JS, et al. Prediction of Prolonged Ventilation after Coronary Artery Bypass Grafting: Data from an Artificial Neural Network. The Heart Surgery Forum . 2017;20:E007&#x2013;E014.</Citation><ArticleIdList><ArticleId IdType="pubmed">28263144</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy R, Karakoc AZ, Cevirme D, Elibol A, Yigit F, Yilmaz &#xdc;, et al. Predictive Factors of Prolonged Ventilation Following Cardiac Surgery with Cardiopulmonary Bypass. Brazilian Journal of Cardiovascular Surgery . 2021;36:780&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641772</ArticleId><ArticleId IdType="pubmed">34236782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreibich M, Kaier K, von Zur M&#xfc;hlen C, Siepe M, Zehender M, Bode C, et al. In-hospital outcomes of patients undergoing concomitant aortic and mitral valve replacement in Germany. Interactive Cardiovascular and Thoracic Surgery . 2022;34:349&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860409</ArticleId><ArticleId IdType="pubmed">34907441</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu J, Xu Z, Wang Y, Chen L, Bai Y, et al. Early identification of delayed extubation following cardiac surgery: Development and validation of a risk prediction model. Frontiers in Cardiovascular Medicine . 2022;9:1002768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9576842</ArticleId><ArticleId IdType="pubmed">36267640</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaud L, Dureau P, Kerleroux B, Charfeddine A, Regan M, Constantin JM, et al. Development and Validation of a Predictive Score for Prolonged Mechanical Ventilation After Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia . 2022;36:825&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">34330573</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Gu H, Qian X, Wu H, Liu Y, Ji P, et al. Establishment of a nomogram for predicting prolonged mechanical ventilation in cardiovascular surgery patients. European Journal of Cardiovascular Nursing . 2023;22:594&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pubmed">36017648</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankar A, Rotstein AJ, Teja B, Carrier FM, Belley-C&#xf4;t&#xe9; EP, Bolliger D, et al. Prolonged mechanical ventilation after cardiac surgery: substudy of the Transfusion Requirements in Cardiac Surgery III trial. Canadian Journal of Anaesthesia = Journal Canadien D&#x2019;anesthesie . 2022;69:1493&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9484719</ArticleId><ArticleId IdType="pubmed">36123418</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Q, Li C, Zhong Y, Luo C, Guo R, Liu Y, et al. Blood Transfusion Predicts Prolonged Mechanical Ventilation in Acute Stanford Type A Aortic Dissection Undergoing Total Aortic Arch Replacement. Frontiers in Cardiovascular Medicine . 2022;9:832396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9053570</ArticleId><ArticleId IdType="pubmed">35498041</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Xu J, Zhao C, Pan G. Risk Factors of Prolonged Mechanical Ventilation in Patients Undergoing Redo Valve Surgery. The Heart Surgery Forum . 2022;25:E683&#x2013;E688.</Citation><ArticleIdList><ArticleId IdType="pubmed">36317905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Gao S, Diao X, Yan W, Yan S, Gao G, et al. Dose-dependent influence of red blood cell transfusion volume on adverse outcomes in cardiac surgery. Perfusion . 2023;38:1436&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">35839260</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X, Sun J, Hong L, Song X, Zhang C, Liu Y, et al. Decreased triiodothyronine (T3) as a predictor for prolonged mechanical ventilation in critically ill patients with cardiac surgery. BMC Anesthesiology . 2022;22:66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905776</ArticleId><ArticleId IdType="pubmed">35264101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi S, Abdi A, Salari N, Shohaimi S, Naghibeiranvand M. Factors associated with long-term mechanical ventilation in patients undergoing cardiovascular surgery. BMC Cardiovascular Disorders . 2023;23:276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10210485</ArticleId><ArticleId IdType="pubmed">37231337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, He H, Cui N, Wang X, Long Y, Liu D. Elevated pulsatility index of the superior mesenteric artery indicated prolonged mechanical ventilation in patients after cardiac valve surgery. Frontiers in Surgery . 2023;9:1049753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9852328</ArticleId><ArticleId IdType="pubmed">36684265</ArticleId></ArticleIdList></Reference><Reference><Citation>Celkan MA, Ustunsoy H, Daglar B, Kazaz H, Kocoglu H. Readmission and mortality in patients undergoing off-pump coronary artery bypass surgery with fast-track recovery protocol. Heart and Vessels . 2005;20:251&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">16314906</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahian DM, O&#x2019;Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1&#x2013;coronary artery bypass grafting surgery. The Annals of Thoracic Surgery . 2009;88:S2&#x2013;S22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19559822</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouveia E Melo R, Mour&#xe3;o M, Caldeira D, Alves M, Lopes A, Duarte A, et al. A systematic review and meta-analysis of the incidence of acute aortic dissections in population-based studies. Journal of Vascular Surgery . 2022;75:709&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">34560218</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Bie M. Predictors for the development of preoperative oxygenation impairment in acute aortic dissection in hypertensive patients. BMC Cardiovascular Disorders . 2020;20:365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7416810</ArticleId><ArticleId IdType="pubmed">32778051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier D, Velly LJ, Guinard B, Bruder N, Guidon C, Vidal Melo MF, et al. Perioperative Open-lung Approach, Regional Ventilation, and Lung Injury in Cardiac Surgery. Anesthesiology . 2020;133:1029&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907969</ArticleId><ArticleId IdType="pubmed">32902561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa Y, Ishikawa S, Ohtaki A, Otani Y, Takahashi T, Sato Y, et al. Impaired lung oxygenation in acute aortic dissection. The Journal of Cardiovascular Surgery . 1999;40:191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">10350101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Yang L, Shi S, Fang Z, Li J, Wang G. Risk Factors for Prolonged Mechanical Ventilation After Pulmonary Endarterectomy: 7 Years&#x2019; Experience From an Experienced Hospital in China. Frontiers in surgery . 2021;8:679273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222625</ArticleId><ArticleId IdType="pubmed">34179069</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Zhang Y, Li S, Wang X, Zhang R, Lu Z, et al. Risk Factors Associated with Prolonged Mechanical Ventilation after Corrective Surgery for Tetralogy of Fallot. Congenital Heart Disease . 2015;10:254&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">25059746</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas AHEM, Appelman YEA. Gender differences in coronary heart disease. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation . 2010;18:598&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3018605</ArticleId><ArticleId IdType="pubmed">21301622</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Li Z, Jiang L, Wang Y, Xi X. Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis. Acta Neurologica Scandinavica . 2018;138:104&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">29845614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe KS, Patel BK, MacKenzie EL, Giovanni SP, Pohlman AS, Churpek MM, et al. Impact of Vasoactive Medications on ICU-Acquired Weakness in Mechanically Ventilated Patients. Chest . 2018;154:781&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689081</ArticleId><ArticleId IdType="pubmed">30217640</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Xie L, Zhu W, Zhou Y. Association of body mass index and all-cause mortality in patients after cardiac surgery: A dose-response meta-analysis. Nutrition (Burbank, Los Angeles County, Calif.) . 2020;72:110696.</Citation><ArticleIdList><ArticleId IdType="pubmed">32007807</ArticleId></ArticleIdList></Reference><Reference><Citation>Spivack SD, Shinozaki T, Albertini JJ, Deane R. Preoperative prediction of postoperative respiratory outcome. Coronary artery bypass grafting. Chest . 1996;109:1222&#x2013;1230.</Citation><ArticleIdList><ArticleId IdType="pubmed">8625671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. Journal of Cardiac Failure . 2002;8:136&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">12140805</ArticleId></ArticleIdList></Reference><Reference><Citation>Robitaille A, Denault AY, Couture P, B&#xe9;lisle S, Fortier A, Guertin MC, et al. Importance of relative pulmonary hypertension in cardiac surgery: the mean systemic-to-pulmonary artery pressure ratio. Journal of Cardiothoracic and Vascular Anesthesia . 2006;20:331&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">16750732</ArticleId></ArticleIdList></Reference><Reference><Citation>Canver CC, Chanda J. Intraoperative and postoperative risk factors for respiratory failure after coronary bypass. The Annals of Thoracic Surgery . 2003;75:853&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">12645706</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy SLC, Grayson AD, Griffiths EM, Pullan DM, Rashid A. Logistic risk model for prolonged ventilation after adult cardiac surgery. The Annals of Thoracic Surgery . 2007;84:528&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">17643630</ArticleId></ArticleIdList></Reference><Reference><Citation>Cislaghi F, Condemi AM, Corona A. Predictors of prolonged mechanical ventilation in a cohort of 5123 cardiac surgical patients. European Journal of Anaesthesiology . 2009;26:396&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">19276979</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado RJ, Saraiva FA, Mancio J, Sousa P, Cerqueira RJ, Barros AS, et al. A systematic review and meta-analysis of randomized controlled studies comparing off-pump versus on-pump coronary artery bypass grafting in the elderly. The Journal of Cardiovascular Surgery . 2022;63:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">34792312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Zhou M, Wei Y, Chen H. Time-varying intensity of oxygen exposure is associated with mortality in critically ill patients with mechanical ventilation. Critical Care (London, England) . 2022;26:239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356484</ArticleId><ArticleId IdType="pubmed">35932009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31283687</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1534-6080</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Transplantation</Title><ISOAbbreviation>Transplantation</ISOAbbreviation></Journal><ArticleTitle>Bilateral Lung Transplantation Provides Better Long-term Survival and Pulmonary Function Than Single Lung Transplantation: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>2634</StartPage><EndPage>2644</EndPage><MedlinePgn>2634-2644</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TP.0000000000002841</ELocationID><Abstract><AbstractText Label="BACKGROUND">Both bilateral lung transplantation (BLT) and single lung transplantation (SLT) are commonly used, but which method is better remains controversial. This meta-analysis was conducted to compare the 2 surgical procedures to identify a better clinical choice.</AbstractText><AbstractText Label="METHODS">Cohort studies comparing SLT and BLT were identified by conducting searches of databases and screening references of retrieved articles. Survival, pulmonary function, surgical indicators, and complications were compared between the 2 groups.</AbstractText><AbstractText Label="RESULTS">Thirty studies (1980 recipients in the SLT group and 2112 recipients in the BLT group) were pooled in the meta-analysis. The long-term overall survival rate (OSR) (OSR-4y and OSR-5y), bronchiolitis obliterans syndrome (BOS)-free survival, BOS-free survival rate (BFSR) (2-5 y), 6-minute walking distance, forced expiratory volume in 1 second (%), forced vital capacity (%), oxygenation index, pulmonary arterial pressure, Arterial partial pressure of oxygen (Pao2), diffusing capacity of the lung for carbon monoxide (Dlco), and BOS were better in the BLT group than in the SLT group. The advantages shown in the BLT group compared with the SLT group in regard to these variables increased with the prolongation of survival time. However, surgical time, ischemic time, postoperative intensive care unit days, and postoperative hospital days were shorter in the SLT group than in the BLT group. Overall survival, short-term OSR (1-3 y), BSFR-1y, in-hospital mortality, postoperative ventilator days, and postoperative complications (except BOS) were similar between the 2 groups. Bacterial pneumonia, graft failure, fungal infection, cardiac arrhythmia, and hemorrhage were the top 5 causes of in-hospital mortality.</AbstractText><AbstractText Label="CONCLUSIONS">BLT appears to be associated with better long-term survival, better postoperative lung function, and less BOS compared with SLT. In-hospital mortality and postoperative complications (except BOS) were similar between the 2 groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haoda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Wuxi People's Hospital affiliated to Nanjing Medical University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Wuxi People's Hospital affiliated to Nanjing Medical University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Wuxi People's Hospital affiliated to Nanjing Medical University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yiping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The second affiliated hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jianjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The second affiliated hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>JianRong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Wuxi People's Hospital affiliated to Nanjing Medical University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenxiong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The second affiliated hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplantation</MedlineTA><NlmUniqueID>0132144</NlmUniqueID><ISSNLinking>0041-1337</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="N">Lung Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31283687</ArticleId><ArticleId IdType="doi">10.1097/TP.0000000000002841</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35244803</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2110-5820</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Annals of intensive care</Title><ISOAbbreviation>Ann Intensive Care</ISOAbbreviation></Journal><ArticleTitle>Intensive care unit capacity and mortality in older adults: a three nations retrospective observational cohort study.</ArticleTitle><Pagination><StartPage>20</StartPage><MedlinePgn>20</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13613-022-00994-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intensive care unit (ICU) admissions among older adults are expected to increase, while the benefit remains uncertain. The availability of ICU beds varies between hospitals and between countries and is an important factor in the decision to admit older adults in the ICU. We aimed to assess if a non-restrictive approach to ICU older adults admission is associated with a corresponding change in survival.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort study that included patients&#x2009;&#x2265;&#x2009;80&#xa0;years who were admitted to each of the three participating hospitals in Australia, Israel, and the United States (USA), between the years 2006-2015, each with distinct ICU capacities and admission criteria. The primary outcomes were in-hospital mortality and all-cause mortality at 6, 12, 18, and 24&#xa0;months following index hospitalization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The cohort included 62,866 patients with a mean age of 85.9&#x2009;&#xb1;&#x2009;4.6&#xa0;years and 58.8% were women. The ICU admission rates were 22.5%, 2.6% and 2.3% in USA, Australia, and Israel, respectively. We constructed a model for ICU admissions based on the USA cohort (highest availability of ICU beds) and then calculated the expected probabilities for the Israeli and Australian cohorts. For the patients in the highest quintile of the admission model, actual ICU admission rates were 67.6% in USA, 22.1% in Australia and 6.0% in Israel. Of these, in-hospital death rates were 52.3% in Israel, 29.8% in Australia, and 22.1% in USA. Two years after hospital discharge, the survival rates in the USA and Australia were 53%, while in Israel 48%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ICU admission of adults&#x2009;&#x2265;&#x2009;80&#xa0;years is associated with increased in-hospital survival compared to ward admission, but survival rates 2 years later are similar.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Abuhasira</LastName><ForeName>Ran</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7031-6498</Identifier><AffiliationInfo><Affiliation>Clinical Research Center, Soroka University Medical Center, Beer Sheva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Anstey</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sir Charles Gairdner Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novack</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Soroka University Medical Center, Beer Sheva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bose</LastName><ForeName>Somnath</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Anesthesia Research Excellence (CARE), Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talmor</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Lior</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. liorfuchs@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Intensive Care Unit, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel. liorfuchs@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Ann Intensive Care</MedlineTA><NlmUniqueID>101562873</NlmUniqueID><ISSNLinking>2110-5820</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aged</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Hospital mortality</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35244803</ArticleId><ArticleId IdType="pmc">PMC8897522</ArticleId><ArticleId IdType="doi">10.1186/s13613-022-00994-x</ArticleId><ArticleId IdType="pii">10.1186/s13613-022-00994-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bagshaw SM, Webb SAR, Delaney A, George C, Pilcher D, Hart GK, et al. Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care BioMed Central. 2009;13:R45. doi: 10.1186/cc7768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7768</ArticleId><ArticleId IdType="pmc">PMC2689489</ArticleId><ArticleId IdType="pubmed">19335921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerolle N, Trinquart L, Bornstain C, Tadi&#xe9; JM, Imbert A, Diehl JL, et al. Increased intensity of treatment and decreased mortality in elderly patients in an intensive care unit over a decade. Crit Care Med. 2010;38:59&#x2013;64. doi: 10.1097/CCM.0b013e3181b088ec.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181b088ec</ArticleId><ArticleId IdType="pubmed">19633539</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations D of E and SA. World Population Ageing 2019 [Internet]. 2019 [cited 2021 May 6]. Available from: https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf.</Citation></Reference><Reference><Citation>Halpern NA, Pastores SM, Greenstein RJ. Critical care medicine in the United States 1985&#x2013;2000: an analysis of bed numbers, use, and costs. Crit Care Med Crit Care Med. 2004;32:1254&#x2013;1259. doi: 10.1097/01.CCM.0000128577.31689.4C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000128577.31689.4C</ArticleId><ArticleId IdType="pubmed">15187502</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA J Am Med Assoc. 2012;307:1513&#x2013;1516. doi: 10.1001/jama.2012.362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.362</ArticleId><ArticleId IdType="pubmed">22419800</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs L, Chronaki CE, Park S, Novack V, Baumfeld Y, Scott D, et al. ICU admission characteristics and mortality rates among elderly and very elderly patients. Intensive Care Med. 2012;38:1654&#x2013;1661. doi: 10.1007/s00134-012-2629-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2629-6</ArticleId><ArticleId IdType="pmc">PMC5718912</ArticleId><ArticleId IdType="pubmed">22797350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Baras M, Iapichino G, Kesecioglu J, Lippert A, Hargreaves C, et al. The Eldicus prospective, observational study of triage decision making in European intensive care units: Part I-European Intensive Care Admission Triage Scores. Crit Care Med. 2012;40:125&#x2013;131. doi: 10.1097/CCM.0b013e31822e5692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31822e5692</ArticleId><ArticleId IdType="pubmed">21926598</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrouste-Orgeas M, Boumendil A, Pateron D, Aergerter P, Somme D, Simon T, et al. Selection of intensive care unit admission criteria for patients aged 80 years and over and compliance of emergency and intensive care unit physicians with the selected criteria: an observational, multicenter, prospective study. Crit Care Med. 2009;37:2919&#x2013;2928. doi: 10.1097/CCM.0b013e3181b019f0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181b019f0</ArticleId><ArticleId IdType="pubmed">19866508</ArticleId></ArticleIdList></Reference><Reference><Citation>Simchen E, Sprung CL, Galai N, Zitser-Gurevich Y, Bar-Lavi Y, Gurman G, et al. Survival of critically ill patients hospitalized in and out of intensive care units under paucity of intensive care unit beds. Crit Care Med Crit Care Med. 2004;32:1654&#x2013;1661. doi: 10.1097/01.CCM.0000133021.22188.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000133021.22188.35</ArticleId><ArticleId IdType="pubmed">15286540</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert R, Reignier J, Tournoux-Facon C, Boulain T, Lesieur O, Gissot V, et al. Refusal of intensive care unit admission due to a full unit: impact on mortality. Am J Respir Crit Care Med. 2012;185:1081&#x2013;1087. doi: 10.1164/rccm.201104-0729OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201104-0729OC</ArticleId><ArticleId IdType="pubmed">22345582</ArticleId></ArticleIdList></Reference><Reference><Citation>Roch A, Wiramus S, Pauly V, Forel JM, Guervilly C, Gainnier M, et al. Long-term outcome in medical patients aged 80 or over following admission to an intensive care unit. Crit Care. 2011;15:R36. doi: 10.1186/cc9984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9984</ArticleId><ArticleId IdType="pmc">PMC3222073</ArticleId><ArticleId IdType="pubmed">21261976</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Artigas A, Kesecioglu J, Pezzi A, Wiis J, Pirracchio R, et al. The Eldicus prospective, observational study of triage decision making in European intensive care units. Part II: Intensive care benefit for the elderly. Crit Care Med. 2012;40:132&#x2013;138. doi: 10.1097/CCM.0b013e318232d6b0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232d6b0</ArticleId><ArticleId IdType="pubmed">22001580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunsch H, Angus DC, Harrison DA, Linde-Zwirble WT, Rowan KM. Comparison of medical admissions to intensive care units in the United States and United Kingdom. Am J Respir Crit Care Med. 2011;183:1666&#x2013;1673. doi: 10.1164/rccm.201012-1961OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201012-1961OC</ArticleId><ArticleId IdType="pubmed">21471089</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676&#x2013;682. doi: 10.1093/aje/kwq433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq433</ArticleId><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar GJ, Greene JD, Scheirer P, Gardner MN, Draper D, Kipnis P. Risk-adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases. Med Care. 2008;46:232&#x2013;239. doi: 10.1097/MLR.0b013e3181589bb6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3181589bb6</ArticleId><ArticleId IdType="pubmed">18388836</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AEW, Pollard TJ, Shen L, Lehman LWH, Feng M, Ghassemi M, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878278</ArticleId><ArticleId IdType="pubmed">27219127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes Ferreira F, Peres Bota D, Bross A, M&#xe9;lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. J Am Med Assoc. 2001;286:1754&#x2013;1758. doi: 10.1001/jama.286.14.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.14.1754</ArticleId><ArticleId IdType="pubmed">11594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs L, Novack V, McLennan S, Anthony Celi L, Baumfeld Y, Park S, et al. Trends in severity of illness on ICU admission and mortality among the elderly. PLoS One Public Lib Sci. 2014;9:e93234&#x2013;e93234. doi: 10.1371/journal.pone.0093234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093234</ArticleId><ArticleId IdType="pmc">PMC3974713</ArticleId><ArticleId IdType="pubmed">24699251</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidet B, Leblanc G, Simon T, Woimant M, Quenot JP, Ganansia O, et al. Effect of systematic intensive care unit triage on long-term mortality among critically ill elderly patients in France a randomized clinical trial. JAMA J Am Med Assoc. 2017;318:1450&#x2013;1459. doi: 10.1001/jama.2017.13889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13889</ArticleId><ArticleId IdType="pmc">PMC5710364</ArticleId><ArticleId IdType="pubmed">28973065</ArticleId></ArticleIdList></Reference><Reference><Citation>Moitra VK, Guerra C, Linde-Zwirble WT, Wunsch H. Relationship between ICU length of stay and long-term mortality for elderly ICU survivors. Crit Care Med. 2016;44:655&#x2013;662. doi: 10.1097/CCM.0000000000001480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001480</ArticleId><ArticleId IdType="pmc">PMC4792682</ArticleId><ArticleId IdType="pubmed">26571190</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker S, M&#xfc;ller J, de Heer G, Braune S, Fuhrmann V, Kluge S. Clinical characteristics and outcome of very elderly patients &#x2265;&#xa0;90 years in intensive care: a retrospective observational study. Ann Intensive Care. 2015;5:1&#x2013;8. doi: 10.1186/s13613-015-0097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-015-0097-1</ArticleId><ArticleId IdType="pmc">PMC4686461</ArticleId><ArticleId IdType="pubmed">26690798</ArticleId></ArticleIdList></Reference><Reference><Citation>International health data comparisons, 2020, Life expectancy, mortality and causes of death - Australian Institute of Health and Welfare [Internet]. [cited 2021 May 6]. Available from: https://www.aihw.gov.au/reports/international-comparisons/international-health-data-comparisons-2018/contents/life-expectancy-mortality-and-causes-of-death.</Citation></Reference><Reference><Citation>Knoema. Life expectancy at age 80 years for both sexes combined [Internet]. 2020 [cited 2021 May 6]. Available from: https://knoema.com/atlas/topics/Demographics/Age/Life-expectancy-at-age-80-years.</Citation></Reference><Reference><Citation>Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob J-J, Cowey CL, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med (NEJM/MMS) 2017;377:1345&#x2013;1356. doi: 10.1056/NEJMoa1709684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1709684</ArticleId><ArticleId IdType="pmc">PMC5706778</ArticleId><ArticleId IdType="pubmed">28889792</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas LEM, de Lange DW, van Dijk D, van Delden JJM. Should we deny ICU admission to the elderly? Ethical considerations in times of COVID-19. Crit Care. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282209</ArticleId><ArticleId IdType="pubmed">32517776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunsch H. Is there a starling curve for intensive care? Chest. 2012: 1393&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3367487</ArticleId><ArticleId IdType="pubmed">22670019</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, et al. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (&#x2265; 80 years) Intensive Care Med. 2017;43:1820&#x2013;1828. doi: 10.1007/s00134-017-4940-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4940-8</ArticleId><ArticleId IdType="pubmed">28936626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31688828</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Consequences of pre-injury utilization of direct oral anticoagulants in patients with traumatic brain injury: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>186</StartPage><EndPage>194</EndPage><MedlinePgn>186-194</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000002518</ELocationID><Abstract><AbstractText Label="BACKGROUND">The rapid adoption and widespread use of direct oral anticoagulants (DOACs) has outpaced research efforts to establish their effects in bleeding trauma patients. In patients with complicated traumatic brain injury (TBI) caused by intracranial hemorrhage, DOAC use may be associated with higher bleeding volume and potentially more disastrous sequelae than use of vitamin K antagonists (VKAs). In the current systematic review and meta-analysis we set out to evaluate the literature on the relationship between preinjury DOAC use and course of the intracranial hemorrhage. (ICH), its treatment and mortality rates in TBI patients, and to compare these outcomes to those of patients with preinjury VKA use.</AbstractText><AbstractText Label="METHODS">PubMed, Embase, Web of Science, and the Cochrane Library were searched using a search strategy including three main terms: "traumatic brain injury," "direct oral anticoagulants," and "vitamin K antagonists." There were 1,446 abstracts screened, and ultimately, six included articles. Random effects modeling meta-analysis was performed on in-hospital mortality, ICH progression and neurosurgical intervention rate.</AbstractText><AbstractText Label="RESULTS">All cohorts had similar baseline and emergency department parameters. Within individual studies surgery rate, reversal agents used, ICH progression and in-hospital mortality differed significantly between DOAC and VKA cohorts. Meta-analysis showed no significant difference in in-hospital mortality (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.23-4.06; I = 76%; p = 0.97), neurosurgical interventions (OR, 0.48; 95% CI, 0.14-1.63; p = 0.24), or ICH progression rates (OR, 1.86; 95% CI, 0.32-10.66; p = 0.49) between patients that used preinjury DOACs versus patients that used VKAs.</AbstractText><AbstractText Label="CONCLUSION">Direct oral anticoagulant-using mild TBI patients do not appear to be at an increased risk of in-hospital mortality, nor of increased ICH progression or surgery rates, compared with those taking VKAs.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Systematic review, level III.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nederpelt</LastName><ForeName>Charlie J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>From the Department of Trauma, Emergency Surgery and Surgical Critical Care (C.N., M.G.R.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Trauma Surgery (C.J.N., S.J.M.v.d.A., P.K., I.B.S.), Department of Thrombosis and Hemostasis (M.V.H.), and Department of Neurosurgery (W.C.P.), Leiden University Medical Center, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Aalst</LastName><ForeName>Stefano J M</ForeName><Initials>SJM</Initials></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Martin G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Krijnen</LastName><ForeName>Pieta</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Huisman</LastName><ForeName>Menno V</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Peul</LastName><ForeName>Wilco C</ForeName><Initials>WC</Initials></Author><Author ValidYN="Y"><LastName>Schipper</LastName><ForeName>Inger B</ForeName><Initials>IB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020198" MajorTopicYN="N">Intracranial Hemorrhage, Traumatic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31688828</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000002518</ArticleId><ArticleId IdType="pii">01586154-202001000-00026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhattacharya B, Maung A, Schuster K, Davis KA. The older they are the harder they fall: injury patterns and outcomes by age after ground level falls. Injury. 2016;47(9):1955&#x2013;1959.</Citation></Reference><Reference><Citation>Mina AA, Knipfer JF, Park DY, Bair HA, Howells GA, Bendick PJ. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. J Trauma. 2002;53(4):668&#x2013;672.</Citation></Reference><Reference><Citation>Karni A, Holtzman R, Bass T, Zorman G, Carter L, Rodriguez L, Bennett-Shipman VJ, Lottenberg L. Traumatic head injury in the anticoagulated elderly patient: a lethal combination. Am Surg. 2001;67(11):1098&#x2013;1100.</Citation></Reference><Reference><Citation>Barnes GD, Kurtz B. Direct oral anticoagulants: unique properties and practical approaches to management. Heart. 2016;102(20):1620&#x2013;1626.</Citation></Reference><Reference><Citation>Wong SL, Marshall LZ, Lawson KA. Direct oral anticoagulant prescription trends, switching patterns, and adherence in Texas Medicaid. Am J Manag Care. 2018;24(8 Spec):SP309&#x2013;SP314.</Citation></Reference><Reference><Citation>Luger S, Hohmann C, Kraft P, et al. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe&#x2014;a multicentric evaluation. Int J Stroke. 2014;9(5):569&#x2013;575.</Citation></Reference><Reference><Citation>Loo SY, Dell'Aniello S, Huiart L, Renoux C. Trends in the prescription of novel oral anticoagulants in UK primary care. Br J Clin Pharmacol. 2017;83(9):2096&#x2013;2106.</Citation></Reference><Reference><Citation>Kjerpeseth LJ, Ellekjaer H, Selmer R, Ariansen I, Furu K, Skovlund E. Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015. Eur J Clin Pharmacol. 2017;73(11):1417&#x2013;1425.</Citation></Reference><Reference><Citation>van den Heuvel JM, H&#xf6;vels AM, B&#xfc;ller HR, Mantel-Teeuwisse AK, de Boer A, Maitland-van der Zee AH. NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in the Netherlands. Thromb J. 2018;16:7.</Citation></Reference><Reference><Citation>Hylek EM, Held C, Alexander JH, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): predictors, characteristics, and clinical outcomes. J Am Coll Cardiol. 2014;63(20):2141&#x2013;2147.</Citation></Reference><Reference><Citation>Caldeira D, Barra M, Pinto FJ, Ferreira JJ, Costa J. Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis. J Neurol. 2015;262(3):516&#x2013;522.</Citation></Reference><Reference><Citation>Gallagher AM, van Staa TP, Murray-Thomas T, Schoof N, Clemens A, Ackermann D, Bartels DB. Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. 2014;4(1):e003839.</Citation></Reference><Reference><Citation>Graham DJ, Reichman ME, Wernecke M, et al. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation. 2015;131(2):157&#x2013;164.</Citation></Reference><Reference><Citation>Adachi T, Hoshino H, Takagi M, Fujioka S. Volume and characteristics of intracerebral hemorrhage with direct oral anticoagulants in comparison with warfarin. Cerebrovasc Dis Extra. 2017;7(1):62&#x2013;71.</Citation></Reference><Reference><Citation>Boulouis G, Morotti A, Pasi M, Goldstein JN, Gurol ME, Charidimou A. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89(3):263&#x2013;270.</Citation></Reference><Reference><Citation>Alonso A, Bengtson LG, MacLehose RF, Lutsey PL, Chen LY, Lakshminarayan K. Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin. Stroke. 2014;45(8):2286&#x2013;2291.</Citation></Reference><Reference><Citation>Wilson D, Seiffge DJ, Traenka C, et al. Outcome of intracerebral hemorrhage associated with different oral anticoagulants. Neurology. 2017;88(18):1693&#x2013;1700.</Citation></Reference><Reference><Citation>Katsanos AH, Schellinger PD, Kohrmann M, Filippatou A, Gurol ME, Caso V, Paciaroni M, Perren F, Alexandrov AV, Tsivgoulis G. Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis. Eur J Neurol. 2018;25(10):1299&#x2013;1302.</Citation></Reference><Reference><Citation>Tsivgoulis G, Wilson D, Katsanos AH, et al. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage. Ann Neurol. 2018;84(5):694&#x2013;704.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336&#x2013;341.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;188.</Citation></Reference><Reference><Citation>Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719&#x2013;748.</Citation></Reference><Reference><Citation>Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712&#x2013;716.</Citation></Reference><Reference><Citation>Batey M, Hecht J, Callahan C, Wahl W. Direct oral anticoagulants do not worsen traumatic brain injury after low-level falls in the elderly. Surgery. 2018;164(4):814&#x2013;819.</Citation></Reference><Reference><Citation>Beynon C, Potzy A, Sakowitz OW, Unterberg AW. Rivaroxaban and intracranial haemorrhage after mild traumatic brain injury: a dangerous combination? Clin Neurol Neurosurg. 2015;136:73&#x2013;78.</Citation></Reference><Reference><Citation>Feeney JM, Santone E, DiFiori M, Kis L, Jayaraman V, Montgomery SC. Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: a TQIP study. J Trauma Acute Care Surg. 2016;81(5):843&#x2013;848.</Citation></Reference><Reference><Citation>Parra MW, Zucker L, Johnson ES, Gullett D, Avila C, Wichner ZA, Kokaram CR. Dabigatran bleed risk with closed head injuries: are we prepared? J Neurosurg. 2013;119(3):760&#x2013;765.</Citation></Reference><Reference><Citation>Prexl O, Bruckbauer M, Voelckel W, Grottke O, Ponschab M, Maegele M, Schochl H. The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old. Scand J Trauma Resusc Emerg Med. 2018;26(1):20.</Citation></Reference><Reference><Citation>Zeeshan M, Jehan F, O'Keeffe T, Khan M, Zakaria ER, Hamidi M, Gries L, Kulvatunyou N, Joseph B. The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI. J Trauma Acute Care Surg. 2018;85(5):915&#x2013;920.</Citation></Reference><Reference><Citation>Barletta JF, Hall S, Sucher JF, Dzandu JK, Haley M, Mangram AJ. The impact of pre-injury direct oral anticoagulants compared to warfarin in geriatric G-60 trauma patients. Eur J Trauma Emerg Surg. 2017;43(4):445&#x2013;449.</Citation></Reference><Reference><Citation>Maung AA, Bhattacharya B, Schuster KM, Davis KA. Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin. J Trauma Acute Care Surg. 2016;81(4):652&#x2013;657.</Citation></Reference><Reference><Citation>Feeney JM, Neulander M, DiFiori M, Kis L, Shapiro DS, Jayaraman V, Marshall WT 3rd, Montgomery SC. Direct oral anticoagulants compared with warfarin in patients with severe blunt trauma. Injury. 2017;48(1):47&#x2013;50.</Citation></Reference><Reference><Citation>Cipriano A, Pecori A, Bionda AE, Bardini M, Frassi F, Leoli F, Lami V, Ghiadoni L, Santini M. Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists. Intern Emerg Med. 2018;13(7):1077&#x2013;1087.</Citation></Reference><Reference><Citation>Riccardi A, Spinola B, Minuto P, Ghinatti M, Guiddo G, Malerba M, Lerza R. Intracranial complications after minor head injury (MHI) in patients taking vitamin K antagonists (VKA) or direct oral anticoagulants (DOACs). Am J Emerg Med. 2017;35(9):1317&#x2013;1319.</Citation></Reference><Reference><Citation>Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke. 2012;43(6):1511&#x2013;1517.</Citation></Reference><Reference><Citation>Ieko M, Naitoh S, Yoshida M, Takahashi N. Profiles of direct oral anticoagulants and clinical usage-dosage and dose regimen differences. J Intensive Care. 2016;4:19.</Citation></Reference><Reference><Citation>Burn J, Pirmohamed M. Direct oral anticoagulants versus warfarin: is new always better than the old? Open Heart. 2018;5(1):e000712.</Citation></Reference><Reference><Citation>Dunham CM, Hoffman DA, Huang GS, Omert LA, Gemmel DJ, Merrell R. Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study. PLoS One. 2014;9(10):e109473.</Citation></Reference><Reference><Citation>Lopes RD, Guimaraes PO, Kolls BJ, et al. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood. 2017;129(22):2980&#x2013;2987.</Citation></Reference><Reference><Citation>Milling TJ Jr., Clark CL, Feronti C, Song SS, Torbati SS, Fermann GJ, Weiss J, Patel D. Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: a retrospective multi-center analysis. Am J Emerg Med. 2018;36(3):396&#x2013;402.</Citation></Reference><Reference><Citation>Singer AJ, Quinn A, Dasgupta N, Thode HC Jr. Management and outcomes of bleeding events in patients in the emergency department taking warfarin or a non-vitamin K antagonist oral anticoagulant. J Emerg Med. 2017;52(1):1&#x2013;7.e1.</Citation></Reference><Reference><Citation>Beynon C, Brenner S, Younsi A, Rizos T, Neumann JO, Pfaff J, Unterberg AW. Management of Patients with acute subdural Hemorrhage during treatment with direct Oral anticoagulants. Neurocrit Care. 2019;30:322&#x2013;333.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25042123</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month><Day>21</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Endovascular treatment for ruptured abdominal aortic aneurysm.</ArticleTitle><Pagination><StartPage>CD005261</StartPage><MedlinePgn>CD005261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD005261.pub3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">An abdominal aortic aneurysm (AAA) (pathological enlargement of the aorta) can develop in both men and women as they grow older. It is most commonly seen in men over the age of 65 years. Progressive aneurysm enlargement can lead to rupture and massive internal bleeding, a fatal event unless timely repair can be achieved. Despite improvements in perioperative care, mortality remains high (approximately 50%) after conventional open surgical repair. A newer minimally invasive technique, endovascular aneurysm repair (EVAR), has been shown to reduce early morbidity and mortality as compared to conventional open surgery for planned AAA repair. Emergency endovascular aneurysm repair (eEVAR) has been used successfully to treat ruptured abdominal aortic aneurysm (RAAA), proving that it is feasible in selected patients. However, it is not yet known if eEVAR will lead to significant improvements in outcomes for these patients or indeed if it can replace conventional open repair as the preferred treatment for this lethal condition.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the advantages and disadvantages of emergency endovascular aneurysm repair (eEVAR) in comparison with conventional open surgical repair for the treatment of ruptured abdominal aortic aneurysm (RAAA). This will be determined by the effect on short-term mortality, major complication rates, aneurysm exclusion, and late complications when compared with the effects in patients who have had conventional open repair of RAAA.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched February 2014) and CENTRAL (2014, Issue 2). Reference lists of relevant publications were also checked.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Randomised controlled trials in which patients with a clinically or radiologically diagnosed RAAA were randomly allocated to eEVAR or conventional open surgical repair.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Studies identified for potential inclusion were independently assessed for eligibility by at least two review authors. Data extraction and quality assessment were also completed independently by two review authors. Disagreements were resolved through discussion. Meta-analysis was performed using fixed-effect models with odds ratios (ORs) and 95% confidence intervals (CIs) for dichotomous data and mean differences with 95% CIs for continuous data.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Three randomised controlled trials were included in this review. A total of 761 patients with a clinical or radiological diagnosis of RAAA were randomised to receive either eEVAR or open surgical repair. Overall risk of bias was low but one study did not adequately report random sequence generation, putting it at risk of selection bias, two studies did not report on outcomes identified in their protocol, indicating reporting bias, and one study was underpowered. There was no clear evidence to support a difference between the two interventions on 30-day (or in-hospital) mortality, OR of 0.91 (95% CI 0.67 to 1.22; P = 0.52). The 30-day complications included myocardial infarction, stroke, composite cardiac complications, renal complications, severe bowel ischaemia, spinal cord ischaemia, re-operation, amputation, and respiratory failure. Individual complication outcomes were reported in only one or two studies and therefore no robust conclusion can currently be drawn. For complication outcomes that did include at least two studies in the meta-analysis there was no clear evidence to support a difference between eEVAR and open repair. Six-month outcomes were evaluated in only a single study, which included mortality and re-operation, with no clear evidence of a difference between the interventions and no overall association. Cost per patient was only evaluated in a single study and therefore no overall associations can currently be derived.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">The conclusions of this review are currently limited by the paucity of data. From the data available there is no difference in the outcomes evaluated in this review between eEVAR and open repair, specifically 30-day mortality. Not enough information was provided for complications in order to make a well informed conclusion at this time. Long-term data are lacking for both survival and late complications. More high quality, randomised controlled trials comparing eEVAR and open repair for the treatment of RAAA are needed in order to better understand if one method is superior to the other, or if there is no difference between the methods on relevant outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Badger</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedenis</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Paul H</ForeName><Initials>PH</Initials></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Kee</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Harkin</LastName><ForeName>Denis W</ForeName><Initials>DW</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CZB/4/788</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005261. doi: 10.1002/14651858.CD005261.pub2.</RefSource><PMID Version="1">17253551</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2017 May 26;5:CD005261. doi: 10.1002/14651858.CD005261.pub4.</RefSource><PMID Version="1">28548204</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001019" MajorTopicYN="N">Aortic Rupture</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061887" MajorTopicYN="N">Conversion to Open Surgery</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25042123</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD005261.pub3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31789638</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Cannabis Use Disorder and Perioperative Outcomes in Major Elective Surgeries: A Retrospective Cohort Analysis.</ArticleTitle><Pagination><StartPage>625</StartPage><EndPage>635</EndPage><MedlinePgn>625-635</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000003067</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although cannabis is known to have cardiovascular and psychoactive effects, the implications of its use before surgery are currently unknown. The objective of the present study was to determine whether patients with an active cannabis use disorder have an elevated risk of postoperative complications.</AbstractText><AbstractText Label="METHODS">The authors conducted a retrospective population-based cohort study of patients undergoing elective surgery in the United States using the Nationwide Inpatient Sample from 2006 to 2015. A sample of 4,186,622 inpatients 18 to 65 yr of age presenting for 1 of 11 elective surgeries including total knee replacement, total hip replacement, coronary artery bypass graft, caesarian section, cholecystectomy, colectomy, hysterectomy, breast surgery, hernia repair, laminectomy, and other spine surgeries was selected. The principal exposure was an active cannabis use disorder, as defined by International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) diagnostic codes for cannabis dependence and cannabis abuse. The primary outcome was a composite endpoint of in-hospital postoperative myocardial infarction, stroke, sepsis, deep vein thrombosis, pulmonary embolus, acute kidney injury requiring dialysis, respiratory failure, and in-hospital mortality. Secondary outcomes included hospital length of stay, total hospital costs, and the individual components of the composite endpoint.</AbstractText><AbstractText Label="RESULTS">The propensity-score matched-pairs cohort consisted of 27,206 patients. There was no statistically significant difference between patients with (400 of 13,603; 2.9%) and without (415 of 13,603; 3.1%) a reported active cannabis use disorder with regard to the composite perioperative outcome (unadjusted odds ratio = 1.29; 95% CI, 1.17 to 1.42; P &lt; 0.001; Adjusted odds ratio = 0.97; 95% CI, 0.84 to 1.11; P = 0.63). However, the adjusted odds of postoperative myocardial infarction was 1.88 (95% CI, 1.31 to 2.69; P &lt; 0.001) times higher for patients with a reported active cannabis use disorder (89 of 13,603; 0.7%) compared with those without (46 of 13,603; 0.3%) an active cannabis use disorder (unadjusted odds ratio = 2.88; 95% CI, 2.34 to 3.55; P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS">An active cannabis use disorder is associated with an increased perioperative risk of myocardial infarction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goel</LastName><ForeName>Akash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada (A.G., N.K.J., H.C.) Harvard T. H. Chan School of Public Health, Boston, Massachusetts (A.G., B.M., M.A.M.) Division of Vascular Surgery, McMaster University, Hamilton, Ontario, Canada (B.M.) Department of Anesthesia and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada (N.K.J., D.N.W., K.S.L.) Department of Anesthesia and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada (D.N.W., K.S.L.) Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (M.A.M.) Department of Anesthesiology, Perioperative and Pain Medicine, and Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (B.T.B.) Leslie Dan Faculty of Pharmacy, University of Toronto, and Krembil Research Institute, University Health Network, Toronto, Ontario, Canada (L.P.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuinness</LastName><ForeName>Brandon</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Jivraj</LastName><ForeName>Naheed K</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Author><Author ValidYN="Y"><LastName>Mittleman</LastName><ForeName>Murray A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Brian T</ForeName><Initials>BT</Initials></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Hance</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kotra</LastName><ForeName>Lakshmi P</ForeName><Initials>LP</Initials></Author><Author ValidYN="Y"><LastName>Ladha</LastName><ForeName>Karim S</ForeName><Initials>KS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2020 Apr;132(4):612-613. doi: 10.1097/ALN.0000000000003135.</RefSource><PMID Version="1">32053558</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002189" MajorTopicYN="N">Marijuana Abuse</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31789638</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000003067</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28884980</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1738-6586</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of clinical neurology (Seoul, Korea)</Title><ISOAbbreviation>J Clin Neurol</ISOAbbreviation></Journal><ArticleTitle>Perioperative Stroke, In-Hospital Mortality, and Postoperative Morbidity Following Transcatheter Aortic Valve Implantation: A Nationwide Study.</ArticleTitle><Pagination><StartPage>351</StartPage><EndPage>358</EndPage><MedlinePgn>351-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3988/jcn.2017.13.4.351</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Perioperative stroke is a significant complication of transcatheter aortic valve implantation (TAVI). This study aimed to quantify perioperative stroke as an independent risk factor for in-hospital mortality and postoperative morbidity in patients receiving TAVI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study was conducted using the National Inpatient Sample. Patients undergoing TAVI during 2012 and 2013 were identified using diagnostic codes of International Classification of Diseases, ninth revision. Univariate and multivariate analyses were performed using patient demographics and comorbidities to identify predictors of mortality and morbidity, defined by a length of stay of &gt;14 days and/or discharge to a place other than home.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data were obtained from 7,556 patients undergoing TAVI during 2012 and 2013. The incidence rates of mortality and morbidity were 4.57 and 71.12%, respectively. Perioperative stroke was an independent risk factor for mortality [odds ratio (OR)=3.182, 95% confidence interval (CI)=1.530-6.618, p=0.002], as were infection (OR=17.899, 95% CI=9.876-32.440, p&lt;0.001) and pericardial tamponade (OR=7.272, 95% CI=2.874-18.402, p&lt;0.001). Stroke also predicted morbidity (OR=5.223, 95% CI=2.005-13.608, p=0.001), which was also associated with age, being female, being Asian, moderate and high Van Walraven scores (VWR), and infection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In conclusion, perioperative stroke was found to be independently associated with in-hospital mortality and postoperative morbidity, as are age and high VWR. Our findings support the use of further preoperative, intraoperative, and postoperative management strategies during TAVI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Korean Neurological Association</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thirumala</LastName><ForeName>Parthasarathy D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA. thirumalapd@upmc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Felix D</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Amol</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulukutla</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeevanantham</LastName><ForeName>Vinodh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Saints Heart and Vascular Institute, St. Anthony Hospital, Oklahoma City, OK, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wechsler</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleason</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Clin Neurol</MedlineTA><NlmUniqueID>101252374</NlmUniqueID><ISSNLinking>1738-6586</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TAVI</Keyword><Keyword MajorTopicYN="N">morbidity</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>The authors have no financial conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28884980</ArticleId><ArticleId IdType="pmc">PMC5653622</ArticleId><ArticleId IdType="doi">10.3988/jcn.2017.13.4.351</ArticleId><ArticleId IdType="pii">13.e31</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040324</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold SV, Reynolds MR, Lei Y, Magnuson EA, Kirtane AJ, Kodali SK, et al. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation. 2014;129:2682&#x2013;2690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4198056</ArticleId><ArticleId IdType="pubmed">24958751</ArticleId></ArticleIdList></Reference><Reference><Citation>Rod&#xe9;s-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864&#x2013;1875.</Citation><ArticleIdList><ArticleId IdType="pubmed">23062535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, et al. A prospective randomized evaluation of the TriGuard&#x2122; HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36:2070&#x2013;2078.</Citation><ArticleIdList><ArticleId IdType="pubmed">25990342</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones BM, Tuzcu EM, Krishnaswamy A, Kapadia SR. Neurologic events after transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4:83&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">28582124</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchetche D, Farah B, Misuraca L, Pierri A, Vahdat O, Lereun C, et al. Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy. JACC Cardiovasc Interv. 2014;7:1138&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">25240554</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds MR, Lei Y, Wang K, Chinnakondepalli K, Vilain KA, Magnuson EA, et al. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol. 2016;67:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4959424</ArticleId><ArticleId IdType="pubmed">26764063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailawadi G, LaPar DJ, Speir AM, Ghanta RK, Yarboro LT, Crosby IK, et al. Contemporary costs associated with transcatheter aortic valve replacement: a propensity-matched cost analysis. Ann Thorac Surg. 2016;101:154&#x2013;160. discussion 160.</Citation><ArticleIdList><ArticleId IdType="pubmed">26409710</ArticleId></ArticleIdList></Reference><Reference><Citation>Dua A, Romanelli M, Upchurch GR, Jr, Pan J, Hood D, Hodgson KJ, et al. Predictors of poor outcome after carotid intervention. J Vasc Surg. 2016;64:663&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">27209401</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh JA, 3rd, Teirstein PS, Stinis C, Price MJ. Risk assessment in patient selection for transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">28582117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwachuku EL, Balzer JR, Yabes JG, Habeych ME, Crammond DJ, Thirumala PD. Diagnostic value of somatosensory evoked potential changes during carotid endarterectomy: a systematic review and meta-analysis. JAMA Neurol. 2015;72:73&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">25383418</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirumala PD, Thiagarajan K, Gedela S, Crammond DJ, Balzer JR. Diagnostic accuracy of EEG changes during carotid endarterectomy in predicting perioperative strokes. J Clin Neurosci. 2016;25:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26474501</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552515</ArticleId><ArticleId IdType="pubmed">21899409</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Saia F, Latib A, Ciuca C, Gasparetto V, Napodano M, Sticchi A, et al. Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. Am Heart J. 2014;168:798&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">25440810</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong TY, Liao YB, Zhao ZG, Xu YN, Wei X, Zuo ZL, et al. Causes of death following transcatheter aortic valve replacement: a systematic review and meta-analysis. J Am Heart Assoc. 2015;4:e002096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4599496</ArticleId><ArticleId IdType="pubmed">26391132</ArticleId></ArticleIdList></Reference><Reference><Citation>The Society of Thoracic Surgeons (US) Online STS adult cardiac surgery risk calculator [Internet] Chicago (IL): The Society of Thoracic Surgeons; 2007.  [cited 2016 Jul 7].  Available from:  http://riskcalc.sts.org/stswebriskcalc/#/</Citation></Reference><Reference><Citation>HCUP Elixhauser Comorbidity Software. Healthcare Cost and Utilization Project (HCUP) [Internet] Rockville (MD): Agency for Healthcare Research and Quality; 2017.  [cited 2016 June 6].  Available from:  http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp.</Citation></Reference><Reference><Citation>HCUP Databases (US) Healthcare Cost and Utilization Project (HCUP) [Internet] Rockville (MD): Agency for Healthcare Research and Quality; 2017.  [cited 2016 Jun 6].  Available from:  http://www.hcup-us.ahrq.gov/nisoverview.jsp.</Citation></Reference><Reference><Citation>Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012;80:128&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">22415849</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel HJ, Likosky DS, Pruitt AL, Murphy ET, Theurer PF, Prager RL. Aortic valve replacement in the moderately elevated risk patient: a population-based analysis of outcomes. Ann Thorac Surg. 2016;102:1466&#x2013;1472.</Citation><ArticleIdList><ArticleId IdType="pubmed">27324524</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">21220731</ArticleId></ArticleIdList></Reference><Reference><Citation>Stortecky S, Windecker S, Pilgrim T, Heg D, Buellesfeld L, Khattab AA, et al. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. Euro-Intervention. 2012;8:62&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">22580250</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi S, Sacco RL. Are the current risks of asymptomatic carotid stenosis exaggerated?: further evidence supporting the CREST 2 trial. JAMA Neurol. 2015;72:1233&#x2013;1234.</Citation><ArticleIdList><ArticleId IdType="pubmed">26390399</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrowsmith JE, Ganugapenta MS. Intraoperative brain monitoring in cardiac surgery. In: Bonser RS, Pagano D, Haverich A, editors. Brain Protection in Cardiac Surgery. Vol. 1. London: Springer-Verlag London; 2011. pp. 83&#x2013;111.</Citation></Reference><Reference><Citation>Thirumala PD, Muluk S, Udesh R, Mehta A, Schindler J, Mulukutla S, et al. Carotid artery disease and periprocedural stroke risk after transcatheter aortic valve implantation. Ann Card Anaesth. 2017;20:145&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5408517</ArticleId><ArticleId IdType="pubmed">28393772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleiman NS, Maini BJ, Reardon MJ, Conte J, Katz S, Rajagopal V, et al. Neurological events following transcatheter aortic valve replacement and their predictors: a report from the CoreValve trials. Circ Cardiovasc Interv. 2016;9:e003551.</Citation><ArticleIdList><ArticleId IdType="pubmed">27601429</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790&#x2013;1798.</Citation><ArticleIdList><ArticleId IdType="pubmed">24678937</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmann K, Sirotina M, De Rosa S, Ehrlich JR, Fox H, Weber J, et al. The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg. 2013;17:359&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715165</ArticleId><ArticleId IdType="pubmed">23644728</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandava P, Kent TA. A method to determine stroke trial success using multidimensional pooled control functions. Stroke. 2009;40:1803&#x2013;1810.</Citation><ArticleIdList><ArticleId IdType="pubmed">19286598</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig IR, Ziegler A, Bluhmki E, Hacke W, Bath PM, Sacco RL, et al. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke. 2008;39:1821&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pubmed">18403738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37833203</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0938</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cardiovascular revascularization medicine : including molecular interventions</Title><ISOAbbreviation>Cardiovasc Revasc Med</ISOAbbreviation></Journal><ArticleTitle>Catheter-directed thrombolysis versus thrombectomy for submassive and massive pulmonary embolism: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>52</EndPage><MedlinePgn>43-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carrev.2023.10.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1553-8389(23)00832-1</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Controversy surrounds the optimal therapy for submassive and massive pulmonary embolism (PE). We conducted a systematic review and meta-analysis to compare the outcomes of catheter-directed thrombolysis (CDT) versus surgical and catheter-based thrombectomy in patients with submassive and massive PE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, Cochrane, and Google Scholar for studies comparing outcomes of CDT versus thrombectomy in submassive and massive PE. Studies were identified and data were extracted by two independent reviewers. A random effects model was used to calculate risk ratios (RRs) with 95&#xa0;% confidence intervals (CIs). Outcomes included in-hospital mortality, procedural complications, hospital and intensive care unit (ICU) length of stay (LOS), 30-day readmissions, and right ventricle/left ventricle (RV/LV) ratio improvement.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight observational studies with 1403 patients were included, of whom 50.0&#xa0;% received CDT. Compared to thrombectomy, CDT was associated with significantly lower in-hospital mortality (RR 0.62; 95&#xa0;% CI 0.43-0.89; p&#xa0;=&#xa0;0.01) and similar rates of major bleeding (p&#xa0;=&#xa0;0.61), blood transfusion (p&#xa0;=&#xa0;0.41), stroke (p&#xa0;=&#xa0;0.41), and atrial fibrillation (p&#xa0;=&#xa0;0.71). The hospital and ICU LOS, 30-day readmissions, and degree of RV/LV ratio improvement were similar between the two strategies (all p&#xa0;&gt;&#xa0;0.1). In subgroup analyses, in-hospital mortality was similar between CDT and catheter-based thrombectomy (p&#xa0;=&#xa0;0.48) but lower with CDT compared with surgical thrombectomy (p&#xa0;=&#xa0;0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with submassive and massive PE, CDT was associated with similar in-hospital mortality compared to catheter-based thrombectomy, but lower in-hospital mortality compared to surgical thrombectomy. Procedural complications, LOS, 30-day readmissions, and RV/LV ratio improvement were similar between CDT and any thrombectomy. Randomized controlled trials are indicated to confirm our findings.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ismayl</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: ismayl.mahmoud@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ismayl</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Northern General Hospital, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamadi</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboeata</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Creighton University School of Medicine, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldsweig</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Baystate Medical Center and University of Massachusetts-Baystate, Springfield, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Revasc Med</MedlineTA><NlmUniqueID>101238551</NlmUniqueID><ISSNLinking>1878-0938</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="Y">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057785" MajorTopicYN="N">Catheters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter-directed thrombolysis</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Thrombectomy</Keyword><Keyword MajorTopicYN="N">Thrombolytic</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37833203</ArticleId><ArticleId IdType="doi">10.1016/j.carrev.2023.10.002</ArticleId><ArticleId IdType="pii">S1553-8389(23)00832-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31166234</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association of Intraoperative Tidal Volumes and Acute Kidney Injury After Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>925</StartPage><EndPage>932</EndPage><MedlinePgn>925-932</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004254</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with acute lung injury who received lower tidal volume (VT) ventilation had significantly fewer days with acute kidney injury (AKI) when compared to those receiving higher VTs. There is a paucity of studies on the relationship between intraoperative VTs and postoperative AKI in patients undergoing noncardiac surgery. We therefore sought to assess the association of mean delivered intraoperative VT per kilogram based on predicted body weight (PBW) and postoperative AKI.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study was conducted in a large tertiary multispecialty academic medical center. Adult patients who underwent noncardiac surgery between January 2005 and July 2016 under general anesthesia with endotracheal intubation and mechanical ventilation were included. A total of 41,224 patients were included in the study.The relationship between mean intraoperative VT per PBW and AKI was assessed using logistic regression, adjusting for prespecified potential confounding variables. The secondary outcomes were postoperative major pulmonary complications, myocardial injury after noncardiac surgery (MINS), and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">The incidence of AKI was 10.9% in the study population. Postoperative renal replacement therapy was required in 0.1% of patients. Higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of AKI. The estimated odds ratio for each 1 mL increase in VT per kilogram of PBW (1 unit) was 1.05 (95% confidence interval [CI], 1.02-1.08; P = .001), after adjusting for potential confounding variables. A higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of postoperative myocardial injury and was not significantly associated with major postoperative pulmonary complications or in-hospital mortality after noncardiac surgery.</AbstractText><AbstractText Label="CONCLUSIONS">In adult patients undergoing noncardiac surgery, higher delivered mean intraoperative VTs per PBW are associated with an increased odds of developing AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Argalious</LastName><ForeName>Maged Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesiology and the Center for Anesthesiology Education, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Guangmei</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Rajeev Krishnaney</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bhavani</LastName><ForeName>Sekar</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="N">Heart Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="Y">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31166234</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004254</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32346051</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Clinical Prognosis of Right-Sided Infective Endocarditis not Associated with Cardiac Devices or Intravenous Drug use: a Cohort Study and Meta-Analysis.</ArticleTitle><Pagination><StartPage>7179</StartPage><MedlinePgn>7179</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7179</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-64220-z</ELocationID><Abstract><AbstractText>Right-sided infective endocarditis (RSIE), classically associated with intravenous drug use or intracardiac devices, is considered a good-prognosis infective endocarditis (IE) form. However, predisposing factors and prognosis for "NODID" RSIE (NOt associated with cardiac Devices or Intravenous Drug use) remain unclear. The aim of this study was to evaluate predisposing factors and prognosis of NODID RSIE compared to other RSIE forms. A retrospective cohort study (January 2008-January 2019) was conducted in a reference center on 300 patients diagnosed with IE. Endocarditis-related events were defined as related to IE in mortality or open-heart surgery during follow-up. A review and meta-analysis of associated literature (January 2008-January 2019) were also performed. Fifty-seven patients presented RSIE (19%), 22 of which were NODID RSIE (39%). Use of intravascular catheters (23% vs 3%; p&#x2009;=&#x2009;0.027) and congenital heart diseases (18% vs 0%; p&#x2009;=&#x2009;0.019) were associated with NODID RSIE. This group had a higher in-hospital mortality (23% vs 3%; p&#x2009;=&#x2009;0.027) and endocarditis-related event rates (41% vs 6%; p&#x2009;=&#x2009;0.001) than non-NODID RSIE. Furthermore, NODID RSIE was independently associated with in-hospital endocarditis-related events (OR&#x2009;=&#x2009;19.29; 95%CI:2.23-167.16; p&#x2009;=&#x2009;0.007). Our meta-analysis evaluated four studies and identified 96 cases (30%) of NODID RSIE from 320 total RSIE cases. NODID RSIE patients demonstrated higher in-hospital mortality (RR&#x2009;=&#x2009;2.81; 95%CI:1.61-4.90; p&#x2009;&lt;&#x2009;0.001; I<sup>2</sup>&#x2009;=&#x2009;0.0%) and necessity of open-heart surgery (RR&#x2009;=&#x2009;13.89; 95%CI:4.14-46.60; p&#x2009;&lt;&#x2009;0.001; I<sup>2</sup>&#x2009;=&#x2009;0.0%) than non-NODID RSIE cases. Our study suggests that NODID RSIE has the highest endocarditis-related event rate and in-hospital mortality among RSIE cases and therefore should not be considered a good-prognosis IE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rigau</LastName><ForeName>Pau Vilardell</ForeName><Initials>PV</Initials><Identifier Source="ORCID">0000-0003-4033-2862</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moral</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain. moral.sergio@yahoo.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosch</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frigola</LastName><ForeName>Josep Maria</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballesteros</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Radiology Department, Centre d&#xb4;Atenci&#xf3; Primaria Pare Claret, Institut Catal&#xe0; de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roqu&#xe9;</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiolog&#xed;a y Salud P&#xfa;blica (CIBERESP), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboal</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugada</LastName><ForeName>Ramon</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004697" MajorTopicYN="N">Endocarditis, Bacterial</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015819" MajorTopicYN="N">Substance Abuse, Intravenous</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32346051</ArticleId><ArticleId IdType="pmc">PMC7188839</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-64220-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-64220-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Habib, G.et al.ESC Guidelines for the management of infective endocarditis. European heart journal36 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26590409</ArticleId></ArticleIdList></Reference><Reference><Citation>Baddour LM, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications. Circulation. 2015;132:1435&#x2013;1486. doi: 10.1161/CIR.0000000000000296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000296</ArticleId><ArticleId IdType="pubmed">26373316</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan SM. Right-sided infective endocarditis: Recent epidemiologic changes. Int. J. Clin. Exp. Med. 2014;7:199&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3902260</ArticleId><ArticleId IdType="pubmed">24482708</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmos C, et al. The Evolving Nature of Infective Endocarditis in Spain: A Population-Based Study (2003 to 2014) J. Am. Coll. Cardiol. 2017;70:2795&#x2013;2804. doi: 10.1016/j.jacc.2017.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.10.005</ArticleId><ArticleId IdType="pubmed">29191329</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill TJ, et al. Challenges in Infective Endocarditis. J. Am. Coll. Cardiol. 2017;69:325&#x2013;44. doi: 10.1016/j.jacc.2016.10.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.10.066</ArticleId><ArticleId IdType="pubmed">28104075</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenspon AJ, et al. 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States 1993 to 2008. J. Am. Coll. Cardiol. 2011;58:1001&#x2013;6. doi: 10.1016/j.jacc.2011.04.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.04.033</ArticleId><ArticleId IdType="pubmed">21867833</ArticleId></ArticleIdList></Reference><Reference><Citation>Diemberger I, et al. Predictors of long-term survival free from relapses after extraction of infected CIED. Europace. 2018;20:1018&#x2013;1027. doi: 10.1093/europace/eux121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eux121</ArticleId><ArticleId IdType="pubmed">29016771</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavi, V.et al.Comparison of Clinical Characteristics and Prognosis in Patients with Right- and Left-sided Infective Endocarditis. Rambam Maimonides Med. J.1&#x2013;8. 10.5041/RMMJ.10338 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363375</ArticleId><ArticleId IdType="pubmed">29993361</ArticleId></ArticleIdList></Reference><Reference><Citation>Revilla A, et al. Endocarditis derecha aislada en pacientes no adictos a drogas por v&#xed;a parenteral. Rev. Espa&#xf1;ola Cardiol. 2008;61:1253&#x2013;1259. doi: 10.1016/S0300-8932(08)75732-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-8932(08)75732-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi, M. Y., Nelson, S. B.&amp;Weiner, R. B.Clinical and Echocardiographic Factors Associated with In-Hospital Mortality in Patients with Infective Endocarditis Affecting the Native Tricuspid Valve. Am. J. Cardiol.1&#x2013;12. 10.1016/j.amjcard.2016.06.011 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27392511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz C, et al. Clinical classification and prognosis of isolated right-sided infective endocarditis. Medicine (Baltimore). 2014;93:1&#x2013;6. doi: 10.1097/MD.0000000000000137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000000137</ArticleId><ArticleId IdType="pmc">PMC4602814</ArticleId><ArticleId IdType="pubmed">25501052</ArticleId></ArticleIdList></Reference><Reference><Citation>Raut N, Potdar A, Sharma S. Tricuspid valve endocarditis in non-drug abusers: A case series from India. Indian Heart J. 2018;70:476&#x2013;481. doi: 10.1016/j.ihj.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ihj.2017.09.011</ArticleId><ArticleId IdType="pmc">PMC6116710</ArticleId><ArticleId IdType="pubmed">30170639</ArticleId></ArticleIdList></Reference><Reference><Citation>Georges H, et al. Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission. BMC Infect. Dis. 2018;18:1&#x2013;8. doi: 10.1186/s12879-018-2989-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-2989-9</ArticleId><ArticleId IdType="pmc">PMC5822595</ArticleId><ArticleId IdType="pubmed">29466956</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal, H., Rifaei, O., Rahman, M. A.&amp;El-sayed, H.Prevalence and characteristics of tricuspid valve endocarditis among patients presented to Ain Shams Hospital echocardiography lab; one year study. Egypt. Hear. J.8&#x2013;12. 10.1016/j.ehj.2017.12.009 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112338</ArticleId><ArticleId IdType="pubmed">30166883</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JS, et al. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis. Clin. Infect. Dis. 2000;30:633&#x2013;638. doi: 10.1086/313753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/313753</ArticleId><ArticleId IdType="pubmed">10770721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasier M, et al. VALIDATION OF THE MINI NUTRITIONAL ASSESSMENT SHORT-FORM (MNA &#xae; -SF): A PRACTICAL TOOL FOR IDENTIFICATION OF NUTRITIONAL STATUS. J. Nutr. Heal. Aging. 2009;13:782&#x2013;788. doi: 10.1007/s12603-009-0214-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-009-0214-7</ArticleId><ArticleId IdType="pubmed">19812868</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:332&#x2013;336. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603&#x2013;605. doi: 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza R, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur. Heart J. 2017;38:1509&#x2013;1516. doi: 10.1093/eurheartj/ehx032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx032</ArticleId><ArticleId IdType="pmc">PMC5429939</ArticleId><ArticleId IdType="pubmed">28329059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, et al. Clinical Features of Right-Sided Infective Endocarditis Occurring in Non-Drug Users. J Korean Med Sci. 2014;29:776&#x2013;781. doi: 10.3346/jkms.2014.29.6.776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2014.29.6.776</ArticleId><ArticleId IdType="pmc">PMC4055809</ArticleId><ArticleId IdType="pubmed">24932077</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrissoheris MP, et al. Endocarditis Complicating Central Venous Catheter Bloodstream Infections: A Unique Form of Health Care Associated Endocarditis. Clin. Cardiol. 2009;32:48&#x2013;54. doi: 10.1002/clc.20498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.20498</ArticleId><ArticleId IdType="pmc">PMC6652999</ArticleId><ArticleId IdType="pubmed">20014189</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner H, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC) Eur. Heart J. 2010;31:2915&#x2013;2957. doi: 10.1093/eurheartj/ehq249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq249</ArticleId><ArticleId IdType="pubmed">20801927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruotsalainen E, et al. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect. Dis. 2006;6:1&#x2013;10. doi: 10.1186/1471-2334-6-137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-6-137</ArticleId><ArticleId IdType="pmc">PMC1584240</ArticleId><ArticleId IdType="pubmed">16965625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsen, L. U. P.et al.Infective endocarditis in patients receiving chronic hemodialysis: A 21-year observational cohort study in Denmark. Am. Heart J. 10.1016/j.ahj.2016.08.012 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27914498</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, V. H.et al.The Association Between Surgical Indications, Operative Risk and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis. Circulation. 10.1161/CIRCULATIONAHA.114.012461 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25480814</ArticleId></ArticleIdList></Reference><Reference><Citation>Witten, J. C.et al.Surgical treatment of right-sided infective endocarditis. J. Thorac. Cardiovasc. Surg.1&#x2013;10. 10.1016/j.jtcvs.2018.07.112 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30503743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ris, T.et al.Inflammatory Biomarkers in Infective Endocarditis: Machine Learning to Predict Mortality. Clin Exp Immunol1&#x2013;13. 10.1111/cei.13266 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514443</ArticleId><ArticleId IdType="pubmed">30697694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanan, S.et al.Baseline C-reactive protein levels and prognosis in patients with infective endocarditis: A prospective cohort study. Indian Heart J.1&#x2013;7. 10.1016/j.ihj.2018.05.001 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309136</ArticleId><ArticleId IdType="pubmed">30595302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Martinez, A.et al.Prognostic factors of Infective Endocarditis in Patients on Hemodialysis: A Case Series from a National Multicenter Registry. Int. J. Cardiol.1&#x2013;46. 10.1016/j.ijcard.2017.04.086 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28487153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, et al. Surgical treatment of isolated right-sided infective endocarditis. Texas Hear. Inst. J. 2011;38:639&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3233320</ArticleId><ArticleId IdType="pubmed">22199423</ArticleId></ArticleIdList></Reference><Reference><Citation>George B, Voelkel A, Kotter J, Leventhal A, Gurley J. A Novel Approach to Percutaneous Removal of Large Tricuspid Valve Vegetations Using Suction Filtration and Veno-Venous Bypass: A Single Center Experience. Catheter. Cardiovasc. Interv. 2017;00:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28471095</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32558895</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1464-3502</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Alcohol and alcoholism (Oxford, Oxfordshire)</Title><ISOAbbreviation>Alcohol Alcohol</ISOAbbreviation></Journal><ArticleTitle>Mortality After Extrahepatic Gastrointestinal and Abdominal Wall Surgery in Patients With Alcoholic Liver Disease: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>497</StartPage><EndPage>511</EndPage><MedlinePgn>497-511</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/alcalc/agaa043</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This meta-analysis aimed to define the perioperative risk of mortality in patients with alcoholic liver disease (ALD) undergoing extrahepatic gastrointestinal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic searches of Embase, Medline and CENTRAL were undertaken to identify studies reporting about patients with ALD undergoing extrahepatic gastrointestinal surgery published since database inception to January 2019. Studies were only considered if they reported on mortality as an outcome. Pooled analysis of mortality was stratified as benign and malignant surgery and specific operative procedures where feasible.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 2899 studies identified, only five studies met inclusion criteria, representing cholecystectomy (one study), umbilical hernia repair surgery (one study) and oesophagectomy (three studies). The total number of patients with ALD in these studies was 172. Therefore, any study on liver disease patients undergoing extrahepatic surgery that crucially included a subset with alcohol aetiology was included as a secondary analysis even though they failed to stratify mortality by underlying aetiology. The total number of studies that met this expanded inclusion criteria was 62, reporting on 37,703 patients with liver disease of which 1735 (4.5%) had a definite diagnosis of ALD. Meta-analysis of proportions of in-hospital mortality in patients with ALD undergoing upper gastrointestinal cancer surgery (oesophagectomy) was 23% [95% confidence interval (CI) 14-35%, I2&#xa0;=&#xa0;0%]. In-hospital mortality following oesophagectomy in liver disease patients of all aetiologies was lower, 14% (95% CI 9-21%, I2&#xa0;=&#xa0;41.1%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Postoperative in-hospital mortality is high in patients with liver disease and ALD in particular. However, the currently available evidence on ALD is limited and precludes definitive conclusions on postoperative mortality risk.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Medical Council on Alcohol and Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adiamah</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nottingham Digestive Diseases Biomedical Research Centre, National Institute for Health Research (NIHR), Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ban</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nottingham Digestive Diseases Biomedical Research Centre, National Institute for Health Research (NIHR), Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Transplant Surgery, Freeman Hospital, Freeman Rd, High Heaton, Newcastle upon Tyne NE7 7DN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jepsen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Hepatology and Gastroenterology and Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark ,8200.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Joe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humes</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Nottingham Digestive Diseases Biomedical Research Centre, National Institute for Health Research (NIHR), Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, NG7 2UH, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Alcohol Alcohol</MedlineTA><NlmUniqueID>8310684</NlmUniqueID><ISSNLinking>0735-0414</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D034861" MajorTopicYN="N">Abdominal Wall</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002763" MajorTopicYN="N">Cholecystectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046449" MajorTopicYN="N">Hernia, Abdominal</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059685" MajorTopicYN="N">Herniorrhaphy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008108" MajorTopicYN="N">Liver Diseases, Alcoholic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32558895</ArticleId><ArticleId IdType="doi">10.1093/alcalc/agaa043</ArticleId><ArticleId IdType="pii">5859922</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18768040</PMID><DateCompleted><Year>2008</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2008</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.</ArticleTitle><Pagination><StartPage>812</StartPage><EndPage>819</EndPage><MedlinePgn>812-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1460-9592.2008.02678.x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Neonates undergoing open-heart surgery are especially at risk for massive bleeding and pronounced inflammation. The efficacy of aprotinin, a serine protease inhibitor, at ameliorating these adverse effects of cardiopulmonary bypass has not been clearly demonstrated in neonates.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Term neonates were enrolled and randomly assigned in a blinded fashion to receive saline (group P, placebo) or high-dose aprotinin (group A). Intraoperative management was standardized: surgeon, anesthesia, cardiopulmonary bypass and hemostasis therapy. Patients were admitted postoperatively to a pediatric cardiac intensive care unit. Primary outcome measure of efficacy was duration of the postoperative mechanical ventilation. Secondary outcome measures were total volume and units of blood products transfused intraoperatively and for 24 h after surgery, duration of chest tube in situ, and intensive care and hospital stays after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-six neonates were enrolled; 13 received aprotinin and 13 received placebo. The study was halted prematurely because of US Food and Drug Administration's concerns about aprotinin's safety. Baseline patient, surgery and cardiopulmonary bypass characteristics were similar between groups. No outcome variables differed between groups (P &gt; 0.05). Duration of postoperative ventilation was 115 +/- 139 h (group A); 126 +/- 82 h (group P); P = 0.29, and total blood product exposure was 8.2 +/- 2.6 U (group A); 8.8 +/- 1.4 U (group P); P = 0.1. Postoperative blood creatinine values did not differ between groups. In-hospital mortality rate was 4%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Aprotinin was not shown to be efficacious in neonates undergoing open-heart surgery. It is unclear whether adult aprotinin safety data are relevant to neonates undergoing open-heart surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Glyn D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Lucile Packard Children's Hospital, Stanford University, CA 94305, USA. jumbo@stanford.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramamoorthy</LastName><ForeName>Chandra</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Pentcheva</LastName><ForeName>Krassimira</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Boltz</LastName><ForeName>M Gail</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Kamra</LastName><ForeName>Komal</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>V Mohan</ForeName><Initials>VM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006490">Hemostatics</NameOfSubstance></Chemical><Chemical><RegistryNumber>9087-70-1</RegistryNumber><NameOfSubstance UI="D007611">Aprotinin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Paediatr Anaesth. 2008 Sep;18(9):809-11. doi: 10.1111/j.1460-9592.2008.02717.x.</RefSource><PMID Version="1">18768039</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007611" MajorTopicYN="N">Aprotinin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006490" MajorTopicYN="N">Hemostatics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>9</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>1</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>9</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18768040</ArticleId><ArticleId IdType="doi">10.1111/j.1460-9592.2008.02678.x</ArticleId><ArticleId IdType="pii">PAN2678</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18759153</PMID><DateCompleted><Year>2009</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2008</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1502-7708</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>12</Issue><PubDate><Year>2008</Year></PubDate></JournalIssue><Title>Scandinavian journal of gastroenterology</Title><ISOAbbreviation>Scand J Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>In-hospital mortality in non-variceal upper gastrointestinal bleeding Forrest 1 patients.</ArticleTitle><Pagination><StartPage>1432</StartPage><EndPage>1441</EndPage><MedlinePgn>1432-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/00365520802307989</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Non-variceal upper gastrointestinal bleeding (NVUGIB) is recognized world-wide as a common cause of emergency hospitalization, and it often represents a life-threatening event. The purpose of this prospective study was to assess in-hospital mortality in NVUGIB Forrest 1 patients admitted to the emergency unit owing to active bleeding.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We enrolled all patients consecutively admitted to the emergency unit for NVUGIB, acutely bleeding at endoscopy (spurting or oozing). Demographic characteristics, clinical and biochemical parameters, endoscopic findings and treatments were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of a total of 142 patients (98 M (69%), mean age+/-SD=66+/-14 years), spurting (16 (11.3%)) and oozing (126 (88.7%)) were identified. All patients received endoscopic treatment within 6 h of admission and were managed according to the guidelines. Seventeen (12%) patients suffered rebleeding, 4 patients (2.8%) required surgery to stop the bleeding, and 8 (5.6%) died during hospitalization (4 within 5 days and the remainder within 24 days of admission) - 3 as a consequence of bleeding (2.1%) and 5 of non-surgical complications (3.5%). Cox regression analysis showed that the lesions in more than one segment of the esophagogastroduodenal tract (p=0.008, hazard ratio (95% CI)=7.623 (1.680-34.600)) and the number of blood units transfused during the first 48 h of hospitalization (p=0.038, 2.075 (1.041-4.135)) were predictive of in-hospital death.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In Forrest 1 patients given rapid endoscopic treatment, in-hospital mortality seems to be related to the contemporaneous presence of bleeding and non-bleeding lesions in more than one segment of the esophagogastroduodenal tract and the number of blood units transfused during the first 48 h of hospitalization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manguso</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>A. Cardarelli Hospital, Gastroenterology Unit, Naples, Italy. manguso@alice.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riccio</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bennato</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Picascia</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Rossana</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>De Nucci</LastName><ForeName>Germana</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Fiorito</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Balzano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Scand J Gastroenterol</MedlineTA><NlmUniqueID>0060105</NlmUniqueID><ISSNLinking>0036-5521</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016099" MajorTopicYN="N">Endoscopy, Gastrointestinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>9</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>3</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>9</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18759153</ArticleId><ArticleId IdType="doi">10.1080/00365520802307989</ArticleId><ArticleId IdType="pii">902012215</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34125453</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Hypothermic circulatory arrest time affects neurological outcomes of frozen elephant trunk for acute type A aortic dissection: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3337</StartPage><EndPage>3351</EndPage><MedlinePgn>3337-3351</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.15700</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The treatment of complex thoracic aorta pathologies remains a challenge for cardiovascular surgeons. After introducing Frozen Elephant Trunk (FET), a significant evolution of surgical techniques has been achieved. The present meta-analysis aimed to assess the efficacy of FET in acute type A aortic dissection (ATAAD) and the effect of circulatory arrest time on post-operative neurologic outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A standard Preferred Reporting Items for Systematic Reviews and Meta-Analyses search was conducted for all observational studies of patients diagnosed with ATAAD undergoing total arch replacement with FET reporting in-hospital mortality, bleeding, and neurological outcomes. A random-effect meta-analysis was performed using STATA software (StataCorp, TX, USA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-five studies were eligible for the present meta-analysis, including 3211 patients with ATAAD who underwent total arch replacement with FET. The pooled estimate for in-hospital mortality, postoperative stroke, and spinal cord injury were 7% (95% CI 5 - 9; I<sup>2</sup> &#x2009;=&#x2009;68.65%), 5% (95% CI 4 - 7; I<sup>2</sup> &#x2009;=&#x2009;63.93%), and 3% (95% CI 2 - 4; I<sup>2</sup> &#x2009;=&#x2009;19.56%), respectively. Univariate meta-regression revealed that with increasing the duration of hypothermic circulatory arrest time, the effect sizes for postoperative stroke and SCI enhances.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">It seems that employing the FET procedure for acute type A dissection is associated with acceptable neurologic outcomes and a similar mortality rate comparing with other aorta pathologies. Besides, increasing hypothermic circulation arrest time appears to be a significant predictor of adverse neurologic outcomes after FET.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mousavizadeh</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1914-697X</Identifier><AffiliationInfo><Affiliation>Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daliri</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1405-7150</Identifier><AffiliationInfo><Affiliation>Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aljadayel</LastName><ForeName>Hadi Abo</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Idhrees</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5981-9705</Identifier><AffiliationInfo><Affiliation>Institute of Cardiac and Aortic Disorders (ICAD), SRM Institutes for Medical Science (SIMS Hospital), Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezaei</LastName><ForeName>Yousef</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6804-4232</Identifier><AffiliationInfo><Affiliation>Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2605-538X</Identifier><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, Royal Blackburn Teaching Hospital, Blackburn, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseini</LastName><ForeName>Saeid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001011" MajorTopicYN="N">Aorta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="Y">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute dissection</Keyword><Keyword MajorTopicYN="N">aorta</Keyword><Keyword MajorTopicYN="N">aortic arch</Keyword><Keyword MajorTopicYN="N">aortic dissection</Keyword><Keyword MajorTopicYN="N">frozen elephant trunk</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>14</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34125453</ArticleId><ArticleId IdType="doi">10.1111/jocs.15700</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Borst HG, Walterbusch G, Schaps D. Extensive aortic replacement using "elephant trunk" prosthesis. Thorac Cardiovasc Surg. 1983;31(1):37-40.</Citation></Reference><Reference><Citation>Kato M, Ohnishi K, Kaneko M, et al. New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation. 1996;94(9 Suppl):Ii188-93.</Citation></Reference><Reference><Citation>Karck M, Chavan A, Hagl C, Friedrich H, Galanski M. The frozen elephant trunk technique: a new treatment for thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2003;125(6):1550-1553.</Citation></Reference><Reference><Citation>Etz CD, Plestis KA, Kari FA, et al. Staged repair of thoracic and thoracoabdominal aortic aneurysms using the elephant trunk technique: a consecutive series of 215 first stage and 120 complete repairs. Eur J Cardiothorac Surg. 2008;34(3):605-615.</Citation></Reference><Reference><Citation>Jakob H, Tsagakis K, Pacini D, Di Bartolomeo R, Mestres C, Mohr F. The International E-vita Open Registry: data sets of 274 patients. J Cardiovasc Surg (Torino). 2011;52(5):717-723.</Citation></Reference><Reference><Citation>Flores J, Kunihara T, Shiiya N, Yoshimoto K, Matsuzaki K, Yasuda K. Extensive deployment of the stented elephant trunk is associated with an increased risk of spinal cord injury. J Thorac Cardiovasc Surg. 2006;131(2):336-342.</Citation></Reference><Reference><Citation>Preventza O, Liao JL, Olive JK, et al. Neurologic complications after the frozen elephant trunk procedure: A meta-analysis of more than 3000 patients. J Thorac Cardiovasc Surg. 2020;160(1):20-33.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-e34.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327(7414):557-560.</Citation></Reference><Reference><Citation>Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443-3457.</Citation></Reference><Reference><Citation>Akbulut M, Ak A, Arslan &#xd6;, et al. Early and mid-term results of frozen elephant trunk procedure for acute type A aortic dissection. Turkish Journal of Thoracic and Cardiovascular Surgery. 2019;27(2):135-142.</Citation></Reference><Reference><Citation>Berger T, Kreibich M, Morlock J, et al. True-lumen and false-lumen diameter changes in the downstream aorta after frozen elephant trunk implantation. Eur J Cardiothorac Surg. 2018;54(2):375-381.</Citation></Reference><Reference><Citation>Chen I, Chen P-L, Weng S-H, et al. Clinical outcomes of vasoRing connector in patients with acute Type A aortic. 2018.</Citation></Reference><Reference><Citation>Chen L-W, Lu L, Dai X-F, et al. Total arch repair with open triple-branched stent graft placement for acute type A aortic dissection: experience with 122 patients. J Thorac Cardiovasc Surg. 2014;148(2):521-528.</Citation></Reference><Reference><Citation>Chen Q, Cheng F, Chen T, Zhao F, Jiang N. Ascending aorta replacement combined with open placement of triple-branched stent graft and total arch replacement combined with stented elephant trunk implantation for treating type A aortic dissection. Int J Clin Exp Med. 2016;9(8):16070-16077.</Citation></Reference><Reference><Citation>Furutachi A, Takamatsu M, Nogami E, et al. Early and mid-term outcomes of total arch replacement with the frozen elephant trunk technique for type A acute aortic dissection. Interact Cardiovasc Thorac Surg. 2019;29(5):753-60.</Citation></Reference><Reference><Citation>Goebel N, Nagib R, Salehi-Gilani S, et al. One-stage hybrid aortic repair using the frozen elephant trunk in acute DeBakey type I aortic dissection. J Thorac Dis. 2018;10(7):4195-4203.</Citation></Reference><Reference><Citation>Gong M, Wu Z, Xu S, et al. Increased risk for the development of postoperative severe hypoxemia in obese women with acute type a aortic dissection. J Cardiothorac Surg. 2019;14(1):1-9.</Citation></Reference><Reference><Citation>Guan X, Gong M, Wang X, et al. Low preoperative fibrinogen level is risk factor for neurological complications in acute aortic dissection. Medicine. 2018;97(21):10830.</Citation></Reference><Reference><Citation>Guan XL, Wang XL, Liu YY, et al. Changes in the hemostatic system of patients with acute aortic dissection undergoing aortic arch surgery. Ann Thorac Surg. 2016;101(3):945-951.</Citation></Reference><Reference><Citation>He J, Peng J, Li W, et al. "Aorta-clamp" technique for surgical repair of acute type A aortic dissection-5 min circulatory arrest at 30&#xb0;C. J Thorac Dis. 2019;11(11):4717-4724.</Citation></Reference><Reference><Citation>Hoffman A, Damberg AL, Sch&#xe4;lte G, Mahnken AH, Raweh A, Autschbach R. Thoracic stent graft sizing for frozen elephant trunk repair in acute type A dissection. J Thorac Cardiovasc Surg. 2013;145(4):964-9.e1.</Citation></Reference><Reference><Citation>Hohri Y, Yamasaki T, Matsuzaki Y, Hiramatsu T. Early and mid-term outcome of frozen elephant trunk using spinal cord protective perfusion strategy for acute type A aortic dissection. Gen Thorac Cardiovasc Surg. 2020;68:1-9.</Citation></Reference><Reference><Citation>Jiang H, Liu Y, Yang Z, Ge Y, Li L, Wang H. Total arch replacement via single upper-hemisternotomy approach in patients with type A dissection. Ann Thorac Surg. 2020;109(5):1394-1399.</Citation></Reference><Reference><Citation>Katayama A, Uchida N, Katayama K, Arakawa M, Sueda T. The frozen elephant trunk technique for acute type A aortic dissection: results from 15 years of experience. Eur J Cardiothorac Surg. 2015;47(2):355-360.</Citation></Reference><Reference><Citation>Kobayashi M, Chaykovska L, van der Loo B, et al. Long-term results of simplified frozen elephant trunk technique in complicated acute type A aortic dissection: A case-control study. Vascular. 2016;24(5):523-530.</Citation></Reference><Reference><Citation>Leontyev S, Tsagakis K, Pacini D, et al. Impact of clinical factors and surgical techniques on early outcome of patients treated with frozen elephant trunk technique by using EVITA open stent-graft: results of a multicentre study. Eur J Cardiothorac Surg. 2016;49(2):660-666.</Citation></Reference><Reference><Citation>Leontyev S, Tsagakis K, Pacini D, et al. Impact of clinical factors and surgical techniques on early outcome of patients treated with frozen elephant trunk technique by using EVITA open stent-graft: results of a multicentre study. Oxford University Press; 2016.</Citation></Reference><Reference><Citation>Li J, Sun Y, Zhou T, et al. David reimplantation with simultaneous total arch replacement and stented elephant trunk for acute type A aortic dissection. J Thorac Cardiovasc Surg. 2019;161:2017-2026.</Citation></Reference><Reference><Citation>Ma M, Feng X, Wang J, et al. Acute Type I aortic dissection: a propensity-matched comparison of elephant trunk and arch debranching repairs. Interact Cardiovasc Thorac Surg. 2018;26(2):183-189.</Citation></Reference><Reference><Citation>Ma M, Liu L, Feng X, et al. Moderate hypothermic circulatory arrest with antegrade cerebral perfusion for rapid total arch replacement in acute type A aortic dissection. Thorac Cardiovasc Surg. 2016;64(02):124-132.</Citation></Reference><Reference><Citation>Ma W-G, Zheng J, Zhang W, et al. Frozen elephant trunk with total arch replacement for type A aortic dissections: does acuity affect operative mortality? J Thorac Cardiovasc Surg. 2014;148(3):963-972.</Citation></Reference><Reference><Citation>Roselli EE, Idrees JJ, Bakaeen FG, et al. Evolution of simplified frozen elephant trunk repair for acute DeBakey type I dissection: midterm outcomes. Ann Thorac Surg. 2018;105(3):749-755.</Citation></Reference><Reference><Citation>Shen K, Tang H, Jing R, Liu F, Zhou X. Application of triple-branched stent graft for Stanford type A aortic dissection: potential risks. Eur J Cardiothorac Surg. 2012;41(3):e12-e17.</Citation></Reference><Reference><Citation>Shi E, Gu T, Yu Y, et al. Simplified total arch repair with a stented graft for acute DeBakey type I dissection. J Thorac Cardiovasc Surg. 2014;148(5):2147-2154.</Citation></Reference><Reference><Citation>Shrestha M, Bachet J, Bavaria J, et al. Current status and recommendations for use of the frozen elephant trunk technique: a position paper by the Vascular Domain of EACTS. Eur J Cardiothorac Surg. 2015;47(5):759-769.</Citation></Reference><Reference><Citation>Sun L, Qi R, Zhu J, Liu Y, Zheng J. Total arch replacement combined with stented elephant trunk implantation: a new &#x201c;standard&#x201d; therapy for type A dissection involving repair of the aortic arch? Circulation. 2011;123(9):971-978.</Citation></Reference><Reference><Citation>Tan L, Xiao J, Zhou X, et al. Untreated distal intimal tears may be associated with paraplegia after total arch replacement and frozen elephant trunk treatment of acute Stanford type A aortic dissection. J Thorac Cardiovasc Surg. 2019;158(2):343-50.</Citation></Reference><Reference><Citation>Xiao Z, Meng W, Zhu D, Guo Y, Zhang E. Treatment strategies for left subclavian artery during total arch replacement combined with stented elephant trunk implantation. J Thorac Cardiovasc Surg. 2014;147(2):639-643.</Citation></Reference><Reference><Citation>Yamamoto H, Kadohama T, Yamaura G, et al. Total arch repair with frozen elephant trunk using the "zone 0 arch repair" strategy for type A acute aortic dissection. J Thorac Cardiovasc Surg. 2020;159(1):36-45.</Citation></Reference><Reference><Citation>Yang S-M, Xu P, Li C-X, et al. A modified total arch replacement combined with a stented elephant trunk implantation for acute type A dissection under deep hypothermic circulatory arrest and selective antegrade cerebral perfusion. J Cardiothorac Surg. 2014;9(1):1-6.</Citation></Reference><Reference><Citation>Yoshitake A, Tochii M, Tokunaga C, et al. Early and long-term results of total arch replacement with the frozen elephant trunk technique for acute type A aortic dissection. Eur J Cardiothorac Surg. 2020;58(4):707-713.</Citation></Reference><Reference><Citation>Yu B, Liu Z, Xue C, et al. Total arch repair with open placement of a novel double-branched stent graft for acute Type A aortic dissection: a single-centre experience with 21 consecutive patients. Interact Cardiovasc Thorac Surg. 2019;28(2):262-269.</Citation></Reference><Reference><Citation>Zhang H, Lang X, Lu F, et al. Acute type A dissection without intimal tear in arch: proximal or extensive repair? J Thorac Cardiovasc Surg. 2014;147(4):1251-1255.</Citation></Reference><Reference><Citation>Moulakakis KG, Mylonas SN, Markatis F, Kotsis T, Kakisis J, Liapis CD. A systematic review and meta-analysis of hybrid aortic arch replacement. Ann Cardiothorac Surg. 2013;2(3):247-260.</Citation></Reference><Reference><Citation>Rezaei Y, Bashir M, Mousavizadeh M, et al. Frozen elephant trunk in total arch replacement: A systematic review and meta-analysis of outcomes and aortic proximalization. J Card Surg. 2021;36:1922-1934.</Citation></Reference><Reference><Citation>Hanif H, Dubois L, Ouzounian M, et al. Aortic arch reconstructive surgery with conventional techniques vs frozen elephant trunk: a systematic review and meta-analysis. Can J Cardiol. 2018;34(3):262-273.</Citation></Reference><Reference><Citation>Tian DH, Wan B, Di Eusanio M, Black D, Yan TD. A systematic review and meta-analysis on the safety and efficacy of the frozen elephant trunk technique in aortic arch surgery. Ann Cardiothorac Surg. 2013;2(5):581-591.</Citation></Reference><Reference><Citation>Czerny M, Schmidli J, Adler S, et al. Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic surgery (EACTS) and the European Society for Vascular Surgery (ESVS). Eur J Cardiothorac Surg. 2019;55(1):133-162.</Citation></Reference><Reference><Citation>Hagl C, Ergin MA, Galla JD, et al. Neurologic outcome after ascending aorta-aortic arch operations: effect of brain protection technique in high-risk patients. J Thorac Cardiovasc Surg. 2001;121(6):1107-1121.</Citation></Reference><Reference><Citation>Miyairi T, Kotsuka Y, Ezure M, et al. Open stent-grafting for aortic arch aneurysm is associated with increased risk of paraplegia. Ann Thorac Surg. 2002;74(1):83-89.</Citation></Reference><Reference><Citation>Mizuno T, Toyama M, Tabuchi N, Wu H, Sunamori M. Stented elephant trunk procedure combined with ascending aorta and arch replacement for acute type A aortic dissection. Eur J Cardiothorac Surg. 2002;22(4):504-509.</Citation></Reference><Reference><Citation>Etz CD, Kari FA, Mueller CS, Brenner RM, Lin H-M, Griepp RB. The collateral network concept: remodeling of the arterial collateral network after experimental segmental artery sacrifice. J Thorac Cardiovasc Surg. 2011;141(4):1029-1036.</Citation></Reference><Reference><Citation>De Paulis R, Czerny M, Weltert L, et al. Current trends in cannulation and neuroprotection during surgery of the aortic arch in Europe. Eur J Cardiothorac Surg. 2015;47(5):917-923.</Citation></Reference><Reference><Citation>Ius F, Fleissner F, Pichlmaier M, et al. Total aortic arch replacement with the frozen elephant trunk technique: 10-year follow-up single-centre experience&#x2020;. Eur J Cardiothorac Surg. 2013;44(5):949-957.</Citation></Reference><Reference><Citation>Su&#xe1;rez FEF, Del Valle DF, Alvarez AG, P&#xe9;rez-Lozano B. Intraoperative care for aortic surgery using circulatory arrest. J Thorac Dis. 2017;9(Suppl 6):S508-S520.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30806696</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>321</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Association of Overlapping Surgery With Perioperative Outcomes.</ArticleTitle><Pagination><StartPage>762</StartPage><EndPage>772</EndPage><MedlinePgn>762-772</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2019.0711</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Overlapping surgery, in which more than 1 procedure performed by the same primary surgeon is scheduled so the start time of one procedure overlaps with the end time of another, is of concern because of potential adverse outcomes.</AbstractText><AbstractText Label="OBJECTIVE">To determine the association between overlapping surgery and mortality, complications, and length of surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Retrospective cohort study of 66&#x202f;430 operations in patients aged 18 to 90 years undergoing total knee or hip arthroplasty; spine surgery; coronary artery bypass graft (CABG) surgery; and craniotomy at 8 centers between January 1, 2010, and May 31, 2018. Patients were followed up until discharge.</AbstractText><AbstractText Label="EXPOSURES">Overlapping surgery (&#x2265;2 operations performed by the same surgeon in which &#x2265;1 hour of 1 case, or the entire case for those &lt;1 hour, occurs when another procedure is being performed).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Primary outcomes were in-hospital mortality or complications (major: thromboembolic event, pneumonia, sepsis, stroke, or myocardial infarction; minor: urinary tract or surgical site infection) and surgery duration.</AbstractText><AbstractText Label="RESULTS">The final sample consisted of 66&#x202f;430 operations (mean patient age, 59 [SD, 15] years; 31&#x202f;915 women [48%]), of which 8224 (12%) were overlapping. After adjusting for confounders, overlapping surgery was not associated with a significant difference in in-hospital mortality (1.9% overlapping vs 1.6% nonoverlapping; difference, 0.3% [95% CI, -0.2% to 0.7%]; P&#x2009;=&#x2009;.21) or risk of complications (12.8% overlapping vs 11.8% nonoverlapping; difference, 0.9% [95% CI, -0.1% to 1.9%]; P&#x2009;=&#x2009;.08). Overlapping surgery was associated with increased surgery length (204 vs 173 minutes; difference, 30 minutes [95% CI, 24 to 37 minutes]; P&#x2009;&lt;&#x2009;.001). Overlapping surgery was significantly associated with increased mortality and increased complications among patients having a high preoperative predicted risk for mortality and complications, compared with low-risk patients (mortality: 5.8% vs 4.7%; difference, 1.2% [95% CI, 0.1% to 2.2%]; P&#x2009;=&#x2009;.03; complications: 29.2% vs 27.0%; difference, 2.3% [95% CI, 0.3% to 4.3%]; P&#x2009;=&#x2009;.03).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adults undergoing common operations, overlapping surgery was not significantly associated with differences in in-hospital mortality or postoperative complication rates but was significantly associated with increased surgery length. Further research is needed to understand the association of overlapping surgery with these outcomes among specific patient subgroups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mello</LastName><ForeName>Michelle M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Law School, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rishel</LastName><ForeName>Chris A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaughn</LastName><ForeName>Michelle T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan School of Medicine, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan School of Medicine, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saager</LastName><ForeName>Leif</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan School of Medicine, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damrose</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadry</LastName><ForeName>Bassam</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jena</LastName><ForeName>Anupam B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital, Boston.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Bureau of Economic Research, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Multicenter Perioperative Outcomes Group (MPOG)</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP5 OD017897</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 DA042314</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Feb 26;321(8):772. doi: 10.1001/jama.2019.1123.</RefSource><PMID Version="1">30806675</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2019 Aug;202(2):200. doi: 10.1097/JU.0000000000000322.</RefSource><PMID Version="1">31063071</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Jul 16;322(3):274. doi: 10.1001/jama.2019.6459.</RefSource><PMID Version="1">31310291</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Jul 16;322(3):274-275. doi: 10.1001/jama.2019.6463.</RefSource><PMID Version="1">31310292</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="N">Craniotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="Y">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Sun reported receiving consulting fees unrelated to this work from Egalet Inc and the Mission Lisa Foundation and receiving grants from the National Institute on Drug Abuse. Dr Jena reported receiving personal fees from Pfizer, Hill Rom Services, Bristol-Myers Squibb, Novartis, Amgen, Eli Lilly, Vertex Pharmaceuticals, AstraZeneca, Tesaro, Sanofi Aventis, Biogen, Precision Health Economics, and Analysis Group, outside the submitted work. No other authors reported disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30806696</ArticleId><ArticleId IdType="pmc">PMC6439866</ArticleId><ArticleId IdType="doi">10.1001/jama.2019.0711</ArticleId><ArticleId IdType="pii">2725689</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mello MM, Livingston EH. The evolving story of overlapping surgery. JAMA. 2017;318(3):233-234. doi:10.1001/jama.2017.8061</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.8061</ArticleId><ArticleId IdType="pubmed">28658474</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons (ACS)  Statements on Principles. ACS website. https://www.facs.org/about-acs/statements/stonprin. Revised April 12, 2016. Accessed December 28, 2018.</Citation></Reference><Reference><Citation>Zhang AL. Overlapping surgery&#x2014;perspectives from the other side of the table. JAMA Intern Med. 2018;178(1):83-84. doi:10.1001/jamainternmed.2017.6846</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2017.6846</ArticleId><ArticleId IdType="pubmed">29204596</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello MM, Livingston EH. Managing the risks of concurrent surgeries. JAMA. 2016;315(15):1563-1564. doi:10.1001/jama.2016.2305</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.2305</ArticleId><ArticleId IdType="pubmed">26985632</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelson J, Saltzman J, Kowalczyk L, Allen S Clash in the name of care. Boston Globe October 25, 2015. 
https://apps.bostonglobe.com/spotlight/clash-in-the-name-of-care/story/. Accessed January 28, 2019.</Citation></Reference><Reference><Citation>Sweeny L, Rosenthal EL, Light T, et al. . Effect of overlapping operations on outcomes in microvascular reconstructions of the head and neck. Otolaryngol Head Neck Surg. 2017;156(4):627-635. doi:10.1177/0194599817691746</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599817691746</ArticleId><ArticleId IdType="pubmed">28322117</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan J, Brock AA, Karsy M, et al. . Managing overlapping surgery: an analysis of 1018 neurosurgical and spine cases. J Neurosurg. 2017;127(5):1096-1104. doi:10.3171/2016.8.JNS161226</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.8.JNS161226</ArticleId><ArticleId IdType="pubmed">27911238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyder JA, Habermann EB, Cima RR. Length of stay after overlapping surgery. JAMA. 2017;318(21):2140. doi:10.1001/jama.2017.16607</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.16607</ArticleId><ArticleId IdType="pubmed">29209713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zygourakis CC, Keefe M, Lee J, et al. . Comparison of patient outcomes in 3725 overlapping vs 3633 nonoverlapping neurosurgical procedures using a single institution&#x2019;s clinical and administrative database. Neurosurgery. 2017;80(2):257-268. doi:10.1093/neuros/nyw067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyw067</ArticleId><ArticleId IdType="pubmed">28173545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zygourakis CC, Lee J, Barba J, Lobo E, Lawton MT. Performing concurrent operations in academic vascular neurosurgery does not affect patient outcomes. J Neurosurg. 2017;127(5):1089-1095. doi:10.3171/2016.6.JNS16822</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.6.JNS16822</ArticleId><ArticleId IdType="pubmed">28106498</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JB, Ban KA, Berian JR, et al. . Concurrent bariatric operations and association with perioperative outcomes: registry based cohort study. BMJ. 2017;358:j4244. doi:10.1136/bmj.j4244</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j4244</ArticleId><ArticleId IdType="pmc">PMC5613750</ArticleId><ArticleId IdType="pubmed">28951446</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JB, Berian JR, Ban KA, et al. . Outcomes of concurrent operations: results from the American College of Surgeons&#x2019; National Surgical Quality Improvement Program. Ann Surg. 2017;266(3):411-420. doi:10.1097/SLA.0000000000002358</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002358</ArticleId><ArticleId IdType="pubmed">28650359</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard BM, Holland CM, Mehta CC, et al. . Association of overlapping surgery with patient outcomes in a large series of neurosurgical cases. JAMA Surg. 2018;153(4):313-321. doi:10.1001/jamasurg.2017.4502</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2017.4502</ArticleId><ArticleId IdType="pmc">PMC5933391</ArticleId><ArticleId IdType="pubmed">29117312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi B, Pincus D, Wasserstein D, et al. . Association of overlapping surgery with increased risk for complications following hip surgery: a population-based, matched cohort study. JAMA Intern Med. 2018;178(1):75-83. doi:10.1001/jamainternmed.2017.6835</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2017.6835</ArticleId><ArticleId IdType="pmc">PMC5833499</ArticleId><ArticleId IdType="pubmed">29204597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl MA, Mooney MA, Sheehy JP, et al. . Overlapping surgeries are not associated with worse patient outcomes: retrospective multivariate analysis of 14&#x2009;872 neurosurgical cases performed at a single institution. Neurosurgery. 2018;83(1):53-59. doi:10.1093/neuros/nyx472</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyx472</ArticleId><ArticleId IdType="pubmed">29029182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LO, Bateman BT, Kheterpal S, et al. ; Multicenter Perioperative Outcomes Group Investigators . Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients: a report from the Multicenter Perioperative Outcomes Group. Anesthesiology. 2017;126(6):1053-1063. doi:10.1097/ALN.0000000000001630</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001630</ArticleId><ArticleId IdType="pmc">PMC5445642</ArticleId><ArticleId IdType="pubmed">28383323</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaff JC, Pasma W, van Buuren S, et al. . Reference values for noninvasive blood pressure in children during anesthesia: a multicentered retrospective observational cohort study. Anesthesiology. 2016;125(5):904-913. doi:10.1097/ALN.0000000000001310</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001310</ArticleId><ArticleId IdType="pmc">PMC5259808</ArticleId><ArticleId IdType="pubmed">27606930</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman MF, Iyer N, Freudzon L, et al. ; Multicenter Perioperative Outcomes Group (MPOG) Perioperative Clinical Research Committee . Alarm limits for intraoperative drug infusions: a report from the Multicenter Perioperative Outcomes Group. Anesth Analg. 2017;125(4):1203-1211. doi:10.1213/ANE.0000000000002305</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002305</ArticleId><ArticleId IdType="pubmed">28759483</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz MF, Brambrink AM, Healy DW, et al. . Success of intubation rescue techniques after failed direct laryngoscopy in adults: a retrospective comparative analysis from the Multicenter Perioperative Outcomes Group. Anesthesiology. 2016;125(4):656-666. doi:10.1097/ALN.0000000000001267</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001267</ArticleId><ArticleId IdType="pubmed">27483124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman BT, Mhyre JM, Ehrenfeld J, et al. . The risk and outcomes of epidural hematomas after perioperative and obstetric epidural catheterization: a report from the Multicenter Perioperative Outcomes Group research consortium. Anesth Analg. 2013;116(6):1380-1385. doi:10.1213/ANE.0b013e318251daed</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e318251daed</ArticleId><ArticleId IdType="pubmed">22504213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Healy D, Aziz MF, et al. ; Multicenter Perioperative Outcomes Group (MPOG) Perioperative Clinical Research Committee . Incidence, predictors, and outcome of difficult mask ventilation combined with difficult laryngoscopy: a report from the multicenter perioperative outcomes group. Anesthesiology. 2013;119(6):1360-1369. doi:10.1097/ALN.0000435832.39353.20</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000435832.39353.20</ArticleId><ArticleId IdType="pubmed">24071617</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender SP, Paganelli WC, Gerety LP, et al. . Intraoperative lung-protective ventilation trends and practice patterns: a report from the Multicenter Perioperative Outcomes Group. Anesth Analg. 2015;121(5):1231-1239. doi:10.1213/ANE.0000000000000940</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000940</ArticleId><ArticleId IdType="pubmed">26332856</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson EH, Louie R, Zingmond DS, et al. . A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg. 2012;256(6):973-981. doi:10.1097/SLA.0b013e31826b4c4f</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31826b4c4f</ArticleId><ArticleId IdType="pubmed">23095667</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HH, Tejwani R, Zhang H, Wiener JS, Routh JC. Hospital surgical volume and associated postoperative complications of pediatric urological surgery in the United States. J Urol. 2015;194(2):506-511. doi:10.1016/j.juro.2015.01.096</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2015.01.096</ArticleId><ArticleId IdType="pmc">PMC4509970</ArticleId><ArticleId IdType="pubmed">25640646</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokkema M, Hurks R, Curran T, et al. . The impact of the present on admission indicator on the accuracy of administrative data for carotid endarterectomy and stenting. J Vasc Surg. 2014;59(1):32-38. doi:10.1016/j.jvs.2013.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2013.07.006</ArticleId><ArticleId IdType="pmc">PMC3874266</ArticleId><ArticleId IdType="pubmed">23993438</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, et al. . Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. doi:10.1097/01.mlr.0000182534.19832.83</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press; 2010.</Citation></Reference><Reference><Citation>Angrist JD, Pischke J-S. Most Harmless Econometrics: An Empiricist&#x2019;s Companion. Princeton, NJ: Princeton University Press; 2009.</Citation></Reference><Reference><Citation>Tsugawa Y, Jena AB, Figueroa JF, Orav EJ, Blumenthal DM, Jha AK. Comparison of hospital mortality and readmission rates for medicare patients treated by male vs female physicians. JAMA Intern Med. 2017;177(2):206-213. doi:10.1001/jamainternmed.2016.7875</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2016.7875</ArticleId><ArticleId IdType="pmc">PMC5558155</ArticleId><ArticleId IdType="pubmed">27992617</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison PD. SAS Global Forum paper 360-2008: convergence failures in logistic regression. Semantic Scholar website. https://pdfs.semanticscholar.org/4f17/1322108dff719da6aa0d354d5f73c9c474de.pdf. 2008. Accessed January 28, 2019.</Citation></Reference><Reference><Citation>Greene W. The behaviour of the maximum likelihood estimator of limited dependent variable models in the presence of fixed effects. Econom J. 2004;7(1):98-119. doi:10.1111/j.1368-423X.2004.00123.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1368-423X.2004.00123.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun EC, Dutton RP, Jena AB. Comparison of anesthesia times and billing patterns by anesthesia practitioners. JAMA Netw Open. 2018;1(7):e184288. doi:10.1001/jamanetworkopen.2018.4288</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.4288</ArticleId><ArticleId IdType="pmc">PMC6324364</ArticleId><ArticleId IdType="pubmed">30646351</ArticleId></ArticleIdList></Reference><Reference><Citation>Childers CP, Maggard-Gibbons M. Understanding costs of care in the operating room. JAMA Surg. 2018;153(4):e176233. doi:10.1001/jamasurg.2017.6233</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2017.6233</ArticleId><ArticleId IdType="pmc">PMC5875376</ArticleId><ArticleId IdType="pubmed">29490366</ArticleId></ArticleIdList></Reference><Reference><Citation>Macario A. What does one minute of operating room time cost? J Clin Anesth. 2010;22(4):233-236. doi:10.1016/j.jclinane.2010.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2010.02.003</ArticleId><ArticleId IdType="pubmed">20522350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data: is it valid? Med Care. 2000;38(8):785-795. doi:10.1097/00005650-200008000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-200008000-00003</ArticleId><ArticleId IdType="pubmed">10929991</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27101493</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Does Obstructive Sleep Apnea Influence Perioperative Outcome? A Qualitative Systematic Review for the Society of Anesthesia and Sleep Medicine Task Force on Preoperative Preparation of Patients with Sleep-Disordered Breathing.</ArticleTitle><Pagination><StartPage>1321</StartPage><EndPage>1334</EndPage><MedlinePgn>1321-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000001178</ELocationID><Abstract><AbstractText>Obstructive sleep apnea (OSA) is a commonly encountered problem in the perioperative setting even though many patients remain undiagnosed at the time of surgery. The objective of this systematic review was to evaluate whether the diagnosis of OSA has an impact on postoperative outcomes. We performed a systematic review of studies published in PubMed-MEDLINE, MEDLINE In-Process, and other nonindexed citations, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Health Technology Assessment up to November 2014. Studies of adult patients with a diagnosis of OSA or high risk thereof, published in the English language, undergoing surgery or procedures under anesthesia care, and reporting &#x2265;1 postoperative outcome were included. Overall, the included studies reported on 413,304 OSA and 8,556,279 control patients. The majority reported worse outcomes for a number of events, including pulmonary and combined complications, among patients with OSA versus the reference group. The association between OSA and in-hospital mortality varied among studies; 9 studies showed no impact of OSA on mortality, 3 studies suggested a decrease in mortality, and 1 study reported increased mortality. In summary, the majority of studies suggest that the presence of OSA is associated with an increased risk of postoperative complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Opperer</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the *Department of Anesthesiology, Hospital for Special Surgery, New York, New York; &#x2020;Department of Anesthesiology, Paracelsus Medical University, Salzburg, Austria; &#x2021;Department of Surgical Sciences, University of Parma, Parma, Italy; &#xa7;Department of Medicine, Section of Pulmonary and Critical Care, University of Chicago, Chicago, Illinois; &#x2016;Departments of Hospital Medicine and Anesthesia Outcomes Research, Cleveland Clinic, Cleveland, Ohio; &#xb6;Division of Pulmonary, Critical Care, and Sleep Medicine, Metro Health Medical Center, Case Western Reserve Hospital, Cleveland, Ohio; and #Department of Anesthesiology, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozowicz</LastName><ForeName>Crispiana</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bugada</LastName><ForeName>Dario</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Mokhlesi</LastName><ForeName>Babak</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Kaw</LastName><ForeName>Roop</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Auckley</LastName><ForeName>Dennis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Frances</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Memtsoudis</LastName><ForeName>Stavros G</ForeName><Initials>SG</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01HL119161</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012891" MajorTopicYN="N">Sleep Apnea Syndromes</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27101493</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000001178</ArticleId><ArticleId IdType="pii">00000539-201605000-00018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35450991</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1760-4788</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>The journal of nutrition, health &amp; aging</Title><ISOAbbreviation>J Nutr Health Aging</ISOAbbreviation></Journal><ArticleTitle>Association between Preoperative hs-crp/Albumin Ratio and Postoperative sirs in Elderly Patients: A Retrospective Observational Cohort Study.</ArticleTitle><Pagination><StartPage>352</StartPage><EndPage>359</EndPage><MedlinePgn>352-359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12603-022-1761-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Systemic inflammatory response syndrome (SIRS) is one of the severe postoperative complications in elderly patients and seriously affects their prognosis and survival rate. Heretofore, there have been no reliable and accurate methods to predict postoperative SIRS in elderly patients. The aim of this study was to determine whether increased preoperative hs-CRP/albumin ratio (CAR) was associated with postoperative SIRS in elderly population.</AbstractText><AbstractText Label="METHODS">The data of patients aged &#x2265; 65 years who underwent general anesthesia in two centers of Third Affiliated Hospital of Sun Yat-sen University between January 2015 and September 2020 were retrieved and analyzed. Based on the perioperative dataset, we used the targeted maximum likelihood estimation (TMLE) to estimate the association between preoperative CAR and postoperative SIRS in elderly population. Patients' CAR was calculated and divided into two groups (&lt; 0.278 and &#x2265; 0.278) according to its normal range in our hospital. Adjusted odd ratios (aORs) and 95% confidence intervals (CIs) were calculated respectively. Further sensitivity analyses were conducted to evaluate the robustness of the results.</AbstractText><AbstractText Label="RESULTS">A total of 16141 elderly patients were accessed and 7009 of them were enrolled in the final analysis, and 1674 (23.9%) patients developed SIRS within 3 days after surgery. Compared with non-SIRS patients, patients with SIRS had a significantly longer postoperative hospitalization, higher cost and higher risk of in-hospital mortality. Compared with patients with preoperative CAR &lt; 0.278, we found that CAR &#x2265; 0.278 had a significantly higher risk for the development of postoperative SIRS after multivariable adjustment [aOR = 1.27; 95% CI (1.21, 1.33)]. The interaction effect of preoperative CAR &#x2265; 0.278 and SIRS was stronger among patients with the following characteristics: aged &#x2265; 75 years, male, comorbid with diabetes mellitus and admitted to ICU after surgery, duration of surgery &lt; 120 minutes, underwent cerebral surgery or skin, spine and joint surgery (all P &lt; 0.001). The above results remained robust in the sensitivity analysis.</AbstractText><AbstractText Label="CONCLUSIONS">Preoperative CAR &#x2265; 0.278 was significantly associated with increased risk of postoperative SIRS in elderly patients. Special attention should be paid to elderly patients with a preoperative CAR &#x2265; 0.278 so as to reduce the incidence of postoperative SIRS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Shaoli Zhou, M.D., Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou, Guangdong Province, 510630, China, Email: 13610272308@139.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>X</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hei</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Q</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Nutr Health Aging</MedlineTA><NlmUniqueID>100893366</NlmUniqueID><ISSNLinking>1279-7707</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="N">Albumins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="Y">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="Y">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAR</Keyword><Keyword MajorTopicYN="N">SIRS</Keyword><Keyword MajorTopicYN="N">elderly patients</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">hs-CRP/albumin ratio</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35450991</ArticleId><ArticleId IdType="doi">10.1007/s12603-022-1761-4</ArticleId><ArticleId IdType="pii">S1279-7707(23)00883-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>